Citrus Sinensis ID: 046065

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160----
Protein Sequence
GVLPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKKFSL
Secondary Structure (PSIPRED)
cccccccEEEEEEccccccccHHHHHHHHHHHHHccccccccccccccccEEEEEEEEcccccccEEEEcccccccccHHHHHHHHHHHHHHHHHHcccccccEEEccccccccccccccccccccccHHHHcccccccEEEEEccccccHHcccccccccccc
Secondary Structure Prediction (SSPRO)
cccccccEEEEEEEcccccccHHHHHHHHHHHHHHHHHHHHHccEEEccccEEEEEEEcccccHHHHHccccccccccHHHHHHHHHHHHHHHHHHHHHHHcccccccccHHHEEEcccccEEEcccccccEccccccEEEEEccccccHHHHHcccccccccc
Coil and Loop (DISEMBL)
GVLPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYmpkrsldyflfdpIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVsnilldedlkpkisdFGLARILRKMILKQIQIElgyippeyvgrgvyykkfsl
Flexible Loop (DISEMBL)
gvlpdgqiiavkklskkstqgfEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSnilldedlkpkISDFGLARILRKMILKQIQIelgyippeyvgrGVYYKKFSL
Low Complexity Region (SEG)
GVLPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKKFSL
Disordered region (IsUnstruct)
*********************FEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKK***
Disordered Region (DISOPRED)
G*LPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKKFSL
Disordered Region (DISEMBL)
GVLPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKKFSL
Disordered Region (DISPRO)
****DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRG********
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
GVLPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKKFSL
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	164	2.2.26 [Sep-21-2011]
Q9LW83	850	G-type lectin S-receptor-	yes	no	0.981	0.189	0.572	5e-50
Q9SXB8	842	G-type lectin S-receptor-	no	no	1.0	0.194	0.569	2e-48
O64793	818	G-type lectin S-receptor-	no	no	0.981	0.196	0.566	5e-47
O65472	690	Putative cysteine-rich re	no	no	0.981	0.233	0.554	8e-46
O65476	662	Putative cysteine-rich re	no	no	0.981	0.243	0.548	8e-46
Q8H199	658	Cysteine-rich receptor-li	no	no	0.957	0.238	0.552	4e-45
Q9LDQ3	669	Putative cysteine-rich re	no	no	0.981	0.240	0.542	4e-45
O81906	849	G-type lectin S-receptor-	no	no	0.981	0.189	0.548	4e-45
Q9LDM5	666	Putative cysteine-rich re	no	no	0.963	0.237	0.538	8e-45
Q8GYA4	669	Cysteine-rich receptor-li	no	no	0.981	0.240	0.548	1e-44

>sp|Q9LW83|CE101_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase CES101 OS=Arabidopsis thaliana GN=CES101 PE=2 SV=2

 Score =  196 bits (498), Expect = 5e-50,   Method: Composition-based stats.
 Identities = 95/166 (57%), Positives = 119/166 (71%), Gaps = 5/166 (3%)

Query: 1   GVLPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYM 59
           G L DG+ +A+K+LS  S QG  EFKNE ML AKLQH NL+++ G C+E  E MLIYEYM
Sbjct: 544 GRLIDGEEVAIKRLSLASGQGLVEFKNEAMLIAKLQHTNLVKLLGCCVEKDEKMLIYEYM 603

Query: 60  PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
           P +SLDYFLFDP+R ++LD K R  I++GIIQGLLYL +Y RL +IHRD+K  NILLDED
Sbjct: 604 PNKSLDYFLFDPLRKIVLDWKLRFRIMEGIIQGLLYLHKYSRLKVIHRDIKAGNILLDED 663

Query: 120 LKPKISDFGLARIL----RKMILKQIQIELGYIPPEYVGRGVYYKK 161
           + PKISDFG+ARI      K   K++    GY+ PEY   G++  K
Sbjct: 664 MNPKISDFGMARIFGAQESKANTKRVAGTFGYMSPEYFREGLFSAK 709

Promotes the expression of genes involved in photosynthesis at least in dedifferentiated calli.
Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|Q9SXB8|Y1133_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330 OS=Arabidopsis thaliana GN=At1g11330 PE=1 SV=3

 Score =  191 bits (485), Expect = 2e-48,   Method: Composition-based stats.
 Identities = 98/172 (56%), Positives = 125/172 (72%), Gaps = 8/172 (4%)

Query: 1   GVLPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYM 59
           G LP+GQ IAVK+LS+KS QG EE  NEV++ +KLQH NL+++ G CIE +E ML+YEYM
Sbjct: 541 GKLPEGQEIAVKRLSRKSGQGLEELMNEVVVISKLQHRNLVKLLGCCIEGEERMLVYEYM 600

Query: 60  PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
           PK+SLD +LFDP++  ILD K R +I++GI +GLLYL    RL IIHRDLK SNILLDE+
Sbjct: 601 PKKSLDAYLFDPMKQKILDWKTRFNIMEGICRGLLYLHRDSRLKIIHRDLKASNILLDEN 660

Query: 120 LKPKISDFGLARILR----KMILKQIQIELGYIPPEYVGRGVYYKK---FSL 164
           L PKISDFGLARI R    +   +++    GY+ PEY   G + +K   FSL
Sbjct: 661 LNPKISDFGLARIFRANEDEANTRRVVGTYGYMSPEYAMEGFFSEKSDVFSL 712

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O64793|Y1675_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g67520 OS=Arabidopsis thaliana GN=At1g67520 PE=2 SV=3

 Score =  186 bits (473), Expect = 5e-47,   Method: Composition-based stats.
 Identities = 94/166 (56%), Positives = 117/166 (70%), Gaps = 5/166 (3%)

Query: 1   GVLPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYM 59
           G L +G+ +A+K+LS  S QG  EFKNE +L AKLQH NL++V G CIE  E MLIYEYM
Sbjct: 513 GKLLNGEEVAIKRLSLASGQGLVEFKNEAILIAKLQHTNLVQVLGCCIEKDEKMLIYEYM 572

Query: 60  PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
             +SLDYFLFDP+R  +LD   R  I++GIIQGLLYL +Y RL +IHRD+K SNILLDED
Sbjct: 573 QNKSLDYFLFDPLRKNVLDWTLRFRIMEGIIQGLLYLHKYSRLKVIHRDIKASNILLDED 632

Query: 120 LKPKISDFGLARIL----RKMILKQIQIELGYIPPEYVGRGVYYKK 161
           + PKISDFGLARI      +   K++    GY+ PEY   G++  K
Sbjct: 633 MNPKISDFGLARIFGAEETRANTKRVAGTFGYMSPEYFREGLFSAK 678

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O65472|CRK12_ARATH Putative cysteine-rich receptor-like protein kinase 12 OS=Arabidopsis thaliana GN=CRK12 PE=3 SV=2

 Score =  182 bits (462), Expect = 8e-46,   Method: Composition-based stats.
 Identities = 92/166 (55%), Positives = 122/166 (73%), Gaps = 5/166 (3%)

Query: 1   GVLPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYM 59
           G L +G  +AVK+LSK S QG +EFKNEV+L AKLQH NL+++ G+C+E +E +L+YE++
Sbjct: 384 GTLVNGTEVAVKRLSKTSEQGAQEFKNEVVLVAKLQHRNLVKLLGYCLEPEEKILVYEFV 443

Query: 60  PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
           P +SLDYFLFDP +   LD  KR +II GI +G+LYL +  RLTIIHRDLK SNILLD D
Sbjct: 444 PNKSLDYFLFDPTKQGQLDWTKRYNIIGGITRGILYLHQDSRLTIIHRDLKASNILLDAD 503

Query: 120 LKPKISDFGLARI--LRKMI--LKQIQIELGYIPPEYVGRGVYYKK 161
           + PKI+DFG+ARI  + + +   K+I    GY+PPEYV  G +  K
Sbjct: 504 MIPKIADFGMARISGIDQSVANTKRIAGTFGYMPPEYVIHGQFSMK 549

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|O65476|CRK16_ARATH Putative cysteine-rich receptor-like protein kinase 16 OS=Arabidopsis thaliana GN=CRK16 PE=3 SV=2

 Score =  182 bits (462), Expect = 8e-46,   Method: Composition-based stats.
 Identities = 91/166 (54%), Positives = 117/166 (70%), Gaps = 5/166 (3%)

Query: 1   GVLPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYM 59
           G  P+G  +AVK+LSK S QG EEFKNEV+L AKLQH NL+R+ GF +E +E +L+YEYM
Sbjct: 352 GTFPNGTEVAVKRLSKISGQGEEEFKNEVLLVAKLQHRNLVRLLGFSVEGEEKILVYEYM 411

Query: 60  PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
           P +SLDYFLFD  R   LD + R +II+G+ +G+LYL +  RLTIIHRDLK  NILLD D
Sbjct: 412 PNKSLDYFLFDHRRRGQLDWRTRYNIIRGVTRGILYLHQDSRLTIIHRDLKAGNILLDVD 471

Query: 120 LKPKISDFGLARILR----KMILKQIQIELGYIPPEYVGRGVYYKK 161
           + PKI+DFG+AR  R    +    ++    GY+PPEYV  G +  K
Sbjct: 472 MNPKIADFGVARNFRVDQTEATTGRVVGTFGYMPPEYVANGQFSMK 517

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8H199|CRK14_ARATH Cysteine-rich receptor-like protein kinase 14 OS=Arabidopsis thaliana GN=CRK14 PE=2 SV=2

 Score =  180 bits (456), Expect = 4e-45,   Method: Composition-based stats.
 Identities = 90/163 (55%), Positives = 119/163 (73%), Gaps = 6/163 (3%)

Query: 1   GVLPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYM 59
           GVL +G  +A+K+LSK S QG  EFKNEV++ AKL H NL+++ GFC+E +E +L+YE++
Sbjct: 354 GVL-NGTEVAIKRLSKASRQGAREFKNEVVVVAKLHHRNLVKLLGFCLEGEEKILVYEFV 412

Query: 60  PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
           P +SLDYFLFDP +   LD  KR +II+GI +G+LYL +  RLTIIHRDLK SNILLD D
Sbjct: 413 PNKSLDYFLFDPTKQGQLDWTKRYNIIRGITRGILYLHQDSRLTIIHRDLKASNILLDAD 472

Query: 120 LKPKISDFGLARIL----RKMILKQIQIELGYIPPEYVGRGVY 158
           + PKI+DFG+ARI          K+I    GY+PPEYV +G +
Sbjct: 473 MNPKIADFGMARIFGIDQSGANTKKIAGTRGYMPPEYVRQGQF 515

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q9LDQ3|CRK35_ARATH Putative cysteine-rich receptor-like protein kinase 35 OS=Arabidopsis thaliana GN=CRK35 PE=3 SV=3

 Score =  180 bits (456), Expect = 4e-45,   Method: Composition-based stats.
 Identities = 90/166 (54%), Positives = 117/166 (70%), Gaps = 5/166 (3%)

Query: 1   GVLPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYM 59
           G L  G  +AVK+LSK S QG EEFKNE +L +KLQH NL+R+ GFC+E +E +L+YE++
Sbjct: 362 GKLSSGPEVAVKRLSKTSGQGAEEFKNEAVLVSKLQHKNLVRLLGFCLEGEEKILVYEFV 421

Query: 60  PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
           P +SLDYFLFDP +   LD  +R +II GI +G+LYL +  RLTIIHRDLK SNILLD D
Sbjct: 422 PNKSLDYFLFDPAKQGELDWTRRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDAD 481

Query: 120 LKPKISDFGLARIL----RKMILKQIQIELGYIPPEYVGRGVYYKK 161
           + PKI+DFG+ARI      +   ++I    GY+ PEY  RG +  K
Sbjct: 482 MNPKIADFGMARIFGVDQSQANTRRIAGTFGYMSPEYAMRGHFSMK 527

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1

 Score =  180 bits (456), Expect = 4e-45,   Method: Composition-based stats.
 Identities = 91/166 (54%), Positives = 117/166 (70%), Gaps = 5/166 (3%)

Query: 1   GVLPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYM 59
           GVL DG+ IAVK+LS KS QG +EFKNE++L AKLQH NL+R+ G C E +E ML+YEYM
Sbjct: 546 GVLEDGREIAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYM 605

Query: 60  PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
           P +SLD+FLFD  +  ++D K R  II+GI +GLLYL    RL IIHRDLKVSN+LLD +
Sbjct: 606 PNKSLDFFLFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAE 665

Query: 120 LKPKISDFGLARIL----RKMILKQIQIELGYIPPEYVGRGVYYKK 161
           + PKISDFG+ARI      +    ++    GY+ PEY   G++  K
Sbjct: 666 MNPKISDFGMARIFGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVK 711

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LDM5|CRK31_ARATH Putative cysteine-rich receptor-like protein kinase 31 OS=Arabidopsis thaliana GN=CRK31 PE=3 SV=1

 Score =  179 bits (454), Expect = 8e-45,   Method: Composition-based stats.
 Identities = 91/169 (53%), Positives = 118/169 (69%), Gaps = 11/169 (6%)

Query: 1   GVLPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYM 59
           G+LP+   IAVK+LS  S QG +EFKNEV++ AKLQH NL+R+ GFCIE  E +L+YE++
Sbjct: 356 GMLPNETEIAVKRLSSNSGQGTQEFKNEVVIVAKLQHKNLVRLLGFCIERDEQILVYEFV 415

Query: 60  PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
             +SLDYFLFDP     LD K+R +II G+ +GLLYL +  RLTIIHRD+K SNILLD D
Sbjct: 416 SNKSLDYFLFDPKMKSQLDWKRRYNIIGGVTRGLLYLHQDSRLTIIHRDIKASNILLDAD 475

Query: 120 LKPKISDFGLARILRKMILKQIQIE-------LGYIPPEYVGRGVYYKK 161
           + PKI+DFG+AR  R   + Q + +        GY+PPEYV  G +  K
Sbjct: 476 MNPKIADFGMARNFR---VDQTEDQTGRVVGTFGYMPPEYVTHGQFSTK 521

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

>sp|Q8GYA4|CRK10_ARATH Cysteine-rich receptor-like protein kinase 10 OS=Arabidopsis thaliana GN=CRK10 PE=1 SV=3

 Score =  178 bits (452), Expect = 1e-44,   Method: Composition-based stats.
 Identities = 91/166 (54%), Positives = 115/166 (69%), Gaps = 5/166 (3%)

Query: 1   GVLPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYM 59
           G L DG  +AVK+LSK S QG  EFKNEV+L AKLQH NL+R+ GFC++ +E +L+YEY+
Sbjct: 365 GTLSDGTEVAVKRLSKSSGQGEVEFKNEVVLVAKLQHRNLVRLLGFCLDGEERVLVYEYV 424

Query: 60  PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
           P +SLDYFLFDP +   LD  +R  II G+ +G+LYL +  RLTIIHRDLK SNILLD D
Sbjct: 425 PNKSLDYFLFDPAKKGQLDWTRRYKIIGGVARGILYLHQDSRLTIIHRDLKASNILLDAD 484

Query: 120 LKPKISDFGLARIL----RKMILKQIQIELGYIPPEYVGRGVYYKK 161
           + PKI+DFG+ARI      +    +I    GY+ PEY   G Y  K
Sbjct: 485 MNPKIADFGMARIFGLDQTEENTSRIVGTYGYMSPEYAMHGQYSMK 530

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: -

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	164
224142425	763	predicted protein [Populus trichocarpa]	0.981	0.211	0.692	1e-58
356558668	909	PREDICTED: uncharacterized protein LOC10	0.981	0.177	0.638	8e-55
255565055	721	conserved hypothetical protein [Ricinus	1.0	0.227	0.633	5e-54
224142427	327	predicted protein [Populus trichocarpa]	1.0	0.501	0.609	2e-52
359497026	738	PREDICTED: G-type lectin S-receptor-like	1.0	0.222	0.609	2e-52
359484771	781	PREDICTED: G-type lectin S-receptor-like	0.969	0.203	0.621	3e-52
296084604	580	unnamed protein product [Vitis vinifera]	0.969	0.274	0.621	9e-52
224082290	335	predicted protein [Populus trichocarpa]	1.0	0.489	0.615	2e-51
224142431	332	predicted protein [Populus trichocarpa]	1.0	0.493	0.615	2e-51
296088199	1130	unnamed protein product [Vitis vinifera]	0.981	0.142	0.614	7e-51

>gi|224142425|ref|XP_002324558.1| predicted protein [Populus trichocarpa] gi|222865992|gb|EEF03123.1| predicted protein [Populus trichocarpa]

 Score =  230 bits (587), Expect = 1e-58,   Method: Composition-based stats.
 Identities = 115/166 (69%), Positives = 132/166 (79%), Gaps = 5/166 (3%)

Query: 1   GVLPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYM 59
           GVLP GQ IAVKKLSK STQGF+EFKNEVMLTAKLQH+NL++V GFC+E +E +LIYEYM
Sbjct: 461 GVLPGGQEIAVKKLSKSSTQGFDEFKNEVMLTAKLQHVNLVKVLGFCVEREEKVLIYEYM 520

Query: 60  PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
           PK+SLD +LFDPIR  +LD K+R  II+GI QGLLYLQEY RLTIIHRDLK SNILLD D
Sbjct: 521 PKKSLDSYLFDPIRRYLLDWKRREEIIEGITQGLLYLQEYSRLTIIHRDLKASNILLDGD 580

Query: 120 LKPKISDFGLARILRK----MILKQIQIELGYIPPEYVGRGVYYKK 161
           +KPKISDFG+ARI  K        ++    GY+PPEYV  GVY  K
Sbjct: 581 MKPKISDFGMARIFTKDEQEANTSRLVGTYGYVPPEYVRNGVYSIK 626

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356558668|ref|XP_003547625.1| PREDICTED: uncharacterized protein LOC100787480 [Glycine max]

 Score =  218 bits (554), Expect = 8e-55,   Method: Composition-based stats.
 Identities = 106/166 (63%), Positives = 133/166 (80%), Gaps = 5/166 (3%)

Query: 1   GVLPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYM 59
           G+L + Q +AVKKLSK STQGFEEFKNEVMLTA+LQH+NL+R+ GF I+ ++ ML+YEYM
Sbjct: 450 GILSNRQEVAVKKLSKASTQGFEEFKNEVMLTARLQHVNLVRLLGFYIDGEQQMLVYEYM 509

Query: 60  PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
           P +SLD +LFDPIR  +LD +KR++II+GI QGLLYLQEY RLTIIHRD+K SNILLD +
Sbjct: 510 PNKSLDSYLFDPIRRYLLDWRKRIYIIEGITQGLLYLQEYSRLTIIHRDIKASNILLDNE 569

Query: 120 LKPKISDFGLARILRKMILK----QIQIELGYIPPEYVGRGVYYKK 161
           +KPKISDFG+ARI RK  L+    +I    GY+ PEY  +G+Y  K
Sbjct: 570 MKPKISDFGMARIFRKDELEANTSKIVGTYGYVSPEYAMKGLYSTK 615

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255565055|ref|XP_002523520.1| conserved hypothetical protein [Ricinus communis] gi|223537227|gb|EEF38859.1| conserved hypothetical protein [Ricinus communis]

 Score =  215 bits (547), Expect = 5e-54,   Method: Composition-based stats.
 Identities = 107/169 (63%), Positives = 131/169 (77%), Gaps = 5/169 (2%)

Query: 1   GVLPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYM 59
           G LP GQ IAVK+LSK S QG +EFKNE+ LTAKLQH+NL+R+ G+C E +E MLIYEYM
Sbjct: 418 GKLPRGQEIAVKRLSKTSNQGLKEFKNELKLTAKLQHVNLVRLLGYCTERKEKMLIYEYM 477

Query: 60  PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
           P +SLD++LFD  R L L+ +KRVHII+GI QGLLYLQEY  LTIIH+D+K SNILLD +
Sbjct: 478 PNKSLDFYLFDQKRRLELNWEKRVHIIEGIAQGLLYLQEYSNLTIIHKDIKSSNILLDSN 537

Query: 120 LKPKISDFGLARILRKMILK----QIQIELGYIPPEYVGRGVYYKKFSL 164
           +KPKISDFG+ARI +K   +    QI    GY+PPEYV RGVY  K+ +
Sbjct: 538 MKPKISDFGMARIFQKENHEANTCQIVGTYGYVPPEYVKRGVYSTKYDV 586

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224142427|ref|XP_002324559.1| predicted protein [Populus trichocarpa] gi|222865993|gb|EEF03124.1| predicted protein [Populus trichocarpa]

 Score =  210 bits (535), Expect = 2e-52,   Method: Compositional matrix adjust.
 Identities = 103/169 (60%), Positives = 131/169 (77%), Gaps = 5/169 (2%)

Query: 1   GVLPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYM 59
           G LP+G+ IAVK+LSK STQG EEFKNEV LT KLQH+N++ V GFC E +E MLIYEYM
Sbjct: 28  GKLPNGKEIAVKRLSKTSTQGEEEFKNEVTLTEKLQHVNIVTVLGFCAEREEKMLIYEYM 87

Query: 60  PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
           P +SLD +++DPIR  +LD +KRV II+G+ QGLLYLQEY   TIIHRD+K SN+LLDE+
Sbjct: 88  PNKSLDIYIYDPIRRYMLDWRKRVQIIEGLTQGLLYLQEYSNFTIIHRDIKSSNVLLDEE 147

Query: 120 LKPKISDFGLARILRKMILK----QIQIELGYIPPEYVGRGVYYKKFSL 164
           + PKISDFG+AR+ RK  L+    +I    GY+PPEYV +G+Y  K+ +
Sbjct: 148 MNPKISDFGMARLFRKDELEANTSRIVGTYGYVPPEYVRKGIYSMKYDV 196

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359497026|ref|XP_003635401.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410-like, partial [Vitis vinifera]

 Score =  210 bits (534), Expect = 2e-52,   Method: Composition-based stats.
 Identities = 103/169 (60%), Positives = 124/169 (73%), Gaps = 5/169 (2%)

Query: 1   GVLPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYM 59
           G LP GQ IAVK+LSK S QG EEFKNEV LTA LQH+NL+++ GFC + +E MLIYE M
Sbjct: 450 GKLPKGQEIAVKRLSKTSHQGLEEFKNEVTLTATLQHVNLVKLLGFCTQREEKMLIYECM 509

Query: 60  PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
           P +SLD++LFDP R   LD  KR+ II+GI QGLLYLQEY   TIIHRDLK SNILLD +
Sbjct: 510 PNKSLDFYLFDPTRRYFLDWTKRIAIIEGITQGLLYLQEYSNFTIIHRDLKASNILLDSE 569

Query: 120 LKPKISDFGLARILRK----MILKQIQIELGYIPPEYVGRGVYYKKFSL 164
           +KPKISDFG+AR  +K        +I    GY+PPEYV RG+Y  K+ +
Sbjct: 570 MKPKISDFGIARAFQKDEHEASTGRIVGTYGYVPPEYVRRGIYSMKYDV 618

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359484771|ref|XP_003633158.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase RKS1-like [Vitis vinifera]

 Score =  209 bits (532), Expect = 3e-52,   Method: Composition-based stats.
 Identities = 102/164 (62%), Positives = 123/164 (75%), Gaps = 5/164 (3%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSL 64
           G+ +AVK+LSK S QG EEFKNEV LTAKLQH+NL+R+ GFC E +E MLIYEYMP +SL
Sbjct: 481 GEEMAVKRLSKTSNQGAEEFKNEVTLTAKLQHVNLVRLQGFCTEGEEKMLIYEYMPNKSL 540

Query: 65  DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKI 124
           D++LFDP R   LD  KR+ II+GI QGLLYLQEY   TIIHRDLK SNILLD ++KPKI
Sbjct: 541 DFYLFDPTRRYFLDWTKRIAIIEGITQGLLYLQEYSNFTIIHRDLKASNILLDSEMKPKI 600

Query: 125 SDFGLARILRK----MILKQIQIELGYIPPEYVGRGVYYKKFSL 164
           SDFG+AR  +K        +I    GY+PPEYV RG+Y  K+ +
Sbjct: 601 SDFGIARAFQKDEHEASTGRIVGTYGYVPPEYVRRGIYSMKYDV 644

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|296084604|emb|CBI25625.3| unnamed protein product [Vitis vinifera]

 Score =  207 bits (528), Expect = 9e-52,   Method: Composition-based stats.
 Identities = 102/164 (62%), Positives = 123/164 (75%), Gaps = 5/164 (3%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSL 64
           G+ +AVK+LSK S QG EEFKNEV LTAKLQH+NL+R+ GFC E +E MLIYEYMP +SL
Sbjct: 280 GEEMAVKRLSKTSNQGAEEFKNEVTLTAKLQHVNLVRLQGFCTEGEEKMLIYEYMPNKSL 339

Query: 65  DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKI 124
           D++LFDP R   LD  KR+ II+GI QGLLYLQEY   TIIHRDLK SNILLD ++KPKI
Sbjct: 340 DFYLFDPTRRYFLDWTKRIAIIEGITQGLLYLQEYSNFTIIHRDLKASNILLDSEMKPKI 399

Query: 125 SDFGLARILRK----MILKQIQIELGYIPPEYVGRGVYYKKFSL 164
           SDFG+AR  +K        +I    GY+PPEYV RG+Y  K+ +
Sbjct: 400 SDFGIARAFQKDEHEASTGRIVGTYGYVPPEYVRRGIYSMKYDV 443

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224082290|ref|XP_002335492.1| predicted protein [Populus trichocarpa] gi|222834258|gb|EEE72735.1| predicted protein [Populus trichocarpa]

 Score =  206 bits (524), Expect = 2e-51,   Method: Compositional matrix adjust.
 Identities = 104/169 (61%), Positives = 125/169 (73%), Gaps = 5/169 (2%)

Query: 1   GVLPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYM 59
           G LP G  IAVK+LS  STQG EEFKNEV LTA+LQH+NL+R+ GFC E  E MLIYEYM
Sbjct: 33  GKLPRGLEIAVKRLSASSTQGLEEFKNEVSLTARLQHVNLVRLLGFCSERGEKMLIYEYM 92

Query: 60  PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
           P +SLD +LFDPIR   LD  KRV II+G+ QGLLYLQEY   TIIHRDLK SNILLD++
Sbjct: 93  PNKSLDLYLFDPIRRYSLDWSKRVRIIEGVTQGLLYLQEYSNFTIIHRDLKSSNILLDDE 152

Query: 120 LKPKISDFGLARILRKMI----LKQIQIELGYIPPEYVGRGVYYKKFSL 164
           + PKISDFG+A++ RK +      +I    GYIPPEY  +G+Y  K+ +
Sbjct: 153 MNPKISDFGMAKLFRKDVYEANTSRIVGTYGYIPPEYARKGIYSIKYDV 201

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224142431|ref|XP_002324561.1| predicted protein [Populus trichocarpa] gi|222865995|gb|EEF03126.1| predicted protein [Populus trichocarpa]

 Score =  206 bits (524), Expect = 2e-51,   Method: Compositional matrix adjust.
 Identities = 104/169 (61%), Positives = 125/169 (73%), Gaps = 5/169 (2%)

Query: 1   GVLPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYM 59
           G LP G  IAVK+LS  STQG EEFKNEV LTA+LQH+NL+R+ GFC E  E MLIYEYM
Sbjct: 30  GKLPRGLEIAVKRLSASSTQGLEEFKNEVSLTARLQHVNLVRLLGFCSERGEKMLIYEYM 89

Query: 60  PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
           P +SLD +LFDPIR   LD  KRV II+G+ QGLLYLQEY   TIIHRDLK SNILLD++
Sbjct: 90  PNKSLDLYLFDPIRRYSLDWSKRVRIIEGVTQGLLYLQEYSNFTIIHRDLKSSNILLDDE 149

Query: 120 LKPKISDFGLARILRKMI----LKQIQIELGYIPPEYVGRGVYYKKFSL 164
           + PKISDFG+A++ RK +      +I    GYIPPEY  +G+Y  K+ +
Sbjct: 150 MNPKISDFGMAKLFRKDVYEANTSRIVGTYGYIPPEYARKGIYSIKYDV 198

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|296088199|emb|CBI35714.3| unnamed protein product [Vitis vinifera]

 Score =  204 bits (520), Expect = 7e-51,   Method: Composition-based stats.
 Identities = 102/166 (61%), Positives = 124/166 (74%), Gaps = 5/166 (3%)

Query: 1   GVLPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYM 59
           G LP GQ IAVK+LSK S QG EEFKNEV LTA LQH+NL+++ GFC + +E MLIYE M
Sbjct: 828 GKLPKGQEIAVKRLSKTSHQGLEEFKNEVTLTATLQHVNLVKLLGFCTQREEKMLIYECM 887

Query: 60  PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
           P +SLD++LFDP   ++LD  KR+HII+GI QGLLYLQEY RL IIHRDLK SNILLD +
Sbjct: 888 PNKSLDFYLFDPEGQVLLDWGKRIHIIEGITQGLLYLQEYSRLRIIHRDLKASNILLDGE 947

Query: 120 LKPKISDFGLARILRK----MILKQIQIELGYIPPEYVGRGVYYKK 161
           +KPKI+DFG+ARI +K        +I    GY+ PEYV +G Y  K
Sbjct: 948 MKPKIADFGIARIFQKDENEANTGRIVGTYGYVSPEYVQKGTYSVK 993

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	164
TAIR|locus:2093397	850	CES101 "CALLUS EXPRESSION OF R	0.981	0.189	0.572	2.1e-44
UNIPROTKB|O49974	848	KIK1 "Serine/threonine-protein	0.981	0.189	0.536	1.3e-40
TAIR|locus:2141176	849	B120 [Arabidopsis thaliana (ta	0.981	0.189	0.548	1.3e-40
TAIR|locus:2123111	669	CRK34 "cysteine-rich RLK (RECE	0.981	0.240	0.542	1.8e-40
TAIR|locus:2121676	669	CRK10 "cysteine-rich RLK (RECE	0.981	0.240	0.548	1.8e-40
TAIR|locus:2123126	666	CRK31 "cysteine-rich RLK (RECE	0.981	0.241	0.542	3e-40
TAIR|locus:2131694	815	AT4G27300 [Arabidopsis thalian	0.981	0.197	0.554	6.6e-40
TAIR|locus:2121706	690	CRK21 "cysteine-rich RLK (RECE	0.981	0.233	0.524	1.1e-39
TAIR|locus:2200151	830	SD1-13 "S-domain-1 13" [Arabid	1.0	0.197	0.540	1.2e-39
TAIR|locus:2200908	842	AT1G61610 [Arabidopsis thalian	0.981	0.191	0.554	2.6e-39

TAIR|locus:2093397 CES101 "CALLUS EXPRESSION OF RBCS 101" [Arabidopsis thaliana (taxid:3702)]

 Score = 475 (172.3 bits), Expect = 2.1e-44, P = 2.1e-44
 Identities = 95/166 (57%), Positives = 119/166 (71%)

Query:     1 GVLPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYM 59
             G L DG+ +A+K+LS  S QG  EFKNE ML AKLQH NL+++ G C+E  E MLIYEYM
Sbjct:   544 GRLIDGEEVAIKRLSLASGQGLVEFKNEAMLIAKLQHTNLVKLLGCCVEKDEKMLIYEYM 603

Query:    60 PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
             P +SLDYFLFDP+R ++LD K R  I++GIIQGLLYL +Y RL +IHRD+K  NILLDED
Sbjct:   604 PNKSLDYFLFDPLRKIVLDWKLRFRIMEGIIQGLLYLHKYSRLKVIHRDIKAGNILLDED 663

Query:   120 LKPKISDFGLARIL----RKMILKQIQIELGYIPPEYVGRGVYYKK 161
             + PKISDFG+ARI      K   K++    GY+ PEY   G++  K
Sbjct:   664 MNPKISDFGMARIFGAQESKANTKRVAGTFGYMSPEYFREGLFSAK 709

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

UNIPROTKB|O49974 KIK1 "Serine/threonine-protein kinase" [Zea mays (taxid:4577)]

 Score = 440 (159.9 bits), Expect = 1.3e-40, P = 1.3e-40
 Identities = 89/166 (53%), Positives = 116/166 (69%)

Query:     1 GVLPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYM 59
             G LP G+ +AVK+L + S QG EEFKNEV+L AKLQH NL+R+ G CI  +E +L+YEYM
Sbjct:   547 GTLPGGEEVAVKRLCRNSGQGLEEFKNEVILIAKLQHRNLVRLLGCCIPREEKILVYEYM 606

Query:    60 PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
             P +SLD FLF+P +  +LD KKR  II+GI +GLLYL    RL ++HRDLK SNILLD D
Sbjct:   607 PNKSLDAFLFNPEKQRLLDWKKRFDIIEGIARGLLYLHRDSRLRVVHRDLKASNILLDAD 666

Query:   120 LKPKISDFGLARIL----RKMILKQIQIELGYIPPEYVGRGVYYKK 161
             +KPKISDFG+AR+      +    ++    GY+ PEY   G++  K
Sbjct:   667 MKPKISDFGMARMFGGDQNQFNTNRVVGTFGYMSPEYAMEGIFSVK 712

GO:0005515 "protein binding" evidence=IPI

TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)]

 Score = 440 (159.9 bits), Expect = 1.3e-40, P = 1.3e-40
 Identities = 91/166 (54%), Positives = 118/166 (71%)

Query:     1 GVLPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYM 59
             GVL DG+ IAVK+LS KS QG +EFKNE++L AKLQH NL+R+ G C E +E ML+YEYM
Sbjct:   546 GVLEDGREIAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYM 605

Query:    60 PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
             P +SLD+FLFD  +  ++D K R  II+GI +GLLYL    RL IIHRDLKVSN+LLD +
Sbjct:   606 PNKSLDFFLFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAE 665

Query:   120 LKPKISDFGLARIL--RKMILKQIQI--ELGYIPPEYVGRGVYYKK 161
             + PKISDFG+ARI    +     +++    GY+ PEY   G++  K
Sbjct:   666 MNPKISDFGMARIFGGNQNEANTVRVVGTYGYMSPEYAMEGLFSVK 711

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0006979 "response to oxidative stress" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2123111 CRK34 "cysteine-rich RLK (RECEPTOR-like protein kinase) 34" [Arabidopsis thaliana (taxid:3702)]

 Score = 434 (157.8 bits), Expect = 1.8e-40, P = 1.8e-40
 Identities = 90/166 (54%), Positives = 117/166 (70%)

Query:     1 GVLPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYM 59
             G L  G  +AVK+LSK S QG EEFKNE +L +KLQH NL+R+ GFC+E +E +L+YE++
Sbjct:   362 GKLSSGPEVAVKRLSKTSGQGAEEFKNEAVLVSKLQHKNLVRLLGFCLEGEEKILVYEFV 421

Query:    60 PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
             P +SLDYFLFDP +   LD  +R +II GI +G+LYL +  RLTIIHRDLK SNILLD D
Sbjct:   422 PNKSLDYFLFDPAKQGELDWTRRYNIIGGIARGILYLHQDSRLTIIHRDLKASNILLDAD 481

Query:   120 LKPKISDFGLARIL----RKMILKQIQIELGYIPPEYVGRGVYYKK 161
             + PKI+DFG+ARI      +   ++I    GY+ PEY  RG +  K
Sbjct:   482 MNPKIADFGMARIFGVDQSQANTRRIAGTFGYMSPEYAMRGHFSMK 527

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2121676 CRK10 "cysteine-rich RLK (RECEPTOR-like protein kinase) 10" [Arabidopsis thaliana (taxid:3702)]

 Score = 434 (157.8 bits), Expect = 1.8e-40, P = 1.8e-40
 Identities = 91/166 (54%), Positives = 115/166 (69%)

Query:     1 GVLPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYM 59
             G L DG  +AVK+LSK S QG  EFKNEV+L AKLQH NL+R+ GFC++ +E +L+YEY+
Sbjct:   365 GTLSDGTEVAVKRLSKSSGQGEVEFKNEVVLVAKLQHRNLVRLLGFCLDGEERVLVYEYV 424

Query:    60 PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
             P +SLDYFLFDP +   LD  +R  II G+ +G+LYL +  RLTIIHRDLK SNILLD D
Sbjct:   425 PNKSLDYFLFDPAKKGQLDWTRRYKIIGGVARGILYLHQDSRLTIIHRDLKASNILLDAD 484

Query:   120 LKPKISDFGLARIL----RKMILKQIQIELGYIPPEYVGRGVYYKK 161
             + PKI+DFG+ARI      +    +I    GY+ PEY   G Y  K
Sbjct:   485 MNPKIADFGMARIFGLDQTEENTSRIVGTYGYMSPEYAMHGQYSMK 530

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0006995 "cellular response to nitrogen starvation" evidence=RCA

TAIR|locus:2123126 CRK31 "cysteine-rich RLK (RECEPTOR-like protein kinase) 31" [Arabidopsis thaliana (taxid:3702)]

 Score = 432 (157.1 bits), Expect = 3.0e-40, P = 3.0e-40
 Identities = 90/166 (54%), Positives = 117/166 (70%)

Query:     1 GVLPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYM 59
             G+LP+   IAVK+LS  S QG +EFKNEV++ AKLQH NL+R+ GFCIE  E +L+YE++
Sbjct:   356 GMLPNETEIAVKRLSSNSGQGTQEFKNEVVIVAKLQHKNLVRLLGFCIERDEQILVYEFV 415

Query:    60 PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
               +SLDYFLFDP     LD K+R +II G+ +GLLYL +  RLTIIHRD+K SNILLD D
Sbjct:   416 SNKSLDYFLFDPKMKSQLDWKRRYNIIGGVTRGLLYLHQDSRLTIIHRDIKASNILLDAD 475

Query:   120 LKPKISDFGLARILRKMILK----QIQIELGYIPPEYVGRGVYYKK 161
             + PKI+DFG+AR  R    +    ++    GY+PPEYV  G +  K
Sbjct:   476 MNPKIADFGMARNFRVDQTEDQTGRVVGTFGYMPPEYVTHGQFSTK 521

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)]

 Score = 433 (157.5 bits), Expect = 6.6e-40, P = 6.6e-40
 Identities = 92/166 (55%), Positives = 114/166 (68%)

Query:     1 GVLPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYM 59
             G L DGQ IAVK+LS  S QG EEFKNEV L AKLQH NL+R+ G CI+ +E MLIYEYM
Sbjct:   517 GKLEDGQEIAVKRLSANSGQGVEEFKNEVKLIAKLQHRNLVRLLGCCIQGEECMLIYEYM 576

Query:    60 PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
             P +SLD+F+FD  R   LD KKR++II G+ +G+LYL +  RL IIHRDLK  N+LLD D
Sbjct:   577 PNKSLDFFIFDERRSTELDWKKRMNIINGVARGILYLHQDSRLRIIHRDLKAGNVLLDND 636

Query:   120 LKPKISDFGLARIL----RKMILKQIQIELGYIPPEYVGRGVYYKK 161
             + PKISDFGLA+       +    ++    GY+PPEY   G +  K
Sbjct:   637 MNPKISDFGLAKSFGGDQSESSTNRVVGTYGYMPPEYAIDGHFSVK 682

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0031625 "ubiquitin protein ligase binding" evidence=IPI

GO:0009506 "plasmodesma" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=RCA

TAIR|locus:2121706 CRK21 "cysteine-rich RLK (RECEPTOR-like protein kinase) 21" [Arabidopsis thaliana (taxid:3702)]

 Score = 428 (155.7 bits), Expect = 1.1e-39, P = 1.1e-39
 Identities = 87/166 (52%), Positives = 119/166 (71%)

Query:     1 GVLPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYM 59
             G+ P+G  +A K+LSK S QG  EFKNEV+L A+LQH NL+ + GF +E +E +L+YE++
Sbjct:   380 GMFPNGTEVAAKRLSKPSDQGEPEFKNEVLLVARLQHKNLVGLLGFSVEGEEKILVYEFV 439

Query:    60 PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
             P +SLD+FLFDPI+ + LD  +R +II+GI +G+LYL +  RLTIIHRDLK SNILLD +
Sbjct:   440 PNKSLDHFLFDPIKRVQLDWPRRHNIIEGITRGILYLHQDSRLTIIHRDLKASNILLDAE 499

Query:   120 LKPKISDFGLARILR----KMILKQIQIELGYIPPEYVGRGVYYKK 161
             + PKI+DFGLAR  R    +    ++    GY+PPEYV  G +  K
Sbjct:   500 MNPKIADFGLARNFRVNQTEANTGRVVGTFGYMPPEYVANGQFSTK 545

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005576 "extracellular region" evidence=ISM

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005739 "mitochondrion" evidence=IDA

TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)]

 Score = 431 (156.8 bits), Expect = 1.2e-39, P = 1.2e-39
 Identities = 93/172 (54%), Positives = 123/172 (71%)

Query:     1 GVLPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYM 59
             G L +G  IAVK+LS+ S QG EEF NEV++ +KLQH NL+R+ GFCIE +E ML+YE+M
Sbjct:   529 GRLQEGLDIAVKRLSRTSGQGVEEFVNEVVVISKLQHRNLVRLLGFCIEGEERMLVYEFM 588

Query:    60 PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
             P+  LD +LFDP++  +LD K R +II GI +GL+YL    RL IIHRDLK SNILLDE+
Sbjct:   589 PENCLDAYLFDPVKQRLLDWKTRFNIIDGICRGLMYLHRDSRLKIIHRDLKASNILLDEN 648

Query:   120 LKPKISDFGLARILR--KMILKQIQI--ELGYIPPEYVGRGVYYKK---FSL 164
             L PKISDFGLARI +  +  +  +++    GY+ PEY   G++ +K   FSL
Sbjct:   649 LNPKISDFGLARIFQGNEDEVSTVRVVGTYGYMAPEYAMGGLFSEKSDVFSL 700

GO:0004672 "protein kinase activity" evidence=IEA;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA

GO:0048544 "recognition of pollen" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=RCA;IDA

GO:0009637 "response to blue light" evidence=RCA

GO:0010155 "regulation of proton transport" evidence=RCA

GO:0016556 "mRNA modification" evidence=RCA

TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)]

 Score = 428 (155.7 bits), Expect = 2.6e-39, P = 2.6e-39
 Identities = 92/166 (55%), Positives = 115/166 (69%)

Query:     1 GVLPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYM 59
             G   +G+ IAVK+LS KS QG EEFKNE++L AKLQH NL+R+ G CIE  E ML+YEYM
Sbjct:   542 GNFSEGREIAVKRLSGKSKQGLEEFKNEILLIAKLQHRNLVRLLGCCIEDNEKMLLYEYM 601

Query:    60 PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
             P +SLD FLFD  +   LD +KR  +I GI +GLLYL    RL IIHRDLK SNILLD +
Sbjct:   602 PNKSLDRFLFDESKQGSLDWRKRWEVIGGIARGLLYLHRDSRLKIIHRDLKASNILLDTE 661

Query:   120 LKPKISDFGLARIL--RKMILKQIQI--ELGYIPPEYVGRGVYYKK 161
             + PKISDFG+ARI   R+     I++    GY+ PEY   G++ +K
Sbjct:   662 MNPKISDFGMARIFNYRQDHANTIRVVGTYGYMAPEYAMEGIFSEK 707

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030246 "carbohydrate binding" evidence=IEA;ISS

GO:0048544 "recognition of pollen" evidence=IEA

GO:0009693 "ethylene biosynthetic process" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.737
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: gw1.XVIII.3331.1 hypothetical protein (310 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	164
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-27
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	6e-27
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-26
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-25
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-24
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	4e-24
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-23
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	5e-19
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	7e-19
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	8e-19
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	6e-17
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-16
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	3e-16
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-16
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	6e-16
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	3e-15
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-15
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	3e-15
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	5e-15
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	6e-15
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	7e-15
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	8e-15
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-14
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-14
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-14
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	5e-14
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-13
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	2e-13
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	4e-13
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	7e-13
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	8e-13
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	8e-13
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-12
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-12
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-12
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-12
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	2e-12
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	3e-12
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	4e-12
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	4e-12
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	5e-12
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	5e-12
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	7e-12
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	1e-11
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-11
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	2e-11
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-11
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	2e-11
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	3e-11
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	3e-11
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	4e-11
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	6e-11
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	6e-11
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	6e-11
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	8e-11
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	9e-11
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-10
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	1e-10
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-10
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-10
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	2e-10
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-10
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-10
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	5e-10
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	7e-10
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	7e-10
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-09
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-09
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	1e-09
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-09
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-09
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	2e-09
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	2e-09
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	2e-09
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	3e-09
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-09
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	4e-09
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	4e-09
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	5e-09
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	5e-09
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	5e-09
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	6e-09
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	7e-09
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	7e-09
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	8e-09
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	9e-09
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	9e-09
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-08
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-08
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	1e-08
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	1e-08
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-08
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-08
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-08
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	2e-08
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-08
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	3e-08
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-08
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-08
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	4e-08
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	4e-08
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	4e-08
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	4e-08
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	5e-08
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	5e-08
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	5e-08
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	6e-08
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	7e-08
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	9e-08
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	9e-08
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-07
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-07
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	1e-07
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	2e-07
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	2e-07
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-07
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-07
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	2e-07
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	2e-07
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-07
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	3e-07
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	3e-07
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-07
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	4e-07
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	4e-07
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	4e-07
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-07
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	4e-07
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	5e-07
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	5e-07
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	5e-07
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	5e-07
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	6e-07
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	7e-07
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	7e-07
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	7e-07
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	8e-07
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	9e-07
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	9e-07
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	9e-07
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-06
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-06
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	1e-06
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	1e-06
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-06
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	1e-06
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-06
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	2e-06
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-06
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	2e-06
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	2e-06
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-06
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	3e-06
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	4e-06
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	4e-06
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	4e-06
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	5e-06
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	5e-06
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	5e-06
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	6e-06
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	6e-06
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	6e-06
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	6e-06
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	6e-06
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	6e-06
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	7e-06
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	8e-06
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	8e-06
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	9e-06
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	9e-06
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	9e-06
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	1e-05
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-05
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-05
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	1e-05
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-05
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	1e-05
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	1e-05
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-05
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-05
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-05
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	2e-05
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-05
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-05
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-05
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-05
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-05
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	2e-05
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-05
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	2e-05
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	3e-05
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	3e-05
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	3e-05
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	3e-05
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	3e-05
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	4e-05
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	4e-05
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	4e-05
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	4e-05
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	4e-05
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	5e-05
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	5e-05
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	5e-05
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	5e-05
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	5e-05
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	6e-05
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	6e-05
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	6e-05
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	6e-05
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	6e-05
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	6e-05
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	7e-05
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	7e-05
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	7e-05
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	8e-05
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	8e-05
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	9e-05
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	1e-04
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	1e-04
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-04
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-04
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	1e-04
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-04
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	2e-04
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-04
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-04
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	2e-04
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	2e-04
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	2e-04
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	3e-04
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-04
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	3e-04
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-04
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-04
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-04
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	3e-04
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-04
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	3e-04
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	4e-04
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	4e-04
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	4e-04
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	5e-04
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	5e-04
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	5e-04
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	6e-04
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	6e-04
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	6e-04
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	7e-04
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	7e-04
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	7e-04
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	7e-04
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	8e-04
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	9e-04
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	9e-04
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	0.001
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	0.001
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	0.001
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	0.002
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	0.002
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	0.002
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	0.002
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	0.002
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	0.003
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	0.003
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	0.003
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	0.003

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  101 bits (253), Expect = 2e-27
 Identities = 55/160 (34%), Positives = 83/160 (51%), Gaps = 10/160 (6%)

Query: 5   DGQIIAVKKLSKKSTQGF-EEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKR 62
            G+ +A+K + K+ +    EE   E+ +  KL H N++++ G   +     L+ EY    
Sbjct: 17  TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGG 76

Query: 63  SLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED-LK 121
           SL   L +    L  D  + + I+  I++GL YL       IIHRDLK  NILLD D  K
Sbjct: 77  SLKDLLKENEGKLSED--EILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGK 131

Query: 122 PKISDFGLARILR--KMILKQIQIELGYIPPEYVGRGVYY 159
            K++DFGL+++L   K +LK I     Y+ PE +    YY
Sbjct: 132 VKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYY 171

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  101 bits (254), Expect = 6e-27
 Identities = 47/124 (37%), Positives = 64/124 (51%), Gaps = 6/124 (4%)

Query: 10  AVKKLSK-KSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSLDYF 67
           AVK L +  S Q  EEF  E  +  KL H N+++ +G C E +  M++ EYMP   L  +
Sbjct: 32  AVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMPGGDLLDY 91

Query: 68  LFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDF 127
           L    R   L     +     I +G+ YL+       IHRDL   N L+ E+L  KISDF
Sbjct: 92  LRKN-RPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDF 147

Query: 128 GLAR 131
           GL+R
Sbjct: 148 GLSR 151

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =   99 bits (250), Expect = 2e-26
 Identities = 44/125 (35%), Positives = 62/125 (49%), Gaps = 7/125 (5%)

Query: 9   IAVKKLSK-KSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSLDY 66
           +AVK L +  S Q  EEF  E  +  KL H N+++ +G C E +   ++ EYM    L  
Sbjct: 31  VAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYMEGGDLLS 90

Query: 67  FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISD 126
           +L      L       +     I +G+ YL+       IHRDL   N L+ E+L  KISD
Sbjct: 91  YLRKNRPKL--SLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISD 145

Query: 127 FGLAR 131
           FGL+R
Sbjct: 146 FGLSR 150

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 96.8 bits (242), Expect = 3e-25
 Identities = 44/134 (32%), Positives = 68/134 (50%), Gaps = 7/134 (5%)

Query: 5   DGQIIAVKKLSKKST-QGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKR 62
               +AVK L + ++ +  EEF  E  +  KL H N++R +G C + +   ++ EYMP  
Sbjct: 27  TETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGG 86

Query: 63  SLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKP 122
            L  FL        L  K  + +   I +G+ YL+       +HRDL   N L+ E+L  
Sbjct: 87  DLLDFLRKHGE--KLTLKDLLQMALQIAKGMEYLES---KNFVHRDLAARNCLVTENLVV 141

Query: 123 KISDFGLARILRKM 136
           KISDFGL+R + + 
Sbjct: 142 KISDFGLSRDIYED 155

Length = 258

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score = 95.0 bits (237), Expect = 2e-24
 Identities = 52/160 (32%), Positives = 77/160 (48%), Gaps = 11/160 (6%)

Query: 5   DGQIIAVKKLSKKST--QGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPK 61
            G+I+AVK L K+S   +  +  + E+ +  +L H N++R+     +     L+ EY   
Sbjct: 23  TGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEG 82

Query: 62  RSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK 121
             L  +L     +   + KK   I   I++GL YL       IIHRDLK  NILLDE+  
Sbjct: 83  GDLFDYLSRGGPLSEDEAKK---IALQILRGLEYLHSNG---IIHRDLKPENILLDENGV 136

Query: 122 PKISDFGLAR--ILRKMILKQIQIELGYIPPEYVGRGVYY 159
            KI+DFGLA+  +     L        Y+ PE +  G  Y
Sbjct: 137 VKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGY 176

Length = 260

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 94.1 bits (235), Expect = 4e-24
 Identities = 45/130 (34%), Positives = 62/130 (47%), Gaps = 11/130 (8%)

Query: 10  AVKKLSK-KSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSLDYF 67
           AVK L +  S +  ++F  E  +  KL H N++R +G C E +   L+ EYM    L  +
Sbjct: 27  AVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDY 86

Query: 68  L------FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK 121
           L      F       L  K  +     I +G+ YL        +HRDL   N L+ EDL 
Sbjct: 87  LRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLV 143

Query: 122 PKISDFGLAR 131
            KISDFGL+R
Sbjct: 144 VKISDFGLSR 153

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score = 91.8 bits (229), Expect = 2e-23
 Identities = 50/160 (31%), Positives = 77/160 (48%), Gaps = 9/160 (5%)

Query: 5   DGQIIAVKKLSKKSTQGFEE-FKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKR 62
            G+++A+K + KK  +   E    E+ +  KL+H N++R+    E ++ + L+ EY    
Sbjct: 23  TGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGG 82

Query: 63  SLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKP 122
            L   L    R+   + +     ++ I+  L YL       I+HRDLK  NILLDED   
Sbjct: 83  DLFDLLKKRGRLSEDEAR---FYLRQILSALEYLHS---KGIVHRDLKPENILLDEDGHV 136

Query: 123 KISDFGLARILR-KMILKQIQIELGYIPPEYVGRGVYYKK 161
           K++DFGLAR L     L        Y+ PE +    Y K 
Sbjct: 137 KLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKA 176

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 80.3 bits (199), Expect = 5e-19
 Identities = 45/136 (33%), Positives = 71/136 (52%), Gaps = 15/136 (11%)

Query: 5   DGQIIAVKK--LSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCI-ETQEYMLIY-EYM 59
            G+++AVK   LS  S +  E  + E+ + + LQH N++R  G    E +  + I+ EY+
Sbjct: 24  TGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYV 83

Query: 60  PKRSLDYFL--FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLD 117
              SL   L  F  +       +K     + I++GL YL       I+HRD+K +NIL+D
Sbjct: 84  SGGSLSSLLKKFGKLPEP--VIRKYT---RQILEGLAYLH---SNGIVHRDIKGANILVD 135

Query: 118 EDLKPKISDFGLARIL 133
            D   K++DFG A+ L
Sbjct: 136 SDGVVKLADFGCAKRL 151

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 80.6 bits (199), Expect = 7e-19
 Identities = 45/140 (32%), Positives = 66/140 (47%), Gaps = 18/140 (12%)

Query: 7   QIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSL 64
             +A+K L +    +  +EF+ E  L + LQH N++  +G C + Q   +++EY+    L
Sbjct: 36  TSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDL 95

Query: 65  DYFLF-------------DPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKV 111
             FL              D      LDC   +HI   I  G+ YL  +     +HRDL  
Sbjct: 96  HEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAA 152

Query: 112 SNILLDEDLKPKISDFGLAR 131
            N L+ E L  KISDFGL+R
Sbjct: 153 RNCLVGEGLTVKISDFGLSR 172

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 79.8 bits (197), Expect = 8e-19
 Identities = 48/156 (30%), Positives = 77/156 (49%), Gaps = 7/156 (4%)

Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYF 67
           +A+K L        ++F+ EV    +L+H +LI +   C   +   +I E M K SL  F
Sbjct: 33  VAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAF 92

Query: 68  LFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDF 127
           L  P    +L     + +   + +G+ YL+E      IHRDL   NIL+ EDL  K++DF
Sbjct: 93  LRSP-EGQVLPVASLIDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADF 148

Query: 128 GLARILRKMIL--KQIQIELGYIPPEYVGRGVYYKK 161
           GLAR++++ +      +I   +  PE    G +  K
Sbjct: 149 GLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTK 184

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 75.6 bits (186), Expect = 6e-17
 Identities = 53/191 (27%), Positives = 90/191 (47%), Gaps = 34/191 (17%)

Query: 1   GVLPDGQ--IIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIY 56
           G+LP     ++AVK L ++ S     +F+ E  L A+  H N+++ +G C   +   L++
Sbjct: 28  GLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLF 87

Query: 57  EYMPKRSLDYFLFD-------------------PIRMLILDCKKRVHIIKGIIQGLLYLQ 97
           EYM    L+ FL                      +  L L C +++ I K +  G+ YL 
Sbjct: 88  EYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS 147

Query: 98  EYFRLTIIHRDLKVSNILLDEDLKPKISDFGLAR-ILRKMILKQIQ---IELGYIPPEYV 153
           E      +HRDL   N L+ E++  KI+DFGL+R I      K  +   I + ++PPE  
Sbjct: 148 ER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPE-- 202

Query: 154 GRGVYYKKFSL 164
              ++Y +++ 
Sbjct: 203 --SIFYNRYTT 211

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 73.4 bits (181), Expect = 2e-16
 Identities = 41/137 (29%), Positives = 68/137 (49%), Gaps = 13/137 (9%)

Query: 5   DGQIIAVKKLS--KKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIY-EYMPK 61
            G  +A+K++S  K   +  +    E+ L   L+H N+++    IET + + I  EY   
Sbjct: 24  TGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAEN 83

Query: 62  RSLDYFL--FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
            SL   +  F P    ++        +  ++QGL YL E     +IHRD+K +NIL  +D
Sbjct: 84  GSLRQIIKKFGPFPESLVAV-----YVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKD 135

Query: 120 LKPKISDFGLARILRKM 136
              K++DFG+A  L  +
Sbjct: 136 GVVKLADFGVATKLNDV 152

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 73.2 bits (180), Expect = 3e-16
 Identities = 45/128 (35%), Positives = 69/128 (53%), Gaps = 8/128 (6%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSL 64
           GQ +AVK L   ST   + F  E  +   L+H NL++ +G  ++     ++ EYM K SL
Sbjct: 29  GQKVAVKCLKDDSTAA-QAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSL 87

Query: 65  DYFLFDPIRMLI-LDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
             +L    R +I L  +    +   + +G+ YL+E      +HRDL   N+L+ EDL  K
Sbjct: 88  VDYLRSRGRAVITLAQQLGFAL--DVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAK 142

Query: 124 ISDFGLAR 131
           +SDFGLA+
Sbjct: 143 VSDFGLAK 150

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 73.3 bits (180), Expect = 3e-16
 Identities = 43/132 (32%), Positives = 70/132 (53%), Gaps = 10/132 (7%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR---VGFCIETQEYMLIYEYMPKR 62
           G+++AVKKL   + +   +F+ E+ +   LQH N+++   V +    +   L+ EY+P  
Sbjct: 33  GEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYG 92

Query: 63  SL-DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK 121
           SL DY      R   LD +K +     I +G+ YL        +HRDL   NIL++ + +
Sbjct: 93  SLRDYLQKHRER---LDHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENR 146

Query: 122 PKISDFGLARIL 133
            KI DFGL ++L
Sbjct: 147 VKIGDFGLTKVL 158

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 72.4 bits (178), Expect = 6e-16
 Identities = 45/134 (33%), Positives = 70/134 (52%), Gaps = 19/134 (14%)

Query: 9   IAVKKLSKKSTQGFE-EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDY 66
           +A+K L   S+     +F  E  +  +  H N+IR+ G   +++  M+I EYM   SLD 
Sbjct: 35  VAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDK 94

Query: 67  FL------FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL 120
           FL      F   ++        V +++GI  G+ YL E   +  +HRDL   NIL++ +L
Sbjct: 95  FLRENDGKFTVGQL--------VGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNL 143

Query: 121 KPKISDFGLARILR 134
             K+SDFGL+R L 
Sbjct: 144 VCKVSDFGLSRRLE 157

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 70.3 bits (173), Expect = 3e-15
 Identities = 40/157 (25%), Positives = 74/157 (47%), Gaps = 7/157 (4%)

Query: 4   PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQ-EYMLIYEYMPKR 62
             G+ +A+K +  +S +  E+  NE+ +  K +H N+++       + E  ++ E+    
Sbjct: 23  RTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGG 82

Query: 63  SLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKP 122
           SL   L        L   +  ++ K +++GL YL       IIHRD+K +NILL  D + 
Sbjct: 83  SLKDLL--KSTNQTLTESQIAYVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEV 137

Query: 123 KISDFGLA-RILRKMILKQIQIELGYIPPEYVGRGVY 158
           K+ DFGL+ ++        +     ++ PE +    Y
Sbjct: 138 KLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPY 174

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 70.4 bits (172), Expect = 3e-15
 Identities = 48/164 (29%), Positives = 83/164 (50%), Gaps = 20/164 (12%)

Query: 9   IAVKKLSKKSTQG-FEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDY 66
           +A+K L    T+   ++F +E  +  +  H N+IR+ G   + +  M+I EYM   +LD 
Sbjct: 36  VAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDK 95

Query: 67  FL------FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL 120
           +L      F   ++        V +++GI  G+ YL +   +  +HRDL   NIL++ +L
Sbjct: 96  YLRDHDGEFSSYQL--------VGMLRGIAAGMKYLSD---MNYVHRDLAARNILVNSNL 144

Query: 121 KPKISDFGLARILRKMILKQIQIELGYIPPEYVG-RGVYYKKFS 163
           + K+SDFGL+R+L            G IP  +     + Y+KF+
Sbjct: 145 ECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFT 188

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 70.5 bits (172), Expect = 3e-15
 Identities = 51/175 (29%), Positives = 89/175 (50%), Gaps = 24/175 (13%)

Query: 5   DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRS 63
           D  ++AVK L   S    ++F  E  L   LQH ++++  G C+E    ++++EYM    
Sbjct: 34  DKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGD 93

Query: 64  LDYFL--FDPIRMLI--------LDCKKRVHIIKGIIQGLLYL-QEYFRLTIIHRDLKVS 112
           L+ FL    P  +L+        L   + +HI + I  G++YL  ++F    +HRDL   
Sbjct: 94  LNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHF----VHRDLATR 149

Query: 113 NILLDEDLKPKISDFGLARILRKMILKQI----QIELGYIPPEYVGRGVYYKKFS 163
           N L+ E+L  KI DFG++R +      ++     + + ++PPE     + Y+KF+
Sbjct: 150 NCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPE----SIMYRKFT 200

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 69.9 bits (171), Expect = 5e-15
 Identities = 48/128 (37%), Positives = 72/128 (56%), Gaps = 7/128 (5%)

Query: 7   QIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIY-EYMPKRSLD 65
             +A+K L K+ +   E F  E  L  +LQH  L+R+ + + TQE + I  EYM   SL 
Sbjct: 31  TKVAIKSL-KQGSMSPEAFLAEANLMKQLQHPRLVRL-YAVVTQEPIYIITEYMENGSLV 88

Query: 66  YFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKIS 125
            FL  P   + L   K + +   I +G+ +++   R   IHRDL+ +NIL+ E L  KI+
Sbjct: 89  DFLKTP-EGIKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIA 144

Query: 126 DFGLARIL 133
           DFGLAR++
Sbjct: 145 DFGLARLI 152

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 69.9 bits (171), Expect = 6e-15
 Identities = 43/133 (32%), Positives = 71/133 (53%), Gaps = 19/133 (14%)

Query: 9   IAVKKLSKKST-QGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDY 66
           +A+K L    T +   +F +E  +  +  H N+I + G   +++  M+I E+M   +LD 
Sbjct: 35  VAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDS 94

Query: 67  FL------FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL 120
           FL      F  I++        V +++GI  G+ YL E   +  +HRDL   NIL++ +L
Sbjct: 95  FLRQNDGQFTVIQL--------VGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNL 143

Query: 121 KPKISDFGLARIL 133
             K+SDFGL+R L
Sbjct: 144 VCKVSDFGLSRFL 156

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 69.1 bits (170), Expect = 7e-15
 Identities = 45/160 (28%), Positives = 71/160 (44%), Gaps = 12/160 (7%)

Query: 5   DGQIIAVKKLSKKS---TQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMP 60
            G++ A+K L KK     +  E    E  + +++ H  ++++ +  +T+E + L+ EY P
Sbjct: 17  TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAP 76

Query: 61  KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL 120
              L   L         +  +       I+  L YL     L II+RDLK  NILLD D 
Sbjct: 77  GGELFSHL-SKEGRFSEERARF--YAAEIVLALEYLH---SLGIIYRDLKPENILLDADG 130

Query: 121 KPKISDFGLARIL--RKMILKQIQIELGYIPPEYVGRGVY 158
             K++DFGLA+ L               Y+ PE +    Y
Sbjct: 131 HIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGY 170

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 69.3 bits (170), Expect = 8e-15
 Identities = 47/127 (37%), Positives = 67/127 (52%), Gaps = 8/127 (6%)

Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSL-DY 66
           +AVK L K  T   E F  E  +  KL+H  L+++   C E +   ++ EYM K SL D+
Sbjct: 33  VAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDF 91

Query: 67  FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISD 126
                 + L L     V +   I +G+ YL+       IHRDL   NIL+ E+L  KI+D
Sbjct: 92  LKSGEGKKLRLPQ--LVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIAD 146

Query: 127 FGLARIL 133
           FGLAR++
Sbjct: 147 FGLARLI 153

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 68.8 bits (168), Expect = 1e-14
 Identities = 49/164 (29%), Positives = 82/164 (50%), Gaps = 20/164 (12%)

Query: 9   IAVKKLSKKSTQG-FEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDY 66
           +A+K L    T+    +F +E  +  +  H N+I + G   +++  M++ EYM   SLD 
Sbjct: 35  VAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDA 94

Query: 67  FL------FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL 120
           FL      F  I++        V +++GI  G+ YL +   +  +HRDL   NIL++ +L
Sbjct: 95  FLRKHDGQFTVIQL--------VGMLRGIASGMKYLSD---MGYVHRDLAARNILVNSNL 143

Query: 121 KPKISDFGLARILRKMILKQIQIELGYIPPEYVG-RGVYYKKFS 163
             K+SDFGL+R+L            G IP  +     + Y+KF+
Sbjct: 144 VCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFT 187

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 68.6 bits (168), Expect = 2e-14
 Identities = 42/132 (31%), Positives = 65/132 (49%), Gaps = 9/132 (6%)

Query: 6   GQIIAVKKLSKKS-TQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQ---EYMLIYEYMPK 61
           G+ +AVK L+     Q   +F+ E+ +   L H N+++     E        LI EY+P 
Sbjct: 33  GEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPS 92

Query: 62  RSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK 121
            SL  +L        ++ K+ +     I +G+ YL        IHRDL   NIL++ +  
Sbjct: 93  GSLRDYL--QRHRDQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDL 147

Query: 122 PKISDFGLARIL 133
            KISDFGLA++L
Sbjct: 148 VKISDFGLAKVL 159

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 68.1 bits (166), Expect = 3e-14
 Identities = 49/178 (27%), Positives = 89/178 (50%), Gaps = 27/178 (15%)

Query: 5   DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRS 63
           D  ++AVK L   +    ++F+ E  L   LQH ++++  G C +    ++++EYM    
Sbjct: 34  DKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGD 93

Query: 64  LDYFL--FDPIRMLILDCKKR-----------VHIIKGIIQGLLYL-QEYFRLTIIHRDL 109
           L+ FL    P  M+++D + R           +HI   I  G++YL  ++F    +HRDL
Sbjct: 94  LNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHF----VHRDL 149

Query: 110 KVSNILLDEDLKPKISDFGLARILRKMILKQI----QIELGYIPPEYVGRGVYYKKFS 163
              N L+  +L  KI DFG++R +      ++     + + ++PPE     + Y+KF+
Sbjct: 150 ATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPE----SIMYRKFT 203

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 67.3 bits (164), Expect = 5e-14
 Identities = 49/176 (27%), Positives = 85/176 (48%), Gaps = 24/176 (13%)

Query: 5   DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRS 63
           D  ++AVK L + S    ++F+ E  L   LQH +++R  G C E +  ++++EYM    
Sbjct: 34  DKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGD 93

Query: 64  LDYFL--FDPIRMLI----------LDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKV 111
           L+ FL    P   ++          L   + + I   I  G++YL     L  +HRDL  
Sbjct: 94  LNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLAS---LHFVHRDLAT 150

Query: 112 SNILLDEDLKPKISDFGLARILRKM----ILKQIQIELGYIPPEYVGRGVYYKKFS 163
            N L+ + L  KI DFG++R +       +  +  + + ++PPE     + Y+KF+
Sbjct: 151 RNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPE----SILYRKFT 202

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 65.8 bits (160), Expect = 2e-13
 Identities = 53/178 (29%), Positives = 84/178 (47%), Gaps = 27/178 (15%)

Query: 6   GQIIAVKKLSK-KSTQGFEEFKNEVMLTAKLQHLNLI-RVGFCIETQEYMLIYEYMPKRS 63
            Q++A+K L    + Q + EF+ E  L A+L H N++  +G   + Q   +++EY+ +  
Sbjct: 34  AQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGD 93

Query: 64  LDYFLF--------------DPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDL 109
           L  FL               D      LD    +HI   I  G+ YL  +F    +H+DL
Sbjct: 94  LHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDL 150

Query: 110 KVSNILLDEDLKPKISDFGLARILRKMILKQIQ----IELGYIPPEYVGRGVYYKKFS 163
              NIL+ E L  KISD GL+R +      ++Q    + + ++PPE     + Y KFS
Sbjct: 151 AARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPE----AIMYGKFS 204

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 65.3 bits (159), Expect = 2e-13
 Identities = 38/130 (29%), Positives = 68/130 (52%), Gaps = 6/130 (4%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSL 64
              +AVK L K+ T   EEF  E  +  +++H NL++ +G C     + +I E+M   +L
Sbjct: 31  SLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL 89

Query: 65  DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKI 124
             +L +  R   ++    +++   I   + YL+   +   IHRDL   N L+ E+   K+
Sbjct: 90  LDYLRECNRQE-VNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKV 145

Query: 125 SDFGLARILR 134
           +DFGL+R++ 
Sbjct: 146 ADFGLSRLMT 155

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 64.7 bits (157), Expect = 4e-13
 Identities = 47/127 (37%), Positives = 70/127 (55%), Gaps = 8/127 (6%)

Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKRSL-DY 66
           +AVK L K  T   + F  E  L   LQH  L+R+   +  +E + +I EYM K SL D+
Sbjct: 33  VAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDF 91

Query: 67  FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISD 126
              D    ++L   K +     I +G+ Y++   R   IHRDL+ +N+L+ E L  KI+D
Sbjct: 92  LKSDEGGKVLL--PKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIAD 146

Query: 127 FGLARIL 133
           FGLAR++
Sbjct: 147 FGLARVI 153

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 64.1 bits (157), Expect = 7e-13
 Identities = 52/159 (32%), Positives = 77/159 (48%), Gaps = 22/159 (13%)

Query: 5   DGQIIAVKKLSKKSTQGFEEF----KNEVMLTAKLQHLNLIR----VGFCIETQEYMLIY 56
            G+++A+KK+  +     E F      E+ L  KL+H N++R    V    +   YM ++
Sbjct: 23  TGELVALKKI--RMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYM-VF 79

Query: 57  EYMPKRSLDYFLFDP-IRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNIL 115
           EYM    L   L  P ++      K     +K +++GL YL       I+HRD+K SNIL
Sbjct: 80  EYMD-HDLTGLLDSPEVKFTESQIK---CYMKQLLEGLQYLH---SNGILHRDIKGSNIL 132

Query: 116 LDEDLKPKISDFGLARILRKMILKQIQ---IELGYIPPE 151
           ++ D   K++DFGLAR   K          I L Y PPE
Sbjct: 133 INNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPE 171

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 63.8 bits (155), Expect = 8e-13
 Identities = 43/130 (33%), Positives = 64/130 (49%), Gaps = 6/130 (4%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLD 65
           GQ +AVK +    T   + F  E  +  KL H NL+R+   I      ++ E M K +L 
Sbjct: 29  GQKVAVKNIKCDVTA--QAFLEETAVMTKLHHKNLVRLLGVILHNGLYIVMELMSKGNLV 86

Query: 66  YFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKIS 125
            FL    R L+    + +     + +G+ YL+      ++HRDL   NIL+ ED   K+S
Sbjct: 87  NFLRTRGRALV-SVIQLLQFSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVS 142

Query: 126 DFGLARILRK 135
           DFGLAR+   
Sbjct: 143 DFGLARVGSM 152

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 63.9 bits (155), Expect = 8e-13
 Identities = 43/140 (30%), Positives = 67/140 (47%), Gaps = 18/140 (12%)

Query: 7   QIIAVKKLSKKSTQGF-EEFKNEVMLTAKLQHLNLI-RVGFCIETQEYMLIYEYMPKRSL 64
           Q +A+K L  K+     EEFK+E M+ ++LQH N++  +G   + Q   +I+ Y     L
Sbjct: 36  QAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDL 95

Query: 65  DYFLF-------------DPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKV 111
             FL              D      L+    VHI+  I  G+ +L  +    ++H+DL  
Sbjct: 96  HEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLAT 152

Query: 112 SNILLDEDLKPKISDFGLAR 131
            N+L+ + L  KISD GL R
Sbjct: 153 RNVLVFDKLNVKISDLGLFR 172

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 63.7 bits (155), Expect = 1e-12
 Identities = 46/139 (33%), Positives = 70/139 (50%), Gaps = 16/139 (11%)

Query: 9   IAVKKLSKKST-QGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSLDY 66
           +AVK L K +T Q  +EF  E  L +   H N+++ +G C+  +   +I E M    L  
Sbjct: 29  VAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLS 88

Query: 67  FLFDPIRML-----ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE--- 118
           +L D  R+      +L  K+ + I   + +G +YL+   ++  IHRDL   N L+ E   
Sbjct: 89  YLRDA-RVERFGPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGY 144

Query: 119 --DLKPKISDFGLARILRK 135
             D   KI DFGLAR + K
Sbjct: 145 DADRVVKIGDFGLARDIYK 163

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 63.6 bits (155), Expect = 1e-12
 Identities = 42/141 (29%), Positives = 68/141 (48%), Gaps = 18/141 (12%)

Query: 5   DGQIIAVKKLSKKSTQGFEE-FKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKR 62
           D +++AVK L + ++    + F+ E  L    QH N+++  G C E    ++++EYM   
Sbjct: 34  DKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHG 93

Query: 63  SLDYFLF----DPIRMLILDCKKR-------VHIIKGIIQGLLYLQ-EYFRLTIIHRDLK 110
            L+ FL     D   +   D           + I   I  G++YL  ++F    +HRDL 
Sbjct: 94  DLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHF----VHRDLA 149

Query: 111 VSNILLDEDLKPKISDFGLAR 131
             N L+  DL  KI DFG++R
Sbjct: 150 TRNCLVGYDLVVKIGDFGMSR 170

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 63.5 bits (154), Expect = 1e-12
 Identities = 46/126 (36%), Positives = 69/126 (54%), Gaps = 7/126 (5%)

Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFL 68
           +AVK L K  T   E F  E  +  KL+H  L+++   +  +   ++ EYM K SL  FL
Sbjct: 33  VAVKTL-KPGTMSPESFLEEAQIMKKLRHDKLVQLYAVVSEEPIYIVTEYMSKGSLLDFL 91

Query: 69  FD-PIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDF 127
            D   R L L     V +   +  G+ Y++   R+  IHRDL+ +NIL+ + L  KI+DF
Sbjct: 92  KDGEGRALKL--PNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADF 146

Query: 128 GLARIL 133
           GLAR++
Sbjct: 147 GLARLI 152

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 63.1 bits (153), Expect = 1e-12
 Identities = 42/125 (33%), Positives = 69/125 (55%), Gaps = 5/125 (4%)

Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFL 68
           +A+K L K  T   E F  E  +  KL+H  L+++   +  +   ++ EYM K SL  FL
Sbjct: 33  VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFL 91

Query: 69  FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFG 128
              +    L   + V +   I  G+ Y++   R+  +HRDL+ +NIL+ E+L  K++DFG
Sbjct: 92  KGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFG 147

Query: 129 LARIL 133
           LAR++
Sbjct: 148 LARLI 152

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 62.4 bits (152), Expect = 2e-12
 Identities = 42/136 (30%), Positives = 65/136 (47%), Gaps = 11/136 (8%)

Query: 3   LPDGQII--AVKKLSK-KSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEY 58
           +  G+ +  AVK L +     G +EF  E  + A+L H  ++R +G C      ML+ E 
Sbjct: 18  MKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEP-LMLVMEL 76

Query: 59  MPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE 118
            P   L  +L     + + D K+  H +     G+ YL+       +HRDL   N+LL  
Sbjct: 77  APLGPLLKYLKKRREIPVSDLKELAHQVA---MGMAYLES---KHFVHRDLAARNVLLVN 130

Query: 119 DLKPKISDFGLARILR 134
             + KISDFG++R L 
Sbjct: 131 RHQAKISDFGMSRALG 146

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 62.4 bits (152), Expect = 3e-12
 Identities = 45/137 (32%), Positives = 58/137 (42%), Gaps = 27/137 (19%)

Query: 9   IAVKKLSKKSTQG-FEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYF 67
           +AVK L         ++F  E  +   L H NLIR+   + T   M++ E  P  SL   
Sbjct: 26  VAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTELAPLGSL--- 82

Query: 68  LFDPIRMLILDCKKR-------VHII----KGIIQGLLYLQEYFRLTIIHRDLKVSNILL 116
                    LD  ++       +  +      I  G+ YL E  R   IHRDL   NILL
Sbjct: 83  ---------LDRLRKDALGHFLISTLCDYAVQIANGMRYL-ESKRF--IHRDLAARNILL 130

Query: 117 DEDLKPKISDFGLARIL 133
             D K KI DFGL R L
Sbjct: 131 ASDDKVKIGDFGLMRAL 147

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 62.2 bits (151), Expect = 4e-12
 Identities = 41/137 (29%), Positives = 73/137 (53%), Gaps = 22/137 (16%)

Query: 6   GQIIAVKKLS----KKSTQG--FEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEY 58
           G ++AVK+++      S Q    E  + E+ L A+L H ++IR +G   E   + L  E+
Sbjct: 25  GTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEW 84

Query: 59  MPKRSLDYFL--FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL 116
           M   S+ + L  +   +  ++     ++  + +++GL YL E     IIHRD+K +N+L+
Sbjct: 85  MAGGSVSHLLSKYGAFKEAVI-----INYTEQLLRGLSYLHEN---QIIHRDVKGANLLI 136

Query: 117 D---EDLKPKISDFGLA 130
           D   + L  +I+DFG A
Sbjct: 137 DSTGQRL--RIADFGAA 151

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 62.0 bits (151), Expect = 4e-12
 Identities = 39/134 (29%), Positives = 63/134 (47%), Gaps = 13/134 (9%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKN----EVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMP 60
           G+I+A+KK   K ++  E+ K     EV +  +L+H N++             L++EY+ 
Sbjct: 26  GEIVAIKKF--KESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVE 83

Query: 61  KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL 120
           +  L+     P  +     +     I  ++Q + Y        IIHRD+K  NIL+ E  
Sbjct: 84  RTLLELLEASPGGLPPDAVRS---YIWQLLQAIAYCH---SHNIIHRDIKPENILVSESG 137

Query: 121 KPKISDFGLARILR 134
             K+ DFG AR LR
Sbjct: 138 VLKLCDFGFARALR 151

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 61.7 bits (150), Expect = 5e-12
 Identities = 41/131 (31%), Positives = 67/131 (51%), Gaps = 8/131 (6%)

Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSL-DY 66
           +AVK L K  T   ++F  E  +  KL+H  LI++   C   +   ++ E M   SL +Y
Sbjct: 33  VAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEY 91

Query: 67  FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISD 126
                 R L L   + + +   +  G+ YL+       IHRDL   N+L+ E+   K++D
Sbjct: 92  LQGGAGRALKL--PQLIDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVAD 146

Query: 127 FGLARILRKMI 137
           FGLAR++++ I
Sbjct: 147 FGLARVIKEDI 157

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 62.5 bits (150), Expect = 5e-12
 Identities = 51/163 (31%), Positives = 73/163 (44%), Gaps = 17/163 (10%)

Query: 5   DGQIIAVKKLSKKST---QGFEEFKNEVMLTAKLQHLNLI--RVGFCIETQEYMLIYEYM 59
           D +++A+K L+KK     +  E F  E+ + A L H   I     F  +     L+ EY+
Sbjct: 21  DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYV 80

Query: 60  PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
              SL+  L    R   L   + + I+  I+  L YL       IIHRD+K  NILLD D
Sbjct: 81  DGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS---KGIIHRDIKPENILLDRD 137

Query: 120 L-KPKISDFGLARILRKMILKQIQIEL--------GYIPPEYV 153
               K+ DFGLA++L           L        GY+ PE +
Sbjct: 138 GRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVL 180

Length = 384

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 61.3 bits (149), Expect = 7e-12
 Identities = 50/166 (30%), Positives = 75/166 (45%), Gaps = 15/166 (9%)

Query: 1   GVLPDGQIIAVKKLSKKSTQGF-EEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEY 58
           GVL     +AVK            +F  E  +  +  H N+++ +G C++ Q   ++ E 
Sbjct: 14  GVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMEL 73

Query: 59  MPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE 118
           +P  SL  FL      L +  KK + +      G+ YL+       IHRDL   N L+ E
Sbjct: 74  VPGGSLLTFLRKKKNRLTV--KKLLQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGE 128

Query: 119 DLKPKISDFGLARILRKMI------LKQIQIELGYIPPEYVGRGVY 158
           +   KISDFG++R     I      LKQI I+  +  PE +  G Y
Sbjct: 129 NNVLKISDFGMSREEEGGIYTVSDGLKQIPIK--WTAPEALNYGRY 172

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 60.9 bits (148), Expect = 1e-11
 Identities = 43/166 (25%), Positives = 75/166 (45%), Gaps = 14/166 (8%)

Query: 7   QIIAVKKLSKKSTQGFE-EFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSL 64
            ++ VK L K   +  + EF+ E+ +  KL H N++R +G C E + + +I EY     L
Sbjct: 36  TLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDL 95

Query: 65  DYFL------FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE 118
             FL       + ++   L  K++V +   I  G+ +L        +HRDL   N L+  
Sbjct: 96  KQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHL---SNARFVHRDLAARNCLVSS 152

Query: 119 DLKPKISDFGLARILRK---MILKQIQIELGYIPPEYVGRGVYYKK 161
             + K+S   L++ +       L+   I L ++ PE V    +  K
Sbjct: 153 QREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTK 198

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 60.4 bits (146), Expect = 1e-11
 Identities = 40/126 (31%), Positives = 65/126 (51%), Gaps = 7/126 (5%)

Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSL-DYF 67
           +AVK + K  +   E F  E  +   LQH  L+++   +  +   +I E+M K SL D+ 
Sbjct: 33  VAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFL 91

Query: 68  LFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDF 127
             D      L   K +     I +G+ ++++      IHRDL+ +NIL+   L  KI+DF
Sbjct: 92  KSDEGSKQPL--PKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADF 146

Query: 128 GLARIL 133
           GLAR++
Sbjct: 147 GLARVI 152

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 60.4 bits (147), Expect = 2e-11
 Identities = 38/133 (28%), Positives = 61/133 (45%), Gaps = 13/133 (9%)

Query: 9   IAVKKLSKKSTQ-GFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDY 66
           +AVK L   ++    E+F  EV + ++L   N+ R+ G C       +I EYM    L+ 
Sbjct: 49  VAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108

Query: 67  FL--------FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE 118
           FL                L     +++   I  G+ YL+    L  +HRDL   N L+ +
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLVGK 165

Query: 119 DLKPKISDFGLAR 131
           +   KI+DFG++R
Sbjct: 166 NYTIKIADFGMSR 178

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 60.1 bits (146), Expect = 2e-11
 Identities = 34/127 (26%), Positives = 70/127 (55%), Gaps = 8/127 (6%)

Query: 9   IAVKKLSKKST-QGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSLDY 66
           +A+K L ++++ +  +E  +E  + A + H +++R +G C+ + +  LI + MP   L  
Sbjct: 39  VAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICL-SSQVQLITQLMPLGCLLD 97

Query: 67  FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISD 126
           ++ +    +    +  ++    I +G+ YL+E     ++HRDL   N+L+      KI+D
Sbjct: 98  YVRNHKDNI--GSQYLLNWCVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITD 152

Query: 127 FGLARIL 133
           FGLA++L
Sbjct: 153 FGLAKLL 159

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 59.7 bits (144), Expect = 2e-11
 Identities = 42/125 (33%), Positives = 68/125 (54%), Gaps = 5/125 (4%)

Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFL 68
           +A+K L K  T   E F  E  +  KL+H  L+ +   +  +   ++ E+M K SL  FL
Sbjct: 33  VAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEFMGKGSLLDFL 91

Query: 69  FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFG 128
            +      L   + V +   I  G+ Y++   R+  IHRDL+ +NIL+ ++L  KI+DFG
Sbjct: 92  KEGDGKY-LKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFG 147

Query: 129 LARIL 133
           LAR++
Sbjct: 148 LARLI 152

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 59.6 bits (145), Expect = 3e-11
 Identities = 36/135 (26%), Positives = 64/135 (47%), Gaps = 13/135 (9%)

Query: 5   DGQIIAVKKLSKKSTQGFEEFKN--EVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPK 61
            G+I+A+KK+  +            E+ L  +L H N+I++      +  + L++E+M  
Sbjct: 23  TGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM-- 80

Query: 62  RSLDYFLFDPIRM--LILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
              D  L+  I+     L        +  ++QGL +        I+HRDLK  N+L++ +
Sbjct: 81  ---DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTE 134

Query: 120 LKPKISDFGLARILR 134
              K++DFGLAR   
Sbjct: 135 GVLKLADFGLARSFG 149

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 59.8 bits (145), Expect = 3e-11
 Identities = 39/137 (28%), Positives = 69/137 (50%), Gaps = 17/137 (12%)

Query: 6   GQIIAVKKL----------SKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLI 55
           G+++AVK++            +     +  ++E+     L HLN+++      T+EY+ I
Sbjct: 26  GEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSI 85

Query: 56  Y-EYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNI 114
           + EY+P  S+   L    R    + +      + +++GL YL       I+HRDLK  N+
Sbjct: 86  FLEYVPGGSIGSCLRTYGR---FEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNL 139

Query: 115 LLDEDLKPKISDFGLAR 131
           L+D D   KISDFG+++
Sbjct: 140 LVDADGICKISDFGISK 156

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 59.0 bits (143), Expect = 4e-11
 Identities = 40/132 (30%), Positives = 61/132 (46%), Gaps = 12/132 (9%)

Query: 9   IAVKKLSKKSTQGFEE-FKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSLDY 66
           +AVK L +  ++  E  F  E ++ +K  H N++R +G   E     ++ E M    L  
Sbjct: 39  VAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKS 98

Query: 67  FLFD----PIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLD---ED 119
           FL +    P R   L  K  +   + + +G  YL+E      IHRD+   N LL      
Sbjct: 99  FLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE-NHF--IHRDIAARNCLLTCKGPG 155

Query: 120 LKPKISDFGLAR 131
              KI+DFG+AR
Sbjct: 156 RVAKIADFGMAR 167

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 58.5 bits (142), Expect = 6e-11
 Identities = 38/131 (29%), Positives = 67/131 (51%), Gaps = 7/131 (5%)

Query: 3   LPDGQIIAVKKLS-KKSTQGFEEFKNEVMLTAKLQHLNLIRVGFC--IETQEYMLIYEYM 59
           LP+ + +A+K++  +K     +E + EV   ++  H N+++  +   +   E  L+  Y+
Sbjct: 23  LPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKY-YTSFVVGDELWLVMPYL 81

Query: 60  PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
              SL   +        LD      ++K +++GL YL    +   IHRD+K  NILL ED
Sbjct: 82  SGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ---IHRDIKAGNILLGED 138

Query: 120 LKPKISDFGLA 130
              KI+DFG++
Sbjct: 139 GSVKIADFGVS 149

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 58.7 bits (143), Expect = 6e-11
 Identities = 40/138 (28%), Positives = 62/138 (44%), Gaps = 17/138 (12%)

Query: 5   DGQIIAVKK--LSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLI-YEYMPK 61
           DG++  +K+  LS  S +  E+  NEV +  KL H N+I+     E +  + I  EY   
Sbjct: 24  DGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADG 83

Query: 62  RSLDYFLFDPIRMLILDCKKRVH------IIKGIIQGLLYLQEYFRLTIIHRDLKVSNIL 115
             L           I   KK         I+   +Q  L L+      I+HRD+K  NI 
Sbjct: 84  GDLSQ--------KIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIF 135

Query: 116 LDEDLKPKISDFGLARIL 133
           L  +   K+ DFG++++L
Sbjct: 136 LTSNGLVKLGDFGISKVL 153

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 58.7 bits (143), Expect = 6e-11
 Identities = 47/142 (33%), Positives = 71/142 (50%), Gaps = 28/142 (19%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKN--EVMLTAKLQ-HLNLIRV-GFCIETQEYMLIYEYMPK 61
           G+++A+KK+ KK    +EE  N  EV    KL  H N++++     E  E   ++EYM  
Sbjct: 24  GELVAIKKM-KKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-- 80

Query: 62  RSLDYFLFDPIRMLILDCKKRV-------HIIKGIIQGLLYL--QEYFRLTIIHRDLKVS 112
              +  L+     L+ D K +         II  I+QGL ++    +F     HRDLK  
Sbjct: 81  ---EGNLYQ----LMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFF-----HRDLKPE 128

Query: 113 NILLDEDLKPKISDFGLARILR 134
           N+L+      KI+DFGLAR +R
Sbjct: 129 NLLVSGPEVVKIADFGLAREIR 150

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 58.2 bits (141), Expect = 8e-11
 Identities = 39/128 (30%), Positives = 66/128 (51%), Gaps = 8/128 (6%)

Query: 6   GQI-IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRS 63
           G+I +A+K + ++     ++F  E  +  KL H NL+++ G C + +   ++ EYM    
Sbjct: 27  GKIDVAIKMI-REGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGC 85

Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           L  +L +  R   L  +  + +   + + + YL+       IHRDL   N L+ ED   K
Sbjct: 86  LLNYLRE--RKGKLGTEWLLDMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVK 140

Query: 124 ISDFGLAR 131
           +SDFGLAR
Sbjct: 141 VSDFGLAR 148

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 58.4 bits (141), Expect = 9e-11
 Identities = 48/178 (26%), Positives = 88/178 (49%), Gaps = 25/178 (14%)

Query: 1   GVLPDGQIIAVKKLSKKST------QGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYM 53
           G+   GQ+IAVK++   ++      + +E+ + EV L   L+H+N+++ +G C++     
Sbjct: 19  GLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTIS 78

Query: 54  LIYEYMPKRSLDYFL--FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKV 111
           +  E++P  S+   L  F P+   +  CK      K I+ G+ YL       ++HRD+K 
Sbjct: 79  IFMEFVPGGSISSILNRFGPLPEPVF-CK----YTKQILDGVAYLHNN---CVVHRDIKG 130

Query: 112 SNILLDEDLKPKISDFGLARIL--------RKMILKQIQIELGYIPPEYVGRGVYYKK 161
           +N++L  +   K+ DFG AR L           +LK +     ++ PE +    Y +K
Sbjct: 131 NNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRK 188

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 58.0 bits (141), Expect = 1e-10
 Identities = 39/134 (29%), Positives = 69/134 (51%), Gaps = 12/134 (8%)

Query: 5   DGQIIAVKKLSKKSTQGFEEFKN-----EVMLTAKLQHLNLIRVGFCIETQEYM-LIYEY 58
            G+I+A+KK+     +  ++  N     E+ L  +L+H N+I +      +  + L++E+
Sbjct: 24  TGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEF 83

Query: 59  MPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE 118
           M    L+  + D   +L     K    +   ++GL YL   +   I+HRDLK +N+L+  
Sbjct: 84  MET-DLEKVIKDKSIVLTPADIKS--YMLMTLRGLEYLHSNW---ILHRDLKPNNLLIAS 137

Query: 119 DLKPKISDFGLARI 132
           D   K++DFGLAR 
Sbjct: 138 DGVLKLADFGLARS 151

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 57.9 bits (140), Expect = 1e-10
 Identities = 43/138 (31%), Positives = 66/138 (47%), Gaps = 24/138 (17%)

Query: 6   GQIIAVKKLS---KKSTQGFEEFKNEVMLTAKLQHLNLIRVGFC-IETQEYMLIYEYMPK 61
            +++A+KK+S   K+S + +++   EV    +L+H N I    C +      L+ EY   
Sbjct: 40  NEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLG 99

Query: 62  RSLDYFLFDPIRMLILDCKKR-------VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNI 114
            + D          IL+  K+         I  G +QGL YL  + R   IHRD+K  NI
Sbjct: 100 SASD----------ILEVHKKPLQEVEIAAICHGALQGLAYLHSHER---IHRDIKAGNI 146

Query: 115 LLDEDLKPKISDFGLARI 132
           LL E    K++DFG A +
Sbjct: 147 LLTEPGTVKLADFGSASL 164

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 57.8 bits (139), Expect = 2e-10
 Identities = 40/130 (30%), Positives = 65/130 (50%), Gaps = 10/130 (7%)

Query: 7   QIIAVKKLS---KKSTQGFEEFKNEVMLTAKLQHLNLIRVGFC-IETQEYMLIYEYMPKR 62
           +++A+KK+S   K+S + +++   EV    +++H N I    C +      L+ EY    
Sbjct: 51  EVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGS 110

Query: 63  SLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKP 122
           + D      +    L   +   I  G +QGL YL  +    +IHRD+K  NILL E  + 
Sbjct: 111 ASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQV 164

Query: 123 KISDFGLARI 132
           K++DFG A I
Sbjct: 165 KLADFGSASI 174

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 57.0 bits (138), Expect = 2e-10
 Identities = 39/137 (28%), Positives = 70/137 (51%), Gaps = 16/137 (11%)

Query: 3   LPDGQIIAVKKLS-----KKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIY- 56
           L DG   AVK++S     +   +  ++ + E+ L +KLQH N+++       ++ + I+ 
Sbjct: 22  LDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFL 81

Query: 57  EYMPKRSLDYFL--FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNI 114
           E +P  SL   L  +      ++    R      I+ GL YL +      +HRD+K +NI
Sbjct: 82  ELVPGGSLAKLLKKYGSFPEPVIRLYTR-----QILLGLEYLHDR---NTVHRDIKGANI 133

Query: 115 LLDEDLKPKISDFGLAR 131
           L+D +   K++DFG+A+
Sbjct: 134 LVDTNGVVKLADFGMAK 150

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 57.3 bits (138), Expect = 2e-10
 Identities = 41/136 (30%), Positives = 65/136 (47%), Gaps = 12/136 (8%)

Query: 8   IIAVKKLSKKSTQ-GFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLD 65
           ++AVK L    T+    +F  E+ + ++L++ N+IR+ G C+      +I EYM    L+
Sbjct: 46  LVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLN 105

Query: 66  YFLFDPIRMLILDCKKRVHIIKGIIQGLLYL-------QEYF-RLTIIHRDLKVSNILLD 117
            FL    R +        +I    I  LLY+        +Y   L  +HRDL   N L+ 
Sbjct: 106 QFLSQ--REIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG 163

Query: 118 EDLKPKISDFGLARIL 133
                KI+DFG++R L
Sbjct: 164 NHYTIKIADFGMSRNL 179

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 56.9 bits (138), Expect = 2e-10
 Identities = 41/137 (29%), Positives = 62/137 (45%), Gaps = 16/137 (11%)

Query: 4   PDGQIIAVKKLSKKSTQGFEEFKNEVM---LTAKLQHLNLIRV-GFCIETQEYMLIYEYM 59
           P G+I+AVK +  +        K  +    +  K     ++   G      +  +  EYM
Sbjct: 24  PTGKIMAVKTI--RLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81

Query: 60  PKRSLDYFL---FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL 116
              SLD  L      I   IL   K   I   +++GL YL E  +  IIHRD+K SNIL+
Sbjct: 82  DGGSLDKILKEVQGRIPERIL--GK---IAVAVLKGLTYLHE--KHKIIHRDVKPSNILV 134

Query: 117 DEDLKPKISDFGLARIL 133
           +   + K+ DFG++  L
Sbjct: 135 NSRGQIKLCDFGVSGQL 151

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 56.8 bits (137), Expect = 3e-10
 Identities = 47/132 (35%), Positives = 67/132 (50%), Gaps = 15/132 (11%)

Query: 6   GQIIAVKKLSKKSTQGFEE-FKNEVMLTAKLQHLNLIRVGFCIETQ---EYMLIYEYMPK 61
           G+++AVK L ++  Q     +K E+ +   L H N+++   C   Q      LI EY+P 
Sbjct: 33  GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPL 92

Query: 62  RSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYL--QEYFRLTIIHRDLKVSNILLDED 119
            SL  +L  P   L L   + +   + I +G+ YL  Q Y     IHRDL   N+LLD D
Sbjct: 93  GSLRDYL--PKHKLNL--AQLLLFAQQICEGMAYLHSQHY-----IHRDLAARNVLLDND 143

Query: 120 LKPKISDFGLAR 131
              KI DFGLA+
Sbjct: 144 RLVKIGDFGLAK 155

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 56.1 bits (135), Expect = 5e-10
 Identities = 34/126 (26%), Positives = 62/126 (49%), Gaps = 7/126 (5%)

Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYF 67
           +A+K + ++     E+F  E  +  KL H  L+++ G C E     L++E+M    L  +
Sbjct: 31  VAIKTI-REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDY 89

Query: 68  LFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDF 127
           L    +      +  + +   + +G+ YL+      +IHRDL   N L+ E+   K+SDF
Sbjct: 90  L--RAQRGKFSQETLLGMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDF 144

Query: 128 GLARIL 133
           G+ R +
Sbjct: 145 GMTRFV 150

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 55.6 bits (134), Expect = 7e-10
 Identities = 47/173 (27%), Positives = 69/173 (39%), Gaps = 42/173 (24%)

Query: 4   PDGQI--IAVK--KLSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEY------ 52
            DG    +AVK  KL   +    EEF +E        H N+++ +G C E          
Sbjct: 23  DDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKP 82

Query: 53  MLIYEYMPKRSLDYFLFD----------PIRMLILDCKKRVHIIKGIIQGLLYLQEYFRL 102
           M+I  +M    L  FL            P++ L+         +  I  G+ YL      
Sbjct: 83  MVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLK-------FMVDIALGMEYLSNR--- 132

Query: 103 TIIHRDLKVSNILLDEDLKPKISDFGLARIL-----------RKMILKQIQIE 144
             IHRDL   N +L ED+   ++DFGL++ +            KM +K I IE
Sbjct: 133 NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIE 185

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 56.0 bits (136), Expect = 7e-10
 Identities = 47/145 (32%), Positives = 75/145 (51%), Gaps = 30/145 (20%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKN---------EVMLTAKL-QHLNLIR---VGFCIETQEY 52
            +++A+KK+       F+ F+N         E+M   +L  H N+++   V      ++ 
Sbjct: 32  KEVVALKKI-------FDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84

Query: 53  MLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRL-TIIHRDLKV 111
            L++EYM     +  L   IR  IL   + VH  + I+  LL   +Y     +IHRDLK 
Sbjct: 85  YLVFEYM-----ETDLHAVIRANIL---EDVHK-RYIMYQLLKALKYIHSGNVIHRDLKP 135

Query: 112 SNILLDEDLKPKISDFGLARILRKM 136
           SNILL+ D + K++DFGLAR L ++
Sbjct: 136 SNILLNSDCRVKLADFGLARSLSEL 160

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 55.0 bits (132), Expect = 1e-09
 Identities = 39/128 (30%), Positives = 64/128 (50%), Gaps = 8/128 (6%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIY-EYMPKRS 63
           G  +AVK +   +T   + F  E  +  +L+H NL+++ G  +E +  + I  EYM K S
Sbjct: 29  GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 86

Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           L  +L    R  +L     +     + + + YL+       +HRDL   N+L+ ED   K
Sbjct: 87  LVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAK 142

Query: 124 ISDFGLAR 131
           +SDFGL +
Sbjct: 143 VSDFGLTK 150

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 55.2 bits (133), Expect = 1e-09
 Identities = 49/179 (27%), Positives = 85/179 (47%), Gaps = 34/179 (18%)

Query: 6   GQIIAVKK--LSKKSTQG-------FEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIY 56
           G+++AVK+  L   S           +    E+ L  +LQH N+++        +++ I+
Sbjct: 25  GELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIF 84

Query: 57  -EYMPKRSL-----DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLK 110
            EY+P  S+     +Y  F+    L+ +       ++ I++GL YL       IIHRD+K
Sbjct: 85  LEYVPGGSVAALLNNYGAFE--ETLVRN------FVRQILKGLNYLHNR---GIIHRDIK 133

Query: 111 VSNILLDEDLKPKISDFGLARILRKMILK--------QIQIELGYIPPEYVGRGVYYKK 161
            +NIL+D     KISDFG+++ L    L          +Q  + ++ PE V +  Y +K
Sbjct: 134 GANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRK 192

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 55.4 bits (133), Expect = 1e-09
 Identities = 41/133 (30%), Positives = 66/133 (49%), Gaps = 10/133 (7%)

Query: 5   DGQIIAVKKLS---KKSTQGFEEFKNEVMLTAKLQHLNLIRVGFC-IETQEYMLIYEYMP 60
           + +++A+KK+S   K+S + +++   EV    KL+H N I+   C +      L+ EY  
Sbjct: 39  NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL 98

Query: 61  KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL 120
             + D      +    L   +   +  G +QGL YL  +    +IHRD+K  NILL E  
Sbjct: 99  GSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPG 152

Query: 121 KPKISDFGLARIL 133
             K+ DFG A I+
Sbjct: 153 LVKLGDFGSASIM 165

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 54.9 bits (132), Expect = 1e-09
 Identities = 41/126 (32%), Positives = 62/126 (49%), Gaps = 7/126 (5%)

Query: 9   IAVKKLSKKST-QGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSLDY 66
           + VK+L   +T      F  EV    +L H N+++ +G CIE+  Y+L+ E+ P   L  
Sbjct: 25  VVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKN 84

Query: 67  FLFDPIRMLILDCKKRV--HIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKI 124
           +L     M+    +K V   +   +  GLL+L    +   IH DL + N  L  DL  KI
Sbjct: 85  YLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKI 141

Query: 125 SDFGLA 130
            D+GLA
Sbjct: 142 GDYGLA 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 54.9 bits (133), Expect = 2e-09
 Identities = 40/136 (29%), Positives = 66/136 (48%), Gaps = 15/136 (11%)

Query: 5   DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKRS 63
            G+ +A+KK+  +  Q  E   NE+++    +H N++         + + ++ EYM   S
Sbjct: 43  TGKEVAIKKMRLRK-QNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGS 101

Query: 64  LDYFL-FDPIRMLILDCKKRVHI---IKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
           L   +  + +RM          I    + ++QGL YL       +IHRD+K  NILL +D
Sbjct: 102 LTDIITQNFVRM------NEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKD 152

Query: 120 LKPKISDFGLARILRK 135
              K++DFG A  L K
Sbjct: 153 GSVKLADFGFAAQLTK 168

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 54.4 bits (131), Expect = 2e-09
 Identities = 39/133 (29%), Positives = 61/133 (45%), Gaps = 9/133 (6%)

Query: 5   DGQIIAVKK--LSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFC-IETQEYMLIYEYMPK 61
           D ++ A+K+  LSK + +  EE  +E  + AKL    +IR     ++  +  ++ EY   
Sbjct: 24  DKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAEN 83

Query: 62  RSL-DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL 120
             L         R L  D      + +  IQ LL L       I+HRD+K  N+ LD   
Sbjct: 84  GDLHKLLKMQRGRPLPED-----QVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYD 138

Query: 121 KPKISDFGLARIL 133
             KI D G+A++L
Sbjct: 139 NVKIGDLGVAKLL 151

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 54.5 bits (131), Expect = 2e-09
 Identities = 41/127 (32%), Positives = 63/127 (49%), Gaps = 9/127 (7%)

Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSLDYF 67
           I V++++K      +   NE  +   L H N+I      +E +  M++ EY P  +L  +
Sbjct: 33  IPVEQMTKDERLAAQ---NECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEY 89

Query: 68  LFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE-DLKPKISD 126
           +      L LD    +H     +Q LL L       I+HRDLK  NILLD+  +  KI D
Sbjct: 90  IQKRCNSL-LDEDTILHFF---VQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGD 145

Query: 127 FGLARIL 133
           FG+++IL
Sbjct: 146 FGISKIL 152

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 54.2 bits (131), Expect = 2e-09
 Identities = 31/138 (22%), Positives = 62/138 (44%), Gaps = 20/138 (14%)

Query: 3   LPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPK 61
              GQ++A+K +     +  +E   E+ +  +     +++  G   +  +  ++ EY   
Sbjct: 25  KETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGA 82

Query: 62  RSLDYFLFDPIRMLILDCKKRVH------IIKGIIQGLLYLQEYFRLTIIHRDLKVSNIL 115
            S        +  ++    K +       I+   ++GL YL        IHRD+K  NIL
Sbjct: 83  GS--------VSDIMKITNKTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNIL 131

Query: 116 LDEDLKPKISDFGLARIL 133
           L+E+ + K++DFG++  L
Sbjct: 132 LNEEGQAKLADFGVSGQL 149

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 54.2 bits (130), Expect = 3e-09
 Identities = 47/153 (30%), Positives = 70/153 (45%), Gaps = 11/153 (7%)

Query: 9   IAVKKL-SKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSLDY 66
           + VK+L    S Q   +F  E      LQH NL++ +G C E   Y+L+ E+ P   L  
Sbjct: 25  VVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKG 84

Query: 67  FLFDPIRMLILDCKKRV--HIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKI 124
           +L    +  ++         +   I  GLL+L    +   IH DL + N LL  DL  KI
Sbjct: 85  YLRSCRKAELMTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKI 141

Query: 125 SDFGLARILRK----MILKQIQIELGYIPPEYV 153
            D+GL+    K    +   Q+ + L +I PE V
Sbjct: 142 GDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELV 174

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 53.7 bits (129), Expect = 3e-09
 Identities = 40/133 (30%), Positives = 64/133 (48%), Gaps = 18/133 (13%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSL 64
           GQ     K+ K+ +   +EF  E  +  KL H  L+++ G C + +   ++ EYM    L
Sbjct: 27  GQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCL 86

Query: 65  DYFL------FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE 118
             +L      F P ++L         + K + +G+ YL+       IHRDL   N L+D+
Sbjct: 87  LNYLREHGKRFQPSQLL--------EMCKDVCEGMAYLESK---QFIHRDLAARNCLVDD 135

Query: 119 DLKPKISDFGLAR 131
               K+SDFGL+R
Sbjct: 136 QGCVKVSDFGLSR 148

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 53.6 bits (129), Expect = 4e-09
 Identities = 29/76 (38%), Positives = 42/76 (55%), Gaps = 9/76 (11%)

Query: 57  EYMPKRSLD--YFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNI 114
           E+M   SLD  Y    PI + IL       I   +++GL YL  Y    I+HRD+K SNI
Sbjct: 83  EFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYL--YNVHRIMHRDIKPSNI 135

Query: 115 LLDEDLKPKISDFGLA 130
           L++   + K+ DFG++
Sbjct: 136 LVNSRGQIKLCDFGVS 151

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 53.8 bits (129), Expect = 4e-09
 Identities = 42/144 (29%), Positives = 68/144 (47%), Gaps = 21/144 (14%)

Query: 8   IIAVKKLSKKSTQGFE-EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLD 65
           ++AVK L   + +    +F  EV + ++L+  N+IR+ G C++     +I EYM    L+
Sbjct: 48  LVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLN 107

Query: 66  YFL--------------FDPI--RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDL 109
            FL                P    +  +     +H+   I  G+ YL     L  +HRDL
Sbjct: 108 QFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDL 164

Query: 110 KVSNILLDEDLKPKISDFGLARIL 133
              N L+ E+L  KI+DFG++R L
Sbjct: 165 ATRNCLVGENLTIKIADFGMSRNL 188

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 53.3 bits (128), Expect = 5e-09
 Identities = 41/153 (26%), Positives = 77/153 (50%), Gaps = 7/153 (4%)

Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSLDYF 67
           IA+K++ ++ ++  +    E+ L + L+H N+++ +G   E   + +  E +P  SL   
Sbjct: 36  IAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSAL 95

Query: 68  LFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE-DLKPKISD 126
           L      L  + +  +   K I++GL YL +     I+HRD+K  N+L++      KISD
Sbjct: 96  LRSKWGPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISD 152

Query: 127 FGLARILRKM--ILKQIQIELGYIPPEYVGRGV 157
           FG ++ L  +    +     L Y+ PE + +G 
Sbjct: 153 FGTSKRLAGINPCTETFTGTLQYMAPEVIDKGP 185

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 53.5 bits (128), Expect = 5e-09
 Identities = 40/130 (30%), Positives = 65/130 (50%), Gaps = 10/130 (7%)

Query: 7   QIIAVKKLS---KKSTQGFEEFKNEVMLTAKLQHLNLIRVGFC-IETQEYMLIYEYMPKR 62
           +++AVKK+S   K++ + +++   EV    +L+H N I    C ++     L+ EY    
Sbjct: 47  EVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGS 106

Query: 63  SLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKP 122
           + D      +    L   +   I  G +QGL YL  +    +IHRD+K  NILL E  + 
Sbjct: 107 ASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQV 160

Query: 123 KISDFGLARI 132
           K++DFG A  
Sbjct: 161 KLADFGSASK 170

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 53.3 bits (128), Expect = 5e-09
 Identities = 44/158 (27%), Positives = 75/158 (47%), Gaps = 9/158 (5%)

Query: 6   GQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPK 61
           G++ A KKL KK     +G +   NE  +  K+    ++ + +  ET++ + L+   M  
Sbjct: 18  GKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNG 77

Query: 62  RSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK 121
             L Y +++ +        + +     II GL +L +     I++RDLK  N+LLD+   
Sbjct: 78  GDLKYHIYN-VGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGN 133

Query: 122 PKISDFGLA-RILRKMILKQIQIELGYIPPEYVGRGVY 158
            +ISD GLA  +     +K      GY+ PE +   VY
Sbjct: 134 VRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVY 171

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 52.8 bits (127), Expect = 6e-09
 Identities = 48/154 (31%), Positives = 74/154 (48%), Gaps = 9/154 (5%)

Query: 3   LPDGQIIAVKK--LSKKSTQGFEEFKNEVMLTAKLQHLNLIRV--GFCIETQEYMLIYEY 58
           L D Q  A+K+  L   S +  E+  NE+ + A + H N+I     F ++  +  ++ EY
Sbjct: 22  LSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAF-LDGNKLCIVMEY 80

Query: 59  MPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE 118
            P   L   +    +   L       I +  IQ L  LQ      I+HRDLK +NILL  
Sbjct: 81  APFGDLSKAISKRKKKRKL--IPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVA 138

Query: 119 DLKPKISDFGLARILRKMILK-QIQIELGYIPPE 151
           +   KI D G++++L+K + K QI     Y+ PE
Sbjct: 139 NDLVKIGDLGISKVLKKNMAKTQIGTPH-YMAPE 171

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 52.6 bits (127), Expect = 7e-09
 Identities = 43/144 (29%), Positives = 70/144 (48%), Gaps = 18/144 (12%)

Query: 4   PDGQIIAVKKLS--KKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPK 61
            DG+I+  K++     + +  ++  +EV +  +L+H N++R    I  +    +Y  M  
Sbjct: 23  SDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM-- 80

Query: 62  RSLDYFLFDPIRMLILDCKK---RVH---IIKGIIQGLLYLQE-----YFRLTIIHRDLK 110
              +Y     +  LI  CKK    +    I + + Q LL L E         T++HRDLK
Sbjct: 81  ---EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLK 137

Query: 111 VSNILLDEDLKPKISDFGLARILR 134
            +NI LD +   K+ DFGLA+IL 
Sbjct: 138 PANIFLDANNNVKLGDFGLAKILG 161

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 52.6 bits (127), Expect = 7e-09
 Identities = 42/160 (26%), Positives = 73/160 (45%), Gaps = 20/160 (12%)

Query: 6   GQIIAVKKLSKKSTQG---FEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPK 61
           G I A+K + K         ++   E  + ++ Q   ++++ +  + ++ + L+ EY+P 
Sbjct: 18  GDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPG 77

Query: 62  RSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK 121
             L   L + +  L  D  +    I  I+  L YL       IIHRDLK  NIL+D +  
Sbjct: 78  GDL-ASLLENVGSLDEDVAR--IYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGH 131

Query: 122 PKISDFGLARI-LRKMILKQIQIE---------LGYIPPE 151
            K++DFGL+++ L +  +     E           YI PE
Sbjct: 132 LKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPE 171

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 52.7 bits (127), Expect = 8e-09
 Identities = 40/149 (26%), Positives = 58/149 (38%), Gaps = 34/149 (22%)

Query: 27  NEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHII 86
           NE  +  +L H  L+ + +  + +E M            Y + D    L+L    R H+ 
Sbjct: 49  NERRILQELNHPFLVNLWYSFQDEENM------------YLVVD----LLLGGDLRYHLS 92

Query: 87  KG--------------IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARI 132
           +               I+  L YL       IIHRD+K  NILLDE     I+DF +A  
Sbjct: 93  QKVKFSEEQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATK 149

Query: 133 LRKMILKQ-IQIELGYIPPEYVGRGVYYK 160
           +    L        GY+ PE + R  Y  
Sbjct: 150 VTPDTLTTSTSGTPGYMAPEVLCRQGYSV 178

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 52.6 bits (127), Expect = 9e-09
 Identities = 27/69 (39%), Positives = 43/69 (62%), Gaps = 4/69 (5%)

Query: 84  HIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARIL-RKMILKQIQ 142
            +++ +++G+ +L  +    I+HRDLK  NIL+  D + KI+DFGLARI   +M L  + 
Sbjct: 111 DLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVV 167

Query: 143 IELGYIPPE 151
           + L Y  PE
Sbjct: 168 VTLWYRAPE 176

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 52.8 bits (126), Expect = 9e-09
 Identities = 48/173 (27%), Positives = 94/173 (54%), Gaps = 24/173 (13%)

Query: 3   LPDGQII----AVKKLSKKS-TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIY 56
           +P+G+ +    A+K L++ +  +   EF +E ++ A + H +L+R+ G C+ +    L+ 
Sbjct: 29  VPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCL-SPTIQLVT 87

Query: 57  EYMPKRSLDYFLF---DPI--RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKV 111
           + MP   L  ++    D I  ++L+  C +       I +G++YL+E     ++HRDL  
Sbjct: 88  QLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ-------IAKGMMYLEER---RLVHRDLAA 137

Query: 112 SNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVG-RGVYYKKFS 163
            N+L+      KI+DFGLAR+L     K+   + G +P +++    ++Y+KF+
Sbjct: 138 RNVLVKSPNHVKITDFGLARLLEGD-EKEYNADGGKMPIKWMALECIHYRKFT 189

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 52.7 bits (127), Expect = 1e-08
 Identities = 41/155 (26%), Positives = 66/155 (42%), Gaps = 34/155 (21%)

Query: 4   PDGQIIAVKKL--SKKSTQGFEEFK-NEVMLTAKLQHLNLIR-VGFCIETQE---YMLIY 56
            DG+  A+KK    K+   G  +    E+ L  +L+H N++  V   +E  +   Y+L  
Sbjct: 25  KDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLF- 83

Query: 57  EYMPKRSLDYFLFD----------PIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIH 106
                   DY   D            R+ I     +  ++  I+ G+ YL   +   ++H
Sbjct: 84  --------DYAEHDLWQIIKFHRQAKRVSIPPSMVK-SLLWQILNGVHYLHSNW---VLH 131

Query: 107 RDLKVSNILL----DEDLKPKISDFGLARILRKMI 137
           RDLK +NIL+     E    KI D GLAR+    +
Sbjct: 132 RDLKPANILVMGEGPERGVVKIGDLGLARLFNAPL 166

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 52.5 bits (127), Expect = 1e-08
 Identities = 39/139 (28%), Positives = 67/139 (48%), Gaps = 27/139 (19%)

Query: 5   DGQIIAVKKLSKKSTQGFEEFK----NEVMLTAKLQHLNLIRVG--FCIETQEYMLIYEY 58
            G+I+A+KK+  +     E        E+ L  +L+H N++++      E + Y L++EY
Sbjct: 23  TGEIVALKKI--RLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLY-LVFEY 79

Query: 59  MPKRSLDYFLFDPIRMLILDCKKRV------HIIKGIIQGLLYLQEYFRLTIIHRDLKVS 112
                 D  L    +  +      +       I+  +++GL Y   +    I+HRDLK  
Sbjct: 80  C-----DMDL----KKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQ 127

Query: 113 NILLDEDLKPKISDFGLAR 131
           NIL++ D   K++DFGLAR
Sbjct: 128 NILINRDGVLKLADFGLAR 146

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 52.3 bits (125), Expect = 1e-08
 Identities = 41/146 (28%), Positives = 64/146 (43%), Gaps = 26/146 (17%)

Query: 9   IAVKKLSKKSTQG-FEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDY 66
           +AVK L + ++     +  +E  L  ++ H ++I++ G C +    +LI EY    SL  
Sbjct: 33  VAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRS 92

Query: 67  FL---------------------FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTII 105
           FL                      D      L     +     I +G+ YL E   + ++
Sbjct: 93  FLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAE---MKLV 149

Query: 106 HRDLKVSNILLDEDLKPKISDFGLAR 131
           HRDL   N+L+ E  K KISDFGL+R
Sbjct: 150 HRDLAARNVLVAEGRKMKISDFGLSR 175

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 52.4 bits (126), Expect = 1e-08
 Identities = 26/47 (55%), Positives = 34/47 (72%), Gaps = 3/47 (6%)

Query: 85  IIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLAR 131
           ++  +++GL YL E F   IIHRDLKVSN+LL +    KI+DFGLAR
Sbjct: 113 LMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR 156

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 51.8 bits (125), Expect = 2e-08
 Identities = 39/137 (28%), Positives = 67/137 (48%), Gaps = 17/137 (12%)

Query: 4   PDGQIIAVKKLSKKSTQGFE-EFKNEVMLTAKLQHLNLIRV--GFCIETQEYMLIYEYMP 60
           P G+I A+KK+     + F  +   E+      +   +++    F  E +   ++ EYM 
Sbjct: 24  PTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEIS-IVLEYMD 82

Query: 61  KRSLDYFLFD----PIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL 116
             SL   L      P  +L         I + I++GL YL    +  IIHRD+K SN+L+
Sbjct: 83  GGSLADLLKKVGKIPEPVLAY-------IARQILKGLDYLHT--KRHIIHRDIKPSNLLI 133

Query: 117 DEDLKPKISDFGLARIL 133
           +   + KI+DFG++++L
Sbjct: 134 NSKGEVKIADFGISKVL 150

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 51.5 bits (123), Expect = 2e-08
 Identities = 49/165 (29%), Positives = 76/165 (46%), Gaps = 14/165 (8%)

Query: 1   GVLPDGQIIAVKKLSKKSTQGFE-EFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEY 58
           G L D   +AVK   +   Q  + +F +E  +  +  H N+++ +G C + Q   ++ E 
Sbjct: 14  GTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMEL 73

Query: 59  MPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE 118
           +P    D+  F   +   L  K+ V        G+ YL+       IHRDL   N L+ E
Sbjct: 74  VPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGE 128

Query: 119 DLKPKISDFGLAR-----ILRKMILKQIQIELGYIPPEYVGRGVY 158
           +   KISDFG++R     I     LKQI I+  +  PE +  G Y
Sbjct: 129 NNVLKISDFGMSRQEDDGIYSSSGLKQIPIK--WTAPEALNYGRY 171

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 52.1 bits (125), Expect = 2e-08
 Identities = 28/83 (33%), Positives = 45/83 (54%), Gaps = 10/83 (12%)

Query: 51  EYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLK 110
           E  ++ E+M   SL+          I D +    + + I+ G+ YL    R  I+HRD+K
Sbjct: 146 EIQVLLEFMDGGSLE-------GTHIADEQFLADVARQILSGIAYLH---RRHIVHRDIK 195

Query: 111 VSNILLDEDLKPKISDFGLARIL 133
            SN+L++     KI+DFG++RIL
Sbjct: 196 PSNLLINSAKNVKIADFGVSRIL 218

Length = 353

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 51.8 bits (125), Expect = 2e-08
 Identities = 18/30 (60%), Positives = 23/30 (76%)

Query: 104 IIHRDLKVSNILLDEDLKPKISDFGLARIL 133
           +IHRDLK SNIL++ +   KI DFGLAR +
Sbjct: 124 VIHRDLKPSNILVNSNCDLKICDFGLARGV 153

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 51.5 bits (123), Expect = 2e-08
 Identities = 47/154 (30%), Positives = 80/154 (51%), Gaps = 16/154 (10%)

Query: 5   DGQIIAVKKLSKKSTQG--FEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPK 61
           +GQ++A+K +S K+ +G  F   + E  L   L+H N++ +   I T+E +  ++EYM  
Sbjct: 29  NGQLVALKVISMKTEEGVPFTAIR-EASLLKGLKHANIVLLHDIIHTKETLTFVFEYMHT 87

Query: 62  RSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK 121
               Y +  P  +       R+ + + +++GL Y+       I+HRDLK  N+L+    +
Sbjct: 88  DLAQYMIQHPGGLH--PYNVRLFMFQ-LLRGLAYIH---GQHILHRDLKPQNLLISYLGE 141

Query: 122 PKISDFGLARILRKMILKQIQ----IELGYIPPE 151
            K++DFGLAR   K I  Q      + L Y PP+
Sbjct: 142 LKLADFGLAR--AKSIPSQTYSSEVVTLWYRPPD 173

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 51.3 bits (123), Expect = 3e-08
 Identities = 39/128 (30%), Positives = 71/128 (55%), Gaps = 6/128 (4%)

Query: 6   GQIIAVKKLSKKSTQGFEEFK-NEVMLTAKLQHLNLIRVGFCIETQ-EYMLIYEYMPKRS 63
           G+I+A+K++   + +G       E+ L  +L+H N++R+   I T+ + ML++EYM K  
Sbjct: 25  GEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDKDL 84

Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
             Y     +R   LD          +++G+ +  E     ++HRDLK  N+L+++  + K
Sbjct: 85  KKYMDTHGVRG-ALDPNTVKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELK 140

Query: 124 ISDFGLAR 131
           ++DFGLAR
Sbjct: 141 LADFGLAR 148

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 51.4 bits (123), Expect = 3e-08
 Identities = 41/144 (28%), Positives = 65/144 (45%), Gaps = 38/144 (26%)

Query: 6   GQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVG--FCIETQEYMLIYEYM-- 59
           GQ +A+KK+ K   +    +    E+ L   L+H N+I +   F    ++   + E +  
Sbjct: 35  GQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELLGT 94

Query: 60  -----------PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRD 108
                       K+ + YFL+                   I++GL Y+       ++HRD
Sbjct: 95  DLHRLLTSRPLEKQFIQYFLYQ------------------ILRGLKYVHS---AGVVHRD 133

Query: 109 LKVSNILLDEDLKPKISDFGLARI 132
           LK SNIL++E+   KI DFGLARI
Sbjct: 134 LKPSNILINENCDLKICDFGLARI 157

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 50.9 bits (122), Expect = 3e-08
 Identities = 46/163 (28%), Positives = 78/163 (47%), Gaps = 28/163 (17%)

Query: 4   PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNL-IRVGFCIETQEYM--------- 53
           P G I+AVK++  ++T   +E K  +M       L++ +R   C  T  +          
Sbjct: 24  PTGTIMAVKRI--RATVNSQEQKRLLM------DLDISMRSVDCPYTVTFYGALFREGDV 75

Query: 54  -LIYEYMPKRSLDYF---LFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDL 109
            +  E M   SLD F   ++D    +  D   +  I   I++ L YL    +L++IHRD+
Sbjct: 76  WICMEVM-DTSLDKFYKKVYDKGLTIPEDILGK--IAVSIVKALEYLHS--KLSVIHRDV 130

Query: 110 KVSNILLDEDLKPKISDFGLARILRKMILKQIQIELG-YIPPE 151
           K SN+L++ + + K+ DFG++  L   + K I      Y+ PE
Sbjct: 131 KPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPE 173

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 50.9 bits (122), Expect = 4e-08
 Identities = 44/140 (31%), Positives = 67/140 (47%), Gaps = 26/140 (18%)

Query: 6   GQIIAVKKLSK------KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCI-------ETQEY 52
           GQ +A+KKLS+       + + + E    +M      H N+I +           E Q+ 
Sbjct: 41  GQNVAIKKLSRPFQNVTHAKRAYRELV--LMKLVN--HKNIIGLLNVFTPQKSLEEFQDV 96

Query: 53  MLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVS 112
            L+ E M     D  L   I+M  LD ++  +++  ++ G+ +L       IIHRDLK S
Sbjct: 97  YLVMELM-----DANLCQVIQMD-LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPS 147

Query: 113 NILLDEDLKPKISDFGLARI 132
           NI++  D   KI DFGLAR 
Sbjct: 148 NIVVKSDCTLKILDFGLART 167

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 51.0 bits (122), Expect = 4e-08
 Identities = 36/133 (27%), Positives = 71/133 (53%), Gaps = 16/133 (12%)

Query: 6   GQIIAVKKLS-KKSTQGFEEFK-NEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKR 62
           G+++A+KK+     T+G       E+ L  +L H N++++   I T+  + L++E++ + 
Sbjct: 25  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD 84

Query: 63  SLDYFLFDPIRMLILDCKKRVHIIKG----IIQGLLYLQEYFRLTIIHRDLKVSNILLDE 118
              +    P+  + L       +IK     ++QGL +   +    ++HRDLK  N+L++ 
Sbjct: 85  LKKFMDASPLSGIPL------PLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINT 135

Query: 119 DLKPKISDFGLAR 131
           +   K++DFGLAR
Sbjct: 136 EGAIKLADFGLAR 148

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 50.7 bits (122), Expect = 4e-08
 Identities = 40/139 (28%), Positives = 66/139 (47%), Gaps = 25/139 (17%)

Query: 6   GQIIAVKKL-SKKSTQGFEEFKNEVMLTAK----LQHLNLIR------VGFCIETQEYML 54
           G+ +A+KK+  ++   G     N+ +   K     QH  +++       G        +L
Sbjct: 25  GETVALKKVALRRLEGGIP---NQALREIKALQACQHPYVVKLLDVFPHGSGF-----VL 76

Query: 55  IYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNI 114
           + EYMP   L   L D  R L     K    ++ +++G+ Y+       I+HRDLK +N+
Sbjct: 77  VMEYMP-SDLSEVLRDEERPLPEAQVKS--YMRMLLKGVAYMHA---NGIMHRDLKPANL 130

Query: 115 LLDEDLKPKISDFGLARIL 133
           L+  D   KI+DFGLAR+ 
Sbjct: 131 LISADGVLKIADFGLARLF 149

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 50.6 bits (121), Expect = 4e-08
 Identities = 34/112 (30%), Positives = 55/112 (49%), Gaps = 3/112 (2%)

Query: 45  FCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTI 104
           F IE   YM + EYM   SLD      +    +       I   +++GL +L+E     I
Sbjct: 68  FFIEGAVYMCM-EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKE--EHNI 124

Query: 105 IHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRG 156
           IHRD+K +N+L++ + + K+ DFG++  L   + K       Y+ PE +  G
Sbjct: 125 IHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSG 176

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 50.5 bits (121), Expect = 5e-08
 Identities = 33/124 (26%), Positives = 63/124 (50%), Gaps = 8/124 (6%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSL 64
           G+ +AVKK+  +  Q  E   NEV++    QH N++ +    +   E  ++ E++   +L
Sbjct: 44  GRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGAL 103

Query: 65  DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKI 124
                D +    ++ ++   +   +++ L +L       +IHRD+K  +ILL  D + K+
Sbjct: 104 T----DIVTHTRMNEEQIATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKL 156

Query: 125 SDFG 128
           SDFG
Sbjct: 157 SDFG 160

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 50.4 bits (120), Expect = 5e-08
 Identities = 42/157 (26%), Positives = 79/157 (50%), Gaps = 12/157 (7%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSL 64
           G+ +AVK +  +  Q  E   NEV++    QH N++ +    +  +E  ++ E++   +L
Sbjct: 46  GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105

Query: 65  DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKI 124
                D +    L+ ++   + + ++Q L YL       +IHRD+K  +ILL  D + K+
Sbjct: 106 T----DIVSQTRLNEEQIATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKL 158

Query: 125 SDFGLARILRKMILKQIQIELG---YIPPEYVGRGVY 158
           SDFG    + K + K+  + +G   ++ PE + R  Y
Sbjct: 159 SDFGFCAQISKDVPKRKSL-VGTPYWMAPEVISRTPY 194

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 50.5 bits (121), Expect = 5e-08
 Identities = 42/143 (29%), Positives = 63/143 (44%), Gaps = 23/143 (16%)

Query: 7   QIIAVKKLSKKSTQGFEEFKNEV--MLTAKL--QHLNLIR-VGFCIETQEYMLIYEYMPK 61
             +AVK L   +T+  ++  + V  M   K+  +H N+I  +G C +     ++ EY   
Sbjct: 43  STVAVKMLKDDATE--KDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAH 100

Query: 62  RSLDYFL-----------FDPIRMLI--LDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRD 108
            +L  FL            D  R     L  K  V     + +G+ +L        IHRD
Sbjct: 101 GNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRD 157

Query: 109 LKVSNILLDEDLKPKISDFGLAR 131
           L   N+L+ ED   KI+DFGLAR
Sbjct: 158 LAARNVLVTEDHVMKIADFGLAR 180

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 50.4 bits (120), Expect = 6e-08
 Identities = 39/134 (29%), Positives = 71/134 (52%), Gaps = 23/134 (17%)

Query: 28  EVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKRSLDYFLFDPIRMLILDCKKRVHI- 85
           EV L   L+H N++ +   I T++ + L++EY+ K          ++  + DC   +++ 
Sbjct: 54  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK---------DLKQYLDDCGNSINMH 104

Query: 86  -----IKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLAR---ILRKMI 137
                +  +++GL Y     R  ++HRDLK  N+L++E  + K++DFGLAR   I  K  
Sbjct: 105 NVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY 161

Query: 138 LKQIQIELGYIPPE 151
             ++ + L Y PP+
Sbjct: 162 SNEV-VTLWYRPPD 174

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 50.3 bits (120), Expect = 7e-08
 Identities = 30/104 (28%), Positives = 50/104 (48%), Gaps = 5/104 (4%)

Query: 28  EVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIK 87
           E ML   + H ++IR+   + +     +   +P  S D + +   R   L   + + I K
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV--LPHYSSDLYTYLTKRSRPLPIDQALIIEK 164

Query: 88  GIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLAR 131
            I++GL YL       IIHRD+K  NI +++  +  I D G A+
Sbjct: 165 QILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQ 205

Length = 357

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 49.9 bits (119), Expect = 9e-08
 Identities = 40/135 (29%), Positives = 69/135 (51%), Gaps = 13/135 (9%)

Query: 6   GQIIAVKKLSKKSTQG-FEEFKNEVMLTAKLQHLNLIRV-GFCIET--QEYMLIYEYMPK 61
           G+ +AVK L  +S      + K E+ +   L H N+++  G C E       LI E++P 
Sbjct: 33  GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 92

Query: 62  RSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYL--QEYFRLTIIHRDLKVSNILLDED 119
            SL  +L  P     ++ K+++     I +G+ YL  ++Y     +HRDL   N+L++ +
Sbjct: 93  GSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYLGSRQY-----VHRDLAARNVLVESE 145

Query: 120 LKPKISDFGLARILR 134
            + KI DFGL + + 
Sbjct: 146 HQVKIGDFGLTKAIE 160

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 49.6 bits (118), Expect = 9e-08
 Identities = 40/127 (31%), Positives = 67/127 (52%), Gaps = 8/127 (6%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV--GFCIETQEYMLIYEYMPKRS 63
           G + A K +  KS +  E++  E+ + A   H N++++   F  E   ++LI E+    +
Sbjct: 30  GVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI-EFCAGGA 88

Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           +D  + +  R L  + + RV + K  ++ L YL E     IIHRDLK  NIL   D   K
Sbjct: 89  VDAVMLELERPLT-EPQIRV-VCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIK 143

Query: 124 ISDFGLA 130
           ++DFG++
Sbjct: 144 LADFGVS 150

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 49.6 bits (118), Expect = 1e-07
 Identities = 45/168 (26%), Positives = 82/168 (48%), Gaps = 20/168 (11%)

Query: 3   LPDGQII----AVKKLSKKST-QGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIY 56
           +P+G  I    A+K +  +S  Q F+E  + ++    L H  ++R +G C       L+ 
Sbjct: 29  IPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGAS-LQLVT 87

Query: 57  EYMPKRSLDYFLFDPIRML--ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNI 114
           +  P  SL     D +R     LD ++ ++    I +G+ YL+E+    ++HR+L   NI
Sbjct: 88  QLSPLGSL----LDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH---RMVHRNLAARNI 140

Query: 115 LLDEDLKPKISDFGLARIL----RKMILKQIQIELGYIPPEYVGRGVY 158
           LL  D   +I+DFG+A +L    +K    + +  + ++  E +  G Y
Sbjct: 141 LLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRY 188

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 49.3 bits (118), Expect = 1e-07
 Identities = 35/149 (23%), Positives = 58/149 (38%), Gaps = 34/149 (22%)

Query: 4   PDGQIIAVKK--LSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFC-IETQEYMLIYEYMP 60
           P   ++AVKK  L   S +  +  + E++ + +LQH N++      I   E  ++   M 
Sbjct: 23  PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA 82

Query: 61  KRSLDYFLFDPIRMLILDCKKRVH------------IIKGIIQGLLYLQEYFRLTIIHRD 108
                   +     L+     + H            I+K ++  L Y+        IHR 
Sbjct: 83  --------YGSCEDLL-----KTHFPEGLPELAIAFILKDVLNALDYIH---SKGFIHRS 126

Query: 109 LKVSNILLDEDLKPKISDFGLARILRKMI 137
           +K S+ILL  D K  +S     R    MI
Sbjct: 127 VKASHILLSGDGKVVLSGL---RYSVSMI 152

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 49.0 bits (117), Expect = 1e-07
 Identities = 38/143 (26%), Positives = 70/143 (48%), Gaps = 16/143 (11%)

Query: 6   GQIIAVKK-----LSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIY-EYM 59
           G+ +AVK+      S ++ +     + E+ L   LQH  +++   C+   E + I+ EYM
Sbjct: 27  GRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYM 86

Query: 60  PKRSLDYFLFDPIRML--ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLD 117
           P  S+     D ++    + +   R +  + I++G+ YL       I+HRD+K +NIL D
Sbjct: 87  PGGSVK----DQLKAYGALTETVTRKYT-RQILEGVEYLH---SNMIVHRDIKGANILRD 138

Query: 118 EDLKPKISDFGLARILRKMILKQ 140
                K+ DFG ++ L+ +    
Sbjct: 139 SAGNVKLGDFGASKRLQTICSSG 161

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 48.7 bits (116), Expect = 2e-07
 Identities = 34/124 (27%), Positives = 62/124 (50%), Gaps = 7/124 (5%)

Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYF 67
           +A+K +++ +    E+F  E  +  KL H  L+++ G C + +   ++ E+M    L  +
Sbjct: 31  VAIKAINEGAMSE-EDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNY 89

Query: 68  LFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDF 127
           L    R   L     + + + + +G+ YL+   R + IHRDL   N L+      K+SDF
Sbjct: 90  LRQ--RQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDF 144

Query: 128 GLAR 131
           G+ R
Sbjct: 145 GMTR 148

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 48.9 bits (116), Expect = 2e-07
 Identities = 46/138 (33%), Positives = 67/138 (48%), Gaps = 29/138 (21%)

Query: 9   IAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDY 66
           +AVKKLS+  +S    +    E+ L   ++H N+I            L+  + P RSL+ 
Sbjct: 45  VAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG-----------LLDVFTPARSLEE 93

Query: 67  F--------LFDPIRMLILDCKKRVH-----IIKGIIQGLLYLQEYFRLTIIHRDLKVSN 113
           F        L       I+ C+K        +I  I++GL Y+       IIHRDLK SN
Sbjct: 94  FNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSN 150

Query: 114 ILLDEDLKPKISDFGLAR 131
           + ++ED + KI DFGLAR
Sbjct: 151 LAVNEDCELKILDFGLAR 168

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 48.7 bits (117), Expect = 2e-07
 Identities = 45/137 (32%), Positives = 65/137 (47%), Gaps = 17/137 (12%)

Query: 5   DGQIIAVKKLSKKSTQGFEEFK-NEVM-----LTAKLQHLNLIRVGFCIETQE--YMLIY 56
             +  A+K L K+  Q  +E K   V      LT    H  +I++ +  + +E  Y  + 
Sbjct: 25  TNKEYAIKILDKR--QLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYF-VL 81

Query: 57  EYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL 116
           EY P   L  ++    +   LD K        I+  L YL       IIHRDLK  NILL
Sbjct: 82  EYAPNGELLQYI---RKYGSLDEKCTRFYAAEILLALEYL---HSKGIIHRDLKPENILL 135

Query: 117 DEDLKPKISDFGLARIL 133
           D+D+  KI+DFG A++L
Sbjct: 136 DKDMHIKITDFGTAKVL 152

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 48.8 bits (117), Expect = 2e-07
 Identities = 24/47 (51%), Positives = 32/47 (68%), Gaps = 3/47 (6%)

Query: 85  IIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLAR 131
           ++  I++GL Y+       IIHRDLK SNI ++ED + KI DFGLAR
Sbjct: 123 LVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLAR 166

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 48.6 bits (116), Expect = 2e-07
 Identities = 35/113 (30%), Positives = 55/113 (48%), Gaps = 10/113 (8%)

Query: 28  EVMLTAKLQHLNLIRV-GFCIETQEY-MLIYEYMPKRSLDYFLFDP-----IRMLILDCK 80
           E  L   L H N++ +   CIE  E   ++Y YM   +L  FL             L  +
Sbjct: 58  ESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQ 117

Query: 81  KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARIL 133
           + VH+   I  G+ YL    +  +IH+D+   N ++DE+L+ KI+D  L+R L
Sbjct: 118 QLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDL 167

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 48.6 bits (116), Expect = 2e-07
 Identities = 38/161 (23%), Positives = 72/161 (44%), Gaps = 16/161 (9%)

Query: 1   GVLPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYM 59
            V P  ++  V K+     +    F     L ++L H +L+++ G C+   E +++ EY+
Sbjct: 24  IVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCV-RDENIMVEEYV 82

Query: 60  PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL--- 116
               LD FL      + L  K  + + K +   L YL++     ++H ++   NIL+   
Sbjct: 83  KFGPLDVFLHREKNNVSLHWK--LDVAKQLASALHYLED---KKLVHGNVCGKNILVARY 137

Query: 117 --DEDLKP--KISDFGLARILRKMILKQIQIELGYIPPEYV 153
             +E   P  K+SD G+   +     +  +I   +I PE +
Sbjct: 138 GLNEGYVPFIKLSDPGIPITVLSREERVERIP--WIAPECI 176

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 48.5 bits (115), Expect = 2e-07
 Identities = 42/139 (30%), Positives = 65/139 (46%), Gaps = 19/139 (13%)

Query: 9   IAVKKLSKKST-QGFEEFKNEV-MLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLD 65
           +AVK L   +T +   +  +E+ M+    +H N+I + G C +     ++ EY  K +L 
Sbjct: 47  VAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLR 106

Query: 66  YFL-----------FDPIRM--LILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVS 112
            +L           FD  ++    L  K  V     + +G+ YL        IHRDL   
Sbjct: 107 EYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAAR 163

Query: 113 NILLDEDLKPKISDFGLAR 131
           N+L+ ED   KI+DFGLAR
Sbjct: 164 NVLVTEDNVMKIADFGLAR 182

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 48.4 bits (115), Expect = 3e-07
 Identities = 40/145 (27%), Positives = 68/145 (46%), Gaps = 13/145 (8%)

Query: 8   IIAVKKLSKKSTQGFE-EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLD 65
           ++AVK L + + +    +F  E+ + ++L+  N+IR+   CI +    +I EYM    L+
Sbjct: 48  LVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLN 107

Query: 66  YFL--FDPIRMLILDCKKRV------HIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLD 117
            FL   +P           +       +   I  G+ YL     L  +HRDL   N L+ 
Sbjct: 108 QFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVG 164

Query: 118 EDLKPKISDFGLARILRKMILKQIQ 142
           ++   KI+DFG++R L      +IQ
Sbjct: 165 KNYTIKIADFGMSRNLYSGDYYRIQ 189

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 48.1 bits (115), Expect = 3e-07
 Identities = 39/141 (27%), Positives = 74/141 (52%), Gaps = 19/141 (13%)

Query: 3   LPDGQIIAVK--KLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIET-QEYMLIY-EY 58
           L  G+++AVK  ++     +  +E  +E+ +   L+H NL++  + +E  +E + I+ EY
Sbjct: 22  LDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKY-YGVEVHREKVYIFMEY 80

Query: 59  MPKRSLDYFL----FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNI 114
               +L+  L         ++      RV+ ++ +++GL YL  +    I+HRD+K +NI
Sbjct: 81  CSGGTLEELLEHGRILDEHVI------RVYTLQ-LLEGLAYLHSH---GIVHRDIKPANI 130

Query: 115 LLDEDLKPKISDFGLARILRK 135
            LD +   K+ DFG A  L+ 
Sbjct: 131 FLDHNGVIKLGDFGCAVKLKN 151

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 48.1 bits (115), Expect = 3e-07
 Identities = 37/141 (26%), Positives = 70/141 (49%), Gaps = 10/141 (7%)

Query: 2   VLPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMP 60
            +  G+++A+K +  +    FE  + E+ +  + +H N++   G  +   +  ++ EY  
Sbjct: 24  DIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCG 83

Query: 61  KRSLDYFLFDPIRMLILDCKKRV--HIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE 118
             SL     D  ++      +    ++ +  ++GL YL E  +   IHRD+K +NILL E
Sbjct: 84  GGSLQ----DIYQVTRGPLSELQIAYVCRETLKGLAYLHETGK---IHRDIKGANILLTE 136

Query: 119 DLKPKISDFGLARILRKMILK 139
           D   K++DFG++  L   I K
Sbjct: 137 DGDVKLADFGVSAQLTATIAK 157

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 48.0 bits (114), Expect = 4e-07
 Identities = 42/132 (31%), Positives = 64/132 (48%), Gaps = 12/132 (9%)

Query: 6   GQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQ----EYMLIYEYM 59
           G+ +A+KKLS+  +S    +    E+ L   +QH N+I +     +     E+   Y  M
Sbjct: 40  GEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVM 99

Query: 60  PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
           P    D      I    L   K  +++  ++ GL Y+       IIHRDLK  N+ ++ED
Sbjct: 100 PYMQTD---LQKIMGHPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNED 153

Query: 120 LKPKISDFGLAR 131
            + KI DFGLAR
Sbjct: 154 CELKILDFGLAR 165

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 47.8 bits (114), Expect = 4e-07
 Identities = 35/137 (25%), Positives = 72/137 (52%), Gaps = 8/137 (5%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV--GFCIETQEYMLIYEYMPKRS 63
           G   A K +  +S +  E+F  E+ + ++ +H N++ +   +  E + ++LI E+    +
Sbjct: 30  GLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILI-EFCDGGA 88

Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           LD  + +  R   L   +  ++ + +++ L +L  +    +IHRDLK  NILL  D   K
Sbjct: 89  LDSIMLELER--GLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVK 143

Query: 124 ISDFGLARILRKMILKQ 140
           ++DFG++   +  + K+
Sbjct: 144 LADFGVSAKNKSTLQKR 160

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 48.0 bits (114), Expect = 4e-07
 Identities = 40/133 (30%), Positives = 65/133 (48%), Gaps = 14/133 (10%)

Query: 7   QIIAVKKLSKKSTQGFEEFKNEVMLTAK-LQHLN---LIR-VGFCIETQEYMLIYEYMPK 61
           + +AVK L   +       K+E++  A  +Q L+   ++R +G C E + +ML+ E    
Sbjct: 23  KTVAVKILKNDNND--PALKDELLREANVMQQLDNPYIVRMIGIC-EAESWMLVMELAEL 79

Query: 62  RSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK 121
             L+ FL     +   +  + VH +     G+ YL+E      +HRDL   N+LL     
Sbjct: 80  GPLNKFLQKNKHVTEKNITELVHQVS---MGMKYLEET---NFVHRDLAARNVLLVTQHY 133

Query: 122 PKISDFGLARILR 134
            KISDFGL++ L 
Sbjct: 134 AKISDFGLSKALG 146

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 48.2 bits (115), Expect = 4e-07
 Identities = 36/139 (25%), Positives = 62/139 (44%), Gaps = 20/139 (14%)

Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFL 68
           +AVKK+     Q  +    E+ +  +L H N+++V   +      L  +     SL    
Sbjct: 33  VAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDV---GSLTELN 89

Query: 69  FDPIRMLILDCKKRVHIIKG-------------IIQGLLYLQEYFRLTIIHRDLKVSNIL 115
              I    ++      + +G             +++GL Y+       ++HRDLK +N+ 
Sbjct: 90  SVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVF 146

Query: 116 LD-EDLKPKISDFGLARIL 133
           ++ EDL  KI DFGLARI+
Sbjct: 147 INTEDLVLKIGDFGLARIV 165

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 48.1 bits (114), Expect = 4e-07
 Identities = 41/128 (32%), Positives = 66/128 (51%), Gaps = 10/128 (7%)

Query: 9   IAVKKLSK---KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYE--YMPKRS 63
           +AVKKLS+     T     ++  V+L   + H N+I +      Q+ +  ++  Y+    
Sbjct: 49  VAVKKLSRPFQNQTHAKRAYRELVLLKC-VNHKNIISLLNVFTPQKSLEEFQDVYLVMEL 107

Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           +D  L   I M  LD ++  +++  ++ G+ +L       IIHRDLK SNI++  D   K
Sbjct: 108 MDANLCQVIHM-ELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLK 163

Query: 124 ISDFGLAR 131
           I DFGLAR
Sbjct: 164 ILDFGLAR 171

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 47.6 bits (113), Expect = 5e-07
 Identities = 42/159 (26%), Positives = 81/159 (50%), Gaps = 11/159 (6%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLN---LIRVGFCIETQEYM-LIYEYMPK 61
           G++ A KKL KK  +     K  ++    L+ +N   ++ + +  E++ ++ L+   M  
Sbjct: 18  GKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNG 77

Query: 62  RSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK 121
             L Y +++ +    L+ ++ +H    I  G+L+L     + I++RD+K  N+LLD+   
Sbjct: 78  GDLKYHIYN-VGERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGN 133

Query: 122 PKISDFGLARILR--KMILKQIQIELGYIPPEYVGRGVY 158
            ++SD GLA  L+  K I ++     GY+ PE +    Y
Sbjct: 134 CRLSDLGLAVELKDGKTITQRAGTN-GYMAPEILKEEPY 171

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 47.4 bits (113), Expect = 5e-07
 Identities = 32/131 (24%), Positives = 59/131 (45%), Gaps = 10/131 (7%)

Query: 4   PDGQIIAVKKLSKKSTQGFE-EFKNEVMLTAKLQHLNLIR-VGFCIETQEYML--IYEYM 59
             G I A+K ++       + +   E+ +    +   +++  G  ++     +    EY 
Sbjct: 24  NTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYC 83

Query: 60  PKRSLDYFLFDPIRMLILDCKKRV--HIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLD 117
              SLD  ++  ++       ++V   I + +++GL YL       IIHRD+K SNILL 
Sbjct: 84  EGGSLDS-IYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLT 139

Query: 118 EDLKPKISDFG 128
              + K+ DFG
Sbjct: 140 RKGQVKLCDFG 150

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 47.7 bits (113), Expect = 5e-07
 Identities = 45/166 (27%), Positives = 76/166 (45%), Gaps = 40/166 (24%)

Query: 9   IAVK--KLSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEY------MLIYEYM 59
           +AVK  K++  +    E+F +E +   +  H N++R +G C++T E       ++I  +M
Sbjct: 29  VAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFM 88

Query: 60  PKRSLDYFL----------FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDL 109
               L  FL          + P +ML       V  +  I  G+ YL      + IHRDL
Sbjct: 89  KHGDLHSFLLYSRLGDCPQYLPTQML-------VKFMTDIASGMEYLSSK---SFIHRDL 138

Query: 110 KVSNILLDEDLKPKISDFGLARI-----------LRKMILKQIQIE 144
              N +L+E++   ++DFGL++            + KM +K I IE
Sbjct: 139 AARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIE 184

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 47.3 bits (113), Expect = 5e-07
 Identities = 22/70 (31%), Positives = 39/70 (55%), Gaps = 9/70 (12%)

Query: 76  ILDCKKRV------HIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGL 129
           +    KR+      +I++  ++GL YL E     +IHRD+K  NILL ++ + K+ DFG+
Sbjct: 103 LRKKGKRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGV 159

Query: 130 ARILRKMILK 139
           +  L   + +
Sbjct: 160 SAQLDSTLGR 169

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 47.1 bits (112), Expect = 6e-07
 Identities = 40/134 (29%), Positives = 64/134 (47%), Gaps = 16/134 (11%)

Query: 6   GQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQ-EYMLIYEYMPK 61
           G++ A KKL+KK     +G+E    E  + AK+    ++ + +  +T+ +  L+   M  
Sbjct: 18  GKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNG 77

Query: 62  RSLDYFLFD-----PIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL 116
             L Y +++     P         +       II GL +L +     II+RDLK  N+LL
Sbjct: 78  GDLRYHIYNVDEENPG----FPEPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLL 130

Query: 117 DEDLKPKISDFGLA 130
           D D   +ISD GLA
Sbjct: 131 DNDGNVRISDLGLA 144

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 47.3 bits (113), Expect = 7e-07
 Identities = 40/137 (29%), Positives = 64/137 (46%), Gaps = 15/137 (10%)

Query: 3   LPDGQIIAVKKLSKKSTQGF-EEFKNEVMLTAKLQHLNLI------RVGFCIETQEYMLI 55
            P G  +A+KK+S    Q F +    E+ +  + +H N+I      R        +  ++
Sbjct: 27  KPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIV 86

Query: 56  YEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNIL 115
            E M        L+  I+   L      + +  I++GL Y+       ++HRDLK SN+L
Sbjct: 87  QELMETD-----LYKLIKTQHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLL 138

Query: 116 LDEDLKPKISDFGLARI 132
           L+ +   KI DFGLARI
Sbjct: 139 LNTNCDLKICDFGLARI 155

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 47.3 bits (112), Expect = 7e-07
 Identities = 35/128 (27%), Positives = 70/128 (54%), Gaps = 10/128 (7%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV--GFCIETQEYMLIYEYMPKRS 63
           G + A K +  KS +  E++  E+ + A   H  ++++   F  + + +++I E+ P  +
Sbjct: 37  GALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI-EFCPGGA 95

Query: 64  LDYFLFDPIRMLILDCKKRVHII-KGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKP 122
           +D  + +  R L    + ++ +I + +++ L YL     + IIHRDLK  N+LL  D   
Sbjct: 96  VDAIMLELDRGLT---EPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDI 149

Query: 123 KISDFGLA 130
           K++DFG++
Sbjct: 150 KLADFGVS 157

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 47.3 bits (112), Expect = 7e-07
 Identities = 40/134 (29%), Positives = 70/134 (52%), Gaps = 23/134 (17%)

Query: 28  EVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKRSLDYFLFDPIRMLILDCKK--RVH 84
           EV L   L+H N++ +   + T + + L++EY+ K          ++  + DC     +H
Sbjct: 54  EVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK---------DLKQYMDDCGNIMSMH 104

Query: 85  IIK----GIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLAR---ILRKMI 137
            +K     I++GL Y     R  ++HRDLK  N+L++E  + K++DFGLAR   +  K  
Sbjct: 105 NVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTY 161

Query: 138 LKQIQIELGYIPPE 151
             ++ + L Y PP+
Sbjct: 162 SNEV-VTLWYRPPD 174

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 46.9 bits (112), Expect = 8e-07
 Identities = 26/65 (40%), Positives = 37/65 (56%), Gaps = 8/65 (12%)

Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYI 148
           +++GL Y+       +IHRDLK SN+L++ED + +I DFG+AR L          E  Y 
Sbjct: 116 LLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS-----PTEHKYF 167

Query: 149 PPEYV 153
             EYV
Sbjct: 168 MTEYV 172

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 46.9 bits (111), Expect = 9e-07
 Identities = 27/78 (34%), Positives = 42/78 (53%), Gaps = 2/78 (2%)

Query: 83  VHIIKGIIQGLLYLQEYFRLT-IIHRDLKVSNILLDEDLKPKISDFGLARILR-KMILKQ 140
              IK +++  L   ++     I+HRDLK  NIL+    + K++DFGLARI   +M L  
Sbjct: 107 AETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTP 166

Query: 141 IQIELGYIPPEYVGRGVY 158
           + + L Y  PE + +  Y
Sbjct: 167 VVVTLWYRAPEVLLQSTY 184

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 47.0 bits (111), Expect = 9e-07
 Identities = 37/130 (28%), Positives = 71/130 (54%), Gaps = 10/130 (7%)

Query: 5   DGQIIAVKKLSKKSTQG--FEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPK 61
           +G+++A+K +  +  +G  F   + E  L   L+H N++ +   I T+E + L++EY+  
Sbjct: 29  NGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHT 87

Query: 62  RSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK 121
               Y    P  +   + K     +  +++GL Y+ + +   I+HRDLK  N+L+ +  +
Sbjct: 88  DLCQYMDKHPGGLHPENVKL---FLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGE 141

Query: 122 PKISDFGLAR 131
            K++DFGLAR
Sbjct: 142 LKLADFGLAR 151

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 47.0 bits (111), Expect = 9e-07
 Identities = 38/157 (24%), Positives = 72/157 (45%), Gaps = 16/157 (10%)

Query: 11  VKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFD 70
           + K  K  ++   + +NE++   +L H N++++   + ++       YM  +  D+ L+ 
Sbjct: 196 IAKRVKAGSRAAIQLENEILALGRLNHENILKIEEILRSEANT----YMITQKYDFDLYS 251

Query: 71  PIRMLILDCKKRVHI--IKGIIQGLLYLQEYFR-LTIIHRDLKVSNILLDEDLKPKISDF 127
            +     D K R  +   + I++ LL   EY     +IHRD+K+ NI L+ D K  + DF
Sbjct: 252 FMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDF 311

Query: 128 GLARILRKMILKQIQIELGYI------PPEYVGRGVY 158
           G A    K   ++   + G++       PE +    Y
Sbjct: 312 GTAMPFEK---EREAFDYGWVGTVATNSPEILAGDGY 345

Length = 501

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 46.8 bits (112), Expect = 1e-06
 Identities = 52/164 (31%), Positives = 81/164 (49%), Gaps = 35/164 (21%)

Query: 6   GQIIAVKKLS-KKSTQGFE-EFKNEVMLTAKLQHLNLIRVGFCIETQEYML------IYE 57
           G+I+A+KKL  +K  +GF      E+ +  KLQH N++ V      +E ++      IY 
Sbjct: 30  GEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTV------KEVVVGSNLDKIYM 83

Query: 58  YMPKRSLDYFLFDPIRMLILDCKKRVHI--IKGIIQGLL----YLQEYFRLTIIHRDLKV 111
            M     +Y   D ++ L+   K+      +K ++  LL    +L + +   I+HRDLK 
Sbjct: 84  VM-----EYVEHD-LKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKT 134

Query: 112 SNILLDEDLKPKISDFGLAR----ILRKMILKQIQIELGYIPPE 151
           SN+LL+     KI DFGLAR     L+     Q+ + L Y  PE
Sbjct: 135 SNLLLNNRGILKICDFGLAREYGSPLKPY--TQLVVTLWYRAPE 176

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 46.7 bits (111), Expect = 1e-06
 Identities = 45/165 (27%), Positives = 79/165 (47%), Gaps = 28/165 (16%)

Query: 6   GQIIAVKKLS-KKSTQGFE-EFKNEVMLTAKLQHLNLIR-----------VGFCIETQEY 52
           G+++A+KK+      +GF      E+ +  +L H N++            + F  +   +
Sbjct: 32  GELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAF 91

Query: 53  MLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHI---IKGIIQGLLYLQEYFRLTIIHRDL 109
            L++EYM     D+ L   +   ++   +  HI   +K +++GL Y     +   +HRD+
Sbjct: 92  YLVFEYM-----DHDLMGLLESGLVHFSED-HIKSFMKQLLEGLNYCH---KKNFLHRDI 142

Query: 110 KVSNILLDEDLKPKISDFGLARILRKMILKQIQ---IELGYIPPE 151
           K SNILL+   + K++DFGLAR+      +      I L Y PPE
Sbjct: 143 KCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPE 187

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 46.5 bits (111), Expect = 1e-06
 Identities = 38/136 (27%), Positives = 71/136 (52%), Gaps = 18/136 (13%)

Query: 5   DGQIIAVKKLSKKS-TQGFEEFK-NEVMLTAKLQHLNLIRVGFCIETQEY--MLIYEYMP 60
            G+I+A+KK+  ++  +G       E+ L  +L H N++R+   +   E    L++E++ 
Sbjct: 23  TGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRL-LDVVHSENKLYLVFEFLD 81

Query: 61  ---KRSLDYFLFDPI-RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL 116
              K+ +D      +   LI   K  ++    ++QG+ Y   +    ++HRDLK  N+L+
Sbjct: 82  LDLKKYMDSSPLTGLDPPLI---KSYLY---QLLQGIAYCHSH---RVLHRDLKPQNLLI 132

Query: 117 DEDLKPKISDFGLARI 132
           D +   K++DFGLAR 
Sbjct: 133 DREGALKLADFGLARA 148

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 46.6 bits (111), Expect = 1e-06
 Identities = 20/47 (42%), Positives = 30/47 (63%), Gaps = 2/47 (4%)

Query: 84  HIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLA 130
            +   I++ L YL+E  +  +IHRD+K SNILLD     K+ DFG++
Sbjct: 118 KMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGIS 162

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 46.5 bits (111), Expect = 1e-06
 Identities = 21/48 (43%), Positives = 31/48 (64%), Gaps = 3/48 (6%)

Query: 85  IIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARI 132
            +  +++G+ YL E     I+HRD+K +NIL+D     KI+DFGLAR 
Sbjct: 120 YMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARP 164

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 46.5 bits (110), Expect = 1e-06
 Identities = 41/138 (29%), Positives = 68/138 (49%), Gaps = 19/138 (13%)

Query: 10  AVKKLSKKSTQG-FEEFKNEVMLTAKL-QHLNLIRVGFCIETQEYM-LIYEYMPKRSLDY 66
           A+K++ + +++    +F  E+ +  KL  H N+I +    E + Y+ L  EY P  +L  
Sbjct: 38  AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD 97

Query: 67  FL-------FDPIRML------ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSN 113
           FL        DP   +       L  ++ +H    + +G+ YL +      IHRDL   N
Sbjct: 98  FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARN 154

Query: 114 ILLDEDLKPKISDFGLAR 131
           IL+ E+   KI+DFGL+R
Sbjct: 155 ILVGENYVAKIADFGLSR 172

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 46.2 bits (110), Expect = 2e-06
 Identities = 21/47 (44%), Positives = 33/47 (70%), Gaps = 3/47 (6%)

Query: 85  IIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLAR 131
           ++K ++ GL Y+    R  I+HRD+K +NIL+ +D   K++DFGLAR
Sbjct: 124 VMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLAR 167

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 46.2 bits (109), Expect = 2e-06
 Identities = 42/138 (30%), Positives = 65/138 (47%), Gaps = 19/138 (13%)

Query: 10  AVKKLSKKSTQG-FEEFKNEVMLTAKL-QHLNLIRVGFCIETQEYMLI-YEYMPKRSLDY 66
           A+K L + +++    +F  E+ +  KL  H N+I +    E + Y+ I  EY P  +L  
Sbjct: 33  AIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLD 92

Query: 67  FL-------FDPI------RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSN 113
           FL        DP           L  ++ +     +  G+ YL E      IHRDL   N
Sbjct: 93  FLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARN 149

Query: 114 ILLDEDLKPKISDFGLAR 131
           +L+ E+L  KI+DFGL+R
Sbjct: 150 VLVGENLASKIADFGLSR 167

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 45.9 bits (109), Expect = 2e-06
 Identities = 38/133 (28%), Positives = 63/133 (47%), Gaps = 10/133 (7%)

Query: 4   PDGQII--AVKKLSK-KSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEY-MLIYEY 58
            DGQ I  AVK L++    +  E+F  E ++     H N++  +G C+ ++   +++  Y
Sbjct: 19  SDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78

Query: 59  MPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE 118
           M    L  F+        +  K  +     + +G+ YL        +HRDL   N +LDE
Sbjct: 79  MKHGDLRNFIRSETHNPTV--KDLIGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDE 133

Query: 119 DLKPKISDFGLAR 131
               K++DFGLAR
Sbjct: 134 SFTVKVADFGLAR 146

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 45.8 bits (108), Expect = 2e-06
 Identities = 40/138 (28%), Positives = 67/138 (48%), Gaps = 19/138 (13%)

Query: 10  AVKKLSKKSTQG-FEEFKNEVMLTAKL-QHLNLIRVGFCIETQEYMLI-YEYMPKRSLDY 66
           A+K++ + +++    +F  E+ +  KL  H N+I +    E + Y+ +  EY P  +L  
Sbjct: 26  AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD 85

Query: 67  FL-------FDPI------RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSN 113
           FL        DP           L  ++ +H    + +G+ YL +      IHRDL   N
Sbjct: 86  FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARN 142

Query: 114 ILLDEDLKPKISDFGLAR 131
           IL+ E+   KI+DFGL+R
Sbjct: 143 ILVGENYVAKIADFGLSR 160

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 45.5 bits (108), Expect = 2e-06
 Identities = 26/80 (32%), Positives = 42/80 (52%), Gaps = 17/80 (21%)

Query: 57  EYMPKRSLDYFLFDPIRMLILDCKKRV------HIIKGIIQGLLYLQEYFRLTIIHRDLK 110
           E+M   SLD          +L    R+       I   +++GL YL+E  +  I+HRD+K
Sbjct: 79  EHMDGGSLD---------QVLKKAGRIPENILGKISIAVLRGLTYLRE--KHKIMHRDVK 127

Query: 111 VSNILLDEDLKPKISDFGLA 130
            SNIL++   + K+ DFG++
Sbjct: 128 PSNILVNSRGEIKLCDFGVS 147

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 45.4 bits (107), Expect = 3e-06
 Identities = 26/71 (36%), Positives = 42/71 (59%), Gaps = 4/71 (5%)

Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILR-KMILKQIQIELGY 147
           +++GL +L  +    ++HRDLK  NIL+    + K++DFGLARI   +M L  + + L Y
Sbjct: 119 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWY 175

Query: 148 IPPEYVGRGVY 158
             PE + +  Y
Sbjct: 176 RAPEVLLQSSY 186

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 45.3 bits (107), Expect = 3e-06
 Identities = 29/71 (40%), Positives = 39/71 (54%), Gaps = 3/71 (4%)

Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYI 148
           II GL ++   F   +++RDLK +NILLDE    +ISD GLA    K          GY+
Sbjct: 106 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYM 162

Query: 149 PPEYVGRGVYY 159
            PE + +GV Y
Sbjct: 163 APEVLQKGVAY 173

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 45.0 bits (106), Expect = 4e-06
 Identities = 39/156 (25%), Positives = 79/156 (50%), Gaps = 10/156 (6%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSL 64
           G+++AVKK+  +  Q  E   NEV++    QH N++ +    +   E  ++ E++   +L
Sbjct: 45  GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 104

Query: 65  DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKI 124
                D +    ++ ++   +   +++ L  L       +IHRD+K  +ILL  D + K+
Sbjct: 105 T----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKL 157

Query: 125 SDFGL-ARILRKMILKQIQIELGY-IPPEYVGRGVY 158
           SDFG  A++ +++  ++  +   Y + PE + R  Y
Sbjct: 158 SDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPY 193

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 45.0 bits (106), Expect = 4e-06
 Identities = 36/138 (26%), Positives = 69/138 (50%), Gaps = 11/138 (7%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSL 64
           G++ AVK +  +    F   + E+ +  + +H N++   G  +  ++  +  EY    SL
Sbjct: 34  GELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSL 93

Query: 65  D--YFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKP 122
              Y +  P+  L +      ++ +  +QGL YL    ++   HRD+K +NILL ++   
Sbjct: 94  QDIYHVTGPLSELQI-----AYVCRETLQGLAYLHSKGKM---HRDIKGANILLTDNGDV 145

Query: 123 KISDFGLARILRKMILKQ 140
           K++DFG+A  +   I K+
Sbjct: 146 KLADFGVAAKITATIAKR 163

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 45.1 bits (106), Expect = 4e-06
 Identities = 41/162 (25%), Positives = 78/162 (48%), Gaps = 10/162 (6%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSL 64
           GQ +A+K+++ +     E   NE+++  +L++ N++  +   +   E  ++ EY+   SL
Sbjct: 44  GQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSL 103

Query: 65  DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKI 124
                D +    +D  +   + +  +Q L +L       +IHRD+K  N+LL  D   K+
Sbjct: 104 T----DVVTETCMDEAQIAAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKL 156

Query: 125 SDFGL-ARILRKMILKQIQIELGY-IPPEYVGRGVYYKKFSL 164
           +DFG  A+I  +   +   +   Y + PE V R  Y  K  +
Sbjct: 157 TDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 198

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 45.1 bits (107), Expect = 5e-06
 Identities = 20/43 (46%), Positives = 29/43 (67%), Gaps = 3/43 (6%)

Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLAR 131
           +++GL Y+       ++HRDLK SN+LL+ +   KI DFGLAR
Sbjct: 117 LLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLAR 156

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 44.9 bits (106), Expect = 5e-06
 Identities = 42/162 (25%), Positives = 77/162 (47%), Gaps = 10/162 (6%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSL 64
           GQ +A+K+++ +     E   NE+++  + +H N++  +   +   E  ++ EY+   SL
Sbjct: 44  GQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSL 103

Query: 65  DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKI 124
                D +    +D  +   + +  +Q L +L       +IHRD+K  NILL  D   K+
Sbjct: 104 T----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKL 156

Query: 125 SDFGL-ARILRKMILKQIQIELGY-IPPEYVGRGVYYKKFSL 164
           +DFG  A+I  +   +   +   Y + PE V R  Y  K  +
Sbjct: 157 TDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 198

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 44.7 bits (105), Expect = 5e-06
 Identities = 40/128 (31%), Positives = 68/128 (53%), Gaps = 10/128 (7%)

Query: 9   IAVKKLSK---KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYE--YMPKRS 63
           +A+KKLS+     T     ++ E++L   + H N+I +      Q+ +  ++  Y+    
Sbjct: 45  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMEL 103

Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           +D  L   I+M  LD ++  +++  ++ G+ +L       IIHRDLK SNI++  D   K
Sbjct: 104 MDANLCQVIQME-LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLK 159

Query: 124 ISDFGLAR 131
           I DFGLAR
Sbjct: 160 ILDFGLAR 167

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 44.7 bits (106), Expect = 6e-06
 Identities = 20/44 (45%), Positives = 29/44 (65%), Gaps = 3/44 (6%)

Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARI 132
           I++GL YL       I+HRD+K  N+L++ +   KI DFGLAR+
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARV 152

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 44.6 bits (105), Expect = 6e-06
 Identities = 44/139 (31%), Positives = 66/139 (47%), Gaps = 19/139 (13%)

Query: 9   IAVKKLSKKST-QGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRSLD 65
           +AVK L   +T +   +  +E+ L   + +H N+I + G C +     +I EY  K +L 
Sbjct: 47  VAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLR 106

Query: 66  YFL-----------FDPIRML--ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVS 112
            FL           FD  ++    L  K  V     + +G+ YL+       IHRDL   
Sbjct: 107 EFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAAR 163

Query: 113 NILLDEDLKPKISDFGLAR 131
           N+L+ ED   KI+DFGLAR
Sbjct: 164 NVLVTEDNVMKIADFGLAR 182

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 44.7 bits (106), Expect = 6e-06
 Identities = 20/43 (46%), Positives = 29/43 (67%), Gaps = 3/43 (6%)

Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLAR 131
           I+ GL +L E     II+RDLK+ N+LLD +   KI+DFG+ +
Sbjct: 105 IVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCK 144

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 44.6 bits (105), Expect = 6e-06
 Identities = 40/143 (27%), Positives = 74/143 (51%), Gaps = 24/143 (16%)

Query: 3   LPDGQII----AVKKLSK-KSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIY 56
           +P+G+ +    A+K+L +  S +  +E  +E  + A + + ++ R+ G C+ T    LI 
Sbjct: 29  IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL-TSTVQLIT 87

Query: 57  EYMPKRSLDYFLFDPIRMLILDCKKRV---HIIKGIIQ---GLLYLQEYFRLTIIHRDLK 110
           + MP   L     D +R    + K  +   +++   +Q   G+ YL+E     ++HRDL 
Sbjct: 88  QLMPFGCL----LDYVR----EHKDNIGSQYLLNWCVQIAKGMNYLEER---RLVHRDLA 136

Query: 111 VSNILLDEDLKPKISDFGLARIL 133
             N+L+      KI+DFGLA++L
Sbjct: 137 ARNVLVKTPQHVKITDFGLAKLL 159

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 44.6 bits (105), Expect = 6e-06
 Identities = 45/166 (27%), Positives = 78/166 (46%), Gaps = 26/166 (15%)

Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKRSLDYF 67
           +A+KKLS+        F+N+       + L L++   C+  +  + L+  + P++SL+ F
Sbjct: 52  VAIKKLSRP-------FQNQTHAKRAYRELVLMK---CVNHKNIIGLLNVFTPQKSLEEF 101

Query: 68  --------LFDP----IRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNIL 115
                   L D     +  + LD ++  +++  ++ G+ +L       IIHRDLK SNI+
Sbjct: 102 QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIV 158

Query: 116 LDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKK 161
           +  D   KI DFGLAR      +    +   Y     V  G+ YK+
Sbjct: 159 VKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKE 204

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 44.3 bits (105), Expect = 6e-06
 Identities = 35/134 (26%), Positives = 69/134 (51%), Gaps = 17/134 (12%)

Query: 5   DGQIIAVKKLS-KKSTQGFEEFK-NEVMLTAKLQHLNLIRVGFCIETQ-EYMLIYEYMPK 61
             +I+A+K++      +G       E+ L  +L+H N++R+   + +  +  L++EY  +
Sbjct: 24  THEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQ 83

Query: 62  RSLDYFLFDPIRMLILDCKKRVHIIKG----IIQGLLYLQEYFRLTIIHRDLKVSNILLD 117
               YF  D     I        I+K     +++GL +   +    ++HRDLK  N+L++
Sbjct: 84  DLKKYF--DSCNGDI-----DPEIVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLIN 133

Query: 118 EDLKPKISDFGLAR 131
           ++ + K++DFGLAR
Sbjct: 134 KNGELKLADFGLAR 147

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 44.1 bits (104), Expect = 7e-06
 Identities = 39/141 (27%), Positives = 62/141 (43%), Gaps = 21/141 (14%)

Query: 6   GQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEY------MLIY 56
            Q +AVK L     S+   EEF  E     +  H N+I+ +G  + ++        M+I 
Sbjct: 27  FQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVIL 86

Query: 57  EYMPKRSLDYFLF------DPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLK 110
            +M    L  FL       +P     L  +  V  +  I  G+ YL        IHRDL 
Sbjct: 87  PFMKHGDLHTFLLMSRIGEEPFT---LPLQTLVRFMIDIASGMEYLSSK---NFIHRDLA 140

Query: 111 VSNILLDEDLKPKISDFGLAR 131
             N +L+E++   ++DFGL++
Sbjct: 141 ARNCMLNENMTVCVADFGLSK 161

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 44.3 bits (104), Expect = 8e-06
 Identities = 41/162 (25%), Positives = 77/162 (47%), Gaps = 10/162 (6%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSL 64
           GQ +A+K+++ +     E   NE+++  + ++ N++  +   +   E  ++ EY+   SL
Sbjct: 44  GQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 103

Query: 65  DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKI 124
                D +    +D  +   + +  +Q L +L       +IHRD+K  NILL  D   K+
Sbjct: 104 T----DVVTETCMDEGQIAAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKL 156

Query: 125 SDFGL-ARILRKMILKQIQIELGY-IPPEYVGRGVYYKKFSL 164
           +DFG  A+I  +   +   +   Y + PE V R  Y  K  +
Sbjct: 157 TDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 198

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 44.2 bits (104), Expect = 8e-06
 Identities = 34/106 (32%), Positives = 58/106 (54%), Gaps = 9/106 (8%)

Query: 28  EVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKRSLDYFLFDPIRMLILDCKKRVHII 86
           EV L   L+H N++ +   I T+  + L++EY+    L  +L +   ++       V I 
Sbjct: 53  EVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL-DSDLKQYLDNCGNLM---SMHNVKIF 108

Query: 87  K-GIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLAR 131
              +++GL Y     +  I+HRDLK  N+L++E  + K++DFGLAR
Sbjct: 109 MFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 43.9 bits (104), Expect = 9e-06
 Identities = 40/132 (30%), Positives = 68/132 (51%), Gaps = 13/132 (9%)

Query: 6   GQIIAVKKLSKKST-QGFEEFK-NEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMP-- 60
           GQI+A+KK+  +S  +G       E+ L  +LQH N++ +    ++     LI+E++   
Sbjct: 25  GQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLSMD 84

Query: 61  -KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
            K+ LD           +D +     +  I+QG+L+        ++HRDLK  N+L+D  
Sbjct: 85  LKKYLDSLPKGQY----MDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNK 137

Query: 120 LKPKISDFGLAR 131
              K++DFGLAR
Sbjct: 138 GVIKLADFGLAR 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 44.3 bits (104), Expect = 9e-06
 Identities = 22/52 (42%), Positives = 36/52 (69%), Gaps = 1/52 (1%)

Query: 80  KKRVHIIKGII-QGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLA 130
           K+ +++IKG++ Q L  L++  R+ I+HRD+K  N+L+  D + KI DFG A
Sbjct: 305 KRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356

Length = 507

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 43.7 bits (103), Expect = 9e-06
 Identities = 42/155 (27%), Positives = 72/155 (46%), Gaps = 14/155 (9%)

Query: 2   VLPDGQIIAVKKLSKKSTQGFE-EFKNEVMLTAKLQHLNLIRV--GFCIETQEYMLIYEY 58
            L   +I+AVK +    T   + +  +E+ +  K     +I     F +E +  +   E+
Sbjct: 22  HLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICT-EF 80

Query: 59  MPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE 118
           M   SLD +   P  +L         I   +++GL YL   + L I+HRD+K SN+L++ 
Sbjct: 81  MDGGSLDVYRKIPEHVL-------GRIAVAVVKGLTYL---WSLKILHRDVKPSNMLVNT 130

Query: 119 DLKPKISDFGLARILRKMILKQIQIELGYIPPEYV 153
             + K+ DFG++  L   I K       Y+ PE +
Sbjct: 131 RGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERI 165

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 43.9 bits (104), Expect = 1e-05
 Identities = 36/141 (25%), Positives = 58/141 (41%), Gaps = 34/141 (24%)

Query: 6   GQIIAVKKLSKKSTQGFEEFK---NE--VMLTAKLQHLNLIRVGFCIETQEYM-LIYEYM 59
           G+I+A+K++ K       E +    E  ++ T K     L+++ +  +  EY+ L  EY+
Sbjct: 26  GEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK--SEWLVKLLYAFQDDEYLYLAMEYV 83

Query: 60  PKRSLDYFLFDPIRMLILDCKKRVHIIKGII---QGLLYLQEYF-------RLTIIHRDL 109
           P       L                   G++       Y+ E F        L  IHRDL
Sbjct: 84  PGGDFRTLL----------------NNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDL 127

Query: 110 KVSNILLDEDLKPKISDFGLA 130
           K  N L+D     K++DFGL+
Sbjct: 128 KPENFLIDASGHIKLTDFGLS 148

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 43.8 bits (103), Expect = 1e-05
 Identities = 38/142 (26%), Positives = 66/142 (46%), Gaps = 14/142 (9%)

Query: 24  EFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR 82
           +F  E  +  +  H N++R +G C + Q   ++ E +  +  D+  F       L  K+ 
Sbjct: 39  KFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELV--QGGDFLTFLRTEGPRLKVKEL 96

Query: 83  VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI----- 137
           + +++    G+ YL+       IHRDL   N L+ E    KISDFG++R     +     
Sbjct: 97  IQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTG 153

Query: 138 -LKQIQIELGYIPPEYVGRGVY 158
            +KQI ++  +  PE +  G Y
Sbjct: 154 GMKQIPVK--WTAPEALNYGRY 173

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 43.5 bits (103), Expect = 1e-05
 Identities = 22/47 (46%), Positives = 30/47 (63%), Gaps = 2/47 (4%)

Query: 84  HIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLA 130
            I    ++ L YL+E   L IIHRD+K SNILLD +   K+ DFG++
Sbjct: 111 KIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGIS 155

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 43.5 bits (102), Expect = 1e-05
 Identities = 40/157 (25%), Positives = 77/157 (49%), Gaps = 12/157 (7%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSL 64
           G+ +AVKK+  +  Q  E   NEV++     H N++ +    +   E  ++ E++   +L
Sbjct: 47  GKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106

Query: 65  DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKI 124
                D +    ++ ++   +   +++ L YL       +IHRD+K  +ILL  D + K+
Sbjct: 107 T----DIVTHTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKL 159

Query: 125 SDFGLARILRKMILKQIQIELG---YIPPEYVGRGVY 158
           SDFG    + K + K+  + +G   ++ PE + R  Y
Sbjct: 160 SDFGFCAQVSKEVPKRKSL-VGTPYWMAPEVISRLPY 195

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 43.5 bits (103), Expect = 1e-05
 Identities = 36/143 (25%), Positives = 63/143 (44%), Gaps = 16/143 (11%)

Query: 1   GVLPDGQI--IAVKKLSKKSTQGFE-EFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIY 56
           GV+       +A+K +++ ++     EF NE  +  +    +++R +G     Q  +++ 
Sbjct: 29  GVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVM 88

Query: 57  EYMPKRSLDYFL--------FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRD 108
           E M K  L  +L         +P        +K + +   I  G+ YL        +HRD
Sbjct: 89  ELMAKGDLKSYLRSRRPEAENNPGLG-PPTLQKFIQMAAEIADGMAYLAA---KKFVHRD 144

Query: 109 LKVSNILLDEDLKPKISDFGLAR 131
           L   N ++ EDL  KI DFG+ R
Sbjct: 145 LAARNCMVAEDLTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 43.5 bits (102), Expect = 1e-05
 Identities = 28/71 (39%), Positives = 38/71 (53%), Gaps = 3/71 (4%)

Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYI 148
           II GL ++   F   +++RDLK +NILLDE    +ISD GLA    K          GY+
Sbjct: 106 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYM 162

Query: 149 PPEYVGRGVYY 159
            PE + +G  Y
Sbjct: 163 APEVLQKGTAY 173

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 43.4 bits (102), Expect = 1e-05
 Identities = 29/105 (27%), Positives = 50/105 (47%), Gaps = 6/105 (5%)

Query: 25  FKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRV 83
           F  E +   +  H N++R+ G        M++ EYM   +LD FL      L+    + +
Sbjct: 53  FLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLV--AGQLM 110

Query: 84  HIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFG 128
            ++ G+  G+ YL E   +  +H+ L    +L++ DL  KIS F 
Sbjct: 111 GMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFR 152

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 43.5 bits (102), Expect = 1e-05
 Identities = 44/140 (31%), Positives = 67/140 (47%), Gaps = 29/140 (20%)

Query: 7   QIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSL 64
           Q +AVKKLS+  +S         E+ L   ++H N+I            L+  + P  S+
Sbjct: 41  QKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIG-----------LLDVFTPATSI 89

Query: 65  DYF--------LFDPIRMLILDCKKRV--HI---IKGIIQGLLYLQEYFRLTIIHRDLKV 111
           + F        L       I+ C+K    H+   I  +++GL Y+       IIHRDLK 
Sbjct: 90  ENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKP 146

Query: 112 SNILLDEDLKPKISDFGLAR 131
           SN+ ++ED + +I DFGLAR
Sbjct: 147 SNVAVNEDCELRILDFGLAR 166

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 43.5 bits (103), Expect = 1e-05
 Identities = 39/133 (29%), Positives = 64/133 (48%), Gaps = 13/133 (9%)

Query: 6   GQIIAVKKL--SKKSTQGFEEFKNEVMLTAKLQH---LNLIRVGFCIETQEYMLIYEYMP 60
           GQI+A+KK   S+      +    E+ +  +L+H   +NLI V      +   L++E++ 
Sbjct: 26  GQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEV--FRRKKRLYLVFEFVD 83

Query: 61  KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL 120
              LD     P     LD  +    +  I++G+ +   +    IIHRD+K  NIL+ +  
Sbjct: 84  HTVLDDLEKYPNG---LDESRVRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSG 137

Query: 121 KPKISDFGLARIL 133
             K+ DFG AR L
Sbjct: 138 VVKLCDFGFARTL 150

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 43.4 bits (102), Expect = 1e-05
 Identities = 35/109 (32%), Positives = 52/109 (47%), Gaps = 8/109 (7%)

Query: 28  EVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK--RVH 84
           E  L +KL H  +++     +E   + +I EY   R LD      +  L    K      
Sbjct: 52  EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLD----CKLEELKHTGKTLSENQ 107

Query: 85  IIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARIL 133
           + +  IQ LL +    +  I+HRDLK  NI L  +L  KI DFG++R+L
Sbjct: 108 VCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKNNLL-KIGDFGVSRLL 155

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 43.0 bits (101), Expect = 2e-05
 Identities = 35/132 (26%), Positives = 65/132 (49%), Gaps = 12/132 (9%)

Query: 7   QIIAVKKLS-KKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLD 65
           Q  A+K++   KS+   E+ + E +L AK++H N++      E   ++ I        ++
Sbjct: 26  QKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIV-------ME 78

Query: 66  YFLFDPIRMLILDCKKRVH----IIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK 121
           Y     +   I   + ++     I++  +Q  L +Q      ++HRD+K  NI L ++ K
Sbjct: 79  YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGK 138

Query: 122 PKISDFGLARIL 133
            K+ DFG AR+L
Sbjct: 139 VKLGDFGSARLL 150

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 43.1 bits (101), Expect = 2e-05
 Identities = 37/142 (26%), Positives = 67/142 (47%), Gaps = 16/142 (11%)

Query: 6   GQIIAVKKL-----SKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYML--IYE 57
           G+ +AVK++     S ++++     + E+ L   L H  +++  G   +  E  L    E
Sbjct: 27  GRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFME 86

Query: 58  YMPKRSLDYFLFDPIRML-ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL 116
           +MP  S+     D ++    L         + I++G+ YL       I+HRD+K +NIL 
Sbjct: 87  HMPGGSIK----DQLKSYGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILR 139

Query: 117 DEDLKPKISDFGLARILRKMIL 138
           D     K+ DFG ++ L+ + L
Sbjct: 140 DSVGNVKLGDFGASKRLQTICL 161

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 43.0 bits (102), Expect = 2e-05
 Identities = 35/136 (25%), Positives = 69/136 (50%), Gaps = 9/136 (6%)

Query: 6   GQIIAVKKLS-KKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRS 63
            Q++A+K +  +++    E+ + E+   ++ +   + +  G  ++  +  +I EY    S
Sbjct: 26  NQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGS 85

Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
                 D ++   LD      I++ ++ GL YL E  +   IHRD+K +NILL E+   K
Sbjct: 86  C----LDLLKPGKLDETYIAFILREVLLGLEYLHEEGK---IHRDIKAANILLSEEGDVK 138

Query: 124 ISDFGLARILRKMILK 139
           ++DFG++  L   + K
Sbjct: 139 LADFGVSGQLTSTMSK 154

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 43.1 bits (101), Expect = 2e-05
 Identities = 44/158 (27%), Positives = 76/158 (48%), Gaps = 9/158 (5%)

Query: 6   GQIIAVKKLSKKSTQ---GFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPK 61
           G++ A KKL KK  +   G     NE  +  K+    ++ + +  ET++ + L+   M  
Sbjct: 25  GKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNG 84

Query: 62  RSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK 121
             L + +++ +     D ++ +     +  GL  LQ   R  I++RDLK  NILLD+   
Sbjct: 85  GDLKFHIYN-MGNPGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGH 140

Query: 122 PKISDFGLA-RILRKMILKQIQIELGYIPPEYVGRGVY 158
            +ISD GLA +I     ++     +GY+ PE +    Y
Sbjct: 141 IRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKY 178

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 43.3 bits (102), Expect = 2e-05
 Identities = 36/128 (28%), Positives = 54/128 (42%), Gaps = 24/128 (18%)

Query: 12  KKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEY---------MPKR 62
           KK+  K+  G +    E+ +   + H  +I            LI+ Y         MPK 
Sbjct: 120 KKVIVKAVTGGKTPGREIDILKTISHRAIIN-----------LIHAYRWKSTVCMVMPKY 168

Query: 63  SLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKP 122
             D F +   R   L  ++ + I + +++ L YL       IIHRD+K  NI LDE    
Sbjct: 169 KCDLFTYVD-RSGPLPLEQAITIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENA 224

Query: 123 KISDFGLA 130
            + DFG A
Sbjct: 225 VLGDFGAA 232

Length = 392

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 42.9 bits (101), Expect = 2e-05
 Identities = 17/41 (41%), Positives = 27/41 (65%)

Query: 93  LLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARIL 133
           +L L    +L II+RD+K+ NILLD +    ++DFGL++  
Sbjct: 115 VLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 42.7 bits (100), Expect = 2e-05
 Identities = 32/138 (23%), Positives = 68/138 (49%), Gaps = 11/138 (7%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSL 64
           G++ A+K +  +  + F   + E+++    +H N++   G  +   +  +  E+    SL
Sbjct: 34  GELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSL 93

Query: 65  D--YFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKP 122
              Y +  P+    +      ++ +  +QGL YL    +   +HRD+K +NILL ++   
Sbjct: 94  QDIYHVTGPLSESQI-----AYVSRETLQGLYYLHSKGK---MHRDIKGANILLTDNGHV 145

Query: 123 KISDFGLARILRKMILKQ 140
           K++DFG++  +   I K+
Sbjct: 146 KLADFGVSAQITATIAKR 163

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 42.8 bits (101), Expect = 2e-05
 Identities = 39/144 (27%), Positives = 66/144 (45%), Gaps = 40/144 (27%)

Query: 6   GQIIAVKKLSKKSTQG--FEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKR 62
           GQ++A+K++  +  +G  F   + E  L   L+H N++ +   I T++ + L++EY+   
Sbjct: 30  GQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDTD 88

Query: 63  SLDY---------------FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHR 107
              Y               FLF  +R L   C +R                     ++HR
Sbjct: 89  LKQYMDDCGGGLSMHNVRLFLFQLLRGLAY-CHQR--------------------RVLHR 127

Query: 108 DLKVSNILLDEDLKPKISDFGLAR 131
           DLK  N+L+ E  + K++DFGLAR
Sbjct: 128 DLKPQNLLISERGELKLADFGLAR 151

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 42.7 bits (100), Expect = 2e-05
 Identities = 42/139 (30%), Positives = 65/139 (46%), Gaps = 19/139 (13%)

Query: 9   IAVKKLSKKSTQ-GFEEFKNEV-MLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLD 65
           +AVK L   +T+    +  +E+ M+    +H N+I + G C +     +I EY  K +L 
Sbjct: 53  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 112

Query: 66  YFL-----------FDP--IRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVS 112
            +L           ++P  +    L  K  V     + +G+ YL        IHRDL   
Sbjct: 113 EYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAAR 169

Query: 113 NILLDEDLKPKISDFGLAR 131
           N+L+ ED   KI+DFGLAR
Sbjct: 170 NVLVTEDNVMKIADFGLAR 188

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 42.8 bits (100), Expect = 3e-05
 Identities = 40/162 (24%), Positives = 77/162 (47%), Gaps = 10/162 (6%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSL 64
           GQ +A+++++ +     E   NE+++  + ++ N++  +   +   E  ++ EY+   SL
Sbjct: 45  GQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104

Query: 65  DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKI 124
                D +    +D  +   + +  +Q L +L       +IHRD+K  NILL  D   K+
Sbjct: 105 T----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKL 157

Query: 125 SDFGL-ARILRKMILKQIQIELGY-IPPEYVGRGVYYKKFSL 164
           +DFG  A+I  +   +   +   Y + PE V R  Y  K  +
Sbjct: 158 TDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 199

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 42.5 bits (100), Expect = 3e-05
 Identities = 28/90 (31%), Positives = 41/90 (45%), Gaps = 20/90 (22%)

Query: 48  ETQEYMLIYEYMPKRSL-------DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYF 100
           + Q   LI E++P   L       D F  D  R  + +C             +L ++   
Sbjct: 72  DAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAEC-------------VLAIEAVH 118

Query: 101 RLTIIHRDLKVSNILLDEDLKPKISDFGLA 130
           +L  IHRD+K  NIL+D     K+SDFGL+
Sbjct: 119 KLGFIHRDIKPDNILIDRGGHIKLSDFGLS 148

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 42.2 bits (99), Expect = 3e-05
 Identities = 35/127 (27%), Positives = 61/127 (48%), Gaps = 8/127 (6%)

Query: 9   IAVKKLSKKSTQGF-EEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSLDY 66
           +A+K L  ++ +   +E   E  +  +L +  ++R +G C E +  ML+ E      L+ 
Sbjct: 25  VAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVC-EAEALMLVMEMASGGPLNK 83

Query: 67  FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISD 126
           FL      + +     V ++  +  G+ YL+       +HRDL   N+LL      KISD
Sbjct: 84  FLSGKKDEITVS--NVVELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISD 138

Query: 127 FGLARIL 133
           FGL++ L
Sbjct: 139 FGLSKAL 145

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 42.5 bits (100), Expect = 3e-05
 Identities = 20/38 (52%), Positives = 26/38 (68%)

Query: 94  LYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLAR 131
           L L     L II+RDLK  NILLDE+   K++DFGL++
Sbjct: 109 LALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK 146

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 42.3 bits (99), Expect = 3e-05
 Identities = 37/137 (27%), Positives = 70/137 (51%), Gaps = 20/137 (14%)

Query: 6   GQIIAVKKL-----SKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCI---ETQEYMLIYE 57
           G+ +AVK++     S+++++     + E+ L   L+H  +++   C+   E ++  +  E
Sbjct: 27  GRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVE 86

Query: 58  YMPKRSLDYFLFDPIRM---LILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNI 114
           YMP  S+     D ++    L  +  +R    + I+QG+ YL       I+HRD+K +NI
Sbjct: 87  YMPGGSIK----DQLKAYGALTENVTRRY--TRQILQGVSYLHSNM---IVHRDIKGANI 137

Query: 115 LLDEDLKPKISDFGLAR 131
           L D     K+ DFG ++
Sbjct: 138 LRDSAGNVKLGDFGASK 154

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 42.3 bits (99), Expect = 4e-05
 Identities = 43/153 (28%), Positives = 71/153 (46%), Gaps = 9/153 (5%)

Query: 6   GQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPK 61
           G++ A KKL KK     +G     NE  +  K+    ++ + +  ET++ + L+   M  
Sbjct: 25  GKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 84

Query: 62  RSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK 121
             L + ++  +     +  + V     I  GL  L    +  I++RDLK  NILLD+   
Sbjct: 85  GDLKFHIYH-MGEAGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGH 140

Query: 122 PKISDFGLA-RILRKMILKQIQIELGYIPPEYV 153
            +ISD GLA  +     +K     +GY+ PE V
Sbjct: 141 IRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV 173

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 42.3 bits (99), Expect = 4e-05
 Identities = 41/138 (29%), Positives = 71/138 (51%), Gaps = 14/138 (10%)

Query: 3   LPDGQII----AVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIY 56
           +PDG+ +    A+K L +  S +  +E  +E  + A +    + R+ G C+ T    L+ 
Sbjct: 29  IPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICL-TSTVQLVT 87

Query: 57  EYMPKRSL-DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNIL 115
           + MP   L DY   +  R   +  +  ++    I +G+ YL+E   + ++HRDL   N+L
Sbjct: 88  QLMPYGCLLDYVRENKDR---IGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVL 141

Query: 116 LDEDLKPKISDFGLARIL 133
           +      KI+DFGLAR+L
Sbjct: 142 VKSPNHVKITDFGLARLL 159

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 42.0 bits (99), Expect = 4e-05
 Identities = 20/41 (48%), Positives = 28/41 (68%), Gaps = 3/41 (7%)

Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGL 129
           ++ GL YL E     I++RDLK+ N+LLD +   KI+DFGL
Sbjct: 110 VVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGL 147

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 42.0 bits (99), Expect = 4e-05
 Identities = 20/43 (46%), Positives = 28/43 (65%), Gaps = 3/43 (6%)

Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLAR 131
           I+ GL Y+       ++HRDLK  N+L++ D + KI DFGLAR
Sbjct: 114 ILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLAR 153

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 42.5 bits (100), Expect = 4e-05
 Identities = 35/141 (24%), Positives = 65/141 (46%), Gaps = 24/141 (17%)

Query: 6   GQIIAVKKLSKKSTQG---FEEFKNEVMLTAKLQHLNLIRVGFCIETQEYML--IYEYMP 60
           G  +A+K L   + +       F+ E  L A+L H N++ +    E    +L  ++EY+P
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62

Query: 61  KRSLDYFLFDPIRMLI-----LDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNIL 115
            R+L        R ++     L   +   ++  ++  L          I+HRDLK  NI+
Sbjct: 63  GRTL--------REVLAADGALPAGETGRLMLQVLDALACAH---NQGIVHRDLKPQNIM 111

Query: 116 LDE-DLKP--KISDFGLARIL 133
           + +  ++P  K+ DFG+  +L
Sbjct: 112 VSQTGVRPHAKVLDFGIGTLL 132

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 41.7 bits (98), Expect = 5e-05
 Identities = 34/113 (30%), Positives = 61/113 (53%), Gaps = 21/113 (18%)

Query: 28  EVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMP---KRSLDYFLFDPIRMLILDCKKRV 83
           E+ L  ++QH N++R+   + +++ + L++EY+    K+ +D     P      D  K  
Sbjct: 51  EISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDS---SP------DFAKNP 101

Query: 84  HIIKG----IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKP-KISDFGLAR 131
            +IK     I++G+ Y   +    ++HRDLK  N+L+D      K++DFGLAR
Sbjct: 102 RLIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLAR 151

Length = 294

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 41.7 bits (98), Expect = 5e-05
 Identities = 18/29 (62%), Positives = 21/29 (72%)

Query: 104 IIHRDLKVSNILLDEDLKPKISDFGLARI 132
           + HRDLK  NIL + D K KI DFGLAR+
Sbjct: 124 VFHRDLKPKNILANADCKLKICDFGLARV 152

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 41.8 bits (98), Expect = 5e-05
 Identities = 23/52 (44%), Positives = 27/52 (51%), Gaps = 13/52 (25%)

Query: 105 IHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRG 156
           IHRDL   NILL E+   KI DFGLAR +             Y  P+YV +G
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDI-------------YKDPDYVRKG 233

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 41.7 bits (98), Expect = 5e-05
 Identities = 21/43 (48%), Positives = 29/43 (67%), Gaps = 2/43 (4%)

Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLAR 131
           ++  L YL +  R  I+HRDL  +NI+L ED K  I+DFGLA+
Sbjct: 122 MVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK 162

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 41.5 bits (98), Expect = 5e-05
 Identities = 36/138 (26%), Positives = 60/138 (43%), Gaps = 14/138 (10%)

Query: 2   VLPDGQIIAVKKLSKKS--TQGFEE-FKNEVMLTAKLQHLNLIRV--GFCIETQEYMLIY 56
           V    +  A+K + K+     G +E   +E  +  +  H  ++++   F  +   YML+ 
Sbjct: 14  VKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLM- 72

Query: 57  EYMPKRSLDYFLFDPIRML-ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNIL 115
           EY     L    +  +R   + D       I  ++    YL       II+RDLK  N+L
Sbjct: 73  EYCLGGEL----WTILRDRGLFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLL 125

Query: 116 LDEDLKPKISDFGLARIL 133
           LD +   K+ DFG A+ L
Sbjct: 126 LDSNGYVKLVDFGFAKKL 143

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 41.5 bits (98), Expect = 6e-05
 Identities = 38/134 (28%), Positives = 58/134 (43%), Gaps = 18/134 (13%)

Query: 5   DGQIIAVKKLSK------KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYE 57
            GQ+ A+K L K               + +++  A    +  +   F  + +E++ L+ E
Sbjct: 25  TGQVYAMKVLRKSDMIKRNQIAHVRA-ERDILADADSPWIVKLYYSF--QDEEHLYLVME 81

Query: 58  YMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGL-LYLQEYFRLTIIHRDLKVSNILL 116
           YMP   L   L   IR  +          +  I  L L L    +L  IHRD+K  NIL+
Sbjct: 82  YMPGGDLMNLL---IRKDVFP----EETARFYIAELVLALDSVHKLGFIHRDIKPDNILI 134

Query: 117 DEDLKPKISDFGLA 130
           D D   K++DFGL 
Sbjct: 135 DADGHIKLADFGLC 148

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 41.4 bits (97), Expect = 6e-05
 Identities = 38/135 (28%), Positives = 63/135 (46%), Gaps = 13/135 (9%)

Query: 5   DGQIIAVKKL--SKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKR 62
           DG+   +K++  SK S +  EE + EV + + ++H N+++     E    + I       
Sbjct: 24  DGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIV------ 77

Query: 63  SLDYF----LFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE 118
            +DY     L+  I            I+   +Q  L L+      I+HRD+K  NI L +
Sbjct: 78  -MDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTK 136

Query: 119 DLKPKISDFGLARIL 133
           D   K+ DFG+AR+L
Sbjct: 137 DGTIKLGDFGIARVL 151

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 41.7 bits (98), Expect = 6e-05
 Identities = 45/153 (29%), Positives = 73/153 (47%), Gaps = 9/153 (5%)

Query: 6   GQIIAVKKLSKKSTQ---GFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPK 61
           G++ A KKL KK  +   G     NE  +  K+    ++ + +  ET++ + L+   M  
Sbjct: 25  GKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 84

Query: 62  RSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK 121
             L + +++ +     D ++ V     I  GL  L    R  I++RDLK  NILLD+   
Sbjct: 85  GDLKFHIYN-MGNPGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGH 140

Query: 122 PKISDFGLA-RILRKMILKQIQIELGYIPPEYV 153
            +ISD GLA  I     ++     +GY+ PE V
Sbjct: 141 IRISDLGLAVEIPEGETIRGRVGTVGYMAPEVV 173

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 41.7 bits (98), Expect = 6e-05
 Identities = 39/129 (30%), Positives = 55/129 (42%), Gaps = 13/129 (10%)

Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKL-----QHLNLIRV-GFCIETQEYMLIYEYMPKR 62
           +AVK L  K T    E +  +M   K+      H N++ + G C      ++I EY    
Sbjct: 68  VAVKML--KPTAHSSE-REALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYG 124

Query: 63  SLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKP 122
            L  FL    R   L  +  +     + +G+ +L        IHRDL   N+LL      
Sbjct: 125 DLLNFLRRK-RESFLTLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIV 180

Query: 123 KISDFGLAR 131
           KI DFGLAR
Sbjct: 181 KICDFGLAR 189

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 41.5 bits (97), Expect = 6e-05
 Identities = 21/43 (48%), Positives = 29/43 (67%), Gaps = 3/43 (6%)

Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLAR 131
           +++GL Y+       IIHRDLK  N+ ++ED + KI DFGLAR
Sbjct: 127 MLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR 166

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 41.3 bits (97), Expect = 6e-05
 Identities = 25/78 (32%), Positives = 44/78 (56%), Gaps = 7/78 (8%)

Query: 85  IIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIE 144
           II+ ++  L Y+    ++ +IHRD+K +NIL+      K+ DFG+A +L +   K+    
Sbjct: 106 IIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTF- 161

Query: 145 LG---YIPPEYVGRGVYY 159
           +G   ++ PE +  G YY
Sbjct: 162 VGTPYWMAPEVITEGKYY 179

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 41.3 bits (97), Expect = 7e-05
 Identities = 19/47 (40%), Positives = 29/47 (61%), Gaps = 3/47 (6%)

Query: 85  IIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLAR 131
           I+  I+ GL  L +++    +HRDL  +NI ++     KI+DFGLAR
Sbjct: 124 ILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLAR 167

Length = 335

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 41.3 bits (97), Expect = 7e-05
 Identities = 32/135 (23%), Positives = 67/135 (49%), Gaps = 13/135 (9%)

Query: 5   DGQIIAVKK--LSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPK 61
           D  ++  K+  L++ S +   +  NE+++ + LQH N+I      ++    ++  EY   
Sbjct: 24  DDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANG 83

Query: 62  RSLDYFLFDPI---RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE 118
            +L    +D I   +  + + +  +  +  I+  + Y+ +     I+HRD+K  NI L +
Sbjct: 84  GTL----YDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTK 136

Query: 119 DLKPKISDFGLARIL 133
               K+ DFG+++IL
Sbjct: 137 AGLIKLGDFGISKIL 151

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 41.3 bits (97), Expect = 7e-05
 Identities = 18/43 (41%), Positives = 28/43 (65%), Gaps = 3/43 (6%)

Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLAR 131
           I+  L YL       +++RDLK+ N++LD+D   KI+DFGL +
Sbjct: 104 IVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCK 143

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 41.2 bits (96), Expect = 8e-05
 Identities = 41/139 (29%), Positives = 65/139 (46%), Gaps = 19/139 (13%)

Query: 9   IAVKKLSKKSTQ-GFEEFKNEV-MLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLD 65
           +AVK L   +T+    +  +E+ M+    +H N+I + G C +     +I EY  K +L 
Sbjct: 50  VAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 109

Query: 66  YFL-----------FDPIRML--ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVS 112
            +L           +D  R+    +  K  V     + +G+ YL        IHRDL   
Sbjct: 110 EYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAAR 166

Query: 113 NILLDEDLKPKISDFGLAR 131
           N+L+ E+   KI+DFGLAR
Sbjct: 167 NVLVTENNVMKIADFGLAR 185

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 41.1 bits (96), Expect = 8e-05
 Identities = 41/158 (25%), Positives = 75/158 (47%), Gaps = 9/158 (5%)

Query: 6   GQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPK 61
           G++ A K+L KK     +G     NE  +  K+    ++ + +  ET++ + L+   M  
Sbjct: 25  GKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNG 84

Query: 62  RSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK 121
             L + +++ +     + ++ +     I+ GL  L    R   ++RDLK  NILLD+   
Sbjct: 85  GDLKFHIYN-MGNPGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGH 140

Query: 122 PKISDFGLA-RILRKMILKQIQIELGYIPPEYVGRGVY 158
            +ISD GLA +I     ++     +GY+ PE +    Y
Sbjct: 141 IRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRY 178

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 40.9 bits (96), Expect = 9e-05
 Identities = 18/51 (35%), Positives = 27/51 (52%), Gaps = 13/51 (25%)

Query: 104 IIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVG 154
           IIHRD+K  N+L+D+    K++DFGL+R              G    ++VG
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRN-------------GLENKKFVG 155

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 40.9 bits (96), Expect = 1e-04
 Identities = 21/43 (48%), Positives = 30/43 (69%), Gaps = 3/43 (6%)

Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLAR 131
           II GL +L +     II+RDLK+ N+LLD+D   KI+DFG+ +
Sbjct: 105 IICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCK 144

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 40.8 bits (95), Expect = 1e-04
 Identities = 23/52 (44%), Positives = 27/52 (51%), Gaps = 13/52 (25%)

Query: 105 IHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRG 156
           IHRDL   NILL E+   KI DFGLAR +             Y  P+YV +G
Sbjct: 196 IHRDLAARNILLSENNVVKICDFGLARDI-------------YKDPDYVRKG 234

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 40.8 bits (95), Expect = 1e-04
 Identities = 40/160 (25%), Positives = 80/160 (50%), Gaps = 13/160 (8%)

Query: 7   QIIAVKKLS-KKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSL 64
           Q++A+K +  +++    E+ + E+ + ++     + +  G  ++  +  +I EY+   S 
Sbjct: 30  QVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSA 89

Query: 65  DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKI 124
                D +R    D  +   ++K I++GL YL    +   IHRD+K +N+LL E    K+
Sbjct: 90  ----LDLLRAGPFDEFQIATMLKEILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKL 142

Query: 125 SDFGLARILRKMILKQIQIELG---YIPPEYVGRGVYYKK 161
           +DFG+A  L    +K+    +G   ++ PE + +  Y  K
Sbjct: 143 ADFGVAGQLTDTQIKR-NTFVGTPFWMAPEVIQQSAYDSK 181

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 41.0 bits (96), Expect = 1e-04
 Identities = 23/64 (35%), Positives = 34/64 (53%), Gaps = 9/64 (14%)

Query: 78  DCKKRVHI---------IKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFG 128
           D K  +HI         +K I +  L L    R  IIHRDLK  N+L+  +   K++DFG
Sbjct: 90  DVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFG 149

Query: 129 LARI 132
           L+++
Sbjct: 150 LSKV 153

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 40.8 bits (95), Expect = 1e-04
 Identities = 25/72 (34%), Positives = 42/72 (58%), Gaps = 3/72 (4%)

Query: 88  GIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGY 147
            +I+GL YL+E  +  I+HRD+K SNIL++   + K+ DFG++  L   +         Y
Sbjct: 111 AVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSY 168

Query: 148 IPPEYVGRGVYY 159
           + PE + +G +Y
Sbjct: 169 MSPERL-QGTHY 179

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 40.5 bits (95), Expect = 1e-04
 Identities = 18/43 (41%), Positives = 27/43 (62%), Gaps = 3/43 (6%)

Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLAR 131
           I  GL +L       II+RDLK+ N++LD +   KI+DFG+ +
Sbjct: 110 IAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCK 149

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 40.4 bits (95), Expect = 1e-04
 Identities = 23/51 (45%), Positives = 31/51 (60%), Gaps = 1/51 (1%)

Query: 84  HIIKGII-QGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARIL 133
           H+IK II Q L  +    +   IHRD+K  NIL+ +  + K+ DFG ARIL
Sbjct: 100 HLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARIL 150

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 40.4 bits (95), Expect = 2e-04
 Identities = 20/47 (42%), Positives = 28/47 (59%)

Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK 135
           I + +L +    +L  IHRD+K  N+LLD     K+SDFGL   L+K
Sbjct: 107 IAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKK 153

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 40.0 bits (93), Expect = 2e-04
 Identities = 33/109 (30%), Positives = 58/109 (53%), Gaps = 6/109 (5%)

Query: 51  EYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLK 110
           E  +  E+M   SLD  L +  + +  +   +V I   +++GL YL+E  +  I+HRD+K
Sbjct: 77  EISICMEHMDGGSLDQVLKEA-KRIPEEILGKVSI--AVLRGLAYLRE--KHQIMHRDVK 131

Query: 111 VSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYY 159
            SNIL++   + K+ DFG++  L   +         Y+ PE + +G +Y
Sbjct: 132 PSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERL-QGTHY 179

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 39.9 bits (93), Expect = 2e-04
 Identities = 36/133 (27%), Positives = 61/133 (45%), Gaps = 13/133 (9%)

Query: 6   GQIIAVKKLSKKSTQGFEEF------KNEVMLTAKLQHLNLIRVGFCIET-QEYMLIYEY 58
            +I A+K LSKK     +E       +N ++ T   +   ++ + F  +T  +  L+ +Y
Sbjct: 18  RRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDY 77

Query: 59  MPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE 118
           M    L + L    R       +    I  ++  L +L +Y    I++RDLK  NILLD 
Sbjct: 78  MSGGELFWHLQKEGR---FSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDA 131

Query: 119 DLKPKISDFGLAR 131
                + DFGL++
Sbjct: 132 TGHIALCDFGLSK 144

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 40.1 bits (93), Expect = 2e-04
 Identities = 32/129 (24%), Positives = 63/129 (48%), Gaps = 13/129 (10%)

Query: 15  SKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIE---TQEYMLIYEYMPKRSLDYFLFDP 71
           S ++++     + E+ L   LQH  +++   C+     +   +  EYMP  S+     D 
Sbjct: 41  SPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVK----DQ 96

Query: 72  IRML--ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGL 129
           ++    + +   R +  + I++G+ YL       I+HRD+K +NIL D     K+ DFG 
Sbjct: 97  LKAYGALTESVTRKYT-RQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGA 152

Query: 130 ARILRKMIL 138
           ++ L+ + +
Sbjct: 153 SKRLQTICM 161

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 40.1 bits (93), Expect = 2e-04
 Identities = 19/54 (35%), Positives = 36/54 (66%), Gaps = 3/54 (5%)

Query: 84  HIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI 137
           +I + I++GL +L ++    +IHRD+K  N+LL E+ + K+ DFG++  L + +
Sbjct: 115 YICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV 165

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 40.0 bits (93), Expect = 2e-04
 Identities = 32/117 (27%), Positives = 53/117 (45%), Gaps = 13/117 (11%)

Query: 24  EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLF--------DPIRM 74
           EF NE  +  +    +++R+ G   + Q  ++I E M +  L  +L         +P++ 
Sbjct: 55  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQA 114

Query: 75  LILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLAR 131
                KK + +   I  G+ YL        +HRDL   N ++ ED   KI DFG+ R
Sbjct: 115 PP-SLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 167

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 40.0 bits (93), Expect = 3e-04
 Identities = 30/88 (34%), Positives = 45/88 (51%), Gaps = 8/88 (9%)

Query: 54  LIYEYMPKRSLDYFLFDPI---RMLILDCKKRV---HIIKGIIQGL-LYLQEYFRLTIIH 106
           L Y +  K +L YF+ D I    M+ L  +  V    + +  I  L L ++   ++  IH
Sbjct: 66  LYYSFQDKDNL-YFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIH 124

Query: 107 RDLKVSNILLDEDLKPKISDFGLARILR 134
           RD+K  NIL+D D   K++DFGL    R
Sbjct: 125 RDIKPDNILIDLDGHIKLTDFGLCTGFR 152

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 39.7 bits (93), Expect = 3e-04
 Identities = 21/46 (45%), Positives = 29/46 (63%), Gaps = 3/46 (6%)

Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILR 134
           I+  L YL       I++RDLK  NILLD++   K++DFG A+ LR
Sbjct: 110 IVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR 152

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 39.6 bits (92), Expect = 3e-04
 Identities = 23/62 (37%), Positives = 33/62 (53%)

Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYI 148
           I + +L +    +L  IHRD+K  N+LLD     K+SDFGL   L+K    +    L + 
Sbjct: 107 IAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHN 166

Query: 149 PP 150
           PP
Sbjct: 167 PP 168

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 39.6 bits (92), Expect = 3e-04
 Identities = 39/135 (28%), Positives = 59/135 (43%), Gaps = 32/135 (23%)

Query: 14  LSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQE---YMLIYEYMPKRSLDYFLFD 70
           L+K   +  E  K EV+L AK++H N+  V F    QE     ++ EY            
Sbjct: 35  LTKMPVKEKEASKKEVILLAKMKHPNI--VTFFASFQENGRLFIVMEYCDGG-------- 84

Query: 71  PIRMLILDCKKRVHIIKGI-----------IQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
                  D  KR++  +G+           +Q  L L+      I+HRD+K  NI L ++
Sbjct: 85  -------DLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKN 137

Query: 120 LK-PKISDFGLARIL 133
               K+ DFG+AR L
Sbjct: 138 GMVAKLGDFGIARQL 152

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 39.7 bits (92), Expect = 3e-04
 Identities = 29/88 (32%), Positives = 49/88 (55%), Gaps = 7/88 (7%)

Query: 77  LDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM 136
           LD  +   I++ I++GL YL    +   IHRD+K +N+LL E  + K++DFG+A  L   
Sbjct: 98  LDETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 154

Query: 137 ILKQIQIELG---YIPPEYVGRGVYYKK 161
            +K+    +G   ++ PE + +  Y  K
Sbjct: 155 QIKR-NTFVGTPFWMAPEVIKQSAYDSK 181

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 39.6 bits (92), Expect = 3e-04
 Identities = 23/52 (44%), Positives = 27/52 (51%), Gaps = 13/52 (25%)

Query: 105 IHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRG 156
           IHRDL   NILL E+   KI DFGLAR +             Y  P+YV +G
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLARDI-------------YKDPDYVRKG 239

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 39.5 bits (92), Expect = 3e-04
 Identities = 30/86 (34%), Positives = 41/86 (47%), Gaps = 15/86 (17%)

Query: 90  IQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELG--- 146
           IQ LL +       +IHRD+K +NILL  +   K+ DFG +    KM    +  ++G   
Sbjct: 150 IQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFS----KMYAATVSDDVGRTF 205

Query: 147 -----YIPPEYVGRGVYYKK---FSL 164
                Y+ PE   R  Y KK   FSL
Sbjct: 206 CGTPYYVAPEIWRRKPYSKKADMFSL 231

Length = 496

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 39.6 bits (92), Expect = 3e-04
 Identities = 40/133 (30%), Positives = 63/133 (47%), Gaps = 13/133 (9%)

Query: 5   DGQIIAVKKLSKKSTQGFEEFKNEVM-----LTAKLQHLNLIRVGFCIETQEYM-LIYEY 58
           DG   AVK L KK+    +E +N +M     L   L+H  L+ + +  +T E +  + +Y
Sbjct: 19  DGSFYAVKVLQKKTILKKKE-QNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDY 77

Query: 59  MPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE 118
           +    L  F         L+ + R +  + +   + YL     L II+RDLK  NILLD 
Sbjct: 78  VNGGEL--FFHLQRERCFLEPRARFYAAE-VASAIGYLHS---LNIIYRDLKPENILLDS 131

Query: 119 DLKPKISDFGLAR 131
                ++DFGL +
Sbjct: 132 QGHVVLTDFGLCK 144

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 39.4 bits (92), Expect = 3e-04
 Identities = 16/34 (47%), Positives = 22/34 (64%)

Query: 101 RLTIIHRDLKVSNILLDEDLKPKISDFGLARILR 134
           ++  IHRD+K  NIL+D D   K++DFGL    R
Sbjct: 119 KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFR 152

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 39.1 bits (92), Expect = 4e-04
 Identities = 20/47 (42%), Positives = 29/47 (61%), Gaps = 3/47 (6%)

Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK 135
           ++  L YL     L I++RDLK  N+LLD D   KI+DFG A+ ++ 
Sbjct: 110 VVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKG 153

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 39.2 bits (92), Expect = 4e-04
 Identities = 40/135 (29%), Positives = 65/135 (48%), Gaps = 18/135 (13%)

Query: 5   DGQIIAVKKLSKKSTQGFEEFKN--EVMLTAKLQH----LNLIRVGFCIETQEYMLIYEY 58
            G+  A+K + KK  +  E+  N  E+    +L      L LI V F  +T    L++E 
Sbjct: 23  TGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFEL 81

Query: 59  MPKRSLDYFLFDPI--RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL 116
           M     D  L++ I  R   L  K+    +  +++ L ++    R  I HRD+K  NIL+
Sbjct: 82  M-----DMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILI 133

Query: 117 DEDLKPKISDFGLAR 131
            +D+  K++DFG  R
Sbjct: 134 KDDIL-KLADFGSCR 147

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 39.1 bits (91), Expect = 4e-04
 Identities = 23/60 (38%), Positives = 32/60 (53%), Gaps = 2/60 (3%)

Query: 94  LYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLAR--ILRKMILKQIQIELGYIPPE 151
           L L    R  +I+RDLK+ NILLD +   K++DFG+ +  IL  +          YI PE
Sbjct: 107 LALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPE 166

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 38.8 bits (90), Expect = 5e-04
 Identities = 19/54 (35%), Positives = 35/54 (64%), Gaps = 3/54 (5%)

Query: 84  HIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI 137
           +I + I++GL +L  +    +IHRD+K  N+LL E+ + K+ DFG++  L + +
Sbjct: 125 YICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV 175

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 39.0 bits (91), Expect = 5e-04
 Identities = 17/35 (48%), Positives = 22/35 (62%), Gaps = 1/35 (2%)

Query: 98  EYFR-LTIIHRDLKVSNILLDEDLKPKISDFGLAR 131
           EY     II+RDLK  N+LLD     K++DFG A+
Sbjct: 132 EYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAK 166

Length = 329

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 38.9 bits (90), Expect = 5e-04
 Identities = 35/137 (25%), Positives = 70/137 (51%), Gaps = 11/137 (8%)

Query: 7   QIIAVKKLS-KKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRS- 63
           +++A+K +  +++    E+ + E+ + ++     + R  G  ++  +  +I EY+   S 
Sbjct: 30  EVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSA 89

Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           LD     P+    +       I++ I++GL YL    +   IHRD+K +N+LL E    K
Sbjct: 90  LDLLKPGPLEETYI-----ATILREILKGLDYLHSERK---IHRDIKAANVLLSEQGDVK 141

Query: 124 ISDFGLARILRKMILKQ 140
           ++DFG+A  L    +K+
Sbjct: 142 LADFGVAGQLTDTQIKR 158

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 38.7 bits (90), Expect = 6e-04
 Identities = 17/43 (39%), Positives = 28/43 (65%), Gaps = 3/43 (6%)

Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLAR 131
           I   L++L +     II+RDLK+ N+LLD +   K++DFG+ +
Sbjct: 105 ITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCK 144

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 38.8 bits (90), Expect = 6e-04
 Identities = 21/43 (48%), Positives = 28/43 (65%), Gaps = 3/43 (6%)

Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLAR 131
           II GL +L       I++RDLK+ NILLD D   KI+DFG+ +
Sbjct: 105 IICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCK 144

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 38.4 bits (89), Expect = 6e-04
 Identities = 24/71 (33%), Positives = 36/71 (50%), Gaps = 5/71 (7%)

Query: 92  GLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLAR--ILRKMILKQIQIELGYIP 149
           GL +L       II+RDLK+ N++LD +   KI+DFG+ +  +   +  K       YI 
Sbjct: 113 GLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIA 169

Query: 150 PEYVGRGVYYK 160
           PE +    Y K
Sbjct: 170 PEIIAYQPYGK 180

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 38.8 bits (90), Expect = 7e-04
 Identities = 16/39 (41%), Positives = 28/39 (71%)

Query: 93  LLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLAR 131
           +L L+   +L I++RD+K+ NILLD +    ++DFGL++
Sbjct: 115 ILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSK 153

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 38.4 bits (89), Expect = 7e-04
 Identities = 17/39 (43%), Positives = 28/39 (71%)

Query: 93  LLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLAR 131
           +L L+   +L II+RD+K+ NILLD +    ++DFGL++
Sbjct: 115 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK 153

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 38.7 bits (90), Expect = 7e-04
 Identities = 24/92 (26%), Positives = 45/92 (48%), Gaps = 7/92 (7%)

Query: 34  KLQHLNLIR-VGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQG 92
           KLQH N+++ +G C   +   LI+EY+  ++L   L +      L  ++R  I  GI + 
Sbjct: 739 KLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGIAKA 792

Query: 93  LLYLQEYFRLTIIHRDLKVSNILLDEDLKPKI 124
           L +L       ++  +L    I++D   +P +
Sbjct: 793 LRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL 824

Length = 968

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 38.6 bits (90), Expect = 7e-04
 Identities = 39/133 (29%), Positives = 64/133 (48%), Gaps = 13/133 (9%)

Query: 5   DGQIIAVKKLSKKSTQGFEEFKNEVM-----LTAKLQHLNLIRVGFCIETQEYM-LIYEY 58
           DG+  AVK L KK+    +E K+ +M     L   ++H  L+ + +  +T + +  + +Y
Sbjct: 19  DGKFYAVKVLQKKAILKKKEQKH-IMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDY 77

Query: 59  MPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE 118
           +    L + L         + + R +  + I   L YL     L II+RDLK  NILLD 
Sbjct: 78  VNGGELFFHLQRERSFP--EPRARFYAAE-IASALGYLHS---LNIIYRDLKPENILLDS 131

Query: 119 DLKPKISDFGLAR 131
                ++DFGL +
Sbjct: 132 QGHVVLTDFGLCK 144

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 38.2 bits (89), Expect = 8e-04
 Identities = 30/131 (22%), Positives = 54/131 (41%), Gaps = 16/131 (12%)

Query: 9   IAVKKLSKKSTQGF-EEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYF 67
           +AVK     ++    E+F  E  +  +  H +++++   I      ++ E  P   L  +
Sbjct: 37  VAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITENPVWIVMELAPLGELRSY 96

Query: 68  LFD-----PIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKP 122
           L        +  LIL   +       +   L YL+       +HRD+   N+L+      
Sbjct: 97  LQVNKYSLDLASLILYSYQ-------LSTALAYLES---KRFVHRDIAARNVLVSSPDCV 146

Query: 123 KISDFGLARIL 133
           K+ DFGL+R L
Sbjct: 147 KLGDFGLSRYL 157

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 38.1 bits (88), Expect = 9e-04
 Identities = 20/47 (42%), Positives = 28/47 (59%)

Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK 135
           I + +L +    +L  IHRD+K  N+LLD     K+SDFGL   L+K
Sbjct: 107 IAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKK 153

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 38.3 bits (89), Expect = 9e-04
 Identities = 18/30 (60%), Positives = 19/30 (63%)

Query: 105 IHRDLKVSNILLDEDLKPKISDFGLARILR 134
           IHRDL   NILL      KI DFGLAR +R
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLARDIR 265

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 38.1 bits (88), Expect = 0.001
 Identities = 41/146 (28%), Positives = 65/146 (44%), Gaps = 25/146 (17%)

Query: 6   GQIIAVKKLSKKSTQGFEEF-KNEVMLTAKLQHLNLIRVGFCIETQEYM--LIYEYMPKR 62
           G++   +K+  K+    +   K +V+L  ++ H+   R        E++  L Y +  K 
Sbjct: 15  GEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKD 74

Query: 63  SLDYFLFDPI----RMLILDCKKRVHIIKGIIQGLL---YLQEY-------FRLTIIHRD 108
           +L YF+ D I     M +L       I  GI    L   Y+ E         ++  IHRD
Sbjct: 75  NL-YFVMDYIPGGDMMSLL-------IRMGIFPEDLARFYIAELTCAVESVHKMGFIHRD 126

Query: 109 LKVSNILLDEDLKPKISDFGLARILR 134
           +K  NIL+D D   K++DFGL    R
Sbjct: 127 IKPDNILIDRDGHIKLTDFGLCTGFR 152

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 38.0 bits (88), Expect = 0.001
 Identities = 19/39 (48%), Positives = 28/39 (71%), Gaps = 3/39 (7%)

Query: 95  YLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARIL 133
           YLQ    L I++RDLK  N+LLD+D   K++DFG A+++
Sbjct: 146 YLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVV 181

Length = 340

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 37.6 bits (87), Expect = 0.001
 Identities = 19/43 (44%), Positives = 28/43 (65%), Gaps = 3/43 (6%)

Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLAR 131
           I+ GL +L       II+RDLK+ N++LD D   KI+DFG+ +
Sbjct: 105 IVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCK 144

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 37.3 bits (86), Expect = 0.002
 Identities = 17/43 (39%), Positives = 28/43 (65%), Gaps = 3/43 (6%)

Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLAR 131
           I+  L YL       +++RD+K+ N++LD+D   KI+DFGL +
Sbjct: 104 IVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCK 143

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 37.5 bits (87), Expect = 0.002
 Identities = 25/71 (35%), Positives = 35/71 (49%), Gaps = 10/71 (14%)

Query: 85  IIKGIIQGLLY-LQEYFRLTIIHRDLKVSNILLDEDLKP-KISDFGLARILRKMILKQIQ 142
           II+ I++ +L+ L       I+HRD+K  NI+  E     KI D G A  LR  I     
Sbjct: 256 IIQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGI----- 310

Query: 143 IELGYIPPEYV 153
               YIP E++
Sbjct: 311 ---NYIPKEFL 318

Length = 566

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 37.1 bits (86), Expect = 0.002
 Identities = 15/44 (34%), Positives = 27/44 (61%), Gaps = 4/44 (9%)

Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL-KPKISDFGLAR 131
           +++G+ +     +  ++HRDLK  N+L+D+     KI+D GL R
Sbjct: 119 LLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 36.9 bits (85), Expect = 0.002
 Identities = 18/43 (41%), Positives = 28/43 (65%), Gaps = 2/43 (4%)

Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLAR 131
           I+  L YL       +++RDLK+ N++LD+D   KI+DFGL +
Sbjct: 104 IVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK 144

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 36.7 bits (85), Expect = 0.002
 Identities = 18/39 (46%), Positives = 24/39 (61%)

Query: 93  LLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLAR 131
            L L+   +  II+RDLK  NILLD     K++DFGL +
Sbjct: 110 SLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCK 148

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 36.9 bits (85), Expect = 0.003
 Identities = 36/134 (26%), Positives = 68/134 (50%), Gaps = 17/134 (12%)

Query: 7   QIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-------LIYEYM 59
           +I+A+KK   K ++  EE K   +   +L+ L  ++    +E +E         L++EY+
Sbjct: 27  EIVAIKKF--KDSEENEEVKETTL--RELKMLRTLKQENIVELKEAFRRRGKLYLVFEYV 82

Query: 60  PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
            K  L+  L + +   +   K R +I + +I+ + +     +  I+HRD+K  N+L+  +
Sbjct: 83  EKNMLE--LLEEMPNGVPPEKVRSYIYQ-LIKAIHWCH---KNDIVHRDIKPENLLISHN 136

Query: 120 LKPKISDFGLARIL 133
              K+ DFG AR L
Sbjct: 137 DVLKLCDFGFARNL 150

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 36.6 bits (84), Expect = 0.003
 Identities = 19/43 (44%), Positives = 28/43 (65%), Gaps = 3/43 (6%)

Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLAR 131
           I+  L YL       I++RDLK+ N++LD+D   KI+DFGL +
Sbjct: 104 IVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCK 143

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 36.5 bits (84), Expect = 0.003
 Identities = 38/132 (28%), Positives = 64/132 (48%), Gaps = 11/132 (8%)

Query: 5   DGQIIAVKKLSKKSTQGFEEFKNEV----MLTAKLQHLNLIRVGFCIETQEYM-LIYEYM 59
           + +  AVK L KK+    +E K+ +    +L   ++H  L+ + F  +T + +  + +Y+
Sbjct: 19  EEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYI 78

Query: 60  PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
               L Y L        L+ + R +  + I   L YL     L I++RDLK  NILLD  
Sbjct: 79  NGGELFYHL--QRERCFLEPRARFYAAE-IASALGYLHS---LNIVYRDLKPENILLDSQ 132

Query: 120 LKPKISDFGLAR 131
               ++DFGL +
Sbjct: 133 GHIVLTDFGLCK 144

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 36.5 bits (84), Expect = 0.003
 Identities = 25/74 (33%), Positives = 39/74 (52%), Gaps = 5/74 (6%)

Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLAR--ILRKMILKQIQIELG 146
           I  GL +L    R  II+RDLK+ N++LD +   KI+DFG+ +  ++  +  +       
Sbjct: 110 ISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPD 166

Query: 147 YIPPEYVGRGVYYK 160
           YI PE +    Y K
Sbjct: 167 YIAPEIIAYQPYGK 180

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	164
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	99.98
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	99.98
KOG0198	313	consensus MEKK and related serine/threonine protei	99.98
KOG0611	668	consensus Predicted serine/threonine protein kinas	99.98
KOG0661	538	consensus MAPK related serine/threonine protein ki	99.97
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	99.97
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.97
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	99.97
KOG0589	426	consensus Serine/threonine protein kinase [General	99.97
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.97
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	99.97
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.97
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.97
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.97
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.97
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.97
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	99.97
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.97
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.97
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.97
KOG0605	550	consensus NDR and related serine/threonine kinases	99.97
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.97
KOG4721	904	consensus Serine/threonine protein kinase, contain	99.97
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.97
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	99.97
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.97
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.97
KOG0584	632	consensus Serine/threonine protein kinase [General	99.97
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.97
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.97
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.97
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	99.97
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.97
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.97
PTZ00267	478	NIMA-related protein kinase; Provisional	99.97
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.97
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.97
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.97
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.97
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.97
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	99.96
KOG0586	596	consensus Serine/threonine protein kinase [General	99.96
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.96
KOG0694	694	consensus Serine/threonine protein kinase [Signal	99.96
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.96
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.96
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.96
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.96
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.96
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.96
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.96
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.96
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.96
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.96
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.96
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	99.96
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.96
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.96
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.96
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.96
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.96
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.96
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.96
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	99.96
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.96
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.96
PHA02988	283	hypothetical protein; Provisional	99.96
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.96
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.96
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.96
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.96
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.96
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.96
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.96
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.96
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.96
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.96
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.96
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.96
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.96
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.96
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.96
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.96
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.96
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.96
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.96
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.96
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.96
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.96
PHA03212	391	serine/threonine kinase US3; Provisional	99.96
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.96
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.95
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.95
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.95
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.95
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.95
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.95
KOG0610	459	consensus Putative serine/threonine protein kinase	99.95
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.95
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.95
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.95
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.95
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.95
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.95
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.95
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.95
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.95
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.95
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.95
PTZ00283	496	serine/threonine protein kinase; Provisional	99.95
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	99.95
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.95
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.95
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.95
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.95
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.95
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.95
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.95
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.95
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.95
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.95
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.95
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.95
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.95
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.95
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.95
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.95
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.95
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.95
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.95
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.95
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.95
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.95
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.95
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.95
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.95
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.95
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.95
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.95
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.95
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.95
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.95
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.95
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.95
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.95
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.95
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.95
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.95
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.95
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.95
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.94
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.94
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.94
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.94
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.94
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.94
PHA03211	461	serine/threonine kinase US3; Provisional	99.94
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.94
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.94
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.94
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.94
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.94
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.94
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.94
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.94
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.94
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.94
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.94
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.94
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.94
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.94
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.94
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.94
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.94
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.94
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.94
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.94
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.94
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.94
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.94
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.94
PHA03207	392	serine/threonine kinase US3; Provisional	99.94
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.94
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.94
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.94
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.94
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.94
PHA03209	357	serine/threonine kinase US3; Provisional	99.94
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.94
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.94
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.94
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.94
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.94
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.94
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.94
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.94
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.94
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.94
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.94
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.94
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.94
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.94
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.94
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.94
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.94
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.94
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.94
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.94
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.94
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.94
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.94
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.94
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.94
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.94
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.94
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.94
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.94
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.94
PTZ00036	440	glycogen synthase kinase; Provisional	99.94
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.94
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.94
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.94
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.94
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.94
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.94
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.94
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.94
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.94
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.94
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.94
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.94
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.94
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.94
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.94
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.94
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.94
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.94
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.94
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.94
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.94
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.94
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.94
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.94
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.94
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.94
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.93
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.93
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.93
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.93
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.93
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.93
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.93
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.93
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.93
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.93
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.93
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.93
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.93
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.93
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.93
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.93
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.93
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.93
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.93
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.93
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.93
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.93
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.93
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.93
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.93
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.93
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.93
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.93
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.93
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.93
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.93
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.93
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.93
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.93
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.93
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.93
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.93
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.93
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.93
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.93
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.93
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.93
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.93
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.93
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.93
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.93
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.93
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.93
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.93
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.93
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.93
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.93
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.93
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.93
KOG1152	772	consensus Signal transduction serine/threonine kin	99.93
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.92
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.92
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.92
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.92
KOG3653	534	consensus Transforming growth factor beta/activin	99.92
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.92
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.92
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.92
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.92
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.92
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.92
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.92
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.92
PLN00009	294	cyclin-dependent kinase A; Provisional	99.92
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.92
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.92
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.92
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.92
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.92
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.92
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.92
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.92
PTZ00284	467	protein kinase; Provisional	99.92
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.92
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.92
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.92
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.92
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.92
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.91
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.91
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.91
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.91
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.91
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.91
PHA03210	501	serine/threonine kinase US3; Provisional	99.91
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.91
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.91
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.91
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.91
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.91
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.91
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.91
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.91
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.91
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.91
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.91
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.91
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.91
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.91
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.91
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.91
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.91
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.9
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.9
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.9
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.9
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.9
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.9
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.9
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.9
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.9
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.9
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.9
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.9
PRK09188	365	serine/threonine protein kinase; Provisional	99.9
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.89
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.89
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.89
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.89
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.89
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.89
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.89
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.89
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.88
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.88
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.88
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.88
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.87
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.86
PHA02882	294	putative serine/threonine kinase; Provisional	99.86
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.85
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.85
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.84
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.84
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.83
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.82
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.81
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.81
PLN00181	793	protein SPA1-RELATED; Provisional	99.8
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.77
PRK10345	210	hypothetical protein; Provisional	99.77
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.76
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.73
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.72
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.72
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.72
smart00090	237	RIO RIO-like kinase.	99.7
PRK12274	218	serine/threonine protein kinase; Provisional	99.69
PRK14879	211	serine/threonine protein kinase; Provisional	99.69
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.67
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.66
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.66
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.62
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.6
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.6
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.58
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.57
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.57
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.47
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.47
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.46
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.41
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.4
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.38
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.37
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.36
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.25
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.2
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.19
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.18
KOG3087	229	consensus Serine/threonine protein kinase [General	99.16
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.11
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.11
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.1
KOG1243	690	consensus Protein kinase [General function predict	99.08
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.08
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.05
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.02
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.01
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.94
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.87
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.82
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.7
PRK09902	216	hypothetical protein; Provisional	98.62
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.59
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.51
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.23
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.13
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.11
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.1
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.99
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	97.9
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.76
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	97.68
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.6
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	97.52
PF01636	239	APH: Phosphotransferase enzyme family This family	97.49
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	97.47
KOG0606	1205	consensus Microtubule-associated serine/threonine	97.47
KOG0576	829	consensus Mitogen-activated protein kinase kinase	97.47
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	97.46
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	97.44
KOG2137	700	consensus Protein kinase [Signal transduction mech	97.43
PLN02876	822	acyl-CoA dehydrogenase	97.37
COG4248	637	Uncharacterized protein with protein kinase and he	96.98
PLN02236	344	choline kinase	96.92
KOG1290	590	consensus Serine/threonine protein kinase [Signal	96.84
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	96.77
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	96.63
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.61
KOG2270	520	consensus Serine/threonine protein kinase involved	96.4
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	95.64
PRK05231	319	homoserine kinase; Provisional	95.41
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	94.83
PRK10271	188	thiK thiamine kinase; Provisional	94.78
KOG2268	465	consensus Serine/threonine protein kinase [Signal	94.53
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	94.45
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	94.44
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	94.25
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	94.09
COG2334	331	Putative homoserine kinase type II (protein kinase	93.89
COG0510	269	ycfN Thiamine kinase and related kinases [Coenzyme	93.89
PHA03111	444	Ser/Thr kinase; Provisional	93.68
PRK06148	1013	hypothetical protein; Provisional	93.24
PRK10593	297	hypothetical protein; Provisional	93.07
PTZ00384	383	choline kinase; Provisional	92.67
PF05445	434	Pox_ser-thr_kin: Poxvirus serine/threonine protein	92.34
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	92.31
smart00587	196	CHK ZnF_C4 abd HLH domain containing kinases domai	92.27
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	91.94
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	91.76
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	91.72
PRK06149	972	hypothetical protein; Provisional	89.78
PRK12396	409	5-methylribose kinase; Reviewed	89.47
PRK09550	401	mtnK methylthioribose kinase; Reviewed	89.42

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=5e-41  Score=238.22  Aligned_cols=155  Identities=30%  Similarity=0.414  Sum_probs=138.5

Q ss_pred             CCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            4 PDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         4 ~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      .++..||||.+.+.  .+...+.+..|+.+|+.++||||+.+ +.++..+..|+|||||.+|+|.+++...+.   +++.
T Consensus        33 ~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~~~---l~e~  109 (429)
T KOG0595|consen   33 KSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRRGR---LPEA  109 (429)
T ss_pred             cCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHHcCC---CCHH
Confidence            46789999999876  45556678899999999999999998 666777889999999999999999987654   9999


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCC------CCeEEccccchhhhhhhhh-hhhcccccccCccee
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED------LKPKISDFGLARILRKMIL-KQIQIELGYIPPEYV  153 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~------~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~aPE~~  153 (164)
                      ....++.|++.|+.+||++   +|+||||||+|||+...      ..+||+|||+|+.+..... ...||||.|||||++
T Consensus       110 t~r~Fm~QLA~alq~L~~~---~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~  186 (429)
T KOG0595|consen  110 TARHFMQQLASALQFLHEN---NIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPEVI  186 (429)
T ss_pred             HHHHHHHHHHHHHHHHHHC---CeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchhHHHHhhCCccccCHHHH
Confidence            9999999999999999998   99999999999999864      4589999999999876554 779999999999999


Q ss_pred             cCCcceeccCC
Q 046065          154 GRGVYYKKFSL  164 (164)
Q Consensus       154 ~~~~~~~~~Di  164 (164)
                      ...+|+.|+|+
T Consensus       187 ~~~~YdAKADL  197 (429)
T KOG0595|consen  187 MSQQYDAKADL  197 (429)
T ss_pred             HhccccchhhH
Confidence            99999999996

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-37  Score=217.03  Aligned_cols=155  Identities=29%  Similarity=0.389  Sum_probs=141.5

Q ss_pred             CCCcEEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCC-cEEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            4 PDGQIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQ-EYMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         4 ~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      ++++.+|+|.+..+ .+...+++.+|+++++.++||+|+.+ +.++..+ ...++|||+.+|+|+.++...+.   +++.
T Consensus       102 ~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~g~---i~E~  178 (364)
T KOG0581|consen  102 PTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRVGR---IPEP  178 (364)
T ss_pred             CCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhcCC---CCHH
Confidence            57899999999655 55667789999999999999999997 8888777 49999999999999999986543   8999


Q ss_pred             HHHHHHHHHHHHHHHhhh-cCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCcceecCCcce
Q 046065           81 KRVHIIKGIIQGLLYLQE-YFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~-~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      ....++.++++||.|||+ +   +|+||||||+|+|+.+.|.+||+|||.+..+.+....+.+||..|||||-+.+..|+
T Consensus       179 ~L~~ia~~VL~GL~YLh~~~---~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS~a~tfvGT~~YMsPERi~g~~Ys  255 (364)
T KOG0581|consen  179 VLGKIARAVLRGLSYLHEER---KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNSIANTFVGTSAYMSPERISGESYS  255 (364)
T ss_pred             HHHHHHHHHHHHHHHHhhcc---CeeeccCCHHHeeeccCCCEEeccccccHHhhhhhcccccccccccChhhhcCCcCC
Confidence            999999999999999996 5   999999999999999999999999999988877777889999999999999999999


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      .++||
T Consensus       256 ~~sDI  260 (364)
T KOG0581|consen  256 VKSDI  260 (364)
T ss_pred             cccce
Confidence            99997

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.1e-36  Score=215.13  Aligned_cols=149  Identities=28%  Similarity=0.419  Sum_probs=126.1

Q ss_pred             CCCcEEEEEEccccccc-------cHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccccc
Q 046065            4 PDGQIIAVKKLSKKSTQ-------GFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRML   75 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~   75 (164)
                      .+|+.||||+++++...       ......+|+++|++++||||+++ +++......|+||||++||.|.+++.....  
T Consensus       195 ~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk~--  272 (475)
T KOG0615|consen  195 KTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVANKY--  272 (475)
T ss_pred             ccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHHhccc--
Confidence            57999999999876211       12345789999999999999998 666677778999999999999998876544  


Q ss_pred             ccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCC---CCeEEccccchhhhhhh-hhhhhcccccccCcc
Q 046065           76 ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED---LKPKISDFGLARILRKM-ILKQIQIELGYIPPE  151 (164)
Q Consensus        76 ~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~---~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE  151 (164)
                       +.+..-+.++.|++-|+.|||++   +|+||||||+|||+..+   ..+||+|||+|+..... .....||||.|+|||
T Consensus       273 -l~ed~~K~~f~Qll~avkYLH~~---GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPE  348 (475)
T KOG0615|consen  273 -LREDLGKLLFKQLLTAVKYLHSQ---GIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPE  348 (475)
T ss_pred             -cccchhHHHHHHHHHHHHHHHHc---CcccccCCcceEEeccCCcceEEEecccchhhccccceehhhhcCCccccChh
Confidence             77788899999999999999999   99999999999999765   67899999999887643 447899999999999


Q ss_pred             eecCCcc
Q 046065          152 YVGRGVY  158 (164)
Q Consensus       152 ~~~~~~~  158 (164)
                      ++.++-+
T Consensus       349 Vl~~kg~  355 (475)
T KOG0615|consen  349 VLASKGV  355 (475)
T ss_pred             heecCCe
Confidence            9966544

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-36  Score=218.32  Aligned_cols=163  Identities=44%  Similarity=0.704  Sum_probs=140.3

Q ss_pred             CccCCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCC-cEEEEEEecCCCChhhhhhCcccccccC
Q 046065            1 GVLPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQ-EYMLIYEYMPKRSLDYFLFDPIRMLILD   78 (164)
Q Consensus         1 ~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~   78 (164)
                      |.+++|..||||.+..........|..|+.++.+++|||++++ ++|.+.+ ..+||+||++.|+|.+++...... .++
T Consensus        94 G~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~  172 (361)
T KOG1187|consen   94 GVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLD  172 (361)
T ss_pred             EEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCC-CCC
Confidence            4678889999998865533214559999999999999999997 9999888 499999999999999999775433 589


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh-hhhh-hh-cccccccCcceecC
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK-MILK-QI-QIELGYIPPEYVGR  155 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~-~~~~-~~-~~~~~~~aPE~~~~  155 (164)
                      |..+.+++.++++||+|||..+...|+|||||++|||+|.+..+||+|||+|..... .... .. .||.+|+|||+...
T Consensus       173 W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~  252 (361)
T KOG1187|consen  173 WETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYAST  252 (361)
T ss_pred             HHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhcc
Confidence            999999999999999999998777899999999999999999999999999966543 2221 12 89999999999998


Q ss_pred             CcceeccCC
Q 046065          156 GVYYKKFSL  164 (164)
Q Consensus       156 ~~~~~~~Di  164 (164)
                      +..+.|+||
T Consensus       253 g~lt~KsDV  261 (361)
T KOG1187|consen  253 GKLTEKSDV  261 (361)
T ss_pred             CCcCccccc
Confidence            999999997

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-35  Score=214.96  Aligned_cols=155  Identities=33%  Similarity=0.502  Sum_probs=132.9

Q ss_pred             CcE-EEEEEccccc--cccHHHHHHHHHHHhccCCCceeeE-eEEeeCC-cEEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            6 GQI-IAVKKLSKKS--TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQ-EYMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         6 ~~~-vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      |.. ||+|.+....  ......|.+|+.+|.+++||||+.+ +.+.... .+++||||+++|+|.+++... ....++..
T Consensus        64 g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~-~~~~l~~~  142 (362)
T KOG0192|consen   64 GTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKK-RKRKLPLK  142 (362)
T ss_pred             CceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhc-ccCCCCHH
Confidence            445 9999987552  2225689999999999999999997 7777776 799999999999999999763 22349999


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCC-eeeCCCCCCceeecCCC-CeEEccccchhhhhhh--hhhhhcccccccCcceec--
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLT-IIHRDLKVSNILLDEDL-KPKISDFGLARILRKM--ILKQIQIELGYIPPEYVG--  154 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~-iih~dlk~~nili~~~~-~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~--  154 (164)
                      .+..++.++++||.|||++   + |||||+||+|+|++.++ .+||+|||+++.....  ......||+.|||||++.  
T Consensus       143 ~~l~~aldiArGm~YLH~~---~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~  219 (362)
T KOG0192|consen  143 VRLRIALDIARGMEYLHSE---GPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGE  219 (362)
T ss_pred             HHHHHHHHHHHHHHHHhcC---CCeeecccChhhEEEcCCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCC
Confidence            9999999999999999998   7 99999999999999997 9999999999876542  234478999999999998  


Q ss_pred             CCcceeccCC
Q 046065          155 RGVYYKKFSL  164 (164)
Q Consensus       155 ~~~~~~~~Di  164 (164)
                      +..|+.|+||
T Consensus       220 ~~~~~~K~Dv  229 (362)
T KOG0192|consen  220 KSPYTEKSDV  229 (362)
T ss_pred             CCcCCccchh
Confidence            6699999997

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.2e-37  Score=209.94  Aligned_cols=162  Identities=23%  Similarity=0.325  Sum_probs=136.9

Q ss_pred             cCCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-e-EEeeCCc-EEEEEEecCCCChhhhhhCc-ccccc
Q 046065            3 LPDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-G-FCIETQE-YMLIYEYMPKRSLDYFLFDP-IRMLI   76 (164)
Q Consensus         3 ~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~-~~~~~~~-~~lv~e~~~~~~L~~~~~~~-~~~~~   76 (164)
                      +.||+.+|.|.+.-.  .....+.+..|+.+|+.++||||+++ + .+.+.+. +++|||+|.+|+|.++++.- .....
T Consensus        41 ~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~  120 (375)
T KOG0591|consen   41 LLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRL  120 (375)
T ss_pred             ccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhcccc
Confidence            578899999988633  34456778899999999999999996 4 5555555 88999999999999998642 12233


Q ss_pred             cCHHHHHHHHHHHHHHHHHhhhcCC-CCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh--hhhhcccccccCccee
Q 046065           77 LDCKKRVHIIKGIIQGLLYLQEYFR-LTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI--LKQIQIELGYIPPEYV  153 (164)
Q Consensus        77 ~~~~~~~~~~~~~~~~l~~lh~~~~-~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~aPE~~  153 (164)
                      +++...++++.|++.||..+|+... .-|+||||||.||+++.+|.+||+|||+++.+.+..  ..+.+|||+||+||.+
T Consensus       121 ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i  200 (375)
T KOG0591|consen  121 IPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERI  200 (375)
T ss_pred             CchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHH
Confidence            9999999999999999999998432 239999999999999999999999999999886543  3679999999999999


Q ss_pred             cCCcceeccCC
Q 046065          154 GRGVYYKKFSL  164 (164)
Q Consensus       154 ~~~~~~~~~Di  164 (164)
                      ....|++||||
T Consensus       201 ~~~~Y~~kSDi  211 (375)
T KOG0591|consen  201 HESGYNFKSDI  211 (375)
T ss_pred             hcCCCCcchhH
Confidence            99999999996

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-35  Score=207.39  Aligned_cols=154  Identities=29%  Similarity=0.351  Sum_probs=135.6

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+++.+|+|.+++.   ..........|..+|..++||+|+.+ -.+.+...+|+|+||++||.|...+.+.+.   +++
T Consensus        48 dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~eg~---F~E  124 (357)
T KOG0598|consen   48 DTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQREGR---FSE  124 (357)
T ss_pred             ccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHhcCC---cch
Confidence            57899999999876   33446678899999999999999998 555666789999999999999999876544   999


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh--hhhhhhcccccccCcceecCCc
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK--MILKQIQIELGYIPPEYVGRGV  157 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~  157 (164)
                      ..+..++.+++.||.|||+.   +|+|||+||+|||+|..|.++|+|||+++....  ......|||+.|||||++.+..
T Consensus       125 ~~arfYlaEi~lAL~~LH~~---gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~g  201 (357)
T KOG0598|consen  125 DRARFYLAEIVLALGYLHSK---GIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKG  201 (357)
T ss_pred             hHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHeeecCCCcEEEeccccchhcccCCCccccccCCccccChHHHhcCC
Confidence            99999999999999999998   999999999999999999999999999975433  3446689999999999999999


Q ss_pred             ceeccC
Q 046065          158 YYKKFS  163 (164)
Q Consensus       158 ~~~~~D  163 (164)
                      |+..+|
T Consensus       202 y~~~vD  207 (357)
T KOG0598|consen  202 YDKAVD  207 (357)
T ss_pred             CCcccc
Confidence            999887

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-35  Score=218.16  Aligned_cols=155  Identities=27%  Similarity=0.394  Sum_probs=140.3

Q ss_pred             cCCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            3 LPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      ..+++.||||.+..+.....+-+..|+.+|+..+|+||+.+ ..+...+.+|+||||+++|+|.+.+....    +++.+
T Consensus       295 ~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~~~----~~E~q  370 (550)
T KOG0578|consen  295 ISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTKTR----MTEGQ  370 (550)
T ss_pred             ccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhccc----ccHHH
Confidence            45678999999988766667788999999999999999996 77777899999999999999999887643    88999


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh--hhhcccccccCcceecCCcce
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL--KQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      +..+++++++||.|||.+   +|+|||||.+|||+..+|.+||+|||++..+.....  ...+|||+|||||+..++.|+
T Consensus       371 IA~Icre~l~aL~fLH~~---gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG  447 (550)
T KOG0578|consen  371 IAAICREILQGLKFLHAR---GIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKPYG  447 (550)
T ss_pred             HHHHHHHHHHHHHHHHhc---ceeeeccccceeEeccCCcEEEeeeeeeeccccccCccccccCCCCccchhhhhhcccC
Confidence            999999999999999998   999999999999999999999999999987765443  567899999999999999999


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      +|.||
T Consensus       448 ~KVDI  452 (550)
T KOG0578|consen  448 PKVDI  452 (550)
T ss_pred             ccccc
Confidence            99997

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.3e-35  Score=215.79  Aligned_cols=156  Identities=30%  Similarity=0.449  Sum_probs=141.6

Q ss_pred             cCCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccC
Q 046065            3 LPDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILD   78 (164)
Q Consensus         3 ~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~   78 (164)
                      +.+|+.||+|.+.+.   ++.+.+.+.+|+++.+.++||||+++ +++++.+..|+|+|+|..++|..+++...   .+.
T Consensus        40 ~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~Krrk---~lt  116 (592)
T KOG0575|consen   40 LDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLKRRK---PLT  116 (592)
T ss_pred             cCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHHhcC---CCC
Confidence            468999999999875   56677889999999999999999998 88888899999999999999999998433   399


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh--hhhhhhcccccccCcceecCC
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK--MILKQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~~aPE~~~~~  156 (164)
                      +..+..++.||+.|+.|||++   +|+|||||..|++++++..+||+|||+|..+..  +.....||||-|+|||++.+.
T Consensus       117 EpEary~l~QIv~GlkYLH~~---~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~  193 (592)
T KOG0575|consen  117 EPEARYFLRQIVEGLKYLHSL---GIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKS  193 (592)
T ss_pred             cHHHHHHHHHHHHHHHHHHhc---CceecccchhheeecCcCcEEecccceeeeecCcccccceecCCCcccChhHhccC
Confidence            999999999999999999999   999999999999999999999999999988763  345779999999999999988


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .+++-+||
T Consensus       194 gHsfEvDi  201 (592)
T KOG0575|consen  194 GHSFEVDI  201 (592)
T ss_pred             CCCCchhh
Confidence            88998886

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.5e-35  Score=211.03  Aligned_cols=156  Identities=29%  Similarity=0.425  Sum_probs=133.0

Q ss_pred             cCCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEeeC--CcEEEEEEecCCCChhhhhhCccccccc
Q 046065            3 LPDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIET--QEYMLIYEYMPKRSLDYFLFDPIRMLIL   77 (164)
Q Consensus         3 ~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~   77 (164)
                      +.+|+.||+|.+..+  .+.......+|+.+|+.++||||+++ +...+.  +.+|+|+||+++ +|.-++...  ...+
T Consensus       139 ~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh-DL~GLl~~p--~vkf  215 (560)
T KOG0600|consen  139 LETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-DLSGLLSSP--GVKF  215 (560)
T ss_pred             cccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc-hhhhhhcCC--Cccc
Confidence            578999999998765  45566677899999999999999999 555554  689999999986 676666543  2348


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh---hhhhhcccccccCcceec
Q 046065           78 DCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM---ILKQIQIELGYIPPEYVG  154 (164)
Q Consensus        78 ~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~~aPE~~~  154 (164)
                      .+.+++.++.|++.||.|||++   +|+|||||.+|||||.+|.+||+|||+|+++...   .++..+.|.+|+|||++.
T Consensus       216 t~~qIKc~mkQLl~Gl~~cH~~---gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLL  292 (560)
T KOG0600|consen  216 TEPQIKCYMKQLLEGLEYCHSR---GVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLL  292 (560)
T ss_pred             ChHHHHHHHHHHHHHHHHHhhc---CeeeccccccceEEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhc
Confidence            9999999999999999999999   9999999999999999999999999999987643   357788899999999996


Q ss_pred             CC-cceeccCC
Q 046065          155 RG-VYYKKFSL  164 (164)
Q Consensus       155 ~~-~~~~~~Di  164 (164)
                      +. .|+.+.|+
T Consensus       293 G~t~Yg~aVDl  303 (560)
T KOG0600|consen  293 GATSYGTAVDL  303 (560)
T ss_pred             CCcccccceee
Confidence            65 78888885

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-35  Score=201.51  Aligned_cols=153  Identities=27%  Similarity=0.379  Sum_probs=138.2

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+|.-+|+|.++++   .-.+.+....|-.+|+.+.||+++++ ..+.+.+.+++||||++||.|.+++++.+.   +++
T Consensus        67 ~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~~r---F~e  143 (355)
T KOG0616|consen   67 HSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKSGR---FSE  143 (355)
T ss_pred             cCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhcCC---CCc
Confidence            45778999999876   34566788899999999999999998 777888899999999999999999987655   999


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCcceecCCcce
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      +.+..++.|++.|++|+|++   +|++||+||+|||+|++|.+||+|||+|...... +-..||||.|+|||.+..+.|+
T Consensus       144 ~~arFYAAeivlAleylH~~---~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-T~TlCGTPeYLAPEii~sk~yn  219 (355)
T KOG0616|consen  144 PHARFYAAEIVLALEYLHSL---DIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-TWTLCGTPEYLAPEIIQSKGYN  219 (355)
T ss_pred             hhHHHHHHHHHHHHHHHHhc---CeeeccCChHHeeeccCCcEEEEeccceEEecCc-EEEecCCccccChHHhhcCCCC
Confidence            99999999999999999998   9999999999999999999999999999876554 5678999999999999999999


Q ss_pred             eccC
Q 046065          160 KKFS  163 (164)
Q Consensus       160 ~~~D  163 (164)
                      .++|
T Consensus       220 kavD  223 (355)
T KOG0616|consen  220 KAVD  223 (355)
T ss_pred             cchh
Confidence            8887

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-33  Score=206.16  Aligned_cols=155  Identities=28%  Similarity=0.409  Sum_probs=132.8

Q ss_pred             CCCcEEEEEEcccc----cc-ccHHHHHHHHHHHhccC-CCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccc
Q 046065            4 PDGQIIAVKKLSKK----ST-QGFEEFKNEVMLTAKLQ-HLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLI   76 (164)
Q Consensus         4 ~~~~~vavK~~~~~----~~-~~~~~~~~e~~~l~~l~-h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~   76 (164)
                      .+++.||+|+++.+    .. ...+.+.+|+.+++.+. ||||+++ ..+.....+++||||+.+|+|.+.+.+.+.   
T Consensus        40 ~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~~g~---  116 (370)
T KOG0583|consen   40 LTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVNKGR---  116 (370)
T ss_pred             cCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHHcCC---
Confidence            46789999987654    12 22345678999999998 9999998 666666779999999999999999987333   


Q ss_pred             cCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCC-CCeEEccccchhhhh--hhhhhhhcccccccCccee
Q 046065           77 LDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED-LKPKISDFGLARILR--KMILKQIQIELGYIPPEYV  153 (164)
Q Consensus        77 ~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~-~~~~l~dfg~~~~~~--~~~~~~~~~~~~~~aPE~~  153 (164)
                      +.+..+..++.|++.|+.|+|++   +|+||||||+|++++.+ +.+||+|||++....  .......+||+.|+|||++
T Consensus       117 l~E~~ar~~F~Qlisav~y~H~~---gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl  193 (370)
T KOG0583|consen  117 LKEDEARKYFRQLISAVAYCHSR---GIVHRDLKPENILLDGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVL  193 (370)
T ss_pred             CChHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEecCCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHh
Confidence            88899999999999999999998   99999999999999999 999999999998773  4556789999999999999


Q ss_pred             cCCc-c-eeccCC
Q 046065          154 GRGV-Y-YKKFSL  164 (164)
Q Consensus       154 ~~~~-~-~~~~Di  164 (164)
                      .+.. | ..++||
T Consensus       194 ~~~~~Y~g~~aDv  206 (370)
T KOG0583|consen  194 SGKGTYSGKAADV  206 (370)
T ss_pred             CCCCCcCCchhhh
Confidence            8887 8 578875

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.6e-34  Score=212.37  Aligned_cols=156  Identities=28%  Similarity=0.442  Sum_probs=139.2

Q ss_pred             cCCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccC
Q 046065            3 LPDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILD   78 (164)
Q Consensus         3 ~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~   78 (164)
                      .++|++.|||++.+.   .......+.+|+.+|+.+.|||++++ +.|+....+|+|.||+++|.|.+.+...+.   ++
T Consensus        34 ~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~kG~---l~  110 (786)
T KOG0588|consen   34 AETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVRKGP---LP  110 (786)
T ss_pred             ccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHhhCC---CC
Confidence            368999999999876   23446788999999999999999998 777778889999999999999988876544   99


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhh-hhhhhhhcccccccCcceecCCc
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILR-KMILKQIQIELGYIPPEYVGRGV  157 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~  157 (164)
                      +..+.++++|++.|+.|+|..   +|+|||+||+|+|+|..+.+||+|||+|..-. ......-||+|.|.|||++.++.
T Consensus       111 e~eaa~ff~QIi~gv~yCH~~---~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G~p  187 (786)
T KOG0588|consen  111 EREAAHFFRQILDGVSYCHAF---NICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSGRP  187 (786)
T ss_pred             CHHHHHHHHHHHHHHHHHhhh---cceeccCCchhhhhhcccCEeeeccceeecccCCccccccCCCcccCCchhhcCCC
Confidence            999999999999999999988   99999999999999999889999999997654 45568899999999999999999


Q ss_pred             c-eeccCC
Q 046065          158 Y-YKKFSL  164 (164)
Q Consensus       158 ~-~~~~Di  164 (164)
                      | +.++||
T Consensus       188 YdG~~sDV  195 (786)
T KOG0588|consen  188 YDGRPSDV  195 (786)
T ss_pred             CCCCcccc
Confidence            9 888886

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=2.9e-34  Score=197.81  Aligned_cols=156  Identities=23%  Similarity=0.318  Sum_probs=133.0

Q ss_pred             cCCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            3 LPDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         3 ~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      ..+|+.||||.+...  .+....-.++|+++|+.++|+|++.+ ..+......++|+|||...-|..+-.-..+   ++.
T Consensus        24 k~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhTvL~eLe~~p~G---~~~  100 (396)
T KOG0593|consen   24 KDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHTVLHELERYPNG---VPS  100 (396)
T ss_pred             CCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchHHHHHHHhccCC---CCH
Confidence            468999999998644  23344557899999999999999997 777788899999999988666555443333   899


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhh--hhhhhhhcccccccCcceecC-C
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILR--KMILKQIQIELGYIPPEYVGR-G  156 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~--~~~~~~~~~~~~~~aPE~~~~-~  156 (164)
                      .....+..|++.|+.|+|.+   +++||||||+||++..+|.+||+|||+|+.+.  ...++-.+.|.||+|||.+.+ .
T Consensus       101 ~~vk~~l~Q~l~ai~~cHk~---n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDt  177 (396)
T KOG0593|consen  101 ELVKKYLYQLLKAIHFCHKN---NCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDT  177 (396)
T ss_pred             HHHHHHHHHHHHHhhhhhhc---CeecccCChhheEEecCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccC
Confidence            99999999999999999998   99999999999999999999999999999875  344577888999999999977 6


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      +|++..||
T Consensus       178 qYG~pVDi  185 (396)
T KOG0593|consen  178 QYGKPVDI  185 (396)
T ss_pred             cCCCcccc
Confidence            88888886

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=9.5e-33  Score=198.28  Aligned_cols=158  Identities=22%  Similarity=0.321  Sum_probs=135.6

Q ss_pred             cCCCcEEEEEEccccccc-cHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            3 LPDGQIIAVKKLSKKSTQ-GFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         3 ~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      ++.++.||||+++.+... ....+.+|+..++.++||||+++ ..+..+..+|+||.|+.+|++.++++....++ +++.
T Consensus        48 ~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~G-l~E~  126 (516)
T KOG0582|consen   48 IPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDG-LEEA  126 (516)
T ss_pred             cccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHcccc-ccHH
Confidence            467899999999877433 35889999999999999999998 77778889999999999999999998754443 8999


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh------hhhcccccccCccee-
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL------KQIQIELGYIPPEYV-  153 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~------~~~~~~~~~~aPE~~-  153 (164)
                      .+.-+.+++++||.|+|.+   +.||||+|+.||||+.+|.++|+|||.+..+.....      ...+|+++|||||++ 
T Consensus       127 ~Ia~iLre~LkaL~YLH~~---G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~  203 (516)
T KOG0582|consen  127 SIATILREVLKALDYLHQN---GHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLM  203 (516)
T ss_pred             HHHHHHHHHHHHHHHHHhc---CceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhh
Confidence            9999999999999999998   999999999999999999999999997655433222      446899999999995 


Q ss_pred             -cCCcceeccCC
Q 046065          154 -GRGVYYKKFSL  164 (164)
Q Consensus       154 -~~~~~~~~~Di  164 (164)
                       .-.-|++|+||
T Consensus       204 q~~~GYdfKaDI  215 (516)
T KOG0582|consen  204 QQLHGYDFKADI  215 (516)
T ss_pred             hcccCccchhhh
Confidence             33368999997

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=99.98  E-value=3.3e-32  Score=198.82  Aligned_cols=155  Identities=32%  Similarity=0.510  Sum_probs=131.0

Q ss_pred             CCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHH
Q 046065            5 DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRV   83 (164)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~   83 (164)
                      ....||+|.+... .-..+.|++|+++|++++|+||+++ +.|.....+++||||++.|+|.++++... ...+...+.+
T Consensus       229 ~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~-~~~l~~~~Ll  306 (468)
T KOG0197|consen  229 GSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTRE-GGLLNLPQLL  306 (468)
T ss_pred             CCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcC-CCccchHHHH
Confidence            3448999998543 2334678899999999999999998 66666677999999999999999998732 2338899999


Q ss_pred             HHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhc---ccccccCcceecCCccee
Q 046065           84 HIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQ---IELGYIPPEYVGRGVYYK  160 (164)
Q Consensus        84 ~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~---~~~~~~aPE~~~~~~~~~  160 (164)
                      .++.|||+|++||.++   ++|||||.++|||++.+..+||+|||+|+...++.+....   -...|.|||.+...+++.
T Consensus       307 ~~a~qIaeGM~YLes~---~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~  383 (468)
T KOG0197|consen  307 DFAAQIAEGMAYLESK---NYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSS  383 (468)
T ss_pred             HHHHHHHHHHHHHHhC---CccchhhhhhheeeccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCccc
Confidence            9999999999999999   9999999999999999999999999999966655543222   244699999999999999


Q ss_pred             ccCC
Q 046065          161 KFSL  164 (164)
Q Consensus       161 ~~Di  164 (164)
                      ||||
T Consensus       384 kSDV  387 (468)
T KOG0197|consen  384 KSDV  387 (468)
T ss_pred             ccce
Confidence            9997

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=99.98  E-value=2.3e-32  Score=200.19  Aligned_cols=156  Identities=27%  Similarity=0.332  Sum_probs=132.1

Q ss_pred             cCCCcEEEEEEcccc---ccccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccccccc
Q 046065            3 LPDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLIL   77 (164)
Q Consensus         3 ~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~   77 (164)
                      ..++++||||++.++   ......-...|-.+|..| +||.|+++ .-+.+...+|+|+||+++|+|.+++..-+.   +
T Consensus        95 ~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~Gs---f  171 (604)
T KOG0592|consen   95 KATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKYGS---F  171 (604)
T ss_pred             cCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHHhCc---c
Confidence            457899999999765   222223345677778888 89999998 555667789999999999999999987544   9


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh-----------hh----hhhc
Q 046065           78 DCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM-----------IL----KQIQ  142 (164)
Q Consensus        78 ~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~-----------~~----~~~~  142 (164)
                      ++.+...++.+|+.||+|||++   +||||||||+|||+|.+++++|+|||.|+.+...           ..    .+++
T Consensus       172 de~caR~YAAeIldAleylH~~---GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFV  248 (604)
T KOG0592|consen  172 DETCARFYAAEILDALEYLHSN---GIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFV  248 (604)
T ss_pred             hHHHHHHHHHHHHHHHHHHHhc---CceeccCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCccccee
Confidence            9999999999999999999999   9999999999999999999999999999877421           11    3488


Q ss_pred             ccccccCcceecCCcceeccCC
Q 046065          143 IELGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       143 ~~~~~~aPE~~~~~~~~~~~Di  164 (164)
                      ||-.|++||++.....+..+||
T Consensus       249 GTAeYVSPElL~~~~~~~~sDi  270 (604)
T KOG0592|consen  249 GTAEYVSPELLNDSPAGPSSDL  270 (604)
T ss_pred             eeecccCHHHhcCCCCCcccch
Confidence            9999999999999999999996

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.98  E-value=1.2e-31  Score=189.86  Aligned_cols=155  Identities=29%  Similarity=0.442  Sum_probs=128.3

Q ss_pred             CCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCC--cEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            5 DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQ--EYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      +|+..|||.+........+.+.+|+.+|+.++||||++. +......  .+++.|||+++|+|.+++...++  .+++..
T Consensus        41 ~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~--~l~E~~  118 (313)
T KOG0198|consen   41 TGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGG--KLPEPL  118 (313)
T ss_pred             CCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCC--CCCHHH
Confidence            478899999875522226678999999999999999997 5433333  58899999999999999987553  399999


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecC-CCCeEEccccchhhhhh-----hhhhhhcccccccCcceecC
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE-DLKPKISDFGLARILRK-----MILKQIQIELGYIPPEYVGR  155 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~-~~~~~l~dfg~~~~~~~-----~~~~~~~~~~~~~aPE~~~~  155 (164)
                      +..++.|+++||.|+|++   +++|+||||+|||++. ++.+||+|||.+.....     .......||+.|||||++..
T Consensus       119 v~~ytr~iL~GL~ylHs~---g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~  195 (313)
T KOG0198|consen  119 VRRYTRQILEGLAYLHSK---GIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRN  195 (313)
T ss_pred             HHHHHHHHHHHHHHHHhC---CEeccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCccccCchhhcC
Confidence            999999999999999988   9999999999999999 79999999999876652     22345789999999999985


Q ss_pred             C-cceeccCC
Q 046065          156 G-VYYKKFSL  164 (164)
Q Consensus       156 ~-~~~~~~Di  164 (164)
                      + ...+++||
T Consensus       196 g~~~~~~sDi  205 (313)
T KOG0198|consen  196 GEVARRESDI  205 (313)
T ss_pred             CCcCCccchh
Confidence            3 33458886

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=99.98  E-value=5.4e-32  Score=193.46  Aligned_cols=148  Identities=26%  Similarity=0.467  Sum_probs=133.4

Q ss_pred             CCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            5 DGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         5 ~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      .|+.||||.+.++   ..++.-.+.+|+++|..++||||+.+ ..++..+...+||||..+|.|++++.+.+.   +++.
T Consensus        77 sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSer~~---LsEr  153 (668)
T KOG0611|consen   77 SGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISERGS---LSER  153 (668)
T ss_pred             CCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHHhcc---ccHH
Confidence            5789999999876   45566788999999999999999998 777777889999999999999999977655   9999


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh-hhhhhcccccccCcceecCCcc
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM-ILKQIQIELGYIPPEYVGRGVY  158 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~  158 (164)
                      ....+++||.+|+.|+|.+   +++|||+|.+|||+|.++.+||+|||++-.+.+. ..+.+||+|-|.+||.+.+..|
T Consensus       154 EaRhfFRQIvSAVhYCHkn---rVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY  229 (668)
T KOG0611|consen  154 EARHFFRQIVSAVHYCHKN---RVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNGTPY  229 (668)
T ss_pred             HHHHHHHHHHHHHHHHhhc---cceecccchhheeecCCCCeeeeccchhhhhccccHHHHhcCCcccCCccccCCCCC
Confidence            9999999999999999998   9999999999999999999999999999877654 4588999999999999987777

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=5.2e-33  Score=200.88  Aligned_cols=155  Identities=30%  Similarity=0.418  Sum_probs=131.6

Q ss_pred             cCCCcEEEEEEccccccccHHH--HHHHHHHHhccC-CCceeeE-eEEeeCC-cEEEEEEecCCCChhhhhhCccccccc
Q 046065            3 LPDGQIIAVKKLSKKSTQGFEE--FKNEVMLTAKLQ-HLNLIRV-GFCIETQ-EYMLIYEYMPKRSLDYFLFDPIRMLIL   77 (164)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~--~~~e~~~l~~l~-h~~i~~~-~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~   77 (164)
                      +++++.||||.|.++-.. ++.  -++|+..|+++. ||||+++ ..+.+.+ .+++||||+. .+|.++++..  ...+
T Consensus        32 ~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md-~NLYqLmK~R--~r~f  107 (538)
T KOG0661|consen   32 KETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMD-CNLYQLMKDR--NRLF  107 (538)
T ss_pred             cCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhh-hhHHHHHhhc--CCcC
Confidence            567899999999765322 232  378999999998 9999998 5565655 8999999995 5999999876  3349


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh-hhhhhcccccccCccee-cC
Q 046065           78 DCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM-ILKQIQIELGYIPPEYV-GR  155 (164)
Q Consensus        78 ~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~-~~  155 (164)
                      ++..+..|+.||++||.|+|.+   |+.|||+||+|||+.....+||+|||+|+...+. .++..+.|.+|+|||++ ..
T Consensus       108 se~~irnim~QilqGL~hiHk~---GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLLrs  184 (538)
T KOG0661|consen  108 SESDIRNIMYQILQGLAHIHKH---GFFHRDLKPENILISGNDVIKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLLRS  184 (538)
T ss_pred             CHHHHHHHHHHHHHHHHHHHhc---CcccccCChhheEecccceeEecccccccccccCCCcchhhhcccccchHHhhhc
Confidence            9999999999999999999999   9999999999999998999999999999988754 45788999999999999 44


Q ss_pred             CcceeccCC
Q 046065          156 GVYYKKFSL  164 (164)
Q Consensus       156 ~~~~~~~Di  164 (164)
                      +-|+.+.||
T Consensus       185 ~~Ys~pvD~  193 (538)
T KOG0661|consen  185 GYYSSPVDM  193 (538)
T ss_pred             cccCCchHH
Confidence            567888775

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.97  E-value=2.2e-31  Score=192.62  Aligned_cols=147  Identities=30%  Similarity=0.461  Sum_probs=120.0

Q ss_pred             CCCcEEEEEEccccc----------ccc----HHHHHHHHHHHhccCCCceeeEeEEeeC---CcEEEEEEecCCCChhh
Q 046065            4 PDGQIIAVKKLSKKS----------TQG----FEEFKNEVMLTAKLQHLNLIRVGFCIET---QEYMLIYEYMPKRSLDY   66 (164)
Q Consensus         4 ~~~~~vavK~~~~~~----------~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~---~~~~lv~e~~~~~~L~~   66 (164)
                      .+++.||||++.+.+          +..    .+...+|+.+|++++||||+++..+.+.   ..+|+|+|||..|.+..
T Consensus       120 ~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w  199 (576)
T KOG0585|consen  120 VDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKW  199 (576)
T ss_pred             CCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCcccc
Confidence            578899999997541          111    2467889999999999999998555543   46899999999888754


Q ss_pred             hhhCcccccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhh-------hhhhh
Q 046065           67 FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILR-------KMILK  139 (164)
Q Consensus        67 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~-------~~~~~  139 (164)
                      .-...   ..+...++.+++++++.||+|||.+   +|+||||||+|+|++.+|++||+|||.+..+.       ..+..
T Consensus       200 ~p~d~---~els~~~Ar~ylrDvv~GLEYLH~Q---giiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~  273 (576)
T KOG0585|consen  200 CPPDK---PELSEQQARKYLRDVVLGLEYLHYQ---GIIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLS  273 (576)
T ss_pred             CCCCc---ccccHHHHHHHHHHHHHHHHHHHhc---CeeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHh
Confidence            33221   1288999999999999999999998   99999999999999999999999999987652       23456


Q ss_pred             hhcccccccCcceecCC
Q 046065          140 QIQIELGYIPPEYVGRG  156 (164)
Q Consensus       140 ~~~~~~~~~aPE~~~~~  156 (164)
                      ..+|||+|+|||.+..+
T Consensus       274 ~tvGTPAF~APE~c~~~  290 (576)
T KOG0585|consen  274 RTVGTPAFFAPELCSGG  290 (576)
T ss_pred             hcCCCccccchHhhcCC
Confidence            68999999999999763

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.97  E-value=9.4e-32  Score=183.58  Aligned_cols=144  Identities=31%  Similarity=0.498  Sum_probs=124.2

Q ss_pred             CCCcEEEEEEcccc----cccc----HHHHHHHHHHHhcc-CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccc
Q 046065            4 PDGQIIAVKKLSKK----STQG----FEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIR   73 (164)
Q Consensus         4 ~~~~~vavK~~~~~----~~~~----~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~   73 (164)
                      ++|+++|+|++..-    ....    .+....|+.+|+++ +||+|+.+ +.+....++++|+|.++.|.|.+.+.+...
T Consensus        40 ~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~Vt  119 (411)
T KOG0599|consen   40 ETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSKVT  119 (411)
T ss_pred             ccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhhee
Confidence            57889999998643    1111    23456789999999 79999999 555666778899999999999999987655


Q ss_pred             ccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh-hhhhhhcccccccCcce
Q 046065           74 MLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK-MILKQIQIELGYIPPEY  152 (164)
Q Consensus        74 ~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~aPE~  152 (164)
                         +++.....+++|+..++.|+|..   +|+|||+||+|||++.+.+++|+|||+++.+.. ...+..||||+|+|||.
T Consensus       120 ---lSEK~tR~iMrqlfegVeylHa~---~IVHRDLKpENILlddn~~i~isDFGFa~~l~~GekLrelCGTPgYLAPEt  193 (411)
T KOG0599|consen  120 ---LSEKETRRIMRQLFEGVEYLHAR---NIVHRDLKPENILLDDNMNIKISDFGFACQLEPGEKLRELCGTPGYLAPET  193 (411)
T ss_pred             ---ecHHHHHHHHHHHHHHHHHHHHh---hhhhcccChhheeeccccceEEeccceeeccCCchhHHHhcCCCcccChhh
Confidence               88999999999999999999998   999999999999999999999999999988865 45688999999999999


Q ss_pred             e
Q 046065          153 V  153 (164)
Q Consensus       153 ~  153 (164)
                      +
T Consensus       194 i  194 (411)
T KOG0599|consen  194 I  194 (411)
T ss_pred             e
Confidence            8

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=99.97  E-value=2e-31  Score=180.60  Aligned_cols=156  Identities=27%  Similarity=0.364  Sum_probs=129.6

Q ss_pred             cCCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            3 LPDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         3 ~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .++|+.||||.+...  ........++|+..|+.++|+||+.+ +.+.....+-+|+||++. +|...+++...  .+..
T Consensus        24 ~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~t-dLe~vIkd~~i--~l~p  100 (318)
T KOG0659|consen   24 TETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMPT-DLEVVIKDKNI--ILSP  100 (318)
T ss_pred             cCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEeccc-cHHHHhccccc--ccCH
Confidence            357999999998755  22335678999999999999999998 666677788899999975 88888876432  3888


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh--hhhcccccccCcceecC-C
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL--KQIQIELGYIPPEYVGR-G  156 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~aPE~~~~-~  156 (164)
                      .+++.|+.++++|++|||.+   .|+|||+||.|+|++++|.+|++|||+++.+.....  ...+.|.+|+|||.+.+ +
T Consensus       101 a~iK~y~~m~LkGl~y~H~~---~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr  177 (318)
T KOG0659|consen  101 ADIKSYMLMTLKGLAYCHSK---WILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSR  177 (318)
T ss_pred             HHHHHHHHHHHHHHHHHHhh---hhhcccCCccceEEcCCCcEEeecccchhccCCCCcccccceeeeeccChHHhccch
Confidence            99999999999999999998   999999999999999999999999999998864322  33367899999998854 4


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .|+...||
T Consensus       178 ~Yg~~VDm  185 (318)
T KOG0659|consen  178 QYGTGVDM  185 (318)
T ss_pred             hcCCcchh
Confidence            77877775

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=1.7e-31  Score=194.14  Aligned_cols=157  Identities=25%  Similarity=0.376  Sum_probs=138.8

Q ss_pred             CCCcEEEEEEccccc--cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCc-EEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKKS--TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQE-YMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+.+.+++|.+....  ....+....|+.++++++||||+.+ +.+..++. .++||+||+||++.+.+.... ...+++
T Consensus        27 ~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k-~~~f~E  105 (426)
T KOG0589|consen   27 SDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQK-GVLFPE  105 (426)
T ss_pred             cCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHh-hccccH
Confidence            456789999987652  3334577899999999999999998 77777777 899999999999999998755 344999


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh--hhhhhcccccccCcceecCCc
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM--ILKQIQIELGYIPPEYVGRGV  157 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~  157 (164)
                      ..+..|+.|++.|+.|||..   +|+|||+|+.||+...++.++|.|||+|+.+...  ...+..||+.||+||.+.+..
T Consensus       106 ~~i~~~~~Q~~~av~ylH~~---~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~p  182 (426)
T KOG0589|consen  106 ERILKWFVQILLAVNYLHEN---RVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDIP  182 (426)
T ss_pred             HHHHHHHHHHHHHHHHHHhh---hhhcccchhhhhhccccCceeecchhhhhhcCCchhhhheecCCCcccCHHHhCCCC
Confidence            99999999999999999988   9999999999999999999999999999988754  446789999999999999999


Q ss_pred             ceeccCC
Q 046065          158 YYKKFSL  164 (164)
Q Consensus       158 ~~~~~Di  164 (164)
                      |+.|+||
T Consensus       183 Yn~KSDi  189 (426)
T KOG0589|consen  183 YNEKSDI  189 (426)
T ss_pred             CCccCcc
Confidence            9999997

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.97  E-value=5.3e-31  Score=190.55  Aligned_cols=155  Identities=23%  Similarity=0.280  Sum_probs=131.4

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+|+.||+|.+...   .......+..|+.+++.++||||+++ ..+...+..++||||+++++|...+.....   +++
T Consensus        18 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~   94 (323)
T cd05571          18 ATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERV---FSE   94 (323)
T ss_pred             CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcCC---CCH
Confidence            46889999998754   23334567889999999999999998 666777789999999999999888865432   788


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh--hhhhhhcccccccCcceecCCc
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK--MILKQIQIELGYIPPEYVGRGV  157 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~  157 (164)
                      .....++.|++.||.|+|+.   +|+||||||+||+++.++.++|+|||++.....  ......+|++.|+|||++.+..
T Consensus        95 ~~~~~~~~qi~~~L~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  171 (323)
T cd05571          95 DRARFYGAEIVSALGYLHSC---DVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND  171 (323)
T ss_pred             HHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCccccChhhhcCCC
Confidence            99999999999999999998   999999999999999999999999999865322  2234567999999999999899


Q ss_pred             ceeccCC
Q 046065          158 YYKKFSL  164 (164)
Q Consensus       158 ~~~~~Di  164 (164)
                      ++.++||
T Consensus       172 ~~~~~Di  178 (323)
T cd05571         172 YGRAVDW  178 (323)
T ss_pred             CCccccC
Confidence            9999997

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=99.97  E-value=9.8e-32  Score=198.28  Aligned_cols=155  Identities=27%  Similarity=0.388  Sum_probs=137.4

Q ss_pred             cCCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            3 LPDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         3 ~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      ..+.+.||+|.+.+.  .......+.+|+++++.++||||+.. .+++....+|+|+||+.+ +|..++.+...   +|+
T Consensus        24 K~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il~~d~~---lpE   99 (808)
T KOG0597|consen   24 KYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTILEQDGK---LPE   99 (808)
T ss_pred             ccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-hHHHHHHhccC---CCH
Confidence            456789999999876  34456789999999999999999997 788888899999999977 99999876544   999


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh--hhhhhhcccccccCcceecCCc
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK--MILKQIQIELGYIPPEYVGRGV  157 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~  157 (164)
                      .....++.++++||.|||+.   +|+|||+||+||+++.++.+|++|||+|+-...  .......|||.|||||+..+..
T Consensus       100 e~v~~~a~~LVsaL~yLhs~---rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~p  176 (808)
T KOG0597|consen  100 EQVRAIAYDLVSALYYLHSN---RILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQP  176 (808)
T ss_pred             HHHHHHHHHHHHHHHHHHhc---CcccccCCcceeeecCCCceeechhhhhhhcccCceeeeeccCcccccCHHHHcCCC
Confidence            99999999999999999998   999999999999999999999999999986543  3346788999999999999999


Q ss_pred             ceeccCC
Q 046065          158 YYKKFSL  164 (164)
Q Consensus       158 ~~~~~Di  164 (164)
                      |+..+|+
T Consensus       177 yd~~sDl  183 (808)
T KOG0597|consen  177 YDHTSDL  183 (808)
T ss_pred             ccchhhH
Confidence            9999985

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.97  E-value=2.4e-32  Score=183.84  Aligned_cols=156  Identities=27%  Similarity=0.392  Sum_probs=132.4

Q ss_pred             cCCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            3 LPDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         3 ~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .++|+.+|+|+++.+  .....+.+.+|+++.++++||||+++ ..+.+....|+|+|++.|+.|..-+....   -.++
T Consensus        33 ~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R~---~ySE  109 (355)
T KOG0033|consen   33 KTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE---FYSE  109 (355)
T ss_pred             ccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHHHH---HHHH
Confidence            467889999998765  34467788999999999999999999 66777788899999999999854443321   2678


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCC---CCeEEccccchhhhhhh-hhhhhcccccccCcceecC
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED---LKPKISDFGLARILRKM-ILKQIQIELGYIPPEYVGR  155 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~---~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~~  155 (164)
                      .....+++|++.++.|+|++   +|+|||+||+|+++.+.   ..+||+|||+|....++ .+.+..|||.|||||++.+
T Consensus       110 a~aSH~~rQiLeal~yCH~n---~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrk  186 (355)
T KOG0033|consen  110 ADASHCIQQILEALAYCHSN---GIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLKK  186 (355)
T ss_pred             HHHHHHHHHHHHHHHHHHhc---CceeccCChhheeeeeccCCCceeecccceEEEeCCccccccccCCCcccCHHHhhc
Confidence            88899999999999999998   99999999999999753   45899999999877643 4577899999999999999


Q ss_pred             CcceeccCC
Q 046065          156 GVYYKKFSL  164 (164)
Q Consensus       156 ~~~~~~~Di  164 (164)
                      ..|++.+||
T Consensus       187 dpy~kpvDi  195 (355)
T KOG0033|consen  187 DPYSKPVDI  195 (355)
T ss_pred             CCCCCcchh
Confidence            999999986

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.97  E-value=1.5e-30  Score=188.55  Aligned_cols=155  Identities=23%  Similarity=0.294  Sum_probs=130.8

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+++.||+|.+...   .......+..|+.+++.++||||+++ ..+...+..++||||+++++|...+....   .+++
T Consensus        18 ~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~---~l~~   94 (328)
T cd05593          18 ASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRER---VFSE   94 (328)
T ss_pred             CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHhcC---CCCH
Confidence            46889999998654   23344567889999999999999998 66666778999999999999988776533   2788


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh--hhhhhhcccccccCcceecCCc
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK--MILKQIQIELGYIPPEYVGRGV  157 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~  157 (164)
                      .....++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....  ......+|++.|+|||++.+..
T Consensus        95 ~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  171 (328)
T cd05593          95 DRTRFYGAEIVSALDYLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDND  171 (328)
T ss_pred             HHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCcCccChhhhcCCC
Confidence            99999999999999999998   999999999999999999999999999865322  2224467899999999999889


Q ss_pred             ceeccCC
Q 046065          158 YYKKFSL  164 (164)
Q Consensus       158 ~~~~~Di  164 (164)
                      ++.++||
T Consensus       172 ~~~~~Di  178 (328)
T cd05593         172 YGRAVDW  178 (328)
T ss_pred             CCccCCc
Confidence            9999996

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.97  E-value=9e-31  Score=192.05  Aligned_cols=155  Identities=24%  Similarity=0.310  Sum_probs=130.4

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+++.||+|.+...   .......+..|..++..++||||+++ ..+......++||||+++|+|.+++.....   +++
T Consensus        24 ~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~---l~~  100 (363)
T cd05628          24 DTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDT---LTE  100 (363)
T ss_pred             CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHhcCC---CCH
Confidence            46789999998654   22334567889999999999999997 666777789999999999999998865433   889


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh----------------------
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI----------------------  137 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~----------------------  137 (164)
                      .....++.|++.||.|+|++   +|+||||||+||+++.++.++|+|||++.......                      
T Consensus       101 ~~~~~~~~qi~~aL~~lH~~---givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (363)
T cd05628         101 EETQFYIAETVLAIDSIHQL---GFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN  177 (363)
T ss_pred             HHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCCEEEeeccCcccccccccccccccccccccccccccccc
Confidence            99999999999999999998   99999999999999999999999999986442110                      


Q ss_pred             ---------------hhhhcccccccCcceecCCcceeccCC
Q 046065          138 ---------------LKQIQIELGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       138 ---------------~~~~~~~~~~~aPE~~~~~~~~~~~Di  164 (164)
                                     ....+||+.|+|||++.+..++.++||
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~Dv  219 (363)
T cd05628         178 SKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDW  219 (363)
T ss_pred             cccccchhhhccccccccccCCccccCHHHHcCCCCCCchhh
Confidence                           123578999999999998899999996

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=1.5e-30  Score=187.35  Aligned_cols=155  Identities=22%  Similarity=0.240  Sum_probs=131.3

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+++.||+|.+...   .......+..|+.+++.++||||+++ ..+...+..++||||+++++|.+.+.....   +++
T Consensus        16 ~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---~~~   92 (312)
T cd05585          16 DTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGR---FDL   92 (312)
T ss_pred             CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHhcCC---CCH
Confidence            46789999998643   23344567889999999999999998 666777789999999999999988865332   788


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh--hhhhhhcccccccCcceecCCc
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK--MILKQIQIELGYIPPEYVGRGV  157 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~  157 (164)
                      .....++.|++.||.|+|+.   +++||||||+||+++.++.++|+|||++.....  .......|++.|+|||++.+..
T Consensus        93 ~~~~~~~~qi~~~l~~lH~~---~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  169 (312)
T cd05585          93 SRARFYTAELLCALENLHKF---NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHG  169 (312)
T ss_pred             HHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCcccCCHHHHcCCC
Confidence            89999999999999999998   999999999999999999999999999875432  2234567899999999999889


Q ss_pred             ceeccCC
Q 046065          158 YYKKFSL  164 (164)
Q Consensus       158 ~~~~~Di  164 (164)
                      ++.++||
T Consensus       170 ~~~~~Dv  176 (312)
T cd05585         170 YTKAVDW  176 (312)
T ss_pred             CCCccce
Confidence            9999996

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.97  E-value=1.9e-30  Score=187.70  Aligned_cols=155  Identities=22%  Similarity=0.290  Sum_probs=130.5

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+|+.||+|.+...   .......+..|+.+++.++||||+++ ..+...+..++||||+++++|...+....   .+++
T Consensus        18 ~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~---~~~~   94 (323)
T cd05595          18 ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER---VFTE   94 (323)
T ss_pred             CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHHcC---CCCH
Confidence            46889999998654   22334567789999999999999998 66667778999999999999988776533   2788


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh--hhhhhhcccccccCcceecCCc
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK--MILKQIQIELGYIPPEYVGRGV  157 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~  157 (164)
                      .....++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....  .......|++.|+|||++.+..
T Consensus        95 ~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  171 (323)
T cd05595          95 ERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND  171 (323)
T ss_pred             HHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCcCcCCcccccCCC
Confidence            99999999999999999998   999999999999999999999999998865322  2224467899999999999899


Q ss_pred             ceeccCC
Q 046065          158 YYKKFSL  164 (164)
Q Consensus       158 ~~~~~Di  164 (164)
                      ++.++||
T Consensus       172 ~~~~~Di  178 (323)
T cd05595         172 YGRAVDW  178 (323)
T ss_pred             CCchhch
Confidence            9999996

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=99.97  E-value=8.8e-31  Score=182.60  Aligned_cols=155  Identities=25%  Similarity=0.315  Sum_probs=128.3

Q ss_pred             CCCcEEEEEEccccc--cccHHHHHHHHHHHhccCCCceeeEeEEee---CCcEEEEEEecCCCChhhhhhCcccccccC
Q 046065            4 PDGQIIAVKKLSKKS--TQGFEEFKNEVMLTAKLQHLNLIRVGFCIE---TQEYMLIYEYMPKRSLDYFLFDPIRMLILD   78 (164)
Q Consensus         4 ~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~---~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~   78 (164)
                      .+++.||+|.++.+.  ....-.-++|+.+|..++||||+.+..+..   .+..|+|||||++ +|..++..-.  ..+.
T Consensus        99 ~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh-DLksl~d~m~--q~F~  175 (419)
T KOG0663|consen   99 KTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH-DLKSLMETMK--QPFL  175 (419)
T ss_pred             CcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh-hHHHHHHhcc--CCCc
Confidence            467899999987663  333455689999999999999999944433   3468999999976 7777776532  2377


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh--hhhhhcccccccCcceecCC
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM--ILKQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~~~  156 (164)
                      ....+.++.|+++|+.|||++   .|+|||+||+|+|+...|.+|++|||+|+.+.+.  ..+..+.|.+|+|||.+.+.
T Consensus       176 ~~evK~L~~QlL~glk~lH~~---wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~  252 (419)
T KOG0663|consen  176 PGEVKTLMLQLLRGLKHLHDN---WILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGA  252 (419)
T ss_pred             hHHHHHHHHHHHHHHHHHhhc---eeEecccchhheeeccCCcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCC
Confidence            888899999999999999998   9999999999999999999999999999988754  35778899999999999554


Q ss_pred             -cceeccCC
Q 046065          157 -VYYKKFSL  164 (164)
Q Consensus       157 -~~~~~~Di  164 (164)
                       .|+...||
T Consensus       253 ~tyst~iDM  261 (419)
T KOG0663|consen  253 KTYSTAVDM  261 (419)
T ss_pred             cccCcchhh
Confidence             67888775

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.97  E-value=3.9e-30  Score=186.13  Aligned_cols=155  Identities=23%  Similarity=0.291  Sum_probs=129.5

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+++.||+|.+...   .......+..|++++..++||||+++ ..+...+..++||||+++++|...+....   .+++
T Consensus        18 ~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~---~l~~   94 (325)
T cd05594          18 ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER---VFSE   94 (325)
T ss_pred             CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHhcC---CCCH
Confidence            46889999998654   22334566789999999999999998 66666778999999999999988876533   2888


Q ss_pred             HHHHHHHHHHHHHHHHhhh-cCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh--hhhhhhcccccccCcceecCC
Q 046065           80 KKRVHIIKGIIQGLLYLQE-YFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK--MILKQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~-~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~~aPE~~~~~  156 (164)
                      .....++.|++.||.|+|+ .   +++|+||||+||+++.++.++|+|||++.....  .......|++.|+|||++.+.
T Consensus        95 ~~~~~~~~qi~~aL~~lH~~~---~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  171 (325)
T cd05594          95 DRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDN  171 (325)
T ss_pred             HHHHHHHHHHHHHHHHHHhcC---CEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCCcccCCHHHHccC
Confidence            9999999999999999997 6   899999999999999999999999999864322  222445789999999999988


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .++.++||
T Consensus       172 ~~~~~~Di  179 (325)
T cd05594         172 DYGRAVDW  179 (325)
T ss_pred             CCCCcccc
Confidence            99999997

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.2e-30  Score=190.87  Aligned_cols=155  Identities=24%  Similarity=0.268  Sum_probs=128.9

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+++.||+|.+...   .......+..|+.+++.++||||+++ ..+......|+||||+++++|.+++.....   +++
T Consensus        24 ~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~---~~~  100 (377)
T cd05629          24 DTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDT---FSE  100 (377)
T ss_pred             CCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHhcCC---CCH
Confidence            57889999998643   23344667889999999999999998 666777789999999999999988865432   788


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh----------------------
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI----------------------  137 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~----------------------  137 (164)
                      .....++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++..+....                      
T Consensus       101 ~~~~~~~~ql~~aL~~LH~~---givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (377)
T cd05629         101 DVTRFYMAECVLAIEAVHKL---GFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRN  177 (377)
T ss_pred             HHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEEeeccccccccccccccccccccccccccccccccc
Confidence            88899999999999999998   99999999999999999999999999985321100                      


Q ss_pred             ---------------------------hhhhcccccccCcceecCCcceeccCC
Q 046065          138 ---------------------------LKQIQIELGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       138 ---------------------------~~~~~~~~~~~aPE~~~~~~~~~~~Di  164 (164)
                                                 ....+||+.|+|||++.+..++.++||
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di  231 (377)
T cd05629         178 SVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDW  231 (377)
T ss_pred             ccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceee
Confidence                                       012468999999999998899999996

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.97  E-value=1.6e-30  Score=188.54  Aligned_cols=154  Identities=21%  Similarity=0.264  Sum_probs=131.7

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+++.||+|.+...   .....+.+..|+.+++.++||||+++ +.+...+..++||||+++++|.+.+.+...   +++
T Consensus        41 ~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~  117 (329)
T PTZ00263         41 GTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGR---FPN  117 (329)
T ss_pred             CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHHcCC---CCH
Confidence            46789999998654   22345678899999999999999997 777777889999999999999988875432   788


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCcceecCCcce
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      .....++.|++.||.|+|++   +++|+||||+||+++.++.++|+|||++...... .....|++.|+|||++.+..++
T Consensus       118 ~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~  193 (329)
T PTZ00263        118 DVAKFYHAELVLAFEYLHSK---DIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-TFTLCGTPEYLAPEVIQSKGHG  193 (329)
T ss_pred             HHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEECCCCCEEEeeccCceEcCCC-cceecCChhhcCHHHHcCCCCC
Confidence            88899999999999999998   9999999999999999999999999998765432 2345789999999999988899


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      .++||
T Consensus       194 ~~~Di  198 (329)
T PTZ00263        194 KAVDW  198 (329)
T ss_pred             Cccee
Confidence            99996

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=99.97  E-value=3.4e-30  Score=188.48  Aligned_cols=155  Identities=25%  Similarity=0.302  Sum_probs=133.1

Q ss_pred             cCCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccC
Q 046065            3 LPDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILD   78 (164)
Q Consensus         3 ~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~   78 (164)
                      ..+|+.+|+|.+.+.   ...+....+.|-.+|...++|.|+++ -.+.+...+||||||+|||++..++.....   ++
T Consensus       163 k~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~~~---L~  239 (550)
T KOG0605|consen  163 KDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRKDT---LT  239 (550)
T ss_pred             ccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHhcCc---Cc
Confidence            467999999999876   45567788889999999999999998 555666789999999999999998876444   99


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh---------------h-------
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK---------------M-------  136 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~---------------~-------  136 (164)
                      +..+..++.+++-|+..+|..   ++|||||||+|+|||..|.+||+|||++..+..               .       
T Consensus       240 e~~arfYiaE~vlAI~~iH~~---gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~  316 (550)
T KOG0605|consen  240 EDWARFYIAETVLAIESIHQL---GYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPS  316 (550)
T ss_pred             hHHHHHHHHHHHHHHHHHHHc---CcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCc
Confidence            999999999999999999999   999999999999999999999999999753210               0       


Q ss_pred             ---------------------------hhhhhcccccccCcceecCCcceeccC
Q 046065          137 ---------------------------ILKQIQIELGYIPPEYVGRGVYYKKFS  163 (164)
Q Consensus       137 ---------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~D  163 (164)
                                                 ...+.+|||-|||||++.+..|+..+|
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cD  370 (550)
T KOG0605|consen  317 DFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECD  370 (550)
T ss_pred             cccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCcccc
Confidence                                       012467899999999999999998887

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=3.1e-30  Score=187.23  Aligned_cols=154  Identities=21%  Similarity=0.284  Sum_probs=131.8

Q ss_pred             CCCcEEEEEEccccc---cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKKS---TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+++.||+|.+....   ......+..|+.++..++||||+++ ..+...+..++||||+++++|.+++.....   +++
T Consensus        24 ~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~---l~~  100 (333)
T cd05600          24 DTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGV---LSE  100 (333)
T ss_pred             CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHHcCC---CCH
Confidence            467899999986542   2334567889999999999999998 666777789999999999999999865432   788


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCcceecCCcce
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      .....++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++..... ......|++.|+|||++.+..++
T Consensus       101 ~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~  176 (333)
T cd05600         101 DHARFYMAEMFEAVDALHEL---GYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-YANSVVGSPDYMAPEVLRGKGYD  176 (333)
T ss_pred             HHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEEEeCcCCccccc-ccCCcccCccccChhHhcCCCCC
Confidence            89999999999999999998   999999999999999999999999999876543 23456789999999999888999


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      .++||
T Consensus       177 ~~~Dv  181 (333)
T cd05600         177 FTVDY  181 (333)
T ss_pred             Cccce
Confidence            99996

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=99.97  E-value=5.3e-31  Score=194.80  Aligned_cols=146  Identities=30%  Similarity=0.417  Sum_probs=129.4

Q ss_pred             CcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHHH
Q 046065            6 GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVH   84 (164)
Q Consensus         6 ~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~   84 (164)
                      ++.||||.+...       -..++.-|++++||||+.+ +.|....=+++|||||..|.|...++....   +....+..
T Consensus       147 netVAVKKV~el-------kETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~~~---itp~llv~  216 (904)
T KOG4721|consen  147 NETVAVKKVREL-------KETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAGRP---ITPSLLVD  216 (904)
T ss_pred             CceehhHHHhhh-------hhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhccCc---cCHHHHHH
Confidence            467888887421       1357788999999999998 888888889999999999999999987655   77888999


Q ss_pred             HHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh-hhhcccccccCcceecCCcceeccC
Q 046065           85 IIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL-KQIQIELGYIPPEYVGRGVYYKKFS  163 (164)
Q Consensus        85 ~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~aPE~~~~~~~~~~~D  163 (164)
                      |..+|+.|+.|||.+   .|||||||..||||..+..+||+|||.+....+..+ ..++||.+|||||++.++..+.|.|
T Consensus       217 Wsk~IA~GM~YLH~h---KIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVD  293 (904)
T KOG4721|consen  217 WSKGIAGGMNYLHLH---KIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVD  293 (904)
T ss_pred             HHHHhhhhhHHHHHh---hHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhhcCCcccccc
Confidence            999999999999999   999999999999999999999999999988765433 6789999999999999999999999


Q ss_pred             C
Q 046065          164 L  164 (164)
Q Consensus       164 i  164 (164)
                      |
T Consensus       294 I  294 (904)
T KOG4721|consen  294 I  294 (904)
T ss_pred             e
Confidence            7

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.97  E-value=3.9e-30  Score=189.79  Aligned_cols=155  Identities=22%  Similarity=0.282  Sum_probs=129.6

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+++.||+|.+...   .......+..|+.+++.++||||+++ ..+...+..++||||+++|+|.+++.....   +++
T Consensus        24 ~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~---~~e  100 (381)
T cd05626          24 DTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEV---FPE  100 (381)
T ss_pred             CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHhcCC---CCH
Confidence            56889999998654   22345678899999999999999998 666777789999999999999988865433   788


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh-----------------------
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM-----------------------  136 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~-----------------------  136 (164)
                      .....++.|++.||.|+|+.   +|+||||||+||+++..+.++|+|||++..+...                       
T Consensus       101 ~~~~~~~~qi~~aL~~LH~~---givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (381)
T cd05626         101 VLARFYIAELTLAIESVHKM---GFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLW  177 (381)
T ss_pred             HHHHHHHHHHHHHHHHHHhC---CeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCccccc
Confidence            88899999999999999998   9999999999999999999999999987532100                       


Q ss_pred             --------------------------hhhhhcccccccCcceecCCcceeccCC
Q 046065          137 --------------------------ILKQIQIELGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       137 --------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Di  164 (164)
                                                .....+||+.|+|||++.+..++.++||
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Di  231 (381)
T cd05626         178 DDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDW  231 (381)
T ss_pred             ccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccce
Confidence                                      0023568999999999988889999996

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=99.97  E-value=5.7e-30  Score=179.55  Aligned_cols=158  Identities=24%  Similarity=0.381  Sum_probs=130.4

Q ss_pred             cCCCcEEEEEEcccccc--ccHHHHHHHHHHHhccCCCc-eeeE-eEEeeCC------cEEEEEEecCCCChhhhhhCcc
Q 046065            3 LPDGQIIAVKKLSKKST--QGFEEFKNEVMLTAKLQHLN-LIRV-GFCIETQ------EYMLIYEYMPKRSLDYFLFDPI   72 (164)
Q Consensus         3 ~~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~-i~~~-~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~   72 (164)
                      ..+|+.||+|.+..+..  .......+|+.+++.++|+| |+++ +.+....      .+++|+|++. .+|..++....
T Consensus        33 ~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d-~DL~~ymd~~~  111 (323)
T KOG0594|consen   33 KRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLD-RDLKKYMDSLP  111 (323)
T ss_pred             ecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEeec-ccHHHHHHhcc
Confidence            45789999999876632  34556789999999999999 9998 6665555      6889999985 48888887644


Q ss_pred             cc-cccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhh--hhhhhhhcccccccC
Q 046065           73 RM-LILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILR--KMILKQIQIELGYIP  149 (164)
Q Consensus        73 ~~-~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~--~~~~~~~~~~~~~~a  149 (164)
                      .. ..++...++.++.|++.|+.|||++   +|+|||+||+|++++..|.+||+|||+|+.+.  ...+....+|.+|+|
T Consensus       112 ~~~~g~~~~~ik~~m~Qll~gl~~~H~~---~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRa  188 (323)
T KOG0594|consen  112 KKPQGLPPRLIKSFMRQLLRGLAFLHSH---GILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRA  188 (323)
T ss_pred             ccccCCCHHHHHHHHHHHHHHHHHHHhC---CeecccCCcceEEECCCCcEeeeccchHHHhcCCcccccccEEEeeccC
Confidence            21 3377789999999999999999999   99999999999999999999999999998654  344577888999999


Q ss_pred             cceecCC-cceeccCC
Q 046065          150 PEYVGRG-VYYKKFSL  164 (164)
Q Consensus       150 PE~~~~~-~~~~~~Di  164 (164)
                      ||++.+. .|+...||
T Consensus       189 PEvLlGs~~Ys~~vDi  204 (323)
T KOG0594|consen  189 PEVLLGSTSYSTSVDI  204 (323)
T ss_pred             HHHhcCCCcCCCCcch
Confidence            9999666 67777775

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.97  E-value=2.8e-30  Score=187.93  Aligned_cols=152  Identities=23%  Similarity=0.257  Sum_probs=130.0

Q ss_pred             CcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            6 GQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         6 ~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      +..||+|.+...   .......+..|+.+++.++||||+++ +.+...+..++||||+++|+|.+++.....   +++..
T Consensus        56 ~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~---~~~~~  132 (340)
T PTZ00426         56 FPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKR---FPNDV  132 (340)
T ss_pred             CeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCC---CCHHH
Confidence            368999988643   23345567889999999999999997 777777889999999999999999875433   78899


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCcceecCCcceec
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKK  161 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~  161 (164)
                      ...++.|++.||.|+|+.   +++||||||+||+++.++.++|+|||++...... .....||+.|+|||++.+..++.+
T Consensus       133 ~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~  208 (340)
T PTZ00426        133 GCFYAAQIVLIFEYLQSL---NIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-TYTLCGTPEYIAPEILLNVGHGKA  208 (340)
T ss_pred             HHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEecCCCCeecCCC-cceecCChhhcCHHHHhCCCCCcc
Confidence            999999999999999998   9999999999999999999999999998765432 244678999999999988889999


Q ss_pred             cCC
Q 046065          162 FSL  164 (164)
Q Consensus       162 ~Di  164 (164)
                      +||
T Consensus       209 ~Di  211 (340)
T PTZ00426        209 ADW  211 (340)
T ss_pred             ccc
Confidence            996

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.97  E-value=7.2e-30  Score=181.63  Aligned_cols=157  Identities=25%  Similarity=0.308  Sum_probs=130.5

Q ss_pred             CCCcEEEEEEccccc---cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKKS---TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+++.||+|.+....   ......+..|+.+++.++|++++++ ..+...+..++|+|++++|+|...+..... ..+++
T Consensus        23 ~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~-~~~~~  101 (285)
T cd05631          23 ATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGN-PGFDE  101 (285)
T ss_pred             cCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCC-CCCCH
Confidence            578899999986542   2223457789999999999999998 666667788999999999999877754222 23788


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh-hhhhhcccccccCcceecCCcc
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM-ILKQIQIELGYIPPEYVGRGVY  158 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~  158 (164)
                      .....++.|++.|+.|+|+.   +++|+||||+||+++.++.++|+|||++...... ......|++.|+|||++.+..+
T Consensus       102 ~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~  178 (285)
T cd05631         102 QRAIFYAAELCCGLEDLQRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKY  178 (285)
T ss_pred             HHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecCCCCCCCccCHhhhcCCCC
Confidence            89999999999999999998   9999999999999999999999999998765432 2245678999999999999999


Q ss_pred             eeccCC
Q 046065          159 YKKFSL  164 (164)
Q Consensus       159 ~~~~Di  164 (164)
                      +.++||
T Consensus       179 ~~~~Dv  184 (285)
T cd05631         179 TFSPDW  184 (285)
T ss_pred             CcccCc
Confidence            999997

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.97  E-value=5.4e-31  Score=195.64  Aligned_cols=142  Identities=30%  Similarity=0.422  Sum_probs=126.5

Q ss_pred             ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCc--EEEEEEecCCCChhhhhhCcccccccCHHHHHHHHHHHHHHHH
Q 046065           18 STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQE--YMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLL   94 (164)
Q Consensus        18 ~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~--~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~   94 (164)
                      .+...+++..|+.+|+.|+||||+++ .+|.+...  ..+|+|.+..|+|..+.++.+.   .+...++.|++||++||.
T Consensus        81 ~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~---vn~kaik~W~RQILkGL~  157 (632)
T KOG0584|consen   81 SPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKHRR---VNIKAIKSWCRQILKGLV  157 (632)
T ss_pred             ChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHhcc---CCHHHHHHHHHHHHHHhh
Confidence            45667899999999999999999997 66666544  6699999999999999987665   778899999999999999


Q ss_pred             HhhhcCCCCeeeCCCCCCceeecC-CCCeEEccccchhhhhhhhhhhhcccccccCcceecCCcceeccCC
Q 046065           95 YLQEYFRLTIIHRDLKVSNILLDE-DLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus        95 ~lh~~~~~~iih~dlk~~nili~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di  164 (164)
                      |||++ .++|||||||.+||+|.. .|.+||+|+|+|......-.....|||.|||||+.. +.|+...||
T Consensus       158 yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~aksvIGTPEFMAPEmYE-E~YnE~VDV  226 (632)
T KOG0584|consen  158 YLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHAKSVIGTPEFMAPEMYE-ENYNELVDV  226 (632)
T ss_pred             hhhcC-CCCccccccccceEEEcCCcCceeecchhHHHHhhccccceeccCccccChHHHh-hhcchhhhh
Confidence            99998 779999999999999976 489999999999988777677789999999999996 899999886

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=3.2e-30  Score=189.12  Aligned_cols=155  Identities=26%  Similarity=0.318  Sum_probs=129.8

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+++.||+|.+...   .......+..|+.++..++||||+++ ..+...+..++||||+++|+|.+++.....   +++
T Consensus        24 ~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~---l~~  100 (364)
T cd05599          24 DTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDT---FTE  100 (364)
T ss_pred             CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHHcCC---CCH
Confidence            46889999998654   23344567789999999999999998 666777789999999999999998865332   889


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh----------------------
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI----------------------  137 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~----------------------  137 (164)
                      .....++.|++.||.|+|+.   +++|+||||+||+++.++.++|+|||++..+....                      
T Consensus       101 ~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (364)
T cd05599         101 EETRFYIAETILAIDSIHKL---GYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISK  177 (364)
T ss_pred             HHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEeecccceeccccccccccccccccccccccccccc
Confidence            99999999999999999998   99999999999999999999999999886432110                      


Q ss_pred             ------------------hhhhcccccccCcceecCCcceeccCC
Q 046065          138 ------------------LKQIQIELGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       138 ------------------~~~~~~~~~~~aPE~~~~~~~~~~~Di  164 (164)
                                        ....+||+.|+|||++.+..++.++||
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di  222 (364)
T cd05599         178 PMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDW  222 (364)
T ss_pred             cccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeee
Confidence                              012468999999999998999999996

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.97  E-value=6.7e-30  Score=188.20  Aligned_cols=155  Identities=22%  Similarity=0.295  Sum_probs=128.9

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+++.||+|.+...   .......+..|+.+++.++||||+++ ..+...+.+++||||+++|+|.+++....   .+++
T Consensus        24 ~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~---~~~~  100 (376)
T cd05598          24 DTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLG---IFEE  100 (376)
T ss_pred             CCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcC---CCCH
Confidence            46889999998643   22334567889999999999999997 66777788999999999999999886543   2788


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh-----------------------
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM-----------------------  136 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~-----------------------  136 (164)
                      .....++.|++.||.|+|+.   +|+||||||+||+++.++.++|+|||++..+...                       
T Consensus       101 ~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (376)
T cd05598         101 DLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEW  177 (376)
T ss_pred             HHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccccccccccccccccccccc
Confidence            88899999999999999998   9999999999999999999999999987432100                       


Q ss_pred             ----------------------hhhhhcccccccCcceecCCcceeccCC
Q 046065          137 ----------------------ILKQIQIELGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       137 ----------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Di  164 (164)
                                            .....+||+.|+|||++.+..++.++||
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di  227 (376)
T cd05598         178 SEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW  227 (376)
T ss_pred             cccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceee
Confidence                                  0013478999999999998899999996

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.97  E-value=6.8e-30  Score=187.23  Aligned_cols=155  Identities=24%  Similarity=0.306  Sum_probs=130.2

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+++.||+|.+...   .......+..|..++..++||+|+++ ..+......++||||+++|+|.+++.+...   +++
T Consensus        24 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~---l~~  100 (360)
T cd05627          24 DTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDT---LSE  100 (360)
T ss_pred             CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHhcCC---CCH
Confidence            46889999998643   23345667889999999999999997 666777789999999999999998865433   788


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh----------------------
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI----------------------  137 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~----------------------  137 (164)
                      .....++.|++.||.|+|+.   +++||||||+||+++.++.++|+|||++..+....                      
T Consensus       101 ~~~~~~~~qi~~~L~~lH~~---givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (360)
T cd05627         101 EATQFYIAETVLAIDAIHQL---GFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMN  177 (360)
T ss_pred             HHHHHHHHHHHHHHHHHHHC---CeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCcccccccccc
Confidence            99999999999999999998   99999999999999999999999999876432110                      


Q ss_pred             ---------------hhhhcccccccCcceecCCcceeccCC
Q 046065          138 ---------------LKQIQIELGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       138 ---------------~~~~~~~~~~~aPE~~~~~~~~~~~Di  164 (164)
                                     ....+||+.|+|||++.+..++.++||
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~Di  219 (360)
T cd05627         178 SKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDW  219 (360)
T ss_pred             cccccccccccccccccccCCCccccCHHHHcCCCCCCccee
Confidence                           113468999999999999999999996

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=99.97  E-value=3.1e-31  Score=186.37  Aligned_cols=154  Identities=27%  Similarity=0.339  Sum_probs=122.2

Q ss_pred             cCCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeEeEEee-C--C-cEE--EEEEecCCCChhhhhhCc-cccc
Q 046065            3 LPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIE-T--Q-EYM--LIYEYMPKRSLDYFLFDP-IRML   75 (164)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~--~-~~~--lv~e~~~~~~L~~~~~~~-~~~~   75 (164)
                      .++++.||||.+-.+...    --+|+++|++++||||+++.+++. .  . ..|  +||||+|. +|.+.++.- ....
T Consensus        46 ~e~~~~vAIKKv~~d~r~----knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~-tL~~~~r~~~~~~~  120 (364)
T KOG0658|consen   46 RETEEEVAIKKVLQDKRY----KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE-TLYRVIRHYTRANQ  120 (364)
T ss_pred             cCCCceeEEEEecCCCCc----CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH-HHHHHHHHHhhcCC
Confidence            456789999997544332    237899999999999999844332 1  2 233  99999986 888887641 1122


Q ss_pred             ccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCC-CCeEEccccchhhhhhh-hhhhhcccccccCccee
Q 046065           76 ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED-LKPKISDFGLARILRKM-ILKQIQIELGYIPPEYV  153 (164)
Q Consensus        76 ~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~-~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~  153 (164)
                      .++...++-++.|+.+|+.|||+.   +|+||||||+|+|+|.+ |.+||+|||.|+.+..+ ...+...|..|+|||.+
T Consensus       121 ~mp~~~iKLYt~Qlfrgl~yLh~~---~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epniSYicSRyYRaPELi  197 (364)
T KOG0658|consen  121 RMPLLEIKLYTYQLFRGLAYLHSH---GICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPNISYICSRYYRAPELI  197 (364)
T ss_pred             CCceeeeHHHHHHHHHHHHHHHhc---CcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCceeEEEeccccCHHHH
Confidence            378888899999999999999998   99999999999999986 89999999999887643 44667789999999999


Q ss_pred             cCC-cceeccCC
Q 046065          154 GRG-VYYKKFSL  164 (164)
Q Consensus       154 ~~~-~~~~~~Di  164 (164)
                      .+. .|+.+.||
T Consensus       198 fga~~Yt~~IDi  209 (364)
T KOG0658|consen  198 FGATEYTTSIDI  209 (364)
T ss_pred             cCccccCceeEE
Confidence            655 78999886

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.97  E-value=6.3e-30  Score=184.94  Aligned_cols=155  Identities=25%  Similarity=0.260  Sum_probs=129.3

Q ss_pred             CCCcEEEEEEcccc----ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccC
Q 046065            4 PDGQIIAVKKLSKK----STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILD   78 (164)
Q Consensus         4 ~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~   78 (164)
                      .+++.||+|.+...    .......+..|+.+++.++||||+++ ..+...+..++||||+++++|.+.+.....   ++
T Consensus        22 ~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~   98 (323)
T cd05584          22 DTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGI---FM   98 (323)
T ss_pred             CCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHHcCC---CC
Confidence            46789999998643    12334567789999999999999997 677777789999999999999888865332   67


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh--hhhhhhcccccccCcceecCC
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK--MILKQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~~aPE~~~~~  156 (164)
                      +.....++.|++.||.|+|+.   +++|+||||+||+++.++.++|+|||++.....  .......|++.|+|||++.+.
T Consensus        99 ~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  175 (323)
T cd05584          99 EDTACFYLSEISLALEHLHQQ---GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRS  175 (323)
T ss_pred             HHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcccccCCCccccChhhccCC
Confidence            888888999999999999998   999999999999999999999999999864322  222346789999999999988


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .++.++||
T Consensus       176 ~~~~~~Di  183 (323)
T cd05584         176 GHGKAVDW  183 (323)
T ss_pred             CCCCccee
Confidence            89999996

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.97  E-value=5.5e-30  Score=189.04  Aligned_cols=155  Identities=23%  Similarity=0.303  Sum_probs=129.2

Q ss_pred             CCCcEEEEEEccccc---cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKKS---TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+++.||+|.+....   ......+..|+.+++.++||||+++ ..+...+..++||||+++|+|.+.+....   .+++
T Consensus        24 ~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~---~~~e  100 (382)
T cd05625          24 DTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMG---IFPE  100 (382)
T ss_pred             CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcC---CCCH
Confidence            467899999986542   2345577889999999999999998 67777788999999999999998886543   2788


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh-----------------------
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM-----------------------  136 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~-----------------------  136 (164)
                      .....++.|++.||.|+|++   +|+||||||+|||++.++.++|+|||++..+...                       
T Consensus       101 ~~~~~~~~qi~~al~~lH~~---~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (382)
T cd05625         101 DLARFYIAELTCAVESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEW  177 (382)
T ss_pred             HHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccccccccccccccccccc
Confidence            88999999999999999998   9999999999999999999999999987532100                       


Q ss_pred             --------------------------hhhhhcccccccCcceecCCcceeccCC
Q 046065          137 --------------------------ILKQIQIELGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       137 --------------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Di  164 (164)
                                                .....+||+.|+|||++.+..++.++||
T Consensus       178 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~Di  231 (382)
T cd05625         178 GDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDW  231 (382)
T ss_pred             cccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeE
Confidence                                      0023468999999999998899999996

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.97  E-value=7.1e-30  Score=193.17  Aligned_cols=156  Identities=20%  Similarity=0.236  Sum_probs=131.5

Q ss_pred             CcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcc-cccccCHHHHH
Q 046065            6 GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPI-RMLILDCKKRV   83 (164)
Q Consensus         6 ~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~   83 (164)
                      ++.||+|.+..........+..|+.+++.++||||+++ +.+...+..++||||+++|+|.+.+.+.. ....+++....
T Consensus        93 ~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~  172 (478)
T PTZ00267         93 KEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG  172 (478)
T ss_pred             CeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHH
Confidence            57788898755555555667889999999999999997 77788889999999999999988775421 22337888889


Q ss_pred             HHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh----hhhhcccccccCcceecCCcce
Q 046065           84 HIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI----LKQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        84 ~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      .++.|++.||.|+|+.   +|+||||||+||+++.++.++|+|||++..+....    ....+||+.|+|||++.+..++
T Consensus       173 ~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  249 (478)
T PTZ00267        173 LLFYQIVLALDEVHSR---KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYS  249 (478)
T ss_pred             HHHHHHHHHHHHHHhC---CEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCC
Confidence            9999999999999998   99999999999999999999999999997654321    2456799999999999989999


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      .++||
T Consensus       250 ~~~Dv  254 (478)
T PTZ00267        250 KKADM  254 (478)
T ss_pred             cHHhH
Confidence            99996

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.97  E-value=2.2e-30  Score=184.78  Aligned_cols=154  Identities=25%  Similarity=0.306  Sum_probs=130.6

Q ss_pred             CCCcEEEEEEccccc---cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKKS---TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+++.||+|.+....   ....+.+..|+.+++.++||||+++ ..+......++||||+++++|.+++.....   +++
T Consensus        24 ~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~  100 (291)
T cd05612          24 ISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGR---FSN  100 (291)
T ss_pred             CCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHHcCC---CCH
Confidence            357899999986432   2344567889999999999999997 666667788999999999999998865433   788


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCcceecCCcce
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      .....++.|++.||.|+|++   +++|+||||+||+++.++.++|+|||++...... .....|++.|+|||++.+..++
T Consensus       101 ~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~  176 (291)
T cd05612         101 STGLFYASEIVCALEYLHSK---EIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-TWTLCGTPEYLAPEVIQSKGHN  176 (291)
T ss_pred             HHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEEecCcchhccCC-cccccCChhhcCHHHHcCCCCC
Confidence            88899999999999999998   9999999999999999999999999998765432 2345789999999999988899


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      .++||
T Consensus       177 ~~~Di  181 (291)
T cd05612         177 KAVDW  181 (291)
T ss_pred             chhhH
Confidence            99996

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.97  E-value=7.5e-30  Score=187.58  Aligned_cols=154  Identities=21%  Similarity=0.233  Sum_probs=127.9

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+++.+|+|.+.+.   .......+.+|+.+++.++||||+++ ..+......++||||+++|+|.+++...    .+++
T Consensus        66 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~----~~~~  141 (370)
T cd05621          66 SSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNY----DVPE  141 (370)
T ss_pred             CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc----CCCH
Confidence            46789999998643   22234567789999999999999998 6666777899999999999999988653    2788


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh---hhhhcccccccCcceecCC
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI---LKQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~aPE~~~~~  156 (164)
                      .....++.|++.||.|+|+.   +|+||||||+||+++.++.+||+|||++.......   .....||+.|+|||++.+.
T Consensus       142 ~~~~~~~~qil~aL~~LH~~---~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~  218 (370)
T cd05621         142 KWAKFYTAEVVLALDAIHSM---GLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQ  218 (370)
T ss_pred             HHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhcc
Confidence            89999999999999999998   99999999999999999999999999987654321   2356799999999999654


Q ss_pred             c----ceeccCC
Q 046065          157 V----YYKKFSL  164 (164)
Q Consensus       157 ~----~~~~~Di  164 (164)
                      .    ++.++||
T Consensus       219 ~~~~~~~~~~Di  230 (370)
T cd05621         219 GGDGYYGRECDW  230 (370)
T ss_pred             CCCCCCCcccCE
Confidence            3    6788886

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.97  E-value=1.4e-29  Score=183.67  Aligned_cols=156  Identities=24%  Similarity=0.324  Sum_probs=133.6

Q ss_pred             CCCcEEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            4 PDGQIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         4 ~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      .++..+|+|.+... .+.....+.+|+++++.++||||+++ +.+...+..++||||+++++|.+++.....   +++..
T Consensus        28 ~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~  104 (331)
T cd06649          28 PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKR---IPEEI  104 (331)
T ss_pred             CCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHHcCC---CCHHH
Confidence            45788999998755 33345678899999999999999998 777778889999999999999999875433   78899


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCcceecCCcceec
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKK  161 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~  161 (164)
                      ...++.|++.|+.|+|+.+  +++|+||||+||+++.++.++|+|||++............|++.|+|||++.+..++.+
T Consensus       105 ~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~  182 (331)
T cd06649         105 LGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQ  182 (331)
T ss_pred             HHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCcccccccccccccCCCCcCcCCHhHhcCCCCCch
Confidence            9999999999999999852  59999999999999999999999999987665444455678999999999998899999


Q ss_pred             cCC
Q 046065          162 FSL  164 (164)
Q Consensus       162 ~Di  164 (164)
                      +||
T Consensus       183 ~Di  185 (331)
T cd06649         183 SDI  185 (331)
T ss_pred             HhH
Confidence            996

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.97  E-value=1e-29  Score=184.33  Aligned_cols=155  Identities=21%  Similarity=0.253  Sum_probs=129.8

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccC
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILD   78 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~   78 (164)
                      .+++.||+|.+...   .......+..|..++..+ +||||+++ ..+...+.+++||||+++++|..++....   .++
T Consensus        18 ~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~---~l~   94 (329)
T cd05588          18 KTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQR---KLP   94 (329)
T ss_pred             CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHHcC---CCC
Confidence            46789999998754   223345677899999888 79999998 66667778999999999999988775433   288


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhh--hhhhhhhcccccccCcceecCC
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILR--KMILKQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~--~~~~~~~~~~~~~~aPE~~~~~  156 (164)
                      +.....++.|++.||.|+|++   +++|+||||+||+++.++.++|+|||++....  .......+|++.|+|||++.+.
T Consensus        95 ~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  171 (329)
T cd05588          95 EEHARFYSAEISLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGE  171 (329)
T ss_pred             HHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCCccccCHHHHcCC
Confidence            999999999999999999998   99999999999999999999999999986422  2223456789999999999989


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .++.++|+
T Consensus       172 ~~~~~~Di  179 (329)
T cd05588         172 DYGFSVDW  179 (329)
T ss_pred             CCCCccce
Confidence            99999996

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.97  E-value=7.9e-30  Score=184.02  Aligned_cols=155  Identities=25%  Similarity=0.265  Sum_probs=130.7

Q ss_pred             CCCcEEEEEEccccc--cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            4 PDGQIIAVKKLSKKS--TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         4 ~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      .+|+.||+|.+....  ......+..|+.+++.++||||+++ ..+...+..++||||+++++|.+.+....   .+++.
T Consensus        22 ~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~   98 (318)
T cd05582          22 DAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEV---MFTEE   98 (318)
T ss_pred             CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcC---CCCHH
Confidence            467899999986542  2234456789999999999999998 66677788999999999999988886533   28899


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh--hhhhhcccccccCcceecCCcc
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM--ILKQIQIELGYIPPEYVGRGVY  158 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~  158 (164)
                      ....++.|++.||.|+|+.   +++|+||||+||+++.++.++|+|||++......  ......|++.|+|||.+.+..+
T Consensus        99 ~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~  175 (318)
T cd05582          99 DVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGH  175 (318)
T ss_pred             HHHHHHHHHHHHHHHHHHC---CEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccCChhhcCHHHHcCCCC
Confidence            9999999999999999998   9999999999999999999999999998654332  2345678999999999988888


Q ss_pred             eeccCC
Q 046065          159 YKKFSL  164 (164)
Q Consensus       159 ~~~~Di  164 (164)
                      +.++||
T Consensus       176 ~~~~Di  181 (318)
T cd05582         176 TQSADW  181 (318)
T ss_pred             CCccce
Confidence            999996

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=7.1e-31  Score=175.57  Aligned_cols=157  Identities=31%  Similarity=0.396  Sum_probs=136.0

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .++-.||+|.+.+.   .......+.+|+++-..++||||+++ +++.+....|+++||++.|++...+.++.. ..+++
T Consensus        45 ks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~~-~~f~e  123 (281)
T KOG0580|consen   45 KSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRM-KRFDE  123 (281)
T ss_pred             cCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHhccc-ccccc
Confidence            34668999998765   22234567889999999999999997 999999999999999999999999885433 33889


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCcceecCCcce
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      .....+..|++.|+.|+|..   ++||||+||+|+|++..+.+|++|||.+-.-..+.-...|||.-|++||+..+..++
T Consensus       124 ~~~a~Yi~q~A~Al~y~h~k---~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~kR~tlcgt~dyl~pEmv~~~~hd  200 (281)
T KOG0580|consen  124 QRAATYIKQLANALLYCHLK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSNKRKTLCGTLDYLPPEMVEGRGHD  200 (281)
T ss_pred             cchhHHHHHHHHHHHHhccC---CcccCCCCHHHhccCCCCCeeccCCCceeecCCCCceeeecccccCCHhhcCCCCcc
Confidence            99999999999999999988   999999999999999999999999998866554455678999999999999999999


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      .+.|+
T Consensus       201 ~~Vd~  205 (281)
T KOG0580|consen  201 KFVDL  205 (281)
T ss_pred             chhhH
Confidence            88874

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.96  E-value=1.2e-29  Score=188.05  Aligned_cols=155  Identities=26%  Similarity=0.399  Sum_probs=134.8

Q ss_pred             CCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            4 PDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         4 ~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      .++..||+|.+++.  .+...+.+.+|+++++.++||||+++ ........+|+||||+.+|.+.+.+.....   ..+.
T Consensus        79 ~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~gr---~~e~  155 (596)
T KOG0586|consen   79 LTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKHGR---MKEK  155 (596)
T ss_pred             CCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHhccc---chhh
Confidence            45789999999866  34445668899999999999999998 677778899999999999999999987655   4457


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh-hhhhhcccccccCcceecCCcc-
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM-ILKQIQIELGYIPPEYVGRGVY-  158 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~-  158 (164)
                      ....++.|+.+|++|||+.   .|+|||||++|++++.+..+||+|||++..+... ..+..+|++.|.|||++.+.+| 
T Consensus       156 ~ar~~F~q~vsaveYcH~k---~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~  232 (596)
T KOG0586|consen  156 EARAKFRQIVSAVEYCHSK---NIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYD  232 (596)
T ss_pred             hhhhhhHHHHHHHHHHhhc---ceeccccchhhcccccccceeeeccccceeecccccccccCCCCCccChHhhcCcccC
Confidence            7888999999999999998   9999999999999999999999999999888754 3478999999999999988888 


Q ss_pred             eeccCC
Q 046065          159 YKKFSL  164 (164)
Q Consensus       159 ~~~~Di  164 (164)
                      ++..|+
T Consensus       233 gpe~D~  238 (596)
T KOG0586|consen  233 GPEVDI  238 (596)
T ss_pred             Ccceeh
Confidence            666664

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.96  E-value=2.4e-29  Score=182.35  Aligned_cols=155  Identities=22%  Similarity=0.264  Sum_probs=129.2

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccC
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILD   78 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~   78 (164)
                      .+++.||+|.+.+.   .......+..|..++..+ +||||+++ +.+...+..++||||+++++|...+....   .++
T Consensus        18 ~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~~---~l~   94 (329)
T cd05618          18 KTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQR---KLP   94 (329)
T ss_pred             CCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHHcC---CCC
Confidence            46789999998754   223345677888888776 79999998 66677788999999999999988775433   288


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhh--hhhhhhhcccccccCcceecCC
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILR--KMILKQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~--~~~~~~~~~~~~~~aPE~~~~~  156 (164)
                      +.....++.|++.|+.|+|+.   +++|+||||+||+++.++.++|+|||++....  ........|++.|+|||++.+.
T Consensus        95 ~~~~~~i~~qi~~~l~~lH~~---~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  171 (329)
T cd05618          95 EEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE  171 (329)
T ss_pred             HHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCCccccCHHHHcCC
Confidence            999999999999999999998   99999999999999999999999999986532  1223456789999999999999


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .++.++||
T Consensus       172 ~~~~~~Di  179 (329)
T cd05618         172 DYGFSVDW  179 (329)
T ss_pred             CCCCccce
Confidence            99999996

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.2e-29  Score=190.14  Aligned_cols=154  Identities=23%  Similarity=0.323  Sum_probs=132.5

Q ss_pred             cCCCcEEEEEEcccc---ccccHHHHHHHHHHHhcc-CCCceeeEeEEee-CCcEEEEEEecCCCChhhhhhCccccccc
Q 046065            3 LPDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKL-QHLNLIRVGFCIE-TQEYMLIYEYMPKRSLDYFLFDPIRMLIL   77 (164)
Q Consensus         3 ~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~   77 (164)
                      ..+++.+|||.++++   ...+.+....|.+++... +||.++++..+++ ...+|+||||+.||++..+....    .+
T Consensus       390 k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~~~~~----~F  465 (694)
T KOG0694|consen  390 KGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHHIHTD----VF  465 (694)
T ss_pred             cCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCCCcEEEEEecc----cc
Confidence            457889999999877   455677888999998888 5999999955555 56799999999999965554322    29


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhh--hhhhhhhcccccccCcceecC
Q 046065           78 DCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILR--KMILKQIQIELGYIPPEYVGR  155 (164)
Q Consensus        78 ~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~--~~~~~~~~~~~~~~aPE~~~~  155 (164)
                      ++..+..++..++.||.|||++   +||+||+|.+|||+|..|.+||+|||+++.-.  ...+...||||.|||||++.+
T Consensus       466 ~e~rarfyaAev~l~L~fLH~~---~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e  542 (694)
T KOG0694|consen  466 SEPRARFYAAEVVLGLQFLHEN---GIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTE  542 (694)
T ss_pred             cHHHHHHHHHHHHHHHHHHHhc---CceeeecchhheEEcccCcEEecccccccccCCCCCccccccCChhhcChhhhcc
Confidence            9999999999999999999998   99999999999999999999999999997654  345577999999999999999


Q ss_pred             CcceeccC
Q 046065          156 GVYYKKFS  163 (164)
Q Consensus       156 ~~~~~~~D  163 (164)
                      ..|+...|
T Consensus       543 ~~Yt~aVD  550 (694)
T KOG0694|consen  543 QSYTRAVD  550 (694)
T ss_pred             Ccccchhh
Confidence            99998877

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.96  E-value=2.8e-29  Score=178.24  Aligned_cols=158  Identities=28%  Similarity=0.341  Sum_probs=130.0

Q ss_pred             CCCcEEEEEEccccc---cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcc-cccccC
Q 046065            4 PDGQIIAVKKLSKKS---TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPI-RMLILD   78 (164)
Q Consensus         4 ~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~   78 (164)
                      .+++.||+|.+....   ......+..|+.+++.++|+||+++ ..+......++||||+++++|...+.... ....++
T Consensus        16 ~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~   95 (280)
T cd05608          16 ATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFP   95 (280)
T ss_pred             cCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCC
Confidence            468899999986542   2233566789999999999999998 55566677899999999999987764321 223488


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh--hhhhcccccccCcceecCC
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI--LKQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~aPE~~~~~  156 (164)
                      +.....++.|++.|+.|+|+.   +++|+||||+||+++.++.++|+|||++..+....  .....|++.|+|||++.+.
T Consensus        96 ~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~  172 (280)
T cd05608          96 EPRACFYTAQIISGLEHLHQR---RIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGE  172 (280)
T ss_pred             HHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCCCcCccCHHHhcCC
Confidence            999999999999999999998   99999999999999999999999999987654322  2345789999999999999


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .++.++||
T Consensus       173 ~~~~~~Dv  180 (280)
T cd05608         173 EYDFSVDY  180 (280)
T ss_pred             CCCccccH
Confidence            99999996

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.96  E-value=2.7e-29  Score=181.72  Aligned_cols=155  Identities=24%  Similarity=0.274  Sum_probs=126.8

Q ss_pred             CCCcEEEEEEccccc---cccHHHHHHHHH-HHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccC
Q 046065            4 PDGQIIAVKKLSKKS---TQGFEEFKNEVM-LTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILD   78 (164)
Q Consensus         4 ~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~   78 (164)
                      .+|+.+|+|.+....   ......+..|.. +++.++||||+++ ..+...+..++||||+++++|...+....   .++
T Consensus        18 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~   94 (325)
T cd05604          18 LDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRER---SFP   94 (325)
T ss_pred             CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHHcC---CCC
Confidence            468899999986541   222334455554 5777899999998 66677788999999999999987776433   288


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh--hhhhhhcccccccCcceecCC
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK--MILKQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~~aPE~~~~~  156 (164)
                      +.....++.|++.||.|+|+.   +++|+||||+||+++.++.++|+|||++.....  .......|++.|+|||++.+.
T Consensus        95 ~~~~~~~~~qi~~al~~lH~~---givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  171 (325)
T cd05604          95 EPRARFYAAEIASALGYLHSI---NIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQ  171 (325)
T ss_pred             HHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcCC
Confidence            899999999999999999998   999999999999999999999999999865322  223456789999999999999


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .++.++||
T Consensus       172 ~~~~~~Dv  179 (325)
T cd05604         172 PYDNTVDW  179 (325)
T ss_pred             CCCCcCcc
Confidence            99999996

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.96  E-value=2.9e-29  Score=180.96  Aligned_cols=155  Identities=26%  Similarity=0.322  Sum_probs=127.0

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccC
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILD   78 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~   78 (164)
                      .+++.||+|.+...   .......+..|..++... +||||+++ ..+...+..++||||+++++|...+.....   ++
T Consensus        18 ~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~---~~   94 (316)
T cd05592          18 GTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGR---FD   94 (316)
T ss_pred             CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHHcCC---CC
Confidence            46788999998654   223334455666666654 89999998 666667788999999999999888865432   88


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhh--hhhhhhhcccccccCcceecCC
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILR--KMILKQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~--~~~~~~~~~~~~~~aPE~~~~~  156 (164)
                      +.....++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++....  .......+||+.|+|||++.+.
T Consensus        95 ~~~~~~~~~qi~~al~~LH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~  171 (316)
T cd05592          95 EARARFYAAEIICGLQFLHKK---GIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQ  171 (316)
T ss_pred             HHHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCCccccCHHHHcCC
Confidence            899999999999999999998   99999999999999999999999999986542  2223456789999999999988


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .++.++||
T Consensus       172 ~~~~~~Dv  179 (316)
T cd05592         172 KYNESVDW  179 (316)
T ss_pred             CCCCcccc
Confidence            99999996

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.96  E-value=2.2e-29  Score=181.94  Aligned_cols=155  Identities=23%  Similarity=0.319  Sum_probs=128.7

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccC
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILD   78 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~   78 (164)
                      .+++.||+|.+...   .......+..|..++..+ +||||+++ ..+...+..++||||+++++|...+.....   ++
T Consensus        18 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~~~---l~   94 (320)
T cd05590          18 ESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR---FD   94 (320)
T ss_pred             CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHHcCC---CC
Confidence            46789999998644   233445667788888776 69999998 666677789999999999999888765433   88


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhh--hhhhhhhcccccccCcceecCC
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILR--KMILKQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~--~~~~~~~~~~~~~~aPE~~~~~  156 (164)
                      +.....++.|++.||.|+|+.   +++|+||||+||+++.++.++|+|||++....  ........|++.|+|||++.+.
T Consensus        95 ~~~~~~~~~ql~~~L~~lH~~---~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  171 (320)
T cd05590          95 EARARFYAAEITSALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEM  171 (320)
T ss_pred             HHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccCccccCHHHHcCC
Confidence            899999999999999999998   99999999999999999999999999986432  2223456789999999999988


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .++.++||
T Consensus       172 ~~~~~~Di  179 (320)
T cd05590         172 LYGPSVDW  179 (320)
T ss_pred             CCCCccch
Confidence            99999996

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.96  E-value=3.2e-29  Score=183.22  Aligned_cols=154  Identities=25%  Similarity=0.410  Sum_probs=134.8

Q ss_pred             CCCcEEEEEEccccccc---cHHHHHHHHHHHhccC-CCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccC
Q 046065            4 PDGQIIAVKKLSKKSTQ---GFEEFKNEVMLTAKLQ-HLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILD   78 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~-h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~   78 (164)
                      .+|+.+|+|.+.+....   ......+|+.+|+.+. ||||+.+ ..++.....++|||++.+|.|.+.+...    .++
T Consensus        58 ~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~----~~s  133 (382)
T KOG0032|consen   58 STGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK----HYS  133 (382)
T ss_pred             CCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc----cCC
Confidence            46899999999877432   3457889999999997 9999998 7777788899999999999998888765    289


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCC----CCeEEccccchhhhhhh-hhhhhcccccccCccee
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED----LKPKISDFGLARILRKM-ILKQIQIELGYIPPEYV  153 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~----~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~  153 (164)
                      +.....++.|++.++.|+|+.   +++|||+||+|+|+...    +.++++|||++...... .....+||+.|+|||++
T Consensus       134 E~da~~~~~~il~av~~lH~~---gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl  210 (382)
T KOG0032|consen  134 ERDAAGIIRQILEAVKYLHSL---GVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVL  210 (382)
T ss_pred             HHHHHHHHHHHHHHHHHHHhC---CceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCCceEeeecCCccccCchhh
Confidence            999999999999999999998   99999999999999653    47999999999877652 34678999999999999


Q ss_pred             cCCcceeccCC
Q 046065          154 GRGVYYKKFSL  164 (164)
Q Consensus       154 ~~~~~~~~~Di  164 (164)
                      ....|+...||
T Consensus       211 ~~~~y~~~~Di  221 (382)
T KOG0032|consen  211 GGRPYGDEVDV  221 (382)
T ss_pred             cCCCCCcccch
Confidence            98999999986

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.96  E-value=4.8e-29  Score=181.06  Aligned_cols=156  Identities=25%  Similarity=0.318  Sum_probs=132.4

Q ss_pred             CCCcEEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            4 PDGQIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         4 ~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      .+++.+|+|.+... .+.....+..|+++++.++||||+++ +.+...+..++||||+++++|.+++.....   ++...
T Consensus        28 ~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~  104 (333)
T cd06650          28 PSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQI  104 (333)
T ss_pred             CCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHHcCC---CCHHH
Confidence            35778999987654 33344668899999999999999997 777888889999999999999998865332   78889


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCcceecCCcceec
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKK  161 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~  161 (164)
                      ...++.+++.|+.|+|+.+  +++|+||||+||+++.++.++|+|||++............++..|+|||++.+..++.+
T Consensus       105 ~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  182 (333)
T cd06650         105 LGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQ  182 (333)
T ss_pred             HHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhccccCCCCccccCHHHhcCCCCCcH
Confidence            9999999999999999741  69999999999999999999999999987665544455678999999999988889999


Q ss_pred             cCC
Q 046065          162 FSL  164 (164)
Q Consensus       162 ~Di  164 (164)
                      +||
T Consensus       183 ~Dv  185 (333)
T cd06650         183 SDI  185 (333)
T ss_pred             HHH
Confidence            985

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.96  E-value=2.6e-29  Score=181.58  Aligned_cols=155  Identities=21%  Similarity=0.277  Sum_probs=128.4

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccC
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILD   78 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~   78 (164)
                      .+++.||+|.+...   .......+..|.+++..+ +||||+++ ..+...+..++||||+++++|...+.....   ++
T Consensus        18 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~---~~   94 (321)
T cd05591          18 GTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRK---FD   94 (321)
T ss_pred             CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHHcCC---CC
Confidence            45789999998654   223345567788888766 79999998 666677789999999999999888765433   78


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh--hhhhhhcccccccCcceecCC
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK--MILKQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~~aPE~~~~~  156 (164)
                      +.....++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++.....  .......|++.|+|||++.+.
T Consensus        95 ~~~~~~~~~qi~~aL~~LH~~---~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  171 (321)
T cd05591          95 EPRSRFYAAEVTLALMFLHRH---GVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQEL  171 (321)
T ss_pred             HHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccCccccCHHHHcCC
Confidence            888999999999999999998   999999999999999999999999998865322  223456789999999999888


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .++.++||
T Consensus       172 ~~~~~~Dv  179 (321)
T cd05591         172 EYGPSVDW  179 (321)
T ss_pred             CCCCccce
Confidence            99999996

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.96  E-value=2.3e-29  Score=185.05  Aligned_cols=154  Identities=22%  Similarity=0.240  Sum_probs=127.1

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+++.||+|.+...   .......+..|+.+++.++||||+++ ..+...+..++||||+++|+|.+++...    .+++
T Consensus        66 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~----~l~~  141 (370)
T cd05596          66 SSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY----DIPE  141 (370)
T ss_pred             CCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHhc----CCCH
Confidence            46789999998643   22334457789999999999999998 5666667789999999999999988653    2788


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh---hhhhhcccccccCcceecCC
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM---ILKQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~~aPE~~~~~  156 (164)
                      .....++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||++......   ......|++.|+|||++.+.
T Consensus       142 ~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  218 (370)
T cd05596         142 KWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQ  218 (370)
T ss_pred             HHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccC
Confidence            88999999999999999998   9999999999999999999999999998765432   12346789999999998543


Q ss_pred             ----cceeccCC
Q 046065          157 ----VYYKKFSL  164 (164)
Q Consensus       157 ----~~~~~~Di  164 (164)
                          .++.++||
T Consensus       219 ~~~~~~~~~~Di  230 (370)
T cd05596         219 GGDGYYGRECDW  230 (370)
T ss_pred             CCCCCCCCceee
Confidence                47888886

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.96  E-value=3.8e-29  Score=180.83  Aligned_cols=155  Identities=25%  Similarity=0.302  Sum_probs=126.4

Q ss_pred             CCCcEEEEEEccccc---cccHHHHHHHHH-HHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccC
Q 046065            4 PDGQIIAVKKLSKKS---TQGFEEFKNEVM-LTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILD   78 (164)
Q Consensus         4 ~~~~~vavK~~~~~~---~~~~~~~~~e~~-~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~   78 (164)
                      .+|+.||+|.+....   ......+..|.. +++.++||||+++ ..+...+..++||||+++++|...+....   .++
T Consensus        18 ~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~---~~~   94 (323)
T cd05575          18 ADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRER---SFP   94 (323)
T ss_pred             CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHhcC---CCC
Confidence            468899999986542   222234445544 5678899999998 66667778999999999999988876533   278


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh--hhhhhhcccccccCcceecCC
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK--MILKQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~~aPE~~~~~  156 (164)
                      +.....++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....  .......|++.|+|||++.+.
T Consensus        95 ~~~~~~~~~qi~~~l~~lH~~---givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  171 (323)
T cd05575          95 EPRARFYAAEIASALGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQ  171 (323)
T ss_pred             HHHHHHHHHHHHHHHHHHHHC---CeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCChhhcChhhhcCC
Confidence            888999999999999999998   999999999999999999999999999865322  223456789999999999988


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .++.++||
T Consensus       172 ~~~~~~Dv  179 (323)
T cd05575         172 PYDRTVDW  179 (323)
T ss_pred             CCCccccc
Confidence            99999996

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.4e-30  Score=193.24  Aligned_cols=153  Identities=30%  Similarity=0.407  Sum_probs=128.8

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeEeEEe-eCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRVGFCI-ETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+.+.||||.++-.   ....|+.++.|+..|+.+.|||++.+..|+ ..-..|||||||- |+-.+++.-.  .+.+.+
T Consensus        49 ~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYCl-GSAsDlleVh--kKplqE  125 (948)
T KOG0577|consen   49 RNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDLLEVH--KKPLQE  125 (948)
T ss_pred             CccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHh-ccHHHHHHHH--hccchH
Confidence            45678999999744   455688999999999999999999995554 5567899999995 4666666432  223778


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCccee---cCC
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYV---GRG  156 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~---~~~  156 (164)
                      ..+..++.+.++||.|||+.   +.||||||.-|||+...|.+||+|||.|+...  ..++++|||+|||||++   ..+
T Consensus       126 vEIAAi~~gaL~gLaYLHS~---~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~--PAnsFvGTPywMAPEVILAMDEG  200 (948)
T KOG0577|consen  126 VEIAAITHGALQGLAYLHSH---NRIHRDIKAGNILLSEPGLVKLADFGSASIMA--PANSFVGTPYWMAPEVILAMDEG  200 (948)
T ss_pred             HHHHHHHHHHHHHHHHHHHh---hHHhhhccccceEecCCCeeeeccccchhhcC--chhcccCCccccchhHheecccc
Confidence            88889999999999999999   99999999999999999999999999997653  24679999999999998   677


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .|+-|.||
T Consensus       201 qYdgkvDv  208 (948)
T KOG0577|consen  201 QYDGKVDV  208 (948)
T ss_pred             ccCCccce
Confidence            99999997

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=5e-30  Score=180.00  Aligned_cols=154  Identities=29%  Similarity=0.423  Sum_probs=129.8

Q ss_pred             CCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEee-----CCcEEEEEEecCCCChhhhhhCccccc
Q 046065            4 PDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIE-----TQEYMLIYEYMPKRSLDYFLFDPIRML   75 (164)
Q Consensus         4 ~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~~~   75 (164)
                      .+|+.||+|.+..-  ..-...+..+|+.+++.++|+||+.+ .....     ....|+|+|++ ..+|.+.++++..  
T Consensus        45 ~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elM-etDL~~iik~~~~--  121 (359)
T KOG0660|consen   45 RTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELM-ETDLHQIIKSQQD--  121 (359)
T ss_pred             CCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHH-hhHHHHHHHcCcc--
Confidence            57899999998633  44556788999999999999999997 33322     34689999999 4589988887654  


Q ss_pred             ccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhh----hhhhhhhcccccccCcc
Q 046065           76 ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILR----KMILKQIQIELGYIPPE  151 (164)
Q Consensus        76 ~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~----~~~~~~~~~~~~~~aPE  151 (164)
                       +.......++.|++.|+.|+|+.   +++|||+||.|++++.+..+|++|||+|+...    ....+..+.|.+|+|||
T Consensus       122 -L~d~H~q~f~YQiLrgLKyiHSA---nViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPE  197 (359)
T KOG0660|consen  122 -LTDDHAQYFLYQILRGLKYIHSA---NVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPE  197 (359)
T ss_pred             -ccHHHHHHHHHHHHHhcchhhcc---cccccccchhheeeccCCCEEeccccceeeccccCcccchhcceeeeeecCHH
Confidence             78889999999999999999999   99999999999999999999999999998874    34447788899999999


Q ss_pred             eec-CCcceeccCC
Q 046065          152 YVG-RGVYYKKFSL  164 (164)
Q Consensus       152 ~~~-~~~~~~~~Di  164 (164)
                      ++. ...||...||
T Consensus       198 lll~~~~Yt~aiDi  211 (359)
T KOG0660|consen  198 LLLNSSEYTKAIDI  211 (359)
T ss_pred             HHhccccccchhhh
Confidence            994 4588888886

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=99.96  E-value=1.1e-29  Score=194.13  Aligned_cols=157  Identities=34%  Similarity=0.539  Sum_probs=134.5

Q ss_pred             CCcEEEEEEccccccc-cHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccc---------
Q 046065            5 DGQIIAVKKLSKKSTQ-GFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIR---------   73 (164)
Q Consensus         5 ~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---------   73 (164)
                      +...||||.++..... ..+.|.+|++++..++|||||++ +.|..++-.++|+||+..|+|.+|++....         
T Consensus       515 ~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~  594 (774)
T KOG1026|consen  515 DEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQ  594 (774)
T ss_pred             cceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCC
Confidence            4567999999766444 67889999999999999999997 999999999999999999999999975211         


Q ss_pred             --ccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh-h---hhcccccc
Q 046065           74 --MLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL-K---QIQIELGY  147 (164)
Q Consensus        74 --~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~-~---~~~~~~~~  147 (164)
                        ...+...+.+.++.||+.|+.||.++   +++||||..+|+||..+..+||+|||+++..=+..+ .   ...-...|
T Consensus       595 ~~~~~L~~~q~L~iA~QIAaGM~YLs~~---~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRW  671 (774)
T KOG1026|consen  595 DTPPPLSTSQFLHIATQIAAGMEYLSSH---HFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRW  671 (774)
T ss_pred             CCCCCCCHHHHHHHHHHHHHHHHHHHhC---cccccchhhhhceeccceEEEecccccchhhhhhhhhcccCCceeeeec
Confidence              22378899999999999999999999   999999999999999999999999999976533322 2   22345689


Q ss_pred             cCcceecCCcceeccCC
Q 046065          148 IPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       148 ~aPE~~~~~~~~~~~Di  164 (164)
                      ||||.+..++||.+|||
T Consensus       672 MppEsIly~kFTteSDV  688 (774)
T KOG1026|consen  672 MPPESILYGKFTTESDV  688 (774)
T ss_pred             CCHHHhhcCcccchhhh
Confidence            99999999999999997

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=2.3e-29  Score=183.61  Aligned_cols=155  Identities=25%  Similarity=0.337  Sum_probs=132.3

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+++.||+|.+...   .......+..|+.++..++||||+++ ..+...+..++||||+++++|..++....   .++.
T Consensus        24 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~  100 (350)
T cd05573          24 DTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKD---VFPE  100 (350)
T ss_pred             CCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHHcC---CCCH
Confidence            46889999998654   22345667889999999999999998 66777788999999999999999887642   3888


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh----------------------
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI----------------------  137 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~----------------------  137 (164)
                      .....++.|++.||.|+|+.   +++|+||||+||+++.++.++|+|||++.......                      
T Consensus       101 ~~~~~i~~qi~~aL~~LH~~---giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (350)
T cd05573         101 ETARFYIAELVLALDSVHKL---GFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRR  177 (350)
T ss_pred             HHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccccccccccccccccccccc
Confidence            99999999999999999998   99999999999999999999999999987654322                      


Q ss_pred             ---------hhhhcccccccCcceecCCcceeccCC
Q 046065          138 ---------LKQIQIELGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       138 ---------~~~~~~~~~~~aPE~~~~~~~~~~~Di  164 (164)
                               .....|++.|+|||++.+..++.++||
T Consensus       178 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di  213 (350)
T cd05573         178 RDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDW  213 (350)
T ss_pred             cccccccccccccccCccccCHHHHcCCCCCCceee
Confidence                     234568999999999999999999996

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.96  E-value=5e-29  Score=180.54  Aligned_cols=155  Identities=23%  Similarity=0.285  Sum_probs=129.0

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccC
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILD   78 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~   78 (164)
                      .+++.||+|.+...   .......+..|..++..+ +||||+.+ ..+...+..++||||+++++|...+.....   ++
T Consensus        18 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---l~   94 (327)
T cd05617          18 KNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRK---LP   94 (327)
T ss_pred             CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCC---CC
Confidence            46788999998754   223345677899988888 69999998 555666788999999999999887754332   88


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhh--hhhhhhhcccccccCcceecCC
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILR--KMILKQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~--~~~~~~~~~~~~~~aPE~~~~~  156 (164)
                      +..+..++.|++.|+.|+|+.   +++|+||||+||+++.++.++|+|||++....  .......+|++.|+|||++.+.
T Consensus        95 ~~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  171 (327)
T cd05617          95 EEHARFYAAEICIALNFLHER---GIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGE  171 (327)
T ss_pred             HHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCCcccCCHHHHCCC
Confidence            999999999999999999998   99999999999999999999999999986432  2223456789999999999999


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .++.++||
T Consensus       172 ~~~~~~Di  179 (327)
T cd05617         172 EYGFSVDW  179 (327)
T ss_pred             CCCchhee
Confidence            99999996

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.96  E-value=6.4e-29  Score=178.15  Aligned_cols=156  Identities=27%  Similarity=0.453  Sum_probs=126.8

Q ss_pred             CcEEEEEEccccc-cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcc-----------
Q 046065            6 GQIIAVKKLSKKS-TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPI-----------   72 (164)
Q Consensus         6 ~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-----------   72 (164)
                      +..||+|.+.... ......+.+|+.++..++||||+++ +.+...+..+++|||+++++|.+++....           
T Consensus        46 ~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~  125 (304)
T cd05096          46 PLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDA  125 (304)
T ss_pred             ceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccc
Confidence            4579999986542 2234568899999999999999997 77777788999999999999998875421           


Q ss_pred             -----cccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh----hhhhcc
Q 046065           73 -----RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI----LKQIQI  143 (164)
Q Consensus        73 -----~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~----~~~~~~  143 (164)
                           ....++......++.|++.||.|+|+.   +++|+||||+||+++.++.++|+|||++.......    .....+
T Consensus       126 ~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~  202 (304)
T cd05096         126 VPPAHCLPAISYSSLLHVALQIASGMKYLSSL---NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVL  202 (304)
T ss_pred             cccccccccccHHHHHHHHHHHHHHHHHHHHC---CccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCC
Confidence                 012356678889999999999999998   99999999999999999999999999987553221    123345


Q ss_pred             cccccCcceecCCcceeccCC
Q 046065          144 ELGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       144 ~~~~~aPE~~~~~~~~~~~Di  164 (164)
                      +..|+|||++..+.++.++||
T Consensus       203 ~~~y~aPE~~~~~~~~~~~Dv  223 (304)
T cd05096         203 PIRWMAWECILMGKFTTASDV  223 (304)
T ss_pred             CccccCHHHHhcCCCCchhhh
Confidence            778999999988899999996

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.96  E-value=5.5e-29  Score=179.85  Aligned_cols=155  Identities=24%  Similarity=0.304  Sum_probs=125.6

Q ss_pred             CCCcEEEEEEccccc---cccHHHHHHHH-HHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccC
Q 046065            4 PDGQIIAVKKLSKKS---TQGFEEFKNEV-MLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILD   78 (164)
Q Consensus         4 ~~~~~vavK~~~~~~---~~~~~~~~~e~-~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~   78 (164)
                      .+++.||+|.+....   ......+..|. .+++.++||||+++ ..+...+..++||||+++++|...+....   .++
T Consensus        18 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~   94 (321)
T cd05603          18 SDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRER---CFL   94 (321)
T ss_pred             CCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcC---CCC
Confidence            467899999986441   22233445555 46788899999998 66667778999999999999987775432   278


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh--hhhhhhcccccccCcceecCC
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK--MILKQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~~aPE~~~~~  156 (164)
                      +.....++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....  .......|++.|+|||++.+.
T Consensus        95 ~~~~~~~~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  171 (321)
T cd05603          95 EPRARFYAAEVASAIGYLHSL---NIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKE  171 (321)
T ss_pred             HHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCCcccCCHHHhcCC
Confidence            888889999999999999998   999999999999999999999999999865321  222446789999999999888


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .++.++||
T Consensus       172 ~~~~~~Di  179 (321)
T cd05603         172 PYDRTVDW  179 (321)
T ss_pred             CCCCcCcc
Confidence            99999996

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.96  E-value=5.9e-29  Score=179.98  Aligned_cols=155  Identities=23%  Similarity=0.281  Sum_probs=125.6

Q ss_pred             CCCcEEEEEEccccc---cccHHHHHHHH-HHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccC
Q 046065            4 PDGQIIAVKKLSKKS---TQGFEEFKNEV-MLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILD   78 (164)
Q Consensus         4 ~~~~~vavK~~~~~~---~~~~~~~~~e~-~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~   78 (164)
                      .+++.||+|.+....   ......+..|. .+++.++||||+++ ..+...+..++||||+++++|.+.+.....   +.
T Consensus        18 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~   94 (325)
T cd05602          18 AEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERC---FL   94 (325)
T ss_pred             CCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHhcCC---CC
Confidence            467889999986542   22223444444 45678899999998 666777789999999999999988865332   77


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh--hhhhhhcccccccCcceecCC
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK--MILKQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~~aPE~~~~~  156 (164)
                      +.....++.|++.||.|+|+.   +++||||||+||+++.++.++|+|||++.....  .......|++.|+|||++.+.
T Consensus        95 ~~~~~~~~~qi~~~L~~lH~~---giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~  171 (325)
T cd05602          95 EPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQ  171 (325)
T ss_pred             HHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCCccccCHHHHcCC
Confidence            888888999999999999998   999999999999999999999999999865422  223456799999999999999


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .++.++||
T Consensus       172 ~~~~~~Di  179 (325)
T cd05602         172 PYDRTVDW  179 (325)
T ss_pred             CCCCcccc
Confidence            99999996

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.96  E-value=4.7e-29  Score=183.43  Aligned_cols=154  Identities=22%  Similarity=0.230  Sum_probs=127.1

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+++.+|+|.+...   .......+.+|..+++.++||||+++ ..+......++||||+++++|.+++...    .++.
T Consensus        66 ~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~----~~~~  141 (371)
T cd05622          66 STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY----DVPE  141 (371)
T ss_pred             CCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc----CCCH
Confidence            46789999998643   22234557789999999999999998 6666677789999999999999988653    2788


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh---hhhhcccccccCcceecCC
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI---LKQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~aPE~~~~~  156 (164)
                      .....++.|++.||.|+|++   +|+||||||+||+++.++.++|+|||++.......   .....||+.|+|||++.+.
T Consensus       142 ~~~~~~~~qi~~aL~~LH~~---~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~  218 (371)
T cd05622         142 KWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQ  218 (371)
T ss_pred             HHHHHHHHHHHHHHHHHHHC---CEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhcc
Confidence            88899999999999999998   99999999999999999999999999987654321   2356799999999999654


Q ss_pred             ----cceeccCC
Q 046065          157 ----VYYKKFSL  164 (164)
Q Consensus       157 ----~~~~~~Di  164 (164)
                          .++.++||
T Consensus       219 ~~~~~~~~~~Di  230 (371)
T cd05622         219 GGDGYYGRECDW  230 (371)
T ss_pred             CCCccCCCccce
Confidence                37888986

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.96  E-value=6.2e-29  Score=179.80  Aligned_cols=154  Identities=23%  Similarity=0.330  Sum_probs=126.5

Q ss_pred             CCCcEEEEEEccccc---cccHHHHHHHHHHH---hccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccc
Q 046065            4 PDGQIIAVKKLSKKS---TQGFEEFKNEVMLT---AKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLI   76 (164)
Q Consensus         4 ~~~~~vavK~~~~~~---~~~~~~~~~e~~~l---~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~   76 (164)
                      .+++.||+|.+....   ......+..|..++   +.++||||+++ +.+...+..++||||+++++|...+...    .
T Consensus        22 ~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~----~   97 (324)
T cd05589          22 KTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTD----V   97 (324)
T ss_pred             CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhhcC----C
Confidence            468899999986442   23345566676654   56679999998 6667778899999999999998777542    2


Q ss_pred             cCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh--hhhhhhcccccccCcceec
Q 046065           77 LDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK--MILKQIQIELGYIPPEYVG  154 (164)
Q Consensus        77 ~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~~aPE~~~  154 (164)
                      +++.....++.|++.|+.|+|+.   +++|+||||+||+++.++.++|+|||++.....  .......|++.|+|||.+.
T Consensus        98 l~~~~~~~~~~qi~~al~~lH~~---~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~  174 (324)
T cd05589          98 FSEPRAVFYAACVVLGLQYLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLT  174 (324)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhC---CeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCcccccccCccccCHhHhc
Confidence            88999999999999999999998   999999999999999999999999998864322  2224567899999999999


Q ss_pred             CCcceeccCC
Q 046065          155 RGVYYKKFSL  164 (164)
Q Consensus       155 ~~~~~~~~Di  164 (164)
                      +..++.++||
T Consensus       175 ~~~~~~~~Di  184 (324)
T cd05589         175 ETSYTRAVDW  184 (324)
T ss_pred             CCCCCcccch
Confidence            8899999996

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.8e-29  Score=185.43  Aligned_cols=151  Identities=28%  Similarity=0.451  Sum_probs=129.0

Q ss_pred             EEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHHH
Q 046065            9 IAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVH   84 (164)
Q Consensus         9 vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~   84 (164)
                      ||+|.....   ...+...+..|+++++.++||||+++ +.+....-+++|||+|++|+|.++++....  .++......
T Consensus       189 VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~--~v~~~ek~~  266 (474)
T KOG0194|consen  189 VAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKK--SLPTLEKLR  266 (474)
T ss_pred             eEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCC--CCCHHHHHH
Confidence            899998753   34566789999999999999999997 877788889999999999999999987443  388999999


Q ss_pred             HHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh-h-hhcccccccCcceecCCcceecc
Q 046065           85 IIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL-K-QIQIELGYIPPEYVGRGVYYKKF  162 (164)
Q Consensus        85 ~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~-~-~~~~~~~~~aPE~~~~~~~~~~~  162 (164)
                      ++.+.+.||+|||+.   .++||||..+|+|++..+.+||+|||+++.-..... . ...-...|+|||.+..+.|++++
T Consensus       267 ~~~~AA~Gl~YLh~k---~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kT  343 (474)
T KOG0194|consen  267 FCYDAARGLEYLHSK---NCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKT  343 (474)
T ss_pred             HHHHHHhHHHHHHHC---CCcchhHhHHHheecCCCeEEeCccccccCCcceeeccccccCcceecChhhhccCcccccc
Confidence            999999999999998   999999999999999999999999999865431111 1 12345689999999999999999


Q ss_pred             CC
Q 046065          163 SL  164 (164)
Q Consensus       163 Di  164 (164)
                      ||
T Consensus       344 DV  345 (474)
T KOG0194|consen  344 DV  345 (474)
T ss_pred             ch
Confidence            97

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=3.4e-29  Score=183.70  Aligned_cols=152  Identities=24%  Similarity=0.289  Sum_probs=130.4

Q ss_pred             CCcEEEEEEccccc--cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            5 DGQIIAVKKLSKKS--TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         5 ~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      +|+.||||++.+.+  ......+..|+++|+.++||||+++ ......-.+|||+|.=.+|+|.+++-.+..  .+.+..
T Consensus        42 TGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~--Gl~E~L  119 (864)
T KOG4717|consen   42 TGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEE--GLNEDL  119 (864)
T ss_pred             ccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhhc--cccHHH
Confidence            68999999998663  3344678899999999999999998 555555679999999999999999876433  288999


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecC-CCCeEEccccchhhhhh-hhhhhhcccccccCcceecCCcce
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE-DLKPKISDFGLARILRK-MILKQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~-~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      ..+++.||+.|+.|+|..   .++|||+||+|+.+.+ -|.+||.|||++-.+.. ......||+.+|-|||++.+..|+
T Consensus       120 a~kYF~QI~~AI~YCHqL---HVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYD  196 (864)
T KOG4717|consen  120 AKKYFAQIVHAISYCHQL---HVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYD  196 (864)
T ss_pred             HHHHHHHHHHHHHHHhhh---hhhcccCCcceeEEeeecCceEeeeccccccCCCcchhhcccchhhccCchhhhcCccC
Confidence            999999999999999998   8999999999999876 58999999999976654 456889999999999999999996


Q ss_pred             ec
Q 046065          160 KK  161 (164)
Q Consensus       160 ~~  161 (164)
                      ..
T Consensus       197 AP  198 (864)
T KOG4717|consen  197 AP  198 (864)
T ss_pred             Cc
Confidence            54

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.96  E-value=6.1e-29  Score=179.33  Aligned_cols=155  Identities=25%  Similarity=0.300  Sum_probs=128.2

Q ss_pred             CCCcEEEEEEccccc---cccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccC
Q 046065            4 PDGQIIAVKKLSKKS---TQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILD   78 (164)
Q Consensus         4 ~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~   78 (164)
                      .+|+.||+|.+....   .........|..++... +||||+++ ..+...+..++||||+++++|...+.....   ++
T Consensus        18 ~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~~---~~   94 (316)
T cd05620          18 GKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGR---FD   94 (316)
T ss_pred             CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHHcCC---CC
Confidence            467899999986541   23345566777777655 89999997 666777889999999999999888765432   78


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhh--hhhhhhhcccccccCcceecCC
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILR--KMILKQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~--~~~~~~~~~~~~~~aPE~~~~~  156 (164)
                      ......++.|++.||.|+|++   +++||||||+||+++.++.++|+|||++....  ........|++.|+|||++.+.
T Consensus        95 ~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  171 (316)
T cd05620          95 LYRATFYAAEIVCGLQFLHSK---GIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGL  171 (316)
T ss_pred             HHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCCcCccCHHHHcCC
Confidence            889999999999999999998   99999999999999999999999999886432  2233456789999999999989


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .++.++||
T Consensus       172 ~~~~~~Di  179 (316)
T cd05620         172 KYTFSVDW  179 (316)
T ss_pred             CCCcccch
Confidence            99999996

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>PHA02988 hypothetical protein; Provisional

Probab=99.96  E-value=1.4e-28  Score=175.03  Aligned_cols=154  Identities=21%  Similarity=0.279  Sum_probs=126.2

Q ss_pred             CCcEEEEEEcccccccc---HHHHHHHHHHHhccCCCceeeE-eEEee----CCcEEEEEEecCCCChhhhhhCcccccc
Q 046065            5 DGQIIAVKKLSKKSTQG---FEEFKNEVMLTAKLQHLNLIRV-GFCIE----TQEYMLIYEYMPKRSLDYFLFDPIRMLI   76 (164)
Q Consensus         5 ~~~~vavK~~~~~~~~~---~~~~~~e~~~l~~l~h~~i~~~-~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~   76 (164)
                      +|+.||+|.+.......   .+.+.+|+.+++.++||||+++ +.+..    ....++||||+++|+|.+++.+...   
T Consensus        42 ~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~---  118 (283)
T PHA02988         42 NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKD---  118 (283)
T ss_pred             CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhCCC---
Confidence            57899999987543222   4667799999999999999997 65554    2457899999999999999876433   


Q ss_pred             cCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCcceecC-
Q 046065           77 LDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGR-  155 (164)
Q Consensus        77 ~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~-  155 (164)
                      ++......++.+++.|+.++|+.  .+++||||||+||+++.++.+||+|||++....... ....++..|+|||++.+ 
T Consensus       119 ~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~y~aPE~~~~~  195 (283)
T PHA02988        119 LSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-FKNVNFMVYFSYKMLNDI  195 (283)
T ss_pred             CChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-ccccCcccccCHHHhhhc
Confidence            77888899999999999999973  167899999999999999999999999987543321 23467889999999966 


Q ss_pred             -CcceeccCC
Q 046065          156 -GVYYKKFSL  164 (164)
Q Consensus       156 -~~~~~~~Di  164 (164)
                       ..++.++||
T Consensus       196 ~~~~~~k~Di  205 (283)
T PHA02988        196 FSEYTIKDDI  205 (283)
T ss_pred             cccccchhhh
Confidence             688999996

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.96  E-value=5.8e-29  Score=180.81  Aligned_cols=157  Identities=27%  Similarity=0.396  Sum_probs=124.5

Q ss_pred             CCcEEEEEEccccc-cccHHHHHHHHHHHhcc-CCCceeeE-eEEeeC-CcEEEEEEecCCCChhhhhhCccc-------
Q 046065            5 DGQIIAVKKLSKKS-TQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIET-QEYMLIYEYMPKRSLDYFLFDPIR-------   73 (164)
Q Consensus         5 ~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~-------   73 (164)
                      +++.||+|.+.... ......+..|+.++..+ +||||+++ +.+... +.++++|||+++|+|.+++.....       
T Consensus        36 ~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~  115 (338)
T cd05102          36 SCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYRE  115 (338)
T ss_pred             cchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccc
Confidence            45689999986442 23345688999999999 89999997 555543 457899999999999888864211       


Q ss_pred             ----------------------------------------------------ccccCHHHHHHHHHHHHHHHHHhhhcCC
Q 046065           74 ----------------------------------------------------MLILDCKKRVHIIKGIIQGLLYLQEYFR  101 (164)
Q Consensus        74 ----------------------------------------------------~~~~~~~~~~~~~~~~~~~l~~lh~~~~  101 (164)
                                                                          ...+.......++.|++.||.|+|+.  
T Consensus       116 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~--  193 (338)
T cd05102         116 KSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASR--  193 (338)
T ss_pred             cchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHC--
Confidence                                                                01256677788999999999999998  


Q ss_pred             CCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh----hhhcccccccCcceecCCcceeccCC
Q 046065          102 LTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL----KQIQIELGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       102 ~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~Di  164 (164)
                       +++||||||+||+++.++.++|+|||+++.......    ....+++.|+|||++.+..++.++||
T Consensus       194 -~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi  259 (338)
T cd05102         194 -KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDV  259 (338)
T ss_pred             -CEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCH
Confidence             999999999999999999999999999976532211    22345678999999988999999996

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.96  E-value=7.5e-29  Score=178.85  Aligned_cols=155  Identities=25%  Similarity=0.304  Sum_probs=127.6

Q ss_pred             CCCcEEEEEEccccc---cccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccC
Q 046065            4 PDGQIIAVKKLSKKS---TQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILD   78 (164)
Q Consensus         4 ~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~   78 (164)
                      .+++.||+|.+..+.   .........|..++... +||||+++ ..+...+..++||||+++|+|..++.....   ++
T Consensus        18 ~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~---~~   94 (316)
T cd05619          18 GTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHK---FD   94 (316)
T ss_pred             CCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCC---CC
Confidence            457899999987541   23344566777777764 89999997 666777788999999999999988865332   78


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhh--hhhhhhhcccccccCcceecCC
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILR--KMILKQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~--~~~~~~~~~~~~~~aPE~~~~~  156 (164)
                      ......++.|++.|+.|+|+.   +++|+||||+||+++.++.++|+|||++....  ........|++.|+|||++.+.
T Consensus        95 ~~~~~~~~~qi~~al~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  171 (316)
T cd05619          95 LPRATFYAAEIICGLQFLHSK---GIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQ  171 (316)
T ss_pred             HHHHHHHHHHHHHHHHHHHhC---CeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCCccccCHHHHcCC
Confidence            888999999999999999998   99999999999999999999999999986432  2223456789999999999888


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .++.++||
T Consensus       172 ~~~~~~Dv  179 (316)
T cd05619         172 KYNTSVDW  179 (316)
T ss_pred             CCCchhhh
Confidence            89999996

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.96  E-value=6.1e-29  Score=182.77  Aligned_cols=156  Identities=23%  Similarity=0.380  Sum_probs=130.8

Q ss_pred             CCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            4 PDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         4 ~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      .+|+.||||.+++-  .+.+...+..|+.+|..+.||.|+.+ ..++..+..++|||-+. |+...++-+. ....+++.
T Consensus       587 ktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-GDMLEMILSs-EkgRL~er  664 (888)
T KOG4236|consen  587 KTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-GDMLEMILSS-EKGRLPER  664 (888)
T ss_pred             ccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-chHHHHHHHh-hcccchHH
Confidence            57899999999865  44555778899999999999999999 66677788999999884 4555555432 22339999


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCC---CCeEEccccchhhhhhhhh-hhhcccccccCcceecCC
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED---LKPKISDFGLARILRKMIL-KQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~---~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~aPE~~~~~  156 (164)
                      ..+.++.||+.||+|||..   +|+|+|+||+|+|+...   ..+||+|||+|+.+..... ++.+|||+|+|||++.+.
T Consensus       665 ~TkFlvtQIL~ALr~LH~k---nIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVLrnk  741 (888)
T KOG4236|consen  665 ITKFLVTQILVALRYLHFK---NIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNK  741 (888)
T ss_pred             HHHHHHHHHHHHHHHhhhc---ceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcCCccccCHHHHhhc
Confidence            9999999999999999998   99999999999999754   4699999999999976555 678999999999999988


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      -|+..-||
T Consensus       742 GyNrSLDM  749 (888)
T KOG4236|consen  742 GYNRSLDM  749 (888)
T ss_pred             cccccccc
Confidence            88877664

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.96  E-value=8.6e-29  Score=179.41  Aligned_cols=156  Identities=22%  Similarity=0.264  Sum_probs=129.1

Q ss_pred             CCCcEEEEEEccccc---cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKKS---TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+++.||+|.+....   ......+..|+.+++.++||||+++ ..+......++||||+++++|.+++.....  .+++
T Consensus        24 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~l~~  101 (330)
T cd05601          24 ATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYED--QFDE  101 (330)
T ss_pred             CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHhcC--CCCH
Confidence            468899999987542   2234567789999999999999998 666667788999999999999999875422  3888


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh---hhhhcccccccCcceec--
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI---LKQIQIELGYIPPEYVG--  154 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~aPE~~~--  154 (164)
                      .....++.|++.||.|+|+.   +++|+||||+||+++.++.++|+|||++..+....   .....|++.|+|||++.  
T Consensus       102 ~~~~~~~~qi~~aL~~lH~~---~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  178 (330)
T cd05601         102 DMAQFYLAELVLAIHSVHQM---GYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTM  178 (330)
T ss_pred             HHHHHHHHHHHHHHHHHHHC---CeEcccCchHheEECCCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccc
Confidence            99999999999999999998   99999999999999999999999999997654322   13356899999999986  


Q ss_pred             ----CCcceeccCC
Q 046065          155 ----RGVYYKKFSL  164 (164)
Q Consensus       155 ----~~~~~~~~Di  164 (164)
                          +..++.++||
T Consensus       179 ~~~~~~~~~~~~Di  192 (330)
T cd05601         179 NGDGKGTYGVECDW  192 (330)
T ss_pred             cccccCCCCCccee
Confidence                4567888886

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.96  E-value=8.1e-30  Score=183.87  Aligned_cols=157  Identities=27%  Similarity=0.342  Sum_probs=134.6

Q ss_pred             cCCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeEeEEe-eCCcEEEEEEecCCCChhhhhhCcccccccC
Q 046065            3 LPDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRVGFCI-ETQEYMLIYEYMPKRSLDYFLFDPIRMLILD   78 (164)
Q Consensus         3 ~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~   78 (164)
                      ..+|+.+|.|.+.+.   ........+.|-.+|.++..+.|+.+.+.+ ..+.+++|+..+.||+|...+.+.++. .++
T Consensus       207 raTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~-gF~  285 (591)
T KOG0986|consen  207 RATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNP-GFD  285 (591)
T ss_pred             ecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCC-CCc
Confidence            456788888887654   222334567899999999999999996555 567899999999999998888775542 399


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh-hhhcccccccCcceecCCc
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL-KQIQIELGYIPPEYVGRGV  157 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~aPE~~~~~~  157 (164)
                      +.....++.+|+.||.+||..   +|+.||+||+|||+|.+|.++|+|+|+|..+..... .+.+||.+|||||++.++.
T Consensus       286 e~ra~FYAAEi~cGLehlH~~---~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~  362 (591)
T KOG0986|consen  286 EQRARFYAAEIICGLEHLHRR---RIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEV  362 (591)
T ss_pred             hHHHHHHHHHHHhhHHHHHhc---ceeeccCChhheeeccCCCeEeeccceEEecCCCCccccccCcccccCHHHHcCCc
Confidence            999999999999999999999   999999999999999999999999999988876544 6669999999999999999


Q ss_pred             ceeccC
Q 046065          158 YYKKFS  163 (164)
Q Consensus       158 ~~~~~D  163 (164)
                      |+...|
T Consensus       363 Y~~s~D  368 (591)
T KOG0986|consen  363 YDFSPD  368 (591)
T ss_pred             ccCCcc
Confidence            998887

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.96  E-value=1.4e-28  Score=177.99  Aligned_cols=155  Identities=24%  Similarity=0.291  Sum_probs=126.9

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCC-ceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccC
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHL-NLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILD   78 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~-~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~   78 (164)
                      .+++.||+|.+...   .....+.+..|..++..++|+ +++.+ ..+...+..|+||||+++++|...+.....   ++
T Consensus        23 ~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~---~~   99 (324)
T cd05587          23 GTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGK---FK   99 (324)
T ss_pred             CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCC---CC
Confidence            35778999998654   233445678899999999765 56777 555666789999999999999888865432   78


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhh--hhhhhhhcccccccCcceecCC
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILR--KMILKQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~--~~~~~~~~~~~~~~aPE~~~~~  156 (164)
                      +.....++.|++.||.|+|+.   +++|+||||+||+++.++.++|+|||++....  ........|++.|+|||++.+.
T Consensus       100 ~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  176 (324)
T cd05587         100 EPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQ  176 (324)
T ss_pred             HHHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCceeeecCCccccChhhhcCC
Confidence            889999999999999999998   99999999999999999999999999986432  2223456789999999999988


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .++.++||
T Consensus       177 ~~~~~~Di  184 (324)
T cd05587         177 PYGKSVDW  184 (324)
T ss_pred             CCCcccch
Confidence            99999996

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.96  E-value=1.4e-28  Score=178.46  Aligned_cols=155  Identities=22%  Similarity=0.259  Sum_probs=127.1

Q ss_pred             CCCcEEEEEEcccc----ccccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccccccc
Q 046065            4 PDGQIIAVKKLSKK----STQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLIL   77 (164)
Q Consensus         4 ~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~   77 (164)
                      .+++.||+|.+...    .......+..|+.+++.+ +|++|+++ ..+...+..++||||+++++|.+.+.....   +
T Consensus        26 ~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---~  102 (332)
T cd05614          26 DTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDN---F  102 (332)
T ss_pred             CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHHcCC---C
Confidence            46789999998643    122345677899999999 58999998 556666778899999999999888865433   8


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh---hhhhhcccccccCcceec
Q 046065           78 DCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM---ILKQIQIELGYIPPEYVG  154 (164)
Q Consensus        78 ~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~~aPE~~~  154 (164)
                      ++.....++.|++.||.|+|+.   +++||||||+||+++.++.++|+|||++......   ......||+.|+|||++.
T Consensus       103 ~~~~~~~~~~qi~~~l~~lH~~---~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  179 (332)
T cd05614         103 SEDEVRFYSGEIILALEHLHKL---GIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIR  179 (332)
T ss_pred             CHHHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHeEECCCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhc
Confidence            8899999999999999999998   9999999999999999999999999998754321   223467899999999997


Q ss_pred             CC-cceeccCC
Q 046065          155 RG-VYYKKFSL  164 (164)
Q Consensus       155 ~~-~~~~~~Di  164 (164)
                      +. .++.++||
T Consensus       180 ~~~~~~~~~Di  190 (332)
T cd05614         180 GKGGHGKAVDW  190 (332)
T ss_pred             CCCCCCCcccc
Confidence            65 47888986

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=1.9e-28  Score=174.32  Aligned_cols=157  Identities=27%  Similarity=0.303  Sum_probs=129.6

Q ss_pred             CCCcEEEEEEccccc---cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKKS---TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+++.||+|.+....   ......+.+|+.+++.++||||+++ ..+...+..++||||+++++|...+..... ..+++
T Consensus        23 ~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~  101 (285)
T cd05605          23 ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGN-PGFDE  101 (285)
T ss_pred             CCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCc-CCCCH
Confidence            467899999986542   2223456789999999999999998 666666789999999999999887754322 23889


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh-hhhhhcccccccCcceecCCcc
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM-ILKQIQIELGYIPPEYVGRGVY  158 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~  158 (164)
                      .....++.|++.|+.|+|+.   +++|+||||+||+++.++.++|+|||++...... ......|++.|+|||++.+..+
T Consensus       102 ~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  178 (285)
T cd05605         102 ERAVFYAAEITCGLEDLHRE---RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERY  178 (285)
T ss_pred             HHHHHHHHHHHHHHHHHHHC---CcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCccccccCCCCccCcHHhcCCCC
Confidence            99999999999999999998   9999999999999999999999999998765332 2244578999999999988889


Q ss_pred             eeccCC
Q 046065          159 YKKFSL  164 (164)
Q Consensus       159 ~~~~Di  164 (164)
                      +.++||
T Consensus       179 ~~~~Di  184 (285)
T cd05605         179 TFSPDW  184 (285)
T ss_pred             Cccccc
Confidence            999996

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.96  E-value=1.7e-28  Score=177.41  Aligned_cols=155  Identities=25%  Similarity=0.299  Sum_probs=126.7

Q ss_pred             CCCcEEEEEEccccc---cccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccC
Q 046065            4 PDGQIIAVKKLSKKS---TQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILD   78 (164)
Q Consensus         4 ~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~   78 (164)
                      .+++.||+|.+....   ......+..|..++..+ +|++++.+ ..+...+..++||||+++|+|...+.....   ++
T Consensus        23 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~---~~   99 (323)
T cd05616          23 GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGR---FK   99 (323)
T ss_pred             CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHHcCC---CC
Confidence            457899999987542   22334566777877777 57888887 556666788999999999999888765332   78


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhh--hhhhhhhcccccccCcceecCC
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILR--KMILKQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~--~~~~~~~~~~~~~~aPE~~~~~  156 (164)
                      +..+..++.|++.||.|+|+.   +++|+||||+||+++.++.++|+|||++....  ........|++.|+|||++.+.
T Consensus       100 ~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  176 (323)
T cd05616         100 EPHAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQ  176 (323)
T ss_pred             HHHHHHHHHHHHHHHHHHHHC---CEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCccccCCCChhhcCHHHhcCC
Confidence            889999999999999999998   99999999999999999999999999986543  2223456789999999999999


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .++.++||
T Consensus       177 ~~~~~~Di  184 (323)
T cd05616         177 PYGKSVDW  184 (323)
T ss_pred             CCCCccch
Confidence            99999996

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.96  E-value=1.3e-28  Score=175.14  Aligned_cols=155  Identities=23%  Similarity=0.322  Sum_probs=128.3

Q ss_pred             CCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            4 PDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         4 ~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      .+++.||+|.+...  .......+.+|+.+++.++||||+++ ..+...+..++||||++++.+..+....   ..+++.
T Consensus        24 ~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~---~~~~~~  100 (287)
T cd07848          24 ETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMP---NGVPPE  100 (287)
T ss_pred             CCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHhcC---CCCCHH
Confidence            46788999998644  23345667889999999999999998 6777778899999999987776554332   237888


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh---hhhhhcccccccCcceecCCc
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM---ILKQIQIELGYIPPEYVGRGV  157 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~  157 (164)
                      .+..++.|++.|+.|+|+.   +++|+||||+||+++.++.++|+|||++......   ......+++.|+|||++.+..
T Consensus       101 ~~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  177 (287)
T cd07848         101 KVRSYIYQLIKAIHWCHKN---DIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAP  177 (287)
T ss_pred             HHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccCcccccccccccccccccccccCCcHHHcCCC
Confidence            9999999999999999988   9999999999999999999999999998765432   123456899999999998888


Q ss_pred             ceeccCC
Q 046065          158 YYKKFSL  164 (164)
Q Consensus       158 ~~~~~Di  164 (164)
                      ++.++||
T Consensus       178 ~~~~~Di  184 (287)
T cd07848         178 YGKAVDM  184 (287)
T ss_pred             CCCchhH
Confidence            9999996

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.96  E-value=1.3e-28  Score=178.05  Aligned_cols=155  Identities=24%  Similarity=0.305  Sum_probs=127.0

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhccC-CCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccC
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQ-HLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILD   78 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~   78 (164)
                      .+++.||+|.+...   .......+..|..++..+. |++++.+ ..+...+..++||||+++++|.+.+.....   ++
T Consensus        23 ~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~---l~   99 (323)
T cd05615          23 GTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGK---FK   99 (323)
T ss_pred             CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHHcCC---CC
Confidence            46889999998754   2233455677888888886 5677777 555666778999999999999888865433   88


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh--hhhhhhcccccccCcceecCC
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK--MILKQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~~aPE~~~~~  156 (164)
                      +.....++.|++.|+.|+|++   +++|+||||+||+++.++.++|+|||++.....  .......|++.|+|||++.+.
T Consensus       100 ~~~~~~i~~qi~~al~~lH~~---~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  176 (323)
T cd05615         100 EPQAVFYAAEISVGLFFLHRR---GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQ  176 (323)
T ss_pred             HHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEeccccccccCCCCccccCccCCccccCHHHHcCC
Confidence            899999999999999999998   999999999999999999999999999865432  123456789999999999988


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .++.++||
T Consensus       177 ~~~~~~Di  184 (323)
T cd05615         177 PYGKSVDW  184 (323)
T ss_pred             CCCCccch
Confidence            99999996

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.96  E-value=3.1e-28  Score=172.59  Aligned_cols=157  Identities=25%  Similarity=0.332  Sum_probs=128.3

Q ss_pred             CCCcEEEEEEccccc---cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKKS---TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+|+.||+|.+..+.   ......+..|+.+++.++||||+++ ..+......++||||+++++|..++..... ..++.
T Consensus        16 ~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~-~~~~~   94 (277)
T cd05607          16 NTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGE-RGLEM   94 (277)
T ss_pred             cCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccc-cCCCH
Confidence            468899999986431   1123345679999999999999998 666667788999999999999887754322 22778


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh-hhhhcccccccCcceecCCcc
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI-LKQIQIELGYIPPEYVGRGVY  158 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~  158 (164)
                      .....++.|++.|+.|+|+.   +++|+||||+||+++.++.++|+|||++....... .....+++.|+|||++.+..+
T Consensus        95 ~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  171 (277)
T cd05607          95 ERVIHYSAQITCGILHLHSM---DIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPY  171 (277)
T ss_pred             HHHHHHHHHHHHHHHHHHHC---CEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCCccCHHHHccCCC
Confidence            88889999999999999998   99999999999999999999999999987654322 234568899999999988889


Q ss_pred             eeccCC
Q 046065          159 YKKFSL  164 (164)
Q Consensus       159 ~~~~Di  164 (164)
                      +.++||
T Consensus       172 ~~~~Dv  177 (277)
T cd05607         172 SYPVDW  177 (277)
T ss_pred             CCchhH
Confidence            999996

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=1.5e-28  Score=178.36  Aligned_cols=156  Identities=20%  Similarity=0.197  Sum_probs=127.4

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+++.||+|.+.+.   .....+.+..|..++..++|+||+++ ..+...+..++||||+++++|.+++.+..  ..+++
T Consensus        24 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~  101 (331)
T cd05597          24 NTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFE--DRLPE  101 (331)
T ss_pred             CCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHhc--CCCCH
Confidence            46789999998643   22234557789999999999999998 66666778999999999999999886522  22788


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh---hhhhcccccccCcceecC-
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI---LKQIQIELGYIPPEYVGR-  155 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~aPE~~~~-  155 (164)
                      .....++.|++.||.|+|++   +++|+||||+||+++.++.++|+|||++..+....   .....|++.|+|||++.. 
T Consensus       102 ~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  178 (331)
T cd05597         102 DMARFYLAEMVLAIDSVHQL---GYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAM  178 (331)
T ss_pred             HHHHHHHHHHHHHHHHHHhC---CeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhc
Confidence            89999999999999999998   99999999999999999999999999986553321   123568999999999863 


Q ss_pred             ----CcceeccCC
Q 046065          156 ----GVYYKKFSL  164 (164)
Q Consensus       156 ----~~~~~~~Di  164 (164)
                          ..++.++||
T Consensus       179 ~~~~~~~~~~~Di  191 (331)
T cd05597         179 EDGKGRYGPECDW  191 (331)
T ss_pred             cccccCCCCccee
Confidence                457888886

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.96  E-value=1.6e-28  Score=177.25  Aligned_cols=155  Identities=25%  Similarity=0.308  Sum_probs=128.9

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccC
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILD   78 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~   78 (164)
                      .+++.||+|.+...   .......+..|..++..+ +||||+++ +.+...+..++||||+++++|...+....   .++
T Consensus        18 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~l~   94 (318)
T cd05570          18 GTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSG---RFD   94 (318)
T ss_pred             CCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcC---CCC
Confidence            35788999998754   223345567788888877 69999998 66677778999999999999988876543   288


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhh--hhhhhhhcccccccCcceecCC
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILR--KMILKQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~--~~~~~~~~~~~~~~aPE~~~~~  156 (164)
                      +.....++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++....  .......+|++.|+|||++.+.
T Consensus        95 ~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~  171 (318)
T cd05570          95 EPRARFYAAEIVLGLQFLHER---GIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQ  171 (318)
T ss_pred             HHHHHHHHHHHHHHHHHHHhC---CeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecCccccCHHHhcCC
Confidence            999999999999999999998   99999999999999999999999999886432  2223445789999999999999


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .++.++||
T Consensus       172 ~~~~~~Di  179 (318)
T cd05570         172 PYGPAVDW  179 (318)
T ss_pred             CCCcchhh
Confidence            99999996

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.96  E-value=1.8e-28  Score=174.76  Aligned_cols=155  Identities=24%  Similarity=0.376  Sum_probs=125.3

Q ss_pred             CCCcEEEEEEccccc-cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            4 PDGQIIAVKKLSKKS-TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         4 ~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      .+++.||+|.+.... ......+.+|+.+++.++||||+++ +.+......++|+|++++ +|.+++.....  .++...
T Consensus        28 ~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~--~~~~~~  104 (288)
T cd07871          28 LTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCGN--LMSMHN  104 (288)
T ss_pred             CCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-CHHHHHHhcCC--CCCHHH
Confidence            467899999986542 2334567889999999999999998 666666778899999975 88887754322  267888


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh--hhhhhcccccccCcceecC-Ccc
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM--ILKQIQIELGYIPPEYVGR-GVY  158 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~~-~~~  158 (164)
                      ...++.|++.||.|+|++   +++|+||||+||+++.++.++|+|||++......  ......+++.|+|||++.+ ..+
T Consensus       105 ~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  181 (288)
T cd07871         105 VKIFMFQLLRGLSYCHKR---KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEY  181 (288)
T ss_pred             HHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccccCceecccccChHHhcCCccc
Confidence            899999999999999998   9999999999999999999999999998654321  2234567899999999865 467


Q ss_pred             eeccCC
Q 046065          159 YKKFSL  164 (164)
Q Consensus       159 ~~~~Di  164 (164)
                      +.++||
T Consensus       182 ~~~~Di  187 (288)
T cd07871         182 STPIDM  187 (288)
T ss_pred             CcHHHH
Confidence            888885

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.96  E-value=3e-29  Score=188.63  Aligned_cols=159  Identities=30%  Similarity=0.392  Sum_probs=135.9

Q ss_pred             cCCCcEEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeEeEEeeCC-------cEEEEEEecCCCChhhhhhCcccc
Q 046065            3 LPDGQIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQ-------EYMLIYEYMPKRSLDYFLFDPIRM   74 (164)
Q Consensus         3 ~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-------~~~lv~e~~~~~~L~~~~~~~~~~   74 (164)
                      .++|+.||||..++. .....+.+.+|++++++++|+|||++....+..       ...++||||++|+|...+.++.+.
T Consensus        35 ketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~  114 (732)
T KOG4250|consen   35 KETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENA  114 (732)
T ss_pred             cccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccc
Confidence            578999999998764 455667889999999999999999985554433       356999999999999999998888


Q ss_pred             cccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCC--CC--eEEccccchhhhhhh-hhhhhcccccccC
Q 046065           75 LILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED--LK--PKISDFGLARILRKM-ILKQIQIELGYIP  149 (164)
Q Consensus        75 ~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~--~~--~~l~dfg~~~~~~~~-~~~~~~~~~~~~a  149 (164)
                      ..+++..++.+...++.||.|||.+   +|+||||||.||++...  |+  -||+|||.|+.+.++ ...+.+||..|++
T Consensus       115 ~GLpE~e~l~lL~d~~~al~~LrEn---~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s~~~S~vGT~~YLh  191 (732)
T KOG4250|consen  115 YGLPESEFLDLLSDLVSALRHLREN---GIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNSLFTSLVGTEEYLH  191 (732)
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHHHc---CceeccCCCCcEEEeecCCCceEEeeecccccccCCCCCeeeeecCchhhcC
Confidence            8899999999999999999999988   99999999999999643  43  599999999988654 4588999999999


Q ss_pred             cceecC-CcceeccCC
Q 046065          150 PEYVGR-GVYYKKFSL  164 (164)
Q Consensus       150 PE~~~~-~~~~~~~Di  164 (164)
                      ||+..+ +.|+.-.|.
T Consensus       192 Pel~E~q~~y~~tVDL  207 (732)
T KOG4250|consen  192 PELYERQKKYTATVDL  207 (732)
T ss_pred             hHHHhhccCcCceeeh
Confidence            999985 777776663

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.96  E-value=2.5e-28  Score=177.26  Aligned_cols=154  Identities=24%  Similarity=0.402  Sum_probs=124.0

Q ss_pred             CCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEeeC-----CcEEEEEEecCCCChhhhhhCccccc
Q 046065            4 PDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIET-----QEYMLIYEYMPKRSLDYFLFDPIRML   75 (164)
Q Consensus         4 ~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~   75 (164)
                      .+++.||+|.+...  .......+.+|+.+++.++||||+++ +.+...     ...++|||+++ ++|.+++.....  
T Consensus        23 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--   99 (338)
T cd07859          23 HTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQVIKANDD--   99 (338)
T ss_pred             CCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecCC-CCHHHHHHhccc--
Confidence            46889999998643  22334568899999999999999997 444322     24789999995 688888765433  


Q ss_pred             ccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh-----hhhhhcccccccCc
Q 046065           76 ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM-----ILKQIQIELGYIPP  150 (164)
Q Consensus        76 ~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~~~~aP  150 (164)
                       +++.....++.|++.||.|||++   +++|+||||+||+++.++.++|+|||++......     ......+++.|+||
T Consensus       100 -~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aP  175 (338)
T cd07859         100 -LTPEHHQFFLYQLLRALKYIHTA---NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAP  175 (338)
T ss_pred             -CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCCCcCCH
Confidence             78899999999999999999998   9999999999999999999999999998754321     11345789999999


Q ss_pred             ceecC--CcceeccCC
Q 046065          151 EYVGR--GVYYKKFSL  164 (164)
Q Consensus       151 E~~~~--~~~~~~~Di  164 (164)
                      |++.+  ..++.++||
T Consensus       176 E~~~~~~~~~~~~~Dv  191 (338)
T cd07859         176 ELCGSFFSKYTPAIDI  191 (338)
T ss_pred             HHHhccccccCchhHH
Confidence            99865  678889986

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.96  E-value=2.7e-28  Score=176.94  Aligned_cols=156  Identities=19%  Similarity=0.181  Sum_probs=127.2

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+++.||+|.+...   .......+..|..++..++|++|+.+ ..+...+..|+||||+++|+|.+++....  ..+++
T Consensus        24 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~--~~l~~  101 (331)
T cd05624          24 HTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFE--DRLPE  101 (331)
T ss_pred             CCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhc--CCCCH
Confidence            46788999998643   22233456788999999999999998 66666778899999999999999986532  23788


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh---hhhhcccccccCcceecC-
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI---LKQIQIELGYIPPEYVGR-  155 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~aPE~~~~-  155 (164)
                      .....++.|++.||.|+|+.   +++||||||+||+++.++.++|+|||++.......   .....|++.|+|||++.+ 
T Consensus       102 ~~~~~~~~qi~~~L~~lH~~---~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  178 (331)
T cd05624         102 DMARFYIAEMVLAIHSIHQL---HYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAM  178 (331)
T ss_pred             HHHHHHHHHHHHHHHHHHHC---CeeeccCchHHEEEcCCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhcc
Confidence            88999999999999999998   99999999999999999999999999986554321   123568999999999865 


Q ss_pred             ----CcceeccCC
Q 046065          156 ----GVYYKKFSL  164 (164)
Q Consensus       156 ----~~~~~~~Di  164 (164)
                          ..++.++||
T Consensus       179 ~~~~~~~~~~~Di  191 (331)
T cd05624         179 EDGMGKYGPECDW  191 (331)
T ss_pred             ccCCCCCCCcccE
Confidence                467888886

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=2.7e-28  Score=176.82  Aligned_cols=155  Identities=24%  Similarity=0.286  Sum_probs=122.9

Q ss_pred             CCCcEEEEEEccccc---cccHHHHHHHHHHHhcc---CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccc
Q 046065            4 PDGQIIAVKKLSKKS---TQGFEEFKNEVMLTAKL---QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLI   76 (164)
Q Consensus         4 ~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l---~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~   76 (164)
                      .+++.||+|.+....   .........|..++...   +||||+.+ ..+......++||||+++++|...+.....   
T Consensus        16 ~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~---   92 (330)
T cd05586          16 DTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGR---   92 (330)
T ss_pred             CCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHhcCC---
Confidence            468899999986542   12223344555555544   69999998 566667789999999999999888765332   


Q ss_pred             cCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh--hhhhhhcccccccCcceec
Q 046065           77 LDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK--MILKQIQIELGYIPPEYVG  154 (164)
Q Consensus        77 ~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~~aPE~~~  154 (164)
                      +++..+..++.|++.|+.|||+.   +++||||||+||+++.++.++|+|||++.....  ......+|++.|+|||++.
T Consensus        93 ~~~~~~~~~~~qil~al~~LH~~---~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~  169 (330)
T cd05586          93 FSEDRAKFYIAELVLALEHLHKY---DIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLL  169 (330)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCCccccCHHHHc
Confidence            88999999999999999999998   999999999999999999999999999865322  2234567899999999986


Q ss_pred             CC-cceeccCC
Q 046065          155 RG-VYYKKFSL  164 (164)
Q Consensus       155 ~~-~~~~~~Di  164 (164)
                      +. .++.++||
T Consensus       170 ~~~~~~~~~Dv  180 (330)
T cd05586         170 DEKGYTKHVDF  180 (330)
T ss_pred             CCCCCCCccce
Confidence            54 47899996

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.96  E-value=1.1e-28  Score=188.91  Aligned_cols=157  Identities=24%  Similarity=0.292  Sum_probs=129.4

Q ss_pred             CcEEEEEEccccccccHHHHHHHHHHHhccC-CCceeeE-eEEee----C---CcEEEEEEecCCCChhhhhhCcccccc
Q 046065            6 GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQ-HLNLIRV-GFCIE----T---QEYMLIYEYMPKRSLDYFLFDPIRMLI   76 (164)
Q Consensus         6 ~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~-~~~~~----~---~~~~lv~e~~~~~~L~~~~~~~~~~~~   76 (164)
                      |..+|+|++........+.+.+|+.+|+.|. |+|||.+ +....    .   .+++|.||||.+|+|-+++....... 
T Consensus        62 ~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~-  140 (738)
T KOG1989|consen   62 GKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTR-  140 (738)
T ss_pred             CceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhcc-
Confidence            4899999988777778889999999999995 9999997 42221    1   24679999999999999998643322 


Q ss_pred             cCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh-----------hhhhcccc
Q 046065           77 LDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI-----------LKQIQIEL  145 (164)
Q Consensus        77 ~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~-----------~~~~~~~~  145 (164)
                      |.+..+++|+.++++|+.+||.. ..+|||||||.+|+|+..++..||+|||.++......           .-....|+
T Consensus       141 lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp  219 (738)
T KOG1989|consen  141 LTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTP  219 (738)
T ss_pred             CChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCc
Confidence            89999999999999999999998 7789999999999999999999999999986432110           01345789


Q ss_pred             cccCccee---cCCcceeccCC
Q 046065          146 GYIPPEYV---GRGVYYKKFSL  164 (164)
Q Consensus       146 ~~~aPE~~---~~~~~~~~~Di  164 (164)
                      .|+|||++   .+..+++|+||
T Consensus       220 ~YRsPEMIDlysg~pI~eKsDI  241 (738)
T KOG1989|consen  220 QYRSPEMIDLYSGLPIGEKSDI  241 (738)
T ss_pred             cccChHHHhhhcCCCCcchhHH
Confidence            99999999   56677999997

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.96  E-value=4.7e-29  Score=184.92  Aligned_cols=152  Identities=32%  Similarity=0.417  Sum_probs=129.9

Q ss_pred             EEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeEeEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHHHH
Q 046065            8 IIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHI   85 (164)
Q Consensus         8 ~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~   85 (164)
                      .||||.++..  .+.+.+.|..|+..+++-+|.||+-+..+..++.+.+|+.+|+|.+|+.++.....  .+.......+
T Consensus       416 dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~AIiTqwCeGsSLY~hlHv~et--kfdm~~~idI  493 (678)
T KOG0193|consen  416 DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPLAIITQWCEGSSLYTHLHVQET--KFDMNTTIDI  493 (678)
T ss_pred             ceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCceeeeehhccCchhhhhccchhh--hhhHHHHHHH
Confidence            7999999877  45578899999999999999999998444445555999999999999999876443  3788889999


Q ss_pred             HHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhh----hhhhhhhhcccccccCccee---cCCcc
Q 046065           86 IKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARIL----RKMILKQIQIELGYIPPEYV---GRGVY  158 (164)
Q Consensus        86 ~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~----~~~~~~~~~~~~~~~aPE~~---~~~~~  158 (164)
                      +.|+++|+.|||.+   +|||+|||..||++..+++|+|+|||++..-    ...+.....|+..|||||++   ....|
T Consensus       494 AqQiaqGM~YLHAK---~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPf  570 (678)
T KOG0193|consen  494 AQQIAQGMDYLHAK---NIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPF  570 (678)
T ss_pred             HHHHHHhhhhhhhh---hhhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCC
Confidence            99999999999998   9999999999999999999999999998643    23455677889999999999   34578


Q ss_pred             eeccCC
Q 046065          159 YKKFSL  164 (164)
Q Consensus       159 ~~~~Di  164 (164)
                      ++.|||
T Consensus       571 S~qSDV  576 (678)
T KOG0193|consen  571 SFQSDV  576 (678)
T ss_pred             Ccccch
Confidence            999986

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.96  E-value=4.8e-28  Score=175.71  Aligned_cols=156  Identities=19%  Similarity=0.198  Sum_probs=126.6

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+++.+|+|.+.+.   .......+..|..++..++|++|+++ ..+...+..++||||+++|+|.+++.+...  .+++
T Consensus        24 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~--~l~~  101 (332)
T cd05623          24 NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFED--RLPE  101 (332)
T ss_pred             CCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHhcC--CCCH
Confidence            35678999998643   22233457788999999999999998 666667788999999999999999865322  2788


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh---hhhhcccccccCcceec--
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI---LKQIQIELGYIPPEYVG--  154 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~aPE~~~--  154 (164)
                      .....++.|++.|+.|+|+.   +++||||||+||+++.++.++|+|||++..+....   .....||+.|+|||++.  
T Consensus       102 ~~~~~~~~qi~~al~~lH~~---~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  178 (332)
T cd05623         102 DMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM  178 (332)
T ss_pred             HHHHHHHHHHHHHHHHHHHC---CeEecCCCHHHEEECCCCCEEEeecchheecccCCcceecccccCccccCHHHHhcc
Confidence            88999999999999999998   99999999999999999999999999986543221   23457899999999985  


Q ss_pred             ---CCcceeccCC
Q 046065          155 ---RGVYYKKFSL  164 (164)
Q Consensus       155 ---~~~~~~~~Di  164 (164)
                         ...++.++||
T Consensus       179 ~~~~~~~~~~~Dv  191 (332)
T cd05623         179 EDGKGKYGPECDW  191 (332)
T ss_pred             ccCCCCCCCcCCE
Confidence               3467889986

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.96  E-value=3.5e-28  Score=179.80  Aligned_cols=148  Identities=20%  Similarity=0.246  Sum_probs=123.4

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      .+++.||+|...      ...+.+|+.+++.++||||+++ +.+......++|+|++. ++|..++.....   ++....
T Consensus       115 ~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~---l~~~~~  184 (391)
T PHA03212        115 KTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLYCYLAAKRN---IAICDI  184 (391)
T ss_pred             CCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHHHHHHhcCC---CCHHHH
Confidence            457788998753      2346789999999999999998 66666777889999985 678777755332   788899


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh---hhhhhhcccccccCcceecCCcce
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK---MILKQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~---~~~~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      ..++.|++.||.|+|+.   +|+||||||+||+++.++.++|+|||++.....   .......||+.|+|||++.+..++
T Consensus       185 ~~i~~qi~~aL~ylH~~---~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  261 (391)
T PHA03212        185 LAIERSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYG  261 (391)
T ss_pred             HHHHHHHHHHHHHHHhC---CcccCCCChHhEEEcCCCCEEEEeCCcccccccccccccccccCccCCCChhhhcCCCCC
Confidence            99999999999999998   999999999999999999999999999865322   223456799999999999988999


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      .++||
T Consensus       262 ~~~Di  266 (391)
T PHA03212        262 PAVDI  266 (391)
T ss_pred             cHHHH
Confidence            99986

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.96  E-value=7.4e-28  Score=173.06  Aligned_cols=156  Identities=24%  Similarity=0.296  Sum_probs=131.9

Q ss_pred             CCCcEEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            4 PDGQIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         4 ~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      .+++.+|+|.+... .+.....+..|+++++.++||||+++ +.+...+..++++||+++++|.+++....   .++...
T Consensus        24 ~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~~---~~~~~~  100 (308)
T cd06615          24 PSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPENI  100 (308)
T ss_pred             CCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhcC---CCCHHH
Confidence            45778999987654 23334567889999999999999997 77788888999999999999999986543   278899


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCcceecCCcceec
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKK  161 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~  161 (164)
                      ...++.|++.||.|+|+.  .+++|+|++|+||+++.++.++|+|||++............++..|+|||.+.+..++.+
T Consensus       101 ~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~  178 (308)
T cd06615         101 LGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYTVQ  178 (308)
T ss_pred             HHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCcccccccccccCCCCcCccChhHhcCCCCCcc
Confidence            999999999999999973  189999999999999999999999999987655444455678899999999988888998


Q ss_pred             cCC
Q 046065          162 FSL  164 (164)
Q Consensus       162 ~Di  164 (164)
                      +|+
T Consensus       179 ~Di  181 (308)
T cd06615         179 SDI  181 (308)
T ss_pred             chH
Confidence            885

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.95  E-value=3.2e-28  Score=181.68  Aligned_cols=155  Identities=24%  Similarity=0.330  Sum_probs=131.9

Q ss_pred             cCCCcEEEEEEccccccccHHHHHHHHHHHhccC-C-----CceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccccc
Q 046065            3 LPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQ-H-----LNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRML   75 (164)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-----~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~   75 (164)
                      ..+++.||||+++++ +........|+.+|..++ |     -|++++ +++...+.+|+|+|.+. .+|.+++++..-. 
T Consensus       208 ~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL~-~NLYellK~n~f~-  284 (586)
T KOG0667|consen  208 HKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELLS-TNLYELLKNNKFR-  284 (586)
T ss_pred             cCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhhh-hhHHHHHHhcCCC-
Confidence            357899999999655 445566688999999996 4     489997 77788899999999985 5999999875432 


Q ss_pred             ccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCC--CCeEEccccchhhhhhhhhhhhcccccccCccee
Q 046065           76 ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED--LKPKISDFGLARILRKMILKQIQIELGYIPPEYV  153 (164)
Q Consensus        76 ~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~--~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~  153 (164)
                      .++...+..++.|++.+|.+||..   +|||+||||+|||+...  ..+||+|||.++...+..+ ....|..|+|||++
T Consensus       285 Glsl~~ir~~~~Qil~~L~~L~~l---~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~vy-tYiQSRfYRAPEVI  360 (586)
T KOG0667|consen  285 GLSLPLVRKFAQQILTALLFLHEL---GIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRVY-TYIQSRFYRAPEVI  360 (586)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCChhheeeccCCcCceeEEecccccccCCcce-eeeeccccccchhh
Confidence            288999999999999999999988   99999999999999653  4699999999987665555 77789999999999


Q ss_pred             cCCcceeccCC
Q 046065          154 GRGVYYKKFSL  164 (164)
Q Consensus       154 ~~~~~~~~~Di  164 (164)
                      .+..|+.+.||
T Consensus       361 LGlpY~~~IDm  371 (586)
T KOG0667|consen  361 LGLPYDTAIDM  371 (586)
T ss_pred             ccCCCCCccce
Confidence            99999999997

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.95  E-value=4.2e-29  Score=173.77  Aligned_cols=157  Identities=25%  Similarity=0.322  Sum_probs=133.5

Q ss_pred             ccCCCcEEEEEEccccccccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            2 VLPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         2 ~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+.+|++||||++.++.-....+..+|+.++..+ +|+||+.+ .++++...+|||||-+.||+|.+.+.+...   +++
T Consensus        99 ~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~~~---F~E  175 (463)
T KOG0607|consen   99 SIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKRKH---FNE  175 (463)
T ss_pred             eeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHHHHHHHhhh---ccH
Confidence            3568899999999988777788999999999999 59999997 788888899999999999999988877554   889


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCC---CeEEccccchhhhhh--h-------hhhhhcccccc
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL---KPKISDFGLARILRK--M-------ILKQIQIELGY  147 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~---~~~l~dfg~~~~~~~--~-------~~~~~~~~~~~  147 (164)
                      ..+..++.+++.||.|||+.   +|-|||+||+|||.....   -+||+||.+++.++.  .       ....++|+..|
T Consensus       176 ~EAs~vvkdia~aLdFlH~k---gIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEf  252 (463)
T KOG0607|consen  176 REASRVVKDIASALDFLHTK---GIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEF  252 (463)
T ss_pred             HHHHHHHHHHHHHHHHHhhc---CcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhh
Confidence            99999999999999999999   999999999999996543   479999999876542  1       12457888999


Q ss_pred             cCccee-----cCCcceeccCC
Q 046065          148 IPPEYV-----GRGVYYKKFSL  164 (164)
Q Consensus       148 ~aPE~~-----~~~~~~~~~Di  164 (164)
                      ||||+.     ..-.|++++|+
T Consensus       253 MAPEVVd~fv~qA~~YDKrCDl  274 (463)
T KOG0607|consen  253 MAPEVVDVFVDQATFYDKRCDL  274 (463)
T ss_pred             cchhHHhhhccccccccccccH
Confidence            999987     34467888874

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.95  E-value=1.1e-27  Score=170.54  Aligned_cols=157  Identities=27%  Similarity=0.302  Sum_probs=129.7

Q ss_pred             CCCcEEEEEEccccc---cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKKS---TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+++.||+|.+....   ......+..|+.+++.++|++++.+ ..+...+..++|||++++++|.+.+..... ..+++
T Consensus        23 ~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~-~~l~~  101 (285)
T cd05630          23 ATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGE-AGFEE  101 (285)
T ss_pred             CCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhcc-cCCCH
Confidence            467899999986542   1223456789999999999999997 666777788999999999999888754222 23888


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh-hhhhhcccccccCcceecCCcc
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM-ILKQIQIELGYIPPEYVGRGVY  158 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~  158 (164)
                      .....++.|++.|+.|+|+.   +++|+||||+||+++.++.++|+|||++...... ......|++.|+|||++.+..+
T Consensus       102 ~~~~~~~~qi~~~l~~lH~~---~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~  178 (285)
T cd05630         102 GRAVFYAAEICCGLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERY  178 (285)
T ss_pred             HHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccccCCCCCccccChHHHcCCCC
Confidence            99999999999999999988   9999999999999999999999999998654322 2234578999999999998899


Q ss_pred             eeccCC
Q 046065          159 YKKFSL  164 (164)
Q Consensus       159 ~~~~Di  164 (164)
                      +.++||
T Consensus       179 ~~~~Di  184 (285)
T cd05630         179 TFSPDW  184 (285)
T ss_pred             CCcccc
Confidence            999996

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.95  E-value=6.2e-28  Score=176.48  Aligned_cols=151  Identities=25%  Similarity=0.388  Sum_probs=122.3

Q ss_pred             CCCcEEEEEEccccc-cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            4 PDGQIIAVKKLSKKS-TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         4 ~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      .+++.||+|.+.... ......+.+|+.+++.++|+||+++ +.+...+.+++|+||+++++|....       ...+..
T Consensus        97 ~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~-------~~~~~~  169 (353)
T PLN00034         97 PTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTH-------IADEQF  169 (353)
T ss_pred             CCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCcccccc-------cCCHHH
Confidence            468899999986542 3345678899999999999999997 7777778899999999999886432       145677


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh--hhhhhcccccccCcceecC----
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM--ILKQIQIELGYIPPEYVGR----  155 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~~----  155 (164)
                      ...++.|++.||.|||++   +++|+||||+||+++.++.++|+|||++..+...  ......|+..|+|||++..    
T Consensus       170 ~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  246 (353)
T PLN00034        170 LADVARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNH  246 (353)
T ss_pred             HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEcccccceecccccccccccccCccccCcccccccccc
Confidence            788999999999999998   9999999999999999999999999998765432  2244678999999998743    


Q ss_pred             -CcceeccCC
Q 046065          156 -GVYYKKFSL  164 (164)
Q Consensus       156 -~~~~~~~Di  164 (164)
                       ...+.++||
T Consensus       247 ~~~~~~~~Dv  256 (353)
T PLN00034        247 GAYDGYAGDI  256 (353)
T ss_pred             CcCCCcchhH
Confidence             223457775

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.95  E-value=6.1e-28  Score=173.07  Aligned_cols=155  Identities=23%  Similarity=0.345  Sum_probs=123.9

Q ss_pred             CCCcEEEEEEcccccc-ccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            4 PDGQIIAVKKLSKKST-QGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      .+++.||+|.+..... .....+.+|+.+++.++||||+++ +.+......++||||++ ++|.+.+....  ..++...
T Consensus        28 ~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~  104 (303)
T cd07869          28 VNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDLCQYMDKHP--GGLHPEN  104 (303)
T ss_pred             CCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCHHHHHHhCC--CCCCHHH
Confidence            3678999999865432 233456789999999999999998 66667778899999996 57776665432  2278888


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh--hhhhhhcccccccCcceecC-Ccc
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK--MILKQIQIELGYIPPEYVGR-GVY  158 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~~aPE~~~~-~~~  158 (164)
                      +..++.|++.||.|+|+.   +++|+||||+||+++.++.++|+|||++.....  .......+++.|+|||++.+ ..+
T Consensus       105 ~~~~~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  181 (303)
T cd07869         105 VKLFLFQLLRGLSYIHQR---YILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEY  181 (303)
T ss_pred             HHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCC
Confidence            899999999999999998   999999999999999999999999999864432  22244567899999999854 457


Q ss_pred             eeccCC
Q 046065          159 YKKFSL  164 (164)
Q Consensus       159 ~~~~Di  164 (164)
                      +.++||
T Consensus       182 ~~~~Di  187 (303)
T cd07869         182 STCLDM  187 (303)
T ss_pred             CcHHHH
Confidence            888885

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.95  E-value=1.7e-27  Score=168.93  Aligned_cols=151  Identities=25%  Similarity=0.325  Sum_probs=129.1

Q ss_pred             CCCcEEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            4 PDGQIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         4 ~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      .+++.||+|.+... .......+..|+.+++.++|||++++ +.+...+..++|+|++++++|....       .+++..
T Consensus        24 ~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~-------~~~~~~   96 (279)
T cd06619          24 LTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVYR-------KIPEHV   96 (279)
T ss_pred             CCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHhh-------cCCHHH
Confidence            46789999998654 23334568899999999999999997 7777788889999999999886542       267888


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCcceecCCcceec
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKK  161 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~  161 (164)
                      ...++.|++.|+.|+|+.   +++|+||||+||+++.++.++|+|||++............++..|+|||++.+..++.+
T Consensus        97 ~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  173 (279)
T cd06619          97 LGRIAVAVVKGLTYLWSL---KILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYGIH  173 (279)
T ss_pred             HHHHHHHHHHHHHHHHHC---CEeeCCCCHHHEEECCCCCEEEeeCCcceecccccccCCCCChhhcCceeecCCCCCCc
Confidence            889999999999999998   99999999999999999999999999987665444455678999999999998889999


Q ss_pred             cCC
Q 046065          162 FSL  164 (164)
Q Consensus       162 ~Di  164 (164)
                      +|+
T Consensus       174 ~Dv  176 (279)
T cd06619         174 SDV  176 (279)
T ss_pred             chH
Confidence            986

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.95  E-value=9.2e-28  Score=171.35  Aligned_cols=123  Identities=24%  Similarity=0.267  Sum_probs=108.2

Q ss_pred             CCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            5 DGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         5 ~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      ++..+|+|.+++.   ......+...|-++|.+++||.++++ ..+......|++||||+||+|..+.+.+.. ..+++.
T Consensus       101 t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~-~~fse~  179 (459)
T KOG0610|consen  101 TNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPG-KRFSES  179 (459)
T ss_pred             CCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCC-Cccchh
Confidence            4578999999876   34445678889999999999999998 777778888999999999999988876443 339999


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchh
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLAR  131 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~  131 (164)
                      .+..++.+++-||+|||.+   +|+.|||||+|||+.++|.+-|+||.++.
T Consensus       180 ~aRFYaAEvl~ALEYLHml---GivYRDLKPENILvredGHIMLsDFDLS~  227 (459)
T KOG0610|consen  180 AARFYAAEVLLALEYLHML---GIVYRDLKPENILVREDGHIMLSDFDLSL  227 (459)
T ss_pred             hHHHHHHHHHHHHHHHHhh---ceeeccCCcceeEEecCCcEEeeeccccc
Confidence            9999999999999999999   99999999999999999999999998753

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=3e-28  Score=191.76  Aligned_cols=154  Identities=30%  Similarity=0.506  Sum_probs=131.8

Q ss_pred             EEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcc----cccccCHHH
Q 046065            8 IIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPI----RMLILDCKK   81 (164)
Q Consensus         8 ~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~~   81 (164)
                      .||+|.+... +.+....|++|+.+|+.++||||+++ +.+......++++||+.+|+|..++++.+    ....+...+
T Consensus       724 ~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~d  803 (1025)
T KOG1095|consen  724 QVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRD  803 (1025)
T ss_pred             EEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHH
Confidence            5999998765 45567789999999999999999997 88888888999999999999999998752    123478889


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhh----cccccccCcceecCCc
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQI----QIELGYIPPEYVGRGV  157 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~----~~~~~~~aPE~~~~~~  157 (164)
                      .+.++.++++|+.||+++   ++|||||..+|+|++....+||+|||+|+.+-...+...    .-...|||||.+..+.
T Consensus       804 Ll~~a~dvA~G~~YLe~~---~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~i  880 (1025)
T KOG1095|consen  804 LLAFALDVAKGMNYLESK---HFVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGI  880 (1025)
T ss_pred             HHHHHHHHhhhhHHHHhC---CCcCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcc
Confidence            999999999999999998   999999999999999999999999999995533322111    2245799999999999


Q ss_pred             ceeccCC
Q 046065          158 YYKKFSL  164 (164)
Q Consensus       158 ~~~~~Di  164 (164)
                      |+.|+||
T Consensus       881 FtskSDv  887 (1025)
T KOG1095|consen  881 FTSKSDV  887 (1025)
T ss_pred             cccccch
Confidence            9999997

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.95  E-value=1e-27  Score=169.03  Aligned_cols=155  Identities=21%  Similarity=0.324  Sum_probs=127.1

Q ss_pred             CCcEEEEEEccccc-cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            5 DGQIIAVKKLSKKS-TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         5 ~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      .+..||+|.+.... ......+..|+..++.++|||++++ +.+...+..++||||+++++|.+++....  ..+++...
T Consensus        32 ~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~  109 (266)
T cd05064          32 RELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHE--GQLVAGQL  109 (266)
T ss_pred             ceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCC--CCCCHHHH
Confidence            35689999987552 2334568899999999999999998 77777788999999999999999886532  23788999


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh---hhhcccccccCcceecCCcce
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL---KQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      ..++.|++.|+.|+|+.   +++|+||||+||+++.++.++++|||.+........   ....++..|+|||.+.+..++
T Consensus       110 ~~~~~~i~~al~~lH~~---~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  186 (266)
T cd05064         110 MGMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFS  186 (266)
T ss_pred             HHHHHHHHHHHHHHHHC---CEeeccccHhhEEEcCCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhhCCcc
Confidence            99999999999999988   999999999999999999999999998754432211   123345689999999888999


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      .++||
T Consensus       187 ~~~Di  191 (266)
T cd05064         187 SASDV  191 (266)
T ss_pred             chhHH
Confidence            99986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.95  E-value=6e-28  Score=177.78  Aligned_cols=157  Identities=27%  Similarity=0.377  Sum_probs=126.3

Q ss_pred             CCcEEEEEEcccc-ccccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccc--------
Q 046065            5 DGQIIAVKKLSKK-STQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIR--------   73 (164)
Q Consensus         5 ~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------   73 (164)
                      +++.||+|.+... .......+.+|+.+++.+ +|+||+++ +.+...+..++||||+++|+|.+++.....        
T Consensus        67 ~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~  146 (374)
T cd05106          67 NVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMA  146 (374)
T ss_pred             ccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhcccccc
Confidence            3467999998654 233355688999999999 89999997 777777889999999999999888753210        


Q ss_pred             -----------------------------------------------------------ccccCHHHHHHHHHHHHHHHH
Q 046065           74 -----------------------------------------------------------MLILDCKKRVHIIKGIIQGLL   94 (164)
Q Consensus        74 -----------------------------------------------------------~~~~~~~~~~~~~~~~~~~l~   94 (164)
                                                                                 ...++......++.|++.||.
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~  226 (374)
T cd05106         147 LPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMD  226 (374)
T ss_pred             ccccccccccccccchhcccccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHH
Confidence                                                                       012566778899999999999


Q ss_pred             HhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh----hhhcccccccCcceecCCcceeccCC
Q 046065           95 YLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL----KQIQIELGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus        95 ~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~Di  164 (164)
                      |+|++   +++||||||+||+++.++.++|+|||++........    ....++..|+|||++.+..++.++||
T Consensus       227 yLH~~---giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv  297 (374)
T cd05106         227 FLASK---NCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDV  297 (374)
T ss_pred             HHHHC---CEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccH
Confidence            99998   999999999999999999999999999875532211    12234567999999988899999996

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.95  E-value=9.1e-28  Score=176.87  Aligned_cols=157  Identities=28%  Similarity=0.385  Sum_probs=127.1

Q ss_pred             CCcEEEEEEccccc-cccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccc--------
Q 046065            5 DGQIIAVKKLSKKS-TQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIR--------   73 (164)
Q Consensus         5 ~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------   73 (164)
                      ++..||+|.+.... ....+.+.+|+.++..+ +||||+++ +.+...+..++||||+++|+|.+++.....        
T Consensus        64 ~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~  143 (375)
T cd05104          64 AAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHE  143 (375)
T ss_pred             cceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhccccccccccc
Confidence            45689999986442 33446788999999999 89999998 777788889999999999999888854210        


Q ss_pred             ----------------------------------------------------------------ccccCHHHHHHHHHHH
Q 046065           74 ----------------------------------------------------------------MLILDCKKRVHIIKGI   89 (164)
Q Consensus        74 ----------------------------------------------------------------~~~~~~~~~~~~~~~~   89 (164)
                                                                                      ...+++.....++.|+
T Consensus       144 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi  223 (375)
T cd05104         144 DHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQV  223 (375)
T ss_pred             chhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHH
Confidence                                                                            0125677888999999


Q ss_pred             HHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh----hhhcccccccCcceecCCcceeccCC
Q 046065           90 IQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL----KQIQIELGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus        90 ~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~Di  164 (164)
                      +.||.|+|+.   +++|+||||+||+++.++.++|+|||++........    ....++..|+|||++.+..++.++||
T Consensus       224 ~~~l~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi  299 (375)
T cd05104         224 AKGMSFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDV  299 (375)
T ss_pred             HHHHHHHHHC---CeeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCH
Confidence            9999999998   999999999999999999999999999876543221    12334567999999998899999996

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.95  E-value=2e-27  Score=167.39  Aligned_cols=155  Identities=22%  Similarity=0.361  Sum_probs=129.8

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      .+++.||+|.+..........+.+|+.+++.++|||++++ +.+...+..++++|++++++|.+++....   .+++...
T Consensus        32 ~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~~  108 (267)
T cd06645          32 NTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG---PLSESQI  108 (267)
T ss_pred             CCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhcC---CCCHHHH
Confidence            4688999999875544445567889999999999999997 77777788999999999999999886543   2889999


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh--hhhhhcccccccCcceec---CCc
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM--ILKQIQIELGYIPPEYVG---RGV  157 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~---~~~  157 (164)
                      ..++.|++.++.|+|+.   +++|+|+||+||+++.++.++|+|||++......  ......|++.|+|||++.   ...
T Consensus       109 ~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  185 (267)
T cd06645         109 AYVSRETLQGLYYLHSK---GKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGG  185 (267)
T ss_pred             HHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECcceeeeEccCcccccccccCcccccChhhhccccCCC
Confidence            99999999999999998   9999999999999999999999999998655322  124457889999999974   455


Q ss_pred             ceeccCC
Q 046065          158 YYKKFSL  164 (164)
Q Consensus       158 ~~~~~Di  164 (164)
                      ++.++|+
T Consensus       186 ~~~~~Dv  192 (267)
T cd06645         186 YNQLCDI  192 (267)
T ss_pred             CCchhhh
Confidence            7888886

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.95  E-value=1.5e-27  Score=170.07  Aligned_cols=154  Identities=27%  Similarity=0.333  Sum_probs=131.3

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+++.+|+|.+...   .......+..|+.+++.++||||+++ +.+...+..+++||++++++|.+++....   .++.
T Consensus        24 ~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~---~l~~  100 (290)
T cd05580          24 GSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSG---RFPE  100 (290)
T ss_pred             CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHHcC---CCCH
Confidence            46789999998644   23345678889999999999999997 67777788999999999999998886543   3888


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCcceecCCcce
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      .....++.|++.||.++|+.   +++|+||+|+||+++.++.++|+|||++...... .....+++.|+|||.+.+..++
T Consensus       101 ~~~~~~~~qil~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~  176 (290)
T cd05580         101 PVARFYAAQVVLALEYLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-TYTLCGTPEYLAPEIILSKGYG  176 (290)
T ss_pred             HHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-CCCCCCCccccChhhhcCCCCC
Confidence            99999999999999999998   9999999999999999999999999998765443 3445688999999999888888


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      .++||
T Consensus       177 ~~~Di  181 (290)
T cd05580         177 KAVDW  181 (290)
T ss_pred             ccccH
Confidence            99986

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.95  E-value=2.3e-27  Score=168.78  Aligned_cols=157  Identities=24%  Similarity=0.300  Sum_probs=129.3

Q ss_pred             CCCcEEEEEEccccc---cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKKS---TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+++.+|+|.+....   ......+..|+.+++.++|+|++.+ ..+...+..++++|++++++|..++..... ..++.
T Consensus        23 ~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~  101 (285)
T cd05632          23 ATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGN-PGFEE  101 (285)
T ss_pred             CCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcC-CCCCH
Confidence            468899999986442   2223456789999999999999998 566667788999999999999887754322 23889


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh-hhhhhhcccccccCcceecCCcc
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK-MILKQIQIELGYIPPEYVGRGVY  158 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~  158 (164)
                      .....++.|++.|+.|+|+.   +++|+|+||+||+++.++.++|+|||++..... .......|+..|+|||.+.+..+
T Consensus       102 ~~~~~~~~ql~~~l~~lH~~---~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~  178 (285)
T cd05632         102 ERALFYAAEILCGLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRY  178 (285)
T ss_pred             HHHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccCCCCCcCccChHHhcCCCC
Confidence            99999999999999999998   999999999999999999999999998865432 22234578999999999988899


Q ss_pred             eeccCC
Q 046065          159 YKKFSL  164 (164)
Q Consensus       159 ~~~~Di  164 (164)
                      +.++|+
T Consensus       179 ~~~~Di  184 (285)
T cd05632         179 TLSPDY  184 (285)
T ss_pred             Ccccch
Confidence            999996

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.95  E-value=9.7e-29  Score=171.17  Aligned_cols=154  Identities=23%  Similarity=0.392  Sum_probs=136.7

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      ++|+.+|+|.+..+  .+.+.+..|+.++.++++++++++ +.++....+|+|||||..|++.++++...  +.+.++.+
T Consensus        56 EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R~--K~L~E~EI  131 (502)
T KOG0574|consen   56 ESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRARR--KPLSEQEI  131 (502)
T ss_pred             ccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHhc--CCccHHHH
Confidence            57899999998654  456889999999999999999997 88888999999999999999999997532  33889999


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh--hhhcccccccCcceecCCccee
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL--KQIQIELGYIPPEYVGRGVYYK  160 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~  160 (164)
                      ..+...-+++|.|||..   .=+|||||.-|||+..+|.+||+|||.+-.+.+.-.  ....|||.|||||++..--|+.
T Consensus       132 s~iL~~TLKGL~YLH~~---~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~~  208 (502)
T KOG0574|consen  132 SAVLRDTLKGLQYLHDL---KKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDT  208 (502)
T ss_pred             HHHHHHHHhHHHHHHHH---HHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCccccCcccccHHHHHHhccch
Confidence            99999999999999999   899999999999999999999999999977765332  5678999999999998888999


Q ss_pred             ccCC
Q 046065          161 KFSL  164 (164)
Q Consensus       161 ~~Di  164 (164)
                      ++||
T Consensus       209 ~ADI  212 (502)
T KOG0574|consen  209 KADI  212 (502)
T ss_pred             hhhH
Confidence            9986

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.95  E-value=3.9e-27  Score=165.28  Aligned_cols=155  Identities=23%  Similarity=0.322  Sum_probs=125.3

Q ss_pred             CCcEEEEEEccccc-cccHHHHHHHHHHHhccCCCceeeEeEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHH
Q 046065            5 DGQIIAVKKLSKKS-TQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRV   83 (164)
Q Consensus         5 ~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~   83 (164)
                      ++..||+|.+.... ....+.+..|+.+++.++||||+++..+......++|+|++++++|.+++....  ..+++....
T Consensus        21 ~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~   98 (257)
T cd05115          21 KQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGGPLNKFLSGKK--DEITVSNVV   98 (257)
T ss_pred             CceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCCCeEEEEEeCCCCCHHHHHHhCC--CCCCHHHHH
Confidence            45579999986553 333466889999999999999999844445667899999999999998886432  238889999


Q ss_pred             HHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh--h---hhhcccccccCcceecCCcc
Q 046065           84 HIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI--L---KQIQIELGYIPPEYVGRGVY  158 (164)
Q Consensus        84 ~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~--~---~~~~~~~~~~aPE~~~~~~~  158 (164)
                      .++.|++.|+.|+|+.   +++|+||||+||+++.++.++|+|||++.......  .   ....+++.|+|||.+....+
T Consensus        99 ~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  175 (257)
T cd05115          99 ELMHQVSMGMKYLEGK---NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKF  175 (257)
T ss_pred             HHHHHHHHHHHHHHhc---CeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCC
Confidence            9999999999999998   99999999999999999999999999987543211  1   11223568999999988888


Q ss_pred             eeccCC
Q 046065          159 YKKFSL  164 (164)
Q Consensus       159 ~~~~Di  164 (164)
                      +.++||
T Consensus       176 ~~~~Di  181 (257)
T cd05115         176 SSRSDV  181 (257)
T ss_pred             CchhhH
Confidence            999986

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.95  E-value=2e-27  Score=176.18  Aligned_cols=156  Identities=24%  Similarity=0.334  Sum_probs=126.4

Q ss_pred             CcEEEEEEcccc-ccccHHHHHHHHHHHhccC-CCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccc---------
Q 046065            6 GQIIAVKKLSKK-STQGFEEFKNEVMLTAKLQ-HLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIR---------   73 (164)
Q Consensus         6 ~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---------   73 (164)
                      +..||+|.+... .....+.+..|+.+++.+. ||||+++ +.+...+..++||||+++|+|.+++.....         
T Consensus        67 ~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~  146 (400)
T cd05105          67 VMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEK  146 (400)
T ss_pred             ceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhcccccc
Confidence            457999998644 2333467889999999996 9999998 777777889999999999999887753210         


Q ss_pred             --------------------------------------------------------------------------------
Q 046065           74 --------------------------------------------------------------------------------   73 (164)
Q Consensus        74 --------------------------------------------------------------------------------   73 (164)
                                                                                                      
T Consensus       147 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  226 (400)
T cd05105         147 PKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLL  226 (400)
T ss_pred             ccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHH
Confidence                                                                                            


Q ss_pred             ----ccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh----hhhhcccc
Q 046065           74 ----MLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI----LKQIQIEL  145 (164)
Q Consensus        74 ----~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~  145 (164)
                          ...++......++.|++.|+.|+|+.   +++|+||||+||+++.++.++|+|||++.......    .....+++
T Consensus       227 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~  303 (400)
T cd05105         227 SDDGSEGLTTLDLLSFTYQVARGMEFLASK---NCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPV  303 (400)
T ss_pred             HhcccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCc
Confidence                01266777788999999999999998   99999999999999999999999999987553221    12345677


Q ss_pred             cccCcceecCCcceeccCC
Q 046065          146 GYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       146 ~~~aPE~~~~~~~~~~~Di  164 (164)
                      .|+|||.+.+..++.++||
T Consensus       304 ~y~aPE~~~~~~~~~~~Di  322 (400)
T cd05105         304 KWMAPESIFDNLYTTLSDV  322 (400)
T ss_pred             ceEChhhhcCCCCCchhhH
Confidence            8999999988899999996

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.2e-29  Score=180.57  Aligned_cols=155  Identities=25%  Similarity=0.370  Sum_probs=136.0

Q ss_pred             CCCcEEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            4 PDGQIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         4 ~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      .+++.||+|++..+ .......+.+|+.++..++++||.++ +.+..+..+|++|||+.+|++.+.+..+..   +.+..
T Consensus        36 ~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~~~~---~~E~~  112 (467)
T KOG0201|consen   36 KTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKSGNI---LDEFE  112 (467)
T ss_pred             cccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhccCCC---Cccce
Confidence            46789999999877 34445678899999999999999996 888889999999999999999999876543   47777


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh--hhhcccccccCcceecCCcce
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL--KQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      +.-++++++.|+.|+|..   +.+|||||+.||++...|.+||.|||.+..+.....  ..++|||.|||||++....|+
T Consensus       113 i~~ilre~l~~l~ylH~~---~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~  189 (467)
T KOG0201|consen  113 IAVILREVLKGLDYLHSE---KKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYD  189 (467)
T ss_pred             eeeehHHHHHHhhhhhhc---ceecccccccceeEeccCcEEEEecceeeeeechhhccccccccccccchhhhcccccc
Confidence            788889999999999998   999999999999999999999999999877654332  568999999999999988999


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      .|+||
T Consensus       190 ~KADI  194 (467)
T KOG0201|consen  190 TKADI  194 (467)
T ss_pred             chhhh
Confidence            99997

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.95  E-value=1.3e-27  Score=181.30  Aligned_cols=159  Identities=19%  Similarity=0.255  Sum_probs=128.7

Q ss_pred             cCCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCC--------cEEEEEEecCCCChhhhhhCc
Q 046065            3 LPDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQ--------EYMLIYEYMPKRSLDYFLFDP   71 (164)
Q Consensus         3 ~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~--------~~~lv~e~~~~~~L~~~~~~~   71 (164)
                      ..+++.||+|.+...  .......+..|+.++..++|+|++++ ..+....        ..++||||+++|+|.+.+...
T Consensus        54 ~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~  133 (496)
T PTZ00283         54 VSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSR  133 (496)
T ss_pred             cCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHh
Confidence            357899999998654  23345567889999999999999997 3332211        257999999999999888653


Q ss_pred             c-cccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh----hhhhhccccc
Q 046065           72 I-RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM----ILKQIQIELG  146 (164)
Q Consensus        72 ~-~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~  146 (164)
                      . ....+++.....++.|++.||.|+|+.   +++||||||+||+++.++.++|+|||+++.+...    ......||+.
T Consensus       134 ~~~~~~l~e~~~~~i~~qll~aL~~lH~~---~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~  210 (496)
T PTZ00283        134 AKTNRTFREHEAGLLFIQVLLAVHHVHSK---HMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPY  210 (496)
T ss_pred             hccCCCCCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcc
Confidence            2 223488899999999999999999998   9999999999999999999999999998765421    2234678999


Q ss_pred             ccCcceecCCcceeccCC
Q 046065          147 YIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       147 ~~aPE~~~~~~~~~~~Di  164 (164)
                      |+|||++.+..++.++||
T Consensus       211 Y~aPE~~~~~~~s~k~DV  228 (496)
T PTZ00283        211 YVAPEIWRRKPYSKKADM  228 (496)
T ss_pred             eeCHHHhCCCCCCcHHHH
Confidence            999999999999999996

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=99.95  E-value=1.8e-28  Score=186.32  Aligned_cols=154  Identities=29%  Similarity=0.468  Sum_probs=132.0

Q ss_pred             CcEEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeEeEEeeCC-cEEEEEEecCCCChhhhhhCcccccccCHHHHH
Q 046065            6 GQIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQ-EYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRV   83 (164)
Q Consensus         6 ~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~   83 (164)
                      ...||||.++.- ...+...|+.|+.+|.+++||||+++.....+. -.++|+||+++|+|+.|+++..  ..+...++.
T Consensus       657 e~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~D--GqftviQLV  734 (996)
T KOG0196|consen  657 EITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQND--GQFTVIQLV  734 (996)
T ss_pred             ceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcC--CceEeehHH
Confidence            357999999755 556778899999999999999999996665555 5679999999999999998743  348888999


Q ss_pred             HHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh---hhh--cccccccCcceecCCcc
Q 046065           84 HIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL---KQI--QIELGYIPPEYVGRGVY  158 (164)
Q Consensus        84 ~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~--~~~~~~~aPE~~~~~~~  158 (164)
                      .+.+.|+.|+.||.++   +.+||||..+|||++.+..+|++|||+++.+.+...   ...  .-...|.|||.+.-+++
T Consensus       735 gMLrGIAsGMkYLsdm---~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKF  811 (996)
T KOG0196|consen  735 GMLRGIASGMKYLSDM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKF  811 (996)
T ss_pred             HHHHHHHHHhHHHhhc---CchhhhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhccc
Confidence            9999999999999999   999999999999999999999999999998865432   222  22457999999999999


Q ss_pred             eeccCC
Q 046065          159 YKKFSL  164 (164)
Q Consensus       159 ~~~~Di  164 (164)
                      |.+|||
T Consensus       812 TsASDV  817 (996)
T KOG0196|consen  812 TSASDV  817 (996)
T ss_pred             Cchhhc
Confidence            999997

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.95  E-value=3.3e-27  Score=168.86  Aligned_cols=154  Identities=23%  Similarity=0.364  Sum_probs=131.1

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      .+++.||+|.+..........+.+|+.+++.++|+|++++ +.+......++|+||+++++|.+++.+.    .++....
T Consensus        43 ~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~  118 (296)
T cd06654          43 ATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET----CMDEGQI  118 (296)
T ss_pred             CCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHhc----CCCHHHH
Confidence            4678999999876655556778899999999999999997 6777778899999999999999988643    2678888


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh--hhhhhcccccccCcceecCCccee
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM--ILKQIQIELGYIPPEYVGRGVYYK  160 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~  160 (164)
                      ..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++|+|||++......  ......+++.|+|||.+.+..++.
T Consensus       119 ~~i~~ql~~aL~~LH~~---gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  195 (296)
T cd06654         119 AAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP  195 (296)
T ss_pred             HHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEECccccchhccccccccCcccCCccccCHHHHcCCCCCc
Confidence            99999999999999998   9999999999999999999999999988754322  123456888999999998888899


Q ss_pred             ccCC
Q 046065          161 KFSL  164 (164)
Q Consensus       161 ~~Di  164 (164)
                      ++||
T Consensus       196 ~~Dv  199 (296)
T cd06654         196 KVDI  199 (296)
T ss_pred             cchH
Confidence            9985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.95  E-value=3.5e-27  Score=164.86  Aligned_cols=156  Identities=26%  Similarity=0.393  Sum_probs=127.3

Q ss_pred             CCCcEEEEEEccccc-cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            4 PDGQIIAVKKLSKKS-TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         4 ~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      .+++.+|+|.+.... ......+..|+.+++.++||||+++ +.+......++|+|++++++|.+++....  ..+++..
T Consensus        18 ~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~   95 (252)
T cd05084          18 ADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG--PRLKVKE   95 (252)
T ss_pred             cCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCC--CCCCHHH
Confidence            468889999875442 3334668899999999999999997 77777778899999999999999886432  2378888


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhh----hcccccccCcceecCCc
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQ----IQIELGYIPPEYVGRGV  157 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~----~~~~~~~~aPE~~~~~~  157 (164)
                      ...++.|++.||.|+|+.   +++|+|++|+||+++.++.++|+|||++..........    ...+..|+|||.+.++.
T Consensus        96 ~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  172 (252)
T cd05084          96 LIQMVENAAAGMEYLESK---HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGR  172 (252)
T ss_pred             HHHHHHHHHHHHHHHHhC---CccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCC
Confidence            999999999999999988   99999999999999999999999999987544322111    12245699999998888


Q ss_pred             ceeccCC
Q 046065          158 YYKKFSL  164 (164)
Q Consensus       158 ~~~~~Di  164 (164)
                      ++.++||
T Consensus       173 ~~~~~Dv  179 (252)
T cd05084         173 YSSESDV  179 (252)
T ss_pred             CChHHHH
Confidence            9999986

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.95  E-value=2.2e-27  Score=187.21  Aligned_cols=158  Identities=22%  Similarity=0.229  Sum_probs=128.3

Q ss_pred             CCCcEEEEEEccccc---cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccc------
Q 046065            4 PDGQIIAVKKLSKKS---TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIR------   73 (164)
Q Consensus         4 ~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~------   73 (164)
                      .+++.||+|.+....   +....++.+|+++++.++|||++++ +.+...+..+++||++++++|.+++.....      
T Consensus        25 ~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e  104 (932)
T PRK13184         25 VCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSK  104 (932)
T ss_pred             CCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccch
Confidence            457899999986542   2334678899999999999999997 777777889999999999999988764211      


Q ss_pred             --ccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh---------------
Q 046065           74 --MLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM---------------  136 (164)
Q Consensus        74 --~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~---------------  136 (164)
                        ....+......++.|++.||.|+|+.   +++||||||+||+++.++.++|+|||++......               
T Consensus       105 ~~~~~lsv~~iL~I~~QIa~AL~yLHs~---GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~  181 (932)
T PRK13184        105 ELAEKTSVGAFLSIFHKICATIEYVHSK---GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNIC  181 (932)
T ss_pred             hhhcccCHHHHHHHHHHHHHHHHHHHHC---CccccCCchheEEEcCCCCEEEEecCcceeccccccccccccccccccc
Confidence              11244567788999999999999998   9999999999999999999999999998755110               


Q ss_pred             -----hhhhhcccccccCcceecCCcceeccCC
Q 046065          137 -----ILKQIQIELGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       137 -----~~~~~~~~~~~~aPE~~~~~~~~~~~Di  164 (164)
                           ......||+.|+|||.+.+..++.++||
T Consensus       182 ~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDI  214 (932)
T PRK13184        182 YSSMTIPGKIVGTPDYMAPERLLGVPASESTDI  214 (932)
T ss_pred             ccccccCCCCCCCCCCCCHHHhcCCCCCcHhHH
Confidence                 0123468999999999998999999996

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.95  E-value=6.4e-27  Score=166.30  Aligned_cols=156  Identities=26%  Similarity=0.467  Sum_probs=128.1

Q ss_pred             CCCcEEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeE-eEEeeC--CcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIET--QEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+++.||+|.+... .......+.+|+.+++.++|||++++ +.+...  ...++|+||+++++|.+++.+...  .++.
T Consensus        31 ~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~--~~~~  108 (284)
T cd05079          31 NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKN--KINL  108 (284)
T ss_pred             CccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccC--CCCH
Confidence            45788999998644 33445678899999999999999997 555543  457899999999999998865322  3788


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh-----hhhhcccccccCcceec
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI-----LKQIQIELGYIPPEYVG  154 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~aPE~~~  154 (164)
                      .....++.|++.||.|+|+.   +++|+|+||+||+++.++.++|+|||++..+....     .....++..|+|||.+.
T Consensus       109 ~~~~~i~~~i~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~  185 (284)
T cd05079         109 KQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLI  185 (284)
T ss_pred             HHHHHHHHHHHHHHHHHHHC---CeeecccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhc
Confidence            89999999999999999998   99999999999999999999999999987654221     12344566799999998


Q ss_pred             CCcceeccCC
Q 046065          155 RGVYYKKFSL  164 (164)
Q Consensus       155 ~~~~~~~~Di  164 (164)
                      +..++.++||
T Consensus       186 ~~~~~~~~Di  195 (284)
T cd05079         186 QSKFYIASDV  195 (284)
T ss_pred             cCCCCccccc
Confidence            8889999996

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.95  E-value=5e-27  Score=164.18  Aligned_cols=157  Identities=25%  Similarity=0.316  Sum_probs=132.1

Q ss_pred             CCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            4 PDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         4 ~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      .+++.|++|.+...  .......+..|+.+++.++|||++++ +.+...+..++++|++++++|.+++.... ...++..
T Consensus        23 ~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~  101 (256)
T cd08529          23 ADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQR-GRPLPED  101 (256)
T ss_pred             CCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhc-CCCCCHH
Confidence            46789999987644  23445678889999999999999997 77777788999999999999999887632 2237888


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh--hhhhhcccccccCcceecCCcc
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM--ILKQIQIELGYIPPEYVGRGVY  158 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~  158 (164)
                      ....++.+++.|+.|+|+.   +++|+|++|+||+++.++.++|+|||++..+...  ......+++.|+|||+..+..+
T Consensus       102 ~~~~i~~~l~~al~~lH~~---~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  178 (256)
T cd08529         102 QVWRFFIQILLGLAHLHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPY  178 (256)
T ss_pred             HHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEeCCCCEEEcccccceeccCccchhhccccCccccCHHHhcCCCC
Confidence            8899999999999999988   9999999999999999999999999998765432  2234568889999999998889


Q ss_pred             eeccCC
Q 046065          159 YKKFSL  164 (164)
Q Consensus       159 ~~~~Di  164 (164)
                      +.++|+
T Consensus       179 ~~~~Di  184 (256)
T cd08529         179 NEKSDV  184 (256)
T ss_pred             CCccch
Confidence            999996

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.95  E-value=6.2e-27  Score=167.45  Aligned_cols=154  Identities=24%  Similarity=0.387  Sum_probs=131.7

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      .+++.||+|.+..........+..|+.+++.++|||++++ +.+......++|+|++++++|..++...    .+++...
T Consensus        42 ~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~l~~~~~  117 (296)
T cd06655          42 ATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTET----CMDEAQI  117 (296)
T ss_pred             CCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHhc----CCCHHHH
Confidence            5688999999876554456678899999999999999997 7777778899999999999999887643    2788999


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh--hhhhcccccccCcceecCCccee
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI--LKQIQIELGYIPPEYVGRGVYYK  160 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~  160 (164)
                      ..++.+++.++.++|+.   +++|+||+|+||+++.++.++|+|||++.......  .....+++.|+|||.+.+..++.
T Consensus       118 ~~i~~~l~~al~~LH~~---~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  194 (296)
T cd06655         118 AAVCRECLQALEFLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP  194 (296)
T ss_pred             HHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCCcCCCccccCcchhcCCCCCc
Confidence            99999999999999998   99999999999999999999999999887654322  23356788999999998888899


Q ss_pred             ccCC
Q 046065          161 KFSL  164 (164)
Q Consensus       161 ~~Di  164 (164)
                      ++|+
T Consensus       195 ~~Dv  198 (296)
T cd06655         195 KVDI  198 (296)
T ss_pred             hhhH
Confidence            9985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.95  E-value=3.7e-27  Score=166.92  Aligned_cols=157  Identities=24%  Similarity=0.383  Sum_probs=125.6

Q ss_pred             CCcEEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccc-------cc
Q 046065            5 DGQIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIR-------ML   75 (164)
Q Consensus         5 ~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------~~   75 (164)
                      +++.||+|.+... .......+.+|+.+++.++||||+++ +.+......++|+|++++++|.+++.+...       ..
T Consensus        35 ~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~  114 (277)
T cd05062          35 PETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQA  114 (277)
T ss_pred             ceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCcccccccccc
Confidence            3567999987543 22334568899999999999999997 666777788999999999999988865221       11


Q ss_pred             ccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh----hhhcccccccCcc
Q 046065           76 ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL----KQIQIELGYIPPE  151 (164)
Q Consensus        76 ~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~aPE  151 (164)
                      .++......++.|++.|+.|+|+.   +++|+|+||+||+++.++.++|+|||++........    ....+++.|+|||
T Consensus       115 ~~~~~~~~~~~~~l~~~l~~lH~~---~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  191 (277)
T cd05062         115 PPSLKKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE  191 (277)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChh
Confidence            245677888999999999999998   999999999999999999999999999865432211    1234467899999


Q ss_pred             eecCCcceeccCC
Q 046065          152 YVGRGVYYKKFSL  164 (164)
Q Consensus       152 ~~~~~~~~~~~Di  164 (164)
                      .+.+..++.++||
T Consensus       192 ~~~~~~~~~~~Di  204 (277)
T cd05062         192 SLKDGVFTTYSDV  204 (277)
T ss_pred             HhhcCCcCchhHH
Confidence            9988889999986

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.95  E-value=8.1e-27  Score=163.26  Aligned_cols=157  Identities=24%  Similarity=0.289  Sum_probs=130.7

Q ss_pred             CCCcEEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            4 PDGQIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         4 ~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      .+++.+|+|.+... .......+..|+.+++.++|+|++++ ..+...+..++++|++++++|.+++..... ..++...
T Consensus        23 ~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~-~~~~~~~  101 (255)
T cd08219          23 NSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRG-KLFPEDT  101 (255)
T ss_pred             CCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccC-CCCCHHH
Confidence            46788999987543 33445677889999999999999998 677777889999999999999888764322 2378889


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh--hhhhcccccccCcceecCCcce
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI--LKQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      ...++.|++.|+.++|++   +++|+|++|+||+++.++.++++|||.+.......  .....+++.|+|||+..+..++
T Consensus       102 ~~~~~~~i~~al~~lH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  178 (255)
T cd08219         102 ILQWFVQMCLGVQHIHEK---RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYN  178 (255)
T ss_pred             HHHHHHHHHHHHHHHhhC---CcccCCCCcceEEECCCCcEEEcccCcceeecccccccccccCCccccCHHHHccCCcC
Confidence            999999999999999998   99999999999999999999999999986554321  2345688899999999888899


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      .++|+
T Consensus       179 ~~~Dv  183 (255)
T cd08219         179 NKSDI  183 (255)
T ss_pred             chhhh
Confidence            99986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.95  E-value=5.2e-27  Score=166.68  Aligned_cols=156  Identities=28%  Similarity=0.487  Sum_probs=127.1

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEee--CCcEEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIE--TQEYMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      .+++.||+|.+..........+..|+.+++.++|||++++ +.+..  ....++|+||+++++|.+++.+...  .++..
T Consensus        31 ~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~l~~~  108 (284)
T cd05081          31 NTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRE--RLDHR  108 (284)
T ss_pred             CCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCc--CCCHH
Confidence            3578899999876555556778899999999999999997 54433  3468899999999999998865322  27888


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh-----hhhcccccccCcceecC
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL-----KQIQIELGYIPPEYVGR  155 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~aPE~~~~  155 (164)
                      ....++.|++.||.|+|+.   +++|+||||+||+++.++.++|+|||++........     ....++..|+|||...+
T Consensus       109 ~~~~~~~~l~~aL~~LH~~---~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  185 (284)
T cd05081         109 KLLLYASQICKGMEYLGSK---RYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTE  185 (284)
T ss_pred             HHHHHHHHHHHHHHHHHHC---CceeccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhcc
Confidence            9999999999999999998   999999999999999999999999999876543211     11223456999999988


Q ss_pred             CcceeccCC
Q 046065          156 GVYYKKFSL  164 (164)
Q Consensus       156 ~~~~~~~Di  164 (164)
                      ..++.++||
T Consensus       186 ~~~~~~~Di  194 (284)
T cd05081         186 SKFSVASDV  194 (284)
T ss_pred             CCcChHHHH
Confidence            889999986

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.95  E-value=6.1e-27  Score=166.99  Aligned_cols=157  Identities=27%  Similarity=0.460  Sum_probs=129.5

Q ss_pred             CCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcc-----------
Q 046065            5 DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPI-----------   72 (164)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-----------   72 (164)
                      ++..+++|.+..........+.+|+.+++.++|+||+++ +.+......++||||+++++|.+++....           
T Consensus        34 ~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~  113 (291)
T cd05094          34 DKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQP  113 (291)
T ss_pred             cceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCccccccccccc
Confidence            455688888765544445678899999999999999998 77777778899999999999999986532           


Q ss_pred             --cccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh----hhhhccccc
Q 046065           73 --RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI----LKQIQIELG  146 (164)
Q Consensus        73 --~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~  146 (164)
                        ....+++.....++.|++.|+.|+|++   +++|+||||+||+++.++.++|+|||++.......    .....++..
T Consensus       114 ~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~  190 (291)
T cd05094         114 RQAKGELGLSQMLHIASQIASGMVYLASQ---HFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIR  190 (291)
T ss_pred             ccCcCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCccee
Confidence              122378889999999999999999998   99999999999999999999999999986543221    123446778


Q ss_pred             ccCcceecCCcceeccCC
Q 046065          147 YIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       147 ~~aPE~~~~~~~~~~~Di  164 (164)
                      |+|||.+.+..++.++||
T Consensus       191 y~aPE~~~~~~~~~~~Di  208 (291)
T cd05094         191 WMPPESIMYRKFTTESDV  208 (291)
T ss_pred             ecChHHhccCCCCchhhH
Confidence            999999988899999996

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.95  E-value=4.1e-27  Score=169.73  Aligned_cols=152  Identities=23%  Similarity=0.323  Sum_probs=124.0

Q ss_pred             EEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeEeEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHHHHH
Q 046065            8 IIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHII   86 (164)
Q Consensus         8 ~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~   86 (164)
                      .||+|.+... .....+.+..|+.+++.++||||+++..+...+..++++|++++|+|.+++.+...  .++......++
T Consensus        38 ~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~~~~v~e~~~~g~l~~~l~~~~~--~~~~~~~~~~~  115 (316)
T cd05108          38 PVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKD--NIGSQYLLNWC  115 (316)
T ss_pred             eEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCCceeeeecCCCCCHHHHHHhccc--cCCHHHHHHHH
Confidence            4899998644 23445678899999999999999998434344567899999999999998876432  27788889999


Q ss_pred             HHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh----hhhcccccccCcceecCCcceecc
Q 046065           87 KGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL----KQIQIELGYIPPEYVGRGVYYKKF  162 (164)
Q Consensus        87 ~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~  162 (164)
                      .|++.||.|||+.   +++|+||||+||+++.++.++|+|||++........    ....++..|+|||.+.+..++.++
T Consensus       116 ~qi~~~L~~LH~~---~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~  192 (316)
T cd05108         116 VQIAKGMNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQS  192 (316)
T ss_pred             HHHHHHHHHHHhc---CeeccccchhheEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchh
Confidence            9999999999998   999999999999999999999999999976543211    223346679999999989999999


Q ss_pred             CC
Q 046065          163 SL  164 (164)
Q Consensus       163 Di  164 (164)
                      ||
T Consensus       193 Di  194 (316)
T cd05108         193 DV  194 (316)
T ss_pred             hh
Confidence            96

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.95  E-value=5.5e-27  Score=167.00  Aligned_cols=157  Identities=29%  Similarity=0.505  Sum_probs=129.6

Q ss_pred             CCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcc----------c
Q 046065            5 DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPI----------R   73 (164)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------~   73 (164)
                      ++..+|+|.+..........+..|+.+++.++|||++++ +.+...+..++++|++++++|.+++....          .
T Consensus        34 ~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~  113 (288)
T cd05093          34 DKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNR  113 (288)
T ss_pred             cceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCC
Confidence            345689998865555556678899999999999999998 77777788999999999999998886432          1


Q ss_pred             ccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh----hhhhcccccccC
Q 046065           74 MLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI----LKQIQIELGYIP  149 (164)
Q Consensus        74 ~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~a  149 (164)
                      ...+++.....++.|++.||.|+|+.   +++|+|+||+||+++.++.++|+|||++.......    .....+++.|+|
T Consensus       114 ~~~l~~~~~~~~~~ql~~aL~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~a  190 (288)
T cd05093         114 PAELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMP  190 (288)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccC
Confidence            12388899999999999999999998   99999999999999999999999999987553221    122345678999


Q ss_pred             cceecCCcceeccCC
Q 046065          150 PEYVGRGVYYKKFSL  164 (164)
Q Consensus       150 PE~~~~~~~~~~~Di  164 (164)
                      ||++.+..++.++||
T Consensus       191 PE~~~~~~~~~~sDi  205 (288)
T cd05093         191 PESIMYRKFTTESDV  205 (288)
T ss_pred             HHHhccCCCCchhhH
Confidence            999988889999996

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.95  E-value=8.2e-27  Score=165.62  Aligned_cols=154  Identities=29%  Similarity=0.444  Sum_probs=126.1

Q ss_pred             CCCcEEEEEEccccc-cccHHHHHHHHHHHhccCCCceeeE-eEEeeC--CcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKKS-TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIET--QEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+++.||+|.+.... ......+.+|+.+++.++|||++++ +.+...  ...+++||++++++|.+++...    .+++
T Consensus        31 ~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~----~l~~  106 (283)
T cd05080          31 GTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH----KLNL  106 (283)
T ss_pred             CCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHHc----CCCH
Confidence            467789999986542 2345667889999999999999997 554443  3578999999999999888653    2889


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh-----hhhcccccccCcceec
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL-----KQIQIELGYIPPEYVG  154 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~aPE~~~  154 (164)
                      .....++.|++.|+.|+|+.   +++|+||||+||+++.++.++|+|||++........     ....++..|+|||.+.
T Consensus       107 ~~~~~i~~~l~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~  183 (283)
T cd05080         107 AQLLLFAQQICEGMAYLHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLK  183 (283)
T ss_pred             HHHHHHHHHHHHHHHHHHHC---CeeccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhc
Confidence            99999999999999999998   999999999999999999999999999876543211     1233456799999998


Q ss_pred             CCcceeccCC
Q 046065          155 RGVYYKKFSL  164 (164)
Q Consensus       155 ~~~~~~~~Di  164 (164)
                      ...++.++||
T Consensus       184 ~~~~~~~~Di  193 (283)
T cd05080         184 ENKFSYASDV  193 (283)
T ss_pred             ccCCCccccc
Confidence            8889999996

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.95  E-value=5.7e-27  Score=169.73  Aligned_cols=157  Identities=18%  Similarity=0.284  Sum_probs=126.3

Q ss_pred             CCCcEEEEEEccccc--cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            4 PDGQIIAVKKLSKKS--TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         4 ~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      .+|+.||+|.+....  ......+..|+.+++.++||||+++ +.+...+..++|+||+++++|.+++..... ..++..
T Consensus        23 ~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~-~~l~~~  101 (327)
T cd08227          23 PTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFM-DGMSEL  101 (327)
T ss_pred             ccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhcc-CCCCHH
Confidence            578899999987542  2334567789999999999999997 777788889999999999999998865322 127888


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh---------hhhhhcccccccCcc
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM---------ILKQIQIELGYIPPE  151 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~---------~~~~~~~~~~~~aPE  151 (164)
                      .+..++.|++.||.|+|+.   +++|+||||+||+++.++.+++.||+........         ......++..|+|||
T Consensus       102 ~~~~i~~qi~~~L~~LH~~---~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE  178 (327)
T cd08227         102 AIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPE  178 (327)
T ss_pred             HHHHHHHHHHHHHHHHHHC---CEecCCCChhhEEEecCCcEEEcccchhhccccccccccccccccccccceecccChH
Confidence            9999999999999999998   9999999999999999999999999865433211         012234667899999


Q ss_pred             eecC--CcceeccCC
Q 046065          152 YVGR--GVYYKKFSL  164 (164)
Q Consensus       152 ~~~~--~~~~~~~Di  164 (164)
                      ++.+  ..++.++||
T Consensus       179 ~~~~~~~~~~~~~Di  193 (327)
T cd08227         179 VLQQNLQGYDAKSDI  193 (327)
T ss_pred             HhhcccCCCCchhhH
Confidence            9975  358899986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.95  E-value=2.6e-27  Score=169.47  Aligned_cols=154  Identities=26%  Similarity=0.396  Sum_probs=130.8

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      .+++.||+|.+..........+.+|+.+++.++|||++++ +.+...+..++++|++++++|..++...    .++....
T Consensus        44 ~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~----~~~~~~~  119 (297)
T cd06659          44 HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQT----RLNEEQI  119 (297)
T ss_pred             CCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhhc----CCCHHHH
Confidence            3678999999865544445667889999999999999997 7777788899999999999998877542    2788899


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh--hhhhhcccccccCcceecCCccee
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM--ILKQIQIELGYIPPEYVGRGVYYK  160 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~  160 (164)
                      ..++.|++.|+.++|+.   +++|+|++|+||+++.++.++|+|||++..+...  ......++..|+|||++.+..++.
T Consensus       120 ~~~~~qi~~~L~~LH~~---~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  196 (297)
T cd06659         120 ATVCESVLQALCYLHSQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGT  196 (297)
T ss_pred             HHHHHHHHHHHHHHHhC---CeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccceecCccccCHHHHccCCCCc
Confidence            99999999999999998   9999999999999999999999999998655432  224467889999999998888999


Q ss_pred             ccCC
Q 046065          161 KFSL  164 (164)
Q Consensus       161 ~~Di  164 (164)
                      ++||
T Consensus       197 ~~Dv  200 (297)
T cd06659         197 EVDI  200 (297)
T ss_pred             hhhH
Confidence            9986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.95  E-value=4.8e-27  Score=172.10  Aligned_cols=152  Identities=29%  Similarity=0.357  Sum_probs=122.0

Q ss_pred             CCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEeeC------CcEEEEEEecCCCChhhhhhCcccc
Q 046065            4 PDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIET------QEYMLIYEYMPKRSLDYFLFDPIRM   74 (164)
Q Consensus         4 ~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~   74 (164)
                      .+|+.||+|.+...  .......+.+|+.+++.++||||+++ +.+...      ...++|||++++ ++.+.+..    
T Consensus        44 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~----  118 (359)
T cd07876          44 VLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIHM----  118 (359)
T ss_pred             CCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCc-CHHHHHhc----
Confidence            46789999998643  23344567889999999999999997 444322      246899999975 55554432    


Q ss_pred             cccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh-hhhhhcccccccCccee
Q 046065           75 LILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM-ILKQIQIELGYIPPEYV  153 (164)
Q Consensus        75 ~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~  153 (164)
                       .++......++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++...... ......+++.|+|||++
T Consensus       119 -~~~~~~~~~~~~qi~~~L~~LH~~---~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~  194 (359)
T cd07876         119 -ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVI  194 (359)
T ss_pred             -cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEecCCCccccccCccCCCCcccCCCCCchhc
Confidence             167788889999999999999998   9999999999999999999999999998754332 22445788999999999


Q ss_pred             cCCcceeccCC
Q 046065          154 GRGVYYKKFSL  164 (164)
Q Consensus       154 ~~~~~~~~~Di  164 (164)
                      .+..++.++||
T Consensus       195 ~~~~~~~~~Di  205 (359)
T cd07876         195 LGMGYKENVDI  205 (359)
T ss_pred             cCCCCCcchhh
Confidence            99999999996

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.95  E-value=5.9e-27  Score=163.47  Aligned_cols=157  Identities=28%  Similarity=0.402  Sum_probs=128.0

Q ss_pred             cCCCcEEEEEEcccccc-ccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            3 LPDGQIIAVKKLSKKST-QGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         3 ~~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      ..+++.+|+|.+....+ .....+..|+.+++.++|||++++ +.+...+..++|||++++++|.+++.....  .++..
T Consensus        16 ~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~   93 (250)
T cd05085          16 LKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKD--ELKTK   93 (250)
T ss_pred             ecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcCC--CCCHH
Confidence            35678899999865532 234467889999999999999997 777777788999999999999988764322  26788


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh---hhhcccccccCcceecCCc
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL---KQIQIELGYIPPEYVGRGV  157 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~  157 (164)
                      ....++.+++.++.|+|+.   +++|+|++|+||+++.++.++|+|||++........   ....+++.|+|||++.+..
T Consensus        94 ~~~~~~~~i~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  170 (250)
T cd05085          94 QLVKFALDAAAGMAYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGR  170 (250)
T ss_pred             HHHHHHHHHHHHHHHHHhC---CeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcccccCHHHhccCC
Confidence            8899999999999999988   999999999999999999999999999865432221   1223456799999998888


Q ss_pred             ceeccCC
Q 046065          158 YYKKFSL  164 (164)
Q Consensus       158 ~~~~~Di  164 (164)
                      ++.++||
T Consensus       171 ~~~~~Di  177 (250)
T cd05085         171 YSSESDV  177 (250)
T ss_pred             CCchhHH
Confidence            9999986

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.95  E-value=7.4e-27  Score=164.35  Aligned_cols=151  Identities=19%  Similarity=0.307  Sum_probs=123.4

Q ss_pred             cEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHHHH
Q 046065            7 QIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHI   85 (164)
Q Consensus         7 ~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~   85 (164)
                      ..|++|.+..........+.+|+.+++.++||||+++ +.+......++++||+++++|..++.....  .+++.....+
T Consensus        33 ~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~--~~~~~~~~~i  110 (262)
T cd05077          33 IKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSD--VLTTPWKFKV  110 (262)
T ss_pred             eeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCC--CCCHHHHHHH
Confidence            3688998766555555678889999999999999997 777777788999999999999888764322  2788889999


Q ss_pred             HHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCC-------eEEccccchhhhhhhhhhhhcccccccCcceec-CCc
Q 046065           86 IKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK-------PKISDFGLARILRKMILKQIQIELGYIPPEYVG-RGV  157 (164)
Q Consensus        86 ~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~-------~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~-~~~  157 (164)
                      +.|++.|+.|+|+.   +++|+||||+||+++.++.       ++++|||++......  ....++..|+|||.+. +..
T Consensus       111 ~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~--~~~~~~~~y~aPE~~~~~~~  185 (262)
T cd05077         111 AKQLASALSYLEDK---DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR--QECVERIPWIAPECVEDSKN  185 (262)
T ss_pred             HHHHHHHHHHhhhC---CeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc--ccccccccccChhhhcCCCC
Confidence            99999999999998   9999999999999986654       899999988654321  2345778899999886 456


Q ss_pred             ceeccCC
Q 046065          158 YYKKFSL  164 (164)
Q Consensus       158 ~~~~~Di  164 (164)
                      ++.++||
T Consensus       186 ~~~~~Di  192 (262)
T cd05077         186 LSIAADK  192 (262)
T ss_pred             CCchhHH
Confidence            7888886

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.95  E-value=7.4e-27  Score=165.86  Aligned_cols=158  Identities=30%  Similarity=0.484  Sum_probs=127.5

Q ss_pred             CCCcEEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccc--------
Q 046065            4 PDGQIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIR--------   73 (164)
Q Consensus         4 ~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------   73 (164)
                      .+++.+|+|.+... .......+..|+.+++.++|||++++ +.+......+++||++++++|.+++.....        
T Consensus        32 ~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~  111 (283)
T cd05090          32 DHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSS  111 (283)
T ss_pred             CCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCcccccc
Confidence            35678999998643 23334678889999999999999997 666777789999999999999988753210        


Q ss_pred             ------ccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh----hhhhcc
Q 046065           74 ------MLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI----LKQIQI  143 (164)
Q Consensus        74 ------~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~----~~~~~~  143 (164)
                            ...++......++.|++.|+.|+|+.   +++|+|+||+||+++.++.++|+|||++.......    .....+
T Consensus       112 ~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  188 (283)
T cd05090         112 DEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSH---FFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL  188 (283)
T ss_pred             ccccccccccCHHHHHHHHHHHHHHHHHHHhc---CeehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCc
Confidence                  12367788889999999999999998   99999999999999999999999999987653221    123345


Q ss_pred             cccccCcceecCCcceeccCC
Q 046065          144 ELGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       144 ~~~~~aPE~~~~~~~~~~~Di  164 (164)
                      +..|+|||++.+..++.++||
T Consensus       189 ~~~y~aPE~~~~~~~~~~~Dv  209 (283)
T cd05090         189 PIRWMPPEAIMYGKFSSDSDI  209 (283)
T ss_pred             cceecChHHhccCCCCchhhh
Confidence            667999999988889999996

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.95  E-value=1.5e-26  Score=164.25  Aligned_cols=155  Identities=25%  Similarity=0.331  Sum_probs=128.0

Q ss_pred             CCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHH
Q 046065            5 DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRV   83 (164)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~   83 (164)
                      ++..+++|.+..........+..|+.+++.++|||++++ +.+...+..++|+||+++++|..++....  ..+++....
T Consensus        29 ~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~--~~l~~~~~~  106 (282)
T cd06643          29 TGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE--RPLTEPQIR  106 (282)
T ss_pred             CCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcC--CCCCHHHHH
Confidence            567889998865555556678889999999999999997 77777788999999999999988765422  237888999


Q ss_pred             HHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh--hhhhhcccccccCcceec-----CC
Q 046065           84 HIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM--ILKQIQIELGYIPPEYVG-----RG  156 (164)
Q Consensus        84 ~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~-----~~  156 (164)
                      .++.|++.||.|+|+.   +++|+||+|+||+++.++.++++|||++......  ......+++.|+|||++.     +.
T Consensus       107 ~~~~qi~~~L~~LH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  183 (282)
T cd06643         107 VVCKQTLEALNYLHEN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR  183 (282)
T ss_pred             HHHHHHHHHHHHHHHC---CeeecCCCcccEEEccCCCEEEccccccccccccccccccccccccccCHhhccccCCCCC
Confidence            9999999999999998   9999999999999999999999999998654322  223456888999999983     44


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .++.++||
T Consensus       184 ~~~~~~Dv  191 (282)
T cd06643         184 PYDYKADV  191 (282)
T ss_pred             CCCccchh
Confidence            57788886

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.95  E-value=5.6e-27  Score=166.34  Aligned_cols=156  Identities=31%  Similarity=0.539  Sum_probs=127.6

Q ss_pred             CcEEEEEEccccc-cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccc----------
Q 046065            6 GQIIAVKKLSKKS-TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIR----------   73 (164)
Q Consensus         6 ~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~----------   73 (164)
                      .+.||+|.+.... ......+.+|+.++..++||||+++ +.+......++++|++++++|.+++.....          
T Consensus        35 ~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~  114 (283)
T cd05048          35 ATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGD  114 (283)
T ss_pred             eeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCccccccccc
Confidence            3679999986442 3345668899999999999999997 666667788999999999999988865311          


Q ss_pred             ---ccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh----hhhhhccccc
Q 046065           74 ---MLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM----ILKQIQIELG  146 (164)
Q Consensus        74 ---~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~  146 (164)
                         ...++......++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++......    ......+++.
T Consensus       115 ~~~~~~l~~~~~~~~~~~l~~al~~lH~~---~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~  191 (283)
T cd05048         115 ETVKSSLDCSDFLHIAIQIAAGMEYLSSH---HFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVR  191 (283)
T ss_pred             ccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCccccc
Confidence               13377888899999999999999998   9999999999999999999999999998654321    1233456788


Q ss_pred             ccCcceecCCcceeccCC
Q 046065          147 YIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       147 ~~aPE~~~~~~~~~~~Di  164 (164)
                      |+|||.+.+..++.++||
T Consensus       192 y~aPE~~~~~~~~~~sDv  209 (283)
T cd05048         192 WMPPEAILYGKFTTESDI  209 (283)
T ss_pred             ccCHHHhccCcCchhhhH
Confidence            999999988899999996

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.95  E-value=1.8e-27  Score=169.88  Aligned_cols=154  Identities=25%  Similarity=0.396  Sum_probs=130.4

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      .+++.||+|.+..........+..|+.+++.++|+|++++ +.+...+..++|+|++++++|..++...    .++....
T Consensus        45 ~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~l~~~~~  120 (292)
T cd06658          45 HTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHT----RMNEEQI  120 (292)
T ss_pred             CCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhcC----CCCHHHH
Confidence            3578999999865544445668899999999999999997 7777778899999999999998887542    2788889


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh--hhhhcccccccCcceecCCccee
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI--LKQIQIELGYIPPEYVGRGVYYK  160 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~  160 (164)
                      ..++.|++.++.|+|+.   +++|+||+|+||+++.++.++|+|||++.......  .....++..|+|||.+.+..++.
T Consensus       121 ~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  197 (292)
T cd06658         121 ATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGT  197 (292)
T ss_pred             HHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCceeecCccccCHHHHccCCCCc
Confidence            99999999999999998   99999999999999999999999999986553221  23456888999999998888999


Q ss_pred             ccCC
Q 046065          161 KFSL  164 (164)
Q Consensus       161 ~~Di  164 (164)
                      ++||
T Consensus       198 ~~Dv  201 (292)
T cd06658         198 EVDI  201 (292)
T ss_pred             hhhH
Confidence            9985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.95  E-value=6e-27  Score=166.80  Aligned_cols=155  Identities=26%  Similarity=0.412  Sum_probs=121.8

Q ss_pred             CCcEEEEEEccccc--cccHHHHHHHHHHHhcc---CCCceeeE-eEEe-----eCCcEEEEEEecCCCChhhhhhCccc
Q 046065            5 DGQIIAVKKLSKKS--TQGFEEFKNEVMLTAKL---QHLNLIRV-GFCI-----ETQEYMLIYEYMPKRSLDYFLFDPIR   73 (164)
Q Consensus         5 ~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~i~~~-~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~~~   73 (164)
                      +++.||+|.+....  ......+.+|+.+++.+   +||||+++ +.+.     .....++|+|+++ ++|.+++.....
T Consensus        26 ~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~  104 (290)
T cd07862          26 GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPE  104 (290)
T ss_pred             CCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhCCC
Confidence            46789999886442  22334556677776665   69999997 5443     2345789999996 588888764322


Q ss_pred             ccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh-hhhhhcccccccCcce
Q 046065           74 MLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM-ILKQIQIELGYIPPEY  152 (164)
Q Consensus        74 ~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~  152 (164)
                       ..+++.....++.|++.||.|+|+.   +++|+||||+||+++.++.++|+|||++...... ......+++.|+|||+
T Consensus       105 -~~~~~~~~~~i~~qi~~aL~~lH~~---~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~  180 (290)
T cd07862         105 -PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV  180 (290)
T ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEcCCCCEEEccccceEeccCCcccccccccccccChHH
Confidence             2378889999999999999999998   9999999999999999999999999998765432 2245678999999999


Q ss_pred             ecCCcceeccCC
Q 046065          153 VGRGVYYKKFSL  164 (164)
Q Consensus       153 ~~~~~~~~~~Di  164 (164)
                      +.+..++.++||
T Consensus       181 ~~~~~~~~~~Di  192 (290)
T cd07862         181 LLQSSYATPVDL  192 (290)
T ss_pred             HhCCCCCCccch
Confidence            988899999996

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.95  E-value=7.3e-27  Score=163.80  Aligned_cols=155  Identities=25%  Similarity=0.329  Sum_probs=126.5

Q ss_pred             CCCcEEEEEEccccc--cccHHHHHHHHHHHhccCCCceeeEeEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            4 PDGQIIAVKKLSKKS--TQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         4 ~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      .+++.+|+|.+....  +.....+..|+.+++.++||||+++..+......++|+|++++++|.+++....   .++...
T Consensus        20 ~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~   96 (257)
T cd05116          20 KSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAELGPLNKFLQKNK---HVTEKN   96 (257)
T ss_pred             CCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCcEEEEecCCCCcHHHHHHhcC---CCCHHH
Confidence            467889999986442  334567889999999999999999844445567789999999999999886543   278899


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh-----hhhcccccccCcceecCC
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL-----KQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~aPE~~~~~  156 (164)
                      ...++.|++.|+.++|+.   +++|+|+||.||+++.++.++|+|||++........     ....+++.|+|||.+...
T Consensus        97 ~~~i~~qi~~al~~lH~~---~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  173 (257)
T cd05116          97 ITELVHQVSMGMKYLEET---NFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYY  173 (257)
T ss_pred             HHHHHHHHHHHHHHHHHC---CEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccC
Confidence            999999999999999998   999999999999999999999999999876543211     122335789999999888


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .++.++||
T Consensus       174 ~~~~~~Di  181 (257)
T cd05116         174 KFSSKSDV  181 (257)
T ss_pred             CcCchhHH
Confidence            88888885

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.95  E-value=9.7e-27  Score=163.87  Aligned_cols=155  Identities=25%  Similarity=0.372  Sum_probs=128.3

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      .+++.||+|.+..........+..|+.+++.++|||++++ +.+...+..++|+|++++++|.+++....   .++....
T Consensus        32 ~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~---~~~~~~~  108 (267)
T cd06646          32 HTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTG---PLSELQI  108 (267)
T ss_pred             CCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhcC---CCCHHHH
Confidence            4678899999865544445567889999999999999997 77777788999999999999998886433   2788899


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh--hhhhcccccccCcceec---CCc
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI--LKQIQIELGYIPPEYVG---RGV  157 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~aPE~~~---~~~  157 (164)
                      ..++.|++.++.|+|+.   +++|+|++|+||+++.++.++|+|||++.......  .....+++.|+|||.+.   ...
T Consensus       109 ~~~~~qi~~~l~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~  185 (267)
T cd06646         109 AYVCRETLQGLAYLHSK---GKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGG  185 (267)
T ss_pred             HHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCCEEECcCccceeecccccccCccccCccccCHhHcccccCCC
Confidence            99999999999999998   99999999999999999999999999987654221  23456888999999884   344


Q ss_pred             ceeccCC
Q 046065          158 YYKKFSL  164 (164)
Q Consensus       158 ~~~~~Di  164 (164)
                      ++.++|+
T Consensus       186 ~~~~~Dv  192 (267)
T cd06646         186 YNQLCDI  192 (267)
T ss_pred             CcchhhH
Confidence            6778885

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.95  E-value=1e-26  Score=163.28  Aligned_cols=156  Identities=26%  Similarity=0.388  Sum_probs=128.2

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      .+++.||+|.+.... ...+.+..|+.+++.++|||++++ ..+...+..++++|++++++|.+++.... ...++....
T Consensus        28 ~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~  105 (261)
T cd05068          28 NNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGA-GRALKLPQL  105 (261)
T ss_pred             cCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccC-CCCCCHHHH
Confidence            456789999986442 234568889999999999999997 66777778899999999999999987543 223788899


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhc---ccccccCcceecCCcce
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQ---IELGYIPPEYVGRGVYY  159 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~---~~~~~~aPE~~~~~~~~  159 (164)
                      ..++.+++.|+.++|+.   +++|+||||+||+++.++.++|+|||++............   .+..|+|||...+..++
T Consensus       106 ~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  182 (261)
T cd05068         106 IDMAAQVASGMAYLEAQ---NYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFS  182 (261)
T ss_pred             HHHHHHHHHHHHHHHhC---CeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccCCCcCceeccCccccccCCCC
Confidence            99999999999999998   9999999999999999999999999998766533222222   24579999999888899


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      .++||
T Consensus       183 ~~~Di  187 (261)
T cd05068         183 IKSDV  187 (261)
T ss_pred             chhhH
Confidence            99986

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.95  E-value=2.2e-28  Score=168.72  Aligned_cols=151  Identities=25%  Similarity=0.278  Sum_probs=120.9

Q ss_pred             CCcEEEEEEccccccccHHHHHHHHHHHhcc-CCCceeeEeEEeeC-----CcEEEEEEecCCCChhhhhhCcccccccC
Q 046065            5 DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKL-QHLNLIRVGFCIET-----QEYMLIYEYMPKRSLDYFLFDPIRMLILD   78 (164)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~~~   78 (164)
                      +|+++|+|.+.     +.+...+|+++.-+. .||||+++...+++     .-+.+|||.++||.|.+.+.+.+. ..+.
T Consensus        86 T~ekfALKvL~-----Ds~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~-~afT  159 (400)
T KOG0604|consen   86 TQEKFALKVLL-----DSPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGD-QAFT  159 (400)
T ss_pred             chhhhHHHHHh-----cCHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHccc-ccch
Confidence            45555555552     334567888876665 69999998444432     235699999999999998876433 3489


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecC---CCCeEEccccchhhhh-hhhhhhhcccccccCcceec
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE---DLKPKISDFGLARILR-KMILKQIQIELGYIPPEYVG  154 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~---~~~~~l~dfg~~~~~~-~~~~~~~~~~~~~~aPE~~~  154 (164)
                      +..+.+++.||+.|+.|||++   +|-|||+||+|+|...   +..+||+|||+|+.-. .......|-||+|.|||+++
T Consensus       160 Erea~eI~~qI~~Av~~lH~~---nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg  236 (400)
T KOG0604|consen  160 EREASEIMKQIGLAVRYLHSM---NIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLG  236 (400)
T ss_pred             HHHHHHHHHHHHHHHHHHHhc---chhhccCChhheeeecCCCCcceEecccccccccCCCccccCCcccccccCHHHhC
Confidence            999999999999999999999   9999999999999964   4578999999997654 34457788999999999999


Q ss_pred             CCcceeccCC
Q 046065          155 RGVYYKKFSL  164 (164)
Q Consensus       155 ~~~~~~~~Di  164 (164)
                      .++|++.+|+
T Consensus       237 ~eKydkscdm  246 (400)
T KOG0604|consen  237 PEKYDKSCDM  246 (400)
T ss_pred             chhcCCCCCc
Confidence            9999999986

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.95  E-value=4.8e-27  Score=166.99  Aligned_cols=158  Identities=23%  Similarity=0.322  Sum_probs=129.7

Q ss_pred             CCcEEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            5 DGQIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         5 ~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      +++.||+|.+... .......+.+|+.+++.++||||+++ +.+...+..++|+||+++++|..++........+++...
T Consensus        25 ~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~  104 (286)
T cd06622          25 TGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVL  104 (286)
T ss_pred             CCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHH
Confidence            5789999987644 33345678899999999999999997 777777889999999999999988876433334889999


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCcceecCCc-----
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGV-----  157 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~-----  157 (164)
                      ..++.+++.|+.|||+.  .+++|+||+|+||+++.++.++|+|||++..+.........+++.|+|||.+.+..     
T Consensus       105 ~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  182 (286)
T cd06622         105 RRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNIGCQSYMAPERIKSGGPNQNP  182 (286)
T ss_pred             HHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCccccCCCccCccCcchhcCCCCCccC
Confidence            99999999999999962  28999999999999999999999999998766544444556788999999985443     


Q ss_pred             -ceeccCC
Q 046065          158 -YYKKFSL  164 (164)
Q Consensus       158 -~~~~~Di  164 (164)
                       ++.++|+
T Consensus       183 ~~~~~~Di  190 (286)
T cd06622         183 TYTVQSDV  190 (286)
T ss_pred             CCCcccch
Confidence             4778885

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.95  E-value=6.8e-27  Score=165.62  Aligned_cols=157  Identities=28%  Similarity=0.479  Sum_probs=129.5

Q ss_pred             CCcEEEEEEccccccc-cHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcc----------
Q 046065            5 DGQIIAVKKLSKKSTQ-GFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPI----------   72 (164)
Q Consensus         5 ~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------   72 (164)
                      +++.||+|.+...... ..+.+.+|+.+++.++|+|++++ +.+......+++||++++++|.+++....          
T Consensus        34 ~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~  113 (280)
T cd05049          34 DKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPD  113 (280)
T ss_pred             CcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccc
Confidence            4578999998655333 45678899999999999999997 77777788999999999999999886532          


Q ss_pred             -cccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh----hhhhcccccc
Q 046065           73 -RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI----LKQIQIELGY  147 (164)
Q Consensus        73 -~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~  147 (164)
                       ....+++.....++.|++.++.++|+.   +++|+||||+||+++.++.++|+|||++.......    .....+++.|
T Consensus       114 ~~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y  190 (280)
T cd05049         114 SPMGELTLSQLLQIAVQIASGMVYLASQ---HFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRW  190 (280)
T ss_pred             cccccccHHHHHHHHHHHHHHHHHHhhC---CeeccccccceEEEcCCCeEEECCcccceecccCcceecCCCCccccee
Confidence             122367888899999999999999998   99999999999999999999999999986543211    1233456789


Q ss_pred             cCcceecCCcceeccCC
Q 046065          148 IPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       148 ~aPE~~~~~~~~~~~Di  164 (164)
                      +|||++.+..++.++||
T Consensus       191 ~aPE~~~~~~~~~~~Di  207 (280)
T cd05049         191 MPPESIMYRKFTTESDV  207 (280)
T ss_pred             cChhhhccCCcchhhhH
Confidence            99999999999999996

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=1.1e-26  Score=163.20  Aligned_cols=155  Identities=26%  Similarity=0.391  Sum_probs=128.9

Q ss_pred             CCCcEEEEEEccccc-----cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccccccc
Q 046065            4 PDGQIIAVKKLSKKS-----TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLIL   77 (164)
Q Consensus         4 ~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~   77 (164)
                      .+++++|+|.+....     ......+.+|+.+++.++||||+++ +.+......++++|++++++|.+.+.....   +
T Consensus        25 ~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~---~  101 (263)
T cd06625          25 DTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGA---L  101 (263)
T ss_pred             CCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHHhCC---C
Confidence            467899999876432     1223567889999999999999997 777777889999999999999988865432   7


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh-----hhhhcccccccCcce
Q 046065           78 DCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI-----LKQIQIELGYIPPEY  152 (164)
Q Consensus        78 ~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~aPE~  152 (164)
                      +......++.|++.|+.++|+.   +++|+|++|+||+++.++.++|+|||++.......     .....++..|+|||+
T Consensus       102 ~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~  178 (263)
T cd06625         102 TETVTRKYTRQILEGVEYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEV  178 (263)
T ss_pred             CHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceeccccccccccccCCCcCccccCcce
Confidence            7888899999999999999998   99999999999999999999999999986543211     133567889999999


Q ss_pred             ecCCcceeccCC
Q 046065          153 VGRGVYYKKFSL  164 (164)
Q Consensus       153 ~~~~~~~~~~Di  164 (164)
                      +.+..++.++||
T Consensus       179 ~~~~~~~~~~Di  190 (263)
T cd06625         179 ISGEGYGRKADV  190 (263)
T ss_pred             eccCCCCchhhh
Confidence            998889999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.95  E-value=1.3e-26  Score=162.31  Aligned_cols=157  Identities=22%  Similarity=0.317  Sum_probs=132.4

Q ss_pred             CCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            4 PDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         4 ~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      .+++.+++|.+...  .+.....+..|+.+++.++|+|++++ +.+...+..++++|++++++|.+++.... ...++..
T Consensus        23 ~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~-~~~~~~~  101 (256)
T cd08221          23 EDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQK-GQLFEEE  101 (256)
T ss_pred             CCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhcc-ccCCCHH
Confidence            46788999987654  34445678899999999999999998 77777788899999999999999887542 2237889


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh--hhhhcccccccCcceecCCcc
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI--LKQIQIELGYIPPEYVGRGVY  158 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~  158 (164)
                      ....++.|++.++.++|+.   +++|+|++|+||+++.++.++|+|||++.......  .....+++.|+|||.+.+..+
T Consensus       102 ~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~~  178 (256)
T cd08221         102 MVLWYLFQIVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKY  178 (256)
T ss_pred             HHHHHHHHHHHHHHHHHhC---CccccCCChHhEEEeCCCCEEECcCcceEEcccccccccccCCCccccCHhhcCCCCC
Confidence            9999999999999999988   99999999999999999999999999987654322  244668899999999988888


Q ss_pred             eeccCC
Q 046065          159 YKKFSL  164 (164)
Q Consensus       159 ~~~~Di  164 (164)
                      +.++|+
T Consensus       179 ~~~~Dv  184 (256)
T cd08221         179 NFKSDI  184 (256)
T ss_pred             CCcchh
Confidence            999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.95  E-value=5.2e-27  Score=167.89  Aligned_cols=154  Identities=24%  Similarity=0.363  Sum_probs=130.9

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      .+++.||+|.+..........+..|+.+++.++|+|++++ +.+......++|+|++++++|.+++.+.    .++....
T Consensus        42 ~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~  117 (297)
T cd06656          42 ATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET----CMDEGQI  117 (297)
T ss_pred             CCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHhC----CCCHHHH
Confidence            5788999999876554455678889999999999999997 7777778899999999999999988643    2678888


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh--hhhhcccccccCcceecCCccee
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI--LKQIQIELGYIPPEYVGRGVYYK  160 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~  160 (164)
                      ..++.|++.++.++|+.   +++|+||+|+||+++.++.++|+|||++.......  .....+++.|+|||.+.+..++.
T Consensus       118 ~~~~~~l~~~L~~LH~~---~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  194 (297)
T cd06656         118 AAVCRECLQALDFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP  194 (297)
T ss_pred             HHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCcccCCccccCHHHHcCCCCCc
Confidence            99999999999999998   99999999999999999999999999886543221  23456788999999998888889


Q ss_pred             ccCC
Q 046065          161 KFSL  164 (164)
Q Consensus       161 ~~Di  164 (164)
                      ++|+
T Consensus       195 ~~Di  198 (297)
T cd06656         195 KVDI  198 (297)
T ss_pred             HHHH
Confidence            8885

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.95  E-value=9e-27  Score=163.98  Aligned_cols=158  Identities=19%  Similarity=0.263  Sum_probs=130.1

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccc-ccccC
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIR-MLILD   78 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~   78 (164)
                      .+++.||+|.+...   .......+..|+.+++.++|||++++ +.+...+..++++|++++++|..++..... ...++
T Consensus        25 ~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~  104 (267)
T cd08228          25 LDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIP  104 (267)
T ss_pred             CCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCC
Confidence            36789999987543   23334567889999999999999997 677777888999999999999888754221 22378


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh--hhhhcccccccCcceecCC
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI--LKQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~aPE~~~~~  156 (164)
                      ......++.|++.|+.|+|+.   +++|+||+|+||+++.++.++|+|||++.......  .....+++.|+|||.+.+.
T Consensus       105 ~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  181 (267)
T cd08228         105 ERTVWKYFVQLCSAVEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN  181 (267)
T ss_pred             HHHHHHHHHHHHHHHHHHhhC---CeeCCCCCHHHEEEcCCCCEEECccccceeccchhHHHhcCCCCccccChhhhccC
Confidence            888999999999999999988   99999999999999999999999999987654322  2345688899999999888


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .++.++|+
T Consensus       182 ~~~~~~Di  189 (267)
T cd08228         182 GYNFKSDI  189 (267)
T ss_pred             CCCchhhH
Confidence            88888885

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=1e-27  Score=181.04  Aligned_cols=158  Identities=29%  Similarity=0.423  Sum_probs=134.8

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      .++..+|||-+..+..+..+.+.+|+.+.+.++|.||+++ +.+.+++.+-+.||.+|||+|.++++..=+...-++...
T Consensus       598 ~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm  677 (1226)
T KOG4279|consen  598 DTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTM  677 (1226)
T ss_pred             cceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhccCCCccchhHH
Confidence            4566789999987777778899999999999999999996 888888878899999999999999976322222378899


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecC-CCCeEEccccchhhhh--hhhhhhhcccccccCcceecCC--c
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE-DLKPKISDFGLARILR--KMILKQIQIELGYIPPEYVGRG--V  157 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~-~~~~~l~dfg~~~~~~--~~~~~~~~~~~~~~aPE~~~~~--~  157 (164)
                      ..+..||++||.|||++   .|+|||||-+|+|+.- .|.+||+|||.++.+-  +.++..+.||..|||||++..+  -
T Consensus       678 ~fYtkQILeGLkYLHen---~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RG  754 (1226)
T KOG4279|consen  678 NFYTKQILEGLKYLHEN---KIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRG  754 (1226)
T ss_pred             HHHHHHHHHHhhhhhhc---ceeeccccCCcEEEeeccceEEecccccchhhccCCccccccccchhhhChHhhccCCcC
Confidence            99999999999999998   9999999999999975 6899999999986653  3556788999999999999554  6


Q ss_pred             ceeccCC
Q 046065          158 YYKKFSL  164 (164)
Q Consensus       158 ~~~~~Di  164 (164)
                      |++++||
T Consensus       755 YG~aADI  761 (1226)
T KOG4279|consen  755 YGKAADI  761 (1226)
T ss_pred             CCchhhh
Confidence            7888886

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=2.2e-26  Score=161.46  Aligned_cols=156  Identities=26%  Similarity=0.373  Sum_probs=132.1

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      .+++.+++|.+..........+..|+.+++.++|||++++ +.+.....++++||++++++|..++....  ..++....
T Consensus        26 ~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~--~~l~~~~~  103 (262)
T cd06613          26 ATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTR--GPLSELQI  103 (262)
T ss_pred             CCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhc--cCCCHHHH
Confidence            3567899999876655566788999999999999999997 67777788999999999999998886532  23888999


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh--hhhhcccccccCcceecCC---c
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI--LKQIQIELGYIPPEYVGRG---V  157 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~aPE~~~~~---~  157 (164)
                      ..++.|++.++.|+|+.   +++|+|++|+||+++.++.++|+|||++.......  .....++..|+|||.+...   .
T Consensus       104 ~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~  180 (262)
T cd06613         104 AYVCRETLKGLAYLHET---GKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGG  180 (262)
T ss_pred             HHHHHHHHHHHHHHHhC---CceecCCChhhEEECCCCCEEECccccchhhhhhhhccccccCCccccCchhhcccccCC
Confidence            99999999999999988   99999999999999999999999999987654322  2345678899999999776   7


Q ss_pred             ceeccCC
Q 046065          158 YYKKFSL  164 (164)
Q Consensus       158 ~~~~~Di  164 (164)
                      ++.++|+
T Consensus       181 ~~~~~Di  187 (262)
T cd06613         181 YDGKCDI  187 (262)
T ss_pred             cCchhhh
Confidence            8888885

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.95  E-value=1.3e-26  Score=162.39  Aligned_cols=155  Identities=24%  Similarity=0.400  Sum_probs=126.7

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      .++..+|+|.+... ......+..|+.+++.++|||++++ +.+......+++|||+++++|.+++.....  .++....
T Consensus        26 ~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~  102 (256)
T cd05114          26 RAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQG--KLSKDML  102 (256)
T ss_pred             ccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCcc--CCCHHHH
Confidence            34568999987533 2234568889999999999999997 677777789999999999999988865322  3788889


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh---hhhcccccccCcceecCCcce
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL---KQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      ..++.+++.|+.|+|+.   +++|+|++|+||+++.++.++++|||.+........   ....++..|+|||.+.+..++
T Consensus       103 ~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  179 (256)
T cd05114         103 LSMCQDVCEGMEYLERN---SFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYS  179 (256)
T ss_pred             HHHHHHHHHHHHHHHHC---CccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhcccCccc
Confidence            99999999999999998   999999999999999999999999998875432221   223445679999999888889


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      .++|+
T Consensus       180 ~~~Di  184 (256)
T cd05114         180 SKSDV  184 (256)
T ss_pred             hhhhh
Confidence            99986

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.95  E-value=1e-26  Score=163.30  Aligned_cols=156  Identities=30%  Similarity=0.436  Sum_probs=128.1

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      .+++.||+|.+... ....+.+..|+.+++.++|+|++++ ..+...+..++++|++++++|.+++..... ..++....
T Consensus        28 ~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~  105 (261)
T cd05072          28 NNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEG-GKVLLPKL  105 (261)
T ss_pred             cCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcC-CCCCHHHH
Confidence            45678999987543 2234678899999999999999998 666677788999999999999998865322 23778888


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh---hhhcccccccCcceecCCcce
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL---KQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      ..++.+++.|+.|+|+.   +++|+|++|+||+++.++.++|+|||.+........   ....++..|+|||.+.+..++
T Consensus       106 ~~~~~~l~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  182 (261)
T cd05072         106 IDFSAQIAEGMAYIERK---NYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFT  182 (261)
T ss_pred             HHHHHHHHHHHHHHHHC---CeeccccchhhEEecCCCcEEECCCccceecCCCceeccCCCccceecCCHHHhccCCCC
Confidence            99999999999999998   999999999999999999999999999976543221   223456689999999888899


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      .++||
T Consensus       183 ~~~Di  187 (261)
T cd05072         183 IKSDV  187 (261)
T ss_pred             hhhhh
Confidence            99996

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.95  E-value=1e-26  Score=166.77  Aligned_cols=156  Identities=26%  Similarity=0.406  Sum_probs=126.9

Q ss_pred             CcEEEEEEcccc-ccccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccc---------
Q 046065            6 GQIIAVKKLSKK-STQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIR---------   73 (164)
Q Consensus         6 ~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---------   73 (164)
                      +..||+|.+... .....+.+..|+.+++.+ +||||+++ +.+......+++|||+++++|.+++.+...         
T Consensus        47 ~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~  126 (304)
T cd05101          47 AVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDI  126 (304)
T ss_pred             ceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCccccccccc
Confidence            457999988644 234456788999999999 89999997 777777788999999999999999865321         


Q ss_pred             ----ccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh----hhhhcccc
Q 046065           74 ----MLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI----LKQIQIEL  145 (164)
Q Consensus        74 ----~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~  145 (164)
                          ...++......++.|++.|+.|+|+.   +++|+||||+||+++.++.++|+|||.+.......    .....+++
T Consensus       127 ~~~~~~~~~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~  203 (304)
T cd05101         127 ARVPDEQMTFKDLVSCTYQVARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPV  203 (304)
T ss_pred             ccCCcccccHHHHHHHHHHHHHHHHHHHHC---CeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCc
Confidence                12367778889999999999999998   99999999999999999999999999987654211    12234567


Q ss_pred             cccCcceecCCcceeccCC
Q 046065          146 GYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       146 ~~~aPE~~~~~~~~~~~Di  164 (164)
                      .|+|||++.+..++.++||
T Consensus       204 ~y~aPE~~~~~~~~~~~Di  222 (304)
T cd05101         204 KWMAPEALFDRVYTHQSDV  222 (304)
T ss_pred             eeeCchhhccCCCCchhhH
Confidence            8999999988889999996

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.95  E-value=1.1e-26  Score=165.87  Aligned_cols=157  Identities=27%  Similarity=0.421  Sum_probs=129.4

Q ss_pred             CCcEEEEEEccccc-cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccc--------c
Q 046065            5 DGQIIAVKKLSKKS-TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIR--------M   74 (164)
Q Consensus         5 ~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------~   74 (164)
                      .+..||+|.+.... ......+..|+.+++.++|||++++ +.+...+..++++|++++++|.+++.....        .
T Consensus        45 ~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~  124 (296)
T cd05051          45 APVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNS  124 (296)
T ss_pred             CceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccC
Confidence            34678999987553 3345678899999999999999997 667777888999999999999998865431        1


Q ss_pred             cccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh----hhhhcccccccCc
Q 046065           75 LILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI----LKQIQIELGYIPP  150 (164)
Q Consensus        75 ~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~aP  150 (164)
                      ..++......++.|++.||.|+|+.   +++|+||||+||+++.++.++|+|||++.......    .....+++.|+||
T Consensus       125 ~~~~~~~~~~~~~~i~~al~~LH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  201 (296)
T cd05051         125 KSLSFSTLLYMATQIASGMRYLESL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAW  201 (296)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHHHc---CccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCH
Confidence            2378899999999999999999998   99999999999999999999999999987553321    1234456789999


Q ss_pred             ceecCCcceeccCC
Q 046065          151 EYVGRGVYYKKFSL  164 (164)
Q Consensus       151 E~~~~~~~~~~~Di  164 (164)
                      |.+.+..++.++||
T Consensus       202 E~~~~~~~~~~~Dv  215 (296)
T cd05051         202 ESVLLGKFTTKSDV  215 (296)
T ss_pred             HHhhcCCCCccchh
Confidence            99988889999996

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.94  E-value=1.4e-26  Score=164.63  Aligned_cols=156  Identities=24%  Similarity=0.340  Sum_probs=131.4

Q ss_pred             CCCcEEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            4 PDGQIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         4 ~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      .+++.||+|.+... .+.....+..|+++++.++|||++++ +.+...+.+++|+||+++++|..++....   .++...
T Consensus        28 ~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~  104 (284)
T cd06620          28 PTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGG---PIPVEI  104 (284)
T ss_pred             CCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHhcc---CCCHHH
Confidence            45788999987654 23445678899999999999999997 77777788999999999999998876533   278889


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCcceecCCcceec
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKK  161 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~  161 (164)
                      ...++.+++.++.|+|+.+  +++|+|++|+||+++.++.++|+|||++............++..|+|||++.+..++.+
T Consensus       105 ~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~  182 (284)
T cd06620         105 LGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGTSTYMSPERIQGGKYTVK  182 (284)
T ss_pred             HHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhhccCccccCcccCCHHHHccCCCCcc
Confidence            9999999999999999732  79999999999999999999999999986554444455678999999999988888999


Q ss_pred             cCC
Q 046065          162 FSL  164 (164)
Q Consensus       162 ~Di  164 (164)
                      +||
T Consensus       183 ~Di  185 (284)
T cd06620         183 SDV  185 (284)
T ss_pred             chH
Confidence            986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.94  E-value=1e-26  Score=163.16  Aligned_cols=157  Identities=31%  Similarity=0.486  Sum_probs=131.3

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      .+++.+|+|.+..........+..|+.+++.++|||++++ +.+......+++||++++++|.+++.+... ..++....
T Consensus        28 ~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~  106 (261)
T cd05148          28 KNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEG-QVLPVASL  106 (261)
T ss_pred             cCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCCC-CCCCHHHH
Confidence            3467899999876655456678899999999999999997 677777788999999999999999876432 23788899


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh--hhhcccccccCcceecCCccee
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL--KQIQIELGYIPPEYVGRGVYYK  160 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~~~  160 (164)
                      ..++.|++.|+.|+|+.   +++|+|++|+||+++.++.++|+|||.+........  ....++..|+|||...+..++.
T Consensus       107 ~~~~~~i~~al~~lH~~---~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~  183 (261)
T cd05148         107 IDMACQVAEGMAYLEEQ---NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFST  183 (261)
T ss_pred             HHHHHHHHHHHHHHHHC---CeeccccCcceEEEcCCceEEEccccchhhcCCccccccCCCCceEecCHHHHccCCCCc
Confidence            99999999999999998   999999999999999999999999999876543221  2334566799999998888899


Q ss_pred             ccCC
Q 046065          161 KFSL  164 (164)
Q Consensus       161 ~~Di  164 (164)
                      ++||
T Consensus       184 ~~Di  187 (261)
T cd05148         184 KSDV  187 (261)
T ss_pred             hhhH
Confidence            9886

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.94  E-value=1.6e-26  Score=161.71  Aligned_cols=156  Identities=30%  Similarity=0.458  Sum_probs=132.1

Q ss_pred             CcEEEEEEccccccc-cHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccc------cccc
Q 046065            6 GQIIAVKKLSKKSTQ-GFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIR------MLIL   77 (164)
Q Consensus         6 ~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~------~~~~   77 (164)
                      +..||+|.+...... ....+..|+..+..++|+|++++ +.+......++++|++++++|.+++.....      ...+
T Consensus        23 ~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~  102 (262)
T cd00192          23 TTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTL  102 (262)
T ss_pred             CceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccC
Confidence            778999998755332 35778899999999999999997 666677789999999999999999876421      2348


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh----hhhhcccccccCccee
Q 046065           78 DCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI----LKQIQIELGYIPPEYV  153 (164)
Q Consensus        78 ~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~aPE~~  153 (164)
                      ++.....++.|++.|+.++|+.   +++|+||+|+||+++.++.++|+|||.+.......    .....+++.|+|||..
T Consensus       103 ~~~~~~~~~~~l~~al~~lH~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~  179 (262)
T cd00192         103 SLKDLLSFAIQIAKGMEYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESL  179 (262)
T ss_pred             CHHHHHHHHHHHHHHHHHHHcC---CcccCccCcceEEECCCCcEEEcccccccccccccccccccCCCcCccccCHHHh
Confidence            9999999999999999999998   99999999999999999999999999997665421    2345678889999999


Q ss_pred             cCCcceeccCC
Q 046065          154 GRGVYYKKFSL  164 (164)
Q Consensus       154 ~~~~~~~~~Di  164 (164)
                      ....++.++||
T Consensus       180 ~~~~~~~~~Di  190 (262)
T cd00192         180 KDGIFTSKSDV  190 (262)
T ss_pred             ccCCcchhhcc
Confidence            88888999986

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.94  E-value=1.9e-26  Score=164.42  Aligned_cols=156  Identities=26%  Similarity=0.421  Sum_probs=127.6

Q ss_pred             CcEEEEEEcccc-ccccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCc-----------
Q 046065            6 GQIIAVKKLSKK-STQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDP-----------   71 (164)
Q Consensus         6 ~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----------   71 (164)
                      ...+|+|.+... .......+.+|+.+++.+ +|+||+++ +.+...+.++++|||+++++|..++...           
T Consensus        42 ~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~  121 (293)
T cd05053          42 TSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDD  121 (293)
T ss_pred             ceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCcccccccc
Confidence            467999988654 233445688899999999 79999997 7777778899999999999999888542           


Q ss_pred             --ccccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh----hhhcccc
Q 046065           72 --IRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL----KQIQIEL  145 (164)
Q Consensus        72 --~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~  145 (164)
                        .....++......++.|++.|+.|+|+.   +++|+||||+||+++.++.++|+|||++........    ....++.
T Consensus       122 ~~~~~~~l~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~  198 (293)
T cd05053         122 PRPPEETLTQKDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPV  198 (293)
T ss_pred             ccccccccCHHHHHHHHHHHHHHHHHHHHC---CccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCc
Confidence              1223478888999999999999999988   999999999999999999999999999976543221    2223456


Q ss_pred             cccCcceecCCcceeccCC
Q 046065          146 GYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       146 ~~~aPE~~~~~~~~~~~Di  164 (164)
                      .|+|||...+..++.++||
T Consensus       199 ~y~aPE~~~~~~~~~~~Di  217 (293)
T cd05053         199 KWMAPEALFDRVYTHQSDV  217 (293)
T ss_pred             cccCHHHhccCCcCcccce
Confidence            7999999988889999996

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.94  E-value=1.6e-26  Score=161.96  Aligned_cols=154  Identities=26%  Similarity=0.421  Sum_probs=125.7

Q ss_pred             CCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHH
Q 046065            5 DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRV   83 (164)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~   83 (164)
                      ++..+|+|.+.... .....+..|+.+++.++|||++++ +.+...+..++|+|++++++|.+++.....  .+++....
T Consensus        27 ~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~  103 (256)
T cd05059          27 GKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKG--KLGTEWLL  103 (256)
T ss_pred             CCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhccc--CCCHHHHH
Confidence            45678999875332 233567889999999999999997 666677778999999999999998865322  37889999


Q ss_pred             HHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhh---hhcccccccCcceecCCccee
Q 046065           84 HIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILK---QIQIELGYIPPEYVGRGVYYK  160 (164)
Q Consensus        84 ~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~aPE~~~~~~~~~  160 (164)
                      .++.|++.++.|+|+.   +++|+|+||+||+++.++.++|+|||.+....+....   ...++..|+|||.+.+..++.
T Consensus       104 ~i~~qi~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~  180 (256)
T cd05059         104 DMCSDVCEAMEYLESN---GFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSS  180 (256)
T ss_pred             HHHHHHHHHHHHHHHC---CcccccccHhhEEECCCCcEEECCcccceecccccccccCCCCCCccccCHHHhccCCCCc
Confidence            9999999999999998   9999999999999999999999999998765433221   222345799999998889999


Q ss_pred             ccCC
Q 046065          161 KFSL  164 (164)
Q Consensus       161 ~~Di  164 (164)
                      ++||
T Consensus       181 ~~Di  184 (256)
T cd05059         181 KSDV  184 (256)
T ss_pred             hhhH
Confidence            9985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.94  E-value=3.4e-26  Score=163.18  Aligned_cols=156  Identities=26%  Similarity=0.361  Sum_probs=128.9

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      .+++.+++|.+....+.....+..|+.+++.++|+|++++ +.+...+..++||||+++++|..++.+...  .++...+
T Consensus        35 ~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~--~l~~~~~  112 (292)
T cd06644          35 ETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDR--GLTEPQI  112 (292)
T ss_pred             CCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhcC--CCCHHHH
Confidence            4578999999876666666778899999999999999997 666777789999999999999887754322  2788999


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh--hhhhhcccccccCcceec-----C
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM--ILKQIQIELGYIPPEYVG-----R  155 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~-----~  155 (164)
                      ..++.|++.++.++|+.   +++|+|++|+||+++.++.++|+|||++......  ......+++.|+|||++.     .
T Consensus       113 ~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  189 (292)
T cd06644         113 QVICRQMLEALQYLHSM---KIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKD  189 (292)
T ss_pred             HHHHHHHHHHHHHHhcC---CeeecCCCcceEEEcCCCCEEEccCccceeccccccccceecCCccccCceeeccccccC
Confidence            99999999999999988   9999999999999999999999999987654322  123456788999999984     3


Q ss_pred             CcceeccCC
Q 046065          156 GVYYKKFSL  164 (164)
Q Consensus       156 ~~~~~~~Di  164 (164)
                      ..++.++|+
T Consensus       190 ~~~~~~~Dv  198 (292)
T cd06644         190 TPYDYKADI  198 (292)
T ss_pred             CCCCchhhh
Confidence            446778885

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.94  E-value=6.9e-27  Score=175.58  Aligned_cols=148  Identities=20%  Similarity=0.239  Sum_probs=122.3

Q ss_pred             CCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHH
Q 046065            5 DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRV   83 (164)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~   83 (164)
                      +++.||+|...      ...+.+|+.+++.++|+||+++ +.+...+..++++|++. ++|..++.....  .+++..+.
T Consensus       193 ~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~--~l~~~~~~  263 (461)
T PHA03211        193 YPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLYTYLGARLR--PLGLAQVT  263 (461)
T ss_pred             CCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHHHHHHhcCC--CCCHHHHH
Confidence            45678888532      2345689999999999999998 66777788899999985 688777754322  38899999


Q ss_pred             HHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh----hhhhcccccccCcceecCCcce
Q 046065           84 HIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI----LKQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        84 ~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      .++.|++.||.|+|+.   +|+||||||+|||++.++.++|+|||+++......    .....||+.|+|||++.+..++
T Consensus       264 ~i~~qi~~aL~yLH~~---gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~  340 (461)
T PHA03211        264 AVARQLLSAIDYIHGE---GIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYT  340 (461)
T ss_pred             HHHHHHHHHHHHHHHC---CEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCC
Confidence            9999999999999998   99999999999999999999999999987653221    1345789999999999999999


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      .++||
T Consensus       341 ~~sDv  345 (461)
T PHA03211        341 PSVDI  345 (461)
T ss_pred             chHHH
Confidence            99986

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.94  E-value=1.1e-27  Score=177.40  Aligned_cols=155  Identities=26%  Similarity=0.435  Sum_probs=132.0

Q ss_pred             CcEEEEEEcccccccc-HHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHH
Q 046065            6 GQIIAVKKLSKKSTQG-FEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRV   83 (164)
Q Consensus         6 ~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~   83 (164)
                      +.+||||.+....... ...|++|+++|.+++||||+++ +.|..++.+++++||++.|+|-+++..+.... +......
T Consensus       562 ~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt-~~t~~~v  640 (807)
T KOG1094|consen  562 PLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPT-AETAPGV  640 (807)
T ss_pred             ceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcc-cccchhH
Confidence            4789999998765443 4789999999999999999997 88999999999999999999999998754322 3455667


Q ss_pred             HHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh----hhhcccccccCcceecCCcce
Q 046065           84 HIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL----KQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        84 ~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      .++.|++.|++||.+.   +++|||+.+.|+|++.++++||+|||+++-+-++.+    ...+-...|||+|.+..++++
T Consensus       641 si~tqiasgmaYLes~---nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFt  717 (807)
T KOG1094|consen  641 SICTQIASGMAYLESL---NFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFT  717 (807)
T ss_pred             HHHHHHHHHHHHHHhh---chhhccccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhcccc
Confidence            7999999999999998   999999999999999999999999999986543333    223446789999999999999


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      .+||+
T Consensus       718 taSDv  722 (807)
T KOG1094|consen  718 TASDV  722 (807)
T ss_pred             chhhh
Confidence            99996

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.94  E-value=1.7e-26  Score=163.48  Aligned_cols=151  Identities=20%  Similarity=0.271  Sum_probs=122.2

Q ss_pred             cEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHHHH
Q 046065            7 QIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHI   85 (164)
Q Consensus         7 ~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~   85 (164)
                      ..|++|.+..........+.+|+.+++.++||||+++ +.+...+..++||||+++++|..++.....  .++......+
T Consensus        45 ~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~--~~~~~~~~~i  122 (274)
T cd05076          45 LRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKG--RVPVAWKITV  122 (274)
T ss_pred             eeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCC--CCCHHHHHHH
Confidence            4689999865544445678889999999999999998 777778889999999999999988865322  3788899999


Q ss_pred             HHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCC-------CeEEccccchhhhhhhhhhhhcccccccCcceecC-Cc
Q 046065           86 IKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL-------KPKISDFGLARILRKMILKQIQIELGYIPPEYVGR-GV  157 (164)
Q Consensus        86 ~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~-------~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~  157 (164)
                      +.|++.||.|+|+.   +++|+||||+||+++..+       .++++|||.+......  ....++..|+|||.+.+ ..
T Consensus       123 ~~qi~~~l~~lH~~---~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~--~~~~~~~~~~aPe~~~~~~~  197 (274)
T cd05076         123 AQQLASALSYLEDK---NLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR--EERVERIPWIAPECVPGGNS  197 (274)
T ss_pred             HHHHHHHHHHHHcC---CccCCCCCcccEEEeccCcccCccceeeecCCccccccccc--cccccCCcccCchhhcCCCC
Confidence            99999999999988   999999999999997543       4799999987543211  22456788999998865 46


Q ss_pred             ceeccCC
Q 046065          158 YYKKFSL  164 (164)
Q Consensus       158 ~~~~~Di  164 (164)
                      ++.++||
T Consensus       198 ~~~~~Dv  204 (274)
T cd05076         198 LSTAADK  204 (274)
T ss_pred             CCcHHHH
Confidence            7888885

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=5.9e-28  Score=180.94  Aligned_cols=153  Identities=22%  Similarity=0.322  Sum_probs=131.3

Q ss_pred             cEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHHHH
Q 046065            7 QIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHI   85 (164)
Q Consensus         7 ~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~   85 (164)
                      -.-|.|.+..++......++-|+.+|..++||+|+.+ ..++..+.+|++.|||+||..+-++-+....  +.+.++.-+
T Consensus        58 ~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~r~--LtE~QIqvv  135 (1187)
T KOG0579|consen   58 LLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELGRV--LTEDQIQVV  135 (1187)
T ss_pred             hhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhccc--cchHHHHHH
Confidence            3456777776777778889999999999999999997 8888889999999999999998888764433  889999999


Q ss_pred             HHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh--hhhhhcccccccCccee-----cCCcc
Q 046065           86 IKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM--ILKQIQIELGYIPPEYV-----GRGVY  158 (164)
Q Consensus        86 ~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~-----~~~~~  158 (164)
                      +.|++.||.|||++   .|||||+|..|||+..+|.++|+|||.+......  .-.++.|||+|||||+.     ....|
T Consensus       136 c~q~ldALn~LHs~---~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PY  212 (1187)
T KOG0579|consen  136 CYQVLDALNWLHSQ---NIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPY  212 (1187)
T ss_pred             HHHHHHHHHHHhhc---chhhhhccccceEEEecCcEeeecccccccchhHHhhhccccCCcccccchheeeccccCCCc
Confidence            99999999999998   9999999999999999999999999988665432  33678999999999987     34567


Q ss_pred             eeccCC
Q 046065          159 YKKFSL  164 (164)
Q Consensus       159 ~~~~Di  164 (164)
                      +-++||
T Consensus       213 DykaDi  218 (1187)
T KOG0579|consen  213 DYKADI  218 (1187)
T ss_pred             hhhhhH
Confidence            888886

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.94  E-value=2.1e-26  Score=162.15  Aligned_cols=155  Identities=29%  Similarity=0.466  Sum_probs=128.1

Q ss_pred             CCCcEEEEEEccccccc---------cHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccc
Q 046065            4 PDGQIIAVKKLSKKSTQ---------GFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIR   73 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~---------~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~   73 (164)
                      .+++.+|+|.+......         ....+..|+.+++.++||||+++ +.+......++++|++++++|..++.....
T Consensus        23 ~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~  102 (267)
T cd06628          23 SSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGA  102 (267)
T ss_pred             CCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHhccC
Confidence            35788999987644221         12467789999999999999998 677777788999999999999999865432


Q ss_pred             ccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh--------hhhhcccc
Q 046065           74 MLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI--------LKQIQIEL  145 (164)
Q Consensus        74 ~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~--------~~~~~~~~  145 (164)
                         ++......++.|++.|+.++|+.   +++|+||+|+||+++.++.++|+|||.+.......        .....++.
T Consensus       103 ---l~~~~~~~~~~~l~~~l~~lH~~---~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~  176 (267)
T cd06628         103 ---FEETLVRNFVRQILKGLNYLHNR---GIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSV  176 (267)
T ss_pred             ---ccHHHHHHHHHHHHHHHHHHHhc---CcccccCCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCc
Confidence               78888999999999999999988   99999999999999999999999999987654211        12345788


Q ss_pred             cccCcceecCCcceeccCC
Q 046065          146 GYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       146 ~~~aPE~~~~~~~~~~~Di  164 (164)
                      .|+|||.+.+..++.++|+
T Consensus       177 ~y~~pe~~~~~~~~~~~Dv  195 (267)
T cd06628         177 FWMAPEVVKQTSYTRKADI  195 (267)
T ss_pred             CccChhHhccCCCCchhhh
Confidence            9999999988888999986

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=1.8e-26  Score=163.58  Aligned_cols=156  Identities=22%  Similarity=0.323  Sum_probs=129.7

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      .+++.+|+|..........+.+..|+.+++.++|||++++ +.+......++|||++++++|.+++....  ..+++...
T Consensus        28 ~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~l~~~~~  105 (280)
T cd06611          28 ETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELE--RGLTEPQI  105 (280)
T ss_pred             CCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhc--CCCCHHHH
Confidence            3678999999876655556778899999999999999997 77777788999999999999999886532  23888999


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh--hhhhhcccccccCcceec-----C
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM--ILKQIQIELGYIPPEYVG-----R  155 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~-----~  155 (164)
                      ..++.|++.++.|+|+.   +++|+|++|+||+++.++.++|+|||++......  ......+++.|+|||.+.     .
T Consensus       106 ~~~~~ql~~~l~~lh~~---~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~  182 (280)
T cd06611         106 RYVCRQMLEALNFLHSH---KVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKD  182 (280)
T ss_pred             HHHHHHHHHHHHHHHHC---CcccCCCChhhEEECCCCCEEEccCccchhhcccccccceeecchhhcCHHHHhhcccCC
Confidence            99999999999999998   9999999999999999999999999987654322  223456888999999974     3


Q ss_pred             CcceeccCC
Q 046065          156 GVYYKKFSL  164 (164)
Q Consensus       156 ~~~~~~~Di  164 (164)
                      ..++.++|+
T Consensus       183 ~~~~~~sDi  191 (280)
T cd06611         183 NPYDYKADI  191 (280)
T ss_pred             CCCCccccH
Confidence            346778885

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.94  E-value=1.8e-26  Score=162.33  Aligned_cols=155  Identities=28%  Similarity=0.462  Sum_probs=129.6

Q ss_pred             CCCcEEEEEEccccc------cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccc
Q 046065            4 PDGQIIAVKKLSKKS------TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLI   76 (164)
Q Consensus         4 ~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~   76 (164)
                      .+++.+|+|.+....      ......+.+|+.+++.++|+|++++ +.+...+..++++|++++++|.+++.+...   
T Consensus        22 ~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---   98 (265)
T cd06631          22 NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGP---   98 (265)
T ss_pred             cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHhcCC---
Confidence            467889999876431      2233567889999999999999997 777777888999999999999999865432   


Q ss_pred             cCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh--------hhhhhhccccccc
Q 046065           77 LDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK--------MILKQIQIELGYI  148 (164)
Q Consensus        77 ~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~--------~~~~~~~~~~~~~  148 (164)
                      ++...+..++.|++.++.|+|+.   +++|+||+|+||+++.++.++|+|||++.....        .......++..|+
T Consensus        99 ~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  175 (265)
T cd06631          99 LPEPVFCKYTKQILDGVAYLHNN---CVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWM  175 (265)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCcccc
Confidence            78889999999999999999998   999999999999999999999999999875421        1123456888999


Q ss_pred             CcceecCCcceeccCC
Q 046065          149 PPEYVGRGVYYKKFSL  164 (164)
Q Consensus       149 aPE~~~~~~~~~~~Di  164 (164)
                      |||++.+..++.++||
T Consensus       176 ~pe~~~~~~~~~~~Dv  191 (265)
T cd06631         176 APEVINESGYGRKSDI  191 (265)
T ss_pred             ChhhhcCCCCcchhhH
Confidence            9999988888999986

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.94  E-value=3.2e-27  Score=176.43  Aligned_cols=152  Identities=22%  Similarity=0.327  Sum_probs=133.0

Q ss_pred             EEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeEeEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHHHHH
Q 046065            8 IIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHII   86 (164)
Q Consensus         8 ~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~   86 (164)
                      -||||.-+++ .+...+.|+.|+.+++.++||+|+++.......-.|+|||.++-|.|..++.....+  ++......++
T Consensus       420 aVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P~WivmEL~~~GELr~yLq~nk~s--L~l~tL~ly~  497 (974)
T KOG4257|consen  420 AVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQPMWIVMELAPLGELREYLQQNKDS--LPLRTLTLYC  497 (974)
T ss_pred             eeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccceeEEEecccchhHHHHHHhcccc--chHHHHHHHH
Confidence            4899998775 566678899999999999999999996666677889999999999999999865443  8889999999


Q ss_pred             HHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh-hh--hcccccccCcceecCCcceeccC
Q 046065           87 KGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL-KQ--IQIELGYIPPEYVGRGVYYKKFS  163 (164)
Q Consensus        87 ~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~-~~--~~~~~~~~aPE~~~~~~~~~~~D  163 (164)
                      .|++.||.|||+.   +.+||||..+|||+.+..++||+|||+++.+.++.+ ..  ..-...|||||.+.-++++.+||
T Consensus       498 ~Qi~talaYLeSk---rfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASD  574 (974)
T KOG4257|consen  498 YQICTALAYLESK---RFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASD  574 (974)
T ss_pred             HHHHHHHHHHHhh---chhhhhhhhhheeecCcceeeecccchhhhccccchhhccccccceeecCccccchhcccchhh
Confidence            9999999999998   999999999999999999999999999998876544 22  22356799999999999999999


Q ss_pred             C
Q 046065          164 L  164 (164)
Q Consensus       164 i  164 (164)
                      |
T Consensus       575 V  575 (974)
T KOG4257|consen  575 V  575 (974)
T ss_pred             H
Confidence            6

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.94  E-value=2.4e-27  Score=153.55  Aligned_cols=156  Identities=22%  Similarity=0.363  Sum_probs=129.5

Q ss_pred             cCCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            3 LPDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         3 ~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .++++.||+|.+..+  ......+.++|+.+++.++|.||+++ ........+-+|+|+|.. .|..+..+..+.  ++.
T Consensus        24 ~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq-dlkkyfdslng~--~d~  100 (292)
T KOG0662|consen   24 RETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSLNGD--LDP  100 (292)
T ss_pred             CCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-HHHHHHHhcCCc--CCH
Confidence            467899999998766  34446778999999999999999998 666677788999999953 676666553322  778


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh--hhhhhhcccccccCcceecCCc
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK--MILKQIQIELGYIPPEYVGRGV  157 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~  157 (164)
                      .....++.|+++++.|+|++   +++|||+||+|++|..+|.+|++|||+++-+.-  .++...+.|.+|++|.++.+++
T Consensus       101 ~~~rsfmlqllrgl~fchsh---nvlhrdlkpqnllin~ngelkladfglarafgipvrcysaevvtlwyrppdvlfgak  177 (292)
T KOG0662|consen  101 EIVRSFMLQLLRGLGFCHSH---NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK  177 (292)
T ss_pred             HHHHHHHHHHHhhhhhhhhh---hhhhccCCcceEEeccCCcEEecccchhhhcCCceEeeeceeeeeeccCcceeeeee
Confidence            88889999999999999999   999999999999999999999999999987653  4667788899999999997764


Q ss_pred             -ceeccCC
Q 046065          158 -YYKKFSL  164 (164)
Q Consensus       158 -~~~~~Di  164 (164)
                       |+...|+
T Consensus       178 ly~tsidm  185 (292)
T KOG0662|consen  178 LYSTSIDM  185 (292)
T ss_pred             hhccchHh
Confidence             4665553

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.94  E-value=1.3e-26  Score=163.08  Aligned_cols=158  Identities=21%  Similarity=0.278  Sum_probs=130.9

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCc-ccccccC
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDP-IRMLILD   78 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~   78 (164)
                      .+++.+|+|.+...   .......+..|+.+++.++|||++++ ..+...+..++++|++++++|.+++... .....++
T Consensus        25 ~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~  104 (267)
T cd08229          25 LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIP  104 (267)
T ss_pred             CCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCC
Confidence            47889999987543   22334577889999999999999997 7777778889999999999999887642 1223478


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh--hhhhcccccccCcceecCC
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI--LKQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~aPE~~~~~  156 (164)
                      +.....++.|++.++.|+|++   +++|+||+|+||+++.++.++++|||++.......  .....++..|+|||...+.
T Consensus       105 ~~~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~  181 (267)
T cd08229         105 EKTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN  181 (267)
T ss_pred             HHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEECcchhhhccccCCcccccccCCcCccCHHHhcCC
Confidence            899999999999999999998   99999999999999999999999999987654322  2345688899999999888


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .++.++|+
T Consensus       182 ~~~~~~Dv  189 (267)
T cd08229         182 GYNFKSDI  189 (267)
T ss_pred             CccchhhH
Confidence            88999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.94  E-value=2e-26  Score=161.89  Aligned_cols=154  Identities=23%  Similarity=0.249  Sum_probs=130.6

Q ss_pred             CCcEEEEEEccccc---cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            5 DGQIIAVKKLSKKS---TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         5 ~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      +++.+|+|.+....   ......+..|+.+++.++||||+++ +.+......++++|++++++|.+++.+...   ++..
T Consensus        17 ~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---l~~~   93 (262)
T cd05572          17 KNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGL---FDEY   93 (262)
T ss_pred             CCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhcCC---CCHH
Confidence            57899999986542   2334678899999999999999997 777777889999999999999999865432   7888


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh-hhhhhcccccccCcceecCCcce
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM-ILKQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      ....++.|++.|+.|+|+.   +++|+|++|+||+++.++.++|+|||.+...... ......+++.|+|||.+.+..++
T Consensus        94 ~~~~~~~~i~~~l~~lH~~---~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~  170 (262)
T cd05572          94 TARFYIACVVLAFEYLHNR---GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYD  170 (262)
T ss_pred             HHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCccChhHhcCCCCC
Confidence            8999999999999999998   9999999999999999999999999998765433 22345678899999999888889


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      .++|+
T Consensus       171 ~~~Di  175 (262)
T cd05572         171 FSVDY  175 (262)
T ss_pred             Chhhh
Confidence            99986

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.94  E-value=1.5e-26  Score=162.65  Aligned_cols=156  Identities=28%  Similarity=0.366  Sum_probs=132.9

Q ss_pred             CCCcEEEEEEccccc-cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            4 PDGQIIAVKKLSKKS-TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         4 ~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      .+++.+|+|.+.... +.....+..|+.+++.++|||++++ +.+...+..++++|++++++|.+++....  ..++...
T Consensus        24 ~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~  101 (265)
T cd06605          24 PTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQ--GRIPERI  101 (265)
T ss_pred             CCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHcc--CCCCHHH
Confidence            357889999987552 3345678899999999999999997 77777888999999999999999887542  2378899


Q ss_pred             HHHHHHHHHHHHHHhhh-cCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCcceecCCccee
Q 046065           82 RVHIIKGIIQGLLYLQE-YFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYK  160 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~-~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~  160 (164)
                      ...++.|++.++.++|+ .   +++|+||+|+||+++.++.++|+|||.+............++..|+|||.+.+..++.
T Consensus       102 ~~~~~~~l~~~l~~lH~~~---~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~  178 (265)
T cd06605         102 LGKIAVAVLKGLTYLHEKH---KIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGNDYSV  178 (265)
T ss_pred             HHHHHHHHHHHHHHHcCCC---CeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhhcccCChhccCHHHHcCCCCCc
Confidence            99999999999999998 7   9999999999999999999999999998766543333477888999999998888999


Q ss_pred             ccCC
Q 046065          161 KFSL  164 (164)
Q Consensus       161 ~~Di  164 (164)
                      ++||
T Consensus       179 ~~Dv  182 (265)
T cd06605         179 KSDI  182 (265)
T ss_pred             hhhH
Confidence            9986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.94  E-value=2.3e-26  Score=161.78  Aligned_cols=156  Identities=26%  Similarity=0.416  Sum_probs=128.2

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      .+++.||+|.+... ......+..|+.+++.++|||++++ +.+...+.+++++|++++++|.+++..... ..++....
T Consensus        29 ~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~l~~~~~  106 (263)
T cd05052          29 KYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVNAVVL  106 (263)
T ss_pred             cCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCC-CCCCHHHH
Confidence            35778999987643 3334568889999999999999997 677777788999999999999998865322 23788889


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhh---hhcccccccCcceecCCcce
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILK---QIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~aPE~~~~~~~~  159 (164)
                      ..++.|++.++.++|+.   +++|+||||+||+++.++.++|+|||++.........   ....+..|+|||.+.+..++
T Consensus       107 ~~~~~ql~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  183 (263)
T cd05052         107 LYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS  183 (263)
T ss_pred             HHHHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhccCCCC
Confidence            99999999999999998   9999999999999999999999999998765433221   22335679999999888999


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      .++||
T Consensus       184 ~~~Dv  188 (263)
T cd05052         184 IKSDV  188 (263)
T ss_pred             chhHH
Confidence            99986

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.94  E-value=8.7e-27  Score=171.51  Aligned_cols=154  Identities=25%  Similarity=0.385  Sum_probs=123.2

Q ss_pred             CCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCC-----cEEEEEEecCCCChhhhhhCccccc
Q 046065            4 PDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQ-----EYMLIYEYMPKRSLDYFLFDPIRML   75 (164)
Q Consensus         4 ~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~~~   75 (164)
                      .+++.||+|.+...  .......+.+|+.+++.++||||+++ +.+....     ..++|+|++. ++|...+....   
T Consensus        23 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~---   98 (372)
T cd07853          23 RDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIVSPQ---   98 (372)
T ss_pred             CCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHHHHhcCC---
Confidence            46889999998643  22234568899999999999999997 5555444     5789999986 57777665433   


Q ss_pred             ccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh---hhhhhcccccccCcce
Q 046065           76 ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM---ILKQIQIELGYIPPEY  152 (164)
Q Consensus        76 ~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~~aPE~  152 (164)
                      .++...+..++.|++.||.|+|+.   +++|+||||+||+++.++.++|+|||++......   ......+++.|+|||.
T Consensus        99 ~l~~~~~~~~~~qi~~aL~~LH~~---~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~  175 (372)
T cd07853          99 PLSSDHVKVFLYQILRGLKYLHSA---GILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEI  175 (372)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChHHEEECCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHH
Confidence            288899999999999999999998   9999999999999999999999999998754322   1233467889999999


Q ss_pred             ecCC-cceeccCC
Q 046065          153 VGRG-VYYKKFSL  164 (164)
Q Consensus       153 ~~~~-~~~~~~Di  164 (164)
                      +.+. .++.++||
T Consensus       176 ~~~~~~~~~~~Di  188 (372)
T cd07853         176 LMGSRHYTSAVDI  188 (372)
T ss_pred             HcCCCCCCcHHHH
Confidence            8764 47888886

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.94  E-value=5e-28  Score=167.87  Aligned_cols=154  Identities=27%  Similarity=0.372  Sum_probs=125.4

Q ss_pred             cEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEee-CCcEEEEEEecCCCChhhhhhCcc--cccccCHH
Q 046065            7 QIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIE-TQEYMLIYEYMPKRSLDYFLFDPI--RMLILDCK   80 (164)
Q Consensus         7 ~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~   80 (164)
                      +.+|+|.+..+  ....+.+..+|+.+++.++|||++++ ..+.. ....++++||++. +|+++++-.+  ....+|..
T Consensus        54 k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~  132 (438)
T KOG0666|consen   54 KEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRS  132 (438)
T ss_pred             hhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHH
Confidence            46888887654  23456788999999999999999998 33333 6789999999986 8888876432  23468999


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCC----CCeEEccccchhhhhhhh-----hhhhcccccccCcc
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED----LKPKISDFGLARILRKMI-----LKQIQIELGYIPPE  151 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~----~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~aPE  151 (164)
                      -.+.+++|++.|+.|||++   =|+|||+||.|||+..+    |++||+|||+++.+.+..     ....+.|++|+|||
T Consensus       133 mvKsilwQil~Gv~YLH~N---WvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPE  209 (438)
T KOG0666|consen  133 MVKSILWQILDGVHYLHSN---WVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPE  209 (438)
T ss_pred             HHHHHHHHHHhhhHHHhhh---heeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChH
Confidence            9999999999999999998   89999999999999765    999999999999886532     25577899999999


Q ss_pred             eecCC-cceeccCC
Q 046065          152 YVGRG-VYYKKFSL  164 (164)
Q Consensus       152 ~~~~~-~~~~~~Di  164 (164)
                      .+.+. -||++.||
T Consensus       210 LLLGa~hYT~AiDv  223 (438)
T KOG0666|consen  210 LLLGARHYTKAIDV  223 (438)
T ss_pred             Hhcccccccchhhh
Confidence            99766 45777775

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.94  E-value=3.2e-27  Score=165.99  Aligned_cols=155  Identities=39%  Similarity=0.576  Sum_probs=125.2

Q ss_pred             CcEEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHH
Q 046065            6 GQIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRV   83 (164)
Q Consensus         6 ~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~   83 (164)
                      +..|+||.+... .......+..|+..++.++||||+++ +.+...+..++|+|++++|+|.+++.... ...++.....
T Consensus        28 ~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~-~~~~~~~~~~  106 (259)
T PF07714_consen   28 NQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKN-KEPLSEQQRL  106 (259)
T ss_dssp             EEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTC-TTTSBHHHHH
T ss_pred             CEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccccccccccccccccc-cccccccccc
Confidence            567999999544 33346788999999999999999998 77776778999999999999999987651 1238889999


Q ss_pred             HHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh----hhhhhcccccccCcceecCCcce
Q 046065           84 HIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM----ILKQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        84 ~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      .++.|++.||.|||+.   +++|++++++||+++.++.+||+|||++......    ..........|+|||.+....++
T Consensus       107 ~i~~~i~~~l~~Lh~~---~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  183 (259)
T PF07714_consen  107 SIAIQIAEALSYLHSN---NIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYT  183 (259)
T ss_dssp             HHHHHHHHHHHHHHHT---TEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEES
T ss_pred             cccccccccccccccc---ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            9999999999999998   9999999999999999999999999998765211    11334566789999999888899


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      .++||
T Consensus       184 ~ksDV  188 (259)
T PF07714_consen  184 KKSDV  188 (259)
T ss_dssp             HHHHH
T ss_pred             ccccc
Confidence            99986

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.94  E-value=2.3e-26  Score=163.24  Aligned_cols=155  Identities=27%  Similarity=0.283  Sum_probs=121.6

Q ss_pred             CCCcEEEEEEcccccc---ccHHHHHHHHHHHh---ccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccc
Q 046065            4 PDGQIIAVKKLSKKST---QGFEEFKNEVMLTA---KLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLI   76 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~---~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~   76 (164)
                      .+++.+|+|.+.....   ........|..+++   ..+|||++.+ ..+...+..++||||+++++|..++.....   
T Consensus        17 ~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~---   93 (279)
T cd05633          17 DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGV---   93 (279)
T ss_pred             CCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHhcCC---
Confidence            4678999998865421   11223344444333   3479999997 566667788999999999999888765432   


Q ss_pred             cCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCcceecC-
Q 046065           77 LDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGR-  155 (164)
Q Consensus        77 ~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~-  155 (164)
                      +++.....++.|++.|+.|+|+.   +++|+||||+||+++.++.++++|||++............+++.|+|||.+.+ 
T Consensus        94 l~~~~~~~i~~qi~~al~~lH~~---~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~  170 (279)
T cd05633          94 FSEKEMRFYATEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKG  170 (279)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHC---CcCCCCCCHHHEEECCCCCEEEccCCcceeccccCccCcCCCcCccCHHHhcCC
Confidence            88999999999999999999998   99999999999999999999999999986554333344578999999999864 


Q ss_pred             CcceeccCC
Q 046065          156 GVYYKKFSL  164 (164)
Q Consensus       156 ~~~~~~~Di  164 (164)
                      ..++.++||
T Consensus       171 ~~~~~~~Di  179 (279)
T cd05633         171 TAYDSSADW  179 (279)
T ss_pred             CCCCchhhh
Confidence            567899986

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.94  E-value=1.8e-26  Score=167.82  Aligned_cols=158  Identities=27%  Similarity=0.411  Sum_probs=125.3

Q ss_pred             CCCcEEEEEEccccc-cccHHHHHHHHHHHhcc-CCCceeeE-eEEee-CCcEEEEEEecCCCChhhhhhCccc------
Q 046065            4 PDGQIIAVKKLSKKS-TQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIE-TQEYMLIYEYMPKRSLDYFLFDPIR------   73 (164)
Q Consensus         4 ~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~------   73 (164)
                      .+++.||+|.+.... ......+..|+.++..+ +|+||+++ +.+.. ....++++||+++++|.+++.....      
T Consensus        35 ~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~  114 (337)
T cd05054          35 ASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYR  114 (337)
T ss_pred             cccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccc
Confidence            345789999986432 22345678899999999 79999997 55544 4567899999999999888753211      


Q ss_pred             ----------------------------------------------------ccccCHHHHHHHHHHHHHHHHHhhhcCC
Q 046065           74 ----------------------------------------------------MLILDCKKRVHIIKGIIQGLLYLQEYFR  101 (164)
Q Consensus        74 ----------------------------------------------------~~~~~~~~~~~~~~~~~~~l~~lh~~~~  101 (164)
                                                                          ...++......++.|++.|+.|+|+.  
T Consensus       115 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~--  192 (337)
T cd05054         115 NKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASR--  192 (337)
T ss_pred             cccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhC--
Confidence                                                                11367888899999999999999988  


Q ss_pred             CCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh----hhhhcccccccCcceecCCcceeccCC
Q 046065          102 LTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI----LKQIQIELGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       102 ~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di  164 (164)
                       +|+|+||||+||+++.++.++|+|||++..+....    .....++..|+|||++.+..++.++||
T Consensus       193 -~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  258 (337)
T cd05054         193 -KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDV  258 (337)
T ss_pred             -CeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCccccH
Confidence             99999999999999999999999999997653221    122345678999999999999999996

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.94  E-value=2.2e-26  Score=161.20  Aligned_cols=152  Identities=29%  Similarity=0.397  Sum_probs=128.1

Q ss_pred             EEEEEEcccccc-ccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHHHH
Q 046065            8 IIAVKKLSKKST-QGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHI   85 (164)
Q Consensus         8 ~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~   85 (164)
                      .||+|.+..... ...+.+..|+.+++.++|||++++ +.+.. ...++++|++++++|.+.+.+... ..+++.....+
T Consensus        25 ~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~  102 (257)
T cd05040          25 PVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDAL-GHFLISTLCDY  102 (257)
T ss_pred             EEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhccc-ccCcHHHHHHH
Confidence            689999876644 556788999999999999999997 55555 788899999999999998876432 34788999999


Q ss_pred             HHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh-----hhhhhcccccccCcceecCCccee
Q 046065           86 IKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM-----ILKQIQIELGYIPPEYVGRGVYYK  160 (164)
Q Consensus        86 ~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~  160 (164)
                      +.|++.||.++|+.   +++|+||+|+||+++.++.++|+|||++..+...     ......++..|+|||.+....++.
T Consensus       103 ~~qi~~~L~~lH~~---~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~  179 (257)
T cd05040         103 AVQIANGMRYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSH  179 (257)
T ss_pred             HHHHHHHHHHHHhC---CccccccCcccEEEecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCc
Confidence            99999999999998   9999999999999999999999999998766431     112345678899999998888999


Q ss_pred             ccCC
Q 046065          161 KFSL  164 (164)
Q Consensus       161 ~~Di  164 (164)
                      ++||
T Consensus       180 ~~Di  183 (257)
T cd05040         180 ASDV  183 (257)
T ss_pred             hhhh
Confidence            9996

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.94  E-value=1.9e-26  Score=165.35  Aligned_cols=156  Identities=26%  Similarity=0.347  Sum_probs=127.9

Q ss_pred             CCcEEEEEEcccc-ccccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            5 DGQIIAVKKLSKK-STQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         5 ~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      ++..+|+|.+... .....+.+..|+.+++.+ +||||+++ +.+...+..++++||+++++|..++..... ..++...
T Consensus        64 ~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~-~~l~~~~  142 (302)
T cd05055          64 AVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRE-SFLTLED  142 (302)
T ss_pred             ceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCC-CCCCHHH
Confidence            3557999987644 233346788999999999 79999997 777777789999999999999998865322 2278899


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh----hhhhcccccccCcceecCCc
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI----LKQIQIELGYIPPEYVGRGV  157 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~  157 (164)
                      ...++.+++.|+.|+|+.   +++|+|+||+||+++.++.++++|||++.......    .....++..|+|||.+....
T Consensus       143 ~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  219 (302)
T cd05055         143 LLSFSYQVAKGMAFLASK---NCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCV  219 (302)
T ss_pred             HHHHHHHHHHHHHHHHHC---CeehhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCC
Confidence            999999999999999998   99999999999999999999999999987553221    12234567899999998888


Q ss_pred             ceeccCC
Q 046065          158 YYKKFSL  164 (164)
Q Consensus       158 ~~~~~Di  164 (164)
                      ++.++||
T Consensus       220 ~~~~~Di  226 (302)
T cd05055         220 YTFESDV  226 (302)
T ss_pred             CCcHhHH
Confidence            9999986

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.94  E-value=2.5e-26  Score=162.48  Aligned_cols=157  Identities=24%  Similarity=0.380  Sum_probs=128.0

Q ss_pred             CCcEEEEEEccccc-cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccc-------cc
Q 046065            5 DGQIIAVKKLSKKS-TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIR-------ML   75 (164)
Q Consensus         5 ~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------~~   75 (164)
                      +++.||+|.+.... ......+..|+.+++.++|||++++ +.+......++|+|++++++|.+++.....       ..
T Consensus        35 ~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~  114 (277)
T cd05032          35 PETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLG  114 (277)
T ss_pred             cceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCC
Confidence            45789999986442 3344568889999999999999998 777777789999999999999998864321       12


Q ss_pred             ccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh----hhhhcccccccCcc
Q 046065           76 ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI----LKQIQIELGYIPPE  151 (164)
Q Consensus        76 ~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~aPE  151 (164)
                      .+++.....++.|++.|+.|+|+.   +++|+||+|+||+++.++.++|+|||+++......    .....++..|+|||
T Consensus       115 ~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  191 (277)
T cd05032         115 PPTLQKFIQMAAEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPE  191 (277)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhC---CccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHH
Confidence            257788899999999999999988   99999999999999999999999999987553321    12334567899999


Q ss_pred             eecCCcceeccCC
Q 046065          152 YVGRGVYYKKFSL  164 (164)
Q Consensus       152 ~~~~~~~~~~~Di  164 (164)
                      .+.++.++.++||
T Consensus       192 ~~~~~~~~~~~Di  204 (277)
T cd05032         192 SLKDGVFTTKSDV  204 (277)
T ss_pred             HHhcCCCCcccch
Confidence            9988889999996

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.94  E-value=4.3e-26  Score=160.57  Aligned_cols=154  Identities=31%  Similarity=0.490  Sum_probs=127.6

Q ss_pred             CcEEEEEEccccc-cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHH
Q 046065            6 GQIIAVKKLSKKS-TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRV   83 (164)
Q Consensus         6 ~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~   83 (164)
                      ...||+|.+.... ......+..|+.+++.++||||+++ +.+...+..++++|++++++|.+++.....  .++.....
T Consensus        32 ~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~--~~~~~~~~  109 (266)
T cd05033          32 EIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDG--KFTVGQLV  109 (266)
T ss_pred             cceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhccC--CCCHHHHH
Confidence            4579999886542 3334568889999999999999997 667777788999999999999998865332  37889999


Q ss_pred             HHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh--hhh--hhhcccccccCcceecCCcce
Q 046065           84 HIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK--MIL--KQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        84 ~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~--~~~--~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      .++.|++.|+.|+|++   +++|+|++|+||+++.++.++|+|||++.....  ...  ....+++.|+|||.+.+..++
T Consensus       110 ~~~~~l~~~l~~Lh~~---~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~  186 (266)
T cd05033         110 GMLRGIASGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFT  186 (266)
T ss_pred             HHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCc
Confidence            9999999999999998   999999999999999999999999999977641  111  123345689999999988999


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      .++||
T Consensus       187 ~~~Dv  191 (266)
T cd05033         187 SASDV  191 (266)
T ss_pred             cccch
Confidence            99996

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.94  E-value=2.2e-26  Score=163.44  Aligned_cols=157  Identities=27%  Similarity=0.408  Sum_probs=126.2

Q ss_pred             CCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            4 PDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         4 ~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      .+++.||+|.+...  .......+..|+.+++.++|||++++ +.+...+..++|+|+++ ++|..++........++..
T Consensus        23 ~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~  101 (285)
T cd07861          23 KTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAE  101 (285)
T ss_pred             CCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCCCCCcCCHH
Confidence            46789999988644  22234567889999999999999998 77777788999999997 5888777653332348899


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh--hhhhhcccccccCcceecCC-c
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM--ILKQIQIELGYIPPEYVGRG-V  157 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~~~-~  157 (164)
                      ....++.|++.||.|+|+.   +++|+|++|+||+++.++.++|+|||++......  ......+++.|+|||.+.+. .
T Consensus       102 ~~~~~~~qi~~~L~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  178 (285)
T cd07861         102 LVKSYLYQILQGILFCHSR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPR  178 (285)
T ss_pred             HHHHHHHHHHHHHHHHHhC---CeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccccCCcccccccChHHhcCCCC
Confidence            9999999999999999998   9999999999999999999999999998654321  12334568889999988554 4


Q ss_pred             ceeccCC
Q 046065          158 YYKKFSL  164 (164)
Q Consensus       158 ~~~~~Di  164 (164)
                      ++.++||
T Consensus       179 ~~~~~Dv  185 (285)
T cd07861         179 YSTPVDI  185 (285)
T ss_pred             cCcHHHH
Confidence            6888885

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.94  E-value=2.3e-26  Score=160.98  Aligned_cols=157  Identities=24%  Similarity=0.324  Sum_probs=128.4

Q ss_pred             CCCcEEEEEEccccc--cccHHHHHHHHHHHhccCCCceeeE-eEEee-CCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKKS--TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIE-TQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+++.||+|.+....  ....+.+..|+.+++.++|+|++++ ..+.. ....++++|++++++|.+++..... ..+++
T Consensus        23 ~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~-~~l~~  101 (257)
T cd08223          23 TDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKG-KLLPE  101 (257)
T ss_pred             CCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcC-CCCCH
Confidence            357889999986542  2344567889999999999999997 44443 3457899999999999988875322 23789


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh--hhhhhcccccccCcceecCCc
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM--ILKQIQIELGYIPPEYVGRGV  157 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~  157 (164)
                      .....++.+++.++.++|+.   +++|+||+|+||+++.++.++|+|||++......  ......+++.|+|||+..+..
T Consensus       102 ~~~~~~~~~l~~~l~~lH~~---~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  178 (257)
T cd08223         102 NQVVEWFVQIAMALQYLHEK---HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKP  178 (257)
T ss_pred             HHHHHHHHHHHHHHHHHHhC---CeeccCCCchhEEEecCCcEEEecccceEEecccCCccccccCCcCccChhHhcCCC
Confidence            99999999999999999998   9999999999999999999999999998765422  224456788999999999999


Q ss_pred             ceeccCC
Q 046065          158 YYKKFSL  164 (164)
Q Consensus       158 ~~~~~Di  164 (164)
                      ++.++|+
T Consensus       179 ~~~~~Dv  185 (257)
T cd08223         179 YNYKSDV  185 (257)
T ss_pred             CCchhhh
Confidence            9999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.94  E-value=1.8e-26  Score=162.69  Aligned_cols=156  Identities=28%  Similarity=0.366  Sum_probs=121.8

Q ss_pred             CcEEEEEEccccc-cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccc--ccccCHHH
Q 046065            6 GQIIAVKKLSKKS-TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIR--MLILDCKK   81 (164)
Q Consensus         6 ~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~   81 (164)
                      ...+|+|.+.... ......+.+|+.+++.++||||+++ +.+......++|||++++++|.+++.....  ....+...
T Consensus        22 ~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~  101 (269)
T cd05042          22 KARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDV  101 (269)
T ss_pred             CeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHH
Confidence            4568888775442 2234567889999999999999997 777777889999999999999999876432  12245677


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh----hhhhcccccccCcceecC--
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI----LKQIQIELGYIPPEYVGR--  155 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~aPE~~~~--  155 (164)
                      ...++.|++.|+.|+|+.   +++|+||||+||+++.++.++|+|||++.......    .....+++.|+|||++..  
T Consensus       102 ~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  178 (269)
T cd05042         102 LQRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRG  178 (269)
T ss_pred             HHHHHHHHHHHHHHHHhc---CEecccccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhcc
Confidence            889999999999999998   99999999999999999999999999986532211    123345677999998743  


Q ss_pred             -----CcceeccCC
Q 046065          156 -----GVYYKKFSL  164 (164)
Q Consensus       156 -----~~~~~~~Di  164 (164)
                           ..++.++||
T Consensus       179 ~~~~~~~~~~~~Di  192 (269)
T cd05042         179 QDLLPKDQTKKSNI  192 (269)
T ss_pred             ccccccccchhhHH
Confidence                 345777775

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.94  E-value=1e-26  Score=172.27  Aligned_cols=148  Identities=22%  Similarity=0.250  Sum_probs=123.1

Q ss_pred             CCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHH
Q 046065            5 DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRV   83 (164)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~   83 (164)
                      +++.||+|.+...     ....+|+.+++.++||||+++ ..+......+++||++. ++|..++....   .+++....
T Consensus       118 ~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~---~l~~~~~~  188 (392)
T PHA03207        118 QRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-CDLFTYVDRSG---PLPLEQAI  188 (392)
T ss_pred             cceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-CCHHHHHHhcC---CCCHHHHH
Confidence            3567888887533     234679999999999999997 66677778899999985 57877774332   38899999


Q ss_pred             HHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh----hhhhcccccccCcceecCCcce
Q 046065           84 HIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI----LKQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        84 ~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      .++.|++.||.|||+.   +|+||||||+||+++..+.++|+|||++.......    .....||+.|+|||++....++
T Consensus       189 ~i~~ql~~aL~~LH~~---givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  265 (392)
T PHA03207        189 TIQRRLLEALAYLHGR---GIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYC  265 (392)
T ss_pred             HHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCC
Confidence            9999999999999998   99999999999999999999999999987654321    2346789999999999989999


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      .++||
T Consensus       266 ~~~Dv  270 (392)
T PHA03207        266 AKTDI  270 (392)
T ss_pred             chhhH
Confidence            99996

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=1e-27  Score=167.53  Aligned_cols=154  Identities=24%  Similarity=0.280  Sum_probs=131.1

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+++.+|+|++.+.   .......-+.|-++|+..+||.+..+ -.+...+.+|+||||+.||.|.-.+.....   +.+
T Consensus       191 at~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsrer~---FsE  267 (516)
T KOG0690|consen  191 ATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSRERV---FSE  267 (516)
T ss_pred             ccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhhhhc---ccc
Confidence            57889999999876   34455677889999999999999998 455567789999999999999877754333   888


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhh-hh-hhhhhcccccccCcceecCCc
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILR-KM-ILKQIQIELGYIPPEYVGRGV  157 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~-~~-~~~~~~~~~~~~aPE~~~~~~  157 (164)
                      .....+..+|+.||.|||++   +|+.||+|.+|+|+|.+|.+||.|||+++.-- .. .....||||.|+|||++....
T Consensus       268 ~RtRFYGaEIvsAL~YLHs~---~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnD  344 (516)
T KOG0690|consen  268 DRTRFYGAEIVSALGYLHSR---NIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDND  344 (516)
T ss_pred             hhhhhhhHHHHHHhhhhhhC---CeeeeechhhhheeccCCceEeeecccchhcccccceeccccCChhhcCchhhcccc
Confidence            99999999999999999998   99999999999999999999999999986532 22 236789999999999998888


Q ss_pred             ceeccC
Q 046065          158 YYKKFS  163 (164)
Q Consensus       158 ~~~~~D  163 (164)
                      |+...|
T Consensus       345 YgraVD  350 (516)
T KOG0690|consen  345 YGRAVD  350 (516)
T ss_pred             ccceee
Confidence            887765

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.94  E-value=3.2e-26  Score=161.12  Aligned_cols=155  Identities=25%  Similarity=0.352  Sum_probs=125.7

Q ss_pred             CCCcEEEEEEccccc-----cccHHHHHHHHHHHhccCCCceeeE-eEEeeC--CcEEEEEEecCCCChhhhhhCccccc
Q 046065            4 PDGQIIAVKKLSKKS-----TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIET--QEYMLIYEYMPKRSLDYFLFDPIRML   75 (164)
Q Consensus         4 ~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~   75 (164)
                      .+++.||+|.+....     ......+..|+.+++.++|||++++ +.+...  ..+++++|++++++|.+++.+...  
T Consensus        25 ~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~--  102 (265)
T cd06652          25 DTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGA--  102 (265)
T ss_pred             CCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHcCC--
Confidence            468899999875331     1234567889999999999999997 544442  357799999999999988865432  


Q ss_pred             ccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh-----hhhhhhcccccccCc
Q 046065           76 ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK-----MILKQIQIELGYIPP  150 (164)
Q Consensus        76 ~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~-----~~~~~~~~~~~~~aP  150 (164)
                       ++......++.|++.+|.++|+.   +++|+||+|+||+++.++.++|+|||.+.....     .......++..|+||
T Consensus       103 -~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP  178 (265)
T cd06652         103 -LTENVTRKYTRQILEGVSYLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSP  178 (265)
T ss_pred             -CCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEecCCCCEEECcCccccccccccccccccccCCCCccccCh
Confidence             67888899999999999999988   999999999999999999999999998875432     112335688899999


Q ss_pred             ceecCCcceeccCC
Q 046065          151 EYVGRGVYYKKFSL  164 (164)
Q Consensus       151 E~~~~~~~~~~~Di  164 (164)
                      |...+..++.++|+
T Consensus       179 E~~~~~~~~~~~Dv  192 (265)
T cd06652         179 EVISGEGYGRKADI  192 (265)
T ss_pred             hhhcCCCCCcchhH
Confidence            99988888999986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.94  E-value=3.4e-26  Score=160.87  Aligned_cols=158  Identities=21%  Similarity=0.301  Sum_probs=131.2

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcc-cccccC
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPI-RMLILD   78 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~   78 (164)
                      .+|+.||+|.+...   .......+.+|+.+++.++|+|++++ +.+...+..++++||+++++|..++.... ....++
T Consensus        25 ~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~  104 (267)
T cd08224          25 LDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIP  104 (267)
T ss_pred             CCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcC
Confidence            36889999987532   23345678899999999999999997 77777788899999999999998886422 123378


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh--hhhhhcccccccCcceecCC
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM--ILKQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~~~  156 (164)
                      ......++.+++.++.|+|+.   +++|+|++|+||+++.++.++++|||++..+...  ......+++.|+|||.+.+.
T Consensus       105 ~~~~~~~~~~l~~~l~~lh~~---~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~  181 (267)
T cd08224         105 ERTIWKYFVQLCSALEHMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN  181 (267)
T ss_pred             HHHHHHHHHHHHHHHHHHHhC---CEecCCcChhhEEECCCCcEEEeccceeeeccCCCcccceecCCccccCHHHhccC
Confidence            899999999999999999998   9999999999999999999999999998655432  22345688899999999888


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .++.++|+
T Consensus       182 ~~~~~~Di  189 (267)
T cd08224         182 GYNFKSDI  189 (267)
T ss_pred             CCCchhcH
Confidence            89999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.94  E-value=2.4e-26  Score=163.17  Aligned_cols=157  Identities=29%  Similarity=0.451  Sum_probs=126.6

Q ss_pred             CCcEEEEEEcccccc-ccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcc----------
Q 046065            5 DGQIIAVKKLSKKST-QGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPI----------   72 (164)
Q Consensus         5 ~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------   72 (164)
                      +++.||+|.+..... ...+.+..|+.++..++||||+++ +.+......++++|++++++|..++....          
T Consensus        34 ~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~  113 (283)
T cd05091          34 QTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDD  113 (283)
T ss_pred             ceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCcccccccc
Confidence            357899999875432 234567889999999999999997 77777778899999999999988874211          


Q ss_pred             ---cccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh----hhhhcccc
Q 046065           73 ---RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI----LKQIQIEL  145 (164)
Q Consensus        73 ---~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~  145 (164)
                         ....++......++.|++.|+.|+|++   +++|+||||+||+++.++.++|+|||++.......    .....+++
T Consensus       114 ~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~---gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~  190 (283)
T cd05091         114 DKTVKSTLEPADFVHIVTQIAAGMEFLSSH---HVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPI  190 (283)
T ss_pred             ccccccccCHHHHHHHHHHHHHHHHHHHHc---CccccccchhheEecCCCceEecccccccccccchheeeccCccCCc
Confidence               112367788889999999999999998   99999999999999999999999999987553221    12334567


Q ss_pred             cccCcceecCCcceeccCC
Q 046065          146 GYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       146 ~~~aPE~~~~~~~~~~~Di  164 (164)
                      .|+|||.+.++.++.++||
T Consensus       191 ~y~aPE~~~~~~~~~~~Dv  209 (283)
T cd05091         191 RWMSPEAIMYGKFSIDSDI  209 (283)
T ss_pred             cccCHHHHhcCCCCcchhH
Confidence            8999999988889999986

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.94  E-value=2.8e-26  Score=162.76  Aligned_cols=157  Identities=28%  Similarity=0.471  Sum_probs=128.7

Q ss_pred             CCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccc----------
Q 046065            5 DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIR----------   73 (164)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~----------   73 (164)
                      ++..+|+|.+..........+..|+.+++.++|+||+++ +.+......++++|++++++|.+++.....          
T Consensus        34 ~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~  113 (280)
T cd05092          34 DKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGED  113 (280)
T ss_pred             CceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhccccc
Confidence            456789998765555556678899999999999999998 666777788999999999999988865321          


Q ss_pred             --ccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh----hhhhcccccc
Q 046065           74 --MLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI----LKQIQIELGY  147 (164)
Q Consensus        74 --~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~  147 (164)
                        ...++......++.|++.|+.|+|+.   +++|+||||+||+++.++.++|+|||++.......    .....+++.|
T Consensus       114 ~~~~~l~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y  190 (280)
T cd05092         114 VAPGQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRW  190 (280)
T ss_pred             CCccccCHHHHHHHHHHHHHHHHHHHHC---CeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccc
Confidence              12377888999999999999999988   99999999999999999999999999986543211    1223346789


Q ss_pred             cCcceecCCcceeccCC
Q 046065          148 IPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       148 ~aPE~~~~~~~~~~~Di  164 (164)
                      +|||.+.+..++.++||
T Consensus       191 ~aPE~~~~~~~~~~~Di  207 (280)
T cd05092         191 MPPESILYRKFTTESDI  207 (280)
T ss_pred             cCHHHhccCCcCchhhH
Confidence            99999988889999996

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.94  E-value=1.3e-26  Score=169.79  Aligned_cols=148  Identities=24%  Similarity=0.279  Sum_probs=122.3

Q ss_pred             CCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHH
Q 046065            5 DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRV   83 (164)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~   83 (164)
                      +++.||+|.....      ....|+.+++.++||||+++ +.+...+..++|+|++. ++|.+++....  ..+++....
T Consensus        90 ~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~~~~~~  160 (357)
T PHA03209         90 QPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDLYTYLTKRS--RPLPIDQAL  160 (357)
T ss_pred             CCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-CcHHHHHHhcc--CCCCHHHHH
Confidence            4668888875322      23568999999999999997 77777788899999985 57877775432  237889999


Q ss_pred             HHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh-hhhhhhcccccccCcceecCCcceecc
Q 046065           84 HIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK-MILKQIQIELGYIPPEYVGRGVYYKKF  162 (164)
Q Consensus        84 ~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~  162 (164)
                      .++.|++.||.|+|++   +|+||||||+||+++..+.++|+|||++..... .......|++.|+|||++.+..++.++
T Consensus       161 ~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  237 (357)
T PHA03209        161 IIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSKA  237 (357)
T ss_pred             HHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEecCccccccccCcccccccccccccCCeecCCCCCCchh
Confidence            9999999999999998   999999999999999999999999999865332 223456789999999999999999999


Q ss_pred             CC
Q 046065          163 SL  164 (164)
Q Consensus       163 Di  164 (164)
                      ||
T Consensus       238 Di  239 (357)
T PHA03209        238 DI  239 (357)
T ss_pred             hH
Confidence            96

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.94  E-value=3.7e-26  Score=160.03  Aligned_cols=154  Identities=30%  Similarity=0.476  Sum_probs=128.7

Q ss_pred             CCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHH
Q 046065            5 DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRV   83 (164)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~   83 (164)
                      .|+.||+|.+..... ..+++..|+.+++.++|+|++++ +.+......++|+|++++++|.+++..... ..+++....
T Consensus        28 ~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~  105 (256)
T cd05039          28 RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGR-AVITLAQQL  105 (256)
T ss_pred             cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCC-CCCCHHHHH
Confidence            467899999865533 45678899999999999999997 666667789999999999999999875432 137899999


Q ss_pred             HHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCcceecCCcceeccC
Q 046065           84 HIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKKFS  163 (164)
Q Consensus        84 ~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D  163 (164)
                      .++.|++.|+.|+|+.   +++|+||+|+||+++.++.++|+|||.+....... .....+..|+|||.+..+.++.++|
T Consensus       106 ~~~~qi~~~l~~lh~~---~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~-~~~~~~~~~~ape~~~~~~~~~~~D  181 (256)
T cd05039         106 GFALDVCEGMEYLEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ-DSGKLPVKWTAPEALREKKFSTKSD  181 (256)
T ss_pred             HHHHHHHHHHHHHHhC---CccchhcccceEEEeCCCCEEEccccccccccccc-ccCCCcccccCchhhcCCcCCcHHH
Confidence            9999999999999998   99999999999999999999999999987653222 2334456799999998888888888


Q ss_pred             C
Q 046065          164 L  164 (164)
Q Consensus       164 i  164 (164)
                      |
T Consensus       182 i  182 (256)
T cd05039         182 V  182 (256)
T ss_pred             H
Confidence            5

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.94  E-value=3.4e-26  Score=162.70  Aligned_cols=156  Identities=27%  Similarity=0.431  Sum_probs=121.9

Q ss_pred             CCCcEEEEEEccccc--cccHHHHHHHHHHHhcc---CCCceeeE-eEEee-----CCcEEEEEEecCCCChhhhhhCcc
Q 046065            4 PDGQIIAVKKLSKKS--TQGFEEFKNEVMLTAKL---QHLNLIRV-GFCIE-----TQEYMLIYEYMPKRSLDYFLFDPI   72 (164)
Q Consensus         4 ~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~i~~~-~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~   72 (164)
                      .+++.||+|.+....  ......+..|+.+++.+   +||||+++ +.+..     ....++++|++++ +|..++....
T Consensus        23 ~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~  101 (288)
T cd07863          23 HSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVP  101 (288)
T ss_pred             CCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEccccc-CHHHHHHhcC
Confidence            468899999986542  22233456677776665   69999997 44432     2347899999974 7877775432


Q ss_pred             cccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh-hhhhcccccccCcc
Q 046065           73 RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI-LKQIQIELGYIPPE  151 (164)
Q Consensus        73 ~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~aPE  151 (164)
                      . ..+++..+..++.|++.|+.|+|+.   +++|+||||+||+++.++.++|+|||++....... .....+++.|+|||
T Consensus       102 ~-~~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE  177 (288)
T cd07863         102 P-PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPE  177 (288)
T ss_pred             C-CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccCccccccCcccCCCccccccccCch
Confidence            2 2378899999999999999999998   99999999999999999999999999987654322 23456788999999


Q ss_pred             eecCCcceeccCC
Q 046065          152 YVGRGVYYKKFSL  164 (164)
Q Consensus       152 ~~~~~~~~~~~Di  164 (164)
                      ++.+..++.++||
T Consensus       178 ~~~~~~~~~~~Di  190 (288)
T cd07863         178 VLLQSTYATPVDM  190 (288)
T ss_pred             HhhCCCCCCcchh
Confidence            9988899999996

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.94  E-value=3.9e-26  Score=160.96  Aligned_cols=158  Identities=27%  Similarity=0.414  Sum_probs=127.8

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      .++..||+|.+........+.+.+|+.+++.++|+||+++ +.+...+..++++|++++++|.+++.........+....
T Consensus        31 ~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~  110 (268)
T cd06624          31 STQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTI  110 (268)
T ss_pred             CCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHH
Confidence            4577899998876555556778899999999999999997 777777888999999999999998875322211377888


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecC-CCCeEEccccchhhhhhh--hhhhhcccccccCcceecCCc--
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE-DLKPKISDFGLARILRKM--ILKQIQIELGYIPPEYVGRGV--  157 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~-~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~--  157 (164)
                      ..++.|++.|+.|+|+.   +++|+|++|+||+++. .+.++|+|||.+......  ......+++.|+|||.+.+..  
T Consensus       111 ~~~~~qi~~al~~lH~~---~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  187 (268)
T cd06624         111 IFYTKQILEGLKYLHDN---QIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRG  187 (268)
T ss_pred             HHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCccccCCCCccccChhhhcccccc
Confidence            88999999999999988   9999999999999976 678999999998654321  123345788999999986543  


Q ss_pred             ceeccCC
Q 046065          158 YYKKFSL  164 (164)
Q Consensus       158 ~~~~~Di  164 (164)
                      ++.++|+
T Consensus       188 ~~~~~Dv  194 (268)
T cd06624         188 YGAPADI  194 (268)
T ss_pred             CCchhhh
Confidence            7888885

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.94  E-value=2.1e-26  Score=162.08  Aligned_cols=155  Identities=28%  Similarity=0.433  Sum_probs=129.5

Q ss_pred             CCCcEEEEEEccccc------cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccc
Q 046065            4 PDGQIIAVKKLSKKS------TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLI   76 (164)
Q Consensus         4 ~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~   76 (164)
                      .+++.+|+|.+....      ......+..|+.+++.++|+|++++ +.+...+..++|+|++++++|.+++.+..   .
T Consensus        23 ~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~---~   99 (268)
T cd06630          23 KTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYG---A   99 (268)
T ss_pred             CCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHHHhC---C
Confidence            578899999986432      1134678889999999999999997 77777888999999999999999886533   2


Q ss_pred             cCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCC-CeEEccccchhhhhhhh------hhhhcccccccC
Q 046065           77 LDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL-KPKISDFGLARILRKMI------LKQIQIELGYIP  149 (164)
Q Consensus        77 ~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~-~~~l~dfg~~~~~~~~~------~~~~~~~~~~~a  149 (164)
                      +++.....++.|++.|+.++|+.   +++|+||+|+||+++.++ .++|+|||.+.......      .....++..|+|
T Consensus       100 ~~~~~~~~~~~ql~~al~~LH~~---~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (268)
T cd06630         100 FKEAVIINYTEQLLRGLSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMA  176 (268)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeC
Confidence            78899999999999999999998   999999999999998775 59999999987654321      123567889999


Q ss_pred             cceecCCcceeccCC
Q 046065          150 PEYVGRGVYYKKFSL  164 (164)
Q Consensus       150 PE~~~~~~~~~~~Di  164 (164)
                      ||.+.+..++.++|+
T Consensus       177 PE~~~~~~~~~~~Dv  191 (268)
T cd06630         177 PEVLRGEQYGRSCDV  191 (268)
T ss_pred             HhHhccCCCCcccch
Confidence            999988888999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.94  E-value=3e-26  Score=160.66  Aligned_cols=153  Identities=26%  Similarity=0.424  Sum_probs=126.0

Q ss_pred             CcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHHH
Q 046065            6 GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVH   84 (164)
Q Consensus         6 ~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~   84 (164)
                      +..+|+|.+.... .....+..|+.+++.++||||+++ +.+......+++||++++++|.+++.....  .+++.....
T Consensus        28 ~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~--~~~~~~~~~  104 (256)
T cd05113          28 QYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGK--RFQPSQLLE  104 (256)
T ss_pred             CCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCC--CCCHHHHHH
Confidence            4469999876432 234568899999999999999998 666667778999999999999998865332  378899999


Q ss_pred             HHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhh---hhcccccccCcceecCCcceec
Q 046065           85 IIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILK---QIQIELGYIPPEYVGRGVYYKK  161 (164)
Q Consensus        85 ~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~aPE~~~~~~~~~~  161 (164)
                      ++.|++.|+.|+|+.   +++|+|++|+||+++.++.++|+|||.+.........   ...++..|+|||...+..++.+
T Consensus       105 ~~~~i~~~l~~lH~~---~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~  181 (256)
T cd05113         105 MCKDVCEGMAYLESK---QFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSK  181 (256)
T ss_pred             HHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhcCcccch
Confidence            999999999999988   9999999999999999999999999988755433221   2334567999999988889999


Q ss_pred             cCC
Q 046065          162 FSL  164 (164)
Q Consensus       162 ~Di  164 (164)
                      +||
T Consensus       182 ~Di  184 (256)
T cd05113         182 SDV  184 (256)
T ss_pred             hHH
Confidence            986

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.94  E-value=4.1e-26  Score=160.21  Aligned_cols=156  Identities=29%  Similarity=0.420  Sum_probs=126.6

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeEeEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRV   83 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~   83 (164)
                      +++..+|+|.+..... ....+.+|+.++++++|+|++++..+......+++||++++++|.+++.+... ..++.....
T Consensus        28 ~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~  105 (260)
T cd05070          28 NGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKDGEG-RALKLPNLV  105 (260)
T ss_pred             cCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEECCCCcEEEEEecCCCcHHHHHHhcCC-CCCCHHHHH
Confidence            4567799999865422 34568899999999999999998444455678899999999999998865322 237888999


Q ss_pred             HHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh---hhhcccccccCcceecCCccee
Q 046065           84 HIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL---KQIQIELGYIPPEYVGRGVYYK  160 (164)
Q Consensus        84 ~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~  160 (164)
                      .++.+++.|+.|+|+.   +++|+|++|+||+++.++.++|+|||.+........   ....++..|+|||...+..++.
T Consensus       106 ~~~~~l~~al~~lH~~---~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  182 (260)
T cd05070         106 DMAAQVAAGMAYIERM---NYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI  182 (260)
T ss_pred             HHHHHHHHHHHHHHHC---CcccCCCccceEEEeCCceEEeCCceeeeeccCcccccccCCCCCccccChHHHhcCCCcc
Confidence            9999999999999998   999999999999999999999999999876543221   2233456799999998888999


Q ss_pred             ccCC
Q 046065          161 KFSL  164 (164)
Q Consensus       161 ~~Di  164 (164)
                      ++||
T Consensus       183 ~~Di  186 (260)
T cd05070         183 KSDV  186 (260)
T ss_pred             hhhh
Confidence            9986

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.94  E-value=2.2e-26  Score=165.46  Aligned_cols=155  Identities=25%  Similarity=0.409  Sum_probs=123.8

Q ss_pred             CCCcEEEEEEccccc-cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            4 PDGQIIAVKKLSKKS-TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         4 ~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      .+++.||+|.+.... ......+.+|+.+++.++||||+++ +.+...+..++|||++++ +|.+.+.....  .++...
T Consensus        29 ~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~--~~~~~~  105 (309)
T cd07872          29 LTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGN--IMSMHN  105 (309)
T ss_pred             CCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-CHHHHHHhcCC--CCCHHH
Confidence            357789999986542 2233457789999999999999998 777777889999999975 77777654322  267888


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh--hhhhhhcccccccCcceecC-Ccc
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK--MILKQIQIELGYIPPEYVGR-GVY  158 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~~aPE~~~~-~~~  158 (164)
                      ...++.|++.|+.|+|+.   +++|+||||+||+++.++.++|+|||++.....  .......+++.|+|||.+.+ ..+
T Consensus       106 ~~~~~~qi~~aL~~lH~~---~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  182 (309)
T cd07872         106 VKIFLYQILRGLAYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEY  182 (309)
T ss_pred             HHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEECccccceecCCCccccccccccccccCCHHHhCCCCC
Confidence            889999999999999998   999999999999999999999999999865432  12234567889999998854 457


Q ss_pred             eeccCC
Q 046065          159 YKKFSL  164 (164)
Q Consensus       159 ~~~~Di  164 (164)
                      +.++||
T Consensus       183 ~~~~Di  188 (309)
T cd07872         183 STQIDM  188 (309)
T ss_pred             CcHHHH
Confidence            888885

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.94  E-value=4.6e-26  Score=161.60  Aligned_cols=155  Identities=28%  Similarity=0.306  Sum_probs=122.0

Q ss_pred             CCCcEEEEEEcccccc---ccHHHHHHHHH---HHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccc
Q 046065            4 PDGQIIAVKKLSKKST---QGFEEFKNEVM---LTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLI   76 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~---~~~~~~~~e~~---~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~   76 (164)
                      .+++.||+|.+.....   ........|..   .++...||+++.+ ..+...+..++|+||+++++|.+.+....   .
T Consensus        17 ~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~~---~   93 (278)
T cd05606          17 DTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG---V   93 (278)
T ss_pred             cCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHhcC---C
Confidence            4578999999865421   11112333433   4444579999997 55666778899999999999988876533   2


Q ss_pred             cCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCcceecCC
Q 046065           77 LDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        77 ~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~  156 (164)
                      +++..+..++.|++.|+.|+|+.   +++|+|++|+||+++.++.++|+|||++..+.........|+..|+|||.+.++
T Consensus        94 l~~~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~  170 (278)
T cd05606          94 FSEAEMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKG  170 (278)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHC---CEEcCCCCHHHEEECCCCCEEEccCcCccccCccCCcCcCCCcCCcCcHHhcCC
Confidence            88999999999999999999998   999999999999999999999999999876544333455789999999999755


Q ss_pred             -cceeccCC
Q 046065          157 -VYYKKFSL  164 (164)
Q Consensus       157 -~~~~~~Di  164 (164)
                       .++.++||
T Consensus       171 ~~~~~~~Di  179 (278)
T cd05606         171 VAYDSSADW  179 (278)
T ss_pred             CCCCcccch
Confidence             68899986

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.94  E-value=2.2e-26  Score=163.02  Aligned_cols=154  Identities=24%  Similarity=0.359  Sum_probs=129.4

Q ss_pred             CCCcEEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            4 PDGQIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         4 ~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      .+++.||+|.+... .......+..|+.+++.++|||++++ +.+...+..++|+|++++++|.+++...    .++...
T Consensus        27 ~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~  102 (277)
T cd06642          27 RTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPG----PLEETY  102 (277)
T ss_pred             CCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhcC----CCCHHH
Confidence            35778999987644 23345678899999999999999997 7777778899999999999998887542    277888


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh--hhhhhcccccccCcceecCCcce
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM--ILKQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      ...++.+++.|+.|+|+.   +++|+|++|+||+++.++.++++|||++..+...  ......++..|+|||.+.+..++
T Consensus       103 ~~~~~~~i~~~l~~lH~~---~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  179 (277)
T cd06642         103 IATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD  179 (277)
T ss_pred             HHHHHHHHHHHHHHHhcC---CeeccCCChheEEEeCCCCEEEccccccccccCcchhhhcccCcccccCHHHhCcCCCc
Confidence            899999999999999988   9999999999999999999999999998765432  22345678899999999888899


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      .++|+
T Consensus       180 ~~~Dv  184 (277)
T cd06642         180 FKADI  184 (277)
T ss_pred             hhhhH
Confidence            99985

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.94  E-value=4.8e-26  Score=161.68  Aligned_cols=155  Identities=25%  Similarity=0.317  Sum_probs=127.1

Q ss_pred             CCCcEEEEEEccccc--cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            4 PDGQIIAVKKLSKKS--TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         4 ~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      .+++.||+|.+....  ....+.+..|+.+++.++|||++++ +.+......++|+|+++++.+..+.....   .+++.
T Consensus        24 ~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~---~~~~~  100 (286)
T cd07847          24 ETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPR---GVPEH  100 (286)
T ss_pred             CCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhCCC---CCCHH
Confidence            368899999876442  2234567889999999999999997 77777778899999999988887765433   28899


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh--hhhhcccccccCcceecC-Cc
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI--LKQIQIELGYIPPEYVGR-GV  157 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~aPE~~~~-~~  157 (164)
                      ....++.|++.+|.|+|+.   +++|+|++|+||+++.++.++|+|||++.......  .....++..|+|||.+.+ ..
T Consensus       101 ~~~~~~~ql~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  177 (286)
T cd07847         101 LIKKIIWQTLQAVNFCHKH---NCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQ  177 (286)
T ss_pred             HHHHHHHHHHHHHHHHHHC---CceecCCChhhEEEcCCCcEEECccccceecCCCcccccCcccccccCCHHHHhCCCC
Confidence            9999999999999999998   99999999999999999999999999987654322  234557788999999865 45


Q ss_pred             ceeccCC
Q 046065          158 YYKKFSL  164 (164)
Q Consensus       158 ~~~~~Di  164 (164)
                      ++.++||
T Consensus       178 ~~~~~Di  184 (286)
T cd07847         178 YGPPVDV  184 (286)
T ss_pred             cCchhhh
Confidence            7888886

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.94  E-value=2.8e-26  Score=160.66  Aligned_cols=148  Identities=22%  Similarity=0.345  Sum_probs=121.8

Q ss_pred             EEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHHHHH
Q 046065            8 IIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHII   86 (164)
Q Consensus         8 ~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~   86 (164)
                      .+++|.+...... ...+.+|+.+++.++|||++++ +.+.. +..++|+|++++++|.+++.....  .++...+..++
T Consensus        32 ~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~  107 (259)
T cd05037          32 SVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKN--NVSLHWKLDVA  107 (259)
T ss_pred             eeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhcc--CCCHHHHHHHH
Confidence            5777776544332 5678899999999999999997 65655 778999999999999999876432  37888999999


Q ss_pred             HHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCC-------CeEEccccchhhhhhhhhhhhcccccccCcceecCC--c
Q 046065           87 KGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL-------KPKISDFGLARILRKMILKQIQIELGYIPPEYVGRG--V  157 (164)
Q Consensus        87 ~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~-------~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~--~  157 (164)
                      .|++.||.|+|++   +++|+||||+||+++..+       .++++|||++.....  .....++..|+|||++...  .
T Consensus       108 ~~i~~~l~~LH~~---~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~--~~~~~~~~~y~aPE~~~~~~~~  182 (259)
T cd05037         108 KQLASALHYLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS--REERVERIPWIAPECIRNGQAS  182 (259)
T ss_pred             HHHHHHHHHHhhC---CeecccCccceEEEecCccccCCceeEEeCCCCccccccc--ccccccCCCccChhhhcCCCCC
Confidence            9999999999988   999999999999999877       799999999876443  2234567789999999776  7


Q ss_pred             ceeccCC
Q 046065          158 YYKKFSL  164 (164)
Q Consensus       158 ~~~~~Di  164 (164)
                      ++.++||
T Consensus       183 ~~~~~Di  189 (259)
T cd05037         183 LTIAADK  189 (259)
T ss_pred             cchhhHH
Confidence            7888885

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.94  E-value=4.4e-26  Score=160.63  Aligned_cols=153  Identities=28%  Similarity=0.461  Sum_probs=125.3

Q ss_pred             cEEEEEEccccc-cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHHH
Q 046065            7 QIIAVKKLSKKS-TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVH   84 (164)
Q Consensus         7 ~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~   84 (164)
                      ..+|+|.+.... ......+..|+.+++.++||||+++ +.+...+..++|||++++++|.+++....  ..++......
T Consensus        33 ~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~  110 (267)
T cd05066          33 IPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHD--GQFTVIQLVG  110 (267)
T ss_pred             eEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcC--CCCCHHHHHH
Confidence            479999886542 2334578889999999999999998 66667778899999999999999986532  2378888899


Q ss_pred             HHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh-----hhhcccccccCcceecCCcce
Q 046065           85 IIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL-----KQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        85 ~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      ++.|++.|+.++|+.   +++|+|+||+|++++.++.++++|||.+........     ....++..|+|||.+.++.++
T Consensus       111 i~~~i~~~l~~lH~~---~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~  187 (267)
T cd05066         111 MLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFT  187 (267)
T ss_pred             HHHHHHHHHHHHHHC---CEeehhhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccC
Confidence            999999999999998   999999999999999999999999999876543221     112234579999999888899


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      .++|+
T Consensus       188 ~~~Dv  192 (267)
T cd05066         188 SASDV  192 (267)
T ss_pred             chhhh
Confidence            99986

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.94  E-value=2e-26  Score=169.08  Aligned_cols=152  Identities=27%  Similarity=0.338  Sum_probs=122.5

Q ss_pred             CCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEeeC------CcEEEEEEecCCCChhhhhhCcccc
Q 046065            4 PDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIET------QEYMLIYEYMPKRSLDYFLFDPIRM   74 (164)
Q Consensus         4 ~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~   74 (164)
                      .+++.||+|.+...  .......+.+|+.+++.++||||+++ +.+...      ...++|||++++ +|...+..    
T Consensus        47 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~----  121 (364)
T cd07875          47 ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQM----  121 (364)
T ss_pred             CCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCCCC-CHHHHHHh----
Confidence            35778999998643  23334567889999999999999997 443322      347899999965 66665532    


Q ss_pred             cccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh-hhhhcccccccCccee
Q 046065           75 LILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI-LKQIQIELGYIPPEYV  153 (164)
Q Consensus        75 ~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~aPE~~  153 (164)
                       .++......++.|++.||.|+|+.   +++|+||||+||+++.++.++|+|||++....... .....+++.|+|||++
T Consensus       122 -~~~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~  197 (364)
T cd07875         122 -ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI  197 (364)
T ss_pred             -cCCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEECCCCcEEEEeCCCccccCCCCcccCCcccCCcCCHHHH
Confidence             267788889999999999999998   99999999999999999999999999997654332 2445789999999999


Q ss_pred             cCCcceeccCC
Q 046065          154 GRGVYYKKFSL  164 (164)
Q Consensus       154 ~~~~~~~~~Di  164 (164)
                      .+..++.++||
T Consensus       198 ~~~~~~~~~Di  208 (364)
T cd07875         198 LGMGYKENVDI  208 (364)
T ss_pred             hCCCCCchhhH
Confidence            98899999996

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.94  E-value=1.1e-26  Score=170.06  Aligned_cols=152  Identities=28%  Similarity=0.346  Sum_probs=122.3

Q ss_pred             CCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEeeC------CcEEEEEEecCCCChhhhhhCcccc
Q 046065            4 PDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIET------QEYMLIYEYMPKRSLDYFLFDPIRM   74 (164)
Q Consensus         4 ~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~   74 (164)
                      .+++.||+|.+...  .......+.+|+.+++.++||||+++ +.+...      ...++|||++++ ++.+.+..    
T Consensus        40 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~----  114 (355)
T cd07874          40 VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQVIQM----  114 (355)
T ss_pred             CCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhhcc-cHHHHHhh----
Confidence            45788999998643  22334567789999999999999997 444322      246899999975 56555532    


Q ss_pred             cccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh-hhhhcccccccCccee
Q 046065           75 LILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI-LKQIQIELGYIPPEYV  153 (164)
Q Consensus        75 ~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~aPE~~  153 (164)
                       .++......++.|++.||.|||+.   +++||||||+||+++.++.++|+|||+++...... .....+++.|+|||++
T Consensus       115 -~l~~~~~~~~~~qi~~aL~~LH~~---givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~  190 (355)
T cd07874         115 -ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI  190 (355)
T ss_pred             -cCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChHHEEECCCCCEEEeeCcccccCCCccccCCccccCCccCHHHH
Confidence             277888889999999999999998   99999999999999999999999999997654332 2446789999999999


Q ss_pred             cCCcceeccCC
Q 046065          154 GRGVYYKKFSL  164 (164)
Q Consensus       154 ~~~~~~~~~Di  164 (164)
                      .+..++.++||
T Consensus       191 ~~~~~~~~~Di  201 (355)
T cd07874         191 LGMGYKENVDI  201 (355)
T ss_pred             cCCCCCchhhH
Confidence            88899999996

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.94  E-value=5.9e-26  Score=160.11  Aligned_cols=153  Identities=28%  Similarity=0.475  Sum_probs=125.3

Q ss_pred             cEEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHHH
Q 046065            7 QIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVH   84 (164)
Q Consensus         7 ~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~   84 (164)
                      ..||+|.+... .......+..|+.+++.++||||+++ +.+......++|+|++++++|.+++....  ..++......
T Consensus        33 ~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~  110 (269)
T cd05065          33 IFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQND--GQFTVIQLVG  110 (269)
T ss_pred             eeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhCC--CCCCHHHHHH
Confidence            36999998654 34445678999999999999999998 66666777899999999999998886532  2378888999


Q ss_pred             HHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh----hhhc---ccccccCcceecCCc
Q 046065           85 IIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL----KQIQ---IELGYIPPEYVGRGV  157 (164)
Q Consensus        85 ~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~----~~~~---~~~~~~aPE~~~~~~  157 (164)
                      ++.|++.|+.|+|+.   +++|+|++|+||+++.++.++++|||++........    ....   .+..|+|||.+.+..
T Consensus       111 i~~~l~~al~~lH~~---g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~  187 (269)
T cd05065         111 MLRGIAAGMKYLSEM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRK  187 (269)
T ss_pred             HHHHHHHHHHHHHHC---CEeecccChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCc
Confidence            999999999999998   999999999999999999999999999875542211    1111   134799999999899


Q ss_pred             ceeccCC
Q 046065          158 YYKKFSL  164 (164)
Q Consensus       158 ~~~~~Di  164 (164)
                      ++.++||
T Consensus       188 ~~~~~Dv  194 (269)
T cd05065         188 FTSASDV  194 (269)
T ss_pred             ccchhhh
Confidence            9999996

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.94  E-value=4.8e-26  Score=160.17  Aligned_cols=155  Identities=28%  Similarity=0.429  Sum_probs=125.2

Q ss_pred             CCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeEeEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHHH
Q 046065            5 DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVH   84 (164)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~   84 (164)
                      +...||+|.+..... ....+..|+.+++.++|||++++.........+++||++++++|.+++.+... ..++......
T Consensus        29 ~~~~valK~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~  106 (262)
T cd05071          29 GTTRVAIKTLKPGTM-SPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMG-KYLRLPQLVD  106 (262)
T ss_pred             CCceEEEEecccCcc-CHHHHHHHHHHHHhCCCCCcceEEEEECCCCcEEEEEcCCCCcHHHHHhhccc-cCCCHHHHHH
Confidence            345799999864322 33567889999999999999998444455668899999999999999865322 2367888899


Q ss_pred             HHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh---hhhcccccccCcceecCCcceec
Q 046065           85 IIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL---KQIQIELGYIPPEYVGRGVYYKK  161 (164)
Q Consensus        85 ~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~  161 (164)
                      ++.|++.||.++|+.   +++|+|++|+||+++.++.++|+|||.+........   ....++..|+|||...+..++.+
T Consensus       107 ~~~~l~~aL~~lH~~---~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~  183 (262)
T cd05071         107 MAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK  183 (262)
T ss_pred             HHHHHHHHHHHHHHC---CccccccCcccEEEcCCCcEEeccCCceeeccccccccccCCcccceecCHhHhccCCCCch
Confidence            999999999999998   999999999999999999999999999875543221   23345678999999988889999


Q ss_pred             cCC
Q 046065          162 FSL  164 (164)
Q Consensus       162 ~Di  164 (164)
                      +||
T Consensus       184 ~Dv  186 (262)
T cd05071         184 SDV  186 (262)
T ss_pred             hhH
Confidence            986

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=5.4e-26  Score=160.67  Aligned_cols=154  Identities=25%  Similarity=0.361  Sum_probs=131.8

Q ss_pred             CCCcEEEEEEccccc-cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            4 PDGQIIAVKKLSKKS-TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         4 ~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      .+++.||+|.+.... ......+..|+.+++.++|+|++++ +.+......++|+|++++++|.+++...    .++...
T Consensus        24 ~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~----~~~~~~   99 (274)
T cd06609          24 RTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG----KLDETY   99 (274)
T ss_pred             CCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhhc----CCCHHH
Confidence            467899999986542 3445677889999999999999998 6667777889999999999999988754    388999


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh--hhhhhcccccccCcceecCCcce
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM--ILKQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      ...++.|++.++.++|+.   +++|+|++|+|++++.++.++++|||++......  ......+++.|+|||.+.+..++
T Consensus       100 ~~~~~~ql~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~  176 (274)
T cd06609         100 IAFILREVLLGLEYLHEE---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYD  176 (274)
T ss_pred             HHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEcccccceeecccccccccccCCccccChhhhccCCCC
Confidence            999999999999999998   9999999999999999999999999998766432  22445678899999999888899


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      .++||
T Consensus       177 ~~sDv  181 (274)
T cd06609         177 EKADI  181 (274)
T ss_pred             chhhH
Confidence            99996

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.94  E-value=6.9e-26  Score=163.23  Aligned_cols=156  Identities=29%  Similarity=0.427  Sum_probs=125.5

Q ss_pred             CcEEEEEEcccc-ccccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccc---------
Q 046065            6 GQIIAVKKLSKK-STQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIR---------   73 (164)
Q Consensus         6 ~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---------   73 (164)
                      ...+|+|.+... .......+..|+.+++.+ +||||+++ +.+...+..++++||+++++|.+++.....         
T Consensus        44 ~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~  123 (314)
T cd05099          44 TVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDI  123 (314)
T ss_pred             ceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccc
Confidence            457899987644 233456688899999999 69999997 666677778999999999999998865321         


Q ss_pred             ----ccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh----hhhcccc
Q 046065           74 ----MLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL----KQIQIEL  145 (164)
Q Consensus        74 ----~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~  145 (164)
                          ...++......++.|++.|+.|+|++   +++|+|+||+||+++.++.++|+|||.++.......    ....++.
T Consensus       124 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~  200 (314)
T cd05099         124 TKVPEEQLSFKDLVSCAYQVARGMEYLESR---RCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPV  200 (314)
T ss_pred             cCCcccccCHHHHHHHHHHHHHHHHHHHHC---CeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCc
Confidence                12377788889999999999999988   999999999999999999999999999976542211    1123345


Q ss_pred             cccCcceecCCcceeccCC
Q 046065          146 GYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       146 ~~~aPE~~~~~~~~~~~Di  164 (164)
                      .|+|||.+.+..++.++||
T Consensus       201 ~y~aPE~~~~~~~~~~~Di  219 (314)
T cd05099         201 KWMAPEALFDRVYTHQSDV  219 (314)
T ss_pred             cccCHHHHccCCcCccchh
Confidence            7999999988889999996

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.94  E-value=5.7e-26  Score=160.90  Aligned_cols=157  Identities=27%  Similarity=0.340  Sum_probs=129.7

Q ss_pred             CCCcEEEEEEccccc---cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKKS---TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+|+.||+|.+....   ......+..|+.+++.++|||++++ ..+...+..++|+|++++++|.+++..... ..+++
T Consensus        16 ~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~   94 (277)
T cd05577          16 ATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGE-PGFPE   94 (277)
T ss_pred             CCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCc-CCCCH
Confidence            468899999886432   2234456789999999999999998 666667789999999999999988865432 23788


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh-hhhhhhcccccccCcceecCCcc
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK-MILKQIQIELGYIPPEYVGRGVY  158 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~  158 (164)
                      .....++.|++.++.|+|+.   +++|+||+|+||+++.++.++|+|||.+..... .......++..|+|||.+.+..+
T Consensus        95 ~~~~~~~~ql~~~l~~lH~~---~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~  171 (277)
T cd05577          95 ARAIFYAAQIICGLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVY  171 (277)
T ss_pred             HHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCCcCCHHHhcCCCC
Confidence            99999999999999999998   999999999999999999999999999876542 22234567889999999988889


Q ss_pred             eeccCC
Q 046065          159 YKKFSL  164 (164)
Q Consensus       159 ~~~~Di  164 (164)
                      +.++||
T Consensus       172 ~~~~Di  177 (277)
T cd05577         172 DFSVDW  177 (277)
T ss_pred             Cchhhh
Confidence            999986

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.94  E-value=7e-26  Score=159.80  Aligned_cols=156  Identities=31%  Similarity=0.408  Sum_probs=122.3

Q ss_pred             CcEEEEEEccccc-cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccc--ccccCHHH
Q 046065            6 GQIIAVKKLSKKS-TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIR--MLILDCKK   81 (164)
Q Consensus         6 ~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~~   81 (164)
                      +..+|+|.+.... ......+..|+.+++.++||||+++ +.+......++||||+++++|.+++.....  ....+...
T Consensus        22 ~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~  101 (269)
T cd05087          22 PAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTT  101 (269)
T ss_pred             ceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHH
Confidence            4578999876543 2233467889999999999999997 666677778999999999999998865321  22355667


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh----hhhhcccccccCcceecCC-
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI----LKQIQIELGYIPPEYVGRG-  156 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~aPE~~~~~-  156 (164)
                      ...++.|++.|+.|+|+.   +++|+|+||+||+++.++.++|+|||++.......    .....++..|+|||++.+. 
T Consensus       102 ~~~~~~qi~~al~~lH~~---~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  178 (269)
T cd05087         102 LQRMACEIALGLLHLHKN---NFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVH  178 (269)
T ss_pred             HHHHHHHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhcccc
Confidence            778999999999999998   99999999999999999999999999986443221    1234567889999998532 


Q ss_pred             ------cceeccCC
Q 046065          157 ------VYYKKFSL  164 (164)
Q Consensus       157 ------~~~~~~Di  164 (164)
                            .++.++||
T Consensus       179 ~~~~~~~~~~~~Di  192 (269)
T cd05087         179 GNLLVVDQTKESNV  192 (269)
T ss_pred             ccccccCCCccchh
Confidence                  35778886

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.94  E-value=4.5e-26  Score=161.55  Aligned_cols=152  Identities=22%  Similarity=0.298  Sum_probs=123.3

Q ss_pred             EEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeEeEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHHHHH
Q 046065            8 IIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHII   86 (164)
Q Consensus         8 ~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~   86 (164)
                      .||+|.+... .......+..|+.+++.++|||++++..+......++++|++++|+|.+++.+...  .++......++
T Consensus        38 ~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~l~~~~~~~g~l~~~l~~~~~--~~~~~~~~~~~  115 (279)
T cd05109          38 PVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQLVTQLMPYGCLLDYVRENKD--RIGSQDLLNWC  115 (279)
T ss_pred             EEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCCcEEEEEcCCCCCHHHHHhhccC--CCCHHHHHHHH
Confidence            4899988644 33345678889999999999999998434345567799999999999988865322  37889999999


Q ss_pred             HHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh----hhhcccccccCcceecCCcceecc
Q 046065           87 KGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL----KQIQIELGYIPPEYVGRGVYYKKF  162 (164)
Q Consensus        87 ~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~  162 (164)
                      .|++.|+.|+|+.   +++|+||||+||+++.++.++|+|||+++.......    ....+++.|+|||.+.+..++.++
T Consensus       116 ~qi~~~L~~lH~~---~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~  192 (279)
T cd05109         116 VQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQS  192 (279)
T ss_pred             HHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchh
Confidence            9999999999998   999999999999999999999999999876543211    223346789999999888899999


Q ss_pred             CC
Q 046065          163 SL  164 (164)
Q Consensus       163 Di  164 (164)
                      ||
T Consensus       193 Di  194 (279)
T cd05109         193 DV  194 (279)
T ss_pred             HH
Confidence            86

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.94  E-value=6.2e-26  Score=160.97  Aligned_cols=152  Identities=24%  Similarity=0.364  Sum_probs=121.9

Q ss_pred             EEEEEEccccc-cccHHHHHHHHHHHhccCCCceeeEeEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHHHHH
Q 046065            8 IIAVKKLSKKS-TQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHII   86 (164)
Q Consensus         8 ~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~   86 (164)
                      .+++|.+.... ......+..|+..++.++||||+++..+......++++|++++|+|.+++.....  .+++.....++
T Consensus        38 ~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~~~~~~i~e~~~~gsL~~~l~~~~~--~~~~~~~~~i~  115 (279)
T cd05111          38 PVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGASLQLVTQLSPLGSLLDHVRQHRD--SLDPQRLLNWC  115 (279)
T ss_pred             EEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECCCccEEEEEeCCCCcHHHHHHhccc--CCCHHHHHHHH
Confidence            47778775332 2233566778888999999999998444455667899999999999999865322  37888999999


Q ss_pred             HHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh----hhhhhcccccccCcceecCCcceecc
Q 046065           87 KGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM----ILKQIQIELGYIPPEYVGRGVYYKKF  162 (164)
Q Consensus        87 ~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~  162 (164)
                      .|++.|+.|+|+.   +++|+||||+||+++.++.++|+|||.++.....    ......++..|+|||.+.++.++.++
T Consensus       116 ~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~  192 (279)
T cd05111         116 VQIAKGMYYLEEH---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQS  192 (279)
T ss_pred             HHHHHHHHHHHHC---CEeccccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchh
Confidence            9999999999998   9999999999999999999999999998754321    11334567789999999888999999


Q ss_pred             CC
Q 046065          163 SL  164 (164)
Q Consensus       163 Di  164 (164)
                      ||
T Consensus       193 Dv  194 (279)
T cd05111         193 DV  194 (279)
T ss_pred             hH
Confidence            96

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.94  E-value=6.9e-26  Score=161.21  Aligned_cols=154  Identities=25%  Similarity=0.402  Sum_probs=129.9

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      .+++.+++|.+..........+.+|+.+++.++|||++++ +.+...+..++++|++++++|.+++...    .++....
T Consensus        42 ~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~----~~~~~~~  117 (285)
T cd06648          42 STGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHT----RMNEEQI  117 (285)
T ss_pred             CCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHhC----CCCHHHH
Confidence            4678899998865444445568899999999999999997 7677778899999999999999888662    2788888


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh--hhhhcccccccCcceecCCccee
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI--LKQIQIELGYIPPEYVGRGVYYK  160 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~  160 (164)
                      ..++.|++.++.++|++   +++|+||+|+||+++.++.++|+|||++.......  .....+++.|+|||...+..++.
T Consensus       118 ~~~~~ql~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  194 (285)
T cd06648         118 ATVCLAVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGT  194 (285)
T ss_pred             HHHHHHHHHHHHHHHhC---CeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccccccCCccccCHHHhcCCCCCC
Confidence            99999999999999998   99999999999999999999999999876543321  23356888999999998888999


Q ss_pred             ccCC
Q 046065          161 KFSL  164 (164)
Q Consensus       161 ~~Di  164 (164)
                      ++||
T Consensus       195 ~~Dv  198 (285)
T cd06648         195 EVDI  198 (285)
T ss_pred             cccH
Confidence            9985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.94  E-value=4.7e-26  Score=162.22  Aligned_cols=156  Identities=22%  Similarity=0.359  Sum_probs=124.1

Q ss_pred             CcEEEEEEccccc-cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccc-------ccc
Q 046065            6 GQIIAVKKLSKKS-TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIR-------MLI   76 (164)
Q Consensus         6 ~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------~~~   76 (164)
                      +..||+|.+.... ......+..|+.+++.++|||++++ +.+......++||||+++|+|.+++.....       ...
T Consensus        36 ~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~  115 (288)
T cd05061          36 ETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP  115 (288)
T ss_pred             ceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCC
Confidence            4579999876442 2334467889999999999999997 666677788999999999999999864221       122


Q ss_pred             cCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh----hhhcccccccCcce
Q 046065           77 LDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL----KQIQIELGYIPPEY  152 (164)
Q Consensus        77 ~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~aPE~  152 (164)
                      ........++.|++.|+.|+|+.   +++|+|+||+||+++.++.++|+|||+++.......    ....++..|+|||.
T Consensus       116 ~~~~~~~~~~~~l~~~l~~lH~~---~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~  192 (288)
T cd05061         116 PTLQEMIQMAAEIADGMAYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPES  192 (288)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhC---CCcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHH
Confidence            45567788999999999999988   999999999999999999999999999875432211    12234667999999


Q ss_pred             ecCCcceeccCC
Q 046065          153 VGRGVYYKKFSL  164 (164)
Q Consensus       153 ~~~~~~~~~~Di  164 (164)
                      +.+..++.++||
T Consensus       193 ~~~~~~~~~~Dv  204 (288)
T cd05061         193 LKDGVFTTSSDM  204 (288)
T ss_pred             hccCCCChHhHH
Confidence            988889999885

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.94  E-value=4.7e-26  Score=163.58  Aligned_cols=156  Identities=27%  Similarity=0.408  Sum_probs=126.1

Q ss_pred             CcEEEEEEcccc-ccccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccc---------
Q 046065            6 GQIIAVKKLSKK-STQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIR---------   73 (164)
Q Consensus         6 ~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---------   73 (164)
                      ...+|+|.+... .......+..|+.+++.+ +|||++++ +.+...+..++|+|++++++|.+++.....         
T Consensus        50 ~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~  129 (307)
T cd05098          50 VTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNP  129 (307)
T ss_pred             cceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCccccccccc
Confidence            357999998654 233445678899999999 79999997 777777889999999999999999865321         


Q ss_pred             ----ccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh----hhhhcccc
Q 046065           74 ----MLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI----LKQIQIEL  145 (164)
Q Consensus        74 ----~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~  145 (164)
                          ...++......++.|++.||.|+|+.   +++|+|+||+||+++.++.++|+|||.+.......    .....+++
T Consensus       130 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~  206 (307)
T cd05098         130 TQVPEEQLSFKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPV  206 (307)
T ss_pred             ccCccccCCHHHHHHHHHHHHHHHHHHHHC---CcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCcc
Confidence                12377888999999999999999988   99999999999999999999999999987554211    11123346


Q ss_pred             cccCcceecCCcceeccCC
Q 046065          146 GYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       146 ~~~aPE~~~~~~~~~~~Di  164 (164)
                      .|+|||.+.+..++.++||
T Consensus       207 ~y~aPE~~~~~~~~~~~Dv  225 (307)
T cd05098         207 KWMAPEALFDRIYTHQSDV  225 (307)
T ss_pred             ceeChHHhccCCCCcHHHH
Confidence            8999999988889999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.94  E-value=5.4e-26  Score=162.38  Aligned_cols=155  Identities=25%  Similarity=0.421  Sum_probs=125.6

Q ss_pred             cEEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcc---------ccc
Q 046065            7 QIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPI---------RML   75 (164)
Q Consensus         7 ~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---------~~~   75 (164)
                      ..||+|.+... .......+..|+++++.++|+|++++ +.+...+..++||||+++++|.+++....         ...
T Consensus        45 ~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~  124 (295)
T cd05097          45 VLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIP  124 (295)
T ss_pred             eEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCC
Confidence            35899998654 23334568899999999999999997 77777788999999999999998885421         011


Q ss_pred             ccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh----hhhcccccccCcc
Q 046065           76 ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL----KQIQIELGYIPPE  151 (164)
Q Consensus        76 ~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~aPE  151 (164)
                      .++......++.+++.|+.|+|+.   +++|+|+||+||+++.++.++|+|||++........    ....++..|+|||
T Consensus       125 ~~~~~~~~~i~~~i~~al~~lH~~---~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  201 (295)
T cd05097         125 SVSIANLLYMAVQIASGMKYLASL---NFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWE  201 (295)
T ss_pred             cccHHHHHHHHHHHHHHHHHHHhc---CeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChh
Confidence            267788889999999999999998   999999999999999999999999999875532211    2234467899999


Q ss_pred             eecCCcceeccCC
Q 046065          152 YVGRGVYYKKFSL  164 (164)
Q Consensus       152 ~~~~~~~~~~~Di  164 (164)
                      ...++.++.++|+
T Consensus       202 ~~~~~~~~~~~Dv  214 (295)
T cd05097         202 SILLGKFTTASDV  214 (295)
T ss_pred             hhccCCcCchhhH
Confidence            9988889999986

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.94  E-value=8e-26  Score=158.26  Aligned_cols=157  Identities=23%  Similarity=0.348  Sum_probs=130.2

Q ss_pred             CCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            4 PDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         4 ~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      .+++.||+|.+...  .......+..|+.+++.++|||++++ +.+...+..++|+|++++++|.+.+..... ..+++.
T Consensus        23 ~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~-~~~~~~  101 (256)
T cd08218          23 EDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRG-VLFPED  101 (256)
T ss_pred             CCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccC-CCCCHH
Confidence            46789999987643  23344578899999999999999998 666677788999999999999888865322 237888


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh--hhhhcccccccCcceecCCcc
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI--LKQIQIELGYIPPEYVGRGVY  158 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~  158 (164)
                      ....++.|++.++.++|+.   +++|+|++|+||+++.++.++++|||.+.......  .....+++.|+|||...+..+
T Consensus       102 ~~~~~~~~l~~~l~~lh~~---~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~  178 (256)
T cd08218         102 QILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPY  178 (256)
T ss_pred             HHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhhhccCCccccCHHHhCCCCC
Confidence            8999999999999999998   99999999999999999999999999987654322  234567888999999988889


Q ss_pred             eeccCC
Q 046065          159 YKKFSL  164 (164)
Q Consensus       159 ~~~~Di  164 (164)
                      +.++|+
T Consensus       179 ~~~~Dv  184 (256)
T cd08218         179 NNKSDI  184 (256)
T ss_pred             CCccch
Confidence            999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.94  E-value=6.1e-26  Score=162.10  Aligned_cols=154  Identities=25%  Similarity=0.375  Sum_probs=130.3

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      .+++.||+|.+........+.+..|+.+++.++|||++++ +.+...+..++|+|++++++|.+++.+..    ++....
T Consensus        42 ~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----l~~~~~  117 (293)
T cd06647          42 ATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC----MDEGQI  117 (293)
T ss_pred             CCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhhcC----CCHHHH
Confidence            4678899999865544455678899999999999999997 77777788999999999999999886532    678888


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh--hhhhhcccccccCcceecCCccee
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM--ILKQIQIELGYIPPEYVGRGVYYK  160 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~  160 (164)
                      ..++.|++.|+.|+|+.   +++|+|++|+||+++.++.++|+|||++......  ......+++.|+|||.+.+..++.
T Consensus       118 ~~i~~~l~~al~~LH~~---gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~  194 (293)
T cd06647         118 AAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP  194 (293)
T ss_pred             HHHHHHHHHHHHHHHhC---CEeeccCCHHHEEEcCCCCEEEccCcceecccccccccccccCChhhcCchhhccCCCCc
Confidence            99999999999999998   9999999999999999999999999987654432  223456788899999998888888


Q ss_pred             ccCC
Q 046065          161 KFSL  164 (164)
Q Consensus       161 ~~Di  164 (164)
                      ++|+
T Consensus       195 ~~Dv  198 (293)
T cd06647         195 KVDI  198 (293)
T ss_pred             hhhH
Confidence            9886

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.94  E-value=7.4e-26  Score=161.77  Aligned_cols=156  Identities=24%  Similarity=0.432  Sum_probs=126.4

Q ss_pred             CcEEEEEEccccc-cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccc--------cc
Q 046065            6 GQIIAVKKLSKKS-TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIR--------ML   75 (164)
Q Consensus         6 ~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------~~   75 (164)
                      +..+|+|.+.... ......+..|+.+++.++|+||+++ +.+...+..++++|++++++|.+++.....        ..
T Consensus        46 ~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~  125 (296)
T cd05095          46 PVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVV  125 (296)
T ss_pred             eeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCccccccccccc
Confidence            4578999986542 3344678899999999999999997 667777788999999999999988865321        12


Q ss_pred             ccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh----hhhcccccccCcc
Q 046065           76 ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL----KQIQIELGYIPPE  151 (164)
Q Consensus        76 ~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~aPE  151 (164)
                      .++......++.|++.|+.|+|+.   +++|+||||+||+++.++.++|+|||++........    ....+++.|+|||
T Consensus       126 ~~~~~~~~~~~~~i~~al~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe  202 (296)
T cd05095         126 TISYSTLIFMATQIASGMKYLSSL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWE  202 (296)
T ss_pred             ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHH
Confidence            366778899999999999999998   999999999999999999999999999875533221    2233467899999


Q ss_pred             eecCCcceeccCC
Q 046065          152 YVGRGVYYKKFSL  164 (164)
Q Consensus       152 ~~~~~~~~~~~Di  164 (164)
                      ...++.++.++||
T Consensus       203 ~~~~~~~~~~~Di  215 (296)
T cd05095         203 SILLGKFTTASDV  215 (296)
T ss_pred             HHhcCCccchhhh
Confidence            9888889999996

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.94  E-value=6.1e-26  Score=160.45  Aligned_cols=157  Identities=27%  Similarity=0.397  Sum_probs=128.2

Q ss_pred             CCcEEEEEEccccccc-cHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccc------cc
Q 046065            5 DGQIIAVKKLSKKSTQ-GFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRM------LI   76 (164)
Q Consensus         5 ~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~------~~   76 (164)
                      +.+.+++|.+...... ....+..|+++++.++|+|++++ ..+......++|||++++++|.+++......      ..
T Consensus        34 ~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~  113 (275)
T cd05046          34 GETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPP  113 (275)
T ss_pred             CcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccC
Confidence            3467899988655333 45678899999999999999997 6666677889999999999999998754311      13


Q ss_pred             cCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh---hhhhhcccccccCccee
Q 046065           77 LDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM---ILKQIQIELGYIPPEYV  153 (164)
Q Consensus        77 ~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~~aPE~~  153 (164)
                      ++......++.|++.++.|+|+.   +++|+||||+||+++..+.++++|||++......   ......++..|+|||.+
T Consensus       114 l~~~~~~~~~~~l~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~  190 (275)
T cd05046         114 LSTKQKVALCTQIALGMDHLSNA---RFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAV  190 (275)
T ss_pred             CCHHHHHHHHHHHHHHHHHhhhc---CcccCcCccceEEEeCCCcEEEcccccccccCcccccccCCceeEEeecChhhh
Confidence            78999999999999999999988   9999999999999999999999999988644321   12334567789999999


Q ss_pred             cCCcceeccCC
Q 046065          154 GRGVYYKKFSL  164 (164)
Q Consensus       154 ~~~~~~~~~Di  164 (164)
                      .+..++.++||
T Consensus       191 ~~~~~~~~~Di  201 (275)
T cd05046         191 QEDDFSTKSDV  201 (275)
T ss_pred             ccCCCCchhhH
Confidence            88888888886

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.94  E-value=2.6e-26  Score=172.17  Aligned_cols=153  Identities=22%  Similarity=0.291  Sum_probs=117.2

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeC--------CcEEEEEEecCCCChhhhhhCc-cc
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIET--------QEYMLIYEYMPKRSLDYFLFDP-IR   73 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~--------~~~~lv~e~~~~~~L~~~~~~~-~~   73 (164)
                      .+++.||+|.+....    ....+|+.+++.++||||+++ ..+...        ..+++||||+++ ++.+++... ..
T Consensus        89 ~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~-~l~~~~~~~~~~  163 (440)
T PTZ00036         89 DTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARN  163 (440)
T ss_pred             CCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCCc-cHHHHHHHHhhc
Confidence            467899999875432    223579999999999999997 443221        135689999975 676665431 12


Q ss_pred             ccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCC-CeEEccccchhhhhhh-hhhhhcccccccCcc
Q 046065           74 MLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL-KPKISDFGLARILRKM-ILKQIQIELGYIPPE  151 (164)
Q Consensus        74 ~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~-~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE  151 (164)
                      ...++......++.|++.||.|||+.   +|+||||||+||+++.++ .+||+|||+++.+... ......+|+.|+|||
T Consensus       164 ~~~l~~~~~~~~~~qi~~gL~yLH~~---~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE  240 (440)
T PTZ00036        164 NHALPLFLVKLYSYQLCRALAYIHSK---FICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPE  240 (440)
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHHC---CEecCCcCHHHEEEcCCCCceeeeccccchhccCCCCcccCCCCcCccCHH
Confidence            23388899999999999999999998   999999999999998764 6999999999765432 234467899999999


Q ss_pred             eecCC-cceeccCC
Q 046065          152 YVGRG-VYYKKFSL  164 (164)
Q Consensus       152 ~~~~~-~~~~~~Di  164 (164)
                      ++.+. .|+.++||
T Consensus       241 ~~~~~~~~~~~~Di  254 (440)
T PTZ00036        241 LMLGATNYTTHIDL  254 (440)
T ss_pred             HhcCCCCCCcHHHH
Confidence            88554 68999885

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.94  E-value=8.9e-26  Score=158.15  Aligned_cols=153  Identities=26%  Similarity=0.417  Sum_probs=124.4

Q ss_pred             CCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEe-eCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            5 DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCI-ETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      +++.+|+|.+....  ..+.+..|+.+++.++|+|++++ +.+. ..+..++++|++++++|.+++.+... ..+++...
T Consensus        28 ~~~~~~~k~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~  104 (256)
T cd05082          28 RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCL  104 (256)
T ss_pred             cCCcEEEEEeCCCc--hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCC-CCCCHHHH
Confidence            46778999875432  34568899999999999999997 5444 44568899999999999998875332 22778888


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCcceecCCcceecc
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKKF  162 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~  162 (164)
                      ..++.|++.++.++|++   +++|+||||+||+++.++.++|+|||++....... ....++..|+|||+..+..++.++
T Consensus       105 ~~~~~~i~~~l~~lH~~---~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~  180 (256)
T cd05082         105 LKFSLDVCEAMEYLEAN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-DTGKLPVKWTAPEALREKKFSTKS  180 (256)
T ss_pred             HHHHHHHHHHHHHHHhC---CEeccccchheEEEcCCCcEEecCCccceeccccC-CCCccceeecCHHHHccCCCCchh
Confidence            99999999999999988   99999999999999999999999999986543221 233445679999999888899999


Q ss_pred             CC
Q 046065          163 SL  164 (164)
Q Consensus       163 Di  164 (164)
                      ||
T Consensus       181 Dv  182 (256)
T cd05082         181 DV  182 (256)
T ss_pred             hh
Confidence            86

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.94  E-value=1.2e-25  Score=157.59  Aligned_cols=153  Identities=27%  Similarity=0.382  Sum_probs=125.7

Q ss_pred             CcEEEEEEcccccc-ccHHHHHHHHHHHhccCCCceeeEeEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHHH
Q 046065            6 GQIIAVKKLSKKST-QGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVH   84 (164)
Q Consensus         6 ~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~   84 (164)
                      +..+|+|.+..... .....+..|+.+++.++|+|++++..+...+..++++|++++++|.+++....   .+++.....
T Consensus        23 ~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~---~~~~~~~~~   99 (257)
T cd05060          23 EVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMELAPLGPLLKYLKKRR---EIPVSDLKE   99 (257)
T ss_pred             cceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcCCceEEEEEeCCCCcHHHHHHhCC---CCCHHHHHH
Confidence            36899999875533 34456888999999999999999844555667899999999999999987644   378899999


Q ss_pred             HHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh--h---hhhcccccccCcceecCCcce
Q 046065           85 IIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI--L---KQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        85 ~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~--~---~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      ++.|++.++.++|+.   +++|+||||+||+++.++.++|+|||.+.......  .   ....++..|+|||.+.+..++
T Consensus       100 ~~~qi~~~l~~lh~~---~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  176 (257)
T cd05060         100 LAHQVAMGMAYLESK---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFS  176 (257)
T ss_pred             HHHHHHHHHHHHhhc---CeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCC
Confidence            999999999999998   99999999999999999999999999987553221  1   112234579999999888999


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      .++||
T Consensus       177 ~~~Di  181 (257)
T cd05060         177 SKSDV  181 (257)
T ss_pred             ccchH
Confidence            99996

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.94  E-value=7.7e-26  Score=159.58  Aligned_cols=153  Identities=20%  Similarity=0.298  Sum_probs=124.9

Q ss_pred             cEEEEEEccccc-cccHHHHHHHHHHHhccCCCceeeEeEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHHHH
Q 046065            7 QIIAVKKLSKKS-TQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHI   85 (164)
Q Consensus         7 ~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~   85 (164)
                      ..||+|...... ....+.+..|+.+++.++|||++++..+......+++||++++++|.+++.....  .++......+
T Consensus        35 ~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~  112 (270)
T cd05056          35 IAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITENPVWIVMELAPLGELRSYLQVNKY--SLDLASLILY  112 (270)
T ss_pred             cceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcCCCcEEEEEcCCCCcHHHHHHhCCC--CCCHHHHHHH
Confidence            468999876553 3455678899999999999999998444445667899999999999999865332  3788999999


Q ss_pred             HHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh---hhhcccccccCcceecCCcceecc
Q 046065           86 IKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL---KQIQIELGYIPPEYVGRGVYYKKF  162 (164)
Q Consensus        86 ~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~~  162 (164)
                      +.+++.|+.|+|+.   +++|+|+||+||+++.++.++++|||++........   ....++..|+|||.+....++.++
T Consensus       113 ~~~l~~~l~~lH~~---~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  189 (270)
T cd05056         113 SYQLSTALAYLESK---RFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSAS  189 (270)
T ss_pred             HHHHHHHHHHHHhC---CeeccccChheEEEecCCCeEEccCceeeecccccceecCCCCccccccChhhhccCCCCchh
Confidence            99999999999988   999999999999999999999999999876543211   123345679999999888889999


Q ss_pred             CC
Q 046065          163 SL  164 (164)
Q Consensus       163 Di  164 (164)
                      ||
T Consensus       190 Di  191 (270)
T cd05056         190 DV  191 (270)
T ss_pred             hh
Confidence            86

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.94  E-value=5.1e-26  Score=163.75  Aligned_cols=157  Identities=25%  Similarity=0.334  Sum_probs=128.2

Q ss_pred             CCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            4 PDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         4 ~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      .+++.||+|.+...  .......+..|+.+++.++|+||+++ +.+......++++|++++++|.+++..... ..+++.
T Consensus        23 ~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~-~~~~~~  101 (314)
T cd08216          23 PTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFP-EGLPEL  101 (314)
T ss_pred             CCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcc-cCCCHH
Confidence            36889999998654  34455678999999999999999997 666777788999999999999998875422 237888


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh---------hhhhhcccccccCcc
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM---------ILKQIQIELGYIPPE  151 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~---------~~~~~~~~~~~~aPE  151 (164)
                      ....++.|++.||.|||+.   +++|+||||+||+++.++.++++|||.+......         ......++..|+|||
T Consensus       102 ~~~~~~~~l~~~L~~LH~~---~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE  178 (314)
T cd08216         102 AIAFILKDVLNALDYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPE  178 (314)
T ss_pred             HHHHHHHHHHHHHHHHHHC---CeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHH
Confidence            9999999999999999998   9999999999999999999999999987644211         112344677899999


Q ss_pred             eecCC--cceeccCC
Q 046065          152 YVGRG--VYYKKFSL  164 (164)
Q Consensus       152 ~~~~~--~~~~~~Di  164 (164)
                      ++...  .++.++||
T Consensus       179 ~~~~~~~~~~~~~Di  193 (314)
T cd08216         179 VLQQNLQGYNEKSDI  193 (314)
T ss_pred             HhcCCCCCCCcchhH
Confidence            98653  47888885

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.94  E-value=1.3e-25  Score=157.66  Aligned_cols=157  Identities=31%  Similarity=0.463  Sum_probs=128.1

Q ss_pred             cCCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeEeEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            3 LPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      ..+++.||+|.+.... .....+..|+.+++.++|+|++++......+..++++|++++++|.+++..... ..++....
T Consensus        27 ~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~  104 (260)
T cd05067          27 YNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPEG-IKLTINKL  104 (260)
T ss_pred             cCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEccCCcEEEEEcCCCCCHHHHHHhcCC-CCCCHHHH
Confidence            3567889999986443 234578899999999999999998444556678999999999999988765322 23788889


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh---hhhcccccccCcceecCCcce
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL---KQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      ..++.|++.||.|+|+.   +++|+|++|+|++++.++.++|+|||.+........   ....++..|+|||++....++
T Consensus       105 ~~i~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~  181 (260)
T cd05067         105 IDMAAQIAEGMAFIERK---NYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT  181 (260)
T ss_pred             HHHHHHHHHHHHHHhcC---CeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhccCCcC
Confidence            99999999999999988   999999999999999999999999999876542211   233456789999999888899


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      .++||
T Consensus       182 ~~~Di  186 (260)
T cd05067         182 IKSDV  186 (260)
T ss_pred             cccch
Confidence            99986

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.94  E-value=8.8e-26  Score=159.94  Aligned_cols=154  Identities=24%  Similarity=0.363  Sum_probs=129.3

Q ss_pred             CCCcEEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            4 PDGQIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         4 ~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      .+++.||+|.+... .......+..|+.+++.++|||++++ +.+...+..++|+|++++++|.+++...    .++...
T Consensus        27 ~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~----~l~~~~  102 (277)
T cd06640          27 RTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAG----PFDEFQ  102 (277)
T ss_pred             cCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhcC----CCCHHH
Confidence            35788999988654 23445678899999999999999998 7777778899999999999999888643    277888


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh--hhhhhcccccccCcceecCCcce
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM--ILKQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      ...++.|++.++.++|+.   +++|+|++|+||+++.++.++++|||++......  ......++..|+|||++.+..++
T Consensus       103 ~~~~~~~l~~~l~~lh~~---~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~  179 (277)
T cd06640         103 IATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYD  179 (277)
T ss_pred             HHHHHHHHHHHHHHHHhC---CccCcCCChhhEEEcCCCCEEEcccccceeccCCccccccccCcccccCHhHhccCCCc
Confidence            889999999999999988   9999999999999999999999999998655432  22345678889999999888889


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      .++|+
T Consensus       180 ~~~Dv  184 (277)
T cd06640         180 SKADI  184 (277)
T ss_pred             cHHHH
Confidence            99885

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.94  E-value=5.6e-26  Score=162.26  Aligned_cols=154  Identities=25%  Similarity=0.385  Sum_probs=129.9

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      .+++.||+|.+..........+.+|+.+++.++|+|++++ ..+...+..++++|++++++|.+++...    .+++...
T Consensus        43 ~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~~  118 (292)
T cd06657          43 SSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT----RMNEEQI  118 (292)
T ss_pred             CCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHhcC----CCCHHHH
Confidence            4688999998865444445668889999999999999997 7777778899999999999998877543    2788889


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh--hhhhhcccccccCcceecCCccee
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM--ILKQIQIELGYIPPEYVGRGVYYK  160 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~  160 (164)
                      ..++.|++.++.|+|+.   +++|+|++|+||+++.++.++|+|||++......  ......+++.|+|||.+.+..++.
T Consensus       119 ~~~~~ql~~~l~~lH~~---givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~  195 (292)
T cd06657         119 AAVCLAVLKALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGP  195 (292)
T ss_pred             HHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEcccccceecccccccccccccCccccCHHHhcCCCCCc
Confidence            99999999999999998   9999999999999999999999999987654322  223456888999999998888899


Q ss_pred             ccCC
Q 046065          161 KFSL  164 (164)
Q Consensus       161 ~~Di  164 (164)
                      ++|+
T Consensus       196 ~~Dv  199 (292)
T cd06657         196 EVDI  199 (292)
T ss_pred             hhhH
Confidence            9985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.94  E-value=3.7e-26  Score=166.46  Aligned_cols=152  Identities=28%  Similarity=0.341  Sum_probs=121.6

Q ss_pred             CCCcEEEEEEccccc--cccHHHHHHHHHHHhccCCCceeeE-eEEeeC------CcEEEEEEecCCCChhhhhhCcccc
Q 046065            4 PDGQIIAVKKLSKKS--TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIET------QEYMLIYEYMPKRSLDYFLFDPIRM   74 (164)
Q Consensus         4 ~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~   74 (164)
                      .+++.||+|.+....  ......+.+|+.+++.++||||+++ +.+...      ...+++++++ +++|..++...   
T Consensus        38 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~~~---  113 (343)
T cd07878          38 RLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVKCQ---  113 (343)
T ss_pred             CCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHhcC---
Confidence            467899999986432  2234557789999999999999997 433221      3467888877 67888776532   


Q ss_pred             cccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCcceec
Q 046065           75 LILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVG  154 (164)
Q Consensus        75 ~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~  154 (164)
                       .++...+..++.|++.||.|+|+.   +++|+||||+||+++.++.++|+|||++...... .....+++.|+|||++.
T Consensus       114 -~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~t~~y~aPE~~~  188 (343)
T cd07878         114 -KLSDEHVQFLIYQLLRGLKYIHSA---GIIHRDLKPSNVAVNEDCELRILDFGLARQADDE-MTGYVATRWYRAPEIML  188 (343)
T ss_pred             -CCCHHHHHHHHHHHHHHHHHHHHC---CeecccCChhhEEECCCCCEEEcCCccceecCCC-cCCccccccccCchHhc
Confidence             288899999999999999999998   9999999999999999999999999998765432 23457899999999986


Q ss_pred             C-CcceeccCC
Q 046065          155 R-GVYYKKFSL  164 (164)
Q Consensus       155 ~-~~~~~~~Di  164 (164)
                      + ..++.++||
T Consensus       189 ~~~~~~~~~Di  199 (343)
T cd07878         189 NWMHYNQTVDI  199 (343)
T ss_pred             CCccCCchhhh
Confidence            6 467889986

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.94  E-value=3.3e-26  Score=160.54  Aligned_cols=154  Identities=28%  Similarity=0.332  Sum_probs=129.7

Q ss_pred             CCcEEEEEEcccccc---ccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            5 DGQIIAVKKLSKKST---QGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         5 ~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      +++.+++|.+.....   .....+..|+.+++.++|||++++ ..+......++++|++++++|..++....   .+++.
T Consensus        17 ~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~   93 (265)
T cd05579          17 TGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVG---SLDED   93 (265)
T ss_pred             CCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHcC---CCCHH
Confidence            588999999865432   345678889999999999999997 66667778899999999999998887543   38899


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh----------hhhhhcccccccCc
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM----------ILKQIQIELGYIPP  150 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~----------~~~~~~~~~~~~aP  150 (164)
                      .+..++.|++.+|.++|+.   +++|+||+|+||+++.++.++|+|||++......          ......++..|+||
T Consensus        94 ~~~~i~~qi~~~L~~lH~~---~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~P  170 (265)
T cd05579          94 VARIYIAEIVLALEYLHSN---GIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAP  170 (265)
T ss_pred             HHHHHHHHHHHHHHHHHHc---CeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCccccCH
Confidence            9999999999999999988   9999999999999999999999999988654322          22345678889999


Q ss_pred             ceecCCcceeccCC
Q 046065          151 EYVGRGVYYKKFSL  164 (164)
Q Consensus       151 E~~~~~~~~~~~Di  164 (164)
                      |...+..++.++|+
T Consensus       171 e~~~~~~~~~~~Dv  184 (265)
T cd05579         171 EVILGQGHSKTVDW  184 (265)
T ss_pred             HHhcCCCCCcchhh
Confidence            99988888888886

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.94  E-value=6.2e-26  Score=163.56  Aligned_cols=154  Identities=25%  Similarity=0.354  Sum_probs=119.2

Q ss_pred             CCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEee--CCcEEEEEEecCCCChhhhhhCcc------ccc
Q 046065            5 DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIE--TQEYMLIYEYMPKRSLDYFLFDPI------RML   75 (164)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~------~~~   75 (164)
                      +++.||+|.+....  ....+.+|+.+++.++||||+++ ..+..  ....++++|++. ++|.+++....      ...
T Consensus        27 ~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~  103 (317)
T cd07868          27 DDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPV  103 (317)
T ss_pred             CCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-CCHHHHHHhcccccccCCcc
Confidence            56789999885432  23457789999999999999998 44433  345789999986 47777764321      112


Q ss_pred             ccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceee----cCCCCeEEccccchhhhhhh-----hhhhhccccc
Q 046065           76 ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL----DEDLKPKISDFGLARILRKM-----ILKQIQIELG  146 (164)
Q Consensus        76 ~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili----~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~~  146 (164)
                      .++......++.|++.||.|||+.   +++|+||||+||++    +..+.+||+|||++......     ......+|+.
T Consensus       104 ~l~~~~~~~i~~qi~~al~~LH~~---~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~  180 (317)
T cd07868         104 QLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW  180 (317)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCcccccc
Confidence            478889999999999999999998   99999999999999    45578999999999765432     1234678999


Q ss_pred             ccCcceecC-CcceeccCC
Q 046065          147 YIPPEYVGR-GVYYKKFSL  164 (164)
Q Consensus       147 ~~aPE~~~~-~~~~~~~Di  164 (164)
                      |+|||++.+ ..++.++||
T Consensus       181 y~aPE~~~~~~~~~~~~Di  199 (317)
T cd07868         181 YRAPELLLGARHYTKAIDI  199 (317)
T ss_pred             ccCCHHHcCCCCcCchhhH
Confidence            999999866 457888886

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.94  E-value=2.5e-26  Score=161.00  Aligned_cols=155  Identities=25%  Similarity=0.345  Sum_probs=131.6

Q ss_pred             CCCcEEEEEEccccc---cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKKS---TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+++.||+|.+....   ......+..|+.+++.++|||++++ ..+......++|+|++.+++|...+....   .++.
T Consensus        23 ~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~   99 (258)
T cd05578          23 DTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKV---KFSE   99 (258)
T ss_pred             cCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhcC---CcCH
Confidence            357899999987542   2345678899999999999999997 66667778999999999999998886542   3888


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh-hhhhhcccccccCcceecCCcc
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM-ILKQIQIELGYIPPEYVGRGVY  158 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~  158 (164)
                      .....++.|+++++.|+|++   +++|+|++|+||+++.++.++|+|||.+...... ......++..|+|||.+.+..+
T Consensus       100 ~~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~  176 (258)
T cd05578         100 EQVKFWICEIVLALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGY  176 (258)
T ss_pred             HHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEEcCCCCEEEeecccccccCCCccccccCCChhhcCHHHHcccCC
Confidence            99999999999999999998   9999999999999999999999999988765433 2345667889999999988888


Q ss_pred             eeccCC
Q 046065          159 YKKFSL  164 (164)
Q Consensus       159 ~~~~Di  164 (164)
                      +.++|+
T Consensus       177 ~~~~Di  182 (258)
T cd05578         177 SVAVDW  182 (258)
T ss_pred             CCcccc
Confidence            999996

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.94  E-value=7.1e-26  Score=158.47  Aligned_cols=155  Identities=27%  Similarity=0.400  Sum_probs=129.8

Q ss_pred             CCCcEEEEEEccccc-----cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccccccc
Q 046065            4 PDGQIIAVKKLSKKS-----TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLIL   77 (164)
Q Consensus         4 ~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~   77 (164)
                      .+++.|++|.+....     ....+.+..|+.+++.++|+|++++ +.+......++++|++++++|.+++....   .+
T Consensus        23 ~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~   99 (258)
T cd06632          23 DDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYG---SF   99 (258)
T ss_pred             CCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHhcC---CC
Confidence            368899999876442     2244678899999999999999998 77777788999999999999999886543   27


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh-hhhhhcccccccCcceecCC
Q 046065           78 DCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM-ILKQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        78 ~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~~~  156 (164)
                      +......++.|++.++.++|+.   +++|+||+|+||+++.++.++|+|||.+...... ......+++.|+|||.+...
T Consensus       100 ~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~  176 (258)
T cd06632         100 PEPVIRLYTRQILLGLEYLHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQ  176 (258)
T ss_pred             CHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEccCccceeccccccccccCCCcceeCHHHhcCC
Confidence            7888889999999999999988   9999999999999999999999999988665432 23456688899999999776


Q ss_pred             c-ceeccCC
Q 046065          157 V-YYKKFSL  164 (164)
Q Consensus       157 ~-~~~~~Di  164 (164)
                      . ++.++|+
T Consensus       177 ~~~~~~~D~  185 (258)
T cd06632         177 GGYGLAADI  185 (258)
T ss_pred             CCCCchhhh
Confidence            6 8888885

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.94  E-value=2.1e-26  Score=161.25  Aligned_cols=155  Identities=29%  Similarity=0.429  Sum_probs=128.8

Q ss_pred             CCCcEEEEEEcccccccc--HHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            4 PDGQIIAVKKLSKKSTQG--FEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~--~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      .+++.+|+|.+.......  ......|+.+++.++||||+++ .........+++||++++++|.+++....   .++..
T Consensus        22 ~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~~~~---~~~~~   98 (260)
T PF00069_consen   22 KNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQKNK---PLSEE   98 (260)
T ss_dssp             TTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHHHHS---SBBHH
T ss_pred             CCCeEEEEEEeccccccccccchhhhhhhccccccccccccccccccccccccccccccccccccccccccc---ccccc
Confidence            467789999987663332  2234569999999999999997 77777888999999999999998887322   27899


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhh--hhhhhhhhcccccccCcceec-CCc
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARIL--RKMILKQIQIELGYIPPEYVG-RGV  157 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~--~~~~~~~~~~~~~~~aPE~~~-~~~  157 (164)
                      .+..++.|++.||.+||+.   +++|+||||+||+++.++.++|+|||.+...  .........++..|+|||+.. +..
T Consensus        99 ~~~~~~~qi~~~L~~Lh~~---~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  175 (260)
T PF00069_consen   99 EILKIAYQILEALAYLHSK---GIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKK  175 (260)
T ss_dssp             HHHHHHHHHHHHHHHHHHT---TEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSS
T ss_pred             ccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            9999999999999999998   9999999999999999999999999998643  223335577889999999997 778


Q ss_pred             ceeccCC
Q 046065          158 YYKKFSL  164 (164)
Q Consensus       158 ~~~~~Di  164 (164)
                      ++.++||
T Consensus       176 ~~~~~Di  182 (260)
T PF00069_consen  176 YTRKSDI  182 (260)
T ss_dssp             BSTHHHH
T ss_pred             ccccccc
Confidence            8888885

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.94  E-value=9.7e-26  Score=157.68  Aligned_cols=157  Identities=27%  Similarity=0.423  Sum_probs=129.7

Q ss_pred             CCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            4 PDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         4 ~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      .+++.+|+|.+...  .......+..|+.+++.++|||++++ +.+...+..++|+|++++++|.+++.+... ..+++.
T Consensus        23 ~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~  101 (256)
T cd08220          23 ADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCN-SLLDED  101 (256)
T ss_pred             CCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhcc-cCCCHH
Confidence            46788999998654  23345678899999999999999997 666677789999999999999999875322 237888


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCC-CCeEEccccchhhhhhh-hhhhhcccccccCcceecCCcc
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED-LKPKISDFGLARILRKM-ILKQIQIELGYIPPEYVGRGVY  158 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~-~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~  158 (164)
                      ....++.+++.++.++|++   +++|+|++|+||+++.+ +.++++|||.+...... ......++..|+|||.+.+..+
T Consensus       102 ~~~~~~~~i~~~l~~lh~~---~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  178 (256)
T cd08220         102 TILHFFVQILLALHHVHTK---LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPY  178 (256)
T ss_pred             HHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccccccccCCcccCchhccCCCC
Confidence            9999999999999999998   99999999999999865 46899999998765432 2234567889999999988888


Q ss_pred             eeccCC
Q 046065          159 YKKFSL  164 (164)
Q Consensus       159 ~~~~Di  164 (164)
                      +.++||
T Consensus       179 ~~~~Dv  184 (256)
T cd08220         179 NQKSDI  184 (256)
T ss_pred             Ccccch
Confidence            999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.94  E-value=1e-25  Score=157.54  Aligned_cols=153  Identities=23%  Similarity=0.365  Sum_probs=130.2

Q ss_pred             CCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHH
Q 046065            5 DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRV   83 (164)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~   83 (164)
                      +++.+++|.+.....  .+.+.+|+.+++.++|||++++ +.+......++++|++++++|.+++....  ..+++....
T Consensus        27 ~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~--~~l~~~~~~  102 (256)
T cd06612          27 TGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITN--KTLTEEEIA  102 (256)
T ss_pred             CCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCc--cCCCHHHHH
Confidence            468899999864432  5678899999999999999997 77777788999999999999999886532  237889999


Q ss_pred             HHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh--hhhhhcccccccCcceecCCcceec
Q 046065           84 HIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM--ILKQIQIELGYIPPEYVGRGVYYKK  161 (164)
Q Consensus        84 ~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~  161 (164)
                      .++.|++.|+.|+|+.   +++|+|++|+||+++.++.++|+|||++......  ......++..|+|||++.+..++.+
T Consensus       103 ~~~~~l~~~l~~lh~~---~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~  179 (256)
T cd06612         103 AILYQTLKGLEYLHSN---KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNK  179 (256)
T ss_pred             HHHHHHHHHHHHHHHC---CcccCCCCcceEEECCCCcEEEcccccchhcccCccccccccCCccccCHHHHhcCCCCch
Confidence            9999999999999998   9999999999999999999999999998765432  2234557889999999988888999


Q ss_pred             cCC
Q 046065          162 FSL  164 (164)
Q Consensus       162 ~Di  164 (164)
                      +||
T Consensus       180 ~Di  182 (256)
T cd06612         180 ADI  182 (256)
T ss_pred             hhH
Confidence            985

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.94  E-value=1.2e-25  Score=158.52  Aligned_cols=156  Identities=26%  Similarity=0.409  Sum_probs=124.7

Q ss_pred             CcEEEEEEccccc--cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCc------EEEEEEecCCCChhhhhhCcc---c
Q 046065            6 GQIIAVKKLSKKS--TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQE------YMLIYEYMPKRSLDYFLFDPI---R   73 (164)
Q Consensus         6 ~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~------~~lv~e~~~~~~L~~~~~~~~---~   73 (164)
                      ++.||+|.+..+.  ......+..|+..++.++|||++++ +.+.....      .++++||+++++|...+....   .
T Consensus        27 ~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~  106 (273)
T cd05035          27 QLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGL  106 (273)
T ss_pred             cceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCC
Confidence            4679999986542  2334578899999999999999997 55544332      689999999999988875421   1


Q ss_pred             ccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh----hhhcccccccC
Q 046065           74 MLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL----KQIQIELGYIP  149 (164)
Q Consensus        74 ~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~a  149 (164)
                      ...++......++.|++.||.|+|+.   +++|+|+||+||+++.++.++|+|||+++.......    .....+..|+|
T Consensus       107 ~~~~~~~~~~~~~~~i~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~  183 (273)
T cd05035         107 PEKLPLQTLLKFMVDIALGMEYLSNR---NFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA  183 (273)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccC
Confidence            23488889999999999999999998   999999999999999999999999999876543211    12334668999


Q ss_pred             cceecCCcceeccCC
Q 046065          150 PEYVGRGVYYKKFSL  164 (164)
Q Consensus       150 PE~~~~~~~~~~~Di  164 (164)
                      ||.+.++.++.++||
T Consensus       184 pe~~~~~~~~~~~Dv  198 (273)
T cd05035         184 IESLADRVYTSKSDV  198 (273)
T ss_pred             HhhcccCCCCcccch
Confidence            999988889999996

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=8.3e-26  Score=162.82  Aligned_cols=156  Identities=24%  Similarity=0.231  Sum_probs=128.7

Q ss_pred             CCcEEEEEEcccccc---ccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            5 DGQIIAVKKLSKKST---QGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         5 ~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      +++.||+|.+.....   .....+..|+.+++.++||||+++ +.+......++++|++.+++|.+++.... ...+++.
T Consensus        25 ~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~l~~~  103 (316)
T cd05574          25 TGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQP-GKCLSEE  103 (316)
T ss_pred             CCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCC-CCccCHH
Confidence            578999999875532   244568889999999999999997 66667778899999999999999886432 2338889


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh-----------------------
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI-----------------------  137 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~-----------------------  137 (164)
                      ....++.|++.+|.|+|+.   +++|+||||+||+++.++.++|+|||++.......                       
T Consensus       104 ~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  180 (316)
T cd05574         104 VARFYAAEVLLALEYLHLL---GIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSET  180 (316)
T ss_pred             HHHHHHHHHHHHHHHHHHC---CeeccCCChHHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchhh
Confidence            9999999999999999998   99999999999999999999999999876432110                       


Q ss_pred             --------hhhhcccccccCcceecCCcceeccCC
Q 046065          138 --------LKQIQIELGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       138 --------~~~~~~~~~~~aPE~~~~~~~~~~~Di  164 (164)
                              .....|+..|+|||+..+..++.++||
T Consensus       181 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di  215 (316)
T cd05574         181 FSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDW  215 (316)
T ss_pred             hcccccCCCCCCcCccCCcCHHHHcCCCCCchHHH
Confidence                    012357888999999988888999986

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.94  E-value=1.2e-25  Score=157.88  Aligned_cols=155  Identities=28%  Similarity=0.402  Sum_probs=125.0

Q ss_pred             CCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeEeEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHHH
Q 046065            5 DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVH   84 (164)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~   84 (164)
                      ++..+|+|.+.... ...+.+..|+.+++.++|+|++++..+......+++||++++++|.+++..... ..++......
T Consensus        29 ~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~~  106 (260)
T cd05069          29 GTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEFMGKGSLLDFLKEGDG-KYLKLPQLVD  106 (260)
T ss_pred             CCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCcEEEEEcCCCCCHHHHHhhCCC-CCCCHHHHHH
Confidence            34568999875432 234567889999999999999998444556678899999999999998865322 2367888899


Q ss_pred             HHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh---hhhcccccccCcceecCCcceec
Q 046065           85 IIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL---KQIQIELGYIPPEYVGRGVYYKK  161 (164)
Q Consensus        85 ~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~  161 (164)
                      ++.|++.|+.|+|+.   +++|+|++|+||+++.++.++|+|||.+........   ....++..|+|||...+..++.+
T Consensus       107 ~~~~l~~al~~lH~~---~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~  183 (260)
T cd05069         107 MAAQIADGMAYIERM---NYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK  183 (260)
T ss_pred             HHHHHHHHHHHHHhC---CEeecccCcceEEEcCCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhccCCcChH
Confidence            999999999999998   999999999999999999999999999876543221   22345678999999988889999


Q ss_pred             cCC
Q 046065          162 FSL  164 (164)
Q Consensus       162 ~Di  164 (164)
                      +||
T Consensus       184 ~Di  186 (260)
T cd05069         184 SDV  186 (260)
T ss_pred             HHH
Confidence            886

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.94  E-value=9.3e-26  Score=161.85  Aligned_cols=154  Identities=28%  Similarity=0.437  Sum_probs=122.3

Q ss_pred             EEEEEEcccc-ccccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccc-----------
Q 046065            8 IIAVKKLSKK-STQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIR-----------   73 (164)
Q Consensus         8 ~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-----------   73 (164)
                      .+|+|.+... .......+.+|+.++..+ +|||++++ +.+...+..++++||+++++|.+++.....           
T Consensus        36 ~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~  115 (303)
T cd05088          36 DAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN  115 (303)
T ss_pred             eEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccc
Confidence            3577766533 223345678899999999 89999998 777777889999999999999998864321           


Q ss_pred             --ccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh-hhhcccccccCc
Q 046065           74 --MLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL-KQIQIELGYIPP  150 (164)
Q Consensus        74 --~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~aP  150 (164)
                        ...++......++.|++.|+.|+|+.   +++|+||||+||+++.++.++|+|||++........ .....+..|+||
T Consensus       116 ~~~~~l~~~~~~~~~~qi~~al~~LH~~---gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aP  192 (303)
T cd05088         116 STASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAI  192 (303)
T ss_pred             cccCcCCHHHHHHHHHHHHHHHHHHHhC---CccccccchheEEecCCCcEEeCccccCcccchhhhcccCCCcccccCH
Confidence              12378889999999999999999988   999999999999999999999999999864321111 122335679999


Q ss_pred             ceecCCcceeccCC
Q 046065          151 EYVGRGVYYKKFSL  164 (164)
Q Consensus       151 E~~~~~~~~~~~Di  164 (164)
                      |...+..++.++||
T Consensus       193 E~~~~~~~~~~~Di  206 (303)
T cd05088         193 ESLNYSVYTTNSDV  206 (303)
T ss_pred             HHHhccCCcccccc
Confidence            99988888999996

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.94  E-value=1.4e-25  Score=161.04  Aligned_cols=155  Identities=24%  Similarity=0.276  Sum_probs=126.6

Q ss_pred             CCCcEEEEEEccccc---cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKKS---TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+++.||+|.+....   ......+..|+.+++.++||||+++ ..+...+..++|||++++++|.+++.....   +++
T Consensus        24 ~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~---~~~  100 (305)
T cd05609          24 ETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGA---LPV  100 (305)
T ss_pred             CCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHHcCC---CCH
Confidence            457889999886542   2334567789999999999999997 666667778999999999999999865432   788


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh-----------------hhhhhc
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM-----------------ILKQIQ  142 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~-----------------~~~~~~  142 (164)
                      .....++.|++.|+.|+|+.   +++|+|++|+||+++..+.++++|||++......                 ......
T Consensus       101 ~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (305)
T cd05609         101 DMARMYFAETVLALEYLHNY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVC  177 (305)
T ss_pred             HHHHHHHHHHHHHHHHHHHC---CccccCCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCc
Confidence            88899999999999999998   9999999999999999999999999987531100                 001245


Q ss_pred             ccccccCcceecCCcceeccCC
Q 046065          143 IELGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       143 ~~~~~~aPE~~~~~~~~~~~Di  164 (164)
                      ++..|+|||.+....++.++|+
T Consensus       178 ~~~~y~aPE~~~~~~~~~~~Di  199 (305)
T cd05609         178 GTPEYIAPEVILRQGYGKPVDW  199 (305)
T ss_pred             cCccccCchhccCCCCCchhhH
Confidence            6788999999988888999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.94  E-value=9.4e-26  Score=158.40  Aligned_cols=154  Identities=23%  Similarity=0.393  Sum_probs=122.9

Q ss_pred             CcEEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeE-eEEe-eCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            6 GQIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCI-ETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         6 ~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      +..+|+|.+... .......+..|+.+++.++|||++++ +.+. ..+..++++|++++++|.+++.....  .......
T Consensus        23 ~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~  100 (262)
T cd05058          23 KIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETH--NPTVKDL  100 (262)
T ss_pred             eEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCC--CCCHHHH
Confidence            457999987543 33345678889999999999999997 5454 34567899999999999999865322  2566777


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh------hhhhcccccccCcceecCC
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI------LKQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~------~~~~~~~~~~~aPE~~~~~  156 (164)
                      ..++.|++.|+.|+|+.   +++|+||||+||+++.++.++|+|||++.......      .....++..|+|||...+.
T Consensus       101 ~~~~~~i~~~l~~lH~~---~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  177 (262)
T cd05058         101 IGFGLQVAKGMEYLASK---KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQ  177 (262)
T ss_pred             HHHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccC
Confidence            88999999999999988   99999999999999999999999999986543211      1233456789999999888


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .++.++||
T Consensus       178 ~~~~~~Di  185 (262)
T cd05058         178 KFTTKSDV  185 (262)
T ss_pred             ccchHHHH
Confidence            89999986

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.94  E-value=3.8e-26  Score=160.30  Aligned_cols=151  Identities=21%  Similarity=0.325  Sum_probs=123.3

Q ss_pred             cEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHHHH
Q 046065            7 QIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHI   85 (164)
Q Consensus         7 ~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~   85 (164)
                      .++|+|.+........+.+..|+.+++.++|||++++ +.+......++||||+++++|..++.....  .++......+
T Consensus        28 ~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~~~  105 (258)
T cd05078          28 TEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKN--LINISWKLEV  105 (258)
T ss_pred             chhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCC--CCCHHHHHHH
Confidence            3578888765544455678889999999999999997 777777888999999999999999875432  3788889999


Q ss_pred             HHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCC--------eEEccccchhhhhhhhhhhhcccccccCcceecCC-
Q 046065           86 IKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK--------PKISDFGLARILRKMILKQIQIELGYIPPEYVGRG-  156 (164)
Q Consensus        86 ~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~--------~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~-  156 (164)
                      +.|++.|+.|+|+.   +++|+|+||+||+++.++.        ++++|||.+.....  .....+++.|+|||.+.+. 
T Consensus       106 ~~qi~~~l~~lH~~---~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~--~~~~~~~~~y~aPE~~~~~~  180 (258)
T cd05078         106 AKQLAWALHFLEDK---GLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLP--KEILLERIPWVPPECIENPQ  180 (258)
T ss_pred             HHHHHHHHHHHHHC---CeecCCCccceEEEecccccccCCCceEEecccccccccCC--chhccccCCccCchhccCCC
Confidence            99999999999998   9999999999999987654        69999998754432  2335678899999999764 


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .++.++||
T Consensus       181 ~~~~~~Di  188 (258)
T cd05078         181 NLSLAADK  188 (258)
T ss_pred             CCCchhhH
Confidence            47888886

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.94  E-value=8.8e-26  Score=161.74  Aligned_cols=155  Identities=24%  Similarity=0.392  Sum_probs=124.3

Q ss_pred             CCCcEEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            4 PDGQIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         4 ~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      .+++.||+|.+... .......+..|+.+++.++||||+++ +.+...+..++|+|+++ ++|.+++.....  .++...
T Consensus        29 ~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~--~~~~~~  105 (301)
T cd07873          29 LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGN--SINMHN  105 (301)
T ss_pred             CCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cCHHHHHHhcCC--CCCHHH
Confidence            35788999998644 23334567789999999999999998 66667778899999997 588877765322  378888


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh--hhhhhhcccccccCcceecCC-cc
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK--MILKQIQIELGYIPPEYVGRG-VY  158 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~~aPE~~~~~-~~  158 (164)
                      ...++.|++.||.|+|+.   +++|+||||+||+++.++.++|+|||++.....  .......+++.|+|||.+.+. .+
T Consensus       106 ~~~~~~qi~~aL~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~  182 (301)
T cd07873         106 VKLFLFQLLRGLNYCHRR---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDY  182 (301)
T ss_pred             HHHHHHHHHHHHHHHHhC---CeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCcccccceeecccCcHHHhCCCCC
Confidence            999999999999999998   999999999999999999999999999865432  122334568899999998654 46


Q ss_pred             eeccCC
Q 046065          159 YKKFSL  164 (164)
Q Consensus       159 ~~~~Di  164 (164)
                      +.++||
T Consensus       183 ~~~~Dv  188 (301)
T cd07873         183 STQIDM  188 (301)
T ss_pred             ccHHHH
Confidence            788875

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.94  E-value=6.7e-26  Score=161.33  Aligned_cols=157  Identities=30%  Similarity=0.515  Sum_probs=127.0

Q ss_pred             CCcEEEEEEccccc-cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcc----------
Q 046065            5 DGQIIAVKKLSKKS-TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPI----------   72 (164)
Q Consensus         5 ~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------   72 (164)
                      ++..||+|.+.... ......+..|+.+++.++|||++++ +.+......++++|++++++|.+++....          
T Consensus        34 ~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~  113 (288)
T cd05050          34 PFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHS  113 (288)
T ss_pred             cceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCcccccccccc
Confidence            56789999986543 2334568889999999999999997 77777778899999999999998886421          


Q ss_pred             ---------cccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh----hh
Q 046065           73 ---------RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI----LK  139 (164)
Q Consensus        73 ---------~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~----~~  139 (164)
                               ....+++.....++.|++.||.|+|+.   +++|+||+|+||+++.++.++|+|||++.......    ..
T Consensus       114 ~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~  190 (288)
T cd05050         114 TSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASE  190 (288)
T ss_pred             ccccccccccccccCHHHHHHHHHHHHHHHHHHHhC---CeecccccHhheEecCCCceEECccccceecccCccccccC
Confidence                     112367788899999999999999988   99999999999999999999999999986543211    12


Q ss_pred             hhcccccccCcceecCCcceeccCC
Q 046065          140 QIQIELGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       140 ~~~~~~~~~aPE~~~~~~~~~~~Di  164 (164)
                      ....+..|+|||...+..++.++||
T Consensus       191 ~~~~~~~y~aPE~~~~~~~~~~~Dv  215 (288)
T cd05050         191 NDAIPIRWMPPESIFYNRYTTESDV  215 (288)
T ss_pred             CCccChhhcCHHHHhcCCCCchhHH
Confidence            2334567999999988899999986

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.94  E-value=1e-25  Score=159.96  Aligned_cols=155  Identities=25%  Similarity=0.350  Sum_probs=128.6

Q ss_pred             CCCcEEEEEEccccc--cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            4 PDGQIIAVKKLSKKS--TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         4 ~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      .+|+.||+|.+....  ......+..|+.+++.++|||++++ ..+......++|+|++ +++|.+++....  ..+++.
T Consensus        23 ~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~~--~~~~~~   99 (286)
T cd07832          23 ETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEE--RPLPEA   99 (286)
T ss_pred             CCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhcC--CCCCHH
Confidence            468899999987553  3345678899999999999999997 6667777889999999 999998886533  238889


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh---hhhhcccccccCcceecCC-
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI---LKQIQIELGYIPPEYVGRG-  156 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~aPE~~~~~-  156 (164)
                      .+..++.|++.++.|+|+.   +++|+|++|+||+++.++.++++|||.+.......   .....++..|+|||.+.+. 
T Consensus       100 ~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  176 (286)
T cd07832         100 QVKSYMRMLLKGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGAR  176 (286)
T ss_pred             HHHHHHHHHHHHHHHHHHC---CeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccccccCcccccCceeeeccc
Confidence            9999999999999999998   99999999999999999999999999987664332   3345688899999998654 


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .++.++||
T Consensus       177 ~~~~~~Di  184 (286)
T cd07832         177 KYDPGVDL  184 (286)
T ss_pred             cCCchhHH
Confidence            45888885

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.94  E-value=9.2e-26  Score=164.47  Aligned_cols=158  Identities=27%  Similarity=0.394  Sum_probs=123.8

Q ss_pred             CCCcEEEEEEccccc-cccHHHHHHHHHHHhcc-CCCceeeE-eEEee-CCcEEEEEEecCCCChhhhhhCccc------
Q 046065            4 PDGQIIAVKKLSKKS-TQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIE-TQEYMLIYEYMPKRSLDYFLFDPIR------   73 (164)
Q Consensus         4 ~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~------   73 (164)
                      .+++.||||.+.... ......+..|+.++..+ +||||+++ +.+.. ....+++|||+++|+|.+++.....      
T Consensus        35 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~  114 (343)
T cd05103          35 ATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYK  114 (343)
T ss_pred             ccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCcccccc
Confidence            457889999986542 23345688999999999 68999997 55544 3457899999999999888754210      


Q ss_pred             ----------------------------------------------------------ccccCHHHHHHHHHHHHHHHHH
Q 046065           74 ----------------------------------------------------------MLILDCKKRVHIIKGIIQGLLY   95 (164)
Q Consensus        74 ----------------------------------------------------------~~~~~~~~~~~~~~~~~~~l~~   95 (164)
                                                                                ...++......++.|++.|+.|
T Consensus       115 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~  194 (343)
T cd05103         115 TKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEF  194 (343)
T ss_pred             ccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHH
Confidence                                                                      0125667778899999999999


Q ss_pred             hhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh----hhhhcccccccCcceecCCcceeccCC
Q 046065           96 LQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI----LKQIQIELGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus        96 lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di  164 (164)
                      +|+.   +++|+||||+||+++.++.++|+|||++.......    .....+++.|+|||.+.+..++.++||
T Consensus       195 lH~~---~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di  264 (343)
T cd05103         195 LASR---KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDV  264 (343)
T ss_pred             HHhC---CeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhH
Confidence            9998   99999999999999999999999999987543211    122334567999999988889999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.93  E-value=9.2e-26  Score=160.34  Aligned_cols=155  Identities=28%  Similarity=0.382  Sum_probs=128.2

Q ss_pred             CCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            4 PDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         4 ~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      .+++.||+|.+...  .......+..|+++++.++|+|++++ +.+...+..++++|+++++.+..+......   ++..
T Consensus        24 ~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~---~~~~  100 (288)
T cd07833          24 ATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGG---LPPD  100 (288)
T ss_pred             CCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHhcCCC---CCHH
Confidence            35789999988654  23345678899999999999999997 777777889999999998767665544322   7889


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh---hhhhhcccccccCcceecCC-
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM---ILKQIQIELGYIPPEYVGRG-  156 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~~aPE~~~~~-  156 (164)
                      ....++.+++.++.|||+.   +++|+|++|+||+++.++.++|+|||++......   ......++..|+|||++.+. 
T Consensus       101 ~~~~~~~~i~~~l~~LH~~---~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~  177 (288)
T cd07833         101 AVRSYIWQLLQAIAYCHSH---NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDT  177 (288)
T ss_pred             HHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCCC
Confidence            9999999999999999998   9999999999999999999999999998766432   22345678889999999877 


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .++.++||
T Consensus       178 ~~~~~~Dv  185 (288)
T cd07833         178 NYGKPVDV  185 (288)
T ss_pred             CcCchhhH
Confidence            78899886

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.93  E-value=1.5e-25  Score=157.35  Aligned_cols=155  Identities=26%  Similarity=0.407  Sum_probs=130.2

Q ss_pred             CCCcEEEEEEcccccc--ccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            4 PDGQIIAVKKLSKKST--QGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      .+++.||+|.+.....  .....+..|+.+++.++|+||+++ +.....+..++|+|++++++|.+++.....   +++.
T Consensus        23 ~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~   99 (264)
T cd06626          23 DTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRI---LDEH   99 (264)
T ss_pred             CCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhhcCC---CChH
Confidence            3678999999876533  356788999999999999999997 666677789999999999999999876432   6788


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh------hhhcccccccCcceec
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL------KQIQIELGYIPPEYVG  154 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~------~~~~~~~~~~aPE~~~  154 (164)
                      ....++.+++.|+.++|+.   +++|+|++|+||+++.++.++|+|||.+........      ....+++.|+|||++.
T Consensus       100 ~~~~i~~~i~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~  176 (264)
T cd06626         100 VIRVYTLQLLEGLAYLHSH---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVIT  176 (264)
T ss_pred             HHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhcc
Confidence            8889999999999999998   999999999999999999999999999876543211      2356788999999997


Q ss_pred             CCc---ceeccCC
Q 046065          155 RGV---YYKKFSL  164 (164)
Q Consensus       155 ~~~---~~~~~Di  164 (164)
                      +..   ++.++||
T Consensus       177 ~~~~~~~~~~~Dv  189 (264)
T cd06626         177 GGKGKGHGRAADI  189 (264)
T ss_pred             CCCCCCCCcccch
Confidence            766   7888886

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.93  E-value=1.1e-25  Score=166.94  Aligned_cols=157  Identities=25%  Similarity=0.353  Sum_probs=125.4

Q ss_pred             CCcEEEEEEcccc-ccccHHHHHHHHHHHhccC-CCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccc--------
Q 046065            5 DGQIIAVKKLSKK-STQGFEEFKNEVMLTAKLQ-HLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIR--------   73 (164)
Q Consensus         5 ~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------   73 (164)
                      .++.||+|.+... .....+.+..|+.++..+. ||||+++ +.+...+..++|+||+++|+|.+++.....        
T Consensus        66 ~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~  145 (401)
T cd05107          66 STMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLD  145 (401)
T ss_pred             CceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcc
Confidence            3568999998654 2333456889999999997 9999998 777777788999999999999888854211        


Q ss_pred             --------------------------------------------------------------------------------
Q 046065           74 --------------------------------------------------------------------------------   73 (164)
Q Consensus        74 --------------------------------------------------------------------------------   73 (164)
                                                                                                      
T Consensus       146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (401)
T cd05107         146 KNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTR  225 (401)
T ss_pred             cccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcc
Confidence                                                                                            


Q ss_pred             -------ccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh----hhhhc
Q 046065           74 -------MLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI----LKQIQ  142 (164)
Q Consensus        74 -------~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~----~~~~~  142 (164)
                             ...++......++.|++.|+.|+|+.   +++|+|+||+||+++..+.++|+|||++.......    .....
T Consensus       226 ~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~  302 (401)
T cd05107         226 RDTLINESPALSYMDLVGFSYQVANGMEFLASK---NCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTF  302 (401)
T ss_pred             hhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcC---CcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcC
Confidence                   01245566788899999999999988   99999999999999999999999999987543211    12345


Q ss_pred             ccccccCcceecCCcceeccCC
Q 046065          143 IELGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       143 ~~~~~~aPE~~~~~~~~~~~Di  164 (164)
                      ++..|+|||.+.+..++.++||
T Consensus       303 ~~~~y~aPE~~~~~~~~~~~Dv  324 (401)
T cd05107         303 LPLKWMAPESIFNNLYTTLSDV  324 (401)
T ss_pred             CCCceeChHHhcCCCCCcHhHH
Confidence            6788999999988888999885

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.93  E-value=1.7e-25  Score=156.50  Aligned_cols=153  Identities=29%  Similarity=0.421  Sum_probs=124.3

Q ss_pred             CCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeEeEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHHH
Q 046065            5 DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVH   84 (164)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~   84 (164)
                      +++.||+|.+....  ....+..|+.+++.++|||++++..+...+..++++|++++++|.+++..... ..++......
T Consensus        28 ~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~-~~~~~~~~~~  104 (254)
T cd05083          28 TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILHNGLYIVMELMSKGNLVNFLRTRGR-ALVSVIQLLQ  104 (254)
T ss_pred             CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCcEEEEECCCCCCHHHHHHhcCc-CCCCHHHHHH
Confidence            56789999875432  33568899999999999999998444445567899999999999999875432 2378888999


Q ss_pred             HHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCcceecCCcceeccCC
Q 046065           85 IIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus        85 ~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di  164 (164)
                      ++.|++.|+.++|+.   +++|+|++|+||+++.++.++|+|||++...... ......+..|+|||.+.+..++.++|+
T Consensus       105 ~~~qi~~al~~lH~~---~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~y~~pe~~~~~~~~~~~Dv  180 (254)
T cd05083         105 FSLDVAEGMEYLESK---KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG-VDNSKLPVKWTAPEALKHKKFSSKSDV  180 (254)
T ss_pred             HHHHHHHHHHHHHhC---CeeccccCcceEEEcCCCcEEECCCccceecccc-CCCCCCCceecCHHHhccCCcCchhhH
Confidence            999999999999988   9999999999999999999999999988653321 222334567999999988889999986

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.93  E-value=2.2e-25  Score=157.40  Aligned_cols=154  Identities=28%  Similarity=0.437  Sum_probs=122.7

Q ss_pred             EEEEEEcccc-ccccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccc-----------
Q 046065            8 IIAVKKLSKK-STQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIR-----------   73 (164)
Q Consensus         8 ~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-----------   73 (164)
                      .+++|.+... .......+..|+.++.++ +|||++++ +.+...+..+++||++++++|.+++.....           
T Consensus        24 ~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~  103 (270)
T cd05047          24 DAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN  103 (270)
T ss_pred             EEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhcccccccccccccc
Confidence            4688877643 233445788899999999 79999997 777777789999999999999998864321           


Q ss_pred             --ccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh-hhhcccccccCc
Q 046065           74 --MLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL-KQIQIELGYIPP  150 (164)
Q Consensus        74 --~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~aP  150 (164)
                        ...++......++.|++.|+.|+|+.   +++|+||||+||+++.++.++++|||++........ .....+..|+||
T Consensus       104 ~~~~~l~~~~~~~~~~~i~~al~~lH~~---~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~~y~ap  180 (270)
T cd05047         104 STASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAI  180 (270)
T ss_pred             CCcCCCCHHHHHHHHHHHHHHHHHHHHC---CEeecccccceEEEcCCCeEEECCCCCccccchhhhccCCCCccccCCh
Confidence              12377888999999999999999988   999999999999999999999999999853322111 122335679999


Q ss_pred             ceecCCcceeccCC
Q 046065          151 EYVGRGVYYKKFSL  164 (164)
Q Consensus       151 E~~~~~~~~~~~Di  164 (164)
                      |++....++.++||
T Consensus       181 E~~~~~~~~~~~Di  194 (270)
T cd05047         181 ESLNYSVYTTNSDV  194 (270)
T ss_pred             HHHccCCCCchhhH
Confidence            99988888999986

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.93  E-value=2.1e-25  Score=157.15  Aligned_cols=155  Identities=25%  Similarity=0.381  Sum_probs=125.6

Q ss_pred             CCCcEEEEEEccccc-----cccHHHHHHHHHHHhccCCCceeeE-eEEee--CCcEEEEEEecCCCChhhhhhCccccc
Q 046065            4 PDGQIIAVKKLSKKS-----TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIE--TQEYMLIYEYMPKRSLDYFLFDPIRML   75 (164)
Q Consensus         4 ~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~   75 (164)
                      .+++.||+|.+....     ......+..|+.+++.++|||++++ +.+..  ....++++|++++++|.+.+.....  
T Consensus        25 ~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~--  102 (266)
T cd06651          25 DTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGA--  102 (266)
T ss_pred             CCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHcCC--
Confidence            467899999875431     1233567889999999999999997 54443  2467899999999999988865332  


Q ss_pred             ccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh-----hhhhhcccccccCc
Q 046065           76 ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM-----ILKQIQIELGYIPP  150 (164)
Q Consensus        76 ~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~~~~aP  150 (164)
                       ++......++.|++.++.++|+.   +++|+|++|+||+++.++.++|+|||++......     ......++..|+||
T Consensus       103 -l~~~~~~~~~~qi~~~l~~LH~~---~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP  178 (266)
T cd06651         103 -LTESVTRKYTRQILEGMSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSP  178 (266)
T ss_pred             -CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCCccccccCH
Confidence             77888889999999999999988   9999999999999999999999999998654321     12335578899999


Q ss_pred             ceecCCcceeccCC
Q 046065          151 EYVGRGVYYKKFSL  164 (164)
Q Consensus       151 E~~~~~~~~~~~Di  164 (164)
                      |.+.+..++.++||
T Consensus       179 E~~~~~~~~~~~Dv  192 (266)
T cd06651         179 EVISGEGYGRKADV  192 (266)
T ss_pred             HHhCCCCCCchhhh
Confidence            99988888999986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.93  E-value=1.7e-25  Score=156.18  Aligned_cols=155  Identities=28%  Similarity=0.405  Sum_probs=127.2

Q ss_pred             CCcEEEEEEccccccc-cHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            5 DGQIIAVKKLSKKSTQ-GFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         5 ~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      +++.||+|.+...... ....+..|+.+++.++|+||+++ ..+......++|+|++++++|.+++.....  .++....
T Consensus        18 ~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~--~~~~~~~   95 (251)
T cd05041          18 GNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKN--RLTVKKL   95 (251)
T ss_pred             CCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcCC--CCCHHHH
Confidence            3788999988655333 45678899999999999999997 677777889999999999999988865322  2678888


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh----hhhcccccccCcceecCCcc
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL----KQIQIELGYIPPEYVGRGVY  158 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~  158 (164)
                      ..++.+++.++.++|+.   +++|+|++|+||+++.++.++|+|||++........    .....+..|+|||.+.+..+
T Consensus        96 ~~~~~~~~~~l~~lH~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~  172 (251)
T cd05041          96 LQMSLDAAAGMEYLESK---NCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRY  172 (251)
T ss_pred             HHHHHHHHHHHHHHHhC---CEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCC
Confidence            99999999999999988   999999999999999999999999999875542111    11223556999999988889


Q ss_pred             eeccCC
Q 046065          159 YKKFSL  164 (164)
Q Consensus       159 ~~~~Di  164 (164)
                      +.++|+
T Consensus       173 ~~~~Di  178 (251)
T cd05041         173 TSESDV  178 (251)
T ss_pred             CcchhH
Confidence            999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.93  E-value=2.4e-25  Score=157.77  Aligned_cols=151  Identities=25%  Similarity=0.425  Sum_probs=123.7

Q ss_pred             EEEEEEccccc-cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHHHH
Q 046065            8 IIAVKKLSKKS-TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHI   85 (164)
Q Consensus         8 ~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~   85 (164)
                      .+|+|.+.... +.....+..|+.+++.++|||++++ +.+.. ...++++|++++++|.+++.+...  .+++.....+
T Consensus        38 ~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~  114 (279)
T cd05057          38 PVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKD--NIGSQYLLNW  114 (279)
T ss_pred             EEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHhccC--CCCHHHHHHH
Confidence            58999876553 3345678889999999999999998 55544 788999999999999998875432  2788999999


Q ss_pred             HHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh----hhhcccccccCcceecCCcceec
Q 046065           86 IKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL----KQIQIELGYIPPEYVGRGVYYKK  161 (164)
Q Consensus        86 ~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~  161 (164)
                      +.|++.|+.|+|+.   +++|+|++|+||+++.++.++|+|||.++.......    ....++..|+|||.+....++.+
T Consensus       115 ~~qi~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~  191 (279)
T cd05057         115 CVQIAKGMSYLEEK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHK  191 (279)
T ss_pred             HHHHHHHHHHHHhC---CEEecccCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCch
Confidence            99999999999998   999999999999999999999999999976543211    12223567999999988888999


Q ss_pred             cCC
Q 046065          162 FSL  164 (164)
Q Consensus       162 ~Di  164 (164)
                      +|+
T Consensus       192 ~Di  194 (279)
T cd05057         192 SDV  194 (279)
T ss_pred             hhH
Confidence            886

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.93  E-value=1.5e-25  Score=159.48  Aligned_cols=158  Identities=24%  Similarity=0.317  Sum_probs=128.3

Q ss_pred             CCCcEEEEEEcccccc-ccHHHHHHHHHHHhccCCCceeeE-eEEee--CCcEEEEEEecCCCChhhhhhCcc-cccccC
Q 046065            4 PDGQIIAVKKLSKKST-QGFEEFKNEVMLTAKLQHLNLIRV-GFCIE--TQEYMLIYEYMPKRSLDYFLFDPI-RMLILD   78 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~   78 (164)
                      .+++.+|+|.+..... .....+.+|+++++.++||||+++ +.+..  .+.+++|||++++++|.+++.... ....++
T Consensus        24 ~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~  103 (287)
T cd06621          24 NTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIG  103 (287)
T ss_pred             CCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCC
Confidence            3578899999865422 344668899999999999999997 55543  346889999999999988765321 223378


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCcceecCCcc
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVY  158 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  158 (164)
                      ......++.|++.++.|+|+.   +++|+|++|+||+++.++.++|+|||++............++..|+|||.+.+..+
T Consensus       104 ~~~~~~i~~~i~~~L~~lH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~  180 (287)
T cd06621         104 EKVLGKIAESVLKGLSYLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTSFYMAPERIQGKPY  180 (287)
T ss_pred             HHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecCCeEEEeeccccccccccccccccCCccccCHHHhcCCCC
Confidence            888999999999999999998   99999999999999999999999999986654333344567888999999988899


Q ss_pred             eeccCC
Q 046065          159 YKKFSL  164 (164)
Q Consensus       159 ~~~~Di  164 (164)
                      +.++||
T Consensus       181 ~~~~Dv  186 (287)
T cd06621         181 SITSDV  186 (287)
T ss_pred             CchhhH
Confidence            999885

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.93  E-value=3.3e-25  Score=155.79  Aligned_cols=158  Identities=27%  Similarity=0.364  Sum_probs=131.4

Q ss_pred             CCCcEEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            4 PDGQIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         4 ~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      .+++.+|+|.+... .......+.+|+.+++.++|+|++++ +.+......++++|++++++|.+.+........+++..
T Consensus        24 ~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~  103 (267)
T cd06610          24 PNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAI  103 (267)
T ss_pred             CCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHH
Confidence            46788999998654 23356778899999999999999997 77777888999999999999999987643323478899


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh------hhhhcccccccCcceecC
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI------LKQIQIELGYIPPEYVGR  155 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~------~~~~~~~~~~~aPE~~~~  155 (164)
                      ...++.|++.|+.++|+.   +++|+|++|+||+++.++.++|+|||++..+....      .....++..|+|||.+..
T Consensus       104 ~~~~~~ql~~al~~lh~~---~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~  180 (267)
T cd06610         104 IATVLKEVLKGLEYLHSN---GQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQ  180 (267)
T ss_pred             HHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHcc
Confidence            999999999999999988   99999999999999999999999999987654321      133467889999999876


Q ss_pred             C-cceeccCC
Q 046065          156 G-VYYKKFSL  164 (164)
Q Consensus       156 ~-~~~~~~Di  164 (164)
                      . .++.++|+
T Consensus       181 ~~~~~~~~Dv  190 (267)
T cd06610         181 VHGYDFKADI  190 (267)
T ss_pred             ccCcCcccch
Confidence            6 67888886

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.93  E-value=1.8e-25  Score=156.86  Aligned_cols=155  Identities=26%  Similarity=0.384  Sum_probs=132.3

Q ss_pred             CCCcEEEEEEcccccc-ccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            4 PDGQIIAVKKLSKKST-QGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      .+++.|++|.+..... .....+..|+..+..++|+|++++ +.+...+..++++|++++++|.+++....   .++...
T Consensus        24 ~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~l~~~~  100 (264)
T cd06623          24 PTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVG---KIPEPV  100 (264)
T ss_pred             CCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHcC---CCCHHH
Confidence            3588999999876533 445778899999999999999998 67777788999999999999999987542   388999


Q ss_pred             HHHHHHHHHHHHHHhhh-cCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh--hhhcccccccCcceecCCcc
Q 046065           82 RVHIIKGIIQGLLYLQE-YFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL--KQIQIELGYIPPEYVGRGVY  158 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~-~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~  158 (164)
                      ...++.|++.++.++|+ .   +++|+|++|+||+++.++.++|+|||.+........  ....++..|+|||.+....+
T Consensus       101 ~~~~~~~l~~~l~~lh~~~---~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~  177 (264)
T cd06623         101 LAYIARQILKGLDYLHTKR---HIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESY  177 (264)
T ss_pred             HHHHHHHHHHHHHHHhccC---CCccCCCCHHHEEECCCCCEEEccCccceecccCCCcccceeecccccCHhhhCCCCC
Confidence            99999999999999998 8   999999999999999999999999999876543222  24567889999999988888


Q ss_pred             eeccCC
Q 046065          159 YKKFSL  164 (164)
Q Consensus       159 ~~~~Di  164 (164)
                      +.++|+
T Consensus       178 ~~~~Dv  183 (264)
T cd06623         178 SYAADI  183 (264)
T ss_pred             CchhhH
Confidence            999886

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.93  E-value=1.4e-25  Score=159.83  Aligned_cols=155  Identities=28%  Similarity=0.418  Sum_probs=125.4

Q ss_pred             cEEEEEEccccc-cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccc-----------
Q 046065            7 QIIAVKKLSKKS-TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIR-----------   73 (164)
Q Consensus         7 ~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-----------   73 (164)
                      ..+|+|.+.... ......+..|+.+++.++||||+++ +.+...+..++++|++++++|.+++.....           
T Consensus        31 ~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~  110 (290)
T cd05045          31 TTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGN  110 (290)
T ss_pred             eeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccc
Confidence            568888876442 2334678899999999999999997 777777888999999999999988754211           


Q ss_pred             ----------ccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh----hh
Q 046065           74 ----------MLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI----LK  139 (164)
Q Consensus        74 ----------~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~----~~  139 (164)
                                ...++......++.|++.|+.|+|+.   +++|+||||+||+++.++.++|+|||++.......    ..
T Consensus       111 ~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~---~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~  187 (290)
T cd05045         111 RNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEM---KLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRS  187 (290)
T ss_pred             cccccccCccccccCHHHHHHHHHHHHHHHHHHHHC---CeehhhhhhheEEEcCCCcEEeccccccccccCccchhccc
Confidence                      12367888899999999999999988   99999999999999999999999999987543211    12


Q ss_pred             hhcccccccCcceecCCcceeccCC
Q 046065          140 QIQIELGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       140 ~~~~~~~~~aPE~~~~~~~~~~~Di  164 (164)
                      ...++..|+|||...+..++.++||
T Consensus       188 ~~~~~~~y~apE~~~~~~~~~~~Di  212 (290)
T cd05045         188 KGRIPVKWMAIESLFDHIYTTQSDV  212 (290)
T ss_pred             CCCCCccccCHHHHccCCcchHhHH
Confidence            2345678999999988889999986

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=2.1e-25  Score=156.91  Aligned_cols=155  Identities=25%  Similarity=0.389  Sum_probs=126.2

Q ss_pred             CCCcEEEEEEcccc-----ccccHHHHHHHHHHHhccCCCceeeE-eEEeeC--CcEEEEEEecCCCChhhhhhCccccc
Q 046065            4 PDGQIIAVKKLSKK-----STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIET--QEYMLIYEYMPKRSLDYFLFDPIRML   75 (164)
Q Consensus         4 ~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~   75 (164)
                      .+++.||+|.+...     .......+.+|+.+++.++|+|++++ +.+...  ..+++++|++++++|.+.+.+...  
T Consensus        25 ~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~--  102 (264)
T cd06653          25 DTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGA--  102 (264)
T ss_pred             CCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHcCC--
Confidence            46889999987532     12334577889999999999999997 554433  457899999999999988865332  


Q ss_pred             ccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh-----hhhhhcccccccCc
Q 046065           76 ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM-----ILKQIQIELGYIPP  150 (164)
Q Consensus        76 ~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~~~~aP  150 (164)
                       ++......++.|++.|+.|+|+.   +++|+|++|+||+++.++.++|+|||++......     ......++..|+||
T Consensus       103 -l~~~~~~~~~~~i~~al~~LH~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aP  178 (264)
T cd06653         103 -LTENVTRRYTRQILQGVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSP  178 (264)
T ss_pred             -CCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECccccccccccccccCccccccCCcccccCH
Confidence             77888899999999999999988   9999999999999999999999999998765321     12345688899999


Q ss_pred             ceecCCcceeccCC
Q 046065          151 EYVGRGVYYKKFSL  164 (164)
Q Consensus       151 E~~~~~~~~~~~Di  164 (164)
                      |.+.+..++.++|+
T Consensus       179 E~~~~~~~~~~~Di  192 (264)
T cd06653         179 EVISGEGYGRKADV  192 (264)
T ss_pred             hhhcCCCCCccccH
Confidence            99988888899986

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.93  E-value=1.8e-25  Score=162.34  Aligned_cols=155  Identities=27%  Similarity=0.415  Sum_probs=124.9

Q ss_pred             cEEEEEEcccc-ccccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcc-----------
Q 046065            7 QIIAVKKLSKK-STQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPI-----------   72 (164)
Q Consensus         7 ~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-----------   72 (164)
                      ..||+|.+... .....+.+..|+.+++++ +||||+++ +.+...+..++++||+++++|.+++....           
T Consensus        45 ~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~  124 (334)
T cd05100          45 VTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTC  124 (334)
T ss_pred             eeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccc
Confidence            36899987644 233456788999999999 79999997 66777778899999999999999886421           


Q ss_pred             --cccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh----hhhhccccc
Q 046065           73 --RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI----LKQIQIELG  146 (164)
Q Consensus        73 --~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~  146 (164)
                        ....++......++.|++.|+.|+|+.   +++|+||||+||+++.++.++|+|||+++......    .....++..
T Consensus       125 ~~~~~~l~~~~~~~~~~qi~~al~~LH~~---givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~  201 (334)
T cd05100         125 KLPEEQLTFKDLVSCAYQVARGMEYLASQ---KCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVK  201 (334)
T ss_pred             cCccccCCHHHHHHHHHHHHHHHHHHHHC---CeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCce
Confidence              112366778888999999999999998   99999999999999999999999999987554321    112233467


Q ss_pred             ccCcceecCCcceeccCC
Q 046065          147 YIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       147 ~~aPE~~~~~~~~~~~Di  164 (164)
                      |+|||++.+..++.++||
T Consensus       202 y~aPE~~~~~~~~~~~Di  219 (334)
T cd05100         202 WMAPEALFDRVYTHQSDV  219 (334)
T ss_pred             EcCHHHhccCCcCchhhh
Confidence            999999998899999996

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.93  E-value=5.4e-26  Score=161.37  Aligned_cols=155  Identities=23%  Similarity=0.377  Sum_probs=124.7

Q ss_pred             CCCcEEEEEEccccc--cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            4 PDGQIIAVKKLSKKS--TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         4 ~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      .+|+.+|+|.+....  ......+..|+.+++.++|||++++ +.+......++++||++ ++|..++....  ..+++.
T Consensus        23 ~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~   99 (284)
T cd07839          23 ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD-QDLKKYFDSCN--GDIDPE   99 (284)
T ss_pred             CCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC-CCHHHHHHhcC--CCCCHH
Confidence            468899999986542  2233567789999999999999997 77777778999999997 47777665422  238899


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh--hhhhhhcccccccCcceecCC-c
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK--MILKQIQIELGYIPPEYVGRG-V  157 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~~aPE~~~~~-~  157 (164)
                      ....++.|++.||.|+|+.   +++|+|++|+||+++.++.++|+|||++.....  .......+++.|+|||.+.+. .
T Consensus       100 ~~~~~~~qi~~al~~LH~~---~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  176 (284)
T cd07839         100 IVKSFMFQLLKGLAFCHSH---NVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL  176 (284)
T ss_pred             HHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCCCccccCCcChHHHhCCcc
Confidence            9999999999999999998   999999999999999999999999999875532  222345678899999998654 4


Q ss_pred             ceeccCC
Q 046065          158 YYKKFSL  164 (164)
Q Consensus       158 ~~~~~Di  164 (164)
                      ++.++||
T Consensus       177 ~~~~~Di  183 (284)
T cd07839         177 YSTSIDM  183 (284)
T ss_pred             cCcHHHH
Confidence            6888885

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.93  E-value=2e-25  Score=157.28  Aligned_cols=153  Identities=29%  Similarity=0.481  Sum_probs=124.8

Q ss_pred             cEEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHHH
Q 046065            7 QIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVH   84 (164)
Q Consensus         7 ~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~   84 (164)
                      ..+|+|.+... .....+.+..|+.+++.++|||++++ +.+...+..++|||++++++|.+++....  ..++......
T Consensus        34 ~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~~~  111 (268)
T cd05063          34 VAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHD--GEFSSYQLVG  111 (268)
T ss_pred             eEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcC--CCCCHHHHHH
Confidence            37899998654 33345678899999999999999998 66677778899999999999999886532  2278888899


Q ss_pred             HHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh-----hhhcccccccCcceecCCcce
Q 046065           85 IIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL-----KQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        85 ~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      ++.+++.|+.|+|+.   +++|+|+||+||+++.++.++++|||++........     .....++.|+|||.+.+..++
T Consensus       112 ~~~~l~~al~~lH~~---~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~  188 (268)
T cd05063         112 MLRGIAAGMKYLSDM---NYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFT  188 (268)
T ss_pred             HHHHHHHHHHHHHHC---CeeccccchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcC
Confidence            999999999999998   999999999999999999999999999865532211     112234569999999888899


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      .++||
T Consensus       189 ~~~Dv  193 (268)
T cd05063         189 SASDV  193 (268)
T ss_pred             hHhHH
Confidence            99985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.93  E-value=1.7e-25  Score=158.42  Aligned_cols=157  Identities=27%  Similarity=0.428  Sum_probs=125.3

Q ss_pred             CCcEEEEEEccccc-cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccc----ccccC
Q 046065            5 DGQIIAVKKLSKKS-TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIR----MLILD   78 (164)
Q Consensus         5 ~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~----~~~~~   78 (164)
                      ++..||+|.+.... ......+..|+.+++.++|+||+++ +.+......++++|++++++|.+++.....    ...++
T Consensus        35 ~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~  114 (277)
T cd05036          35 VELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLT  114 (277)
T ss_pred             CceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCC
Confidence            45678999876442 2233568889999999999999997 667777788999999999999998865321    12378


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCC---CeEEccccchhhhhhhhh----hhhcccccccCcc
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL---KPKISDFGLARILRKMIL----KQIQIELGYIPPE  151 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~---~~~l~dfg~~~~~~~~~~----~~~~~~~~~~aPE  151 (164)
                      +.....++.|++.++.|+|+.   +++|+||||+||+++.++   .++|+|||++........    .....+..|+|||
T Consensus       115 ~~~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  191 (277)
T cd05036         115 MKDLLFCARDVAKGCKYLEEN---HFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPE  191 (277)
T ss_pred             HHHHHHHHHHHHHHHHHHHHC---CEeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHH
Confidence            889999999999999999998   999999999999998654   589999999876532211    1223346799999


Q ss_pred             eecCCcceeccCC
Q 046065          152 YVGRGVYYKKFSL  164 (164)
Q Consensus       152 ~~~~~~~~~~~Di  164 (164)
                      ++.+..++.++||
T Consensus       192 ~~~~~~~~~~~Di  204 (277)
T cd05036         192 AFLDGIFTSKTDV  204 (277)
T ss_pred             HHhcCCcCchhHH
Confidence            9988899999996

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.93  E-value=3.1e-25  Score=156.48  Aligned_cols=155  Identities=24%  Similarity=0.355  Sum_probs=120.6

Q ss_pred             cEEEEEEccccc-cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccc-ccccCHHHHH
Q 046065            7 QIIAVKKLSKKS-TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIR-MLILDCKKRV   83 (164)
Q Consensus         7 ~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~~~~   83 (164)
                      ..+++|.+.... ......+.+|+.+++.++|||++++ +.+......++||||+++++|.+++.+... ....+.....
T Consensus        23 ~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~  102 (268)
T cd05086          23 ARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ  102 (268)
T ss_pred             ceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHH
Confidence            345667665432 2334578899999999999999997 777777788999999999999998875322 2235667788


Q ss_pred             HHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh----hhhhhcccccccCcceecC----
Q 046065           84 HIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM----ILKQIQIELGYIPPEYVGR----  155 (164)
Q Consensus        84 ~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~~aPE~~~~----  155 (164)
                      .++.|++.||.|+|+.   +++|+||||+||+++.++.++|+|||++......    ......++..|+|||++..    
T Consensus       103 ~~~~~i~~al~~lH~~---~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  179 (268)
T cd05086         103 RMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGG  179 (268)
T ss_pred             HHHHHHHHHHHHHHHC---CeeccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCc
Confidence            8999999999999988   9999999999999999999999999987532211    1234567889999999843    


Q ss_pred             ---CcceeccCC
Q 046065          156 ---GVYYKKFSL  164 (164)
Q Consensus       156 ---~~~~~~~Di  164 (164)
                         ..++.++||
T Consensus       180 ~~~~~~~~~~Di  191 (268)
T cd05086         180 LITAEQTKPSNV  191 (268)
T ss_pred             cccCCCCCcchh
Confidence               234677875

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.93  E-value=5.6e-25  Score=156.43  Aligned_cols=154  Identities=27%  Similarity=0.424  Sum_probs=130.7

Q ss_pred             CCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHH
Q 046065            5 DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRV   83 (164)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~   83 (164)
                      +++.+++|.+..... ....+..|+++++.++|+|++++ +.+......++++|++++++|.+++....  ..++.....
T Consensus        43 ~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~l~~~~~~  119 (286)
T cd06614          43 TGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNF--VRMNEPQIA  119 (286)
T ss_pred             CCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhc--cCCCHHHHH
Confidence            578899999865543 45678899999999999999997 77777888999999999999999987643  238889999


Q ss_pred             HHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh--hhhhhcccccccCcceecCCcceec
Q 046065           84 HIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM--ILKQIQIELGYIPPEYVGRGVYYKK  161 (164)
Q Consensus        84 ~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~  161 (164)
                      .++.+++.++.++|+.   +++|+|++|+||+++.++.++|+|||++......  ......++..|+|||.+.+..++.+
T Consensus       120 ~i~~~i~~~L~~lH~~---gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~  196 (286)
T cd06614         120 YVCREVLQGLEYLHSQ---NVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPK  196 (286)
T ss_pred             HHHHHHHHHHHHHHhC---CeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhccccCCcccCCHhHhcCCCCCCc
Confidence            9999999999999998   9999999999999999999999999988654322  1233457788999999988889999


Q ss_pred             cCC
Q 046065          162 FSL  164 (164)
Q Consensus       162 ~Di  164 (164)
                      +|+
T Consensus       197 ~Dv  199 (286)
T cd06614         197 VDI  199 (286)
T ss_pred             ccc
Confidence            996

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.93  E-value=3e-25  Score=157.34  Aligned_cols=155  Identities=28%  Similarity=0.449  Sum_probs=127.2

Q ss_pred             CCcEEEEEEccccccc-cHHHHHHHHHHHhccCCCceeeE-eEEee--CCcEEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            5 DGQIIAVKKLSKKSTQ-GFEEFKNEVMLTAKLQHLNLIRV-GFCIE--TQEYMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         5 ~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~-~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      +++.+|+|.+...... ....+..|+.+++.++|+|++++ +.+..  ....++++|++++++|.+++.....  .++..
T Consensus        32 ~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~--~~~~~  109 (284)
T cd05038          32 TGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRD--QINLK  109 (284)
T ss_pred             CceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCcc--ccCHH
Confidence            4788999998755332 45678899999999999999997 55555  4468899999999999999865432  37888


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh-----hhhcccccccCcceecC
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL-----KQIQIELGYIPPEYVGR  155 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~aPE~~~~  155 (164)
                      ....++.|++.||.++|+.   +++|+|++|+||+++.++.++|+|||.+........     ....++..|+|||....
T Consensus       110 ~~~~~~~~l~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~  186 (284)
T cd05038         110 RLLLFSSQICKGMDYLGSQ---RYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRT  186 (284)
T ss_pred             HHHHHHHHHHHHHHHHHhC---CeecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHcc
Confidence            9999999999999999988   999999999999999999999999999876652211     12234556999999988


Q ss_pred             CcceeccCC
Q 046065          156 GVYYKKFSL  164 (164)
Q Consensus       156 ~~~~~~~Di  164 (164)
                      ..++.++||
T Consensus       187 ~~~~~~~Di  195 (284)
T cd05038         187 SKFSSASDV  195 (284)
T ss_pred             CCCCcccch
Confidence            888999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.93  E-value=2.2e-25  Score=158.03  Aligned_cols=156  Identities=26%  Similarity=0.347  Sum_probs=127.1

Q ss_pred             CcEEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeE-eEEee-CCcEEEEEEecCCCChhhhhhCcccc-----ccc
Q 046065            6 GQIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIE-TQEYMLIYEYMPKRSLDYFLFDPIRM-----LIL   77 (164)
Q Consensus         6 ~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~-----~~~   77 (164)
                      ++.|++|.+... .......+..|+.+++.++|||++++ +.+.. ....++++|++++++|..++......     ..+
T Consensus        35 ~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l  114 (280)
T cd05043          35 EEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQAL  114 (280)
T ss_pred             eeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCC
Confidence            678999988644 33445678899999999999999997 65554 46688999999999999988653221     348


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh----hhhcccccccCccee
Q 046065           78 DCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL----KQIQIELGYIPPEYV  153 (164)
Q Consensus        78 ~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~aPE~~  153 (164)
                      +......++.+++.||.|||+.   +++|+|++|+||+++.++.++++|||+++.+.....    ....++..|+|||++
T Consensus       115 ~~~~~~~i~~~i~~~l~~LH~~---~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~  191 (280)
T cd05043         115 STQQLVHMAIQIACGMSYLHKR---GVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESL  191 (280)
T ss_pred             CHHHHHHHHHHHHHHHHHHHHC---CEeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHH
Confidence            8899999999999999999998   999999999999999999999999999875532211    223456789999999


Q ss_pred             cCCcceeccCC
Q 046065          154 GRGVYYKKFSL  164 (164)
Q Consensus       154 ~~~~~~~~~Di  164 (164)
                      .+..++.++||
T Consensus       192 ~~~~~~~~~Di  202 (280)
T cd05043         192 VNKEYSSASDV  202 (280)
T ss_pred             hcCCCCchhhH
Confidence            88889999986

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.93  E-value=2.3e-25  Score=158.68  Aligned_cols=155  Identities=25%  Similarity=0.382  Sum_probs=123.4

Q ss_pred             CCCcEEEEEEccccc-cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            4 PDGQIIAVKKLSKKS-TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         4 ~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      .+++.||+|.+.... ......+.+|+.+++.++|+||+++ +.+......++|+||+++ +|.+++.....  .++...
T Consensus        28 ~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~--~~~~~~  104 (291)
T cd07844          28 LTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGG--GLSMHN  104 (291)
T ss_pred             CCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC-CHHHHHHhCCC--CCCHHH
Confidence            367899999986442 2223456789999999999999998 666677788999999974 88887764322  378889


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh--hhhhhhcccccccCcceecC-Ccc
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK--MILKQIQIELGYIPPEYVGR-GVY  158 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~~aPE~~~~-~~~  158 (164)
                      ...++.|++.||.|+|+.   +++|+||+|+||+++.++.++|+|||++.....  .......+++.|+|||++.+ ..+
T Consensus       105 ~~~~~~ql~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  181 (291)
T cd07844         105 VRLFLFQLLRGLAYCHQR---RVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEY  181 (291)
T ss_pred             HHHHHHHHHHHHHHHHhC---CeecccCCHHHEEEcCCCCEEECccccccccCCCCccccccccccccCCcHHhhcCccc
Confidence            999999999999999998   999999999999999999999999998864321  11123346788999999865 457


Q ss_pred             eeccCC
Q 046065          159 YKKFSL  164 (164)
Q Consensus       159 ~~~~Di  164 (164)
                      +.++||
T Consensus       182 ~~~~Dv  187 (291)
T cd07844         182 STSLDM  187 (291)
T ss_pred             CcHHHH
Confidence            888885

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.93  E-value=3.1e-25  Score=155.12  Aligned_cols=155  Identities=32%  Similarity=0.478  Sum_probs=128.9

Q ss_pred             CcEEEEEEccccccc-cHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHH
Q 046065            6 GQIIAVKKLSKKSTQ-GFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRV   83 (164)
Q Consensus         6 ~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~   83 (164)
                      ++.||+|.+...... ....+..|+.+++.++|+|++++ ..+...+..++++|++++++|.+++...... .+++....
T Consensus        28 ~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~-~~~~~~~~  106 (258)
T smart00219       28 EVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPK-ELSLSDLL  106 (258)
T ss_pred             CceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhc-cCCHHHHH
Confidence            478999998655332 45678899999999999999997 7777778899999999999999988653221 17889999


Q ss_pred             HHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh---hhhcccccccCcceecCCccee
Q 046065           84 HIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL---KQIQIELGYIPPEYVGRGVYYK  160 (164)
Q Consensus        84 ~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~  160 (164)
                      .++.|++.++.++|+.   +++|+|++|+||+++.++.++|+|||++........   ....+++.|+|||...+..++.
T Consensus       107 ~~~~ql~~~l~~lh~~---~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~  183 (258)
T smart00219      107 SFALQIARGMEYLESK---NFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTS  183 (258)
T ss_pred             HHHHHHHHHHHHHhcC---CeeecccccceEEEccCCeEEEcccCCceecccccccccccCCCcccccChHHhccCCCCc
Confidence            9999999999999998   999999999999999999999999999876543211   1233668899999998888999


Q ss_pred             ccCC
Q 046065          161 KFSL  164 (164)
Q Consensus       161 ~~Di  164 (164)
                      ++||
T Consensus       184 ~~Di  187 (258)
T smart00219      184 KSDV  187 (258)
T ss_pred             chhH
Confidence            9986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.93  E-value=3.7e-25  Score=155.32  Aligned_cols=156  Identities=31%  Similarity=0.451  Sum_probs=127.3

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      .+++.||+|.+.... .....+..|+.+++.++|+|++++ ..+......++++|++++++|.+++.+... ..++....
T Consensus        28 ~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~-~~~~~~~~  105 (261)
T cd05034          28 NGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEG-KKLRLPQL  105 (261)
T ss_pred             cCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhcccc-CCCCHHHH
Confidence            445679999886442 234568899999999999999998 666666788999999999999998866321 23788889


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh---hhhcccccccCcceecCCcce
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL---KQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      ..++.+++.|+.|+|+.   +++|+|++|+||+++.++.++++|||.+........   .....+..|+|||.+.+..++
T Consensus       106 ~~~~~~i~~al~~lh~~---~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~  182 (261)
T cd05034         106 VDMAAQIAEGMAYLESR---NYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFT  182 (261)
T ss_pred             HHHHHHHHHHHHHHHhC---CcccCCcchheEEEcCCCCEEECccccceeccchhhhhhhccCCCccccCHHHhccCCcC
Confidence            99999999999999988   999999999999999999999999999876543211   223345689999999888889


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      .++||
T Consensus       183 ~~~Di  187 (261)
T cd05034         183 IKSDV  187 (261)
T ss_pred             chhHH
Confidence            99885

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.93  E-value=2.1e-25  Score=159.54  Aligned_cols=154  Identities=29%  Similarity=0.434  Sum_probs=122.3

Q ss_pred             EEEEEEcccc-ccccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcc------------
Q 046065            8 IIAVKKLSKK-STQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPI------------   72 (164)
Q Consensus         8 ~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~------------   72 (164)
                      .+++|.+... .....+.+..|+.++.++ +||||+++ +.+...+..++++|++++++|.+++....            
T Consensus        31 ~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~  110 (297)
T cd05089          31 NAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEH  110 (297)
T ss_pred             eeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhcccccccccccccc
Confidence            4678877532 233346788899999999 79999998 66677778999999999999999886532            


Q ss_pred             -cccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh-hhhcccccccCc
Q 046065           73 -RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL-KQIQIELGYIPP  150 (164)
Q Consensus        73 -~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~aP  150 (164)
                       ....++......++.|++.|+.++|+.   +++|+||||+||+++.++.++|+|||++........ .....+..|+||
T Consensus       111 ~~~~~l~~~~~~~i~~qi~~al~~lH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aP  187 (297)
T cd05089         111 GTASTLTSQQLLQFASDVATGMQYLSEK---QFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAI  187 (297)
T ss_pred             CccCCCCHHHHHHHHHHHHHHHHHHHHC---CcccCcCCcceEEECCCCeEEECCcCCCccccceeccCCCCcCccccCc
Confidence             112377889999999999999999998   999999999999999999999999999864322111 112234579999


Q ss_pred             ceecCCcceeccCC
Q 046065          151 EYVGRGVYYKKFSL  164 (164)
Q Consensus       151 E~~~~~~~~~~~Di  164 (164)
                      |...+..++.++||
T Consensus       188 E~~~~~~~~~~~Dv  201 (297)
T cd05089         188 ESLNYSVYTTKSDV  201 (297)
T ss_pred             hhhccCCCCchhhH
Confidence            99988889999996

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.93  E-value=3.7e-26  Score=171.11  Aligned_cols=154  Identities=23%  Similarity=0.316  Sum_probs=127.0

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+...||+|.+.+.   ...+......|-.+|...+.+=|+++ -.+.+++.+|+||+|++||++..++-+-   ..+++
T Consensus       652 DT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrm---gIFeE  728 (1034)
T KOG0608|consen  652 DTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM---GIFEE  728 (1034)
T ss_pred             chhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHHh---ccCHH
Confidence            45567788877654   23445566778889999999999998 6667788999999999999998877542   33899


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh------------------------
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK------------------------  135 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~------------------------  135 (164)
                      ..+..+..++..|++++|.+   ++|||||||+|||||.+|.+||.|||++.-+..                        
T Consensus       729 ~LARFYIAEltcAiesVHkm---GFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~  805 (1034)
T KOG0608|consen  729 DLARFYIAELTCAIESVHKM---GFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEW  805 (1034)
T ss_pred             HHHHHHHHHHHHHHHHHHhc---cceecccCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhh
Confidence            99999999999999999999   999999999999999999999999999864410                        


Q ss_pred             ----h---------------h-hhhhcccccccCcceecCCcceeccC
Q 046065          136 ----M---------------I-LKQIQIELGYIPPEYVGRGVYYKKFS  163 (164)
Q Consensus       136 ----~---------------~-~~~~~~~~~~~aPE~~~~~~~~~~~D  163 (164)
                          .               + .-.++||+.|+|||++.+.-|+.-+|
T Consensus       806 ~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cd  853 (1034)
T KOG0608|consen  806 ADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCD  853 (1034)
T ss_pred             ccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccch
Confidence                0               0 12468899999999999888887776

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.93  E-value=5.7e-25  Score=155.80  Aligned_cols=154  Identities=24%  Similarity=0.374  Sum_probs=128.9

Q ss_pred             CCCcEEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            4 PDGQIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         4 ~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      .+++.||+|..... .......+..|+.+++.++|||++++ +.+......++|+|++++++|..++...    .++...
T Consensus        27 ~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~----~~~~~~  102 (277)
T cd06641          27 RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG----PLDETQ  102 (277)
T ss_pred             CCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhcC----CCCHHH
Confidence            46789999987543 23334568889999999999999997 7777778899999999999999887643    278888


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh--hhhhhcccccccCcceecCCcce
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM--ILKQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      ...++.+++.++.++|+.   +++|+|++|+||+++.++.++++|||++......  ......++..|+|||.+....++
T Consensus       103 ~~~~~~~l~~~l~~lh~~---~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~  179 (277)
T cd06641         103 IATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD  179 (277)
T ss_pred             HHHHHHHHHHHHHHHccC---CeecCCCCHHhEEECCCCCEEEeecccceecccchhhhccccCCccccChhhhccCCCC
Confidence            999999999999999988   9999999999999999999999999988655432  22345678899999999888888


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      .++|+
T Consensus       180 ~~~Dv  184 (277)
T cd06641         180 SKADI  184 (277)
T ss_pred             chhhH
Confidence            88885

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.93  E-value=2.9e-25  Score=159.93  Aligned_cols=154  Identities=25%  Similarity=0.359  Sum_probs=118.6

Q ss_pred             CCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEee--CCcEEEEEEecCCCChhhhhhCc------cccc
Q 046065            5 DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIE--TQEYMLIYEYMPKRSLDYFLFDP------IRML   75 (164)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~--~~~~~lv~e~~~~~~L~~~~~~~------~~~~   75 (164)
                      +++.||+|.+....  ....+.+|+.+++.++|||++++ ..+..  ....++++|++++ +|.+++...      ....
T Consensus        27 ~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~  103 (317)
T cd07867          27 DEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIKFHRASKANKKPM  103 (317)
T ss_pred             ccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-cHHHHHHhhhccccCCCCc
Confidence            45789999875432  23457789999999999999998 44432  3467899999864 776665421      1122


Q ss_pred             ccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceee----cCCCCeEEccccchhhhhhh-----hhhhhccccc
Q 046065           76 ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL----DEDLKPKISDFGLARILRKM-----ILKQIQIELG  146 (164)
Q Consensus        76 ~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili----~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~~  146 (164)
                      .+++.....++.|++.||.|+|+.   +++|+||||+||++    +.++.++|+|||++......     ......+++.
T Consensus       104 ~l~~~~~~~i~~qi~~aL~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~  180 (317)
T cd07867         104 QLPRSMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW  180 (317)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHhC---CEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceeccc
Confidence            478888999999999999999998   99999999999999    45678999999999765432     1234578899


Q ss_pred             ccCcceecC-CcceeccCC
Q 046065          147 YIPPEYVGR-GVYYKKFSL  164 (164)
Q Consensus       147 ~~aPE~~~~-~~~~~~~Di  164 (164)
                      |+|||++.+ ..++.++||
T Consensus       181 y~aPE~~~~~~~~~~~~Di  199 (317)
T cd07867         181 YRAPELLLGARHYTKAIDI  199 (317)
T ss_pred             ccCcHHhcCCCccCcHHHH
Confidence            999999866 457888886

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.93  E-value=4.1e-25  Score=155.90  Aligned_cols=156  Identities=26%  Similarity=0.361  Sum_probs=124.6

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhcc-CCCceeeE-eEEeeC------CcEEEEEEecCCCChhhhhhCccccc
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIET------QEYMLIYEYMPKRSLDYFLFDPIRML   75 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~   75 (164)
                      .+++.||+|.+.... .....+..|+.+++.+ +|+|++++ +.+...      ...++++|++++++|.+++..... .
T Consensus        29 ~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~-~  106 (272)
T cd06637          29 KTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKG-N  106 (272)
T ss_pred             CCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccC-C
Confidence            467889999986442 3345678899999988 79999997 554432      347899999999999998875322 2


Q ss_pred             ccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh--hhhhhhcccccccCccee
Q 046065           76 ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK--MILKQIQIELGYIPPEYV  153 (164)
Q Consensus        76 ~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~~aPE~~  153 (164)
                      .+++.....++.|++.|+.|||+.   +++|+|++|+||+++.++.++|+|||++.....  .......|++.|+|||++
T Consensus       107 ~l~~~~~~~~~~qi~~~l~~LH~~---~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~  183 (272)
T cd06637         107 TLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI  183 (272)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHEEECCCCCEEEccCCCceecccccccCCcccccccccCHhHh
Confidence            378888999999999999999998   999999999999999999999999999875532  223446788999999998


Q ss_pred             c-----CCcceeccCC
Q 046065          154 G-----RGVYYKKFSL  164 (164)
Q Consensus       154 ~-----~~~~~~~~Di  164 (164)
                      .     ...++.++||
T Consensus       184 ~~~~~~~~~~~~~~Dv  199 (272)
T cd06637         184 ACDENPDATYDFKSDL  199 (272)
T ss_pred             ccccCcCCCCCchhhH
Confidence            5     3457788885

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.93  E-value=2.8e-25  Score=156.79  Aligned_cols=154  Identities=26%  Similarity=0.455  Sum_probs=122.5

Q ss_pred             EEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEeeC------CcEEEEEEecCCCChhhhhhCcc---ccc
Q 046065            8 IIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIET------QEYMLIYEYMPKRSLDYFLFDPI---RML   75 (164)
Q Consensus         8 ~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~---~~~   75 (164)
                      .+|+|.+...  .......+..|+.+++.++|+||+++ +.+...      ...++++||+++++|.+++....   ...
T Consensus        28 ~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~  107 (272)
T cd05075          28 KVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQ  107 (272)
T ss_pred             eEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcc
Confidence            6899987654  23345678889999999999999997 555332      24679999999999988774311   123


Q ss_pred             ccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh----hhhcccccccCcc
Q 046065           76 ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL----KQIQIELGYIPPE  151 (164)
Q Consensus        76 ~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~aPE  151 (164)
                      .++......++.|++.|+.|+|+.   +++|+|+||+||+++.++.++|+|||++........    ....+++.|+|||
T Consensus       108 ~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe  184 (272)
T cd05075         108 YLPTQMLVKFMTDIASGMEYLSSK---SFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIE  184 (272)
T ss_pred             cCCHHHHHHHHHHHHHHHHHHHHC---CeeccccchhheEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHH
Confidence            378888999999999999999998   999999999999999999999999999876543211    2234567899999


Q ss_pred             eecCCcceeccCC
Q 046065          152 YVGRGVYYKKFSL  164 (164)
Q Consensus       152 ~~~~~~~~~~~Di  164 (164)
                      ...+..++.++||
T Consensus       185 ~~~~~~~~~~~Di  197 (272)
T cd05075         185 SLADRVYTTKSDV  197 (272)
T ss_pred             HccCCCcChHHHH
Confidence            9998889999985

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.93  E-value=5.4e-25  Score=154.56  Aligned_cols=156  Identities=27%  Similarity=0.403  Sum_probs=125.0

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeEeEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRV   83 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~   83 (164)
                      .++..+|+|.+... ....+.+.+|+.+++.++|+|++++.........++++|++++++|.+++..... ..++...+.
T Consensus        28 ~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~  105 (260)
T cd05073          28 NKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEG-SKQPLPKLI  105 (260)
T ss_pred             cCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcCCCeEEEEEeCCCCcHHHHHHhCCc-cccCHHHHH
Confidence            34567899987543 2234568889999999999999998444444778899999999999998865322 236778888


Q ss_pred             HHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh---hhhcccccccCcceecCCccee
Q 046065           84 HIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL---KQIQIELGYIPPEYVGRGVYYK  160 (164)
Q Consensus        84 ~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~  160 (164)
                      .++.|++.|+.++|+.   +++|+||+|+|++++..+.++|+|||.+..+.....   ....++..|+|||++....++.
T Consensus       106 ~~~~~l~~aL~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~  182 (260)
T cd05073         106 DFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTI  182 (260)
T ss_pred             HHHHHHHHHHHHHHhC---CccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhccCCcCc
Confidence            9999999999999988   999999999999999999999999999876543211   2234556799999998888899


Q ss_pred             ccCC
Q 046065          161 KFSL  164 (164)
Q Consensus       161 ~~Di  164 (164)
                      ++|+
T Consensus       183 ~~Di  186 (260)
T cd05073         183 KSDV  186 (260)
T ss_pred             cccc
Confidence            9986

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.93  E-value=3.6e-25  Score=156.30  Aligned_cols=155  Identities=26%  Similarity=0.419  Sum_probs=126.5

Q ss_pred             CCCcEEEEEEccccc---c-------ccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcc
Q 046065            4 PDGQIIAVKKLSKKS---T-------QGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPI   72 (164)
Q Consensus         4 ~~~~~vavK~~~~~~---~-------~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~   72 (164)
                      .+++.+|+|.+....   .       ...+.+..|+.+++.++|||++++ +.+...+..++|+|++++++|.+.+....
T Consensus        24 ~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~  103 (272)
T cd06629          24 TTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYG  103 (272)
T ss_pred             CCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhhcc
Confidence            468899999875321   1       112457789999999999999997 77777788899999999999999887642


Q ss_pred             cccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh----hhhhhccccccc
Q 046065           73 RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM----ILKQIQIELGYI  148 (164)
Q Consensus        73 ~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~~  148 (164)
                         .++...+..++.|++.++.++|+.   +++|+|++|+||+++.++.++++|||++......    ......++..|+
T Consensus       104 ---~l~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~  177 (272)
T cd06629         104 ---RFEEQLVRFFTEQVLEGLAYLHSK---GILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWM  177 (272)
T ss_pred             ---CCCHHHHHHHHHHHHHHHHHHhhC---CeeecCCChhhEEEcCCCeEEEeeccccccccccccccccccccCCcccc
Confidence               378888999999999999999998   9999999999999999999999999998654321    123456788999


Q ss_pred             CcceecCCc--ceeccCC
Q 046065          149 PPEYVGRGV--YYKKFSL  164 (164)
Q Consensus       149 aPE~~~~~~--~~~~~Di  164 (164)
                      |||.+....  ++.++|+
T Consensus       178 ~PE~~~~~~~~~~~~~Dv  195 (272)
T cd06629         178 APEVIHSYSQGYSAKVDI  195 (272)
T ss_pred             CHHHhccccCCCCccchh
Confidence            999987654  7888886

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.93  E-value=2.5e-25  Score=154.46  Aligned_cols=149  Identities=17%  Similarity=0.156  Sum_probs=120.9

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      .+++.+|+|.+.....     ...|...+....|||++++ ..+......+++||++++++|.+.+.....   +++...
T Consensus        16 ~~~~~~~~K~i~~~~~-----~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---l~~~~~   87 (237)
T cd05576          16 RTQQTFILKGLRKSSE-----YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLN---IPEECV   87 (237)
T ss_pred             cCCcEEEEEeecchhh-----hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhcC---CCHHHH
Confidence            4688999999864421     2334445555679999997 666777788999999999999888865433   888999


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCcceecCCcceecc
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKKF  162 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~  162 (164)
                      ..++.|++.|+.|+|+.   +++|+|+||+||+++.++.++++|||.+...... .....++..|+|||...+..++.++
T Consensus        88 ~~~~~ql~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~  163 (237)
T cd05576          88 KRWAAEMVVALDALHRE---GIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-CDGEAVENMYCAPEVGGISEETEAC  163 (237)
T ss_pred             HHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEecccchhccccc-cccCCcCccccCCcccCCCCCCchh
Confidence            99999999999999998   9999999999999999999999999987554432 2334557789999999888889999


Q ss_pred             CC
Q 046065          163 SL  164 (164)
Q Consensus       163 Di  164 (164)
                      |+
T Consensus       164 Dv  165 (237)
T cd05576         164 DW  165 (237)
T ss_pred             hH
Confidence            85

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.93  E-value=2.4e-25  Score=156.12  Aligned_cols=161  Identities=25%  Similarity=0.359  Sum_probs=129.0

Q ss_pred             CCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEee--CCcEEEEEEecCCCChhhhhhCccc-cccc
Q 046065            4 PDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIE--TQEYMLIYEYMPKRSLDYFLFDPIR-MLIL   77 (164)
Q Consensus         4 ~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~   77 (164)
                      .+++.+|+|.+...  .....+.+..|+.+++.++|||++++ +.+..  ....++++|++++++|.+++..... ...+
T Consensus        23 ~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l  102 (265)
T cd08217          23 SDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYI  102 (265)
T ss_pred             CCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCC
Confidence            46788999988643  23345668889999999999999997 44432  3457899999999999988865321 2348


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhcC--CCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh--hhhhcccccccCccee
Q 046065           78 DCKKRVHIIKGIIQGLLYLQEYF--RLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI--LKQIQIELGYIPPEYV  153 (164)
Q Consensus        78 ~~~~~~~~~~~~~~~l~~lh~~~--~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~aPE~~  153 (164)
                      +......++.+++.|+.++|..+  ..+++|+|++|+||+++.++.++++|||++.......  .....+++.|+|||.+
T Consensus       103 ~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~  182 (265)
T cd08217         103 EEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQL  182 (265)
T ss_pred             CHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccCCcccccccccCCCccChhhh
Confidence            88899999999999999999221  2299999999999999999999999999987665322  3445788999999999


Q ss_pred             cCCcceeccCC
Q 046065          154 GRGVYYKKFSL  164 (164)
Q Consensus       154 ~~~~~~~~~Di  164 (164)
                      .+..++.++|+
T Consensus       183 ~~~~~~~~~Dv  193 (265)
T cd08217         183 NHMSYDEKSDI  193 (265)
T ss_pred             cCCCCCchhHH
Confidence            88889999885

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.93  E-value=4e-25  Score=156.88  Aligned_cols=157  Identities=25%  Similarity=0.406  Sum_probs=126.2

Q ss_pred             CCCcEEEEEEccccc-cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            4 PDGQIIAVKKLSKKS-TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         4 ~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      .+|+.||+|.+.... ......+..|+.+++.++|+|++++ +.+...+..++|+|++++ +|.+++........+++..
T Consensus        23 ~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~  101 (284)
T cd07836          23 TTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNT  101 (284)
T ss_pred             CCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-cHHHHHHhcCCCCCcCHHH
Confidence            468899999986552 3334567789999999999999998 777777888999999985 8887776543333488999


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh--hhhhhcccccccCcceecCC-cc
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM--ILKQIQIELGYIPPEYVGRG-VY  158 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~~~-~~  158 (164)
                      ...++.|++.|+.|+|+.   +++|+|++|+||+++.++.++++|||.+......  ......+++.|+|||.+.+. .+
T Consensus       102 ~~~~~~qi~~~l~~lH~~---~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~  178 (284)
T cd07836         102 VKSFTYQLLKGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTY  178 (284)
T ss_pred             HHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccccccccccccccChHHhcCCCCC
Confidence            999999999999999998   9999999999999999999999999998654321  12334568889999988554 45


Q ss_pred             eeccCC
Q 046065          159 YKKFSL  164 (164)
Q Consensus       159 ~~~~Di  164 (164)
                      +.++||
T Consensus       179 ~~~~Dv  184 (284)
T cd07836         179 STSIDI  184 (284)
T ss_pred             CcHHHH
Confidence            777775

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=4.7e-25  Score=154.73  Aligned_cols=153  Identities=22%  Similarity=0.229  Sum_probs=122.7

Q ss_pred             CCCcEEEEEEccccc---cccHHHHHHHHHH-HhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccC
Q 046065            4 PDGQIIAVKKLSKKS---TQGFEEFKNEVML-TAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILD   78 (164)
Q Consensus         4 ~~~~~vavK~~~~~~---~~~~~~~~~e~~~-l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~   78 (164)
                      .+++.||+|.+....   ......+..|..+ ....+|+|++++ +.+...+..++++||+++++|.+++.....   ++
T Consensus        19 ~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~   95 (260)
T cd05611          19 STGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGG---LP   95 (260)
T ss_pred             CCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHHcCC---CC
Confidence            357899999986432   1122233445444 445589999997 677777789999999999999998865432   78


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCcceecCCcc
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVY  158 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  158 (164)
                      ......++.|++.||.|+|+.   +++|+|++|+||+++.++.++|+|||++.....  .....+++.|+|||.+.+..+
T Consensus        96 ~~~~~~i~~qi~~aL~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--~~~~~~~~~y~~pe~~~~~~~  170 (260)
T cd05611          96 EDWAKQYIAEVVLGVEDLHQR---GIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE--NKKFVGTPDYLAPETILGVGD  170 (260)
T ss_pred             HHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCcEEEeecccceeccc--cccCCCCcCccChhhhcCCCC
Confidence            899999999999999999998   999999999999999999999999998865432  233467888999999988888


Q ss_pred             eeccCC
Q 046065          159 YKKFSL  164 (164)
Q Consensus       159 ~~~~Di  164 (164)
                      +.++||
T Consensus       171 ~~~~Dv  176 (260)
T cd05611         171 DKMSDW  176 (260)
T ss_pred             cchhhh
Confidence            999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=5.2e-25  Score=153.68  Aligned_cols=155  Identities=25%  Similarity=0.355  Sum_probs=131.0

Q ss_pred             CCCcEEEEEEcccccc--ccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            4 PDGQIIAVKKLSKKST--QGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      .+++.||+|.+.....  .....+..|+.++..++|||++++ ..+...+..++++|++++++|.+++....   .+++.
T Consensus        23 ~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~---~l~~~   99 (254)
T cd06627          23 ETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFG---PFPES   99 (254)
T ss_pred             CCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhcc---CCCHH
Confidence            3578899999876533  455678899999999999999997 66677778899999999999998886542   38899


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh--hhhcccccccCcceecCCcc
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL--KQIQIELGYIPPEYVGRGVY  158 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~aPE~~~~~~~  158 (164)
                      ....++.|++.++.++|+.   +++|+|++|+||+++.++.++|+|||.+........  ....++..|+|||...+..+
T Consensus       100 ~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~  176 (254)
T cd06627         100 LVAVYVYQVLQGLAYLHEQ---GVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGA  176 (254)
T ss_pred             HHHHHHHHHHHHHHHHhhC---CcccCCCCHHHEEECCCCCEEEeccccceecCCCcccccccccchhhcCHhhhcCCCC
Confidence            9999999999999999988   999999999999999999999999999876643222  34567889999999987778


Q ss_pred             eeccCC
Q 046065          159 YKKFSL  164 (164)
Q Consensus       159 ~~~~Di  164 (164)
                      +.++||
T Consensus       177 ~~~~Dv  182 (254)
T cd06627         177 STASDI  182 (254)
T ss_pred             CcchhH
Confidence            888885

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.93  E-value=1.9e-25  Score=177.28  Aligned_cols=161  Identities=21%  Similarity=0.294  Sum_probs=125.0

Q ss_pred             CCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEee--CCcEEEEEEecCCCChhhhhhCccc-cccc
Q 046065            4 PDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIE--TQEYMLIYEYMPKRSLDYFLFDPIR-MLIL   77 (164)
Q Consensus         4 ~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~   77 (164)
                      .+++.+|+|.+...  .......+..|+.+++.++||||+++ ..+..  ...+|+||||+++++|..++..... ...+
T Consensus        36 ~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L  115 (1021)
T PTZ00266         36 RTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKI  115 (1021)
T ss_pred             CCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCC
Confidence            35678999988644  23345678899999999999999997 54433  3458899999999999998865321 2348


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhcC----CCCeeeCCCCCCceeecC-----------------CCCeEEccccchhhhhhh
Q 046065           78 DCKKRVHIIKGIIQGLLYLQEYF----RLTIIHRDLKVSNILLDE-----------------DLKPKISDFGLARILRKM  136 (164)
Q Consensus        78 ~~~~~~~~~~~~~~~l~~lh~~~----~~~iih~dlk~~nili~~-----------------~~~~~l~dfg~~~~~~~~  136 (164)
                      ++..++.++.|++.||.|||+..    ..+|+|+||||+|||++.                 .+.++|+|||++......
T Consensus       116 ~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~  195 (1021)
T PTZ00266        116 EEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIE  195 (1021)
T ss_pred             CHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCcccccccc
Confidence            99999999999999999999852    135999999999999964                 234899999999765432


Q ss_pred             -hhhhhcccccccCcceecC--CcceeccCC
Q 046065          137 -ILKQIQIELGYIPPEYVGR--GVYYKKFSL  164 (164)
Q Consensus       137 -~~~~~~~~~~~~aPE~~~~--~~~~~~~Di  164 (164)
                       ......|++.|+|||++.+  ..++.++||
T Consensus       196 s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDV  226 (1021)
T PTZ00266        196 SMAHSCVGTPYYWSPELLLHETKSYDDKSDM  226 (1021)
T ss_pred             ccccccCCCccccCHHHHhccCCCCCchhHH
Confidence             2245678999999999854  357889886

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.93  E-value=2.1e-25  Score=157.14  Aligned_cols=155  Identities=30%  Similarity=0.433  Sum_probs=125.7

Q ss_pred             cEEEEEEccccc-cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcc----cccccCHH
Q 046065            7 QIIAVKKLSKKS-TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPI----RMLILDCK   80 (164)
Q Consensus         7 ~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~~~~   80 (164)
                      +.+|+|.+.... ......+..|+.+++.++||||+++ +.+......++++|++++++|.+++....    ....++..
T Consensus        27 ~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~  106 (269)
T cd05044          27 IRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLK  106 (269)
T ss_pred             eeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHH
Confidence            578899875442 3345678899999999999999997 67777778999999999999998886422    12236778


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCC-----CeEEccccchhhhhhhhh----hhhcccccccCcc
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL-----KPKISDFGLARILRKMIL----KQIQIELGYIPPE  151 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~-----~~~l~dfg~~~~~~~~~~----~~~~~~~~~~aPE  151 (164)
                      ....++.|++.++.|+|+.   +++|+|++|+||+++.++     .++++|||++........    ....++..|+|||
T Consensus       107 ~~~~~~~~l~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  183 (269)
T cd05044         107 ELLDICLDVAKGCVYLEQM---HFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPE  183 (269)
T ss_pred             HHHHHHHHHHHHHHHHHhC---CcccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHH
Confidence            8899999999999999988   999999999999999877     899999999865532211    2234567899999


Q ss_pred             eecCCcceeccCC
Q 046065          152 YVGRGVYYKKFSL  164 (164)
Q Consensus       152 ~~~~~~~~~~~Di  164 (164)
                      .+.++.++.++||
T Consensus       184 ~~~~~~~~~~~Dv  196 (269)
T cd05044         184 SLLDGKFTTQSDV  196 (269)
T ss_pred             HHccCCcccchhH
Confidence            9998999999996

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=5.6e-25  Score=155.68  Aligned_cols=154  Identities=25%  Similarity=0.416  Sum_probs=127.9

Q ss_pred             CCCcEEEEEEcccc-ccccHHHHHHHHHHHhccC---CCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccC
Q 046065            4 PDGQIIAVKKLSKK-STQGFEEFKNEVMLTAKLQ---HLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILD   78 (164)
Q Consensus         4 ~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~---h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~   78 (164)
                      .+++.||+|.+... .......+..|+.+++.++   |||++++ +.+......++++|++++++|.+++...    .++
T Consensus        24 ~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~l~   99 (277)
T cd06917          24 PTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKAG----PIA   99 (277)
T ss_pred             CCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHcc----CCC
Confidence            56889999998654 3344566788999998886   9999997 7777778899999999999999887653    378


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh--hhhhcccccccCcceecCC
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI--LKQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~aPE~~~~~  156 (164)
                      +.....++.+++.++.++|+.   +++|+|++|+||+++..+.++|+|||.+.......  .....++..|+|||.+.++
T Consensus       100 ~~~~~~i~~~i~~~l~~lh~~---~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  176 (277)
T cd06917         100 EKYISVIIREVLVALKYIHKV---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEG  176 (277)
T ss_pred             HHHHHHHHHHHHHHHHHHHhC---CcccCCcCHHHEEEcCCCCEEEccCCceeecCCCccccccccCCcceeCHHHhccC
Confidence            899999999999999999988   99999999999999999999999999987654322  2345688899999998654


Q ss_pred             -cceeccCC
Q 046065          157 -VYYKKFSL  164 (164)
Q Consensus       157 -~~~~~~Di  164 (164)
                       .++.++|+
T Consensus       177 ~~~~~~~Dv  185 (277)
T cd06917         177 KYYDTKADI  185 (277)
T ss_pred             CccccchhH
Confidence             45888885

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.93  E-value=2.4e-25  Score=159.73  Aligned_cols=151  Identities=25%  Similarity=0.456  Sum_probs=121.4

Q ss_pred             EEEEEEccccc-cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHHHH
Q 046065            8 IIAVKKLSKKS-TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHI   85 (164)
Q Consensus         8 ~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~   85 (164)
                      .+|+|.+.... +.....+..|+.+++.++|||++++ +.+. ....++++|++++|+|.+++.....  .++......+
T Consensus        38 ~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~-~~~~~~v~e~~~~g~l~~~~~~~~~--~~~~~~~~~~  114 (303)
T cd05110          38 PVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCL-SPTIQLVTQLMPHGCLLDYVHEHKD--NIGSQLLLNW  114 (303)
T ss_pred             eEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEc-CCCceeeehhcCCCCHHHHHHhccc--CCCHHHHHHH
Confidence            47888876442 2333467889999999999999998 5444 4556799999999999988865322  2788889999


Q ss_pred             HHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh----hhhhcccccccCcceecCCcceec
Q 046065           86 IKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI----LKQIQIELGYIPPEYVGRGVYYKK  161 (164)
Q Consensus        86 ~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~  161 (164)
                      +.|++.|+.|+|+.   +++|+||||+||+++.++.++|+|||++.......    .....++..|+|||.+.+..++.+
T Consensus       115 ~~qi~~~L~~LH~~---~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~  191 (303)
T cd05110         115 CVQIAKGMMYLEER---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQ  191 (303)
T ss_pred             HHHHHHHHHHHhhc---CeeccccccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChH
Confidence            99999999999998   99999999999999999999999999997654221    123345678999999988889999


Q ss_pred             cCC
Q 046065          162 FSL  164 (164)
Q Consensus       162 ~Di  164 (164)
                      +||
T Consensus       192 ~Di  194 (303)
T cd05110         192 SDV  194 (303)
T ss_pred             HHH
Confidence            885

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.93  E-value=8.7e-25  Score=152.07  Aligned_cols=155  Identities=28%  Similarity=0.405  Sum_probs=132.8

Q ss_pred             CCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHH
Q 046065            5 DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRV   83 (164)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~   83 (164)
                      +++.+++|.+..........+..|+..++.++|+|++++ +.+......++++|++++++|.+++....  ..++.....
T Consensus        24 ~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~--~~~~~~~~~  101 (253)
T cd05122          24 TGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTN--QTLTESQIA  101 (253)
T ss_pred             CCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcC--CCCCHHHHH
Confidence            678899999876544456778899999999999999997 66667788899999999999999886642  238899999


Q ss_pred             HHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh-hhhhcccccccCcceecCCcceecc
Q 046065           84 HIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI-LKQIQIELGYIPPEYVGRGVYYKKF  162 (164)
Q Consensus        84 ~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~~~~  162 (164)
                      .++.+++.++.++|+.   +++|+|++|+||+++.++.++|+|||.+....... .....++..|+|||...+..++.++
T Consensus       102 ~i~~~i~~~l~~lh~~---~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~  178 (253)
T cd05122         102 YVCKELLKGLEYLHSN---GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKA  178 (253)
T ss_pred             HHHHHHHHHHHHhhcC---CEecCCCCHHHEEEccCCeEEEeeccccccccccccccceecCCcccCHHHHcCCCCCccc
Confidence            9999999999999998   99999999999999999999999999987665432 3456688899999999888888898


Q ss_pred             CC
Q 046065          163 SL  164 (164)
Q Consensus       163 Di  164 (164)
                      |+
T Consensus       179 Dv  180 (253)
T cd05122         179 DI  180 (253)
T ss_pred             cH
Confidence            86

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.93  E-value=3e-25  Score=158.63  Aligned_cols=155  Identities=26%  Similarity=0.362  Sum_probs=126.1

Q ss_pred             CCCcEEEEEEccccccc-----cHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccccccc
Q 046065            4 PDGQIIAVKKLSKKSTQ-----GFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLIL   77 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~   77 (164)
                      .+++.||+|.+......     ....+..|+.+++.++|+|++++ +.+...+..++|+|++ +++|.+++....  ..+
T Consensus        23 ~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~~--~~~   99 (298)
T cd07841          23 ETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKS--IVL   99 (298)
T ss_pred             CCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHHHhccC--CCC
Confidence            46789999998754322     23456789999999999999997 7777777889999999 889999886543  238


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh--hhhhhcccccccCcceecC
Q 046065           78 DCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM--ILKQIQIELGYIPPEYVGR  155 (164)
Q Consensus        78 ~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~~  155 (164)
                      ++.....++.|++.||.|+|+.   +++|+||+|+||+++.++.++|+|||++......  ......+++.|+|||.+.+
T Consensus       100 ~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  176 (298)
T cd07841         100 TPADIKSYMLMTLRGLEYLHSN---WILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFG  176 (298)
T ss_pred             CHHHHHHHHHHHHHHHHHHHhC---CeeecCCChhhEEEcCCCCEEEccceeeeeccCCCccccccccceeeeCHHHHhC
Confidence            8899999999999999999998   9999999999999999999999999998765432  2233456788999998854


Q ss_pred             -CcceeccCC
Q 046065          156 -GVYYKKFSL  164 (164)
Q Consensus       156 -~~~~~~~Di  164 (164)
                       ..++.++||
T Consensus       177 ~~~~~~~~Dv  186 (298)
T cd07841         177 ARHYGVGVDM  186 (298)
T ss_pred             CCCCCcHHHH
Confidence             456788875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.93  E-value=2.9e-25  Score=159.78  Aligned_cols=156  Identities=26%  Similarity=0.373  Sum_probs=123.8

Q ss_pred             CCcEEEEEEccccc---cccHHHHHHHHHHHhccCCCceeeE-eEEeeC--CcEEEEEEecCCCChhhhhhCccc--ccc
Q 046065            5 DGQIIAVKKLSKKS---TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIET--QEYMLIYEYMPKRSLDYFLFDPIR--MLI   76 (164)
Q Consensus         5 ~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~--~~~   76 (164)
                      +++.||+|.+....   ......+.+|+.+++.++|||++++ +.+...  ..+++|+|++++ ++.+.+.....  ...
T Consensus        26 ~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~  104 (316)
T cd07842          26 DGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQIIKFHRQAKRVS  104 (316)
T ss_pred             CCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCCc-CHHHHHHhhccCCCcC
Confidence            67899999987632   3445667889999999999999998 666666  668899999875 66666543221  224


Q ss_pred             cCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecC----CCCeEEccccchhhhhhhh-----hhhhcccccc
Q 046065           77 LDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE----DLKPKISDFGLARILRKMI-----LKQIQIELGY  147 (164)
Q Consensus        77 ~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~----~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~  147 (164)
                      ++......++.|++.|+.|+|+.   +++|+||||+||+++.    ++.++|+|||++.......     .....+++.|
T Consensus       105 ~~~~~~~~i~~qi~~~l~~lH~~---~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y  181 (316)
T cd07842         105 IPPSMVKSLLWQILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWY  181 (316)
T ss_pred             cCHHHHHHHHHHHHHHHHHHHhC---CEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccc
Confidence            78899999999999999999998   9999999999999999    8999999999987653221     1345678899


Q ss_pred             cCcceecC-CcceeccCC
Q 046065          148 IPPEYVGR-GVYYKKFSL  164 (164)
Q Consensus       148 ~aPE~~~~-~~~~~~~Di  164 (164)
                      +|||.+.+ ..++.++||
T Consensus       182 ~aPE~~~~~~~~~~~~Dv  199 (316)
T cd07842         182 RAPELLLGARHYTKAIDI  199 (316)
T ss_pred             cCHHHHhCCCCCCcHHHH
Confidence            99998765 457888885

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.93  E-value=6.7e-25  Score=156.38  Aligned_cols=155  Identities=25%  Similarity=0.349  Sum_probs=121.4

Q ss_pred             CCCcEEEEEEccccc-cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            4 PDGQIIAVKKLSKKS-TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         4 ~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      .+++.||+|.+.... ......+.+|+.+++.++|+||+++ +.+......++|+|++. +++...+....  ..++...
T Consensus        28 ~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~~~~~~  104 (291)
T cd07870          28 INGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQHP--GGLHPYN  104 (291)
T ss_pred             CCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHhCC--CCCCHHH
Confidence            467899999986543 2223456789999999999999998 66666677899999996 67766654322  1267778


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh--hhhhhcccccccCcceecCC-cc
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM--ILKQIQIELGYIPPEYVGRG-VY  158 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~~~-~~  158 (164)
                      ...++.|++.||.|+|+.   +++|+||||+||+++.++.++|+|||++......  ......+++.|+|||.+.+. .+
T Consensus       105 ~~~~~~qi~~~L~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  181 (291)
T cd07870         105 VRLFMFQLLRGLAYIHGQ---HILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDY  181 (291)
T ss_pred             HHHHHHHHHHHHHHHHhC---CcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCCCccccccccCCceeecCCCC
Confidence            888999999999999998   9999999999999999999999999988654321  12334568899999998653 46


Q ss_pred             eeccCC
Q 046065          159 YKKFSL  164 (164)
Q Consensus       159 ~~~~Di  164 (164)
                      +.++||
T Consensus       182 ~~~~Dv  187 (291)
T cd07870         182 SSALDI  187 (291)
T ss_pred             CcHHHH
Confidence            788885

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=1.9e-26  Score=180.77  Aligned_cols=155  Identities=22%  Similarity=0.239  Sum_probs=128.9

Q ss_pred             cCCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeEeEE-eeCCcEEEEEEecCCCChhhhhhCcccccccC
Q 046065            3 LPDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRVGFC-IETQEYMLIYEYMPKRSLDYFLFDPIRMLILD   78 (164)
Q Consensus         3 ~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~-~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~   78 (164)
                      ..+++.||+|++++.   +.....-|+.|-.+|...+.+=|+.+.+. .+...+|+||||++||+|-.++.+-.   .+|
T Consensus        97 k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~---~~p  173 (1317)
T KOG0612|consen   97 KSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFD---RLP  173 (1317)
T ss_pred             eccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCchHHHHHhhcC---CCh
Confidence            457889999999875   34445667888889999998888888555 45567899999999999999986543   399


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh---hhhcccccccCccee--
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL---KQIQIELGYIPPEYV--  153 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~aPE~~--  153 (164)
                      +.++..++.+|+-||.-+|++   |.||||+||+|+|+|..|.+||+|||.+-.+...+.   ...+|||-|++||++  
T Consensus       174 E~~ArFY~aEiVlAldslH~m---gyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs  250 (1317)
T KOG0612|consen  174 EDWARFYTAEIVLALDSLHSM---GYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQS  250 (1317)
T ss_pred             HHHHHHHHHHHHHHHHHHHhc---cceeccCCcceeEecccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHh
Confidence            999999999999999999999   999999999999999999999999998866653332   567899999999999  


Q ss_pred             --cC-CcceeccC
Q 046065          154 --GR-GVYYKKFS  163 (164)
Q Consensus       154 --~~-~~~~~~~D  163 (164)
                        .+ +.|+.-+|
T Consensus       251 ~~~~~g~yG~ecD  263 (1317)
T KOG0612|consen  251 QGDGKGEYGRECD  263 (1317)
T ss_pred             hcCCccccCCccc
Confidence              22 56666665

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.93  E-value=6.3e-25  Score=156.67  Aligned_cols=155  Identities=27%  Similarity=0.367  Sum_probs=124.5

Q ss_pred             CCCcEEEEEEccccc--cccHHHHHHHHHHHhccCCCceeeE-eEEeeC--CcEEEEEEecCCCChhhhhhCcccccccC
Q 046065            4 PDGQIIAVKKLSKKS--TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIET--QEYMLIYEYMPKRSLDYFLFDPIRMLILD   78 (164)
Q Consensus         4 ~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~   78 (164)
                      .+++.+|+|.+....  ......+.+|+.+++.++|||++++ +.+...  +..++|+|++++ +|..++.....  .++
T Consensus        28 ~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~~--~l~  104 (293)
T cd07843          28 KTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQ--PFL  104 (293)
T ss_pred             CCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcCc-CHHHHHHhccC--CCC
Confidence            357889999986542  2233456789999999999999997 666555  778999999974 88887765322  388


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh--hhhhhcccccccCcceecCC
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM--ILKQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~~~  156 (164)
                      ......++.|++.||.|||+.   +++|+||+|+||+++.++.++|+|||.+......  ......+++.|+|||.+.+.
T Consensus       105 ~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~  181 (293)
T cd07843         105 QSEVKCLMLQLLSGVAHLHDN---WILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGA  181 (293)
T ss_pred             HHHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCcEEEeecCceeeccCCccccccccccccccCchhhcCC
Confidence            999999999999999999998   9999999999999999999999999988765432  22345578889999998654


Q ss_pred             c-ceeccCC
Q 046065          157 V-YYKKFSL  164 (164)
Q Consensus       157 ~-~~~~~Di  164 (164)
                      . ++.++|+
T Consensus       182 ~~~~~~~Di  190 (293)
T cd07843         182 KEYSTAIDM  190 (293)
T ss_pred             ccccchhhH
Confidence            4 5888885

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.93  E-value=3.7e-25  Score=157.09  Aligned_cols=156  Identities=22%  Similarity=0.350  Sum_probs=125.4

Q ss_pred             CCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            4 PDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         4 ~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      .+++.||+|.+..+  .......+..|+++++.++|||++++ +.+......++|+||+. ++|..++..... ..++..
T Consensus        23 ~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~-~~l~~~  100 (284)
T cd07860          23 LTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASPL-SGIPLP  100 (284)
T ss_pred             CCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhCCC-CCCCHH
Confidence            46889999988644  23334578899999999999999997 77777788999999996 578877754322 237889


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh--hhhhhcccccccCcceecCCc-
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM--ILKQIQIELGYIPPEYVGRGV-  157 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~-  157 (164)
                      ....++.|++.|+.|+|+.   +++|+|++|+||+++.++.++|+|||++......  ......+++.|+|||.+.+.. 
T Consensus       101 ~~~~~~~~i~~~l~~lh~~---~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  177 (284)
T cd07860         101 LIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY  177 (284)
T ss_pred             HHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccccccccccccCCeEEecCCC
Confidence            9999999999999999998   9999999999999999999999999998755422  123345678899999886544 


Q ss_pred             ceeccCC
Q 046065          158 YYKKFSL  164 (164)
Q Consensus       158 ~~~~~Di  164 (164)
                      ++.++||
T Consensus       178 ~~~~~Dv  184 (284)
T cd07860         178 YSTAVDI  184 (284)
T ss_pred             CCcHHHH
Confidence            5777875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.93  E-value=5.2e-25  Score=156.89  Aligned_cols=155  Identities=24%  Similarity=0.282  Sum_probs=124.8

Q ss_pred             CCCcEEEEEEccccc----cccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccccccc
Q 046065            4 PDGQIIAVKKLSKKS----TQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLIL   77 (164)
Q Consensus         4 ~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~   77 (164)
                      ++|+.||+|.+....    ......+..|+.++..+ +|+||+.+ ..+......++|+|++++++|.+++.....   +
T Consensus        26 ~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---l  102 (290)
T cd05613          26 DSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRER---F  102 (290)
T ss_pred             CCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHHcCC---C
Confidence            478899999986431    22345677899999999 58999998 555556678899999999999988865432   7


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh---hhhhcccccccCcceec
Q 046065           78 DCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI---LKQIQIELGYIPPEYVG  154 (164)
Q Consensus        78 ~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~aPE~~~  154 (164)
                      +......++.|++.||.++|+.   +++|+||+|+||+++.++.++|+|||++.......   .....++..|+|||.+.
T Consensus       103 ~~~~~~~~~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  179 (290)
T cd05613         103 KEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVR  179 (290)
T ss_pred             CHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHeEECCCCCEEEeeCccceecccccccccccccCCcccCChhhcc
Confidence            8888899999999999999998   99999999999999999999999999987654321   12356888999999986


Q ss_pred             CC--cceeccCC
Q 046065          155 RG--VYYKKFSL  164 (164)
Q Consensus       155 ~~--~~~~~~Di  164 (164)
                      +.  .++.++||
T Consensus       180 ~~~~~~~~~~Dv  191 (290)
T cd05613         180 GGDGGHDKAVDW  191 (290)
T ss_pred             CCCCCCCccccH
Confidence            53  35777875

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.93  E-value=3.3e-26  Score=171.40  Aligned_cols=152  Identities=26%  Similarity=0.409  Sum_probs=132.9

Q ss_pred             EEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHHHHH
Q 046065            8 IIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHII   86 (164)
Q Consensus         8 ~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~   86 (164)
                      -||||.++.+ .-....|+.|+.+|+.++|||++++ +.|....-+|+|+||+..|+|.+++++... ..++....+.++
T Consensus       294 TvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr-~ev~avvLlyMA  371 (1157)
T KOG4278|consen  294 TVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNR-SEVPAVVLLYMA  371 (1157)
T ss_pred             eeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhch-hhcchhHHHHHH
Confidence            4889988544 3346789999999999999999997 999999999999999999999999988543 237778888999


Q ss_pred             HHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcc---cccccCcceecCCcceeccC
Q 046065           87 KGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQI---ELGYIPPEYVGRGVYYKKFS  163 (164)
Q Consensus        87 ~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~---~~~~~aPE~~~~~~~~~~~D  163 (164)
                      .||.+|+.||...   ++||||+..+|+|+.++..+|++|||++++.....++.-.|   ...|.|||.+..+.++.|+|
T Consensus       372 tQIsSaMeYLEkk---nFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSD  448 (1157)
T KOG4278|consen  372 TQISSAMEYLEKK---NFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSD  448 (1157)
T ss_pred             HHHHHHHHHHHHh---hhhhhhhhhhhccccccceEEeeccchhhhhcCCceecccCccCcccccCcccccccccccchh
Confidence            9999999999998   99999999999999999999999999999887665544433   46799999999999999999


Q ss_pred             C
Q 046065          164 L  164 (164)
Q Consensus       164 i  164 (164)
                      |
T Consensus       449 V  449 (1157)
T KOG4278|consen  449 V  449 (1157)
T ss_pred             h
Confidence            6

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.93  E-value=1.9e-25  Score=158.61  Aligned_cols=154  Identities=26%  Similarity=0.382  Sum_probs=125.8

Q ss_pred             CCcEEEEEEccccc--cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            5 DGQIIAVKKLSKKS--TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         5 ~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      +++.||+|.+....  ......+..|+.+++.++|||++++ +.+...+..++|+||+++++|..+......   ++...
T Consensus        25 ~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~---~~~~~  101 (286)
T cd07846          25 TGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNG---LDESR  101 (286)
T ss_pred             CCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhccCC---CCHHH
Confidence            57899999876542  2234567889999999999999997 777777889999999999888877654322   78899


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh--hhhhhhcccccccCcceecC-Ccc
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK--MILKQIQIELGYIPPEYVGR-GVY  158 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~~aPE~~~~-~~~  158 (164)
                      ...++.|++.++.|+|+.   +++|+|++|+||+++.++.++|+|||++.....  .......++..|+|||.+.+ ..+
T Consensus       102 ~~~~~~~i~~~l~~LH~~---~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  178 (286)
T cd07846         102 VRKYLFQILRGIEFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKY  178 (286)
T ss_pred             HHHHHHHHHHHHHHHHHC---CccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCcccceeeccCcHHhcccccc
Confidence            999999999999999998   999999999999999999999999999875532  22234567889999999865 346


Q ss_pred             eeccCC
Q 046065          159 YKKFSL  164 (164)
Q Consensus       159 ~~~~Di  164 (164)
                      +.++||
T Consensus       179 ~~~~Dv  184 (286)
T cd07846         179 GRAVDI  184 (286)
T ss_pred             CchHhH
Confidence            788885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.93  E-value=3.2e-25  Score=154.98  Aligned_cols=158  Identities=27%  Similarity=0.373  Sum_probs=132.1

Q ss_pred             CCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccc-ccccCH
Q 046065            4 PDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIR-MLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~   79 (164)
                      .+++.+|+|.+...  .......+..|+.+++.++|+||+++ ..+......++|+|++++++|.+++..... ...++.
T Consensus        23 ~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~  102 (256)
T cd08530          23 SDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPE  102 (256)
T ss_pred             CCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCH
Confidence            46789999998653  23345567889999999999999997 666777889999999999999988865221 233788


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCcceecCCcce
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      .....++.+++.|+.++|+.   +++|+|++|+||+++..+.++|+|||++............+++.|+|||...+..++
T Consensus       103 ~~~~~~~~~l~~al~~lh~~---~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~  179 (256)
T cd08530         103 QEIWRIFIQLLRGLQALHEQ---KILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIGTPHYMAPEVWKGRPYS  179 (256)
T ss_pred             HHHHHHHHHHHHHHHHHhhC---CcccCCCCcceEEEecCCcEEEeeccchhhhccCCcccccCCccccCHHHHCCCCCC
Confidence            88999999999999999998   999999999999999999999999999877655444445678899999999888889


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      .++|+
T Consensus       180 ~~~D~  184 (256)
T cd08530         180 YKSDI  184 (256)
T ss_pred             chhhH
Confidence            88885

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.93  E-value=9.2e-25  Score=152.55  Aligned_cols=157  Identities=24%  Similarity=0.344  Sum_probs=132.0

Q ss_pred             CCcEEEEEEcccccc--ccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcc-cccccCHH
Q 046065            5 DGQIIAVKKLSKKST--QGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPI-RMLILDCK   80 (164)
Q Consensus         5 ~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~   80 (164)
                      +++.+++|.+.....  .....+..|+++++.++|+|++++ +.+...+..++++|++++++|...+.+.. ....++..
T Consensus        24 ~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~  103 (258)
T cd08215          24 DGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEE  103 (258)
T ss_pred             CCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHH
Confidence            578999999875532  455678899999999999999997 66667788899999999999998887632 12348899


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh--hhhhhcccccccCcceecCCcc
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM--ILKQIQIELGYIPPEYVGRGVY  158 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~  158 (164)
                      ....++.+++.|+.++|+.   +++|+|++|+||+++.++.++|+|||++......  ......+++.|+|||...+..+
T Consensus       104 ~~~~i~~~i~~~l~~lh~~---~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~  180 (258)
T cd08215         104 QILDWFVQLCLALKYLHSR---KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPY  180 (258)
T ss_pred             HHHHHHHHHHHHHHHHHhC---CEecccCChHHeEEcCCCcEEECCccceeecccCcceecceeeeecccChhHhccCCC
Confidence            9999999999999999998   9999999999999999999999999998765433  2234568889999999988888


Q ss_pred             eeccCC
Q 046065          159 YKKFSL  164 (164)
Q Consensus       159 ~~~~Di  164 (164)
                      +.++|+
T Consensus       181 ~~~~Dv  186 (258)
T cd08215         181 NYKSDI  186 (258)
T ss_pred             CccccH
Confidence            999985

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.93  E-value=9.5e-25  Score=155.14  Aligned_cols=157  Identities=24%  Similarity=0.273  Sum_probs=122.5

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhcc-CCCceeeE-eEEe-----eCCcEEEEEEecCCCChhhhhhCcc-ccc
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKL-QHLNLIRV-GFCI-----ETQEYMLIYEYMPKRSLDYFLFDPI-RML   75 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~~-~~~   75 (164)
                      .+++.+|+|.+.... .....+..|+.+++.+ +|||++++ +.+.     ..+.++++|||+++++|.+++.... ...
T Consensus        41 ~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~  119 (286)
T cd06638          41 KNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGE  119 (286)
T ss_pred             CCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCc
Confidence            457889999875432 2234577899999999 69999997 5443     2345889999999999988775321 123


Q ss_pred             ccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh--hhhhhcccccccCccee
Q 046065           76 ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM--ILKQIQIELGYIPPEYV  153 (164)
Q Consensus        76 ~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~  153 (164)
                      .+++.....++.|++.|+.|+|+.   +++|+|+||+||+++.++.++|+|||++......  ......+++.|+|||.+
T Consensus       120 ~~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~  196 (286)
T cd06638         120 RMEEPIIAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVI  196 (286)
T ss_pred             cccHHHHHHHHHHHHHHHHHHHhC---CccccCCCHHhEEECCCCCEEEccCCceeecccCCCccccccCCCcccChhhh
Confidence            378888999999999999999998   9999999999999999999999999998655432  22345688999999998


Q ss_pred             cC-----CcceeccCC
Q 046065          154 GR-----GVYYKKFSL  164 (164)
Q Consensus       154 ~~-----~~~~~~~Di  164 (164)
                      ..     ..++.++||
T Consensus       197 ~~~~~~~~~~~~~~Dv  212 (286)
T cd06638         197 ACEQQLDSTYDARCDV  212 (286)
T ss_pred             chhhhccccccchhhh
Confidence            53     447888886

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.93  E-value=9.6e-26  Score=167.01  Aligned_cols=153  Identities=24%  Similarity=0.335  Sum_probs=128.7

Q ss_pred             CCcEEEEEEccccc--------cccHHHHHHHHHHHhccC---CCceeeE-eEEeeCCcEEEEEEec-CCCChhhhhhCc
Q 046065            5 DGQIIAVKKLSKKS--------TQGFEEFKNEVMLTAKLQ---HLNLIRV-GFCIETQEYMLIYEYM-PKRSLDYFLFDP   71 (164)
Q Consensus         5 ~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---h~~i~~~-~~~~~~~~~~lv~e~~-~~~~L~~~~~~~   71 (164)
                      +..+|.+|.+.+..        ......+-.|+++|..++   |+||+++ .++++.+.+|++||.- ++.+|.+++...
T Consensus       585 n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~k  664 (772)
T KOG1152|consen  585 NNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFK  664 (772)
T ss_pred             cceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeEEEecCCCCCcchhhhhhcc
Confidence            35689999987651        122334557999999997   9999997 7777778888999874 556677777554


Q ss_pred             ccccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCcc
Q 046065           72 IRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPE  151 (164)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE  151 (164)
                      .+   +.+..++-++.|++-|+++||+.   +|+|||||-+|++++.+|.+||+|||.+...+++....+.||..|.|||
T Consensus       665 p~---m~E~eAk~IFkQV~agi~hlh~~---~ivhrdikdenvivd~~g~~klidfgsaa~~ksgpfd~f~gtv~~aape  738 (772)
T KOG1152|consen  665 PR---MDEPEAKLIFKQVVAGIKHLHDQ---GIVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSGPFDVFVGTVDYAAPE  738 (772)
T ss_pred             Cc---cchHHHHHHHHHHHhcccccccc---CceecccccccEEEecCCeEEEeeccchhhhcCCCcceeeeeccccchh
Confidence            33   88999999999999999999998   9999999999999999999999999999999999899999999999999


Q ss_pred             eecCCcc-eeccC
Q 046065          152 YVGRGVY-YKKFS  163 (164)
Q Consensus       152 ~~~~~~~-~~~~D  163 (164)
                      +++++.| .+.-|
T Consensus       739 vl~g~~y~gk~qd  751 (772)
T KOG1152|consen  739 VLGGEKYLGKPQD  751 (772)
T ss_pred             hhCCCccCCCcch
Confidence            9999998 44444

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.92  E-value=1.1e-24  Score=152.49  Aligned_cols=154  Identities=25%  Similarity=0.440  Sum_probs=125.7

Q ss_pred             CCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHH
Q 046065            5 DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRV   83 (164)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~   83 (164)
                      ++..+|+|.+... ......+..|+++++.++|||++++ +.+......++++|++++++|.+++.....  .+++....
T Consensus        27 ~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~  103 (256)
T cd05112          27 EKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRG--KFSQETLL  103 (256)
T ss_pred             CCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCcc--CCCHHHHH
Confidence            4678999987543 2234568889999999999999997 666677788999999999999988864322  26788889


Q ss_pred             HHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh---hhhcccccccCcceecCCccee
Q 046065           84 HIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL---KQIQIELGYIPPEYVGRGVYYK  160 (164)
Q Consensus        84 ~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~  160 (164)
                      .++.+++.++.++|+.   +++|+|++|+||+++.++.++|+|||.+........   ....++..|+|||.+.++.++.
T Consensus       104 ~~~~~l~~~l~~lH~~---~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~  180 (256)
T cd05112         104 GMCLDVCEGMAYLESS---NVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSS  180 (256)
T ss_pred             HHHHHHHHHHHHHHHC---CccccccccceEEEcCCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhccCCcCh
Confidence            9999999999999998   999999999999999999999999999865543222   2233456899999998888999


Q ss_pred             ccCC
Q 046065          161 KFSL  164 (164)
Q Consensus       161 ~~Di  164 (164)
                      ++||
T Consensus       181 ~~Dv  184 (256)
T cd05112         181 KSDV  184 (256)
T ss_pred             HHHH
Confidence            9986

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.92  E-value=5.4e-25  Score=154.01  Aligned_cols=157  Identities=24%  Similarity=0.342  Sum_probs=128.9

Q ss_pred             CCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            4 PDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         4 ~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      .+|+.+|+|.+...  .......+.+|+.+++.++|+|++++ +.+...+..++++|++++++|.+++..... ..+++.
T Consensus        23 ~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~  101 (257)
T cd08225          23 SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRG-VLFSED  101 (257)
T ss_pred             CCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccC-CCCCHH
Confidence            35788999998654  22344567889999999999999997 777777889999999999999988865322 236888


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCC-CeEEccccchhhhhhhh--hhhhcccccccCcceecCCc
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL-KPKISDFGLARILRKMI--LKQIQIELGYIPPEYVGRGV  157 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~-~~~l~dfg~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~  157 (164)
                      ....++.+++.++.|+|+.   +++|+|++|+||+++.++ .++++|||.+.......  .....+++.|+|||...+..
T Consensus       102 ~~~~~~~~l~~~l~~lh~~---~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~  178 (257)
T cd08225         102 QILSWFVQISLGLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRP  178 (257)
T ss_pred             HHHHHHHHHHHHHHHHHHC---CcccccCCHHHEEEcCCCCeEEecccccchhccCCcccccccCCCccccCHHHHcCCC
Confidence            9999999999999999988   999999999999998875 46999999887654322  23346888999999998888


Q ss_pred             ceeccCC
Q 046065          158 YYKKFSL  164 (164)
Q Consensus       158 ~~~~~Di  164 (164)
                      ++.++|+
T Consensus       179 ~~~~~Dv  185 (257)
T cd08225         179 YNNKTDI  185 (257)
T ss_pred             CCchhhH
Confidence            8999885

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.92  E-value=8.8e-25  Score=158.39  Aligned_cols=157  Identities=22%  Similarity=0.289  Sum_probs=123.9

Q ss_pred             CCCcEEEEEEccccc--cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            4 PDGQIIAVKKLSKKS--TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         4 ~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      .+|+.||+|.+....  ....+.+.+|+.+++.++||||+++ +.+...+..++|+|++.++++.+++.+... ..+++.
T Consensus        23 ~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~-~~~~~~  101 (328)
T cd08226          23 PTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFP-EGMSEA  101 (328)
T ss_pred             CCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhcc-cCCCHH
Confidence            478999999986542  2234677889999999999999997 777777788999999999999988875332 237888


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh-hh--------hhhcccccccCcc
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM-IL--------KQIQIELGYIPPE  151 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~-~~--------~~~~~~~~~~aPE  151 (164)
                      .+..++.|++.||.|+|+.   +++|+||||+||+++.++.+++.||+.+...... ..        ....++..|+|||
T Consensus       102 ~~~~~~~qi~~aL~~lH~~---~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE  178 (328)
T cd08226         102 LIGNILFGALRGLNYLHQN---GYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPE  178 (328)
T ss_pred             HHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChh
Confidence            8899999999999999988   9999999999999999999999999865332211 00        1123456799999


Q ss_pred             eecCC--cceeccCC
Q 046065          152 YVGRG--VYYKKFSL  164 (164)
Q Consensus       152 ~~~~~--~~~~~~Di  164 (164)
                      ++.+.  .++.++||
T Consensus       179 ~~~~~~~~~~~~~Di  193 (328)
T cd08226         179 LLRQDLYGYNVKSDI  193 (328)
T ss_pred             hhcCCCCCCCchhhH
Confidence            99664  46788885

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.92  E-value=7.3e-25  Score=160.27  Aligned_cols=152  Identities=29%  Similarity=0.376  Sum_probs=122.6

Q ss_pred             CCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEeeC------CcEEEEEEecCCCChhhhhhCcccc
Q 046065            4 PDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIET------QEYMLIYEYMPKRSLDYFLFDPIRM   74 (164)
Q Consensus         4 ~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~   74 (164)
                      .+++.||+|.+...  .......+.+|+.+++.++|||++++ +.+...      ...++|+|++. ++|.+.+...   
T Consensus        39 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---  114 (353)
T cd07850          39 VTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMD---  114 (353)
T ss_pred             CCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccC-CCHHHHHhhc---
Confidence            46889999998643  23334567789999999999999997 444322      24689999996 4777766432   


Q ss_pred             cccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh-hhhhcccccccCccee
Q 046065           75 LILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI-LKQIQIELGYIPPEYV  153 (164)
Q Consensus        75 ~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~aPE~~  153 (164)
                        ++......++.|++.||.|+|+.   +++|+||||+||+++.++.++|+|||++....... .....++..|+|||.+
T Consensus       115 --l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~  189 (353)
T cd07850         115 --LDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI  189 (353)
T ss_pred             --CCHHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEccCccceeCCCCCCCCCCcccccccCHHHH
Confidence              77888889999999999999998   99999999999999999999999999997654322 2345678899999999


Q ss_pred             cCCcceeccCC
Q 046065          154 GRGVYYKKFSL  164 (164)
Q Consensus       154 ~~~~~~~~~Di  164 (164)
                      .+..++.++||
T Consensus       190 ~~~~~~~~~Dv  200 (353)
T cd07850         190 LGMGYKENVDI  200 (353)
T ss_pred             hCCCCCCchhh
Confidence            98899999986

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.92  E-value=1.4e-25  Score=162.57  Aligned_cols=145  Identities=30%  Similarity=0.404  Sum_probs=117.5

Q ss_pred             CCcEEEEEEccccccccHHHHHHHHHHHhc--cCCCceeeEeEEee-----CCcEEEEEEecCCCChhhhhhCccccccc
Q 046065            5 DGQIIAVKKLSKKSTQGFEEFKNEVMLTAK--LQHLNLIRVGFCIE-----TQEYMLIYEYMPKRSLDYFLFDPIRMLIL   77 (164)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~   77 (164)
                      +++.||||++..+   ..+.|..|-.+++.  ++|+||+++...+.     ...++||++|.+.|+|.+++....    +
T Consensus       232 ~~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~nt----i  304 (534)
T KOG3653|consen  232 DNRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKANT----I  304 (534)
T ss_pred             cCceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHhcc----c
Confidence            3589999999644   44566666666554  57999999733322     337999999999999999998754    7


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhcC------CCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh----hhhhhcccccc
Q 046065           78 DCKKRVHIIKGIIQGLLYLQEYF------RLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM----ILKQIQIELGY  147 (164)
Q Consensus        78 ~~~~~~~~~~~~~~~l~~lh~~~------~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~  147 (164)
                      ++....+++..+++||.|||+-+      .+.|.|||+|..|||+..++++.|+|||+|..+...    ..-+.+||..|
T Consensus       305 sw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RY  384 (534)
T KOG3653|consen  305 SWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRY  384 (534)
T ss_pred             cHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhh
Confidence            88889999999999999999765      357999999999999999999999999999776532    22457899999


Q ss_pred             cCcceecCC
Q 046065          148 IPPEYVGRG  156 (164)
Q Consensus       148 ~aPE~~~~~  156 (164)
                      ||||++.++
T Consensus       385 MAPEvLEga  393 (534)
T KOG3653|consen  385 MAPEVLEGA  393 (534)
T ss_pred             cCHHHHhhh
Confidence            999999654

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.92  E-value=2.1e-24  Score=155.09  Aligned_cols=153  Identities=29%  Similarity=0.410  Sum_probs=123.4

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+++.||+|.+...   .....+.+..|+.+++.++|||++++ +.+......++|+|+++ +++.+.+.....  .++.
T Consensus        38 ~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~~--~l~~  114 (307)
T cd06607          38 RTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKK--PLQE  114 (307)
T ss_pred             CCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-CCHHHHHHHccc--CCCH
Confidence            36789999987533   22334568899999999999999998 77777788999999997 566666543222  2788


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCcceec---CC
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVG---RG  156 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~---~~  156 (164)
                      .....++.|++.++.|+|+.   +++|+|++|+||+++.++.++|+|||++.....  .....+++.|+|||++.   .+
T Consensus       115 ~~~~~~~~ql~~~L~~LH~~---~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~  189 (307)
T cd06607         115 VEIAAICHGALQGLAYLHSH---ERIHRDIKAGNILLTEPGTVKLADFGSASLVSP--ANSFVGTPYWMAPEVILAMDEG  189 (307)
T ss_pred             HHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEECCCCCEEEeecCcceecCC--CCCccCCccccCceeeeccCCC
Confidence            89999999999999999998   999999999999999999999999998865432  23456788999999883   45


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .++.++||
T Consensus       190 ~~~~~sDv  197 (307)
T cd06607         190 QYDGKVDV  197 (307)
T ss_pred             CCCcccch
Confidence            67888886

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.92  E-value=2.2e-25  Score=150.13  Aligned_cols=161  Identities=24%  Similarity=0.282  Sum_probs=130.8

Q ss_pred             cCCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEe-----eCCcEEEEEEecCCCChhhhhhCccccc-
Q 046065            3 LPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCI-----ETQEYMLIYEYMPKRSLDYFLFDPIRML-   75 (164)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~~~~~-   75 (164)
                      +.+++.||+|.+.-...++.+..++|++..++++|||++++ ....     ...+.|+++.|...|+|.+.+......+ 
T Consensus        43 ~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~  122 (302)
T KOG2345|consen   43 LSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGN  122 (302)
T ss_pred             cCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCC
Confidence            46788999999877766777888999999999999999996 3322     2235899999999999999887643322 


Q ss_pred             ccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhh-----h------hhhhhhccc
Q 046065           76 ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILR-----K------MILKQIQIE  144 (164)
Q Consensus        76 ~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~-----~------~~~~~~~~~  144 (164)
                      .+++.+.+.++.++++||.++|+. .++..|+|+||.||++...+.+.+.|||.++...     +      +.+.....|
T Consensus       123 ~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct  201 (302)
T KOG2345|consen  123 FVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCT  201 (302)
T ss_pred             ccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCC
Confidence            489999999999999999999998 4469999999999999999999999999987542     1      123456678


Q ss_pred             ccccCcceec---CCcceeccCC
Q 046065          145 LGYIPPEYVG---RGVYYKKFSL  164 (164)
Q Consensus       145 ~~~~aPE~~~---~~~~~~~~Di  164 (164)
                      ..|+|||.+.   +-..+.++||
T Consensus       202 ~pyRAPELf~vk~~~ti~ertDI  224 (302)
T KOG2345|consen  202 IPYRAPELFNVKSHCTITERTDI  224 (302)
T ss_pred             CcccCchheecccCcccccccch
Confidence            8999999993   3455788886

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.92  E-value=9.5e-25  Score=152.18  Aligned_cols=154  Identities=29%  Similarity=0.348  Sum_probs=130.5

Q ss_pred             CCcEEEEEEcccccc---ccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            5 DGQIIAVKKLSKKST---QGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         5 ~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      +++.+|+|.+.....   .....+..|+.+++.++|||++++ ..+...+..+++||++++++|.+++.....   ++..
T Consensus        17 ~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~---l~~~   93 (250)
T cd05123          17 TGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGR---FSEE   93 (250)
T ss_pred             CCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHhcCC---CCHH
Confidence            578999999865422   234578889999999999999997 667777889999999999999998875432   7889


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh--hhhhhcccccccCcceecCCcc
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM--ILKQIQIELGYIPPEYVGRGVY  158 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~  158 (164)
                      ....++.|+++++.++|+.   +++|+|++|+||+++.++.++|+|||.+......  ......++..|+|||...+...
T Consensus        94 ~~~~~~~qi~~~l~~lh~~---~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~  170 (250)
T cd05123          94 RARFYAAEIVLALEYLHSL---GIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGY  170 (250)
T ss_pred             HHHHHHHHHHHHHHHHHHC---CceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCccccChHHhCCCCC
Confidence            9999999999999999998   9999999999999999999999999998765432  3345677889999999988888


Q ss_pred             eeccCC
Q 046065          159 YKKFSL  164 (164)
Q Consensus       159 ~~~~Di  164 (164)
                      +.++|+
T Consensus       171 ~~~~D~  176 (250)
T cd05123         171 GKAVDW  176 (250)
T ss_pred             CchhhH
Confidence            888885

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.92  E-value=2.1e-24  Score=150.65  Aligned_cols=154  Identities=27%  Similarity=0.402  Sum_probs=131.6

Q ss_pred             CCcEEEEEEccccc--cccHHHHHHHHHHHhccCCCceeeE-eEEeeC--CcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            5 DGQIIAVKKLSKKS--TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIET--QEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         5 ~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      +++.|++|.+....  +...+.+..|+..++.++|||++++ +.....  ...++++|++++++|.+++.+..   .+++
T Consensus        24 ~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~  100 (260)
T cd06606          24 TGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFG---KLPE  100 (260)
T ss_pred             CCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcC---CCCH
Confidence            68899999986553  2456778899999999999999997 666666  67889999999999999887643   3888


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh----hhhhcccccccCcceecC
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI----LKQIQIELGYIPPEYVGR  155 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~aPE~~~~  155 (164)
                      .....++.+++.++.|+|+.   +++|+|++|+||+++.++.++|+|||.+.......    .....++..|+|||....
T Consensus       101 ~~~~~~~~~l~~~l~~lh~~---~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~  177 (260)
T cd06606         101 PVIRKYTRQILEGLAYLHSN---GIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRG  177 (260)
T ss_pred             HHHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcC
Confidence            99999999999999999998   99999999999999999999999999987665432    345678889999999988


Q ss_pred             CcceeccCC
Q 046065          156 GVYYKKFSL  164 (164)
Q Consensus       156 ~~~~~~~Di  164 (164)
                      ..++.++||
T Consensus       178 ~~~~~~~Dv  186 (260)
T cd06606         178 EEYGRAADI  186 (260)
T ss_pred             CCCCchhhH
Confidence            888999886

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.92  E-value=2e-24  Score=165.98  Aligned_cols=156  Identities=25%  Similarity=0.343  Sum_probs=126.6

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhcc-CCCceeeE-eEEee-----CCcEEEEEEecCCCChhhhhhCcccccc
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIE-----TQEYMLIYEYMPKRSLDYFLFDPIRMLI   76 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~~~~   76 (164)
                      .+++..|+|++......+ .++..|..+++.. .|||++.. +.+.-     .+++|||||||.+|+..++++.-. ...
T Consensus        42 ~~~~~aa~kI~~~~~d~d-eEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~r  119 (953)
T KOG0587|consen   42 KTGQLAAIKIMDPTEDEE-EEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNR  119 (953)
T ss_pred             ecCceeeeEeecCCcccc-HHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhc-ccc
Confidence            567889999987664433 4567788888888 69999997 44432     357999999999999999998755 334


Q ss_pred             cCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh--hhhhhcccccccCcceec
Q 046065           77 LDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM--ILKQIQIELGYIPPEYVG  154 (164)
Q Consensus        77 ~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~  154 (164)
                      +.+..+.-+.+.++.|+.+||..   .++|||+|-.|||+..++.+||.|||.+..+...  ......|||.|||||++.
T Consensus       120 l~E~~IaYI~re~lrgl~HLH~n---kviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEVia  196 (953)
T KOG0587|consen  120 LKEEWIAYILREILRGLAHLHNN---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIA  196 (953)
T ss_pred             hhhHHHHHHHHHHHHHHHHHhhc---ceeeecccCceEEEeccCcEEEeeeeeeeeeecccccccCcCCCcccccceeee
Confidence            88999999999999999999998   9999999999999999999999999998777543  235678999999999994


Q ss_pred             CC-----cceeccCC
Q 046065          155 RG-----VYYKKFSL  164 (164)
Q Consensus       155 ~~-----~~~~~~Di  164 (164)
                      -+     -|+.++|+
T Consensus       197 c~e~~d~tyd~R~D~  211 (953)
T KOG0587|consen  197 CDESPDATYDYRSDL  211 (953)
T ss_pred             cccCCCCCcccccch
Confidence            32     34555553

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.92  E-value=2.3e-24  Score=152.14  Aligned_cols=148  Identities=24%  Similarity=0.345  Sum_probs=118.8

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      .+++.+|+|.........     .|+.....+ +|||++++ ..+...+..++||||+++++|.+++.+..   .+++..
T Consensus        39 ~~~~~~~~k~~~~~~~~~-----~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~---~l~~~~  110 (267)
T PHA03390         39 PTQKLFVQKIIKAKNFNA-----IEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG---KLSEAE  110 (267)
T ss_pred             CCCcEEEEEEEehhhcch-----hhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhcC---CCCHHH
Confidence            457788998875432111     123222222 79999997 66677788999999999999999987643   388999


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCC-CeEEccccchhhhhhhhhhhhcccccccCcceecCCccee
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL-KPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYK  160 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~-~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~  160 (164)
                      ...++.|+++|+.++|+.   +++|+||+|+||+++.++ .++++|||++......  ....+++.|+|||++.+..++.
T Consensus       111 ~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~  185 (267)
T PHA03390        111 VKKIIRQLVEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP--SCYDGTLDYFSPEKIKGHNYDV  185 (267)
T ss_pred             HHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC--ccCCCCCcccChhhhcCCCCCc
Confidence            999999999999999998   999999999999999988 9999999988654322  2346788999999999889999


Q ss_pred             ccCC
Q 046065          161 KFSL  164 (164)
Q Consensus       161 ~~Di  164 (164)
                      ++|+
T Consensus       186 ~~Dv  189 (267)
T PHA03390        186 SFDW  189 (267)
T ss_pred             hhhH
Confidence            9985

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.92  E-value=4e-24  Score=152.39  Aligned_cols=157  Identities=27%  Similarity=0.312  Sum_probs=123.4

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhcc-CCCceeeE-eEEeeC-----CcEEEEEEecCCCChhhhhhCcc-ccc
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIET-----QEYMLIYEYMPKRSLDYFLFDPI-RML   75 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~-~~~   75 (164)
                      .+++.+|+|.+.... .....+..|+.++..+ +|||++++ +.+...     +..++|+||+++++|.+++.... ...
T Consensus        45 ~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~  123 (291)
T cd06639          45 KDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQ  123 (291)
T ss_pred             CCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCC
Confidence            468899999885432 2234567889999988 79999997 554432     35789999999999988875421 223


Q ss_pred             ccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh--hhhhcccccccCccee
Q 046065           76 ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI--LKQIQIELGYIPPEYV  153 (164)
Q Consensus        76 ~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~aPE~~  153 (164)
                      .+++.....++.|++.|+.++|+.   +++|+||||+||+++.++.++|+|||++.......  .....++..|+|||.+
T Consensus       124 ~~~~~~~~~~~~qi~~al~~lH~~---~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~  200 (291)
T cd06639         124 RLDEAMISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVI  200 (291)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEEcCCCCEEEeecccchhcccccccccCccCCccccChhhh
Confidence            378889999999999999999988   99999999999999999999999999987654322  2345678899999998


Q ss_pred             cCCc-----ceeccCC
Q 046065          154 GRGV-----YYKKFSL  164 (164)
Q Consensus       154 ~~~~-----~~~~~Di  164 (164)
                      ....     ++.++||
T Consensus       201 ~~~~~~~~~~~~~~Di  216 (291)
T cd06639         201 ACEQQYDYSYDARCDV  216 (291)
T ss_pred             cCCCCcccccCCccch
Confidence            5443     5788886

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.92  E-value=3.3e-26  Score=181.38  Aligned_cols=150  Identities=29%  Similarity=0.392  Sum_probs=125.4

Q ss_pred             ccCCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccC
Q 046065            2 VLPDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILD   78 (164)
Q Consensus         2 ~~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~   78 (164)
                      ..++|+..|+|-+.-+  .......+.+|..++..++|||++++ +.=......++.||||.+|+|.+.+.-++.   .+
T Consensus      1256 N~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~~gri---~d 1332 (1509)
T KOG4645|consen 1256 NLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLEHGRI---ED 1332 (1509)
T ss_pred             cCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCcHHHHHHhcch---hh
Confidence            3578899999987655  23345678899999999999999998 444455678899999999999999876544   66


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh------hhhhhcccccccCcce
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM------ILKQIQIELGYIPPEY  152 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~------~~~~~~~~~~~~aPE~  152 (164)
                      +....-+..|++.|+.|||.+   +|+|||+||.||+++.+|.+|++|||.|..+...      ..+...||+.|||||+
T Consensus      1333 E~vt~vyt~qll~gla~LH~~---gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEv 1409 (1509)
T KOG4645|consen 1333 EMVTRVYTKQLLEGLAYLHEH---GIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEV 1409 (1509)
T ss_pred             hhHHHHHHHHHHHHHHHHHhc---CceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchh
Confidence            777777889999999999998   9999999999999999999999999999876533      2357889999999999


Q ss_pred             ecCCc
Q 046065          153 VGRGV  157 (164)
Q Consensus       153 ~~~~~  157 (164)
                      +.+..
T Consensus      1410 it~t~ 1414 (1509)
T KOG4645|consen 1410 ITGTK 1414 (1509)
T ss_pred             hcccc
Confidence            96654

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.92  E-value=2.7e-24  Score=153.49  Aligned_cols=156  Identities=24%  Similarity=0.358  Sum_probs=121.8

Q ss_pred             CCCcEEEEEEccccc--cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            4 PDGQIIAVKKLSKKS--TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         4 ~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      .+++.||+|.+....  ......+..|+.+++.++|||++++ +.+......++|+||++ ++|.+.+..... ...+..
T Consensus        25 ~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~-~~~~~~  102 (294)
T PLN00009         25 VTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LDLKKHMDSSPD-FAKNPR  102 (294)
T ss_pred             CCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-ccHHHHHHhCCC-CCcCHH
Confidence            467899999986442  2234567889999999999999998 77777788999999996 477777654322 225778


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecC-CCCeEEccccchhhhhhh--hhhhhcccccccCcceecCC-
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE-DLKPKISDFGLARILRKM--ILKQIQIELGYIPPEYVGRG-  156 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~-~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~~~-  156 (164)
                      ....++.|++.||.|+|+.   +++|+||+|+||+++. ++.++|+|||++......  ......+++.|+|||.+.+. 
T Consensus       103 ~~~~~~~qi~~aL~~LH~~---~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~  179 (294)
T PLN00009        103 LIKTYLYQILRGIAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSR  179 (294)
T ss_pred             HHHHHHHHHHHHHHHHHhC---CeeCCCCCcceEEEECCCCEEEEcccccccccCCCccccccCceeecccCHHHHhCCC
Confidence            8889999999999999998   9999999999999985 567899999998654321  12334567899999988654 


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .++.++||
T Consensus       180 ~~~~~~Dv  187 (294)
T PLN00009        180 HYSTPVDI  187 (294)
T ss_pred             CCCcHHHH
Confidence            56888885

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.92  E-value=8.3e-25  Score=158.88  Aligned_cols=154  Identities=23%  Similarity=0.371  Sum_probs=123.7

Q ss_pred             CCCcEEEEEEccccc--cccHHHHHHHHHHHhccCCCceeeE-eEEe----eCCcEEEEEEecCCCChhhhhhCcccccc
Q 046065            4 PDGQIIAVKKLSKKS--TQGFEEFKNEVMLTAKLQHLNLIRV-GFCI----ETQEYMLIYEYMPKRSLDYFLFDPIRMLI   76 (164)
Q Consensus         4 ~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~----~~~~~~lv~e~~~~~~L~~~~~~~~~~~~   76 (164)
                      .+++.||+|.+....  ......+..|+.+++.++||||+++ +.+.    .....++|+||+. ++|.+++.....   
T Consensus        28 ~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~---  103 (334)
T cd07855          28 RSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSDQP---  103 (334)
T ss_pred             CCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehhh-hhHHHHhccCCC---
Confidence            468899999987542  2345667889999999999999997 4433    2345789999995 588888765332   


Q ss_pred             cCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh------hhhhcccccccCc
Q 046065           77 LDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI------LKQIQIELGYIPP  150 (164)
Q Consensus        77 ~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~------~~~~~~~~~~~aP  150 (164)
                      +++.....++.|++.||.|||+.   +++|+|+||+||+++.++.++|+|||++.......      .....++..|+||
T Consensus       104 ~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~P  180 (334)
T cd07855         104 LTEEHIRYFLYQLLRGLKYIHSA---NVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAP  180 (334)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccCh
Confidence            88999999999999999999998   99999999999999999999999999986553211      1345788899999


Q ss_pred             ceecC-CcceeccCC
Q 046065          151 EYVGR-GVYYKKFSL  164 (164)
Q Consensus       151 E~~~~-~~~~~~~Di  164 (164)
                      |.+.+ ..++.++||
T Consensus       181 E~~~~~~~~~~~~Di  195 (334)
T cd07855         181 ELLLSLPEYTTAIDM  195 (334)
T ss_pred             HHhcCCcccccccch
Confidence            99865 457888986

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.92  E-value=2.7e-24  Score=152.55  Aligned_cols=158  Identities=25%  Similarity=0.340  Sum_probs=121.7

Q ss_pred             CCCcEEEEEEccccc-cccHHHHHHHHHH-HhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcc-cccccCH
Q 046065            4 PDGQIIAVKKLSKKS-TQGFEEFKNEVML-TAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPI-RMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~~-~~~~~~~~~e~~~-l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~   79 (164)
                      .+|+.||+|.+.... ......+..|... ++..+|||++++ +.+...+..++++|+++ ++|.+++.... ....+++
T Consensus        24 ~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~  102 (283)
T cd06617          24 PTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPE  102 (283)
T ss_pred             CCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCH
Confidence            468999999986542 1222345556554 666789999997 77777788999999996 67877765421 2234889


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh-hhhcccccccCcceecC---
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL-KQIQIELGYIPPEYVGR---  155 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~aPE~~~~---  155 (164)
                      .....++.|++.|+.|+|++  .+++|+|+||+||+++.++.++|+|||++..+..... ....++..|+|||.+.+   
T Consensus       103 ~~~~~~~~qi~~~l~~lH~~--~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  180 (283)
T cd06617         103 DILGKIAVSIVKALEYLHSK--LSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELN  180 (283)
T ss_pred             HHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecccccccccccccccccCCccccChhhcCCccc
Confidence            99999999999999999973  2799999999999999999999999999876543322 33567889999998864   


Q ss_pred             -CcceeccCC
Q 046065          156 -GVYYKKFSL  164 (164)
Q Consensus       156 -~~~~~~~Di  164 (164)
                       ..++.++|+
T Consensus       181 ~~~~~~~~Di  190 (283)
T cd06617         181 QKGYDVKSDV  190 (283)
T ss_pred             ccccCccccc
Confidence             345788885

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.92  E-value=2.9e-24  Score=152.46  Aligned_cols=156  Identities=25%  Similarity=0.346  Sum_probs=123.6

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhcc-CCCceeeE-eEEee------CCcEEEEEEecCCCChhhhhhCccccc
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIE------TQEYMLIYEYMPKRSLDYFLFDPIRML   75 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~------~~~~~lv~e~~~~~~L~~~~~~~~~~~   75 (164)
                      .+++.+|+|.+.... .....+..|+.+++.+ +|+|++++ +.+..      ....+++|||+++++|.+++..... .
T Consensus        39 ~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~-~  116 (282)
T cd06636          39 KTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKG-N  116 (282)
T ss_pred             CCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccC-C
Confidence            467889999875442 2334577888888888 69999997 44432      3467899999999999988865322 2


Q ss_pred             ccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh--hhhhhhcccccccCccee
Q 046065           76 ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK--MILKQIQIELGYIPPEYV  153 (164)
Q Consensus        76 ~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~~aPE~~  153 (164)
                      .+++.....++.|++.|+.|+|+.   +++|+|++|+||+++.++.++|+|||++.....  .......+++.|+|||.+
T Consensus       117 ~~~~~~~~~~~~qi~~al~~LH~~---~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l  193 (282)
T cd06636         117 ALKEDWIAYICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI  193 (282)
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCcchhhhhccccCCCcccccccccCHhhc
Confidence            377888899999999999999998   999999999999999999999999999875532  223456788999999998


Q ss_pred             c-----CCcceeccCC
Q 046065          154 G-----RGVYYKKFSL  164 (164)
Q Consensus       154 ~-----~~~~~~~~Di  164 (164)
                      .     +..++.++|+
T Consensus       194 ~~~~~~~~~~~~~~Dv  209 (282)
T cd06636         194 ACDENPDATYDYRSDI  209 (282)
T ss_pred             CcccCcCcCCCcccch
Confidence            5     3567888886

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.92  E-value=2.9e-24  Score=154.10  Aligned_cols=155  Identities=26%  Similarity=0.410  Sum_probs=120.1

Q ss_pred             CCCcEEEEEEccccc--cccHHHHHHHHHHHhccCCCceeeE-eEEeeCC--------cEEEEEEecCCCChhhhhhCcc
Q 046065            4 PDGQIIAVKKLSKKS--TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQ--------EYMLIYEYMPKRSLDYFLFDPI   72 (164)
Q Consensus         4 ~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~--------~~~lv~e~~~~~~L~~~~~~~~   72 (164)
                      .+++.||+|.+....  ......+..|+.+++.++||||+++ +.+...+        ..++|+|++.+ ++...+....
T Consensus        35 ~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~  113 (310)
T cd07865          35 KTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DLAGLLSNKN  113 (310)
T ss_pred             CCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCCc-CHHHHHHhcc
Confidence            468899999876442  2223455789999999999999997 5554332        35899999864 7776665432


Q ss_pred             cccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh------hhhhhccccc
Q 046065           73 RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM------ILKQIQIELG  146 (164)
Q Consensus        73 ~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~------~~~~~~~~~~  146 (164)
                        ..++......++.|++.|+.|+|+.   +++|+||+|+||+++.++.++|+|||++......      ......++..
T Consensus       114 --~~~~~~~~~~i~~qi~~al~~lH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~  188 (310)
T cd07865         114 --VKFTLSEIKKVMKMLLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLW  188 (310)
T ss_pred             --cCCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCcc
Confidence              2378999999999999999999998   9999999999999999999999999998755321      1123456788


Q ss_pred             ccCcceecCC-cceeccCC
Q 046065          147 YIPPEYVGRG-VYYKKFSL  164 (164)
Q Consensus       147 ~~aPE~~~~~-~~~~~~Di  164 (164)
                      |+|||.+.+. .++.++||
T Consensus       189 y~aPE~~~~~~~~~~~~Di  207 (310)
T cd07865         189 YRPPELLLGERDYGPPIDM  207 (310)
T ss_pred             ccCcHHhcCCcccCchhhh
Confidence            9999988654 36888886

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.92  E-value=9.5e-25  Score=158.18  Aligned_cols=153  Identities=29%  Similarity=0.403  Sum_probs=126.1

Q ss_pred             CCcEEEEEEccccc--cccHHHHHHHHHHHhccCCCceeeE-eEEeeCC-----cEEEEEEecCCCChhhhhhCcccccc
Q 046065            5 DGQIIAVKKLSKKS--TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQ-----EYMLIYEYMPKRSLDYFLFDPIRMLI   76 (164)
Q Consensus         5 ~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~~~~~~   76 (164)
                      +++.+|+|.+....  ....+.+..|+.+++.++|+|++++ +.+....     ..++++|+++ ++|.+++....   .
T Consensus        24 ~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~---~   99 (330)
T cd07834          24 TGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQ---P   99 (330)
T ss_pred             CCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchh-hhHHHHHhCCC---C
Confidence            47899999886542  3445678899999999999999997 5555443     6789999997 47888776543   3


Q ss_pred             cCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh-----hhhhcccccccCcc
Q 046065           77 LDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI-----LKQIQIELGYIPPE  151 (164)
Q Consensus        77 ~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~aPE  151 (164)
                      +++.....++.+++.|+.++|+.   +++|+||||+||+++.++.++|+|||.+.......     .....+++.|+|||
T Consensus       100 l~~~~~~~i~~~l~~~l~~LH~~---gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE  176 (330)
T cd07834         100 LTDDHIQYFLYQILRGLKYLHSA---NVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPE  176 (330)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccCceEeecccccccccccccccccCcCCce
Confidence            88899999999999999999998   99999999999999999999999999987654322     33456788999999


Q ss_pred             eecCC-cceeccCC
Q 046065          152 YVGRG-VYYKKFSL  164 (164)
Q Consensus       152 ~~~~~-~~~~~~Di  164 (164)
                      .+.+. .++.++|+
T Consensus       177 ~~~~~~~~~~~sDi  190 (330)
T cd07834         177 LLLSSSRYTKAIDI  190 (330)
T ss_pred             eeecccCCCcchhH
Confidence            99877 78888886

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.92  E-value=1.1e-24  Score=143.60  Aligned_cols=159  Identities=24%  Similarity=0.318  Sum_probs=126.9

Q ss_pred             cCCCcEEEEEEccccccc-cHHHHHHHHHHHh-ccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcc-cccccC
Q 046065            3 LPDGQIIAVKKLSKKSTQ-GFEEFKNEVMLTA-KLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPI-RMLILD   78 (164)
Q Consensus         3 ~~~~~~vavK~~~~~~~~-~~~~~~~e~~~l~-~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~   78 (164)
                      +.+|...|+|.+...-+. ...+.+.|+.+.. ...+|.++++ +........|+.||.+. .||+.+.++-. .....|
T Consensus        68 ~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~-tSldkfy~~v~~~g~~ip  146 (282)
T KOG0984|consen   68 IQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD-TSLDKFYRKVLKKGGTIP  146 (282)
T ss_pred             ccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh-hhHHHHHHHHHhcCCcCc
Confidence            457889999998766333 3345678887544 4579999997 88888899999999985 48877765521 233489


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh-hhhcccccccCcceec---
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL-KQIQIELGYIPPEYVG---  154 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~aPE~~~---  154 (164)
                      +..+.+++..+..||.|||++  ..++|||+||+||||+..|.+|++|||.+-.+.++.. +...|--.|||||.+.   
T Consensus       147 E~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~  224 (282)
T KOG0984|consen  147 EDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPEL  224 (282)
T ss_pred             hHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehhhhHHHHhcCCCccCChhhcCccc
Confidence            999999999999999999996  5899999999999999999999999999877766544 3356666799999983   


Q ss_pred             -CCcceeccCC
Q 046065          155 -RGVYYKKFSL  164 (164)
Q Consensus       155 -~~~~~~~~Di  164 (164)
                       ...|+-||||
T Consensus       225 n~~gY~vksDv  235 (282)
T KOG0984|consen  225 NQKGYSVKSDV  235 (282)
T ss_pred             Ccccceeehhh
Confidence             3378889886

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.92  E-value=2e-24  Score=153.74  Aligned_cols=155  Identities=23%  Similarity=0.274  Sum_probs=125.3

Q ss_pred             CCCcEEEEEEcccc----ccccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccccccc
Q 046065            4 PDGQIIAVKKLSKK----STQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLIL   77 (164)
Q Consensus         4 ~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~   77 (164)
                      .+++.||+|.+...    .......+..|+.++..+ +|||++++ ..+......++|+||+++++|...+....   .+
T Consensus        26 ~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~  102 (288)
T cd05583          26 DAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQRE---HF  102 (288)
T ss_pred             cCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhhcC---Cc
Confidence            46788999987643    122345677899999999 59999998 66666777889999999999988876533   27


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh---hhhhcccccccCcceec
Q 046065           78 DCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI---LKQIQIELGYIPPEYVG  154 (164)
Q Consensus        78 ~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~aPE~~~  154 (164)
                      +......++.|++.+|.++|+.   +++|+|++|+||+++.++.++++|||++..+....   .....++..|+|||.+.
T Consensus       103 ~~~~~~~~~~ql~~~l~~lH~~---~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  179 (288)
T cd05583         103 TESEVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIR  179 (288)
T ss_pred             CHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHeEECCCCCEEEEECccccccccccccccccccCCccccCHHHhc
Confidence            8888999999999999999988   99999999999999999999999999986543221   12356788999999987


Q ss_pred             CCc--ceeccCC
Q 046065          155 RGV--YYKKFSL  164 (164)
Q Consensus       155 ~~~--~~~~~Di  164 (164)
                      +..  .+.++|+
T Consensus       180 ~~~~~~~~~~Dv  191 (288)
T cd05583         180 GGSGGHDKAVDW  191 (288)
T ss_pred             CCCCCCcchhhh
Confidence            665  6778885

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.92  E-value=2.9e-24  Score=153.27  Aligned_cols=157  Identities=23%  Similarity=0.309  Sum_probs=121.5

Q ss_pred             CCCcEEEEEEccccc--cccHHHHHHHHHHHhccC-CCceeeE-eEEeeCCc-----EEEEEEecCCCChhhhhhCccc-
Q 046065            4 PDGQIIAVKKLSKKS--TQGFEEFKNEVMLTAKLQ-HLNLIRV-GFCIETQE-----YMLIYEYMPKRSLDYFLFDPIR-   73 (164)
Q Consensus         4 ~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~-~~~~~~~~-----~~lv~e~~~~~~L~~~~~~~~~-   73 (164)
                      .+++.||+|.+....  ......+.+|+.+++.+. |||++++ ..+...+.     .++++||+++ +|.+++..... 
T Consensus        24 ~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~  102 (295)
T cd07837          24 NTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRG  102 (295)
T ss_pred             CCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhccc
Confidence            468899999876442  223456788999999995 6999997 44444443     7899999985 78777754221 


Q ss_pred             -ccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecC-CCCeEEccccchhhhhh--hhhhhhcccccccC
Q 046065           74 -MLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE-DLKPKISDFGLARILRK--MILKQIQIELGYIP  149 (164)
Q Consensus        74 -~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~-~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~~a  149 (164)
                       ...+++.....++.|++.||.|+|+.   +++|+|++|+||+++. ++.++|+|||++..+..  .......+++.|+|
T Consensus       103 ~~~~~~~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~a  179 (295)
T cd07837         103 PGRPLPAKTIKSFMYQLLKGVAHCHKH---GVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRA  179 (295)
T ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEecCCCeEEEeecccceecCCCccccCCcccccCCCC
Confidence             23478899999999999999999998   9999999999999998 88999999999875432  12233456788999


Q ss_pred             cceecC-CcceeccCC
Q 046065          150 PEYVGR-GVYYKKFSL  164 (164)
Q Consensus       150 PE~~~~-~~~~~~~Di  164 (164)
                      ||.+.+ ..++.++||
T Consensus       180 PE~~~~~~~~~~~~Di  195 (295)
T cd07837         180 PEVLLGSTHYSTPVDI  195 (295)
T ss_pred             hHHhhCCCCCCchHHH
Confidence            998854 456888885

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>PTZ00284 protein kinase; Provisional

Probab=99.92  E-value=2e-24  Score=163.28  Aligned_cols=152  Identities=18%  Similarity=0.203  Sum_probs=114.5

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCC------CceeeE-eEEeeC-CcEEEEEEecCCCChhhhhhCccccc
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQH------LNLIRV-GFCIET-QEYMLIYEYMPKRSLDYFLFDPIRML   75 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~-~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~   75 (164)
                      .+++.||||.+... .........|+.+++.++|      .+++.+ .++... ..+++|+|++ +++|.+++.....  
T Consensus       152 ~~~~~vAvK~i~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~~--  227 (467)
T PTZ00284        152 KRKEYCAVKIVRNV-PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKHGP--  227 (467)
T ss_pred             CCCeEEEEEEEecc-hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHHcCC--
Confidence            45788999998543 2223345567777766654      457776 444333 4578888887 6688777765332  


Q ss_pred             ccCHHHHHHHHHHHHHHHHHhhh-cCCCCeeeCCCCCCceeecCCC----------------CeEEccccchhhhhhhhh
Q 046065           76 ILDCKKRVHIIKGIIQGLLYLQE-YFRLTIIHRDLKVSNILLDEDL----------------KPKISDFGLARILRKMIL  138 (164)
Q Consensus        76 ~~~~~~~~~~~~~~~~~l~~lh~-~~~~~iih~dlk~~nili~~~~----------------~~~l~dfg~~~~~~~~~~  138 (164)
                       +++..+..++.|++.||.|||+ .   +|+||||||+|||++..+                .+||+|||.+.... ...
T Consensus       228 -l~~~~~~~i~~qi~~aL~yLH~~~---gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~-~~~  302 (467)
T PTZ00284        228 -FSHRHLAQIIFQTGVALDYFHTEL---HLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDER-HSR  302 (467)
T ss_pred             -CCHHHHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCc-ccc
Confidence             8889999999999999999996 5   899999999999998655                48999999875322 223


Q ss_pred             hhhcccccccCcceecCCcceeccCC
Q 046065          139 KQIQIELGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       139 ~~~~~~~~~~aPE~~~~~~~~~~~Di  164 (164)
                      ...+||+.|+|||++.+..|+.++||
T Consensus       303 ~~~~gt~~Y~APE~~~~~~~~~~~Di  328 (467)
T PTZ00284        303 TAIVSTRHYRSPEVVLGLGWMYSTDM  328 (467)
T ss_pred             ccccCCccccCcHHhhcCCCCcHHHH
Confidence            45678999999999999999999986

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.92  E-value=4.5e-24  Score=150.71  Aligned_cols=157  Identities=26%  Similarity=0.402  Sum_probs=123.2

Q ss_pred             CCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCC------cEEEEEEecCCCChhhhhhCc---c
Q 046065            5 DGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQ------EYMLIYEYMPKRSLDYFLFDP---I   72 (164)
Q Consensus         5 ~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~------~~~lv~e~~~~~~L~~~~~~~---~   72 (164)
                      +++.||+|.+..+  .....+.+.+|+.+++.++|||++++ +.+....      ..+++++++++++|..++...   .
T Consensus        26 ~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  105 (273)
T cd05074          26 SFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGE  105 (273)
T ss_pred             CceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccC
Confidence            4678999998654  23345678899999999999999997 5443321      246888999999998776431   1


Q ss_pred             cccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh----hhhhccccccc
Q 046065           73 RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI----LKQIQIELGYI  148 (164)
Q Consensus        73 ~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~  148 (164)
                      ....++......++.|++.|+.|+|+.   +++|+|+||+||+++.++.++++|||++.......    .....+++.|+
T Consensus       106 ~~~~l~~~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~  182 (273)
T cd05074         106 EPFTLPLQTLVRFMIDIASGMEYLSSK---NFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWL  182 (273)
T ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHhC---CEeecccchhhEEEcCCCCEEECcccccccccCCcceecCCCccCchhhc
Confidence            122378888999999999999999988   99999999999999999999999999987653221    12234567899


Q ss_pred             CcceecCCcceeccCC
Q 046065          149 PPEYVGRGVYYKKFSL  164 (164)
Q Consensus       149 aPE~~~~~~~~~~~Di  164 (164)
                      +||....+.++.++||
T Consensus       183 ~pe~~~~~~~~~~sDi  198 (273)
T cd05074         183 ALESLADNVYTTHSDV  198 (273)
T ss_pred             CHhHHhcCccchhhhh
Confidence            9999988888999986

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.92  E-value=4.4e-24  Score=150.50  Aligned_cols=158  Identities=24%  Similarity=0.361  Sum_probs=125.6

Q ss_pred             CCcEEEEEEccccc----------cccHHHHHHHHHHHhc-cCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCc-
Q 046065            5 DGQIIAVKKLSKKS----------TQGFEEFKNEVMLTAK-LQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDP-   71 (164)
Q Consensus         5 ~~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~-l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~-   71 (164)
                      .++.+|+|.+....          ......+..|+.++.. ++|||++++ +.+...+..++++||+++++|.+++... 
T Consensus        25 ~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~  104 (269)
T cd08528          25 GQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLK  104 (269)
T ss_pred             CCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHH
Confidence            36789999875331          1123456678887765 699999997 7777788899999999999998877432 


Q ss_pred             ccccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh-hhhhhcccccccCc
Q 046065           72 IRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM-ILKQIQIELGYIPP  150 (164)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aP  150 (164)
                      .....++....+.++.|++.++.++|+.  .+++|+|++|+||+++.++.++|+|||.+...... ......++..|+||
T Consensus       105 ~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~P  182 (269)
T cd08528         105 EKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCP  182 (269)
T ss_pred             hccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCHHHEEECCCCcEEEecccceeecccccccccccCcccCcCh
Confidence            1123378889999999999999999962  17999999999999999999999999998765433 33456788899999


Q ss_pred             ceecCCcceeccCC
Q 046065          151 EYVGRGVYYKKFSL  164 (164)
Q Consensus       151 E~~~~~~~~~~~Di  164 (164)
                      |.+.+..++.++|+
T Consensus       183 e~~~~~~~~~~~Dv  196 (269)
T cd08528         183 EIVKNEPYGEKADV  196 (269)
T ss_pred             hhhcCCCCchHHHH
Confidence            99988888988885

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.92  E-value=4.4e-24  Score=150.59  Aligned_cols=157  Identities=25%  Similarity=0.337  Sum_probs=124.1

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCC------cEEEEEEecCCCChhhhhhCcc-cc
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQ------EYMLIYEYMPKRSLDYFLFDPI-RM   74 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~-~~   74 (164)
                      .+++.+++|.+..... ....+..|+.+++.+ +|+|++++ +.+....      ..++|+|++++++|.+++.... ..
T Consensus        29 ~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~  107 (275)
T cd06608          29 KTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKG  107 (275)
T ss_pred             CCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcC
Confidence            3577899998765432 345688999999999 79999997 5554432      4789999999999988876532 12


Q ss_pred             cccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh--hhhhhhcccccccCcce
Q 046065           75 LILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK--MILKQIQIELGYIPPEY  152 (164)
Q Consensus        75 ~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~~aPE~  152 (164)
                      ..++......++.|++.|+.|+|+.   +++|+|++|+||+++.++.++|+|||++.....  .......++..|+|||+
T Consensus       108 ~~~~~~~~~~~~~ql~~al~~lH~~---~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~  184 (275)
T cd06608         108 KRLKEEWIAYILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEV  184 (275)
T ss_pred             CCCCHHHHHHHHHHHHHHHHHHhcC---CcccCCCCHHHEEEccCCeEEECCCccceecccchhhhcCccccccccCHhH
Confidence            3378899999999999999999998   999999999999999999999999999865532  22244568889999998


Q ss_pred             ecC-----CcceeccCC
Q 046065          153 VGR-----GVYYKKFSL  164 (164)
Q Consensus       153 ~~~-----~~~~~~~Di  164 (164)
                      +..     ..++.++||
T Consensus       185 ~~~~~~~~~~~~~~~Dv  201 (275)
T cd06608         185 IACDEQPDASYDARSDV  201 (275)
T ss_pred             hcccccccCCccccccH
Confidence            753     346778885

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.92  E-value=3.5e-24  Score=154.01  Aligned_cols=155  Identities=29%  Similarity=0.400  Sum_probs=121.3

Q ss_pred             CCCcEEEEEEccccc--cccHHHHHHHHHHHhccCCCceeeE-eEEeeC--CcEEEEEEecCCCChhhhhhCcccccccC
Q 046065            4 PDGQIIAVKKLSKKS--TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIET--QEYMLIYEYMPKRSLDYFLFDPIRMLILD   78 (164)
Q Consensus         4 ~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~   78 (164)
                      .+|+.||+|.+....  ......+..|+.+++.++|+|++++ +.+...  +..++|+|++.+ +|.+++....  ..++
T Consensus        30 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~--~~l~  106 (309)
T cd07845          30 TSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMP--TPFS  106 (309)
T ss_pred             CCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCCC-CHHHHHHhcc--cCCC
Confidence            468899999986442  2223345679999999999999998 444433  457899999964 7877776432  2378


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh--hhhhhcccccccCcceecC-
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM--ILKQIQIELGYIPPEYVGR-  155 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~~-  155 (164)
                      +.....++.|++.|+.|+|+.   +++|+||+|+||+++.++.++|+|||.+......  ......+++.|+|||.+.+ 
T Consensus       107 ~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  183 (309)
T cd07845         107 ESQVKCLMLQLLRGLQYLHEN---FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGC  183 (309)
T ss_pred             HHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECccceeeecCCccCCCCcccccccccChhhhcCC
Confidence            899999999999999999998   9999999999999999999999999998765432  1233345778999999865 


Q ss_pred             CcceeccCC
Q 046065          156 GVYYKKFSL  164 (164)
Q Consensus       156 ~~~~~~~Di  164 (164)
                      ..++.++||
T Consensus       184 ~~~~~~~Dv  192 (309)
T cd07845         184 TTYTTAIDM  192 (309)
T ss_pred             CCcCchHHH
Confidence            457888885

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.92  E-value=3.3e-24  Score=152.19  Aligned_cols=156  Identities=25%  Similarity=0.383  Sum_probs=125.7

Q ss_pred             CCCcEEEEEEccccc--cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            4 PDGQIIAVKKLSKKS--TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         4 ~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      .+|+.||+|.+..+.  ......+..|+.+++.++|||++++ +.+...+..++++|+++ ++|.+++..... ..+++.
T Consensus        22 ~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~-~~~~~~   99 (283)
T cd07835          22 LTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYMDSSPL-TGLDPP   99 (283)
T ss_pred             CCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-cCHHHHHhhCCC-CCCCHH
Confidence            478899999986542  2234567889999999999999997 77777788999999995 688888765331 237899


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh--hhhhhhcccccccCcceecCC-c
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK--MILKQIQIELGYIPPEYVGRG-V  157 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~~aPE~~~~~-~  157 (164)
                      ....++.|++.+|.|+|+.   +++|+|++|+||+++.++.++|+|||.+.....  .......+++.|+|||++.+. .
T Consensus       100 ~~~~~~~~i~~~L~~lH~~---~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  176 (283)
T cd07835         100 LIKSYLYQLLQGIAYCHSH---RVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQ  176 (283)
T ss_pred             HHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCccccccCCCCCceeecCcc
Confidence            9999999999999999998   999999999999999999999999999865432  112334568889999988554 4


Q ss_pred             ceeccCC
Q 046065          158 YYKKFSL  164 (164)
Q Consensus       158 ~~~~~Di  164 (164)
                      ++.++||
T Consensus       177 ~~~~~Di  183 (283)
T cd07835         177 YSTPVDI  183 (283)
T ss_pred             cCcHHHH
Confidence            6888885

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.91  E-value=1.2e-23  Score=151.74  Aligned_cols=153  Identities=29%  Similarity=0.413  Sum_probs=123.0

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+++.+|+|.+...   .......+..|+.+++.++|||++++ +.+......++|+||+++ ++.+.+....  ..+++
T Consensus        48 ~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g-~l~~~~~~~~--~~l~~  124 (317)
T cd06635          48 RTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHK--KPLQE  124 (317)
T ss_pred             CCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCCC-CHHHHHHHhc--CCCCH
Confidence            46789999998643   22234568889999999999999997 777777888999999975 7766664322  23788


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCcceec---CC
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVG---RG  156 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~---~~  156 (164)
                      .....++.+++.++.|+|+.   +++|+|++|+||+++.++.++|+|||++.....  .....+++.|+|||.+.   .+
T Consensus       125 ~~~~~i~~~i~~~l~~lH~~---~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~  199 (317)
T cd06635         125 VEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASIASP--ANSFVGTPYWMAPEVILAMDEG  199 (317)
T ss_pred             HHHHHHHHHHHHHHHHHHHC---CcccCCCCcccEEECCCCCEEEecCCCccccCC--cccccCCccccChhhhhcCCCC
Confidence            89999999999999999998   999999999999999999999999998764332  23456788999999973   45


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .++.++||
T Consensus       200 ~~~~~~Dv  207 (317)
T cd06635         200 QYDGKVDV  207 (317)
T ss_pred             CCCccccH
Confidence            67888885

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.91  E-value=5.3e-24  Score=151.10  Aligned_cols=155  Identities=30%  Similarity=0.441  Sum_probs=125.6

Q ss_pred             CCCcEEEEEEccccc--cccHHHHHHHHHHHhccCCCceeeE-eEEeeC--CcEEEEEEecCCCChhhhhhCcccccccC
Q 046065            4 PDGQIIAVKKLSKKS--TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIET--QEYMLIYEYMPKRSLDYFLFDPIRMLILD   78 (164)
Q Consensus         4 ~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~   78 (164)
                      .+++.+|+|.+....  ......+..|+.+++.++|+|++++ +.+...  +..++|+|++++ +|..++....  ..++
T Consensus        22 ~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~--~~~~   98 (287)
T cd07840          22 KTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPE--VKFT   98 (287)
T ss_pred             CCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccccc-cHHHHHhccC--CCCC
Confidence            357899999987652  3445667889999999999999997 666665  678999999974 8887776532  2388


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh---hhhhcccccccCcceecC
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI---LKQIQIELGYIPPEYVGR  155 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~aPE~~~~  155 (164)
                      +.....++.|++.|+.++|+.   +++|+|++|+||+++.++.++|+|||.+.......   .....++..|+|||.+.+
T Consensus        99 ~~~~~~i~~~i~~al~~LH~~---~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~  175 (287)
T cd07840          99 ESQIKCYMKQLLEGLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLG  175 (287)
T ss_pred             HHHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccccccccccccCCceeeEc
Confidence            999999999999999999998   99999999999999999999999999987654332   234456788999997754


Q ss_pred             -CcceeccCC
Q 046065          156 -GVYYKKFSL  164 (164)
Q Consensus       156 -~~~~~~~Di  164 (164)
                       ..++.++||
T Consensus       176 ~~~~~~~~Dv  185 (287)
T cd07840         176 ATRYGPEVDM  185 (287)
T ss_pred             cccCChHHHH
Confidence             456888885

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.91  E-value=4.8e-24  Score=154.90  Aligned_cols=154  Identities=25%  Similarity=0.333  Sum_probs=121.9

Q ss_pred             CCCcEEEEEEcccccccc--------------HHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhh
Q 046065            4 PDGQIIAVKKLSKKSTQG--------------FEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFL   68 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~--------------~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~   68 (164)
                      .+++.||+|.+.......              ...+.+|+.+++.++|+|++++ +.+...+..++++|++. ++|.+++
T Consensus        32 ~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l  110 (335)
T PTZ00024         32 LTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVV  110 (335)
T ss_pred             CCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCCcEEEEEeccc-cCHHHHH
Confidence            467899999875431111              1246789999999999999997 77777778899999996 5888887


Q ss_pred             hCcccccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh-------------
Q 046065           69 FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK-------------  135 (164)
Q Consensus        69 ~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~-------------  135 (164)
                      ....   .++......++.|++.|+.++|+.   +++|+||+|+||+++.++.++|+|||.+.....             
T Consensus       111 ~~~~---~~~~~~~~~~~~ql~~aL~~LH~~---~i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~  184 (335)
T PTZ00024        111 DRKI---RLTESQVKCILLQILNGLNVLHKW---YFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETM  184 (335)
T ss_pred             HhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeecccccHHHeEECCCCCEEECCccceeecccccccccccccccc
Confidence            6432   278899999999999999999998   999999999999999999999999998865441             


Q ss_pred             ---hhhhhhcccccccCcceecCC-cceeccCC
Q 046065          136 ---MILKQIQIELGYIPPEYVGRG-VYYKKFSL  164 (164)
Q Consensus       136 ---~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di  164 (164)
                         .......+++.|+|||.+.+. .++.++||
T Consensus       185 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv  217 (335)
T PTZ00024        185 QRREEMTSKVVTLWYRAPELLMGAEKYHFAVDM  217 (335)
T ss_pred             cccccccccccccCCCCChhcccCCCCCcHHHH
Confidence               111233467789999998654 46888875

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=1.7e-26  Score=169.02  Aligned_cols=149  Identities=23%  Similarity=0.211  Sum_probs=128.1

Q ss_pred             EEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHHH
Q 046065            9 IAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVH   84 (164)
Q Consensus         9 vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~   84 (164)
                      +|+|.+++.   +..+.+.+..|-.+|..+++|.|+++ --+.+....|+.||.|-||.||..++..+.   ++......
T Consensus       448 fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdRg~---Fdd~tarF  524 (732)
T KOG0614|consen  448 FALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRDRGS---FDDYTARF  524 (732)
T ss_pred             HHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhhcCC---cccchhhh
Confidence            566666544   45566778889999999999999997 556666678899999999999999987554   88889999


Q ss_pred             HHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh-hhhcccccccCcceecCCcceeccC
Q 046065           85 IIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL-KQIQIELGYIPPEYVGRGVYYKKFS  163 (164)
Q Consensus        85 ~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~aPE~~~~~~~~~~~D  163 (164)
                      ++.-+++|.+|||..   +||.||+||+|++++.+|.+||.|||+|+.+.++.. -.+||||.|+|||++..+-.+...|
T Consensus       525 ~~acv~EAfeYLH~k---~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILnKGHD~avD  601 (732)
T KOG0614|consen  525 YVACVLEAFEYLHRK---GIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVD  601 (732)
T ss_pred             hHHHHHHHHHHHHhc---CceeccCChhheeeccCCceEEeehhhHHHhccCCceeeecCCcccccchhhhccCcchhhH
Confidence            999999999999998   999999999999999999999999999998876544 5689999999999998877777665

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.91  E-value=2.2e-24  Score=152.54  Aligned_cols=155  Identities=29%  Similarity=0.377  Sum_probs=128.7

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhccC-CCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccC
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQ-HLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILD   78 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~   78 (164)
                      .+++.||+|.+...   .......+..|..+++.++ ||||+++ +.+......+++||++++++|.+++....   .++
T Consensus        24 ~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~l~  100 (280)
T cd05581          24 ETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYG---SLD  100 (280)
T ss_pred             CCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHHcC---CCC
Confidence            46889999998653   1223456788999999998 9999998 66667778999999999999999887643   388


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh---------------------
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI---------------------  137 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~---------------------  137 (164)
                      ......++.|++.++.++|+.   +++|+|++|+||+++.++.++++|||++.......                     
T Consensus       101 ~~~~~~i~~ql~~~l~~Lh~~---~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (280)
T cd05581         101 EKCTRFYAAEILLALEYLHSK---GIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRR  177 (280)
T ss_pred             HHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCcccccccccccc
Confidence            999999999999999999998   99999999999999999999999999987654221                     


Q ss_pred             -hhhhcccccccCcceecCCcceeccCC
Q 046065          138 -LKQIQIELGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       138 -~~~~~~~~~~~aPE~~~~~~~~~~~Di  164 (164)
                       .....++..|+|||......++.++||
T Consensus       178 ~~~~~~~~~~~~~Pe~~~~~~~~~~~Di  205 (280)
T cd05581         178 RFASFVGTAEYVSPELLNEKPAGKSSDL  205 (280)
T ss_pred             ccccccCCccccCHHHhCCCCCChhhhH
Confidence             123456788999999988888888886

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.91  E-value=5e-25  Score=150.76  Aligned_cols=157  Identities=24%  Similarity=0.354  Sum_probs=127.1

Q ss_pred             cCCCcEEEEEEcccc-ccccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            3 LPDGQIIAVKKLSKK-STQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         3 ~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .++|...|||.+... ..+...+++..+.++.+. ++|+|++. +++..+...++.||.+.. .+..+++....  .+|+
T Consensus       114 rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs~-C~ekLlkrik~--piPE  190 (391)
T KOG0983|consen  114 RSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMST-CAEKLLKRIKG--PIPE  190 (391)
T ss_pred             cccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHHH-HHHHHHHHhcC--CchH
Confidence            467899999999876 445567889999877776 49999996 888888888888988743 45555554332  2889


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh-hhhhhhcccccccCcceec---C
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK-MILKQIQIELGYIPPEYVG---R  155 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~aPE~~~---~  155 (164)
                      ..+.++...+++||.||-+.|  +|+|||+||+|||+|..|.+|++|||.+-.+.+ .......|-+.|||||-+.   .
T Consensus       191 ~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~  268 (391)
T KOG0983|consen  191 RILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDK  268 (391)
T ss_pred             HhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccccccccCCccccCccccCCCCC
Confidence            999999999999999999987  899999999999999999999999998865543 3345567888999999994   4


Q ss_pred             CcceeccCC
Q 046065          156 GVYYKKFSL  164 (164)
Q Consensus       156 ~~~~~~~Di  164 (164)
                      ..|+-++||
T Consensus       269 ~kYDiRaDV  277 (391)
T KOG0983|consen  269 PKYDIRADV  277 (391)
T ss_pred             Cccchhhhh
Confidence            478888886

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.91  E-value=2.6e-24  Score=163.66  Aligned_cols=139  Identities=22%  Similarity=0.292  Sum_probs=112.1

Q ss_pred             HHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcc-c-ccccCHHHHHHHHHHHHHHHHHhhh
Q 046065           22 FEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPI-R-MLILDCKKRVHIIKGIIQGLLYLQE   98 (164)
Q Consensus        22 ~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~l~~lh~   98 (164)
                      ...+..|+.+++.++||||+++ +.+...+..++++|++. +++..++.... . ...........++.|++.||.|||+
T Consensus       207 ~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~  285 (501)
T PHA03210        207 AIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD  285 (501)
T ss_pred             HHHHHHHHHHHHhCCCCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh
Confidence            3457789999999999999998 77777778889999885 46666554321 1 1112345667899999999999999


Q ss_pred             cCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh---hhhhcccccccCcceecCCcceeccCC
Q 046065           99 YFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI---LKQIQIELGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus        99 ~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~~Di  164 (164)
                      +   +|+||||||+|||++.++.++|+|||++..+....   .....|++.|+|||++.+..++.++||
T Consensus       286 ~---gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di  351 (501)
T PHA03210        286 K---KLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDI  351 (501)
T ss_pred             C---CeecCCCCHHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHH
Confidence            8   99999999999999999999999999997664322   234678999999999999999999996

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.91  E-value=5.6e-24  Score=154.72  Aligned_cols=154  Identities=25%  Similarity=0.408  Sum_probs=122.9

Q ss_pred             CCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEeeC-----CcEEEEEEecCCCChhhhhhCccccc
Q 046065            4 PDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIET-----QEYMLIYEYMPKRSLDYFLFDPIRML   75 (164)
Q Consensus         4 ~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~   75 (164)
                      .+++.||+|.+...  .......+..|+.+++.++|+||+++ +.+...     ...++++|++. ++|.+++.....  
T Consensus        28 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~--  104 (337)
T cd07858          28 ETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQIIRSSQT--  104 (337)
T ss_pred             CCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCCC-CCHHHHHhcCCC--
Confidence            46889999998643  23334567789999999999999997 444332     24789999996 688887765432  


Q ss_pred             ccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh--hhhhhcccccccCccee
Q 046065           76 ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM--ILKQIQIELGYIPPEYV  153 (164)
Q Consensus        76 ~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~  153 (164)
                       ++......++.|++.|+.|+|+.   +++|+|++|+||+++.++.++|+|||++......  ......++..|+|||.+
T Consensus       105 -l~~~~~~~i~~qi~~aL~~LH~~---~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~  180 (337)
T cd07858         105 -LSDDHCQYFLYQLLRGLKYIHSA---NVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELL  180 (337)
T ss_pred             -CCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCEEECcCccccccCCCcccccccccccCccChHHH
Confidence             88999999999999999999998   9999999999999999999999999998765432  12345678899999988


Q ss_pred             cC-CcceeccCC
Q 046065          154 GR-GVYYKKFSL  164 (164)
Q Consensus       154 ~~-~~~~~~~Di  164 (164)
                      .. ..++.++||
T Consensus       181 ~~~~~~~~~~Di  192 (337)
T cd07858         181 LNCSEYTTAIDV  192 (337)
T ss_pred             hcCCCCCCcccH
Confidence            64 467888886

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.91  E-value=5.4e-24  Score=154.73  Aligned_cols=153  Identities=27%  Similarity=0.400  Sum_probs=120.6

Q ss_pred             CCCcEEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeE-eEEeeC-----CcEEEEEEecCCCChhhhhhCcccccc
Q 046065            4 PDGQIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIET-----QEYMLIYEYMPKRSLDYFLFDPIRMLI   76 (164)
Q Consensus         4 ~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~   76 (164)
                      .+|+.||+|.+... .......+..|+.+++.++|||++++ +.+...     ...++++|++++ ++.+.+...    .
T Consensus        28 ~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~----~  102 (336)
T cd07849          28 PTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQ----H  102 (336)
T ss_pred             CCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhccc-CHHHHHhcC----C
Confidence            56889999998643 23345567889999999999999997 443322     247899999864 777666442    2


Q ss_pred             cCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh-----hhhhhcccccccCcc
Q 046065           77 LDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM-----ILKQIQIELGYIPPE  151 (164)
Q Consensus        77 ~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~~~~aPE  151 (164)
                      +++.....++.|++.||.++|+.   +++|+||||+||+++.++.++|+|||++......     ......+++.|+|||
T Consensus       103 l~~~~~~~i~~ql~~aL~~LH~~---~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE  179 (336)
T cd07849         103 LSNDHIQYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPE  179 (336)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhC---CeeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChH
Confidence            78889999999999999999998   9999999999999999999999999998654321     113356788999999


Q ss_pred             eecC-CcceeccCC
Q 046065          152 YVGR-GVYYKKFSL  164 (164)
Q Consensus       152 ~~~~-~~~~~~~Di  164 (164)
                      .+.+ ..++.++||
T Consensus       180 ~~~~~~~~~~~~Dv  193 (336)
T cd07849         180 IMLNSKGYTKAIDI  193 (336)
T ss_pred             HhhCCCCCCcHHHH
Confidence            8754 467888886

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.91  E-value=8.8e-24  Score=171.58  Aligned_cols=148  Identities=24%  Similarity=0.380  Sum_probs=120.4

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      .+++.||+|.+......    ...|++.+++++||||+++ +.+......++||||+++|+|.+++..      +++...
T Consensus       713 ~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~------l~~~~~  782 (968)
T PLN00113        713 KNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERR  782 (968)
T ss_pred             CCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHhc------CCHHHH
Confidence            57889999998533221    1356889999999999997 777777888999999999999999853      778889


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCcceecCCcceecc
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKKF  162 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~  162 (164)
                      ..++.+++.|+.|+|..+..+++|||+||+||+++.++..++. ++.+.....  .....+++.|+|||+..+..++.|+
T Consensus       783 ~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~s  859 (968)
T PLN00113        783 RKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT--DTKCFISSAYVAPETRETKDITEKS  859 (968)
T ss_pred             HHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc--CCCccccccccCcccccCCCCCccc
Confidence            9999999999999997666799999999999999988877765 554432211  1234678999999999999999999


Q ss_pred             CC
Q 046065          163 SL  164 (164)
Q Consensus       163 Di  164 (164)
                      ||
T Consensus       860 Dv  861 (968)
T PLN00113        860 DI  861 (968)
T ss_pred             ch
Confidence            97

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.91  E-value=2.1e-24  Score=151.83  Aligned_cols=154  Identities=22%  Similarity=0.301  Sum_probs=132.5

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhcc-CCCceeeEeEEee-CCcEEEEEEecCCCChhhhhhCcccccccC
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKL-QHLNLIRVGFCIE-TQEYMLIYEYMPKRSLDYFLFDPIRMLILD   78 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~   78 (164)
                      ++.+.+|+|++++.   ..++..+...|-.++... +||.++-+..|.. .+.+++|.||+++|+|.-.+.+.+.   +|
T Consensus       273 ~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ggdlmfhmqrqrk---lp  349 (593)
T KOG0695|consen  273 KTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK---LP  349 (593)
T ss_pred             ccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecCcceeeehhhhhc---Cc
Confidence            56678999998765   455667788888888888 6999999977765 5678999999999999877776544   99


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhh-hh-hhhhhhcccccccCcceecCC
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARIL-RK-MILKQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~-~~-~~~~~~~~~~~~~aPE~~~~~  156 (164)
                      +..+..+..+++-||.|||++   +||.||+|.+|+++|..|.+||+|+|+++.- .. ..+...||||.|+|||.+.+.
T Consensus       350 eeharfys~ei~lal~flh~r---giiyrdlkldnvlldaeghikltdygmcke~l~~gd~tstfcgtpnyiapeilrge  426 (593)
T KOG0695|consen  350 EEHARFYSAEICLALNFLHER---GIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGE  426 (593)
T ss_pred             HHHhhhhhHHHHHHHHHHhhc---CeeeeeccccceEEccCCceeecccchhhcCCCCCcccccccCCCcccchhhhccc
Confidence            999999999999999999999   9999999999999999999999999998653 22 334678999999999999999


Q ss_pred             cceeccC
Q 046065          157 VYYKKFS  163 (164)
Q Consensus       157 ~~~~~~D  163 (164)
                      .|.+..|
T Consensus       427 eygfsvd  433 (593)
T KOG0695|consen  427 EYGFSVD  433 (593)
T ss_pred             ccCceeh
Confidence            9998776

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.91  E-value=1.3e-23  Score=152.41  Aligned_cols=152  Identities=29%  Similarity=0.389  Sum_probs=120.8

Q ss_pred             CCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEee-CCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIE-TQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+++.||+|.+...  .......+..|+.+++.++|||++++ +.+.. ....++++|++ +++|..++...    .++.
T Consensus        33 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~----~~~~  107 (328)
T cd07856          33 LTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLTSR----PLEK  107 (328)
T ss_pred             CCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHhcC----CCCH
Confidence            46889999987543  23345667889999999999999998 55544 45688999998 46888777542    2677


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCcceecC-Ccc
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGR-GVY  158 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~-~~~  158 (164)
                      .....++.|++.|+.++|+.   +++|+|++|+|++++.++.++|+|||.+..... ......++..|+|||.+.+ ..+
T Consensus       108 ~~~~~~~~ql~~aL~~LH~~---~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~  183 (328)
T cd07856         108 QFIQYFLYQILRGLKYVHSA---GVVHRDLKPSNILINENCDLKICDFGLARIQDP-QMTGYVSTRYYRAPEIMLTWQKY  183 (328)
T ss_pred             HHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEeECCCCCEEeCccccccccCC-CcCCCcccccccCceeeeccCCc
Confidence            78888999999999999998   999999999999999999999999998865432 2234456788999998755 567


Q ss_pred             eeccCC
Q 046065          159 YKKFSL  164 (164)
Q Consensus       159 ~~~~Di  164 (164)
                      +.++||
T Consensus       184 ~~~~Dv  189 (328)
T cd07856         184 DVEVDI  189 (328)
T ss_pred             CcHHHH
Confidence            888885

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.91  E-value=1.2e-23  Score=149.02  Aligned_cols=154  Identities=23%  Similarity=0.286  Sum_probs=120.3

Q ss_pred             CCCcEEEEEEccccc-cccHHHHHHHHHHHhccC-CCceeeE-eEEeeC--CcEEEEEEecCCCChhhhhhCcccccccC
Q 046065            4 PDGQIIAVKKLSKKS-TQGFEEFKNEVMLTAKLQ-HLNLIRV-GFCIET--QEYMLIYEYMPKRSLDYFLFDPIRMLILD   78 (164)
Q Consensus         4 ~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~-~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~   78 (164)
                      .+++.||+|.+.... .........|+.++..+. |+|++++ +.+...  +..++|+|+++ +++.+.+....  ..++
T Consensus        22 ~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~~~~   98 (282)
T cd07831          22 KTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD-MNLYELIKGRK--RPLP   98 (282)
T ss_pred             CCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC-ccHHHHHHhcc--CCCC
Confidence            467899999986542 222233457888888884 9999997 666665  67899999997 47777765432  2378


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh-hhhhcccccccCcceecC-C
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI-LKQIQIELGYIPPEYVGR-G  156 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~aPE~~~~-~  156 (164)
                      +.....++.|++.||.++|+.   +++|+|++|+||+++. +.++|+|||.+....... .....++..|+|||.+.. .
T Consensus        99 ~~~~~~~~~qi~~~L~~LH~~---~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  174 (282)
T cd07831          99 EKRVKSYMYQLLKSLDHMHRN---GIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDG  174 (282)
T ss_pred             HHHHHHHHHHHHHHHHHHHHC---CceecccCHHHEEEcC-CCeEEEecccccccccCCCcCCCCCCcccCChhHhhcCC
Confidence            899999999999999999998   9999999999999999 999999999987654322 234567889999997644 4


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .++.++||
T Consensus       175 ~~~~~~Di  182 (282)
T cd07831         175 YYGPKMDI  182 (282)
T ss_pred             CCCcchhH
Confidence            56888885

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.91  E-value=1e-23  Score=150.04  Aligned_cols=158  Identities=26%  Similarity=0.348  Sum_probs=122.3

Q ss_pred             CCCcEEEEEEccccc-cccHHHHHHHHHHHhccC-CCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhC--cccccccC
Q 046065            4 PDGQIIAVKKLSKKS-TQGFEEFKNEVMLTAKLQ-HLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFD--PIRMLILD   78 (164)
Q Consensus         4 ~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~   78 (164)
                      .+++.+|+|.+.... ......+..|+.++..+. |+||+++ +.+......++++|+++. ++.++...  ......++
T Consensus        27 ~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~-~l~~l~~~~~~~~~~~l~  105 (288)
T cd06616          27 PSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDI-SLDKFYKYVYEVLKSVIP  105 (288)
T ss_pred             CCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccC-CHHHHHHHHHHhhcCCCC
Confidence            457899999986542 233456788999999985 9999997 767777788999999864 55443321  01112388


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh-hhhhcccccccCcceecCC-
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI-LKQIQIELGYIPPEYVGRG-  156 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~aPE~~~~~-  156 (164)
                      +.....++.+++.|+.|+|+.  .+++|+||||+||+++.++.++|+|||++....... .....+++.|+|||++.+. 
T Consensus       106 ~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  183 (288)
T cd06616         106 EEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSA  183 (288)
T ss_pred             HHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCccccccCccCccCHHHhcccc
Confidence            899999999999999999963  289999999999999999999999999987654322 2334678899999999766 


Q ss_pred             --cceeccCC
Q 046065          157 --VYYKKFSL  164 (164)
Q Consensus       157 --~~~~~~Di  164 (164)
                        .++.++||
T Consensus       184 ~~~~~~~~Di  193 (288)
T cd06616         184 RDGYDVRSDV  193 (288)
T ss_pred             ccCCcchhhh
Confidence              67889986

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.91  E-value=6.7e-24  Score=154.70  Aligned_cols=152  Identities=26%  Similarity=0.386  Sum_probs=120.4

Q ss_pred             CCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCC------cEEEEEEecCCCChhhhhhCcccc
Q 046065            4 PDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQ------EYMLIYEYMPKRSLDYFLFDPIRM   74 (164)
Q Consensus         4 ~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~   74 (164)
                      .+++.||+|.+...  .......+..|+.+++.++||||+++ +.+....      .+++|+|++ +++|..++...   
T Consensus        38 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~---  113 (343)
T cd07880          38 RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMKHE---  113 (343)
T ss_pred             CCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHhcC---
Confidence            46889999998543  22234567889999999999999997 4443322      357999998 67888777542   


Q ss_pred             cccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCcceec
Q 046065           75 LILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVG  154 (164)
Q Consensus        75 ~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~  154 (164)
                       .+++.....++.|++.|+.|+|+.   +++|+||+|+||+++.++.++++|||++...... .....+++.|+|||.+.
T Consensus       114 -~l~~~~~~~i~~qi~~al~~LH~~---gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~y~aPE~~~  188 (343)
T cd07880         114 -KLSEDRIQFLVYQMLKGLKYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE-MTGYVVTRWYRAPEVIL  188 (343)
T ss_pred             -CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccccccccC-ccccccCCcccCHHHHh
Confidence             288899999999999999999998   9999999999999999999999999998754322 23446788999999986


Q ss_pred             C-CcceeccCC
Q 046065          155 R-GVYYKKFSL  164 (164)
Q Consensus       155 ~-~~~~~~~Di  164 (164)
                      + ..++.++|+
T Consensus       189 ~~~~~~~~~Di  199 (343)
T cd07880         189 NWMHYTQTVDI  199 (343)
T ss_pred             CCCCCCcHHHH
Confidence            5 357788775

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.91  E-value=9e-26  Score=152.92  Aligned_cols=155  Identities=25%  Similarity=0.432  Sum_probs=122.9

Q ss_pred             CCCcEEEEEEccc--cccccHHHHHHHHHHHhccCCCceeeE-eEEee--------CCcEEEEEEecCCCChhhhhhCcc
Q 046065            4 PDGQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIE--------TQEYMLIYEYMPKRSLDYFLFDPI   72 (164)
Q Consensus         4 ~~~~~vavK~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~--------~~~~~lv~e~~~~~~L~~~~~~~~   72 (164)
                      .+|+.||+|.+..  .+.......++|+.+|..++|+|++.+ ..|..        ...+|+||.+|++ +|.-++.+..
T Consensus        40 n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ceh-DLaGlLsn~~  118 (376)
T KOG0669|consen   40 NTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEH-DLAGLLSNRK  118 (376)
T ss_pred             CccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhh-hHHHHhcCcc
Confidence            4577889887543  344556677899999999999999986 44432        2348999999976 6666665432


Q ss_pred             cccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh------hhhhhccccc
Q 046065           73 RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM------ILKQIQIELG  146 (164)
Q Consensus        73 ~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~------~~~~~~~~~~  146 (164)
                        ..+....+.+++.++..||.|+|..   .|+|||+|+.|+||+.++.++|+|||+++.+...      .++..+.|.+
T Consensus       119 --vr~sls~Ikk~Mk~Lm~GL~~iHr~---kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLw  193 (376)
T KOG0669|consen  119 --VRFSLSEIKKVMKGLMNGLYYIHRN---KILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLW  193 (376)
T ss_pred             --ccccHHHHHHHHHHHHHHHHHHHHh---hHHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeee
Confidence              2278889999999999999999988   9999999999999999999999999999766422      2345667999


Q ss_pred             ccCcceecC-CcceeccCC
Q 046065          147 YIPPEYVGR-GVYYKKFSL  164 (164)
Q Consensus       147 ~~aPE~~~~-~~~~~~~Di  164 (164)
                      |++||.+.+ ++|+++.||
T Consensus       194 YrppEllLG~r~yg~~iDi  212 (376)
T KOG0669|consen  194 YRPPELLLGDREYGPPIDI  212 (376)
T ss_pred             cCCHHHhhcccccCCcchh
Confidence            999999844 578888886

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.91  E-value=1.8e-23  Score=148.49  Aligned_cols=155  Identities=28%  Similarity=0.426  Sum_probs=122.0

Q ss_pred             CCcEEEEEEccccc--cccHHHHHHHHHHHhcc---CCCceeeE-eEEeeCCc-----EEEEEEecCCCChhhhhhCccc
Q 046065            5 DGQIIAVKKLSKKS--TQGFEEFKNEVMLTAKL---QHLNLIRV-GFCIETQE-----YMLIYEYMPKRSLDYFLFDPIR   73 (164)
Q Consensus         5 ~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~i~~~-~~~~~~~~-----~~lv~e~~~~~~L~~~~~~~~~   73 (164)
                      +++.||+|.+....  ......+..|+.+++.+   +|||++++ +.+.....     .++++|++++ +|.+++.....
T Consensus        23 ~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~~-~l~~~l~~~~~  101 (287)
T cd07838          23 TGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPK  101 (287)
T ss_pred             CCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhccc-CHHHHHHHccC
Confidence            57899999986442  22234456677766655   59999997 66665554     8899999974 78777754322


Q ss_pred             ccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh-hhhhhcccccccCcce
Q 046065           74 MLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM-ILKQIQIELGYIPPEY  152 (164)
Q Consensus        74 ~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~  152 (164)
                       ..+++.....++.|+++||.++|+.   +++|+|++|+||+++.++.++|+|||.+...... ......++..|+|||.
T Consensus       102 -~~l~~~~~~~~~~~i~~al~~LH~~---~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~  177 (287)
T cd07838         102 -PGLPPETIKDLMRQLLRGVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEV  177 (287)
T ss_pred             -CCCCHHHHHHHHHHHHHHHHHHHHC---CeeeccCChhhEEEccCCCEEEeccCcceeccCCcccccccccccccChHH
Confidence             2388999999999999999999998   9999999999999999999999999998765432 2234457888999999


Q ss_pred             ecCCcceeccCC
Q 046065          153 VGRGVYYKKFSL  164 (164)
Q Consensus       153 ~~~~~~~~~~Di  164 (164)
                      +.+..++.++|+
T Consensus       178 ~~~~~~~~~~Di  189 (287)
T cd07838         178 LLQSSYATPVDM  189 (287)
T ss_pred             hccCCCCCcchh
Confidence            988889999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.91  E-value=1.4e-23  Score=152.51  Aligned_cols=153  Identities=29%  Similarity=0.476  Sum_probs=121.4

Q ss_pred             CCCcEEEEEEcccc--ccccHHHHHHHHHHHhcc-CCCceeeE-eEEeeC--CcEEEEEEecCCCChhhhhhCccccccc
Q 046065            4 PDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIET--QEYMLIYEYMPKRSLDYFLFDPIRMLIL   77 (164)
Q Consensus         4 ~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~   77 (164)
                      .+++.+|+|.+...  .......+..|+.+++.+ +||||+++ +.+...  ...++|+|+++ ++|..++...    .+
T Consensus        30 ~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~  104 (337)
T cd07852          30 RTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRAN----IL  104 (337)
T ss_pred             CCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccc-cCHHHHHhcC----CC
Confidence            35788999987543  233345677899999999 99999997 555433  35789999997 5888877653    27


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh-------hhhhhcccccccCc
Q 046065           78 DCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM-------ILKQIQIELGYIPP  150 (164)
Q Consensus        78 ~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~-------~~~~~~~~~~~~aP  150 (164)
                      ++.....++.|++.||.|||+.   +++|+|++|+||+++.++.++|+|||.+......       ......+++.|+||
T Consensus       105 ~~~~~~~i~~qi~~~L~~LH~~---~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aP  181 (337)
T cd07852         105 EDVHKRYIMYQLLKALKYIHSG---NVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAP  181 (337)
T ss_pred             CHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCc
Confidence            7888888999999999999998   9999999999999999999999999998755321       22345678899999


Q ss_pred             ceecC-CcceeccCC
Q 046065          151 EYVGR-GVYYKKFSL  164 (164)
Q Consensus       151 E~~~~-~~~~~~~Di  164 (164)
                      |.+.+ ..++.++||
T Consensus       182 E~~~~~~~~~~~sDi  196 (337)
T cd07852         182 EILLGSTRYTKGVDM  196 (337)
T ss_pred             eeeeccccccccchH
Confidence            98754 457888885

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.91  E-value=2.9e-23  Score=149.61  Aligned_cols=153  Identities=29%  Similarity=0.393  Sum_probs=122.6

Q ss_pred             CCCcEEEEEEccccc---cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKKS---TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+++.|++|.+....   ......+..|+.+++.++|||++++ +.+......++|+|++. +++.+.+....  ..++.
T Consensus        44 ~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~--~~l~~  120 (313)
T cd06633          44 HTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHK--KPLQE  120 (313)
T ss_pred             CCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcC--CCCCH
Confidence            357889999986432   2234567889999999999999998 77777788899999996 47766664322  23788


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCcceec---CC
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVG---RG  156 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~---~~  156 (164)
                      .....++.|++.++.|+|+.   +++|+|++|+||+++.++.++|+|||++....  ......++..|+|||.+.   +.
T Consensus       121 ~~~~~~~~qi~~al~~LH~~---gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~  195 (313)
T cd06633         121 VEIAAITHGALQGLAYLHSH---NMIHRDIKAGNILLTEPGQVKLADFGSASKSS--PANSFVGTPYWMAPEVILAMDEG  195 (313)
T ss_pred             HHHHHHHHHHHHHHHHHHHC---CeecCCCChhhEEECCCCCEEEeecCCCcccC--CCCCccccccccChhhccccCCC
Confidence            88899999999999999998   99999999999999999999999999875422  123456788999999984   45


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .++.++||
T Consensus       196 ~~~~~sDv  203 (313)
T cd06633         196 QYDGKVDV  203 (313)
T ss_pred             CCCchhhH
Confidence            67888885

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.91  E-value=2.1e-23  Score=163.32  Aligned_cols=144  Identities=22%  Similarity=0.267  Sum_probs=119.3

Q ss_pred             CCCcEEEEEEccccc---cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKKS---TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+++.||+|.+....   ......+..|+.+++.++||||+++ ..+......++||||+++++|..++....   .+++
T Consensus        27 ~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~~~---~l~~  103 (669)
T cd05610          27 NNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYG---YFDE  103 (669)
T ss_pred             CCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHhcC---CCCH
Confidence            357899999986442   2234567889999999999999997 66666778999999999999999886533   2778


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh--hhhhhcccccccCccee
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM--ILKQIQIELGYIPPEYV  153 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~  153 (164)
                      ...+.++.|++.||.|||..   +|+|+||||+|||++.++.++|+|||++......  ......+++.|++||..
T Consensus       104 ~~~~~i~~qil~aL~yLH~~---gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~~~~~~~~~~~~t~~~~~pe~~  176 (669)
T cd05610         104 EMAVKYISEVALALDYLHRH---GIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRELNMMDILTTPSMAKPKND  176 (669)
T ss_pred             HHHHHHHHHHHHHHHHHHhC---CEEeCCccHHHEEEcCCCCEEEEeCCCCccccCCcccccccccCccccCcccc
Confidence            88899999999999999998   9999999999999999999999999999765432  22346788899999865

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.91  E-value=2.2e-23  Score=149.92  Aligned_cols=153  Identities=30%  Similarity=0.420  Sum_probs=122.6

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+++.+|+|.+...   .......+..|+.+++.++|+|++++ +.+......++|+|++. +++.+.+....  ..++.
T Consensus        38 ~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~--~~l~~  114 (308)
T cd06634          38 RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHK--KPLQE  114 (308)
T ss_pred             CCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHHcC--CCCCH
Confidence            45788999987643   22234567889999999999999997 77777788899999996 57766654322  22788


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCcceec---CC
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVG---RG  156 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~---~~  156 (164)
                      .....++.+++.++.|+|+.   +++|+||+|+||+++.++.++++|||++.....  .....+++.|+|||.+.   .+
T Consensus       115 ~~~~~~~~~l~~~l~~LH~~---~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~  189 (308)
T cd06634         115 VEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--ANXFVGTPYWMAPEVILAMDEG  189 (308)
T ss_pred             HHHHHHHHHHHHHHHHHHhC---CcccCCCCHHhEEECCCCcEEECCcccceeecC--cccccCCccccCHHHHhhcccC
Confidence            88899999999999999988   999999999999999999999999998865432  23456788999999974   35


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .++.++||
T Consensus       190 ~~~~~~Di  197 (308)
T cd06634         190 QYDGKVDV  197 (308)
T ss_pred             CCCcccch
Confidence            67888886

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.91  E-value=1.7e-23  Score=149.82  Aligned_cols=155  Identities=27%  Similarity=0.431  Sum_probs=121.0

Q ss_pred             CCCcEEEEEEccccc--cccHHHHHHHHHHHhccCCCceeeE-eEEeeCC----------cEEEEEEecCCCChhhhhhC
Q 046065            4 PDGQIIAVKKLSKKS--TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQ----------EYMLIYEYMPKRSLDYFLFD   70 (164)
Q Consensus         4 ~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~----------~~~lv~e~~~~~~L~~~~~~   70 (164)
                      .+++.||+|.+....  ......+..|+.+++.++|||++++ +.+....          .+++++|++++ ++...+..
T Consensus        30 ~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~  108 (302)
T cd07864          30 DTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLES  108 (302)
T ss_pred             CCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhc
Confidence            467899999986542  2334567789999999999999997 5554433          68899999976 66666654


Q ss_pred             cccccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh---hhhhcccccc
Q 046065           71 PIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI---LKQIQIELGY  147 (164)
Q Consensus        71 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~  147 (164)
                      ..  ..++......++.|++.||.|||+.   +++|+|++|+||+++.++.++|+|||.+.......   .....++..|
T Consensus       109 ~~--~~~~~~~~~~i~~qi~~aL~~LH~~---~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y  183 (302)
T cd07864         109 GL--VHFSEDHIKSFMKQLLEGLNYCHKK---NFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWY  183 (302)
T ss_pred             CC--CCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCcEEeCcccccccccCCcccccccceeccCc
Confidence            31  2378899999999999999999998   99999999999999999999999999987654322   1233457789


Q ss_pred             cCcceecC-CcceeccCC
Q 046065          148 IPPEYVGR-GVYYKKFSL  164 (164)
Q Consensus       148 ~aPE~~~~-~~~~~~~Di  164 (164)
                      +|||.+.+ ..++.++||
T Consensus       184 ~~PE~~~~~~~~~~~~Di  201 (302)
T cd07864         184 RPPELLLGEERYGPAIDV  201 (302)
T ss_pred             cChHHhcCCCCCCchhHH
Confidence            99998854 356888885

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.91  E-value=6.4e-24  Score=150.49  Aligned_cols=155  Identities=25%  Similarity=0.360  Sum_probs=126.8

Q ss_pred             CCCcEEEEEEccccc--cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            4 PDGQIIAVKKLSKKS--TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         4 ~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      .+++.+++|.+....  +.....+..|+.+++.++|+|++++ +.+...+..++++|++++ ++.+++....  ..++..
T Consensus        22 ~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~~~--~~~~~~   98 (283)
T cd05118          22 LTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQ--RGLPES   98 (283)
T ss_pred             CCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-CHHHHHHhhc--ccCCHH
Confidence            468889999986542  2345677889999999999999997 777777889999999975 8877775532  237889


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh--hhhhcccccccCcceecCC-c
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI--LKQIQIELGYIPPEYVGRG-V  157 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~aPE~~~~~-~  157 (164)
                      ....++.+++.++.++|+.   +++|+|++|+||+++.++.++|+|||.+.......  .....++..|+|||.+.+. .
T Consensus        99 ~~~~~~~~i~~~l~~LH~~---~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~  175 (283)
T cd05118          99 LIKSYLYQLLQGLAFCHSH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKG  175 (283)
T ss_pred             HHHHHHHHHHHHHHHHHHC---CeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCCC
Confidence            9999999999999999998   99999999999999999999999999987654322  2234577889999999776 7


Q ss_pred             ceeccCC
Q 046065          158 YYKKFSL  164 (164)
Q Consensus       158 ~~~~~Di  164 (164)
                      ++.++|+
T Consensus       176 ~~~~~Di  182 (283)
T cd05118         176 YSTPVDI  182 (283)
T ss_pred             CCchhHH
Confidence            7888885

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.91  E-value=8.1e-24  Score=149.87  Aligned_cols=155  Identities=27%  Similarity=0.382  Sum_probs=127.8

Q ss_pred             CCCcEEEEEEccccc--cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            4 PDGQIIAVKKLSKKS--TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         4 ~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      .+++.+|+|.+....  ......+..|+.+++.++|+|++++ +.+...+..++|+|+++ ++|.+++....  ..++..
T Consensus        22 ~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~~~--~~~~~~   98 (282)
T cd07829          22 KTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKRP--GPLSPN   98 (282)
T ss_pred             CCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cCHHHHHHhhc--cCCCHH
Confidence            358899999987552  3345667889999999999999997 67777788999999997 58988887642  238899


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh--hhhhhcccccccCcceecCC-c
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM--ILKQIQIELGYIPPEYVGRG-V  157 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~~~-~  157 (164)
                      ....++.+++.++.++|+.   +++|+|++|+||+++.++.++|+|||.+......  ......++..|+|||.+.+. .
T Consensus        99 ~~~~~~~~i~~~l~~LH~~---~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  175 (282)
T cd07829          99 LIKSIMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKH  175 (282)
T ss_pred             HHHHHHHHHHHHHHHHHHC---CcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCccccCcCcCChHHhcCCcC
Confidence            9999999999999999998   9999999999999999999999999998765432  22334557789999998766 7


Q ss_pred             ceeccCC
Q 046065          158 YYKKFSL  164 (164)
Q Consensus       158 ~~~~~Di  164 (164)
                      ++.++||
T Consensus       176 ~~~~~Dv  182 (282)
T cd07829         176 YSTAVDI  182 (282)
T ss_pred             CCccccH
Confidence            8888886

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.90  E-value=1.7e-23  Score=148.40  Aligned_cols=155  Identities=30%  Similarity=0.358  Sum_probs=124.2

Q ss_pred             CCcEEEEEEcccccc-ccHHHHHHHHHHHhccC-CCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            5 DGQIIAVKKLSKKST-QGFEEFKNEVMLTAKLQ-HLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         5 ~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~-h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      +++.|++|.+..... .......+|+..++.+. |+|++++ +.+...+..++|||++ +++|.+.+.... ...++...
T Consensus        23 ~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~-~~~~~~~~  100 (283)
T cd07830          23 TGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRK-GKPFSESV  100 (283)
T ss_pred             CCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhcc-cccCCHHH
Confidence            477899998764422 22234457899999998 9999997 7777788899999999 778988776543 12378999


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh-hhhhhcccccccCcceecC-Ccce
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM-ILKQIQIELGYIPPEYVGR-GVYY  159 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~~-~~~~  159 (164)
                      ...++.|++.++.|+|++   +++|+|++|+||+++.++.++|+|||.+...... ......++..|+|||++.+ ..++
T Consensus       101 ~~~~~~~l~~~l~~Lh~~---~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~  177 (283)
T cd07830         101 IRSIIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYS  177 (283)
T ss_pred             HHHHHHHHHHHHHHHHHC---CcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCCCCCcccccCceeeecCcCcC
Confidence            999999999999999998   9999999999999999999999999998765432 2234567889999998843 4578


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      .++|+
T Consensus       178 ~~~Di  182 (283)
T cd07830         178 SPVDI  182 (283)
T ss_pred             Cccch
Confidence            88885

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.90  E-value=1.9e-23  Score=151.70  Aligned_cols=152  Identities=26%  Similarity=0.327  Sum_probs=118.3

Q ss_pred             CcEEEEEEcccc--ccccHHHHHHHHHHHhcc-CCCceeeE-eEEeeC----CcEEEEEEecCCCChhhhhhCccccccc
Q 046065            6 GQIIAVKKLSKK--STQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIET----QEYMLIYEYMPKRSLDYFLFDPIRMLIL   77 (164)
Q Consensus         6 ~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~----~~~~lv~e~~~~~~L~~~~~~~~~~~~~   77 (164)
                      ++.||+|.+...  .....+.+..|+.+++.+ +||||+++ ......    ...++++|++. ++|...+.....   +
T Consensus        27 ~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L~~~l~~~~~---~  102 (332)
T cd07857          27 EETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELME-ADLHQIIRSGQP---L  102 (332)
T ss_pred             CceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEeccc-CCHHHHHhcCCC---C
Confidence            678999988643  222345678899999999 59999997 433221    34678888875 688888765332   7


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh------hhhhcccccccCcc
Q 046065           78 DCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI------LKQIQIELGYIPPE  151 (164)
Q Consensus        78 ~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~------~~~~~~~~~~~aPE  151 (164)
                      +......++.|++.||.|+|+.   +++|+||||+||+++.++.++|+|||.+..+....      .....|++.|+|||
T Consensus       103 ~~~~~~~~~~qi~~aL~~LH~~---givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE  179 (332)
T cd07857         103 TDAHFQSFIYQILCGLKYIHSA---NVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPE  179 (332)
T ss_pred             CHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcH
Confidence            8899999999999999999998   99999999999999999999999999987553211      13356889999999


Q ss_pred             eecC-CcceeccCC
Q 046065          152 YVGR-GVYYKKFSL  164 (164)
Q Consensus       152 ~~~~-~~~~~~~Di  164 (164)
                      .+.+ ..++.++||
T Consensus       180 ~~~~~~~~~~~~Di  193 (332)
T cd07857         180 IMLSFQSYTKAIDV  193 (332)
T ss_pred             HHhCCCCCCcHHHH
Confidence            8755 467888885

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.90  E-value=2.2e-23  Score=152.15  Aligned_cols=152  Identities=30%  Similarity=0.369  Sum_probs=119.1

Q ss_pred             CCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEeeC------CcEEEEEEecCCCChhhhhhCcccc
Q 046065            4 PDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIET------QEYMLIYEYMPKRSLDYFLFDPIRM   74 (164)
Q Consensus         4 ~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~   74 (164)
                      .+++.||+|.+...  .......+.+|+.+++.++||||+++ +.+...      ...+++++++ +++|.+++...   
T Consensus        40 ~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~~---  115 (345)
T cd07877          40 KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ---  115 (345)
T ss_pred             CCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHhcC---
Confidence            56889999998643  22234567789999999999999997 443321      2356777765 77888776542   


Q ss_pred             cccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCcceec
Q 046065           75 LILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVG  154 (164)
Q Consensus        75 ~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~  154 (164)
                       .+++..+..++.|++.|+.|+|+.   +++|+|+||+||+++.++.++|+|||++..... ......++..|+|||.+.
T Consensus       116 -~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~y~aPE~~~  190 (345)
T cd07877         116 -KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-EMTGYVATRWYRAPEIML  190 (345)
T ss_pred             -CCCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChHHEEEcCCCCEEEecccccccccc-cccccccCCCccCHHHHh
Confidence             278889999999999999999998   999999999999999999999999999865432 223456788999999986


Q ss_pred             C-CcceeccCC
Q 046065          155 R-GVYYKKFSL  164 (164)
Q Consensus       155 ~-~~~~~~~Di  164 (164)
                      + ..++.++||
T Consensus       191 ~~~~~~~~~Dv  201 (345)
T cd07877         191 NWMHYNQTVDI  201 (345)
T ss_pred             CccCCCchhhH
Confidence            5 457888885

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=6.4e-24  Score=153.05  Aligned_cols=144  Identities=24%  Similarity=0.289  Sum_probs=115.2

Q ss_pred             CCcEEEEEEccccccccHHHHHHHHHHHh--ccCCCceeeE-e-EEeeCC---cEEEEEEecCCCChhhhhhCccccccc
Q 046065            5 DGQIIAVKKLSKKSTQGFEEFKNEVMLTA--KLQHLNLIRV-G-FCIETQ---EYMLIYEYMPKRSLDYFLFDPIRMLIL   77 (164)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~e~~~l~--~l~h~~i~~~-~-~~~~~~---~~~lv~e~~~~~~L~~~~~~~~~~~~~   77 (164)
                      .|+.||||+++..++   ++|.+|.+++.  +++|+||+.+ + ...+.+   ++|||++|-+.|||.+++....    +
T Consensus       233 rGe~VAVKiF~srdE---~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~t----v  305 (513)
T KOG2052|consen  233 RGEDVAVKIFSSRDE---RSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRNT----V  305 (513)
T ss_pred             cCCceEEEEecccch---hhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhhcc----C
Confidence            378999999975533   34666666655  5599999996 2 222333   4899999999999999997632    8


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhcC-----CCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh------hhhhhccccc
Q 046065           78 DCKKRVHIIKGIIQGLLYLQEYF-----RLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM------ILKQIQIELG  146 (164)
Q Consensus        78 ~~~~~~~~~~~~~~~l~~lh~~~-----~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~------~~~~~~~~~~  146 (164)
                      +......++..++.||.+||...     .+.|-|||||..|||+..++.+-|+|+|+|-...+.      ..+..+||-.
T Consensus       306 ~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKR  385 (513)
T KOG2052|consen  306 TTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKR  385 (513)
T ss_pred             CHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceee
Confidence            88889999999999999999865     367999999999999999999999999999654322      2356789999


Q ss_pred             ccCcceecC
Q 046065          147 YIPPEYVGR  155 (164)
Q Consensus       147 ~~aPE~~~~  155 (164)
                      |||||++..
T Consensus       386 YMAPEvLde  394 (513)
T KOG2052|consen  386 YMAPEVLDE  394 (513)
T ss_pred             ccChHHhhh
Confidence            999999954

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.90  E-value=7.6e-24  Score=156.26  Aligned_cols=149  Identities=23%  Similarity=0.240  Sum_probs=117.9

Q ss_pred             CCCcEEEEEEcccc--ccccHHHHHHHHHHHhcc-CCCceeeEeEEee-CCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKL-QHLNLIRVGFCIE-TQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      ++...||+|.+...  .+...+.+..|+..|.++ +|.+|+.+..++- ++.+|+|||+ ...+|..++.+....  .+.
T Consensus       383 s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~-Gd~DL~kiL~k~~~~--~~~  459 (677)
T KOG0596|consen  383 SDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMEC-GDIDLNKILKKKKSI--DPD  459 (677)
T ss_pred             CCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeec-ccccHHHHHHhccCC--Cch
Confidence            45567787776433  455678899999999999 5999999855554 5667899995 567899999874432  444


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh----hhhcccccccCcceecC
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL----KQIQIELGYIPPEYVGR  155 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~aPE~~~~  155 (164)
                      ..+..+..||+.|+.++|+.   +|+|.||||.|+++ -.|++||+|||.|.-+.....    ...+||+.||+||.+..
T Consensus       460 ~~lk~ywkqML~aV~~IH~~---gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~  535 (677)
T KOG0596|consen  460 WFLKFYWKQMLLAVKTIHQH---GIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTD  535 (677)
T ss_pred             HHHHHHHHHHHHHHHHHHHh---ceeecCCCcccEEE-EeeeEEeeeechhcccCccccceeeccccCcccccCHHHHhh
Confidence            58888999999999999999   99999999999998 467899999999987764332    56789999999999954


Q ss_pred             Ccce
Q 046065          156 GVYY  159 (164)
Q Consensus       156 ~~~~  159 (164)
                      +.++
T Consensus       536 ~~s~  539 (677)
T KOG0596|consen  536 MSSS  539 (677)
T ss_pred             cccc
Confidence            4443

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.90  E-value=3e-23  Score=148.31  Aligned_cols=155  Identities=24%  Similarity=0.343  Sum_probs=119.8

Q ss_pred             CCcEEEEEEccccc-cccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            5 DGQIIAVKKLSKKS-TQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         5 ~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      +++.||+|.+.... ......+..|+.++... +|||++++ +.+......++++|+++ +++..+......  .+++..
T Consensus        39 ~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~l~~~~~~--~l~~~~  115 (296)
T cd06618          39 TGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS-TCLDKLLKRIQG--PIPEDI  115 (296)
T ss_pred             CCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC-cCHHHHHHHhcC--CCCHHH
Confidence            47899999986542 22344566777766666 59999997 88888888999999985 467666654222  378888


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh-hhhhcccccccCcceecCCc---
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI-LKQIQIELGYIPPEYVGRGV---  157 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~---  157 (164)
                      ...++.+++.++.|+|+.  .+++|+||+|+||+++.++.++|+|||++..+.... .....+++.|+|||.+.+..   
T Consensus       116 ~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  193 (296)
T cd06618         116 LGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNP  193 (296)
T ss_pred             HHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCCCcccCCCCCccccCHhhcCCCCCcc
Confidence            899999999999999972  189999999999999999999999999987654322 23345778899999996554   


Q ss_pred             -ceeccCC
Q 046065          158 -YYKKFSL  164 (164)
Q Consensus       158 -~~~~~Di  164 (164)
                       ++.++||
T Consensus       194 ~~~~~~Di  201 (296)
T cd06618         194 KYDIRADV  201 (296)
T ss_pred             ccccchhH
Confidence             7888885

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.90  E-value=2.7e-23  Score=143.66  Aligned_cols=154  Identities=32%  Similarity=0.446  Sum_probs=131.9

Q ss_pred             CCcEEEEEEcccccccc-HHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            5 DGQIIAVKKLSKKSTQG-FEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         5 ~~~~vavK~~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      +++.+++|.+....... ...+..|++.++.++|+|++++ +.+......++++|++++++|..++.....   ++....
T Consensus        13 ~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~---~~~~~~   89 (244)
T smart00220       13 TGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRGR---LSEDEA   89 (244)
T ss_pred             CCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhccC---CCHHHH
Confidence            57899999987654433 6788899999999999999997 777777889999999999999988865432   778889


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh-hhhhhcccccccCcceecCCcceec
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM-ILKQIQIELGYIPPEYVGRGVYYKK  161 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~  161 (164)
                      ..++.+++.++.++|+.   +++|+|++|.||+++.++.++++|||.+...... ......++..|+|||...+..++.+
T Consensus        90 ~~~~~~l~~~l~~lh~~---~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~  166 (244)
T smart00220       90 RFYARQILSALEYLHSN---GIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVLLGKGYGKA  166 (244)
T ss_pred             HHHHHHHHHHHHHHHHc---CeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHHHccCCCCch
Confidence            99999999999999998   9999999999999999999999999998766543 3345667889999999988888889


Q ss_pred             cCC
Q 046065          162 FSL  164 (164)
Q Consensus       162 ~Di  164 (164)
                      +||
T Consensus       167 ~Di  169 (244)
T smart00220      167 VDV  169 (244)
T ss_pred             hhH
Confidence            886

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.90  E-value=1.9e-23  Score=152.29  Aligned_cols=153  Identities=27%  Similarity=0.408  Sum_probs=120.6

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeC--------------CcEEEEEEecCCCChhhhh
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIET--------------QEYMLIYEYMPKRSLDYFL   68 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~--------------~~~~lv~e~~~~~~L~~~~   68 (164)
                      .+++.||+|.+..........+..|+.+++.++|||++++ ..+...              ...++++|+++ ++|.+++
T Consensus        28 ~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~  106 (342)
T cd07854          28 DCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVL  106 (342)
T ss_pred             CCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeeccc-ccHHHHH
Confidence            4688999999876655566778899999999999999997 433322              24689999997 5887777


Q ss_pred             hCcccccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecC-CCCeEEccccchhhhhhh-----hhhhhc
Q 046065           69 FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE-DLKPKISDFGLARILRKM-----ILKQIQ  142 (164)
Q Consensus        69 ~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~-~~~~~l~dfg~~~~~~~~-----~~~~~~  142 (164)
                      ...    .+++.....++.|++.|+.|||+.   +++|+||||+||+++. ++.++++|||.+......     ......
T Consensus       107 ~~~----~l~~~~~~~~~~qi~~aL~~LH~~---givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  179 (342)
T cd07854         107 EQG----PLSEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGL  179 (342)
T ss_pred             HcC----CCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCceEEECCcccceecCCcccccccccccc
Confidence            542    278899999999999999999998   9999999999999975 557899999998754321     112345


Q ss_pred             ccccccCcceecC-CcceeccCC
Q 046065          143 IELGYIPPEYVGR-GVYYKKFSL  164 (164)
Q Consensus       143 ~~~~~~aPE~~~~-~~~~~~~Di  164 (164)
                      ++..|+|||.+.+ ..++.++||
T Consensus       180 ~~~~y~aPE~~~~~~~~~~~~Di  202 (342)
T cd07854         180 VTKWYRSPRLLLSPNNYTKAIDM  202 (342)
T ss_pred             ccccccCHHHHhCccccCchhhH
Confidence            7888999998754 457888886

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.90  E-value=2.6e-23  Score=149.24  Aligned_cols=155  Identities=27%  Similarity=0.405  Sum_probs=118.3

Q ss_pred             CCCcEEEEEEccccc--cccHHHHHHHHHHHhccCCCceeeE-eEEeeC--------CcEEEEEEecCCCChhhhhhCcc
Q 046065            4 PDGQIIAVKKLSKKS--TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIET--------QEYMLIYEYMPKRSLDYFLFDPI   72 (164)
Q Consensus         4 ~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~--------~~~~lv~e~~~~~~L~~~~~~~~   72 (164)
                      .+++.+|+|.+....  ......+.+|+.+++.++||||+++ +.+...        ...++|+||+.. ++...+....
T Consensus        31 ~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~-~l~~~~~~~~  109 (311)
T cd07866          31 KTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DLSGLLENPS  109 (311)
T ss_pred             CCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecCCc-CHHHHHhccc
Confidence            467889999876442  2223456789999999999999997 444322        236899999865 5655554321


Q ss_pred             cccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh-------------h
Q 046065           73 RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL-------------K  139 (164)
Q Consensus        73 ~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~-------------~  139 (164)
                        ..+++..+..++.|+++||.|+|+.   +++|+|++|+||+++.++.++|+|||++........             .
T Consensus       110 --~~~~~~~~~~i~~~l~~al~~lH~~---~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~  184 (311)
T cd07866         110 --VKLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYT  184 (311)
T ss_pred             --cCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccc
Confidence              2388999999999999999999998   999999999999999999999999999875532111             2


Q ss_pred             hhcccccccCcceecCC-cceeccCC
Q 046065          140 QIQIELGYIPPEYVGRG-VYYKKFSL  164 (164)
Q Consensus       140 ~~~~~~~~~aPE~~~~~-~~~~~~Di  164 (164)
                      ...+++.|+|||.+.+. .++.++||
T Consensus       185 ~~~~~~~y~aPE~~~~~~~~~~~~Dv  210 (311)
T cd07866         185 NLVVTRWYRPPELLLGERRYTTAVDI  210 (311)
T ss_pred             cceeccCcCChHHhhCCCccCchhHh
Confidence            23567889999987554 57888886

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.90  E-value=2.4e-23  Score=161.16  Aligned_cols=156  Identities=26%  Similarity=0.355  Sum_probs=129.7

Q ss_pred             CcEEEEEEcccc-ccccHHHHHHHHHHHhccC-CCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcc-----cc---
Q 046065            6 GQIIAVKKLSKK-STQGFEEFKNEVMLTAKLQ-HLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPI-----RM---   74 (164)
Q Consensus         6 ~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~-h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-----~~---   74 (164)
                      .-.||||.+... ...+.+.+..|+.+++.+. |+|++.+ +.|...+..++|.||+..|+|..+++..+     ..   
T Consensus       328 ~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~  407 (609)
T KOG0200|consen  328 YVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGV  407 (609)
T ss_pred             eEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCC
Confidence            346999998654 3356778999999999995 9999997 88888888999999999999999998654     00   


Q ss_pred             -----cccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhh---hhc--cc
Q 046065           75 -----LILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILK---QIQ--IE  144 (164)
Q Consensus        75 -----~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~---~~~--~~  144 (164)
                           ..+.......++.|++.|++||++.   +++|||+..+||++..+..+|++|||+++........   ...  -.
T Consensus       408 ~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~---~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP  484 (609)
T KOG0200|consen  408 FPNERDALTTKDLLSFAYQIANGMEYLASV---PCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLP  484 (609)
T ss_pred             CccccCCcCHHHHHHHHHHHHHHHHHHhhC---CccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccc
Confidence                 1277889999999999999999998   9999999999999999999999999999865432221   112  23


Q ss_pred             ccccCcceecCCcceeccCC
Q 046065          145 LGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       145 ~~~~aPE~~~~~~~~~~~Di  164 (164)
                      ..|||||.+....|+.||||
T Consensus       485 ~kWmApEsl~~~~ft~kSDV  504 (609)
T KOG0200|consen  485 VKWMAPESLFDRVFTSKSDV  504 (609)
T ss_pred             eeecCHHHhccCcccccchh
Confidence            45999999999999999997

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.90  E-value=3.7e-23  Score=150.75  Aligned_cols=151  Identities=30%  Similarity=0.410  Sum_probs=118.3

Q ss_pred             CCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEeeC------CcEEEEEEecCCCChhhhhhCcccc
Q 046065            4 PDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIET------QEYMLIYEYMPKRSLDYFLFDPIRM   74 (164)
Q Consensus         4 ~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~   74 (164)
                      .+++.||+|.+...  .......+..|+.+++.++||||+++ +.+...      ..+++|+|++.. ++......    
T Consensus        38 ~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~----  112 (342)
T cd07879          38 RTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGH----  112 (342)
T ss_pred             CCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEeccccc-CHHHHHcC----
Confidence            46889999988643  22234567889999999999999997 544432      246899999863 66554421    


Q ss_pred             cccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCcceec
Q 046065           75 LILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVG  154 (164)
Q Consensus        75 ~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~  154 (164)
                       .++......++.|++.|+.|+|+.   +++|+||+|+||+++.++.++|+|||++..... ......+++.|+|||.+.
T Consensus       113 -~~~~~~~~~~~~qi~~aL~~LH~~---~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~-~~~~~~~~~~y~aPE~~~  187 (342)
T cd07879         113 -PLSEDKVQYLVYQMLCGLKYIHSA---GIIHRDLKPGNLAVNEDCELKILDFGLARHADA-EMTGYVVTRWYRAPEVIL  187 (342)
T ss_pred             -CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC-CCCCceeeecccChhhhc
Confidence             278888999999999999999998   999999999999999999999999999865432 223456788899999986


Q ss_pred             C-CcceeccCC
Q 046065          155 R-GVYYKKFSL  164 (164)
Q Consensus       155 ~-~~~~~~~Di  164 (164)
                      + ..++.++||
T Consensus       188 ~~~~~~~~~Dv  198 (342)
T cd07879         188 NWMHYNQTVDI  198 (342)
T ss_pred             CccccCchHHH
Confidence            5 467888885

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=2.1e-24  Score=155.18  Aligned_cols=154  Identities=25%  Similarity=0.330  Sum_probs=126.1

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhccC-CCceeeEeEEee-CCcEEEEEEecCCCChhhhhhCcccccccC
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQ-HLNLIRVGFCIE-TQEYMLIYEYMPKRSLDYFLFDPIRMLILD   78 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~   78 (164)
                      .+.+.+|||++.++   ...+.+--..|-++|.... -|.++++.+|.+ .+.+|+||||+.+|+|...+++-+.   +.
T Consensus       372 gtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~Gk---FK  448 (683)
T KOG0696|consen  372 GTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGK---FK  448 (683)
T ss_pred             CcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecCchhhhHHHHhcc---cC
Confidence            45678999999876   2223343456778887775 467777866665 5789999999999999888876443   78


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhh--hhhhhhhcccccccCcceecCC
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILR--KMILKQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~--~~~~~~~~~~~~~~aPE~~~~~  156 (164)
                      ++.+..++.+++.||-+||++   +||.||+|.+|+|++..|.+||+|||++..--  ...+...+|||-|+|||++..-
T Consensus       449 Ep~AvFYAaEiaigLFFLh~k---gIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~Yq  525 (683)
T KOG0696|consen  449 EPVAVFYAAEIAIGLFFLHSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQ  525 (683)
T ss_pred             CchhhhhhHHHHHHhhhhhcC---CeeeeeccccceEeccCCceEeeecccccccccCCcceeeecCCCcccccceEEec
Confidence            889999999999999999998   99999999999999999999999999986532  2334678999999999999888


Q ss_pred             cceeccC
Q 046065          157 VYYKKFS  163 (164)
Q Consensus       157 ~~~~~~D  163 (164)
                      .|+...|
T Consensus       526 PYgksvD  532 (683)
T KOG0696|consen  526 PYGKSVD  532 (683)
T ss_pred             ccccchh
Confidence            8887766

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.90  E-value=9e-23  Score=148.41  Aligned_cols=138  Identities=17%  Similarity=0.162  Sum_probs=105.5

Q ss_pred             CCcEEEEEEcccc-----ccccHHHHHHHHHHHhccCCCceee-EeEEeeCCcEEEEEEecCCCChhhhhhCcccccccC
Q 046065            5 DGQIIAVKKLSKK-----STQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILD   78 (164)
Q Consensus         5 ~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~-~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~   78 (164)
                      +++.+|||.+...     .+.....+.+|+++++.++|+|++. +..   .+..++||||+++++|... ..      ..
T Consensus        43 ~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~~~~LVmE~~~G~~L~~~-~~------~~  112 (365)
T PRK09188         43 PGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TGKDGLVRGWTEGVPLHLA-RP------HG  112 (365)
T ss_pred             CCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cCCcEEEEEccCCCCHHHh-Cc------cc
Confidence            5677899986533     1223456889999999999999986 432   2467999999999998632 11      11


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC-CCCceeecCCCCeEEccccchhhhhhhh----------hhhhcccccc
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDL-KVSNILLDEDLKPKISDFGLARILRKMI----------LKQIQIELGY  147 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dl-k~~nili~~~~~~~l~dfg~~~~~~~~~----------~~~~~~~~~~  147 (164)
                         ...++.++++++.++|++   +|+|||| ||+|||++.++.++|+|||+++.+....          .....+++.|
T Consensus       113 ---~~~~~~~i~~aL~~lH~~---gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~  186 (365)
T PRK09188        113 ---DPAWFRSAHRALRDLHRA---GITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRT  186 (365)
T ss_pred             ---hHHHHHHHHHHHHHHHHC---CCeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCcc
Confidence               146788999999999998   9999999 9999999989999999999998654221          1356778889


Q ss_pred             cCcceecCCcc
Q 046065          148 IPPEYVGRGVY  158 (164)
Q Consensus       148 ~aPE~~~~~~~  158 (164)
                      +|||.+..++.
T Consensus       187 ~~pe~~~~~~~  197 (365)
T PRK09188        187 YAPDALTPRER  197 (365)
T ss_pred             CCcccCChhhh
Confidence            99999965543

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.89  E-value=1.8e-23  Score=156.18  Aligned_cols=149  Identities=23%  Similarity=0.353  Sum_probs=120.3

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      ++++..++|++.....    ...+|+.++... +||||+++ ..+......|+|||.+.++.+.+.+....    .....
T Consensus       345 ~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~----~~~~e  416 (612)
T KOG0603|consen  345 PTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKP----EFCSE  416 (612)
T ss_pred             ccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhcc----hhHHH
Confidence            4566778888765521    234577666666 79999998 66666778999999999988876665432    33367


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceee-cCCCCeEEccccchhhhhhhhhhhhcccccccCcceecCCccee
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL-DEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYK  160 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili-~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~  160 (164)
                      +..|+.+|+.|+.|||++   +++|||+||+|||+ +..+.++|+|||+++....+ ....+-|..|.|||+.....||+
T Consensus       417 ~~~w~~~lv~Av~~LH~~---gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-~~tp~~t~~y~APEvl~~~~yt~  492 (612)
T KOG0603|consen  417 ASQWAAELVSAVDYLHEQ---GVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-CDTPALTLQYVAPEVLAIQEYTE  492 (612)
T ss_pred             HHHHHHHHHHHHHHHHhc---CeeecCCChhheeecCCCCcEEEEEechhhhCchh-hcccchhhcccChhhhccCCCCc
Confidence            778999999999999998   99999999999999 58899999999999887765 45566788899999999999999


Q ss_pred             ccCC
Q 046065          161 KFSL  164 (164)
Q Consensus       161 ~~Di  164 (164)
                      ++|+
T Consensus       493 acD~  496 (612)
T KOG0603|consen  493 ACDW  496 (612)
T ss_pred             chhh
Confidence            9996

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.89  E-value=2.8e-23  Score=151.38  Aligned_cols=152  Identities=29%  Similarity=0.376  Sum_probs=120.9

Q ss_pred             CCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCC------cEEEEEEecCCCChhhhhhCcccc
Q 046065            4 PDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQ------EYMLIYEYMPKRSLDYFLFDPIRM   74 (164)
Q Consensus         4 ~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~   74 (164)
                      .+++.||+|.+...  .......+.+|+.+++.++|||++++ ..+....      ..++|+|++ +++|.+++...   
T Consensus        38 ~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---  113 (343)
T cd07851          38 KTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKCQ---  113 (343)
T ss_pred             CCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHhcC---
Confidence            35789999987643  23334567789999999999999997 4443332      378999988 56898887652   


Q ss_pred             cccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCcceec
Q 046065           75 LILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVG  154 (164)
Q Consensus        75 ~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~  154 (164)
                       .+++.....++.|++.|+.++|+.   +++|+|++|+||+++.++.++|+|||++...... .....++..|+|||.+.
T Consensus       114 -~l~~~~~~~~~~ql~~aL~~LH~~---gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~-~~~~~~~~~y~aPE~~~  188 (343)
T cd07851         114 -KLSDDHIQFLVYQILRGLKYIHSA---GIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-MTGYVATRWYRAPEIML  188 (343)
T ss_pred             -CCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEECCCCCEEEcccccccccccc-ccCCcccccccCHHHHh
Confidence             288899999999999999999998   9999999999999999999999999998765432 23456788899999985


Q ss_pred             C-CcceeccCC
Q 046065          155 R-GVYYKKFSL  164 (164)
Q Consensus       155 ~-~~~~~~~Di  164 (164)
                      + ..++.++||
T Consensus       189 ~~~~~~~~~Dv  199 (343)
T cd07851         189 NWMHYNQTVDI  199 (343)
T ss_pred             CCCCCCchHhH
Confidence            5 356888885

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.89  E-value=1.9e-23  Score=165.08  Aligned_cols=83  Identities=35%  Similarity=0.520  Sum_probs=71.3

Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhh----h----------------hhh
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILR----K----------------MIL  138 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~----~----------------~~~  138 (164)
                      ....++++++|+.|+.|+|++   ++||||+||.||++++++.+||+|||+|....    .                ...
T Consensus       696 ~d~~wrLFreIlEGLaYIH~~---giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~  772 (1351)
T KOG1035|consen  696 RDEAWRLFREILEGLAYIHDQ---GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDL  772 (1351)
T ss_pred             hHHHHHHHHHHHHHHHHHHhC---ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCccc
Confidence            567789999999999999999   99999999999999999999999999998621    0                012


Q ss_pred             hhhcccccccCcceecCCc---ceeccCC
Q 046065          139 KQIQIELGYIPPEYVGRGV---YYKKFSL  164 (164)
Q Consensus       139 ~~~~~~~~~~aPE~~~~~~---~~~~~Di  164 (164)
                      ++..||.-|+|||++.+..   |+.|+||
T Consensus       773 Ts~VGTalYvAPEll~~~~~~~Yn~KiDm  801 (1351)
T KOG1035|consen  773 TSQVGTALYVAPELLSDTSSNKYNSKIDM  801 (1351)
T ss_pred             ccccceeeeecHHHhcccccccccchhhh
Confidence            4567899999999996665   9999996

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.89  E-value=5.4e-24  Score=145.09  Aligned_cols=159  Identities=27%  Similarity=0.327  Sum_probs=123.4

Q ss_pred             cCCCcEEEEEEcccc-ccccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCc--cccccc
Q 046065            3 LPDGQIIAVKKLSKK-STQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDP--IRMLIL   77 (164)
Q Consensus         3 ~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~   77 (164)
                      .+.|+..|||.+... ......+++.|.....+- +.|||+++ +.++.++..|+.||.+. .|++.+.+..  .....+
T Consensus        86 k~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~SlDklYk~vy~vq~~~i  164 (361)
T KOG1006|consen   86 KPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-ISLDKLYKRVYSVQKSRI  164 (361)
T ss_pred             CccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-hhHHHHHHHHHHHHhccC
Confidence            367899999998755 334556788888755554 79999997 99999999999999985 4776665431  111238


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh-hhhcccccccCcceecCC
Q 046065           78 DCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL-KQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        78 ~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~aPE~~~~~  156 (164)
                      ++....+++--.+.||.||-..  ..|||||+||+|||++..|.+||+|||.+-.+.++.. +...|-..|||||-+...
T Consensus       165 pE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~  242 (361)
T KOG1006|consen  165 PENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPS  242 (361)
T ss_pred             cHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHHHHhhhccCCccccChhccCCc
Confidence            8888888887788999999875  4899999999999999999999999999866654433 456677789999999433


Q ss_pred             --cceeccCC
Q 046065          157 --VYYKKFSL  164 (164)
Q Consensus       157 --~~~~~~Di  164 (164)
                        -|+-+||+
T Consensus       243 ~~gyDiRSDv  252 (361)
T KOG1006|consen  243 DKGYDIRSDV  252 (361)
T ss_pred             cCCcchhhhh
Confidence              47888885

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.89  E-value=1.9e-23  Score=159.88  Aligned_cols=152  Identities=28%  Similarity=0.339  Sum_probs=116.4

Q ss_pred             CcEEEEEEccccccccHHHHHHHHHHHhcc-CCCceeeEeEEe-eCCcEEEEEEecCCCChhhhhhCcccc-cccCHHHH
Q 046065            6 GQIIAVKKLSKKSTQGFEEFKNEVMLTAKL-QHLNLIRVGFCI-ETQEYMLIYEYMPKRSLDYFLFDPIRM-LILDCKKR   82 (164)
Q Consensus         6 ~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~~~~~~~~-~~~~~~~~   82 (164)
                      ++.||||.+-..   ......+|+..|+.- +||||+++-..+ +..+.|+..|.|. .+|.+++...... ........
T Consensus       533 ~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~-~sL~dlie~~~~d~~~~~~i~~  608 (903)
T KOG1027|consen  533 GREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA-CSLQDLIESSGLDVEMQSDIDP  608 (903)
T ss_pred             CceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh-hhHHHHHhccccchhhcccccH
Confidence            578999987533   233567899999999 599999985554 4567889999984 6999998774111 11121445


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecC---C--CCeEEccccchhhhhhhh-----hhhhcccccccCcce
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE---D--LKPKISDFGLARILRKMI-----LKQIQIELGYIPPEY  152 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~---~--~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~aPE~  152 (164)
                      .....|+++|+.+||+.   +|+|||+||+||||..   +  .+++|+|||+++.+....     .....||.+|+|||+
T Consensus       609 ~~~l~q~~~GlaHLHsl---~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~  685 (903)
T KOG1027|consen  609 ISVLSQIASGLAHLHSL---KIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQ  685 (903)
T ss_pred             HHHHHHHHHHHHHHHhc---ccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHH
Confidence            67788999999999998   9999999999999976   3  468999999998775322     246789999999999


Q ss_pred             ecCCcceeccCC
Q 046065          153 VGRGVYYKKFSL  164 (164)
Q Consensus       153 ~~~~~~~~~~Di  164 (164)
                      +....-+.+.||
T Consensus       686 L~~~~~~~avDi  697 (903)
T KOG1027|consen  686 LREDRKTQAVDI  697 (903)
T ss_pred             HhccccCcccch
Confidence            987777777775

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.89  E-value=2.4e-23  Score=157.43  Aligned_cols=153  Identities=29%  Similarity=0.365  Sum_probs=129.1

Q ss_pred             EEEEEEccccccc-cHHHHHHHHHHHhccCCCceeeEeEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHHHHH
Q 046065            8 IIAVKKLSKKSTQ-GFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHII   86 (164)
Q Consensus         8 ~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~   86 (164)
                      .||||.+...... ....|++|+.+|.+++||+++++.....+.-..+|||+++.|+|.+.++... ...+.......++
T Consensus       140 ~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~qp~mMV~ELaplGSLldrLrka~-~~~llv~~Lcdya  218 (1039)
T KOG0199|consen  140 NVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLDQPAMMVFELAPLGSLLDRLRKAK-KAILLVSRLCDYA  218 (1039)
T ss_pred             eEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeeccchhhHHhhhcccchHHHHHhhcc-ccceeHHHHHHHH
Confidence            6999999766433 6788999999999999999999844444477789999999999999988722 2337788999999


Q ss_pred             HHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh--hh---hhhcccccccCcceecCCcceec
Q 046065           87 KGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM--IL---KQIQIELGYIPPEYVGRGVYYKK  161 (164)
Q Consensus        87 ~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~--~~---~~~~~~~~~~aPE~~~~~~~~~~  161 (164)
                      .|++.|+.||.++   ++||||+..+|+++.....+||+|||+.+-+...  .+   ......+.|-|||.+.-++++.+
T Consensus       219 ~QiA~aM~YLesk---rlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFSha  295 (1039)
T KOG0199|consen  219 MQIAKAMQYLESK---RLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHA  295 (1039)
T ss_pred             HHHHHHHHHHhhh---hhhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhcccccccc
Confidence            9999999999998   9999999999999999999999999998877532  22   22344678999999999999999


Q ss_pred             cCC
Q 046065          162 FSL  164 (164)
Q Consensus       162 ~Di  164 (164)
                      ||+
T Consensus       296 SDv  298 (1039)
T KOG0199|consen  296 SDV  298 (1039)
T ss_pred             chh
Confidence            996

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.89  E-value=6.5e-24  Score=159.42  Aligned_cols=155  Identities=25%  Similarity=0.361  Sum_probs=135.0

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      .+++..|+|.++.....+.+.+..|+-+++..+||||+.+ +.+...+.+|++||||.+|+|.+...-..   .+.+.++
T Consensus        38 ~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~~Tg---plselqi  114 (829)
T KOG0576|consen   38 RSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHVTG---PLSELQI  114 (829)
T ss_pred             ccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceeeecc---cchhHHH
Confidence            4578899999988777777888999999999999999997 88888899999999999999988765432   2888999


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh--hhhhcccccccCccee---cCCc
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI--LKQIQIELGYIPPEYV---GRGV  157 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~aPE~~---~~~~  157 (164)
                      ...+++.++++.|+|++   +=+|||||-.||++...|.+|+.|||.+..+....  ...+.||++|||||+-   .++-
T Consensus       115 ayvcRetl~gl~ylhs~---gk~hRdiKGanilltd~gDvklaDfgvsaqitati~KrksfiGtpywmapEvaaverkgg  191 (829)
T KOG0576|consen  115 AYVCRETLQGLKYLHSQ---GKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGG  191 (829)
T ss_pred             HHHHhhhhccchhhhcC---CcccccccccceeecccCceeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhccc
Confidence            99999999999999998   88999999999999999999999999987775432  2568899999999987   5667


Q ss_pred             ceeccCC
Q 046065          158 YYKKFSL  164 (164)
Q Consensus       158 ~~~~~Di  164 (164)
                      |..++||
T Consensus       192 ynqlcdi  198 (829)
T KOG0576|consen  192 YNQLCDI  198 (829)
T ss_pred             ccccccc
Confidence            8888885

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.89  E-value=7.5e-23  Score=143.57  Aligned_cols=139  Identities=27%  Similarity=0.382  Sum_probs=114.9

Q ss_pred             HHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCc-ccccccCHHHHHHHHHHHHHHHHHhhhc
Q 046065           22 FEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDP-IRMLILDCKKRVHIIKGIIQGLLYLQEY   99 (164)
Q Consensus        22 ~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~lh~~   99 (164)
                      ...+..|+.+++.++|||++++ +.+......++++||+++++|..++.+. .....+++.....++.|++.|+.++|+.
T Consensus        46 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~  125 (260)
T cd08222          46 TVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQR  125 (260)
T ss_pred             HHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHc
Confidence            3456678999999999999997 6777777889999999999998887642 1223488999999999999999999998


Q ss_pred             CCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh--hhhhhcccccccCcceecCCcceeccCC
Q 046065          100 FRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM--ILKQIQIELGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       100 ~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di  164 (164)
                         +++|+|++|+|++++. +.++++|||++......  ......+++.|+|||.+.+..++.++|+
T Consensus       126 ---~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv  188 (260)
T cd08222         126 ---RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDI  188 (260)
T ss_pred             ---CccccCCChhheEeec-CCEeecccCceeecCCCcccccCCCCCcCccCHHHHccCCCCchhhH
Confidence               9999999999999975 56999999998665432  2234567889999999988888888885

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.88  E-value=8e-25  Score=150.09  Aligned_cols=154  Identities=25%  Similarity=0.381  Sum_probs=119.7

Q ss_pred             CCCcEEEEEEcccccc--ccHHHHHHHHHHHhccCCCceeeEeEEeeC------CcEEEEEEecCCCChhhhhhCccccc
Q 046065            4 PDGQIIAVKKLSKKST--QGFEEFKNEVMLTAKLQHLNLIRVGFCIET------QEYMLIYEYMPKRSLDYFLFDPIRML   75 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~~   75 (164)
                      .||+.||+|.+.+-.+  ....++.+|..++..++|.|+++...+...      .+.|+++|.+.. +|..++.+...  
T Consensus        76 RdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQS-DLHKIIVSPQ~--  152 (449)
T KOG0664|consen   76 RSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQS-DLHKIIVSPQA--  152 (449)
T ss_pred             CCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHHh-hhhheeccCCC--
Confidence            3688999998864322  234678899999999999999996333322      235677787753 67666665544  


Q ss_pred             ccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh---hhhhcccccccCcce
Q 046065           76 ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI---LKQIQIELGYIPPEY  152 (164)
Q Consensus        76 ~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~aPE~  152 (164)
                       +..+..+-+..||++||.|+|+.   +|+||||||.|+++.++..+||+|||+++......   .+..+.|-+|+|||.
T Consensus       153 -Ls~DHvKVFlYQILRGLKYLHsA---~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEi  228 (449)
T KOG0664|consen  153 -LTPDHVKVFVYQILRGLKYLHTA---NILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPEL  228 (449)
T ss_pred             -CCcchhhhhHHHHHhhhHHHhhc---chhhccCCCccEEeccCceEEecccccccccchhhhhhhHHHHHHHHhccHHH
Confidence             77788888999999999999999   99999999999999999999999999998765332   245667889999999


Q ss_pred             ecCC-cceeccCC
Q 046065          153 VGRG-VYYKKFSL  164 (164)
Q Consensus       153 ~~~~-~~~~~~Di  164 (164)
                      +.+. .|+...||
T Consensus       229 LMGaRhYs~AvDi  241 (449)
T KOG0664|consen  229 LMGARRYTGAVDI  241 (449)
T ss_pred             hhcchhhcCccce
Confidence            9554 66777775

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.88  E-value=7.2e-22  Score=143.43  Aligned_cols=157  Identities=27%  Similarity=0.388  Sum_probs=125.4

Q ss_pred             CCCcEEEEEEccccc-------cccHHHHHHHHHHHhccCCCceeeE-eEE-eeCCcEEEEEEecCCCChhhhhhCcccc
Q 046065            4 PDGQIIAVKKLSKKS-------TQGFEEFKNEVMLTAKLQHLNLIRV-GFC-IETQEYMLIYEYMPKRSLDYFLFDPIRM   74 (164)
Q Consensus         4 ~~~~~vavK~~~~~~-------~~~~~~~~~e~~~l~~l~h~~i~~~-~~~-~~~~~~~lv~e~~~~~~L~~~~~~~~~~   74 (164)
                      ..++-||+|+-..+.       ........+|.++.+.++||-|+++ +++ .+...+|-|+|||+|.+|+-++++..- 
T Consensus       486 ~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhkl-  564 (775)
T KOG1151|consen  486 TEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKL-  564 (775)
T ss_pred             chhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHhhhh-
Confidence            345679999854331       1223566789999999999999997 444 456789999999999999999987654 


Q ss_pred             cccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecC---CCCeEEccccchhhhhhhh---------hhhhc
Q 046065           75 LILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE---DLKPKISDFGLARILRKMI---------LKQIQ  142 (164)
Q Consensus        75 ~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~---~~~~~l~dfg~~~~~~~~~---------~~~~~  142 (164)
                        +.+..+..+.-|++.||.||... ..+|||-|+||.|||+-.   .|.+||.|||++....+..         +....
T Consensus       565 --mSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgA  641 (775)
T KOG1151|consen  565 --MSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGA  641 (775)
T ss_pred             --hhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccC
Confidence              77888899999999999999987 779999999999999954   4679999999998775432         24578


Q ss_pred             ccccccCcceec----CCcceeccCC
Q 046065          143 IELGYIPPEYVG----RGVYYKKFSL  164 (164)
Q Consensus       143 ~~~~~~aPE~~~----~~~~~~~~Di  164 (164)
                      ||.||++||.+.    ..+++.|.||
T Consensus       642 GTYWYLPPEcFvVgkePPKIsnKVDV  667 (775)
T KOG1151|consen  642 GTYWYLPPECFVVGKEPPKISNKVDV  667 (775)
T ss_pred             ceeeecCcceeecCCCCCccccceee
Confidence            999999999983    2356777775

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.88  E-value=1.4e-23  Score=160.99  Aligned_cols=152  Identities=24%  Similarity=0.323  Sum_probs=130.1

Q ss_pred             EEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeEeEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHHHHH
Q 046065            8 IIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHII   86 (164)
Q Consensus         8 ~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~   86 (164)
                      +||+|.+... .++...++++|+.+|..++|||++++..+...++..+|+++++.|+|.++++..+.  .+..+..+.|.
T Consensus       727 pVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~~qlvtq~mP~G~LlDyvr~hr~--~igsq~lLnw~  804 (1177)
T KOG1025|consen  727 PVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLSTLQLVTQLMPLGCLLDYVREHRD--NIGSQDLLNWC  804 (1177)
T ss_pred             eeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccchHHHHHHhcccchHHHHHHHhhc--cccHHHHHHHH
Confidence            7899987655 56667899999999999999999998444444558899999999999999987543  37788999999


Q ss_pred             HHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh----hhhcccccccCcceecCCcceecc
Q 046065           87 KGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL----KQIQIELGYIPPEYVGRGVYYKKF  162 (164)
Q Consensus        87 ~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~aPE~~~~~~~~~~~  162 (164)
                      .||++||.|||.+   +++||||..+|+|+.....+|+.|||++..+.....    ....-.+.|||-|.+..+.|+.++
T Consensus       805 ~QIAkgM~YLe~q---rlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqS  881 (1177)
T KOG1025|consen  805 YQIAKGMKYLEEQ---RLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQS  881 (1177)
T ss_pred             HHHHHHHHHHHhc---chhhhhhhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchh
Confidence            9999999999988   999999999999999999999999999988764322    334456789999999999999999


Q ss_pred             CC
Q 046065          163 SL  164 (164)
Q Consensus       163 Di  164 (164)
                      ||
T Consensus       882 DV  883 (1177)
T KOG1025|consen  882 DV  883 (1177)
T ss_pred             hh
Confidence            97

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.88  E-value=1.1e-21  Score=134.48  Aligned_cols=155  Identities=33%  Similarity=0.504  Sum_probs=129.1

Q ss_pred             CCcEEEEEEccccccc-cHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            5 DGQIIAVKKLSKKSTQ-GFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         5 ~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      +++.+|+|........ ....+..|+..++.++|+|++++ ..+......++++|++++++|.+++......  ++....
T Consensus        23 ~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~--~~~~~~  100 (225)
T smart00221       23 TGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGGK--LSEEEA  100 (225)
T ss_pred             CCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhcccC--CCHHHH
Confidence            4688999998766444 56778899999999999999997 6666677889999999999999988653221  678888


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh---hhhhhcccccccCccee-cCCcc
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM---ILKQIQIELGYIPPEYV-GRGVY  158 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~~aPE~~-~~~~~  158 (164)
                      ..++.+++.++.++|+.   +++|+|++|.|++++.++.++|+|||.+......   ......++..|++||.. ....+
T Consensus       101 ~~~~~~l~~~l~~lh~~---~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~  177 (225)
T smart00221      101 RFYLRQILEALEYLHSL---GIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGY  177 (225)
T ss_pred             HHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCC
Confidence            99999999999999998   9999999999999999999999999988766543   22445677889999998 66677


Q ss_pred             eeccCC
Q 046065          159 YKKFSL  164 (164)
Q Consensus       159 ~~~~Di  164 (164)
                      +.++|+
T Consensus       178 ~~~~Dv  183 (225)
T smart00221      178 GEAVDI  183 (225)
T ss_pred             CchhhH
Confidence            778875

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.87  E-value=6.9e-23  Score=142.49  Aligned_cols=150  Identities=30%  Similarity=0.364  Sum_probs=119.7

Q ss_pred             CcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeEeEEee-------CCcEEEEEEecCCCChhhhhhCcccccc
Q 046065            6 GQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRVGFCIE-------TQEYMLIYEYMPKRSLDYFLFDPIRMLI   76 (164)
Q Consensus         6 ~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-------~~~~~lv~e~~~~~~L~~~~~~~~~~~~   76 (164)
                      +++||+|.+...  ...-+++..+|..++..++|+|++++..+..       ....|+|||++. .+|...+..     .
T Consensus        41 ~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~-~nl~~vi~~-----e  114 (369)
T KOG0665|consen   41 GRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMD-ANLCQVILM-----E  114 (369)
T ss_pred             cCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhh-hHHHHHHHH-----h
Confidence            568888887533  1222456788999999999999999733332       225789999985 477666642     2


Q ss_pred             cCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh-hhhhhcccccccCcceecC
Q 046065           77 LDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM-ILKQIQIELGYIPPEYVGR  155 (164)
Q Consensus        77 ~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~~  155 (164)
                      ++......++.|++.|+.++|+.   +|+|||+||+||++..+..+|+.|||+|..-... ..+-.+.+..|.|||++.+
T Consensus       115 lDH~tis~i~yq~~~~ik~lhs~---~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~  191 (369)
T KOG0665|consen  115 LDHETISYILYQMLCGIKHLHSA---GIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILG  191 (369)
T ss_pred             cchHHHHHHHHHHHHHHHHHHhc---ceeecccCcccceecchhheeeccchhhcccCcccccCchhheeeccCchheec
Confidence            77788899999999999999999   9999999999999999999999999999765433 3355677889999999998


Q ss_pred             CcceeccCC
Q 046065          156 GVYYKKFSL  164 (164)
Q Consensus       156 ~~~~~~~Di  164 (164)
                      ..|.+..||
T Consensus       192 ~~~ke~vdi  200 (369)
T KOG0665|consen  192 MGYKENVDI  200 (369)
T ss_pred             cCCcccchh
Confidence            889888886

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.86  E-value=9.5e-21  Score=128.00  Aligned_cols=155  Identities=34%  Similarity=0.493  Sum_probs=128.5

Q ss_pred             CCcEEEEEEccccccc-cHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            5 DGQIIAVKKLSKKSTQ-GFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         5 ~~~~vavK~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      +++.+++|........ ..+.+.+|+..++.+.|++++++ .........++++|++++++|.+++....  ..++....
T Consensus        17 ~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~--~~~~~~~~   94 (215)
T cd00180          17 TGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENE--GKLSEDEI   94 (215)
T ss_pred             CCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhcc--CCCCHHHH
Confidence            4788999998655332 34678899999999999999997 66666678899999999999999887542  23788899


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecC-CCCeEEccccchhhhhhhh--hhhhcccccccCcceecCC-cc
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE-DLKPKISDFGLARILRKMI--LKQIQIELGYIPPEYVGRG-VY  158 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~-~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~aPE~~~~~-~~  158 (164)
                      ..++.+++.++.++|+.   +++|+|++|.||+++. .+.++++|||.+.......  .....+...|++||..... .+
T Consensus        95 ~~~~~~l~~~l~~lh~~---~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~  171 (215)
T cd00180          95 LRILLQILEGLEYLHSN---GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYY  171 (215)
T ss_pred             HHHHHHHHHHHHHHHhC---CeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCccChhHhcccCCC
Confidence            99999999999999998   9999999999999999 8999999999987665432  3446678889999999776 67


Q ss_pred             eeccCC
Q 046065          159 YKKFSL  164 (164)
Q Consensus       159 ~~~~Di  164 (164)
                      +.++|+
T Consensus       172 ~~~~D~  177 (215)
T cd00180         172 SEKSDI  177 (215)
T ss_pred             Cchhhh
Confidence            777775

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.86  E-value=4e-21  Score=137.37  Aligned_cols=129  Identities=19%  Similarity=0.179  Sum_probs=97.0

Q ss_pred             HHHHhccCCCceeeE-eEEeeCC----cEEEEEEecCCCChhhhhhCcccccccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 046065           29 VMLTAKLQHLNLIRV-GFCIETQ----EYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLT  103 (164)
Q Consensus        29 ~~~l~~l~h~~i~~~-~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~  103 (164)
                      ...+..++|+|++++ +......    ..++++|.+. .++.+.+....   ..+......++.|++.|+.|+|+.   +
T Consensus        74 ~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~---~~~~~~~~~i~~qi~~~l~~lH~~---~  146 (294)
T PHA02882         74 WKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIK---CKNKKLIKNIMKDMLTTLEYIHEH---G  146 (294)
T ss_pred             HHHhccCCCCCCCcEEEeeeEecCCceEEEEEEehhc-cCHHHHHHhhc---cCCHHHHHHHHHHHHHHHHHHHhC---C
Confidence            345566789999997 3322221    2346667653 35555554322   156777889999999999999998   9


Q ss_pred             eeeCCCCCCceeecCCCCeEEccccchhhhhhh---------hhhhhcccccccCcceecCCcceeccCC
Q 046065          104 IIHRDLKVSNILLDEDLKPKISDFGLARILRKM---------ILKQIQIELGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       104 iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~---------~~~~~~~~~~~~aPE~~~~~~~~~~~Di  164 (164)
                      ++||||||+|||++.++.++|+|||+++.+...         ......||+.|+|||+..+..++.++||
T Consensus       147 iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~Di  216 (294)
T PHA02882        147 ISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDL  216 (294)
T ss_pred             eecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHH
Confidence            999999999999999999999999998765311         1123468999999999999999999996

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.85  E-value=1.7e-21  Score=130.67  Aligned_cols=143  Identities=20%  Similarity=0.300  Sum_probs=114.4

Q ss_pred             cCCCcEEEEEEccccccccHHHHHHHHHHHhccC-CCceeeE-eEEee--CCcEEEEEEecCCCChhhhhhCcccccccC
Q 046065            3 LPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQ-HLNLIRV-GFCIE--TQEYMLIYEYMPKRSLDYFLFDPIRMLILD   78 (164)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~-~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~   78 (164)
                      +.+.+++.||.+..   -....+.+|+.+|..+. ||||+++ ....+  .....+++|++.+.+...+...      +.
T Consensus        60 ~~~~eK~ViKiLKP---VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~t------l~  130 (338)
T KOG0668|consen   60 ITNNEKCVIKILKP---VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYPT------LT  130 (338)
T ss_pred             cCCCceEEEeeech---HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhhh------hc
Confidence            45678899999853   33456899999999995 9999998 43333  2356799999988777665533      67


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCC-CCeEEccccchhhhhhhh-hhhhcccccccCcceecCC
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED-LKPKISDFGLARILRKMI-LKQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~-~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~aPE~~~~~  156 (164)
                      ...+..++.++++||.|+|++   +|.|||+||.|+|||+. ..++|+|.|+|.+..... ..-.+.|..|-.||.+..-
T Consensus       131 d~dIryY~~elLkALdyCHS~---GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy  207 (338)
T KOG0668|consen  131 DYDIRYYIYELLKALDYCHSM---GIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDY  207 (338)
T ss_pred             hhhHHHHHHHHHHHHhHHHhc---CcccccCCcceeeechhhceeeeeecchHhhcCCCceeeeeeehhhcCCchheeec
Confidence            778899999999999999999   99999999999999974 679999999998886543 3455667788999998544


Q ss_pred             c
Q 046065          157 V  157 (164)
Q Consensus       157 ~  157 (164)
                      +
T Consensus       208 ~  208 (338)
T KOG0668|consen  208 Q  208 (338)
T ss_pred             h
Confidence            3

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.85  E-value=1.7e-20  Score=141.82  Aligned_cols=150  Identities=21%  Similarity=0.255  Sum_probs=105.5

Q ss_pred             CCcEEEEEEccccccccHHH--------------HHHHHHHHhccCCCce-----eeE-eEEe--------eCCcEEEEE
Q 046065            5 DGQIIAVKKLSKKSTQGFEE--------------FKNEVMLTAKLQHLNL-----IRV-GFCI--------ETQEYMLIY   56 (164)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~--------------~~~e~~~l~~l~h~~i-----~~~-~~~~--------~~~~~~lv~   56 (164)
                      +++.||||.+........+.              ...|+..+..++|.++     +++ +++.        ..+..++|+
T Consensus       185 ~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~  264 (507)
T PLN03224        185 KKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVW  264 (507)
T ss_pred             cCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEE
Confidence            35689999986443222222              2346667777766554     332 3332        235689999


Q ss_pred             EecCCCChhhhhhCccc---------------------ccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcee
Q 046065           57 EYMPKRSLDYFLFDPIR---------------------MLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNIL  115 (164)
Q Consensus        57 e~~~~~~L~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nil  115 (164)
                      ||+++++|.+++.....                     ...+++..+..++.|++.++.|+|+.   +++|||+||+||+
T Consensus       265 Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~---~ivHrDLKp~NIL  341 (507)
T PLN03224        265 KFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRI---GIVHRDIKPENLL  341 (507)
T ss_pred             EcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCchHhEE
Confidence            99999999888864211                     01235567888999999999999998   9999999999999


Q ss_pred             ecCCCCeEEccccchhhhhhhhh-h--hhcccccccCcceecCCc
Q 046065          116 LDEDLKPKISDFGLARILRKMIL-K--QIQIELGYIPPEYVGRGV  157 (164)
Q Consensus       116 i~~~~~~~l~dfg~~~~~~~~~~-~--~~~~~~~~~aPE~~~~~~  157 (164)
                      ++.++.++|+|||++........ .  ...+++.|+|||.+....
T Consensus       342 l~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~  386 (507)
T PLN03224        342 VTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQ  386 (507)
T ss_pred             ECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCC
Confidence            99999999999999865432211 1  123478999999986544

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.84  E-value=2e-20  Score=125.75  Aligned_cols=122  Identities=18%  Similarity=0.118  Sum_probs=90.2

Q ss_pred             CCCcEEEEEEccccccc--c-------H-----------------HHHHHHHHHHhccCCCceeeEeEEeeCCcEEEEEE
Q 046065            4 PDGQIIAVKKLSKKSTQ--G-------F-----------------EEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYE   57 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~--~-------~-----------------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e   57 (164)
                      ++|+.||+|.+....+.  .       .                 .....|+..+..+.++++........ ...++|||
T Consensus        19 ~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~~p~~~~~-~~~~iVmE   97 (190)
T cd05147          19 ANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIPCPEPILL-KSHVLVME   97 (190)
T ss_pred             CCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCcEEEe-cCCEEEEE
Confidence            47999999998654211  1       0                 12234889999998777644322222 23379999


Q ss_pred             ecCCCChhhhhhCcccccccCHHHHHHHHHHHHHHHHHh-hhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhh
Q 046065           58 YMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYL-QEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARIL  133 (164)
Q Consensus        58 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l-h~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~  133 (164)
                      +++++++........   .++......++.|++.++.++ |+.   +++|+|+||+||+++ ++.++|+|||++...
T Consensus        98 ~i~g~~l~~~~~~~~---~~~~~~~~~i~~qi~~~L~~l~H~~---giiHrDlkP~NIli~-~~~v~LiDFG~a~~~  167 (190)
T cd05147          98 FIGDDGWAAPRLKDA---PLSESKARELYLQVIQIMRILYQDC---RLVHADLSEYNLLYH-DGKLYIIDVSQSVEH  167 (190)
T ss_pred             EeCCCCCcchhhhcC---CCCHHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEE-CCcEEEEEccccccC
Confidence            999877654432222   277888999999999999999 677   999999999999998 478999999999754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.84  E-value=1.1e-20  Score=134.19  Aligned_cols=152  Identities=18%  Similarity=0.211  Sum_probs=118.8

Q ss_pred             CcEEEEEEccccccccHHHHHHHHHHHhccC-C-Cc----eeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccC
Q 046065            6 GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQ-H-LN----LIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILD   78 (164)
Q Consensus         6 ~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h-~~----i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~   78 (164)
                      +..||+|++.. -....+..+.|+.++.++. + |+    ++.+ +++...+..++|+|.+ |.|+.+++.+... ..+|
T Consensus       114 ~~~vAlKIik~-V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y-~~fp  190 (415)
T KOG0671|consen  114 KEHVALKIIKN-VDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNY-IPFP  190 (415)
T ss_pred             CceehHHHHHH-HHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc-ChhHHHHhccCCc-cccc
Confidence            67899999853 3344556678999999993 2 22    3333 5566678899999987 5689999987432 3489


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCC--------------------CCeEEccccchhhhhhhhh
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED--------------------LKPKISDFGLARILRKMIL  138 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~--------------------~~~~l~dfg~~~~~~~~~~  138 (164)
                      ...+..++.|+++++.+||+.   +++|-|+||+||++.+.                    ..++++|||.|..-... -
T Consensus       191 i~~ir~m~~QL~~sv~fLh~~---kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~-h  266 (415)
T KOG0671|consen  191 IDHIRHMGYQLLESVAFLHDL---KLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH-H  266 (415)
T ss_pred             hHHHHHHHHHHHHHHHHHHhc---ceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccC-c
Confidence            999999999999999999998   99999999999998421                    23799999999764332 2


Q ss_pred             hhhcccccccCcceecCCcceeccCC
Q 046065          139 KQIQIELGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       139 ~~~~~~~~~~aPE~~~~~~~~~~~Di  164 (164)
                      ...+.|-.|+|||++.+--++.++||
T Consensus       267 s~iVsTRHYRAPEViLgLGwS~pCDv  292 (415)
T KOG0671|consen  267 STIVSTRHYRAPEVILGLGWSQPCDV  292 (415)
T ss_pred             ceeeeccccCCchheeccCcCCccCc
Confidence            45677889999999998889999986

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.83  E-value=1.1e-20  Score=139.29  Aligned_cols=154  Identities=21%  Similarity=0.246  Sum_probs=124.7

Q ss_pred             CcEEEEEEccccccccHHHHHHHHHHHhccCC------CceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccC
Q 046065            6 GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQH------LNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILD   78 (164)
Q Consensus         6 ~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h------~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~   78 (164)
                      |..||||++.+++.-. ..=+.|+++|++|..      -+++++ --+...+.+|+|||.+ .-+|...++.-+....+.
T Consensus       457 ~~~vAiKIIRnNE~M~-KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~  534 (752)
T KOG0670|consen  457 GQEVAIKIIRNNEVMH-KTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLH  534 (752)
T ss_pred             CCeeEEEEeecchHHh-hhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCccccee
Confidence            6689999997663221 223679999999942      356665 5566778899999987 458999998754444578


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCC-CCeEEccccchhhhhhhhhhhhcccccccCcceecCCc
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED-LKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGV  157 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  157 (164)
                      ......++.|+.-||..|-.+   +|+|.||||+|||+... ..+||+|||.|.....+..+....+-.|.|||++.+-.
T Consensus       535 ikaVRsYaqQLflALklLK~c---~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~eneitPYLVSRFYRaPEIiLG~~  611 (752)
T KOG0670|consen  535 IKAVRSYAQQLFLALKLLKKC---GVLHADIKPDNILVNESKNILKLCDFGSASFASENEITPYLVSRFYRAPEIILGLP  611 (752)
T ss_pred             ehHHHHHHHHHHHHHHHHHhc---CeeecccCccceEeccCcceeeeccCccccccccccccHHHHHHhccCcceeecCc
Confidence            888899999999999999988   99999999999999875 67899999999888776666677788899999999999


Q ss_pred             ceeccCC
Q 046065          158 YYKKFSL  164 (164)
Q Consensus       158 ~~~~~Di  164 (164)
                      |+...|+
T Consensus       612 yd~~iD~  618 (752)
T KOG0670|consen  612 YDYPIDT  618 (752)
T ss_pred             ccCCccc
Confidence            9887775

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.82  E-value=4.6e-21  Score=137.07  Aligned_cols=158  Identities=21%  Similarity=0.233  Sum_probs=131.0

Q ss_pred             CCCcEEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeE-e-EEeeCCcEEEEEEecCCCChhhhhhC-----ccccc
Q 046065            4 PDGQIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-G-FCIETQEYMLIYEYMPKRSLDYFLFD-----PIRML   75 (164)
Q Consensus         4 ~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~-~-~~~~~~~~~lv~e~~~~~~L~~~~~~-----~~~~~   75 (164)
                      .+.+.|.+|.+..+ ++-+...++.|...+..+.|||+.++ + ..++....++++.+..-|+|..|+..     .....
T Consensus       312 n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aq  391 (563)
T KOG1024|consen  312 NDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQ  391 (563)
T ss_pred             chHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCcccc
Confidence            34566777777655 45567788999999999999999997 4 44556678888899989999999983     33334


Q ss_pred             ccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh----hhhcccccccCcc
Q 046065           76 ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL----KQIQIELGYIPPE  151 (164)
Q Consensus        76 ~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~aPE  151 (164)
                      .+...+...++.|++.|+.++|..   +++|.||..+|++||..-.+||+|-.+++.+....+    ........||+||
T Consensus       392 tvtt~qlV~masQla~am~hlh~~---~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslE  468 (563)
T KOG1024|consen  392 TVTTIQLVLMASQLAMAMEHLHNH---GVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLE  468 (563)
T ss_pred             chhHHHHHHHHHHHHHHHHHHHhc---CcccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHH
Confidence            477889999999999999999999   999999999999999999999999999987765433    3455677899999


Q ss_pred             eecCCcceeccCC
Q 046065          152 YVGRGVYYKKFSL  164 (164)
Q Consensus       152 ~~~~~~~~~~~Di  164 (164)
                      .+.++.|+.++|+
T Consensus       469 al~n~~yssasDv  481 (563)
T KOG1024|consen  469 ALQNSHYSSASDV  481 (563)
T ss_pred             HHhhhhhcchhhh
Confidence            9999999999996

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.81  E-value=4.8e-19  Score=119.20  Aligned_cols=122  Identities=22%  Similarity=0.233  Sum_probs=91.8

Q ss_pred             CCCcEEEEEEccccccc--c------------------------HHHHHHHHHHHhccCCCceeeEeEEeeCCcEEEEEE
Q 046065            4 PDGQIIAVKKLSKKSTQ--G------------------------FEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYE   57 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~--~------------------------~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e   57 (164)
                      .+|+.||||.+....+.  .                        ...+..|.+.+..+.++++.....+... ..++|||
T Consensus        19 ~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~-~~~lVmE   97 (190)
T cd05145          19 GDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVPVPEPILLK-KNVLVME   97 (190)
T ss_pred             CCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCCCceEEEec-CCEEEEE
Confidence            47899999998754211  0                        1123578889999998887654322222 2479999


Q ss_pred             ecCCCChhhh-hhCcccccccCHHHHHHHHHHHHHHHHHhhh-cCCCCeeeCCCCCCceeecCCCCeEEccccchhhhh
Q 046065           58 YMPKRSLDYF-LFDPIRMLILDCKKRVHIIKGIIQGLLYLQE-YFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILR  134 (164)
Q Consensus        58 ~~~~~~L~~~-~~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~-~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~  134 (164)
                      +++++++... +..    ..++......++.|++.++.++|+ .   +++|+|+||+||+++ ++.++|+|||++....
T Consensus        98 ~~~g~~~~~~~l~~----~~~~~~~~~~i~~~l~~~l~~lH~~~---givHrDlkP~NIll~-~~~~~liDFG~a~~~~  168 (190)
T cd05145          98 FIGDDGSPAPRLKD----VPLEEEEAEELYEQVVEQMRRLYQEA---GLVHGDLSEYNILYH-DGKPYIIDVSQAVELD  168 (190)
T ss_pred             EecCCCchhhhhhh----ccCCHHHHHHHHHHHHHHHHHHHHhC---CEecCCCChhhEEEE-CCCEEEEEcccceecC
Confidence            9988755433 322    126677888999999999999998 7   999999999999998 8899999999997654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.81  E-value=1.4e-19  Score=139.26  Aligned_cols=104  Identities=29%  Similarity=0.339  Sum_probs=80.5

Q ss_pred             eeCCcEEEEEEecCCCChhhhhhCccccc-----------------ccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC
Q 046065           47 IETQEYMLIYEYMPKRSLDYFLFDPIRML-----------------ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDL  109 (164)
Q Consensus        47 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~-----------------~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dl  109 (164)
                      ......++|+||+++++|.+++.......                 ......+..++.|++.||.|+|+.   +|+||||
T Consensus       205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~---gIiHRDL  281 (566)
T PLN03225        205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHST---GIVHRDV  281 (566)
T ss_pred             ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHC---CEEeCcC
Confidence            34557899999999999988886432110                 011234567899999999999998   9999999


Q ss_pred             CCCceeecC-CCCeEEccccchhhhhhh---hhhhhcccccccCccee
Q 046065          110 KVSNILLDE-DLKPKISDFGLARILRKM---ILKQIQIELGYIPPEYV  153 (164)
Q Consensus       110 k~~nili~~-~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~~aPE~~  153 (164)
                      ||+|||++. .+.+||+|||++..+...   ......+++.|+|||.+
T Consensus       282 KP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~  329 (566)
T PLN03225        282 KPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQY  329 (566)
T ss_pred             CHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHh
Confidence            999999986 578999999999765322   22456789999999965

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.80  E-value=2.7e-20  Score=148.57  Aligned_cols=108  Identities=16%  Similarity=0.116  Sum_probs=83.7

Q ss_pred             cEEEEEEecCCCChhhhhhCcccccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecC------------
Q 046065           51 EYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE------------  118 (164)
Q Consensus        51 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~------------  118 (164)
                      .+++++|++ +++|.+++....  ..++...+..++.|++.||.|||++   +|+||||||+|||++.            
T Consensus        54 ~~~~~~e~~-~~~L~~~l~~~~--~~~~~~~~~~i~~qi~~al~~lH~~---gIvHrDlKP~NiLl~~~~~~k~~d~~~~  127 (793)
T PLN00181         54 SIVRALECE-DVSLRQWLDNPD--RSVDAFECFHVFRQIVEIVNAAHSQ---GIVVHNVRPSCFVMSSFNHVSFIESASC  127 (793)
T ss_pred             hhhhhhccC-CccHHHHHhccc--ccccHHHHHHHHHHHHHHHHHHHhC---CeeeccCCchhEEEcccCcEEEeecccc
Confidence            456778876 569999997532  2388999999999999999999988   9999999999999954            


Q ss_pred             -------CCCeEEccccchhhhhhh------------------hhhhhcccccccCcceecCCcceeccCC
Q 046065          119 -------DLKPKISDFGLARILRKM------------------ILKQIQIELGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       119 -------~~~~~l~dfg~~~~~~~~------------------~~~~~~~~~~~~aPE~~~~~~~~~~~Di  164 (164)
                             ++.+|++|||+++.....                  ......||++|||||++.+..|+.++||
T Consensus       128 ~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDV  198 (793)
T PLN00181        128 SDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDV  198 (793)
T ss_pred             CcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhh
Confidence                   445677777776532100                  0011357889999999999999999997

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.77  E-value=6.8e-19  Score=120.74  Aligned_cols=141  Identities=21%  Similarity=0.355  Sum_probs=104.2

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhcc-CCCceee-E-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKL-QHLNLIR-V-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~-~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      +++..+++|.+... .-....|.+|..---.+ .|.||+. + ..+...+.+.+++||+|.|+|.+-+...    .+.+.
T Consensus        47 ~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~~----GigE~  121 (378)
T KOG1345|consen   47 QSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEAA----GIGEA  121 (378)
T ss_pred             CCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCcc----cccHH
Confidence            34567888887533 22345677787755555 5889998 4 5555566677999999999998776542    27788


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecC--CCCeEEccccchhhhhhhhhhhhcccccccCccee
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE--DLKPKISDFGLARILRKMILKQIQIELGYIPPEYV  153 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~--~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~  153 (164)
                      ..+.++.|+++|+.|+|+.   +++|||||.+||||..  .-++||+|||........ ....-.+..|-+||.+
T Consensus       122 ~~K~v~~ql~SAi~fMHsk---nlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t-V~~~~~~~~y~~pe~~  192 (378)
T KOG1345|consen  122 NTKKVFAQLLSAIEFMHSK---NLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT-VKYLEYVNNYHAPELC  192 (378)
T ss_pred             HHHHHHHHHHHHHHHhhcc---chhhcccccceEEEecCCccEEEeeecccccccCce-ehhhhhhcccCCcHHH
Confidence            8899999999999999998   9999999999999954  347999999998653321 1112234457888877

>PRK10345 hypothetical protein; Provisional

Probab=99.77  E-value=1e-17  Score=113.93  Aligned_cols=114  Identities=22%  Similarity=0.311  Sum_probs=86.7

Q ss_pred             EEEEccccccccHHHHHHHHHHHhcc-----CCCceeeE-eEEeeCC---cEE-EEEEe--cCCCChhhhhhCccccccc
Q 046065           10 AVKKLSKKSTQGFEEFKNEVMLTAKL-----QHLNLIRV-GFCIETQ---EYM-LIYEY--MPKRSLDYFLFDPIRMLIL   77 (164)
Q Consensus        10 avK~~~~~~~~~~~~~~~e~~~l~~l-----~h~~i~~~-~~~~~~~---~~~-lv~e~--~~~~~L~~~~~~~~~~~~~   77 (164)
                      +||.+..........+.+|+..++.+     .||||+++ +.+..+.   ..+ +|+||  +++++|.+++.+..    +
T Consensus        28 ~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~~----~  103 (210)
T PRK10345         28 CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQCR----Y  103 (210)
T ss_pred             EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHccc----c
Confidence            68887655444556789999999999     57999998 6555542   323 78999  55899999997632    4


Q ss_pred             CHHHHHHHHHHHHHHH-HHhhhcCCCCeeeCCCCCCceeecCC----CCeEEcc-ccchhh
Q 046065           78 DCKKRVHIIKGIIQGL-LYLQEYFRLTIIHRDLKVSNILLDED----LKPKISD-FGLARI  132 (164)
Q Consensus        78 ~~~~~~~~~~~~~~~l-~~lh~~~~~~iih~dlk~~nili~~~----~~~~l~d-fg~~~~  132 (164)
                      ++.  ..++.+++.++ .|+|++   +|+||||||+||+++..    +.++|+| ||.+..
T Consensus       104 ~e~--~~~~~~~L~~l~~yLh~~---~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~~~~  159 (210)
T PRK10345        104 EED--VAQLRQLLKKLKRYLLDN---RIVTMELKPQNILCQRISESEVIPVVCDNIGESTF  159 (210)
T ss_pred             cHh--HHHHHHHHHHHHHHHHHC---CEeecCCCHHHEEEeccCCCCCcEEEEECCCCcce
Confidence            444  35567777776 999998   99999999999999743    3799999 666554

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.76  E-value=3.7e-18  Score=122.60  Aligned_cols=116  Identities=22%  Similarity=0.382  Sum_probs=98.5

Q ss_pred             CCcEEEEEEccccccccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            5 DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      ..+.||+|.+..-  ....++..|+++|..+ ++.||+.+ +....+++..+|+||+++....++...      ++...+
T Consensus        63 ~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~~------l~~~~i  134 (418)
T KOG1167|consen   63 KRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYRS------LSLAEI  134 (418)
T ss_pred             ccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCccCHHHHHhc------CCHHHH
Confidence            4578999988643  1235688999999999 58999998 555566788999999999888888765      778889


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCC-CCeEEccccchh
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED-LKPKISDFGLAR  131 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~-~~~~l~dfg~~~  131 (164)
                      ..+++.+..||.++|..   +|+|||+||.|++.+.. ++-.|+|||+|.
T Consensus       135 ~~Yl~~ll~Al~~~h~~---GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~  181 (418)
T KOG1167|consen  135 RWYLRNLLKALAHLHKN---GIVHRDIKPSNFLYNRRTQRGVLVDFGLAQ  181 (418)
T ss_pred             HHHHHHHHHHhhhhhcc---CccccCCCccccccccccCCceEEechhHH
Confidence            99999999999999988   99999999999999864 678899999987

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.73  E-value=3.2e-17  Score=112.23  Aligned_cols=114  Identities=16%  Similarity=0.258  Sum_probs=87.5

Q ss_pred             CCcEEEEEEcccccccc---HHH------HHHHHHHHhccCCCceeeE-eEEeeC--------CcEEEEEEecCCCChhh
Q 046065            5 DGQIIAVKKLSKKSTQG---FEE------FKNEVMLTAKLQHLNLIRV-GFCIET--------QEYMLIYEYMPKRSLDY   66 (164)
Q Consensus         5 ~~~~vavK~~~~~~~~~---~~~------~~~e~~~l~~l~h~~i~~~-~~~~~~--------~~~~lv~e~~~~~~L~~   66 (164)
                      ++..+|+|.+....+..   .++      +.+|+..+..+.|+++..+ ......        +..+++|||++|.+|.+
T Consensus        53 ~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~  132 (232)
T PRK10359         53 DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELND  132 (232)
T ss_pred             CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHH
Confidence            35679999987553222   222      5688899999999999997 332321        34789999999999977


Q ss_pred             hhhCcccccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhh
Q 046065           67 FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARIL  133 (164)
Q Consensus        67 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~  133 (164)
                      +..       ++.    ....+++.++..+|..   +++|+|++|.|++++.++ ++++|||.....
T Consensus       133 ~~~-------~~~----~~~~~i~~~l~~lH~~---gi~H~Dikp~Nili~~~g-i~liDfg~~~~~  184 (232)
T PRK10359        133 MPE-------ISE----DVKAKIKASIESLHQH---GMVSGDPHKGNFIVSKNG-LRIIDLSGKRCT  184 (232)
T ss_pred             hhh-------ccH----HHHHHHHHHHHHHHHc---CCccCCCChHHEEEeCCC-EEEEECCCcccc
Confidence            632       222    2456889999999998   999999999999999888 999999987654

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.72  E-value=2.9e-17  Score=111.19  Aligned_cols=153  Identities=20%  Similarity=0.226  Sum_probs=112.3

Q ss_pred             cCCCcEEEEEEccccccccHHHHHHHHHHHhccC-CCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            3 LPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQ-HLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      +.+|++||+|.-+.+..  ...+.-|..+.+.++ ...|..+ .+..+..--.+||+.+ +++|.+++.-+...  ++..
T Consensus        37 i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLfnfC~R~--ftmk  111 (341)
T KOG1163|consen   37 ITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSLEDLFNFCSRR--FTMK  111 (341)
T ss_pred             ccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-CccHHHHHHHHhhh--hhHH
Confidence            46799999998654422  234678999999996 4677777 3334444556899976 78998887654332  7778


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecC---CCCeEEccccchhhhhhhh---------hhhhccccccc
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE---DLKPKISDFGLARILRKMI---------LKQIQIELGYI  148 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~---~~~~~l~dfg~~~~~~~~~---------~~~~~~~~~~~  148 (164)
                      ..+-++.|++.-++|+|.+   +.+||||||+|+|..-   ..++.++|||+++.+.+..         ...+.||..|.
T Consensus       112 TvLMLaDQml~RiEyvH~r---~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYA  188 (341)
T KOG1163|consen  112 TVLMLADQMLSRIEYVHLR---NFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYA  188 (341)
T ss_pred             hHHHHHHHHHHHHHHHHhh---ccccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeeh
Confidence            8888999999999999999   9999999999999964   3568999999998764321         14567787786


Q ss_pred             CcceecCCcceeccC
Q 046065          149 PPEYVGRGVYYKKFS  163 (164)
Q Consensus       149 aPE~~~~~~~~~~~D  163 (164)
                      +=-...+.+.+.+.|
T Consensus       189 SinAh~g~eqSRRDD  203 (341)
T KOG1163|consen  189 SINAHLGIEQSRRDD  203 (341)
T ss_pred             hhhhhhhhhhhhhhh
Confidence            655554444455544

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.72  E-value=1.2e-16  Score=114.24  Aligned_cols=155  Identities=32%  Similarity=0.440  Sum_probs=122.4

Q ss_pred             cEEEEEEccccccc---cHHHHHHHHHHHhccCCC-ceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            7 QIIAVKKLSKKSTQ---GFEEFKNEVMLTAKLQHL-NLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         7 ~~vavK~~~~~~~~---~~~~~~~e~~~l~~l~h~-~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      +.+++|.+......   ....+.+|+.++..+.|+ +++++ .........+++++++.++++.+++........+....
T Consensus        23 ~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~  102 (384)
T COG0515          23 KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESE  102 (384)
T ss_pred             cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHH
Confidence            45788888765322   367788999999999887 79997 44444445789999999999996665432112378889


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCC-CeEEccccchhhhhhh--------hhhhhcccccccCcce
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL-KPKISDFGLARILRKM--------ILKQIQIELGYIPPEY  152 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~-~~~l~dfg~~~~~~~~--------~~~~~~~~~~~~aPE~  152 (164)
                      ...+..|++.++.++|..   +++|||+||+|++++..+ .+++.|||.+......        ......++..|+|||.
T Consensus       103 ~~~~~~~~~~~l~~~H~~---~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~  179 (384)
T COG0515         103 ALFILAQILSALEYLHSK---GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEV  179 (384)
T ss_pred             HHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHH
Confidence            999999999999999998   899999999999999988 7999999998755432        2356789999999999


Q ss_pred             ecC---CcceeccCC
Q 046065          153 VGR---GVYYKKFSL  164 (164)
Q Consensus       153 ~~~---~~~~~~~Di  164 (164)
                      ..+   ..++...|+
T Consensus       180 ~~~~~~~~~~~~~D~  194 (384)
T COG0515         180 LLGLSLAYASSSSDI  194 (384)
T ss_pred             hcCCCCCCCCchHhH
Confidence            976   466766664

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.72  E-value=4.5e-17  Score=114.66  Aligned_cols=154  Identities=21%  Similarity=0.216  Sum_probs=119.2

Q ss_pred             cCCCcEEEEEEccccccccHHHHHHHHHHHhccC-CCceeeEeEEeeCCc-EEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            3 LPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQ-HLNLIRVGFCIETQE-YMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      +-+++.||||+-...+.  ...+..|.+.++.|. .++|..+-++...+. -.+|+|++ |+||.+++.-+.+.  ++..
T Consensus        50 l~nne~VAIKfEPrkS~--APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLFD~CgR~--FSvK  124 (449)
T KOG1165|consen   50 LYNNEPVAIKFEPRKSE--APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPSLEDLFDLCGRR--FSVK  124 (449)
T ss_pred             cccCceEEEEeccccCC--cchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcCHHHHHHHhcCc--ccHH
Confidence            34678999999654322  234678899888884 688888766655544 34888876 78998888765443  7888


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCC-----CeEEccccchhhhhhhh---------hhhhccccc
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL-----KPKISDFGLARILRKMI---------LKQIQIELG  146 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~-----~~~l~dfg~~~~~~~~~---------~~~~~~~~~  146 (164)
                      ...-++.||+.-++++|++   .+|.|||||+|+||.+.+     .+.++|||+|+.+.+..         -.++.||..
T Consensus       125 TV~miA~Qmi~rie~vH~k---~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTAR  201 (449)
T KOG1165|consen  125 TVAMIAKQMITRIEYVHEK---DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTAR  201 (449)
T ss_pred             hHHHHHHHHHHHHHHHHhc---ceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCcccccccccccee
Confidence            8999999999999999998   999999999999998643     48899999998775321         146789999


Q ss_pred             ccCcceecCCcceeccCC
Q 046065          147 YIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       147 ~~aPE~~~~~~~~~~~Di  164 (164)
                      ||+=-...+++.+.+.|+
T Consensus       202 YMSINTHlGrEQSRRDDL  219 (449)
T KOG1165|consen  202 YMSINTHLGREQSRRDDL  219 (449)
T ss_pred             eeEeeccccchhhhhhhH
Confidence            999877777777777764

>smart00090 RIO RIO-like kinase

Probab=99.70  E-value=2.5e-16  Score=109.27  Aligned_cols=124  Identities=18%  Similarity=0.104  Sum_probs=89.3

Q ss_pred             cCCCcEEEEEEccccccc------------------------cHHHHHHHHHHHhccCCCceeeEeEEeeCCcEEEEEEe
Q 046065            3 LPDGQIIAVKKLSKKSTQ------------------------GFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEY   58 (164)
Q Consensus         3 ~~~~~~vavK~~~~~~~~------------------------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~   58 (164)
                      ..+|+.||+|.+......                        ....+..|+..+..+.+..+.....+.. ...++|||+
T Consensus        51 ~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~i~~p~~~~~-~~~~lV~E~  129 (237)
T smart00090       51 DGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAGVPVPKPIAW-RRNVLVMEF  129 (237)
T ss_pred             CCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCeeeEe-cCceEEEEE
Confidence            457899999998643210                        0123457999999997533322222222 345799999


Q ss_pred             cCCCChhhhhhCcccccccCHHHHHHHHHHHHHHHHHhhhcCCCC-eeeCCCCCCceeecCCCCeEEccccchhhhh
Q 046065           59 MPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLT-IIHRDLKVSNILLDEDLKPKISDFGLARILR  134 (164)
Q Consensus        59 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~-iih~dlk~~nili~~~~~~~l~dfg~~~~~~  134 (164)
                      +++.++........   .........++.|++.++.++|+.   + ++|+|+||+||+++ .+.++++|||.+....
T Consensus       130 ~~g~~L~~~~~~~~---~~~~~~~~~i~~qi~~~l~~LH~~---g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      130 IGGDGLPAPRLKDV---EPEEEEEFELYDDILEEMRKLYKE---GELVHGDLSEYNILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             ecCCcccccccccC---CcchHHHHHHHHHHHHHHHHHHhc---CCEEeCCCChhhEEEE-CCCEEEEEChhhhccC
Confidence            99988765542211   144555678899999999999998   8 99999999999999 8889999999987543

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.69  E-value=4.6e-16  Score=104.80  Aligned_cols=112  Identities=20%  Similarity=0.147  Sum_probs=83.4

Q ss_pred             CCcEEEEEEccccccccHH-----HHHHHHHHHhccC-CCceeeEeEEeeCCcEEEEEEecCCCChhhhhhCcccccccC
Q 046065            5 DGQIIAVKKLSKKSTQGFE-----EFKNEVMLTAKLQ-HLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILD   78 (164)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~-----~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~   78 (164)
                      ++.+++.+.+... +.+.+     .+.+|+++|+.++ +++++++..+   +..+++|||+.+.+|.+....        
T Consensus        24 ~~~k~~~~~l~~~-~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~---~~~~lvmeyI~G~~L~~~~~~--------   91 (218)
T PRK12274         24 GERKFVRRDLSAA-PWWLRGVAWWLARREALALRQLDGLPRTPRLLHW---DGRHLDRSYLAGAAMYQRPPR--------   91 (218)
T ss_pred             CCceeeecccccc-hhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE---cCEEEEEeeecCccHHhhhhh--------
Confidence            3455555555322 22222     5678999999995 5778877333   456899999999888654311        


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCC-CCCceeecCCCCeEEccccchhhh
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDL-KVSNILLDEDLKPKISDFGLARIL  133 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dl-k~~nili~~~~~~~l~dfg~~~~~  133 (164)
                        ....++.|++.++.++|++   +|+|+|| ||.||+++.++.++|+|||++...
T Consensus        92 --~~~~~~~qi~~~L~~lH~~---GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~  142 (218)
T PRK12274         92 --GDLAYFRAARRLLQQLHRC---GVAHNDLAKEANWLVQEDGSPAVIDFQLAVRG  142 (218)
T ss_pred             --hhHHHHHHHHHHHHHHHHC---cCccCCCCCcceEEEcCCCCEEEEECCCceec
Confidence              1134678999999999998   9999999 799999999999999999999743

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.69  E-value=5.4e-16  Score=105.86  Aligned_cols=118  Identities=20%  Similarity=0.279  Sum_probs=93.2

Q ss_pred             CCcEEEEEEccccccc--------cHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccccc
Q 046065            5 DGQIIAVKKLSKKSTQ--------GFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRML   75 (164)
Q Consensus         5 ~~~~vavK~~~~~~~~--------~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~   75 (164)
                      +|..+++|........        ....+..|+..+..+.|+++..+ ..+......+++||++++++|.+++...    
T Consensus        18 ~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~----   93 (211)
T PRK14879         18 LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSN----   93 (211)
T ss_pred             CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhc----
Confidence            5677889975432111        12356789999999999888775 5555666788999999999998887542    


Q ss_pred             ccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhh
Q 046065           76 ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARIL  133 (164)
Q Consensus        76 ~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~  133 (164)
                        .. ....++.+++.++.++|+.   +++|+|++|.||+++ ++.++++|||.+...
T Consensus        94 --~~-~~~~i~~~i~~~l~~lH~~---~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~  144 (211)
T PRK14879         94 --GM-EELELSREIGRLVGKLHSA---GIIHGDLTTSNMILS-GGKIYLIDFGLAEFS  144 (211)
T ss_pred             --cH-HHHHHHHHHHHHHHHHHhC---CcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence              12 6678889999999999998   999999999999999 788999999988643

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.67  E-value=3.6e-17  Score=126.21  Aligned_cols=130  Identities=28%  Similarity=0.395  Sum_probs=107.2

Q ss_pred             HHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 046065           25 FKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLT  103 (164)
Q Consensus        25 ~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~  103 (164)
                      +..|..+-..+.|||++.. ..+.+.....-.||||++ +|..++.....   +....+-.++.|++.|+.|+|++   +
T Consensus       368 i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~~~---~~~~e~~c~fKqL~~Gv~y~h~~---G  440 (601)
T KOG0590|consen  368 ITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSNGK---LTPLEADCFFKQLLRGVKYLHSM---G  440 (601)
T ss_pred             hhhheeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhcccc---cchhhhhHHHHHHHHHHHHHHhc---C
Confidence            5567777888899998874 555555554445999999 99888876422   77778888999999999999999   9


Q ss_pred             eeeCCCCCCceeecCCCCeEEccccchhhhh----h--hhhhhhcccccccCcceecCCcceec
Q 046065          104 IIHRDLKVSNILLDEDLKPKISDFGLARILR----K--MILKQIQIELGYIPPEYVGRGVYYKK  161 (164)
Q Consensus       104 iih~dlk~~nili~~~~~~~l~dfg~~~~~~----~--~~~~~~~~~~~~~aPE~~~~~~~~~~  161 (164)
                      +-|||+|++|+++..+|.+|++|||.+..+.    .  ......+|+..|+|||++.+++|++.
T Consensus       441 iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr  504 (601)
T KOG0590|consen  441 LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPR  504 (601)
T ss_pred             ceeccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcc
Confidence            9999999999999999999999999987653    1  23367889999999999999999764

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.66  E-value=9.4e-16  Score=103.81  Aligned_cols=115  Identities=23%  Similarity=0.304  Sum_probs=88.8

Q ss_pred             CCcEEEEEEccccc---cc-----cHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccccc
Q 046065            5 DGQIIAVKKLSKKS---TQ-----GFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRML   75 (164)
Q Consensus         5 ~~~~vavK~~~~~~---~~-----~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~   75 (164)
                      ++..+++|......   +.     ...++..|+.++..+.++++... .........+++||++++++|...+....   
T Consensus        16 ~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~~---   92 (199)
T TIGR03724        16 LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEGN---   92 (199)
T ss_pred             CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhhcH---
Confidence            56789999854321   11     12456789999999988776554 44445566789999999999988764321   


Q ss_pred             ccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhh
Q 046065           76 ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARIL  133 (164)
Q Consensus        76 ~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~  133 (164)
                          .   .++.+++.++.++|+.   +++|+|++|.|++++ ++.++++|||.+...
T Consensus        93 ----~---~~~~~i~~~l~~lH~~---gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        93 ----D---ELLREIGRLVGKLHKA---GIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             ----H---HHHHHHHHHHHHHHHC---CeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence                0   6788999999999998   999999999999999 889999999988654

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.66  E-value=5.8e-16  Score=112.20  Aligned_cols=153  Identities=18%  Similarity=0.093  Sum_probs=113.6

Q ss_pred             cEEEEEEccccccccHHHHHHHHHHHhccCC----CceeeEeEEe--eCCcEEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            7 QIIAVKKLSKKSTQGFEEFKNEVMLTAKLQH----LNLIRVGFCI--ETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         7 ~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h----~~i~~~~~~~--~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      +.+|+|............+..|..++..+..    +++..+....  .....++||+.+ |.+|.++..... ...++..
T Consensus        45 ~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~-~~~fs~~  122 (322)
T KOG1164|consen   45 KEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNP-PGRFSRK  122 (322)
T ss_pred             eeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEecc-CccHHHHHHhCC-CCCcCHh
Confidence            4688887654422222267788888888862    4566653333  344567888866 789998875433 2348889


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCC-----CCeEEccccchhhhh---hh----h-----hhhhcc
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED-----LKPKISDFGLARILR---KM----I-----LKQIQI  143 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~-----~~~~l~dfg~~~~~~---~~----~-----~~~~~~  143 (164)
                      ....++.|++.+|.++|+.   +++|||+||.|+++...     ..+.+.|||+++.+.   ..    .     .....|
T Consensus       123 T~l~ia~q~l~~l~~lH~~---G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rG  199 (322)
T KOG1164|consen  123 TVLRIAIQNLNALEDLHSK---GFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRG  199 (322)
T ss_pred             HHHHHHHHHHHHHHHHHhc---CcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCC
Confidence            9999999999999999998   99999999999999864     458999999998322   11    1     123459


Q ss_pred             cccccCcceecCCcceeccCC
Q 046065          144 ELGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       144 ~~~~~aPE~~~~~~~~~~~Di  164 (164)
                      |..|.++.+..+...+.+.|+
T Consensus       200 T~ry~S~~~H~~~e~~r~DDl  220 (322)
T KOG1164|consen  200 TLRYASINVHLGIEQGRRDDL  220 (322)
T ss_pred             ccccccHHHhCCCccCCchhh
Confidence            999999999998898988885

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.62  E-value=4.1e-15  Score=114.41  Aligned_cols=96  Identities=21%  Similarity=0.330  Sum_probs=82.3

Q ss_pred             HHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHHHHHHHHHHHHHHhhhcCC
Q 046065           23 EEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFR  101 (164)
Q Consensus        23 ~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~  101 (164)
                      .++..|+.+++.++|+++..+ .........++||||+++++|.+++.           ....++.+++.++.++|+.  
T Consensus       381 ~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~--  447 (535)
T PRK09605        381 ERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKA--  447 (535)
T ss_pred             HHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhC--
Confidence            467889999999999998876 55555567789999999999988764           2356889999999999998  


Q ss_pred             CCeeeCCCCCCceeecCCCCeEEccccchhhh
Q 046065          102 LTIIHRDLKVSNILLDEDLKPKISDFGLARIL  133 (164)
Q Consensus       102 ~~iih~dlk~~nili~~~~~~~l~dfg~~~~~  133 (164)
                       +++|+|+||+||++ .++.++|+|||++...
T Consensus       448 -giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        448 -GIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             -CCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence             99999999999999 5778999999998754

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.60  E-value=6.9e-15  Score=99.62  Aligned_cols=119  Identities=21%  Similarity=0.162  Sum_probs=85.8

Q ss_pred             cCCCcEEEEEEccccccc----------------------cHHHHHHHHHHHhccCCCceeeEeEEeeCCcEEEEEEecC
Q 046065            3 LPDGQIIAVKKLSKKSTQ----------------------GFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMP   60 (164)
Q Consensus         3 ~~~~~~vavK~~~~~~~~----------------------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~   60 (164)
                      .++|+.||||.+....+.                      .......|...+..+.++++.-.... .....+++||+++
T Consensus        36 ~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v~~~~-~~~~~~lv~e~~~  114 (198)
T cd05144          36 DPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPVPKPI-DWNRHAVVMEYID  114 (198)
T ss_pred             cCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCCCcee-ecCCceEEEEEeC
Confidence            357899999986543210                      01124568888888877643211111 2245589999999


Q ss_pred             CCChhhhhhCcccccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhh
Q 046065           61 KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILR  134 (164)
Q Consensus        61 ~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~  134 (164)
                      +++|......         .....++.+++.++.++|+.   +++|+|++|.||+++.++.++|+|||.+....
T Consensus       115 g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~---gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         115 GVELYRVRVL---------EDPEEVLDEILEEIVKAYKH---GIIHGDLSEFNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             Ccchhhcccc---------ccHHHHHHHHHHHHHHHHHC---CCCcCCCCcccEEEcCCCcEEEEECCccccCC
Confidence            9888765321         23456778999999999998   99999999999999999999999999985543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.60  E-value=1.5e-15  Score=100.74  Aligned_cols=87  Identities=22%  Similarity=0.144  Sum_probs=72.9

Q ss_pred             CChhhhhhCcccccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhh
Q 046065           62 RSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQI  141 (164)
Q Consensus        62 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~  141 (164)
                      |+|.+++....  ..+++..++.++.|++.||.|+|+.   +      ||+||+++.++.+++  ||++......   ..
T Consensus         1 GsL~~~l~~~~--~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~~~~~---~~   64 (176)
T smart00750        1 VSLADILEVRG--RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAFKTPE---QS   64 (176)
T ss_pred             CcHHHHHHHhC--CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEeeccc---cC
Confidence            57888886422  2389999999999999999999987   4      999999999999998  9988654432   23


Q ss_pred             cccccccCcceecCCcceeccCC
Q 046065          142 QIELGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       142 ~~~~~~~aPE~~~~~~~~~~~Di  164 (164)
                      .|++.|+|||++.+..++.++||
T Consensus        65 ~g~~~y~aPE~~~~~~~~~~~Di   87 (176)
T smart00750       65 RVDPYFMAPEVIQGQSYTEKADI   87 (176)
T ss_pred             CCcccccChHHhcCCCCcchhhH
Confidence            67899999999999999999996

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.58  E-value=2.9e-14  Score=99.15  Aligned_cols=118  Identities=22%  Similarity=0.180  Sum_probs=85.4

Q ss_pred             CcEEEEEEccccc-------------cccHHHHHHHHHHHhccCCCce--eeE-eEEeeC-C---cEEEEEEecCC-CCh
Q 046065            6 GQIIAVKKLSKKS-------------TQGFEEFKNEVMLTAKLQHLNL--IRV-GFCIET-Q---EYMLIYEYMPK-RSL   64 (164)
Q Consensus         6 ~~~vavK~~~~~~-------------~~~~~~~~~e~~~l~~l~h~~i--~~~-~~~~~~-~---~~~lv~e~~~~-~~L   64 (164)
                      +..+++|......             ......+.+|+.++..+.|+++  +.+ ...... .   ..++|+|++++ .+|
T Consensus        55 ~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L  134 (239)
T PRK01723         55 GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDL  134 (239)
T ss_pred             CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCH
Confidence            5677888764210             1123457889999999988775  443 332222 2   23599999987 688


Q ss_pred             hhhhhCcccccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhh
Q 046065           65 DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILR  134 (164)
Q Consensus        65 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~  134 (164)
                      .+++....    ++..    .+.+++.++.++|+.   +|+|+|+||.|||++.++.++|+|||.++...
T Consensus       135 ~~~l~~~~----l~~~----~~~~i~~~l~~lH~~---GI~HrDlkp~NILv~~~~~v~LIDfg~~~~~~  193 (239)
T PRK01723        135 VALLQEAP----LSEE----QWQAIGQLIARFHDA---GVYHADLNAHNILLDPDGKFWLIDFDRGELRT  193 (239)
T ss_pred             HHHHhcCC----CCHH----HHHHHHHHHHHHHHC---CCCCCCCCchhEEEcCCCCEEEEECCCcccCC
Confidence            87775421    3332    356899999999998   99999999999999988899999999886543

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.57  E-value=6e-14  Score=90.37  Aligned_cols=115  Identities=21%  Similarity=0.210  Sum_probs=89.4

Q ss_pred             CcEEEEEEccccccccHHHHHHHHHHHhccCC--CceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            6 GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQH--LNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         6 ~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h--~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      ++.+++|.......  ...+..|+..++.+++  ..++++ ......+..++++|+++++.+...          +....
T Consensus        21 ~~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~----------~~~~~   88 (155)
T cd05120          21 DEDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV----------SEEEK   88 (155)
T ss_pred             CCeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC----------CHHHH
Confidence            35788888754422  4567889999999976  477776 444445678899999988766543          34455


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhh
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARI  132 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~  132 (164)
                      ..+..+++.++..+|..+..+++|+|++|.|++++..+.++++|||.+..
T Consensus        89 ~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          89 EDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             HHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            67788999999999987445799999999999999989999999999864

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.57  E-value=7.7e-16  Score=106.22  Aligned_cols=148  Identities=23%  Similarity=0.349  Sum_probs=114.6

Q ss_pred             CcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            6 GQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         6 ~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      |..+.+|++..+  .+...+.|.+|.-.++.+.||||+.+ +.|.....+.++..|++.|+|...+.+..+.. .+..++
T Consensus       213 gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vv-vd~sqa  291 (448)
T KOG0195|consen  213 GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVV-VDHSQA  291 (448)
T ss_pred             CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEE-EecchH
Confidence            445666777655  34556778899999999999999997 99999999999999999999999998755432 777889


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCcceecCCcc
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVY  158 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~  158 (164)
                      .+++.++++++.|||+. +.-|..--+....++||.+.+.+|+ ++-++  .+.+..+..-+|+||+||.+.++.-
T Consensus       292 v~faldiargmaflhsl-ep~ipr~~lns~hvmidedltaris-mad~k--fsfqe~gr~y~pawmspealqrkpe  363 (448)
T KOG0195|consen  292 VRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARIS-MADTK--FSFQEVGRAYSPAWMSPEALQRKPE  363 (448)
T ss_pred             HHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhhee-cccce--eeeeccccccCcccCCHHHHhcCch
Confidence            99999999999999998 5556666788899999998776654 22221  1222334455889999999976643

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.47  E-value=2e-14  Score=108.26  Aligned_cols=142  Identities=23%  Similarity=0.288  Sum_probs=112.9

Q ss_pred             CCcEEEEEEcccc--ccccHHHHHHHHHHHhccC-CCceeeEeEEee-CCcEEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            5 DGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQ-HLNLIRVGFCIE-TQEYMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         5 ~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      .|..+|+|.+.+.  ..........|-.++..++ ||.++++.+..+ ....++++++..+|.+...+.+...   +.+.
T Consensus        21 a~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~~---f~~~   97 (612)
T KOG0603|consen   21 AGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEVM---FDEL   97 (612)
T ss_pred             ccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhccccCCc---hHHH
Confidence            3567888887654  2222224566888899996 999999966654 5678899999999888766654333   6667


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCcceec
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVG  154 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~  154 (164)
                      ....+..+++-+++.+|..   +++++|+|++||+++.+|.+++.|||+++..-.....  ||+..|||||++.
T Consensus        98 ~~~~~~aelaLald~lh~l---~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~--cgt~eymApEI~~  166 (612)
T KOG0603|consen   98 DVAFYLAELALALDHLHKL---GIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA--CGTYEYRAPEIIN  166 (612)
T ss_pred             HHHHHHHHHHHHHhhcchh---HHHHhcccccceeecccCccccCCchhhhHhHhhhhc--ccchhhhhhHhhh
Confidence            7777888899999999988   9999999999999999999999999999876544333  9999999999986

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.47  E-value=4.6e-13  Score=89.75  Aligned_cols=75  Identities=25%  Similarity=0.241  Sum_probs=58.1

Q ss_pred             cEEEEEEecCCCChhh-hhhCcccccccCHHHHHHHHHHHHHHHHHhhh-cCCCCeeeCCCCCCceeecCCCCeEEcccc
Q 046065           51 EYMLIYEYMPKRSLDY-FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQE-YFRLTIIHRDLKVSNILLDEDLKPKISDFG  128 (164)
Q Consensus        51 ~~~lv~e~~~~~~L~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~-~~~~~iih~dlk~~nili~~~~~~~l~dfg  128 (164)
                      ..+++||+++++.+.. .+....    .. .....++.+++.++.++|. .   +++|+|++|+||+++ ++.++++|||
T Consensus        89 ~~~lv~e~~~g~~~~~~~l~~~~----~~-~~~~~~~~~~~~~l~~lh~~~---~ivH~Dl~p~Nili~-~~~~~liDfg  159 (187)
T cd05119          89 RHVLVMEFIGGDGIPAPRLKDVR----LL-EDPEELYDQILELMRKLYREA---GLVHGDLSEYNILVD-DGKVYIIDVP  159 (187)
T ss_pred             CCEEEEEEeCCCCccChhhhhhh----hc-ccHHHHHHHHHHHHHHHhhcc---CcCcCCCChhhEEEE-CCcEEEEECc
Confidence            4689999999855422 111110    11 4567888999999999998 7   999999999999999 8899999999


Q ss_pred             chhhhh
Q 046065          129 LARILR  134 (164)
Q Consensus       129 ~~~~~~  134 (164)
                      .+....
T Consensus       160 ~a~~~~  165 (187)
T cd05119         160 QAVEID  165 (187)
T ss_pred             cccccc
Confidence            996543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.46  E-value=1.2e-13  Score=110.14  Aligned_cols=151  Identities=17%  Similarity=0.175  Sum_probs=106.6

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccC---CCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQ---HLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+|+.||+|+-....+ | + |..=.+++.+|+   -+.|+.+ ......+...+|+||.+.|+|.+++...   ...++
T Consensus       720 ~~~~~~alK~e~P~~~-W-E-fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N~~---~~m~e  793 (974)
T KOG1166|consen  720 SNGKLVALKVEKPPNP-W-E-FYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEYSPYGTLLDLINTN---KVMDE  793 (974)
T ss_pred             CCCcEEEEEeecCCCc-e-e-eeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeeccccccHHHhhccC---CCCCc
Confidence            3588999998532211 1 1 111122233333   2334444 2233345567999999999999998733   33888


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCC-------CCeEEccccchhhh---hhh-hhhhhccccccc
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED-------LKPKISDFGLARIL---RKM-ILKQIQIELGYI  148 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~-------~~~~l~dfg~~~~~---~~~-~~~~~~~~~~~~  148 (164)
                      .....+..||+..++.+|.+   +|||+||||+|+|+-..       .-++|+|||.+-..   .+. .....++|-.+-
T Consensus       794 ~lv~~~~~qml~ive~lH~~---~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~  870 (974)
T KOG1166|consen  794 YLVMFFSCQMLRIVEHLHAM---GIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFD  870 (974)
T ss_pred             hhhhHHHHHHHHHHHHHHhc---ceecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccch
Confidence            89999999999999999999   99999999999999532       34899999988433   333 346677888899


Q ss_pred             CcceecCCcceeccC
Q 046065          149 PPEYVGRGVYYKKFS  163 (164)
Q Consensus       149 aPE~~~~~~~~~~~D  163 (164)
                      .+|+..++.++=..|
T Consensus       871 C~EM~~grpWtYq~D  885 (974)
T KOG1166|consen  871 CIEMREGRPWTYQID  885 (974)
T ss_pred             hHHHhcCCCCchhhh
Confidence            999998888876666

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.41  E-value=1.9e-12  Score=95.43  Aligned_cols=110  Identities=21%  Similarity=0.258  Sum_probs=83.5

Q ss_pred             CCcEEEEEEccccccccHHHHHHHHHHHhccC-----CC---ceeeE-eEEee-C---CcEEEEEEecCCCChhhhhhCc
Q 046065            5 DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQ-----HL---NLIRV-GFCIE-T---QEYMLIYEYMPKRSLDYFLFDP   71 (164)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~---~i~~~-~~~~~-~---~~~~lv~e~~~~~~L~~~~~~~   71 (164)
                      +.+-||+|+++ ......+..+.|+.+|+.+.     |+   .|+++ +.+.. +   ...++|+|++ |-+|..++...
T Consensus       102 ~~r~VAlKVvK-SAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s  179 (590)
T KOG1290|consen  102 NKRYVALKVVK-SAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYS  179 (590)
T ss_pred             CCeEEEEEEEe-hhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHh
Confidence            34679999974 44555677889999999983     32   56665 33332 2   2478999988 55887777654


Q ss_pred             ccccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCC
Q 046065           72 IRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED  119 (164)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~  119 (164)
                      ... .+|....++++.|++.||.|||..+  +|||-||||+|||+...
T Consensus       180 ~Yr-Glpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~  224 (590)
T KOG1290|consen  180 NYR-GLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCST  224 (590)
T ss_pred             CCC-CCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeecc
Confidence            322 2899999999999999999999964  99999999999998644

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.40  E-value=2.8e-14  Score=105.61  Aligned_cols=107  Identities=29%  Similarity=0.330  Sum_probs=90.5

Q ss_pred             EEEEEEecCCCChhhhhhCcccccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchh
Q 046065           52 YMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLAR  131 (164)
Q Consensus        52 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~  131 (164)
                      +|+.|++|...+|.+|+.........+....+.++.|++.++.|   +   +.+|+|+||.||....+..++|.|||+..
T Consensus       331 lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k---~~ihrdlkp~nif~~~d~q~kIgDFgl~t  404 (516)
T KOG1033|consen  331 LYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---K---GLIHRDLKPSNIFFSDDDQLKIGDFGLVT  404 (516)
T ss_pred             hhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---c---cchhhhccccccccccchhhhhhhhhhee
Confidence            57899999999999999765544446777888999999999999   4   99999999999999888899999999875


Q ss_pred             hhhh-h-------hhhhhcccccccCcceecCCcceeccCC
Q 046065          132 ILRK-M-------ILKQIQIELGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       132 ~~~~-~-------~~~~~~~~~~~~aPE~~~~~~~~~~~Di  164 (164)
                      .... .       ......||.+||+||.+.+..|+.|.||
T Consensus       405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdI  445 (516)
T KOG1033|consen  405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDI  445 (516)
T ss_pred             ecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcch
Confidence            4432 1       1256789999999999999999999996

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.38  E-value=7.9e-13  Score=98.99  Aligned_cols=120  Identities=32%  Similarity=0.457  Sum_probs=97.9

Q ss_pred             HhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHHHHHHHHHHHHHHhhhcCCCCe-eeCCC
Q 046065           32 TAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTI-IHRDL  109 (164)
Q Consensus        32 l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~i-ih~dl  109 (164)
                      |+.+.|.|+.++ +.+...+..+.|.++|+.|+|.+.+...  ...++......+.++++.||.|+|+.   .| .|+.+
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~--~~~~d~~F~~s~~rdi~~Gl~ylh~s---~i~~hg~l   75 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNE--DIKLDYFFILSFIRDISKGLAYLHNS---PIGYHGAL   75 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcc--ccCccHHHHHHHHHHHHHHHHHHhcC---cceeeeee
Confidence            456789999997 8888888999999999999999999762  23377788888999999999999987   55 99999


Q ss_pred             CCCceeecCCCCeEEccccchhhhhhh----hhhhhcccccccCcceecCC
Q 046065          110 KVSNILLDEDLKPKISDFGLARILRKM----ILKQIQIELGYIPPEYVGRG  156 (164)
Q Consensus       110 k~~nili~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~~aPE~~~~~  156 (164)
                      +..|++++....+|++|||+.......    .........-|.|||.+...
T Consensus        76 ~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~  126 (484)
T KOG1023|consen   76 KSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGA  126 (484)
T ss_pred             ccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhccc
Confidence            999999999999999999998776421    11122234459999999664

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.37  E-value=6.6e-12  Score=94.34  Aligned_cols=78  Identities=24%  Similarity=0.214  Sum_probs=57.2

Q ss_pred             CCcEEEEEEecCCCChhhhhhCcccccccCHHHHHHHHHHHHH-HHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccc
Q 046065           49 TQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQ-GLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDF  127 (164)
Q Consensus        49 ~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~-~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~df  127 (164)
                      ....++||||++|++|.+........  .   ....++..++. .+..+|..   +++|+|++|.||+++.++.++++||
T Consensus       230 ~~~~vLvmE~i~G~~L~~~~~~~~~~--~---~~~~ia~~~~~~~l~ql~~~---g~~H~D~hPgNilv~~~g~i~liDf  301 (437)
T TIGR01982       230 TSERVLTMEWIDGIPLSDIAALDEAG--L---DRKALAENLARSFLNQVLRD---GFFHADLHPGNIFVLKDGKIIALDF  301 (437)
T ss_pred             cCCceEEEEeECCcccccHHHHHhcC--C---CHHHHHHHHHHHHHHHHHhC---CceeCCCCcccEEECCCCcEEEEeC
Confidence            44568999999999998775431110  1   12344455544 35667766   9999999999999999999999999


Q ss_pred             cchhhhh
Q 046065          128 GLARILR  134 (164)
Q Consensus       128 g~~~~~~  134 (164)
                      |++..+.
T Consensus       302 G~~~~l~  308 (437)
T TIGR01982       302 GIVGRLS  308 (437)
T ss_pred             CCeeECC
Confidence            9986553

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.36  E-value=5.2e-12  Score=83.27  Aligned_cols=115  Identities=18%  Similarity=0.117  Sum_probs=79.2

Q ss_pred             CCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeEeEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHHH
Q 046065            5 DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVH   84 (164)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~   84 (164)
                      +++.+++|....... ....+..|+..++.+...+++...........++|||++++.++....        ..   ...
T Consensus        20 ~~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~~~~~~lv~e~i~G~~l~~~~--------~~---~~~   87 (170)
T cd05151          20 ANKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFDPETGVLITEFIEGSELLTED--------FS---DPE   87 (170)
T ss_pred             CCeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEeCCCCeEEEEecCCCcccccc--------cc---CHH
Confidence            367899998654321 123457889999988655554422222333457999999998775430        11   123


Q ss_pred             HHHHHHHHHHHhhhcC--CCCeeeCCCCCCceeecCCCCeEEccccchhh
Q 046065           85 IIKGIIQGLLYLQEYF--RLTIIHRDLKVSNILLDEDLKPKISDFGLARI  132 (164)
Q Consensus        85 ~~~~~~~~l~~lh~~~--~~~iih~dlk~~nili~~~~~~~l~dfg~~~~  132 (164)
                      ...+++.++..+|+..  ...++|+|++|.|++++ ++.++++||+.+..
T Consensus        88 ~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          88 NLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             HHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence            4578889999999872  12369999999999998 67799999999864

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.25  E-value=5e-11  Score=78.37  Aligned_cols=97  Identities=23%  Similarity=0.310  Sum_probs=77.0

Q ss_pred             HHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHHHHHHHHHHHHHHhhhcCC
Q 046065           23 EEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFR  101 (164)
Q Consensus        23 ~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~  101 (164)
                      .+...|++++..+.--.+... .+..+.+...++|||+++..|.+.+...          ...++..+-.-+.-||.+  
T Consensus        44 ~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~--  111 (204)
T COG3642          44 ERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA----------RPDLLREVGRLVGKLHKA--  111 (204)
T ss_pred             HHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhc----------chHHHHHHHHHHHHHHhc--
Confidence            456789999999976666665 5556667778999999998888777553          134566777778889988  


Q ss_pred             CCeeeCCCCCCceeecCCCCeEEccccchhhh
Q 046065          102 LTIIHRDLKVSNILLDEDLKPKISDFGLARIL  133 (164)
Q Consensus       102 ~~iih~dlk~~nili~~~~~~~l~dfg~~~~~  133 (164)
                       +|+|+|+.++|+++...+ +.++|||++..-
T Consensus       112 -givHGDLTtsNiIl~~~~-i~~IDfGLg~~s  141 (204)
T COG3642         112 -GIVHGDLTTSNIILSGGR-IYFIDFGLGEFS  141 (204)
T ss_pred             -CeecCCCccceEEEeCCc-EEEEECCccccc
Confidence             999999999999996655 999999999754

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.20  E-value=5.9e-11  Score=83.94  Aligned_cols=98  Identities=20%  Similarity=0.258  Sum_probs=61.9

Q ss_pred             EEEEEecCCCChhhhhhC---c-ccccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEcccc
Q 046065           53 MLIYEYMPKRSLDYFLFD---P-IRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFG  128 (164)
Q Consensus        53 ~lv~e~~~~~~L~~~~~~---~-~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg  128 (164)
                      +++|+-+ .++|..++..   . .....+.......+..|+++.++++|..   +++|+||+|+|++++.+|.+.|+||+
T Consensus       115 ~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~---GlVHgdi~~~nfll~~~G~v~Lg~F~  190 (288)
T PF14531_consen  115 FLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSY---GLVHGDIKPENFLLDQDGGVFLGDFS  190 (288)
T ss_dssp             EEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEEEST-SGGGEEE-TTS-EEE--GG
T ss_pred             hhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhc---ceEecccceeeEEEcCCCCEEEcChH
Confidence            4556655 5677776542   1 1111234455567778999999999999   99999999999999999999999998


Q ss_pred             chhhhhhhhhhhhcccccccCcceecC
Q 046065          129 LARILRKMILKQIQIELGYIPPEYVGR  155 (164)
Q Consensus       129 ~~~~~~~~~~~~~~~~~~~~aPE~~~~  155 (164)
                      .....+..... ...+..|.+||....
T Consensus       191 ~~~r~g~~~~~-~~~~~~~~PPe~~~~  216 (288)
T PF14531_consen  191 SLVRAGTRYRC-SEFPVAFTPPELESC  216 (288)
T ss_dssp             GEEETTEEEEG-GGS-TTTS-HHHHHH
T ss_pred             HHeecCceeec-cCCCcccCChhhhhh
Confidence            76544432222 334467899998743

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.19  E-value=5e-12  Score=98.04  Aligned_cols=147  Identities=29%  Similarity=0.313  Sum_probs=112.0

Q ss_pred             cEEEEEEccccc--cccHHHHHHHHHHHhccC-CCceeeE-eEEeeCCcEEEEEEecCCCChhhhh-hCcccccccCHHH
Q 046065            7 QIIAVKKLSKKS--TQGFEEFKNEVMLTAKLQ-HLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFL-FDPIRMLILDCKK   81 (164)
Q Consensus         7 ~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~-h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~-~~~~~~~~~~~~~   81 (164)
                      ..+|+|.+....  .....++..|..+-+.+. |+|++.. .........++.+++..++++.... ....  ...+...
T Consensus        47 ~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~--~~~~~~~  124 (601)
T KOG0590|consen   47 SSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDS--TGTSSSS  124 (601)
T ss_pred             ceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccccCcccccccccccccCCc--cCCCCcc
Confidence            345666654332  233445556787777776 9999997 6666667788999999898887776 3222  1256677


Q ss_pred             HHHHHHHHHHHHHHhh-hcCCCCeeeCCCCCCceeecCCC-CeEEccccchhhhhh-hh----hhhhcc-cccccCccee
Q 046065           82 RVHIIKGIIQGLLYLQ-EYFRLTIIHRDLKVSNILLDEDL-KPKISDFGLARILRK-MI----LKQIQI-ELGYIPPEYV  153 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh-~~~~~~iih~dlk~~nili~~~~-~~~l~dfg~~~~~~~-~~----~~~~~~-~~~~~aPE~~  153 (164)
                      ...++.|+..++.|+| ..   ++.|+|+||+|.+++..+ .+++.|||+|..+.. ..    ....+| ++.|+|||..
T Consensus       125 ~~~~~~ql~s~l~~~H~~~---~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~  201 (601)
T KOG0590|consen  125 ASRYLPQLNSGLSYLHPEN---GVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHL  201 (601)
T ss_pred             hhhhhhhhccCccccCccc---ccccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccc
Confidence            7889999999999999 66   999999999999999999 999999999977644 22    144677 9999999999


Q ss_pred             cCCcc
Q 046065          154 GRGVY  158 (164)
Q Consensus       154 ~~~~~  158 (164)
                      .+..|
T Consensus       202 ~~~~~  206 (601)
T KOG0590|consen  202 SGKAY  206 (601)
T ss_pred             cchhh
Confidence            88655

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.18  E-value=1.7e-10  Score=77.60  Aligned_cols=97  Identities=18%  Similarity=0.179  Sum_probs=68.7

Q ss_pred             HHHHHHHhccCC--CceeeEeEEeeCCcEEEEEEecCCCChh-hhhhCcccccccCHHHHHHHHHHHHHHHHHh-hhcCC
Q 046065           26 KNEVMLTAKLQH--LNLIRVGFCIETQEYMLIYEYMPKRSLD-YFLFDPIRMLILDCKKRVHIIKGIIQGLLYL-QEYFR  101 (164)
Q Consensus        26 ~~e~~~l~~l~h--~~i~~~~~~~~~~~~~lv~e~~~~~~L~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l-h~~~~  101 (164)
                      ..|++.|.++..  .++..+..+   ..-++|||++.+..+. ..+++.    .++......+..+++.++..+ |..  
T Consensus        74 ~kE~r~L~rl~~~Gv~vP~pi~~---~~~~lvME~Ig~~~~~~~~Lkd~----~~~~~~~~~i~~~i~~~l~~l~H~~--  144 (197)
T cd05146          74 EKEMHNLKRMQKAGIPCPEVVVL---KKHVLVMSFIGDDQVPAPKLKDA----KLNDEEMKNAYYQVLSMMKQLYKEC--  144 (197)
T ss_pred             HHHHHHHHHHHHcCCCCCeEEEe---cCCEEEEEEcCCCCccchhhhcc----ccCHHHHHHHHHHHHHHHHHHHHhC--
Confidence            378888888853  344444322   5677999999765442 122221    144445566778999999988 777  


Q ss_pred             CCeeeCCCCCCceeecCCCCeEEccccchhhh
Q 046065          102 LTIIHRDLKVSNILLDEDLKPKISDFGLARIL  133 (164)
Q Consensus       102 ~~iih~dlk~~nili~~~~~~~l~dfg~~~~~  133 (164)
                       +++|+|+++.||++. ++.+.++|||.+-..
T Consensus       145 -glVHGDLs~~NIL~~-~~~v~iIDF~qav~~  174 (197)
T cd05146         145 -NLVHADLSEYNMLWH-DGKVWFIDVSQSVEP  174 (197)
T ss_pred             -CeecCCCCHHHEEEE-CCcEEEEECCCceeC
Confidence             999999999999996 467999999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.16  E-value=3.1e-10  Score=74.69  Aligned_cols=108  Identities=26%  Similarity=0.313  Sum_probs=79.4

Q ss_pred             HHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCC-CChhhhhhCcccccccCHHHHHHHHHHHHHHHHHhhhc
Q 046065           22 FEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPK-RSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEY   99 (164)
Q Consensus        22 ~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~   99 (164)
                      ..+...|++.+.++.--.|.-. .++.+...-.++|||+++ .++.+++.+..... ........++..+-+.+.-||..
T Consensus        54 r~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~n  132 (229)
T KOG3087|consen   54 RKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDN  132 (229)
T ss_pred             HHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhC
Confidence            4567889999999876566655 555566777799999977 46666665432211 22223367888899999999998


Q ss_pred             CCCCeeeCCCCCCceeecCCC---CeEEccccchhhh
Q 046065          100 FRLTIIHRDLKVSNILLDEDL---KPKISDFGLARIL  133 (164)
Q Consensus       100 ~~~~iih~dlk~~nili~~~~---~~~l~dfg~~~~~  133 (164)
                         +++|+|+..+||++-+++   .+.++|||++...
T Consensus       133 ---diiHGDLTTSNill~~~~~~~~~~lIdfgls~~s  166 (229)
T KOG3087|consen  133 ---DIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS  166 (229)
T ss_pred             ---CeecccccccceEEecCCCcCceEEEeecchhcc
Confidence               999999999999996654   3589999998643

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.11  E-value=1.3e-09  Score=77.02  Aligned_cols=124  Identities=22%  Similarity=0.190  Sum_probs=83.8

Q ss_pred             CCcEEEEEEcccccc-ccH----------HHHHHHHHHHhccCCCceeeE---eEEee-----CCcEEEEEEecCCC-Ch
Q 046065            5 DGQIIAVKKLSKKST-QGF----------EEFKNEVMLTAKLQHLNLIRV---GFCIE-----TQEYMLIYEYMPKR-SL   64 (164)
Q Consensus         5 ~~~~vavK~~~~~~~-~~~----------~~~~~e~~~l~~l~h~~i~~~---~~~~~-----~~~~~lv~e~~~~~-~L   64 (164)
                      +|+.|.||......- ...          ..+.+|...+..+..-+|...   .+...     ....++|+|++++. +|
T Consensus        44 ~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL  123 (268)
T PRK15123         44 AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISL  123 (268)
T ss_pred             CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccH
Confidence            356788886532210 001          136788887777743333332   23222     23467999999875 78


Q ss_pred             hhhhhCcccccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecC-------CCCeEEccccchhh
Q 046065           65 DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE-------DLKPKISDFGLARI  132 (164)
Q Consensus        65 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~-------~~~~~l~dfg~~~~  132 (164)
                      .+++..... ...+......++.+++..+.-||+.   +++|+|+++.|||++.       ...+.++||+.+..
T Consensus       124 ~~~~~~~~~-~~~~~~~~~~ll~~la~~i~~LH~~---Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~~  194 (268)
T PRK15123        124 EDYCADWAT-NPPDPRLKRMLIKRVATMVRDMHAA---GINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQI  194 (268)
T ss_pred             HHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHHHC---cCccCCCChhhEEEeccccCCCCCceEEEEECCcccc
Confidence            888753211 1134456668889999999999999   9999999999999975       46789999998753

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.11  E-value=2.1e-10  Score=83.44  Aligned_cols=96  Identities=21%  Similarity=0.307  Sum_probs=66.8

Q ss_pred             cEEEEEEecCCCChhhhhhCcccccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeec--CC--CCeEEcc
Q 046065           51 EYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLD--ED--LKPKISD  126 (164)
Q Consensus        51 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~--~~--~~~~l~d  126 (164)
                      .+|+||.-.+ .+|..++....    .+.....-+..|+++|+.+||.+   ++-|||+|.+||++.  .+  ..+.++|
T Consensus       317 tlylvMkrY~-~tLr~yl~~~~----~s~r~~~~~laQlLEav~hL~~h---gvAhRDlKSDNiL~ElddD~~P~LVvaD  388 (598)
T KOG4158|consen  317 TLYLVMKRYR-QTLREYLWTRH----RSYRTGRVILAQLLEAVTHLHKH---GVAHRDLKSDNILLELDDDEIPQLVVAD  388 (598)
T ss_pred             eEEEehhcch-hhHHHHHhcCC----CchHHHHHHHHHHHHHHHHHHHc---cchhhcccccceEEEecCCCCcEEEEcc
Confidence            3677776654 36666654322    44556667789999999999999   999999999999993  22  4588999


Q ss_pred             ccchhhhhhhh--------hhhhcccccccCcceec
Q 046065          127 FGLARILRKMI--------LKQIQIELGYIPPEYVG  154 (164)
Q Consensus       127 fg~~~~~~~~~--------~~~~~~~~~~~aPE~~~  154 (164)
                      ||.+.--+...        ....-|.-..||||+..
T Consensus       389 FGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~t  424 (598)
T KOG4158|consen  389 FGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIAT  424 (598)
T ss_pred             cceeeeccccccccccccccccCCCcceecchhhhh
Confidence            99763222111        12234556789999883

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.10  E-value=1.6e-11  Score=98.29  Aligned_cols=143  Identities=20%  Similarity=0.221  Sum_probs=94.4

Q ss_pred             CCcEEEEEEccccccc-cHHHHH---HHHHHHhccCCCceeeEeEEeeCCc-EEEEEEecCCCChhhhhhCcccccccCH
Q 046065            5 DGQIIAVKKLSKKSTQ-GFEEFK---NEVMLTAKLQHLNLIRVGFCIETQE-YMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         5 ~~~~vavK~~~~~~~~-~~~~~~---~e~~~l~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      +...|.||.+-++.+. ..+.+.   .|++ ...+++||.+.+..+...+. .|+|=+|+- -+|.+.+--   ...+..
T Consensus        45 ~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqyvk-hnLyDRlST---RPFL~~  119 (1431)
T KOG1240|consen   45 REGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQYVK-HNLYDRLST---RPFLVL  119 (1431)
T ss_pred             CCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHHHh-hhhhhhhcc---chHHHH
Confidence            3445889987766533 334443   3444 55568999999855444443 345545543 367666532   222444


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhh--hh-hhh--h----hhhcccccccCc
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARI--LR-KMI--L----KQIQIELGYIPP  150 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~--~~-~~~--~----~~~~~~~~~~aP  150 (164)
                      ...+-++.|++.|+.-+|..   +|.|+|||.+||||.+=.++.|+||..-+.  +. ++.  .    ..-..-..|+||
T Consensus       120 iEKkWiaFQLL~al~qcH~~---gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAP  196 (1431)
T KOG1240|consen  120 IEKKWIAFQLLKALSQCHKL---GVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAP  196 (1431)
T ss_pred             HHHHHHHHHHHHHHHHHHHc---CccccccccceEEEeeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecCh
Confidence            55556778999999999988   999999999999999999999999986532  11 111  1    222234469999


Q ss_pred             ceecC
Q 046065          151 EYVGR  155 (164)
Q Consensus       151 E~~~~  155 (164)
                      |-+-.
T Consensus       197 ERFv~  201 (1431)
T KOG1240|consen  197 ERFVS  201 (1431)
T ss_pred             Hhhhc
Confidence            98844

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.08  E-value=9.5e-10  Score=84.31  Aligned_cols=121  Identities=18%  Similarity=0.208  Sum_probs=93.4

Q ss_pred             cCCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            3 LPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      ..++.+|.|...+...........+.+..|+.++||||+++ ..+...+..|+|+|-+.  .|...+.+      +....
T Consensus        34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~  105 (690)
T KOG1243|consen   34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEE  105 (690)
T ss_pred             eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHH
Confidence            45788888888765533444556778889999999999997 66677788999999875  35545544      22333


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhh
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARIL  133 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~  133 (164)
                      ..-.+.||+.||.|||+.  .+++|+|+.-..++++..|.-+|.+|...+..
T Consensus       106 v~~Gl~qIl~AL~FL~~d--~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~  155 (690)
T KOG1243|consen  106 VCLGLFQILAALSFLNDD--CNLVHGNVCKDSVFVNESGEWKLGGLELVSKA  155 (690)
T ss_pred             HHHHHHHHHHHHHHHhcc--CCeeeccEeeeeEEEcCCCcEEEeeeEEEecc
Confidence            344568999999999864  39999999999999999999999999877543

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.08  E-value=1.5e-09  Score=72.73  Aligned_cols=119  Identities=25%  Similarity=0.260  Sum_probs=72.6

Q ss_pred             cCCCcEEEEEEcccc-------------ccc---------c----HHHHHHHHHHHhccCCCc--eeeEeEEeeCCcEEE
Q 046065            3 LPDGQIIAVKKLSKK-------------STQ---------G----FEEFKNEVMLTAKLQHLN--LIRVGFCIETQEYML   54 (164)
Q Consensus         3 ~~~~~~vavK~~~~~-------------~~~---------~----~~~~~~e~~~l~~l~h~~--i~~~~~~~~~~~~~l   54 (164)
                      -++|+.+|+|+....             ...         +    ..+...|.+.|..+..-+  +.++..+   ..-.+
T Consensus         7 ~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~---~~~~i   83 (188)
T PF01163_consen    7 DPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY---NRNVI   83 (188)
T ss_dssp             ECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE---ETTEE
T ss_pred             CCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE---eCCEE
Confidence            467889999987531             000         1    235667999999997543  4444322   24469


Q ss_pred             EEEecC--CCChhhhhhCcccccccCHHHHHHHHHHHHHHHHH-hhhcCCCCeeeCCCCCCceeecCCCCeEEccccchh
Q 046065           55 IYEYMP--KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLY-LQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLAR  131 (164)
Q Consensus        55 v~e~~~--~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~-lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~  131 (164)
                      ||||++  +..+..+....     +.......+..+++..+.. +|..   +++|+|+.+.||+++.+ .+.++|||.+.
T Consensus        84 vME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~---givHGDLs~~NIlv~~~-~~~iIDf~qav  154 (188)
T PF01163_consen   84 VMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKA---GIVHGDLSEYNILVDDG-KVYIIDFGQAV  154 (188)
T ss_dssp             EEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCT---TEEESS-STTSEEEETT-CEEE--GTTEE
T ss_pred             EEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhc---CceecCCChhhEEeecc-eEEEEecCcce
Confidence            999998  65555443322     1123345566677764444 5677   99999999999999877 89999999875


Q ss_pred             hh
Q 046065          132 IL  133 (164)
Q Consensus       132 ~~  133 (164)
                      ..
T Consensus       155 ~~  156 (188)
T PF01163_consen  155 DS  156 (188)
T ss_dssp             ET
T ss_pred             ec
Confidence            43

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.05  E-value=9.2e-10  Score=84.33  Aligned_cols=75  Identities=19%  Similarity=0.215  Sum_probs=51.7

Q ss_pred             CCcEEEEEEecCCCChhhhhh--C-cccccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCC----C
Q 046065           49 TQEYMLIYEYMPKRSLDYFLF--D-PIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL----K  121 (164)
Q Consensus        49 ~~~~~lv~e~~~~~~L~~~~~--~-~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~----~  121 (164)
                      ....++||||+.|+.+.+...  . +.....+.......++.|+.       ..   +++|+|++|.||+++.++    .
T Consensus       233 st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-------~~---GffHaDpHPGNIlv~~~g~~~~~  302 (537)
T PRK04750        233 CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-------RD---GFFHADMHPGNIFVSYDPPENPR  302 (537)
T ss_pred             CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------hC---CeeeCCCChHHeEEecCCCCCCe
Confidence            455679999999999976432  1 11111133333344444443       23   999999999999999887    8


Q ss_pred             eEEccccchhhh
Q 046065          122 PKISDFGLARIL  133 (164)
Q Consensus       122 ~~l~dfg~~~~~  133 (164)
                      ++++|||+...+
T Consensus       303 i~llDFGivg~l  314 (537)
T PRK04750        303 YIALDFGIVGSL  314 (537)
T ss_pred             EEEEecceEEEC
Confidence            999999987654

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.02  E-value=1.7e-10  Score=92.12  Aligned_cols=73  Identities=34%  Similarity=0.481  Sum_probs=61.4

Q ss_pred             HHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhh-----------------hhhhhhhcccccccCc
Q 046065           88 GIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILR-----------------KMILKQIQIELGYIPP  150 (164)
Q Consensus        88 ~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~-----------------~~~~~~~~~~~~~~aP  150 (164)
                      +++-+++|+|+.   +|+|||+||+|.+|..-|..|+.|||+++..-                 .....+.+||+.|+||
T Consensus       151 dmvla~Eylh~y---givhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaP  227 (1205)
T KOG0606|consen  151 DMVLAVEYLHSY---GIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAP  227 (1205)
T ss_pred             hhhHHhHhhccC---CeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccCh
Confidence            346789999998   99999999999999999999999999986431                 1123567999999999


Q ss_pred             ceecCCcceeccC
Q 046065          151 EYVGRGVYYKKFS  163 (164)
Q Consensus       151 E~~~~~~~~~~~D  163 (164)
                      |++.+.-|.+..|
T Consensus       228 eVilrqgygkpvd  240 (1205)
T KOG0606|consen  228 EVILRQGYGKPVD  240 (1205)
T ss_pred             hhhhhhccCCCcc
Confidence            9998888887766

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.01  E-value=4.8e-10  Score=79.72  Aligned_cols=132  Identities=22%  Similarity=0.189  Sum_probs=93.3

Q ss_pred             HhccCCCceeeEeEEe------eCCcEEEEEEecCCCChhhhhhCcc-cccccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 046065           32 TAKLQHLNLIRVGFCI------ETQEYMLIYEYMPKRSLDYFLFDPI-RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTI  104 (164)
Q Consensus        32 l~~l~h~~i~~~~~~~------~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~i  104 (164)
                      +-.+.|.|+++...++      +.....++.||+..|++.+++++-. ....+......+|+.|+..||.|||+. .+.+
T Consensus       121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Ppi  199 (458)
T KOG1266|consen  121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPPI  199 (458)
T ss_pred             HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCcc
Confidence            4445688899873333      2345779999999999999998622 223377888889999999999999998 8899


Q ss_pred             eeCCCCCCceeecCCCCeEEccccchhhh---hh---hhhhhhcccccccCcceecCCcceeccCC
Q 046065          105 IHRDLKVSNILLDEDLKPKISDFGLARIL---RK---MILKQIQIELGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       105 ih~dlk~~nili~~~~~~~l~dfg~~~~~---~~---~~~~~~~~~~~~~aPE~~~~~~~~~~~Di  164 (164)
                      +|+++..+.+.+.++|-+|+.--.....-   ..   .......+-++|-|||.-.--+-+..+||
T Consensus       200 ihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dI  265 (458)
T KOG1266|consen  200 IHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDI  265 (458)
T ss_pred             ccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhh
Confidence            99999999999999998886542222111   11   11122345677888887655555555554

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.94  E-value=2e-08  Score=68.83  Aligned_cols=124  Identities=17%  Similarity=0.210  Sum_probs=79.1

Q ss_pred             CCcEEEEEEcccccc-ccHHHHHHHHHHHhccCCC--ceeeEeEEeeC----CcEEEEEEecCCCChhhhhhCccccccc
Q 046065            5 DGQIIAVKKLSKKST-QGFEEFKNEVMLTAKLQHL--NLIRVGFCIET----QEYMLIYEYMPKRSLDYFLFDPIRMLIL   77 (164)
Q Consensus         5 ~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~--~i~~~~~~~~~----~~~~lv~e~~~~~~L~~~~~~~~~~~~~   77 (164)
                      +|+.+++|....... .....+..|+.+++.+.+.  ++.++..+...    +..+++||++++.++......    ..+
T Consensus        21 ~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~----~~~   96 (223)
T cd05154          21 GGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLR----PEL   96 (223)
T ss_pred             CCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCCC----CCC
Confidence            357899998754322 1345678899999998653  34444333222    256899999998877654421    013


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhc-----------------------------------------------------CCCCe
Q 046065           78 DCKKRVHIIKGIIQGLLYLQEY-----------------------------------------------------FRLTI  104 (164)
Q Consensus        78 ~~~~~~~~~~~~~~~l~~lh~~-----------------------------------------------------~~~~i  104 (164)
                      +......++.+++.++..+|+.                                                     ....+
T Consensus        97 ~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  176 (223)
T cd05154          97 SPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGL  176 (223)
T ss_pred             CHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEE
Confidence            3333444444444444444432                                                     02457


Q ss_pred             eeCCCCCCceeecC--CCCeEEccccchhh
Q 046065          105 IHRDLKVSNILLDE--DLKPKISDFGLARI  132 (164)
Q Consensus       105 ih~dlk~~nili~~--~~~~~l~dfg~~~~  132 (164)
                      +|+|+.|.|++++.  .+.+.++||+.+..
T Consensus       177 ~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         177 VHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             EECCCCcccEEEcCCCCcEEEEEecccccc
Confidence            99999999999988  56689999998754

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.87  E-value=1.9e-08  Score=68.64  Aligned_cols=105  Identities=24%  Similarity=0.263  Sum_probs=77.0

Q ss_pred             HHHHHHHHHHhccCCCceee--E-eEEeeC----CcEEEEEEecCC-CChhhhhhCcccccccCHHHHHHHHHHHHHHHH
Q 046065           23 EEFKNEVMLTAKLQHLNLIR--V-GFCIET----QEYMLIYEYMPK-RSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLL   94 (164)
Q Consensus        23 ~~~~~e~~~l~~l~h~~i~~--~-~~~~~~----~~~~lv~e~~~~-~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~   94 (164)
                      ....+|...+..+..-+|..  + .+....    ...++|+|.+++ .+|.+++.....   .+......++.+++..+.
T Consensus        56 ~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i~  132 (206)
T PF06293_consen   56 SRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLIA  132 (206)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHHH
Confidence            45677777766664333333  2 333332    235799999987 478888765322   445666788899999999


Q ss_pred             HhhhcCCCCeeeCCCCCCceeecCCC---CeEEccccchhhh
Q 046065           95 YLQEYFRLTIIHRDLKVSNILLDEDL---KPKISDFGLARIL  133 (164)
Q Consensus        95 ~lh~~~~~~iih~dlk~~nili~~~~---~~~l~dfg~~~~~  133 (164)
                      -||++   +++|+|+++.|||++..+   .+.++||+-+...
T Consensus       133 ~lH~~---gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  133 KLHDA---GIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHC---cCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            99998   999999999999999877   7999999977643

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.82  E-value=2.6e-09  Score=80.74  Aligned_cols=154  Identities=21%  Similarity=0.218  Sum_probs=112.7

Q ss_pred             CCCcEEEEEEcc--ccccccHHHHHHHHHHHhccC-CCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLS--KKSTQGFEEFKNEVMLTAKLQ-HLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~--~~~~~~~~~~~~e~~~l~~l~-h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .++..+|+|.-.  ...+....+-.+|+...+.++ |+|.++. ..+...+..++-+|.+. .+|..+......  .++.
T Consensus       141 ~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~~-~sl~~~~~~~~~--~~p~  217 (524)
T KOG0601|consen  141 ESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELCG-ESLQSYCHTPCN--FLPD  217 (524)
T ss_pred             cCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcceeeecccc-chhHHhhhcccc--cCCc
Confidence            456778888732  223444444466777777775 8999985 66666777888888875 566665544222  2777


Q ss_pred             HHHHHHHHHHHH----HHHHhhhcCCCCeeeCCCCCCceeecCC-CCeEEccccchhhhhhhhh-------hhhcccccc
Q 046065           80 KKRVHIIKGIIQ----GLLYLQEYFRLTIIHRDLKVSNILLDED-LKPKISDFGLARILRKMIL-------KQIQIELGY  147 (164)
Q Consensus        80 ~~~~~~~~~~~~----~l~~lh~~~~~~iih~dlk~~nili~~~-~~~~l~dfg~~~~~~~~~~-------~~~~~~~~~  147 (164)
                      ...+..+.+..+    |+.++|+.   .++|.+++|.|++...+ ...+++|||+...+.....       -...+...|
T Consensus       218 ~~l~~~~~~~~~~~~~al~~~hs~---~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y  294 (524)
T KOG0601|consen  218 NLLWNSLRDWLSRDVTALSHLHSN---NIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIY  294 (524)
T ss_pred             hhhhhHHhhhhhcccccccccCCC---cccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceE
Confidence            888888888888    99999988   99999999999999988 7889999999877654322       122456679


Q ss_pred             cCcceecCCcceeccCC
Q 046065          148 IPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       148 ~aPE~~~~~~~~~~~Di  164 (164)
                      ++||.. ++.+++.+|+
T Consensus       295 ~~ke~~-~~l~~~~~di  310 (524)
T KOG0601|consen  295 AAKELL-NGLATFASDI  310 (524)
T ss_pred             eChhhh-ccccchHhhh
Confidence            999998 5677777765

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.70  E-value=1.1e-08  Score=77.34  Aligned_cols=154  Identities=21%  Similarity=0.161  Sum_probs=102.8

Q ss_pred             CCCcEEEEEEccccccccHHH--HHHHHHHHhccC-CCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEE--FKNEVMLTAKLQ-HLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~--~~~e~~~l~~l~-h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .++..|++|-+.+......+.  -+.|+.+...+. |.+++.. ..|......++-.|||.++++.....-   ...+.+
T Consensus       289 ~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~---~~~~d~  365 (524)
T KOG0601|consen  289 EGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVT---SQMLDE  365 (524)
T ss_pred             CCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcCcchhhhhHH---HHhcCc
Confidence            345677777765443222222  245777777664 7777775 566666666688899998887655522   223777


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCC-CCeEEccccchhhhhhhhhhhhccccccc--CcceecCC
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED-LKPKISDFGLARILRKMILKQIQIELGYI--PPEYVGRG  156 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~--aPE~~~~~  156 (164)
                      ...+....|++.++.++|+.   .++|.|++|+||++..+ +..++.||+....+.-.. ....+..++.  ++......
T Consensus       366 ~~~~~~~~q~~~~l~~i~s~---~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~-~~~~~~~r~~p~~~~~~e~~  441 (524)
T KOG0601|consen  366 DPRLRLTAQILTALNVIHSK---LFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSS-GVFHHIDRLYPIAEILLEDY  441 (524)
T ss_pred             chhhhhHHHHHhccccccch---hhhcccccccceeeccchhhhhccccccccccceec-ccccccccccccchhhcccc
Confidence            78888999999999999988   99999999999999886 778899999875421111 1112222333  45555555


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .+..+.|+
T Consensus       442 ~~~~~~~~  449 (524)
T KOG0601|consen  442 PHLSKADI  449 (524)
T ss_pred             cccccccc
Confidence            66666653

>PRK09902 hypothetical protein; Provisional

Probab=98.62  E-value=8.7e-07  Score=60.19  Aligned_cols=123  Identities=16%  Similarity=0.163  Sum_probs=86.5

Q ss_pred             CcEEEEEEcccc------ccccHHHHHHHHHHHhccCC--CceeeEeEEee--C---CcEEEEEEecCC-CChhhhhhCc
Q 046065            6 GQIIAVKKLSKK------STQGFEEFKNEVMLTAKLQH--LNLIRVGFCIE--T---QEYMLIYEYMPK-RSLDYFLFDP   71 (164)
Q Consensus         6 ~~~vavK~~~~~------~~~~~~~~~~e~~~l~~l~h--~~i~~~~~~~~--~---~~~~lv~e~~~~-~~L~~~~~~~   71 (164)
                      |+.+-+|.-.+.      .|.....+..|...+..+..  ..+..+.++..  .   ...+||+|.+++ .+|.+++.+.
T Consensus        41 g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~  120 (216)
T PRK09902         41 GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTEDMAGFISIADWYAQH  120 (216)
T ss_pred             CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEeCCCCccHHHHHhcC
Confidence            345777775422      14445678999998888843  22444433322  1   135699997753 6787777553


Q ss_pred             ccccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCC--eEEccccchhh
Q 046065           72 IRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK--PKISDFGLARI  132 (164)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~--~~l~dfg~~~~  132 (164)
                      .- ...+......+..+++..+.-+|+.   ++.|+|+.+.||+++..+.  +.++||.-++.
T Consensus       121 ~~-~~~~~~~k~~il~~va~~ia~LH~~---Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        121 AV-SPYSDEVRQAMLKAVALAFKKMHSV---NRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             Cc-CCcchHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            21 1245566678889999999999999   9999999999999987677  99999997754

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.59  E-value=6.7e-07  Score=67.58  Aligned_cols=126  Identities=20%  Similarity=0.293  Sum_probs=91.1

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEe----eCCcEEEEEEecCC-CChhhhhhCc------
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCI----ETQEYMLIYEYMPK-RSLDYFLFDP------   71 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~----~~~~~~lv~e~~~~-~~L~~~~~~~------   71 (164)
                      -||..|.+|++..+........-.-++.++++.|+|++.+ ..+.    ....+.+|++|.|. ++|.+.....      
T Consensus       299 ~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~  378 (655)
T KOG3741|consen  299 VDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKR  378 (655)
T ss_pred             cCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccc
Confidence            3688899999843321111112345778999999999998 2222    23467899999875 6676555321      


Q ss_pred             ------ccccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhh
Q 046065           72 ------IRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARI  132 (164)
Q Consensus        72 ------~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~  132 (164)
                            ......++..+|.++.|+..||.++|+.   ++-.+-+.+.+|+++...+++|+.-|....
T Consensus       379 ~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHss---GLAck~L~~~kIlv~G~~RIriS~C~i~Dv  442 (655)
T KOG3741|consen  379 TNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSS---GLACKTLDLKKILVTGKMRIRISGCGIMDV  442 (655)
T ss_pred             cccccccCCCCchHHHHHHHHHHHHHHHHHHHhc---CceeecccHhHeEeeCcceEEEecccceee
Confidence                  1122377899999999999999999998   998899999999999888888876665443

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.51  E-value=2.8e-06  Score=58.05  Aligned_cols=67  Identities=22%  Similarity=0.325  Sum_probs=51.0

Q ss_pred             cEEEEEEecCCCChhhhhhCcccccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccch
Q 046065           51 EYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLA  130 (164)
Q Consensus        51 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~  130 (164)
                      ..++++||++|..|.+...       +++    .....+.+++.-+|..   +++|+|+.|.|+++..++ ++++||+..
T Consensus       117 ~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~---G~~HGD~hpgNFlv~~~~-i~iID~~~k  181 (229)
T PF06176_consen  117 SYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKH---GFYHGDPHPGNFLVSNNG-IRIIDTQGK  181 (229)
T ss_pred             EEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHc---CCccCCCCcCcEEEECCc-EEEEECccc
Confidence            4568999999988765431       222    2335566778999998   999999999999998555 999999876


Q ss_pred             hh
Q 046065          131 RI  132 (164)
Q Consensus       131 ~~  132 (164)
                      +.
T Consensus       182 ~~  183 (229)
T PF06176_consen  182 RM  183 (229)
T ss_pred             cc
Confidence            43

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.23  E-value=1.5e-05  Score=61.34  Aligned_cols=89  Identities=19%  Similarity=0.195  Sum_probs=54.9

Q ss_pred             CceeeEeEE-eeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceee
Q 046065           38 LNLIRVGFC-IETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL  116 (164)
Q Consensus        38 ~~i~~~~~~-~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili  116 (164)
                      +++.=...+ .....-.++|||+.|..+.+...-....  .+.........++.--.- +++    +++|.|..|-|+++
T Consensus       226 ~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g--~d~k~ia~~~~~~f~~q~-~~d----gffHaDpHpGNi~v  298 (517)
T COG0661         226 PDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAG--IDRKELAELLVRAFLRQL-LRD----GFFHADPHPGNILV  298 (517)
T ss_pred             CCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcC--CCHHHHHHHHHHHHHHHH-Hhc----CccccCCCccceEE
Confidence            443333333 3456667999999998887774321111  332222222211111111 122    89999999999999


Q ss_pred             cCCCCeEEccccchhhh
Q 046065          117 DEDLKPKISDFGLARIL  133 (164)
Q Consensus       117 ~~~~~~~l~dfg~~~~~  133 (164)
                      ..+|++.+.|||+...+
T Consensus       299 ~~~g~i~~lDfGi~g~l  315 (517)
T COG0661         299 RSDGRIVLLDFGIVGRL  315 (517)
T ss_pred             ecCCcEEEEcCcceecC
Confidence            99999999999987654

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.13  E-value=2.8e-05  Score=52.31  Aligned_cols=103  Identities=20%  Similarity=0.147  Sum_probs=76.0

Q ss_pred             HHHHHHhccCC-CceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 046065           27 NEVMLTAKLQH-LNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTI  104 (164)
Q Consensus        27 ~e~~~l~~l~h-~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~i  104 (164)
                      .|.-++..+++ ++++++ +.|..    +++.|+.+.+++......-......++..+.+++.+++..+.+++....-.+
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~   83 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFF   83 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcE
Confidence            47778888865 567775 77733    5788999877664321111112236889999999999999999998643357


Q ss_pred             eeCCCCCCceeecCCCCeEEccccchhhh
Q 046065          105 IHRDLKVSNILLDEDLKPKISDFGLARIL  133 (164)
Q Consensus       105 ih~dlk~~nili~~~~~~~l~dfg~~~~~  133 (164)
                      .-.|++++|+-++.+++++++|.......
T Consensus        84 ~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   84 YLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEeecchHHeEEeCCCcEEEEechhcchh
Confidence            77899999999999999999998876443

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.11  E-value=7e-05  Score=52.30  Aligned_cols=31  Identities=26%  Similarity=0.390  Sum_probs=27.0

Q ss_pred             CCeeeCCCCCCceeecCCCCeEEccccchhh
Q 046065          102 LTIIHRDLKVSNILLDEDLKPKISDFGLARI  132 (164)
Q Consensus       102 ~~iih~dlk~~nili~~~~~~~l~dfg~~~~  132 (164)
                      ..++|+|+.|.|+|++..+.+.|+||+.+..
T Consensus       163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~  193 (244)
T cd05150         163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLGV  193 (244)
T ss_pred             eEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence            4689999999999999877778999998753

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.10  E-value=3.2e-05  Score=54.43  Aligned_cols=95  Identities=20%  Similarity=0.178  Sum_probs=60.9

Q ss_pred             HHHHHHHHHhccCCC--ceeeEeEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHHHHHHHHHHHHHHhhhcCC
Q 046065           24 EFKNEVMLTAKLQHL--NLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFR  101 (164)
Q Consensus        24 ~~~~e~~~l~~l~h~--~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~  101 (164)
                      ...+|.+.|..+.-.  .+..+.   .-+.-.+|||++++..|...--        ......+++..++.-+.-.-..  
T Consensus       155 ~A~rEf~~L~~L~~~G~~VP~P~---~~nRHaVvMe~ieG~eL~~~r~--------~~en~~~il~~il~~~~~~~~~--  221 (304)
T COG0478         155 AAEREFEALQRLYPEGVKVPKPI---AWNRHAVVMEYIEGVELYRLRL--------DVENPDEILDKILEEVRKAYRR--  221 (304)
T ss_pred             HHHHHHHHHHHhhhcCCCCCCcc---ccccceeeeehcccceeecccC--------cccCHHHHHHHHHHHHHHHHHc--
Confidence            456788888888533  343331   1244569999999877754431        1222233333443333332233  


Q ss_pred             CCeeeCCCCCCceeecCCCCeEEccccchhh
Q 046065          102 LTIIHRDLKVSNILLDEDLKPKISDFGLARI  132 (164)
Q Consensus       102 ~~iih~dlk~~nili~~~~~~~l~dfg~~~~  132 (164)
                       +++|+|+.+=||+++.+|.+.++||--+..
T Consensus       222 -GiVHGDlSefNIlV~~dg~~~vIDwPQ~v~  251 (304)
T COG0478         222 -GIVHGDLSEFNILVTEDGDIVVIDWPQAVP  251 (304)
T ss_pred             -CccccCCchheEEEecCCCEEEEeCccccc
Confidence             999999999999999999999999876543

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.99  E-value=0.00032  Score=47.59  Aligned_cols=101  Identities=20%  Similarity=0.299  Sum_probs=64.8

Q ss_pred             HHHHHHHHHHHhccC------CCceeeE-eEEeeCCcEEEEEEecC------CCChhhhhhCcccccccCHHHHHHHHHH
Q 046065           22 FEEFKNEVMLTAKLQ------HLNLIRV-GFCIETQEYMLIYEYMP------KRSLDYFLFDPIRMLILDCKKRVHIIKG   88 (164)
Q Consensus        22 ~~~~~~e~~~l~~l~------h~~i~~~-~~~~~~~~~~lv~e~~~------~~~L~~~~~~~~~~~~~~~~~~~~~~~~   88 (164)
                      .....+|+.-...+.      +..|.++ +....+-...+|+|.+.      +.+|.+++.+..    ++. ...+.+.+
T Consensus        55 ~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~~~----~~~-~~~~~L~~  129 (199)
T PF10707_consen   55 YRQNRRELRYYKQLSLRRGVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKEGG----LTE-ELRQALDE  129 (199)
T ss_pred             hHHHHHHHHHHHHHhhccCCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHcCC----ccH-HHHHHHHH
Confidence            345566666555444      6677776 77777777889998863      245666664432    333 33333333


Q ss_pred             HHHHHHHhhhcCCCCeeeCCCCCCceeecCC--C--CeEEcc-ccchhhh
Q 046065           89 IIQGLLYLQEYFRLTIIHRDLKVSNILLDED--L--KPKISD-FGLARIL  133 (164)
Q Consensus        89 ~~~~l~~lh~~~~~~iih~dlk~~nili~~~--~--~~~l~d-fg~~~~~  133 (164)
                      +   ..++-+.   +|+..|++|.||++...  +  .+.|+| ||....+
T Consensus       130 f---~~~l~~~---~Iv~~dl~~~NIv~~~~~~~~~~lvlIDG~G~~~~i  173 (199)
T PF10707_consen  130 F---KRYLLDH---HIVIRDLNPHNIVVQRRDSGEFRLVLIDGLGEKELI  173 (199)
T ss_pred             H---HHHHHHc---CCeecCCCcccEEEEecCCCceEEEEEeCCCCcccc
Confidence            3   4555655   89999999999999653  2  578888 6665543

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=97.90  E-value=0.00054  Score=47.48  Aligned_cols=30  Identities=20%  Similarity=0.251  Sum_probs=26.0

Q ss_pred             CCeeeCCCCCCceeecCCCCeEEccccchhh
Q 046065          102 LTIIHRDLKVSNILLDEDLKPKISDFGLARI  132 (164)
Q Consensus       102 ~~iih~dlk~~nili~~~~~~~l~dfg~~~~  132 (164)
                      ..++|+|+.|.|++++..+ +.++||+.+..
T Consensus       153 ~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~  182 (226)
T TIGR02172       153 STCLHGDFQIGNLITSGKG-TYWIDLGDFGY  182 (226)
T ss_pred             CceEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence            3568999999999999877 99999998753

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.76  E-value=0.00046  Score=53.33  Aligned_cols=80  Identities=16%  Similarity=0.166  Sum_probs=49.8

Q ss_pred             eeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecC----CCCe
Q 046065           47 IETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE----DLKP  122 (164)
Q Consensus        47 ~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~----~~~~  122 (164)
                      .....-.|+|||++|..+.+...-....  ++...+.....+...-+-+.|     +.+|.|-.|-||++..    ++.+
T Consensus       272 ~~st~RVLtME~~~G~~i~Dl~~i~~~g--i~~~~i~~~l~~~~~~qIf~~-----GffHaDPHPGNilv~~~~~~~~~i  344 (538)
T KOG1235|consen  272 DLSTKRVLTMEYVDGIKINDLDAIDKRG--ISPHDILNKLVEAYLEQIFKT-----GFFHADPHPGNILVRPNPEGDEEI  344 (538)
T ss_pred             hcCcceEEEEEecCCccCCCHHHHHHcC--CCHHHHHHHHHHHHHHHHHhc-----CCccCCCCCCcEEEecCCCCCccE
Confidence            3344567999999997775553211111  333333322222222222233     8999999999999984    5678


Q ss_pred             EEccccchhhh
Q 046065          123 KISDFGLARIL  133 (164)
Q Consensus       123 ~l~dfg~~~~~  133 (164)
                      .+.|||+...+
T Consensus       345 vllDhGl~~~i  355 (538)
T KOG1235|consen  345 VLLDHGLYAVI  355 (538)
T ss_pred             EEEcccccccc
Confidence            99999987654

>TIGR02721 ycfN_thiK thiamine kinase

Probab=97.68  E-value=0.00053  Score=48.28  Aligned_cols=30  Identities=23%  Similarity=0.317  Sum_probs=25.7

Q ss_pred             CCeeeCCCCCCceeecCCCCeEEccccchhh
Q 046065          102 LTIIHRDLKVSNILLDEDLKPKISDFGLARI  132 (164)
Q Consensus       102 ~~iih~dlk~~nili~~~~~~~l~dfg~~~~  132 (164)
                      ..++|+|+.|.|++++.++ +.++||+.+..
T Consensus       146 ~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       146 LAPLHMDVHAYNLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             CeeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence            3589999999999998877 78999998753

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.60  E-value=0.001  Score=46.51  Aligned_cols=74  Identities=24%  Similarity=0.321  Sum_probs=49.4

Q ss_pred             EEEEEEecCCCCh-hhhhhCcccccccCHHHHHHHHHHHHHHHHHhhh-cCCCCeeeCCCCCCceeecCCCCeEEccccc
Q 046065           52 YMLIYEYMPKRSL-DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQE-YFRLTIIHRDLKVSNILLDEDLKPKISDFGL  129 (164)
Q Consensus        52 ~~lv~e~~~~~~L-~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~-~~~~~iih~dlk~~nili~~~~~~~l~dfg~  129 (164)
                      ..|||||++.... .-.+.+.    .+.......+..++++.+.-|-. +   +++|+|+..=|||+. .+.+.++|+|-
T Consensus       141 nVLvMEfIg~~g~pAP~LkDv----~~e~~e~~~~~~~~v~~~~~l~~~a---~LVHgDLSEyNiL~~-~~~p~iID~~Q  212 (268)
T COG1718         141 NVLVMEFIGDDGLPAPRLKDV----PLELEEAEGLYEDVVEYMRRLYKEA---GLVHGDLSEYNILVH-DGEPYIIDVSQ  212 (268)
T ss_pred             CeEEEEeccCCCCCCCCcccC----CcCchhHHHHHHHHHHHHHHHHHhc---CcccccchhhheEEE-CCeEEEEECcc
Confidence            3599999865311 1111111    12222455556667766666655 4   999999999999998 88899999998


Q ss_pred             hhhh
Q 046065          130 ARIL  133 (164)
Q Consensus       130 ~~~~  133 (164)
                      +-..
T Consensus       213 aV~~  216 (268)
T COG1718         213 AVTI  216 (268)
T ss_pred             cccc
Confidence            7544

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=97.52  E-value=0.00054  Score=47.23  Aligned_cols=86  Identities=20%  Similarity=0.188  Sum_probs=57.0

Q ss_pred             HHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHHHHHHHHHHHHHHhhhcCC
Q 046065           23 EEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFR  101 (164)
Q Consensus        23 ~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~  101 (164)
                      ..+..+.+++.++.  .|+++ ..  ..-.+.++.|.|-....-            +   .- +..--+++|.-.|+. .
T Consensus       103 ~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i~------------~---~N-~i~agi~~L~~fH~~-~  161 (308)
T PF07387_consen  103 ALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKIN------------F---SN-FITAGIKDLMDFHSE-N  161 (308)
T ss_pred             hhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCcccc------------h---hH-HHHHhHHHHHHhhcc-C
Confidence            34566777877775  46776 32  444567999998532221            0   01 111113456667755 4


Q ss_pred             CCeeeCCCCCCceeecCCCCeEEccccc
Q 046065          102 LTIIHRDLKVSNILLDEDLKPKISDFGL  129 (164)
Q Consensus       102 ~~iih~dlk~~nili~~~~~~~l~dfg~  129 (164)
                      .+.+|+|..|+|||.|..|.+||.|=+.
T Consensus       162 ~~~lHGD~np~NiM~D~~G~lKlVDP~~  189 (308)
T PF07387_consen  162 QHCLHGDCNPDNIMCDKFGYLKLVDPVC  189 (308)
T ss_pred             CCeecCCCChhheeecCCCCEEecChhh
Confidence            5899999999999999999999999653

The function of this family is unknown.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=97.49  E-value=0.0019  Score=44.33  Aligned_cols=32  Identities=41%  Similarity=0.449  Sum_probs=22.1

Q ss_pred             CCCeeeCCCCCCceeec-CCCCeEEccccchhh
Q 046065          101 RLTIIHRDLKVSNILLD-EDLKPKISDFGLARI  132 (164)
Q Consensus       101 ~~~iih~dlk~~nili~-~~~~~~l~dfg~~~~  132 (164)
                      ...++|+|+.|.||+++ .++.+.++||+.+..
T Consensus       165 ~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  165 PPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             CEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             CcEEEEeccccccceeeeccceeEEEecccceE
Confidence            44799999999999999 566668999998754

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=97.47  E-value=0.0016  Score=43.23  Aligned_cols=112  Identities=20%  Similarity=0.196  Sum_probs=69.4

Q ss_pred             CCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeEeEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHHH
Q 046065            5 DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVH   84 (164)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~   84 (164)
                      .|..+|+|.-..++  ...++..|++++..+...++-.-.+.+...  ++.|||+.|.+|.......      +-...  
T Consensus        44 ~~~~~a~Kvrr~ds--~r~~l~kEakiLeil~g~~~~p~vy~yg~~--~i~me~i~G~~L~~~~~~~------~rk~l--  111 (201)
T COG2112          44 RGGEVALKVRRRDS--PRRNLEKEAKILEILAGEGVTPEVYFYGED--FIRMEYIDGRPLGKLEIGG------DRKHL--  111 (201)
T ss_pred             cCceEEEEEecCCc--chhhHHHHHHHHHHhhhcCCCceEEEechh--hhhhhhhcCcchhhhhhcc------cHHHH--
Confidence            35688888854443  346789999999999876665533333322  2349999998887765431      11122  


Q ss_pred             HHHHHHHHHHHhhhcCCCCeeeCCCC-CCceeecCCCCeEEccccchhhh
Q 046065           85 IIKGIIQGLLYLQEYFRLTIIHRDLK-VSNILLDEDLKPKISDFGLARIL  133 (164)
Q Consensus        85 ~~~~~~~~l~~lh~~~~~~iih~dlk-~~nili~~~~~~~l~dfg~~~~~  133 (164)
                        ..++.+.--|-..   +|-|+.+. |...++...+.+.|+||..|+..
T Consensus       112 --~~vlE~a~~LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k  156 (201)
T COG2112         112 --LRVLEKAYKLDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATFK  156 (201)
T ss_pred             --HHHHHHHHHHHHh---ccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence              2233332223333   78887764 44555556668999999999854

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=97.47  E-value=6.6e-05  Score=61.31  Aligned_cols=122  Identities=19%  Similarity=0.122  Sum_probs=84.9

Q ss_pred             CCCceeeEe-EEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCce
Q 046065           36 QHLNLIRVG-FCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNI  114 (164)
Q Consensus        36 ~h~~i~~~~-~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~ni  114 (164)
                      .+|.+++.. ........+|+++++.+++|...+.....   ........+...+.++.++||+.   .+.|+|++|.|.
T Consensus       862 ~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~---~saepaRs~i~~~vqs~e~L~s~---~r~h~~~~p~~~  935 (1205)
T KOG0606|consen  862 RSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGC---LSAEPARSPILERVQSLESLHSS---LRKHRDLKPDSL  935 (1205)
T ss_pred             CCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCCC---cccccccchhHHHHhhhhccccc---hhhcccccccch
Confidence            345555431 22334567899999999999888766432   33333344556777889999986   689999999999


Q ss_pred             eecCCCCeEEccccchhhhh----------------------h-----------hhhhhhcccccccCcceecCCcceec
Q 046065          115 LLDEDLKPKISDFGLARILR----------------------K-----------MILKQIQIELGYIPPEYVGRGVYYKK  161 (164)
Q Consensus       115 li~~~~~~~l~dfg~~~~~~----------------------~-----------~~~~~~~~~~~~~aPE~~~~~~~~~~  161 (164)
                      ++...+.-++.||+..+...                      .           .......+++.|.+||...++.....
T Consensus       936 l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ 1015 (1205)
T KOG0606|consen  936 LIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSA 1015 (1205)
T ss_pred             hhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCc
Confidence            99999988899987432110                      0           00123567899999999988887776


Q ss_pred             cC
Q 046065          162 FS  163 (164)
Q Consensus       162 ~D  163 (164)
                      +|
T Consensus      1016 ad 1017 (1205)
T KOG0606|consen 1016 AD 1017 (1205)
T ss_pred             ch
Confidence            66

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=97.47  E-value=7.6e-05  Score=58.23  Aligned_cols=130  Identities=15%  Similarity=0.092  Sum_probs=85.1

Q ss_pred             HHHHHHHHHhccCCCc-eeeE-eEEeeCCcEEEEEEecCCC-ChhhhhhCcccccccCHHHHHHHHHHHHHHHHHhhhcC
Q 046065           24 EFKNEVMLTAKLQHLN-LIRV-GFCIETQEYMLIYEYMPKR-SLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYF  100 (164)
Q Consensus        24 ~~~~e~~~l~~l~h~~-i~~~-~~~~~~~~~~lv~e~~~~~-~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~  100 (164)
                      ...-++++|.+++||| .+.. +.+..+.-.+++++++.++ +-...+.  .....+.........+.-..+++++|+. 
T Consensus       279 ~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~--~se~~~~~~~~~~~~r~et~~l~~l~~~-  355 (829)
T KOG0576|consen  279 SRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMT--VSEIALEQYQFAYPLRKETRPLAELHSS-  355 (829)
T ss_pred             hhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCC--hhhHhhhhhhhhhhhhhhcccccccccc-
Confidence            4456889999999999 3332 4555555677999998776 2211111  1111244445555556666788888864 


Q ss_pred             CCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh-hhhhhcccccccCcceecCCcceeccC
Q 046065          101 RLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM-ILKQIQIELGYIPPEYVGRGVYYKKFS  163 (164)
Q Consensus       101 ~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~D  163 (164)
                        .=+|+|    ||+.. ++..+..+|+....+... ..+...+++.|+|||+.....+..+.|
T Consensus       356 --~~~~~d----~~l~s-~~~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~  412 (829)
T KOG0576|consen  356 --YKVHRD----NILGS-EEEVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQENTIDGCPD  412 (829)
T ss_pred             --cccCcc----ccccc-ccccccccccCCcccCcccccccCCCCCCCCCchhhcccccccCCC
Confidence              346776    55543 366888999988766543 235677899999999998888877665

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=97.46  E-value=0.0026  Score=44.20  Aligned_cols=31  Identities=26%  Similarity=0.427  Sum_probs=25.9

Q ss_pred             CCeeeCCCCCCceeecCCCCeEEccccchhh
Q 046065          102 LTIIHRDLKVSNILLDEDLKPKISDFGLARI  132 (164)
Q Consensus       102 ~~iih~dlk~~nili~~~~~~~l~dfg~~~~  132 (164)
                      ..++|+|+.+.|++++..+..-++||+.+..
T Consensus       164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~  194 (235)
T cd05155         164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV  194 (235)
T ss_pred             ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence            4589999999999998766567999998753

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=97.44  E-value=0.0021  Score=44.50  Aligned_cols=31  Identities=29%  Similarity=0.424  Sum_probs=27.1

Q ss_pred             CCeeeCCCCCCceeecC-CCCeEEccccchhh
Q 046065          102 LTIIHRDLKVSNILLDE-DLKPKISDFGLARI  132 (164)
Q Consensus       102 ~~iih~dlk~~nili~~-~~~~~l~dfg~~~~  132 (164)
                      ..++|+|+.+.||+++. ++.+.++||..+..
T Consensus       170 ~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~  201 (235)
T cd05157         170 IVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY  201 (235)
T ss_pred             EEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence            46899999999999997 57899999998754

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=97.43  E-value=0.00012  Score=57.20  Aligned_cols=76  Identities=16%  Similarity=0.293  Sum_probs=58.2

Q ss_pred             HHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh------hhh-----hhhcccccccCcceecC
Q 046065           87 KGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK------MIL-----KQIQIELGYIPPEYVGR  155 (164)
Q Consensus        87 ~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~------~~~-----~~~~~~~~~~aPE~~~~  155 (164)
                      .+.+.|+.|+|..  ..++|+++.|++|.++..+..|+..|+++.....      ..+     .......-|.|||.+..
T Consensus       106 ~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            4555788999974  5899999999999999999999999998754432      111     11233556999999988


Q ss_pred             CcceeccCC
Q 046065          156 GVYYKKFSL  164 (164)
Q Consensus       156 ~~~~~~~Di  164 (164)
                      ...+.++|+
T Consensus       184 ~~~~~~sd~  192 (700)
T KOG2137|consen  184 TTNTPASDV  192 (700)
T ss_pred             ccccccccc
Confidence            777888875

>PLN02876 acyl-CoA dehydrogenase

Probab=97.37  E-value=0.0055  Score=50.39  Aligned_cols=57  Identities=19%  Similarity=0.311  Sum_probs=35.2

Q ss_pred             EEEEEEccccc-cccHHHHHHHHHHHhccC-CCce--eeE-eEEeeC---CcEEEEEEecCCCCh
Q 046065            8 IIAVKKLSKKS-TQGFEEFKNEVMLTAKLQ-HLNL--IRV-GFCIET---QEYMLIYEYMPKRSL   64 (164)
Q Consensus         8 ~vavK~~~~~~-~~~~~~~~~e~~~l~~l~-h~~i--~~~-~~~~~~---~~~~lv~e~~~~~~L   64 (164)
                      .+++|...... ......+.+|+++++.+. |+++  .++ ..+.+.   +..|+|||++++..+
T Consensus        67 ~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~~  131 (822)
T PLN02876         67 RYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRIF  131 (822)
T ss_pred             eEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCccc
Confidence            56666653321 122345789999999995 6655  443 333332   457899999987543

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=96.98  E-value=0.0017  Score=48.86  Aligned_cols=100  Identities=11%  Similarity=0.088  Sum_probs=70.8

Q ss_pred             EEEEEEecCCCC-hhhhhh---CcccccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccc
Q 046065           52 YMLIYEYMPKRS-LDYFLF---DPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDF  127 (164)
Q Consensus        52 ~~lv~e~~~~~~-L~~~~~---~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~df  127 (164)
                      ..++|..+++.. +..+..   ..+.-..+.++..+...+.++.+-..+|..   +-.-+|++++|+|+...+.+.|.|-
T Consensus        85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~---Gh~vGDVn~~~~lVsd~~~V~LVds  161 (637)
T COG4248          85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEH---GHVVGDVNQNSFLVSDDSKVVLVDS  161 (637)
T ss_pred             eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhc---CCcccccCccceeeecCceEEEEcc
Confidence            346666665532 222221   122223478899999999999999999998   9999999999999999999999985


Q ss_pred             cchhh-hhhhhhhhhcccccccCcceec
Q 046065          128 GLARI-LRKMILKQIQIELGYIPPEYVG  154 (164)
Q Consensus       128 g~~~~-~~~~~~~~~~~~~~~~aPE~~~  154 (164)
                      ..-.. .+.......+|++.|.+||.-.
T Consensus       162 Dsfqi~~ng~~~~cpVg~~eftPPElQ~  189 (637)
T COG4248         162 DSFQINANGTLHLCPVGVSEFTPPELQT  189 (637)
T ss_pred             cceeeccCCceEecccCccccCCHHHhc
Confidence            43221 2223335577899999999753

>PLN02236 choline kinase

Probab=96.92  E-value=0.011  Score=43.76  Aligned_cols=31  Identities=32%  Similarity=0.503  Sum_probs=26.7

Q ss_pred             CCeeeCCCCCCceeecC-CCCeEEccccchhh
Q 046065          102 LTIIHRDLKVSNILLDE-DLKPKISDFGLARI  132 (164)
Q Consensus       102 ~~iih~dlk~~nili~~-~~~~~l~dfg~~~~  132 (164)
                      ..++|+|+++.|||++. ++.+.++||..+..
T Consensus       200 ~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~  231 (344)
T PLN02236        200 IGFCHNDLQYGNIMIDEETRAITIIDYEYASY  231 (344)
T ss_pred             ceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence            46899999999999986 46799999998864

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=96.84  E-value=0.00046  Score=52.20  Aligned_cols=44  Identities=23%  Similarity=0.261  Sum_probs=35.8

Q ss_pred             CCeEEccccchhhhhhhhhhhhcccccccCcceecCCcceeccCC
Q 046065          120 LKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       120 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di  164 (164)
                      .++||+|||.|+..... ++....|..|+|||++.+..|+..+||
T Consensus       391 i~vKIaDlGNACW~~kh-FT~DIQTRQYRapEVllGsgY~~~ADi  434 (590)
T KOG1290|consen  391 IRVKIADLGNACWVHKH-FTEDIQTRQYRAPEVLLGSGYSTSADI  434 (590)
T ss_pred             eeEEEeeccchhhhhhh-hchhhhhhhccCcceeecCCCCCchhH
Confidence            47999999999865432 344556888999999999999999986

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=96.77  E-value=0.00056  Score=54.78  Aligned_cols=60  Identities=10%  Similarity=0.024  Sum_probs=43.2

Q ss_pred             eeCCCCCC-ceeecCCCCeEEccccchhhhhhhh----hhhhcccccccCcceecCCcceeccCC
Q 046065          105 IHRDLKVS-NILLDEDLKPKISDFGLARILRKMI----LKQIQIELGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       105 ih~dlk~~-nili~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di  164 (164)
                      .+++..|. |+++...+..++.||+.+.......    .....||+.|+|||++.+..++.++||
T Consensus       499 ~~~~~~p~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~~~vGT~~Y~APE~l~~~~~~~~~Di  563 (669)
T cd05610         499 PTQKPRPHGNLYQTPKQVKIGTPYRTPKSVRRGAAPVEGERILGTPDYLAPELLLGKPHGPAVDW  563 (669)
T ss_pred             CCCCCCCCCceeECCccccccccCCCchhhhcccccccCCceeeCccccCHHHcCCCCCCcHHHH
Confidence            33455555 5666666677888999886653221    134578999999999998899999986

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=96.63  E-value=0.026  Score=40.36  Aligned_cols=31  Identities=32%  Similarity=0.609  Sum_probs=25.5

Q ss_pred             CCeeeCCCCCCceeecCCCC-eEEccccchhh
Q 046065          102 LTIIHRDLKVSNILLDEDLK-PKISDFGLARI  132 (164)
Q Consensus       102 ~~iih~dlk~~nili~~~~~-~~l~dfg~~~~  132 (164)
                      ..++|+|+.|.|++++.++. +-|+||+.+..
T Consensus       185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i  216 (276)
T cd05152         185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV  216 (276)
T ss_pred             CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence            35899999999999987555 56999998754

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.61  E-value=0.014  Score=43.39  Aligned_cols=53  Identities=26%  Similarity=0.394  Sum_probs=42.9

Q ss_pred             cCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhh
Q 046065           77 LDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARI  132 (164)
Q Consensus        77 ~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~  132 (164)
                      -...+...++++.+..+.-+...  ...-|||+.-.||+|+ +|.+.|+||.+++.
T Consensus       318 ~~~~e~lsff~s~~sil~~lekk--f~fehrnlt~~niLId-~GnvtLIDfklsRl  370 (488)
T COG5072         318 DRSEEELSFFWSCISILDILEKK--FPFEHRNLTLDNILID-EGNVTLIDFKLSRL  370 (488)
T ss_pred             ccHHHHHHHHHHHHHHHhhhhhc--CCcccccccccceeee-cCceEEEEeeeeec
Confidence            34566777888877776666654  3678999999999999 99999999999874

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=96.40  E-value=0.043  Score=41.07  Aligned_cols=122  Identities=16%  Similarity=0.139  Sum_probs=73.7

Q ss_pred             cCCCcEEEEEEcccc------------------------ccccH--HHHHHHHHHHhccCCCceeeEeEEeeCCcEEEEE
Q 046065            3 LPDGQIIAVKKLSKK------------------------STQGF--EEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIY   56 (164)
Q Consensus         3 ~~~~~~vavK~~~~~------------------------~~~~~--~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~   56 (164)
                      -.+|+.+|||+....                        .|...  -+...|++=|+++....|....-....+ -.|||
T Consensus       165 ~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP~PePIlLk~-hVLVM  243 (520)
T KOG2270|consen  165 EEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIPCPEPILLKN-HVLVM  243 (520)
T ss_pred             cCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCCCCCceeeec-ceEee
Confidence            357889999987642                        01111  1344577767777655544333333332 34899


Q ss_pred             EecCCCChhhhhhCcccccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchh
Q 046065           57 EYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLAR  131 (164)
Q Consensus        57 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~  131 (164)
                      +|+.. +-+  .........+....+.++-.+++.-+..|-..  ++++|-||.-=|+|+ +.|.+.++|-+-+-
T Consensus       244 ~FlGr-dgw--~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~--c~LVHADLSEfN~Ly-hdG~lyiIDVSQSV  312 (520)
T KOG2270|consen  244 EFLGR-DGW--AAPKLKDASLSTSKARELYQQCVRIMRRLYQK--CRLVHADLSEFNLLY-HDGKLYIIDVSQSV  312 (520)
T ss_pred             eeccC-CCC--cCcccccccCChHHHHHHHHHHHHHHHHHHHH--hceeccchhhhhheE-ECCEEEEEEccccc
Confidence            99863 221  11111112255556666667777777666554  399999999989887 56779999987653

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=95.64  E-value=0.038  Score=39.89  Aligned_cols=32  Identities=34%  Similarity=0.400  Sum_probs=27.7

Q ss_pred             CCCeeeCCCCCCceeecCC----CCeEEccccchhh
Q 046065          101 RLTIIHRDLKVSNILLDED----LKPKISDFGLARI  132 (164)
Q Consensus       101 ~~~iih~dlk~~nili~~~----~~~~l~dfg~~~~  132 (164)
                      +..++|+|+.+.||+++.+    +.+.++||+.+..
T Consensus       178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~  213 (302)
T cd05156         178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY  213 (302)
T ss_pred             CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence            4578999999999999874    7899999998864

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>PRK05231 homoserine kinase; Provisional

Probab=95.41  E-value=0.012  Score=42.81  Aligned_cols=31  Identities=32%  Similarity=0.386  Sum_probs=26.4

Q ss_pred             CCCeeeCCCCCCceeecCCCCeEEccccchh
Q 046065          101 RLTIIHRDLKVSNILLDEDLKPKISDFGLAR  131 (164)
Q Consensus       101 ~~~iih~dlk~~nili~~~~~~~l~dfg~~~  131 (164)
                      +.+++|+|+.|.|++++.+...-++||+.+.
T Consensus       186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             CcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            4579999999999999866556899999875

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=94.83  E-value=0.024  Score=41.10  Aligned_cols=31  Identities=35%  Similarity=0.427  Sum_probs=27.4

Q ss_pred             CCCeeeCCCCCCceeecCCCCeEEccccchh
Q 046065          101 RLTIIHRDLKVSNILLDEDLKPKISDFGLAR  131 (164)
Q Consensus       101 ~~~iih~dlk~~nili~~~~~~~l~dfg~~~  131 (164)
                      ..+++|+|+.+.|++++.++.+.++||+.+.
T Consensus       186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             CCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence            4589999999999999988877899999874

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PRK10271 thiK thiamine kinase; Provisional

Probab=94.78  E-value=0.029  Score=37.71  Aligned_cols=29  Identities=17%  Similarity=0.258  Sum_probs=25.4

Q ss_pred             CeeeCCCCCCceeecCCCCeEEccccchhh
Q 046065          103 TIIHRDLKVSNILLDEDLKPKISDFGLARI  132 (164)
Q Consensus       103 ~iih~dlk~~nili~~~~~~~l~dfg~~~~  132 (164)
                      -.+|+|+.|.|+++..++ ++++|++.+..
T Consensus        78 ~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~  106 (188)
T PRK10271         78 APLHMDVHAGNLVHSASG-LRLIDWEYAGD  106 (188)
T ss_pred             eeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence            569999999999997777 89999998764

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=94.53  E-value=0.047  Score=40.23  Aligned_cols=91  Identities=18%  Similarity=0.161  Sum_probs=56.8

Q ss_pred             HHHHHHHHhccC-CCceeeEeEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHHHHHHHHHHHHHHhhhcCCCC
Q 046065           25 FKNEVMLTAKLQ-HLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLT  103 (164)
Q Consensus        25 ~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~  103 (164)
                      ...|...|+.+. |-.-++  .-.+.+.-++|||++.+-.|.+.-.-      .+.+   .+...+...+--|..+   +
T Consensus       157 a~kEfafmkaL~e~gfpVP--kpiD~~RH~Vvmelv~g~Pl~~v~~v------~d~~---~ly~~lm~~Iv~la~~---G  222 (465)
T KOG2268|consen  157 ATKEFAFMKALYERGFPVP--KPIDHNRHCVVMELVDGYPLRQVRHV------EDPP---TLYDDLMGLIVRLANH---G  222 (465)
T ss_pred             HHHHHHHHHHHHHcCCCCC--CcccccceeeHHHhhcccceeeeeec------CChH---HHHHHHHHHHHHHHHc---C
Confidence            346788888774 322111  12233566799999888666543211      1111   1223333334445555   9


Q ss_pred             eeeCCCCCCceeecCCCCeEEccccc
Q 046065          104 IIHRDLKVSNILLDEDLKPKISDFGL  129 (164)
Q Consensus       104 iih~dlk~~nili~~~~~~~l~dfg~  129 (164)
                      +||+|..-=||++..++.++++||=-
T Consensus       223 lIHgDFNEFNimv~dd~~i~vIDFPQ  248 (465)
T KOG2268|consen  223 LIHGDFNEFNIMVKDDDKIVVIDFPQ  248 (465)
T ss_pred             ceecccchheeEEecCCCEEEeechH
Confidence            99999999999999999999999863

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=94.45  E-value=0.029  Score=38.30  Aligned_cols=30  Identities=37%  Similarity=0.532  Sum_probs=21.3

Q ss_pred             CeeeCCCCCCceee-cCCCCeEEccccchhh
Q 046065          103 TIIHRDLKVSNILL-DEDLKPKISDFGLARI  132 (164)
Q Consensus       103 ~iih~dlk~~nili-~~~~~~~l~dfg~~~~  132 (164)
                      -+.|+|+.+.||++ ..++.++++||..+..
T Consensus       144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred             eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence            57999999999999 7889999999998864

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=94.44  E-value=0.03  Score=40.21  Aligned_cols=31  Identities=35%  Similarity=0.427  Sum_probs=26.9

Q ss_pred             CCeeeCCCCCCceeecCCCCeEEccccchhh
Q 046065          102 LTIIHRDLKVSNILLDEDLKPKISDFGLARI  132 (164)
Q Consensus       102 ~~iih~dlk~~nili~~~~~~~l~dfg~~~~  132 (164)
                      ..++|+|+.|.|++++.++.+.|+||+.+..
T Consensus       175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~  205 (296)
T cd05153         175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT  205 (296)
T ss_pred             CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence            4699999999999999877778999998753

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=94.25  E-value=0.003  Score=54.65  Aligned_cols=138  Identities=13%  Similarity=0.025  Sum_probs=89.5

Q ss_pred             HHHHHHHhccCCCceeeE-eEEee--CCcEEEEEEecCCCChhhhhhCcccccc-cCHHHHHHHHHHH-HHHHHHhhhcC
Q 046065           26 KNEVMLTAKLQHLNLIRV-GFCIE--TQEYMLIYEYMPKRSLDYFLFDPIRMLI-LDCKKRVHIIKGI-IQGLLYLQEYF  100 (164)
Q Consensus        26 ~~e~~~l~~l~h~~i~~~-~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~-~~~~~~~~~~~~~-~~~l~~lh~~~  100 (164)
                      ..|...++...|+++... .-...  ....+..++++.+|.+.+.+-++..... +.... .....++ ..+..-+|..-
T Consensus      1277 l~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~-v~~~~kvsvl~~~~~ls~t 1355 (2724)
T KOG1826|consen 1277 LSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSP-VHLRHKVSVLNRNVILSLT 1355 (2724)
T ss_pred             hhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhch-HHHHHHHHHhccchhhhcc
Confidence            334445566688887774 33332  2346788899999999888876443211 21111 2222233 33444444332


Q ss_pred             --CCCeeeCCCCCCceeecCCCCeEEccccchhhhhh--hhhhhhcccccccCcceecCCcceeccCC
Q 046065          101 --RLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK--MILKQIQIELGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       101 --~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~~~~~~Di  164 (164)
                        +.-.+|+++|+-|.+|..+-.+++.++|+.+....  .......+++.|+.|+...+-+++.|+|+
T Consensus      1356 nlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdi 1423 (2724)
T KOG1826|consen 1356 NLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDI 1423 (2724)
T ss_pred             cCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHH
Confidence              33478999999999999999999999999984332  12245667888999999887788887764

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=94.09  E-value=0.16  Score=36.64  Aligned_cols=29  Identities=28%  Similarity=0.390  Sum_probs=25.1

Q ss_pred             CCeeeCCCCCCceeecCCCCeEEccccchh
Q 046065          102 LTIIHRDLKVSNILLDEDLKPKISDFGLAR  131 (164)
Q Consensus       102 ~~iih~dlk~~nili~~~~~~~l~dfg~~~  131 (164)
                      .+++|+|+.+.|++++. +.+.++||+.+.
T Consensus       187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~  215 (313)
T TIGR02906       187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT  215 (313)
T ss_pred             CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence            47899999999999987 668999999654

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only]

Probab=93.89  E-value=0.2  Score=36.87  Aligned_cols=29  Identities=41%  Similarity=0.601  Sum_probs=25.8

Q ss_pred             eeeCCCCCCceeecCCCC-eEEccccchhh
Q 046065          104 IIHRDLKVSNILLDEDLK-PKISDFGLARI  132 (164)
Q Consensus       104 iih~dlk~~nili~~~~~-~~l~dfg~~~~  132 (164)
                      +||+|+.|.|++++.... +-++||+.+..
T Consensus       199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~  228 (331)
T COG2334         199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAGY  228 (331)
T ss_pred             eeecCCCccceeEcCCCCeeeEEEcccccc
Confidence            999999999999998875 88999998753

>COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism]

Probab=93.89  E-value=0.17  Score=36.16  Aligned_cols=30  Identities=27%  Similarity=0.336  Sum_probs=27.2

Q ss_pred             CeeeCCCCCCceeecCCCCeEEccccchhh
Q 046065          103 TIIHRDLKVSNILLDEDLKPKISDFGLARI  132 (164)
Q Consensus       103 ~iih~dlk~~nili~~~~~~~l~dfg~~~~  132 (164)
                      -++|+|+.|.|++.+..+.++|+||.-|..
T Consensus       154 v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~  183 (269)
T COG0510         154 VPCHNDLNPGNLLLTDKGGLFLIDWEYAGL  183 (269)
T ss_pred             eeecCCCCccceEEcCCCcEEEEecccCCC
Confidence            589999999999999989999999998754

>PHA03111 Ser/Thr kinase; Provisional

Probab=93.68  E-value=0.16  Score=37.53  Aligned_cols=53  Identities=23%  Similarity=0.243  Sum_probs=32.9

Q ss_pred             HHHHHHHHHHHHHHHHh-hhcCCCCeeeCCCCCCceeecCCC------------------CeEEccccchhh
Q 046065           80 KKRVHIIKGIIQGLLYL-QEYFRLTIIHRDLKVSNILLDEDL------------------KPKISDFGLARI  132 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~l-h~~~~~~iih~dlk~~nili~~~~------------------~~~l~dfg~~~~  132 (164)
                      ...+.++.|++-..-.+ ..-+-...+|-||||+|||+....                  +++|.||.+++.
T Consensus       279 ~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv  350 (444)
T PHA03111        279 EYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITLKDATYVFNEPIKACLNDFDFSQV  350 (444)
T ss_pred             HHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEECCeEEEeccchhhhhcccCHHHH
Confidence            44556667775432122 111123689999999999995432                  367778887754

>PRK06148 hypothetical protein; Provisional

Probab=93.24  E-value=0.24  Score=42.00  Aligned_cols=31  Identities=39%  Similarity=0.492  Sum_probs=25.9

Q ss_pred             CCCeeeCCCCCCceeecCCC--CeE-Eccccchh
Q 046065          101 RLTIIHRDLKVSNILLDEDL--KPK-ISDFGLAR  131 (164)
Q Consensus       101 ~~~iih~dlk~~nili~~~~--~~~-l~dfg~~~  131 (164)
                      +..+||+|+.+.||+++.++  .+. |+|||.+.
T Consensus       202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~  235 (1013)
T PRK06148        202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAV  235 (1013)
T ss_pred             CcceECCCCCcccEEEcCCCCcceEEEEECcccc
Confidence            45799999999999998764  555 99999874

>PRK10593 hypothetical protein; Provisional

Probab=93.07  E-value=1.2  Score=32.32  Aligned_cols=56  Identities=13%  Similarity=0.024  Sum_probs=34.5

Q ss_pred             EEEEEEccccccccHHHHHHHHHHHhccCC---CceeeE-eEEee---CCcEEEEEEecCCCChh
Q 046065            8 IIAVKKLSKKSTQGFEEFKNEVMLTAKLQH---LNLIRV-GFCIE---TQEYMLIYEYMPKRSLD   65 (164)
Q Consensus         8 ~vavK~~~~~~~~~~~~~~~e~~~l~~l~h---~~i~~~-~~~~~---~~~~~lv~e~~~~~~L~   65 (164)
                      .+.+|... . ......+..|+..++.+.-   ..+.++ ..+..   .+..++|||++++.++.
T Consensus        39 ~~~~k~~~-~-~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~~~  101 (297)
T PRK10593         39 NPMPLMAR-S-FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGVSVE  101 (297)
T ss_pred             CEEEEEec-c-cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCEecC
Confidence            45667742 2 1122467889999888842   234454 33332   35689999999987653

>PTZ00384 choline kinase; Provisional

Probab=92.67  E-value=0.87  Score=34.35  Aligned_cols=29  Identities=31%  Similarity=0.279  Sum_probs=24.1

Q ss_pred             CeeeCCCCCCceeecCCCCeEEccccchhh
Q 046065          103 TIIHRDLKVSNILLDEDLKPKISDFGLARI  132 (164)
Q Consensus       103 ~iih~dlk~~nili~~~~~~~l~dfg~~~~  132 (164)
                      ...|.|+-+.||+.+. +.+.++||..|..
T Consensus       228 VfCHNDL~~gNIL~~~-~~l~lID~EYA~~  256 (383)
T PTZ00384        228 LFCHNDLFFTNILDFN-QGIYFIDFDFAGF  256 (383)
T ss_pred             eeeeccCCcccEEecC-CCEEEEEeccccC
Confidence            5799999999998754 5599999998753

>PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly

Probab=92.34  E-value=0.13  Score=38.14  Aligned_cols=52  Identities=29%  Similarity=0.441  Sum_probs=32.8

Q ss_pred             HHHHHHHHHHHHHHHHhh--hc-CCCCeeeCCCCCCceeecCCC------------------CeEEccccchhhh
Q 046065           80 KKRVHIIKGIIQGLLYLQ--EY-FRLTIIHRDLKVSNILLDEDL------------------KPKISDFGLARIL  133 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh--~~-~~~~iih~dlk~~nili~~~~------------------~~~l~dfg~~~~~  133 (164)
                      .....++.|++  |-|+-  .. +-...+|-||||+|||+....                  +++|.||.+++..
T Consensus       275 ~YvkfifLQia--LLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~  347 (434)
T PF05445_consen  275 EYVKFIFLQIA--LLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVA  347 (434)
T ss_pred             HHHHHHHHHHH--HHHeeeecCCCcceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhc
Confidence            34455666664  44411  11 112689999999999995322                  3688888888643

; GO: 0004672 protein kinase activity, 0005524 ATP binding

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=92.31  E-value=0.085  Score=38.32  Aligned_cols=32  Identities=28%  Similarity=0.408  Sum_probs=28.0

Q ss_pred             CCCeeeCCCCCCceeecCCCCeEEccccchhh
Q 046065          101 RLTIIHRDLKVSNILLDEDLKPKISDFGLARI  132 (164)
Q Consensus       101 ~~~iih~dlk~~nili~~~~~~~l~dfg~~~~  132 (164)
                      ..+++|+|+.+.|++++.++.+.++||..+..
T Consensus       195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~  226 (309)
T TIGR02904       195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF  226 (309)
T ss_pred             ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence            34799999999999999988899999998753

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain

Probab=92.27  E-value=0.14  Score=34.72  Aligned_cols=31  Identities=29%  Similarity=0.370  Sum_probs=25.7

Q ss_pred             CCeeeCCCCCCceeecCCC-----CeEEccccchhh
Q 046065          102 LTIIHRDLKVSNILLDEDL-----KPKISDFGLARI  132 (164)
Q Consensus       102 ~~iih~dlk~~nili~~~~-----~~~l~dfg~~~~  132 (164)
                      ..++|+|+.+.|+++..++     .+.++||..+..
T Consensus       120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~  155 (196)
T smart00587      120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHY  155 (196)
T ss_pred             eEEeeCCCCccceeeccCCCCCccceEEEecccCCc
Confidence            4689999999999997543     589999998754

subfamily of choline kinases

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=91.94  E-value=0.18  Score=36.94  Aligned_cols=31  Identities=23%  Similarity=0.483  Sum_probs=27.7

Q ss_pred             CCeeeCCCCCCceeecCCCCeEEccccchhh
Q 046065          102 LTIIHRDLKVSNILLDEDLKPKISDFGLARI  132 (164)
Q Consensus       102 ~~iih~dlk~~nili~~~~~~~l~dfg~~~~  132 (164)
                      ..++|+|..+.|++++..+.+-+.||+++..
T Consensus       198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l  228 (321)
T COG3173         198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATL  228 (321)
T ss_pred             ceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence            4689999999999999988899999998754

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=91.76  E-value=0.18  Score=37.11  Aligned_cols=30  Identities=30%  Similarity=0.429  Sum_probs=25.8

Q ss_pred             CeeeCCCCCCceeecC-CCCeEEccccchhh
Q 046065          103 TIIHRDLKVSNILLDE-DLKPKISDFGLARI  132 (164)
Q Consensus       103 ~iih~dlk~~nili~~-~~~~~l~dfg~~~~  132 (164)
                      -+.|+|+.+.||+++. ++.++++||+.|..
T Consensus       183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag~  213 (330)
T PLN02421        183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY  213 (330)
T ss_pred             EEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence            4799999999999975 57899999998754

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=91.72  E-value=2.3  Score=30.77  Aligned_cols=56  Identities=21%  Similarity=0.253  Sum_probs=29.6

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccC--CC-ceeeE-eEEeeCCcEEEEEEecCCC
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQ--HL-NLIRV-GFCIETQEYMLIYEYMPKR   62 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--h~-~i~~~-~~~~~~~~~~lv~e~~~~~   62 (164)
                      .+++.+.||.-...   ....+..|+.-|+.+.  .+ .+.++ ......+..+|++|+++.+
T Consensus        38 ~~~~~~FvK~~~~~---~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~   97 (288)
T PF03881_consen   38 TDGGSYFVKVNSES---GRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG   97 (288)
T ss_dssp             TTS-EEEEEEEEGG---GCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred             CCCccEEEEecChh---hHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence            45778899986522   2245677888888773  22 34444 3333345568999998765

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>PRK06149 hypothetical protein; Provisional

Probab=89.78  E-value=0.68  Score=39.26  Aligned_cols=31  Identities=26%  Similarity=0.393  Sum_probs=25.1

Q ss_pred             CCCeeeCCCCCCceeecCCC--C---eEEccccchh
Q 046065          101 RLTIIHRDLKVSNILLDEDL--K---PKISDFGLAR  131 (164)
Q Consensus       101 ~~~iih~dlk~~nili~~~~--~---~~l~dfg~~~  131 (164)
                      +.++||+|+.+.|++++.+.  .   .-|+|||.+.
T Consensus       207 ~~g~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~~  242 (972)
T PRK06149        207 PLQAVHLDITDDNVVGSRDADGRWQPDGVIDFGDLV  242 (972)
T ss_pred             cccccCCCCCcccEEEcCCCCCCcceeEEEEcccch
Confidence            45799999999999998642  2   4799999764

>PRK12396 5-methylribose kinase; Reviewed

Probab=89.47  E-value=0.29  Score=37.00  Aligned_cols=29  Identities=28%  Similarity=0.440  Sum_probs=24.4

Q ss_pred             CCeeeCCCCCCceeecCCCCeEEccccchh
Q 046065          102 LTIIHRDLKVSNILLDEDLKPKISDFGLAR  131 (164)
Q Consensus       102 ~~iih~dlk~~nili~~~~~~~l~dfg~~~  131 (164)
                      ..++|+|+.|.|||+..++ +|++|..++-
T Consensus       227 ~aLlHGDlHtGSI~v~~~~-~kvIDpEFAf  255 (409)
T PRK12396        227 QALIHGDLHTGSVFVKNDS-TKVIDPEFAF  255 (409)
T ss_pred             hhhccCcCCCCCEEecCCc-eEEEcccccc
Confidence            4689999999999998764 8999977763

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=89.42  E-value=0.85  Score=34.62  Aligned_cols=30  Identities=27%  Similarity=0.441  Sum_probs=25.3

Q ss_pred             CCCeeeCCCCCCceeecCCCCeEEccccchh
Q 046065          101 RLTIIHRDLKVSNILLDEDLKPKISDFGLAR  131 (164)
Q Consensus       101 ~~~iih~dlk~~nili~~~~~~~l~dfg~~~  131 (164)
                      ...++|+|+.+.|||+..+ .++++|+.++.
T Consensus       222 ~~~l~HgDl~~gni~~~~~-~~~viD~E~a~  251 (401)
T PRK09550        222 AEALLHGDLHTGSIFVTEE-ETKVIDPEFAF  251 (401)
T ss_pred             CCceeeccCCcccEEeeCC-CcEEEeccccc
Confidence            4479999999999999766 48999998764

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	164
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		4e-25
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		2e-24
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-19
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		3e-19
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		1e-15
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-15
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-15
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		8e-15
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-13
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-13
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-13
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-13
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-13
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-13
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-13
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-13
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		3e-13
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		3e-13
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		3e-13
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		4e-13
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		5e-13
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		7e-13
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		8e-13
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-12
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-12
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-12
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-12
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-12
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-12
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-12
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-12
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-12
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-12
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		3e-12
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-12
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		3e-12
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		3e-12
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		3e-12
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-12
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-12
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-12
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-12
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		3e-12
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		3e-12
2pl0_A	289	Lck Bound To Imatinib Length = 289		3e-12
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		4e-12
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		5e-12
3a4o_X	286	Lyn Kinase Domain Length = 286		7e-12
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		8e-12
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		8e-12
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-11
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-11
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		3e-11
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-11
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		4e-11
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		4e-11
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		5e-11
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		5e-11
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		5e-11
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		5e-11
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		5e-11
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		6e-11
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		6e-11
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		6e-11
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		7e-11
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		7e-11
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		7e-11
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		7e-11
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		8e-11
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		9e-11
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		9e-11
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		1e-10
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		1e-10
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-10
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		2e-10
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		2e-10
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		2e-10
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		2e-10
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		2e-10
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		2e-10
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-10
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		2e-10
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		2e-10
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		2e-10
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		2e-10
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		2e-10
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		2e-10
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-10
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		2e-10
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-10
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		2e-10
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		2e-10
4h58_A	275	Braf In Complex With Compound 3 Length = 275		2e-10
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-10
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		3e-10
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-10
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		3e-10
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		4e-10
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		4e-10
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		5e-10
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		5e-10
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		6e-10
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		6e-10
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		9e-10
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		9e-10
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-09
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-09
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		2e-09
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-09
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		2e-09
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		2e-09
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		3e-09
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		6e-09
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		6e-09
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		7e-09
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		8e-09
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		8e-09
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		8e-09
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		8e-09
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-08
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-08
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-08
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-08
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-08
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		1e-08
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-08
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		3e-08
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-08
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		3e-08
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		3e-08
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		4e-08
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		4e-08
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		4e-08
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		4e-08
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		4e-08
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		4e-08
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		4e-08
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		4e-08
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-08
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-08
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		4e-08
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		4e-08
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		4e-08
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		4e-08
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		4e-08
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-08
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		4e-08
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		4e-08
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		4e-08
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		4e-08
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		4e-08
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		5e-08
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-08
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-08
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		5e-08
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		5e-08
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		5e-08
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-08
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		5e-08
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		5e-08
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		5e-08
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		5e-08
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		5e-08
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		5e-08
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		5e-08
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		6e-08
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		6e-08
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		6e-08
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		6e-08
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		6e-08
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		6e-08
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		6e-08
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		6e-08
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		6e-08
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		6e-08
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		6e-08
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		6e-08
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		6e-08
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		6e-08
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		7e-08
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		8e-08
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		8e-08
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		8e-08
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-08
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		8e-08
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		9e-08
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		9e-08
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		1e-07
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-07
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		1e-07
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-07
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		1e-07
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-07
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-07
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-07
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-07
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-07
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-07
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-07
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-07
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		2e-07
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		2e-07
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-07
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		3e-07
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		3e-07
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-07
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-07
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-07
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		4e-07
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		4e-07
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		4e-07
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		5e-07
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		7e-07
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		8e-07
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		8e-07
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		8e-07
3kk8_A	284	Camkii Substrate Complex A Length = 284		8e-07
3kk9_A	282	Camkii Substrate Complex B Length = 282		9e-07
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-06
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		1e-06
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-06
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-06
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		1e-06
1fvr_A	327	Tie2 Kinase Domain Length = 327		1e-06
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		1e-06
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		1e-06
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-06
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		1e-06
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		1e-06
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-06
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-06
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-06
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-06
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		2e-06
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-06
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		2e-06
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		2e-06
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-06
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-06
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-06
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-06
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-06
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-06
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		2e-06
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		2e-06
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		2e-06
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-06
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-06
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-06
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		2e-06
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		2e-06
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-06
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		3e-06
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		3e-06
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		3e-06
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		3e-06
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		3e-06
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		3e-06
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-06
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		3e-06
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		3e-06
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-06
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		4e-06
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		4e-06
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-06
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		4e-06
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		4e-06
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		4e-06
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		4e-06
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		4e-06
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		4e-06
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		4e-06
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		4e-06
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		4e-06
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		4e-06
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		5e-06
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		5e-06
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		5e-06
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		5e-06
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		5e-06
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		5e-06
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		5e-06
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		5e-06
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		5e-06
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		5e-06
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		5e-06
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		5e-06
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		5e-06
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		5e-06
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		5e-06
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		5e-06
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		5e-06
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		5e-06
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		5e-06
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		5e-06
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		5e-06
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		5e-06
3hec_A	348	P38 In Complex With Imatinib Length = 348		5e-06
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		5e-06
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		5e-06
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		5e-06
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		5e-06
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		5e-06
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		5e-06
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		5e-06
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		5e-06
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		5e-06
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		5e-06
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		5e-06
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		5e-06
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		5e-06
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		6e-06
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		6e-06
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		6e-06
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		6e-06
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		6e-06
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		6e-06
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		6e-06
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		7e-06
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		7e-06
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		7e-06
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		7e-06
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		7e-06
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		7e-06
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		7e-06
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		7e-06
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		7e-06
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		8e-06
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		8e-06
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		8e-06
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		8e-06
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		8e-06
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		8e-06
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		8e-06
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		9e-06
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		9e-06
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		9e-06
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-05
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-05
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		1e-05
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		1e-05
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-05
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-05
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-05
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-05
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		1e-05
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-05
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		1e-05
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-05
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		1e-05
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-05
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-05
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-05
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-05
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-05
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-05
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-05
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		1e-05
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		1e-05
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		1e-05
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-05
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-05
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		1e-05
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-05
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-05
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		1e-05
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		1e-05
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		1e-05
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-05
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		1e-05
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-05
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		1e-05
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-05
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-05
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-05
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		1e-05
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-05
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-05
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		1e-05
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-05
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-05
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-05
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		1e-05
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		1e-05
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-05
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-05
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-05
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-05
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-05
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-05
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-05
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-05
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-05
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-05
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		1e-05
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-05
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-05
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-05
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-05
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-05
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		2e-05
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		2e-05
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-05
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-05
4fl3_A	635	Structural And Biophysical Characterization Of The		2e-05
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		2e-05
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-05
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		2e-05
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		2e-05
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-05
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-05
4fl2_A	636	Structural And Biophysical Characterization Of The		2e-05
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-05
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-05
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-05
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-05
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-05
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-05
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		2e-05
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-05
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		2e-05
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-05
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-05
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		2e-05
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		2e-05
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		2e-05
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-05
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		2e-05
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		2e-05
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-05
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		2e-05
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		2e-05
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-05
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-05
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		2e-05
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		2e-05
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		2e-05
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		2e-05
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		2e-05
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-05
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		2e-05
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		2e-05
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		2e-05
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-05
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		3e-05
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		3e-05
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		3e-05
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-05
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		3e-05
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		3e-05
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		3e-05
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		3e-05
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-05
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		3e-05
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		3e-05
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-05
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		3e-05
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		3e-05
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		3e-05
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		3e-05
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		3e-05
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		3e-05
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		3e-05
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-05
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-05
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		3e-05
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		3e-05
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		3e-05
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		3e-05
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		3e-05
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-05
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		4e-05
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		4e-05
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		4e-05
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		4e-05
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		4e-05
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-05
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		4e-05
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		4e-05
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		4e-05
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-05
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		4e-05
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		4e-05
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		4e-05
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		4e-05
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		4e-05
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		4e-05
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		4e-05
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-05
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		4e-05
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		4e-05
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		4e-05
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		4e-05
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		4e-05
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		4e-05
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		4e-05
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		4e-05
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		4e-05
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		4e-05
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-05
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		4e-05
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		4e-05
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		4e-05
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		5e-05
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		5e-05
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		5e-05
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		5e-05
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-05
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		5e-05
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		5e-05
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		5e-05
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		5e-05
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-05
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		5e-05
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		5e-05
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-05
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		5e-05
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		5e-05
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		5e-05
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		5e-05
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		5e-05
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		5e-05
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		5e-05
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		5e-05
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		5e-05
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		5e-05
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		5e-05
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		5e-05
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		5e-05
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		5e-05
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		5e-05
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		5e-05
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-05
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		5e-05
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		5e-05
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		5e-05
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		5e-05
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		5e-05
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		5e-05
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		6e-05
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		6e-05
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-05
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		6e-05
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		6e-05
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		6e-05
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		6e-05
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		6e-05
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		6e-05
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		6e-05
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		6e-05
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		6e-05
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		6e-05
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		6e-05
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		6e-05
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		6e-05
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		6e-05
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		6e-05
3soa_A	444	Full-Length Human Camkii Length = 444		7e-05
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		7e-05
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		7e-05
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		7e-05
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		7e-05
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-05
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		7e-05
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-05
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		7e-05
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		7e-05
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		7e-05
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		7e-05
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		7e-05
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		7e-05
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		7e-05
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		7e-05
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		7e-05
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		7e-05
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		7e-05
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		8e-05
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		8e-05
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		8e-05
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		8e-05
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		8e-05
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		8e-05
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		8e-05
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		8e-05
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		8e-05
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		8e-05
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		8e-05
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		8e-05
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		8e-05
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		8e-05
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		9e-05
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		9e-05
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		9e-05
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		9e-05
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		9e-05
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		9e-05
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		9e-05
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		1e-04
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		1e-04
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-04
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-04
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		1e-04
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		1e-04
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-04
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		1e-04
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		1e-04
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-04
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-04
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		1e-04
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		1e-04
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-04
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		1e-04
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		1e-04
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-04
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-04
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-04
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-04
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-04
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		1e-04
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-04
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-04
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		1e-04
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-04
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		2e-04
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-04
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-04
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-04
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-04
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-04
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		2e-04
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		2e-04
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-04
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-04
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-04
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-04
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		2e-04
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-04
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		2e-04
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		2e-04
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-04
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		2e-04
4fvr_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain M		2e-04
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		2e-04
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		2e-04
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		2e-04
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		2e-04
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		2e-04
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		2e-04
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		2e-04
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		2e-04
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		2e-04
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		2e-04
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-04
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-04
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-04
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		2e-04
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-04
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		2e-04
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-04
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-04
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		2e-04
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		2e-04
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		2e-04
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-04
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		2e-04
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-04
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-04
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-04
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-04
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		2e-04
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		3e-04
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		3e-04
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-04
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-04
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		3e-04
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-04
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		3e-04
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		3e-04
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		4e-04
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		4e-04
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		4e-04
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		4e-04
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		4e-04
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		4e-04
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		4e-04
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		4e-04
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		4e-04
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		4e-04
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		4e-04
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		4e-04
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		4e-04
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		4e-04
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		4e-04
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		5e-04
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		5e-04
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-04
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		5e-04
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		5e-04
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		5e-04
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		5e-04
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		5e-04
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		5e-04
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		6e-04
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		6e-04
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		6e-04
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		7e-04
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		8e-04
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		8e-04
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		8e-04
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		8e-04
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		8e-04
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-04
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		8e-04
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-04
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		9e-04
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		9e-04
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-04

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  110 bits (274), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 64/167 (38%), Positives = 98/167 (58%), Gaps = 6/167 (3%)
Query: 1   GVLPDGQIIAVKKLSKKSTQGFE-EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEY 58
           G L DG ++AVK+L ++ TQG E +F+ EV + +   H NL+R+ GFC+   E +L+Y Y
Sbjct: 49  GRLADGXLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 108
Query: 59  MPKRSLDYFLFD-PIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLD 117
           M   S+   L + P     LD  KR  I  G  +GL YL ++    IIHRD+K +NILLD
Sbjct: 109 MANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLD 168
Query: 118 EDLKPKISDFGLARIL---RKMILKQIQIELGYIPPEYVGRGVYYKK 161
           E+ +  + DFGLA+++      +   ++  +G+I PEY+  G   +K
Sbjct: 169 EEFEAVVGDFGLAKLMDYKDXHVXXAVRGXIGHIAPEYLSTGKSSEK 215

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  107 bits (268), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 63/167 (37%), Positives = 97/167 (58%), Gaps = 6/167 (3%)
Query: 1   GVLPDGQIIAVKKLSKKSTQGFE-EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEY 58
           G L DG ++AVK+L ++  QG E +F+ EV + +   H NL+R+ GFC+   E +L+Y Y
Sbjct: 57  GRLADGTLVAVKRLKEERXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 116
Query: 59  MPKRSLDYFLFD-PIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLD 117
           M   S+   L + P     LD  KR  I  G  +GL YL ++    IIHRD+K +NILLD
Sbjct: 117 MANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLD 176
Query: 118 EDLKPKISDFGLARIL---RKMILKQIQIELGYIPPEYVGRGVYYKK 161
           E+ +  + DFGLA+++      +   ++  +G+I PEY+  G   +K
Sbjct: 177 EEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIGHIAPEYLSTGKSSEK 223

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 91.3 bits (225), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 61/162 (37%), Positives = 97/162 (59%), Gaps = 9/162 (5%)
Query: 1   GVLPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYM 59
           GVL DG  +A+K+ + +S+QG EEF+ E+   +  +H +L+  +GFC E  E +LIY+YM
Sbjct: 58  GVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYM 117
Query: 60  PKRSLDYFLF-DPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE 118
              +L   L+   +  + +  ++R+ I  G  +GL YL       IIHRD+K  NILLDE
Sbjct: 118 ENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDE 174
Query: 119 DLKPKISDFGLAR----ILRKMILKQIQIELGYIPPEYVGRG 156
           +  PKI+DFG+++    + +  +   ++  LGYI PEY  +G
Sbjct: 175 NFVPKITDFGISKKGTELGQTHLXXVVKGTLGYIDPEYFIKG 216

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 90.9 bits (224), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 61/162 (37%), Positives = 97/162 (59%), Gaps = 9/162 (5%)
Query: 1   GVLPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYM 59
           GVL DG  +A+K+ + +S+QG EEF+ E+   +  +H +L+  +GFC E  E +LIY+YM
Sbjct: 58  GVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYM 117
Query: 60  PKRSLDYFLF-DPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE 118
              +L   L+   +  + +  ++R+ I  G  +GL YL       IIHRD+K  NILLDE
Sbjct: 118 ENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDE 174
Query: 119 DLKPKISDFGLAR----ILRKMILKQIQIELGYIPPEYVGRG 156
           +  PKI+DFG+++    + +  +   ++  LGYI PEY  +G
Sbjct: 175 NFVPKITDFGISKKGTELDQTHLXXVVKGTLGYIDPEYFIKG 216

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 79.0 bits (193), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/160 (36%), Positives = 78/160 (48%), Gaps = 20/160 (12%)
Query: 5   DGQIIAVKKLSKKSTQGFEE----FKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYM 59
           +   +AVKKL+       EE    F  E+ + AK QH NL+ + GF  +  +  L+Y YM
Sbjct: 53  NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 112
Query: 60  PKRSLDYFLFDPIRMLI----LDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNIL 115
           P  SL     D +  L     L    R  I +G   G+ +L E      IHRD+K +NIL
Sbjct: 113 PNGSL----LDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANIL 165
Query: 116 LDEDLKPKISDFGLARILRK----MILKQIQIELGYIPPE 151
           LDE    KISDFGLAR   K    ++  +I     Y+ PE
Sbjct: 166 LDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPE 205

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 78.6 bits (192), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/160 (36%), Positives = 78/160 (48%), Gaps = 20/160 (12%)
Query: 5   DGQIIAVKKLSKKSTQGFEE----FKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYM 59
           +   +AVKKL+       EE    F  E+ + AK QH NL+ + GF  +  +  L+Y YM
Sbjct: 53  NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 112
Query: 60  PKRSLDYFLFDPIRMLI----LDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNIL 115
           P  SL     D +  L     L    R  I +G   G+ +L E      IHRD+K +NIL
Sbjct: 113 PNGSL----LDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANIL 165
Query: 116 LDEDLKPKISDFGLARILRK----MILKQIQIELGYIPPE 151
           LDE    KISDFGLAR   K    ++  +I     Y+ PE
Sbjct: 166 LDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPE 205

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 78.6 bits (192), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 58/160 (36%), Positives = 78/160 (48%), Gaps = 20/160 (12%)
Query: 5   DGQIIAVKKLSKKSTQGFEE----FKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYM 59
           +   +AVKKL+       EE    F  E+ + AK QH NL+ + GF  +  +  L+Y YM
Sbjct: 47  NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM 106
Query: 60  PKRSLDYFLFDPIRMLI----LDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNIL 115
           P  SL     D +  L     L    R  I +G   G+ +L E      IHRD+K +NIL
Sbjct: 107 PNGSL----LDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANIL 159
Query: 116 LDEDLKPKISDFGLARILRK----MILKQIQIELGYIPPE 151
           LDE    KISDFGLAR   K    ++  +I     Y+ PE
Sbjct: 160 LDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPE 199

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 57/160 (35%), Positives = 75/160 (46%), Gaps = 20/160 (12%)
Query: 5   DGQIIAVKKLSKKSTQGFEE----FKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYM 59
           +   +AVKKL+       EE    F  E+ + AK QH NL+ + GF  +  +  L+Y Y 
Sbjct: 44  NNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYX 103
Query: 60  PKRSLDYFLFDPIRML----ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNIL 115
           P  SL     D +  L     L    R  I +G   G+ +L E      IHRD+K +NIL
Sbjct: 104 PNGSL----LDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENHH---IHRDIKSANIL 156
Query: 116 LDEDLKPKISDFGLARILRK----MILKQIQIELGYIPPE 151
           LDE    KISDFGLAR   K    +   +I     Y  PE
Sbjct: 157 LDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPE 196

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 72.4 bits (176), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 47/144 (32%), Positives = 75/144 (52%), Gaps = 11/144 (7%)
Query: 24  EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFL--FDPIRMLILDCK 80
           +F  E  +  +  H N+IR+ G   +++  M++ EYM   SLD FL   D    +I    
Sbjct: 92  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI---- 147
Query: 81  KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQ 140
           + V +++GI  G+ YL +   +  +HRDL   NIL++ +L  K+SDFGLAR+L       
Sbjct: 148 QLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAA 204
Query: 141 IQIELGYIPPEYVG-RGVYYKKFS 163
                G IP  +     + Y+KF+
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFT 228

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 51/175 (29%), Positives = 88/175 (50%), Gaps = 24/175 (13%)
Query: 5   DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRS 63
           D  ++AVK L   S    ++F  E  L   LQH ++++  G C+E    ++++EYM    
Sbjct: 42  DKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGD 101
Query: 64  LDYFL--FDPIRMLI--------LDCKKRVHIIKGIIQGLLYL-QEYFRLTIIHRDLKVS 112
           L+ FL    P  +L+        L   + +HI + I  G++YL  ++F    +HRDL   
Sbjct: 102 LNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHF----VHRDLATR 157
Query: 113 NILLDEDLKPKISDFGLARILRKM----ILKQIQIELGYIPPEYVGRGVYYKKFS 163
           N L+ E+L  KI DFG++R +       +     + + ++PPE     + Y+KF+
Sbjct: 158 NCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPE----SIMYRKFT 208

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 72.0 bits (175), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 75/144 (52%), Gaps = 11/144 (7%)
Query: 24  EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFL--FDPIRMLILDCK 80
           +F  E  +  +  H N+IR+ G   +++  M++ EYM   SLD FL   D    +I    
Sbjct: 92  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI---- 147
Query: 81  KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQ 140
           + V +++GI  G+ YL +   +  +HRDL   NIL++ +L  K+SDFGL+R+L       
Sbjct: 148 QLVGMLRGIASGMKYLSD---MGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 141 IQIELGYIPPEYVG-RGVYYKKFS 163
                G IP  +     + Y+KF+
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFT 228

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 75/144 (52%), Gaps = 11/144 (7%)
Query: 24  EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFL--FDPIRMLILDCK 80
           +F  E  +  +  H N+IR+ G   +++  M++ EYM   SLD FL   D    +I    
Sbjct: 63  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI---- 118
Query: 81  KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQ 140
           + V +++GI  G+ YL +   +  +HRDL   NIL++ +L  K+SDFGL+R+L       
Sbjct: 119 QLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 175
Query: 141 IQIELGYIPPEYVG-RGVYYKKFS 163
                G IP  +     + Y+KF+
Sbjct: 176 YTTRGGKIPIRWTSPEAIAYRKFT 199

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 71.6 bits (174), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 75/144 (52%), Gaps = 11/144 (7%)
Query: 24  EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFL--FDPIRMLILDCK 80
           +F  E  +  +  H N+IR+ G   +++  M++ EYM   SLD FL   D    +I    
Sbjct: 80  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI---- 135
Query: 81  KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQ 140
           + V +++GI  G+ YL +   +  +HRDL   NIL++ +L  K+SDFGL+R+L       
Sbjct: 136 QLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 192
Query: 141 IQIELGYIPPEYVG-RGVYYKKFS 163
                G IP  +     + Y+KF+
Sbjct: 193 YTTRGGKIPIRWTSPEAIAYRKFT 216

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 75/144 (52%), Gaps = 11/144 (7%)
Query: 24  EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFL--FDPIRMLILDCK 80
           +F  E  +  +  H N+IR+ G   +++  M++ EYM   SLD FL   D    +I    
Sbjct: 92  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI---- 147
Query: 81  KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQ 140
           + V +++GI  G+ YL +   +  +HRDL   NIL++ +L  K+SDFGL+R+L       
Sbjct: 148 QLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 141 IQIELGYIPPEYVG-RGVYYKKFS 163
                G IP  +     + Y+KF+
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFT 228

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 75/144 (52%), Gaps = 11/144 (7%)
Query: 24  EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFL--FDPIRMLILDCK 80
           +F  E  +  +  H N+IR+ G   +++  M++ EYM   SLD FL   D    +I    
Sbjct: 92  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI---- 147
Query: 81  KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQ 140
           + V +++GI  G+ YL +   +  +HRDL   NIL++ +L  K+SDFGL+R+L       
Sbjct: 148 QLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 141 IQIELGYIPPEYVG-RGVYYKKFS 163
                G IP  +     + Y+KF+
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFT 228

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 71.2 bits (173), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 75/144 (52%), Gaps = 11/144 (7%)
Query: 24  EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFL--FDPIRMLILDCK 80
           +F  E  +  +  H N+IR+ G   +++  M++ EYM   SLD FL   D    +I    
Sbjct: 92  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI---- 147
Query: 81  KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQ 140
           + V +++GI  G+ YL +   +  +HRDL   NIL++ +L  K+SDFGL+R+L       
Sbjct: 148 QLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 141 IQIELGYIPPEYVG-RGVYYKKFS 163
                G IP  +     + Y+KF+
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFT 228

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 71.2 bits (173), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 75/144 (52%), Gaps = 11/144 (7%)
Query: 24  EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFL--FDPIRMLILDCK 80
           +F  E  +  +  H N+IR+ G   +++  M++ EYM   SLD FL   D    +I    
Sbjct: 92  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI---- 147
Query: 81  KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQ 140
           + V +++GI  G+ YL +   +  +HRDL   NIL++ +L  K+SDFGL+R+L       
Sbjct: 148 QLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 141 IQIELGYIPPEYVG-RGVYYKKFS 163
                G IP  +     + Y+KF+
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFT 228

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 75/144 (52%), Gaps = 11/144 (7%)
Query: 24  EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFL--FDPIRMLILDCK 80
           +F  E  +  +  H N+IR+ G   +++  M++ EYM   SLD FL   D    +I    
Sbjct: 90  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI---- 145
Query: 81  KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQ 140
           + V +++GI  G+ YL +   +  +HRDL   NIL++ +L  K+SDFGL+R+L       
Sbjct: 146 QLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 202
Query: 141 IQIELGYIPPEYVG-RGVYYKKFS 163
                G IP  +     + Y+KF+
Sbjct: 203 YTTRGGKIPIRWTSPEAIAYRKFT 226

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 46/144 (31%), Positives = 74/144 (51%), Gaps = 11/144 (7%)
Query: 24  EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFL--FDPIRMLILDCK 80
           +F  E  +  +  H N+IR+ G   +++  M++ EYM   SLD FL   D    +I    
Sbjct: 92  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVI---- 147
Query: 81  KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQ 140
           + V +++GI  G+ YL +   +  +HRDL   NIL++ +L  K+SDFGL R+L       
Sbjct: 148 QLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAA 204
Query: 141 IQIELGYIPPEYVG-RGVYYKKFS 163
                G IP  +     + Y+KF+
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFT 228

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 70.5 bits (171), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 88/178 (49%), Gaps = 27/178 (15%)
Query: 5   DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRS 63
           D  ++AVK L   +    ++F+ E  L   LQH ++++  G C +    ++++EYM    
Sbjct: 44  DKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGD 103
Query: 64  LDYFL--FDPIRMLILDCKKR-----------VHIIKGIIQGLLYL-QEYFRLTIIHRDL 109
           L+ FL    P  M+++D + R           +HI   I  G++YL  ++F    +HRDL
Sbjct: 104 LNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHF----VHRDL 159
Query: 110 KVSNILLDEDLKPKISDFGLARILRKM----ILKQIQIELGYIPPEYVGRGVYYKKFS 163
              N L+  +L  KI DFG++R +       +     + + ++PPE     + Y+KF+
Sbjct: 160 ATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPE----SIMYRKFT 213

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 83/159 (52%), Gaps = 10/159 (6%)
Query: 9   IAVKKLSKKST-QGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDY 66
           +A+K L    T +   +F +E  +  +  H N+I + G   + +  M+I EYM   SLD 
Sbjct: 60  VAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDA 119
Query: 67  FLF-DPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKIS 125
           FL  +  R  ++   + V +++GI  G+ YL +   ++ +HRDL   NIL++ +L  K+S
Sbjct: 120 FLRKNDGRFTVI---QLVGMLRGIGSGMKYLSD---MSAVHRDLAARNILVNSNLVCKVS 173
Query: 126 DFGLARILRKMILKQIQIELGYIPPEYVG-RGVYYKKFS 163
           DFG++R+L            G IP  +     + Y+KF+
Sbjct: 174 DFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFT 212

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 69.7 bits (169), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 83/159 (52%), Gaps = 10/159 (6%)
Query: 9   IAVKKLSKKST-QGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDY 66
           +A+K L    T +   +F +E  +  +  H N+I + G   + +  M+I EYM   SLD 
Sbjct: 39  VAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDA 98
Query: 67  FLF-DPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKIS 125
           FL  +  R  ++   + V +++GI  G+ YL +   ++ +HRDL   NIL++ +L  K+S
Sbjct: 99  FLRKNDGRFTVI---QLVGMLRGIGSGMKYLSD---MSYVHRDLAARNILVNSNLVCKVS 152
Query: 126 DFGLARILRKMILKQIQIELGYIPPEYVG-RGVYYKKFS 163
           DFG++R+L            G IP  +     + Y+KF+
Sbjct: 153 DFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFT 191

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 69.7 bits (169), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 48/159 (30%), Positives = 83/159 (52%), Gaps = 10/159 (6%)
Query: 9   IAVKKLSKKST-QGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDY 66
           +A+K L    T +   +F +E  +  +  H N+I + G   + +  M+I EYM   SLD 
Sbjct: 45  VAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKPVMIITEYMENGSLDA 104
Query: 67  FLF-DPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKIS 125
           FL  +  R  ++   + V +++GI  G+ YL +   ++ +HRDL   NIL++ +L  K+S
Sbjct: 105 FLRKNDGRFTVI---QLVGMLRGIGSGMKYLSD---MSYVHRDLAARNILVNSNLVCKVS 158
Query: 126 DFGLARILRKMILKQIQIELGYIPPEYVG-RGVYYKKFS 163
           DFG++R+L            G IP  +     + Y+KF+
Sbjct: 159 DFGMSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFT 197

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 68.9 bits (167), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 74/144 (51%), Gaps = 11/144 (7%)
Query: 24  EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFL--FDPIRMLILDCK 80
           +F  E  +  +  H N+IR+ G   +++  M++ E M   SLD FL   D    +I    
Sbjct: 92  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVI---- 147
Query: 81  KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQ 140
           + V +++GI  G+ YL +   +  +HRDL   NIL++ +L  K+SDFGL+R+L       
Sbjct: 148 QLVGMLRGIASGMKYLSD---MGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 141 IQIELGYIPPEYVG-RGVYYKKFS 163
                G IP  +     + Y+KF+
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFT 228

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 78/158 (49%), Gaps = 8/158 (5%)
Query: 9   IAVKKLSKKSTQ-GFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDY 66
           +A+K L    T+    +F +E  +  +  H N+IR+ G     +  M++ EYM   SLD 
Sbjct: 80  VAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDT 139
Query: 67  FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISD 126
           FL        +   + V +++G+  G+ YL +   L  +HRDL   N+L+D +L  K+SD
Sbjct: 140 FLRTHDGQFTI--MQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSD 194
Query: 127 FGLARILRKMILKQIQIELGYIPPEYVG-RGVYYKKFS 163
           FGL+R+L            G IP  +     + ++ FS
Sbjct: 195 FGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRTFS 232

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 74/144 (51%), Gaps = 11/144 (7%)
Query: 24  EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFL--FDPIRMLILDCK 80
           +F  E  +  +  H N+IR+ G   +++  M++ E M   SLD FL   D    +I    
Sbjct: 63  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVI---- 118
Query: 81  KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQ 140
           + V +++GI  G+ YL +   +  +HRDL   NIL++ +L  K+SDFGL+R+L       
Sbjct: 119 QLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 175
Query: 141 IQIELGYIPPEYVG-RGVYYKKFS 163
                G IP  +     + Y+KF+
Sbjct: 176 YTTRGGKIPIRWTSPEAIAYRKFT 199

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 68.6 bits (166), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 85/163 (52%), Gaps = 12/163 (7%)
Query: 7   QIIAVKKLSKKSTQ-GFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSL 64
             +A+K L    T+    EF +E  +  + +H N+IR+ G    +   M++ E+M   +L
Sbjct: 45  SCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGAL 104
Query: 65  DYFL-FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           D FL  +  +  ++   + V +++GI  G+ YL E   ++ +HRDL   NIL++ +L  K
Sbjct: 105 DSFLRLNDGQFTVI---QLVGMLRGIASGMRYLAE---MSYVHRDLAARNILVNSNLVCK 158
Query: 124 ISDFGLARILRKMILKQIQIEL--GYIPPEYVG-RGVYYKKFS 163
           +SDFGL+R L +      +     G IP  +     + ++KF+
Sbjct: 159 VSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEAIAFRKFT 201

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 74/144 (51%), Gaps = 11/144 (7%)
Query: 24  EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFL--FDPIRMLILDCK 80
           +F  E  +  +  H N+IR+ G   +++  M++ E M   SLD FL   D    +I    
Sbjct: 92  DFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVI---- 147
Query: 81  KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQ 140
           + V +++GI  G+ YL +   +  +HRDL   NIL++ +L  K+SDFGL+R+L       
Sbjct: 148 QLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA 204
Query: 141 IQIELGYIPPEYVG-RGVYYKKFS 163
                G IP  +     + Y+KF+
Sbjct: 205 YTTRGGKIPIRWTSPEAIAYRKFT 228

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 78/158 (49%), Gaps = 8/158 (5%)
Query: 9   IAVKKLSKKSTQ-GFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDY 66
           +A+K L    T+    +F +E  +  +  H N+IR+ G     +  M++ EYM   SLD 
Sbjct: 80  VAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDT 139
Query: 67  FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISD 126
           FL        +   + V +++G+  G+ YL +   L  +HRDL   N+L+D +L  K+SD
Sbjct: 140 FLRTHDGQFTI--MQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSD 194
Query: 127 FGLARILRKMILKQIQIELGYIPPEYVG-RGVYYKKFS 163
           FGL+R+L            G IP  +     + ++ FS
Sbjct: 195 FGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFS 232

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 68.2 bits (165), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 10/154 (6%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKRSLDYF 67
           +AVK L K+ +   + F  E  L  +LQH  L+R+ + + TQE + +I EYM   SL  F
Sbjct: 40  VAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDF 97
Query: 68  LFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDF 127
           L  P   + L   K + +   I +G+ +++E      IHRDL+ +NIL+ + L  KI+DF
Sbjct: 98  LKTP-SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADF 153
Query: 128 GLARILRK---MILKQIQIELGYIPPEYVGRGVY 158
           GLAR++        +  +  + +  PE +  G +
Sbjct: 154 GLARLIEDAEXTAREGAKFPIKWTAPEAINYGTF 187

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 10/154 (6%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKRSLDYF 67
           +AVK L K+ +   + F  E  L  +LQH  L+R+ + + TQE + +I EYM   SL  F
Sbjct: 35  VAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDF 92
Query: 68  LFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDF 127
           L  P   + L   K + +   I +G+ +++E      IHRDL+ +NIL+ + L  KI+DF
Sbjct: 93  LKTP-SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADF 148
Query: 128 GLARILRK---MILKQIQIELGYIPPEYVGRGVY 158
           GLAR++        +  +  + +  PE +  G +
Sbjct: 149 GLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 182

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 10/154 (6%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKRSLDYF 67
           +AVK L K+ +   + F  E  L  +LQH  L+R+ + + TQE + +I EYM   SL  F
Sbjct: 40  VAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDF 97
Query: 68  LFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDF 127
           L  P   + L   K + +   I +G+ +++E      IHRDL+ +NIL+ + L  KI+DF
Sbjct: 98  LKTP-SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADF 153
Query: 128 GLARILRK---MILKQIQIELGYIPPEYVGRGVY 158
           GLAR++        +  +  + +  PE +  G +
Sbjct: 154 GLARLIEDNEXTAREGAKFPIKWTAPEAINYGTF 187

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 10/154 (6%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKRSLDYF 67
           +AVK L K+ +   + F  E  L  +LQH  L+R+ + + TQE + +I EYM   SL  F
Sbjct: 46  VAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDF 103
Query: 68  LFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDF 127
           L  P   + L   K + +   I +G+ +++E      IHRDL+ +NIL+ + L  KI+DF
Sbjct: 104 LKTP-SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADF 159
Query: 128 GLARILRK---MILKQIQIELGYIPPEYVGRGVY 158
           GLAR++        +  +  + +  PE +  G +
Sbjct: 160 GLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 193

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 10/154 (6%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKRSLDYF 67
           +AVK L K+ +   + F  E  L  +LQH  L+R+ + + TQE + +I EYM   SL  F
Sbjct: 45  VAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDF 102
Query: 68  LFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDF 127
           L  P   + L   K + +   I +G+ +++E      IHRDL+ +NIL+ + L  KI+DF
Sbjct: 103 LKTP-SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADF 158
Query: 128 GLARILRK---MILKQIQIELGYIPPEYVGRGVY 158
           GLAR++        +  +  + +  PE +  G +
Sbjct: 159 GLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 192

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 10/154 (6%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKRSLDYF 67
           +AVK L K+ +   + F  E  L  +LQH  L+R+ + + TQE + +I EYM   SL  F
Sbjct: 41  VAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDF 98
Query: 68  LFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDF 127
           L  P   + L   K + +   I +G+ +++E      IHRDL+ +NIL+ + L  KI+DF
Sbjct: 99  LKTP-SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADF 154
Query: 128 GLARILRK---MILKQIQIELGYIPPEYVGRGVY 158
           GLAR++        +  +  + +  PE +  G +
Sbjct: 155 GLARLIEDNEXTAREGAKFPIKWTAPEAINYGTF 188

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 10/154 (6%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKRSLDYF 67
           +AVK L K+ +   + F  E  L  +LQH  L+R+ + + TQE + +I EYM   SL  F
Sbjct: 40  VAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDF 97
Query: 68  LFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDF 127
           L  P   + L   K + +   I +G+ +++E      IHRDL+ +NIL+ + L  KI+DF
Sbjct: 98  LKTP-SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADF 153
Query: 128 GLARILRK---MILKQIQIELGYIPPEYVGRGVY 158
           GLAR++        +  +  + +  PE +  G +
Sbjct: 154 GLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 187

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 10/154 (6%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKRSLDYF 67
           +AVK L K+ +   + F  E  L  +LQH  L+R+ + + TQE + +I EYM   SL  F
Sbjct: 40  VAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDF 97
Query: 68  LFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDF 127
           L  P   + L   K + +   I +G+ +++E      IHRDL+ +NIL+ + L  KI+DF
Sbjct: 98  LKTP-SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADF 153
Query: 128 GLARILRK---MILKQIQIELGYIPPEYVGRGVY 158
           GLAR++        +  +  + +  PE +  G +
Sbjct: 154 GLARLIEDNEXTAREGAKFPIKWTAPEAINYGTF 187

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 10/154 (6%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKRSLDYF 67
           +AVK L K+ +   + F  E  L  +LQH  L+R+ + + TQE + +I EYM   SL  F
Sbjct: 49  VAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDF 106
Query: 68  LFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDF 127
           L  P   + L   K + +   I +G+ +++E      IHRDL+ +NIL+ + L  KI+DF
Sbjct: 107 LKTP-SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADF 162
Query: 128 GLARILRK---MILKQIQIELGYIPPEYVGRGVY 158
           GLAR++        +  +  + +  PE +  G +
Sbjct: 163 GLARLIEDNEXTAREGAKFPIKWTAPEAINYGTF 196

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 10/154 (6%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKRSLDYF 67
           +AVK L K+ +   + F  E  L  +LQH  L+R+ + + TQE + +I EYM   SL  F
Sbjct: 42  VAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDF 99
Query: 68  LFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDF 127
           L  P   + L   K + +   I +G+ +++E      IHRDL+ +NIL+ + L  KI+DF
Sbjct: 100 LKTP-SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADF 155
Query: 128 GLARILRK---MILKQIQIELGYIPPEYVGRGVY 158
           GLAR++        +  +  + +  PE +  G +
Sbjct: 156 GLARLIEDNEXTAREGAKFPIKWTAPEAINYGTF 189

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 10/154 (6%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKRSLDYF 67
           +AVK L K+ +   + F  E  L  +LQH  L+R+ + + TQE + +I EYM   SL  F
Sbjct: 48  VAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDF 105
Query: 68  LFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDF 127
           L  P   + L   K + +   I +G+ +++E      IHRDL+ +NIL+ + L  KI+DF
Sbjct: 106 LKTP-SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADF 161
Query: 128 GLARILRK---MILKQIQIELGYIPPEYVGRGVY 158
           GLAR++        +  +  + +  PE +  G +
Sbjct: 162 GLARLIEDNEXTAREGAKFPIKWTAPEAINYGTF 195

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 85/176 (48%), Gaps = 24/176 (13%)
Query: 5   DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRS 63
           D  ++AVK L + S    ++F+ E  L   LQH +++R  G C E +  ++++EYM    
Sbjct: 70  DKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGD 129
Query: 64  LDYFL--FDPIRMLI----------LDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKV 111
           L+ FL    P   L+          L   + + +   +  G++YL     L  +HRDL  
Sbjct: 130 LNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLAT 186
Query: 112 SNILLDEDLKPKISDFGLARILRKM----ILKQIQIELGYIPPEYVGRGVYYKKFS 163
            N L+ + L  KI DFG++R +       +  +  + + ++PPE     + Y+KF+
Sbjct: 187 RNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPE----SILYRKFT 238

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 67.8 bits (164), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 10/154 (6%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKRSLDYF 67
           +AVK L K+ +   + F  E  L  +LQH  L+R+ + + TQE + +I EYM   SL  F
Sbjct: 46  VAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDF 103
Query: 68  LFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDF 127
           L  P   + L   K + +   I +G+ +++E      IHRDL+ +NIL+ + L  KI+DF
Sbjct: 104 LKTP-SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADF 159
Query: 128 GLARILRK---MILKQIQIELGYIPPEYVGRGVY 158
           GLAR++        +  +  + +  PE +  G +
Sbjct: 160 GLARLIEDNEXTAREGAKFPIKWTAPEAINYGTF 193

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 85/176 (48%), Gaps = 24/176 (13%)
Query: 5   DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRS 63
           D  ++AVK L + S    ++F+ E  L   LQH +++R  G C E +  ++++EYM    
Sbjct: 41  DKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGD 100
Query: 64  LDYFL--FDPIRMLI----------LDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKV 111
           L+ FL    P   L+          L   + + +   +  G++YL     L  +HRDL  
Sbjct: 101 LNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLAT 157
Query: 112 SNILLDEDLKPKISDFGLARILRKM----ILKQIQIELGYIPPEYVGRGVYYKKFS 163
            N L+ + L  KI DFG++R +       +  +  + + ++PPE     + Y+KF+
Sbjct: 158 RNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPE----SILYRKFT 209

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 85/176 (48%), Gaps = 24/176 (13%)
Query: 5   DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRS 63
           D  ++AVK L + S    ++F+ E  L   LQH +++R  G C E +  ++++EYM    
Sbjct: 47  DKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGD 106
Query: 64  LDYFL--FDPIRMLI----------LDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKV 111
           L+ FL    P   L+          L   + + +   +  G++YL     L  +HRDL  
Sbjct: 107 LNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLAT 163
Query: 112 SNILLDEDLKPKISDFGLARILRKM----ILKQIQIELGYIPPEYVGRGVYYKKFS 163
            N L+ + L  KI DFG++R +       +  +  + + ++PPE     + Y+KF+
Sbjct: 164 RNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPE----SILYRKFT 215

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 67.4 bits (163), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/154 (32%), Positives = 82/154 (53%), Gaps = 10/154 (6%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKRSLDYF 67
           +AVK L K+ +   + F  E  L  +LQH  L+R+ + + TQE + +I EYM   SL  F
Sbjct: 50  VAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDF 107
Query: 68  LFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDF 127
           L  P   + L   K + +   I +G+ +++E      IHRDL+ +NIL+ + L  KI+DF
Sbjct: 108 LKTP-SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADF 163
Query: 128 GLARILRK---MILKQIQIELGYIPPEYVGRGVY 158
           GLAR++        +  +  + +  PE +  G +
Sbjct: 164 GLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 197

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 67.4 bits (163), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 48/158 (30%), Positives = 79/158 (50%), Gaps = 8/158 (5%)
Query: 9   IAVKKLSKKSTQGFE-EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDY 66
           +A+K L    T+    +F  E  +  +  H N+IR+ G   + +  M+I EYM   +LD 
Sbjct: 76  VAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDK 135
Query: 67  FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISD 126
           FL +  +       + V +++GI  G+ YL     +  +HRDL   NIL++ +L  K+SD
Sbjct: 136 FLRE--KDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSD 190
Query: 127 FGLARILRKMILKQIQIELGYIPPEYVG-RGVYYKKFS 163
           FGL+R+L            G IP  +     + Y+KF+
Sbjct: 191 FGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFT 228

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 67.0 bits (162), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 42/132 (31%), Positives = 74/132 (56%), Gaps = 9/132 (6%)
Query: 7   QIIAVKKLSKKSTQ-GFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSL 64
             +A+K L    T+    EF +E  +  + +H N+IR+ G    +   M++ E+M   +L
Sbjct: 43  SCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGAL 102
Query: 65  DYFL-FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           D FL  +  +  ++   + V +++GI  G+ YL E   ++ +HRDL   NIL++ +L  K
Sbjct: 103 DSFLRLNDGQFTVI---QLVGMLRGIASGMRYLAE---MSYVHRDLAARNILVNSNLVCK 156
Query: 124 ISDFGLARILRK 135
           +SDFGL+R L +
Sbjct: 157 VSDFGLSRFLEE 168

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 66.6 bits (161), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 81/163 (49%), Gaps = 11/163 (6%)
Query: 1   GVLPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYM 59
           G   +   +AVK L K  T   + F  E  L   LQH  L+R+   +  +E + +I EYM
Sbjct: 32  GYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTREEPIYIITEYM 90
Query: 60  PKRSL-DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE 118
            K SL D+   D    ++L   K +     I +G+ Y++   R   IHRDL+ +N+L+ E
Sbjct: 91  AKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSE 145
Query: 119 DLKPKISDFGLARILRK---MILKQIQIELGYIPPEYVGRGVY 158
            L  KI+DFGLAR++        +  +  + +  PE +  G +
Sbjct: 146 SLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCF 188

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 49/154 (31%), Positives = 82/154 (53%), Gaps = 10/154 (6%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKRSLDYF 67
           +AVK L K+ +   + F  E  L  +LQH  L+R+ + + TQE + +I EYM   SL  F
Sbjct: 36  VAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRL-YAVVTQEPIYIITEYMENGSLVDF 93
Query: 68  LFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDF 127
           L  P   + L   K + +   I +G+ +++E      IHR+L+ +NIL+ + L  KI+DF
Sbjct: 94  LKTP-SGIKLTINKLLDMAAQIAEGMAFIEER---NYIHRNLRAANILVSDTLSCKIADF 149
Query: 128 GLARILRK---MILKQIQIELGYIPPEYVGRGVY 158
           GLAR++        +  +  + +  PE +  G +
Sbjct: 150 GLARLIEDNEYTAREGAKFPIKWTAPEAINYGTF 183

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 66.2 bits (160), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 74/148 (50%), Gaps = 19/148 (12%)
Query: 24  EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFL------FDPIRMLI 76
           +F  E  +  +  H N+I + G   +++  M++ EYM   SLD FL      F  I++  
Sbjct: 69  DFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTVIQL-- 126
Query: 77  LDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM 136
                 V +++GI  G+ YL +   +  +HRDL   NIL++ +L  K+SDFGL+R+L   
Sbjct: 127 ------VGMLRGISAGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDD 177
Query: 137 ILKQIQIELGYIPPEYVG-RGVYYKKFS 163
                    G IP  +     + ++KF+
Sbjct: 178 PEAAYTTRGGKIPIRWTAPEAIAFRKFT 205

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 65.5 bits (158), Expect = 1e-11,   Method: Composition-based stats.
 Identities = 42/126 (33%), Positives = 71/126 (56%), Gaps = 7/126 (5%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSL-DYF 67
           +A+K L K  T   E F  E  +  KL+H  L+++   +  +   ++ EYM K SL D+ 
Sbjct: 294 VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFL 352
Query: 68  LFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDF 127
             +  + L L   + V +   I  G+ Y++   R+  +HRDL+ +NIL+ E+L  K++DF
Sbjct: 353 KGETGKYLRL--PQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADF 407
Query: 128 GLARIL 133
           GLAR++
Sbjct: 408 GLARLI 413

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 65.1 bits (157), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 81/163 (49%), Gaps = 11/163 (6%)
Query: 1   GVLPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYM 59
           G   +   +AVK L K  T   + F  E  L   LQH  L+R+   +  +E + +I E+M
Sbjct: 31  GYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEFM 89
Query: 60  PKRSL-DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE 118
            K SL D+   D    ++L   K +     I +G+ Y++   R   IHRDL+ +N+L+ E
Sbjct: 90  AKGSLLDFLKSDEGGKVLL--PKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSE 144
Query: 119 DLKPKISDFGLARILRK---MILKQIQIELGYIPPEYVGRGVY 158
            L  KI+DFGLAR++        +  +  + +  PE +  G +
Sbjct: 145 SLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCF 187

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/126 (33%), Positives = 71/126 (56%), Gaps = 7/126 (5%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSL-DYF 67
           +A+K L K  T   E F  E  +  KL+H  L+++   +  +   ++ EYM K SL D+ 
Sbjct: 35  VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIXIVTEYMSKGSLLDFL 93
Query: 68  LFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDF 127
             +  + L L   + V +   I  G+ Y++   R+  +HRDL+ +NIL+ E+L  K++DF
Sbjct: 94  KGETGKYLRL--PQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADF 148
Query: 128 GLARIL 133
           GLAR++
Sbjct: 149 GLARLI 154

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 64.3 bits (155), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 42/126 (33%), Positives = 71/126 (56%), Gaps = 7/126 (5%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSL-DYF 67
           +A+K L K  T   E F  E  +  KL+H  L+++   +  +   ++ EYM K SL D+ 
Sbjct: 38  VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFL 96
Query: 68  LFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDF 127
             +  + L L   + V +   I  G+ Y++   R+  +HRDL+ +NIL+ E+L  K++DF
Sbjct: 97  KGETGKYLRL--PQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADF 151
Query: 128 GLARIL 133
           GLAR++
Sbjct: 152 GLARLI 157

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 42/126 (33%), Positives = 71/126 (56%), Gaps = 7/126 (5%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSL-DYF 67
           +A+K L K  T   E F  E  +  KL+H  L+++   +  +   ++ EYM K SL D+ 
Sbjct: 211 VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFL 269
Query: 68  LFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDF 127
             +  + L L   + V +   I  G+ Y++   R+  +HRDL+ +NIL+ E+L  K++DF
Sbjct: 270 KGETGKYLRL--PQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADF 324
Query: 128 GLARIL 133
           GLAR++
Sbjct: 325 GLARLI 330

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 63.9 bits (154), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 42/126 (33%), Positives = 71/126 (56%), Gaps = 7/126 (5%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSL-DYF 67
           +A+K L K  T   E F  E  +  KL+H  L+++   +  +   ++ EYM K SL D+ 
Sbjct: 211 VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFL 269
Query: 68  LFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDF 127
             +  + L L   + V +   I  G+ Y++   R+  +HRDL+ +NIL+ E+L  K++DF
Sbjct: 270 KGETGKYLRL--PQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADF 324
Query: 128 GLARIL 133
           GLAR++
Sbjct: 325 GLARLI 330

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 80/166 (48%), Gaps = 22/166 (13%)
Query: 9   IAVKKLSKKSTQG-FEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDY 66
           +A+K L    T+    +F +E  +  +  H N+I + G   ++   M+I E+M   SLD 
Sbjct: 64  VAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDS 123
Query: 67  FL------FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL 120
           FL      F  I++        V +++GI  G+ YL +   +  +HRDL   NIL++ +L
Sbjct: 124 FLRQNDGQFTVIQL--------VGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNL 172
Query: 121 KPKISDFGLARILRKMILKQIQIEL--GYIPPEYVG-RGVYYKKFS 163
             K+SDFGL+R L              G IP  +     + Y+KF+
Sbjct: 173 VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFT 218

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 42/125 (33%), Positives = 69/125 (55%), Gaps = 5/125 (4%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFL 68
           +A+K L K  T   E F  E  +  KL+H  L+++   +  +   ++ EYM K SL  FL
Sbjct: 45  VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFL 103
Query: 69  FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFG 128
              +    L   + V +   I  G+ Y++   R+  +HRDL+ +NIL+ E+L  K++DFG
Sbjct: 104 KGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFG 159
Query: 129 LARIL 133
           LAR++
Sbjct: 160 LARLI 164

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 42/125 (33%), Positives = 69/125 (55%), Gaps = 5/125 (4%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFL 68
           +A+K L K  T   E F  E  +  KL+H  L+++   +  +   ++ EYM K SL  FL
Sbjct: 34  VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFL 92
Query: 69  FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFG 128
              +    L   + V +   I  G+ Y++   R+  +HRDL+ +NIL+ E+L  K++DFG
Sbjct: 93  KGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFG 148
Query: 129 LARIL 133
           LAR++
Sbjct: 149 LARLI 153

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 42/125 (33%), Positives = 69/125 (55%), Gaps = 5/125 (4%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFL 68
           +A+K L K  T   E F  E  +  KL+H  L+++   +  +   ++ EYM K SL  FL
Sbjct: 36  VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFL 94
Query: 69  FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFG 128
              +    L   + V +   I  G+ Y++   R+  +HRDL+ +NIL+ E+L  K++DFG
Sbjct: 95  KGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFG 150
Query: 129 LARIL 133
           LAR++
Sbjct: 151 LARLI 155

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 63.5 bits (153), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 42/126 (33%), Positives = 71/126 (56%), Gaps = 7/126 (5%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSL-DYF 67
           +A+K L K  T   E F  E  +  KL+H  L+++   +  +   ++ EYM K SL D+ 
Sbjct: 211 VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVGEYMSKGSLLDFL 269
Query: 68  LFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDF 127
             +  + L L   + V +   I  G+ Y++   R+  +HRDL+ +NIL+ E+L  K++DF
Sbjct: 270 KGETGKYLRL--PQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADF 324
Query: 128 GLARIL 133
           GLAR++
Sbjct: 325 GLARLI 330

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 42/125 (33%), Positives = 69/125 (55%), Gaps = 5/125 (4%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFL 68
           +A+K L K  T   E F  E  +  KL+H  L+++   +  +   ++ EYM K SL  FL
Sbjct: 45  VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVCEYMSKGSLLDFL 103
Query: 69  FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFG 128
              +    L   + V +   I  G+ Y++   R+  +HRDL+ +NIL+ E+L  K++DFG
Sbjct: 104 KGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFG 159
Query: 129 LARIL 133
           LAR++
Sbjct: 160 LARLI 164

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 42/125 (33%), Positives = 69/125 (55%), Gaps = 5/125 (4%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFL 68
           +A+K L K  T   E F  E  +  KL+H  L+++   +  +   ++ EYM K SL  FL
Sbjct: 45  VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVIEYMSKGSLLDFL 103
Query: 69  FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFG 128
              +    L   + V +   I  G+ Y++   R+  +HRDL+ +NIL+ E+L  K++DFG
Sbjct: 104 KGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFG 159
Query: 129 LARIL 133
           LAR++
Sbjct: 160 LARLI 164

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 63.2 bits (152), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 42/125 (33%), Positives = 69/125 (55%), Gaps = 5/125 (4%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFL 68
           +A+K L K  T   E F  E  +  KL+H  L+++   +  +   ++ EYM K SL  FL
Sbjct: 45  VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVIEYMSKGSLLDFL 103
Query: 69  FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFG 128
              +    L   + V +   I  G+ Y++   R+  +HRDL+ +NIL+ E+L  K++DFG
Sbjct: 104 KGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFG 159
Query: 129 LARIL 133
           LAR++
Sbjct: 160 LARLI 164

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 84/177 (47%), Gaps = 26/177 (14%)
Query: 7   QIIAVKKLSKKSTQGF-EEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSL 64
           Q +A+K L  K+     EEF++E ML A+LQH N++ + G   + Q   +I+ Y     L
Sbjct: 40  QAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDL 99
Query: 65  DYFLF-----------DPIRML--ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKV 111
             FL            D  R +   L+    VH++  I  G+ YL  +    ++H+DL  
Sbjct: 100 HEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLAT 156
Query: 112 SNILLDEDLKPKISDFGLARILRKM----ILKQIQIELGYIPPEYVGRGVYYKKFSL 164
            N+L+ + L  KISD GL R +       +L    + + ++ PE     + Y KFS+
Sbjct: 157 RNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPE----AIMYGKFSI 209

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 42/126 (33%), Positives = 71/126 (56%), Gaps = 7/126 (5%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSL-DYF 67
           +A+K L K  T   E F  E  +  KL+H  L+++   +  +   ++ EYM K SL D+ 
Sbjct: 42  VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMNKGSLLDFL 100
Query: 68  LFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDF 127
             +  + L L   + V +   I  G+ Y++   R+  +HRDL+ +NIL+ E+L  K++DF
Sbjct: 101 KGETGKYLRL--PQLVDMSAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADF 155
Query: 128 GLARIL 133
           GLAR++
Sbjct: 156 GLARLI 161

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 42/126 (33%), Positives = 71/126 (56%), Gaps = 7/126 (5%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSL-DYF 67
           +A+K L K  T   E F  E  +  KL+H  L+++   +  +   ++ EYM K SL D+ 
Sbjct: 42  VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMNKGSLLDFL 100
Query: 68  LFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDF 127
             +  + L L   + V +   I  G+ Y++   R+  +HRDL+ +NIL+ E+L  K++DF
Sbjct: 101 KGETGKYLRL--PQLVDMSAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADF 155
Query: 128 GLARIL 133
           GLAR++
Sbjct: 156 GLARLI 161

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 63.2 bits (152), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 52/177 (29%), Positives = 84/177 (47%), Gaps = 26/177 (14%)
Query: 7   QIIAVKKLSKKSTQGF-EEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSL 64
           Q +A+K L  K+     EEF++E ML A+LQH N++ + G   + Q   +I+ Y     L
Sbjct: 57  QAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDL 116
Query: 65  DYFLF-----------DPIRML--ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKV 111
             FL            D  R +   L+    VH++  I  G+ YL  +    ++H+DL  
Sbjct: 117 HEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLAT 173
Query: 112 SNILLDEDLKPKISDFGLARILRKM----ILKQIQIELGYIPPEYVGRGVYYKKFSL 164
            N+L+ + L  KISD GL R +       +L    + + ++ PE     + Y KFS+
Sbjct: 174 RNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPE----AIMYGKFSI 226

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 62.8 bits (151), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 45/132 (34%), Positives = 69/132 (52%), Gaps = 10/132 (7%)
Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIET--QEYMLIYEYMPKR 62
           G+++AVKKL   + +   +F+ E+ +   LQH N+++  G C     +   LI EY+P  
Sbjct: 42  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 101
Query: 63  SL-DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK 121
           SL DY      R   +D  K +     I +G+ YL        IHRDL   NIL++ + +
Sbjct: 102 SLRDYLQAHAER---IDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENR 155
Query: 122 PKISDFGLARIL 133
            KI DFGL ++L
Sbjct: 156 VKIGDFGLTKVL 167

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 41/125 (32%), Positives = 69/125 (55%), Gaps = 5/125 (4%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFL 68
           +A+K L K  T   E F  E  +  K++H  L+++   +  +   ++ EYM K SL  FL
Sbjct: 45  VAIKTL-KPGTMSPEAFLQEAQVMKKIRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFL 103
Query: 69  FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFG 128
              +    L   + V +   I  G+ Y++   R+  +HRDL+ +NIL+ E+L  K++DFG
Sbjct: 104 KGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFG 159
Query: 129 LARIL 133
           LAR++
Sbjct: 160 LARLI 164

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 62.8 bits (151), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 42/125 (33%), Positives = 68/125 (54%), Gaps = 5/125 (4%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFL 68
           +A+K L K  T   E F  E  +  KL+H  L+++   +  +   ++ EYM K SL  FL
Sbjct: 45  VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFL 103
Query: 69  FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFG 128
              +    L   + V +   I  G+ Y++   R+  +HRDL  +NIL+ E+L  K++DFG
Sbjct: 104 KGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHRDLAAANILVGENLVCKVADFG 159
Query: 129 LARIL 133
           LAR++
Sbjct: 160 LARLI 164

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/132 (34%), Positives = 69/132 (52%), Gaps = 10/132 (7%)
Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIET--QEYMLIYEYMPKR 62
           G+++AVKKL   + +   +F+ E+ +   LQH N+++  G C     +   LI EY+P  
Sbjct: 57  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 116
Query: 63  SL-DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK 121
           SL DY      R   +D  K +     I +G+ YL        IHRDL   NIL++ + +
Sbjct: 117 SLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENR 170
Query: 122 PKISDFGLARIL 133
            KI DFGL ++L
Sbjct: 171 VKIGDFGLTKVL 182

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/132 (34%), Positives = 69/132 (52%), Gaps = 10/132 (7%)
Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIET--QEYMLIYEYMPKR 62
           G+++AVKKL   + +   +F+ E+ +   LQH N+++  G C     +   LI EY+P  
Sbjct: 57  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 116
Query: 63  SL-DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK 121
           SL DY      R   +D  K +     I +G+ YL        IHRDL   NIL++ + +
Sbjct: 117 SLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENR 170
Query: 122 PKISDFGLARIL 133
            KI DFGL ++L
Sbjct: 171 VKIGDFGLTKVL 182

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 44/133 (33%), Positives = 67/133 (50%), Gaps = 5/133 (3%)
Query: 1   GVLPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMP 60
           G       +A+K L K  T   E F  E  +  KL+H  L+++   +  +   ++ EYM 
Sbjct: 28  GTWNGNTKVAIKTL-KPGTMSPESFLEEAQIMKKLKHDKLVQLYAVVSEEPIYIVTEYMN 86
Query: 61  KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL 120
           K SL  FL D      L     V +   +  G+ Y++   R+  IHRDL+ +NIL+   L
Sbjct: 87  KGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGNGL 142
Query: 121 KPKISDFGLARIL 133
             KI+DFGLAR++
Sbjct: 143 ICKIADFGLARLI 155

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/132 (34%), Positives = 69/132 (52%), Gaps = 10/132 (7%)
Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIET--QEYMLIYEYMPKR 62
           G+++AVKKL   + +   +F+ E+ +   LQH N+++  G C     +   LI EY+P  
Sbjct: 45  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 104
Query: 63  SL-DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK 121
           SL DY      R   +D  K +     I +G+ YL        IHRDL   NIL++ + +
Sbjct: 105 SLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENR 158
Query: 122 PKISDFGLARIL 133
            KI DFGL ++L
Sbjct: 159 VKIGDFGLTKVL 170

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/132 (34%), Positives = 69/132 (52%), Gaps = 10/132 (7%)
Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIET--QEYMLIYEYMPKR 62
           G+++AVKKL   + +   +F+ E+ +   LQH N+++  G C     +   LI EY+P  
Sbjct: 70  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 129
Query: 63  SL-DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK 121
           SL DY      R   +D  K +     I +G+ YL        IHRDL   NIL++ + +
Sbjct: 130 SLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENR 183
Query: 122 PKISDFGLARIL 133
            KI DFGL ++L
Sbjct: 184 VKIGDFGLTKVL 195

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/132 (34%), Positives = 69/132 (52%), Gaps = 10/132 (7%)
Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIET--QEYMLIYEYMPKR 62
           G+++AVKKL   + +   +F+ E+ +   LQH N+++  G C     +   LI EY+P  
Sbjct: 37  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 96
Query: 63  SL-DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK 121
           SL DY      R   +D  K +     I +G+ YL        IHRDL   NIL++ + +
Sbjct: 97  SLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENR 150
Query: 122 PKISDFGLARIL 133
            KI DFGL ++L
Sbjct: 151 VKIGDFGLTKVL 162

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/132 (34%), Positives = 69/132 (52%), Gaps = 10/132 (7%)
Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIET--QEYMLIYEYMPKR 62
           G+++AVKKL   + +   +F+ E+ +   LQH N+++  G C     +   LI EY+P  
Sbjct: 42  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 101
Query: 63  SL-DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK 121
           SL DY      R   +D  K +     I +G+ YL        IHRDL   NIL++ + +
Sbjct: 102 SLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENR 155
Query: 122 PKISDFGLARIL 133
            KI DFGL ++L
Sbjct: 156 VKIGDFGLTKVL 167

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/132 (34%), Positives = 69/132 (52%), Gaps = 10/132 (7%)
Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIET--QEYMLIYEYMPKR 62
           G+++AVKKL   + +   +F+ E+ +   LQH N+++  G C     +   LI EY+P  
Sbjct: 46  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 105
Query: 63  SL-DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK 121
           SL DY      R   +D  K +     I +G+ YL        IHRDL   NIL++ + +
Sbjct: 106 SLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENR 159
Query: 122 PKISDFGLARIL 133
            KI DFGL ++L
Sbjct: 160 VKIGDFGLTKVL 171

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/132 (34%), Positives = 69/132 (52%), Gaps = 10/132 (7%)
Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIET--QEYMLIYEYMPKR 62
           G+++AVKKL   + +   +F+ E+ +   LQH N+++  G C     +   LI EY+P  
Sbjct: 39  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 98
Query: 63  SL-DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK 121
           SL DY      R   +D  K +     I +G+ YL        IHRDL   NIL++ + +
Sbjct: 99  SLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENR 152
Query: 122 PKISDFGLARIL 133
            KI DFGL ++L
Sbjct: 153 VKIGDFGLTKVL 164

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 62.0 bits (149), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/132 (34%), Positives = 69/132 (52%), Gaps = 10/132 (7%)
Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIET--QEYMLIYEYMPKR 62
           G+++AVKKL   + +   +F+ E+ +   LQH N+++  G C     +   LI EY+P  
Sbjct: 39  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 98
Query: 63  SL-DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK 121
           SL DY      R   +D  K +     I +G+ YL        IHRDL   NIL++ + +
Sbjct: 99  SLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENR 152
Query: 122 PKISDFGLARIL 133
            KI DFGL ++L
Sbjct: 153 VKIGDFGLTKVL 164

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/132 (34%), Positives = 69/132 (52%), Gaps = 10/132 (7%)
Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIET--QEYMLIYEYMPKR 62
           G+++AVKKL   + +   +F+ E+ +   LQH N+++  G C     +   LI EY+P  
Sbjct: 44  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 103
Query: 63  SL-DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK 121
           SL DY      R   +D  K +     I +G+ YL        IHRDL   NIL++ + +
Sbjct: 104 SLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENR 157
Query: 122 PKISDFGLARIL 133
            KI DFGL ++L
Sbjct: 158 VKIGDFGLTKVL 169

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/132 (34%), Positives = 69/132 (52%), Gaps = 10/132 (7%)
Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIET--QEYMLIYEYMPKR 62
           G+++AVKKL   + +   +F+ E+ +   LQH N+++  G C     +   LI EY+P  
Sbjct: 39  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 98
Query: 63  SL-DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK 121
           SL DY      R   +D  K +     I +G+ YL        IHRDL   NIL++ + +
Sbjct: 99  SLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENR 152
Query: 122 PKISDFGLARIL 133
            KI DFGL ++L
Sbjct: 153 VKIGDFGLTKVL 164

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/132 (34%), Positives = 69/132 (52%), Gaps = 10/132 (7%)
Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIET--QEYMLIYEYMPKR 62
           G+++AVKKL   + +   +F+ E+ +   LQH N+++  G C     +   LI EY+P  
Sbjct: 43  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 102
Query: 63  SL-DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK 121
           SL DY      R   +D  K +     I +G+ YL        IHRDL   NIL++ + +
Sbjct: 103 SLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENR 156
Query: 122 PKISDFGLARIL 133
            KI DFGL ++L
Sbjct: 157 VKIGDFGLTKVL 168

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/132 (34%), Positives = 69/132 (52%), Gaps = 10/132 (7%)
Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIET--QEYMLIYEYMPKR 62
           G+++AVKKL   + +   +F+ E+ +   LQH N+++  G C     +   LI EY+P  
Sbjct: 38  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 97
Query: 63  SL-DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK 121
           SL DY      R   +D  K +     I +G+ YL        IHRDL   NIL++ + +
Sbjct: 98  SLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENR 151
Query: 122 PKISDFGLARIL 133
            KI DFGL ++L
Sbjct: 152 VKIGDFGLTKVL 163

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 81/156 (51%), Gaps = 21/156 (13%)
Query: 9   IAVKKL--SKKSTQGFEEFKNEVMLTAKLQHLN-LIRVGFCIETQEYMLIYEYMPKRSLD 65
           +AVK L  +  + Q  + FKNEV +  K +H+N L+ +G+  + Q   ++ ++    SL 
Sbjct: 38  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLY 96
Query: 66  YFLFDPIRMLILDCK----KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK 121
           + L       I++ K    K + I +   QG+ YL      +IIHRDLK +NI L EDL 
Sbjct: 97  HHLH------IIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLT 147
Query: 122 PKISDFGLARILRKMI----LKQIQIELGYIPPEYV 153
            KI DFGLA +  +       +Q+   + ++ PE +
Sbjct: 148 VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 183

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 81/156 (51%), Gaps = 21/156 (13%)
Query: 9   IAVKKL--SKKSTQGFEEFKNEVMLTAKLQHLN-LIRVGFCIETQEYMLIYEYMPKRSLD 65
           +AVK L  +  + Q  + FKNEV +  K +H+N L+ +G+  + Q   ++ ++    SL 
Sbjct: 61  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLY 119
Query: 66  YFLFDPIRMLILDCK----KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK 121
           + L       I++ K    K + I +   QG+ YL      +IIHRDLK +NI L EDL 
Sbjct: 120 HHLH------IIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLT 170
Query: 122 PKISDFGLARILRKMI----LKQIQIELGYIPPEYV 153
            KI DFGLA +  +       +Q+   + ++ PE +
Sbjct: 171 VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 206

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/125 (32%), Positives = 68/125 (54%), Gaps = 5/125 (4%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFL 68
           +A+K L K  T   E F  E  +  KL+H  L+++   +  +   ++ EYM K  L  FL
Sbjct: 45  VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGCLLDFL 103
Query: 69  FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFG 128
              +    L   + V +   I  G+ Y++   R+  +HRDL+ +NIL+ E+L  K++DFG
Sbjct: 104 KGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFG 159
Query: 129 LARIL 133
           LAR++
Sbjct: 160 LARLI 164

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 81/156 (51%), Gaps = 21/156 (13%)
Query: 9   IAVKKL--SKKSTQGFEEFKNEVMLTAKLQHLN-LIRVGFCIETQEYMLIYEYMPKRSLD 65
           +AVK L  +  + Q  + FKNEV +  K +H+N L+ +G+  + Q   ++ ++    SL 
Sbjct: 60  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLY 118
Query: 66  YFLFDPIRMLILDCK----KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK 121
           + L       I++ K    K + I +   QG+ YL      +IIHRDLK +NI L EDL 
Sbjct: 119 HHLH------IIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLT 169
Query: 122 PKISDFGLARILRKMI----LKQIQIELGYIPPEYV 153
            KI DFGLA +  +       +Q+   + ++ PE +
Sbjct: 170 VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 205

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 41/125 (32%), Positives = 68/125 (54%), Gaps = 5/125 (4%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFL 68
           +A+K L K  T   E F  E  +  KL+H  L+++   +  +   ++ EYM K  L  FL
Sbjct: 45  VAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVMEYMSKGCLLDFL 103
Query: 69  FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFG 128
              +    L   + V +   I  G+ Y++   R+  +HRDL+ +NIL+ E+L  K++DFG
Sbjct: 104 KGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFG 159
Query: 129 LARIL 133
           LAR++
Sbjct: 160 LARLI 164

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 81/156 (51%), Gaps = 21/156 (13%)
Query: 9   IAVKKL--SKKSTQGFEEFKNEVMLTAKLQHLN-LIRVGFCIETQEYMLIYEYMPKRSLD 65
           +AVK L  +  + Q  + FKNEV +  K +H+N L+ +G+  + Q   ++ ++    SL 
Sbjct: 38  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLY 96
Query: 66  YFLFDPIRMLILDCK----KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK 121
           + L       I++ K    K + I +   QG+ YL      +IIHRDLK +NI L EDL 
Sbjct: 97  HHLH------IIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLT 147
Query: 122 PKISDFGLARILRKMI----LKQIQIELGYIPPEYV 153
            KI DFGLA +  +       +Q+   + ++ PE +
Sbjct: 148 VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 183

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 81/156 (51%), Gaps = 21/156 (13%)
Query: 9   IAVKKL--SKKSTQGFEEFKNEVMLTAKLQHLN-LIRVGFCIETQEYMLIYEYMPKRSLD 65
           +AVK L  +  + Q  + FKNEV +  K +H+N L+ +G+  + Q   ++ ++    SL 
Sbjct: 35  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLY 93
Query: 66  YFLFDPIRMLILDCK----KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK 121
           + L       I++ K    K + I +   QG+ YL      +IIHRDLK +NI L EDL 
Sbjct: 94  HHLH------IIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLT 144
Query: 122 PKISDFGLARILRKMI----LKQIQIELGYIPPEYV 153
            KI DFGLA +  +       +Q+   + ++ PE +
Sbjct: 145 VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 180

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 61.6 bits (148), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 81/156 (51%), Gaps = 21/156 (13%)
Query: 9   IAVKKL--SKKSTQGFEEFKNEVMLTAKLQHLN-LIRVGFCIETQEYMLIYEYMPKRSLD 65
           +AVK L  +  + Q  + FKNEV +  K +H+N L+ +G+  + Q   ++ ++    SL 
Sbjct: 33  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLY 91
Query: 66  YFLFDPIRMLILDCK----KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK 121
           + L       I++ K    K + I +   QG+ YL      +IIHRDLK +NI L EDL 
Sbjct: 92  HHLH------IIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLT 142
Query: 122 PKISDFGLARILRKMI----LKQIQIELGYIPPEYV 153
            KI DFGLA +  +       +Q+   + ++ PE +
Sbjct: 143 VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/156 (32%), Positives = 80/156 (51%), Gaps = 21/156 (13%)
Query: 9   IAVKKL--SKKSTQGFEEFKNEVMLTAKLQHLN-LIRVGFCIETQEYMLIYEYMPKRSLD 65
           +AVK L  +  + Q  + FKNEV +  K +H+N L+ +G+    Q   ++ ++    SL 
Sbjct: 33  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLY 91
Query: 66  YFLFDPIRMLILDCK----KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK 121
           + L       I++ K    K + I +   QG+ YL      +IIHRDLK +NI L EDL 
Sbjct: 92  HHLH------IIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLT 142
Query: 122 PKISDFGLARILRKMI----LKQIQIELGYIPPEYV 153
            KI DFGLA +  +       +Q+   + ++ PE +
Sbjct: 143 VKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 80/156 (51%), Gaps = 21/156 (13%)
Query: 9   IAVKKL--SKKSTQGFEEFKNEVMLTAKLQHLN-LIRVGFCIETQEYMLIYEYMPKRSLD 65
           +AVK L  +  + Q  + FKNEV +  K +H+N L+ +G+  + Q   ++ ++    SL 
Sbjct: 33  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLY 91
Query: 66  YFLFDPIRMLILDCK----KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK 121
           + L       I++ K    K + I +   QG+ YL      +IIHRDLK +NI L EDL 
Sbjct: 92  HHLH------IIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLT 142
Query: 122 PKISDFGLA----RILRKMILKQIQIELGYIPPEYV 153
            KI DFGLA    R       +Q+   + ++ PE +
Sbjct: 143 VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 178

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 48/166 (28%), Positives = 79/166 (47%), Gaps = 22/166 (13%)
Query: 9   IAVKKLSKKSTQG-FEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDY 66
           +A+K L    T+    +F +E  +  +  H N+I + G   ++   M+I E+M   SLD 
Sbjct: 38  VAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDS 97
Query: 67  FL------FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL 120
           FL      F  I++        V +++GI  G+ YL +   +  +HR L   NIL++ +L
Sbjct: 98  FLRQNDGQFTVIQL--------VGMLRGIAAGMKYLAD---MNYVHRALAARNILVNSNL 146
Query: 121 KPKISDFGLARILRKMILKQIQIEL--GYIPPEYVG-RGVYYKKFS 163
             K+SDFGL+R L              G IP  +     + Y+KF+
Sbjct: 147 VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFT 192

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 60.8 bits (146), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 80/156 (51%), Gaps = 21/156 (13%)
Query: 9   IAVKKL--SKKSTQGFEEFKNEVMLTAKLQHLN-LIRVGFCIETQEYMLIYEYMPKRSLD 65
           +AVK L  +  + Q  + FKNEV +  K +H+N L+ +G+  + Q   ++ ++    SL 
Sbjct: 61  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLY 119
Query: 66  YFLFDPIRMLILDCK----KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK 121
           + L       I++ K    K + I +   QG+ YL      +IIHRDLK +NI L EDL 
Sbjct: 120 HHLH------IIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLT 170
Query: 122 PKISDFGLA----RILRKMILKQIQIELGYIPPEYV 153
            KI DFGLA    R       +Q+   + ++ PE +
Sbjct: 171 VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 206

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 60.8 bits (146), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 51/156 (32%), Positives = 80/156 (51%), Gaps = 21/156 (13%)
Query: 9   IAVKKL--SKKSTQGFEEFKNEVMLTAKLQHLN-LIRVGFCIETQEYMLIYEYMPKRSLD 65
           +AVK L  +  + Q  + FKNEV +  K +H+N L+ +G+  + Q   ++ ++    SL 
Sbjct: 53  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLY 111
Query: 66  YFLFDPIRMLILDCK----KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK 121
           + L       I++ K    K + I +   QG+ YL      +IIHRDLK +NI L EDL 
Sbjct: 112 HHLH------IIETKFEMIKLIDIARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLT 162
Query: 122 PKISDFGLA----RILRKMILKQIQIELGYIPPEYV 153
            KI DFGLA    R       +Q+   + ++ PE +
Sbjct: 163 VKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 198

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 60.5 bits (145), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 45/183 (24%), Positives = 87/183 (47%), Gaps = 34/183 (18%)
Query: 8   IIAVKKLSKKSTQGFE-EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLD 65
           ++AVK L ++++   + +F+ E  L A+  + N++++ G C   +   L++EYM    L+
Sbjct: 79  MVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLN 138
Query: 66  YFL--FDPIRMLI-------------------LDCKKRVHIIKGIIQGLLYLQEYFRLTI 104
            FL    P  +                     L C +++ I + +  G+ YL E      
Sbjct: 139 EFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKF 195
Query: 105 IHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQ----IELGYIPPEYVGRGVYYK 160
           +HRDL   N L+ E++  KI+DFGL+R +      +      I + ++PPE     ++Y 
Sbjct: 196 VHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPE----SIFYN 251
Query: 161 KFS 163
           +++
Sbjct: 252 RYT 254

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 44/132 (33%), Positives = 69/132 (52%), Gaps = 10/132 (7%)
Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIET--QEYMLIYEYMPKR 62
           G+++AVKKL   + +   +F+ E+ +   LQH N+++  G C     +   LI EY+P  
Sbjct: 40  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 99
Query: 63  SL-DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK 121
           SL DY      R   +D  K +     I +G+ YL        IHR+L   NIL++ + +
Sbjct: 100 SLRDYLQKHKER---IDHIKLLQYTSQICKGMEYLGTK---RYIHRNLATRNILVENENR 153
Query: 122 PKISDFGLARIL 133
            KI DFGL ++L
Sbjct: 154 VKIGDFGLTKVL 165

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 60.1 bits (144), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 72/148 (48%), Gaps = 19/148 (12%)
Query: 24  EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFL------FDPIRMLI 76
           +F  E  +  +  H N++ + G     +  M++ E+M   +LD FL      F  I++  
Sbjct: 90  DFLCEASIMGQFDHPNVVHLEGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQL-- 147
Query: 77  LDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM 136
                 V +++GI  G+ YL +   +  +HRDL   NIL++ +L  K+SDFGL+R++   
Sbjct: 148 ------VGMLRGIAAGMRYLAD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDD 198
Query: 137 ILKQIQIELGYIPPEYVG-RGVYYKKFS 163
                    G IP  +     + Y+KF+
Sbjct: 199 PEAVYTTTGGKIPVRWTAPEAIQYRKFT 226

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 60.1 bits (144), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 78/152 (51%), Gaps = 13/152 (8%)
Query: 9   IAVKKL--SKKSTQGFEEFKNEVMLTAKLQHLN-LIRVGFCIETQEYMLIYEYMPKRSLD 65
           +AVK L  +  + Q  + FKNEV +  K +H+N L+ +G+  + Q   ++ ++    SL 
Sbjct: 37  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLY 95
Query: 66  YFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKIS 125
           + L         + KK + I +   +G+ YL      +IIHRDLK +NI L ED   KI 
Sbjct: 96  HHLH--ASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIG 150
Query: 126 DFGLARILRKMI----LKQIQIELGYIPPEYV 153
           DFGLA +  +       +Q+   + ++ PE +
Sbjct: 151 DFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 182

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 59.7 bits (143), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 40/125 (32%), Positives = 67/125 (53%), Gaps = 5/125 (4%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFL 68
           +A+K L K      E F  E  +  KL+H  L+++   +  +   ++ EYM K SL  FL
Sbjct: 212 VAIKTL-KPGNMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFL 270
Query: 69  FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFG 128
              +    L   + V +   I  G+ Y++   R+  +HRDL+ +NIL+ E+L  K++DFG
Sbjct: 271 KGEMGKY-LRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFG 326
Query: 129 LARIL 133
           L R++
Sbjct: 327 LGRLI 331

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 77/152 (50%), Gaps = 13/152 (8%)
Query: 9   IAVKKL--SKKSTQGFEEFKNEVMLTAKLQHLN-LIRVGFCIETQEYMLIYEYMPKRSLD 65
           +AVK L  +  + Q  + FKNEV +  K +H+N L+ +G+  + Q   ++ ++    SL 
Sbjct: 49  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLY 107
Query: 66  YFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKIS 125
           + L         + KK + I +   +G+ YL      +IIHRDLK +NI L ED   KI 
Sbjct: 108 HHLH--ASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIG 162
Query: 126 DFGLA----RILRKMILKQIQIELGYIPPEYV 153
           DFGLA    R       +Q+   + ++ PE +
Sbjct: 163 DFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 59.3 bits (142), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 44/137 (32%), Positives = 70/137 (51%), Gaps = 20/137 (14%)
Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIET--QEYMLIYEYMPKR 62
           G+++AVKKL   + +   +F+ E+ +   LQH N+++  G C     +   LI E++P  
Sbjct: 42  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYG 101
Query: 63  SLDYFLFDPIRMLILDCKKRVHIIK------GIIQGLLYLQEYFRLTIIHRDLKVSNILL 116
           SL        R  +   K+R+  IK       I +G+ YL        IHRDL   NIL+
Sbjct: 102 SL--------REYLQKHKERIDHIKLLQYTSQICKGMEYLGTK---RYIHRDLATRNILV 150
Query: 117 DEDLKPKISDFGLARIL 133
           + + + KI DFGL ++L
Sbjct: 151 ENENRVKIGDFGLTKVL 167

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 58.9 bits (141), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 76/152 (50%), Gaps = 13/152 (8%)
Query: 9   IAVKKL--SKKSTQGFEEFKNEVMLTAKLQHLN-LIRVGFCIETQEYMLIYEYMPKRSLD 65
           +AVK L  +  + Q  + FKNEV +  K +H+N L+ +G+    Q   ++ ++    SL 
Sbjct: 49  VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQ-LAIVTQWCEGSSLY 107
Query: 66  YFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKIS 125
           + L         + KK + I +   +G+ YL      +IIHRDLK +NI L ED   KI 
Sbjct: 108 HHLH--ASETKFEMKKLIDIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIG 162
Query: 126 DFGLA----RILRKMILKQIQIELGYIPPEYV 153
           DFGLA    R       +Q+   + ++ PE +
Sbjct: 163 DFGLATEKSRWSGSHQFEQLSGSILWMAPEVI 194

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 66/133 (49%), Gaps = 10/133 (7%)
Query: 5   DGQIIAVKKLS---KKSTQGFEEFKNEVMLTAKLQHLNLIRVGFC-IETQEYMLIYEYMP 60
           + +++A+KK+S   K+S + +++   EV    KL+H N I+   C +      L+ EY  
Sbjct: 78  NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL 137
Query: 61  KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL 120
             + D        +  ++     H   G +QGL YL  +    +IHRD+K  NILL E  
Sbjct: 138 GSASDLLEVHKKPLQEVEIAAVTH---GALQGLAYLHSH---NMIHRDVKAGNILLSEPG 191
Query: 121 KPKISDFGLARIL 133
             K+ DFG A I+
Sbjct: 192 LVKLGDFGSASIM 204

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/151 (29%), Positives = 73/151 (48%), Gaps = 14/151 (9%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSL-DYF 67
           +AVK + K  +   E F  E  +   LQH  L+++   +  +   +I E+M K SL D+ 
Sbjct: 209 VAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFL 267
Query: 68  LFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDF 127
             D      L   K +     I +G+ ++++      IHRDL+ +NIL+   L  KI+DF
Sbjct: 268 KSDEGSKQPL--PKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADF 322
Query: 128 GLARILRKMILKQIQIELGYIPPEYVGRGVY 158
           GLAR+  K  +K       +  PE +  G +
Sbjct: 323 GLARVGAKFPIK-------WTAPEAINFGSF 346

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 41/133 (30%), Positives = 66/133 (49%), Gaps = 10/133 (7%)
Query: 5   DGQIIAVKKLS---KKSTQGFEEFKNEVMLTAKLQHLNLIRVGFC-IETQEYMLIYEYMP 60
           + +++A+KK+S   K+S + +++   EV    KL+H N I+   C +      L+ EY  
Sbjct: 39  NSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL 98
Query: 61  KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL 120
             + D        +  ++     H   G +QGL YL  +    +IHRD+K  NILL E  
Sbjct: 99  GSASDLLEVHKKPLQEVEIAAVTH---GALQGLAYLHSH---NMIHRDVKAGNILLSEPG 152
Query: 121 KPKISDFGLARIL 133
             K+ DFG A I+
Sbjct: 153 LVKLGDFGSASIM 165

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 58.2 bits (139), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 39/130 (30%), Positives = 68/130 (52%), Gaps = 4/130 (3%)
Query: 6   GQIIAVKKLSKKS--TQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKR 62
           G  +AVK L ++    +   EF  EV +  +L+H N++  +G   +     ++ EY+ + 
Sbjct: 60  GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRG 119
Query: 63  SLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKP 122
           SL   L        LD ++R+ +   + +G+ YL       I+HRDLK  N+L+D+    
Sbjct: 120 SLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRDLKSPNLLVDKKYTV 178
Query: 123 KISDFGLARI 132
           K+ DFGL+R+
Sbjct: 179 KVCDFGLSRL 188

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 77/161 (47%), Gaps = 24/161 (14%)
Query: 13  KLSKKSTQGFEEFKNEVMLTAKLQH-LNLIRVGFCIETQEYMLIYEYMPKRSL------- 64
           K+S KS   +++FKNE+ +   +++   L   G      E  +IYEYM   S+       
Sbjct: 80  KISIKSK--YDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYF 137
Query: 65  -----DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
                +Y  F PI+  ++ C     IIK ++    Y+       I HRD+K SNIL+D++
Sbjct: 138 FVLDKNYTCFIPIQ--VIKC-----IIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKN 188
Query: 120 LKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYK 160
            + K+SDFG +  +    +K  +    ++PPE+      Y 
Sbjct: 189 GRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYN 229

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 57.4 bits (137), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/159 (28%), Positives = 80/159 (50%), Gaps = 11/159 (6%)
Query: 6   GQIIAVKKLSKKS---TQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPK 61
           G  +A+K + KK+       +  +NEV +  +L+H +++ +    E   Y+ L+ E    
Sbjct: 36  GLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHN 95
Query: 62  RSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK 121
             ++ +L + ++    +  +  H +  II G+LYL  +    I+HRDL +SN+LL  ++ 
Sbjct: 96  GEMNRYLKNRVKPFSENEAR--HFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMN 150
Query: 122 PKISDFGLARILRKMILKQIQI--ELGYIPPEYVGRGVY 158
            KI+DFGLA  L+    K   +     YI PE   R  +
Sbjct: 151 IKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAH 189

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 74/154 (48%), Gaps = 10/154 (6%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSL-DYF 67
           +AVK + K  +   E F  E  +   LQH  L+++   +  +   +I E+M K SL D+ 
Sbjct: 215 VAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFL 273
Query: 68  LFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDF 127
             D      L   K +     I +G+ ++++      IHRDL+ +NIL+   L  KI+DF
Sbjct: 274 KSDEGSKQPL--PKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADF 328
Query: 128 GLARILRK---MILKQIQIELGYIPPEYVGRGVY 158
           GLAR++        +  +  + +  PE +  G +
Sbjct: 329 GLARVIEDNEYTAREGAKFPIKWTAPEAINFGSF 362

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 56.6 bits (135), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 43/154 (27%), Positives = 74/154 (48%), Gaps = 10/154 (6%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSL-DYF 67
           +AVK + K  +   E F  E  +   LQH  L+++   +  +   +I E+M K SL D+ 
Sbjct: 42  VAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFL 100
Query: 68  LFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDF 127
             D      L   K +     I +G+ ++++      IHRDL+ +NIL+   L  KI+DF
Sbjct: 101 KSDEGSKQPL--PKLIDFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADF 155
Query: 128 GLARILRK---MILKQIQIELGYIPPEYVGRGVY 158
           GLAR++        +  +  + +  PE +  G +
Sbjct: 156 GLARVIEDNEYTAREGAKFPIKWTAPEAINFGSF 189

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 56.2 bits (134), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 93/173 (53%), Gaps = 24/173 (13%)
Query: 3   LPDGQII----AVKKLSKKS-TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIY 56
           +P+G+ +    A+K L++ +  +   EF +E ++ A + H +L+R+ G C+ +    L+ 
Sbjct: 60  VPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCL-SPTIQLVT 118
Query: 57  EYMPKRSLDYFLFD-----PIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKV 111
           + MP   L  ++ +       ++L+  C +       I +G++YL+E     ++HRDL  
Sbjct: 119 QLMPHGCLLEYVHEHKDNIGSQLLLNWCVQ-------IAKGMMYLEER---RLVHRDLAA 168
Query: 112 SNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVG-RGVYYKKFS 163
            N+L+      KI+DFGLAR+L     K+   + G +P +++    ++Y+KF+
Sbjct: 169 RNVLVKSPNHVKITDFGLARLLEG-DEKEYNADGGKMPIKWMALECIHYRKFT 220

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 66/126 (52%), Gaps = 7/126 (5%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYF 67
           +A+K + ++     E+F  E  +  KL H  L+++ G C+E     L++E+M    L  +
Sbjct: 34  VAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY 92
Query: 68  LFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDF 127
           L    +  +   +  + +   + +G+ YL+E    ++IHRDL   N L+ E+   K+SDF
Sbjct: 93  L--RTQRGLFAAETLLGMCLDVCEGMAYLEE---ASVIHRDLAARNCLVGENQVIKVSDF 147
Query: 128 GLARIL 133
           G+ R +
Sbjct: 148 GMTRFV 153

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 40/135 (29%), Positives = 69/135 (51%), Gaps = 22/135 (16%)
Query: 8   IIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSL-D 65
            +AVK L K+ T   EEF  E  +  +++H NL+++ G C     + ++ EYMP  +L D
Sbjct: 59  TVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTLEPPFYIVTEYMPYGNLLD 117
Query: 66  YFLFDPIRMLILDCKKR-------VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE 118
           Y         + +C +        +++   I   + YL+   +   IHRDL   N L+ E
Sbjct: 118 Y---------LRECNREEVTAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGE 165
Query: 119 DLKPKISDFGLARIL 133
           +   K++DFGL+R++
Sbjct: 166 NHVVKVADFGLSRLM 180

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 39/138 (28%), Positives = 69/138 (50%), Gaps = 4/138 (2%)
Query: 6   GQIIAVKKLSKKS--TQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKR 62
           G  +AVK L ++    +   EF  EV +  +L+H N++  +G   +     ++ EY+ + 
Sbjct: 60  GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRG 119
Query: 63  SLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKP 122
           SL   L        LD ++R+ +   + +G+ YL       I+HR+LK  N+L+D+    
Sbjct: 120 SLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNR-NPPIVHRNLKSPNLLVDKKYTV 178
Query: 123 KISDFGLARILRKMILKQ 140
           K+ DFGL+R+     L  
Sbjct: 179 KVCDFGLSRLKASTFLSS 196

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 56.2 bits (134), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 92/171 (53%), Gaps = 20/171 (11%)
Query: 3   LPDGQII----AVKKLSKKS-TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIY 56
           +P+G+ +    A+K L++ +  +   EF +E ++ A + H +L+R+ G C+ +    L+ 
Sbjct: 37  VPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCL-SPTIQLVT 95
Query: 57  EYMPKRSLDYFLF---DPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSN 113
           + MP   L  ++    D I   +L     ++    I +G++YL+E     ++HRDL   N
Sbjct: 96  QLMPHGCLLEYVHEHKDNIGSQLL-----LNWCVQIAKGMMYLEER---RLVHRDLAARN 147
Query: 114 ILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVG-RGVYYKKFS 163
           +L+      KI+DFGLAR+L     K+   + G +P +++    ++Y+KF+
Sbjct: 148 VLVKSPNHVKITDFGLARLLEG-DEKEYNADGGKMPIKWMALECIHYRKFT 197

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 79/161 (49%), Gaps = 12/161 (7%)
Query: 7   QIIAVKKLS-KKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSL 64
           + +AVK +  K++    E  K E+ + A L H N+++  G   E     L  EY     L
Sbjct: 33  EAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 92
Query: 65  DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKI 124
              +   I M   D ++  H    ++ G++YL     + I HRD+K  N+LLDE    KI
Sbjct: 93  FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKI 146
Query: 125 SDFGLARIL----RKMILKQIQIELGYIPPEYVGRGVYYKK 161
           SDFGLA +     R+ +L ++   L Y+ PE + R  ++ +
Sbjct: 147 SDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 66/126 (52%), Gaps = 7/126 (5%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYF 67
           +A+K + K+ +   ++F  E  +  KL H  L+++ G C+E     L++E+M    L  +
Sbjct: 54  VAIKTI-KEGSMSEDDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY 112
Query: 68  LFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDF 127
           L    +  +   +  + +   + +G+ YL+E     +IHRDL   N L+ E+   K+SDF
Sbjct: 113 L--RTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDF 167
Query: 128 GLARIL 133
           G+ R +
Sbjct: 168 GMTRFV 173

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 55.8 bits (133), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 65/126 (51%), Gaps = 7/126 (5%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYF 67
           +A+K + ++     E+F  E  +  KL H  L+++ G C+E     L++E+M    L  +
Sbjct: 34  VAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY 92
Query: 68  LFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDF 127
           L    +  +   +  + +   + +G+ YL+E     +IHRDL   N L+ E+   K+SDF
Sbjct: 93  L--RTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDF 147
Query: 128 GLARIL 133
           G+ R +
Sbjct: 148 GMTRFV 153

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 65/126 (51%), Gaps = 7/126 (5%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYF 67
           +A+K + ++     E+F  E  +  KL H  L+++ G C+E     L++E+M    L  +
Sbjct: 32  VAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY 90
Query: 68  LFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDF 127
           L    +  +   +  + +   + +G+ YL+E     +IHRDL   N L+ E+   K+SDF
Sbjct: 91  L--RTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDF 145
Query: 128 GLARIL 133
           G+ R +
Sbjct: 146 GMTRFV 151

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 65/126 (51%), Gaps = 7/126 (5%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYF 67
           +A+K + ++     E+F  E  +  KL H  L+++ G C+E     L++E+M    L  +
Sbjct: 37  VAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDY 95
Query: 68  LFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDF 127
           L    +  +   +  + +   + +G+ YL+E     +IHRDL   N L+ E+   K+SDF
Sbjct: 96  L--RTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDF 150
Query: 128 GLARIL 133
           G+ R +
Sbjct: 151 GMTRFV 156

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 55.5 bits (132), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/171 (29%), Positives = 76/171 (44%), Gaps = 23/171 (13%)
Query: 6   GQIIAVKKLSKKS----TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMP 60
           G  +AVK          +Q  E  + E  L A L+H N+I + G C++     L+ E+  
Sbjct: 30  GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFAR 89
Query: 61  KRSLDYFLFD---PIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL- 116
              L+  L     P  +L       V+    I +G+ YL +   + IIHRDLK SNIL+ 
Sbjct: 90  GGPLNRVLSGKRIPPDIL-------VNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILIL 142
Query: 117 ----DEDLKP---KISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYK 160
               + DL     KI+DFGLAR   +           ++ PE +   ++ K
Sbjct: 143 QKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASMFSK 193

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/135 (34%), Positives = 66/135 (48%), Gaps = 17/135 (12%)
Query: 6   GQIIAVKKL-SKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIE---TQEYMLIYEYMPK 61
           G+++AVK L +    Q    +K E+ +   L H ++I+   C E        L+ EY+P 
Sbjct: 60  GEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPL 119
Query: 62  RSL-DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYL--QEYFRLTIIHRDLKVSNILLDE 118
            SL DY     I +  L     +   + I +G+ YL  Q Y     IHRDL   N+LLD 
Sbjct: 120 GSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYLHAQHY-----IHRDLAARNVLLDN 169
Query: 119 DLKPKISDFGLARIL 133
           D   KI DFGLA+ +
Sbjct: 170 DRLVKIGDFGLAKAV 184

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 79/161 (49%), Gaps = 13/161 (8%)
Query: 8   IIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDY 66
            +AVK L K+ T   EEF  E  +  +++H NL+++ G C     + +I E+M   +L  
Sbjct: 45  TVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLD 103
Query: 67  FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISD 126
           +L +  R  + +    +++   I   + YL+   +   IHRDL   N L+ E+   K++D
Sbjct: 104 YLRECNRQEV-NAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVAD 159
Query: 127 FGLARIL---RKMILKQIQIELGYIPPEYVGRGVYYKKFSL 164
           FGL+R++           +  + +  PE +     Y KFS+
Sbjct: 160 FGLSRLMTGDTXTAHAGAKFPIKWTAPESLA----YNKFSI 196

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/162 (29%), Positives = 84/162 (51%), Gaps = 14/162 (8%)
Query: 6   GQIIAVKKLSKKSTQGFEE-FKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKRS 63
           G++ AVK + KK+ +G E   +NE+ +  K++H N++ +    E+  ++ L+ + +    
Sbjct: 47  GKLFAVKCIPKKALKGKESSIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGE 106
Query: 64  LDYFLFDPI-RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL---DED 119
           L    FD I        K    +I+ ++  + YL    R+ I+HRDLK  N+L    DE+
Sbjct: 107 L----FDRIVEKGFYTEKDASTLIRQVLDAVYYLH---RMGIVHRDLKPENLLYYSQDEE 159
Query: 120 LKPKISDFGLARILRKM-ILKQIQIELGYIPPEYVGRGVYYK 160
            K  ISDFGL+++  K  ++       GY+ PE + +  Y K
Sbjct: 160 SKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEVLAQKPYSK 201

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 81/169 (47%), Gaps = 22/169 (13%)
Query: 9   IAVKKLSKKSTQGFE-EFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSLDY 66
           +AVK L +  ++  E +F  E ++ +KL H N++R +G  +++    ++ E M    L  
Sbjct: 64  VAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKS 123
Query: 67  FLFD-------PIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLD-- 117
           FL +       P  + +LD    +H+ + I  G  YL+E      IHRD+   N LL   
Sbjct: 124 FLRETRPRPSQPSSLAMLDL---LHVARDIACGCQYLEENH---FIHRDIAARNCLLTCP 177
Query: 118 -EDLKPKISDFGLAR-ILRKMILKQ---IQIELGYIPPEYVGRGVYYKK 161
                 KI DFG+AR I R    ++     + + ++PPE    G++  K
Sbjct: 178 GPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSK 226

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 54.3 bits (129), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 79/161 (49%), Gaps = 13/161 (8%)
Query: 8   IIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDY 66
            +AVK L K+ T   EEF  E  +  +++H NL+++ G C     + +I E+M   +L  
Sbjct: 45  TVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLD 103
Query: 67  FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISD 126
           +L +  R  + +    +++   I   + YL+   +   IHRDL   N L+ E+   K++D
Sbjct: 104 YLRECNRQEV-NAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVAD 159
Query: 127 FGLARILRK---MILKQIQIELGYIPPEYVGRGVYYKKFSL 164
           FGL+R++           +  + +  PE +     Y KFS+
Sbjct: 160 FGLSRLMTGDTYTAHAGAKFPIKWTAPESLA----YNKFSI 196

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 79/161 (49%), Gaps = 13/161 (8%)
Query: 8   IIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDY 66
            +AVK L K+ T   EEF  E  +  +++H NL+++ G C     + +I E+M   +L  
Sbjct: 41  TVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLD 99
Query: 67  FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISD 126
           +L +  R  + +    +++   I   + YL+   +   IHRDL   N L+ E+   K++D
Sbjct: 100 YLRECNRQEV-NAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVAD 155
Query: 127 FGLARILRK---MILKQIQIELGYIPPEYVGRGVYYKKFSL 164
           FGL+R++           +  + +  PE +     Y KFS+
Sbjct: 156 FGLSRLMTGDTYTAPAGAKFPIKWTAPESLA----YNKFSI 192

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 79/161 (49%), Gaps = 13/161 (8%)
Query: 8   IIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDY 66
            +AVK L K+ T   EEF  E  +  +++H NL+++ G C     + +I E+M   +L  
Sbjct: 40  TVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLD 98
Query: 67  FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISD 126
           +L +  R  + +    +++   I   + YL+   +   IHRDL   N L+ E+   K++D
Sbjct: 99  YLRECNRQEV-NAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVAD 154
Query: 127 FGLARILRK---MILKQIQIELGYIPPEYVGRGVYYKKFSL 164
           FGL+R++           +  + +  PE +     Y KFS+
Sbjct: 155 FGLSRLMTGDTYTAHAGAKFPIKWTAPESLA----YNKFSI 191

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 81/169 (47%), Gaps = 22/169 (13%)
Query: 9   IAVKKLSKKSTQGFE-EFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSLDY 66
           +AVK L +  ++  E +F  E ++ +KL H N++R +G  +++    ++ E M    L  
Sbjct: 78  VAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGGDLKS 137
Query: 67  FLFD-------PIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL--- 116
           FL +       P  + +LD    +H+ + I  G  YL+E      IHRD+   N LL   
Sbjct: 138 FLRETRPRPSQPSSLAMLD---LLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCP 191
Query: 117 DEDLKPKISDFGLAR-ILRKMILKQ---IQIELGYIPPEYVGRGVYYKK 161
                 KI DFG+AR I R    ++     + + ++PPE    G++  K
Sbjct: 192 GPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSK 240

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 78/161 (48%), Gaps = 12/161 (7%)
Query: 7   QIIAVKKLS-KKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSL 64
           + +AVK +  K++    E  K E+ +   L H N+++  G   E     L  EY     L
Sbjct: 33  EAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 92
Query: 65  DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKI 124
              +   I M   D ++  H    ++ G++YL     + I HRD+K  N+LLDE    KI
Sbjct: 93  FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKI 146
Query: 125 SDFGLARIL----RKMILKQIQIELGYIPPEYVGRGVYYKK 161
           SDFGLA +     R+ +L ++   L Y+ PE + R  ++ +
Sbjct: 147 SDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAE 187

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 79/161 (49%), Gaps = 13/161 (8%)
Query: 8   IIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDY 66
            +AVK L K+ T   EEF  E  +  +++H NL+++ G C     + +I E+M   +L  
Sbjct: 45  TVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLD 103
Query: 67  FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISD 126
           +L +  R  + +    +++   I   + YL+   +   IHRDL   N L+ E+   K++D
Sbjct: 104 YLRECNRQEV-NAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVAD 159
Query: 127 FGLARILRK---MILKQIQIELGYIPPEYVGRGVYYKKFSL 164
           FGL+R++           +  + +  PE +     Y KFS+
Sbjct: 160 FGLSRLMTGDTYTAHAGAKFPIKWTAPESLA----YNKFSI 196

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 79/161 (49%), Gaps = 13/161 (8%)
Query: 8   IIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDY 66
            +AVK L K+ T   EEF  E  +  +++H NL+++ G C     + +I E+M   +L  
Sbjct: 40  TVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLD 98
Query: 67  FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISD 126
           +L +  R  + +    +++   I   + YL+   +   IHRDL   N L+ E+   K++D
Sbjct: 99  YLRECNRQEV-NAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVAD 154
Query: 127 FGLARILRK---MILKQIQIELGYIPPEYVGRGVYYKKFSL 164
           FGL+R++           +  + +  PE +     Y KFS+
Sbjct: 155 FGLSRLMTGDTYTAHAGAKFPIKWTAPESLA----YNKFSI 191

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 79/161 (49%), Gaps = 13/161 (8%)
Query: 8   IIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDY 66
            +AVK L K+ T   EEF  E  +  +++H NL+++ G C     + +I E+M   +L  
Sbjct: 44  TVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLD 102
Query: 67  FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISD 126
           +L +  R  + +    +++   I   + YL+   +   IHRDL   N L+ E+   K++D
Sbjct: 103 YLRECNRQEV-NAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVAD 158
Query: 127 FGLARILRK---MILKQIQIELGYIPPEYVGRGVYYKKFSL 164
           FGL+R++           +  + +  PE +     Y KFS+
Sbjct: 159 FGLSRLMTGDTYTAHAGAKFPIKWTAPESLA----YNKFSI 195

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 79/161 (49%), Gaps = 13/161 (8%)
Query: 8   IIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDY 66
            +AVK L K+ T   EEF  E  +  +++H NL+++ G C     + +I E+M   +L  
Sbjct: 42  TVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLD 100
Query: 67  FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISD 126
           +L +  R  + +    +++   I   + YL+   +   IHRDL   N L+ E+   K++D
Sbjct: 101 YLRECNRQEV-NAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVAD 156
Query: 127 FGLARILRK---MILKQIQIELGYIPPEYVGRGVYYKKFSL 164
           FGL+R++           +  + +  PE +     Y KFS+
Sbjct: 157 FGLSRLMTGDTYTAHAGAKFPIKWTAPESLA----YNKFSI 193

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 79/161 (49%), Gaps = 13/161 (8%)
Query: 8   IIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDY 66
            +AVK L K+ T   EEF  E  +  +++H NL+++ G C     + +I E+M   +L  
Sbjct: 42  TVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLD 100
Query: 67  FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISD 126
           +L +  R  + +    +++   I   + YL+   +   IHRDL   N L+ E+   K++D
Sbjct: 101 YLRECNRQEV-NAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVAD 156
Query: 127 FGLARILRK---MILKQIQIELGYIPPEYVGRGVYYKKFSL 164
           FGL+R++           +  + +  PE +     Y KFS+
Sbjct: 157 FGLSRLMTGDTYTAPAGAKFPIKWTAPESLA----YNKFSI 193

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 79/161 (49%), Gaps = 13/161 (8%)
Query: 8   IIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDY 66
            +AVK L K+ T   EEF  E  +  +++H NL+++ G C     + +I E+M   +L  
Sbjct: 42  TVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLD 100
Query: 67  FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISD 126
           +L +  R  + +    +++   I   + YL+   +   IHRDL   N L+ E+   K++D
Sbjct: 101 YLRECNRQEV-NAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVAD 156
Query: 127 FGLARILRK---MILKQIQIELGYIPPEYVGRGVYYKKFSL 164
           FGL+R++           +  + +  PE +     Y KFS+
Sbjct: 157 FGLSRLMTGDTYTAHAGAKFPIKWTAPESLA----YNKFSI 193

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 78/161 (48%), Gaps = 12/161 (7%)
Query: 7   QIIAVKKLS-KKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSL 64
           + +AVK +  K++    E  K E+ +   L H N+++  G   E     L  EY     L
Sbjct: 32  EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 91
Query: 65  DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKI 124
              +   I M   D ++  H    ++ G++YL     + I HRD+K  N+LLDE    KI
Sbjct: 92  FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKI 145
Query: 125 SDFGLARIL----RKMILKQIQIELGYIPPEYVGRGVYYKK 161
           SDFGLA +     R+ +L ++   L Y+ PE + R  ++ +
Sbjct: 146 SDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAE 186

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 78/161 (48%), Gaps = 12/161 (7%)
Query: 7   QIIAVKKLS-KKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSL 64
           + +AVK +  K++    E  K E+ +   L H N+++  G   E     L  EY     L
Sbjct: 32  EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 91
Query: 65  DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKI 124
              +   I M   D ++  H    ++ G++YL     + I HRD+K  N+LLDE    KI
Sbjct: 92  FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKI 145
Query: 125 SDFGLARIL----RKMILKQIQIELGYIPPEYVGRGVYYKK 161
           SDFGLA +     R+ +L ++   L Y+ PE + R  ++ +
Sbjct: 146 SDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAE 186

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 78/161 (48%), Gaps = 12/161 (7%)
Query: 7   QIIAVKKLS-KKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSL 64
           + +AVK +  K++    E  K E+ +   L H N+++  G   E     L  EY     L
Sbjct: 32  EAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 91
Query: 65  DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKI 124
              +   I M   D ++  H    ++ G++YL     + I HRD+K  N+LLDE    KI
Sbjct: 92  FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKI 145
Query: 125 SDFGLARIL----RKMILKQIQIELGYIPPEYVGRGVYYKK 161
           SDFGLA +     R+ +L ++   L Y+ PE + R  ++ +
Sbjct: 146 SDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAE 186

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 35/126 (27%), Positives = 64/126 (50%), Gaps = 7/126 (5%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYF 67
           +A+K + ++     E+F  E  +  KL H  L+++ G C+E     L+ E+M    L  +
Sbjct: 35  VAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDY 93
Query: 68  LFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDF 127
           L    +  +   +  + +   + +G+ YL+E     +IHRDL   N L+ E+   K+SDF
Sbjct: 94  L--RTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDF 148
Query: 128 GLARIL 133
           G+ R +
Sbjct: 149 GMTRFV 154

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 67/129 (51%), Gaps = 10/129 (7%)
Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYM-LIYEYMPKRS 63
           G  +AVK +   +T   + F  E  +  +L+H NL+++ G  +E +  + ++ EYM K S
Sbjct: 35  GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 92
Query: 64  L-DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKP 122
           L DY       +L  DC  +  +   + + + YL+       +HRDL   N+L+ ED   
Sbjct: 93  LVDYLRSRGRSVLGGDCLLKFSL--DVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVA 147
Query: 123 KISDFGLAR 131
           K+SDFGL +
Sbjct: 148 KVSDFGLTK 156

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 78/161 (48%), Gaps = 13/161 (8%)
Query: 8   IIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDY 66
            +AVK L K+ T   EEF  E  +  +++H NL+++ G C     + +I E+M   +L  
Sbjct: 38  TVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLD 96
Query: 67  FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISD 126
           +L +  R  +      +++   I   + YL+   +   IHRDL   N L+ E+   K++D
Sbjct: 97  YLRECNRQEV-SAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVAD 152
Query: 127 FGLARILRKMILKQ---IQIELGYIPPEYVGRGVYYKKFSL 164
           FGL+R++           +  + +  PE +     Y KFS+
Sbjct: 153 FGLSRLMTGDTFTAHAGAKFPIKWTAPESLA----YNKFSI 189

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 78/161 (48%), Gaps = 12/161 (7%)
Query: 7   QIIAVKKLS-KKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSL 64
           + +AVK +  K++    E  K E+ +   L H N+++  G   E     L  EY     L
Sbjct: 32  EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 91
Query: 65  DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKI 124
              +   I M   D ++  H    ++ G++YL     + I HRD+K  N+LLDE    KI
Sbjct: 92  FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKI 145
Query: 125 SDFGLARIL----RKMILKQIQIELGYIPPEYVGRGVYYKK 161
           SDFGLA +     R+ +L ++   L Y+ PE + R  ++ +
Sbjct: 146 SDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAE 186

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 79/161 (49%), Gaps = 13/161 (8%)
Query: 8   IIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDY 66
            +AVK L K+ T   EEF  E  +  +++H NL+++ G C     + +I E+M   +L  
Sbjct: 41  TVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLD 99
Query: 67  FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISD 126
           +L +  R  + +    +++   I   + YL+   +   IHRDL   N L+ E+   K++D
Sbjct: 100 YLRECNRQEV-NAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVAD 155
Query: 127 FGLARIL---RKMILKQIQIELGYIPPEYVGRGVYYKKFSL 164
           FGL+R++           +  + +  PE +     Y KFS+
Sbjct: 156 FGLSRLMTGDTXTAHAGAKFPIKWTAPESLA----YNKFSI 192

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 79/161 (49%), Gaps = 13/161 (8%)
Query: 8   IIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDY 66
            +AVK L K+ T   EEF  E  +  +++H NL+++ G C     + +I E+M   +L  
Sbjct: 53  TVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLD 111
Query: 67  FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISD 126
           +L +  R  + +    +++   I   + YL+   +   IHRDL   N L+ E+   K++D
Sbjct: 112 YLRECNRQEV-NAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVAD 167
Query: 127 FGLARILRK---MILKQIQIELGYIPPEYVGRGVYYKKFSL 164
           FGL+R++           +  + +  PE +     Y KFS+
Sbjct: 168 FGLSRLMTGDTYTAHAGAKFPIKWTAPESLA----YNKFSI 204

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 43/151 (28%), Positives = 74/151 (49%), Gaps = 11/151 (7%)
Query: 9   IAVK--KLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDY 66
           +AVK  K+   + + F+ F+NEV +  K +H+N++     +      ++ ++    SL  
Sbjct: 61  VAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYK 120
Query: 67  FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISD 126
            L   ++       + + I +   QG+ YL       IIHRD+K +NI L E L  KI D
Sbjct: 121 HLH--VQETKFQMFQLIDIARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGD 175
Query: 127 FGLARI-LRKMILKQIQIELG---YIPPEYV 153
           FGLA +  R    +Q++   G   ++ PE +
Sbjct: 176 FGLATVKSRWSGSQQVEQPTGSVLWMAPEVI 206

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 38/129 (29%), Positives = 68/129 (52%), Gaps = 9/129 (6%)
Query: 6   GQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKR 62
           G+ +AVK + K   ++   ++   EV +   L H N++++   IET++ + L+ EY    
Sbjct: 39  GKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGG 98
Query: 63  SLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKP 122
            +  +L    RM   + + +    + I+  + Y  + F   I+HRDLK  N+LLD D+  
Sbjct: 99  EVFDYLVAHGRMKEKEARAK---FRQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNI 152
Query: 123 KISDFGLAR 131
           KI+DFG + 
Sbjct: 153 KIADFGFSN 161

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 67/129 (51%), Gaps = 10/129 (7%)
Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYM-LIYEYMPKRS 63
           G  +AVK +   +T   + F  E  +  +L+H NL+++ G  +E +  + ++ EYM K S
Sbjct: 44  GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 101
Query: 64  L-DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKP 122
           L DY       +L  DC  +  +   + + + YL+       +HRDL   N+L+ ED   
Sbjct: 102 LVDYLRSRGRSVLGGDCLLKFSL--DVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVA 156
Query: 123 KISDFGLAR 131
           K+SDFGL +
Sbjct: 157 KVSDFGLTK 165

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 38/129 (29%), Positives = 68/129 (52%), Gaps = 9/129 (6%)
Query: 6   GQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKR 62
           G+ +AVK + K   ++   ++   EV +   L H N++++   IET++ + L+ EY    
Sbjct: 39  GKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGG 98
Query: 63  SLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKP 122
            +  +L    RM   + + +    + I+  + Y  + F   I+HRDLK  N+LLD D+  
Sbjct: 99  EVFDYLVAHGRMKEKEARAK---FRQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNI 152
Query: 123 KISDFGLAR 131
           KI+DFG + 
Sbjct: 153 KIADFGFSN 161

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 38/129 (29%), Positives = 68/129 (52%), Gaps = 9/129 (6%)
Query: 6   GQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKR 62
           G+ +AVK + K   ++   ++   EV +   L H N++++   IET++ + L+ EY    
Sbjct: 39  GKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGG 98
Query: 63  SLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKP 122
            +  +L    RM   + + +    + I+  + Y  + F   I+HRDLK  N+LLD D+  
Sbjct: 99  EVFDYLVAHGRMKEKEARAK---FRQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNI 152
Query: 123 KISDFGLAR 131
           KI+DFG + 
Sbjct: 153 KIADFGFSN 161

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/133 (33%), Positives = 65/133 (48%), Gaps = 13/133 (9%)
Query: 6   GQIIAVKKL-SKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQ---EYMLIYEYMPK 61
           G+++AVK L +    Q    +K E+ +   L H ++I+   C E Q      L+ EY+P 
Sbjct: 43  GEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPL 102
Query: 62  RSL-DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL 120
            SL DY     I +  L     +   + I +G+ YL        IHR+L   N+LLD D 
Sbjct: 103 GSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYLHSQH---YIHRNLAARNVLLDNDR 154
Query: 121 KPKISDFGLARIL 133
             KI DFGLA+ +
Sbjct: 155 LVKIGDFGLAKAV 167

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 67/129 (51%), Gaps = 10/129 (7%)
Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYM-LIYEYMPKRS 63
           G  +AVK +   +T   + F  E  +  +L+H NL+++ G  +E +  + ++ EYM K S
Sbjct: 29  GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 86
Query: 64  L-DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKP 122
           L DY       +L  DC  +  +   + + + YL+       +HRDL   N+L+ ED   
Sbjct: 87  LVDYLRSRGRSVLGGDCLLKFSL--DVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVA 141
Query: 123 KISDFGLAR 131
           K+SDFGL +
Sbjct: 142 KVSDFGLTK 150

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 79/161 (49%), Gaps = 13/161 (8%)
Query: 8   IIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDY 66
            +AVK L K+ T   EEF  E  +  +++H NL+++ G C     + +I E+M   +L  
Sbjct: 45  TVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLD 103
Query: 67  FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISD 126
           +L +  R  + +    +++   I   + YL+   +   IHRDL   N L+ E+   K++D
Sbjct: 104 YLRECNRQEV-NAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVAD 159
Query: 127 FGLARILRK---MILKQIQIELGYIPPEYVGRGVYYKKFSL 164
           FGL+R++           +  + +  PE +     Y KFS+
Sbjct: 160 FGLSRLMTGDTYTAHAGAKFPIKWTAPESLA----YNKFSI 196

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 78/161 (48%), Gaps = 13/161 (8%)
Query: 8   IIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDY 66
            +AVK L K+ T   EEF  E  +  +++H NL+++ G C     + +I E+M   +L  
Sbjct: 38  TVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLD 96
Query: 67  FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISD 126
           +L +  R  +      +++   I   + YL+   +   IHRDL   N L+ E+   K++D
Sbjct: 97  YLRECNRQEV-SAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVAD 152
Query: 127 FGLARIL---RKMILKQIQIELGYIPPEYVGRGVYYKKFSL 164
           FGL+R++           +  + +  PE +     Y KFS+
Sbjct: 153 FGLSRLMTGDTXTAHAGAKFPIKWTAPESLA----YNKFSI 189

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 78/161 (48%), Gaps = 12/161 (7%)
Query: 7   QIIAVKKLS-KKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSL 64
           + +AVK +  K++    E  K E+ +   L H N+++  G   E     L  EY     L
Sbjct: 32  EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 91
Query: 65  DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKI 124
              +   I M   D ++  H    ++ G++YL     + I HRD+K  N+LLDE    KI
Sbjct: 92  FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKI 145
Query: 125 SDFGLARIL----RKMILKQIQIELGYIPPEYVGRGVYYKK 161
           SDFGLA +     R+ +L ++   L Y+ PE + R  ++ +
Sbjct: 146 SDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 78/161 (48%), Gaps = 12/161 (7%)
Query: 7   QIIAVKKLS-KKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSL 64
           + +AVK +  K++    E  K E+ +   L H N+++  G   E     L  EY     L
Sbjct: 32  EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 91
Query: 65  DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKI 124
              +   I M   D ++  H    ++ G++YL     + I HRD+K  N+LLDE    KI
Sbjct: 92  FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKI 145
Query: 125 SDFGLARIL----RKMILKQIQIELGYIPPEYVGRGVYYKK 161
           SDFGLA +     R+ +L ++   L Y+ PE + R  ++ +
Sbjct: 146 SDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 78/161 (48%), Gaps = 12/161 (7%)
Query: 7   QIIAVKKLS-KKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSL 64
           + +AVK +  K++    E  K E+ +   L H N+++  G   E     L  EY     L
Sbjct: 33  EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 92
Query: 65  DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKI 124
              +   I M   D ++  H    ++ G++YL     + I HRD+K  N+LLDE    KI
Sbjct: 93  FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKI 146
Query: 125 SDFGLARIL----RKMILKQIQIELGYIPPEYVGRGVYYKK 161
           SDFGLA +     R+ +L ++   L Y+ PE + R  ++ +
Sbjct: 147 SDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 78/161 (48%), Gaps = 12/161 (7%)
Query: 7   QIIAVKKLS-KKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSL 64
           + +AVK +  K++    E  K E+ +   L H N+++  G   E     L  EY     L
Sbjct: 33  EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 92
Query: 65  DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKI 124
              +   I M   D ++  H    ++ G++YL     + I HRD+K  N+LLDE    KI
Sbjct: 93  FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKI 146
Query: 125 SDFGLARIL----RKMILKQIQIELGYIPPEYVGRGVYYKK 161
           SDFGLA +     R+ +L ++   L Y+ PE + R  ++ +
Sbjct: 147 SDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/133 (33%), Positives = 65/133 (48%), Gaps = 13/133 (9%)
Query: 6   GQIIAVKKL-SKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQ---EYMLIYEYMPK 61
           G+++AVK L +    Q    +K E+ +   L H ++I+   C E Q      L+ EY+P 
Sbjct: 43  GEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYVPL 102
Query: 62  RSL-DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL 120
            SL DY     I +  L     +   + I +G+ YL        IHR+L   N+LLD D 
Sbjct: 103 GSLRDYLPRHSIGLAQL-----LLFAQQICEGMAYLHAQH---YIHRNLAARNVLLDNDR 154
Query: 121 KPKISDFGLARIL 133
             KI DFGLA+ +
Sbjct: 155 LVKIGDFGLAKAV 167

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 78/161 (48%), Gaps = 12/161 (7%)
Query: 7   QIIAVKKLS-KKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSL 64
           + +AVK +  K++    E  K E+ +   L H N+++  G   E     L  EY     L
Sbjct: 33  EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 92
Query: 65  DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKI 124
              +   I M   D ++  H    ++ G++YL     + I HRD+K  N+LLDE    KI
Sbjct: 93  FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKI 146
Query: 125 SDFGLARIL----RKMILKQIQIELGYIPPEYVGRGVYYKK 161
           SDFGLA +     R+ +L ++   L Y+ PE + R  ++ +
Sbjct: 147 SDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 53.5 bits (127), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 78/161 (48%), Gaps = 12/161 (7%)
Query: 7   QIIAVKKLS-KKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSL 64
           + +AVK +  K++    E  K E+ +   L H N+++  G   E     L  EY     L
Sbjct: 33  EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 92
Query: 65  DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKI 124
              +   I M   D ++  H    ++ G++YL     + I HRD+K  N+LLDE    KI
Sbjct: 93  FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKI 146
Query: 125 SDFGLARIL----RKMILKQIQIELGYIPPEYVGRGVYYKK 161
           SDFGLA +     R+ +L ++   L Y+ PE + R  ++ +
Sbjct: 147 SDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 78/161 (48%), Gaps = 13/161 (8%)
Query: 8   IIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDY 66
            +AVK L K+ T   EEF  E  +  +++H NL+++ G C     + +I E+M   +L  
Sbjct: 40  TVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLD 98
Query: 67  FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISD 126
           +L +  R  +      +++   I   + YL+   +   IHRDL   N L+ E+   K++D
Sbjct: 99  YLRECNRQEV-SAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVAD 154
Query: 127 FGLARILRK---MILKQIQIELGYIPPEYVGRGVYYKKFSL 164
           FGL+R++           +  + +  PE +     Y KFS+
Sbjct: 155 FGLSRLMTGDTYTAHAGAKFPIKWTAPESLA----YNKFSI 191

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 78/161 (48%), Gaps = 12/161 (7%)
Query: 7   QIIAVKKLS-KKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSL 64
           + +AVK +  K++    E  K E+ +   L H N+++  G   E     L  EY     L
Sbjct: 33  EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 92
Query: 65  DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKI 124
              +   I M   D ++  H    ++ G++YL     + I HRD+K  N+LLDE    KI
Sbjct: 93  FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKI 146
Query: 125 SDFGLARIL----RKMILKQIQIELGYIPPEYVGRGVYYKK 161
           SDFGLA +     R+ +L ++   L Y+ PE + R  ++ +
Sbjct: 147 SDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 78/161 (48%), Gaps = 12/161 (7%)
Query: 7   QIIAVKKLS-KKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSL 64
           + +AVK +  K++    E  K E+ +   L H N+++  G   E     L  EY     L
Sbjct: 33  EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 92
Query: 65  DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKI 124
              +   I M   D ++  H    ++ G++YL     + I HRD+K  N+LLDE    KI
Sbjct: 93  FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKI 146
Query: 125 SDFGLARIL----RKMILKQIQIELGYIPPEYVGRGVYYKK 161
           SDFGLA +     R+ +L ++   L Y+ PE + R  ++ +
Sbjct: 147 SDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 187

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 67/129 (51%), Gaps = 10/129 (7%)
Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYM-LIYEYMPKRS 63
           G  +AVK +   +T   + F  E  +  +L+H NL+++ G  +E +  + ++ EYM K S
Sbjct: 216 GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 273
Query: 64  L-DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKP 122
           L DY       +L  DC  +  +   + + + YL+       +HRDL   N+L+ ED   
Sbjct: 274 LVDYLRSRGRSVLGGDCLLKFSL--DVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVA 328
Query: 123 KISDFGLAR 131
           K+SDFGL +
Sbjct: 329 KVSDFGLTK 337

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 78/161 (48%), Gaps = 12/161 (7%)
Query: 7   QIIAVKKLS-KKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSL 64
           + +AVK +  K++    E  K E+ +   L H N+++  G   E     L  EY     L
Sbjct: 32  EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 91
Query: 65  DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKI 124
              +   I M   D ++  H    ++ G++YL     + I HRD+K  N+LLDE    KI
Sbjct: 92  FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKI 145
Query: 125 SDFGLARIL----RKMILKQIQIELGYIPPEYVGRGVYYKK 161
           SDFGLA +     R+ +L ++   L Y+ PE + R  ++ +
Sbjct: 146 SDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 78/161 (48%), Gaps = 13/161 (8%)
Query: 8   IIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDY 66
            +AVK L K+ T   EEF  E  +  +++H NL+++ G C     + +I E+M   +L  
Sbjct: 45  TVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLD 103
Query: 67  FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISD 126
           +L +  R  +      +++   I   + YL+   +   IHRDL   N L+ E+   K++D
Sbjct: 104 YLRECNRQEV-SAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVAD 159
Query: 127 FGLARILRK---MILKQIQIELGYIPPEYVGRGVYYKKFSL 164
           FGL+R++           +  + +  PE +     Y KFS+
Sbjct: 160 FGLSRLMTGDTYTAHAGAKFPIKWTAPESLA----YNKFSI 196

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 53.5 bits (127), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 78/161 (48%), Gaps = 12/161 (7%)
Query: 7   QIIAVKKLS-KKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSL 64
           + +AVK +  K++    E  K E+ +   L H N+++  G   E     L  EY     L
Sbjct: 31  EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 90
Query: 65  DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKI 124
              +   I M   D ++  H    ++ G++YL     + I HRD+K  N+LLDE    KI
Sbjct: 91  FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKI 144
Query: 125 SDFGLARIL----RKMILKQIQIELGYIPPEYVGRGVYYKK 161
           SDFGLA +     R+ +L ++   L Y+ PE + R  ++ +
Sbjct: 145 SDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 185

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 78/161 (48%), Gaps = 12/161 (7%)
Query: 7   QIIAVKKLS-KKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSL 64
           + +AVK +  K++    E  K E+ +   L H N+++  G   E     L  EY     L
Sbjct: 32  EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 91
Query: 65  DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKI 124
              +   I M   D ++  H    ++ G++YL     + I HRD+K  N+LLDE    KI
Sbjct: 92  FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKI 145
Query: 125 SDFGLARIL----RKMILKQIQIELGYIPPEYVGRGVYYKK 161
           SDFGLA +     R+ +L ++   L Y+ PE + R  ++ +
Sbjct: 146 SDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 78/161 (48%), Gaps = 12/161 (7%)
Query: 7   QIIAVKKLS-KKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSL 64
           + +AVK +  K++    E  K E+ +   L H N+++  G   E     L  EY     L
Sbjct: 32  EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 91
Query: 65  DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKI 124
              +   I M   D ++  H    ++ G++YL     + I HRD+K  N+LLDE    KI
Sbjct: 92  FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKI 145
Query: 125 SDFGLARIL----RKMILKQIQIELGYIPPEYVGRGVYYKK 161
           SDFGLA +     R+ +L ++   L Y+ PE + R  ++ +
Sbjct: 146 SDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 78/161 (48%), Gaps = 13/161 (8%)
Query: 8   IIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDY 66
            +AVK L K+ T   EEF  E  +  +++H NL+++ G C     + +I E+M   +L  
Sbjct: 40  TVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLD 98
Query: 67  FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISD 126
           +L +  R  +      +++   I   + YL+   +   IHRDL   N L+ E+   K++D
Sbjct: 99  YLRECNRQEV-SAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVAD 154
Query: 127 FGLARILRK---MILKQIQIELGYIPPEYVGRGVYYKKFSL 164
           FGL+R++           +  + +  PE +     Y KFS+
Sbjct: 155 FGLSRLMTGDTYTAHAGAKFPIKWTAPESLA----YNKFSI 191

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 84/161 (52%), Gaps = 14/161 (8%)
Query: 7   QIIAVKKLSKKSTQGFE-EFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKRSL 64
           +++A+K ++KK+ +G E   +NE+ +  K++H N++ +    E+  ++ LI + +    L
Sbjct: 44  KLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL 103
Query: 65  DYFLFDPI-RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNIL---LDEDL 120
               FD I        +    +I  ++  + YL +   L I+HRDLK  N+L   LDED 
Sbjct: 104 ----FDRIVEKGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDS 156
Query: 121 KPKISDFGLARILRK-MILKQIQIELGYIPPEYVGRGVYYK 160
           K  ISDFGL+++     +L       GY+ PE + +  Y K
Sbjct: 157 KIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSK 197

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 78/161 (48%), Gaps = 12/161 (7%)
Query: 7   QIIAVKKLS-KKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSL 64
           + +AVK +  K++    E  K E+ +   L H N+++  G   E     L  EY     L
Sbjct: 32  EAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 91
Query: 65  DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKI 124
              +   I M   D ++  H    ++ G++YL     + I HRD+K  N+LLDE    KI
Sbjct: 92  FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKI 145
Query: 125 SDFGLARIL----RKMILKQIQIELGYIPPEYVGRGVYYKK 161
           SDFGLA +     R+ +L ++   L Y+ PE + R  ++ +
Sbjct: 146 SDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 78/161 (48%), Gaps = 12/161 (7%)
Query: 7   QIIAVKKLS-KKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSL 64
           + +AVK +  K++    E  K E+ +   L H N+++  G   E     L  EY     L
Sbjct: 32  EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 91
Query: 65  DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKI 124
              +   I M   D ++  H    ++ G++YL     + I HRD+K  N+LLDE    KI
Sbjct: 92  FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKI 145
Query: 125 SDFGLARIL----RKMILKQIQIELGYIPPEYVGRGVYYKK 161
           SDFGLA +     R+ +L ++   L Y+ PE + R  ++ +
Sbjct: 146 SDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 53.1 bits (126), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/161 (29%), Positives = 78/161 (48%), Gaps = 12/161 (7%)
Query: 7   QIIAVKKLS-KKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSL 64
           + +AVK +  K++    E  K E+ +   L H N+++  G   E     L  EY     L
Sbjct: 32  EAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGEL 91
Query: 65  DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKI 124
              +   I M   D ++  H    ++ G++YL     + I HRD+K  N+LLDE    KI
Sbjct: 92  FDRIEPDIGMPEPDAQRFFH---QLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKI 145
Query: 125 SDFGLARIL----RKMILKQIQIELGYIPPEYVGRGVYYKK 161
           SDFGLA +     R+ +L ++   L Y+ PE + R  ++ +
Sbjct: 146 SDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAE 186

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 53.1 bits (126), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 78/161 (48%), Gaps = 13/161 (8%)
Query: 8   IIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDY 66
            +AVK L K+ T   EEF  E  +  +++H NL+++ G C     + +I E+M   +L  
Sbjct: 38  TVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLD 96
Query: 67  FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISD 126
           +L +  R  +      +++   I   + YL+   +   IHRDL   N L+ E+   K++D
Sbjct: 97  YLRECNRQEV-SAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVAD 152
Query: 127 FGLARIL---RKMILKQIQIELGYIPPEYVGRGVYYKKFSL 164
           FGL+R++           +  + +  PE +     Y KFS+
Sbjct: 153 FGLSRLMTGDTXTAHAGAKFPIKWTAPESLA----YNKFSI 189

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 78/161 (48%), Gaps = 13/161 (8%)
Query: 8   IIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDY 66
            +AVK L K+ T   EEF  E  +  +++H NL+++ G C     + +I E+M   +L  
Sbjct: 40  TVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLD 98
Query: 67  FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISD 126
           +L +  R  +      +++   I   + YL+   +   IHRDL   N L+ E+   K++D
Sbjct: 99  YLRECNRQEV-SAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVAD 154
Query: 127 FGLARILRK---MILKQIQIELGYIPPEYVGRGVYYKKFSL 164
           FGL+R++           +  + +  PE +     Y KFS+
Sbjct: 155 FGLSRLMTGDTYTAHAGAKFPIKWTAPESLA----YNKFSI 191

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 68/129 (52%), Gaps = 9/129 (6%)
Query: 6   GQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKR 62
           G+ +AV+ + K   ++   ++   EV +   L H N++++   IET++ + L+ EY    
Sbjct: 39  GKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGG 98
Query: 63  SLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKP 122
            +  +L    RM   + + +    + I+  + Y  + F   I+HRDLK  N+LLD D+  
Sbjct: 99  EVFDYLVAHGRMKEKEARAK---FRQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNI 152
Query: 123 KISDFGLAR 131
           KI+DFG + 
Sbjct: 153 KIADFGFSN 161

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 78/161 (48%), Gaps = 13/161 (8%)
Query: 8   IIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDY 66
            +AVK L K+ T   EEF  E  +  +++H NL+++ G C     + +I E+M   +L  
Sbjct: 40  TVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIIEFMTYGNLLD 98
Query: 67  FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISD 126
           +L +  R  +      +++   I   + YL+   +   IHRDL   N L+ E+   K++D
Sbjct: 99  YLRECNRQEV-SAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVAD 154
Query: 127 FGLARILRK---MILKQIQIELGYIPPEYVGRGVYYKKFSL 164
           FGL+R++           +  + +  PE +     Y KFS+
Sbjct: 155 FGLSRLMTGDTYTAHAGAKFPIKWTAPESLA----YNKFSI 191

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 68/129 (52%), Gaps = 9/129 (6%)
Query: 6   GQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKR 62
           G+ +AV+ + K   ++   ++   EV +   L H N++++   IET++ + L+ EY    
Sbjct: 39  GKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGG 98
Query: 63  SLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKP 122
            +  +L    RM   + + +    + I+  + Y  + F   I+HRDLK  N+LLD D+  
Sbjct: 99  EVFDYLVAHGRMKEKEARAK---FRQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNI 152
Query: 123 KISDFGLAR 131
           KI+DFG + 
Sbjct: 153 KIADFGFSN 161

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 52.8 bits (125), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 83/163 (50%), Gaps = 12/163 (7%)
Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSL 64
           G+ +AVK +  +  Q  E   NEV++    QH N++ +    +  +E  ++ E++   +L
Sbjct: 70  GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGAL 129
Query: 65  DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKI 124
                D +  + L+ ++   + + ++Q L YL       +IHRD+K  +ILL  D + K+
Sbjct: 130 T----DIVSQVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKL 182
Query: 125 SDFGLARILRKMILKQIQIELG---YIPPEYVGRGVYYKKFSL 164
           SDFG    + K + K+  + +G   ++ PE + R +Y  +  +
Sbjct: 183 SDFGFCAQISKDVPKRKXL-VGTPYWMAPEVISRSLYATEVDI 224

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 52.8 bits (125), Expect = 9e-08,   Method: Composition-based stats.
 Identities = 37/126 (29%), Positives = 68/126 (53%), Gaps = 6/126 (4%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYF 67
           +AVK L K+ T   EEF  E  +  +++H NL+++ G C     + +I E+M   +L  +
Sbjct: 287 VAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDY 345
Query: 68  LFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDF 127
           L +  R  + +    +++   I   + YL+   +   IHR+L   N L+ E+   K++DF
Sbjct: 346 LRECNRQEV-NAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADF 401
Query: 128 GLARIL 133
           GL+R++
Sbjct: 402 GLSRLM 407

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 52.8 bits (125), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 65/138 (47%), Gaps = 17/138 (12%)
Query: 5   DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR--VGFCIETQ----EYMLIYEY 58
           D + +AVK  S  + Q F   KN +     ++H N+ R  VG    T     EY+L+ EY
Sbjct: 35  DERPVAVKVFSFANRQNFINEKN-IYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEY 93
Query: 59  MPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQ------EYFRLTIIHRDLKVS 112
            P  SL  +L       +  C+    +   + +GL YL       ++++  I HRDL   
Sbjct: 94  YPNGSLXKYLSLHTSDWVSSCR----LAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSR 149
Query: 113 NILLDEDLKPKISDFGLA 130
           N+L+  D    ISDFGL+
Sbjct: 150 NVLVKNDGTCVISDFGLS 167

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 75/152 (49%), Gaps = 17/152 (11%)
Query: 9   IAVKKL---SKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQE-YMLIYEYMPKRSL 64
           +A+K +    ++  +  + F+ EV  +++L H N++ +    E  + Y L+ EY+   +L
Sbjct: 39  VAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTL 98
Query: 65  DYFL--FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKP 122
             ++    P     L     ++    I+ G+ +  +   + I+HRD+K  NIL+D +   
Sbjct: 99  SEYIESHGP-----LSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTL 150
Query: 123 KISDFGLARILRKMILKQIQIELG---YIPPE 151
           KI DFG+A+ L +  L Q    LG   Y  PE
Sbjct: 151 KIFDFGIAKALSETSLTQTNHVLGTVQYFSPE 182

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 52.4 bits (124), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 61/127 (48%), Gaps = 6/127 (4%)
Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSL 64
           GQ     K+ K+ +   +EF  E     KL H  L++  G C +     ++ EY+    L
Sbjct: 31  GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCL 90
Query: 65  DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKI 124
             +L    + L  +  + + +   + +G+ +L+ +     IHRDL   N L+D DL  K+
Sbjct: 91  LNYLRSHGKGL--EPSQLLEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKV 145
Query: 125 SDFGLAR 131
           SDFG+ R
Sbjct: 146 SDFGMTR 152

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-07,   Method: Composition-based stats.
 Identities = 38/133 (28%), Positives = 69/133 (51%), Gaps = 20/133 (15%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYF 67
           +AVK L K+ T   EEF  E  +  +++H NL+++ G C     + +I E+M   +L   
Sbjct: 248 VAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNL--- 303
Query: 68  LFDPIRMLILDCKKR-------VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL 120
             D +R    +C ++       +++   I   + YL+   +   IHR+L   N L+ E+ 
Sbjct: 304 -LDYLR----ECNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENH 355
Query: 121 KPKISDFGLARIL 133
             K++DFGL+R++
Sbjct: 356 LVKVADFGLSRLM 368

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 84/161 (52%), Gaps = 14/161 (8%)
Query: 7   QIIAVKKLSKKSTQGFE-EFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKRSL 64
           +++A+K ++K++ +G E   +NE+ +  K++H N++ +    E+  ++ LI + +    L
Sbjct: 44  KLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL 103
Query: 65  DYFLFDPI-RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNIL---LDEDL 120
               FD I        +    +I  ++  + YL +   L I+HRDLK  N+L   LDED 
Sbjct: 104 ----FDRIVEKGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDS 156
Query: 121 KPKISDFGLARILRK-MILKQIQIELGYIPPEYVGRGVYYK 160
           K  ISDFGL+++     +L       GY+ PE + +  Y K
Sbjct: 157 KIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSK 197

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 84/161 (52%), Gaps = 14/161 (8%)
Query: 7   QIIAVKKLSKKSTQGFE-EFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKRSL 64
           +++A+K ++K++ +G E   +NE+ +  K++H N++ +    E+  ++ LI + +    L
Sbjct: 44  KLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL 103
Query: 65  DYFLFDPI-RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNIL---LDEDL 120
               FD I        +    +I  ++  + YL +   L I+HRDLK  N+L   LDED 
Sbjct: 104 ----FDRIVEKGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDS 156
Query: 121 KPKISDFGLARILRK-MILKQIQIELGYIPPEYVGRGVYYK 160
           K  ISDFGL+++     +L       GY+ PE + +  Y K
Sbjct: 157 KIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSK 197

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 75/154 (48%), Gaps = 11/154 (7%)
Query: 7   QIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQ-EYMLIYEYMPKRSLD 65
           +II  K L+K   QG    + E+     L+H ++I++   I+++ E +++ EY      D
Sbjct: 39  KIINKKVLAKSDMQG--RIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFD 96
Query: 66  YFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKIS 125
           Y     ++   +  ++     + II  + Y     R  I+HRDLK  N+LLDE L  KI+
Sbjct: 97  YI----VQRDKMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIA 149
Query: 126 DFGLARILRK-MILKQIQIELGYIPPEYVGRGVY 158
           DFGL+ I+     LK       Y  PE +   +Y
Sbjct: 150 DFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLY 183

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 84/161 (52%), Gaps = 14/161 (8%)
Query: 7   QIIAVKKLSKKSTQGFE-EFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKRSL 64
           +++A+K ++K++ +G E   +NE+ +  K++H N++ +    E+  ++ LI + +    L
Sbjct: 44  KLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL 103
Query: 65  DYFLFDPI-RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNIL---LDEDL 120
               FD I        +    +I  ++  + YL +   L I+HRDLK  N+L   LDED 
Sbjct: 104 ----FDRIVEKGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDS 156
Query: 121 KPKISDFGLARILRK-MILKQIQIELGYIPPEYVGRGVYYK 160
           K  ISDFGL+++     +L       GY+ PE + +  Y K
Sbjct: 157 KIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSK 197

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 52.0 bits (123), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/137 (28%), Positives = 64/137 (46%), Gaps = 20/137 (14%)
Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR---VGFCIETQEYMLIYEYMPKR 62
           G ++AVK+L         +F+ E+ +   L    +++   V +    Q   L+ EY+P  
Sbjct: 40  GALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSG 99
Query: 63  SLDYFL------FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL 116
            L  FL       D  R+L+   +        I +G+ YL        +HRDL   NIL+
Sbjct: 100 CLRDFLQRHRARLDASRLLLYSSQ--------ICKGMEYLGSR---RCVHRDLAARNILV 148
Query: 117 DEDLKPKISDFGLARIL 133
           + +   KI+DFGLA++L
Sbjct: 149 ESEAHVKIADFGLAKLL 165

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/137 (28%), Positives = 64/137 (46%), Gaps = 20/137 (14%)
Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR---VGFCIETQEYMLIYEYMPKR 62
           G ++AVK+L         +F+ E+ +   L    +++   V +    Q   L+ EY+P  
Sbjct: 39  GALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSG 98
Query: 63  SLDYFL------FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL 116
            L  FL       D  R+L+   +        I +G+ YL        +HRDL   NIL+
Sbjct: 99  CLRDFLQRHRARLDASRLLLYSSQ--------ICKGMEYLGSR---RCVHRDLAARNILV 147
Query: 117 DEDLKPKISDFGLARIL 133
           + +   KI+DFGLA++L
Sbjct: 148 ESEAHVKIADFGLAKLL 164

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 75/154 (48%), Gaps = 11/154 (7%)
Query: 7   QIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQ-EYMLIYEYMPKRSLD 65
           +II  K L+K   QG    + E+     L+H ++I++   I+++ E +++ EY      D
Sbjct: 35  KIINKKVLAKSDMQG--RIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFD 92
Query: 66  YFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKIS 125
           Y     ++   +  ++     + II  + Y     R  I+HRDLK  N+LLDE L  KI+
Sbjct: 93  YI----VQRDKMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIA 145
Query: 126 DFGLARILRK-MILKQIQIELGYIPPEYVGRGVY 158
           DFGL+ I+     LK       Y  PE +   +Y
Sbjct: 146 DFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLY 179

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 75/154 (48%), Gaps = 11/154 (7%)
Query: 7   QIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQ-EYMLIYEYMPKRSLD 65
           +II  K L+K   QG    + E+     L+H ++I++   I+++ E +++ EY      D
Sbjct: 45  KIINKKVLAKSDMQG--RIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFD 102
Query: 66  YFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKIS 125
           Y     ++   +  ++     + II  + Y     R  I+HRDLK  N+LLDE L  KI+
Sbjct: 103 YI----VQRDKMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIA 155
Query: 126 DFGLARILRK-MILKQIQIELGYIPPEYVGRGVY 158
           DFGL+ I+     LK       Y  PE +   +Y
Sbjct: 156 DFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLY 189

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/154 (29%), Positives = 75/154 (48%), Gaps = 11/154 (7%)
Query: 7   QIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQ-EYMLIYEYMPKRSLD 65
           +II  K L+K   QG    + E+     L+H ++I++   I+++ E +++ EY      D
Sbjct: 44  KIINKKVLAKSDMQG--RIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYAGNELFD 101
Query: 66  YFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKIS 125
           Y     ++   +  ++     + II  + Y     R  I+HRDLK  N+LLDE L  KI+
Sbjct: 102 YI----VQRDKMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIA 154
Query: 126 DFGLARILRK-MILKQIQIELGYIPPEYVGRGVY 158
           DFGL+ I+     LK       Y  PE +   +Y
Sbjct: 155 DFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLY 188

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 39/137 (28%), Positives = 64/137 (46%), Gaps = 20/137 (14%)
Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR---VGFCIETQEYMLIYEYMPKR 62
           G ++AVK+L         +F+ E+ +   L    +++   V +    Q   L+ EY+P  
Sbjct: 52  GALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSG 111
Query: 63  SLDYFL------FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL 116
            L  FL       D  R+L+   +        I +G+ YL        +HRDL   NIL+
Sbjct: 112 CLRDFLQRHRARLDASRLLLYSSQ--------ICKGMEYLGSR---RCVHRDLAARNILV 160
Query: 117 DEDLKPKISDFGLARIL 133
           + +   KI+DFGLA++L
Sbjct: 161 ESEAHVKIADFGLAKLL 177

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 72/132 (54%), Gaps = 14/132 (10%)
Query: 6   GQIIAVKKLS---KKSTQGFEEFKNEVMLTAKLQH---LNLIRVGFCIETQEYMLIYEYM 59
           G+++AVKK+    + ST     F+  ++LT    H   +NL+ V      ++  L+++YM
Sbjct: 34  GEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYM 93
Query: 60  PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
                +  L   IR  IL+   + +++  +I+ + YL       ++HRD+K SNILL+ +
Sbjct: 94  -----ETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAE 145
Query: 120 LKPKISDFGLAR 131
              K++DFGL+R
Sbjct: 146 CHVKVADFGLSR 157

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 51.6 bits (122), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/160 (27%), Positives = 78/160 (48%), Gaps = 12/160 (7%)
Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIE-TQEYMLIYEYMPKRSL 64
           G++ A+K + K         +NE+ +  K++H N++ +    E T  Y L+ + +    L
Sbjct: 34  GKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGEL 93
Query: 65  DYFLFDPI-RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL---DEDL 120
               FD I    +   K    +I+ ++  + YL E     I+HRDLK  N+L    +E+ 
Sbjct: 94  ----FDRILERGVYTEKDASLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENS 146
Query: 121 KPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYK 160
           K  I+DFGL+++ +  I+       GY+ PE + +  Y K
Sbjct: 147 KIMITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQKPYSK 186

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/139 (28%), Positives = 71/139 (51%), Gaps = 16/139 (11%)
Query: 5   DGQIIAVKKLSKKSTQG-------FEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYE 57
           D  ++A+K L    ++G       F+EF+ EV + + L H N++++ + +      ++ E
Sbjct: 43  DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKL-YGLMHNPPRMVME 101
Query: 58  YMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNIL-- 115
           ++P   L + L D    +    K R+ +   I  G+ Y+Q      I+HRDL+  NI   
Sbjct: 102 FVPCGDLYHRLLDKAHPIKWSVKLRLML--DIALGIEYMQNQ-NPPIVHRDLRSPNIFLQ 158
Query: 116 -LDEDLK--PKISDFGLAR 131
            LDE+     K++DFGL++
Sbjct: 159 SLDENAPVCAKVADFGLSQ 177

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/137 (28%), Positives = 64/137 (46%), Gaps = 20/137 (14%)
Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR---VGFCIETQEYMLIYEYMPKR 62
           G ++AVK+L         +F+ E+ +   L    +++   V +     E  L+ EY+P  
Sbjct: 36  GALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRPELRLVMEYLPSG 95
Query: 63  SLDYFL------FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL 116
            L  FL       D  R+L+   +        I +G+ YL        +HRDL   NIL+
Sbjct: 96  CLRDFLQRHRARLDASRLLLYSSQ--------ICKGMEYLGSR---RCVHRDLAARNILV 144
Query: 117 DEDLKPKISDFGLARIL 133
           + +   KI+DFGLA++L
Sbjct: 145 ESEAHVKIADFGLAKLL 161

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 51.2 bits (121), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 67/129 (51%), Gaps = 9/129 (6%)
Query: 6   GQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKR 62
           G+ +AVK + K   ++   ++   EV +   L H N++++   IET++ + L+ EY    
Sbjct: 32  GKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASGG 91
Query: 63  SLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKP 122
            +  +L     M   + + +    + I+  + Y  + F   I+HRDLK  N+LLD D+  
Sbjct: 92  EVFDYLVAHGWMKEKEARAK---FRQIVSAVQYCHQKF---IVHRDLKAENLLLDADMNI 145
Query: 123 KISDFGLAR 131
           KI+DFG + 
Sbjct: 146 KIADFGFSN 154

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/132 (29%), Positives = 66/132 (50%), Gaps = 9/132 (6%)
Query: 6   GQIIAVKKLSKKSTQGF-EEFKNEVMLTAKLQHLNLIRV-GFCIET--QEYMLIYEYMPK 61
           G+ +AVK L  +S      + K E+ +   L H N+++  G C E       LI E++P 
Sbjct: 38  GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 97
Query: 62  RSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK 121
            SL  +L  P     ++ K+++     I +G+ YL        +HRDL   N+L++ + +
Sbjct: 98  GSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQ 152
Query: 122 PKISDFGLARIL 133
            KI DFGL + +
Sbjct: 153 VKIGDFGLTKAI 164

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 50.8 bits (120), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/132 (29%), Positives = 66/132 (50%), Gaps = 9/132 (6%)
Query: 6   GQIIAVKKLSKKSTQGF-EEFKNEVMLTAKLQHLNLIRV-GFCIET--QEYMLIYEYMPK 61
           G+ +AVK L  +S      + K E+ +   L H N+++  G C E       LI E++P 
Sbjct: 50  GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPS 109
Query: 62  RSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK 121
            SL  +L  P     ++ K+++     I +G+ YL        +HRDL   N+L++ + +
Sbjct: 110 GSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQ 164
Query: 122 PKISDFGLARIL 133
            KI DFGL + +
Sbjct: 165 VKIGDFGLTKAI 176

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 41/134 (30%), Positives = 71/134 (52%), Gaps = 23/134 (17%)
Query: 28  EVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKRSLDYFLFDPIRMLILDCKK--RVH 84
           EV L   L+H N++ +   I T++ + L++EY+ K          ++  + DC     +H
Sbjct: 50  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDKD---------LKQYLDDCGNIINMH 100
Query: 85  IIK----GIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLAR---ILRKMI 137
            +K     +++GL Y     R  ++HRDLK  N+L++E  + K++DFGLAR   I  K  
Sbjct: 101 NVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTY 157
Query: 138 LKQIQIELGYIPPE 151
             ++ + L Y PP+
Sbjct: 158 DNEV-VTLWYRPPD 170

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 66/129 (51%), Gaps = 9/129 (6%)
Query: 6   GQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKR 62
           G+ +AVK + K   ++   ++   EV +   L H N++++   IET++ + L+ EY    
Sbjct: 39  GKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEVIETEKTLYLVXEYASGG 98
Query: 63  SLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKP 122
            +  +L    R    + + +    + I+  + Y  + F   I+HRDLK  N+LLD D   
Sbjct: 99  EVFDYLVAHGRXKEKEARAK---FRQIVSAVQYCHQKF---IVHRDLKAENLLLDADXNI 152
Query: 123 KISDFGLAR 131
           KI+DFG + 
Sbjct: 153 KIADFGFSN 161

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 50.4 bits (119), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/138 (34%), Positives = 70/138 (50%), Gaps = 19/138 (13%)
Query: 23  EEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKRSLDYFLFDPI--RMLILDC 79
           EE  NE+ L   L H N+I++    E ++Y  L+ E+         LF+ I  R    +C
Sbjct: 91  EEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGE----LFEQIINRHKFDEC 146
Query: 80  KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED---LKPKISDFGLARILRKM 136
               +I+K I+ G+ YL ++    I+HRD+K  NILL+     L  KI DFGL+    K 
Sbjct: 147 -DAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD 202
Query: 137 ILKQIQIELG---YIPPE 151
              +++  LG   YI PE
Sbjct: 203 Y--KLRDRLGTAYYIAPE 218

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 50.1 bits (118), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 67/129 (51%), Gaps = 9/129 (6%)
Query: 6   GQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKR 62
           G+ +AVK + K   +    ++   EV +   L H N++++   IET++ + L+ EY    
Sbjct: 40  GREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLVMEYASGG 99
Query: 63  SLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKP 122
            +  +L    RM   + + +    + I+  + Y  + +   I+HRDLK  N+LLD D+  
Sbjct: 100 EVFDYLVAHGRMKEKEARAK---FRQIVSAVQYCHQKY---IVHRDLKAENLLLDGDMNI 153
Query: 123 KISDFGLAR 131
           KI+DFG + 
Sbjct: 154 KIADFGFSN 162

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 49.7 bits (117), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 73/160 (45%), Gaps = 14/160 (8%)
Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKRSL 64
            +II  KKLS +    F++ + E  +  KLQH N++R+   I+ + +  L+++ +    L
Sbjct: 59  AKIINTKKLSARD---FQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL 115
Query: 65  DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKP-- 122
                D +           H I+ I++ + Y        I+HR+LK  N+LL    K   
Sbjct: 116 ---FEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAA 169
Query: 123 -KISDFGLA-RILRKMILKQIQIELGYIPPEYVGRGVYYK 160
            K++DFGLA  +             GY+ PE + +  Y K
Sbjct: 170 VKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSK 209

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 47/156 (30%), Positives = 83/156 (53%), Gaps = 15/156 (9%)
Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQ-EYMLIYEYMPKRSL 64
           G  +A K +  +  +  EE KNE+ +  +L H NLI++    E++ + +L+ EY+    L
Sbjct: 114 GLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173
Query: 65  -DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNIL-LDEDLKP 122
            D  + +   +  LD    +  +K I +G+ ++ + +   I+H DLK  NIL ++ D K 
Sbjct: 174 FDRIIDESYNLTELDT---ILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQ 227
Query: 123 -KISDFGLARILRKMILKQIQIELG---YIPPEYVG 154
            KI DFGLAR  R    +++++  G   ++ PE V 
Sbjct: 228 IKIIDFGLAR--RYKPREKLKVNFGTPEFLAPEVVN 261

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 73/160 (45%), Gaps = 14/160 (8%)
Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKRSL 64
            +II  KKLS +    F++ + E  +  KLQH N++R+   I+ + +  L+++ +    L
Sbjct: 36  AKIINTKKLSARD---FQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL 92
Query: 65  DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKP-- 122
                D +           H I+ I++ + Y        I+HR+LK  N+LL    K   
Sbjct: 93  ---FEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAA 146
Query: 123 -KISDFGLA-RILRKMILKQIQIELGYIPPEYVGRGVYYK 160
            K++DFGLA  +             GY+ PE + +  Y K
Sbjct: 147 VKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSK 186

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 38/139 (27%), Positives = 70/139 (50%), Gaps = 16/139 (11%)
Query: 5   DGQIIAVKKLSKKSTQG-------FEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYE 57
           D  ++A+K L    ++G       F+EF+ EV + + L H N++++ + +      ++ E
Sbjct: 43  DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKL-YGLMHNPPRMVME 101
Query: 58  YMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNIL-- 115
           ++P   L + L D    +    K R+ +   I  G+ Y+Q      I+HRDL+  NI   
Sbjct: 102 FVPCGDLYHRLLDKAHPIKWSVKLRLML--DIALGIEYMQNQ-NPPIVHRDLRSPNIFLQ 158
Query: 116 -LDEDLK--PKISDFGLAR 131
            LDE+     K++DFG ++
Sbjct: 159 SLDENAPVCAKVADFGTSQ 177

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 49.7 bits (117), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 73/160 (45%), Gaps = 14/160 (8%)
Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKRSL 64
            +II  KKLS +    F++ + E  +  KLQH N++R+   I+ + +  L+++ +    L
Sbjct: 36  AKIINTKKLSARD---FQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL 92
Query: 65  DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKP-- 122
                D +           H I+ I++ + Y        I+HR+LK  N+LL    K   
Sbjct: 93  ---FEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAA 146
Query: 123 -KISDFGLA-RILRKMILKQIQIELGYIPPEYVGRGVYYK 160
            K++DFGLA  +             GY+ PE + +  Y K
Sbjct: 147 VKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSK 186

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 49.3 bits (116), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 43/160 (26%), Positives = 73/160 (45%), Gaps = 14/160 (8%)
Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKRSL 64
            +II  KKLS +    F++ + E  +  KLQH N++R+   I+ + +  L+++ +    L
Sbjct: 35  AKIINTKKLSARD---FQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL 91
Query: 65  DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKP-- 122
                D +           H I+ I++ + Y        I+HR+LK  N+LL    K   
Sbjct: 92  ---FEDIVAREFYSEADASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAA 145
Query: 123 -KISDFGLA-RILRKMILKQIQIELGYIPPEYVGRGVYYK 160
            K++DFGLA  +             GY+ PE + +  Y K
Sbjct: 146 VKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSK 185

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 66/129 (51%), Gaps = 9/129 (6%)
Query: 6   GQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKR 62
           G+ +A+K + K   +    ++   EV +   L H N++++   IET++ + LI EY    
Sbjct: 37  GREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGG 96
Query: 63  SLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKP 122
            +  +L    RM   + + +    + I+  + Y  +     I+HRDLK  N+LLD D+  
Sbjct: 97  EVFDYLVAHGRMKEKEARSK---FRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNI 150
Query: 123 KISDFGLAR 131
           KI+DFG + 
Sbjct: 151 KIADFGFSN 159

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 49.3 bits (116), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/146 (30%), Positives = 68/146 (46%), Gaps = 20/146 (13%)
Query: 1   GVLPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKL-QHLNLIRVGFCIETQEYM-LIYEY 58
           G+  D  I  +K+ + K      +F  E+ +  KL  H N+I +    E + Y+ L  EY
Sbjct: 40  GLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 97
Query: 59  MPKRSLDYFL-------FDPIRML------ILDCKKRVHIIKGIIQGLLYLQEYFRLTII 105
            P  +L  FL        DP   +       L  ++ +H    + +G+ YL +      I
Sbjct: 98  APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFI 154
Query: 106 HRDLKVSNILLDEDLKPKISDFGLAR 131
           HRDL   NIL+ E+   KI+DFGL+R
Sbjct: 155 HRDLAARNILVGENYVAKIADFGLSR 180

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 37/129 (28%), Positives = 66/129 (51%), Gaps = 9/129 (6%)
Query: 6   GQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKR 62
           G+ +A+K + K   +    ++   EV +   L H N++++   IET++ + LI EY    
Sbjct: 40  GREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGG 99
Query: 63  SLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKP 122
            +  +L    RM   + + +    + I+  + Y  +     I+HRDLK  N+LLD D+  
Sbjct: 100 EVFDYLVAHGRMKEKEARSK---FRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNI 153
Query: 123 KISDFGLAR 131
           KI+DFG + 
Sbjct: 154 KIADFGFSN 162

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/134 (32%), Positives = 67/134 (50%), Gaps = 15/134 (11%)
Query: 6   GQIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQ---EYMLIYEYMPK 61
           G+++AVK L +    Q    ++ E+ +   L H ++++   C E Q      L+ EY+P 
Sbjct: 37  GEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPL 96
Query: 62  RSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYL--QEYFRLTIIHRDLKVSNILLDED 119
            SL  +L  P   + L   + +   + I +G+ YL  Q Y     IHR L   N+LLD D
Sbjct: 97  GSLRDYL--PRHCVGL--AQLLLFAQQICEGMAYLHAQHY-----IHRALAARNVLLDND 147
Query: 120 LKPKISDFGLARIL 133
              KI DFGLA+ +
Sbjct: 148 RLVKIGDFGLAKAV 161

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/134 (32%), Positives = 67/134 (50%), Gaps = 15/134 (11%)
Query: 6   GQIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQ---EYMLIYEYMPK 61
           G+++AVK L +    Q    ++ E+ +   L H ++++   C E Q      L+ EY+P 
Sbjct: 38  GEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEYVPL 97
Query: 62  RSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYL--QEYFRLTIIHRDLKVSNILLDED 119
            SL  +L  P   + L   + +   + I +G+ YL  Q Y     IHR L   N+LLD D
Sbjct: 98  GSLRDYL--PRHCVGL--AQLLLFAQQICEGMAYLHAQHY-----IHRALAARNVLLDND 148
Query: 120 LKPKISDFGLARIL 133
              KI DFGLA+ +
Sbjct: 149 RLVKIGDFGLAKAV 162

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/146 (30%), Positives = 68/146 (46%), Gaps = 20/146 (13%)
Query: 1   GVLPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKL-QHLNLIRVGFCIETQEYM-LIYEY 58
           G+  D  I  +K+ + K      +F  E+ +  KL  H N+I +    E + Y+ L  EY
Sbjct: 50  GLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 107
Query: 59  MPKRSLDYFL-------FDPIRML------ILDCKKRVHIIKGIIQGLLYLQEYFRLTII 105
            P  +L  FL        DP   +       L  ++ +H    + +G+ YL +      I
Sbjct: 108 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFI 164
Query: 106 HRDLKVSNILLDEDLKPKISDFGLAR 131
           HRDL   NIL+ E+   KI+DFGL+R
Sbjct: 165 HRDLAARNILVGENYVAKIADFGLSR 190

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 66/119 (55%), Gaps = 8/119 (6%)
Query: 37  HLNLIRVGFCIETQEYM-LIYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLY 95
           H N+I++    ET  +  L+++ M K  L  +L + + +   + +K   I++ +++ +  
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRK---IMRALLEVICA 139
Query: 96  LQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK-MILKQIQIELGYIPPEYV 153
           L    +L I+HRDLK  NILLD+D+  K++DFG +  L     L+++     Y+ PE +
Sbjct: 140 LH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEII 195

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 35/119 (29%), Positives = 66/119 (55%), Gaps = 8/119 (6%)
Query: 37  HLNLIRVGFCIETQEYM-LIYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLY 95
           H N+I++    ET  +  L+++ M K  L  +L + + +   + +K   I++ +++ +  
Sbjct: 70  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRK---IMRALLEVICA 126
Query: 96  LQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK-MILKQIQIELGYIPPEYV 153
           L    +L I+HRDLK  NILLD+D+  K++DFG +  L     L+++     Y+ PE +
Sbjct: 127 LH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEII 182

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/135 (28%), Positives = 68/135 (50%), Gaps = 18/135 (13%)
Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSL 64
           G+++ +K+L +   +    F  EV +   L+H N+++ +G   + +    I EY+   +L
Sbjct: 35  GEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTL 94
Query: 65  DYFLFDPIRMLI--LDCK----KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE 118
                   R +I  +D +    +RV   K I  G+ YL     + IIHRDL   N L+ E
Sbjct: 95  --------RGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRE 143
Query: 119 DLKPKISDFGLARIL 133
           +    ++DFGLAR++
Sbjct: 144 NKNVVVADFGLARLM 158

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 69/147 (46%), Gaps = 26/147 (17%)
Query: 8   IIAVKKLSKKSTQG-FEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLD 65
            +AVK L + ++     +  +E  +  ++ H ++I++ G C +    +LI EY    SL 
Sbjct: 55  TVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLR 114
Query: 66  YFLFDPIRM-------------LILDCKKRVHIIKG--------IIQGLLYLQEYFRLTI 104
            FL +  ++               LD      +  G        I QG+ YL E   +++
Sbjct: 115 GFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MSL 171
Query: 105 IHRDLKVSNILLDEDLKPKISDFGLAR 131
           +HRDL   NIL+ E  K KISDFGL+R
Sbjct: 172 VHRDLAARNILVAEGRKMKISDFGLSR 198

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 78/171 (45%), Gaps = 30/171 (17%)
Query: 6   GQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
           G  +AVKKLS+  +S    +    E+ L   ++H N+I            L+  + P RS
Sbjct: 67  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG-----------LLDVFTPARS 115
Query: 64  LDYF--------LFDPIRMLILDCKKRVH-----IIKGIIQGLLYLQEYFRLTIIHRDLK 110
           L+ F        L       I+ C+K        +I  I++GL Y+       IIHRDLK
Sbjct: 116 LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLK 172
Query: 111 VSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKK 161
            SN+ ++ED + KI DFGLAR     +   +     Y  PE +   ++Y +
Sbjct: 173 PSNLAVNEDCELKILDFGLARHTDDEMXGXVATRW-YRAPEIMLNWMHYNQ 222

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 48.9 bits (115), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/158 (25%), Positives = 77/158 (48%), Gaps = 11/158 (6%)
Query: 6   GQIIAVKKLSKKSTQGFE---EFKNEVMLTAKLQHLNLIRVGFCIET-QEYMLIYEYMPK 61
           G  +AVK L+++  +  +   + + E+      +H ++I++   I T  +  ++ EY+  
Sbjct: 41  GHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSG 100
Query: 62  RSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK 121
             L  ++    R   LD K+   + + I+ G+ Y     R  ++HRDLK  N+LLD  + 
Sbjct: 101 GELFDYICKNGR---LDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMN 154
Query: 122 PKISDFGLARILRK-MILKQIQIELGYIPPEYVGRGVY 158
            KI+DFGL+ ++     L+       Y  PE +   +Y
Sbjct: 155 AKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLY 192

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 38/139 (27%), Positives = 70/139 (50%), Gaps = 16/139 (11%)
Query: 5   DGQIIAVKKLSKKSTQG-------FEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYE 57
           D  ++A+K L    ++G       F+EF+ EV + + L H N++++ + +      ++ E
Sbjct: 43  DKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKL-YGLMHNPPRMVME 101
Query: 58  YMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNIL-- 115
           ++P   L + L D    +    K R+ +   I  G+ Y+Q      I+HRDL+  NI   
Sbjct: 102 FVPCGDLYHRLLDKAHPIKWSVKLRLML--DIALGIEYMQNQ-NPPIVHRDLRSPNIFLQ 158
Query: 116 -LDEDLK--PKISDFGLAR 131
            LDE+     K++DF L++
Sbjct: 159 SLDENAPVCAKVADFSLSQ 177

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 68/141 (48%), Gaps = 29/141 (20%)
Query: 6   GQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
           G  +AVKKLS+  +S    +    E+ L   ++H N+I            L+  + P RS
Sbjct: 47  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG-----------LLDVFTPARS 95
Query: 64  LDYF--------LFDPIRMLILDCKKRVH-----IIKGIIQGLLYLQEYFRLTIIHRDLK 110
           L+ F        L       I+ C+K        +I  I++GL Y+       IIHRDLK
Sbjct: 96  LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLK 152
Query: 111 VSNILLDEDLKPKISDFGLAR 131
            SN+ ++ED + KI DFGLAR
Sbjct: 153 PSNLAVNEDCELKILDFGLAR 173

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 68/141 (48%), Gaps = 29/141 (20%)
Query: 6   GQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
           G  +AVKKLS+  +S    +    E+ L   ++H N+I            L+  + P RS
Sbjct: 67  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG-----------LLDVFTPARS 115
Query: 64  LDYF--------LFDPIRMLILDCKKRVH-----IIKGIIQGLLYLQEYFRLTIIHRDLK 110
           L+ F        L       I+ C+K        +I  I++GL Y+       IIHRDLK
Sbjct: 116 LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLK 172
Query: 111 VSNILLDEDLKPKISDFGLAR 131
            SN+ ++ED + KI DFGLAR
Sbjct: 173 PSNLAVNEDCELKILDFGLAR 193

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 77/162 (47%), Gaps = 13/162 (8%)
Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSL 64
           GQ     K+ K+ +   +EF  E  +   L H  L+++ G C + +   +I EYM    L
Sbjct: 47  GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL 106
Query: 65  DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKI 124
             +L + +R      ++ + + K + + + YL+       +HRDL   N L+++    K+
Sbjct: 107 LNYLRE-MRHR-FQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKV 161
Query: 125 SDFGLAR-ILRKMILKQI--QIELGYIPPEYVGRGVYYKKFS 163
           SDFGL+R +L       +  +  + + PPE     + Y KFS
Sbjct: 162 SDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV----LMYSKFS 199

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 68/141 (48%), Gaps = 29/141 (20%)
Query: 6   GQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
           G  +AVKKLS+  +S    +    E+ L   ++H N+I            L+  + P RS
Sbjct: 66  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG-----------LLDVFTPARS 114
Query: 64  LDYF--------LFDPIRMLILDCKKRVH-----IIKGIIQGLLYLQEYFRLTIIHRDLK 110
           L+ F        L       I+ C+K        +I  I++GL Y+       IIHRDLK
Sbjct: 115 LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLK 171
Query: 111 VSNILLDEDLKPKISDFGLAR 131
            SN+ ++ED + KI DFGLAR
Sbjct: 172 PSNLAVNEDCELKILDFGLAR 192

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 75/162 (46%), Gaps = 13/162 (8%)
Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSL 64
           GQ     K+ K+ +   +EF  E  +   L H  L+++ G C + +   +I EYM    L
Sbjct: 38  GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL 97
Query: 65  DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKI 124
             +L +         ++ + + K + + + YL+       +HRDL   N L+++    K+
Sbjct: 98  LNYLREMRHRF--QTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKV 152
Query: 125 SDFGLAR-ILRKMILKQI--QIELGYIPPEYVGRGVYYKKFS 163
           SDFGL+R +L       +  +  + + PPE     + Y KFS
Sbjct: 153 SDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV----LMYSKFS 190

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 68/141 (48%), Gaps = 29/141 (20%)
Query: 6   GQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
           G  +AVKKLS+  +S    +    E+ L   ++H N+I            L+  + P RS
Sbjct: 57  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG-----------LLDVFTPARS 105
Query: 64  LDYF--------LFDPIRMLILDCKKRVH-----IIKGIIQGLLYLQEYFRLTIIHRDLK 110
           L+ F        L       I+ C+K        +I  I++GL Y+       IIHRDLK
Sbjct: 106 LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLK 162
Query: 111 VSNILLDEDLKPKISDFGLAR 131
            SN+ ++ED + KI DFGLAR
Sbjct: 163 PSNLAVNEDCELKILDFGLAR 183

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 68/141 (48%), Gaps = 29/141 (20%)
Query: 6   GQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
           G  +AVKKLS+  +S    +    E+ L   ++H N+I            L+  + P RS
Sbjct: 53  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG-----------LLDVFTPARS 101
Query: 64  LDYF--------LFDPIRMLILDCKKRVH-----IIKGIIQGLLYLQEYFRLTIIHRDLK 110
           L+ F        L       I+ C+K        +I  I++GL Y+       IIHRDLK
Sbjct: 102 LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLK 158
Query: 111 VSNILLDEDLKPKISDFGLAR 131
            SN+ ++ED + KI DFGLAR
Sbjct: 159 PSNLAVNEDCELKILDFGLAR 179

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 68/141 (48%), Gaps = 29/141 (20%)
Query: 6   GQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
           G  +AVKKLS+  +S    +    E+ L   ++H N+I            L+  + P RS
Sbjct: 43  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG-----------LLDVFTPARS 91
Query: 64  LDYF--------LFDPIRMLILDCKKRVH-----IIKGIIQGLLYLQEYFRLTIIHRDLK 110
           L+ F        L       I+ C+K        +I  I++GL Y+       IIHRDLK
Sbjct: 92  LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLK 148
Query: 111 VSNILLDEDLKPKISDFGLAR 131
            SN+ ++ED + KI DFGLAR
Sbjct: 149 PSNLAVNEDCELKILDFGLAR 169

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 68/141 (48%), Gaps = 29/141 (20%)
Query: 6   GQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
           G  +AVKKLS+  +S    +    E+ L   ++H N+I            L+  + P RS
Sbjct: 43  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG-----------LLDVFTPARS 91
Query: 64  LDYF--------LFDPIRMLILDCKKRVH-----IIKGIIQGLLYLQEYFRLTIIHRDLK 110
           L+ F        L       I+ C+K        +I  I++GL Y+       IIHRDLK
Sbjct: 92  LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLK 148
Query: 111 VSNILLDEDLKPKISDFGLAR 131
            SN+ ++ED + KI DFGLAR
Sbjct: 149 PSNLAVNEDCELKILDFGLAR 169

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 68/141 (48%), Gaps = 29/141 (20%)
Query: 6   GQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
           G  +AVKKLS+  +S    +    E+ L   ++H N+I            L+  + P RS
Sbjct: 47  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG-----------LLDVFTPARS 95
Query: 64  LDYF--------LFDPIRMLILDCKKRVH-----IIKGIIQGLLYLQEYFRLTIIHRDLK 110
           L+ F        L       I+ C+K        +I  I++GL Y+       IIHRDLK
Sbjct: 96  LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLK 152
Query: 111 VSNILLDEDLKPKISDFGLAR 131
            SN+ ++ED + KI DFGLAR
Sbjct: 153 PSNLAVNEDCELKILDFGLAR 173

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 68/141 (48%), Gaps = 29/141 (20%)
Query: 6   GQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
           G  +AVKKLS+  +S    +    E+ L   ++H N+I            L+  + P RS
Sbjct: 47  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG-----------LLDVFTPARS 95
Query: 64  LDYF--------LFDPIRMLILDCKKRVH-----IIKGIIQGLLYLQEYFRLTIIHRDLK 110
           L+ F        L       I+ C+K        +I  I++GL Y+       IIHRDLK
Sbjct: 96  LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLK 152
Query: 111 VSNILLDEDLKPKISDFGLAR 131
            SN+ ++ED + KI DFGLAR
Sbjct: 153 PSNLAVNEDCELKILDFGLAR 173

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 48.5 bits (114), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/95 (31%), Positives = 56/95 (58%), Gaps = 7/95 (7%)
Query: 37  HLNLIRVGFCIETQEYM-LIYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLY 95
           H N+I++    ET  +  L+++ M K  L  +L + + +   + +K   I++ +++ +  
Sbjct: 83  HPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRK---IMRALLEVICA 139
Query: 96  LQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLA 130
           L    +L I+HRDLK  NILLD+D+  K++DFG +
Sbjct: 140 LH---KLNIVHRDLKPENILLDDDMNIKLTDFGFS 171

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 75/162 (46%), Gaps = 13/162 (8%)
Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSL 64
           GQ     K+ K+ +   +EF  E  +   L H  L+++ G C + +   +I EYM    L
Sbjct: 32  GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL 91
Query: 65  DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKI 124
             +L +         ++ + + K + + + YL+       +HRDL   N L+++    K+
Sbjct: 92  LNYLREMRHRF--QTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKV 146
Query: 125 SDFGLAR-ILRKMILKQI--QIELGYIPPEYVGRGVYYKKFS 163
           SDFGL+R +L       +  +  + + PPE     + Y KFS
Sbjct: 147 SDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV----LMYSKFS 184

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 75/162 (46%), Gaps = 13/162 (8%)
Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSL 64
           GQ     K+ K+ +   +EF  E  +   L H  L+++ G C + +   +I EYM    L
Sbjct: 31  GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL 90
Query: 65  DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKI 124
             +L +         ++ + + K + + + YL+       +HRDL   N L+++    K+
Sbjct: 91  LNYLREMRHRF--QTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKV 145
Query: 125 SDFGLAR-ILRKMILKQI--QIELGYIPPEYVGRGVYYKKFS 163
           SDFGL+R +L       +  +  + + PPE     + Y KFS
Sbjct: 146 SDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV----LMYSKFS 183

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 75/162 (46%), Gaps = 13/162 (8%)
Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSL 64
           GQ     K+ K+ +   +EF  E  +   L H  L+++ G C + +   +I EYM    L
Sbjct: 27  GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL 86
Query: 65  DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKI 124
             +L +         ++ + + K + + + YL+       +HRDL   N L+++    K+
Sbjct: 87  LNYLREMRHRF--QTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKV 141
Query: 125 SDFGLAR-ILRKMILKQI--QIELGYIPPEYVGRGVYYKKFS 163
           SDFGL+R +L       +  +  + + PPE     + Y KFS
Sbjct: 142 SDFGLSRYVLDDEYTSSVGSKFPVRWSPPEV----LMYSKFS 179

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 65/136 (47%), Gaps = 20/136 (14%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV------GFCIETQEYMLIYEYMPKR 62
           +AVK    +  Q ++  + E+  T  ++H NL++       G  +E  E  LI  +  K 
Sbjct: 41  VAVKIFPLQDKQSWQS-EREIFSTPGMKHENLLQFIAAEKRGSNLEV-ELWLITAFHDKG 98
Query: 63  SLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQE--------YFRLTIIHRDLKVSNI 114
           SL  +L    +  I+   +  H+ + + +GL YL E          + +I HRD K  N+
Sbjct: 99  SLTDYL----KGNIITWNELCHVAETMSRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNV 154
Query: 115 LLDEDLKPKISDFGLA 130
           LL  DL   ++DFGLA
Sbjct: 155 LLKSDLTAVLADFGLA 170

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 38/139 (27%), Positives = 66/139 (47%), Gaps = 13/139 (9%)
Query: 5   DGQIIAVKKL--SKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKR 62
           DG+   +K++  S+ S++  EE + EV + A ++H N+++     E    + I       
Sbjct: 48  DGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIV------ 101
Query: 63  SLDYF----LFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE 118
            +DY     LF  I        +   I+   +Q  L L+      I+HRD+K  NI L +
Sbjct: 102 -MDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTK 160
Query: 119 DLKPKISDFGLARILRKMI 137
           D   ++ DFG+AR+L   +
Sbjct: 161 DGTVQLGDFGIARVLNSTV 179

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 74/162 (45%), Gaps = 13/162 (8%)
Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSL 64
           GQ     K+ K+ +   +EF  E  +   L H  L+++ G C + +   +I EYM    L
Sbjct: 32  GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL 91
Query: 65  DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKI 124
             +L +         ++ + + K + + + YL+       +HRDL   N L+++    K+
Sbjct: 92  LNYLREMRHRF--QTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKV 146
Query: 125 SDFGLARIL---RKMILKQIQIELGYIPPEYVGRGVYYKKFS 163
           SDFGL+R +        +  +  + + PPE     + Y KFS
Sbjct: 147 SDFGLSRYVLDDEYTSSRGSKFPVRWSPPEV----LMYSKFS 184

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 77/162 (47%), Gaps = 13/162 (8%)
Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSL 64
           GQ     K+ K+ +   +EF  E  +   L H  L+++ G C + +   +I EYM    L
Sbjct: 47  GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCL 106
Query: 65  DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKI 124
             +L + +R      ++ + + K + + + YL+       +HRDL   N L+++    K+
Sbjct: 107 LNYLRE-MRHR-FQTQQLLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKV 161
Query: 125 SDFGLAR-ILRKMILKQI--QIELGYIPPEYVGRGVYYKKFS 163
           SDFGL+R +L       +  +  + + PPE     + Y KFS
Sbjct: 162 SDFGLSRYVLDDEETSSVGSKFPVRWSPPEV----LMYSKFS 199

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 67/141 (47%), Gaps = 29/141 (20%)
Query: 6   GQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
           G  +AVKKLS+  +S    +    E+ L   ++H N+I            L+  + P RS
Sbjct: 43  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG-----------LLDVFTPARS 91
Query: 64  LDYF--------LFDPIRMLILDCKKRVH-----IIKGIIQGLLYLQEYFRLTIIHRDLK 110
           L+ F        L       I+ C K        +I  I++GL Y+       IIHRDLK
Sbjct: 92  LEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLK 148
Query: 111 VSNILLDEDLKPKISDFGLAR 131
            SN+ ++ED + KI DFGLAR
Sbjct: 149 PSNLAVNEDCELKILDFGLAR 169

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 40/163 (24%), Positives = 70/163 (42%), Gaps = 11/163 (6%)
Query: 5   DGQIIAVKKLSKKSTQGFE-EFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKR 62
           D  ++AVK   +      + +F  E  +  +  H N++R +G C + Q   ++ E +  +
Sbjct: 138 DNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELV--Q 195
Query: 63  SLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKP 122
             D+  F       L  K  + ++     G+ YL+       IHRDL   N L+ E    
Sbjct: 196 GGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVL 252
Query: 123 KISDFGLARILRKMILKQI----QIELGYIPPEYVGRGVYYKK 161
           KISDFG++R     +        Q+ + +  PE +  G Y  +
Sbjct: 253 KISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYSSE 295

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 48/141 (34%), Positives = 68/141 (48%), Gaps = 29/141 (20%)
Query: 6   GQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
           G  +AVKKLSK  +S    +    E+ L   ++H N+I            L+  + P RS
Sbjct: 59  GLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVIG-----------LLDVFTPARS 107
Query: 64  LDYF--------LFDPIRMLILDCKKRVH-----IIKGIIQGLLYLQEYFRLTIIHRDLK 110
           L+ F        L       I+ C+K        +I  I++GL Y+       IIHRDLK
Sbjct: 108 LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLK 164
Query: 111 VSNILLDEDLKPKISDFGLAR 131
            SN+ ++ED + KI DFGLAR
Sbjct: 165 PSNLAVNEDCELKILDFGLAR 185

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 35/129 (27%), Positives = 70/129 (54%), Gaps = 8/129 (6%)
Query: 6   GQIIAVKKLS-KKSTQGFEEFK-NEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKR 62
           G+++A+KK+     T+G       E+ L  +L H N++++   I T+  + L++E++ + 
Sbjct: 28  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD 87
Query: 63  SLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKP 122
             D+     +  + L   K    +  ++QGL +   +    ++HRDLK  N+L++ +   
Sbjct: 88  LKDFMDASALTGIPLPLIKSY--LFQLLQGLAFCHSH---RVLHRDLKPENLLINTEGAI 142
Query: 123 KISDFGLAR 131
           K++DFGLAR
Sbjct: 143 KLADFGLAR 151

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/158 (24%), Positives = 78/158 (49%), Gaps = 11/158 (6%)
Query: 6   GQIIAVKKLSKKSTQGFE---EFKNEVMLTAKLQHLNLIRVGFCIET-QEYMLIYEYMPK 61
           G  +AVK L+++  +  +   + K E+      +H ++I++   I T  ++ ++ EY+  
Sbjct: 36  GHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSG 95
Query: 62  RSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK 121
             L  ++    R+  ++ ++   + + I+  + Y     R  ++HRDLK  N+LLD  + 
Sbjct: 96  GELFDYICKHGRVEEMEARR---LFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMN 149
Query: 122 PKISDFGLARILRK-MILKQIQIELGYIPPEYVGRGVY 158
            KI+DFGL+ ++     L+       Y  PE +   +Y
Sbjct: 150 AKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLY 187

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 40/163 (24%), Positives = 70/163 (42%), Gaps = 11/163 (6%)
Query: 5   DGQIIAVKKLSKKSTQGFE-EFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKR 62
           D  ++AVK   +      + +F  E  +  +  H N++R +G C + Q   ++ E +  +
Sbjct: 138 DNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELV--Q 195
Query: 63  SLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKP 122
             D+  F       L  K  + ++     G+ YL+       IHRDL   N L+ E    
Sbjct: 196 GGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVL 252
Query: 123 KISDFGLARILRKMILKQI----QIELGYIPPEYVGRGVYYKK 161
           KISDFG++R     +        Q+ + +  PE +  G Y  +
Sbjct: 253 KISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSE 295

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/139 (26%), Positives = 71/139 (51%), Gaps = 16/139 (11%)
Query: 3   LPDGQII----AVKKLSKKST-QGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIY 56
           +P+G+ I     +K +  KS  Q F+   + ++    L H +++R+ G C       L+ 
Sbjct: 35  IPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLC-PGSSLQLVT 93
Query: 57  EYMPKRSLDYFLFDPIRMLILDCKKRVHIIKG--IIQGLLYLQEYFRLTIIHRDLKVSNI 114
           +Y+P  SL     D +R        ++ +  G  I +G+ YL+E+    ++HR+L   N+
Sbjct: 94  QYLPLGSL----LDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNV 146
Query: 115 LLDEDLKPKISDFGLARIL 133
           LL    + +++DFG+A +L
Sbjct: 147 LLKSPSQVQVADFGVADLL 165

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 68/147 (46%), Gaps = 26/147 (17%)
Query: 8   IIAVKKLSKKSTQG-FEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLD 65
            +AVK L + ++     +  +E  +  ++ H ++I++ G C +    +LI EY    SL 
Sbjct: 55  TVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLR 114
Query: 66  YFLFDPIRM-------------LILDCKKRVHIIKG--------IIQGLLYLQEYFRLTI 104
            FL +  ++               LD      +  G        I QG+ YL E   + +
Sbjct: 115 GFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKL 171
Query: 105 IHRDLKVSNILLDEDLKPKISDFGLAR 131
           +HRDL   NIL+ E  K KISDFGL+R
Sbjct: 172 VHRDLAARNILVAEGRKMKISDFGLSR 198

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 47.8 bits (112), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/147 (29%), Positives = 68/147 (46%), Gaps = 26/147 (17%)
Query: 8   IIAVKKLSKKSTQG-FEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLD 65
            +AVK L + ++     +  +E  +  ++ H ++I++ G C +    +LI EY    SL 
Sbjct: 55  TVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLR 114
Query: 66  YFLFDPIRM-------------LILDCKKRVHIIKG--------IIQGLLYLQEYFRLTI 104
            FL +  ++               LD      +  G        I QG+ YL E   + +
Sbjct: 115 GFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKL 171
Query: 105 IHRDLKVSNILLDEDLKPKISDFGLAR 131
           +HRDL   NIL+ E  K KISDFGL+R
Sbjct: 172 VHRDLAARNILVAEGRKMKISDFGLSR 198

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/158 (24%), Positives = 78/158 (49%), Gaps = 11/158 (6%)
Query: 6   GQIIAVKKLSKKSTQGFE---EFKNEVMLTAKLQHLNLIRVGFCIET-QEYMLIYEYMPK 61
           G  +AVK L+++  +  +   + K E+      +H ++I++   I T  ++ ++ EY+  
Sbjct: 36  GHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSG 95
Query: 62  RSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK 121
             L  ++    R+  ++ ++   + + I+  + Y     R  ++HRDLK  N+LLD  + 
Sbjct: 96  GELFDYICKHGRVEEMEARR---LFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMN 149
Query: 122 PKISDFGLARILRK-MILKQIQIELGYIPPEYVGRGVY 158
            KI+DFGL+ ++     L+       Y  PE +   +Y
Sbjct: 150 AKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLY 187

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 78/171 (45%), Gaps = 30/171 (17%)
Query: 6   GQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
           G  +AVKKLS+  +S    +    E+ L   ++H N+I            L+  + P RS
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG-----------LLDVFTPARS 95
Query: 64  LDYF--------LFDPIRMLILDCKKRVH-----IIKGIIQGLLYLQEYFRLTIIHRDLK 110
           L+ F        L       I+ C+K        +I  I++GL Y+       IIHRDLK
Sbjct: 96  LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLK 152
Query: 111 VSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKK 161
            SN+ ++ED + KI DFGLAR     +   +     Y  PE +   ++Y +
Sbjct: 153 PSNLAVNEDCELKILDFGLARHTDDEMTGYVATRW-YRAPEIMLNAMHYNQ 202

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 68/146 (46%), Gaps = 20/146 (13%)
Query: 1   GVLPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKL-QHLNLIRVGFCIETQEYM-LIYEY 58
           G+  D  I  +K+ + K      +F  E+ +  KL  H N+I +    E + Y+ L  EY
Sbjct: 47  GLRMDAAIKRMKEYASKDDH--RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEY 104
Query: 59  MPKRSLDYFL-------FDPIRML------ILDCKKRVHIIKGIIQGLLYLQEYFRLTII 105
            P  +L  FL        DP   +       L  ++ +H    + +G+ YL +      I
Sbjct: 105 APHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFI 161
Query: 106 HRDLKVSNILLDEDLKPKISDFGLAR 131
           HR+L   NIL+ E+   KI+DFGL+R
Sbjct: 162 HRNLAARNILVGENYVAKIADFGLSR 187

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/171 (29%), Positives = 78/171 (45%), Gaps = 30/171 (17%)
Query: 6   GQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
           G  +AVKKLS+  +S    +    E+ L   ++H N+I            L+  + P RS
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG-----------LLDVFTPARS 95
Query: 64  LDYF--------LFDPIRMLILDCKKRVH-----IIKGIIQGLLYLQEYFRLTIIHRDLK 110
           L+ F        L       I+ C+K        +I  I++GL Y+       IIHRDLK
Sbjct: 96  LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLK 152
Query: 111 VSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKK 161
            SN+ ++ED + KI DFGLAR     +   +     Y  PE +   ++Y +
Sbjct: 153 PSNLAVNEDCELKILDFGLARHTDDEMTGXVATRW-YRAPEIMLNWMHYNQ 202

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/129 (27%), Positives = 69/129 (53%), Gaps = 8/129 (6%)
Query: 6   GQIIAVKKLS-KKSTQGFEEFK-NEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKR 62
           G+++A+KK+     T+G       E+ L  +L H N++++   I T+  + L++E++   
Sbjct: 31  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSMD 90
Query: 63  SLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKP 122
             D+     +  + L   K    +  ++QGL +   +    ++HRDLK  N+L++ +   
Sbjct: 91  LKDFMDASALTGIPLPLIKSY--LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAI 145
Query: 123 KISDFGLAR 131
           K++DFGLAR
Sbjct: 146 KLADFGLAR 154

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 49/171 (28%), Positives = 74/171 (43%), Gaps = 27/171 (15%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKL-----QHLNLIRV-GFCIETQEYMLIYEYMPKR 62
           +AVK L  KST   +E K  +M   K+     QH N++ + G C      ++I EY    
Sbjct: 79  VAVKML--KSTAHADE-KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYG 135
Query: 63  SLDYFL--------FDP---IRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKV 111
            L  FL         DP   I    L  +  +H    + QG+ +L        IHRD+  
Sbjct: 136 DLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLASK---NCIHRDVAA 192
Query: 112 SNILLDEDLKPKISDFGLARILRK----MILKQIQIELGYIPPEYVGRGVY 158
            N+LL      KI DFGLAR +      ++    ++ + ++ PE +   VY
Sbjct: 193 RNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVY 243

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 37/139 (26%), Positives = 72/139 (51%), Gaps = 16/139 (11%)
Query: 3   LPDGQII----AVKKLSKKST-QGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIY 56
           +P+G+ I     +K +  KS  Q F+   + ++    L H +++R+ G C  +    L+ 
Sbjct: 53  IPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSS-LQLVT 111
Query: 57  EYMPKRSLDYFLFDPIRMLILDCKKRVHIIKG--IIQGLLYLQEYFRLTIIHRDLKVSNI 114
           +Y+P  SL     D +R        ++ +  G  I +G+ YL+E+    ++HR+L   N+
Sbjct: 112 QYLPLGSL----LDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEH---GMVHRNLAARNV 164
Query: 115 LLDEDLKPKISDFGLARIL 133
           LL    + +++DFG+A +L
Sbjct: 165 LLKSPSQVQVADFGVADLL 183

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 65/126 (51%), Gaps = 10/126 (7%)
Query: 8   IIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV--GFCIETQEYMLIYEYMPKRSLD 65
           + A K +  KS +  E++  E+ + A   H N++++   F  E   ++LI E+    ++D
Sbjct: 64  LAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI-EFCAGGAVD 122
Query: 66  YFLFDPIRMLILDCKKRVHII-KGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKI 124
             + +  R L    + ++ ++ K  +  L YL +     IIHRDLK  NIL   D   K+
Sbjct: 123 AVMLELERPLT---ESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKL 176
Query: 125 SDFGLA 130
           +DFG++
Sbjct: 177 ADFGVS 182

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 35/129 (27%), Positives = 69/129 (53%), Gaps = 8/129 (6%)
Query: 6   GQIIAVKKLS-KKSTQGFEEFK-NEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKR 62
           G+++A+KK+     T+G       E+ L  +L H N++++   I T+  + L++E++   
Sbjct: 30  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSMD 89
Query: 63  SLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKP 122
             D+     +  + L   K    +  ++QGL +   +    ++HRDLK  N+L++ +   
Sbjct: 90  LKDFMDASALTGIPLPLIKSY--LFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAI 144
Query: 123 KISDFGLAR 131
           K++DFGLAR
Sbjct: 145 KLADFGLAR 153

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 79/157 (50%), Gaps = 10/157 (6%)
Query: 5   DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRS 63
            G+++AVKK+  +  Q  E   NEV++    QH N++ +    +   E  ++ E++   +
Sbjct: 48  SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 107
Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           L     D +    ++ ++   +   ++Q L  L       +IHRD+K  +ILL  D + K
Sbjct: 108 LT----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVK 160
Query: 124 ISDFGL-ARILRKMILKQIQIELGY-IPPEYVGRGVY 158
           +SDFG  A++ +++  ++  +   Y + PE + R  Y
Sbjct: 161 LSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY 197

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 47.4 bits (111), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/126 (33%), Positives = 59/126 (46%), Gaps = 10/126 (7%)
Query: 10  AVKKLSK-KSTQGFEEFKNEVMLTAKLQHLN---LIRVGFCIETQEYMLIYEYMPKRSLD 65
           A+K LS+    Q  E F  E +L   L H N   LI +    E   ++L+  YM    L 
Sbjct: 53  AIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLL-PYMCHGDLL 111
Query: 66  YFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKIS 125
            F+  P R   +  K  +     + +G+ YL E      +HRDL   N +LDE    K++
Sbjct: 112 QFIRSPQRNPTV--KDLISFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVA 166
Query: 126 DFGLAR 131
           DFGLAR
Sbjct: 167 DFGLAR 172

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 79/163 (48%), Gaps = 16/163 (9%)
Query: 7   QIIAVKKLSKKSTQGFEEFK--NEVMLTAKLQHLNLIRVGFCIE-TQEYMLIYEYMPKRS 63
           Q  AVK ++K S +  +      EV L  KL H N++++   +E +  + ++ E      
Sbjct: 48  QEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGE 107
Query: 64  LDYFLFDPI-RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL---DED 119
           L    FD I +           IIK +  G+ Y+ ++    I+HRDLK  NILL   ++D
Sbjct: 108 L----FDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKD 160
Query: 120 LKPKISDFGLARILRKMILKQIQIELG-YIPPEYVGRGVYYKK 161
              KI DFGL+   ++    + +I    YI PE V RG Y +K
Sbjct: 161 CDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPE-VLRGTYDEK 202

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 68/141 (48%), Gaps = 29/141 (20%)
Query: 6   GQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
           G  +AVKKLS+  +S    +    E+ L   ++H N+I            L+  + P RS
Sbjct: 45  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG-----------LLDVFTPARS 93
Query: 64  LDYF--------LFDPIRMLILDCKKRVH-----IIKGIIQGLLYLQEYFRLTIIHRDLK 110
           L+ F        L       I+ C+K        +I  I++GL Y+       IIHRDLK
Sbjct: 94  LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLK 150
Query: 111 VSNILLDEDLKPKISDFGLAR 131
            SN+ ++ED + KI DFGLAR
Sbjct: 151 PSNLAVNEDCELKILDFGLAR 171

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 65/126 (51%), Gaps = 10/126 (7%)
Query: 8   IIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV--GFCIETQEYMLIYEYMPKRSLD 65
           + A K +  KS +  E++  E+ + A   H N++++   F  E   ++LI E+    ++D
Sbjct: 64  LAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI-EFCAGGAVD 122
Query: 66  YFLFDPIRMLILDCKKRVHII-KGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKI 124
             + +  R L    + ++ ++ K  +  L YL +     IIHRDLK  NIL   D   K+
Sbjct: 123 AVMLELERPLT---ESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKL 176
Query: 125 SDFGLA 130
           +DFG++
Sbjct: 177 ADFGVS 182

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 47.0 bits (110), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 36/126 (28%), Positives = 65/126 (51%), Gaps = 10/126 (7%)
Query: 8   IIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV--GFCIETQEYMLIYEYMPKRSLD 65
           + A K +  KS +  E++  E+ + A   H N++++   F  E   ++LI E+    ++D
Sbjct: 64  LAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI-EFCAGGAVD 122
Query: 66  YFLFDPIRMLILDCKKRVHII-KGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKI 124
             + +  R L    + ++ ++ K  +  L YL +     IIHRDLK  NIL   D   K+
Sbjct: 123 AVMLELERPLT---ESQIQVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKL 176
Query: 125 SDFGLA 130
           +DFG++
Sbjct: 177 ADFGVS 182

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 79/157 (50%), Gaps = 10/157 (6%)
Query: 5   DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRS 63
            G+++AVKK+  +  Q  E   NEV++    QH N++ +    +   E  ++ E++   +
Sbjct: 44  SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 103
Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           L     D +    ++ ++   +   ++Q L  L       +IHRD+K  +ILL  D + K
Sbjct: 104 LT----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVK 156
Query: 124 ISDFGL-ARILRKMILKQIQIELGY-IPPEYVGRGVY 158
           +SDFG  A++ +++  ++  +   Y + PE + R  Y
Sbjct: 157 LSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY 193

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 68/141 (48%), Gaps = 29/141 (20%)
Query: 6   GQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
           G  +AVKKLS+  +S    +    E+ L   ++H N+I            L+  + P RS
Sbjct: 54  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG-----------LLDVFTPARS 102
Query: 64  LDYF--------LFDPIRMLILDCKKRVH-----IIKGIIQGLLYLQEYFRLTIIHRDLK 110
           L+ F        L       I+ C+K        +I  I++GL Y+       IIHRDLK
Sbjct: 103 LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLK 159
Query: 111 VSNILLDEDLKPKISDFGLAR 131
            SN+ ++ED + KI DFGLAR
Sbjct: 160 PSNLAVNEDCELKILDFGLAR 180

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 68/141 (48%), Gaps = 29/141 (20%)
Query: 6   GQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
           G  +AVKKLS+  +S    +    E+ L   ++H N+I            L+  + P RS
Sbjct: 66  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG-----------LLDVFTPARS 114
Query: 64  LDYF--------LFDPIRMLILDCKKRVH-----IIKGIIQGLLYLQEYFRLTIIHRDLK 110
           L+ F        L       I+ C+K        +I  I++GL Y+       IIHRDLK
Sbjct: 115 LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLK 171
Query: 111 VSNILLDEDLKPKISDFGLAR 131
            SN+ ++ED + KI DFGLAR
Sbjct: 172 PSNLAVNEDCELKILDFGLAR 192

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 68/141 (48%), Gaps = 29/141 (20%)
Query: 6   GQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
           G  +AVKKLS+  +S    +    E+ L   ++H N+I            L+  + P RS
Sbjct: 54  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG-----------LLDVFTPARS 102
Query: 64  LDYF--------LFDPIRMLILDCKKRVH-----IIKGIIQGLLYLQEYFRLTIIHRDLK 110
           L+ F        L       I+ C+K        +I  I++GL Y+       IIHRDLK
Sbjct: 103 LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLK 159
Query: 111 VSNILLDEDLKPKISDFGLAR 131
            SN+ ++ED + KI DFGLAR
Sbjct: 160 PSNLAVNEDCELKILDFGLAR 180

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 68/141 (48%), Gaps = 29/141 (20%)
Query: 6   GQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
           G  +AVKKLS+  +S    +    E+ L   ++H N+I            L+  + P RS
Sbjct: 52  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG-----------LLDVFTPARS 100
Query: 64  LDYF--------LFDPIRMLILDCKKRVH-----IIKGIIQGLLYLQEYFRLTIIHRDLK 110
           L+ F        L       I+ C+K        +I  I++GL Y+       IIHRDLK
Sbjct: 101 LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLK 157
Query: 111 VSNILLDEDLKPKISDFGLAR 131
            SN+ ++ED + KI DFGLAR
Sbjct: 158 PSNLAVNEDCELKILDFGLAR 178

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 68/141 (48%), Gaps = 29/141 (20%)
Query: 6   GQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
           G  +AVKKLS+  +S    +    E+ L   ++H N+I            L+  + P RS
Sbjct: 58  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG-----------LLDVFTPARS 106
Query: 64  LDYF--------LFDPIRMLILDCKKRVH-----IIKGIIQGLLYLQEYFRLTIIHRDLK 110
           L+ F        L       I+ C+K        +I  I++GL Y+       IIHRDLK
Sbjct: 107 LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLK 163
Query: 111 VSNILLDEDLKPKISDFGLAR 131
            SN+ ++ED + KI DFGLAR
Sbjct: 164 PSNLAVNEDCELKILDFGLAR 184

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 68/141 (48%), Gaps = 29/141 (20%)
Query: 6   GQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
           G  +AVKKLS+  +S    +    E+ L   ++H N+I            L+  + P RS
Sbjct: 46  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG-----------LLDVFTPARS 94
Query: 64  LDYF--------LFDPIRMLILDCKKRVH-----IIKGIIQGLLYLQEYFRLTIIHRDLK 110
           L+ F        L       I+ C+K        +I  I++GL Y+       IIHRDLK
Sbjct: 95  LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLK 151
Query: 111 VSNILLDEDLKPKISDFGLAR 131
            SN+ ++ED + KI DFGLAR
Sbjct: 152 PSNLAVNEDCELKILDFGLAR 172

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 68/141 (48%), Gaps = 29/141 (20%)
Query: 6   GQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
           G  +AVKKLS+  +S    +    E+ L   ++H N+I            L+  + P RS
Sbjct: 52  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG-----------LLDVFTPARS 100
Query: 64  LDYF--------LFDPIRMLILDCKKRVH-----IIKGIIQGLLYLQEYFRLTIIHRDLK 110
           L+ F        L       I+ C+K        +I  I++GL Y+       IIHRDLK
Sbjct: 101 LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLK 157
Query: 111 VSNILLDEDLKPKISDFGLAR 131
            SN+ ++ED + KI DFGLAR
Sbjct: 158 PSNLAVNEDCELKILDFGLAR 178

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 68/141 (48%), Gaps = 29/141 (20%)
Query: 6   GQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
           G  +AVKKLS+  +S    +    E+ L   ++H N+I            L+  + P RS
Sbjct: 49  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG-----------LLDVFTPARS 97
Query: 64  LDYF--------LFDPIRMLILDCKKRVH-----IIKGIIQGLLYLQEYFRLTIIHRDLK 110
           L+ F        L       I+ C+K        +I  I++GL Y+       IIHRDLK
Sbjct: 98  LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLK 154
Query: 111 VSNILLDEDLKPKISDFGLAR 131
            SN+ ++ED + KI DFGLAR
Sbjct: 155 PSNLAVNEDCELKILDFGLAR 175

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 68/141 (48%), Gaps = 29/141 (20%)
Query: 6   GQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
           G  +AVKKLS+  +S    +    E+ L   ++H N+I            L+  + P RS
Sbjct: 67  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG-----------LLDVFTPARS 115
Query: 64  LDYF--------LFDPIRMLILDCKKRVH-----IIKGIIQGLLYLQEYFRLTIIHRDLK 110
           L+ F        L       I+ C+K        +I  I++GL Y+       IIHRDLK
Sbjct: 116 LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLK 172
Query: 111 VSNILLDEDLKPKISDFGLAR 131
            SN+ ++ED + KI DFGLAR
Sbjct: 173 PSNLAVNEDCELKILDFGLAR 193

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 68/141 (48%), Gaps = 29/141 (20%)
Query: 6   GQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
           G  +AVKKLS+  +S    +    E+ L   ++H N+I            L+  + P RS
Sbjct: 70  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG-----------LLDVFTPARS 118
Query: 64  LDYF--------LFDPIRMLILDCKKRVH-----IIKGIIQGLLYLQEYFRLTIIHRDLK 110
           L+ F        L       I+ C+K        +I  I++GL Y+       IIHRDLK
Sbjct: 119 LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLK 175
Query: 111 VSNILLDEDLKPKISDFGLAR 131
            SN+ ++ED + KI DFGLAR
Sbjct: 176 PSNLAVNEDCELKILDFGLAR 196

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 68/141 (48%), Gaps = 29/141 (20%)
Query: 6   GQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
           G  +AVKKLS+  +S    +    E+ L   ++H N+I            L+  + P RS
Sbjct: 54  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG-----------LLDVFTPARS 102
Query: 64  LDYF--------LFDPIRMLILDCKKRVH-----IIKGIIQGLLYLQEYFRLTIIHRDLK 110
           L+ F        L       I+ C+K        +I  I++GL Y+       IIHRDLK
Sbjct: 103 LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLK 159
Query: 111 VSNILLDEDLKPKISDFGLAR 131
            SN+ ++ED + KI DFGLAR
Sbjct: 160 PSNLAVNEDCELKILDFGLAR 180

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 68/141 (48%), Gaps = 29/141 (20%)
Query: 6   GQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
           G  +AVKKLS+  +S    +    E+ L   ++H N+I            L+  + P RS
Sbjct: 59  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG-----------LLDVFTPARS 107
Query: 64  LDYF--------LFDPIRMLILDCKKRVH-----IIKGIIQGLLYLQEYFRLTIIHRDLK 110
           L+ F        L       I+ C+K        +I  I++GL Y+       IIHRDLK
Sbjct: 108 LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLK 164
Query: 111 VSNILLDEDLKPKISDFGLAR 131
            SN+ ++ED + KI DFGLAR
Sbjct: 165 PSNLAVNEDCELKILDFGLAR 185

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 68/141 (48%), Gaps = 29/141 (20%)
Query: 6   GQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
           G  +AVKKLS+  +S    +    E+ L   ++H N+I            L+  + P RS
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG-----------LLDVFTPARS 95
Query: 64  LDYF--------LFDPIRMLILDCKKRVH-----IIKGIIQGLLYLQEYFRLTIIHRDLK 110
           L+ F        L       I+ C+K        +I  I++GL Y+       IIHRDLK
Sbjct: 96  LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLK 152
Query: 111 VSNILLDEDLKPKISDFGLAR 131
            SN+ ++ED + KI DFGLAR
Sbjct: 153 PSNLAVNEDCELKILDFGLAR 173

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 68/141 (48%), Gaps = 29/141 (20%)
Query: 6   GQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
           G  +AVKKLS+  +S    +    E+ L   ++H N+I            L+  + P RS
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG-----------LLDVFTPARS 95
Query: 64  LDYF--------LFDPIRMLILDCKKRVH-----IIKGIIQGLLYLQEYFRLTIIHRDLK 110
           L+ F        L       I+ C+K        +I  I++GL Y+       IIHRDLK
Sbjct: 96  LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLK 152
Query: 111 VSNILLDEDLKPKISDFGLAR 131
            SN+ ++ED + KI DFGLAR
Sbjct: 153 PSNLAVNEDCELKILDFGLAR 173

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 68/141 (48%), Gaps = 29/141 (20%)
Query: 6   GQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
           G  +AVKKLS+  +S    +    E+ L   ++H N+I            L+  + P RS
Sbjct: 59  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG-----------LLDVFTPARS 107
Query: 64  LDYF--------LFDPIRMLILDCKKRVH-----IIKGIIQGLLYLQEYFRLTIIHRDLK 110
           L+ F        L       I+ C+K        +I  I++GL Y+       IIHRDLK
Sbjct: 108 LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLK 164
Query: 111 VSNILLDEDLKPKISDFGLAR 131
            SN+ ++ED + KI DFGLAR
Sbjct: 165 PSNLAVNEDCELKILDFGLAR 185

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 68/141 (48%), Gaps = 29/141 (20%)
Query: 6   GQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
           G  +AVKKLS+  +S    +    E+ L   ++H N+I            L+  + P RS
Sbjct: 49  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG-----------LLDVFTPARS 97
Query: 64  LDYF--------LFDPIRMLILDCKKRVH-----IIKGIIQGLLYLQEYFRLTIIHRDLK 110
           L+ F        L       I+ C+K        +I  I++GL Y+       IIHRDLK
Sbjct: 98  LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLK 154
Query: 111 VSNILLDEDLKPKISDFGLAR 131
            SN+ ++ED + KI DFGLAR
Sbjct: 155 PSNLAVNEDCELKILDFGLAR 175

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 68/141 (48%), Gaps = 29/141 (20%)
Query: 6   GQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
           G  +AVKKLS+  +S    +    E+ L   ++H N+I            L+  + P RS
Sbjct: 70  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG-----------LLDVFTPARS 118
Query: 64  LDYF--------LFDPIRMLILDCKKRVH-----IIKGIIQGLLYLQEYFRLTIIHRDLK 110
           L+ F        L       I+ C+K        +I  I++GL Y+       IIHRDLK
Sbjct: 119 LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLK 175
Query: 111 VSNILLDEDLKPKISDFGLAR 131
            SN+ ++ED + KI DFGLAR
Sbjct: 176 PSNLAVNEDCELKILDFGLAR 196

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 68/141 (48%), Gaps = 29/141 (20%)
Query: 6   GQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
           G  +AVKKLS+  +S    +    E+ L   ++H N+I            L+  + P RS
Sbjct: 54  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG-----------LLDVFTPARS 102
Query: 64  LDYF--------LFDPIRMLILDCKKRVH-----IIKGIIQGLLYLQEYFRLTIIHRDLK 110
           L+ F        L       I+ C+K        +I  I++GL Y+       IIHRDLK
Sbjct: 103 LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLK 159
Query: 111 VSNILLDEDLKPKISDFGLAR 131
            SN+ ++ED + KI DFGLAR
Sbjct: 160 PSNLAVNEDCELKILDFGLAR 180

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 68/141 (48%), Gaps = 29/141 (20%)
Query: 6   GQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
           G  +AVKKLS+  +S    +    E+ L   ++H N+I            L+  + P RS
Sbjct: 49  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG-----------LLDVFTPARS 97
Query: 64  LDYF--------LFDPIRMLILDCKKRVH-----IIKGIIQGLLYLQEYFRLTIIHRDLK 110
           L+ F        L       I+ C+K        +I  I++GL Y+       IIHRDLK
Sbjct: 98  LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLK 154
Query: 111 VSNILLDEDLKPKISDFGLAR 131
            SN+ ++ED + KI DFGLAR
Sbjct: 155 PSNLAVNEDCELKILDFGLAR 175

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 68/141 (48%), Gaps = 29/141 (20%)
Query: 6   GQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
           G  +AVKKLS+  +S    +    E+ L   ++H N+I            L+  + P RS
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG-----------LLDVFTPARS 95
Query: 64  LDYF--------LFDPIRMLILDCKKRVH-----IIKGIIQGLLYLQEYFRLTIIHRDLK 110
           L+ F        L       I+ C+K        +I  I++GL Y+       IIHRDLK
Sbjct: 96  LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLK 152
Query: 111 VSNILLDEDLKPKISDFGLAR 131
            SN+ ++ED + KI DFGLAR
Sbjct: 153 PSNLAVNEDCELKILDFGLAR 173

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 68/141 (48%), Gaps = 29/141 (20%)
Query: 6   GQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
           G  +AVKKLS+  +S    +    E+ L   ++H N+I            L+  + P RS
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG-----------LLDVFTPARS 95
Query: 64  LDYF--------LFDPIRMLILDCKKRVH-----IIKGIIQGLLYLQEYFRLTIIHRDLK 110
           L+ F        L       I+ C+K        +I  I++GL Y+       IIHRDLK
Sbjct: 96  LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLK 152
Query: 111 VSNILLDEDLKPKISDFGLAR 131
            SN+ ++ED + KI DFGLAR
Sbjct: 153 PSNLAVNEDCELKILDFGLAR 173

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 68/141 (48%), Gaps = 29/141 (20%)
Query: 6   GQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
           G  +AVKKLS+  +S    +    E+ L   ++H N+I            L+  + P RS
Sbjct: 43  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG-----------LLDVFTPARS 91
Query: 64  LDYF--------LFDPIRMLILDCKKRVH-----IIKGIIQGLLYLQEYFRLTIIHRDLK 110
           L+ F        L       I+ C+K        +I  I++GL Y+       IIHRDLK
Sbjct: 92  LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLK 148
Query: 111 VSNILLDEDLKPKISDFGLAR 131
            SN+ ++ED + KI DFGLAR
Sbjct: 149 PSNLAVNEDCELKILDFGLAR 169

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 68/141 (48%), Gaps = 29/141 (20%)
Query: 6   GQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
           G  +AVKKLS+  +S    +    E+ L   ++H N+I            L+  + P RS
Sbjct: 52  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG-----------LLDVFTPARS 100
Query: 64  LDYF--------LFDPIRMLILDCKKRVH-----IIKGIIQGLLYLQEYFRLTIIHRDLK 110
           L+ F        L       I+ C+K        +I  I++GL Y+       IIHRDLK
Sbjct: 101 LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLK 157
Query: 111 VSNILLDEDLKPKISDFGLAR 131
            SN+ ++ED + KI DFGLAR
Sbjct: 158 PSNLAVNEDXELKILDFGLAR 178

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 68/141 (48%), Gaps = 29/141 (20%)
Query: 6   GQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
           G  +AVKKLS+  +S    +    E+ L   ++H N+I            L+  + P RS
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG-----------LLDVFTPARS 95
Query: 64  LDYF--------LFDPIRMLILDCKKRVH-----IIKGIIQGLLYLQEYFRLTIIHRDLK 110
           L+ F        L       I+ C+K        +I  I++GL Y+       IIHRDLK
Sbjct: 96  LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLK 152
Query: 111 VSNILLDEDLKPKISDFGLAR 131
            SN+ ++ED + KI DFGLAR
Sbjct: 153 PSNLAVNEDCELKILDFGLAR 173

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 68/141 (48%), Gaps = 29/141 (20%)
Query: 6   GQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
           G  +AVKKLS+  +S    +    E+ L   ++H N+I            L+  + P RS
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG-----------LLDVFTPARS 95
Query: 64  LDYF--------LFDPIRMLILDCKKRVH-----IIKGIIQGLLYLQEYFRLTIIHRDLK 110
           L+ F        L       I+ C+K        +I  I++GL Y+       IIHRDLK
Sbjct: 96  LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLK 152
Query: 111 VSNILLDEDLKPKISDFGLAR 131
            SN+ ++ED + KI DFGLAR
Sbjct: 153 PSNLAVNEDCELKILDFGLAR 173

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 79/163 (48%), Gaps = 16/163 (9%)
Query: 7   QIIAVKKLSKKSTQGFEEFK--NEVMLTAKLQHLNLIRVGFCIE-TQEYMLIYEYMPKRS 63
           Q  AVK ++K S +  +      EV L  KL H N++++   +E +  + ++ E      
Sbjct: 48  QEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGE 107
Query: 64  LDYFLFDPI-RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL---DED 119
           L    FD I +           IIK +  G+ Y+ ++    I+HRDLK  NILL   ++D
Sbjct: 108 L----FDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKD 160
Query: 120 LKPKISDFGLARILRKMILKQIQIELG-YIPPEYVGRGVYYKK 161
              KI DFGL+   ++    + +I    YI PE V RG Y +K
Sbjct: 161 CDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPE-VLRGTYDEK 202

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 68/141 (48%), Gaps = 29/141 (20%)
Query: 6   GQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
           G  +AVKKLS+  +S    +    E+ L   ++H N+I            L+  + P RS
Sbjct: 44  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG-----------LLDVFTPARS 92
Query: 64  LDYF--------LFDPIRMLILDCKKRVH-----IIKGIIQGLLYLQEYFRLTIIHRDLK 110
           L+ F        L       I+ C+K        +I  I++GL Y+       IIHRDLK
Sbjct: 93  LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLK 149
Query: 111 VSNILLDEDLKPKISDFGLAR 131
            SN+ ++ED + KI DFGLAR
Sbjct: 150 PSNLAVNEDCELKILDFGLAR 170

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 68/141 (48%), Gaps = 29/141 (20%)
Query: 6   GQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
           G  +AVKKLS+  +S    +    E+ L   ++H N+I            L+  + P RS
Sbjct: 44  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG-----------LLDVFTPARS 92
Query: 64  LDYF--------LFDPIRMLILDCKKRVH-----IIKGIIQGLLYLQEYFRLTIIHRDLK 110
           L+ F        L       I+ C+K        +I  I++GL Y+       IIHRDLK
Sbjct: 93  LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLK 149
Query: 111 VSNILLDEDLKPKISDFGLAR 131
            SN+ ++ED + KI DFGLAR
Sbjct: 150 PSNLAVNEDCELKILDFGLAR 170

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 79/163 (48%), Gaps = 16/163 (9%)
Query: 7   QIIAVKKLSKKSTQGFEEFK--NEVMLTAKLQHLNLIRVGFCIE-TQEYMLIYEYMPKRS 63
           Q  AVK ++K S +  +      EV L  KL H N++++   +E +  + ++ E      
Sbjct: 48  QEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGE 107
Query: 64  LDYFLFDPI-RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL---DED 119
           L    FD I +           IIK +  G+ Y+ ++    I+HRDLK  NILL   ++D
Sbjct: 108 L----FDEIIKRKRFSEHDAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKD 160
Query: 120 LKPKISDFGLARILRKMILKQIQIELG-YIPPEYVGRGVYYKK 161
              KI DFGL+   ++    + +I    YI PE V RG Y +K
Sbjct: 161 CDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPE-VLRGTYDEK 202

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 68/141 (48%), Gaps = 29/141 (20%)
Query: 6   GQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
           G  +AVKKLS+  +S    +    E+ L   ++H N+I            L+  + P RS
Sbjct: 52  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG-----------LLDVFTPARS 100
Query: 64  LDYF--------LFDPIRMLILDCKKRVH-----IIKGIIQGLLYLQEYFRLTIIHRDLK 110
           L+ F        L       I+ C+K        +I  I++GL Y+       IIHRDLK
Sbjct: 101 LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLK 157
Query: 111 VSNILLDEDLKPKISDFGLAR 131
            SN+ ++ED + KI DFGLAR
Sbjct: 158 PSNLAVNEDXELKILDFGLAR 178

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 68/141 (48%), Gaps = 29/141 (20%)
Query: 6   GQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
           G  +AVKKLS+  +S    +    E+ L   ++H N+I            L+  + P RS
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG-----------LLDVFTPARS 95
Query: 64  LDYF--------LFDPIRMLILDCKKRVH-----IIKGIIQGLLYLQEYFRLTIIHRDLK 110
           L+ F        L       I+ C+K        +I  I++GL Y+       IIHRDLK
Sbjct: 96  LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLK 152
Query: 111 VSNILLDEDLKPKISDFGLAR 131
            SN+ ++ED + KI DFGLAR
Sbjct: 153 PSNLAVNEDCELKILDFGLAR 173

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 71/150 (47%), Gaps = 10/150 (6%)
Query: 8   IIAVKKLSKKSTQ--GFE-EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRS 63
           I+A+K L K   +  G E + + EV + + L+H N++R+ G+  +     LI EY P   
Sbjct: 39  ILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP--- 95
Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           L     +  ++   D ++    I  +   L Y        +IHRD+K  N+LL  + + K
Sbjct: 96  LGTVYRELQKLSRFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSNGELK 152
Query: 124 ISDFGLARILRKMILKQIQIELGYIPPEYV 153
           I+DFG +          +   L Y+PPE +
Sbjct: 153 IADFGWSVHAPSSRRTTLCGTLDYLPPEMI 182

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 79/157 (50%), Gaps = 10/157 (6%)
Query: 5   DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRS 63
            G+++AVKK+  +  Q  E   NEV++    QH N++ +    +   E  ++ E++   +
Sbjct: 53  SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 112
Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           L     D +    ++ ++   +   ++Q L  L       +IHRD+K  +ILL  D + K
Sbjct: 113 LT----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVK 165
Query: 124 ISDFGL-ARILRKMILKQIQIELGY-IPPEYVGRGVY 158
           +SDFG  A++ +++  ++  +   Y + PE + R  Y
Sbjct: 166 LSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY 202

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 48/171 (28%), Positives = 74/171 (43%), Gaps = 27/171 (15%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKL-----QHLNLIRV-GFCIETQEYMLIYEYMPKR 62
           +AVK L  KST   +E K  +M   K+     QH N++ + G C      ++I EY    
Sbjct: 79  VAVKML--KSTAHADE-KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYG 135
Query: 63  SLDYFLFDPIRMLILD-----------CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKV 111
            L  FL    R+L  D            +  +H    + QG+ +L        IHRD+  
Sbjct: 136 DLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAA 192
Query: 112 SNILLDEDLKPKISDFGLARILRK----MILKQIQIELGYIPPEYVGRGVY 158
            N+LL      KI DFGLAR +      ++    ++ + ++ PE +   VY
Sbjct: 193 RNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVY 243

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 47.0 bits (110), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 68/141 (48%), Gaps = 29/141 (20%)
Query: 6   GQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
           G  +AVKKLS+  +S    +    E+ L   ++H N+I            L+  + P RS
Sbjct: 53  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG-----------LLDVFTPARS 101
Query: 64  LDYF--------LFDPIRMLILDCKKRVH-----IIKGIIQGLLYLQEYFRLTIIHRDLK 110
           L+ F        L       I+ C+K        +I  I++GL Y+       IIHRDLK
Sbjct: 102 LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLK 158
Query: 111 VSNILLDEDLKPKISDFGLAR 131
            SN+ ++ED + KI DFGLAR
Sbjct: 159 PSNLAVNEDCELKILDFGLAR 179

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 47.0 bits (110), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 76/161 (47%), Gaps = 10/161 (6%)
Query: 8   IIAVKKLSKKSTQ--GFE-EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRS 63
           I+A+K L K   +  G E + + EV + + L+H N++R+ G+  +     LI EY P   
Sbjct: 39  ILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP--- 95
Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           L     +  ++   D ++    I  +   L Y        +IHRD+K  N+LL  + + K
Sbjct: 96  LGTVYRELQKLSRFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSNGELK 152
Query: 124 ISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKKFSL 164
           I+DFG +          +   L Y+PPE +   ++ +K  L
Sbjct: 153 IADFGWSVHAPSSRRDTLCGTLDYLPPEMIEGRMHDEKVDL 193

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 68/141 (48%), Gaps = 29/141 (20%)
Query: 6   GQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
           G  +AVKKLS+  +S    +    E+ L   ++H N+I            L+  + P RS
Sbjct: 53  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG-----------LLDVFTPARS 101
Query: 64  LDYF--------LFDPIRMLILDCKKRVH-----IIKGIIQGLLYLQEYFRLTIIHRDLK 110
           L+ F        L       I+ C+K        +I  I++GL Y+       IIHRDLK
Sbjct: 102 LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLK 158
Query: 111 VSNILLDEDLKPKISDFGLAR 131
            SN+ ++ED + KI DFGLAR
Sbjct: 159 PSNLAVNEDCELKILDFGLAR 179

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 68/141 (48%), Gaps = 29/141 (20%)
Query: 6   GQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
           G  +AVKKLS+  +S    +    E+ L   ++H N+I            L+  + P RS
Sbjct: 58  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG-----------LLDVFTPARS 106
Query: 64  LDYF--------LFDPIRMLILDCKKRVH-----IIKGIIQGLLYLQEYFRLTIIHRDLK 110
           L+ F        L       I+ C+K        +I  I++GL Y+       IIHRDLK
Sbjct: 107 LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLK 163
Query: 111 VSNILLDEDLKPKISDFGLAR 131
            SN+ ++ED + KI DFGLAR
Sbjct: 164 PSNLAVNEDXELKILDFGLAR 184

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/143 (32%), Positives = 70/143 (48%), Gaps = 19/143 (13%)
Query: 18  STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPI--RM 74
           ST    +   EV +   L H N++++  F  + + Y L+ E      L    FD I  RM
Sbjct: 76  STSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGEL----FDEIIHRM 131
Query: 75  LILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKP---KISDFGLAR 131
              +    V IIK ++ G+ YL ++    I+HRDLK  N+LL+   K    KI DFGL+ 
Sbjct: 132 KFNEVDAAV-IIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSA 187
Query: 132 ILRKMILKQIQIELG---YIPPE 151
           +      K+++  LG   YI PE
Sbjct: 188 VFENQ--KKMKERLGTAYYIAPE 208

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 79/157 (50%), Gaps = 10/157 (6%)
Query: 5   DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRS 63
            G+++AVKK+  +  Q  E   NEV++    QH N++ +    +   E  ++ E++   +
Sbjct: 55  SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 114
Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           L     D +    ++ ++   +   ++Q L  L       +IHRD+K  +ILL  D + K
Sbjct: 115 LT----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVK 167
Query: 124 ISDFGL-ARILRKMILKQIQIELGY-IPPEYVGRGVY 158
           +SDFG  A++ +++  ++  +   Y + PE + R  Y
Sbjct: 168 LSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY 204

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 77/160 (48%), Gaps = 18/160 (11%)
Query: 7   QIIAVKKLSK---KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIET-QEYMLIYEYMPKR 62
           Q +A+K +S+   K +      + E+     L+H ++I++   I T  + +++ EY    
Sbjct: 35  QKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYAGGE 94
Query: 63  SLDYFLFDPIRMLILDCKKRVHIIKG--IIQGLLYLQEY-FRLTIIHRDLKVSNILLDED 119
             DY +           KKR+   +G    Q ++   EY  R  I+HRDLK  N+LLD++
Sbjct: 95  LFDYIVE----------KKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDN 144
Query: 120 LKPKISDFGLARILRK-MILKQIQIELGYIPPEYVGRGVY 158
           L  KI+DFGL+ I+     LK       Y  PE +   +Y
Sbjct: 145 LNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLY 184

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 46.6 bits (109), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 81/174 (46%), Gaps = 24/174 (13%)
Query: 5   DGQIIAVKKLSKKSTQGFEE--FKNEVMLTAKLQHLNLIRVGFCIETQEYMLIY---EYM 59
           DG+I+  K+L   S    E+    +EV L  +L+H N++R    I  +    +Y   EY 
Sbjct: 30  DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYC 89
Query: 60  PKRSLDYFLFDPIRMLILDCKKRVH-----IIKGIIQGLLYLQEYFRL-----TIIHRDL 109
               L         ++    K+R +     +++ + Q  L L+E  R      T++HRDL
Sbjct: 90  EGGDL-------ASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDL 142
Query: 110 KVSNILLDEDLKPKISDFGLARILR--KMILKQIQIELGYIPPEYVGRGVYYKK 161
           K +N+ LD     K+ DFGLARIL   +   K+      Y+ PE + R  Y +K
Sbjct: 143 KPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYMSPEQMNRMSYNEK 196

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 80/161 (49%), Gaps = 10/161 (6%)
Query: 8   IIAVKKL--SKKSTQGFE-EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRS 63
           I+A+K L  S+   +G E + + E+ + A L H N++R+  +  + +   LI EY P+  
Sbjct: 50  IVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGE 109
Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           L   L    +    D ++   I++ +   L+Y        +IHRD+K  N+LL    + K
Sbjct: 110 LYKEL---QKSCTFDEQRTATIMEELADALMYCHGK---KVIHRDIKPENLLLGLKGELK 163
Query: 124 ISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKKFSL 164
           I+DFG +     +  K +   L Y+PPE +   ++ +K  L
Sbjct: 164 IADFGWSVHAPSLRRKTMCGTLDYLPPEMIEGRMHNEKVDL 204

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 68/141 (48%), Gaps = 29/141 (20%)
Query: 6   GQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
           G  +AVKKLS+  +S    +    E+ L   ++H N+I            L+  + P RS
Sbjct: 53  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG-----------LLDVFTPARS 101
Query: 64  LDYF--------LFDPIRMLILDCKKRVH-----IIKGIIQGLLYLQEYFRLTIIHRDLK 110
           L+ F        L       I+ C+K        +I  I++GL Y+       IIHRDLK
Sbjct: 102 LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLK 158
Query: 111 VSNILLDEDLKPKISDFGLAR 131
            SN+ ++ED + KI DFGLAR
Sbjct: 159 PSNLAVNEDSELKILDFGLAR 179

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 34/137 (24%), Positives = 68/137 (49%), Gaps = 10/137 (7%)
Query: 4   PDGQIIAVKKLS-KKSTQGFEEFKNEVMLTAKLQHLNLIR--VGFCIETQEYMLIYEYMP 60
           P  + +A+K+++ +K     +E   E+   ++  H N++     F ++ + ++++     
Sbjct: 33  PKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSG 92
Query: 61  KRSLDYFLF----DPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL 116
              LD           +  +LD      I++ +++GL YL +  +   IHRD+K  NILL
Sbjct: 93  GSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILL 149
Query: 117 DEDLKPKISDFGLARIL 133
            ED   +I+DFG++  L
Sbjct: 150 GEDGSVQIADFGVSAFL 166

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 70/150 (46%), Gaps = 10/150 (6%)
Query: 8   IIAVKKLSKKSTQ--GFE-EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRS 63
           I+A+K L K   +  G E + + EV + + L+H N++R+ G+  +     LI EY P   
Sbjct: 36  ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP--- 92
Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           L     +  ++   D ++    I  +   L Y        +IHRD+K  N+LL    + K
Sbjct: 93  LGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELK 149
Query: 124 ISDFGLARILRKMILKQIQIELGYIPPEYV 153
           I+DFG +          +   L Y+PPE +
Sbjct: 150 IADFGWSCHAPSSRRTTLSGTLDYLPPEMI 179

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 74/132 (56%), Gaps = 14/132 (10%)
Query: 6   GQIIAVKKLS-KKSTQGFEEFK-NEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMP-- 60
           G+++A+KK+     T+G       E+ L  +L H N++++   I T+  + L++E++   
Sbjct: 31  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSMD 90
Query: 61  -KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
            K+ +D      I + ++    + ++ + ++QGL +   +    ++HRDLK  N+L++ +
Sbjct: 91  LKKFMDASALTGIPLPLI----KSYLFQ-LLQGLAFCHSH---RVLHRDLKPENLLINTE 142
Query: 120 LKPKISDFGLAR 131
              K++DFGLAR
Sbjct: 143 GAIKLADFGLAR 154

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 46.6 bits (109), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 76/161 (47%), Gaps = 10/161 (6%)
Query: 8   IIAVKKLSKKSTQ--GFE-EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRS 63
           I+A+K L K   +  G E + + EV + + L+H N++R+ G+  +     LI EY P   
Sbjct: 35  ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP--- 91
Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           L     +  ++   D ++    I  +   L Y        +IHRD+K  N+LL    + K
Sbjct: 92  LGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELK 148
Query: 124 ISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKKFSL 164
           I+DFG +         ++   L Y+PPE +   ++ +K  L
Sbjct: 149 IADFGWSVHAPSSRRTELCGTLDYLPPEMIEGRMHDEKVDL 189

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 40/132 (30%), Positives = 71/132 (53%), Gaps = 12/132 (9%)
Query: 6   GQIIAVKKLS----KKSTQGFEEFK-NEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYM 59
            QI+A+KK+      ++  G       E+ L  +L H N+I +      +  + L++++M
Sbjct: 35  NQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 94
Query: 60  PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
            +  L+  + D    L+L        +   +QGL YL +++   I+HRDLK +N+LLDE+
Sbjct: 95  -ETDLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDEN 148
Query: 120 LKPKISDFGLAR 131
              K++DFGLA+
Sbjct: 149 GVLKLADFGLAK 160

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 68/141 (48%), Gaps = 29/141 (20%)
Query: 6   GQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
           G  +AVKKLS+  +S    +    E+ L   ++H N+I            L+  + P RS
Sbjct: 49  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG-----------LLDVFTPARS 97
Query: 64  LDYF--------LFDPIRMLILDCKKRVH-----IIKGIIQGLLYLQEYFRLTIIHRDLK 110
           L+ F        L       I+ C+K        +I  I++GL Y+       IIHRDLK
Sbjct: 98  LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLK 154
Query: 111 VSNILLDEDLKPKISDFGLAR 131
            SN+ ++ED + KI DFGLAR
Sbjct: 155 PSNLAVNEDSELKILDFGLAR 175

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 46.2 bits (108), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 71/132 (53%), Gaps = 14/132 (10%)
Query: 6   GQIIAVKKLS-KKSTQGFEEFK-NEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMP-- 60
           G+++A+KK+     T+G       E+ L  +L H N++++   I T+  + L++E++   
Sbjct: 29  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLSMD 88
Query: 61  -KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
            K+ +D      I + ++        +  ++QGL +   +    ++HRDLK  N+L++ +
Sbjct: 89  LKKFMDASALTGIPLPLIKS-----YLFQLLQGLAFCHSH---RVLHRDLKPENLLINTE 140
Query: 120 LKPKISDFGLAR 131
              K++DFGLAR
Sbjct: 141 GAIKLADFGLAR 152

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 41/132 (31%), Positives = 73/132 (55%), Gaps = 11/132 (8%)
Query: 6   GQIIAVKKLSKKSTQGFEEFK-NEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMP--- 60
           G  +A+K++   S +G       E+ L  +L+H N++R+   I T+  + L++E+M    
Sbjct: 30  GVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMDNDL 89
Query: 61  KRSLDY-FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
           K+ +D   + +  R L L+  K  +    ++QGL +  E     I+HRDLK  N+L+++ 
Sbjct: 90  KKYMDSRTVGNTPRGLELNLVK--YFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKR 144
Query: 120 LKPKISDFGLAR 131
            + K+ DFGLAR
Sbjct: 145 GQLKLGDFGLAR 156

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 29/71 (40%), Positives = 39/71 (54%), Gaps = 3/71 (4%)
Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYI 148
           II GL ++   F   +++RDLK +NILLDE    +ISD GLA    K          GY+
Sbjct: 301 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYM 357
Query: 149 PPEYVGRGVYY 159
            PE + +GV Y
Sbjct: 358 APEVLQKGVAY 368

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 29/71 (40%), Positives = 39/71 (54%), Gaps = 3/71 (4%)
Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYI 148
           II GL ++   F   +++RDLK +NILLDE    +ISD GLA    K          GY+
Sbjct: 300 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYM 356
Query: 149 PPEYVGRGVYY 159
            PE + +GV Y
Sbjct: 357 APEVLQKGVAY 367

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 79/157 (50%), Gaps = 10/157 (6%)
Query: 5   DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRS 63
            G+++AVKK+  +  Q  E   NEV++    QH N++ +    +   E  ++ E++   +
Sbjct: 98  SGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGA 157
Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           L     D +    ++ ++   +   ++Q L  L       +IHRD+K  +ILL  D + K
Sbjct: 158 LT----DIVTHTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVK 210
Query: 124 ISDFGL-ARILRKMILKQIQIELGY-IPPEYVGRGVY 158
           +SDFG  A++ +++  ++  +   Y + PE + R  Y
Sbjct: 211 LSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPY 247

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 29/71 (40%), Positives = 39/71 (54%), Gaps = 3/71 (4%)
Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYI 148
           II GL ++   F   +++RDLK +NILLDE    +ISD GLA    K          GY+
Sbjct: 301 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYM 357
Query: 149 PPEYVGRGVYY 159
            PE + +GV Y
Sbjct: 358 APEVLQKGVAY 368

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 29/71 (40%), Positives = 39/71 (54%), Gaps = 3/71 (4%)
Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYI 148
           II GL ++   F   +++RDLK +NILLDE    +ISD GLA    K          GY+
Sbjct: 301 IILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYM 357
Query: 149 PPEYVGRGVYY 159
            PE + +GV Y
Sbjct: 358 APEVLQKGVAY 368

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 46.2 bits (108), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 71/150 (47%), Gaps = 10/150 (6%)
Query: 8   IIAVKKLSKKSTQ--GFE-EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRS 63
           I+A+K L K   +  G E + + EV + + L+H N++R+ G+  +     LI EY P+  
Sbjct: 40  ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGE 99
Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           +   L    ++   D ++    I  +   L Y        +IHRD+K  N+LL    + K
Sbjct: 100 VYKEL---QKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELK 153
Query: 124 ISDFGLARILRKMILKQIQIELGYIPPEYV 153
           I+DFG +          +   L Y+PPE +
Sbjct: 154 IADFGWSVHAPSSRRXXLXGTLDYLPPEMI 183

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 34/137 (24%), Positives = 68/137 (49%), Gaps = 10/137 (7%)
Query: 4   PDGQIIAVKKLS-KKSTQGFEEFKNEVMLTAKLQHLNLIR--VGFCIETQEYMLIYEYMP 60
           P  + +A+K+++ +K     +E   E+   ++  H N++     F ++ + ++++     
Sbjct: 38  PKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSG 97
Query: 61  KRSLDYFLF----DPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL 116
              LD           +  +LD      I++ +++GL YL +  +   IHRD+K  NILL
Sbjct: 98  GSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQ---IHRDVKAGNILL 154
Query: 117 DEDLKPKISDFGLARIL 133
            ED   +I+DFG++  L
Sbjct: 155 GEDGSVQIADFGVSAFL 171

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 34/117 (29%), Positives = 65/117 (55%), Gaps = 8/117 (6%)
Query: 37  HLNLIRVGFCIETQEYM-LIYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLY 95
           H ++I +    E+  +M L+++ M K  L  +L + +    L  K+   I++ +++ + +
Sbjct: 159 HPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKV---ALSEKETRSIMRSLLEAVSF 215
Query: 96  LQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK-MILKQIQIELGYIPPE 151
           L       I+HRDLK  NILLD++++ ++SDFG +  L     L+++    GY+ PE
Sbjct: 216 LHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPE 269

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 46.2 bits (108), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 71/150 (47%), Gaps = 10/150 (6%)
Query: 8   IIAVKKLSKKSTQ--GFE-EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRS 63
           I+A+K L K   +  G E + + EV + + L+H N++R+ G+  ++    LI EY P   
Sbjct: 35  ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDSTRVYLILEYAP--- 91
Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           L     +  ++   D ++    I  +   L Y        +IHRD+K  N+LL    + K
Sbjct: 92  LGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---KVIHRDIKPENLLLGSAGELK 148
Query: 124 ISDFGLARILRKMILKQIQIELGYIPPEYV 153
           I+DFG +          +   L Y+PPE +
Sbjct: 149 IADFGWSVHAPSSRRAALCGTLDYLPPEMI 178

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 46.2 bits (108), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/128 (31%), Positives = 68/128 (53%), Gaps = 10/128 (7%)
Query: 9   IAVKKLSK---KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYE--YMPKRS 63
           +A+KKLS+     T     ++ E++L   + H N+I +      Q+ +  ++  Y+    
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           +D  L   I+M  LD ++  +++  ++ G+ +L       IIHRDLK SNI++  D   K
Sbjct: 111 MDANLXQVIQME-LDHERMSYLLYQMLXGIKHLHS---AGIIHRDLKPSNIVVKSDXTLK 166
Query: 124 ISDFGLAR 131
           I DFGLAR
Sbjct: 167 ILDFGLAR 174

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 74/152 (48%), Gaps = 7/152 (4%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSLDYF 67
           IA+K++ ++ ++  +    E+ L   L+H N+++ +G   E     +  E +P  SL   
Sbjct: 36  IAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSAL 95
Query: 68  LFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE-DLKPKISD 126
           L      L  + +      K I++GL YL +     I+HRD+K  N+L++      KISD
Sbjct: 96  LRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISD 152
Query: 127 FGLARILRKM--ILKQIQIELGYIPPEYVGRG 156
           FG ++ L  +    +     L Y+ PE + +G
Sbjct: 153 FGTSKRLAGINPCTETFTGTLQYMAPEIIDKG 184

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 54/109 (49%), Gaps = 7/109 (6%)
Query: 25  FKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRV 83
           FK EVM   + +H N++  +G C+      +I      R+L   + D    ++LD  K  
Sbjct: 76  FKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDA--KIVLDVNKTR 133
Query: 84  HIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARI 132
            I + I++G+ YL       I+H+DLK  N+  D   K  I+DFGL  I
Sbjct: 134 QIAQEIVKGMGYLHAK---GILHKDLKSKNVFYDNG-KVVITDFGLFSI 178

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/140 (31%), Positives = 67/140 (47%), Gaps = 14/140 (10%)
Query: 26  KNEVMLTAKLQHLNLIRVGFCIET-QEYMLIYEYMPKRSLDYFLFDPI-RMLILDCKKRV 83
           + E+ +  +L H N+I++    ET  E  L+ E +    L    FD I        +   
Sbjct: 96  RTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGEL----FDRIVEKGYYSERDAA 151
Query: 84  HIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE---DLKPKISDFGLARILRKMIL-K 139
             +K I++ + YL E     I+HRDLK  N+L      D   KI+DFGL++I+   +L K
Sbjct: 152 DAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMK 208
Query: 140 QIQIELGYIPPEYVGRGVYY 159
            +    GY  PE + RG  Y
Sbjct: 209 TVCGTPGYCAPEIL-RGCAY 227

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 79/174 (45%), Gaps = 24/174 (13%)
Query: 5   DGQIIAVKKLSKKSTQGFEE--FKNEVMLTAKLQHLNLIRVGFCIETQEYMLIY---EYM 59
           DG+I+  K+L   S    E+    +EV L  +L+H N++R    I  +    +Y   EY 
Sbjct: 30  DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYC 89
Query: 60  PKRSLDYFLFDPIRMLILDCKKRVH-----IIKGIIQGLLYLQEYFRL-----TIIHRDL 109
               L         ++    K+R +     +++ + Q  L L+E  R      T++HRDL
Sbjct: 90  EGGDL-------ASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDL 142
Query: 110 KVSNILLDEDLKPKISDFGLARILR--KMILKQIQIELGYIPPEYVGRGVYYKK 161
           K +N+ LD     K+ DFGLARIL       K       Y+ PE + R  Y +K
Sbjct: 143 KPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEK 196

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 81/170 (47%), Gaps = 29/170 (17%)
Query: 6   GQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
           G+ +A+KKLS+  +S    +    E++L   +QH N+I            L+  + P  S
Sbjct: 49  GEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIG-----------LLDVFTPASS 97
Query: 64  L----DYFLFDP--------IRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKV 111
           L    D++L  P        I  L    +K  +++  +++GL Y+       ++HRDLK 
Sbjct: 98  LRNFYDFYLVMPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKP 154
Query: 112 SNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKK 161
            N+ ++ED + KI DFGLAR     +   + +   Y  PE +   ++Y +
Sbjct: 155 GNLAVNEDCELKILDFGLARHADAEMTGYV-VTRWYRAPEVILSWMHYNQ 203

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 71/132 (53%), Gaps = 14/132 (10%)
Query: 6   GQIIAVKKLS-KKSTQGFEEFK-NEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMP-- 60
           G+++A+KK+     T+G       E+ L  +L H N++++   I T+  + L++E++   
Sbjct: 30  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD 89
Query: 61  -KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
            K+ +D      I + ++        +  ++QGL +   +    ++HRDLK  N+L++ +
Sbjct: 90  LKKFMDASALTGIPLPLIKS-----YLFQLLQGLAFCHSH---RVLHRDLKPENLLINTE 141
Query: 120 LKPKISDFGLAR 131
              K++DFGLAR
Sbjct: 142 GAIKLADFGLAR 153

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 51/174 (29%), Positives = 79/174 (45%), Gaps = 24/174 (13%)
Query: 5   DGQIIAVKKLSKKSTQGFEE--FKNEVMLTAKLQHLNLIRVGFCIETQEYMLIY---EYM 59
           DG+I+  K+L   S    E+    +EV L  +L+H N++R    I  +    +Y   EY 
Sbjct: 30  DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYC 89
Query: 60  PKRSLDYFLFDPIRMLILDCKKRVH-----IIKGIIQGLLYLQEYFRL-----TIIHRDL 109
               L         ++    K+R +     +++ + Q  L L+E  R      T++HRDL
Sbjct: 90  EGGDL-------ASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDL 142
Query: 110 KVSNILLDEDLKPKISDFGLARILR--KMILKQIQIELGYIPPEYVGRGVYYKK 161
           K +N+ LD     K+ DFGLARIL       K       Y+ PE + R  Y +K
Sbjct: 143 KPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEK 196

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 71/132 (53%), Gaps = 14/132 (10%)
Query: 6   GQIIAVKKLS-KKSTQGFEEFK-NEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMP-- 60
           G+++A+KK+     T+G       E+ L  +L H N++++   I T+  + L++E++   
Sbjct: 29  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD 88
Query: 61  -KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
            K+ +D      I + ++        +  ++QGL +   +    ++HRDLK  N+L++ +
Sbjct: 89  LKKFMDASALTGIPLPLIKS-----YLFQLLQGLAFCHSH---RVLHRDLKPENLLINTE 140
Query: 120 LKPKISDFGLAR 131
              K++DFGLAR
Sbjct: 141 GAIKLADFGLAR 152

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 71/132 (53%), Gaps = 14/132 (10%)
Query: 6   GQIIAVKKLS-KKSTQGFEEFK-NEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMP-- 60
           G+++A+KK+     T+G       E+ L  +L H N++++   I T+  + L++E++   
Sbjct: 29  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD 88
Query: 61  -KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
            K+ +D      I + ++        +  ++QGL +   +    ++HRDLK  N+L++ +
Sbjct: 89  LKKFMDASALTGIPLPLIKS-----YLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTE 140
Query: 120 LKPKISDFGLAR 131
              K++DFGLAR
Sbjct: 141 GAIKLADFGLAR 152

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 71/132 (53%), Gaps = 14/132 (10%)
Query: 6   GQIIAVKKLS-KKSTQGFEEFK-NEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMP-- 60
           G+++A+KK+     T+G       E+ L  +L H N++++   I T+  + L++E++   
Sbjct: 28  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD 87
Query: 61  -KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
            K+ +D      I + ++        +  ++QGL +   +    ++HRDLK  N+L++ +
Sbjct: 88  LKKFMDASALTGIPLPLIKS-----YLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTE 139
Query: 120 LKPKISDFGLAR 131
              K++DFGLAR
Sbjct: 140 GAIKLADFGLAR 151

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 71/132 (53%), Gaps = 14/132 (10%)
Query: 6   GQIIAVKKLS-KKSTQGFEEFK-NEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMP-- 60
           G+++A+KK+     T+G       E+ L  +L H N++++   I T+  + L++E++   
Sbjct: 32  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD 91
Query: 61  -KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
            K+ +D      I + ++        +  ++QGL +   +    ++HRDLK  N+L++ +
Sbjct: 92  LKKFMDASALTGIPLPLIKS-----YLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTE 143
Query: 120 LKPKISDFGLAR 131
              K++DFGLAR
Sbjct: 144 GAIKLADFGLAR 155

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 71/132 (53%), Gaps = 14/132 (10%)
Query: 6   GQIIAVKKLS-KKSTQGFEEFK-NEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMP-- 60
           G+++A+KK+     T+G       E+ L  +L H N++++   I T+  + L++E++   
Sbjct: 35  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD 94
Query: 61  -KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
            K+ +D      I + ++        +  ++QGL +   +    ++HRDLK  N+L++ +
Sbjct: 95  LKKFMDASALTGIPLPLIKS-----YLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTE 146
Query: 120 LKPKISDFGLAR 131
              K++DFGLAR
Sbjct: 147 GAIKLADFGLAR 158

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 71/132 (53%), Gaps = 14/132 (10%)
Query: 6   GQIIAVKKLS-KKSTQGFEEFK-NEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMP-- 60
           G+++A+KK+     T+G       E+ L  +L H N++++   I T+  + L++E++   
Sbjct: 29  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD 88
Query: 61  -KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
            K+ +D      I + ++        +  ++QGL +   +    ++HRDLK  N+L++ +
Sbjct: 89  LKKFMDASALTGIPLPLIKS-----YLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTE 140
Query: 120 LKPKISDFGLAR 131
              K++DFGLAR
Sbjct: 141 GAIKLADFGLAR 152

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 71/132 (53%), Gaps = 14/132 (10%)
Query: 6   GQIIAVKKLS-KKSTQGFEEFK-NEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMP-- 60
           G+++A+KK+     T+G       E+ L  +L H N++++   I T+  + L++E++   
Sbjct: 31  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD 90
Query: 61  -KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
            K+ +D      I + ++        +  ++QGL +   +    ++HRDLK  N+L++ +
Sbjct: 91  LKKFMDASALTGIPLPLIKS-----YLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTE 142
Query: 120 LKPKISDFGLAR 131
              K++DFGLAR
Sbjct: 143 GAIKLADFGLAR 154

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 71/132 (53%), Gaps = 14/132 (10%)
Query: 6   GQIIAVKKLS-KKSTQGFEEFK-NEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMP-- 60
           G+++A+KK+     T+G       E+ L  +L H N++++   I T+  + L++E++   
Sbjct: 30  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD 89
Query: 61  -KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
            K+ +D      I + ++        +  ++QGL +   +    ++HRDLK  N+L++ +
Sbjct: 90  LKKFMDASALTGIPLPLIKS-----YLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTE 141
Query: 120 LKPKISDFGLAR 131
              K++DFGLAR
Sbjct: 142 GAIKLADFGLAR 153

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/141 (32%), Positives = 68/141 (48%), Gaps = 29/141 (20%)
Query: 6   GQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
           G  +AVKKLS+  +S    +    E+ L   ++H N+I            L+  + P RS
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG-----------LLDVFTPARS 95
Query: 64  LDYF--------LFDPIRMLILDCKKRVH-----IIKGIIQGLLYLQEYFRLTIIHRDLK 110
           L+ F        L       I+ C+K        +I  I++GL Y+       IIHRDLK
Sbjct: 96  LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLK 152
Query: 111 VSNILLDEDLKPKISDFGLAR 131
            SN+ ++ED + KI D+GLAR
Sbjct: 153 PSNLAVNEDCELKILDYGLAR 173

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/152 (26%), Positives = 74/152 (48%), Gaps = 7/152 (4%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSLDYF 67
           IA+K++ ++ ++  +    E+ L   L+H N+++ +G   E     +  E +P  SL   
Sbjct: 50  IAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSAL 109
Query: 68  LFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE-DLKPKISD 126
           L      L  + +      K I++GL YL +     I+HRD+K  N+L++      KISD
Sbjct: 110 LRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISD 166
Query: 127 FGLARILRKM--ILKQIQIELGYIPPEYVGRG 156
           FG ++ L  +    +     L Y+ PE + +G
Sbjct: 167 FGTSKRLAGINPCTETFTGTLQYMAPEIIDKG 198

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 71/132 (53%), Gaps = 14/132 (10%)
Query: 6   GQIIAVKKLS-KKSTQGFEEFK-NEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMP-- 60
           G+++A+KK+     T+G       E+ L  +L H N++++   I T+  + L++E++   
Sbjct: 30  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD 89
Query: 61  -KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
            K+ +D      I + ++        +  ++QGL +   +    ++HRDLK  N+L++ +
Sbjct: 90  LKKFMDASALTGIPLPLIKS-----YLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTE 141
Query: 120 LKPKISDFGLAR 131
              K++DFGLAR
Sbjct: 142 GAIKLADFGLAR 153

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 71/132 (53%), Gaps = 14/132 (10%)
Query: 6   GQIIAVKKLS-KKSTQGFEEFK-NEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMP-- 60
           G+++A+KK+     T+G       E+ L  +L H N++++   I T+  + L++E++   
Sbjct: 27  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD 86
Query: 61  -KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
            K+ +D      I + ++        +  ++QGL +   +    ++HRDLK  N+L++ +
Sbjct: 87  LKKFMDASALTGIPLPLIKS-----YLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTE 138
Query: 120 LKPKISDFGLAR 131
              K++DFGLAR
Sbjct: 139 GAIKLADFGLAR 150

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 71/132 (53%), Gaps = 14/132 (10%)
Query: 6   GQIIAVKKLS-KKSTQGFEEFK-NEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMP-- 60
           G+++A+KK+     T+G       E+ L  +L H N++++   I T+  + L++E++   
Sbjct: 28  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD 87
Query: 61  -KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
            K+ +D      I + ++        +  ++QGL +   +    ++HRDLK  N+L++ +
Sbjct: 88  LKKFMDASALTGIPLPLIKS-----YLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTE 139
Query: 120 LKPKISDFGLAR 131
              K++DFGLAR
Sbjct: 140 GAIKLADFGLAR 151

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 71/132 (53%), Gaps = 14/132 (10%)
Query: 6   GQIIAVKKLS-KKSTQGFEEFK-NEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMP-- 60
           G+++A+KK+     T+G       E+ L  +L H N++++   I T+  + L++E++   
Sbjct: 32  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD 91
Query: 61  -KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
            K+ +D      I + ++        +  ++QGL +   +    ++HRDLK  N+L++ +
Sbjct: 92  LKKFMDASALTGIPLPLIKS-----YLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTE 143
Query: 120 LKPKISDFGLAR 131
              K++DFGLAR
Sbjct: 144 GAIKLADFGLAR 155

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 71/132 (53%), Gaps = 14/132 (10%)
Query: 6   GQIIAVKKLS-KKSTQGFEEFK-NEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMP-- 60
           G+++A+KK+     T+G       E+ L  +L H N++++   I T+  + L++E++   
Sbjct: 27  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD 86
Query: 61  -KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
            K+ +D      I + ++        +  ++QGL +   +    ++HRDLK  N+L++ +
Sbjct: 87  LKKFMDASALTGIPLPLIKS-----YLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTE 138
Query: 120 LKPKISDFGLAR 131
              K++DFGLAR
Sbjct: 139 GAIKLADFGLAR 150

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 71/132 (53%), Gaps = 14/132 (10%)
Query: 6   GQIIAVKKLS-KKSTQGFEEFK-NEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMP-- 60
           G+++A+KK+     T+G       E+ L  +L H N++++   I T+  + L++E++   
Sbjct: 28  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD 87
Query: 61  -KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
            K+ +D      I + ++        +  ++QGL +   +    ++HRDLK  N+L++ +
Sbjct: 88  LKKFMDASALTGIPLPLIKS-----YLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTE 139
Query: 120 LKPKISDFGLAR 131
              K++DFGLAR
Sbjct: 140 GAIKLADFGLAR 151

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 71/132 (53%), Gaps = 14/132 (10%)
Query: 6   GQIIAVKKLS-KKSTQGFEEFK-NEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMP-- 60
           G+++A+KK+     T+G       E+ L  +L H N++++   I T+  + L++E++   
Sbjct: 27  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD 86
Query: 61  -KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
            K+ +D      I + ++        +  ++QGL +   +    ++HRDLK  N+L++ +
Sbjct: 87  LKKFMDASALTGIPLPLIKS-----YLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTE 138
Query: 120 LKPKISDFGLAR 131
              K++DFGLAR
Sbjct: 139 GAIKLADFGLAR 150

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/129 (27%), Positives = 70/129 (54%), Gaps = 8/129 (6%)
Query: 6   GQIIAVKKLS-KKSTQGFEEFK-NEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKR 62
           G+++A+KK+     T+G       E+ L  +L H N++++   I T+  + L++E++  +
Sbjct: 31  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL-HQ 89
Query: 63  SLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKP 122
            L  F+ D   +  +        +  ++QGL +   +    ++HRDLK  N+L++ +   
Sbjct: 90  DLKTFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAI 145
Query: 123 KISDFGLAR 131
           K++DFGLAR
Sbjct: 146 KLADFGLAR 154

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 71/132 (53%), Gaps = 14/132 (10%)
Query: 6   GQIIAVKKLS-KKSTQGFEEFK-NEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMP-- 60
           G+++A+KK+     T+G       E+ L  +L H N++++   I T+  + L++E++   
Sbjct: 31  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD 90
Query: 61  -KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
            K+ +D      I + ++        +  ++QGL +   +    ++HRDLK  N+L++ +
Sbjct: 91  LKKFMDASALTGIPLPLIKS-----YLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTE 142
Query: 120 LKPKISDFGLAR 131
              K++DFGLAR
Sbjct: 143 GAIKLADFGLAR 154

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 71/145 (48%), Gaps = 16/145 (11%)
Query: 5   DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRS 63
           D +  A+KK+ + + +      +EVML A L H  ++R     +E + ++     + K+S
Sbjct: 30  DSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKS 88
Query: 64  L---------DYFLFDPIRMLILDCKKRVH--IIKGIIQGLLYLQEYFRLTIIHRDLKVS 112
                     +  L+D I    L+ ++  +  + + I++ L Y+       IIHRDLK  
Sbjct: 89  TLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPM 145
Query: 113 NILLDEDLKPKISDFGLARILRKMI 137
           NI +DE    KI DFGLA+ + + +
Sbjct: 146 NIFIDESRNVKIGDFGLAKNVHRSL 170

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 71/132 (53%), Gaps = 14/132 (10%)
Query: 6   GQIIAVKKLS-KKSTQGFEEFK-NEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMP-- 60
           G+++A+KK+     T+G       E+ L  +L H N++++   I T+  + L++E++   
Sbjct: 27  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD 86
Query: 61  -KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
            K+ +D      I + ++        +  ++QGL +   +    ++HRDLK  N+L++ +
Sbjct: 87  LKKFMDASALTGIPLPLIKS-----YLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTE 138
Query: 120 LKPKISDFGLAR 131
              K++DFGLAR
Sbjct: 139 GAIKLADFGLAR 150

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 71/132 (53%), Gaps = 14/132 (10%)
Query: 6   GQIIAVKKLS-KKSTQGFEEFK-NEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMP-- 60
           G+++A+KK+     T+G       E+ L  +L H N++++   I T+  + L++E++   
Sbjct: 35  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD 94
Query: 61  -KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
            K+ +D      I + ++        +  ++QGL +   +    ++HRDLK  N+L++ +
Sbjct: 95  LKKFMDASALTGIPLPLIKS-----YLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTE 146
Query: 120 LKPKISDFGLAR 131
              K++DFGLAR
Sbjct: 147 GAIKLADFGLAR 158

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 77/162 (47%), Gaps = 10/162 (6%)
Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSL 64
           GQ +A+++++ +     E   NE+++  + ++ N++  +   +   E  ++ EY+   SL
Sbjct: 45  GQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104
Query: 65  DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKI 124
                D +    +D  +   + +  +Q L +L       +IHRD+K  NILL  D   K+
Sbjct: 105 ----TDVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKL 157
Query: 125 SDFGL-ARILRKMILKQIQIELGY-IPPEYVGRGVYYKKFSL 164
           +DFG  A+I  +   +   +   Y + PE V R  Y  K  +
Sbjct: 158 TDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 199

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 71/132 (53%), Gaps = 14/132 (10%)
Query: 6   GQIIAVKKLS-KKSTQGFEEFK-NEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMP-- 60
           G+++A+KK+     T+G       E+ L  +L H N++++   I T+  + L++E++   
Sbjct: 28  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD 87
Query: 61  -KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
            K+ +D      I + ++        +  ++QGL +   +    ++HRDLK  N+L++ +
Sbjct: 88  LKKFMDASALTGIPLPLIKS-----YLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTE 139
Query: 120 LKPKISDFGLAR 131
              K++DFGLAR
Sbjct: 140 GAIKLADFGLAR 151

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 71/132 (53%), Gaps = 14/132 (10%)
Query: 6   GQIIAVKKLS-KKSTQGFEEFK-NEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMP-- 60
           G+++A+KK+     T+G       E+ L  +L H N++++   I T+  + L++E++   
Sbjct: 28  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD 87
Query: 61  -KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
            K+ +D      I + ++        +  ++QGL +   +    ++HRDLK  N+L++ +
Sbjct: 88  LKKFMDASALTGIPLPLIKS-----YLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTE 139
Query: 120 LKPKISDFGLAR 131
              K++DFGLAR
Sbjct: 140 GAIKLADFGLAR 151

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 45.8 bits (107), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 71/132 (53%), Gaps = 14/132 (10%)
Query: 6   GQIIAVKKLS-KKSTQGFEEFK-NEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMP-- 60
           G+++A+KK+     T+G       E+ L  +L H N++++   I T+  + L++E++   
Sbjct: 29  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD 88
Query: 61  -KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
            K+ +D      I + ++        +  ++QGL +   +    ++HRDLK  N+L++ +
Sbjct: 89  LKKFMDASALTGIPLPLIKS-----YLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTE 140
Query: 120 LKPKISDFGLAR 131
              K++DFGLAR
Sbjct: 141 GAIKLADFGLAR 152

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 75/161 (46%), Gaps = 10/161 (6%)
Query: 8   IIAVKKLSKKSTQ--GFE-EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRS 63
           I+A+K L K   +  G E + + EV + + L+H N++R+ G+  +     LI EY P   
Sbjct: 38  ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP--- 94
Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           L     +  ++   D ++    I  +   L Y        +IHRD+K  N+LL    + K
Sbjct: 95  LGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELK 151
Query: 124 ISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKKFSL 164
           I+DFG +          +   L Y+PPE +   ++ +K  L
Sbjct: 152 IADFGWSVHAPSSRRDDLCGTLDYLPPEMIEGRMHDEKVDL 192

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 71/132 (53%), Gaps = 14/132 (10%)
Query: 6   GQIIAVKKLS-KKSTQGFEEFK-NEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMP-- 60
           G+++A+KK+     T+G       E+ L  +L H N++++   I T+  + L++E++   
Sbjct: 28  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD 87
Query: 61  -KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
            K+ +D      I + ++        +  ++QGL +   +    ++HRDLK  N+L++ +
Sbjct: 88  LKKFMDASALTGIPLPLIKS-----YLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTE 139
Query: 120 LKPKISDFGLAR 131
              K++DFGLAR
Sbjct: 140 GAIKLADFGLAR 151

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/129 (27%), Positives = 75/129 (58%), Gaps = 9/129 (6%)
Query: 6   GQIIAVKKLS-KKSTQGFEEFK-NEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKR 62
           G+I+A+K++      +G       E+ L  +L H N++ +   I ++  + L++E+M ++
Sbjct: 45  GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFM-EK 103
Query: 63  SLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKP 122
            L   L D  +  + D + ++++ + +++G+ +  ++    I+HRDLK  N+L++ D   
Sbjct: 104 DLKKVL-DENKTGLQDSQIKIYLYQ-LLRGVAHCHQH---RILHRDLKPQNLLINSDGAL 158
Query: 123 KISDFGLAR 131
           K++DFGLAR
Sbjct: 159 KLADFGLAR 167

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 73/167 (43%), Gaps = 23/167 (13%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKL-----QHLNLIRV-GFCIETQEYMLIYEYMPKR 62
           +AVK L  KST   +E K  +M   K+     QH N++ + G C      ++I EY    
Sbjct: 71  VAVKML--KSTAHADE-KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYG 127
Query: 63  SLDYFL-------FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNIL 115
            L  FL        D      L+ +  +H    + QG+ +L        IHRD+   N+L
Sbjct: 128 DLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVL 184
Query: 116 LDEDLKPKISDFGLARILRK----MILKQIQIELGYIPPEYVGRGVY 158
           L      KI DFGLAR +      ++    ++ + ++ PE +   VY
Sbjct: 185 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVY 231

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/129 (30%), Positives = 63/129 (48%), Gaps = 13/129 (10%)
Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCI-ETQEYMLIYEYMPKRSL 64
            +II  KKLS +  Q  E    E  +   L+H N++R+   I E   + LI++ +    L
Sbjct: 52  AKIINTKKLSARDHQKLE---REARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL 108
Query: 65  DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKP-- 122
                D +           H I+ I++ +L+  +   + ++HRDLK  N+LL   LK   
Sbjct: 109 ---FEDIVAREYYSEADASHCIQQILEAVLHCHQ---MGVVHRDLKPENLLLASKLKGAA 162
Query: 123 -KISDFGLA 130
            K++DFGLA
Sbjct: 163 VKLADFGLA 171

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 70/150 (46%), Gaps = 10/150 (6%)
Query: 8   IIAVKKLSKKSTQ--GFE-EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRS 63
           I+A+K L K   +  G E + + EV + + L+H N++R+ G+  +     LI EY P   
Sbjct: 39  ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP--- 95
Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           L     +  ++   D ++    I  +   L Y        +IHRD+K  N+LL    + K
Sbjct: 96  LGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELK 152
Query: 124 ISDFGLARILRKMILKQIQIELGYIPPEYV 153
           I+DFG +          +   L Y+PPE +
Sbjct: 153 IADFGWSVHAPSSRRTTLCGTLDYLPPEMI 182

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 70/150 (46%), Gaps = 10/150 (6%)
Query: 8   IIAVKKLSKKSTQ--GFE-EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRS 63
           I+A+K L K   +  G E + + EV + + L+H N++R+ G+  +     LI EY P   
Sbjct: 40  ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP--- 96
Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           L     +  ++   D ++    I  +   L Y        +IHRD+K  N+LL    + K
Sbjct: 97  LGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELK 153
Query: 124 ISDFGLARILRKMILKQIQIELGYIPPEYV 153
           I+DFG +          +   L Y+PPE +
Sbjct: 154 IADFGWSVHAPSSRRTTLCGTLDYLPPEXI 183

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 27/77 (35%), Positives = 43/77 (55%), Gaps = 4/77 (5%)
Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILR-KMILKQIQIELGY 147
           +++GL +L  +    ++HRDLK  NIL+    + K++DFGLARI   +M L  + + L Y
Sbjct: 129 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWY 185
Query: 148 IPPEYVGRGVYYKKFSL 164
             PE + +  Y     L
Sbjct: 186 RAPEVLLQSSYATPVDL 202

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 70/150 (46%), Gaps = 10/150 (6%)
Query: 8   IIAVKKLSKKSTQ--GFE-EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRS 63
           I+A+K L K   +  G E + + EV + + L+H N++R+ G+  +     LI EY P   
Sbjct: 38  ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP--- 94
Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           L     +  ++   D ++    I  +   L Y        +IHRD+K  N+LL    + K
Sbjct: 95  LGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELK 151
Query: 124 ISDFGLARILRKMILKQIQIELGYIPPEYV 153
           I+DFG +          +   L Y+PPE +
Sbjct: 152 IADFGWSVHAPSSRRAALCGTLDYLPPEMI 181

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 76/161 (47%), Gaps = 10/161 (6%)
Query: 8   IIAVKKLSKKSTQ--GFE-EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRS 63
           I+A+K L K   +  G E + + EV + + L+H N++R+ G+  +     LI EY P+  
Sbjct: 40  ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPRGE 99
Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           +   L    ++   D ++    I  +   L Y        +IHRD+K  N+LL    + K
Sbjct: 100 VYKEL---QKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELK 153
Query: 124 ISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKKFSL 164
           I+DFG +          +   L Y+PPE +   ++ +K  L
Sbjct: 154 IADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDL 194

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 74/132 (56%), Gaps = 14/132 (10%)
Query: 6   GQIIAVKKLS-KKSTQGFEEFK-NEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMP-- 60
           G+++A+KK+     T+G       E+ L  +L H N++++   I T+  + L++E++   
Sbjct: 28  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD 87
Query: 61  -KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
            K+ +D      I + ++    + ++ + ++QGL +   +    ++HRDLK  N+L++ +
Sbjct: 88  LKKFMDASALTGIPLPLI----KSYLFQ-LLQGLAFCHSH---RVLHRDLKPQNLLINTE 139
Query: 120 LKPKISDFGLAR 131
              K++DFGLAR
Sbjct: 140 GAIKLADFGLAR 151

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 27/77 (35%), Positives = 43/77 (55%), Gaps = 4/77 (5%)
Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILR-KMILKQIQIELGY 147
           +++GL +L  +    ++HRDLK  NIL+    + K++DFGLARI   +M L  + + L Y
Sbjct: 129 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWY 185
Query: 148 IPPEYVGRGVYYKKFSL 164
             PE + +  Y     L
Sbjct: 186 RAPEVLLQSSYATPVDL 202

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 27/77 (35%), Positives = 43/77 (55%), Gaps = 4/77 (5%)
Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILR-KMILKQIQIELGY 147
           +++GL +L  +    ++HRDLK  NIL+    + K++DFGLARI   +M L  + + L Y
Sbjct: 129 LLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWY 185
Query: 148 IPPEYVGRGVYYKKFSL 164
             PE + +  Y     L
Sbjct: 186 RAPEVLLQSSYATPVDL 202

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 75/161 (46%), Gaps = 10/161 (6%)
Query: 8   IIAVKKLSKKSTQ--GFE-EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRS 63
           I+A+K L K   +  G E + + EV + + L+H N++R+ G+  +     LI EY P   
Sbjct: 35  ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP--- 91
Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           L     +  ++   D ++    I  +   L Y        +IHRD+K  N+LL    + K
Sbjct: 92  LGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELK 148
Query: 124 ISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKKFSL 164
           I+DFG +          +   L Y+PPE +   ++ +K  L
Sbjct: 149 IADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDL 189

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/129 (27%), Positives = 75/129 (58%), Gaps = 9/129 (6%)
Query: 6   GQIIAVKKLS-KKSTQGFEEFK-NEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKR 62
           G+I+A+K++      +G       E+ L  +L H N++ +   I ++  + L++E+M ++
Sbjct: 45  GRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFM-EK 103
Query: 63  SLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKP 122
            L   L D  +  + D + ++++ + +++G+ +  ++    I+HRDLK  N+L++ D   
Sbjct: 104 DLKKVL-DENKTGLQDSQIKIYLYQ-LLRGVAHCHQH---RILHRDLKPQNLLINSDGAL 158
Query: 123 KISDFGLAR 131
           K++DFGLAR
Sbjct: 159 KLADFGLAR 167

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 70/150 (46%), Gaps = 10/150 (6%)
Query: 8   IIAVKKLSKKSTQ--GFE-EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRS 63
           I+A+K L K   +  G E + + EV + + L+H N++R+ G+  +     LI EY P   
Sbjct: 35  ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP--- 91
Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           L     +  ++   D ++    I  +   L Y        +IHRD+K  N+LL    + K
Sbjct: 92  LGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELK 148
Query: 124 ISDFGLARILRKMILKQIQIELGYIPPEYV 153
           I+DFG +          +   L Y+PPE +
Sbjct: 149 IADFGWSVHAPSSRRAALCGTLDYLPPEMI 178

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 75/161 (46%), Gaps = 10/161 (6%)
Query: 8   IIAVKKLSKKSTQ--GFE-EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRS 63
           I+A+K L K   +  G E + + EV + + L+H N++R+ G+  +     LI EY P   
Sbjct: 40  ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP--- 96
Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           L     +  ++   D ++    I  +   L Y        +IHRD+K  N+LL    + K
Sbjct: 97  LGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELK 153
Query: 124 ISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKKFSL 164
           I+DFG +          +   L Y+PPE +   ++ +K  L
Sbjct: 154 IADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDL 194

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 75/161 (46%), Gaps = 10/161 (6%)
Query: 8   IIAVKKLSKKSTQ--GFE-EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRS 63
           I+A+K L K   +  G E + + EV + + L+H N++R+ G+  +     LI EY P   
Sbjct: 35  ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP--- 91
Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           L     +  ++   D ++    I  +   L Y        +IHRD+K  N+LL    + K
Sbjct: 92  LGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELK 148
Query: 124 ISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKKFSL 164
           I+DFG +          +   L Y+PPE +   ++ +K  L
Sbjct: 149 IADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDL 189

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/145 (28%), Positives = 73/145 (50%), Gaps = 16/145 (11%)
Query: 5   DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRS 63
           D +  A+KK+ + + +      +EVML A L H  ++R     +E + ++     + K+S
Sbjct: 30  DSRYYAIKKI-RHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKS 88
Query: 64  -----LDY----FLFDPIRMLILDCKKRVH--IIKGIIQGLLYLQEYFRLTIIHRDLKVS 112
                ++Y     L+D I    L+ ++  +  + + I++ L Y+       IIHRDLK  
Sbjct: 89  TLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPM 145
Query: 113 NILLDEDLKPKISDFGLARILRKMI 137
           NI +DE    KI DFGLA+ + + +
Sbjct: 146 NIFIDESRNVKIGDFGLAKNVHRSL 170

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 75/161 (46%), Gaps = 10/161 (6%)
Query: 8   IIAVKKLSKKSTQ--GFE-EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRS 63
           I+A+K L K   +  G E + + EV + + L+H N++R+ G+  +     LI EY P   
Sbjct: 32  ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP--- 88
Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           L     +  ++   D ++    I  +   L Y        +IHRD+K  N+LL    + K
Sbjct: 89  LGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELK 145
Query: 124 ISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKKFSL 164
           I+DFG +          +   L Y+PPE +   ++ +K  L
Sbjct: 146 IADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDL 186

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 73/167 (43%), Gaps = 23/167 (13%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKL-----QHLNLIRV-GFCIETQEYMLIYEYMPKR 62
           +AVK L  KST   +E K  +M   K+     QH N++ + G C      ++I EY    
Sbjct: 79  VAVKML--KSTAHADE-KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYG 135
Query: 63  SLDYFL-------FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNIL 115
            L  FL        D      L+ +  +H    + QG+ +L        IHRD+   N+L
Sbjct: 136 DLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVL 192
Query: 116 LDEDLKPKISDFGLARILRK----MILKQIQIELGYIPPEYVGRGVY 158
           L      KI DFGLAR +      ++    ++ + ++ PE +   VY
Sbjct: 193 LTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVY 239

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 75/161 (46%), Gaps = 10/161 (6%)
Query: 8   IIAVKKLSKKSTQ--GFE-EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRS 63
           I+A+K L K   +  G E + + EV + + L+H N++R+ G+  +     LI EY P   
Sbjct: 35  ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP--- 91
Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           L     +  ++   D ++    I  +   L Y        +IHRD+K  N+LL    + K
Sbjct: 92  LGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELK 148
Query: 124 ISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKKFSL 164
           I+DFG +          +   L Y+PPE +   ++ +K  L
Sbjct: 149 IADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDL 189

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 78/157 (49%), Gaps = 12/157 (7%)
Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSL 64
           G+++AVKK+  +  Q  E   NEV++    QH N++ +    +   E  ++ E++   +L
Sbjct: 176 GKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGAL 235
Query: 65  DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKI 124
                D +    ++ ++   +   ++Q L  L       +IHRD+K  +ILL  D + K+
Sbjct: 236 ----TDIVTHTRMNEEQIAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKL 288
Query: 125 SDFGLARILRKMILKQIQIELG---YIPPEYVGRGVY 158
           SDFG    + K + ++  + +G   ++ PE + R  Y
Sbjct: 289 SDFGFCAQVSKEVPRRKXL-VGTPYWMAPELISRLPY 324

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 75/161 (46%), Gaps = 10/161 (6%)
Query: 8   IIAVKKLSKKSTQ--GFE-EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRS 63
           I+A+K L K   +  G E + + EV + + L+H N++R+ G+  +     LI EY P   
Sbjct: 36  ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP--- 92
Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           L     +  ++   D ++    I  +   L Y        +IHRD+K  N+LL    + K
Sbjct: 93  LGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELK 149
Query: 124 ISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKKFSL 164
           I+DFG +          +   L Y+PPE +   ++ +K  L
Sbjct: 150 IADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHDEKVDL 190

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 40/128 (31%), Positives = 68/128 (53%), Gaps = 10/128 (7%)
Query: 9   IAVKKLSK---KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYE--YMPKRS 63
           +A+KKLS+     T     ++ E++L   + H N+I +      Q+ +  ++  Y+    
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           +D  L   I+M  LD ++  +++  ++ G+ +L       IIHRDLK SNI++  D   K
Sbjct: 111 MDANLXQVIQME-LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDXTLK 166
Query: 124 ISDFGLAR 131
           I DFGLAR
Sbjct: 167 ILDFGLAR 174

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 74/132 (56%), Gaps = 14/132 (10%)
Query: 6   GQIIAVKKLS-KKSTQGFEEFK-NEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMP-- 60
           G+++A+KK+     T+G       E+ L  +L H N++++   I T+  + L++E++   
Sbjct: 31  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEHVDQD 90
Query: 61  -KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
            K+ +D      I + ++    + ++ + ++QGL +   +    ++HRDLK  N+L++ +
Sbjct: 91  LKKFMDASALTGIPLPLI----KSYLFQ-LLQGLAFCHSH---RVLHRDLKPQNLLINTE 142
Query: 120 LKPKISDFGLAR 131
              K++DFGLAR
Sbjct: 143 GAIKLADFGLAR 154

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 70/150 (46%), Gaps = 10/150 (6%)
Query: 8   IIAVKKLSKKSTQ--GFE-EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRS 63
           I+A+K L K   +  G E + + EV + + L+H N++R+ G+  +     LI EY P   
Sbjct: 35  ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP--- 91
Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           L     +  ++   D ++    I  +   L Y        +IHRD+K  N+LL    + K
Sbjct: 92  LGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELK 148
Query: 124 ISDFGLARILRKMILKQIQIELGYIPPEYV 153
           I+DFG +          +   L Y+PPE +
Sbjct: 149 IADFGWSVHAPSSRRTXLCGTLDYLPPEMI 178

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/133 (27%), Positives = 67/133 (50%), Gaps = 13/133 (9%)
Query: 6   GQIIAVKKLSKKSTQGFEE--FKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKR 62
           G+I+A+KK  +       +     E+ L  +L+H NL+ +   C + + + L++E+    
Sbjct: 50  GRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEF---- 105
Query: 63  SLDYFLFDPIRMLI--LDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL 120
            +D+ + D + +    LD +     +  II G+ +   +    IIHRD+K  NIL+ +  
Sbjct: 106 -VDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSG 161
Query: 121 KPKISDFGLARIL 133
             K+ DFG AR L
Sbjct: 162 VVKLCDFGFARTL 174

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 70/150 (46%), Gaps = 10/150 (6%)
Query: 8   IIAVKKLSKKSTQ--GFE-EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRS 63
           I+A+K L K   +  G E + + EV + + L+H N++R+ G+  +     LI EY P   
Sbjct: 34  ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP--- 90
Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           L     +  ++   D ++    I  +   L Y        +IHRD+K  N+LL    + K
Sbjct: 91  LGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELK 147
Query: 124 ISDFGLARILRKMILKQIQIELGYIPPEYV 153
           I+DFG +          +   L Y+PPE +
Sbjct: 148 IADFGWSVHAPSSRRTTLCGTLDYLPPEMI 177

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 75/161 (46%), Gaps = 10/161 (6%)
Query: 8   IIAVKKLSKKSTQ--GFE-EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRS 63
           I+A+K L K   +  G E + + EV + + L+H N++R+ G+  +     LI EY P   
Sbjct: 38  ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP--- 94
Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           L     +  ++   D ++    I  +   L Y        +IHRD+K  N+LL    + K
Sbjct: 95  LGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELK 151
Query: 124 ISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKKFSL 164
           I+DFG +          +   L Y+PPE +   ++ +K  L
Sbjct: 152 IADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDL 192

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 75/161 (46%), Gaps = 10/161 (6%)
Query: 8   IIAVKKLSKKSTQ--GFE-EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRS 63
           I+A+K L K   +  G E + + EV + + L+H N++R+ G+  +     LI EY P   
Sbjct: 40  ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP--- 96
Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           L     +  ++   D ++    I  +   L Y        +IHRD+K  N+LL    + K
Sbjct: 97  LGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELK 153
Query: 124 ISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKKFSL 164
           I+DFG +          +   L Y+PPE +   ++ +K  L
Sbjct: 154 IADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDL 194

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 45.4 bits (106), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/128 (31%), Positives = 68/128 (53%), Gaps = 10/128 (7%)
Query: 9   IAVKKLSK---KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYE--YMPKRS 63
           +A+KKLS+     T     ++ E++L   + H N+I +      Q+ +  ++  Y+    
Sbjct: 45  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 103
Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           +D  L   I+M  LD ++  +++  ++ G+ +L       IIHRDLK SNI++  D   K
Sbjct: 104 MDANLXQVIQME-LDHERMSYLLYQMLXGIKHLHS---AGIIHRDLKPSNIVVKSDXTLK 159
Query: 124 ISDFGLAR 131
           I DFGLAR
Sbjct: 160 ILDFGLAR 167

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/128 (31%), Positives = 68/128 (53%), Gaps = 10/128 (7%)
Query: 9   IAVKKLSK---KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYE--YMPKRS 63
           +A+KKLS+     T     ++ E++L   + H N+I +      Q+ +  ++  Y+    
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           +D  L   I+M  LD ++  +++  ++ G+ +L       IIHRDLK SNI++  D   K
Sbjct: 111 MDANLXQVIQME-LDHERMSYLLYQMLXGIKHLHS---AGIIHRDLKPSNIVVKSDXTLK 166
Query: 124 ISDFGLAR 131
           I DFGLAR
Sbjct: 167 ILDFGLAR 174

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 33/113 (29%), Positives = 56/113 (49%), Gaps = 8/113 (7%)
Query: 23  EEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK 81
           +E   E  +  +L +  ++R +G C E + +ML+ E      L+ +L        +  K 
Sbjct: 415 DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKN 470
Query: 82  RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILR 134
            + ++  +  G+ YL+E      +HRDL   N+LL      KISDFGL++ LR
Sbjct: 471 IIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALR 520

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 75/161 (46%), Gaps = 10/161 (6%)
Query: 8   IIAVKKLSKKSTQ--GFE-EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRS 63
           I+A+K L K   +  G E + + EV + + L+H N++R+ G+  +     LI EY P   
Sbjct: 36  ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP--- 92
Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           L     +  ++   D ++    I  +   L Y        +IHRD+K  N+LL    + K
Sbjct: 93  LGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELK 149
Query: 124 ISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKKFSL 164
           I+DFG +          +   L Y+PPE +   ++ +K  L
Sbjct: 150 IADFGWSVHAPSSRRDTLCGTLDYLPPEMIEGRMHDEKVDL 190

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 75/161 (46%), Gaps = 10/161 (6%)
Query: 8   IIAVKKLSKKSTQ--GFE-EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRS 63
           I+A+K L K   +  G E + + EV + + L+H N++R+ G+  +     LI EY P   
Sbjct: 38  ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP--- 94
Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           L     +  ++   D ++    I  +   L Y        +IHRD+K  N+LL    + K
Sbjct: 95  LGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELK 151
Query: 124 ISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKKFSL 164
           I+DFG +          +   L Y+PPE +   ++ +K  L
Sbjct: 152 IADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDL 192

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/128 (31%), Positives = 68/128 (53%), Gaps = 10/128 (7%)
Query: 9   IAVKKLSK---KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYE--YMPKRS 63
           +A+KKLS+     T     ++ E++L   + H N+I +      Q+ +  ++  Y+    
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           +D  L   I+M  LD ++  +++  ++ G+ +L       IIHRDLK SNI++  D   K
Sbjct: 111 MDANLCQVIQME-LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDXTLK 166
Query: 124 ISDFGLAR 131
           I DFGLAR
Sbjct: 167 ILDFGLAR 174

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/132 (26%), Positives = 71/132 (53%), Gaps = 14/132 (10%)
Query: 6   GQIIAVKKLS-KKSTQGFEEFK-NEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMP-- 60
           G+++A+KK+     T+G       E+ L  +L H N++++   I T+  + L++E++   
Sbjct: 28  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD 87
Query: 61  -KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
            K+ +D      I + ++        +  ++QGL +   +    ++HRDLK  N+L++ +
Sbjct: 88  LKKFMDASALTGIPLPLIKS-----YLFQLLQGLSFCHSH---RVLHRDLKPQNLLINTE 139
Query: 120 LKPKISDFGLAR 131
              K++DFGLAR
Sbjct: 140 GAIKLADFGLAR 151

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/140 (29%), Positives = 70/140 (50%), Gaps = 28/140 (20%)
Query: 6   GQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
           G+ +A+KKLS+  +S    +    E++L   +QH N+I            L+  + P  S
Sbjct: 67  GEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIG-----------LLDVFTPASS 115
Query: 64  L----DYFLFDP--------IRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKV 111
           L    D++L  P        I  +    +K  +++  +++GL Y+       ++HRDLK 
Sbjct: 116 LRNFYDFYLVMPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKP 172
Query: 112 SNILLDEDLKPKISDFGLAR 131
            N+ ++ED + KI DFGLAR
Sbjct: 173 GNLAVNEDCELKILDFGLAR 192

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/150 (28%), Positives = 70/150 (46%), Gaps = 10/150 (6%)
Query: 8   IIAVKKLSKKSTQ--GFE-EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRS 63
           I+A+K L K   +  G E + + EV + + L+H N++R+ G+  +     LI EY P   
Sbjct: 35  ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP--- 91
Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           L     +  ++   D ++    I  +   L Y        +IHRD+K  N+LL    + K
Sbjct: 92  LGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELK 148
Query: 124 ISDFGLARILRKMILKQIQIELGYIPPEYV 153
           I+DFG +          +   L Y+PPE +
Sbjct: 149 IADFGWSVHAPSSRRXXLCGTLDYLPPEMI 178

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Composition-based stats.
 Identities = 33/113 (29%), Positives = 56/113 (49%), Gaps = 8/113 (7%)
Query: 23  EEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK 81
           +E   E  +  +L +  ++R +G C E + +ML+ E      L+ +L        +  K 
Sbjct: 416 DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKN 471
Query: 82  RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILR 134
            + ++  +  G+ YL+E      +HRDL   N+LL      KISDFGL++ LR
Sbjct: 472 IIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALR 521

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 77/162 (47%), Gaps = 10/162 (6%)
Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSL 64
           GQ +A+++++ +     E   NE+++  + ++ N++  +   +   E  ++ EY+   SL
Sbjct: 46  GQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 105
Query: 65  DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKI 124
                D +    +D  +   + +  +Q L +L       +IHRD+K  NILL  D   K+
Sbjct: 106 ----TDVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKL 158
Query: 125 SDFGL-ARILRKMILKQIQIELGY-IPPEYVGRGVYYKKFSL 164
           +DFG  A+I  +   +   +   Y + PE V R  Y  K  +
Sbjct: 159 TDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDI 200

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/75 (40%), Positives = 42/75 (56%), Gaps = 11/75 (14%)
Query: 86  IKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARIL-----RKMILKQ 140
           ++ I+ G  YL    R  +IHRDLK+ N+ L+EDL+ KI DFGLA  +     RK +L  
Sbjct: 121 LRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCG 177
Query: 141 IQIELGYIPPEYVGR 155
                 YI PE + +
Sbjct: 178 TP---NYIAPEVLSK 189

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/157 (25%), Positives = 77/157 (49%), Gaps = 12/157 (7%)
Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSL 64
           G+ +AVKK+  +  Q  E   NEV++     H N++ +    +   E  ++ E++   +L
Sbjct: 70  GKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGAL 129
Query: 65  DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKI 124
                D +    ++ ++   +   +++ L YL       +IHRD+K  +ILL  D + K+
Sbjct: 130 T----DIVTHTRMNEEQIATVCLSVLRALSYLHNQ---GVIHRDIKSDSILLTSDGRIKL 182
Query: 125 SDFGLARILRKMILKQIQIELG---YIPPEYVGRGVY 158
           SDFG    + K + K+  + +G   ++ PE + R  Y
Sbjct: 183 SDFGFCAQVSKEVPKRKXL-VGTPYWMAPEVISRLPY 218

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 77/162 (47%), Gaps = 10/162 (6%)
Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSL 64
           GQ +A+++++ +     E   NE+++  + ++ N++  +   +   E  ++ EY+   SL
Sbjct: 45  GQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104
Query: 65  DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKI 124
                D +    +D  +   + +  +Q L +L       +IHRD+K  NILL  D   K+
Sbjct: 105 ----TDVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKL 157
Query: 125 SDFGL-ARILRKMILKQIQIELGY-IPPEYVGRGVYYKKFSL 164
           +DFG  A+I  +   +   +   Y + PE V R  Y  K  +
Sbjct: 158 TDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDI 199

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 75/161 (46%), Gaps = 10/161 (6%)
Query: 8   IIAVKKLSKKSTQ--GFE-EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRS 63
           I+A+K L K   +  G E + + EV + + L+H N++R+ G+  +     LI EY P   
Sbjct: 38  ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP--- 94
Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           L     +  ++   D ++    I  +   L Y        +IHRD+K  N+LL    + K
Sbjct: 95  LGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELK 151
Query: 124 ISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKKFSL 164
           I+DFG +          +   L Y+PPE +   ++ +K  L
Sbjct: 152 IADFGWSVHAPSSRRXXLCGTLDYLPPEMIEGRMHDEKVDL 192

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 70/141 (49%), Gaps = 15/141 (10%)
Query: 28  EVMLTAKLQ---HLNLIR-VGFCIETQ-----EYMLIYEYMPKRSLDYFLFDPIRMLILD 78
           EV L  +L+   H N++R +  C  ++     +  L++E++ +    Y    P   L  +
Sbjct: 53  EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAE 112
Query: 79  CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILR-KMI 137
             K   +++  ++GL +L       I+HRDLK  NIL+      K++DFGLARI   +M 
Sbjct: 113 TIK--DLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA 167
Query: 138 LKQIQIELGYIPPEYVGRGVY 158
           L  + + L Y  PE + +  Y
Sbjct: 168 LAPVVVTLWYRAPEVLLQSTY 188

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 47/141 (33%), Positives = 67/141 (47%), Gaps = 29/141 (20%)
Query: 6   GQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
           G  IAVKKLS+  +S    +    E+ L   ++H N+I            L+  + P  S
Sbjct: 76  GLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG-----------LLDVFTPATS 124
Query: 64  LDYF--------LFDPIRMLILDCKKRVH-----IIKGIIQGLLYLQEYFRLTIIHRDLK 110
           L+ F        L       I+ C+K        +I  I++GL Y+       IIHRDLK
Sbjct: 125 LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLK 181
Query: 111 VSNILLDEDLKPKISDFGLAR 131
            SN+ ++ED + KI DFGLAR
Sbjct: 182 PSNLAVNEDCELKILDFGLAR 202

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 70/141 (49%), Gaps = 15/141 (10%)
Query: 28  EVMLTAKLQ---HLNLIR-VGFCIETQ-----EYMLIYEYMPKRSLDYFLFDPIRMLILD 78
           EV L  +L+   H N++R +  C  ++     +  L++E++ +    Y    P   L  +
Sbjct: 61  EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAE 120
Query: 79  CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILR-KMI 137
             K   +++  ++GL +L       I+HRDLK  NIL+      K++DFGLARI   +M 
Sbjct: 121 TIK--DLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA 175
Query: 138 LKQIQIELGYIPPEYVGRGVY 158
           L  + + L Y  PE + +  Y
Sbjct: 176 LTPVVVTLWYRAPEVLLQSTY 196

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 75/161 (46%), Gaps = 10/161 (6%)
Query: 8   IIAVKKLSKKSTQ--GFE-EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRS 63
           I+A+K L K   +  G E + + EV + + L+H N++R+ G+  +     LI EY P   
Sbjct: 37  ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP--- 93
Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           L     +  ++   D ++    I  +   L Y        +IHRD+K  N+LL    + K
Sbjct: 94  LGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELK 150
Query: 124 ISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKKFSL 164
           I+DFG +          +   L Y+PPE +   ++ +K  L
Sbjct: 151 IADFGWSVHAPSSRRXXLCGTLDYLPPEMIEGRMHDEKVDL 191

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/109 (32%), Positives = 55/109 (50%), Gaps = 6/109 (5%)
Query: 28  EVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIK 87
           E+ + ++++H N+I+V    E Q +  +        LD F F   R   LD     +I +
Sbjct: 79  EIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFID-RHPRLDEPLASYIFR 137
Query: 88  GIIQGLLYLQEYFRL-TIIHRDLKVSNILLDEDLKPKISDFGLARILRK 135
            ++  + YL    RL  IIHRD+K  NI++ ED   K+ DFG A  L +
Sbjct: 138 QLVSAVGYL----RLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER 182

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/139 (30%), Positives = 64/139 (46%), Gaps = 19/139 (13%)
Query: 9   IAVKKLSKKSTQ-GFEEFKNEV-MLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLD 65
           +AVK L   +T+    +  +E+ M+    +H N+I + G C +     +I EY  K +L 
Sbjct: 63  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 122
Query: 66  YFL-----------FDPIRML--ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVS 112
            +L           F+P       L  K  V     + +G+ YL        IHRDL   
Sbjct: 123 EYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAAR 179
Query: 113 NILLDEDLKPKISDFGLAR 131
           N+L+ ED   KI+DFGLAR
Sbjct: 180 NVLVTEDNVMKIADFGLAR 198

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/142 (26%), Positives = 65/142 (45%), Gaps = 7/142 (4%)
Query: 24  EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR 82
           + + EV + + L+H N++R+ G+  +     LI EY P   L     +  ++   D ++ 
Sbjct: 80  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRT 136
Query: 83  VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQ 142
              I  +   L Y        +IHRD+K  N+LL    + KI+DFG +          + 
Sbjct: 137 ATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRDDLC 193
Query: 143 IELGYIPPEYVGRGVYYKKFSL 164
             L Y+PPE +   ++ +K  L
Sbjct: 194 GTLDYLPPEMIEGRMHDEKVDL 215

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 29/84 (34%), Positives = 42/84 (50%), Gaps = 11/84 (13%)
Query: 54  LIYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQE-------YFRLTIIH 106
           LI  +  K SL  FL    +  ++   +  HI + + +GL YL E         +  I H
Sbjct: 99  LITAFHEKGSLSDFL----KANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISH 154
Query: 107 RDLKVSNILLDEDLKPKISDFGLA 130
           RD+K  N+LL  +L   I+DFGLA
Sbjct: 155 RDIKSKNVLLKNNLTACIADFGLA 178

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/75 (40%), Positives = 42/75 (56%), Gaps = 11/75 (14%)
Query: 86  IKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARIL-----RKMILKQ 140
           ++ I+ G  YL    R  +IHRDLK+ N+ L+EDL+ KI DFGLA  +     RK +L  
Sbjct: 145 LRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCG 201
Query: 141 IQIELGYIPPEYVGR 155
                 YI PE + +
Sbjct: 202 TP---NYIAPEVLSK 213

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 70/141 (49%), Gaps = 15/141 (10%)
Query: 28  EVMLTAKLQ---HLNLIR-VGFCIETQ-----EYMLIYEYMPKRSLDYFLFDPIRMLILD 78
           EV L  +L+   H N++R +  C  ++     +  L++E++ +    Y    P   L  +
Sbjct: 53  EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAE 112
Query: 79  CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILR-KMI 137
             K   +++  ++GL +L       I+HRDLK  NIL+      K++DFGLARI   +M 
Sbjct: 113 TIK--DLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA 167
Query: 138 LKQIQIELGYIPPEYVGRGVY 158
           L  + + L Y  PE + +  Y
Sbjct: 168 LDPVVVTLWYRAPEVLLQSTY 188

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 38/141 (26%), Positives = 67/141 (47%), Gaps = 24/141 (17%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV---------------GFCIETQEYM 53
           +A+KK+     Q  +    E+ +  +L H N+++V               G   E     
Sbjct: 39  VAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVY 98
Query: 54  LIYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSN 113
           ++ EYM     +     P+    L+   R+ + + +++GL Y+       ++HRDLK +N
Sbjct: 99  IVQEYMETDLANVLEQGPL----LEEHARLFMYQ-LLRGLKYIHS---ANVLHRDLKPAN 150
Query: 114 ILLD-EDLKPKISDFGLARIL 133
           + ++ EDL  KI DFGLARI+
Sbjct: 151 LFINTEDLVLKIGDFGLARIM 171

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 75/161 (46%), Gaps = 10/161 (6%)
Query: 8   IIAVKKLSKKSTQ--GFE-EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRS 63
           I+A+K L K   +  G E + + EV + + L+H N++R+ G+  +     LI EY P   
Sbjct: 52  ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP--- 108
Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           L     +  ++   D ++    I  +   L Y        +IHRD+K  N+LL    + K
Sbjct: 109 LGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELK 165
Query: 124 ISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKKFSL 164
           I+DFG +          +   L Y+PPE +   ++ +K  L
Sbjct: 166 IADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDL 206

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 45.1 bits (105), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 23/45 (51%), Positives = 31/45 (68%), Gaps = 3/45 (6%)
Query: 86  IKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLA 130
           ++ I+ G  YL    R  +IHRDLK+ N+ L+EDL+ KI DFGLA
Sbjct: 123 LRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 164

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 23/45 (51%), Positives = 31/45 (68%), Gaps = 3/45 (6%)
Query: 86  IKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLA 130
           ++ I+ G  YL    R  +IHRDLK+ N+ L+EDL+ KI DFGLA
Sbjct: 123 LRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 164

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 64/132 (48%), Gaps = 10/132 (7%)
Query: 5   DGQII--AVKKLSKKSTQG-FEEFKNEVMLTAKLQHLNLIRV-GFCIETQ-EYMLIYEYM 59
           DG+ I  AVK L++ +  G   +F  E ++     H N++ + G C+ ++   +++  YM
Sbjct: 47  DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 106
Query: 60  PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
               L  F+ +      +  K  +     + +G+ YL        +HRDL   N +LDE 
Sbjct: 107 KHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEK 161
Query: 120 LKPKISDFGLAR 131
              K++DFGLAR
Sbjct: 162 FTVKVADFGLAR 173

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 23/45 (51%), Positives = 31/45 (68%), Gaps = 3/45 (6%)
Query: 86  IKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLA 130
           ++ I+ G  YL    R  +IHRDLK+ N+ L+EDL+ KI DFGLA
Sbjct: 127 LRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLA 168

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 35/129 (27%), Positives = 70/129 (54%), Gaps = 8/129 (6%)
Query: 6   GQIIAVKKLS-KKSTQGFEEFK-NEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKR 62
           G+++A+KK+     T+G       E+ L  +L H N++++   I T+  + L++E++  +
Sbjct: 27  GEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEHV-HQ 85
Query: 63  SLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKP 122
            L  F+ D   +  +        +  ++QGL +   +    ++HRDLK  N+L++ +   
Sbjct: 86  DLKTFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAI 141
Query: 123 KISDFGLAR 131
           K++DFGLAR
Sbjct: 142 KLADFGLAR 150

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 30/75 (40%), Positives = 42/75 (56%), Gaps = 11/75 (14%)
Query: 86  IKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARIL-----RKMILKQ 140
           ++ I+ G  YL    R  +IHRDLK+ N+ L+EDL+ KI DFGLA  +     RK +L  
Sbjct: 147 LRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCG 203
Query: 141 IQIELGYIPPEYVGR 155
                 YI PE + +
Sbjct: 204 TP---NYIAPEVLSK 215

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/142 (26%), Positives = 65/142 (45%), Gaps = 7/142 (4%)
Query: 24  EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR 82
           + + EV + + L+H N++R+ G+  +     LI EY P   L     +  ++   D ++ 
Sbjct: 80  QLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP---LGTVYRELQKLSKFDEQRT 136
Query: 83  VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQ 142
              I  +   L Y        +IHRD+K  N+LL    + KI+DFG +          + 
Sbjct: 137 ATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLC 193
Query: 143 IELGYIPPEYVGRGVYYKKFSL 164
             L Y+PPE +   ++ +K  L
Sbjct: 194 GTLDYLPPEMIEGRMHDEKVDL 215

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 42/131 (32%), Positives = 67/131 (51%), Gaps = 10/131 (7%)
Query: 6   GQIIAVKKLSK---KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYE--YMP 60
           G  +AVKKLS+     T     ++  V+L   + H N+I +      Q+ +  ++  Y+ 
Sbjct: 49  GINVAVKKLSRPFQNQTHAKRAYRELVLLKC-VNHKNIISLLNVFTPQKTLEEFQDVYLV 107
Query: 61  KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL 120
              +D  L   I M  LD ++  +++  ++ G+ +L       IIHRDLK SNI++  D 
Sbjct: 108 MELMDANLCQVIHME-LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDC 163
Query: 121 KPKISDFGLAR 131
             KI DFGLAR
Sbjct: 164 TLKILDFGLAR 174

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 64/132 (48%), Gaps = 10/132 (7%)
Query: 5   DGQII--AVKKLSKKSTQG-FEEFKNEVMLTAKLQHLNLIRV-GFCIETQ-EYMLIYEYM 59
           DG+ I  AVK L++ +  G   +F  E ++     H N++ + G C+ ++   +++  YM
Sbjct: 74  DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 133
Query: 60  PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
               L  F+ +      +  K  +     + +G+ YL        +HRDL   N +LDE 
Sbjct: 134 KHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEK 188
Query: 120 LKPKISDFGLAR 131
              K++DFGLAR
Sbjct: 189 FTVKVADFGLAR 200

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 80/166 (48%), Gaps = 26/166 (15%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKRSLDYF 67
           +A+KKLS+        F+N+       + L L++   C+  +  + L+  + P++SL+ F
Sbjct: 52  VAIKKLSRP-------FQNQTHAKRAYRELVLMK---CVNHKNIIGLLNVFTPQKSLEEF 101
Query: 68  --------LFDP----IRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNIL 115
                   L D     +  + LD ++  +++  ++ G+ +L       IIHRDLK SNI+
Sbjct: 102 QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIV 158
Query: 116 LDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKK 161
           +  D   KI DFGLAR      + + ++   Y     V  G+ YK+
Sbjct: 159 VKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMGYKE 204

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 80/166 (48%), Gaps = 26/166 (15%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKRSLDYF 67
           +A+KKLS+        F+N+       + L L++   C+  +  + L+  + P++SL+ F
Sbjct: 52  VAIKKLSRP-------FQNQTHAKRAYRELVLMK---CVNHKNIIGLLNVFTPQKSLEEF 101
Query: 68  --------LFDP----IRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNIL 115
                   L D     +  + LD ++  +++  ++ G+ +L       IIHRDLK SNI+
Sbjct: 102 QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIV 158
Query: 116 LDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKK 161
           +  D   KI DFGLAR      + + ++   Y     V  G+ YK+
Sbjct: 159 VKSDCTLKILDFGLARTAGTSFMMEPEVVTRYYRAPEVILGMGYKE 204

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 64/132 (48%), Gaps = 10/132 (7%)
Query: 5   DGQII--AVKKLSKKSTQG-FEEFKNEVMLTAKLQHLNLIRV-GFCIETQ-EYMLIYEYM 59
           DG+ I  AVK L++ +  G   +F  E ++     H N++ + G C+ ++   +++  YM
Sbjct: 73  DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 132
Query: 60  PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
               L  F+ +      +  K  +     + +G+ YL        +HRDL   N +LDE 
Sbjct: 133 KHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEK 187
Query: 120 LKPKISDFGLAR 131
              K++DFGLAR
Sbjct: 188 FTVKVADFGLAR 199

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 64/132 (48%), Gaps = 10/132 (7%)
Query: 5   DGQII--AVKKLSKKSTQG-FEEFKNEVMLTAKLQHLNLIRV-GFCIETQ-EYMLIYEYM 59
           DG+ I  AVK L++ +  G   +F  E ++     H N++ + G C+ ++   +++  YM
Sbjct: 50  DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 109
Query: 60  PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
               L  F+ +      +  K  +     + +G+ YL        +HRDL   N +LDE 
Sbjct: 110 KHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEK 164
Query: 120 LKPKISDFGLAR 131
              K++DFGLAR
Sbjct: 165 FTVKVADFGLAR 176

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 44.7 bits (104), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 64/132 (48%), Gaps = 10/132 (7%)
Query: 5   DGQII--AVKKLSKKSTQG-FEEFKNEVMLTAKLQHLNLIRV-GFCIETQ-EYMLIYEYM 59
           DG+ I  AVK L++ +  G   +F  E ++     H N++ + G C+ ++   +++  YM
Sbjct: 52  DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111
Query: 60  PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
               L  F+ +      +  K  +     + +G+ YL        +HRDL   N +LDE 
Sbjct: 112 KHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEK 166
Query: 120 LKPKISDFGLAR 131
              K++DFGLAR
Sbjct: 167 FTVKVADFGLAR 178

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 64/132 (48%), Gaps = 10/132 (7%)
Query: 5   DGQII--AVKKLSKKSTQG-FEEFKNEVMLTAKLQHLNLIRV-GFCIETQ-EYMLIYEYM 59
           DG+ I  AVK L++ +  G   +F  E ++     H N++ + G C+ ++   +++  YM
Sbjct: 54  DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 113
Query: 60  PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
               L  F+ +      +  K  +     + +G+ YL        +HRDL   N +LDE 
Sbjct: 114 KHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEK 168
Query: 120 LKPKISDFGLAR 131
              K++DFGLAR
Sbjct: 169 FTVKVADFGLAR 180

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 64/132 (48%), Gaps = 10/132 (7%)
Query: 5   DGQII--AVKKLSKKSTQG-FEEFKNEVMLTAKLQHLNLIRV-GFCIETQ-EYMLIYEYM 59
           DG+ I  AVK L++ +  G   +F  E ++     H N++ + G C+ ++   +++  YM
Sbjct: 53  DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 112
Query: 60  PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
               L  F+ +      +  K  +     + +G+ YL        +HRDL   N +LDE 
Sbjct: 113 KHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEK 167
Query: 120 LKPKISDFGLAR 131
              K++DFGLAR
Sbjct: 168 FTVKVADFGLAR 179

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 42/131 (32%), Positives = 67/131 (51%), Gaps = 10/131 (7%)
Query: 6   GQIIAVKKLSK---KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYE--YMP 60
           G  +AVKKLS+     T     ++  V+L   + H N+I +      Q+ +  ++  Y+ 
Sbjct: 47  GINVAVKKLSRPFQNQTHAKRAYRELVLLKC-VNHKNIISLLNVFTPQKTLEEFQDVYLV 105
Query: 61  KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL 120
              +D  L   I M  LD ++  +++  ++ G+ +L       IIHRDLK SNI++  D 
Sbjct: 106 MELMDANLCQVIHME-LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDC 161
Query: 121 KPKISDFGLAR 131
             KI DFGLAR
Sbjct: 162 TLKILDFGLAR 172

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 63/127 (49%), Gaps = 12/127 (9%)
Query: 9   IAVKKLSKKST-QGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYF 67
           +AVK   K  T    E+F +E ++   L H +++++   IE +   +I E  P   L ++
Sbjct: 43  VAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHY 102
Query: 68  LF---DPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKI 124
           L    + +++L L     V     I + + YL+    +  +HRD+ V NIL+      K+
Sbjct: 103 LERNKNSLKVLTL-----VLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKL 154
Query: 125 SDFGLAR 131
            DFGL+R
Sbjct: 155 GDFGLSR 161

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 64/132 (48%), Gaps = 10/132 (7%)
Query: 5   DGQII--AVKKLSKKSTQG-FEEFKNEVMLTAKLQHLNLIRV-GFCIETQ-EYMLIYEYM 59
           DG+ I  AVK L++ +  G   +F  E ++     H N++ + G C+ ++   +++  YM
Sbjct: 55  DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 114
Query: 60  PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
               L  F+ +      +  K  +     + +G+ YL        +HRDL   N +LDE 
Sbjct: 115 KHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEK 169
Query: 120 LKPKISDFGLAR 131
              K++DFGLAR
Sbjct: 170 FTVKVADFGLAR 181

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 64/132 (48%), Gaps = 10/132 (7%)
Query: 5   DGQII--AVKKLSKKSTQG-FEEFKNEVMLTAKLQHLNLIRV-GFCIETQ-EYMLIYEYM 59
           DG+ I  AVK L++ +  G   +F  E ++     H N++ + G C+ ++   +++  YM
Sbjct: 55  DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 114
Query: 60  PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
               L  F+ +      +  K  +     + +G+ YL        +HRDL   N +LDE 
Sbjct: 115 KHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEK 169
Query: 120 LKPKISDFGLAR 131
              K++DFGLAR
Sbjct: 170 FTVKVADFGLAR 181

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/128 (31%), Positives = 68/128 (53%), Gaps = 10/128 (7%)
Query: 9   IAVKKLSK---KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYE--YMPKRS 63
           +A+KKLS+     T     ++ E++L   + H N+I +      Q+ +  ++  Y+    
Sbjct: 53  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 111
Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           +D  L   I+M  LD ++  +++  ++ G+ +L       IIHRDLK SNI++  D   K
Sbjct: 112 MDANLCQVIQME-LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLK 167
Query: 124 ISDFGLAR 131
           I DFGLAR
Sbjct: 168 ILDFGLAR 175

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/128 (31%), Positives = 68/128 (53%), Gaps = 10/128 (7%)
Query: 9   IAVKKLSK---KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYE--YMPKRS 63
           +A+KKLS+     T     ++ E++L   + H N+I +      Q+ +  ++  Y+    
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           +D  L   I+M  LD ++  +++  ++ G+ +L       IIHRDLK SNI++  D   K
Sbjct: 111 MDANLCQVIQME-LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLK 166
Query: 124 ISDFGLAR 131
           I DFGLAR
Sbjct: 167 ILDFGLAR 174

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/128 (31%), Positives = 68/128 (53%), Gaps = 10/128 (7%)
Query: 9   IAVKKLSK---KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYE--YMPKRS 63
           +A+KKLS+     T     ++ E++L   + H N+I +      Q+ +  ++  Y+    
Sbjct: 53  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 111
Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           +D  L   I+M  LD ++  +++  ++ G+ +L       IIHRDLK SNI++  D   K
Sbjct: 112 MDANLCQVIQME-LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLK 167
Query: 124 ISDFGLAR 131
           I DFGLAR
Sbjct: 168 ILDFGLAR 175

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 63/127 (49%), Gaps = 12/127 (9%)
Query: 9   IAVKKLSKKST-QGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYF 67
           +AVK   K  T    E+F +E ++   L H +++++   IE +   +I E  P   L ++
Sbjct: 55  VAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHY 114
Query: 68  LF---DPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKI 124
           L    + +++L L     V     I + + YL+    +  +HRD+ V NIL+      K+
Sbjct: 115 LERNKNSLKVLTL-----VLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKL 166
Query: 125 SDFGLAR 131
            DFGL+R
Sbjct: 167 GDFGLSR 173

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/132 (28%), Positives = 64/132 (48%), Gaps = 10/132 (7%)
Query: 5   DGQII--AVKKLSKKSTQG-FEEFKNEVMLTAKLQHLNLIRV-GFCIETQ-EYMLIYEYM 59
           DG+ I  AVK L++ +  G   +F  E ++     H N++ + G C+ ++   +++  YM
Sbjct: 54  DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 113
Query: 60  PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
               L  F+ +      +  K  +     + +G+ YL        +HRDL   N +LDE 
Sbjct: 114 KHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEK 168
Query: 120 LKPKISDFGLAR 131
              K++DFGLAR
Sbjct: 169 FTVKVADFGLAR 180

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 46/141 (32%), Positives = 67/141 (47%), Gaps = 29/141 (20%)
Query: 6   GQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
           G  +AVKKLS+  +S    +    E+ L   ++H N+I            L+  + P RS
Sbjct: 47  GHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG-----------LLDVFTPARS 95
Query: 64  LDYF--------LFDPIRMLILDCKKRVH-----IIKGIIQGLLYLQEYFRLTIIHRDLK 110
           L+ F        L       I+ C+K        +I  I++GL Y+       IIHRDLK
Sbjct: 96  LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLK 152
Query: 111 VSNILLDEDLKPKISDFGLAR 131
            SN+ ++ED + KI DF LAR
Sbjct: 153 PSNLAVNEDCELKILDFYLAR 173

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 44.7 bits (104), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 36/127 (28%), Positives = 63/127 (49%), Gaps = 12/127 (9%)
Query: 9   IAVKKLSKKST-QGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYF 67
           +AVK   K  T    E+F +E ++   L H +++++   IE +   +I E  P   L ++
Sbjct: 39  VAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHY 98
Query: 68  LF---DPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKI 124
           L    + +++L L     V     I + + YL+    +  +HRD+ V NIL+      K+
Sbjct: 99  LERNKNSLKVLTL-----VLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKL 150
Query: 125 SDFGLAR 131
            DFGL+R
Sbjct: 151 GDFGLSR 157

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/128 (31%), Positives = 68/128 (53%), Gaps = 10/128 (7%)
Query: 9   IAVKKLSK---KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYE--YMPKRS 63
           +A+KKLS+     T     ++ E++L   + H N+I +      Q+ +  ++  Y+    
Sbjct: 45  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 103
Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           +D  L   I+M  LD ++  +++  ++ G+ +L       IIHRDLK SNI++  D   K
Sbjct: 104 MDANLCQVIQME-LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLK 159
Query: 124 ISDFGLAR 131
           I DFGLAR
Sbjct: 160 ILDFGLAR 167

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/128 (31%), Positives = 68/128 (53%), Gaps = 10/128 (7%)
Query: 9   IAVKKLSK---KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYE--YMPKRS 63
           +A+KKLS+     T     ++ E++L   + H N+I +      Q+ +  ++  Y+    
Sbjct: 46  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 104
Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           +D  L   I+M  LD ++  +++  ++ G+ +L       IIHRDLK SNI++  D   K
Sbjct: 105 MDANLCQVIQME-LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLK 160
Query: 124 ISDFGLAR 131
           I DFGLAR
Sbjct: 161 ILDFGLAR 168

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/128 (31%), Positives = 68/128 (53%), Gaps = 10/128 (7%)
Query: 9   IAVKKLSK---KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYE--YMPKRS 63
           +A+KKLS+     T     ++ E++L   + H N+I +      Q+ +  ++  Y+    
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           +D  L   I+M  LD ++  +++  ++ G+ +L       IIHRDLK SNI++  D   K
Sbjct: 111 MDANLCQVIQME-LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLK 166
Query: 124 ISDFGLAR 131
           I DFGLAR
Sbjct: 167 ILDFGLAR 174

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/128 (31%), Positives = 68/128 (53%), Gaps = 10/128 (7%)
Query: 9   IAVKKLSK---KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYE--YMPKRS 63
           +A+KKLS+     T     ++ E++L   + H N+I +      Q+ +  ++  Y+    
Sbjct: 46  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 104
Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           +D  L   I+M  LD ++  +++  ++ G+ +L       IIHRDLK SNI++  D   K
Sbjct: 105 MDANLCQVIQME-LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLK 160
Query: 124 ISDFGLAR 131
           I DFGLAR
Sbjct: 161 ILDFGLAR 168

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/128 (31%), Positives = 68/128 (53%), Gaps = 10/128 (7%)
Query: 9   IAVKKLSK---KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYE--YMPKRS 63
           +A+KKLS+     T     ++ E++L   + H N+I +      Q+ +  ++  Y+    
Sbjct: 51  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 109
Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           +D  L   I+M  LD ++  +++  ++ G+ +L       IIHRDLK SNI++  D   K
Sbjct: 110 MDANLCQVIQME-LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLK 165
Query: 124 ISDFGLAR 131
           I DFGLAR
Sbjct: 166 ILDFGLAR 173

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/162 (24%), Positives = 77/162 (47%), Gaps = 10/162 (6%)
Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSL 64
           GQ +A+++++ +     E   NE+++  + ++ N++  +   +   E  ++ EY+   SL
Sbjct: 45  GQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104
Query: 65  DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKI 124
                D +    +D  +   + +  +Q L +L       +IHRD+K  NILL  D   K+
Sbjct: 105 ----TDVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKL 157
Query: 125 SDFGL-ARILRKMILKQIQIELGY-IPPEYVGRGVYYKKFSL 164
           +DFG  A+I  +   +   +   Y + PE V R  Y  K  +
Sbjct: 158 TDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKAYGPKVDI 199

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/128 (31%), Positives = 68/128 (53%), Gaps = 10/128 (7%)
Query: 9   IAVKKLSK---KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYE--YMPKRS 63
           +A+KKLS+     T     ++ E++L   + H N+I +      Q+ +  ++  Y+    
Sbjct: 90  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 148
Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           +D  L   I+M  LD ++  +++  ++ G+ +L       IIHRDLK SNI++  D   K
Sbjct: 149 MDANLCQVIQME-LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLK 204
Query: 124 ISDFGLAR 131
           I DFGLAR
Sbjct: 205 ILDFGLAR 212

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/141 (31%), Positives = 67/141 (47%), Gaps = 29/141 (20%)
Query: 6   GQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
           G  +AVKKLS+  +S    +    E+ L   ++H N+I            L+  + P RS
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG-----------LLDVFTPARS 95
Query: 64  LDYF-------------LFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLK 110
           L+ F             L + ++   L       +I  I++GL Y+       IIHRDLK
Sbjct: 96  LEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLK 152
Query: 111 VSNILLDEDLKPKISDFGLAR 131
            SN+ ++ED + KI DFGLAR
Sbjct: 153 PSNLAVNEDXELKILDFGLAR 173

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 45/141 (31%), Positives = 67/141 (47%), Gaps = 29/141 (20%)
Query: 6   GQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
           G  +AVKKLS+  +S    +    E+ L   ++H N+I            L+  + P RS
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG-----------LLDVFTPARS 95
Query: 64  LDYF-------------LFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLK 110
           L+ F             L + ++   L       +I  I++GL Y+       IIHRDLK
Sbjct: 96  LEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLK 152
Query: 111 VSNILLDEDLKPKISDFGLAR 131
            SN+ ++ED + KI DFGLAR
Sbjct: 153 PSNLAVNEDCELKILDFGLAR 173

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 40/129 (31%), Positives = 68/129 (52%), Gaps = 10/129 (7%)
Query: 9   IAVKKLSK---KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYE--YMPKRS 63
           +A+KKLS+     T     ++ E++L   + H N+I +      Q+ +  ++  Y+    
Sbjct: 90  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 148
Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           +D  L   I+M  LD ++  +++  ++ G+ +L       IIHRDLK SNI++  D   K
Sbjct: 149 MDANLCQVIQME-LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLK 204
Query: 124 ISDFGLARI 132
           I DFGLAR 
Sbjct: 205 ILDFGLART 213

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 64/138 (46%), Gaps = 17/138 (12%)
Query: 4   PDGQIIAVKKLSKKSTQGFE-EFKNEVMLTAKLQHLNLIRVGFCIET-------QEYMLI 55
           P G+I+A+KK+       F      E+ +    +H N+I + F I+         E  +I
Sbjct: 34  PTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITI-FNIQRPDSFENFNEVYII 92
Query: 56  YEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNIL 115
            E M     D       +ML  D     HI   I Q L  ++      +IHRDLK SN+L
Sbjct: 93  QELM---QTDLHRVISTQMLSDD-----HIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLL 144
Query: 116 LDEDLKPKISDFGLARIL 133
           ++ +   K+ DFGLARI+
Sbjct: 145 INSNCDLKVCDFGLARII 162

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 64/138 (46%), Gaps = 17/138 (12%)
Query: 4   PDGQIIAVKKLSKKSTQGFE-EFKNEVMLTAKLQHLNLIRVGFCIET-------QEYMLI 55
           P G+I+A+KK+       F      E+ +    +H N+I + F I+         E  +I
Sbjct: 34  PTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITI-FNIQRPDSFENFNEVYII 92
Query: 56  YEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNIL 115
            E M     D       +ML  D     HI   I Q L  ++      +IHRDLK SN+L
Sbjct: 93  QELM---QTDLHRVISTQMLSDD-----HIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLL 144
Query: 116 LDEDLKPKISDFGLARIL 133
           ++ +   K+ DFGLARI+
Sbjct: 145 INSNCDLKVCDFGLARII 162

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/138 (31%), Positives = 64/138 (46%), Gaps = 17/138 (12%)
Query: 4   PDGQIIAVKKLSKKSTQGFE-EFKNEVMLTAKLQHLNLIRVGFCIET-------QEYMLI 55
           P G+I+A+KK+       F      E+ +    +H N+I + F I+         E  +I
Sbjct: 34  PTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITI-FNIQRPDSFENFNEVYII 92
Query: 56  YEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNIL 115
            E M     D       +ML  D     HI   I Q L  ++      +IHRDLK SN+L
Sbjct: 93  QELM---QTDLHRVISTQMLSDD-----HIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLL 144
Query: 116 LDEDLKPKISDFGLARIL 133
           ++ +   K+ DFGLARI+
Sbjct: 145 INSNCDLKVCDFGLARII 162

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 62/141 (43%), Gaps = 28/141 (19%)
Query: 9   IAVK--KLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEY-----MLIYEYMP 60
           +AVK  KL   S +  EEF +E        H N+IR+ G CIE         M+I  +M 
Sbjct: 65  VAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMK 124
Query: 61  KRSL-DYFLFD---------PIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLK 110
              L  Y L+          P++ L+         +  I  G+ YL        +HRDL 
Sbjct: 125 YGDLHTYLLYSRLETGPKHIPLQTLL-------KFMVDIALGMEYLSNR---NFLHRDLA 174
Query: 111 VSNILLDEDLKPKISDFGLAR 131
             N +L +D+   ++DFGL++
Sbjct: 175 ARNCMLRDDMTVCVADFGLSK 195

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 44.3 bits (103), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 36/136 (26%), Positives = 71/136 (52%), Gaps = 8/136 (5%)
Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSL 64
           GQI+A+K++  +S    +E   E+ +  +    ++++  G   +  +  ++ EY    S+
Sbjct: 54  GQIVAIKQVPVESD--LQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSV 111
Query: 65  DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKI 124
              +   +R   L   +   I++  ++GL YL  +F +  IHRD+K  NILL+ +   K+
Sbjct: 112 SDIIR--LRNKTLTEDEIATILQSTLKGLEYL--HF-MRKIHRDIKAGNILLNTEGHAKL 166
Query: 125 SDFGLARILRKMILKQ 140
           +DFG+A  L   + K+
Sbjct: 167 ADFGVAGQLTDXMAKR 182

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/141 (32%), Positives = 67/141 (47%), Gaps = 29/141 (20%)
Query: 6   GQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
           G  +AVKKLS+  +S    +    E+ L   ++H N+I            L+  + P RS
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG-----------LLDVFTPARS 95
Query: 64  LDYF--------LFDPIRMLILDCKKRVH-----IIKGIIQGLLYLQEYFRLTIIHRDLK 110
           L+ F        L       I+ C+K        +I  I++GL Y+       IIHRDLK
Sbjct: 96  LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLK 152
Query: 111 VSNILLDEDLKPKISDFGLAR 131
            SN+ ++ED + KI  FGLAR
Sbjct: 153 PSNLAVNEDCELKILGFGLAR 173

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 79/166 (47%), Gaps = 26/166 (15%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKRSLDYF 67
           +A+KKLS+        F+N+       + L L++   C+  +  + L+  + P++SL+ F
Sbjct: 52  VAIKKLSRP-------FQNQTHAKRAYRELVLMK---CVNHKNIIGLLNVFTPQKSLEEF 101
Query: 68  --------LFDP----IRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNIL 115
                   L D     +  + LD ++  +++  ++ G+ +L       IIHRDLK SNI+
Sbjct: 102 QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIV 158
Query: 116 LDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKK 161
           +  D   KI DFGLAR      +   ++   Y     V  G+ YK+
Sbjct: 159 VKSDCTLKILDFGLARTAGTSFMMTPEVVTRYYRAPEVILGMGYKE 204

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 75/170 (44%), Gaps = 33/170 (19%)
Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLD 65
            +II  KKLS +  Q  E    E  +   L+H N++R            +++ + +    
Sbjct: 34  AKIINTKKLSARDHQKLE---REARICRLLKHSNIVR------------LHDSISEEGFH 78
Query: 66  YFLFDPIR--MLILDCKKR--------VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNIL 115
           Y +FD +    L  D   R         H I+ I++ +L+  +   + ++HRDLK  N+L
Sbjct: 79  YLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQ---MGVVHRDLKPENLL 135
Query: 116 LDEDLKP---KISDFGLARILR--KMILKQIQIELGYIPPEYVGRGVYYK 160
           L    K    K++DFGLA  ++  +          GY+ PE + +  Y K
Sbjct: 136 LASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRKEAYGK 185

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 69/136 (50%), Gaps = 26/136 (19%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKRSLDYF 67
           +A+KKLS+        F+N+       + L L++   C+  +  + L+  + P++SL+ F
Sbjct: 54  VAIKKLSRP-------FQNQTHAKRAYRELVLMK---CVNHKNIIGLLNVFTPQKSLEEF 103
Query: 68  --------LFDP----IRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNIL 115
                   L D     +  + LD ++  +++  ++ G+ +L       IIHRDLK SNI+
Sbjct: 104 QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIV 160
Query: 116 LDEDLKPKISDFGLAR 131
           +  D   KI DFGLAR
Sbjct: 161 VKSDCTLKILDFGLAR 176

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 82/170 (48%), Gaps = 27/170 (15%)
Query: 6   GQIIAVKKLSK---KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPK 61
           GQ  AVK +SK   K     E    EV L  +L H N++++    E + Y  L+ E    
Sbjct: 51  GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTG 110
Query: 62  RSLDYFLFDPI----RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLD 117
             L    FD I    R   +D  +   II+ ++ G+ Y+    +  I+HRDLK  N+LL+
Sbjct: 111 GEL----FDEIISRKRFSEVDAAR---IIRQVLSGITYMH---KNKIVHRDLKPENLLLE 160
Query: 118 ---EDLKPKISDFGLARILRKMILKQIQIELG---YIPPEYVGRGVYYKK 161
              +D   +I DFGL+        K+++ ++G   YI PE V  G Y +K
Sbjct: 161 SKSKDANIRIIDFGLSTHFEAS--KKMKDKIGTAYYIAPE-VLHGTYDEK 207

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 69/136 (50%), Gaps = 26/136 (19%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKRSLDYF 67
           +A+KKLS+        F+N+       + L L++   C+  +  + L+  + P++SL+ F
Sbjct: 52  VAIKKLSRP-------FQNQTHAKRAYRELVLMK---CVNHKNIIGLLNVFTPQKSLEEF 101
Query: 68  --------LFDP----IRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNIL 115
                   L D     +  + LD ++  +++  ++ G+ +L       IIHRDLK SNI+
Sbjct: 102 QDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIV 158
Query: 116 LDEDLKPKISDFGLAR 131
           +  D   KI DFGLAR
Sbjct: 159 VKSDCTLKILDFGLAR 174

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 57/113 (50%), Gaps = 8/113 (7%)
Query: 23  EEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK 81
           +E   E  +  +L +  ++R +G C E + +ML+ E      L+ +L    +   +  K 
Sbjct: 71  DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKN 126
Query: 82  RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILR 134
            + ++  +  G+ YL+E      +HRDL   N+LL      KISDFGL++ LR
Sbjct: 127 IIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 176

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 69/136 (50%), Gaps = 26/136 (19%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKRSLDYF 67
           +A+KKLS+        F+N+       + L L++   C+  +  + L+  + P++SL+ F
Sbjct: 52  VAIKKLSRP-------FQNQTHAKRAYRELVLMK---CVNHKNIIGLLNVFTPQKSLEEF 101
Query: 68  --------LFDP----IRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNIL 115
                   L D     +  + LD ++  +++  ++ G+ +L       IIHRDLK SNI+
Sbjct: 102 QDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIV 158
Query: 116 LDEDLKPKISDFGLAR 131
           +  D   KI DFGLAR
Sbjct: 159 VKSDATLKILDFGLAR 174

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 82/170 (48%), Gaps = 27/170 (15%)
Query: 6   GQIIAVKKLSK---KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPK 61
           GQ  AVK +SK   K     E    EV L  +L H N++++    E + Y  L+ E    
Sbjct: 75  GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTG 134
Query: 62  RSLDYFLFDPI----RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLD 117
             L    FD I    R   +D  +   II+ ++ G+ Y+    +  I+HRDLK  N+LL+
Sbjct: 135 GEL----FDEIISRKRFSEVDAAR---IIRQVLSGITYMH---KNKIVHRDLKPENLLLE 184
Query: 118 ---EDLKPKISDFGLARILRKMILKQIQIELG---YIPPEYVGRGVYYKK 161
              +D   +I DFGL+        K+++ ++G   YI PE +  G Y +K
Sbjct: 185 SKSKDANIRIIDFGLSTHFEAS--KKMKDKIGTAYYIAPEVL-HGTYDEK 231

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 57/113 (50%), Gaps = 8/113 (7%)
Query: 23  EEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK 81
           +E   E  +  +L +  ++R +G C E + +ML+ E      L+ +L    +   +  K 
Sbjct: 57  DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKN 112
Query: 82  RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILR 134
            + ++  +  G+ YL+E      +HRDL   N+LL      KISDFGL++ LR
Sbjct: 113 IIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 162

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/170 (31%), Positives = 82/170 (48%), Gaps = 27/170 (15%)
Query: 6   GQIIAVKKLSK---KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPK 61
           GQ  AVK +SK   K     E    EV L  +L H N++++    E + Y  L+ E    
Sbjct: 74  GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTG 133
Query: 62  RSLDYFLFDPI----RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLD 117
             L    FD I    R   +D  +   II+ ++ G+ Y+    +  I+HRDLK  N+LL+
Sbjct: 134 GEL----FDEIISRKRFSEVDAAR---IIRQVLSGITYMH---KNKIVHRDLKPENLLLE 183
Query: 118 ---EDLKPKISDFGLARILRKMILKQIQIELG---YIPPEYVGRGVYYKK 161
              +D   +I DFGL+        K+++ ++G   YI PE +  G Y +K
Sbjct: 184 SKSKDANIRIIDFGLSTHFEAS--KKMKDKIGTAYYIAPEVL-HGTYDEK 230

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 64/139 (46%), Gaps = 19/139 (13%)
Query: 9   IAVKKLSKKSTQ-GFEEFKNEV-MLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLD 65
           +AVK L   +T+    +  +E+ M+    +H N+I + G C +     +I EY  K +L 
Sbjct: 104 VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 163
Query: 66  YFL-----------FDPIRML--ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVS 112
            +L           ++P       L  K  V     + +G+ YL        IHRDL   
Sbjct: 164 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAAR 220
Query: 113 NILLDEDLKPKISDFGLAR 131
           N+L+ ED   KI+DFGLAR
Sbjct: 221 NVLVTEDNVMKIADFGLAR 239

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 46/141 (32%), Positives = 67/141 (47%), Gaps = 29/141 (20%)
Query: 6   GQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
           G  +AVKKLS+  +S    +    E+ L   ++H N+I            L+  + P RS
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG-----------LLDVFTPARS 95
Query: 64  LDYF--------LFDPIRMLILDCKKRVH-----IIKGIIQGLLYLQEYFRLTIIHRDLK 110
           L+ F        L       I+ C+K        +I  I++GL Y+       IIHRDLK
Sbjct: 96  LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLK 152
Query: 111 VSNILLDEDLKPKISDFGLAR 131
            SN+ ++ED + KI D GLAR
Sbjct: 153 PSNLAVNEDCELKILDAGLAR 173

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 57/113 (50%), Gaps = 8/113 (7%)
Query: 23  EEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK 81
           +E   E  +  +L +  ++R +G C E + +ML+ E      L+ +L    +   +  K 
Sbjct: 73  DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKN 128
Query: 82  RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILR 134
            + ++  +  G+ YL+E      +HRDL   N+LL      KISDFGL++ LR
Sbjct: 129 IIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 178

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 57/113 (50%), Gaps = 8/113 (7%)
Query: 23  EEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK 81
           +E   E  +  +L +  ++R +G C E + +ML+ E      L+ +L    +   +  K 
Sbjct: 73  DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKN 128
Query: 82  RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILR 134
            + ++  +  G+ YL+E      +HRDL   N+LL      KISDFGL++ LR
Sbjct: 129 IIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 178

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 57/113 (50%), Gaps = 8/113 (7%)
Query: 23  EEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK 81
           +E   E  +  +L +  ++R +G C E + +ML+ E      L+ +L    +   +  K 
Sbjct: 53  DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKN 108
Query: 82  RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILR 134
            + ++  +  G+ YL+E      +HRDL   N+LL      KISDFGL++ LR
Sbjct: 109 IIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 158

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 57/113 (50%), Gaps = 8/113 (7%)
Query: 23  EEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK 81
           +E   E  +  +L +  ++R +G C E + +ML+ E      L+ +L    +   +  K 
Sbjct: 57  DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKN 112
Query: 82  RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILR 134
            + ++  +  G+ YL+E      +HRDL   N+LL      KISDFGL++ LR
Sbjct: 113 IIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 162

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 79/161 (49%), Gaps = 10/161 (6%)
Query: 8   IIAVKKL--SKKSTQGFE-EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRS 63
           I+A+K L  S+   +G E + + E+ + + L+H N++R+  +  + +   L+ E+ P+  
Sbjct: 42  IMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGE 101
Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           L   L    R    D ++    ++ +   L Y  E     +IHRD+K  N+L+    + K
Sbjct: 102 LYKELQKHGR---FDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELK 155
Query: 124 ISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKKFSL 164
           I+DFG +     +  + +   L Y+PPE +    + +K  L
Sbjct: 156 IADFGWSVHAPSLRRRXMCGTLDYLPPEMIEGKTHDEKVDL 196

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 57/113 (50%), Gaps = 8/113 (7%)
Query: 23  EEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK 81
           +E   E  +  +L +  ++R +G C E + +ML+ E      L+ +L    +   +  K 
Sbjct: 51  DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKN 106
Query: 82  RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILR 134
            + ++  +  G+ YL+E      +HRDL   N+LL      KISDFGL++ LR
Sbjct: 107 IIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 156

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 33/113 (29%), Positives = 57/113 (50%), Gaps = 8/113 (7%)
Query: 23  EEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK 81
           +E   E  +  +L +  ++R +G C E + +ML+ E      L+ +L    +   +  K 
Sbjct: 63  DELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKN 118
Query: 82  RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILR 134
            + ++  +  G+ YL+E      +HRDL   N+LL      KISDFGL++ LR
Sbjct: 119 IIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 168

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 64/139 (46%), Gaps = 19/139 (13%)
Query: 9   IAVKKLSKKSTQ-GFEEFKNEV-MLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLD 65
           +AVK L   +T+    +  +E+ M+    +H N+I + G C +     +I EY  K +L 
Sbjct: 63  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 122
Query: 66  YFL-----------FDPIRML--ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVS 112
            +L           ++P       L  K  V     + +G+ YL        IHRDL   
Sbjct: 123 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAAR 179
Query: 113 NILLDEDLKPKISDFGLAR 131
           N+L+ ED   KI+DFGLAR
Sbjct: 180 NVLVTEDNVMKIADFGLAR 198

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 69/136 (50%), Gaps = 26/136 (19%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKRSLDYF 67
           +A+KKLS+        F+N+       + L L++   C+  +  + L+  + P++SL+ F
Sbjct: 57  VAIKKLSRP-------FQNQTHAKRAYRELVLMK---CVNHKNIIGLLNVFTPQKSLEEF 106
Query: 68  --------LFDP----IRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNIL 115
                   L D     +  + LD ++  +++  ++ G+ +L       IIHRDLK SNI+
Sbjct: 107 QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIV 163
Query: 116 LDEDLKPKISDFGLAR 131
           +  D   KI DFGLAR
Sbjct: 164 VKSDCTLKILDFGLAR 179

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 64/139 (46%), Gaps = 19/139 (13%)
Query: 9   IAVKKLSKKSTQ-GFEEFKNEV-MLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLD 65
           +AVK L   +T+    +  +E+ M+    +H N+I + G C +     +I EY  K +L 
Sbjct: 55  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 114
Query: 66  YFL-----------FDPIRML--ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVS 112
            +L           ++P       L  K  V     + +G+ YL        IHRDL   
Sbjct: 115 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAAR 171
Query: 113 NILLDEDLKPKISDFGLAR 131
           N+L+ ED   KI+DFGLAR
Sbjct: 172 NVLVTEDNVMKIADFGLAR 190

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 69/136 (50%), Gaps = 26/136 (19%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKRSLDYF 67
           +A+KKLS+        F+N+       + L L++   C+  +  + L+  + P++SL+ F
Sbjct: 53  VAIKKLSRP-------FQNQTHAKRAYRELVLMK---CVNHKNIIGLLNVFTPQKSLEEF 102
Query: 68  --------LFDP----IRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNIL 115
                   L D     +  + LD ++  +++  ++ G+ +L       IIHRDLK SNI+
Sbjct: 103 QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIV 159
Query: 116 LDEDLKPKISDFGLAR 131
           +  D   KI DFGLAR
Sbjct: 160 VKSDCTLKILDFGLAR 175

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 79/161 (49%), Gaps = 10/161 (6%)
Query: 8   IIAVKKL--SKKSTQGFE-EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRS 63
           I+A+K L  S+   +G E + + E+ + + L+H N++R+  +  + +   L+ E+ P+  
Sbjct: 41  IMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGE 100
Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           L   L    R    D ++    ++ +   L Y  E     +IHRD+K  N+L+    + K
Sbjct: 101 LYKELQKHGR---FDEQRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELK 154
Query: 124 ISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKKFSL 164
           I+DFG +     +  + +   L Y+PPE +    + +K  L
Sbjct: 155 IADFGWSVHAPSLRRRXMCGTLDYLPPEMIEGKTHDEKVDL 195

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 64/139 (46%), Gaps = 19/139 (13%)
Query: 9   IAVKKLSKKSTQ-GFEEFKNEV-MLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLD 65
           +AVK L   +T+    +  +E+ M+    +H N+I + G C +     +I EY  K +L 
Sbjct: 63  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 122
Query: 66  YFL-----------FDPIRML--ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVS 112
            +L           ++P       L  K  V     + +G+ YL        IHRDL   
Sbjct: 123 EYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAAR 179
Query: 113 NILLDEDLKPKISDFGLAR 131
           N+L+ ED   KI+DFGLAR
Sbjct: 180 NVLVTEDNVMKIADFGLAR 198

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 69/136 (50%), Gaps = 26/136 (19%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKRSLDYF 67
           +A+KKLS+        F+N+       + L L++   C+  +  + L+  + P++SL+ F
Sbjct: 52  VAIKKLSRP-------FQNQTHAKRAYRELVLMK---CVNHKNIIGLLNVFTPQKSLEEF 101
Query: 68  --------LFDP----IRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNIL 115
                   L D     +  + LD ++  +++  ++ G+ +L       IIHRDLK SNI+
Sbjct: 102 QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIV 158
Query: 116 LDEDLKPKISDFGLAR 131
           +  D   KI DFGLAR
Sbjct: 159 VKSDCTLKILDFGLAR 174

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 64/139 (46%), Gaps = 19/139 (13%)
Query: 9   IAVKKLSKKSTQ-GFEEFKNEV-MLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLD 65
           +AVK L   +T+    +  +E+ M+    +H N+I + G C +     +I EY  K +L 
Sbjct: 56  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 115
Query: 66  YFL-----------FDPIRML--ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVS 112
            +L           ++P       L  K  V     + +G+ YL        IHRDL   
Sbjct: 116 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAAR 172
Query: 113 NILLDEDLKPKISDFGLAR 131
           N+L+ ED   KI+DFGLAR
Sbjct: 173 NVLVTEDNVMKIADFGLAR 191

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 23/45 (51%), Positives = 30/45 (66%), Gaps = 3/45 (6%)
Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARIL 133
           I+  L YL       IIHRDLK  NILL+ED+  +I+DFG A++L
Sbjct: 139 IVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVL 180

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 23/45 (51%), Positives = 30/45 (66%), Gaps = 3/45 (6%)
Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARIL 133
           I+  L YL       IIHRDLK  NILL+ED+  +I+DFG A++L
Sbjct: 141 IVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVL 182

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 43.9 bits (102), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 19/30 (63%), Positives = 25/30 (83%)
Query: 104 IIHRDLKVSNILLDEDLKPKISDFGLARIL 133
           IIHRDLK  NILL+ED+  +I+DFG A++L
Sbjct: 150 IIHRDLKPENILLNEDMHIQITDFGTAKVL 179

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 23/45 (51%), Positives = 30/45 (66%), Gaps = 3/45 (6%)
Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARIL 133
           I+  L YL       IIHRDLK  NILL+ED+  +I+DFG A++L
Sbjct: 144 IVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVL 185

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 23/45 (51%), Positives = 30/45 (66%), Gaps = 3/45 (6%)
Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARIL 133
           I+  L YL       IIHRDLK  NILL+ED+  +I+DFG A++L
Sbjct: 141 IVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVL 182

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 23/45 (51%), Positives = 30/45 (66%), Gaps = 3/45 (6%)
Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARIL 133
           I+  L YL       IIHRDLK  NILL+ED+  +I+DFG A++L
Sbjct: 141 IVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVL 182

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 23/45 (51%), Positives = 30/45 (66%), Gaps = 3/45 (6%)
Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARIL 133
           I+  L YL       IIHRDLK  NILL+ED+  +I+DFG A++L
Sbjct: 142 IVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVL 183

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 69/136 (50%), Gaps = 26/136 (19%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKRSLDYF 67
           +A+KKLS+        F+N+       + L L++   C+  +  + L+  + P++SL+ F
Sbjct: 52  VAIKKLSRP-------FQNQTHAKRAYRELVLMK---CVNHKNIIGLLNVFTPQKSLEEF 101
Query: 68  --------LFDP----IRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNIL 115
                   L D     +  + LD ++  +++  ++ G+ +L       IIHRDLK SNI+
Sbjct: 102 QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIV 158
Query: 116 LDEDLKPKISDFGLAR 131
           +  D   KI DFGLAR
Sbjct: 159 VKSDCTLKILDFGLAR 174

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/136 (29%), Positives = 69/136 (50%), Gaps = 26/136 (19%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKRSLDYF 67
           +A+KKLS+        F+N+       + L L++   C+  +  + L+  + P++SL+ F
Sbjct: 46  VAIKKLSRP-------FQNQTHAKRAYRELVLMK---CVNHKNIIGLLNVFTPQKSLEEF 95
Query: 68  --------LFDP----IRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNIL 115
                   L D     +  + LD ++  +++  ++ G+ +L       IIHRDLK SNI+
Sbjct: 96  QDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIV 152
Query: 116 LDEDLKPKISDFGLAR 131
           +  D   KI DFGLAR
Sbjct: 153 VKSDCTLKILDFGLAR 168

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 23/45 (51%), Positives = 30/45 (66%), Gaps = 3/45 (6%)
Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARIL 133
           I+  L YL       IIHRDLK  NILL+ED+  +I+DFG A++L
Sbjct: 141 IVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVL 182

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 64/139 (46%), Gaps = 19/139 (13%)
Query: 9   IAVKKLSKKSTQ-GFEEFKNEV-MLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLD 65
           +AVK L   +T+    +  +E+ M+    +H N+I + G C +     +I EY  K +L 
Sbjct: 52  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 111
Query: 66  YFL-----------FDPIRML--ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVS 112
            +L           ++P       L  K  V     + +G+ YL        IHRDL   
Sbjct: 112 EYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAAR 168
Query: 113 NILLDEDLKPKISDFGLAR 131
           N+L+ ED   KI+DFGLAR
Sbjct: 169 NVLVTEDNVMKIADFGLAR 187

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 19/30 (63%), Positives = 25/30 (83%)
Query: 104 IIHRDLKVSNILLDEDLKPKISDFGLARIL 133
           IIHRDLK  NILL+ED+  +I+DFG A++L
Sbjct: 150 IIHRDLKPENILLNEDMHIQITDFGTAKVL 179

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 23/45 (51%), Positives = 30/45 (66%), Gaps = 3/45 (6%)
Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARIL 133
           I+  L YL       IIHRDLK  NILL+ED+  +I+DFG A++L
Sbjct: 139 IVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVL 180

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 23/45 (51%), Positives = 30/45 (66%), Gaps = 3/45 (6%)
Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARIL 133
           I+  L YL       IIHRDLK  NILL+ED+  +I+DFG A++L
Sbjct: 146 IVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVL 187

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 23/45 (51%), Positives = 30/45 (66%), Gaps = 3/45 (6%)
Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARIL 133
           I+  L YL       IIHRDLK  NILL+ED+  +I+DFG A++L
Sbjct: 141 IVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVL 182

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 23/45 (51%), Positives = 30/45 (66%), Gaps = 3/45 (6%)
Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARIL 133
           I+  L YL       IIHRDLK  NILL+ED+  +I+DFG A++L
Sbjct: 139 IVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVL 180

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 23/45 (51%), Positives = 30/45 (66%), Gaps = 3/45 (6%)
Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARIL 133
           I+  L YL       IIHRDLK  NILL+ED+  +I+DFG A++L
Sbjct: 139 IVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVL 180

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 23/45 (51%), Positives = 30/45 (66%), Gaps = 3/45 (6%)
Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARIL 133
           I+  L YL       IIHRDLK  NILL+ED+  +I+DFG A++L
Sbjct: 142 IVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVL 183

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 23/45 (51%), Positives = 30/45 (66%), Gaps = 3/45 (6%)
Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARIL 133
           I+  L YL       IIHRDLK  NILL+ED+  +I+DFG A++L
Sbjct: 141 IVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVL 182

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 43.9 bits (102), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 82/170 (48%), Gaps = 27/170 (15%)
Query: 6   GQIIAVKKLSK---KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPK 61
           GQ  AVK +SK   K     E    EV L  +L H N++++    E + Y  L+ E    
Sbjct: 57  GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTG 116
Query: 62  RSLDYFLFDPI----RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLD 117
             L    FD I    R   +D  +   II+ ++ G+ Y+    +  I+HRDLK  N+LL+
Sbjct: 117 GEL----FDEIISRKRFSEVDAAR---IIRQVLSGITYMH---KNKIVHRDLKPENLLLE 166
Query: 118 ---EDLKPKISDFGLARILRKMILKQIQIELG---YIPPEYVGRGVYYKK 161
              +D   +I DFGL+        K+++ ++G   YI PE V  G Y +K
Sbjct: 167 SKSKDANIRIIDFGLSTHFEAS--KKMKDKIGTAYYIAPE-VLHGTYDEK 213

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/128 (31%), Positives = 68/128 (53%), Gaps = 10/128 (7%)
Query: 9   IAVKKLSK---KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYE--YMPKRS 63
           +A+KKLS+     T     ++ E++L   + H N+I +      Q+ +  ++  Y+    
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           +D  L   I+M  LD ++  +++  ++ G+ +L       IIHRDLK SNI++  D   K
Sbjct: 111 MDANLSQVIQME-LDHERMSYLLYQMLVGIKHLHS---AGIIHRDLKPSNIVVKSDATLK 166
Query: 124 ISDFGLAR 131
           I DFGLAR
Sbjct: 167 ILDFGLAR 174

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 65/134 (48%), Gaps = 18/134 (13%)
Query: 26  KNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPI----RMLILDCKK 81
           + E+ +  KL H  +I++    + ++Y ++ E M    L    FD +    R+    CK 
Sbjct: 202 ETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKL 257
Query: 82  RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL---DEDLKPKISDFGLARIL-RKMI 137
             +      Q LL +Q      IIHRDLK  N+LL   +ED   KI+DFG ++IL    +
Sbjct: 258 YFY------QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 311
Query: 138 LKQIQIELGYIPPE 151
           ++ +     Y+ PE
Sbjct: 312 MRTLCGTPTYLAPE 325

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 64/139 (46%), Gaps = 19/139 (13%)
Query: 9   IAVKKLSKKSTQ-GFEEFKNEV-MLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLD 65
           +AVK L   +T+    +  +E+ M+    +H N+I + G C +     +I EY  K +L 
Sbjct: 63  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 122
Query: 66  YFL-----------FDPIRML--ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVS 112
            +L           ++P       L  K  V     + +G+ YL        IHRDL   
Sbjct: 123 EYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAAR 179
Query: 113 NILLDEDLKPKISDFGLAR 131
           N+L+ ED   KI+DFGLAR
Sbjct: 180 NVLVTEDNVMKIADFGLAR 198

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 23/45 (51%), Positives = 30/45 (66%), Gaps = 3/45 (6%)
Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARIL 133
           I+  L YL       IIHRDLK  NILL+ED+  +I+DFG A++L
Sbjct: 123 IVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVL 164

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 19/30 (63%), Positives = 25/30 (83%)
Query: 104 IIHRDLKVSNILLDEDLKPKISDFGLARIL 133
           IIHRDLK  NILL+ED+  +I+DFG A++L
Sbjct: 128 IIHRDLKPENILLNEDMHIQITDFGTAKVL 157

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 19/30 (63%), Positives = 25/30 (83%)
Query: 104 IIHRDLKVSNILLDEDLKPKISDFGLARIL 133
           IIHRDLK  NILL+ED+  +I+DFG A++L
Sbjct: 129 IIHRDLKPENILLNEDMHIQITDFGTAKVL 158

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 75/161 (46%), Gaps = 10/161 (6%)
Query: 8   IIAVKKLSKKSTQ--GFE-EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRS 63
           I+A+K L K   +  G E + + EV + + L+H N++R+ G+  +     LI EY P   
Sbjct: 38  ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP--- 94
Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           L     +  ++   D ++    I  +   L Y        +IHRD+K  N+LL    + K
Sbjct: 95  LGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELK 151
Query: 124 ISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKKFSL 164
           I++FG +          +   L Y+PPE +   ++ +K  L
Sbjct: 152 IANFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDL 192

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 23/45 (51%), Positives = 30/45 (66%), Gaps = 3/45 (6%)
Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARIL 133
           I+  L YL       IIHRDLK  NILL+ED+  +I+DFG A++L
Sbjct: 118 IVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVL 159

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 42/139 (30%), Positives = 64/139 (46%), Gaps = 19/139 (13%)
Query: 9   IAVKKLSKKSTQ-GFEEFKNEV-MLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLD 65
           +AVK L   +T+    +  +E+ M+    +H N+I + G C +     +I EY  K +L 
Sbjct: 48  VAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLR 107
Query: 66  YFL-----------FDPIRML--ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVS 112
            +L           ++P       L  K  V     + +G+ YL        IHRDL   
Sbjct: 108 EYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAAR 164
Query: 113 NILLDEDLKPKISDFGLAR 131
           N+L+ ED   KI+DFGLAR
Sbjct: 165 NVLVTEDNVMKIADFGLAR 183

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 19/30 (63%), Positives = 25/30 (83%)
Query: 104 IIHRDLKVSNILLDEDLKPKISDFGLARIL 133
           IIHRDLK  NILL+ED+  +I+DFG A++L
Sbjct: 131 IIHRDLKPENILLNEDMHIQITDFGTAKVL 160

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 41/141 (29%), Positives = 70/141 (49%), Gaps = 15/141 (10%)
Query: 28  EVMLTAKLQ---HLNLIR-VGFCIETQ-----EYMLIYEYMPKRSLDYFLFDPIRMLILD 78
           EV L  +L+   H N++R +  C  ++     +  L++E++ +    Y    P   L  +
Sbjct: 53  EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAE 112
Query: 79  CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILR-KMI 137
             K   +++  ++GL +L       I+HRDLK  NIL+      K++DFGLARI   +M 
Sbjct: 113 TIK--DLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA 167
Query: 138 LKQIQIELGYIPPEYVGRGVY 158
           L  + + L Y  PE + +  Y
Sbjct: 168 LFPVVVTLWYRAPEVLLQSTY 188

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 39/162 (24%), Positives = 77/162 (47%), Gaps = 10/162 (6%)
Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSL 64
           GQ +A+++++ +     E   NE+++  + ++ N++  +   +   E  ++ EY+   SL
Sbjct: 46  GQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 105
Query: 65  DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKI 124
                D +    +D  +   + +  +Q L +L       +IHR++K  NILL  D   K+
Sbjct: 106 T----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIHRNIKSDNILLGMDGSVKL 158
Query: 125 SDFGL-ARILRKMILKQIQIELGY-IPPEYVGRGVYYKKFSL 164
           +DFG  A+I  +   +   +   Y + PE V R  Y  K  +
Sbjct: 159 TDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 200

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 46/141 (32%), Positives = 67/141 (47%), Gaps = 29/141 (20%)
Query: 6   GQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
           G  +AVKKLS+  +S    +    E+ L   ++H N+I            L+  + P RS
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG-----------LLDVFTPARS 95
Query: 64  LDYF--------LFDPIRMLILDCKKRVH-----IIKGIIQGLLYLQEYFRLTIIHRDLK 110
           L+ F        L       I+ C+K        +I  I++GL Y+       IIHRDLK
Sbjct: 96  LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLK 152
Query: 111 VSNILLDEDLKPKISDFGLAR 131
            SN+ ++ED + KI D GLAR
Sbjct: 153 PSNLAVNEDCELKILDGGLAR 173

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 21/47 (44%), Positives = 31/47 (65%), Gaps = 3/47 (6%)
Query: 84  HIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLA 130
           + ++  IQG+ YL       +IHRDLK+ N+ L++D+  KI DFGLA
Sbjct: 146 YFMRQTIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLA 189

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 21/47 (44%), Positives = 31/47 (65%), Gaps = 3/47 (6%)
Query: 84  HIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLA 130
           + ++  IQG+ YL       +IHRDLK+ N+ L++D+  KI DFGLA
Sbjct: 146 YFMRQTIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLA 189

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/153 (28%), Positives = 72/153 (47%), Gaps = 11/153 (7%)
Query: 8   IIAVKKLSKKSTQ--GFE-EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRS 63
           I+A+K L K   +  G E + + EV + + L+H N++R+ G+  +     LI EY P   
Sbjct: 37  ILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP--- 93
Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           L     +  ++   D ++    I  +   L Y        +IHRD+K  N+LL    + K
Sbjct: 94  LGTVYRELQKLSKFDEQRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELK 150
Query: 124 ISDFGLARILRKMILKQIQIELGYIPPEYV-GR 155
           I++FG +          +   L Y+PPE + GR
Sbjct: 151 IANFGWSVHAPSSRRTTLCGTLDYLPPEMIEGR 183

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/128 (31%), Positives = 68/128 (53%), Gaps = 10/128 (7%)
Query: 9   IAVKKLSK---KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYE--YMPKRS 63
           +A+KKLS+     T     ++ E++L   + H N+I +      Q+ +  ++  Y+    
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           +D  L   I+M  LD ++  +++  ++ G+ +L       IIHRDLK SNI++  D   K
Sbjct: 111 MDANLSQVIQME-LDHERMSYLLYQMLVGIKHLHS---AGIIHRDLKPSNIVVKSDATLK 166
Query: 124 ISDFGLAR 131
           I DFGLAR
Sbjct: 167 ILDFGLAR 174

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 21/47 (44%), Positives = 31/47 (65%), Gaps = 3/47 (6%)
Query: 84  HIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLA 130
           + ++  IQG+ YL       +IHRDLK+ N+ L++D+  KI DFGLA
Sbjct: 130 YFMRQTIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLA 173

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 43.5 bits (101), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 40/134 (29%), Positives = 65/134 (48%), Gaps = 18/134 (13%)
Query: 26  KNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPI----RMLILDCKK 81
           + E+ +  KL H  +I++    + ++Y ++ E M    L    FD +    R+    CK 
Sbjct: 188 ETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKL 243
Query: 82  RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL---DEDLKPKISDFGLARIL-RKMI 137
             +      Q LL +Q      IIHRDLK  N+LL   +ED   KI+DFG ++IL    +
Sbjct: 244 YFY------QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 297
Query: 138 LKQIQIELGYIPPE 151
           ++ +     Y+ PE
Sbjct: 298 MRTLCGTPTYLAPE 311

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 21/47 (44%), Positives = 31/47 (65%), Gaps = 3/47 (6%)
Query: 84  HIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLA 130
           + ++  IQG+ YL       +IHRDLK+ N+ L++D+  KI DFGLA
Sbjct: 146 YFMRQTIQGVQYLHNN---RVIHRDLKLGNLFLNDDMDVKIGDFGLA 189

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 68/142 (47%), Gaps = 13/142 (9%)
Query: 26  KNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHI 85
           + E+ +  KL H  +I++    + ++Y ++ E M    L   +    R+    CK   + 
Sbjct: 69  ETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY- 127
Query: 86  IKGIIQGLLYLQEYFRLTIIHRDLKVSNILL---DEDLKPKISDFGLARILRKM-ILKQI 141
                Q LL +Q      IIHRDLK  N+LL   +ED   KI+DFG ++IL +  +++ +
Sbjct: 128 -----QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL 182
Query: 142 QIELGYIPPE---YVGRGVYYK 160
                Y+ PE    VG   Y +
Sbjct: 183 CGTPTYLAPEVLVSVGTAGYNR 204

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 34/132 (25%), Positives = 70/132 (53%), Gaps = 14/132 (10%)
Query: 6   GQIIAVKKLS-KKSTQGFEEFK-NEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMP-- 60
           G+++A+ K+     T+G       E+ L  +L H N++++   I T+  + L++E++   
Sbjct: 28  GEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD 87
Query: 61  -KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
            K+ +D      I + ++        +  ++QGL +   +    ++HRDLK  N+L++ +
Sbjct: 88  LKKFMDASALTGIPLPLIKS-----YLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTE 139
Query: 120 LKPKISDFGLAR 131
              K++DFGLAR
Sbjct: 140 GAIKLADFGLAR 151

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 34/132 (25%), Positives = 70/132 (53%), Gaps = 14/132 (10%)
Query: 6   GQIIAVKKLS-KKSTQGFEEFK-NEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMP-- 60
           G+++A+ K+     T+G       E+ L  +L H N++++   I T+  + L++E++   
Sbjct: 27  GEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQD 86
Query: 61  -KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
            K+ +D      I + ++        +  ++QGL +   +    ++HRDLK  N+L++ +
Sbjct: 87  LKKFMDASALTGIPLPLIKS-----YLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTE 138
Query: 120 LKPKISDFGLAR 131
              K++DFGLAR
Sbjct: 139 GAIKLADFGLAR 150

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 46/141 (32%), Positives = 67/141 (47%), Gaps = 29/141 (20%)
Query: 6   GQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
           G  +AVKKLS+  +S    +    E+ L   ++H N+I            L+  + P RS
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG-----------LLDVFTPARS 95
Query: 64  LDYF--------LFDPIRMLILDCKKRVH-----IIKGIIQGLLYLQEYFRLTIIHRDLK 110
           L+ F        L       I+ C+K        +I  I++GL Y+       IIHRDLK
Sbjct: 96  LEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLK 152
Query: 111 VSNILLDEDLKPKISDFGLAR 131
            SN+ ++ED + KI D GLAR
Sbjct: 153 PSNLAVNEDCELKILDRGLAR 173

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/128 (31%), Positives = 68/128 (53%), Gaps = 10/128 (7%)
Query: 9   IAVKKLSK---KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYE--YMPKRS 63
           +A+KKLS+     T     ++ E++L   + H N+I +      Q+ +  ++  Y+    
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           +D  L   I+M  LD ++  +++  ++ G+ +L       IIHRDLK SNI++  D   K
Sbjct: 111 MDANLSQVIQME-LDHERMSYLLYQMLVGIKHLHS---AGIIHRDLKPSNIVVKSDATLK 166
Query: 124 ISDFGLAR 131
           I DFGLAR
Sbjct: 167 ILDFGLAR 174

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 34/126 (26%), Positives = 64/126 (50%), Gaps = 5/126 (3%)
Query: 9   IAVKKLSKKSTQGFEEFK-NEVMLTAKLQHLNLIRVGFCIETQEYMLIYE-YMPKRSLDY 66
           +A+KK+S    Q + +    E+ +  + +H N+I +   I       + + Y+ +  ++ 
Sbjct: 55  VAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 114
Query: 67  FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISD 126
            L+  ++   L      + +  I++GL Y+       ++HRDLK SN+LL+     KI D
Sbjct: 115 DLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICD 171
Query: 127 FGLARI 132
           FGLAR+
Sbjct: 172 FGLARV 177

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/128 (31%), Positives = 68/128 (53%), Gaps = 10/128 (7%)
Query: 9   IAVKKLSK---KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYE--YMPKRS 63
           +A+KKLS+     T     ++ E++L   + H N+I +      Q+ +  ++  Y+    
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL 110
Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           +D  L   I+M  LD ++  +++  ++ G+ +L       IIHRDLK SNI++  D   K
Sbjct: 111 MDANLSQVIQME-LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDATLK 166
Query: 124 ISDFGLAR 131
           I DFGLAR
Sbjct: 167 ILDFGLAR 174

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 67/142 (47%), Gaps = 13/142 (9%)
Query: 26  KNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHI 85
           + E+ +  KL H  +I++    + ++Y ++ E M    L   +    R+    CK   + 
Sbjct: 63  ETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY- 121
Query: 86  IKGIIQGLLYLQEYFRLTIIHRDLKVSNILL---DEDLKPKISDFGLARIL-RKMILKQI 141
                Q LL +Q      IIHRDLK  N+LL   +ED   KI+DFG ++IL    +++ +
Sbjct: 122 -----QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL 176
Query: 142 QIELGYIPPE---YVGRGVYYK 160
                Y+ PE    VG   Y +
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNR 198

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 67/142 (47%), Gaps = 13/142 (9%)
Query: 26  KNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHI 85
           + E+ +  KL H  +I++    + ++Y ++ E M    L   +    R+    CK   + 
Sbjct: 62  ETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY- 120
Query: 86  IKGIIQGLLYLQEYFRLTIIHRDLKVSNILL---DEDLKPKISDFGLARIL-RKMILKQI 141
                Q LL +Q      IIHRDLK  N+LL   +ED   KI+DFG ++IL    +++ +
Sbjct: 121 -----QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL 175
Query: 142 QIELGYIPPE---YVGRGVYYK 160
                Y+ PE    VG   Y +
Sbjct: 176 CGTPTYLAPEVLVSVGTAGYNR 197

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 43/146 (29%), Positives = 69/146 (47%), Gaps = 21/146 (14%)
Query: 26  KNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPI----RMLILDCKK 81
           + E+ +  KL H  +I++    + ++Y ++ E M    L    FD +    R+    CK 
Sbjct: 63  ETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKL 118
Query: 82  RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL---DEDLKPKISDFGLARIL-RKMI 137
             +      Q LL +Q      IIHRDLK  N+LL   +ED   KI+DFG ++IL    +
Sbjct: 119 YFY------QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL 172
Query: 138 LKQIQIELGYIPPE---YVGRGVYYK 160
           ++ +     Y+ PE    VG   Y +
Sbjct: 173 MRTLCGTPTYLAPEVLVSVGTAGYNR 198

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 21/45 (46%), Positives = 32/45 (71%), Gaps = 3/45 (6%)
Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARIL 133
           +++GL Y+       +IHRDLK SN+L++E+ + KI DFG+AR L
Sbjct: 168 LLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGL 209

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 64/132 (48%), Gaps = 10/132 (7%)
Query: 5   DGQII--AVKKLSKKSTQG-FEEFKNEVMLTAKLQHLNLIRV-GFCIETQ-EYMLIYEYM 59
           DG+ I  AVK L++ +  G   +F  E ++     H N++ + G C+ ++   +++  YM
Sbjct: 114 DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 173
Query: 60  PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
               L  F+ +      +  K  +     + +G+ +L        +HRDL   N +LDE 
Sbjct: 174 KHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEK 228
Query: 120 LKPKISDFGLAR 131
              K++DFGLAR
Sbjct: 229 FTVKVADFGLAR 240

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 40/138 (28%), Positives = 71/138 (51%), Gaps = 14/138 (10%)
Query: 3   LPDGQ----IIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIY 56
           +PDG+     +A+K L +  S +  +E  +E  + A +    + R+ G C+ T    L+ 
Sbjct: 39  IPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRLLGICL-TSTVQLVT 97
Query: 57  EYMPKRSL-DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNIL 115
           + MP   L D+   +  R   L  +  ++    I +G+ YL++   + ++HRDL   N+L
Sbjct: 98  QLMPYGCLLDHVRENRGR---LGSQDLLNWCMQIAKGMSYLED---VRLVHRDLAARNVL 151
Query: 116 LDEDLKPKISDFGLARIL 133
           +      KI+DFGLAR+L
Sbjct: 152 VKSPNHVKITDFGLARLL 169

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 43.5 bits (101), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 71/153 (46%), Gaps = 26/153 (16%)
Query: 6   GQIIAVKKLSKKSTQGF---EEFKNEVMLTAKLQHLNLIRVGFCIE-------TQEYMLI 55
           G+ +AVK  S +  + +    E  N VML    +H N++  GF          + +  LI
Sbjct: 60  GENVAVKIFSSRDEKSWFRETELYNTVML----RHENIL--GFIASDMTSRHSSTQLWLI 113
Query: 56  YEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQ-EYF----RLTIIHRDLK 110
             Y    SL    +D +++  LD    + I+  I  GL +L  E F    +  I HRDLK
Sbjct: 114 THYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLK 169
Query: 111 VSNILLDEDLKPKISDFGLARILRKMILKQIQI 143
             NIL+ ++ +  I+D GLA ++      Q+ +
Sbjct: 170 SKNILVKKNGQCCIADLGLA-VMHSQSTNQLDV 201

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 41/142 (28%), Positives = 67/142 (47%), Gaps = 13/142 (9%)
Query: 26  KNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHI 85
           + E+ +  KL H  +I++    + ++Y ++ E M    L   +    R+    CK   + 
Sbjct: 63  ETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFY- 121
Query: 86  IKGIIQGLLYLQEYFRLTIIHRDLKVSNILL---DEDLKPKISDFGLARIL-RKMILKQI 141
                Q LL +Q      IIHRDLK  N+LL   +ED   KI+DFG ++IL    +++ +
Sbjct: 122 -----QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTL 176
Query: 142 QIELGYIPPE---YVGRGVYYK 160
                Y+ PE    VG   Y +
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNR 198

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 47/173 (27%), Positives = 74/173 (42%), Gaps = 29/173 (16%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKL-----QHLNLIRV-GFCIETQEYMLIYEYMPKR 62
           +AVK L  KST   +E K  +M   K+     QH N++ + G C      ++I EY    
Sbjct: 79  VAVKML--KSTAHADE-KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYG 135
Query: 63  SLDYFL-----------FDPIRML--ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDL 109
            L  FL           ++P       L  +  +H    + QG+ +L        IHRD+
Sbjct: 136 DLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLAS---KNCIHRDV 192
Query: 110 KVSNILLDEDLKPKISDFGLARILRK----MILKQIQIELGYIPPEYVGRGVY 158
              N+LL      KI DFGLAR +      ++    ++ + ++ PE +   VY
Sbjct: 193 AARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVY 245

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 43.1 bits (100), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 64/132 (48%), Gaps = 10/132 (7%)
Query: 5   DGQII--AVKKLSKKSTQG-FEEFKNEVMLTAKLQHLNLIRV-GFCIETQ-EYMLIYEYM 59
           DG+ I  AVK L++ +  G   +F  E ++     H N++ + G C+ ++   +++  YM
Sbjct: 55  DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 114
Query: 60  PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
               L  F+ +      +  K  +     + +G+ +L        +HRDL   N +LDE 
Sbjct: 115 KHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEK 169
Query: 120 LKPKISDFGLAR 131
              K++DFGLAR
Sbjct: 170 FTVKVADFGLAR 181

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 38/127 (29%), Positives = 62/127 (48%), Gaps = 13/127 (10%)
Query: 8   IIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCI-ETQEYMLIYEYMPKRSLDY 66
           II  KKLS +  Q  E    E  +   L+H N++R+   I E   + LI++ +    L  
Sbjct: 43  IINTKKLSARDHQKLE---REARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGEL-- 97
Query: 67  FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKP---K 123
              D +           H I+ I++ +L+  +   + ++HR+LK  N+LL   LK    K
Sbjct: 98  -FEDIVAREYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVK 153
Query: 124 ISDFGLA 130
           ++DFGLA
Sbjct: 154 LADFGLA 160

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 23/50 (46%), Positives = 33/50 (66%), Gaps = 1/50 (2%)
Query: 86  IKGIIQGLLYLQEYFRLT-IIHRDLKVSNILLDEDLKPKISDFGLARILR 134
           +K I+  LL  +++   + IIHRDLK +N LL++D   KI DFGLAR + 
Sbjct: 133 VKTILYNLLLGEKFIHESGIIHRDLKPANCLLNQDCSVKICDFGLARTIN 182

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 64/132 (48%), Gaps = 10/132 (7%)
Query: 5   DGQII--AVKKLSKKSTQG-FEEFKNEVMLTAKLQHLNLIRV-GFCIETQ-EYMLIYEYM 59
           DG+ I  AVK L++ +  G   +F  E ++     H N++ + G C+ ++   +++  YM
Sbjct: 60  DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 119
Query: 60  PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
               L  F+ +      +  K  +     + +G+ +L        +HRDL   N +LDE 
Sbjct: 120 KHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEK 174
Query: 120 LKPKISDFGLAR 131
              K++DFGLAR
Sbjct: 175 FTVKVADFGLAR 186

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 64/132 (48%), Gaps = 10/132 (7%)
Query: 5   DGQII--AVKKLSKKSTQG-FEEFKNEVMLTAKLQHLNLIRV-GFCIETQ-EYMLIYEYM 59
           DG+ I  AVK L++ +  G   +F  E ++     H N++ + G C+ ++   +++  YM
Sbjct: 56  DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 115
Query: 60  PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
               L  F+ +      +  K  +     + +G+ +L        +HRDL   N +LDE 
Sbjct: 116 KHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEK 170
Query: 120 LKPKISDFGLAR 131
              K++DFGLAR
Sbjct: 171 FTVKVADFGLAR 182

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 64/132 (48%), Gaps = 10/132 (7%)
Query: 5   DGQII--AVKKLSKKSTQG-FEEFKNEVMLTAKLQHLNLIRV-GFCIETQ-EYMLIYEYM 59
           DG+ I  AVK L++ +  G   +F  E ++     H N++ + G C+ ++   +++  YM
Sbjct: 56  DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 115
Query: 60  PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
               L  F+ +      +  K  +     + +G+ +L        +HRDL   N +LDE 
Sbjct: 116 KHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEK 170
Query: 120 LKPKISDFGLAR 131
              K++DFGLAR
Sbjct: 171 FTVKVADFGLAR 182

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 64/132 (48%), Gaps = 10/132 (7%)
Query: 5   DGQII--AVKKLSKKSTQG-FEEFKNEVMLTAKLQHLNLIRV-GFCIETQ-EYMLIYEYM 59
           DG+ I  AVK L++ +  G   +F  E ++     H N++ + G C+ ++   +++  YM
Sbjct: 53  DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 112
Query: 60  PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
               L  F+ +      +  K  +     + +G+ +L        +HRDL   N +LDE 
Sbjct: 113 KHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEK 167
Query: 120 LKPKISDFGLAR 131
              K++DFGLAR
Sbjct: 168 FTVKVADFGLAR 179

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 21/45 (46%), Positives = 32/45 (71%), Gaps = 3/45 (6%)
Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARIL 133
           +++GL Y+       +IHRDLK SN+L++E+ + KI DFG+AR L
Sbjct: 167 LLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGL 208

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 36/132 (27%), Positives = 64/132 (48%), Gaps = 10/132 (7%)
Query: 5   DGQII--AVKKLSKKSTQG-FEEFKNEVMLTAKLQHLNLIRV-GFCIETQ-EYMLIYEYM 59
           DG+ I  AVK L++ +  G   +F  E ++     H N++ + G C+ ++   +++  YM
Sbjct: 55  DGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 114
Query: 60  PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
               L  F+ +      +  K  +     + +G+ +L        +HRDL   N +LDE 
Sbjct: 115 KHGDLRNFIRNETHNPTV--KDLIGFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEK 169
Query: 120 LKPKISDFGLAR 131
              K++DFGLAR
Sbjct: 170 FTVKVADFGLAR 181

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 34/126 (26%), Positives = 64/126 (50%), Gaps = 5/126 (3%)
Query: 9   IAVKKLSKKSTQGF-EEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYE-YMPKRSLDY 66
           +A+KK+S    Q + +    E+ +  + +H N+I +   I       + + Y+ +  ++ 
Sbjct: 55  VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 114
Query: 67  FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISD 126
            L+  ++   L      + +  I++GL Y+       ++HRDLK SN+LL+     KI D
Sbjct: 115 DLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICD 171
Query: 127 FGLARI 132
           FGLAR+
Sbjct: 172 FGLARV 177

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 34/126 (26%), Positives = 64/126 (50%), Gaps = 5/126 (3%)
Query: 9   IAVKKLSKKSTQGF-EEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYE-YMPKRSLDY 66
           +A+KK+S    Q + +    E+ +  + +H N+I +   I       + + Y+ +  ++ 
Sbjct: 71  VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 130
Query: 67  FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISD 126
            L+  ++   L      + +  I++GL Y+       ++HRDLK SN+LL+     KI D
Sbjct: 131 DLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICD 187
Query: 127 FGLARI 132
           FGLAR+
Sbjct: 188 FGLARV 193

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 34/126 (26%), Positives = 64/126 (50%), Gaps = 5/126 (3%)
Query: 9   IAVKKLSKKSTQGF-EEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYE-YMPKRSLDY 66
           +A+KK+S    Q + +    E+ +  + +H N+I +   I       + + Y+ +  ++ 
Sbjct: 56  VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 115
Query: 67  FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISD 126
            L+  ++   L      + +  I++GL Y+       ++HRDLK SN+LL+     KI D
Sbjct: 116 DLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICD 172
Query: 127 FGLARI 132
           FGLAR+
Sbjct: 173 FGLARV 178

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 34/126 (26%), Positives = 64/126 (50%), Gaps = 5/126 (3%)
Query: 9   IAVKKLSKKSTQGF-EEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYE-YMPKRSLDY 66
           +A+KK+S    Q + +    E+ +  + +H N+I +   I       + + Y+ +  ++ 
Sbjct: 53  VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 112
Query: 67  FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISD 126
            L+  ++   L      + +  I++GL Y+       ++HRDLK SN+LL+     KI D
Sbjct: 113 DLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICD 169
Query: 127 FGLARI 132
           FGLAR+
Sbjct: 170 FGLARV 175

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 34/126 (26%), Positives = 64/126 (50%), Gaps = 5/126 (3%)
Query: 9   IAVKKLSKKSTQGF-EEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYE-YMPKRSLDY 66
           +A+KK+S    Q + +    E+ +  + +H N+I +   I       + + Y+ +  ++ 
Sbjct: 49  VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 108
Query: 67  FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISD 126
            L+  ++   L      + +  I++GL Y+       ++HRDLK SN+LL+     KI D
Sbjct: 109 DLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICD 165
Query: 127 FGLARI 132
           FGLAR+
Sbjct: 166 FGLARV 171

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 23/50 (46%), Positives = 32/50 (64%), Gaps = 1/50 (2%)
Query: 86  IKGIIQGLLYLQEYFRLT-IIHRDLKVSNILLDEDLKPKISDFGLARILR 134
           IK I+  LL  + +   + IIHRDLK +N LL++D   K+ DFGLAR + 
Sbjct: 131 IKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTIN 180

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 34/126 (26%), Positives = 64/126 (50%), Gaps = 5/126 (3%)
Query: 9   IAVKKLSKKSTQGF-EEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYE-YMPKRSLDY 66
           +A+KK+S    Q + +    E+ +  + +H N+I +   I       + + Y+ +  ++ 
Sbjct: 49  VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 108
Query: 67  FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISD 126
            L+  ++   L      + +  I++GL Y+       ++HRDLK SN+LL+     KI D
Sbjct: 109 DLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICD 165
Query: 127 FGLARI 132
           FGLAR+
Sbjct: 166 FGLARV 171

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 34/126 (26%), Positives = 64/126 (50%), Gaps = 5/126 (3%)
Query: 9   IAVKKLSKKSTQGF-EEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYE-YMPKRSLDY 66
           +A+KK+S    Q + +    E+ +  + +H N+I +   I       + + Y+ +  ++ 
Sbjct: 56  VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 115
Query: 67  FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISD 126
            L+  ++   L      + +  I++GL Y+       ++HRDLK SN+LL+     KI D
Sbjct: 116 DLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICD 172
Query: 127 FGLARI 132
           FGLAR+
Sbjct: 173 FGLARV 178

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 34/126 (26%), Positives = 64/126 (50%), Gaps = 5/126 (3%)
Query: 9   IAVKKLSKKSTQGF-EEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYE-YMPKRSLDY 66
           +A+KK+S    Q + +    E+ +  + +H N+I +   I       + + Y+ +  ++ 
Sbjct: 57  VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 116
Query: 67  FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISD 126
            L+  ++   L      + +  I++GL Y+       ++HRDLK SN+LL+     KI D
Sbjct: 117 DLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICD 173
Query: 127 FGLARI 132
           FGLAR+
Sbjct: 174 FGLARV 179

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 34/126 (26%), Positives = 64/126 (50%), Gaps = 5/126 (3%)
Query: 9   IAVKKLSKKSTQGF-EEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYE-YMPKRSLDY 66
           +A+KK+S    Q + +    E+ +  + +H N+I +   I       + + Y+ +  ++ 
Sbjct: 48  VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 107
Query: 67  FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISD 126
            L+  ++   L      + +  I++GL Y+       ++HRDLK SN+LL+     KI D
Sbjct: 108 DLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICD 164
Query: 127 FGLARI 132
           FGLAR+
Sbjct: 165 FGLARV 170

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 43.1 bits (100), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 34/126 (26%), Positives = 64/126 (50%), Gaps = 5/126 (3%)
Query: 9   IAVKKLSKKSTQGF-EEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYE-YMPKRSLDY 66
           +A+KK+S    Q + +    E+ +  + +H N+I +   I       + + Y+ +  ++ 
Sbjct: 55  VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 114
Query: 67  FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISD 126
            L+  ++   L      + +  I++GL Y+       ++HRDLK SN+LL+     KI D
Sbjct: 115 DLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICD 171
Query: 127 FGLARI 132
           FGLAR+
Sbjct: 172 FGLARV 177

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 70/166 (42%), Gaps = 31/166 (18%)
Query: 4   PDGQII--AVKKLSK---KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEY 58
           P G+ +  AVK L        +  ++F  EV     L H NLIR+   + T    ++ E 
Sbjct: 32  PSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTEL 91
Query: 59  MPKRSLDYFLFDPIRMLILDCKKRVHIIKG--------IIQGLLYLQEYFRLTIIHRDLK 110
            P  SL     D +R      K + H + G        + +G+ YL+       IHRDL 
Sbjct: 92  APLGSL----LDRLR------KHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLA 138
Query: 111 VSNILLDEDLKPKISDFGLARILRK-----MILKQIQIELGYIPPE 151
             N+LL      KI DFGL R L +     ++ +  ++   +  PE
Sbjct: 139 ARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 34/126 (26%), Positives = 64/126 (50%), Gaps = 5/126 (3%)
Query: 9   IAVKKLSKKSTQGF-EEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYE-YMPKRSLDY 66
           +A+KK+S    Q + +    E+ +  + +H N+I +   I       + + Y+ +  ++ 
Sbjct: 51  VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 110
Query: 67  FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISD 126
            L+  ++   L      + +  I++GL Y+       ++HRDLK SN+LL+     KI D
Sbjct: 111 DLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICD 167
Query: 127 FGLARI 132
           FGLAR+
Sbjct: 168 FGLARV 173

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 79/158 (50%), Gaps = 24/158 (15%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLI-RVGFCIETQEYMLIYEYMPKRSLDYF 67
           + +K L K      E F     + +KL H +L+   G C+   E +L+ E++   SLD +
Sbjct: 43  VLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTY 102
Query: 68  L---FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL--DEDLKP 122
           L    + I +L      ++ + K +   + +L+E    T+IH ++   NILL  +ED K 
Sbjct: 103 LKKNKNCINILW-----KLEVAKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKT 154
Query: 123 ------KISDFGLA-RILRKMILKQIQIELGYIPPEYV 153
                 K+SD G++  +L K IL++    + ++PPE +
Sbjct: 155 GNPPFIKLSDPGISITVLPKDILQE---RIPWVPPECI 189

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 34/126 (26%), Positives = 64/126 (50%), Gaps = 5/126 (3%)
Query: 9   IAVKKLSKKSTQGF-EEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYE-YMPKRSLDY 66
           +A+KK+S    Q + +    E+ +  + +H N+I +   I       + + Y+ +  ++ 
Sbjct: 59  VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 118
Query: 67  FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISD 126
            L+  ++   L      + +  I++GL Y+       ++HRDLK SN+LL+     KI D
Sbjct: 119 DLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICD 175
Query: 127 FGLARI 132
           FGLAR+
Sbjct: 176 FGLARV 181

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 34/126 (26%), Positives = 64/126 (50%), Gaps = 5/126 (3%)
Query: 9   IAVKKLSKKSTQGF-EEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYE-YMPKRSLDY 66
           +A+KK+S    Q + +    E+ +  + +H N+I +   I       + + Y+ +  ++ 
Sbjct: 51  VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 110
Query: 67  FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISD 126
            L+  ++   L      + +  I++GL Y+       ++HRDLK SN+LL+     KI D
Sbjct: 111 DLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICD 167
Query: 127 FGLARI 132
           FGLAR+
Sbjct: 168 FGLARV 173

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 81/178 (45%), Gaps = 26/178 (14%)
Query: 5   DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEY------------ 52
           DG+   +K++   +    E+ + EV   AKL H+N++    C +  +Y            
Sbjct: 35  DGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRS 90
Query: 53  -----MLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHR 107
                 +  E+  K +L+ ++ +  R   LD    + + + I +G+ Y+       +I+R
Sbjct: 91  KTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLALELFEQITKGVDYIHSK---KLINR 146
Query: 108 DLKVSNILLDEDLKPKISDFGLARILRKMILK-QIQIELGYIPPEYVGRGVYYKKFSL 164
           DLK SNI L +  + KI DFGL   L+    + + +  L Y+ PE +    Y K+  L
Sbjct: 147 DLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRSKGTLRYMSPEQISSQDYGKEVDL 204

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 43.1 bits (100), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 34/126 (26%), Positives = 64/126 (50%), Gaps = 5/126 (3%)
Query: 9   IAVKKLSKKSTQGF-EEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYE-YMPKRSLDY 66
           +A+KK+S    Q + +    E+ +  + +H N+I +   I       + + Y+ +  ++ 
Sbjct: 55  VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 114
Query: 67  FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISD 126
            L+  ++   L      + +  I++GL Y+       ++HRDLK SN+LL+     KI D
Sbjct: 115 DLYKLLKCQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICD 171
Query: 127 FGLARI 132
           FGLAR+
Sbjct: 172 FGLARV 177

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 70/166 (42%), Gaps = 31/166 (18%)
Query: 4   PDGQII--AVKKLSK---KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEY 58
           P G+ +  AVK L        +  ++F  EV     L H NLIR+   + T    ++ E 
Sbjct: 32  PSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTEL 91
Query: 59  MPKRSLDYFLFDPIRMLILDCKKRVHIIKG--------IIQGLLYLQEYFRLTIIHRDLK 110
            P  SL     D +R      K + H + G        + +G+ YL+       IHRDL 
Sbjct: 92  APLGSL----LDRLR------KHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLA 138
Query: 111 VSNILLDEDLKPKISDFGLARILRK-----MILKQIQIELGYIPPE 151
             N+LL      KI DFGL R L +     ++ +  ++   +  PE
Sbjct: 139 ARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPE 184

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 44/153 (28%), Positives = 71/153 (46%), Gaps = 26/153 (16%)
Query: 6   GQIIAVKKLSKKSTQGF---EEFKNEVMLTAKLQHLNLIRVGFCIE-------TQEYMLI 55
           G+ +AVK  S +  + +    E  N VML    +H N++  GF          + +  LI
Sbjct: 31  GENVAVKIFSSRDEKSWFRETELYNTVML----RHENIL--GFIASDMTSRHSSTQLWLI 84
Query: 56  YEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQ-EYF----RLTIIHRDLK 110
             Y    SL    +D +++  LD    + I+  I  GL +L  E F    +  I HRDLK
Sbjct: 85  THYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLK 140
Query: 111 VSNILLDEDLKPKISDFGLARILRKMILKQIQI 143
             NIL+ ++ +  I+D GLA ++      Q+ +
Sbjct: 141 SKNILVKKNGQCCIADLGLA-VMHSQSTNQLDV 172

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 34/126 (26%), Positives = 64/126 (50%), Gaps = 5/126 (3%)
Query: 9   IAVKKLSKKSTQGF-EEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYE-YMPKRSLDY 66
           +A+KK+S    Q + +    E+ +  + +H N+I +   I       + + Y+ +  ++ 
Sbjct: 55  VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 114
Query: 67  FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISD 126
            L+  ++   L      + +  I++GL Y+       ++HRDLK SN+LL+     KI D
Sbjct: 115 DLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICD 171
Query: 127 FGLARI 132
           FGLAR+
Sbjct: 172 FGLARV 177

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 34/126 (26%), Positives = 64/126 (50%), Gaps = 5/126 (3%)
Query: 9   IAVKKLSKKSTQGF-EEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYE-YMPKRSLDY 66
           +A+KK+S    Q + +    E+ +  + +H N+I +   I       + + Y+ +  ++ 
Sbjct: 51  VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 110
Query: 67  FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISD 126
            L+  ++   L      + +  I++GL Y+       ++HRDLK SN+LL+     KI D
Sbjct: 111 DLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICD 167
Query: 127 FGLARI 132
           FGLAR+
Sbjct: 168 FGLARV 173

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 43/140 (30%), Positives = 66/140 (47%), Gaps = 25/140 (17%)
Query: 6   GQIIAVKKLSKKSTQGF---EEFKNEVMLTAKLQHLNLIRVGFCIE-------TQEYMLI 55
           G+ +AVK  S +  + +    E  N VML    +H N++  GF          + +  LI
Sbjct: 31  GENVAVKIFSSRDEKSWFRETELYNTVML----RHENIL--GFIASDMTSRHSSTQLWLI 84
Query: 56  YEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQ-EYF----RLTIIHRDLK 110
             Y    SL    +D +++  LD    + I+  I  GL +L  E F    +  I HRDLK
Sbjct: 85  THYHEMGSL----YDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLK 140
Query: 111 VSNILLDEDLKPKISDFGLA 130
             NIL+ ++ +  I+D GLA
Sbjct: 141 SKNILVKKNGQCCIADLGLA 160

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 34/126 (26%), Positives = 64/126 (50%), Gaps = 5/126 (3%)
Query: 9   IAVKKLSKKSTQGF-EEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYE-YMPKRSLDY 66
           +A+KK+S    Q + +    E+ +  + +H N+I +   I       + + Y+ +  ++ 
Sbjct: 51  VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 110
Query: 67  FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISD 126
            L+  ++   L      + +  I++GL Y+       ++HRDLK SN+LL+     KI D
Sbjct: 111 DLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICD 167
Query: 127 FGLARI 132
           FGLAR+
Sbjct: 168 FGLARV 173

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 42.7 bits (99), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 70/166 (42%), Gaps = 31/166 (18%)
Query: 4   PDGQII--AVKKLSK---KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEY 58
           P G+ +  AVK L        +  ++F  EV     L H NLIR+   + T    ++ E 
Sbjct: 42  PSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTEL 101
Query: 59  MPKRSLDYFLFDPIRMLILDCKKRVHIIKG--------IIQGLLYLQEYFRLTIIHRDLK 110
            P  SL     D +R      K + H + G        + +G+ YL+       IHRDL 
Sbjct: 102 APLGSL----LDRLR------KHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLA 148
Query: 111 VSNILLDEDLKPKISDFGLARILRK-----MILKQIQIELGYIPPE 151
             N+LL      KI DFGL R L +     ++ +  ++   +  PE
Sbjct: 149 ARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPE 194

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 42.7 bits (99), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 70/166 (42%), Gaps = 31/166 (18%)
Query: 4   PDGQII--AVKKLSK---KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEY 58
           P G+ +  AVK L        +  ++F  EV     L H NLIR+   + T    ++ E 
Sbjct: 36  PSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTEL 95
Query: 59  MPKRSLDYFLFDPIRMLILDCKKRVHIIKG--------IIQGLLYLQEYFRLTIIHRDLK 110
            P  SL     D +R      K + H + G        + +G+ YL+       IHRDL 
Sbjct: 96  APLGSL----LDRLR------KHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLA 142
Query: 111 VSNILLDEDLKPKISDFGLARILRK-----MILKQIQIELGYIPPE 151
             N+LL      KI DFGL R L +     ++ +  ++   +  PE
Sbjct: 143 ARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 188

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 42.7 bits (99), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 70/166 (42%), Gaps = 31/166 (18%)
Query: 4   PDGQII--AVKKLSK---KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEY 58
           P G+ +  AVK L        +  ++F  EV     L H NLIR+   + T    ++ E 
Sbjct: 42  PSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTEL 101
Query: 59  MPKRSLDYFLFDPIRMLILDCKKRVHIIKG--------IIQGLLYLQEYFRLTIIHRDLK 110
            P  SL     D +R      K + H + G        + +G+ YL+       IHRDL 
Sbjct: 102 APLGSL----LDRLR------KHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLA 148
Query: 111 VSNILLDEDLKPKISDFGLARILRK-----MILKQIQIELGYIPPE 151
             N+LL      KI DFGL R L +     ++ +  ++   +  PE
Sbjct: 149 ARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 194

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 42.7 bits (99), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 87/171 (50%), Gaps = 16/171 (9%)
Query: 3   LPDGQIIAVKKLSKKSTQGFEEFKNEVM-LTAKLQHLN----LIRVGFCIETQEYMLIYE 57
           +P GQI+AVK++  ++T   +E K  +M L   ++ ++    +   G      +  +  E
Sbjct: 73  VPSGQIMAVKRI--RATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICME 130
Query: 58  YMPKRSLDYF---LFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNI 114
            M   SLD F   + D  + +  D   ++ +   I++ L +L  + +L++IHRD+K SN+
Sbjct: 131 LM-DTSLDKFYKQVIDKGQTIPEDILGKIAV--SIVKALEHL--HSKLSVIHRDVKPSNV 185
Query: 115 LLDEDLKPKISDFGLARILRKMILKQIQIEL-GYIPPEYVGRGVYYKKFSL 164
           L++   + K+ DFG++  L   + K I      Y+ PE +   +  K +S+
Sbjct: 186 LINALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYSV 236

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 42.7 bits (99), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 70/166 (42%), Gaps = 31/166 (18%)
Query: 4   PDGQII--AVKKLSK---KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEY 58
           P G+ +  AVK L        +  ++F  EV     L H NLIR+   + T    ++ E 
Sbjct: 32  PSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTEL 91
Query: 59  MPKRSLDYFLFDPIRMLILDCKKRVHIIKG--------IIQGLLYLQEYFRLTIIHRDLK 110
            P  SL     D +R      K + H + G        + +G+ YL+       IHRDL 
Sbjct: 92  APLGSL----LDRLR------KHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLA 138
Query: 111 VSNILLDEDLKPKISDFGLARILRK-----MILKQIQIELGYIPPE 151
             N+LL      KI DFGL R L +     ++ +  ++   +  PE
Sbjct: 139 ARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 42.7 bits (99), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 34/126 (26%), Positives = 64/126 (50%), Gaps = 5/126 (3%)
Query: 9   IAVKKLSKKSTQGF-EEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYE-YMPKRSLDY 66
           +A+KK+S    Q + +    E+ +  + +H N+I +   I       + + Y+ +  ++ 
Sbjct: 51  VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 110
Query: 67  FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISD 126
            L+  ++   L      + +  I++GL Y+       ++HRDLK SN+LL+     KI D
Sbjct: 111 DLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKIXD 167
Query: 127 FGLARI 132
           FGLAR+
Sbjct: 168 FGLARV 173

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 42.7 bits (99), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 33/132 (25%), Positives = 60/132 (45%), Gaps = 12/132 (9%)
Query: 9   IAVKKLSKKSTQGFE-EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPK----- 61
           +A+K +++ ++     EF NE  +  +    +++R+ G   + Q  ++I E M +     
Sbjct: 48  VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS 107
Query: 62  --RSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
             RSL   + +   +      K + +   I  G+ YL        +HRDL   N ++ ED
Sbjct: 108 YLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 164
Query: 120 LKPKISDFGLAR 131
              KI DFG+ R
Sbjct: 165 FTVKIGDFGMTR 176

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 42.7 bits (99), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 49/88 (55%), Gaps = 7/88 (7%)
Query: 77  LDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM 136
           LD  +   I++ I++GL YL    +   IHRD+K +N+LL E  + K++DFG+A  L   
Sbjct: 121 LDETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 177
Query: 137 ILKQIQIELG---YIPPEYVGRGVYYKK 161
            +K+    +G   ++ PE + +  Y  K
Sbjct: 178 QIKRNTF-VGTPFWMAPEVIKQSAYDSK 204

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/133 (24%), Positives = 61/133 (45%), Gaps = 14/133 (10%)
Query: 9   IAVKKLSKKSTQGFE-EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDY 66
           +A+K +++ ++     EF NE  +  +    +++R+ G   + Q  ++I E M +  L  
Sbjct: 45  VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS 104
Query: 67  FL--------FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE 118
           +L         +P+ +      K + +   I  G+ YL        +HRDL   N ++ E
Sbjct: 105 YLRSLRPEMENNPV-LAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAE 160
Query: 119 DLKPKISDFGLAR 131
           D   KI DFG+ R
Sbjct: 161 DFTVKIGDFGMTR 173

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/133 (24%), Positives = 61/133 (45%), Gaps = 14/133 (10%)
Query: 9   IAVKKLSKKSTQGFE-EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDY 66
           +A+K +++ ++     EF NE  +  +    +++R+ G   + Q  ++I E M +  L  
Sbjct: 80  VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS 139
Query: 67  FL--------FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE 118
           +L         +P+ +      K + +   I  G+ YL        +HRDL   N ++ E
Sbjct: 140 YLRSLRPEMENNPV-LAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAE 195
Query: 119 DLKPKISDFGLAR 131
           D   KI DFG+ R
Sbjct: 196 DFTVKIGDFGMTR 208

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 70/166 (42%), Gaps = 31/166 (18%)
Query: 4   PDGQII--AVKKLSK---KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEY 58
           P G+ +  AVK L        +  ++F  EV     L H NLIR+   + T    ++ E 
Sbjct: 36  PSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTEL 95
Query: 59  MPKRSLDYFLFDPIRMLILDCKKRVHIIKG--------IIQGLLYLQEYFRLTIIHRDLK 110
            P  SL     D +R      K + H + G        + +G+ YL+       IHRDL 
Sbjct: 96  APLGSL----LDRLR------KHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLA 142
Query: 111 VSNILLDEDLKPKISDFGLARILRK-----MILKQIQIELGYIPPE 151
             N+LL      KI DFGL R L +     ++ +  ++   +  PE
Sbjct: 143 ARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 188

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/73 (34%), Positives = 39/73 (53%), Gaps = 9/73 (12%)
Query: 85  IIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQ-- 142
           +++ ++ GL Y+    R  I+HRD+K +N+L+  D   K++DFGLAR        Q    
Sbjct: 130 VMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 186
Query: 143 ----IELGYIPPE 151
               + L Y PPE
Sbjct: 187 XNRVVTLWYRPPE 199

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/133 (24%), Positives = 61/133 (45%), Gaps = 14/133 (10%)
Query: 9   IAVKKLSKKSTQGFE-EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDY 66
           +A+K +++ ++     EF NE  +  +    +++R+ G   + Q  ++I E M +  L  
Sbjct: 52  VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS 111
Query: 67  FL--------FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE 118
           +L         +P+ +      K + +   I  G+ YL        +HRDL   N ++ E
Sbjct: 112 YLRSLRPEMENNPV-LAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAE 167
Query: 119 DLKPKISDFGLAR 131
           D   KI DFG+ R
Sbjct: 168 DFTVKIGDFGMTR 180

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/133 (24%), Positives = 61/133 (45%), Gaps = 14/133 (10%)
Query: 9   IAVKKLSKKSTQGFE-EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDY 66
           +A+K +++ ++     EF NE  +  +    +++R+ G   + Q  ++I E M +  L  
Sbjct: 52  VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS 111
Query: 67  FL--------FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE 118
           +L         +P+ +      K + +   I  G+ YL        +HRDL   N ++ E
Sbjct: 112 YLRSLRPEMENNPV-LAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAE 167
Query: 119 DLKPKISDFGLAR 131
           D   KI DFG+ R
Sbjct: 168 DFTVKIGDFGMTR 180

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/133 (24%), Positives = 61/133 (45%), Gaps = 14/133 (10%)
Query: 9   IAVKKLSKKSTQGFE-EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDY 66
           +A+K +++ ++     EF NE  +  +    +++R+ G   + Q  ++I E M +  L  
Sbjct: 43  VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS 102
Query: 67  FL--------FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE 118
           +L         +P+ +      K + +   I  G+ YL        +HRDL   N ++ E
Sbjct: 103 YLRSLRPEMENNPV-LAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAE 158
Query: 119 DLKPKISDFGLAR 131
           D   KI DFG+ R
Sbjct: 159 DFTVKIGDFGMTR 171

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/133 (24%), Positives = 61/133 (45%), Gaps = 14/133 (10%)
Query: 9   IAVKKLSKKSTQGFE-EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDY 66
           +A+K +++ ++     EF NE  +  +    +++R+ G   + Q  ++I E M +  L  
Sbjct: 51  VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS 110
Query: 67  FL--------FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE 118
           +L         +P+ +      K + +   I  G+ YL        +HRDL   N ++ E
Sbjct: 111 YLRSLRPEMENNPV-LAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAE 166
Query: 119 DLKPKISDFGLAR 131
           D   KI DFG+ R
Sbjct: 167 DFTVKIGDFGMTR 179

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/133 (24%), Positives = 61/133 (45%), Gaps = 14/133 (10%)
Query: 9   IAVKKLSKKSTQGFE-EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDY 66
           +A+K +++ ++     EF NE  +  +    +++R+ G   + Q  ++I E M +  L  
Sbjct: 49  VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS 108
Query: 67  FL--------FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE 118
           +L         +P+ +      K + +   I  G+ YL        +HRDL   N ++ E
Sbjct: 109 YLRSLRPEMENNPV-LAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAE 164
Query: 119 DLKPKISDFGLAR 131
           D   KI DFG+ R
Sbjct: 165 DFTVKIGDFGMTR 177

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 42.7 bits (99), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 49/88 (55%), Gaps = 7/88 (7%)
Query: 77  LDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM 136
           LD  +   I++ I++GL YL    +   IHRD+K +N+LL E  + K++DFG+A  L   
Sbjct: 101 LDETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 157
Query: 137 ILKQIQIELG---YIPPEYVGRGVYYKK 161
            +K+    +G   ++ PE + +  Y  K
Sbjct: 158 QIKRNTF-VGTPFWMAPEVIKQSAYDSK 184

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 38/145 (26%), Positives = 70/145 (48%), Gaps = 16/145 (11%)
Query: 5   DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRS 63
           D +  A+KK+ + + +      +EV L A L H  ++R     +E + ++     + K+S
Sbjct: 30  DSRYYAIKKI-RHTEEKLSTILSEVXLLASLNHQYVVRYYAAWLERRNFVKPXTAVKKKS 88
Query: 64  L---------DYFLFDPIRMLILDCKKRVH--IIKGIIQGLLYLQEYFRLTIIHRDLKVS 112
                     +  L+D I    L+ ++  +  + + I++ L Y+       IIHR+LK  
Sbjct: 89  TLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRNLKPX 145
Query: 113 NILLDEDLKPKISDFGLARILRKMI 137
           NI +DE    KI DFGLA+ + + +
Sbjct: 146 NIFIDESRNVKIGDFGLAKNVHRSL 170

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/132 (25%), Positives = 60/132 (45%), Gaps = 12/132 (9%)
Query: 9   IAVKKLSKKSTQGFE-EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPK----- 61
           +A+K +++ ++     EF NE  +  +    +++R+ G   + Q  ++I E M +     
Sbjct: 58  VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS 117
Query: 62  --RSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
             RSL   + +   +      K + +   I  G+ YL        +HRDL   N ++ ED
Sbjct: 118 YLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAED 174
Query: 120 LKPKISDFGLAR 131
              KI DFG+ R
Sbjct: 175 FTVKIGDFGMTR 186

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/133 (24%), Positives = 61/133 (45%), Gaps = 14/133 (10%)
Query: 9   IAVKKLSKKSTQGFE-EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDY 66
           +A+K +++ ++     EF NE  +  +    +++R+ G   + Q  ++I E M +  L  
Sbjct: 51  VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS 110
Query: 67  FL--------FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE 118
           +L         +P+ +      K + +   I  G+ YL        +HRDL   N ++ E
Sbjct: 111 YLRSLRPEMENNPV-LAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAE 166
Query: 119 DLKPKISDFGLAR 131
           D   KI DFG+ R
Sbjct: 167 DFTVKIGDFGMTR 179

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/73 (34%), Positives = 39/73 (53%), Gaps = 9/73 (12%)
Query: 85  IIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQ-- 142
           +++ ++ GL Y+    R  I+HRD+K +N+L+  D   K++DFGLAR        Q    
Sbjct: 129 VMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 185
Query: 143 ----IELGYIPPE 151
               + L Y PPE
Sbjct: 186 XNRVVTLWYRPPE 198

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/67 (37%), Positives = 40/67 (59%), Gaps = 3/67 (4%)
Query: 88  GIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLA-RILRKMILKQIQIELG 146
            I++ L YL+E  +  +IHRD+K SNILLDE  + K+ DFG++ R++      +      
Sbjct: 132 AIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAA 189
Query: 147 YIPPEYV 153
           Y+ PE +
Sbjct: 190 YMAPERI 196

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 51/154 (33%), Positives = 69/154 (44%), Gaps = 34/154 (22%)
Query: 4   PDGQIIAVKKLSKKSTQGFEEFK------NEVMLTAKLQHL-----NLIRVGFCIETQEY 52
           P GQI+AVK++  +ST   +E K      + VM ++   ++      L R G C    E 
Sbjct: 45  PSGQIMAVKRI--RSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMEL 102
Query: 53  MLIYEYMPKRSLDYF-------LFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTII 105
           M         S D F       L D I   IL       I    ++ L +L+E   L II
Sbjct: 103 M-------STSFDKFYKYVYSVLDDVIPEEILG-----KITLATVKALNHLKE--NLKII 148
Query: 106 HRDLKVSNILLDEDLKPKISDFGLARILRKMILK 139
           HRD+K SNILLD     K+ DFG++  L   I K
Sbjct: 149 HRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAK 182

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/126 (26%), Positives = 62/126 (49%), Gaps = 5/126 (3%)
Query: 9   IAVKKLSKKSTQGF-EEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYE-YMPKRSLDY 66
           +A+KK+S    Q + +    E+ +  + +H N+I +   I       + + Y+    +  
Sbjct: 71  VAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGA 130
Query: 67  FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISD 126
            L+  ++   L      + +  I++GL Y+       ++HRDLK SN+LL+     KI D
Sbjct: 131 DLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTXDLKICD 187
Query: 127 FGLARI 132
           FGLAR+
Sbjct: 188 FGLARV 193

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/73 (34%), Positives = 39/73 (53%), Gaps = 9/73 (12%)
Query: 85  IIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQ-- 142
           +++ ++ GL Y+    R  I+HRD+K +N+L+  D   K++DFGLAR        Q    
Sbjct: 130 VMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 186
Query: 143 ----IELGYIPPE 151
               + L Y PPE
Sbjct: 187 XNRVVTLWYRPPE 199

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/133 (24%), Positives = 61/133 (45%), Gaps = 14/133 (10%)
Query: 9   IAVKKLSKKSTQGFE-EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDY 66
           +A+K +++ ++     EF NE  +  +    +++R+ G   + Q  ++I E M +  L  
Sbjct: 58  VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS 117
Query: 67  FL--------FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE 118
           +L         +P+ +      K + +   I  G+ YL        +HRDL   N ++ E
Sbjct: 118 YLRSLRPEMENNPV-LAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAE 173
Query: 119 DLKPKISDFGLAR 131
           D   KI DFG+ R
Sbjct: 174 DFTVKIGDFGMTR 186

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 25/73 (34%), Positives = 39/73 (53%), Gaps = 9/73 (12%)
Query: 85  IIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQ-- 142
           +++ ++ GL Y+    R  I+HRD+K +N+L+  D   K++DFGLAR        Q    
Sbjct: 130 VMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRY 186
Query: 143 ----IELGYIPPE 151
               + L Y PPE
Sbjct: 187 XNRVVTLWYRPPE 199

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 49/88 (55%), Gaps = 7/88 (7%)
Query: 77  LDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM 136
           LD  +   I++ I++GL YL    +   IHRD+K +N+LL E  + K++DFG+A  L   
Sbjct: 116 LDETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172
Query: 137 ILKQIQIELG---YIPPEYVGRGVYYKK 161
            +K+    +G   ++ PE + +  Y  K
Sbjct: 173 QIKRNXF-VGTPFWMAPEVIKQSAYDSK 199

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 29/88 (32%), Positives = 49/88 (55%), Gaps = 7/88 (7%)
Query: 77  LDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM 136
           LD  +   I++ I++GL YL    +   IHRD+K +N+LL E  + K++DFG+A  L   
Sbjct: 101 LDETQIATILREILKGLDYLHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 157
Query: 137 ILKQIQIELG---YIPPEYVGRGVYYKK 161
            +K+    +G   ++ PE + +  Y  K
Sbjct: 158 QIKRNXF-VGTPFWMAPEVIKQSAYDSK 184

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 45/171 (26%), Positives = 87/171 (50%), Gaps = 16/171 (9%)
Query: 3   LPDGQIIAVKKLSKKSTQGFEEFKNEVM-LTAKLQHLN----LIRVGFCIETQEYMLIYE 57
           +P GQI+AVK++  ++T   +E K  +M L   ++ ++    +   G      +  +  E
Sbjct: 29  VPSGQIMAVKRI--RATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICME 86
Query: 58  YMPKRSLDYF---LFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNI 114
            M   SLD F   + D  + +  D   ++ +   I++ L +L  + +L++IHRD+K SN+
Sbjct: 87  LM-DTSLDKFYKQVIDKGQTIPEDILGKIAV--SIVKALEHL--HSKLSVIHRDVKPSNV 141
Query: 115 LLDEDLKPKISDFGLARILRKMILKQIQIEL-GYIPPEYVGRGVYYKKFSL 164
           L++   + K+ DFG++  L   + K I      Y+ PE +   +  K +S+
Sbjct: 142 LINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSV 192

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 34/126 (26%), Positives = 63/126 (50%), Gaps = 5/126 (3%)
Query: 9   IAVKKLSKKSTQGF-EEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYE-YMPKRSLDY 66
           +A+KK+S    Q + +    E+ +    +H N+I +   I       + + Y+ +  ++ 
Sbjct: 53  VAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 112
Query: 67  FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISD 126
            L+  ++   L      + +  I++GL Y+       ++HRDLK SN+LL+     KI D
Sbjct: 113 DLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICD 169
Query: 127 FGLARI 132
           FGLAR+
Sbjct: 170 FGLARV 175

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/112 (33%), Positives = 58/112 (51%), Gaps = 10/112 (8%)
Query: 51  EYMLIYEYMPKRSLDYFLFDPIRM--LILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRD 108
           E  +  E+M   SLD  L    R+   IL    +V I   +I+GL YL+E  +  I+HRD
Sbjct: 97  EISICMEHMDGGSLDQVLKKAGRIPEQILG---KVSI--AVIKGLTYLREKHK--IMHRD 149
Query: 109 LKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYK 160
           +K SNIL++   + K+ DFG++  L   +         Y+ PE + +G +Y 
Sbjct: 150 VKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERL-QGTHYS 200

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 42.4 bits (98), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 33/126 (26%), Positives = 64/126 (50%), Gaps = 5/126 (3%)
Query: 9   IAVKKLSKKSTQGF-EEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYE-YMPKRSLDY 66
           +A++K+S    Q + +    E+ +  + +H N+I +   I       + + Y+ +  ++ 
Sbjct: 55  VAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 114
Query: 67  FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISD 126
            L+  ++   L      + +  I++GL Y+       ++HRDLK SN+LL+     KI D
Sbjct: 115 DLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICD 171
Query: 127 FGLARI 132
           FGLAR+
Sbjct: 172 FGLARV 177

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/73 (34%), Positives = 43/73 (58%), Gaps = 3/73 (4%)
Query: 88  GIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGY 147
            +I+GL YL+E  +  I+HRD+K SNIL++   + K+ DFG++  L   +  +      Y
Sbjct: 115 AVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFVGTRSY 172
Query: 148 IPPEYVGRGVYYK 160
           + PE + +G +Y 
Sbjct: 173 MSPERL-QGTHYS 184

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 35/121 (28%), Positives = 60/121 (49%), Gaps = 11/121 (9%)
Query: 44  GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLT 103
           G  ++  +  +I EY+   S      D +R    D  +   ++K I++GL YL    +  
Sbjct: 88  GSYLKGSKLWIIMEYLGGGSA----LDLLRAGPFDEFQIATMLKEILKGLDYLHSEKK-- 141
Query: 104 IIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELG---YIPPEYVGRGVYYK 160
            IHRD+K +N+LL E    K++DFG+A  L    +K+    +G   ++ PE + +  Y  
Sbjct: 142 -IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTF-VGTPFWMAPEVIQQSAYDS 199
Query: 161 K 161
           K
Sbjct: 200 K 200

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/73 (34%), Positives = 42/73 (57%), Gaps = 3/73 (4%)
Query: 88  GIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGY 147
            +I+GL YL+E  +  I+HRD+K SNIL++   + K+ DFG++  L   +         Y
Sbjct: 174 AVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSY 231
Query: 148 IPPEYVGRGVYYK 160
           + PE + +G +Y 
Sbjct: 232 MSPERL-QGTHYS 243

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 81/160 (50%), Gaps = 17/160 (10%)
Query: 3   LPDGQ----IIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIY 56
           +P+G+     +A+K+L +  S +  +E  +E  + A + + ++ R+ G C+ T    LI 
Sbjct: 34  IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL-TSTVQLIT 92
Query: 57  EYMPKRSLDYFLFDPIRMLILDCKKR--VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNI 114
           + MP   L     D +R    +   +  ++    I +G+ YL++     ++HRDL   N+
Sbjct: 93  QLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAEGMNYLEDR---RLVHRDLAARNV 145
Query: 115 LLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVG 154
           L+      KI+DFGLA++L     K+   E G +P +++ 
Sbjct: 146 LVKTPQHVKITDFGLAKLLGAE-EKEYHAEGGKVPIKWMA 184

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 21/43 (48%), Positives = 30/43 (69%), Gaps = 3/43 (6%)
Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLAR 131
           +++GL Y+       IIHRDLK SN+ ++ED + +I DFGLAR
Sbjct: 132 LLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLAR 171

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/73 (34%), Positives = 42/73 (57%), Gaps = 3/73 (4%)
Query: 88  GIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGY 147
            +I+GL YL+E  +  I+HRD+K SNIL++   + K+ DFG++  L   +         Y
Sbjct: 139 AVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSY 196
Query: 148 IPPEYVGRGVYYK 160
           + PE + +G +Y 
Sbjct: 197 MSPERL-QGTHYS 208

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/135 (24%), Positives = 72/135 (53%), Gaps = 21/135 (15%)
Query: 6   GQIIAVKKLS-KKSTQGFEEFK-NEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKR 62
           G+  A+KK+  +K  +G       E+ +  +L+H N++++   I T++ + L++E++ + 
Sbjct: 26  GETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQD 85
Query: 63  SLDYFLFDPIRMLILDCKKRVHIIKG------IIQGLLYLQEYFRLTIIHRDLKVSNILL 116
                    ++ L+  C+  +  +        ++ G+ Y  +     ++HRDLK  N+L+
Sbjct: 86  ---------LKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLI 133
Query: 117 DEDLKPKISDFGLAR 131
           + + + KI+DFGLAR
Sbjct: 134 NREGELKIADFGLAR 148

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/135 (24%), Positives = 72/135 (53%), Gaps = 21/135 (15%)
Query: 6   GQIIAVKKLS-KKSTQGFEEFK-NEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKR 62
           G+  A+KK+  +K  +G       E+ +  +L+H N++++   I T++ + L++E++ + 
Sbjct: 26  GETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQD 85
Query: 63  SLDYFLFDPIRMLILDCKKRVHIIKG------IIQGLLYLQEYFRLTIIHRDLKVSNILL 116
                    ++ L+  C+  +  +        ++ G+ Y  +     ++HRDLK  N+L+
Sbjct: 86  ---------LKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLI 133
Query: 117 DEDLKPKISDFGLAR 131
           + + + KI+DFGLAR
Sbjct: 134 NREGELKIADFGLAR 148

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/135 (24%), Positives = 72/135 (53%), Gaps = 21/135 (15%)
Query: 6   GQIIAVKKLS-KKSTQGFEEFK-NEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKR 62
           G+  A+KK+  +K  +G       E+ +  +L+H N++++   I T++ + L++E++ + 
Sbjct: 26  GETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQD 85
Query: 63  SLDYFLFDPIRMLILDCKKRVHIIKG------IIQGLLYLQEYFRLTIIHRDLKVSNILL 116
                    ++ L+  C+  +  +        ++ G+ Y  +     ++HRDLK  N+L+
Sbjct: 86  ---------LKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLI 133
Query: 117 DEDLKPKISDFGLAR 131
           + + + KI+DFGLAR
Sbjct: 134 NREGELKIADFGLAR 148

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/73 (34%), Positives = 42/73 (57%), Gaps = 3/73 (4%)
Query: 88  GIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGY 147
            +I+GL YL+E  +  I+HRD+K SNIL++   + K+ DFG++  L   +         Y
Sbjct: 112 AVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSY 169
Query: 148 IPPEYVGRGVYYK 160
           + PE + +G +Y 
Sbjct: 170 MSPERL-QGTHYS 181

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 72/150 (48%), Gaps = 19/150 (12%)
Query: 11  VKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLF 69
           +KK S  +T       +EV +  +L H N++++  F  + + Y L+ E      L    F
Sbjct: 54  IKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGEL----F 109
Query: 70  DPI--RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE---DLKPKI 124
           D I  R    +    V I+K ++ G  YL ++    I+HRDLK  N+LL+    D   KI
Sbjct: 110 DEIILRQKFSEVDAAV-IMKQVLSGTTYLHKH---NIVHRDLKPENLLLESKSRDALIKI 165
Query: 125 SDFGLARILRKMILKQIQIELG---YIPPE 151
            DFGL+      +  +++  LG   YI PE
Sbjct: 166 VDFGLSAHFE--VGGKMKERLGTAYYIAPE 193

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/73 (34%), Positives = 42/73 (57%), Gaps = 3/73 (4%)
Query: 88  GIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGY 147
            +I+GL YL+E  +  I+HRD+K SNIL++   + K+ DFG++  L   +         Y
Sbjct: 112 AVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSY 169
Query: 148 IPPEYVGRGVYYK 160
           + PE + +G +Y 
Sbjct: 170 MSPERL-QGTHYS 181

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/73 (34%), Positives = 42/73 (57%), Gaps = 3/73 (4%)
Query: 88  GIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGY 147
            +I+GL YL+E  +  I+HRD+K SNIL++   + K+ DFG++  L   +         Y
Sbjct: 112 AVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSY 169
Query: 148 IPPEYVGRGVYYK 160
           + PE + +G +Y 
Sbjct: 170 MSPERL-QGTHYS 181

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 42.0 bits (97), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/141 (31%), Positives = 66/141 (46%), Gaps = 29/141 (20%)
Query: 6   GQIIAVKKLSK--KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
           G  +AVKKLS+  +S    +    E+ L   ++H N+I            L+  + P RS
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIG-----------LLDVFTPARS 95
Query: 64  LDYF-------------LFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLK 110
           L+ F             L + ++   L       +I  I++GL Y+       IIHRDLK
Sbjct: 96  LEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLK 152
Query: 111 VSNILLDEDLKPKISDFGLAR 131
            SN+ ++ED + KI DFGL R
Sbjct: 153 PSNLAVNEDSELKILDFGLCR 173

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/73 (34%), Positives = 42/73 (57%), Gaps = 3/73 (4%)
Query: 88  GIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGY 147
            +I+GL YL+E  +  I+HRD+K SNIL++   + K+ DFG++  L   +         Y
Sbjct: 112 AVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSY 169
Query: 148 IPPEYVGRGVYYK 160
           + PE + +G +Y 
Sbjct: 170 MSPERL-QGTHYS 181

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 25/73 (34%), Positives = 42/73 (57%), Gaps = 3/73 (4%)
Query: 88  GIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGY 147
            +I+GL YL+E  +  I+HRD+K SNIL++   + K+ DFG++  L   +         Y
Sbjct: 112 AVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSY 169
Query: 148 IPPEYVGRGVYYK 160
           + PE + +G +Y 
Sbjct: 170 MSPERL-QGTHYS 181

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/126 (26%), Positives = 63/126 (50%), Gaps = 5/126 (3%)
Query: 9   IAVKKLSKKSTQGF-EEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYE-YMPKRSLDY 66
           +A+KK+S    Q + +    E+ +    +H N+I +   I       + + Y+ +  ++ 
Sbjct: 53  VAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDIIRAPTIEQMKDVYIVQDLMET 112
Query: 67  FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISD 126
            L+  ++   L      + +  I++GL Y+       ++HRDLK SN+LL+     KI D
Sbjct: 113 DLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTSDLKICD 169
Query: 127 FGLARI 132
           FGLAR+
Sbjct: 170 FGLARV 175

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/126 (26%), Positives = 64/126 (50%), Gaps = 5/126 (3%)
Query: 9   IAVKKLSKKSTQGF-EEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYE-YMPKRSLDY 66
           +A+KK+S    Q + +    E+ +  + +H N+I +   +       + + Y+ +  ++ 
Sbjct: 71  VAIKKISPFEHQTYCQRTLREIQILLRFRHENVIGIRDILRASTLEAMRDVYIVQDLMET 130
Query: 67  FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISD 126
            L+  ++   L      + +  I++GL Y+       ++HRDLK SN+L++     KI D
Sbjct: 131 DLYKLLKSQQLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLINTTCDLKICD 187
Query: 127 FGLARI 132
           FGLARI
Sbjct: 188 FGLARI 193

>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/158 (27%), Positives = 78/158 (49%), Gaps = 24/158 (15%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLI-RVGFCIETQEYMLIYEYMPKRSLDYF 67
           + +K L K      E F     + +KL H +L+   G C    E +L+ E++   SLD +
Sbjct: 43  VLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTY 102
Query: 68  L---FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL--DEDLKP 122
           L    + I +L      ++ + K +   + +L+E    T+IH ++   NILL  +ED K 
Sbjct: 103 LKKNKNCINILW-----KLEVAKQLAWAMHFLEEN---TLIHGNVCAKNILLIREEDRKT 154
Query: 123 ------KISDFGLA-RILRKMILKQIQIELGYIPPEYV 153
                 K+SD G++  +L K IL++    + ++PPE +
Sbjct: 155 GNPPFIKLSDPGISITVLPKDILQE---RIPWVPPECI 189

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 81/160 (50%), Gaps = 17/160 (10%)
Query: 3   LPDGQ----IIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIY 56
           +P+G+     +A+K+L +  S +  +E  +E  + A + + ++ R+ G C+ T    LI 
Sbjct: 40  IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL-TSTVQLIT 98
Query: 57  EYMPKRSLDYFLFDPIRMLILDCKKR--VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNI 114
           + MP   L     D +R    +   +  ++    I +G+ YL++     ++HRDL   N+
Sbjct: 99  QLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNV 151
Query: 115 LLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVG 154
           L+      KI+DFGLA++L     K+   E G +P +++ 
Sbjct: 152 LVKTPQHVKITDFGLAKLLGAE-EKEYHAEGGKVPIKWMA 190

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 81/160 (50%), Gaps = 17/160 (10%)
Query: 3   LPDGQ----IIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIY 56
           +P+G+     +A+K+L +  S +  +E  +E  + A + + ++ R+ G C+ T    LI 
Sbjct: 31  IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL-TSTVQLIT 89
Query: 57  EYMPKRSLDYFLFDPIRMLILDCKKR--VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNI 114
           + MP   L     D +R    +   +  ++    I +G+ YL++     ++HRDL   N+
Sbjct: 90  QLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNV 142
Query: 115 LLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVG 154
           L+      KI+DFGLA++L     K+   E G +P +++ 
Sbjct: 143 LVKTPQHVKITDFGLAKLLGAE-EKEYHAEGGKVPIKWMA 181

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 81/160 (50%), Gaps = 17/160 (10%)
Query: 3   LPDGQ----IIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIY 56
           +P+G+     +A+K+L +  S +  +E  +E  + A + + ++ R+ G C+ T    LI 
Sbjct: 39  IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL-TSTVQLIT 97
Query: 57  EYMPKRSLDYFLFDPIRMLILDCKKR--VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNI 114
           + MP   L     D +R    +   +  ++    I +G+ YL++     ++HRDL   N+
Sbjct: 98  QLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNV 150
Query: 115 LLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVG 154
           L+      KI+DFGLA++L     K+   E G +P +++ 
Sbjct: 151 LVKTPQHVKITDFGLAKLLGAE-EKEYHAEGGKVPIKWMA 189

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 81/160 (50%), Gaps = 17/160 (10%)
Query: 3   LPDGQ----IIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIY 56
           +P+G+     +A+K+L +  S +  +E  +E  + A + + ++ R+ G C+ T    LI 
Sbjct: 40  IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL-TSTVQLIT 98
Query: 57  EYMPKRSLDYFLFDPIRMLILDCKKR--VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNI 114
           + MP   L     D +R    +   +  ++    I +G+ YL++     ++HRDL   N+
Sbjct: 99  QLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNV 151
Query: 115 LLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVG 154
           L+      KI+DFGLA++L     K+   E G +P +++ 
Sbjct: 152 LVKTPQHVKITDFGLAKLLGAE-EKEYHAEGGKVPIKWMA 190

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 81/160 (50%), Gaps = 17/160 (10%)
Query: 3   LPDGQ----IIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIY 56
           +P+G+     +A+K+L +  S +  +E  +E  + A + + ++ R+ G C+ T    LI 
Sbjct: 40  IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL-TSTVQLIT 98
Query: 57  EYMPKRSLDYFLFDPIRMLILDCKKR--VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNI 114
           + MP   L     D +R    +   +  ++    I +G+ YL++     ++HRDL   N+
Sbjct: 99  QLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNV 151
Query: 115 LLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVG 154
           L+      KI+DFGLA++L     K+   E G +P +++ 
Sbjct: 152 LVKTPQHVKITDFGLAKLLGAE-EKEYHAEGGKVPIKWMA 190

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 79/170 (46%), Gaps = 27/170 (15%)
Query: 6   GQIIAVKKLSK---KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPK 61
           GQ  AVK +SK   K     E    EV L  +L H N+ ++    E + Y  L+ E    
Sbjct: 51  GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTG 110
Query: 62  RSLDYFLFDPI----RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLD 117
             L    FD I    R   +D  +   II+ ++ G+ Y     +  I+HRDLK  N+LL+
Sbjct: 111 GEL----FDEIISRKRFSEVDAAR---IIRQVLSGITYXH---KNKIVHRDLKPENLLLE 160
Query: 118 ---EDLKPKISDFGLARILRKMILKQIQIELG---YIPPEYVGRGVYYKK 161
              +D   +I DFGL+        K+ + ++G   YI PE V  G Y +K
Sbjct: 161 SKSKDANIRIIDFGLSTHFEAS--KKXKDKIGTAYYIAPE-VLHGTYDEK 207

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 81/160 (50%), Gaps = 17/160 (10%)
Query: 3   LPDGQ----IIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIY 56
           +P+G+     +A+K+L +  S +  +E  +E  + A + + ++ R+ G C+ T    LI 
Sbjct: 44  IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL-TSTVQLIT 102
Query: 57  EYMPKRSLDYFLFDPIRMLILDCKKR--VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNI 114
           + MP   L     D +R    +   +  ++    I +G+ YL++     ++HRDL   N+
Sbjct: 103 QLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNV 155
Query: 115 LLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVG 154
           L+      KI+DFGLA++L     K+   E G +P +++ 
Sbjct: 156 LVKTPQHVKITDFGLAKLLGAE-EKEYHAEGGKVPIKWMA 194

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 81/160 (50%), Gaps = 17/160 (10%)
Query: 3   LPDGQ----IIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIY 56
           +P+G+     +A+K+L +  S +  +E  +E  + A + + ++ R+ G C+ T    LI 
Sbjct: 43  IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL-TSTVQLIT 101
Query: 57  EYMPKRSLDYFLFDPIRMLILDCKKR--VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNI 114
           + MP   L     D +R    +   +  ++    I +G+ YL++     ++HRDL   N+
Sbjct: 102 QLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNV 154
Query: 115 LLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVG 154
           L+      KI+DFGLA++L     K+   E G +P +++ 
Sbjct: 155 LVKTPQHVKITDFGLAKLLGAE-EKEYHAEGGKVPIKWMA 193

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 81/160 (50%), Gaps = 17/160 (10%)
Query: 3   LPDGQ----IIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIY 56
           +P+G+     +A+K+L +  S +  +E  +E  + A + + ++ R+ G C+ T    LI 
Sbjct: 44  IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL-TSTVQLIT 102
Query: 57  EYMPKRSLDYFLFDPIRMLILDCKKR--VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNI 114
           + MP   L     D +R    +   +  ++    I +G+ YL++     ++HRDL   N+
Sbjct: 103 QLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNV 155
Query: 115 LLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVG 154
           L+      KI+DFGLA++L     K+   E G +P +++ 
Sbjct: 156 LVKTPQHVKITDFGLAKLLGAE-EKEYHAEGGKVPIKWMA 194

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 81/160 (50%), Gaps = 17/160 (10%)
Query: 3   LPDGQ----IIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIY 56
           +P+G+     +A+K+L +  S +  +E  +E  + A + + ++ R+ G C+ T    LI 
Sbjct: 47  IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL-TSTVQLIT 105
Query: 57  EYMPKRSLDYFLFDPIRMLILDCKKR--VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNI 114
           + MP   L     D +R    +   +  ++    I +G+ YL++     ++HRDL   N+
Sbjct: 106 QLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNV 158
Query: 115 LLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVG 154
           L+      KI+DFGLA++L     K+   E G +P +++ 
Sbjct: 159 LVKTPQHVKITDFGLAKLLGAE-EKEYHAEGGKVPIKWMA 197

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 81/160 (50%), Gaps = 17/160 (10%)
Query: 3   LPDGQ----IIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIY 56
           +P+G+     +A+K+L +  S +  +E  +E  + A + + ++ R+ G C+ T    LI 
Sbjct: 37  IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL-TSTVQLIT 95
Query: 57  EYMPKRSLDYFLFDPIRMLILDCKKR--VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNI 114
           + MP   L     D +R    +   +  ++    I +G+ YL++     ++HRDL   N+
Sbjct: 96  QLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNV 148
Query: 115 LLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVG 154
           L+      KI+DFGLA++L     K+   E G +P +++ 
Sbjct: 149 LVKTPQHVKITDFGLAKLLGAE-EKEYHAEGGKVPIKWMA 187

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 81/160 (50%), Gaps = 17/160 (10%)
Query: 3   LPDGQ----IIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIY 56
           +P+G+     +A+K+L +  S +  +E  +E  + A + + ++ R+ G C+ T    LI 
Sbjct: 37  IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL-TSTVQLIT 95
Query: 57  EYMPKRSLDYFLFDPIRMLILDCKKR--VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNI 114
           + MP   L     D +R    +   +  ++    I +G+ YL++     ++HRDL   N+
Sbjct: 96  QLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNV 148
Query: 115 LLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVG 154
           L+      KI+DFGLA++L     K+   E G +P +++ 
Sbjct: 149 LVKTPQHVKITDFGLAKLLGAE-EKEYHAEGGKVPIKWMA 187

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 81/160 (50%), Gaps = 17/160 (10%)
Query: 3   LPDGQ----IIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIY 56
           +P+G+     +A+K+L +  S +  +E  +E  + A + + ++ R+ G C+ T    LI 
Sbjct: 62  IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL-TSTVQLIT 120
Query: 57  EYMPKRSLDYFLFDPIRMLILDCKKR--VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNI 114
           + MP   L     D +R    +   +  ++    I +G+ YL++     ++HRDL   N+
Sbjct: 121 QLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNV 173
Query: 115 LLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVG 154
           L+      KI+DFGLA++L     K+   E G +P +++ 
Sbjct: 174 LVKTPQHVKITDFGLAKLLGAE-EKEYHAEGGKVPIKWMA 212

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/150 (30%), Positives = 72/150 (48%), Gaps = 19/150 (12%)
Query: 11  VKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLF 69
           +KK S  +T       +EV +  +L H N++++  F  + + Y L+ E      L    F
Sbjct: 37  IKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGEL----F 92
Query: 70  DPI--RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE---DLKPKI 124
           D I  R    +    V I+K ++ G  YL ++    I+HRDLK  N+LL+    D   KI
Sbjct: 93  DEIILRQKFSEVDAAV-IMKQVLSGTTYLHKH---NIVHRDLKPENLLLESKSRDALIKI 148
Query: 125 SDFGLARILRKMILKQIQIELG---YIPPE 151
            DFGL+      +  +++  LG   YI PE
Sbjct: 149 VDFGLSAHFE--VGGKMKERLGTAYYIAPE 176

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 34/110 (30%), Positives = 58/110 (52%), Gaps = 6/110 (5%)
Query: 51  EYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLK 110
           E  +  E+M   SLD  L +  R +  +   +V I   +++GL YL+E  +  I+HRD+K
Sbjct: 88  EISICMEHMDGGSLDQVLKEAKR-IPEEILGKVSI--AVLRGLAYLREKHQ--IMHRDVK 142
Query: 111 VSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYK 160
            SNIL++   + K+ DFG++  L   +         Y+ PE + +G +Y 
Sbjct: 143 PSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMAPERL-QGTHYS 191

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 81/160 (50%), Gaps = 17/160 (10%)
Query: 3   LPDGQ----IIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIY 56
           +P+G+     +A+K+L +  S +  +E  +E  + A + + ++ R+ G C+ T    LI 
Sbjct: 44  IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL-TSTVQLIM 102
Query: 57  EYMPKRSLDYFLFDPIRMLILDCKKR--VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNI 114
           + MP   L     D +R    +   +  ++    I +G+ YL++     ++HRDL   N+
Sbjct: 103 QLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNV 155
Query: 115 LLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVG 154
           L+      KI+DFGLA++L     K+   E G +P +++ 
Sbjct: 156 LVKTPQHVKITDFGLAKLLGAE-EKEYHAEGGKVPIKWMA 194

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 81/161 (50%), Gaps = 19/161 (11%)
Query: 3   LPDGQ----IIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIY 56
           +P+G+     +A+K+L +  S +  +E  +E  + A + + ++ R+ G C+ T    LI 
Sbjct: 37  IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL-TSTVQLIT 95
Query: 57  EYMP-KRSLDYFLF--DPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSN 113
           + MP    LDY     D I    L     ++    I +G+ YL++     ++HRDL   N
Sbjct: 96  QLMPFGXLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLEDR---RLVHRDLAARN 147
Query: 114 ILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVG 154
           +L+      KI+DFGLA++L     K+   E G +P +++ 
Sbjct: 148 VLVKTPQHVKITDFGLAKLLGAE-EKEYHAEGGKVPIKWMA 187

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 47/178 (26%), Positives = 75/178 (42%), Gaps = 45/178 (25%)
Query: 23  EEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFL---FDP-------- 71
           E+ + EV   AKL H+N++    C +       ++Y P+ S D      +DP        
Sbjct: 50  EKAEREVKALAKLDHVNIVHYNGCWDG------FDYDPETSDDSLESSDYDPENSKNSSR 103
Query: 72  -------IRMLILDC--------KKR---------VHIIKGIIQGLLYLQEYFRLTIIHR 107
                  I+M   D         K+R         + + + I +G+ Y+       +IHR
Sbjct: 104 SKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK---KLIHR 160
Query: 108 DLKVSNILLDEDLKPKISDFGLARILRKMILK-QIQIELGYIPPEYVGRGVYYKKFSL 164
           DLK SNI L +  + KI DFGL   L+    + + +  L Y+ PE +    Y K+  L
Sbjct: 161 DLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDL 218

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 21/43 (48%), Positives = 30/43 (69%), Gaps = 3/43 (6%)
Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLAR 131
           +++GL Y+       IIHRDLK SN+ ++ED + +I DFGLAR
Sbjct: 140 LLRGLKYIHS---AGIIHRDLKPSNVAVNEDSELRILDFGLAR 179

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 33/133 (24%), Positives = 60/133 (45%), Gaps = 14/133 (10%)
Query: 9   IAVKKLSKKSTQGFE-EFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDY 66
           +A+K +++ ++     EF NE  +  +    +++R+ G   + Q  ++I E M +  L  
Sbjct: 45  VAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKS 104
Query: 67  FL--------FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE 118
           +L         +P+ +      K + +   I  G+ YL        +HRDL   N  + E
Sbjct: 105 YLRSLRPEMENNPV-LAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCXVAE 160
Query: 119 DLKPKISDFGLAR 131
           D   KI DFG+ R
Sbjct: 161 DFTVKIGDFGMTR 173

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 81/160 (50%), Gaps = 17/160 (10%)
Query: 3   LPDGQ----IIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIY 56
           +P+G+     +A+K+L +  S +  +E  +E  + A + + ++ R+ G C+ T    LI 
Sbjct: 38  IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL-TSTVQLIM 96
Query: 57  EYMPKRSLDYFLFDPIRMLILDCKKR--VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNI 114
           + MP   L     D +R    +   +  ++    I +G+ YL++     ++HRDL   N+
Sbjct: 97  QLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNV 149
Query: 115 LLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVG 154
           L+      KI+DFGLA++L     K+   E G +P +++ 
Sbjct: 150 LVKTPQHVKITDFGLAKLLGAE-EKEYHAEGGKVPIKWMA 188

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 81/160 (50%), Gaps = 17/160 (10%)
Query: 3   LPDGQ----IIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIY 56
           +P+G+     +A+K+L +  S +  +E  +E  + A + + ++ R+ G C+ T    LI 
Sbjct: 37  IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL-TSTVQLIT 95
Query: 57  EYMPKRSLDYFLFDPIRMLILDCKKR--VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNI 114
           + MP   L     D +R    +   +  ++    I +G+ YL++     ++HRDL   N+
Sbjct: 96  QLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNV 148
Query: 115 LLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVG 154
           L+      KI+DFGLA++L     K+   E G +P +++ 
Sbjct: 149 LVKTPQHVKITDFGLAKLLGAE-EKEYHAEGGKVPIKWMA 187

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 41.6 bits (96), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 21/43 (48%), Positives = 30/43 (69%), Gaps = 3/43 (6%)
Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLAR 131
           +++GL Y+       IIHRDLK SN+ ++ED + +I DFGLAR
Sbjct: 140 LLRGLKYIHS---AGIIHRDLKPSNVAVNEDSELRILDFGLAR 179

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 81/160 (50%), Gaps = 17/160 (10%)
Query: 3   LPDGQ----IIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIY 56
           +P+G+     +A+K+L +  S +  +E  +E  + A + + ++ R+ G C+ T    LI 
Sbjct: 41  IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL-TSTVQLIM 99
Query: 57  EYMPKRSLDYFLFDPIRMLILDCKKR--VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNI 114
           + MP   L     D +R    +   +  ++    I +G+ YL++     ++HRDL   N+
Sbjct: 100 QLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNV 152
Query: 115 LLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVG 154
           L+      KI+DFGLA++L     K+   E G +P +++ 
Sbjct: 153 LVKTPQHVKITDFGLAKLLGAE-EKEYHAEGGKVPIKWMA 191

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 81/160 (50%), Gaps = 17/160 (10%)
Query: 3   LPDGQ----IIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIY 56
           +P+G+     +A+K+L +  S +  +E  +E  + A + + ++ R+ G C+ T    LI 
Sbjct: 37  IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL-TSTVQLIM 95
Query: 57  EYMPKRSLDYFLFDPIRMLILDCKKR--VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNI 114
           + MP   L     D +R    +   +  ++    I +G+ YL++     ++HRDL   N+
Sbjct: 96  QLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNV 148
Query: 115 LLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVG 154
           L+      KI+DFGLA++L     K+   E G +P +++ 
Sbjct: 149 LVKTPQHVKITDFGLAKLLGAE-EKEYHAEGGKVPIKWMA 187

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 81/160 (50%), Gaps = 17/160 (10%)
Query: 3   LPDGQ----IIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIY 56
           +P+G+     +A+K+L +  S +  +E  +E  + A + + ++ R+ G C+ T    LI 
Sbjct: 40  IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL-TSTVQLIM 98
Query: 57  EYMPKRSLDYFLFDPIRMLILDCKKR--VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNI 114
           + MP   L     D +R    +   +  ++    I +G+ YL++     ++HRDL   N+
Sbjct: 99  QLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNV 151
Query: 115 LLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVG 154
           L+      KI+DFGLA++L     K+   E G +P +++ 
Sbjct: 152 LVKTPQHVKITDFGLAKLLGAE-EKEYHAEGGKVPIKWMA 190

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 41.2 bits (95), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 46/180 (25%), Positives = 74/180 (41%), Gaps = 36/180 (20%)
Query: 9   IAVKKLSKKSTQGFEEFKNEVMLTAKL-----QHLNLIRV-GFCIETQEYMLIYEYMPKR 62
           +AVK L  KST   +E K  +M   K+     QH N++ + G C      ++I EY    
Sbjct: 64  VAVKML--KSTAHADE-KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYG 120
Query: 63  SLDYFLFDPIRMLI--------------------LDCKKRVHIIKGIIQGLLYLQEYFRL 102
            L  FL      ++                    L+ +  +H    + QG+ +L      
Sbjct: 121 DLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASK--- 177
Query: 103 TIIHRDLKVSNILLDEDLKPKISDFGLARILRK----MILKQIQIELGYIPPEYVGRGVY 158
             IHRD+   N+LL      KI DFGLAR +      ++    ++ + ++ PE +   VY
Sbjct: 178 NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVY 237

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 41.2 bits (95), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 45/161 (27%), Positives = 81/161 (50%), Gaps = 19/161 (11%)
Query: 3   LPDGQ----IIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIY 56
           +P+G+     +A+K+L +  S +  +E  +E  + A + + ++ R+ G C+ T    LI 
Sbjct: 38  IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL-TSTVQLIM 96
Query: 57  EYMP-KRSLDYFLF--DPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSN 113
           + MP    LDY     D I    L     ++    I +G+ YL++     ++HRDL   N
Sbjct: 97  QLMPFGXLLDYVREHKDNIGSQYL-----LNWCVQIAKGMNYLEDR---RLVHRDLAARN 148
Query: 114 ILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVG 154
           +L+      KI+DFGLA++L     K+   E G +P +++ 
Sbjct: 149 VLVKTPQHVKITDFGLAKLLGAE-EKEYHAEGGKVPIKWMA 188

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 41.2 bits (95), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 42/160 (26%), Positives = 81/160 (50%), Gaps = 17/160 (10%)
Query: 3   LPDGQ----IIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIY 56
           +P+G+     +A+K+L +  S +  +E  +E  + A + + ++ R+ G C+ T    LI 
Sbjct: 39  IPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICL-TSTVQLIM 97
Query: 57  EYMPKRSLDYFLFDPIRMLILDCKKR--VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNI 114
           + MP   L     D +R    +   +  ++    I +G+ YL++     ++HRDL   N+
Sbjct: 98  QLMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR---RLVHRDLAARNV 150
Query: 115 LLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVG 154
           L+      KI+DFGLA++L     K+   E G +P +++ 
Sbjct: 151 LVKTPQHVKITDFGLAKLLGAE-EKEYHAEGGKVPIKWMA 189

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 41.2 bits (95), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 35/127 (27%), Positives = 60/127 (47%), Gaps = 8/127 (6%)
Query: 9   IAVKKLSKKSTQG-FEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSLDY 66
           +A+K L + + +   EE   E  +  +L +  ++R +G C + +  ML+ E      L  
Sbjct: 40  VAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHK 98
Query: 67  FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISD 126
           FL      + +       ++  +  G+ YL+E      +HRDL   N+LL      KISD
Sbjct: 99  FLVGKREEIPVS--NVAELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISD 153
Query: 127 FGLARIL 133
           FGL++ L
Sbjct: 154 FGLSKAL 160

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 41.2 bits (95), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 38/138 (27%), Positives = 62/138 (44%), Gaps = 31/138 (22%)
Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLD 65
            +II  KKLS +  Q  E    E  +   L+H N++R            +++ + +    
Sbjct: 61  AKIINTKKLSARDHQKLER---EARICRLLKHPNIVR------------LHDSISEEGFH 105
Query: 66  YFLFDPIR--MLILDCKKR--------VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNIL 115
           Y +FD +    L  D   R         H I  I++ + ++ ++    I+HRDLK  N+L
Sbjct: 106 YLVFDLVTGGELFEDIVAREYYSEADASHCIHQILESVNHIHQH---DIVHRDLKPENLL 162
Query: 116 LDEDLKP---KISDFGLA 130
           L    K    K++DFGLA
Sbjct: 163 LASKCKGAAVKLADFGLA 180

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 40.8 bits (94), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 45/135 (33%), Positives = 60/135 (44%), Gaps = 21/135 (15%)
Query: 28  EVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKRSLDYFLFDPIRMLILDCKKRV--H 84
           EV L  +LQH N+I +   I     + LI+EY       Y   +P      D   RV   
Sbjct: 83  EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKNP------DVSMRVIKS 136
Query: 85  IIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL---DEDLKP--KISDFGLARILRKMILK 139
            +  +I G+ +         +HRDLK  N+LL   D    P  KI DFGLAR    + ++
Sbjct: 137 FLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GIPIR 192
Query: 140 QIQ---IELGYIPPE 151
           Q     I L Y PPE
Sbjct: 193 QFTHEIITLWYRPPE 207

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 40.8 bits (94), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 49/151 (32%), Positives = 75/151 (49%), Gaps = 14/151 (9%)
Query: 12  KKLSKKSTQGF--EEFKNEVMLTAKLQHLNLIRVGFCIETQ-EYMLIYEYMPKRSLDYFL 68
           K+ +K S +G   E+ + EV +  ++QH N+I +    E + + +LI E +    L  FL
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
Query: 69  FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNI-LLDEDL-KPKIS- 125
            +      L  ++    +K I+ G+ YL     L I H DLK  NI LLD ++ KP+I  
Sbjct: 106 AEKES---LTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 126 -DFGLA-RILRKMILKQIQIELGYIPPEYVG 154
            DFGLA +I      K I     ++ PE V 
Sbjct: 160 IDFGLAHKIDFGNEFKNIFGTPAFVAPEIVN 190

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 40.8 bits (94), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 66/126 (52%), Gaps = 13/126 (10%)
Query: 12  KKLSKKSTQGF--EEFKNEVMLTAKLQHLNLIRVGFCIETQ-EYMLIYEYMPKRSLDYFL 68
           K+ +K S +G   E+ + EV +  ++QH N+I +    E + + +LI E +    L  FL
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
Query: 69  FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNI-LLDEDL-KPKIS- 125
            +      L  ++    +K I+ G+ YL     L I H DLK  NI LLD ++ KP+I  
Sbjct: 106 AEKES---LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 126 -DFGLA 130
            DFGLA
Sbjct: 160 IDFGLA 165

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 40.8 bits (94), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 66/126 (52%), Gaps = 13/126 (10%)
Query: 12  KKLSKKSTQGF--EEFKNEVMLTAKLQHLNLIRVGFCIETQ-EYMLIYEYMPKRSLDYFL 68
           K+ +K S +G   E+ + EV +  ++QH N+I +    E + + +LI E +    L  FL
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
Query: 69  FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNI-LLDEDL-KPKIS- 125
            +      L  ++    +K I+ G+ YL     L I H DLK  NI LLD ++ KP+I  
Sbjct: 106 AEKES---LTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 126 -DFGLA 130
            DFGLA
Sbjct: 160 IDFGLA 165

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 40.8 bits (94), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 49/178 (27%), Positives = 78/178 (43%), Gaps = 31/178 (17%)
Query: 6   GQIIAVKKL-SKKSTQGFEEFKNEVMLTAKLQHLNLIRV------GFCIETQEYMLIYEY 58
           G+ +AVK   + +    F E   E+  T  ++H N++        G    TQ Y LI +Y
Sbjct: 60  GEKVAVKVFFTTEEASWFRE--TEIYQTVLMRHENILGFIAADIKGTGSWTQLY-LITDY 116
Query: 59  MPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQ-EYF----RLTIIHRDLKVSN 113
               SL    +D ++   LD K  + +    + GL +L  E F    +  I HRDLK  N
Sbjct: 117 HENGSL----YDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKN 172
Query: 114 ILLDEDLKPKISDFGLARILRKMILKQIQIELG---------YIPPEYVGRGVYYKKF 162
           IL+ ++    I+D GLA    K I    ++++          Y+PPE +   +    F
Sbjct: 173 ILVKKNGTCCIADLGLA---VKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHF 227

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 40.8 bits (94), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/127 (22%), Positives = 66/127 (51%), Gaps = 8/127 (6%)
Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSL 64
           G + A K +  KS +  E++  E+ + A   H  ++++ G      +  ++ E+ P  ++
Sbjct: 36  GALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAV 95
Query: 65  DYFLFDPIRMLILDCKKRVHII-KGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           D  + +  R L    + ++ ++ + +++ L +L       IIHRDLK  N+L+  +   +
Sbjct: 96  DAIMLELDRGL---TEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIR 149
Query: 124 ISDFGLA 130
           ++DFG++
Sbjct: 150 LADFGVS 156

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 40.8 bits (94), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 66/126 (52%), Gaps = 13/126 (10%)
Query: 12  KKLSKKSTQGF--EEFKNEVMLTAKLQHLNLIRVGFCIETQ-EYMLIYEYMPKRSLDYFL 68
           K+ +K S +G   E+ + EV +  ++QH N+I +    E + + +LI E +    L  FL
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
Query: 69  FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNI-LLDEDL-KPKIS- 125
            +      L  ++    +K I+ G+ YL     L I H DLK  NI LLD ++ KP+I  
Sbjct: 106 AEKES---LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 126 -DFGLA 130
            DFGLA
Sbjct: 160 IDFGLA 165

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 40.8 bits (94), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 66/126 (52%), Gaps = 13/126 (10%)
Query: 12  KKLSKKSTQGF--EEFKNEVMLTAKLQHLNLIRVGFCIETQ-EYMLIYEYMPKRSLDYFL 68
           K+ +K S +G   E+ + EV +  ++QH N+I +    E + + +LI E +    L  FL
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
Query: 69  FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNI-LLDEDL-KPKIS- 125
            +      L  ++    +K I+ G+ YL     L I H DLK  NI LLD ++ KP+I  
Sbjct: 106 AEKES---LTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 126 -DFGLA 130
            DFGLA
Sbjct: 160 IDFGLA 165

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 40.8 bits (94), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 66/126 (52%), Gaps = 13/126 (10%)
Query: 12  KKLSKKSTQGF--EEFKNEVMLTAKLQHLNLIRVGFCIETQ-EYMLIYEYMPKRSLDYFL 68
           K+ +K S +G   E+ + EV +  ++QH N+I +    E + + +LI E +    L  FL
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
Query: 69  FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNI-LLDEDL-KPKIS- 125
            +      L  ++    +K I+ G+ YL     L I H DLK  NI LLD ++ KP+I  
Sbjct: 106 AEKES---LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 126 -DFGLA 130
            DFGLA
Sbjct: 160 IDFGLA 165

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 40.8 bits (94), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 66/126 (52%), Gaps = 13/126 (10%)
Query: 12  KKLSKKSTQGF--EEFKNEVMLTAKLQHLNLIRVGFCIETQ-EYMLIYEYMPKRSLDYFL 68
           K+ +K S +G   E+ + EV +  ++QH N+I +    E + + +LI E +    L  FL
Sbjct: 45  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 104
Query: 69  FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNI-LLDEDL-KPKIS- 125
            +      L  ++    +K I+ G+ YL     L I H DLK  NI LLD ++ KP+I  
Sbjct: 105 AEKES---LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKI 158
Query: 126 -DFGLA 130
            DFGLA
Sbjct: 159 IDFGLA 164

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 40.8 bits (94), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 66/126 (52%), Gaps = 13/126 (10%)
Query: 12  KKLSKKSTQGF--EEFKNEVMLTAKLQHLNLIRVGFCIETQ-EYMLIYEYMPKRSLDYFL 68
           K+ +K S +G   E+ + EV +  ++QH N+I +    E + + +LI E +    L  FL
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
Query: 69  FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNI-LLDEDL-KPKIS- 125
            +      L  ++    +K I+ G+ YL     L I H DLK  NI LLD ++ KP+I  
Sbjct: 106 AEKES---LTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 126 -DFGLA 130
            DFGLA
Sbjct: 160 IDFGLA 165

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 40.4 bits (93), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 37/138 (26%), Positives = 60/138 (43%), Gaps = 21/138 (15%)
Query: 9   IAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEY------MLIYEYM 59
           +AVK L     ++   EEF  E     +  H ++ + VG  + ++        M+I  +M
Sbjct: 54  VAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFM 113
Query: 60  PKRSLDYFLF------DPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSN 113
               L  FL       +P  + +   +  V  +  I  G+ YL        IHRDL   N
Sbjct: 114 KHGDLHAFLLASRIGENPFNLPL---QTLVRFMVDIACGMEYLSSR---NFIHRDLAARN 167
Query: 114 ILLDEDLKPKISDFGLAR 131
            +L ED+   ++DFGL+R
Sbjct: 168 CMLAEDMTVCVADFGLSR 185

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 40.4 bits (93), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 66/126 (52%), Gaps = 13/126 (10%)
Query: 12  KKLSKKSTQGF--EEFKNEVMLTAKLQHLNLIRVGFCIETQ-EYMLIYEYMPKRSLDYFL 68
           K+ +K S +G   E+ + EV +  ++QH N+I +    E + + +LI E +    L  FL
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
Query: 69  FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNI-LLDEDL-KPKIS- 125
            +      L  ++    +K I+ G+ YL     L I H DLK  NI LLD ++ KP+I  
Sbjct: 106 AEKES---LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 126 -DFGLA 130
            DFGLA
Sbjct: 160 IDFGLA 165

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 40.4 bits (93), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 29/127 (22%), Positives = 66/127 (51%), Gaps = 8/127 (6%)
Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSL 64
           G + A K +  KS +  E++  E+ + A   H  ++++ G      +  ++ E+ P  ++
Sbjct: 44  GALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAV 103
Query: 65  DYFLFDPIRMLILDCKKRVHII-KGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           D  + +  R L    + ++ ++ + +++ L +L       IIHRDLK  N+L+  +   +
Sbjct: 104 DAIMLELDRGL---TEPQIQVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIR 157
Query: 124 ISDFGLA 130
           ++DFG++
Sbjct: 158 LADFGVS 164

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 40.4 bits (93), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 66/126 (52%), Gaps = 13/126 (10%)
Query: 12  KKLSKKSTQGF--EEFKNEVMLTAKLQHLNLIRVGFCIETQ-EYMLIYEYMPKRSLDYFL 68
           K+ +K S +G   E+ + EV +  ++QH N+I +    E + + +LI E +    L  FL
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
Query: 69  FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNI-LLDEDL-KPKIS- 125
            +      L  ++    +K I+ G+ YL     L I H DLK  NI LLD ++ KP+I  
Sbjct: 106 AEKES---LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 126 -DFGLA 130
            DFGLA
Sbjct: 160 IDFGLA 165

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 40.4 bits (93), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 66/126 (52%), Gaps = 13/126 (10%)
Query: 12  KKLSKKSTQGF--EEFKNEVMLTAKLQHLNLIRVGFCIETQ-EYMLIYEYMPKRSLDYFL 68
           K+ +K S +G   E+ + EV +  ++QH N+I +    E + + +LI E +    L  FL
Sbjct: 45  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 104
Query: 69  FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNI-LLDEDL-KPKIS- 125
            +      L  ++    +K I+ G+ YL     L I H DLK  NI LLD ++ KP+I  
Sbjct: 105 AEKES---LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKI 158
Query: 126 -DFGLA 130
            DFGLA
Sbjct: 159 IDFGLA 164

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 40.4 bits (93), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 66/126 (52%), Gaps = 13/126 (10%)
Query: 12  KKLSKKSTQGF--EEFKNEVMLTAKLQHLNLIRVGFCIETQ-EYMLIYEYMPKRSLDYFL 68
           K+ +K S +G   E+ + EV +  ++QH N+I +    E + + +LI E +    L  FL
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
Query: 69  FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNI-LLDEDL-KPKIS- 125
            +      L  ++    +K I+ G+ YL     L I H DLK  NI LLD ++ KP+I  
Sbjct: 106 AEKES---LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 126 -DFGLA 130
            DFGLA
Sbjct: 160 IDFGLA 165

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 40.4 bits (93), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 66/126 (52%), Gaps = 13/126 (10%)
Query: 12  KKLSKKSTQGF--EEFKNEVMLTAKLQHLNLIRVGFCIETQ-EYMLIYEYMPKRSLDYFL 68
           K+ +K S +G   E+ + EV +  ++QH N+I +    E + + +LI E +    L  FL
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFL 105
Query: 69  FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNI-LLDEDL-KPKIS- 125
            +      L  ++    +K I+ G+ YL     L I H DLK  NI LLD ++ KP+I  
Sbjct: 106 AEKES---LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 126 -DFGLA 130
            DFGLA
Sbjct: 160 IDFGLA 165

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 40.4 bits (93), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 26/77 (33%), Positives = 44/77 (57%), Gaps = 7/77 (9%)
Query: 85  IIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIE 144
           I++ I++GL YL    +   IHRD+K +N+LL E    K++DFG+A  L    +K+    
Sbjct: 121 ILREILKGLDYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXF- 176
Query: 145 LG---YIPPEYVGRGVY 158
           +G   ++ PE + +  Y
Sbjct: 177 VGTPFWMAPEVIKQSAY 193

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 40.4 bits (93), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 22/46 (47%), Positives = 30/46 (65%), Gaps = 3/46 (6%)
Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILR 134
           I+ GL +L +     II+RDLK  N+LLD+D   +ISD GLA  L+
Sbjct: 298 IVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 40.4 bits (93), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 22/46 (47%), Positives = 30/46 (65%), Gaps = 3/46 (6%)
Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILR 134
           I+ GL +L +     II+RDLK  N+LLD+D   +ISD GLA  L+
Sbjct: 298 IVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 40.4 bits (93), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 22/46 (47%), Positives = 30/46 (65%), Gaps = 3/46 (6%)
Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILR 134
           I+ GL +L +     II+RDLK  N+LLD+D   +ISD GLA  L+
Sbjct: 298 IVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 40.4 bits (93), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 22/46 (47%), Positives = 30/46 (65%), Gaps = 3/46 (6%)
Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILR 134
           I+ GL +L +     II+RDLK  N+LLD+D   +ISD GLA  L+
Sbjct: 298 IVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 40.4 bits (93), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 43/126 (34%), Positives = 66/126 (52%), Gaps = 13/126 (10%)
Query: 12  KKLSKKSTQGF--EEFKNEVMLTAKLQHLNLIRVGFCIETQ-EYMLIYEYMPKRSLDYFL 68
           K+ +K S +G   E+ + EV +  ++QH N+I +    E + + +LI E +    L  FL
Sbjct: 46  KRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILIGELVAGGELFDFL 105
Query: 69  FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNI-LLDEDL-KPKIS- 125
            +      L  ++    +K I+ G+ YL     L I H DLK  NI LLD ++ KP+I  
Sbjct: 106 AEKES---LTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKI 159
Query: 126 -DFGLA 130
            DFGLA
Sbjct: 160 IDFGLA 165

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 40.4 bits (93), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 34/127 (26%), Positives = 60/127 (47%), Gaps = 8/127 (6%)
Query: 9   IAVKKLSKKSTQG-FEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSLDY 66
           +A+K L + + +   EE   E  +  +L +  ++R +G C + +  ML+ E      L  
Sbjct: 366 VAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHK 424
Query: 67  FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISD 126
           FL    +   +       ++  +  G+ YL+E      +HR+L   N+LL      KISD
Sbjct: 425 FLVG--KREEIPVSNVAELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISD 479
Query: 127 FGLARIL 133
           FGL++ L
Sbjct: 480 FGLSKAL 486

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 40.0 bits (92), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 21/43 (48%), Positives = 29/43 (67%), Gaps = 3/43 (6%)
Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLAR 131
           +++GL Y+       IIHRDLK  N+ ++ED + KI DFGLAR
Sbjct: 137 MLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR 176

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 40.0 bits (92), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 24/59 (40%), Positives = 34/59 (57%), Gaps = 1/59 (1%)
Query: 96  LQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLA-RILRKMILKQIQIELGYIPPEYV 153
           L++  R  I++RDLK  NILLD+    +ISD GLA  +     +K     +GY+ PE V
Sbjct: 299 LEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV 357

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 40.0 bits (92), Expect = 5e-04,   Method: Composition-based stats.
 Identities = 24/59 (40%), Positives = 34/59 (57%), Gaps = 1/59 (1%)
Query: 96  LQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLA-RILRKMILKQIQIELGYIPPEYV 153
           L++  R  I++RDLK  NILLD+    +ISD GLA  +     +K     +GY+ PE V
Sbjct: 299 LEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVV 357

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 40.0 bits (92), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 42/157 (26%), Positives = 73/157 (46%), Gaps = 25/157 (15%)
Query: 7   QIIAVKKLSKKSTQGFEEFKN---EVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
           ++ A+K ++K+      E +N   E+ +   L+H  L+ + +  + +E M +        
Sbjct: 41  KMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMV------- 93
Query: 64  LDYFLFDPIRMLILDCKKRVHI--------IKGIIQGLLYLQEYFRLTIIHRDLKVSNIL 115
           +D  L   +R  +   ++ VH         I  ++  L YLQ      IIHRD+K  NIL
Sbjct: 94  VDLLLGGDLRYHL---QQNVHFKEETVKLFICELVMALDYLQNQ---RIIHRDMKPDNIL 147
Query: 116 LDEDLKPKISDFGLARIL-RKMILKQIQIELGYIPPE 151
           LDE     I+DF +A +L R+  +  +     Y+ PE
Sbjct: 148 LDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPE 184

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 40.0 bits (92), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 19/55 (34%), Positives = 36/55 (65%), Gaps = 3/55 (5%)
Query: 83  VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI 137
            +I + I++GL +L ++    +IHRD+K  N+LL E+ + K+ DFG++  L + +
Sbjct: 132 AYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV 183

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 40.0 bits (92), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 48/168 (28%), Positives = 74/168 (44%), Gaps = 39/168 (23%)
Query: 5   DGQIIAVKKLSKKSTQGFEEFKNEV-MLTAKLQHLNLIRVGFCIETQ---EYMLI----- 55
           D + +AVK++  +    F     EV +L    +H N+IR  FC E     +Y+ I     
Sbjct: 47  DNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRY-FCTEKDRQFQYIAIELCAA 102
Query: 56  --YEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSN 113
              EY+ ++   +   +PI +L           +    GL +L     L I+HRDLK  N
Sbjct: 103 TLQEYVEQKDFAHLGLEPITLL-----------QQTTSGLAHLHS---LNIVHRDLKPHN 148
Query: 114 ILLD-----EDLKPKISDFGLARIL---RKMILKQIQI--ELGYIPPE 151
           IL+        +K  ISDFGL + L   R    ++  +    G+I PE
Sbjct: 149 ILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 39.7 bits (91), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 76/163 (46%), Gaps = 15/163 (9%)
Query: 7   QIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKRSLD 65
           +++AVK + + +    E  + E++    L+H N++R    I T  ++ +I EY     L 
Sbjct: 46  ELVAVKYIERGAAID-ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELY 104
Query: 66  YFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKP--K 123
             + +  R    + +      + ++ G+ Y      + I HRDLK+ N LLD    P  K
Sbjct: 105 ERICNAGRFSEDEAR---FFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLK 158
Query: 124 ISDFGLARILRKMILKQIQIELG---YIPPEYVGRGVYYKKFS 163
           I DFG ++    ++  Q +  +G   YI PE + R  Y  K +
Sbjct: 159 ICDFGYSK--SSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIA 199

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 39.7 bits (91), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 21/49 (42%), Positives = 31/49 (63%), Gaps = 1/49 (2%)
Query: 86  IKGIIQGLLYLQEYFRLT-IIHRDLKVSNILLDEDLKPKISDFGLARIL 133
           IK ++  LL   +Y     I+HRDLK +N L+++D   K+ DFGLAR +
Sbjct: 158 IKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTV 206

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 39.7 bits (91), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 41/159 (25%), Positives = 75/159 (47%), Gaps = 14/159 (8%)
Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKRSL 64
            +++AVK + ++  +  E  K E++    L+H N++R    I T  ++ ++ EY     L
Sbjct: 44  NELVAVKYI-ERGEKIDENVKREIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGEL 102
Query: 65  DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKP-- 122
              + +  R    + +      + +I G+ Y      + + HRDLK+ N LLD    P  
Sbjct: 103 FERICNAGRFSEDEAR---FFFQQLISGVSYAHA---MQVAHRDLKLENTLLDGSPAPRL 156
Query: 123 KISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKK 161
           KI+DFG ++    ++  Q +  +G   P Y+   V  KK
Sbjct: 157 KIADFGYSKA--SVLHSQPKSAVGT--PAYIAPEVLLKK 191

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 39.7 bits (91), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 63/152 (41%), Gaps = 8/152 (5%)
Query: 10  AVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLF 69
           A KK+ K   +  + FK E+ +   L H N+IR+    E  +   IY  M   +      
Sbjct: 38  AAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE--DNTDIYLVMELCTGGELFE 95
Query: 70  DPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL--DEDLKP-KISD 126
             +   +        I+K ++  + Y     +L + HRDLK  N L   D    P K+ D
Sbjct: 96  RVVHKRVFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLID 152
Query: 127 FGLARILRKMILKQIQIELGYIPPEYVGRGVY 158
           FGLA   +   + + ++   Y     V  G+Y
Sbjct: 153 FGLAARFKPGKMMRTKVGTPYYVSPQVLEGLY 184

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 39.7 bits (91), Expect = 8e-04,   Method: Composition-based stats.
 Identities = 26/71 (36%), Positives = 37/71 (52%), Gaps = 5/71 (7%)
Query: 92  GLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLAR--ILRKMILKQIQIELGYIP 149
           GL +LQ      II+RDLK+ N++LD +   KI+DFG+ +  I   +  K       YI 
Sbjct: 454 GLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIA 510
Query: 150 PEYVGRGVYYK 160
           PE +    Y K
Sbjct: 511 PEIIAYQPYGK 521

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 39.7 bits (91), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 39/152 (25%), Positives = 63/152 (41%), Gaps = 8/152 (5%)
Query: 10  AVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLF 69
           A KK+ K   +  + FK E+ +   L H N+IR+    E  +   IY  M   +      
Sbjct: 55  AAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFE--DNTDIYLVMELCTGGELFE 112
Query: 70  DPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL--DEDLKP-KISD 126
             +   +        I+K ++  + Y     +L + HRDLK  N L   D    P K+ D
Sbjct: 113 RVVHKRVFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLID 169
Query: 127 FGLARILRKMILKQIQIELGYIPPEYVGRGVY 158
           FGLA   +   + + ++   Y     V  G+Y
Sbjct: 170 FGLAARFKPGKMMRTKVGTPYYVSPQVLEGLY 201

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 39.7 bits (91), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 41/140 (29%), Positives = 65/140 (46%), Gaps = 19/140 (13%)
Query: 8   IIAVKKLSKKSTQ-GFEEFKNEV-MLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSL 64
            +AVK L   +T+    +  +E+ M+    +H N+I + G C +     +I EY  K +L
Sbjct: 69  TVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 128
Query: 65  DYFL-----------FDPIRML--ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKV 111
             +L           +D  R+    +  K  V     + +G+ YL        IHRDL  
Sbjct: 129 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAA 185
Query: 112 SNILLDEDLKPKISDFGLAR 131
            N+L+ E+   KI+DFGLAR
Sbjct: 186 RNVLVTENNVMKIADFGLAR 205

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 39.7 bits (91), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 41/140 (29%), Positives = 65/140 (46%), Gaps = 19/140 (13%)
Query: 8   IIAVKKLSKKSTQ-GFEEFKNEV-MLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSL 64
            +AVK L   +T+    +  +E+ M+    +H N+I + G C +     +I EY  K +L
Sbjct: 58  TVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 117
Query: 65  DYFL-----------FDPIRML--ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKV 111
             +L           +D  R+    +  K  V     + +G+ YL        IHRDL  
Sbjct: 118 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAA 174
Query: 112 SNILLDEDLKPKISDFGLAR 131
            N+L+ E+   KI+DFGLAR
Sbjct: 175 RNVLVTENNVMKIADFGLAR 194

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 39.7 bits (91), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 41/140 (29%), Positives = 65/140 (46%), Gaps = 19/140 (13%)
Query: 8   IIAVKKLSKKSTQ-GFEEFKNEV-MLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSL 64
            +AVK L   +T+    +  +E+ M+    +H N+I + G C +     +I EY  K +L
Sbjct: 69  TVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 128
Query: 65  DYFL-----------FDPIRML--ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKV 111
             +L           +D  R+    +  K  V     + +G+ YL        IHRDL  
Sbjct: 129 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAA 185
Query: 112 SNILLDEDLKPKISDFGLAR 131
            N+L+ E+   KI+DFGLAR
Sbjct: 186 RNVLVTENNVMKIADFGLAR 205

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 39.7 bits (91), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 41/140 (29%), Positives = 65/140 (46%), Gaps = 19/140 (13%)
Query: 8   IIAVKKLSKKSTQ-GFEEFKNEV-MLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSL 64
            +AVK L   +T+    +  +E+ M+    +H N+I + G C +     +I EY  K +L
Sbjct: 115 TVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 174
Query: 65  DYFL-----------FDPIRML--ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKV 111
             +L           +D  R+    +  K  V     + +G+ YL        IHRDL  
Sbjct: 175 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAA 231
Query: 112 SNILLDEDLKPKISDFGLAR 131
            N+L+ E+   KI+DFGLAR
Sbjct: 232 RNVLVTENNVMKIADFGLAR 251

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 39.7 bits (91), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 41/140 (29%), Positives = 65/140 (46%), Gaps = 19/140 (13%)
Query: 8   IIAVKKLSKKSTQ-GFEEFKNEV-MLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSL 64
            +AVK L   +T+    +  +E+ M+    +H N+I + G C +     +I EY  K +L
Sbjct: 61  TVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 120
Query: 65  DYFL-----------FDPIRML--ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKV 111
             +L           +D  R+    +  K  V     + +G+ YL        IHRDL  
Sbjct: 121 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAA 177
Query: 112 SNILLDEDLKPKISDFGLAR 131
            N+L+ E+   KI+DFGLAR
Sbjct: 178 RNVLVTENNVMKIADFGLAR 197

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 39.7 bits (91), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 41/140 (29%), Positives = 65/140 (46%), Gaps = 19/140 (13%)
Query: 8   IIAVKKLSKKSTQ-GFEEFKNEV-MLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSL 64
            +AVK L   +T+    +  +E+ M+    +H N+I + G C +     +I EY  K +L
Sbjct: 69  TVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNL 128
Query: 65  DYFL-----------FDPIRML--ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKV 111
             +L           +D  R+    +  K  V     + +G+ YL        IHRDL  
Sbjct: 129 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAA 185
Query: 112 SNILLDEDLKPKISDFGLAR 131
            N+L+ E+   KI+DFGLAR
Sbjct: 186 RNVLVTENNVMKIADFGLAR 205

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	164
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-59
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	7e-57
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	2e-52
3soc_A	322	Activin receptor type-2A; structural genomics cons	1e-42
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-37
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-34
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	2e-32
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-31
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	5e-30
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-29
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	3e-29
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	9e-29
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-28
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	3e-28
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	6e-27
3q4u_A	301	Activin receptor type-1; structural genomics conso	1e-26
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	4e-26
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-25
4aoj_A	329	High affinity nerve growth factor receptor; transf	4e-23
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	8e-23
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	2e-22
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	3e-22
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	5e-22
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	6e-22
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	8e-22
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	8e-22
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	8e-22
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-21
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-21
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-21
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-21
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	2e-21
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	3e-21
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	4e-21
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	4e-21
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	4e-21
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	4e-21
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	6e-21
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	7e-21
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	8e-21
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	9e-21
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	1e-20
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-20
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-20
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-20
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	4e-20
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	4e-20
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	5e-20
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	6e-20
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	6e-20
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	1e-19
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	1e-19
3pls_A	298	Macrophage-stimulating protein receptor; protein k	2e-19
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-19
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	4e-19
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	5e-19
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	5e-19
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	6e-19
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	7e-19
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-18
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	4e-18
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	4e-18
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	4e-18
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	5e-18
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	8e-18
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-17
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-17
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	2e-17
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-17
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-17
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-17
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-17
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-17
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	4e-17
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	5e-17
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	8e-17
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	1e-16
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	1e-16
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	1e-16
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-16
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-16
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	1e-16
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-16
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-16
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	5e-16
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	9e-16
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-15
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	1e-15
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-15
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-15
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	3e-15
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	3e-15
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	5e-15
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	6e-15
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	6e-15
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	6e-15
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	7e-15
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-14
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-14
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	3e-14
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-14
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-14
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-14
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	4e-14
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	4e-14
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	5e-14
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	5e-14
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	6e-14
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	6e-14
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	7e-14
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	8e-14
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-13
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	2e-13
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-13
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-13
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	2e-13
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	3e-13
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-13
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	4e-13
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-13
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	4e-13
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	5e-13
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	5e-13
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	6e-13
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	7e-13
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	8e-13
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	8e-13
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-12
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-12
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-12
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-12
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-12
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	2e-12
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-12
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-12
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	2e-12
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	3e-12
3bhy_A	283	Death-associated protein kinase 3; death associate	3e-12
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-12
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	3e-12
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	4e-12
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	5e-12
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	5e-12
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	7e-12
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	8e-12
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	9e-12
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-11
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-11
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-11
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-11
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-11
3fme_A	290	Dual specificity mitogen-activated protein kinase;	2e-11
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-11
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-11
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-11
3an0_A	340	Dual specificity mitogen-activated protein kinase;	2e-11
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	2e-11
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-11
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-11
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	3e-11
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	3e-11
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-11
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	3e-11
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	4e-11
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	4e-11
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	5e-11
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	5e-11
3ork_A	311	Serine/threonine protein kinase; structural genomi	7e-11
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	8e-11
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	1e-10
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-10
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-10
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	2e-10
3aln_A	327	Dual specificity mitogen-activated protein kinase;	2e-10
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	3e-10
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-10
3rp9_A	458	Mitogen-activated protein kinase; structural genom	4e-10
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	5e-10
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	5e-10
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	6e-10
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	6e-10
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	7e-10
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	9e-10
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-09
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	1e-09
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-09
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-09
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	1e-09
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-09
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-09
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-09
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-09
2dyl_A	318	Dual specificity mitogen-activated protein kinase	2e-09
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-09
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-09
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	5e-09
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-08
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	1e-08
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	3e-08
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	5e-08
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	2e-07
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	4e-07
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-06
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-06
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-06
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	2e-06
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	2e-06
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	2e-06
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-06
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-06
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	3e-06
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-06
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	4e-06
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	4e-06
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	4e-06
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	4e-06
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	5e-06
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	5e-06
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	5e-06
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	7e-06
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	8e-06
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	3e-04
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	5e-04
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	6e-04
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	7e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  187 bits (476), Expect = 1e-59
 Identities = 63/165 (38%), Positives = 93/165 (56%), Gaps = 12/165 (7%)

Query: 1   GVLPDGQIIAVKKLSKKSTQGFE-EFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEY 58
           G L DG ++AVK+L ++ TQG E +F+ EV + +   H NL+R  GFC+   E +L+Y Y
Sbjct: 49  GRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPY 108

Query: 59  MPKRSLDYFLFDPIR-MLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLD 117
           M   S+   L +       LD  KR  I  G  +GL YL ++    IIHRD+K +NILLD
Sbjct: 109 MANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLD 168

Query: 118 EDLKPKISDFGLARILRKMILKQIQIE------LGYIPPEYVGRG 156
           E+ +  + DFGLA+++     K   +       +G+I PEY+  G
Sbjct: 169 EEFEAVVGDFGLAKLMDY---KDTHVTTAVRGTIGHIAPEYLSTG 210

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  179 bits (456), Expect = 7e-57
 Identities = 58/170 (34%), Positives = 84/170 (49%), Gaps = 14/170 (8%)

Query: 1   GVLPDGQIIAVKKLSK----KSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLI 55
           G + +   +AVKKL+      + +  ++F  E+ + AK QH NL+  +GF  +  +  L+
Sbjct: 50  GYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLV 108

Query: 56  YEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNIL 115
           Y YMP  SL   L        L    R  I +G   G+ +L E      IHRD+K +NIL
Sbjct: 109 YVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANIL 165

Query: 116 LDEDLKPKISDFGLARIL----RKMILKQIQIELGYIPPEYVGRGVYYKK 161
           LDE    KISDFGLAR      + ++  +I     Y+ PE + RG    K
Sbjct: 166 LDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEAL-RGEITPK 214

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  168 bits (428), Expect = 2e-52
 Identities = 63/164 (38%), Positives = 94/164 (57%), Gaps = 13/164 (7%)

Query: 1   GVLPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYM 59
           GVL DG  +A+K+ + +S+QG EEF+ E+   +  +H +L+  +GFC E  E +LIY+YM
Sbjct: 58  GVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYM 117

Query: 60  PKRSLDYFLFDPIR-MLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE 118
              +L   L+      + +  ++R+ I  G  +GL YL       IIHRD+K  NILLDE
Sbjct: 118 ENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDE 174

Query: 119 DLKPKISDFGLARILRKMILKQIQIE------LGYIPPEYVGRG 156
           +  PKI+DFG+++      L Q  +       LGYI PEY  +G
Sbjct: 175 NFVPKITDFGISKKG--TELDQTHLSTVVKGTLGYIDPEYFIKG 216

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  142 bits (361), Expect = 1e-42
 Identities = 40/176 (22%), Positives = 74/176 (42%), Gaps = 21/176 (11%)

Query: 4   PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIE----TQEYMLIYEY 58
              + +AVK    +  Q ++  + EV     ++H N+++ +G          +  LI  +
Sbjct: 45  LLNEYVAVKIFPIQDKQSWQ-NEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAF 103

Query: 59  MPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYL-------QEYFRLTIIHRDLKV 111
             K SL  FL   +    +   +  HI + + +GL YL       ++  +  I HRD+K 
Sbjct: 104 HEKGSLSDFLKANV----VSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKS 159

Query: 112 SNILLDEDLKPKISDFGLARILRKMILKQIQIE----LGYIPPEYVGRGVYYKKFS 163
            N+LL  +L   I+DFGLA                    Y+ PE +   + +++ +
Sbjct: 160 KNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDA 215

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  130 bits (329), Expect = 1e-37
 Identities = 45/170 (26%), Positives = 69/170 (40%), Gaps = 27/170 (15%)

Query: 5   DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIET-----QEYMLIYEY 58
           D + +AVK  S  + Q F   K  +     ++H N+ R +            EY+L+ EY
Sbjct: 35  DERPVAVKVFSFANRQNFINEK-NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEY 93

Query: 59  MPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYL------QEYFRLTIIHRDLKVS 112
            P  SL  +L         D      +   + +GL YL       ++++  I HRDL   
Sbjct: 94  YPNGSLXKYLSLHT----SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSR 149

Query: 113 NILLDEDLKPKISDFGLARILRKMILKQIQIE----------LGYIPPEY 152
           N+L+  D    ISDFGL+  L    L +   E          + Y+ PE 
Sbjct: 150 NVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEV 199

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  121 bits (305), Expect = 2e-34
 Identities = 38/133 (28%), Positives = 68/133 (51%), Gaps = 4/133 (3%)

Query: 6   GQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKR 62
           G  +AVK L ++    +   EF  EV +  +L+H N++  +G   +     ++ EY+ + 
Sbjct: 60  GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRG 119

Query: 63  SLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKP 122
           SL   L        LD ++R+ +   + +G+ YL       I+HR+LK  N+L+D+    
Sbjct: 120 SLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTV 178

Query: 123 KISDFGLARILRK 135
           K+ DFGL+R+   
Sbjct: 179 KVCDFGLSRLKAS 191

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  116 bits (292), Expect = 2e-32
 Identities = 34/133 (25%), Positives = 56/133 (42%), Gaps = 6/133 (4%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSL 64
            + +A+K++  +S    + F  E+   +++ H N+++  G C       L+ EY    SL
Sbjct: 31  AKDVAIKQI--ESESERKAFIVELRQLSRVNHPNIVKLYGAC--LNPVCLVMEYAEGGSL 86

Query: 65  DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK-PK 123
              L     +        +       QG+ YL       +IHRDLK  N+LL       K
Sbjct: 87  YNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLK 146

Query: 124 ISDFGLARILRKM 136
           I DFG A  ++  
Sbjct: 147 ICDFGTACDIQTH 159

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  114 bits (287), Expect = 1e-31
 Identities = 36/129 (27%), Positives = 63/129 (48%), Gaps = 6/129 (4%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSL 64
           G+++ +K+L +   +    F  EV +   L+H N+++ +G   + +    I EY+   +L
Sbjct: 35  GEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTL 94

Query: 65  DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKI 124
              +            +RV   K I  G+ YL     + IIHRDL   N L+ E+    +
Sbjct: 95  RGIIKSMDSQYPW--SQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVV 149

Query: 125 SDFGLARIL 133
           +DFGLAR++
Sbjct: 150 ADFGLARLM 158

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  107 bits (269), Expect = 3e-29
 Identities = 36/142 (25%), Positives = 67/142 (47%), Gaps = 18/142 (12%)

Query: 4   PDGQIIAVKKLSKKSTQG-------FEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLI 55
            D  ++A+K L    ++G       F+EF+ EV + + L H N+++  G         ++
Sbjct: 42  KDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM--HNPPRMV 99

Query: 56  YEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNIL 115
            E++P   L + L D      +    ++ ++  I  G+ Y+Q      I+HRDL+  NI 
Sbjct: 100 MEFVPCGDLYHRLLDKAH--PIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIF 156

Query: 116 LDE-----DLKPKISDFGLARI 132
           L        +  K++DFGL++ 
Sbjct: 157 LQSLDENAPVCAKVADFGLSQQ 178

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  107 bits (269), Expect = 3e-29
 Identities = 43/143 (30%), Positives = 66/143 (46%), Gaps = 17/143 (11%)

Query: 6   GQIIAVKKL----SKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMP 60
           G  +AVK       +  +Q  E  + E  L A L+H N+I   G C++     L+ E+  
Sbjct: 30  GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFAR 89

Query: 61  KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL 120
              L+  L        +     V+    I +G+ YL +   + IIHRDLK SNIL+ + +
Sbjct: 90  GGPLNRVLSGKR----IPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKV 145

Query: 121 KP--------KISDFGLARILRK 135
           +         KI+DFGLAR   +
Sbjct: 146 ENGDLSNKILKITDFGLAREWHR 168

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  106 bits (266), Expect = 9e-29
 Identities = 42/134 (31%), Positives = 66/134 (49%), Gaps = 9/134 (6%)

Query: 10  AVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSLDY 66
           AVK L+    + Q  + FKNEV +  K +H+N++  +G+     +  ++ ++    SL +
Sbjct: 50  AVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYH 108

Query: 67  FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISD 126
            L         + KK + I +   +G+ YL      +IIHRDLK +NI L ED   KI D
Sbjct: 109 HLHASETKF--EMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGD 163

Query: 127 FGLARILRKMILKQ 140
           FGLA    +     
Sbjct: 164 FGLATEKSRWSGSH 177

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  105 bits (264), Expect = 1e-28
 Identities = 31/133 (23%), Positives = 53/133 (39%), Gaps = 7/133 (5%)

Query: 6   GQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIR-VGFCIE--TQEYMLIYEYMP 60
           G  I VK L  +  ST+   +F  E        H N++  +G C         LI  +MP
Sbjct: 33  GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMP 92

Query: 61  KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL 120
             SL   L +     ++D  + V     + +G+ +L       I    L   ++++DED+
Sbjct: 93  YGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDM 150

Query: 121 KPKISDFGLARIL 133
             +IS   +    
Sbjct: 151 TARISMADVKFSF 163

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  105 bits (264), Expect = 3e-28
 Identities = 36/126 (28%), Positives = 60/126 (47%), Gaps = 9/126 (7%)

Query: 10  AVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSLDY 66
           A++ +  +  +    + FK EVM   + +H N++  +G C+      +I      R+L  
Sbjct: 59  AIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYS 118

Query: 67  FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISD 126
            + D     +LD  K   I + I++G+ YL       I+H+DLK  N+  D   K  I+D
Sbjct: 119 VVRDAKI--VLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYDNG-KVVITD 172

Query: 127 FGLARI 132
           FGL  I
Sbjct: 173 FGLFSI 178

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  102 bits (256), Expect = 6e-27
 Identities = 36/140 (25%), Positives = 60/140 (42%), Gaps = 19/140 (13%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKNE--VMLTAKLQHLNLIR-VGFCIE----TQEYMLIYEY 58
           G+ +AVK      T     +  E  +  T  ++H N++  +   I+      +  LI +Y
Sbjct: 60  GEKVAVKVFF---TTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDY 116

Query: 59  MPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYL-----QEYFRLTIIHRDLKVSN 113
               SL    +D ++   LD K  + +    + GL +L         +  I HRDLK  N
Sbjct: 117 HENGSL----YDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKN 172

Query: 114 ILLDEDLKPKISDFGLARIL 133
           IL+ ++    I+D GLA   
Sbjct: 173 ILVKKNGTCCIADLGLAVKF 192

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  100 bits (252), Expect = 1e-26
 Identities = 38/140 (27%), Positives = 65/140 (46%), Gaps = 19/140 (13%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKNE--VMLTAKLQHLNLIR-VGFCIETQ----EYMLIYEY 58
           G+ +AVK  S   ++  + +  E  +  T  L+H N++  +   + ++    +  LI  Y
Sbjct: 31  GENVAVKIFS---SRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHY 87

Query: 59  MPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLT-----IIHRDLKVSN 113
               SL  +L    ++  LD    + I+  I  GL +L      T     I HRDLK  N
Sbjct: 88  HEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKN 143

Query: 114 ILLDEDLKPKISDFGLARIL 133
           IL+ ++ +  I+D GLA + 
Sbjct: 144 ILVKKNGQCCIADLGLAVMH 163

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score = 98.3 bits (245), Expect = 3e-25
 Identities = 33/139 (23%), Positives = 59/139 (42%), Gaps = 15/139 (10%)

Query: 5   DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQ----EYMLIYEYM 59
            G+ +AVK  S +  + +   + E+  T  L+H N++  +    +      +  L+ +Y 
Sbjct: 64  RGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH 122

Query: 60  PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYL-----QEYFRLTIIHRDLKVSNI 114
              SL    FD +    +  +  + +      GL +L         +  I HRDLK  NI
Sbjct: 123 EHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNI 178

Query: 115 LLDEDLKPKISDFGLARIL 133
           L+ ++    I+D GLA   
Sbjct: 179 LVKKNGTCCIADLGLAVRH 197

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 92.0 bits (229), Expect = 4e-23
 Identities = 41/146 (28%), Positives = 70/146 (47%), Gaps = 18/146 (12%)

Query: 1   GVLPDGQII--AVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYE 57
            +LP+   +  AVK L + S    ++F+ E  L   LQH +++R  G C E +  ++++E
Sbjct: 64  NLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFE 123

Query: 58  YMPKRSLDYFL------------FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTII 105
           YM    L+ FL             + +    L   + + +   +  G++YL     L  +
Sbjct: 124 YMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFV 180

Query: 106 HRDLKVSNILLDEDLKPKISDFGLAR 131
           HRDL   N L+ + L  KI DFG++R
Sbjct: 181 HRDLATRNCLVGQGLVVKIGDFGMSR 206

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 91.3 bits (227), Expect = 8e-23
 Identities = 37/131 (28%), Positives = 60/131 (45%), Gaps = 8/131 (6%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQE--YMLIYEYMPKR 62
           G ++AVK+L         +F+ E+ +   L    +++  G           L+ EY+P  
Sbjct: 52  GALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSG 111

Query: 63  SLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKP 122
            L  FL        LD  + +     I +G+ YL        +HRDL   NIL++ +   
Sbjct: 112 CLRDFL--QRHRARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHV 166

Query: 123 KISDFGLARIL 133
           KI+DFGLA++L
Sbjct: 167 KIADFGLAKLL 177

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 89.2 bits (222), Expect = 2e-22
 Identities = 36/134 (26%), Positives = 64/134 (47%), Gaps = 7/134 (5%)

Query: 1   GVLPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYM 59
           G   +   +A+K + ++     E+F  E  +  KL H  L++  G C+E     L+ E+M
Sbjct: 27  GYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFM 85

Query: 60  PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
               L  +L     +     +  + +   + +G+ YL+E     +IHRDL   N L+ E+
Sbjct: 86  EHGCLSDYLRTQRGLFAA--ETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGEN 140

Query: 120 LKPKISDFGLARIL 133
              K+SDFG+ R +
Sbjct: 141 QVIKVSDFGMTRFV 154

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 91.0 bits (226), Expect = 3e-22
 Identities = 36/125 (28%), Positives = 65/125 (52%), Gaps = 6/125 (4%)

Query: 10  AVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSLDYFL 68
           AVK L K+ T   EEF  E  +  +++H NL++ +G C     + +I E+M   +L  +L
Sbjct: 249 AVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 307

Query: 69  FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFG 128
            +      +     +++   I   + YL++      IHR+L   N L+ E+   K++DFG
Sbjct: 308 REC-NRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFG 363

Query: 129 LARIL 133
           L+R++
Sbjct: 364 LSRLM 368

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 88.4 bits (220), Expect = 5e-22
 Identities = 39/147 (26%), Positives = 64/147 (43%), Gaps = 19/147 (12%)

Query: 1   GVLPDGQII--AVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYE 57
            + P    +  AVK L   +    ++F+ E  L   LQH ++++  G C +    ++++E
Sbjct: 38  NLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFE 97

Query: 58  YMPKRSLDYFL-------------FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTI 104
           YM    L+ FL                     L   + +HI   I  G++YL        
Sbjct: 98  YMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLAS---QHF 154

Query: 105 IHRDLKVSNILLDEDLKPKISDFGLAR 131
           +HRDL   N L+  +L  KI DFG++R
Sbjct: 155 VHRDLATRNCLVGANLLVKIGDFGMSR 181

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 88.1 bits (219), Expect = 6e-22
 Identities = 34/134 (25%), Positives = 63/134 (47%), Gaps = 7/134 (5%)

Query: 1   GVLPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYM 59
           G       +A+K + K+ +   +EF  E  +   L H  L++  G C + +   +I EYM
Sbjct: 43  GKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 101

Query: 60  PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
               L  +L +         ++ + + K + + + YL+       +HRDL   N L+++ 
Sbjct: 102 ANGCLLNYLREMRHRFQT--QQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQ 156

Query: 120 LKPKISDFGLARIL 133
              K+SDFGL+R +
Sbjct: 157 GVVKVSDFGLSRYV 170

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 89.9 bits (223), Expect = 8e-22
 Identities = 43/134 (32%), Positives = 67/134 (50%), Gaps = 7/134 (5%)

Query: 1   GVLPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYM 59
           G       +A+K L K  T   E F  E  +  KL+H  L++      E +   ++ EYM
Sbjct: 286 GTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 343

Query: 60  PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
            K SL  FL        L   + V +   I  G+ Y++    +  +HRDL+ +NIL+ E+
Sbjct: 344 SKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGEN 399

Query: 120 LKPKISDFGLARIL 133
           L  K++DFGLAR++
Sbjct: 400 LVCKVADFGLARLI 413

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 88.1 bits (219), Expect = 8e-22
 Identities = 37/125 (29%), Positives = 65/125 (52%), Gaps = 6/125 (4%)

Query: 10  AVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSLDYFL 68
           AVK L K+ T   EEF  E  +  +++H NL++ +G C     + +I E+M   +L  +L
Sbjct: 42  AVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL 100

Query: 69  FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFG 128
            +      +     +++   I   + YL++      IHRDL   N L+ E+   K++DFG
Sbjct: 101 REC-NRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFG 156

Query: 129 LARIL 133
           L+R++
Sbjct: 157 LSRLM 161

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 88.1 bits (219), Expect = 8e-22
 Identities = 43/131 (32%), Positives = 67/131 (51%), Gaps = 8/131 (6%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEY--MLIYEYMPKR 62
           G+++AVKKL   + +   +F+ E+ +   LQH N+++  G C         LI EY+P  
Sbjct: 39  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 98

Query: 63  SLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKP 122
           SL  +L        +D  K +     I +G+ YL        IHRDL   NIL++ + + 
Sbjct: 99  SLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRV 153

Query: 123 KISDFGLARIL 133
           KI DFGL ++L
Sbjct: 154 KIGDFGLTKVL 164

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 88.2 bits (219), Expect = 1e-21
 Identities = 41/132 (31%), Positives = 64/132 (48%), Gaps = 11/132 (8%)

Query: 6   GQIIAVKKL-SKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQE--YMLIYEYMPK 61
           G+++AVK L +    Q    +K E+ +   L H ++I+  G C +       L+ EY+P 
Sbjct: 60  GEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPL 119

Query: 62  RSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK 121
            SL  +L        +   + +   + I +G+ YL        IHRDL   N+LLD D  
Sbjct: 120 GSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRL 172

Query: 122 PKISDFGLARIL 133
            KI DFGLA+ +
Sbjct: 173 VKIGDFGLAKAV 184

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 89.0 bits (221), Expect = 1e-21
 Identities = 39/134 (29%), Positives = 62/134 (46%), Gaps = 7/134 (5%)

Query: 1   GVLPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYM 59
                   +AVK + K  +   E F  E  +   LQH  L++      + +   +I E+M
Sbjct: 207 ATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 264

Query: 60  PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
            K SL  FL            K +     I +G+ ++++      IHRDL+ +NIL+   
Sbjct: 265 AKGSLLDFLKSDEGSK-QPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSAS 320

Query: 120 LKPKISDFGLARIL 133
           L  KI+DFGLAR++
Sbjct: 321 LVCKIADFGLARVI 334

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 87.0 bits (216), Expect = 2e-21
 Identities = 38/163 (23%), Positives = 72/163 (44%), Gaps = 19/163 (11%)

Query: 10  AVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSLDYFL 68
            +K L K      E F     + +KL H +L+   G C+   E +L+ E++   SLD +L
Sbjct: 44  LLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYL 103

Query: 69  FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKP------ 122
                 + +    ++ + K +   + +L+E    T+IH ++   NILL  +         
Sbjct: 104 KKNKNCINI--LWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPP 158

Query: 123 --KISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKKFS 163
             K+SD G++  +    + Q +I   ++PPE +      K  +
Sbjct: 159 FIKLSDPGISITVLPKDILQERIP--WVPPECI---ENPKNLN 196

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 87.4 bits (217), Expect = 2e-21
 Identities = 43/132 (32%), Positives = 67/132 (50%), Gaps = 8/132 (6%)

Query: 5   DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEY--MLIYEYMPK 61
            G+++AVKKL   + +   +F+ E+ +   LQH N+++  G C         LI EY+P 
Sbjct: 69  TGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPY 128

Query: 62  RSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK 121
            SL  +L        +D  K +     I +G+ YL        IHRDL   NIL++ + +
Sbjct: 129 GSLRDYL--QKHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENR 183

Query: 122 PKISDFGLARIL 133
            KI DFGL ++L
Sbjct: 184 VKIGDFGLTKVL 195

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 86.1 bits (214), Expect = 2e-21
 Identities = 37/134 (27%), Positives = 62/134 (46%), Gaps = 7/134 (5%)

Query: 1   GVLPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYM 59
           G       +AVK + K+ +   +EF  E     KL H  L++  G C +     ++ EY+
Sbjct: 27  GKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85

Query: 60  PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
               L  +L    + L     + + +   + +G+ +L+       IHRDL   N L+D D
Sbjct: 86  SNGCLLNYLRSHGKGLEP--SQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRD 140

Query: 120 LKPKISDFGLARIL 133
           L  K+SDFG+ R +
Sbjct: 141 LCVKVSDFGMTRYV 154

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 88.2 bits (219), Expect = 3e-21
 Identities = 38/128 (29%), Positives = 64/128 (50%), Gaps = 8/128 (6%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEY-MLIYEYMPKRS 63
           G  +AVK +   +T   + F  E  +  +L+H NL++ +G  +E +    ++ EYM K S
Sbjct: 216 GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 273

Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           L  +L    R + L     +     + + + YL+       +HRDL   N+L+ ED   K
Sbjct: 274 LVDYLRSRGRSV-LGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAK 329

Query: 124 ISDFGLAR 131
           +SDFGL +
Sbjct: 330 VSDFGLTK 337

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 87.3 bits (217), Expect = 4e-21
 Identities = 34/128 (26%), Positives = 54/128 (42%), Gaps = 7/128 (5%)

Query: 10  AVKKLSKKST-QGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSLDYF 67
           AVK   +        +F  E  +  +  H N++R +G C + Q   ++ E +       F
Sbjct: 143 AVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTF 202

Query: 68  LFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDF 127
           L      L +  K  + ++     G+ YL+       IHRDL   N L+ E    KISDF
Sbjct: 203 LRTEGARLRV--KTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDF 257

Query: 128 GLARILRK 135
           G++R    
Sbjct: 258 GMSREEAD 265

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 86.6 bits (215), Expect = 4e-21
 Identities = 49/161 (30%), Positives = 77/161 (47%), Gaps = 16/161 (9%)

Query: 10  AVKKLSKKST-QGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSLDYF 67
           A+K L    T +   +F +E  +  +  H N+IR  G     +  M++ EYM   SLD F
Sbjct: 81  AIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTF 140

Query: 68  LFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDF 127
           L        +   + V +++G+  G+ YL +   L  +HRDL   N+L+D +L  K+SDF
Sbjct: 141 LRTHDGQFTI--MQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDF 195

Query: 128 GLARILRKMILKQIQIELGYIP-----PEYVGRGVYYKKFS 163
           GL+R+L            G IP     PE     + ++ FS
Sbjct: 196 GLSRVLEDDPDAAYTTTGGKIPIRWTAPE----AIAFRTFS 232

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 86.1 bits (214), Expect = 4e-21
 Identities = 44/142 (30%), Positives = 67/142 (47%), Gaps = 18/142 (12%)

Query: 7   QIIAVKKLSKKST-QGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSL 64
           Q +A+K L  K+     EEF++E ML A+LQH N++  +G   + Q   +I+ Y     L
Sbjct: 40  QAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDL 99

Query: 65  DYFL-------------FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKV 111
             FL              D      L+    VH++  I  G+ YL       ++H+DL  
Sbjct: 100 HEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLAT 156

Query: 112 SNILLDEDLKPKISDFGLARIL 133
            N+L+ + L  KISD GL R +
Sbjct: 157 RNVLVYDKLNVKISDLGLFREV 178

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 87.0 bits (216), Expect = 4e-21
 Identities = 50/161 (31%), Positives = 78/161 (48%), Gaps = 16/161 (9%)

Query: 10  AVKKLSKKST-QGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSLDYF 67
           A+K L    T +   +F  E  +  +  H N+IR  G   +++  M++ EYM   SLD F
Sbjct: 77  AIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSF 136

Query: 68  LFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDF 127
           L        +   + V +++GI  G+ YL +   +  +HRDL   NIL++ +L  K+SDF
Sbjct: 137 LRKHDAQFTV--IQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDF 191

Query: 128 GLARILRKMILKQIQIELGYIP-----PEYVGRGVYYKKFS 163
           GL R+L            G IP     PE     + Y+KF+
Sbjct: 192 GLGRVLEDDPEAAYTTRGGKIPIRWTSPE----AIAYRKFT 228

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 85.4 bits (212), Expect = 6e-21
 Identities = 41/137 (29%), Positives = 55/137 (40%), Gaps = 12/137 (8%)

Query: 3   LPDGQII--AVKKLSKKST---QGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIY 56
            P G+ +  AVK L        +  ++F  EV     L H NLIR  G  +      ++ 
Sbjct: 41  APSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVT 99

Query: 57  EYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL 116
           E  P  SL   L       +L           + +G+ YL+       IHRDL   N+LL
Sbjct: 100 ELAPLGSLLDRLRKHQGHFLL--GTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLL 154

Query: 117 DEDLKPKISDFGLARIL 133
                 KI DFGL R L
Sbjct: 155 ATRDLVKIGDFGLMRAL 171

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 87.1 bits (216), Expect = 7e-21
 Identities = 43/134 (32%), Positives = 67/134 (50%), Gaps = 7/134 (5%)

Query: 1   GVLPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYM 59
           G       +A+K L K  T   E F  E  +  KL+H  L++      E +   ++ EYM
Sbjct: 203 GTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYM 260

Query: 60  PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
            K SL  FL        L   + V +   I  G+ Y++    +  +HRDL+ +NIL+ E+
Sbjct: 261 SKGSLLDFLKGETGKY-LRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGEN 316

Query: 120 LKPKISDFGLARIL 133
           L  K++DFGLAR++
Sbjct: 317 LVCKVADFGLARLI 330

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 85.4 bits (212), Expect = 8e-21
 Identities = 38/133 (28%), Positives = 65/133 (48%), Gaps = 9/133 (6%)

Query: 5   DGQIIAVKKL-SKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEY--MLIYEYMP 60
            G+ +AVK L  +       + K E+ +   L H N+++  G C E       LI E++P
Sbjct: 49  TGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLP 108

Query: 61  KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL 120
             SL  +L  P     ++ K+++     I +G+ YL        +HRDL   N+L++ + 
Sbjct: 109 SGSLKEYL--PKNKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEH 163

Query: 121 KPKISDFGLARIL 133
           + KI DFGL + +
Sbjct: 164 QVKIGDFGLTKAI 176

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 85.8 bits (213), Expect = 9e-21
 Identities = 50/161 (31%), Positives = 78/161 (48%), Gaps = 16/161 (9%)

Query: 10  AVKKLSKKST-QGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSLDYF 67
           A+K L    T +   +F  E  +  +  H N+IR  G   + +  M+I EYM   +LD F
Sbjct: 77  AIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKF 136

Query: 68  LFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDF 127
           L +      +   + V +++GI  G+ YL     +  +HRDL   NIL++ +L  K+SDF
Sbjct: 137 LREKDGEFSV--LQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDF 191

Query: 128 GLARILRKMILKQIQIELGYIP-----PEYVGRGVYYKKFS 163
           GL+R+L            G IP     PE     + Y+KF+
Sbjct: 192 GLSRVLEDDPEATYTTSGGKIPIRWTAPE----AISYRKFT 228

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 85.4 bits (212), Expect = 1e-20
 Identities = 32/126 (25%), Positives = 65/126 (51%), Gaps = 8/126 (6%)

Query: 10  AVKKLSKKSTQG-FEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSLDYF 67
           A+K+L + ++    +E  +E  + A + + ++ R +G C+      LI + MP   L  +
Sbjct: 48  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDY 106

Query: 68  LFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDF 127
           + +    +    +  ++    I +G+ YL++     ++HRDL   N+L+      KI+DF
Sbjct: 107 VREHKDNIGS--QYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDF 161

Query: 128 GLARIL 133
           GLA++L
Sbjct: 162 GLAKLL 167

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 85.0 bits (211), Expect = 1e-20
 Identities = 35/142 (24%), Positives = 62/142 (43%), Gaps = 14/142 (9%)

Query: 1   GVLPDGQII--AVKKLSKKSTQG-FEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIY 56
           GV+ D      A+K +++ ++     EF NE  +  +    +++R +G   + Q  ++I 
Sbjct: 48  GVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIM 107

Query: 57  EYMPKRSLDYFL-------FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDL 109
           E M +  L  +L        +   +      K + +   I  G+ YL        +HRDL
Sbjct: 108 ELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDL 164

Query: 110 KVSNILLDEDLKPKISDFGLAR 131
              N ++ ED   KI DFG+ R
Sbjct: 165 AARNCMVAEDFTVKIGDFGMTR 186

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 84.2 bits (209), Expect = 2e-20
 Identities = 36/127 (28%), Positives = 61/127 (48%), Gaps = 10/127 (7%)

Query: 10  AVKKLSKKST--QGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSLDY 66
           AVK L  ++      +E   E  +  +L +  ++R +G C E + +ML+ E      L+ 
Sbjct: 48  AVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNK 106

Query: 67  FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISD 126
           +L        +  K  + ++  +  G+ YL+E      +HRDL   N+LL      KISD
Sbjct: 107 YLQQNRH---VKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISD 160

Query: 127 FGLARIL 133
           FGL++ L
Sbjct: 161 FGLSKAL 167

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 83.8 bits (208), Expect = 2e-20
 Identities = 37/128 (28%), Positives = 63/128 (49%), Gaps = 8/128 (6%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEY-MLIYEYMPKRS 63
           G  +AVK +   +T   + F  E  +  +L+H NL++ +G  +E +    ++ EYM K S
Sbjct: 44  GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGS 101

Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           L  +L       +L     +     + + + YL+       +HRDL   N+L+ ED   K
Sbjct: 102 LVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAK 157

Query: 124 ISDFGLAR 131
           +SDFGL +
Sbjct: 158 VSDFGLTK 165

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 83.5 bits (207), Expect = 4e-20
 Identities = 35/126 (27%), Positives = 58/126 (46%), Gaps = 8/126 (6%)

Query: 10  AVKKLSKKST-QGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSLDYF 67
           A+K L + +     EE   E  +  +L +  ++R +G C + +  ML+ E      L  F
Sbjct: 41  AIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKF 99

Query: 68  LFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDF 127
           L      + +       ++  +  G+ YL+E      +HRDL   N+LL      KISDF
Sbjct: 100 LVGKREEIPV--SNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDF 154

Query: 128 GLARIL 133
           GL++ L
Sbjct: 155 GLSKAL 160

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 83.0 bits (206), Expect = 4e-20
 Identities = 48/135 (35%), Positives = 70/135 (51%), Gaps = 9/135 (6%)

Query: 1   GVLPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQE-YMLIYEY 58
           G       +AVK L K+ +   + F  E  L  +LQH  L+R       TQE   +I EY
Sbjct: 32  GYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVV--TQEPIYIITEY 88

Query: 59  MPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE 118
           M   SL  FL  P  +  L   K + +   I +G+ +++E      IHRDL+ +NIL+ +
Sbjct: 89  MENGSLVDFLKTPSGIK-LTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSD 144

Query: 119 DLKPKISDFGLARIL 133
            L  KI+DFGLAR++
Sbjct: 145 TLSCKIADFGLARLI 159

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 85.0 bits (210), Expect = 5e-20
 Identities = 36/133 (27%), Positives = 61/133 (45%), Gaps = 9/133 (6%)

Query: 4   PDGQI-IAVKKLSKKST-QGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMP 60
              QI +A+K L + +     EE   E  +  +L +  ++R +G C + +  ML+ E   
Sbjct: 360 RKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAG 418

Query: 61  KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL 120
              L  FL      + +       ++  +  G+ YL+E      +HR+L   N+LL    
Sbjct: 419 GGPLHKFLVGKREEIPV--SNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRH 473

Query: 121 KPKISDFGLARIL 133
             KISDFGL++ L
Sbjct: 474 YAKISDFGLSKAL 486

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 83.5 bits (207), Expect = 6e-20
 Identities = 32/126 (25%), Positives = 62/126 (49%), Gaps = 8/126 (6%)

Query: 10  AVKKLSKKST-QGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSLDYF 67
            +K +  KS  Q F+   + ++    L H +++R +G C       L+ +Y+P  SL   
Sbjct: 46  CIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDH 104

Query: 68  LFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDF 127
           +      L    +  ++    I +G+ YL+E     ++HR+L   N+LL    + +++DF
Sbjct: 105 VRQHRGALGP--QLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADF 159

Query: 128 GLARIL 133
           G+A +L
Sbjct: 160 GVADLL 165

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 83.1 bits (206), Expect = 6e-20
 Identities = 34/126 (26%), Positives = 60/126 (47%), Gaps = 8/126 (6%)

Query: 9   IAVKKLSKKSTQG-FEEFKNEVMLTAKLQHLNLIR-VGFCIETQE-YMLIYEYMPKRSLD 65
            AVK L++ +  G   +F  E ++     H N++  +G C+ ++   +++  YM    L 
Sbjct: 56  CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 115

Query: 66  YFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKIS 125
            F+ +      +  K  +     + +G+ YL        +HRDL   N +LDE    K++
Sbjct: 116 NFIRNETHNPTV--KDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVA 170

Query: 126 DFGLAR 131
           DFGLAR
Sbjct: 171 DFGLAR 176

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 82.8 bits (205), Expect = 1e-19
 Identities = 32/126 (25%), Positives = 65/126 (51%), Gaps = 8/126 (6%)

Query: 10  AVKKLSKKSTQG-FEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSLDYF 67
           A+K+L + ++    +E  +E  + A + + ++ R +G C+      LI + MP   L  +
Sbjct: 48  AIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT-STVQLITQLMPFGCLLDY 106

Query: 68  LFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDF 127
           + +    +    +  ++    I +G+ YL++     ++HRDL   N+L+      KI+DF
Sbjct: 107 VREHKDNIGS--QYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDF 161

Query: 128 GLARIL 133
           GLA++L
Sbjct: 162 GLAKLL 167

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 82.9 bits (205), Expect = 1e-19
 Identities = 33/126 (26%), Positives = 60/126 (47%), Gaps = 8/126 (6%)

Query: 9   IAVKKLSKKSTQG-FEEFKNEVMLTAKLQHLNLIR-VGFCIETQE-YMLIYEYMPKRSLD 65
            AVK L++ +  G   +F  E ++     H N++  +G C+ ++   +++  YM    L 
Sbjct: 120 CAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLR 179

Query: 66  YFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKIS 125
            F+ +      +  K  +     + +G+ +L        +HRDL   N +LDE    K++
Sbjct: 180 NFIRNETHNPTV--KDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVA 234

Query: 126 DFGLAR 131
           DFGLAR
Sbjct: 235 DFGLAR 240

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 81.9 bits (203), Expect = 2e-19
 Identities = 38/126 (30%), Positives = 59/126 (46%), Gaps = 8/126 (6%)

Query: 9   IAVKKLSKKSTQG-FEEFKNEVMLTAKLQHLNLIR-VGFCIETQE-YMLIYEYMPKRSLD 65
            A+K LS+ +     E F  E +L   L H N++  +G  +  +    ++  YM    L 
Sbjct: 52  CAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLL 111

Query: 66  YFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKIS 125
            F+  P R   +  K  +     + +G+ YL E      +HRDL   N +LDE    K++
Sbjct: 112 QFIRSPQRNPTV--KDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVA 166

Query: 126 DFGLAR 131
           DFGLAR
Sbjct: 167 DFGLAR 172

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 82.0 bits (203), Expect = 2e-19
 Identities = 40/137 (29%), Positives = 62/137 (45%), Gaps = 12/137 (8%)

Query: 4   PDGQIIAVKKLSKKST-QGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPK 61
           P    +AVK L +  + Q   +F  E ++ +K  H N++R +G  +++    ++ E M  
Sbjct: 58  PSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAG 117

Query: 62  RSLDYFL----FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLD 117
             L  FL      P +   L     +H+ + I  G  YL+E      IHRD+   N LL 
Sbjct: 118 GDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLT 174

Query: 118 ---EDLKPKISDFGLAR 131
                   KI DFG+AR
Sbjct: 175 CPGPGRVAKIGDFGMAR 191

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 80.7 bits (200), Expect = 4e-19
 Identities = 29/126 (23%), Positives = 52/126 (41%), Gaps = 8/126 (6%)

Query: 10  AVKKLSKKST-QGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSLDYF 67
           A+K     ++    E+F  E +   +  H ++++ +G   E     +I E      L  F
Sbjct: 47  AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSF 105

Query: 68  LFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDF 127
           L      L L     +     +   L YL+       +HRD+   N+L+  +   K+ DF
Sbjct: 106 LQVRKYSLDL--ASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDF 160

Query: 128 GLARIL 133
           GL+R +
Sbjct: 161 GLSRYM 166

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 80.3 bits (199), Expect = 5e-19
 Identities = 35/126 (27%), Positives = 59/126 (46%), Gaps = 8/126 (6%)

Query: 10  AVKKLSKKST-QGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSLDYF 67
           AVK   K  T    E+F +E ++   L H ++++ +G   E +   +I E  P   L ++
Sbjct: 44  AVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGII-EEEPTWIIMELYPYGELGHY 102

Query: 68  LFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDF 127
           L      L +     V     I + + YL+    +  +HRD+ V NIL+      K+ DF
Sbjct: 103 LERNKNSLKV--LTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDF 157

Query: 128 GLARIL 133
           GL+R +
Sbjct: 158 GLSRYI 163

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 81.3 bits (201), Expect = 5e-19
 Identities = 40/137 (29%), Positives = 62/137 (45%), Gaps = 12/137 (8%)

Query: 4   PDGQIIAVKKLSKKST-QGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPK 61
           P    +AVK L +  + Q   +F  E ++ +K  H N++R +G  +++    ++ E M  
Sbjct: 99  PSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAG 158

Query: 62  RSLDYFL----FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLD 117
             L  FL      P +   L     +H+ + I  G  YL+E      IHRD+   N LL 
Sbjct: 159 GDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLT 215

Query: 118 ---EDLKPKISDFGLAR 131
                   KI DFG+AR
Sbjct: 216 CPGPGRVAKIGDFGMAR 232

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 80.8 bits (200), Expect = 6e-19
 Identities = 42/156 (26%), Positives = 71/156 (45%), Gaps = 28/156 (17%)

Query: 1   GVLPDGQII--AVKKLSKKST-QGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIY 56
           G+LP       AVK L ++++     +F+ E  L A+  + N+++ +G C   +   L++
Sbjct: 70  GLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLF 129

Query: 57  EYMPKRSLDYFL---------------------FDPIRMLILDCKKRVHIIKGIIQGLLY 95
           EYM    L+ FL                             L C +++ I + +  G+ Y
Sbjct: 130 EYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAY 189

Query: 96  LQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLAR 131
           L E      +HRDL   N L+ E++  KI+DFGL+R
Sbjct: 190 LSE---RKFVHRDLATRNCLVGENMVVKIADFGLSR 222

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 80.4 bits (199), Expect = 7e-19
 Identities = 36/133 (27%), Positives = 58/133 (43%), Gaps = 14/133 (10%)

Query: 10  AVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQ-----EYMLIYEYMPK 61
           AVK +     S +  EEF +E        H N+IR +G CIE       + M+I  +M  
Sbjct: 66  AVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKY 125

Query: 62  RSLDYFL---FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE 118
             L  +L           +  +  +  +  I  G+ YL        +HRDL   N +L +
Sbjct: 126 GDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRD 182

Query: 119 DLKPKISDFGLAR 131
           D+   ++DFGL++
Sbjct: 183 DMTVCVADFGLSK 195

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 78.9 bits (195), Expect = 2e-18
 Identities = 39/168 (23%), Positives = 66/168 (39%), Gaps = 28/168 (16%)

Query: 5   DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIE----TQEYMLIYEYM 59
           DG   A+K++     Q  EE + E  +     H N++R V +C+       E  L+  + 
Sbjct: 53  DGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFF 112

Query: 60  PKRSLDYFLFDPIRMLI-----LDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNI 114
            + +L    ++ I  L      L   + + ++ GI +GL  +         HRDLK +NI
Sbjct: 113 KRGTL----WNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNI 165

Query: 115 LLDEDLKPKISDFGLARILRKMILKQIQIELG-----------YIPPE 151
           LL ++ +P + D G        +    Q               Y  PE
Sbjct: 166 LLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPE 213

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 78.5 bits (194), Expect = 4e-18
 Identities = 39/138 (28%), Positives = 63/138 (45%), Gaps = 19/138 (13%)

Query: 10  AVKKLSKKSTQG-FEEFKNEVMLTAKL-QHLNLIR-VGFCIETQEYMLIYEYMPKRSLDY 66
           A+K++ + +++    +F  E+ +  KL  H N+I  +G C       L  EY P  +L  
Sbjct: 56  AIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLD 115

Query: 67  FL-------------FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSN 113
           FL                     L  ++ +H    + +G+ YL +      IHRDL   N
Sbjct: 116 FLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARN 172

Query: 114 ILLDEDLKPKISDFGLAR 131
           IL+ E+   KI+DFGL+R
Sbjct: 173 ILVGENYVAKIADFGLSR 190

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 78.5 bits (194), Expect = 4e-18
 Identities = 37/135 (27%), Positives = 55/135 (40%), Gaps = 15/135 (11%)

Query: 9   IAVKKLSKKST--QGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEY------MLIYEYM 59
           +AVK L          EEF  E     +  H ++ + VG  + ++        M+I  +M
Sbjct: 54  VAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFM 113

Query: 60  PKRSLDYFLFD---PIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL 116
               L  FL           L  +  V  +  I  G+ YL        IHRDL   N +L
Sbjct: 114 KHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCML 170

Query: 117 DEDLKPKISDFGLAR 131
            ED+   ++DFGL+R
Sbjct: 171 AEDMTVCVADFGLSR 185

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 78.1 bits (193), Expect = 4e-18
 Identities = 40/141 (28%), Positives = 64/141 (45%), Gaps = 16/141 (11%)

Query: 5   DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRS 63
           D +  A+KK+     +      +EVML A L H  ++R     +E + ++     + K+S
Sbjct: 30  DSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKS 88

Query: 64  LDYF---------LFDPIRM--LILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVS 112
             +          L+D I    L     +   + + I++ L Y+       IIHRDLK  
Sbjct: 89  TLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPM 145

Query: 113 NILLDEDLKPKISDFGLARIL 133
           NI +DE    KI DFGLA+ +
Sbjct: 146 NIFIDESRNVKIGDFGLAKNV 166

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 78.1 bits (193), Expect = 5e-18
 Identities = 38/138 (27%), Positives = 62/138 (44%), Gaps = 19/138 (13%)

Query: 10  AVKKLSKKSTQG-FEEFKNEVMLTAKL-QHLNLIR-VGFCIETQEYMLIYEYMPKRSLDY 66
           AVK L   +T+    +  +E+ +   + +H N+I  +G C +     +I EY  K +L  
Sbjct: 71  AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 130

Query: 67  FL-------------FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSN 113
           +L              + +    +  K  V     + +G+ YL        IHRDL   N
Sbjct: 131 YLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARN 187

Query: 114 ILLDEDLKPKISDFGLAR 131
           +L+ E+   KI+DFGLAR
Sbjct: 188 VLVTENNVMKIADFGLAR 205

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 77.8 bits (192), Expect = 8e-18
 Identities = 38/138 (27%), Positives = 62/138 (44%), Gaps = 19/138 (13%)

Query: 10  AVKKLSKKSTQG-FEEFKNEVMLTAKL-QHLNLIR-VGFCIETQEYMLIYEYMPKRSLDY 66
           AVK L   +T+    +  +E+ +   + +H N+I  +G C +     +I EY  K +L  
Sbjct: 117 AVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 176

Query: 67  FL-------------FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSN 113
           +L              + +    +  K  V     + +G+ YL        IHRDL   N
Sbjct: 177 YLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARN 233

Query: 114 ILLDEDLKPKISDFGLAR 131
           +L+ E+   KI+DFGLAR
Sbjct: 234 VLVTENNVMKIADFGLAR 251

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 76.9 bits (190), Expect = 1e-17
 Identities = 42/148 (28%), Positives = 63/148 (42%), Gaps = 26/148 (17%)

Query: 7   QIIAVKKLSKKSTQG-FEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSL 64
             +AVK L + ++     +  +E  +  ++ H ++I+  G C +    +LI EY    SL
Sbjct: 54  TTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSL 113

Query: 65  DYFL---------------------FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLT 103
             FL                      D      L     +     I QG+ YL E   + 
Sbjct: 114 RGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MK 170

Query: 104 IIHRDLKVSNILLDEDLKPKISDFGLAR 131
           ++HRDL   NIL+ E  K KISDFGL+R
Sbjct: 171 LVHRDLAARNILVAEGRKMKISDFGLSR 198

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 77.0 bits (190), Expect = 2e-17
 Identities = 41/165 (24%), Positives = 73/165 (44%), Gaps = 24/165 (14%)

Query: 6   GQIIAVKKLSKKS--TQGFEE-FKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPK 61
            ++ A K + K         E    E+ +   L H +++      E  +++ ++ E   +
Sbjct: 66  KEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR 125

Query: 62  RSLDYFLFDPIRMLILDCKKRV------HIIKGIIQGLLYLQEYFRLTIIHRDLKVSNIL 115
           RSL     +  +      +K +      + ++ I+ G  YL    R  +IHRDLK+ N+ 
Sbjct: 126 RSL----LELHKR-----RKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLF 173

Query: 116 LDEDLKPKISDFGLARILRK--MILKQIQIELGYIPPEYVGRGVY 158
           L+EDL+ KI DFGLA  +       K +     YI PE + +  +
Sbjct: 174 LNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 218

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 76.7 bits (189), Expect = 2e-17
 Identities = 39/165 (23%), Positives = 69/165 (41%), Gaps = 12/165 (7%)

Query: 6   GQIIAVKKLSKKSTQGFEE-FKNEVMLTAKLQHLNLIRVGFCIETQEYMLIY---EYMPK 61
           G + A+K  +  S     +    E  +  KL H N++++    E           E+ P 
Sbjct: 34  GDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPC 93

Query: 62  RSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL----D 117
            SL   L +P     L   + + +++ ++ G+ +L+E     I+HR++K  NI+     D
Sbjct: 94  GSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGED 150

Query: 118 EDLKPKISDFGLARILRK-MILKQIQIELGYIPPEYVGRGVYYKK 161
                K++DFG AR L        +     Y+ P+   R V  K 
Sbjct: 151 GQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKD 195

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 77.6 bits (191), Expect = 2e-17
 Identities = 30/127 (23%), Positives = 53/127 (41%), Gaps = 8/127 (6%)

Query: 10  AVKKLSKKST-QGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSLDYF 67
           A+K     ++    E+F  E +   +  H ++++ +G   E     +I E      L  F
Sbjct: 422 AIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSF 480

Query: 68  LFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDF 127
           L    R   LD    +     +   L YL+       +HRD+   N+L+  +   K+ DF
Sbjct: 481 LQV--RKFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDF 535

Query: 128 GLARILR 134
           GL+R + 
Sbjct: 536 GLSRYME 542

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 76.2 bits (188), Expect = 3e-17
 Identities = 38/136 (27%), Positives = 55/136 (40%), Gaps = 17/136 (12%)

Query: 10  AVKKLSKKSTQG-FEEFKNEVMLTAKL-QHLNLIR-VGFCIETQEYMLIYEYMPKRSLDY 66
           AVK L   +     E   +E+ + + L QH N++  +G C      ++I EY     L  
Sbjct: 80  AVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLN 139

Query: 67  FL-----------FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNIL 115
           FL              I       +  +H    + QG+ +L        IHRD+   N+L
Sbjct: 140 FLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVL 196

Query: 116 LDEDLKPKISDFGLAR 131
           L      KI DFGLAR
Sbjct: 197 LTNGHVAKIGDFGLAR 212

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 76.4 bits (188), Expect = 3e-17
 Identities = 39/165 (23%), Positives = 69/165 (41%), Gaps = 12/165 (7%)

Query: 6   GQIIAVKKLSKKSTQGFEE-FKNEVMLTAKLQHLNLIRVGFCIETQEYMLIY---EYMPK 61
           G + A+K  +  S     +    E  +  KL H N++++    E           E+ P 
Sbjct: 34  GDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPC 93

Query: 62  RSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL----D 117
            SL   L +P     L   + + +++ ++ G+ +L+E     I+HR++K  NI+     D
Sbjct: 94  GSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGED 150

Query: 118 EDLKPKISDFGLARILRK-MILKQIQIELGYIPPEYVGRGVYYKK 161
                K++DFG AR L        +     Y+ P+   R V  K 
Sbjct: 151 GQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKD 195

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 75.8 bits (187), Expect = 3e-17
 Identities = 37/145 (25%), Positives = 60/145 (41%), Gaps = 20/145 (13%)

Query: 4   PDGQIIAVKKLSKKSTQG-FEEFKNEVMLTAKL-QHLNLIR-VGFC-IETQEYMLIYEYM 59
              + +AVK L + +T        +E+ +   +  HLN++  +G C       M+I E+ 
Sbjct: 55  ATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFC 114

Query: 60  PKRSLDYFL-------------FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIH 106
              +L  +L              + +    L  +  +     + +G+ +L        IH
Sbjct: 115 KFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIH 171

Query: 107 RDLKVSNILLDEDLKPKISDFGLAR 131
           RDL   NILL E    KI DFGLAR
Sbjct: 172 RDLAARNILLSEKNVVKICDFGLAR 196

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 75.4 bits (186), Expect = 3e-17
 Identities = 36/136 (26%), Positives = 67/136 (49%), Gaps = 5/136 (3%)

Query: 3   LPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIY-EYMPK 61
           L +   IA+K++ ++ ++  +    E+ L   L+H N+++         ++ I+ E +P 
Sbjct: 44  LSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPG 103

Query: 62  RSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLD-EDL 120
            SL   L      L  + +      K I++GL YL +     I+HRD+K  N+L++    
Sbjct: 104 GSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSG 160

Query: 121 KPKISDFGLARILRKM 136
             KISDFG ++ L  +
Sbjct: 161 VLKISDFGTSKRLAGI 176

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 75.3 bits (186), Expect = 4e-17
 Identities = 41/165 (24%), Positives = 73/165 (44%), Gaps = 24/165 (14%)

Query: 6   GQIIAVKKLSKKS--TQGFEE-FKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPK 61
            ++ A K + K         E    E+ +   L H +++      E  +++ ++ E   +
Sbjct: 40  KEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR 99

Query: 62  RSLDYFLFDPIRMLILDCKKRV------HIIKGIIQGLLYLQEYFRLTIIHRDLKVSNIL 115
           RSL     +  +      +K +      + ++ I+ G  YL    R  +IHRDLK+ N+ 
Sbjct: 100 RSL----LELHKR-----RKALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLF 147

Query: 116 LDEDLKPKISDFGLARILRK--MILKQIQIELGYIPPEYVGRGVY 158
           L+EDL+ KI DFGLA  +       K +     YI PE + +  +
Sbjct: 148 LNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 192

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 75.4 bits (186), Expect = 5e-17
 Identities = 39/140 (27%), Positives = 56/140 (40%), Gaps = 21/140 (15%)

Query: 10  AVKKLSKKSTQG-FEEFKNEVMLTAKL-QHLNLIR-VGFCIETQEYMLIYEYMPKRSLDY 66
           AVK L   +     E   +E+ + + L  H+N++  +G C      ++I EY     L  
Sbjct: 57  AVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLN 116

Query: 67  FL---------------FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKV 111
           FL                     L LD +  +     + +G+ +L        IHRDL  
Sbjct: 117 FLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAA 173

Query: 112 SNILLDEDLKPKISDFGLAR 131
            NILL      KI DFGLAR
Sbjct: 174 RNILLTHGRITKICDFGLAR 193

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 75.6 bits (186), Expect = 8e-17
 Identities = 35/159 (22%), Positives = 60/159 (37%), Gaps = 13/159 (8%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKRSL 64
           G   A K +        E  + E+   + L+H  L+ +    E    M +IYE+M     
Sbjct: 182 GNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGE- 240

Query: 65  DYFLFDPI--RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL--DEDL 120
              LF+ +      +   + V  ++ + +GL ++ E      +H DLK  NI+       
Sbjct: 241 ---LFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSN 294

Query: 121 KPKISDFGLARILRK-MILKQIQIELGYIPPEYVGRGVY 158
           + K+ DFGL   L     +K       +  PE       
Sbjct: 295 ELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV 333

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 74.8 bits (184), Expect = 1e-16
 Identities = 42/179 (23%), Positives = 78/179 (43%), Gaps = 26/179 (14%)

Query: 5   DGQIIAVKKLSKK-----------------STQGFEEFKNEVMLTAKLQHLNLIRVGFCI 47
           D +  A+KK  K                      +++FKNE+ +   +++   +     I
Sbjct: 53  DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGII 112

Query: 48  ETQEYM-LIYEYMPKRSL-----DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFR 101
              + + +IYEYM   S+      +F+ D      +  +    IIK ++    Y+  +  
Sbjct: 113 TNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYI--HNE 170

Query: 102 LTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYV-GRGVYY 159
             I HRD+K SNIL+D++ + K+SDFG +  +    +K  +    ++PPE+      Y 
Sbjct: 171 KNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNESSYN 229

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 74.7 bits (184), Expect = 1e-16
 Identities = 40/138 (28%), Positives = 60/138 (43%), Gaps = 19/138 (13%)

Query: 10  AVKKLSKKSTQG-FEEFKNEVMLTAKL-QHLNLIR-VGFCIETQEYMLIYEYMPKRSLDY 66
           AVK L   +T+    +  +E+ +   + +H N+I  +G C +     +I EY  K +L  
Sbjct: 105 AVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLRE 164

Query: 67  FL-------------FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSN 113
           +L                     L  K  V     + +G+ YL        IHRDL   N
Sbjct: 165 YLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARN 221

Query: 114 ILLDEDLKPKISDFGLAR 131
           +L+ ED   KI+DFGLAR
Sbjct: 222 VLVTEDNVMKIADFGLAR 239

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 75.1 bits (184), Expect = 1e-16
 Identities = 41/165 (24%), Positives = 68/165 (41%), Gaps = 15/165 (9%)

Query: 6   GQIIAVKKLSKKSTQGFEE-FKNEVMLTAKLQHLNLIRVGFCIETQEYM-------LIYE 57
           G+ +A+K+  ++ +    E +  E+ +  KL H N++      +  + +       L  E
Sbjct: 39  GEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAME 98

Query: 58  YMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLD 117
           Y     L  +L        L       ++  I   L YL       IIHRDLK  NI+L 
Sbjct: 99  YCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYL---HENRIIHRDLKPENIVLQ 155

Query: 118 ---EDLKPKISDFGLARILRK-MILKQIQIELGYIPPEYVGRGVY 158
              + L  KI D G A+ L +  +  +    L Y+ PE + +  Y
Sbjct: 156 PGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKY 200

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 74.8 bits (184), Expect = 1e-16
 Identities = 41/162 (25%), Positives = 68/162 (41%), Gaps = 13/162 (8%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKRSL 64
           G++   K ++          KNE+ +  +L H  LI +    E +  M LI E++     
Sbjct: 76  GRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGE- 134

Query: 65  DYFLFDPI--RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL--DEDL 120
              LFD I      +   + ++ ++   +GL ++ E    +I+H D+K  NI+    +  
Sbjct: 135 ---LFDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKAS 188

Query: 121 KPKISDFGLARILRK-MILKQIQIELGYIPPEYVGRGVYYKK 161
             KI DFGLA  L    I+K       +  PE V R      
Sbjct: 189 SVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFY 230

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 73.9 bits (182), Expect = 1e-16
 Identities = 42/168 (25%), Positives = 67/168 (39%), Gaps = 32/168 (19%)

Query: 5   DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRS 63
           DG+   +K++   +    E+ + EV   AKL H+N++   G                 RS
Sbjct: 35  DGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRS 90

Query: 64  LDYFLFDPIRM----------LILDCKKR-------VHIIKGIIQGLLYLQEYFRLTIIH 106
               LF  I+M           I   +         + + + I +G+ Y+       +I+
Sbjct: 91  KTKCLF--IQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS---KKLIN 145

Query: 107 RDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELG---YIPPE 151
           RDLK SNI L +  + KI DFGL   L+    +      G   Y+ PE
Sbjct: 146 RDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSK--GTLRYMSPE 191

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 73.9 bits (182), Expect = 1e-16
 Identities = 32/143 (22%), Positives = 56/143 (39%), Gaps = 17/143 (11%)

Query: 5   DGQIIAVKKLS-KKSTQGFEEFKNEVMLTAKLQHLNLIR----------VGFCIETQEYM 53
           D    A+K++         E+   EV   AKL+H  ++R                +   +
Sbjct: 29  DDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKV 88

Query: 54  LIY---EYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLK 110
            +Y   +   K +L  ++     +   +    +HI   I + + +L       ++HRDLK
Sbjct: 89  YLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLK 145

Query: 111 VSNILLDEDLKPKISDFGLARIL 133
            SNI    D   K+ DFGL   +
Sbjct: 146 PSNIFFTMDDVVKVGDFGLVTAM 168

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 73.8 bits (182), Expect = 2e-16
 Identities = 42/167 (25%), Positives = 76/167 (45%), Gaps = 24/167 (14%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSL 64
           G++ A+K + K         +NE+ +  K++H N++        T  Y L+ + +    L
Sbjct: 34  GKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGEL 93

Query: 65  DYFLFDPIRMLILDCKKR-------VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL- 116
               FD I       ++          +I+ ++  + YL E     I+HRDLK  N+L  
Sbjct: 94  ----FDRI------LERGVYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYL 140

Query: 117 --DEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKK 161
             +E+ K  I+DFGL+++ +  I+       GY+ PE + +  Y K 
Sbjct: 141 TPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQKPYSKA 187

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 74.0 bits (182), Expect = 2e-16
 Identities = 44/154 (28%), Positives = 77/154 (50%), Gaps = 17/154 (11%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKRSL 64
           G  +A K +  +  +  EE KNE+ +  +L H NLI++    E++  + L+ EY+     
Sbjct: 114 GLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGE- 172

Query: 65  DYFLFDPI--RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL--DEDL 120
              LFD I      L     +  +K I +G+ ++ +   + I+H DLK  NIL    +  
Sbjct: 173 ---LFDRIIDESYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAK 226

Query: 121 KPKISDFGLARILRKMILKQIQIELG---YIPPE 151
           + KI DFGLAR  +    +++++  G   ++ PE
Sbjct: 227 QIKIIDFGLARRYKPR--EKLKVNFGTPEFLAPE 258

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 72.4 bits (178), Expect = 5e-16
 Identities = 40/160 (25%), Positives = 63/160 (39%), Gaps = 12/160 (7%)

Query: 5   DGQIIAVK--KLSKKSTQGFEEFKNEVMLTAKLQHLNLIR-----VGFCIETQEYMLIYE 57
               +A    +  K +    + FK E  +   LQH N++R            +  +L+ E
Sbjct: 50  TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE 109

Query: 58  YMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLD 117
            M   +L  +L    R  ++  K      + I++GL +L       IIHRDLK  NI + 
Sbjct: 110 LMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFIT 165

Query: 118 -EDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRG 156
                 KI D GLA + R    K +     ++ PE     
Sbjct: 166 GPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEK 205

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 72.1 bits (177), Expect = 9e-16
 Identities = 33/140 (23%), Positives = 56/140 (40%), Gaps = 12/140 (8%)

Query: 5   DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQ-HLNLIR-VGFCI--------ETQEYML 54
            G+  A+K+L     +       EV    KL  H N+++                 E++L
Sbjct: 52  SGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLL 111

Query: 55  IYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNI 114
           + E    + +++      R   L C   + I     + + ++    +  IIHRDLKV N+
Sbjct: 112 LTELCKGQLVEFLKKMESRGP-LSCDTVLKIFYQTCRAVQHMH-RQKPPIIHRDLKVENL 169

Query: 115 LLDEDLKPKISDFGLARILR 134
           LL      K+ DFG A  + 
Sbjct: 170 LLSNQGTIKLCDFGSATTIS 189

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 71.9 bits (177), Expect = 1e-15
 Identities = 35/145 (24%), Positives = 61/145 (42%), Gaps = 26/145 (17%)

Query: 10  AVKKLSKKSTQG-FEEFKNEVMLTAKL-QHLNLIR-VGFCIETQEYMLIYEYMPKRSLDY 66
           AVK L +K+     E   +E+ +  +L  H N++  +G C  +    LI+EY     L  
Sbjct: 79  AVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLN 138

Query: 67  FL--------------------FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIH 106
           +L                     +   + +L  +  +     + +G+ +L+     + +H
Sbjct: 139 YLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVH 195

Query: 107 RDLKVSNILLDEDLKPKISDFGLAR 131
           RDL   N+L+      KI DFGLAR
Sbjct: 196 RDLAARNVLVTHGKVVKICDFGLAR 220

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 71.0 bits (175), Expect = 1e-15
 Identities = 45/161 (27%), Positives = 75/161 (46%), Gaps = 15/161 (9%)

Query: 6   GQIIAVKKLSKKS--TQGFEE-FKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPK 61
           G  +A+K + KK+    G  +  +NEV +  +L+H +++ +    E   Y+ L+ E    
Sbjct: 36  GLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHN 95

Query: 62  RSLDYFLFDPI--RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
             +       +  R+      +  H +  II G+LYL       I+HRDL +SN+LL  +
Sbjct: 96  GEM----NRYLKNRVKPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRN 148

Query: 120 LKPKISDFGLARILRK--MILKQIQIELGYIPPEYVGRGVY 158
           +  KI+DFGLA  L+        +     YI PE   R  +
Sbjct: 149 MNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAH 189

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 70.3 bits (173), Expect = 2e-15
 Identities = 40/169 (23%), Positives = 67/169 (39%), Gaps = 28/169 (16%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKRSL 64
               A KK+ K   +  + FK E+ +   L H N+IR+    E    + L+ E       
Sbjct: 34  RIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGE- 92

Query: 65  DYFLFDPIRMLILDCKKRVH--------IIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL 116
              LF+ +         +          I+K ++  + Y  +   L + HRDLK  N L 
Sbjct: 93  ---LFERV-------VHKRVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLF 139

Query: 117 ---DEDLKPKISDFGLARILRK-MILKQIQIELGYIPPEYVGRGVYYKK 161
                D   K+ DFGLA   +   +++       Y+ P+ V  G+Y  +
Sbjct: 140 LTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQ-VLEGLYGPE 187

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 70.9 bits (174), Expect = 2e-15
 Identities = 33/132 (25%), Positives = 64/132 (48%), Gaps = 7/132 (5%)

Query: 5   DGQIIAVKK--LSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPK 61
           DG+   +K+  +S+ S++  EE + EV + A ++H N+++      E     ++ +Y   
Sbjct: 48  DGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEG 107

Query: 62  RSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK 121
             L   +     +L     + +     I   L ++ +     I+HRD+K  NI L +D  
Sbjct: 108 GDLFKRINAQKGVL-FQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGT 163

Query: 122 PKISDFGLARIL 133
            ++ DFG+AR+L
Sbjct: 164 VQLGDFGIARVL 175

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 70.3 bits (173), Expect = 3e-15
 Identities = 37/167 (22%), Positives = 62/167 (37%), Gaps = 19/167 (11%)

Query: 6   GQIIAVKKLSKKSTQG-FEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKRS 63
           G    +K ++K  +Q   E+ + E+ +   L H N+I++    E    M ++ E      
Sbjct: 47  GLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGE 106

Query: 64  LDYFLFDPIRMLILDC-----KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL-- 116
           L     + I                 ++K ++  L Y        ++H+DLK  NIL   
Sbjct: 107 L----LERIVSAQARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQD 159

Query: 117 -DEDLKPKISDFGLARILRK-MILKQIQIELGYIPPEYVGRGVYYKK 161
                  KI DFGLA + +             Y+ PE V +     K
Sbjct: 160 TSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPE-VFKRDVTFK 205

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 70.9 bits (174), Expect = 3e-15
 Identities = 36/145 (24%), Positives = 68/145 (46%), Gaps = 23/145 (15%)

Query: 3   LPDGQIIAVKKLSKKSTQGFEEFKN-EVMLTAKLQHLNLIRVGFCIETQEYM-------L 54
              G+++A+KK+ +      + FKN E+ +  KL H N++R+ +   +           L
Sbjct: 76  CDSGELVAIKKVLQ-----DKRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 130

Query: 55  IYEYMP---KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKV 111
           + +Y+P    R   ++      + ++  K  ++    + + L Y+       I HRD+K 
Sbjct: 131 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY---QLFRSLAYIH---SFGICHRDIKP 184

Query: 112 SNILLDEDLKP-KISDFGLARILRK 135
            N+LLD D    K+ DFG A+ L +
Sbjct: 185 QNLLLDPDTAVLKLCDFGSAKQLVR 209

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 70.2 bits (172), Expect = 5e-15
 Identities = 39/159 (24%), Positives = 66/159 (41%), Gaps = 21/159 (13%)

Query: 5   DGQIIAVKKLSKKSTQGFEEFKNEV-MLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKR 62
           D + +AVK++  +    F     EV +L    +H N+IR     + +++  +  E     
Sbjct: 47  DNRDVAVKRILPEC---FSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAAT 103

Query: 63  SLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE---- 118
             +Y      +       + + +++    GL +L     L I+HRDLK  NIL+      
Sbjct: 104 LQEYVE---QKDFAHLGLEPITLLQQTTSGLAHLHS---LNIVHRDLKPHNILISMPNAH 157

Query: 119 -DLKPKISDFGLARILRK-----MILKQIQIELGYIPPE 151
             +K  ISDFGL + L            +    G+I PE
Sbjct: 158 GKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE 196

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 70.2 bits (172), Expect = 6e-15
 Identities = 41/171 (23%), Positives = 66/171 (38%), Gaps = 30/171 (17%)

Query: 5   DGQIIAVKKLSKKSTQGFEEFKNEV-MLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKR 62
            G+ +AVK++        +    E+ +LT    H N+IR      T  ++ +  E     
Sbjct: 38  QGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCNLN 94

Query: 63  SLDYFL---FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLD-- 117
             D           + +      + +++ I  G+ +L     L IIHRDLK  NIL+   
Sbjct: 95  LQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTS 151

Query: 118 -----------EDLKPKISDFGLARILR------KMILKQIQIELGYIPPE 151
                      E+L+  ISDFGL + L       +  L       G+  PE
Sbjct: 152 SRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPE 202

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 70.1 bits (172), Expect = 6e-15
 Identities = 41/164 (25%), Positives = 74/164 (45%), Gaps = 30/164 (18%)

Query: 6   GQIIAVKKLSKKSTQGFEE--------FKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYE 57
            + +A++ +SK+                + E+ +  KL H  +I++    + ++Y ++ E
Sbjct: 160 CKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLE 219

Query: 58  YMPKRSLDYFLFDPIRMLILDCKKRV------HIIKGIIQGLLYLQEYFRLTIIHRDLKV 111
            M    L    FD +        KR+           ++  + YL E     IIHRDLK 
Sbjct: 220 LMEGGEL----FDKVVG-----NKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKP 267

Query: 112 SNILL---DEDLKPKISDFGLARILRKM-ILKQIQIELGYIPPE 151
            N+LL   +ED   KI+DFG ++IL +  +++ +     Y+ PE
Sbjct: 268 ENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPE 311

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 69.6 bits (171), Expect = 6e-15
 Identities = 35/165 (21%), Positives = 66/165 (40%), Gaps = 18/165 (10%)

Query: 8   IIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKRSLDY 66
           I+ V K +       E+ K E  +   L+H +++ +     +   + +++E+M       
Sbjct: 56  IVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGAD--- 112

Query: 67  FLFDPI-----RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL---DE 118
            L   I        +       H ++ I++ L Y  +     IIHRD+K   +LL   + 
Sbjct: 113 -LCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKEN 168

Query: 119 DLKPKISDFGLARILRK--MILKQIQIELGYIPPEYVGRGVYYKK 161
               K+  FG+A  L +  ++         ++ PE V R  Y K 
Sbjct: 169 SAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKP 213

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 69.2 bits (170), Expect = 7e-15
 Identities = 37/137 (27%), Positives = 61/137 (44%), Gaps = 8/137 (5%)

Query: 5   DGQIIAVKK--LSKKSTQGFEEFKNEVMLTAKLQHLNLIRV--GFCIETQEYMLIY-EYM 59
           DG+I+  K+      +    +   +EV L  +L+H N++R        T   + I  EY 
Sbjct: 30  DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYC 89

Query: 60  PKRSLDYFLFDPIRM-LILDCKKRVHIIKGIIQGLLYL--QEYFRLTIIHRDLKVSNILL 116
               L   +    +    LD +  + ++  +   L     +     T++HRDLK +N+ L
Sbjct: 90  EGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL 149

Query: 117 DEDLKPKISDFGLARIL 133
           D     K+ DFGLARIL
Sbjct: 150 DGKQNVKLGDFGLARIL 166

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 69.5 bits (170), Expect = 1e-14
 Identities = 29/157 (18%), Positives = 59/157 (37%), Gaps = 24/157 (15%)

Query: 5   DGQIIAVKKLSKKSTQGFEE-FKNEVMLTAKLQHLNLIRV---GFCIETQEYMLIY---E 57
           +G+ + +K L        +     E    A++ H +++++       +     + Y   E
Sbjct: 105 NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVME 164

Query: 58  YMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLD 117
           Y+  +SL            L   + +  +  I+  L YL     + +++ DLK  NI+L 
Sbjct: 165 YVGGQSLKRSKGQK-----LPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLT 216

Query: 118 EDLKPKISDFGLARILRKMILKQIQIELG---YIPPE 151
           E+ + K+ D G         +       G   +  PE
Sbjct: 217 EE-QLKLIDLGAVS-----RINSFGYLYGTPGFQAPE 247

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 68.5 bits (167), Expect = 2e-14
 Identities = 29/185 (15%), Positives = 55/185 (29%), Gaps = 43/185 (23%)

Query: 5   DGQIIAVKKLSK---KSTQGFEEFKNEVMLTAKLQ------------------------- 36
            G+   V          +   ++ K EV+    L+                         
Sbjct: 102 TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQ 161

Query: 37  HLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLI--------LDCKKRVHIIKG 88
              +IRV         +  +   P+   +  L     +L+        L    R+ +   
Sbjct: 162 KKKMIRVRLDERDMWVLSRFFLYPRMQSN--LQTFGEVLLSHSSTHKSLVHHARLQLTLQ 219

Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYI 148
           +I+ L  L       ++H  L+  +I+LD+     ++ F      R        I  G+ 
Sbjct: 220 VIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV--RDGASAVSPIGRGFA 274

Query: 149 PPEYV 153
           PPE  
Sbjct: 275 PPETT 279

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 67.7 bits (166), Expect = 3e-14
 Identities = 40/166 (24%), Positives = 71/166 (42%), Gaps = 34/166 (20%)

Query: 6   GQIIAVKKLSKKSTQGFEE--------FKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYE 57
            + +A+K +SK+                + E+ +  KL H  +I++    + ++Y ++ E
Sbjct: 35  CKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLE 94

Query: 58  YMPKRSLDYFLFDPIRMLILDCKKRVH--------IIKGIIQGLLYLQEYFRLTIIHRDL 109
            M    L    FD +                        ++  + YL E     IIHRDL
Sbjct: 95  LMEGGEL----FDKV-------VGNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDL 140

Query: 110 KVSNILL---DEDLKPKISDFGLARILRKM-ILKQIQIELGYIPPE 151
           K  N+LL   +ED   KI+DFG ++IL +  +++ +     Y+ PE
Sbjct: 141 KPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPE 186

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 67.6 bits (166), Expect = 3e-14
 Identities = 32/159 (20%), Positives = 62/159 (38%), Gaps = 14/159 (8%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKRSL 64
            +    K +  K        K E+ +    +H N++ +    E+ E + +I+E++    +
Sbjct: 30  KKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDI 88

Query: 65  DYFLFDPI--RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL--DEDL 120
               F+ I      L+ ++ V  +  + + L +L       I H D++  NI+       
Sbjct: 89  ----FERINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSS 141

Query: 121 KPKISDFGLARILRK-MILKQIQIELGYIPPEYVGRGVY 158
             KI +FG AR L+     + +     Y  PE     V 
Sbjct: 142 TIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV 180

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 67.3 bits (165), Expect = 3e-14
 Identities = 53/171 (30%), Positives = 75/171 (43%), Gaps = 30/171 (17%)

Query: 6   GQIIAVKKLSKKSTQG--FEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKR 62
            Q  AVK ++K S +         EV L  KL H N++++   +E      ++ E     
Sbjct: 47  QQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGG 106

Query: 63  SLDYFLFDPIRMLILDCKKRVH--------IIKGIIQGLLYLQEYFRLTIIHRDLKVSNI 114
            L    FD I        KR          IIK +  G+ Y+ +     I+HRDLK  NI
Sbjct: 107 EL----FDEI-------IKRKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENI 152

Query: 115 LL---DEDLKPKISDFGLARILRK-MILKQIQIELGYIPPEYVGRGVYYKK 161
           LL   ++D   KI DFGL+   ++   +K       YI PE V RG Y +K
Sbjct: 153 LLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPE-VLRGTYDEK 202

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 67.7 bits (165), Expect = 3e-14
 Identities = 27/188 (14%), Positives = 53/188 (28%), Gaps = 39/188 (20%)

Query: 5   DGQIIAVKKLSKKSTQG---FEEFKNEVMLTAKLQ------------------------- 36
            G+   V              ++ K EV+    L+                         
Sbjct: 97  TGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQ 156

Query: 37  HLNLIRVGFCIETQEYMLIYEYMPKRSLDYF-LFDPIRMLI-----LDCKKRVHIIKGII 90
              +IRV         +  +   P+   +     + +         L    R+ +   +I
Sbjct: 157 KKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVI 216

Query: 91  QGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPP 150
           + L  L       ++H  L+  +I+LD+     ++ F      R        +  G+ PP
Sbjct: 217 RLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV--RDGARVVSSVSRGFEPP 271

Query: 151 EYVGRGVY 158
           E   R   
Sbjct: 272 ELEARRAT 279

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 67.3 bits (165), Expect = 4e-14
 Identities = 30/142 (21%), Positives = 53/142 (37%), Gaps = 24/142 (16%)

Query: 5   DGQIIAVKKL---SKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMP 60
           DG  +A+KK+        +   +   E+ L  +L H N+I+     IE  E  ++ E   
Sbjct: 56  DGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELAD 115

Query: 61  KRSLDYFLFDPIRMLILDCKKR---------VHIIKGIIQGLLYLQEYFRLTIIHRDLKV 111
              L          +I   KK+               +   L ++       ++HRD+K 
Sbjct: 116 AGDLSR--------MIKHFKKQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKP 164

Query: 112 SNILLDEDLKPKISDFGLARIL 133
           +N+ +      K+ D GL R  
Sbjct: 165 ANVFITATGVVKLGDLGLGRFF 186

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 67.4 bits (165), Expect = 4e-14
 Identities = 37/135 (27%), Positives = 68/135 (50%), Gaps = 8/135 (5%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSL 64
           G+ +AVK +  +  Q  E   NEV++    QH N++      +  +E  ++ E++   +L
Sbjct: 70  GRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGAL 129

Query: 65  DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKI 124
                D +  + L+ ++   + + ++Q L YL       +IHRD+K  +ILL  D + K+
Sbjct: 130 T----DIVSQVRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLDGRVKL 182

Query: 125 SDFGLARILRKMILK 139
           SDFG    + K + K
Sbjct: 183 SDFGFCAQISKDVPK 197

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 67.1 bits (164), Expect = 5e-14
 Identities = 32/140 (22%), Positives = 54/140 (38%), Gaps = 19/140 (13%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSL 64
           G   AVKK+  +  +       E++  A L    ++   G   E     +  E +   SL
Sbjct: 83  GFQCAVKKVRLEVFR-----VEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSL 137

Query: 65  DYFL--FDPIR-MLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED-L 120
              +     +     L      + +   ++GL YL       I+H D+K  N+LL  D  
Sbjct: 138 GQLIKQMGCLPEDRAL------YYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGS 188

Query: 121 KPKISDFGLARILRKMILKQ 140
           +  + DFG A  L+   L +
Sbjct: 189 RAALCDFGHALCLQPDGLGK 208

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 66.5 bits (163), Expect = 5e-14
 Identities = 39/158 (24%), Positives = 70/158 (44%), Gaps = 12/158 (7%)

Query: 6   GQIIAVKKLSKKSTQGF---EEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPK 61
             I+A+K L K   +      + + EV + + L+H N++R+         + LI EY P 
Sbjct: 34  KFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPL 93

Query: 62  RSLDYFLFDPIRML-ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL 120
            ++    +  ++ L   D ++    I  +   L Y        +IHRD+K  N+LL    
Sbjct: 94  GTV----YRELQKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAG 146

Query: 121 KPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVY 158
           + KI+DFG +          +   L Y+PPE +   ++
Sbjct: 147 ELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMH 184

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 67.0 bits (164), Expect = 6e-14
 Identities = 37/157 (23%), Positives = 74/157 (47%), Gaps = 19/157 (12%)

Query: 5   DGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNL--IR-VGFCIETQEYMLIYEYM 59
             QI A+K ++ +    Q  + ++NE+    KLQ  +   IR   + I  Q   ++ E  
Sbjct: 51  KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMECG 110

Query: 60  PKRSLDYFLFDPIR-MLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE 118
                +  L   ++    +D  +R    K +++ +  + ++    I+H DLK +N L+ +
Sbjct: 111 -----NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD 162

Query: 119 DLKPKISDFGLARILR---KMILKQIQI-ELGYIPPE 151
               K+ DFG+A  ++     ++K  Q+  + Y+PPE
Sbjct: 163 G-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 198

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 67.0 bits (163), Expect = 6e-14
 Identities = 19/184 (10%), Positives = 42/184 (22%), Gaps = 37/184 (20%)

Query: 6   GQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRVGFCI--------------- 47
            +  A+K  +     S    E         A+L   +                       
Sbjct: 87  LEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQP 146

Query: 48  ------------ETQEYMLIYEYMP---KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQG 92
                           Y+L+        +       F  +            +   +I+ 
Sbjct: 147 PFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRL 206

Query: 93  LLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEY 152
              LQ      ++H      N+ +  D +  + D      +         + + Y P E+
Sbjct: 207 AANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-GPASSVPVTYAPREF 262

Query: 153 VGRG 156
           +   
Sbjct: 263 LNAS 266

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 66.6 bits (163), Expect = 7e-14
 Identities = 32/135 (23%), Positives = 64/135 (47%), Gaps = 8/135 (5%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSL 64
           GQ +A+++++ +     E   NE+++  + ++ N++  +   +   E  ++ EY+   SL
Sbjct: 45  GQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSL 104

Query: 65  DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKI 124
                D +    +D  +   + +  +Q L +L       +IHRD+K  NILL  D   K+
Sbjct: 105 T----DVVTETCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKL 157

Query: 125 SDFGLARILRKMILK 139
           +DFG    +     K
Sbjct: 158 TDFGFCAQITPEQSK 172

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 66.6 bits (163), Expect = 8e-14
 Identities = 40/156 (25%), Positives = 77/156 (49%), Gaps = 17/156 (10%)

Query: 5   DGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNL--IRVGFCIETQEYMLIYEYMP 60
             QI A+K ++ +    Q  + ++NE+    KLQ  +   IR+     T +Y  IY  M 
Sbjct: 32  KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY--IYMVME 89

Query: 61  KRSLDYFLFDPIR-MLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
             ++D  L   ++    +D  +R    K +++ +  + ++    I+H DLK +N L+ + 
Sbjct: 90  CGNID--LNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDG 144

Query: 120 LKPKISDFGLARILR---KMILKQIQI-ELGYIPPE 151
              K+ DFG+A  ++     ++K  Q+  + Y+PPE
Sbjct: 145 -MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 179

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 66.4 bits (162), Expect = 1e-13
 Identities = 40/156 (25%), Positives = 77/156 (49%), Gaps = 17/156 (10%)

Query: 5   DGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNL--IRVGFCIETQEYMLIYEYMP 60
             QI A+K ++ +    Q  + ++NE+    KLQ  +   IR+     T +Y  IY  M 
Sbjct: 79  KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQY--IYMVME 136

Query: 61  KRSLDYFLFDPIR-MLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
             ++D  L   ++    +D  +R    K +++ +  + ++    I+H DLK +N L+ + 
Sbjct: 137 CGNID--LNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVDG 191

Query: 120 LKPKISDFGLARILR---KMILKQIQI-ELGYIPPE 151
              K+ DFG+A  ++     ++K  Q+  + Y+PPE
Sbjct: 192 -MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE 226

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 65.9 bits (161), Expect = 2e-13
 Identities = 50/172 (29%), Positives = 75/172 (43%), Gaps = 30/172 (17%)

Query: 5   DGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPK 61
                A+K + K   ST    +   EV +   L H N++++  F  + + Y L+ E    
Sbjct: 61  THVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKG 120

Query: 62  RSLDYFLFDPIRMLILDCKKRVH--------IIKGIIQGLLYLQEYFRLTIIHRDLKVSN 113
             L    FD I         R+         IIK ++ G+ YL +     I+HRDLK  N
Sbjct: 121 GEL----FDEI-------IHRMKFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPEN 166

Query: 114 ILL---DEDLKPKISDFGLARILRKM-ILKQIQIELGYIPPEYVGRGVYYKK 161
           +LL   ++D   KI DFGL+ +      +K+      YI PE V R  Y +K
Sbjct: 167 LLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPE-VLRKKYDEK 217

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 65.4 bits (160), Expect = 2e-13
 Identities = 30/142 (21%), Positives = 67/142 (47%), Gaps = 18/142 (12%)

Query: 5   DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRS 63
            G + A K +  KS +  E++  E+ + A   H  +++ +G      +  ++ E+ P  +
Sbjct: 43  TGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGA 102

Query: 64  LDYFLFDPIRMLILDCKKRV------HIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLD 117
           +D         ++L+  + +       + + +++ L +L       IIHRDLK  N+L+ 
Sbjct: 103 VD--------AIMLELDRGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMT 151

Query: 118 EDLKPKISDFGLARILRKMILK 139
            +   +++DFG++    K + K
Sbjct: 152 LEGDIRLADFGVSAKNLKTLQK 173

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 65.4 bits (160), Expect = 2e-13
 Identities = 40/170 (23%), Positives = 65/170 (38%), Gaps = 19/170 (11%)

Query: 5   DGQIIAVKKLSKK--STQGFEEFKNEVMLTAKL-QHLNLIRVGFCIETQEYMLIY-EYMP 60
           DG++ AVK+        +       EV    K+ QH   +R+    E    + +  E   
Sbjct: 81  DGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC- 139

Query: 61  KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL 120
             SL            L   +    ++  +  L +L       ++H D+K +NI L    
Sbjct: 140 GPSLQQHCEA--WGASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRG 194

Query: 121 KPKISDFGLARILRKMILKQIQIELG---YIPPEYVGRGVYYKK---FSL 164
           + K+ DFGL   L      ++Q   G   Y+ PE + +G Y      FSL
Sbjct: 195 RCKLGDFGLLVELGTAGAGEVQE--GDPRYMAPE-LLQGSYGTAADVFSL 241

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 65.4 bits (160), Expect = 2e-13
 Identities = 42/164 (25%), Positives = 74/164 (45%), Gaps = 15/164 (9%)

Query: 6   GQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKR 62
           G   A K ++ K  S + F++ + E  +  KLQH N++R+   I+ + +  L+++ +   
Sbjct: 54  GLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG 113

Query: 63  SLDYFLFDPI-RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL---DE 118
            L    F+ I            H I+ I++ + Y        I+HR+LK  N+LL    +
Sbjct: 114 EL----FEDIVAREFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAK 166

Query: 119 DLKPKISDFGLARILRKM-ILKQIQIELGYIPPEYVGRGVYYKK 161
               K++DFGLA  +             GY+ PE + +  Y K 
Sbjct: 167 GAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKP 210

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 65.1 bits (159), Expect = 3e-13
 Identities = 35/147 (23%), Positives = 68/147 (46%), Gaps = 32/147 (21%)

Query: 6   GQIIAVKKLSKKSTQG--------FEEFKNEVMLTAKL-QHLNLIRVGFCIETQEYM-LI 55
           G   AVK +   + +          E  + E  +  ++  H ++I +    E+  +M L+
Sbjct: 119 GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLV 178

Query: 56  YEYMPKRSLDYFLFDPIRMLILDCKKRVH--------IIKGIIQGLLYLQEYFRLTIIHR 107
           ++ M K  L    FD +        ++V         I++ +++ + +L       I+HR
Sbjct: 179 FDLMRKGEL----FDYL-------TEKVALSEKETRSIMRSLLEAVSFLHA---NNIVHR 224

Query: 108 DLKVSNILLDEDLKPKISDFGLARILR 134
           DLK  NILLD++++ ++SDFG +  L 
Sbjct: 225 DLKPENILLDDNMQIRLSDFGFSCHLE 251

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 64.5 bits (158), Expect = 3e-13
 Identities = 42/164 (25%), Positives = 74/164 (45%), Gaps = 15/164 (9%)

Query: 6   GQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKR 62
           G   A K ++ K  S + F++ + E  +  KLQH N++R+   I+ + +  L+++ +   
Sbjct: 31  GLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGG 90

Query: 63  SLDYFLFDPI-RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL---DE 118
            L    F+ I            H I+ I++ + Y        I+HR+LK  N+LL    +
Sbjct: 91  EL----FEDIVAREFYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAK 143

Query: 119 DLKPKISDFGLARILRKM-ILKQIQIELGYIPPEYVGRGVYYKK 161
               K++DFGLA  +             GY+ PE + +  Y K 
Sbjct: 144 GAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKP 187

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 65.1 bits (159), Expect = 4e-13
 Identities = 51/173 (29%), Positives = 73/173 (42%), Gaps = 31/173 (17%)

Query: 5   DGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMP 60
            GQ  AVK +SK+        E    EV L  +L H N++++    E + Y  L+ E   
Sbjct: 50  TGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYT 109

Query: 61  KRSLDYFLFDPIRMLILDCKKRVH--------IIKGIIQGLLYLQEYFRLTIIHRDLKVS 112
              L    FD I         R          II+ ++ G+ Y+ +     I+HRDLK  
Sbjct: 110 GGEL----FDEI-------ISRKRFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPE 155

Query: 113 NILL---DEDLKPKISDFGLARILRK-MILKQIQIELGYIPPEYVGRGVYYKK 161
           N+LL    +D   +I DFGL+        +K       YI PE V  G Y +K
Sbjct: 156 NLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE-VLHGTYDEK 207

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 64.9 bits (158), Expect = 4e-13
 Identities = 29/144 (20%), Positives = 59/144 (40%), Gaps = 13/144 (9%)

Query: 3   LPDGQIIAVKK--LSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYM 59
            P G+ + V++  L   S +     + E+ ++    H N++      I   E  ++  +M
Sbjct: 49  KPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 108

Query: 60  PKRSLDYFLFDPIRMLILDCKKRVHI---IKGIIQGLLYLQEYFRLTIIHRDLKVSNILL 116
              S      D I    +D    + I   ++G+++ L Y+     +  +HR +K S+IL+
Sbjct: 109 AYGSA----KDLICTHFMDGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILI 161

Query: 117 DEDLKPKISDFGLARILRKMILKQ 140
             D K  +S       +     +Q
Sbjct: 162 SVDGKVYLSGLRSNLSMISHGQRQ 185

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 64.5 bits (157), Expect = 4e-13
 Identities = 40/194 (20%), Positives = 68/194 (35%), Gaps = 57/194 (29%)

Query: 8   IIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKRSLDY 66
           I+   K+ + + +  E  K EV L  KL H N+ R+    E ++Y+ L+ E      L  
Sbjct: 58  IMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHL-- 115

Query: 67  FLFDPIRMLILDCKKRV-----------------------------------------HI 85
              D + + I D   +                                          +I
Sbjct: 116 --LDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNI 173

Query: 86  IKGIIQGLLYLQEYFRLTIIHRDLKVSNILL--DEDLKPKISDFGLARILRKMILKQIQI 143
           ++ I   L YL       I HRD+K  N L   ++  + K+ DFGL++   K+   +   
Sbjct: 174 MRQIFSALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYG 230

Query: 144 EL------GYIPPE 151
                    ++ PE
Sbjct: 231 MTTKAGTPYFVAPE 244

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 64.2 bits (157), Expect = 5e-13
 Identities = 40/148 (27%), Positives = 67/148 (45%), Gaps = 33/148 (22%)

Query: 6   GQIIAVKKLSKKSTQGF---------EEFKNEVMLTAKL-QHLNLIRVGFCIETQEYM-L 54
            +  AVK +       F         E    EV +  K+  H N+I++    ET  +  L
Sbjct: 42  CKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 101

Query: 55  IYEYMPKRSLDYFLFDPIRMLILDCKKRVH--------IIKGIIQGLLYLQEYFRLTIIH 106
           +++ M K  L    FD +        ++V         I++ +++ +  L +   L I+H
Sbjct: 102 VFDLMKKGEL----FDYL-------TEKVTLSEKETRKIMRALLEVICALHK---LNIVH 147

Query: 107 RDLKVSNILLDEDLKPKISDFGLARILR 134
           RDLK  NILLD+D+  K++DFG +  L 
Sbjct: 148 RDLKPENILLDDDMNIKLTDFGFSCQLD 175

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 64.3 bits (157), Expect = 5e-13
 Identities = 36/147 (24%), Positives = 67/147 (45%), Gaps = 23/147 (15%)

Query: 1   GVLPDGQIIAVKKLSKKSTQGFEEFKN-EVMLTAKLQHLNLIRVGFCIETQEYM------ 53
             L +   +A+KK+ +      + FKN E+ +   ++H N++ +     +          
Sbjct: 59  AKLVESDEVAIKKVLQ-----DKRFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFL 113

Query: 54  -LIYEYMP---KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDL 109
            L+ EY+P    R+  ++      M +L  K  ++    +++ L Y+     + I HRD+
Sbjct: 114 NLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMY---QLLRSLAYIH---SIGICHRDI 167

Query: 110 KVSNILLDEDLKP-KISDFGLARILRK 135
           K  N+LLD      K+ DFG A+IL  
Sbjct: 168 KPQNLLLDPPSGVLKLIDFGSAKILIA 194

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 64.2 bits (157), Expect = 6e-13
 Identities = 41/167 (24%), Positives = 66/167 (39%), Gaps = 18/167 (10%)

Query: 6   GQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHL-NLIRVGFCIETQEYM-LIYEYMPK 61
           GQ  A K L K+        E  +E+ +    +    +I +    E    + LI EY   
Sbjct: 54  GQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAG 113

Query: 62  RSLDYFLFDPIRMLILDC---KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL-- 116
             +    F      + +       + +IK I++G+ YL +     I+H DLK  NILL  
Sbjct: 114 GEI----FSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSS 166

Query: 117 -DEDLKPKISDFGLARILR-KMILKQIQIELGYIPPEYVGRGVYYKK 161
                  KI DFG++R +     L++I     Y+ PE +        
Sbjct: 167 IYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTA 213

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 63.9 bits (156), Expect = 7e-13
 Identities = 44/169 (26%), Positives = 70/169 (41%), Gaps = 20/169 (11%)

Query: 6   GQIIAVKKLSKKSTQGF------EEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEY 58
           G   A K + K+ ++        EE + EV +  ++ H N+I +    E +  + LI E 
Sbjct: 37  GLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILEL 96

Query: 59  MPKRSLDYFLFDPI-RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL- 116
           +    L    FD + +   L  ++    IK I+ G+ YL       I H DLK  NI+L 
Sbjct: 97  VSGGEL----FDFLAQKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLL 149

Query: 117 ---DEDLKPKISDFGLARILRK-MILKQIQIELGYIPPEYVGRGVYYKK 161
                    K+ DFGLA  +   +  K I     ++ PE V       +
Sbjct: 150 DKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLE 198

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 63.9 bits (156), Expect = 8e-13
 Identities = 51/172 (29%), Positives = 75/172 (43%), Gaps = 30/172 (17%)

Query: 5   DGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPK 61
             Q  AVK ++K     +       EV L  KL H N++++     ++  + ++ E    
Sbjct: 46  TQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTG 105

Query: 62  RSLDYFLFDPIRMLILDCKKRVH--------IIKGIIQGLLYLQEYFRLTIIHRDLKVSN 113
             L    FD I        KR          IIK +  G+ Y+ +     I+HRDLK  N
Sbjct: 106 GEL----FDEI-------IKRKRFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPEN 151

Query: 114 ILL---DEDLKPKISDFGLARILRK-MILKQIQIELGYIPPEYVGRGVYYKK 161
           ILL   ++D   KI DFGL+   ++   +K       YI PE V RG Y +K
Sbjct: 152 ILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPE-VLRGTYDEK 202

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 63.4 bits (155), Expect = 8e-13
 Identities = 38/133 (28%), Positives = 63/133 (47%), Gaps = 14/133 (10%)

Query: 25  FKNEVMLTAKLQHLNLIRV---GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK 81
           F+ EV  +++L H N++ +       E   Y L+ EY+   +L  ++        L    
Sbjct: 58  FEREVHNSSQLSHQNIVSMIDVDE--EDDCYYLVMEYIEGPTLSEYIESHGP---LSVDT 112

Query: 82  RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQI 141
            ++    I+ G+ +      + I+HRD+K  NIL+D +   KI DFG+A+ L +  L Q 
Sbjct: 113 AINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQT 169

Query: 142 QIELG---YIPPE 151
              LG   Y  PE
Sbjct: 170 NHVLGTVQYFSPE 182

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 63.5 bits (155), Expect = 1e-12
 Identities = 38/171 (22%), Positives = 73/171 (42%), Gaps = 28/171 (16%)

Query: 6   GQIIAVKKLSKKSTQGFEE--FKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKR 62
           GQ  A   ++ K     +    + E  +   L+H N++R+   I  + +  LI++ +   
Sbjct: 36  GQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGG 95

Query: 63  SLDYFLFDPIRMLILDCKKR-------VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNIL 115
            L    F+ I        +         H I+ I++ +L+  +   + ++HR+LK  N+L
Sbjct: 96  EL----FEDI------VAREYYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLL 142

Query: 116 L---DEDLKPKISDFGLARILR--KMILKQIQIELGYIPPEYVGRGVYYKK 161
           L    +    K++DFGLA  +   +          GY+ PE + +  Y K 
Sbjct: 143 LASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKP 193

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 63.1 bits (154), Expect = 1e-12
 Identities = 35/142 (24%), Positives = 56/142 (39%), Gaps = 27/142 (19%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQ-HLNLIRVGFCIETQEYM-LIYEYMPKRS 63
            Q  AVK + K+          EV +  + Q H N++ +    E ++   L++E M   S
Sbjct: 38  SQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGS 97

Query: 64  LDYFLFDPIRMLILDCKKRVH--------IIKGIIQGLLYLQEYFRLTIIHRDLKVSNIL 115
           +       I        KR H        +++ +   L +L       I HRDLK  NIL
Sbjct: 98  I----LSHIH-------KRRHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENIL 143

Query: 116 L---DEDLKPKISDFGLARILR 134
               ++    KI DF L   ++
Sbjct: 144 CEHPNQVSPVKICDFDLGSGIK 165

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 63.0 bits (154), Expect = 1e-12
 Identities = 44/169 (26%), Positives = 70/169 (41%), Gaps = 20/169 (11%)

Query: 6   GQIIAVKKLSKKSTQG------FEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEY 58
           G   A K + K+ ++        EE + EV +  ++ H N+I +    E +  + LI E 
Sbjct: 37  GLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILEL 96

Query: 59  MPKRSLDYFLFDPI-RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL- 116
           +    L    FD + +   L  ++    IK I+ G+ YL       I H DLK  NI+L 
Sbjct: 97  VSGGEL----FDFLAQKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLL 149

Query: 117 ---DEDLKPKISDFGLARILRK-MILKQIQIELGYIPPEYVGRGVYYKK 161
                    K+ DFGLA  +   +  K I     ++ PE V       +
Sbjct: 150 DKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLE 198

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 63.1 bits (154), Expect = 1e-12
 Identities = 37/168 (22%), Positives = 64/168 (38%), Gaps = 24/168 (14%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKNEV-MLTAKLQHLNLIRVGFCIETQEYM-----LIYEYM 59
           GQ  A+K L         + + EV          +++ +    E   +      +I E M
Sbjct: 54  GQKCALKLLYDS-----PKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECM 108

Query: 60  PKRSLDYFLFDPIRMLILDC---KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL 116
               L    F  I+         ++   I++ I   + +L       I HRD+K  N+L 
Sbjct: 109 EGGEL----FSRIQERGDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLY 161

Query: 117 ---DEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKK 161
              ++D   K++DFG A+   +  L+       Y+ PE +G   Y K 
Sbjct: 162 TSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKS 209

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 62.6 bits (153), Expect = 2e-12
 Identities = 37/161 (22%), Positives = 76/161 (47%), Gaps = 12/161 (7%)

Query: 6   GQIIAVKKLSKK--STQGFEE-FKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPK 61
             I+A+K L K     +G E   + E+ + + L+H N++R+      ++ + L+ E+ P+
Sbjct: 39  KFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPR 98

Query: 62  RSLDYFLFDPIRML-ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL 120
             L    +  ++     D ++    ++ +   L Y        +IHRD+K  N+L+    
Sbjct: 99  GEL----YKELQKHGRFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKG 151

Query: 121 KPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKK 161
           + KI+DFG +     +  + +   L Y+PPE +    + +K
Sbjct: 152 ELKIADFGWSVHAPSLRRRTMCGTLDYLPPEMIEGKTHDEK 192

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 62.7 bits (153), Expect = 2e-12
 Identities = 40/172 (23%), Positives = 71/172 (41%), Gaps = 27/172 (15%)

Query: 3   LPDGQIIAVKKLSKKSTQGFEEFKN------EVMLTAKLQHL--NLIRVGFCIET-QEYM 53
           + D   +A+K + K     + E  N      EV+L  K+      +IR+    E    ++
Sbjct: 65  VSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV 124

Query: 54  LIYEYMPKRSLDYFLFDPIRMLILDCKKRV------HIIKGIIQGLLYLQEYFRLTIIHR 107
           LI E  P+   D  LFD I       +  +           +++ + +        ++HR
Sbjct: 125 LILER-PEPVQD--LFDFITE-----RGALQEELARSFFWQVLEAVRHCH---NCGVLHR 173

Query: 108 DLKVSNILLDED-LKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVY 158
           D+K  NIL+D +  + K+ DFG   +L+  +         Y PPE++    Y
Sbjct: 174 DIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRY 225

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 62.2 bits (152), Expect = 2e-12
 Identities = 34/134 (25%), Positives = 58/134 (43%), Gaps = 13/134 (9%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKN----EVMLTAKLQHLNLIRVGFCIETQ-EYMLIYEYMP 60
           GQI+A+KK     ++     K     E+ +  +L+H NL+ +      +    L++EY  
Sbjct: 28  GQIVAIKKF--LESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCD 85

Query: 61  KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL 120
              L         +     K    I    +Q + +  ++     IHRD+K  NIL+ +  
Sbjct: 86  HTVLHELDRYQRGVPEHLVKS---ITWQTLQAVNFCHKHN---CIHRDVKPENILITKHS 139

Query: 121 KPKISDFGLARILR 134
             K+ DFG AR+L 
Sbjct: 140 VIKLCDFGFARLLT 153

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 62.2 bits (152), Expect = 2e-12
 Identities = 38/135 (28%), Positives = 64/135 (47%), Gaps = 15/135 (11%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKN----EVMLTAKLQHLNLIRVG--FCIETQEYMLIYEYM 59
           G+I+A+KK     +   +  K     E+ L  +L+H NL+ +      + + Y L++E++
Sbjct: 50  GRIVAIKKF--LESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWY-LVFEFV 106

Query: 60  PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
               LD     P  +     +K    +  II G+ +   +    IIHRD+K  NIL+ + 
Sbjct: 107 DHTILDDLELFPNGLDYQVVQK---YLFQIINGIGFCHSHN---IIHRDIKPENILVSQS 160

Query: 120 LKPKISDFGLARILR 134
              K+ DFG AR L 
Sbjct: 161 GVVKLCDFGFARTLA 175

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 62.3 bits (152), Expect = 2e-12
 Identities = 42/170 (24%), Positives = 69/170 (40%), Gaps = 30/170 (17%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKRSL 64
               AVK + K      EE   E++L    QH N+I +    +  +Y+ ++ E M    L
Sbjct: 47  NMEFAVKIIDKSKRDPTEE--IEILLRY-GQHPNIITLKDVYDDGKYVYVVTELMKGGEL 103

Query: 65  DYFLFDPIRMLILDCKKR-------VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL- 116
                D I       +++         ++  I + + YL       ++HRDLK SNIL  
Sbjct: 104 ----LDKI------LRQKFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYV 150

Query: 117 --DEDLKP-KISDFGLARILR--KMILKQIQIELGYIPPEYVGRGVYYKK 161
               + +  +I DFG A+ LR    +L        ++ PE + R  Y   
Sbjct: 151 DESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAA 200

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 62.3 bits (152), Expect = 3e-12
 Identities = 44/168 (26%), Positives = 73/168 (43%), Gaps = 27/168 (16%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSL 64
            +  A+K L K   +  +  + E+ +  +L H N+I+         E  L+ E +    L
Sbjct: 78  QKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGEL 135

Query: 65  DYFLFDPIRMLILDCKKR-------VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL- 116
               FD I       +K           +K I++ + YL E     I+HRDLK  N+L  
Sbjct: 136 ----FDRI------VEKGYYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYA 182

Query: 117 --DEDLKPKISDFGLARILRK-MILKQIQIELGYIPPEYVGRGVYYKK 161
               D   KI+DFGL++I+   +++K +    GY  PE +    Y  +
Sbjct: 183 TPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPE 230

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 61.8 bits (151), Expect = 3e-12
 Identities = 41/171 (23%), Positives = 70/171 (40%), Gaps = 24/171 (14%)

Query: 6   GQIIAVKKLSKKSTQG------FEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEY 58
           G+  A K + K+           EE + EV +  +++H N+I +    E +  + LI E 
Sbjct: 30  GKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILEL 89

Query: 59  MPKRSLDYFLFDPI-RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL- 116
           +    L    FD +     L   +    +K I+ G+ YL       I H DLK  NI+L 
Sbjct: 90  VSGGEL----FDFLAEKESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLL 142

Query: 117 ---DEDLKPKISDFGLARILRKMILKQIQIELG---YIPPEYVGRGVYYKK 161
                + + K+ DFG+A  +      + +   G   ++ PE V       +
Sbjct: 143 DKNVPNPRIKLIDFGIAHKIEAG--NEFKNIFGTPEFVAPEIVNYEPLGLE 191

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 62.3 bits (152), Expect = 3e-12
 Identities = 46/169 (27%), Positives = 71/169 (42%), Gaps = 20/169 (11%)

Query: 6   GQIIAVKKLSKKSTQGF------EEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEY 58
           G   A K + K+ T+        E+ + EV +  ++QH N+I +    E +  + LI E 
Sbjct: 36  GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 95

Query: 59  MPKRSLDYFLFDPI-RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL- 116
           +    L    FD +     L  ++    +K I+ G+ YL     L I H DLK  NI+L 
Sbjct: 96  VAGGEL----FDFLAEKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLL 148

Query: 117 ---DEDLKPKISDFGLARILRK-MILKQIQIELGYIPPEYVGRGVYYKK 161
                  + KI DFGLA  +      K I     ++ PE V       +
Sbjct: 149 DRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLE 197

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 62.0 bits (151), Expect = 3e-12
 Identities = 34/139 (24%), Positives = 68/139 (48%), Gaps = 9/139 (6%)

Query: 3   LPDGQIIAVKKLSKKSTQG-FEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMP 60
               +++A+K +  +  +   E+ + E+ + ++     + +  G  ++  +  +I EY+ 
Sbjct: 44  NRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 103

Query: 61  KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL 120
             S      D +    LD  +   I++ I++GL YL        IHRD+K +N+LL E  
Sbjct: 104 GGSAL----DLLEPGPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHG 156

Query: 121 KPKISDFGLARILRKMILK 139
           + K++DFG+A  L    +K
Sbjct: 157 EVKLADFGVAGQLTDTQIK 175

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 61.8 bits (150), Expect = 4e-12
 Identities = 24/120 (20%), Positives = 44/120 (36%), Gaps = 4/120 (3%)

Query: 15  SKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLI-YEYMPKRSLDYFLFDPIR 73
              S    +    ++         N +        + Y+ I  +   K +L  ++     
Sbjct: 98  PLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCS 157

Query: 74  MLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARIL 133
           +   +    +HI   I + + +L       ++HRDLK SNI    D   K+ DFGL   +
Sbjct: 158 LEDREHGVCLHIFIQIAEAVEFL---HSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAM 214

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 61.8 bits (150), Expect = 5e-12
 Identities = 35/135 (25%), Positives = 63/135 (46%), Gaps = 13/135 (9%)

Query: 4   PDGQIIAVKKLS-KKSTQGFEEFKNEVMLTAKLQHLNLIRV--GFCIETQEYMLIYEYMP 60
           P G ++A K +  +       +   E+ +  +     ++     F  + +  + + E+M 
Sbjct: 56  PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM-EHMD 114

Query: 61  KRSLDYFL--FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE 118
             SLD  L     I   IL       +   +I+GL YL+E  +  I+HRD+K SNIL++ 
Sbjct: 115 GGSLDQVLKKAGRIPEQIL-----GKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNS 167

Query: 119 DLKPKISDFGLARIL 133
             + K+ DFG++  L
Sbjct: 168 RGEIKLCDFGVSGQL 182

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 61.4 bits (150), Expect = 5e-12
 Identities = 40/140 (28%), Positives = 68/140 (48%), Gaps = 26/140 (18%)

Query: 5   DGQIIAVKKLSKKSTQGFEE-FKN----EVMLTAKLQHLNLIRVGFCIETQEY--MLIYE 57
             QI+A+KK+        ++        E+ L  +L H N+I +       +    L+++
Sbjct: 34  TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL-LDAFGHKSNISLVFD 92

Query: 58  YMPKRSLDYFLFDPIRMLILDCKKR--VHIIKG----IIQGLLYLQEYFRLTIIHRDLKV 111
           +M     D      + ++I D         IK      +QGL YL +++   I+HRDLK 
Sbjct: 93  FME---TD------LEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKP 140

Query: 112 SNILLDEDLKPKISDFGLAR 131
           +N+LLDE+   K++DFGLA+
Sbjct: 141 NNLLLDENGVLKLADFGLAK 160

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 61.3 bits (149), Expect = 7e-12
 Identities = 49/182 (26%), Positives = 73/182 (40%), Gaps = 41/182 (22%)

Query: 6   GQIIAVKKLSKK-------------STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQE 51
               A+K + K                +  EE  NE+ L   L H N+I++     + + 
Sbjct: 61  HSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKY 120

Query: 52  YMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVH--------IIKGIIQGLLYLQEYFRLT 103
           + L+ E+     L    F+ I         R          I+K I+ G+ YL +     
Sbjct: 121 FYLVTEFYEGGEL----FEQI-------INRHKFDECDAANIMKQILSGICYLHK---HN 166

Query: 104 IIHRDLKVSNILL---DEDLKPKISDFGLARILRK-MILKQIQIELGYIPPEYVGRGVYY 159
           I+HRD+K  NILL   +  L  KI DFGL+    K   L+       YI PE V +  Y 
Sbjct: 167 IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPE-VLKKKYN 225

Query: 160 KK 161
           +K
Sbjct: 226 EK 227

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 60.7 bits (148), Expect = 8e-12
 Identities = 39/137 (28%), Positives = 68/137 (49%), Gaps = 21/137 (15%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKN-----EVMLTAKLQHLNLIRVGFCIETQE-YMLIYEYM 59
           G  +A+K++   S +G           E+ L  +L+H N++R+   I T+    L++E+M
Sbjct: 30  GVYVALKEVKLDSEEGT----PSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFM 85

Query: 60  P---KRSLD--YFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNI 114
               K+ +D       P  + +   K        ++QGL +  E     I+HRDLK  N+
Sbjct: 86  DNDLKKYMDSRTVGNTPRGLELNLVKY---FQWQLLQGLAFCHENK---ILHRDLKPQNL 139

Query: 115 LLDEDLKPKISDFGLAR 131
           L+++  + K+ DFGLAR
Sbjct: 140 LINKRGQLKLGDFGLAR 156

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 61.0 bits (148), Expect = 9e-12
 Identities = 42/144 (29%), Positives = 65/144 (45%), Gaps = 32/144 (22%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKN---------EVMLTAKLQHLNLIRV-------GFCIET 49
            + +A+KKLS+        F+N         E++L   + H N+I +           E 
Sbjct: 87  DRNVAIKKLSRP-------FQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEF 139

Query: 50  QEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDL 109
           Q+  L+ E M     D  L   I+M +   +    + + ++ G+ +L       IIHRDL
Sbjct: 140 QDVYLVMELM-----DANLCQVIQMELDHERMSYLLYQ-MLCGIKHLHS---AGIIHRDL 190

Query: 110 KVSNILLDEDLKPKISDFGLARIL 133
           K SNI++  D   KI DFGLAR  
Sbjct: 191 KPSNIVVKSDCTLKILDFGLARTA 214

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 60.6 bits (148), Expect = 1e-11
 Identities = 34/139 (24%), Positives = 65/139 (46%), Gaps = 29/139 (20%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKN--------EVMLTAKLQHLNLIRVGFCIETQE--YMLI 55
           G+I+A+K++        +            E+ L  +L H N++ +   +   E    L+
Sbjct: 45  GRIVALKRIR------LDAEDEGIPSTAIREISLLKELHHPNIVSL-IDVIHSERCLTLV 97

Query: 56  YEYMP---KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVS 112
           +E+M    K+ LD        +     K     +  +++G+ +  ++    I+HRDLK  
Sbjct: 98  FEFMEKDLKKVLDEN---KTGLQDSQIKI---YLYQLLRGVAHCHQHR---ILHRDLKPQ 148

Query: 113 NILLDEDLKPKISDFGLAR 131
           N+L++ D   K++DFGLAR
Sbjct: 149 NLLINSDGALKLADFGLAR 167

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 60.4 bits (147), Expect = 1e-11
 Identities = 41/171 (23%), Positives = 75/171 (43%), Gaps = 32/171 (18%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQ-HLNLIRVGFCIETQEYM-LIYEYMPKRS 63
            Q  AVK +SK+        + E+      + H N++++      Q +  L+ E +    
Sbjct: 36  NQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGE 92

Query: 64  LDYFLFDPIRMLILDCKKRVH--------IIKGIIQGLLYLQEYFRLTIIHRDLKVSNIL 115
           L    F+ I       KK+ H        I++ ++  + ++ +   + ++HRDLK  N+L
Sbjct: 93  L----FERI-------KKKKHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLL 138

Query: 116 L---DEDLKPKISDFGLARILR--KMILKQIQIELGYIPPEYVGRGVYYKK 161
               +++L+ KI DFG AR+       LK     L Y  PE + +  Y + 
Sbjct: 139 FTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDES 189

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 60.5 bits (147), Expect = 1e-11
 Identities = 43/140 (30%), Positives = 66/140 (47%), Gaps = 22/140 (15%)

Query: 6   GQIIAVKKLS---KKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPK 61
            +++A+KK+S   K+S + +++   EV    KL+H N I+  G  +      L+ EY   
Sbjct: 79  SEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG 138

Query: 62  RSLDYFLFDPIRMLILDCKKRVH------IIKGIIQGLLYLQEYFRLTIIHRDLKVSNIL 115
            + D         L+   KK +       +  G +QGL YL       +IHRD+K  NIL
Sbjct: 139 SASD---------LLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNIL 186

Query: 116 LDEDLKPKISDFGLARILRK 135
           L E    K+ DFG A I+  
Sbjct: 187 LSEPGLVKLGDFGSASIMAP 206

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 60.4 bits (147), Expect = 1e-11
 Identities = 32/150 (21%), Positives = 59/150 (39%), Gaps = 31/150 (20%)

Query: 3   LPDGQIIAVKK-LSKKSTQGFEEFKN----EVMLTAKLQHLNLIRVGFCIETQEY----- 52
              G  +A+KK +          F+N     +   A L H N++++     T        
Sbjct: 45  KSTGMSVAIKKVIQDPR------FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRD 98

Query: 53  ---MLIYEYMP---KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIH 106
               ++ EY+P    R    +    +    +  K  +     +I+ +  L     + + H
Sbjct: 99  IYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLF---QLIRSIGCLHLP-SVNVCH 154

Query: 107 RDLKVSNILLDE---DLKPKISDFGLARIL 133
           RD+K  N+L++E    L  K+ DFG A+ L
Sbjct: 155 RDIKPHNVLVNEADGTL--KLCDFGSAKKL 182

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 60.0 bits (146), Expect = 1e-11
 Identities = 34/139 (24%), Positives = 66/139 (47%), Gaps = 12/139 (8%)

Query: 3   LPDGQIIAVKKLS-KKSTQGFEEFKNEVMLTAKLQHLNLIRVGFC--IETQEYMLIYEYM 59
            P  + +A+K+++ +K     +E   E+   ++  H N++   +   +   E  L+ + +
Sbjct: 37  APKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSY-YTSFVVKDELWLVMKLL 95

Query: 60  PKRSL-----DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNI 114
              S+             +  +LD      I++ +++GL YL    +   IHRD+K  NI
Sbjct: 96  SGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNI 152

Query: 115 LLDEDLKPKISDFGLARIL 133
           LL ED   +I+DFG++  L
Sbjct: 153 LLGEDGSVQIADFGVSAFL 171

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 60.0 bits (146), Expect = 2e-11
 Identities = 34/140 (24%), Positives = 68/140 (48%), Gaps = 19/140 (13%)

Query: 4   PDGQIIAVKKL-SKKSTQGFEEFKNEV-MLTAKLQHLNLIRV--GFCIETQEYMLIYEYM 59
           P GQI+AVK++ +  ++Q  +    ++ +    +     +        E   ++ + E M
Sbjct: 30  PSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM-ELM 88

Query: 60  PKRSLDYFLFDPIRMLILDCKKRV------HIIKGIIQGLLYLQEYFRLTIIHRDLKVSN 113
              SLD F        ++D  + +       I   I++ L +L  + +L++IHRD+K SN
Sbjct: 89  DT-SLDKFY-----KQVIDKGQTIPEDILGKIAVSIVKALEHL--HSKLSVIHRDVKPSN 140

Query: 114 ILLDEDLKPKISDFGLARIL 133
           +L++   + K+ DFG++  L
Sbjct: 141 VLINALGQVKMCDFGISGYL 160

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 59.6 bits (145), Expect = 2e-11
 Identities = 43/174 (24%), Positives = 68/174 (39%), Gaps = 29/174 (16%)

Query: 3   LPDGQIIAVKKLSKKSTQGFEEFKNEV----------MLTAKLQHLNLIRVGFCIETQE- 51
           L D   +A+K + +    G+    + V           + A   H  +IR+    ETQE 
Sbjct: 53  LTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEG 112

Query: 52  YMLIYEYMPKRSLDYFLFDPIRMLILDCKKRV------HIIKGIIQGLLYLQEYFRLTII 105
           +ML+ E  P  + D  LFD I       K  +           ++  + +        ++
Sbjct: 113 FMLVLER-PLPAQD--LFDYITE-----KGPLGEGPSRCFFGQVVAAIQHC---HSRGVV 161

Query: 106 HRDLKVSNILLD-EDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVY 158
           HRD+K  NIL+D      K+ DFG   +L             Y PPE++ R  Y
Sbjct: 162 HRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRVYSPPEWISRHQY 215

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 59.5 bits (145), Expect = 2e-11
 Identities = 32/139 (23%), Positives = 67/139 (48%), Gaps = 28/139 (20%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKN--------EVMLTAKLQHLNLIRVGFCIETQE--YMLI 55
           G+++A+KK+        +            E+ L  +L H N++++   +   E    L+
Sbjct: 28  GEVVALKKIR------LDTETEGVPSTAIREISLLKELNHPNIVKL-LDVIHTENKLYLV 80

Query: 56  YEYMP---KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVS 112
           +E++    K+ +D      I + ++        +  ++QGL +   +    ++HRDLK  
Sbjct: 81  FEFLHQDLKKFMDASALTGIPLPLIKS-----YLFQLLQGLAFCHSHR---VLHRDLKPQ 132

Query: 113 NILLDEDLKPKISDFGLAR 131
           N+L++ +   K++DFGLAR
Sbjct: 133 NLLINTEGAIKLADFGLAR 151

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 59.5 bits (145), Expect = 2e-11
 Identities = 29/139 (20%), Positives = 64/139 (46%), Gaps = 29/139 (20%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKN--------EVMLTAKLQHLNLIRVGFCIETQE--YMLI 55
            +I+A+K++        ++           E+ L  +L+H N++R+   +   +    L+
Sbjct: 27  HEIVALKRVR------LDDDDEGVPSSALREICLLKELKHKNIVRL-HDVLHSDKKLTLV 79

Query: 56  YEYMP---KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVS 112
           +E+     K+  D        +     K     +  +++GL +        ++HRDLK  
Sbjct: 80  FEFCDQDLKKYFDSC---NGDLDPEIVKS---FLFQLLKGLGFCHSRN---VLHRDLKPQ 130

Query: 113 NILLDEDLKPKISDFGLAR 131
           N+L++ + + K+++FGLAR
Sbjct: 131 NLLINRNGELKLANFGLAR 149

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 59.3 bits (144), Expect = 2e-11
 Identities = 36/147 (24%), Positives = 62/147 (42%), Gaps = 24/147 (16%)

Query: 3   LPDGQIIAVKKLSKK--------STQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYML 54
               + + VK + K+              +   E+ + ++++H N+I+V    E Q +  
Sbjct: 46  KEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF-- 103

Query: 55  IYEYMPKRSLDYFLFDPIRMLILDCKKRV------HIIKGIIQGLLYLQEYFRLTIIHRD 108
               M K      LF  I     D   R+      +I + ++  + YL+      IIHRD
Sbjct: 104 FQLVMEKHGSGLDLFAFI-----DRHPRLDEPLASYIFRQLVSAVGYLR---LKDIIHRD 155

Query: 109 LKVSNILLDEDLKPKISDFGLARILRK 135
           +K  NI++ ED   K+ DFG A  L +
Sbjct: 156 IKDENIVIAEDFTIKLIDFGSAAYLER 182

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 59.2 bits (144), Expect = 3e-11
 Identities = 37/155 (23%), Positives = 62/155 (40%), Gaps = 17/155 (10%)

Query: 6   GQIIAVKKLSKK--STQGFEE-FKNEVMLTAKLQHLNLIRV---GFCIETQEYMLIYEYM 59
            +I+A+K +S+   S   F    + E     +LQ  +++ +   G  I+ Q Y +    +
Sbjct: 59  ERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFG-EIDGQLY-VDMRLI 116

Query: 60  PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
               L   L     +      + V I++ I   L            HRD+K  NIL+  D
Sbjct: 117 NGVDLAAMLRRQGPLAP---PRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSAD 170

Query: 120 LKPKISDFGLARILRKMILKQIQIELG---YIPPE 151
               + DFG+A       L Q+   +G   Y+ PE
Sbjct: 171 DFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPE 205

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 59.3 bits (144), Expect = 3e-11
 Identities = 34/141 (24%), Positives = 65/141 (46%), Gaps = 20/141 (14%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSL 64
           GQI+A+K++        +E   E+ +  +    ++++  G   +  +  ++ EY    S+
Sbjct: 54  GQIVAIKQV--PVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSV 111

Query: 65  DYFLFDPIRMLILDCKKRVH------IIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE 118
                     +I    K +       I++  ++GL YL     +  IHRD+K  NILL+ 
Sbjct: 112 S--------DIIRLRNKTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNT 160

Query: 119 DLKPKISDFGLARILRKMILK 139
           +   K++DFG+A  L   + K
Sbjct: 161 EGHAKLADFGVAGQLTDTMAK 181

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 59.2 bits (144), Expect = 3e-11
 Identities = 36/135 (26%), Positives = 69/135 (51%), Gaps = 22/135 (16%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKN-----EVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYM 59
             ++A+K++  +  +G           EV L   L+H N++ +   I T++ + L++EY+
Sbjct: 27  DNLVALKEIRLEHEEGA----PCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL 82

Query: 60  P---KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL 116
               K+ LD        + + + K     +  +++GL Y        ++HRDLK  N+L+
Sbjct: 83  DKDLKQYLDDC---GNIINMHNVKL---FLFQLLRGLAYCHRQK---VLHRDLKPQNLLI 133

Query: 117 DEDLKPKISDFGLAR 131
           +E  + K++DFGLAR
Sbjct: 134 NERGELKLADFGLAR 148

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 59.2 bits (144), Expect = 3e-11
 Identities = 38/136 (27%), Positives = 66/136 (48%), Gaps = 17/136 (12%)

Query: 6   GQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKR 62
           G+ +A+K + K   +    ++   EV +   L H N++++   IET++ + LI EY    
Sbjct: 40  GREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGG 99

Query: 63  SLDYFLFDPI----RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE 118
            +    FD +    RM   + +      + I+  + Y     +  I+HRDLK  N+LLD 
Sbjct: 100 EV----FDYLVAHGRMKEKEARS---KFRQIVSAVQYCH---QKRIVHRDLKAENLLLDA 149

Query: 119 DLKPKISDFGLARILR 134
           D+  KI+DFG +    
Sbjct: 150 DMNIKIADFGFSNEFT 165

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 59.1 bits (144), Expect = 3e-11
 Identities = 32/139 (23%), Positives = 68/139 (48%), Gaps = 29/139 (20%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKN--------EVMLTAKLQHLNLIRVGFCIETQE--YMLI 55
           G+  A+KK+        E+           E+ +  +L+H N++++ + +   +   +L+
Sbjct: 26  GETFALKKIR------LEKEDEGIPSTTIREISILKELKHSNIVKL-YDVIHTKKRLVLV 78

Query: 56  YEYMP---KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVS 112
           +E++    K+ LD        +  +  K     +  ++ G+ Y  +     ++HRDLK  
Sbjct: 79  FEHLDQDLKKLLDVC---EGGLESVTAKS---FLLQLLNGIAYCHDRR---VLHRDLKPQ 129

Query: 113 NILLDEDLKPKISDFGLAR 131
           N+L++ + + KI+DFGLAR
Sbjct: 130 NLLINREGELKIADFGLAR 148

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 58.8 bits (143), Expect = 3e-11
 Identities = 37/136 (27%), Positives = 57/136 (41%), Gaps = 12/136 (8%)

Query: 6   GQIIAVKKLSKKSTQGFEEF----KNEVMLTAKLQHLNLIR---VGFCIETQEYMLIYEY 58
               AVK L KK  +         K E+ L  +L+H N+I+   V +  E Q+  ++ EY
Sbjct: 30  LCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEY 89

Query: 59  MPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE 118
                 +  + D +        +       +I GL YL       I+H+D+K  N+LL  
Sbjct: 90  CVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTT 144

Query: 119 DLKPKISDFGLARILR 134
               KIS  G+A  L 
Sbjct: 145 GGTLKISALGVAEALH 160

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 59.3 bits (144), Expect = 4e-11
 Identities = 36/144 (25%), Positives = 64/144 (44%), Gaps = 31/144 (21%)

Query: 4   PDGQIIAVKKLSKKSTQGFEEFKN---------EVMLTAKLQHLNLIRV-------GFCI 47
             G  +A+KKL +        F++         E+ L   ++H N+I +           
Sbjct: 48  RTGAKVAIKKLYRP-------FQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLD 100

Query: 48  ETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHR 107
           +  ++ L+  +M        L   ++   L   +   ++  +++GL Y+       IIHR
Sbjct: 101 DFTDFYLVMPFM-----GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHA---AGIIHR 152

Query: 108 DLKVSNILLDEDLKPKISDFGLAR 131
           DLK  N+ ++ED + KI DFGLAR
Sbjct: 153 DLKPGNLAVNEDCELKILDFGLAR 176

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 59.2 bits (144), Expect = 4e-11
 Identities = 36/144 (25%), Positives = 65/144 (45%), Gaps = 31/144 (21%)

Query: 4   PDGQIIAVKKLSKKSTQGFEEFKN---------EVMLTAKLQHLNLIRVG--FCIETQEY 52
            +   +A+KK+S         F++         E+ +  + +H N+I +       T E 
Sbjct: 50  LNKVRVAIKKISP--------FEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQ 101

Query: 53  M----LIYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRD 108
           M    ++ + M     +  L+  ++   L      + +  I++GL Y+       ++HRD
Sbjct: 102 MKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRD 153

Query: 109 LKVSNILLDEDLKPKISDFGLARI 132
           LK SN+LL+     KI DFGLAR+
Sbjct: 154 LKPSNLLLNTTCDLKICDFGLARV 177

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 58.5 bits (142), Expect = 5e-11
 Identities = 38/145 (26%), Positives = 66/145 (45%), Gaps = 19/145 (13%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKNEV-MLTAKLQHLNL-------IRVGFCIETQEYMLIYE 57
           GQ+ A+K +        EE K E+ ML     H N+       I+        +  L+ E
Sbjct: 49  GQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVME 107

Query: 58  YMPKRSLDYFLFDPIRMLILDCKKRVHI---IKGIIQGLLYLQEYFRLTIIHRDLKVSNI 114
           +    S+     D I+    +  K   I    + I++GL +L +     +IHRD+K  N+
Sbjct: 108 FCGAGSVT----DLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNV 160

Query: 115 LLDEDLKPKISDFGLARILRKMILK 139
           LL E+ + K+ DFG++  L + + +
Sbjct: 161 LLTENAEVKLVDFGVSAQLDRTVGR 185

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 58.6 bits (142), Expect = 5e-11
 Identities = 36/172 (20%), Positives = 66/172 (38%), Gaps = 31/172 (18%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQ-HLNLIRVGFCIETQE--------YMLIY 56
            +  A+K L         + + EV L  +     +++R+   ++  E         +++ 
Sbjct: 87  QEKFALKMLQDC-----PKARREVELHWRASQCPHIVRI---VDVYENLYAGRKCLLIVM 138

Query: 57  EYMPKRSLDYFLFDPIRMLILDC---KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSN 113
           E +    L    F  I+         ++   I+K I + + YL     + I HRD+K  N
Sbjct: 139 ECLDGGEL----FSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPEN 191

Query: 114 ILL---DEDLKPKISDFGLARILRK-MILKQIQIELGYIPPEYVGRGVYYKK 161
           +L      +   K++DFG A+       L        Y+ PE +G   Y K 
Sbjct: 192 LLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKS 243

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 58.0 bits (141), Expect = 7e-11
 Identities = 34/142 (23%), Positives = 59/142 (41%), Gaps = 26/142 (18%)

Query: 25  FKNEVMLTAKLQHLNLIRV---GFCIETQEYM--LIYEYMPKRSLDYFLFDPIRMLI--- 76
           F+ E    A L H  ++ V   G        +  ++ EY+   +L        R ++   
Sbjct: 59  FRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTL--------RDIVHTE 110

Query: 77  --LDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILR 134
             +  K+ + +I    Q L       +  IIHRD+K +NI++      K+ DFG+AR + 
Sbjct: 111 GPMTPKRAIEVIADACQAL---NFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA 167

Query: 135 --KMILKQIQIELG---YIPPE 151
                + Q    +G   Y+ PE
Sbjct: 168 DSGNSVTQTAAVIGTAQYLSPE 189

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 58.0 bits (141), Expect = 8e-11
 Identities = 36/140 (25%), Positives = 56/140 (40%), Gaps = 27/140 (19%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKN--------EVMLTAKLQHLNLIRVGFCIETQE-YMLIY 56
            + +A+K++        E  +         EV L  +LQH N+I +   I       LI+
Sbjct: 59  NETVAIKRIR------LEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF 112

Query: 57  EYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL 116
           EY     L  ++     + +   K     +  +I G+ +         +HRDLK  N+LL
Sbjct: 113 EYAEN-DLKKYMDKNPDVSMRVIKS---FLYQLINGVNFCHSRR---CLHRDLKPQNLLL 165

Query: 117 DEDLKP-----KISDFGLAR 131
                      KI DFGLAR
Sbjct: 166 SVSDASETPVLKIGDFGLAR 185

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 57.7 bits (139), Expect = 1e-10
 Identities = 17/146 (11%), Positives = 42/146 (28%), Gaps = 17/146 (11%)

Query: 5   DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQ-EYMLIYEYMPKRS 63
           + Q   +K     +   F      +           ++       Q   +L+ E     +
Sbjct: 94  NKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGT 153

Query: 64  LDYFL--FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL----- 116
           L   +  +      ++     +     ++  +  + +     IIH D+K  N +L     
Sbjct: 154 LLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFL 210

Query: 117 ------DEDLKPKISDFGLARILRKM 136
                 D      + D G +  ++  
Sbjct: 211 EQDDEDDLSAGLALIDLGQSIDMKLF 236

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 57.7 bits (140), Expect = 1e-10
 Identities = 36/144 (25%), Positives = 68/144 (47%), Gaps = 32/144 (22%)

Query: 4   PDGQIIAVKKLSKKSTQGFEEFKN---------EVMLTAKLQHLNLIRV-------GFCI 47
             G+ +A+KKLS+        F++         E++L   +QH N+I +           
Sbjct: 47  RSGEKVAIKKLSRP-------FQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLR 99

Query: 48  ETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHR 107
              ++ L+  +M        L   + +   + K + +++  +++GL Y+       ++HR
Sbjct: 100 NFYDFYLVMPFM-----QTDLQKIMGLKFSEEKIQ-YLVYQMLKGLKYIHS---AGVVHR 150

Query: 108 DLKVSNILLDEDLKPKISDFGLAR 131
           DLK  N+ ++ED + KI DFGLAR
Sbjct: 151 DLKPGNLAVNEDCELKILDFGLAR 174

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 56.8 bits (138), Expect = 2e-10
 Identities = 37/137 (27%), Positives = 65/137 (47%), Gaps = 18/137 (13%)

Query: 6   GQIIAVKKLSK---KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPK 61
           G  +AVK L++   +S     + K E+      +H ++I++   I T     ++ EY+  
Sbjct: 36  GHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSG 95

Query: 62  RSLDYFLFDPI----RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLD 117
             L    FD I    R+      +   + + I+  + Y     R  ++HRDLK  N+LLD
Sbjct: 96  GEL----FDYICKHGRVEE---MEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLD 145

Query: 118 EDLKPKISDFGLARILR 134
             +  KI+DFGL+ ++ 
Sbjct: 146 AHMNAKIADFGLSNMMS 162

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 57.1 bits (138), Expect = 2e-10
 Identities = 31/141 (21%), Positives = 61/141 (43%), Gaps = 19/141 (13%)

Query: 5   DGQIIAVKKLSKKSTQGFEEFK-NEVMLTAKLQHLNLIRV-GFCIETQEY--MLIYEYMP 60
           D +  A+K++      G       E+ L  +L+H N+I +    +   +    L+++Y  
Sbjct: 47  DDKDYALKQIEG---TGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 103

Query: 61  ---KRSLDYFLFDPI--RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNIL 115
                 + +        + + L       ++  I+ G+ YL   +   ++HRDLK +NIL
Sbjct: 104 HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANIL 160

Query: 116 LDEDLKP----KISDFGLARI 132
           +  +       KI+D G AR+
Sbjct: 161 VMGEGPERGRVKIADMGFARL 181

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 56.9 bits (138), Expect = 2e-10
 Identities = 40/138 (28%), Positives = 63/138 (45%), Gaps = 14/138 (10%)

Query: 4   PDGQIIAVKKLSKKSTQGFEEFKNEVM----LTAKLQHLNLIRV--GFCIETQEYMLIYE 57
           P GQI+AVK++  +ST   +E K  +M    +        +++       E   ++ + E
Sbjct: 45  PSGQIMAVKRI--RSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICM-E 101

Query: 58  YMPKRSLDYFLFDPIRMLILDCKKRV--HIIKGIIQGLLYLQEYFRLTIIHRDLKVSNIL 115
            M   S D F      +L     + +   I    ++ L +L     L IIHRD+K SNIL
Sbjct: 102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHL--KENLKIIHRDIKPSNIL 158

Query: 116 LDEDLKPKISDFGLARIL 133
           LD     K+ DFG++  L
Sbjct: 159 LDRSGNIKLCDFGISGQL 176

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 56.3 bits (136), Expect = 3e-10
 Identities = 37/137 (27%), Positives = 69/137 (50%), Gaps = 18/137 (13%)

Query: 6   GQIIAVKKLSK---KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPK 61
           G  +AVK L++   +S     + + E+      +H ++I++   I T   + ++ EY+  
Sbjct: 41  GHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSG 100

Query: 62  RSLDYFLFDPI----RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLD 117
             L    FD I    R+   + ++   + + I+ G+ Y     R  ++HRDLK  N+LLD
Sbjct: 101 GEL----FDYICKNGRLDEKESRR---LFQQILSGVDYCH---RHMVVHRDLKPENVLLD 150

Query: 118 EDLKPKISDFGLARILR 134
             +  KI+DFGL+ ++ 
Sbjct: 151 AHMNAKIADFGLSNMMS 167

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 56.0 bits (135), Expect = 4e-10
 Identities = 31/151 (20%), Positives = 66/151 (43%), Gaps = 41/151 (27%)

Query: 4   PDGQIIAVKKLSKKSTQGFEEFKN---------EVMLTAKLQHLNLIRVGFCIETQEYM- 53
            + +++A+KK+          F++         E+ +  +L H ++++V   +  ++   
Sbjct: 76  LEKRVVAIKKI-------LRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEK 128

Query: 54  -----LIYEYMPK------RSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRL 102
                ++ E          R+  Y     I+ L+ +          ++ G+ Y+      
Sbjct: 129 FDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYN----------LLVGVKYVHSA--- 175

Query: 103 TIIHRDLKVSNILLDEDLKPKISDFGLARIL 133
            I+HRDLK +N L+++D   K+ DFGLAR +
Sbjct: 176 GILHRDLKPANCLVNQDCSVKVCDFGLARTV 206

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 56.0 bits (135), Expect = 5e-10
 Identities = 36/129 (27%), Positives = 61/129 (47%), Gaps = 8/129 (6%)

Query: 6   GQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPK 61
           G++ A KKL KK     +G     NE  +  K+    ++ + +  ET++ + L+   M  
Sbjct: 209 GKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 268

Query: 62  RSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK 121
             L + ++   +    + +   +  + I  GL  L       I++RDLK  NILLD+   
Sbjct: 269 GDLKFHIYHMGQAGFPEARAVFYAAE-ICCGLEDLHR---ERIVYRDLKPENILLDDHGH 324

Query: 122 PKISDFGLA 130
            +ISD GLA
Sbjct: 325 IRISDLGLA 333

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 55.7 bits (135), Expect = 5e-10
 Identities = 33/146 (22%), Positives = 63/146 (43%), Gaps = 35/146 (23%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTA--------KLQHLNLIRV---------GFCIE 48
           GQ +A+KK+        E  K    +TA         L+H N++ +          +   
Sbjct: 42  GQKVALKKVL------MENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 95

Query: 49  TQEYMLIYEYMP---KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTII 105
                L++++        L       ++  + + K    +++ ++ GL Y+       I+
Sbjct: 96  KGSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIK---RVMQMLLNGLYYIHRNK---IL 146

Query: 106 HRDLKVSNILLDEDLKPKISDFGLAR 131
           HRD+K +N+L+  D   K++DFGLAR
Sbjct: 147 HRDMKAANVLITRDGVLKLADFGLAR 172

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 55.7 bits (135), Expect = 6e-10
 Identities = 37/145 (25%), Positives = 61/145 (42%), Gaps = 31/145 (21%)

Query: 4   PDGQIIAVKKLSKKSTQGFEEFKN---------EVMLTAKLQHLNLIRVG--FCIETQEY 52
           P G+I+A+KK+          F           E+ +    +H N+I +      ++ E 
Sbjct: 34  PTGEIVAIKKIEP--------FDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFEN 85

Query: 53  M----LIYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRD 108
                +I E M        L   I   +L      + I   ++ +  L       +IHRD
Sbjct: 86  FNEVYIIQELM-----QTDLHRVISTQMLSDDHIQYFIYQTLRAVKVLHG---SNVIHRD 137

Query: 109 LKVSNILLDEDLKPKISDFGLARIL 133
           LK SN+L++ +   K+ DFGLARI+
Sbjct: 138 LKPSNLLINSNCDLKVCDFGLARII 162

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 55.5 bits (134), Expect = 6e-10
 Identities = 41/142 (28%), Positives = 66/142 (46%), Gaps = 32/142 (22%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKN---------EVMLTAKLQHLNLIRV-------GFCIET 49
            + +A+KKLS+        F+N         E++L   + H N+I +           E 
Sbjct: 50  ERNVAIKKLSRP-------FQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 102

Query: 50  QEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDL 109
           Q+  ++ E M     D  L   I+M +   +   +++  ++ G+ +L       IIHRDL
Sbjct: 103 QDVYIVMELM-----DANLCQVIQMELDHERMS-YLLYQMLCGIKHLHS---AGIIHRDL 153

Query: 110 KVSNILLDEDLKPKISDFGLAR 131
           K SNI++  D   KI DFGLAR
Sbjct: 154 KPSNIVVKSDCTLKILDFGLAR 175

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 55.4 bits (134), Expect = 7e-10
 Identities = 42/144 (29%), Positives = 64/144 (44%), Gaps = 31/144 (21%)

Query: 4   PDGQIIAVKKLSKKSTQGFEEFKN---------EVMLTAKLQHLNLIRV-------GFCI 47
             G  +AVKKLS+        F++         E+ L   ++H N+I +           
Sbjct: 52  KTGLRVAVKKLSRP-------FQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLE 104

Query: 48  ETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHR 107
           E  +  L+   M        L + ++   L       +I  I++GL Y+       IIHR
Sbjct: 105 EFNDVYLVTHLM-----GADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHR 156

Query: 108 DLKVSNILLDEDLKPKISDFGLAR 131
           DLK SN+ ++ED + KI DFGLAR
Sbjct: 157 DLKPSNLAVNEDCELKILDFGLAR 180

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 55.1 bits (133), Expect = 9e-10
 Identities = 38/144 (26%), Positives = 68/144 (47%), Gaps = 34/144 (23%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKN---------EVMLTAKLQHL----NLIRVGFCIETQEY 52
           G+++AVKK+          F+N         E+M+   L  L    N++ +   +     
Sbjct: 34  GEVVAVKKIFDA-------FQNSTDAQRTFREIMI---LTELSGHENIVNLLNVLRADND 83

Query: 53  MLIY---EYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDL 109
             +Y   +YM     +  L   IR  IL+   + +++  +I+ + YL       ++HRD+
Sbjct: 84  RDVYLVFDYM-----ETDLHAVIRANILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDM 135

Query: 110 KVSNILLDEDLKPKISDFGLARIL 133
           K SNILL+ +   K++DFGL+R  
Sbjct: 136 KPSNILLNAECHVKVADFGLSRSF 159

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 54.5 bits (132), Expect = 1e-09
 Identities = 41/135 (30%), Positives = 59/135 (43%), Gaps = 16/135 (11%)

Query: 6   GQIIAVKKLSKKSTQGFEE-FKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKRS 63
            + +AVK +  K      E  K E+ +   L H N+++            L  EY     
Sbjct: 32  EEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 91

Query: 64  LDYFLFDPI----RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
           L    FD I     M   D ++       ++ G++YL     + I HRD+K  N+LLDE 
Sbjct: 92  L----FDRIEPDIGMPEPDAQR---FFHQLMAGVVYLH---GIGITHRDIKPENLLLDER 141

Query: 120 LKPKISDFGLARILR 134
              KISDFGLA + R
Sbjct: 142 DNLKISDFGLATVFR 156

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 55.0 bits (133), Expect = 1e-09
 Identities = 31/146 (21%), Positives = 54/146 (36%), Gaps = 27/146 (18%)

Query: 5   DGQIIAVKKLSKKSTQGFEE--FKN---------EVMLTAKLQH------LNLIRVGFCI 47
           +G  +A+K++    + G       +         E+ L     H       ++       
Sbjct: 45  EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEP 104

Query: 48  ETQEYMLIYEYMPKRSLDYFLFDPIR--MLILDCKKRVHIIKGIIQGLLYLQEYFRLTII 105
              +  L+ E M        L   I    +++  +   + +  I+ GL  L E     ++
Sbjct: 105 AMHKLYLVTELM-----RTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHE---AGVV 156

Query: 106 HRDLKVSNILLDEDLKPKISDFGLAR 131
           HRDL   NILL ++    I DF LAR
Sbjct: 157 HRDLHPGNILLADNNDITICDFNLAR 182

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 55.3 bits (133), Expect = 1e-09
 Identities = 44/163 (26%), Positives = 71/163 (43%), Gaps = 13/163 (7%)

Query: 6   GQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLN---LIRVGFCIETQEYM-LIYEY 58
           G++ A+K L KK     QG     NE ++ + +   +   ++ + +   T + +  I + 
Sbjct: 214 GKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDL 273

Query: 59  MPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE 118
           M    L Y L    +  +            II GL ++       +++RDLK +NILLDE
Sbjct: 274 MNGGDLHYHLS---QHGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDE 327

Query: 119 DLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKK 161
               +ISD GLA    K          GY+ PE + +GV Y  
Sbjct: 328 HGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAYDS 370

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 54.6 bits (132), Expect = 1e-09
 Identities = 20/47 (42%), Positives = 30/47 (63%), Gaps = 3/47 (6%)

Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK 135
           +I+G+ YL       IIHRD+K SN+L+ ED   KI+DFG++   + 
Sbjct: 146 LIKGIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKG 189

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 54.8 bits (132), Expect = 1e-09
 Identities = 37/130 (28%), Positives = 65/130 (50%), Gaps = 8/130 (6%)

Query: 6   GQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPK 61
           G++ A KKL+KK     +G++    E  + AK+    ++ + +  ET+  + L+   M  
Sbjct: 210 GKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNG 269

Query: 62  RSLDYFLFDPI-RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL 120
             + Y +++           + +     I+ GL +L +     II+RDLK  N+LLD+D 
Sbjct: 270 GDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDG 326

Query: 121 KPKISDFGLA 130
             +ISD GLA
Sbjct: 327 NVRISDLGLA 336

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 54.2 bits (131), Expect = 1e-09
 Identities = 36/153 (23%), Positives = 65/153 (42%), Gaps = 42/153 (27%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKN---------EVMLTAKLQHLNLIRV------------- 43
            + +A+KK+            +         E+ +  +L H N+++V             
Sbjct: 36  DKRVAIKKIV---------LTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD 86

Query: 44  --GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFR 101
             G   E     ++ EYM     +  L + +    L  +     +  +++GL Y+     
Sbjct: 87  DVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLLEEHARLFMYQLLRGLKYIHS--- 138

Query: 102 LTIIHRDLKVSNILLD-EDLKPKISDFGLARIL 133
             ++HRDLK +N+ ++ EDL  KI DFGLARI+
Sbjct: 139 ANVLHRDLKPANLFINTEDLVLKIGDFGLARIM 171

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 54.2 bits (131), Expect = 1e-09
 Identities = 41/137 (29%), Positives = 66/137 (48%), Gaps = 19/137 (13%)

Query: 6   GQIIAVKKLSK---KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPK 61
            Q +A+K +S+   K +      + E+     L+H ++I++   I T   + ++ EY   
Sbjct: 34  QQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYAGG 93

Query: 62  RSLDYFLFDPI----RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLD 117
                 LFD I    RM      +     + II  + Y     R  I+HRDLK  N+LLD
Sbjct: 94  E-----LFDYIVEKKRMTE---DEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLD 142

Query: 118 EDLKPKISDFGLARILR 134
           ++L  KI+DFGL+ I+ 
Sbjct: 143 DNLNVKIADFGLSNIMT 159

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 54.3 bits (131), Expect = 2e-09
 Identities = 38/174 (21%), Positives = 67/174 (38%), Gaps = 35/174 (20%)

Query: 5   DGQIIAVKK--LSKKSTQGFEEFKNEVMLTAKL-QHLNLIRVGFCIETQEYMLIY-EYMP 60
           DG I A+K+       +   +    EV   A L QH +++R        ++MLI  EY  
Sbjct: 35  DGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCN 94

Query: 61  KRSLDYFLFDPIRML-ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
             SL   + +  R++      +   ++  + +GL Y+     ++++H D+K SNI +   
Sbjct: 95  GGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRT 151

Query: 120 LKP-------------------KISDFGLARILRKMILKQIQIELG---YIPPE 151
             P                   KI D G    +        Q+E G   ++  E
Sbjct: 152 SIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP-----QVEEGDSRFLANE 200

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 54.2 bits (131), Expect = 2e-09
 Identities = 39/138 (28%), Positives = 55/138 (39%), Gaps = 22/138 (15%)

Query: 6   GQIIAVKKLSKKSTQGFEE-FKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKRS 63
            + +AVK +  K      E  K E+ +   L H N+++            L  EY     
Sbjct: 32  EEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGE 91

Query: 64  LDYFLFDPIRMLILDCKKR-------VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL 116
           L    FD I                       ++ G++YL     + I HRD+K  N+LL
Sbjct: 92  L----FDRI------EPDIGMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLL 138

Query: 117 DEDLKPKISDFGLARILR 134
           DE    KISDFGLA + R
Sbjct: 139 DERDNLKISDFGLATVFR 156

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 54.3 bits (131), Expect = 2e-09
 Identities = 22/50 (44%), Positives = 33/50 (66%), Gaps = 2/50 (4%)

Query: 84  HIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARIL 133
            +   I++ L YL+E  +  +IHRD+K SNILLDE  + K+ DFG++  L
Sbjct: 128 KMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGQIKLCDFGISGRL 175

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 53.7 bits (130), Expect = 2e-09
 Identities = 32/143 (22%), Positives = 60/143 (41%), Gaps = 25/143 (17%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTA-----------KLQHLNLIRVGFCIETQEY-- 52
           G  +A+K +   +          + ++              +H N++R+     T     
Sbjct: 34  GHFVALKSVRVPNG---GGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDR 90

Query: 53  ----MLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRD 108
                L++E++ +  L  +L D      L  +    +++  ++GL +L       I+HRD
Sbjct: 91  EIKVTLVFEHVDQ-DLRTYL-DKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRD 145

Query: 109 LKVSNILLDEDLKPKISDFGLAR 131
           LK  NIL+      K++DFGLAR
Sbjct: 146 LKPENILVTSGGTVKLADFGLAR 168

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 54.0 bits (130), Expect = 2e-09
 Identities = 34/144 (23%), Positives = 65/144 (45%), Gaps = 31/144 (21%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKN---------EVMLTAKLQH------LNLIRVGFCIETQ 50
            + +A+KK+++        F++         E+ +  +L+        +LI     ++  
Sbjct: 51  EKNVAIKKVNR-------MFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD 103

Query: 51  EYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRV-HIIKGIIQGLLYLQEYFRLTIIHRDL 109
           E  ++ E       D  L    +  I   ++ +  I+  ++ G  ++ E     IIHRDL
Sbjct: 104 ELYIVLEIA-----DSDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHE---SGIIHRDL 155

Query: 110 KVSNILLDEDLKPKISDFGLARIL 133
           K +N LL++D   K+ DFGLAR +
Sbjct: 156 KPANCLLNQDCSVKVCDFGLARTI 179

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 53.0 bits (128), Expect = 5e-09
 Identities = 18/43 (41%), Positives = 29/43 (67%), Gaps = 3/43 (6%)

Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLAR 131
           +++GL +L  +    ++HRDLK  NIL+    + K++DFGLAR
Sbjct: 129 LLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLAR 168

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 51.9 bits (125), Expect = 1e-08
 Identities = 29/141 (20%), Positives = 54/141 (38%), Gaps = 22/141 (15%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKL-QHLNLIRVGFCIETQEYMLIYEYMPKRSL 64
            +  A+K L         + + EV L  +  Q  +++R+    E          +    +
Sbjct: 43  QEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI---VM 94

Query: 65  DYF----LFDPIRMLILDC---KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL- 116
           +      LF  I+         ++   I+K I + + YL     + I HRD+K  N+L  
Sbjct: 95  ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYT 151

Query: 117 --DEDLKPKISDFGLARILRK 135
               +   K++DFG A+    
Sbjct: 152 SKRPNAILKLTDFGFAKETTG 172

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 52.0 bits (125), Expect = 1e-08
 Identities = 21/86 (24%), Positives = 41/86 (47%), Gaps = 10/86 (11%)

Query: 54  LIYEYMP---KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLK 110
           +I EY+P    + L  F+     + +      ++    + + + ++     L I HRD+K
Sbjct: 115 VIMEYVPDTLHKVLKSFIRSGRSIPMNLISIYIY---QLFRAVGFIHS---LGICHRDIK 168

Query: 111 VSNILLD-EDLKPKISDFGLARILRK 135
             N+L++ +D   K+ DFG A+ L  
Sbjct: 169 PQNLLVNSKDNTLKLCDFGSAKKLIP 194

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 50.4 bits (121), Expect = 3e-08
 Identities = 21/47 (44%), Positives = 28/47 (59%), Gaps = 3/47 (6%)

Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK 135
           ++  L YLQ      IIHRD+K  NILLDE     I+DF +A +L +
Sbjct: 124 LVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 50.1 bits (120), Expect = 5e-08
 Identities = 35/139 (25%), Positives = 60/139 (43%), Gaps = 24/139 (17%)

Query: 6   GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMPKRSL 64
            +++AVK + + +    E  + E++    L+H N++R    I T  ++ +I EY     L
Sbjct: 45  KELVAVKYIERGAAID-ENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGEL 103

Query: 65  DYFLFDPIRMLILDCKKR-------VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLD 117
               ++ I      C              + ++ G+ Y      + I HRDLK+ N LLD
Sbjct: 104 ----YERI------CNAGRFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLD 150

Query: 118 EDLKP--KISDFGLARILR 134
               P  KI DFG ++   
Sbjct: 151 GSPAPRLKICDFGYSKSSV 169

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 48.0 bits (115), Expect = 2e-07
 Identities = 23/48 (47%), Positives = 30/48 (62%), Gaps = 3/48 (6%)

Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM 136
           I+  L YL       IIHRDLK  NILL+ED+  +I+DFG A++L   
Sbjct: 139 IVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 183

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 47.2 bits (112), Expect = 4e-07
 Identities = 20/43 (46%), Positives = 24/43 (55%), Gaps = 3/43 (6%)

Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLAR 131
           + +G+ +L        IHRDL   NILL E    KI DFGLAR
Sbjct: 202 VAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLAR 241

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 46.2 bits (110), Expect = 1e-06
 Identities = 34/162 (20%), Positives = 64/162 (39%), Gaps = 28/162 (17%)

Query: 5   DGQIIAVKKLSKKSTQGFEE---FKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMP 60
            GQ+ A+K ++K       E   F+ E  +        + ++ F  + + Y+ L+ EY  
Sbjct: 85  TGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYV 144

Query: 61  --------KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVS 112
                    +  +    +  R  + +          I+  +  +     L  +HRD+K  
Sbjct: 145 GGDLLTLLSKFGERIPAEMARFYLAE----------IVMAIDSVHR---LGYVHRDIKPD 191

Query: 113 NILLDEDLKPKISDFGLARILRKMILKQIQIELG---YIPPE 151
           NILLD     +++DFG    LR     +  + +G   Y+ PE
Sbjct: 192 NILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPE 233

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 45.9 bits (109), Expect = 1e-06
 Identities = 12/126 (9%), Positives = 35/126 (27%), Gaps = 12/126 (9%)

Query: 10  AVKKL--SKKSTQGF-EEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLI-YEYMPKRSLD 65
           A+  +           +E  +  +  +++    + RV   + T+   L+  E++   SL 
Sbjct: 60  ALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQ 119

Query: 66  YFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKIS 125
                            +  ++ +           R  +       S + +  D    ++
Sbjct: 120 EVADTS-----PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLA 171

Query: 126 DFGLAR 131
                 
Sbjct: 172 YPATMP 177

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 46.2 bits (109), Expect = 1e-06
 Identities = 19/42 (45%), Positives = 27/42 (64%), Gaps = 3/42 (7%)

Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLA 130
           I  GL +LQ      II+RDLK+ N++LD +   KI+DFG+ 
Sbjct: 451 IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMC 489

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 45.3 bits (108), Expect = 2e-06
 Identities = 30/140 (21%), Positives = 61/140 (43%), Gaps = 31/140 (22%)

Query: 4   PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHL----NLIRVGFCI---ETQEYMLIY 56
            + + + VK L     +   + K E+ +   L++L    N+I +   +    ++   L++
Sbjct: 59  TNNEKVVVKILKPVKKK---KIKREIKI---LENLRGGPNIITLADIVKDPVSRTPALVF 112

Query: 57  EYMP----KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVS 112
           E++     K+         IR            +  I++ L Y      + I+HRD+K  
Sbjct: 113 EHVNNTDFKQLYQTLTDYDIR----------FYMYEILKALDYCH---SMGIMHRDVKPH 159

Query: 113 NILLD-EDLKPKISDFGLAR 131
           N+++D E  K ++ D+GLA 
Sbjct: 160 NVMIDHEHRKLRLIDWGLAE 179

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 45.3 bits (108), Expect = 2e-06
 Identities = 19/42 (45%), Positives = 23/42 (54%), Gaps = 3/42 (7%)

Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLA 130
           I   L YL     L I++RDLK  NILLD      ++DFGL 
Sbjct: 148 IASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLC 186

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 45.1 bits (107), Expect = 2e-06
 Identities = 23/138 (16%), Positives = 52/138 (37%), Gaps = 25/138 (18%)

Query: 5   DGQIIAVKKLSKKSTQGFEE---FKNEVMLTAKLQHLNLIRVGFCIETQEYM-LIYEYMP 60
             ++ A+K L+K       E   F+ E  +        +  + +  +    + L+ +Y  
Sbjct: 98  ADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYV 157

Query: 61  --------KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVS 112
                    +  D    +  R  + +          ++  +  + +   L  +HRD+K  
Sbjct: 158 GGDLLTLLSKFEDRLPEEMARFYLAE----------MVIAIDSVHQ---LHYVHRDIKPD 204

Query: 113 NILLDEDLKPKISDFGLA 130
           NIL+D +   +++DFG  
Sbjct: 205 NILMDMNGHIRLADFGSC 222

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 44.9 bits (107), Expect = 2e-06
 Identities = 17/42 (40%), Positives = 27/42 (64%), Gaps = 3/42 (7%)

Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLA 130
           I+  L YL       +++RD+K+ N++LD+D   KI+DFGL 
Sbjct: 114 IVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLC 152

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 45.1 bits (107), Expect = 3e-06
 Identities = 18/42 (42%), Positives = 27/42 (64%), Gaps = 2/42 (4%)

Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLA 130
           I+  L YL       +++RDLK+ N++LD+D   KI+DFGL 
Sbjct: 257 IVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLC 296

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 44.5 bits (106), Expect = 3e-06
 Identities = 19/42 (45%), Positives = 27/42 (64%), Gaps = 3/42 (7%)

Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLA 130
           I  GL +LQ      II+RDLK+ N++LD +   KI+DFG+ 
Sbjct: 130 IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMC 168

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 44.5 bits (106), Expect = 3e-06
 Identities = 18/42 (42%), Positives = 28/42 (66%), Gaps = 3/42 (7%)

Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLA 130
           II  L++L +     II+RDLK+ N+LLD +   K++DFG+ 
Sbjct: 133 IISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMC 171

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 44.6 bits (106), Expect = 4e-06
 Identities = 18/42 (42%), Positives = 26/42 (61%), Gaps = 3/42 (7%)

Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLA 130
           I   L YL E     II+RDLK+ N+LLD +   K++D+G+ 
Sbjct: 162 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMC 200

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 44.5 bits (106), Expect = 4e-06
 Identities = 17/42 (40%), Positives = 24/42 (57%), Gaps = 3/42 (7%)

Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLA 130
           I   L +L +     II+RDLK  NI+L+     K++DFGL 
Sbjct: 130 ISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLC 168

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 44.5 bits (106), Expect = 4e-06
 Identities = 21/42 (50%), Positives = 28/42 (66%), Gaps = 3/42 (7%)

Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLA 130
           II GL +L       I++RDLK+ NILLD+D   KI+DFG+ 
Sbjct: 127 IILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMC 165

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 44.5 bits (106), Expect = 4e-06
 Identities = 20/42 (47%), Positives = 27/42 (64%), Gaps = 3/42 (7%)

Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLA 130
           +   L +L     L II+RDLK  NILLDE+   K++DFGL+
Sbjct: 135 LALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLS 173

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 44.3 bits (105), Expect = 5e-06
 Identities = 20/66 (30%), Positives = 33/66 (50%), Gaps = 6/66 (9%)

Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELG-- 146
           ++  L  +     +  IHRD+K  N+LLD+    K++DFG    + K  + +    +G  
Sbjct: 177 VVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTP 233

Query: 147 -YIPPE 151
            YI PE
Sbjct: 234 DYISPE 239

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 44.2 bits (105), Expect = 5e-06
 Identities = 18/42 (42%), Positives = 28/42 (66%), Gaps = 3/42 (7%)

Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLA 130
           I+  L +L +   L II+RD+K+ NILLD +    ++DFGL+
Sbjct: 168 IVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLS 206

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 44.1 bits (105), Expect = 5e-06
 Identities = 18/42 (42%), Positives = 26/42 (61%), Gaps = 3/42 (7%)

Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLA 130
           I   L YL E     II+RDLK+ N+LLD +   K++D+G+ 
Sbjct: 119 ISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMC 157

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 43.7 bits (104), Expect = 7e-06
 Identities = 20/42 (47%), Positives = 25/42 (59%), Gaps = 3/42 (7%)

Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLA 130
           +   L YL       II+RDLK  NILLD++   KI+DFG A
Sbjct: 115 VCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFA 153

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 43.4 bits (103), Expect = 8e-06
 Identities = 16/42 (38%), Positives = 25/42 (59%), Gaps = 3/42 (7%)

Query: 89  IIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLA 130
           I+    YL     L +I+RDLK  N+L+D+    +++DFG A
Sbjct: 150 IVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFA 188

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 39.1 bits (90), Expect = 3e-04
 Identities = 11/59 (18%), Positives = 19/59 (32%), Gaps = 2/59 (3%)

Query: 76  ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILR 134
           +        I+  +   L   +   R    HRDL   N+LL +    K+      +   
Sbjct: 157 LSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNVLLKKTSLKKLHYTLNGKSST 213

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 38.2 bits (89), Expect = 5e-04
 Identities = 25/89 (28%), Positives = 35/89 (39%), Gaps = 15/89 (16%)

Query: 56  YEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNIL 115
           YE + K     F    +R               I+Q L  L    +  IIH DLK  NIL
Sbjct: 186 YELIKKNKFQGFSLPLVR----------KFAHSILQCLDALH---KNRIIHCDLKPENIL 232

Query: 116 LDEDLKP--KISDFGLARILRKMILKQIQ 142
           L +  +   K+ DFG +    + +   IQ
Sbjct: 233 LKQQGRSGIKVIDFGSSCYEHQRVYTYIQ 261

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 38.2 bits (89), Expect = 6e-04
 Identities = 25/89 (28%), Positives = 37/89 (41%), Gaps = 13/89 (14%)

Query: 56  YEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNIL 115
           Y+ +   +      +  R             + +   LL+L     L+IIH DLK  NIL
Sbjct: 143 YDLLRNTNFRGVSLNLTR----------KFAQQMCTALLFLAT-PELSIIHCDLKPENIL 191

Query: 116 LDEDLKP--KISDFGLARILRKMILKQIQ 142
           L    +   KI DFG +  L + I + IQ
Sbjct: 192 LCNPKRSAIKIVDFGSSCQLGQRIYQYIQ 220

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 37.8 bits (88), Expect = 7e-04
 Identities = 20/65 (30%), Positives = 29/65 (44%), Gaps = 8/65 (12%)

Query: 84  HIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKP------KISDFGLARILRKMI 137
            I K ++ GL Y+       IIH D+K  N+L++    P      KI+D G A    +  
Sbjct: 135 QISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHY 192

Query: 138 LKQIQ 142
              IQ
Sbjct: 193 TNSIQ 197

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	164
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	99.98
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.98
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	99.98
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.98
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	99.97
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	99.97
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.97
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	99.97
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.97
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.97
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	99.97
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.97
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.97
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	99.97
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	99.97
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.97
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	99.97
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.97
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.97
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.97
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.97
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.97
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.97
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	99.97
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.97
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.97
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.97
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.97
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.97
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.97
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.97
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.97
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.97
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.97
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.97
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.97
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.97
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.97
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.97
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.97
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.97
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.97
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.97
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.97
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.97
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.97
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.97
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.97
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.97
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.97
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.97
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.97
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.97
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.97
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.97
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.97
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.97
3niz_A	311	Rhodanese family protein; structural genomics, str	99.97
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.97
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.97
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.97
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.97
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.97
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.97
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.97
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.97
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.97
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.97
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.97
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.97
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.97
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.97
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.97
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.97
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.97
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.97
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.97
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.97
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.97
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.97
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.97
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.97
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.96
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.96
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.96
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.96
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.96
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.96
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.96
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.96
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.96
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.96
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.96
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.96
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.96
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.96
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.96
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.96
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.96
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.96
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.96
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.96
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.96
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.96
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.96
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.96
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.96
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.96
3bhy_A	283	Death-associated protein kinase 3; death associate	99.96
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.96
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.96
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.96
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.96
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.96
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.96
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.96
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.96
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.96
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.96
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.96
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.96
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.96
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.96
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.96
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.96
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.96
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.96
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.96
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.96
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.96
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.96
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.96
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.96
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.96
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.96
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.96
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.96
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.96
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.96
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.96
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.96
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.96
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.96
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.96
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.96
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.96
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.96
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.96
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.96
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.96
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.96
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.96
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.96
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.96
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.96
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.96
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.96
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.96
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.96
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.96
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.96
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.96
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.96
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.96
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.96
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.96
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.96
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.96
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.96
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.96
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.96
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.96
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.96
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.96
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.96
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.96
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.96
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.95
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.95
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.95
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.95
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.95
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.95
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.95
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.95
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.95
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.95
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.95
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.95
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.95
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.95
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.95
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.95
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.95
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.95
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.95
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.95
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.95
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.95
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.95
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.95
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.95
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.95
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.95
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.95
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.95
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.95
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.95
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.95
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.95
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.95
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.95
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.95
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.95
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.94
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.94
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.94
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.94
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.94
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.94
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.94
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.94
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.94
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.93
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.93
3uqc_A	286	Probable conserved transmembrane protein; structur	99.9
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.9
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.9
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.87
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.75
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.53
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.34
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.14
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.99
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.54
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.41
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.38
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.34
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.05
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.93
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.92
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.24
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.15
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.1
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.08
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.99
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.86
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	96.4
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	95.45
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	94.42
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	93.65
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	92.58
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	92.5
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	92.13
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	91.85
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	91.72
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	91.54
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	90.81
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	89.45
3mes_A	424	Choline kinase; malaria, structural genomics, stru	86.83

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=3.9e-42  Score=248.33  Aligned_cols=158  Identities=23%  Similarity=0.344  Sum_probs=137.6

Q ss_pred             cCCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            3 LPDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         3 ~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      ..+|+.||||.+...  .....+.+.+|+.+++.++||||+++ +.+.+.+.+|+|||||++|+|.+++..... ..+++
T Consensus        46 ~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~-~~~~e  124 (350)
T 4b9d_A           46 TEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKG-VLFQE  124 (350)
T ss_dssp             TTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTT-CCCCH
T ss_pred             CCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCC-CCCCH
Confidence            357899999999755  33446778999999999999999998 777788889999999999999999864322 22788


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh--hhhhhcccccccCcceecCCc
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM--ILKQIQIELGYIPPEYVGRGV  157 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~  157 (164)
                      ..+..++.|++.||.|+|++   +|+||||||+|||++.++.+||+|||+|+.+...  .....+||+.|||||++.+..
T Consensus       125 ~~~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~  201 (350)
T 4b9d_A          125 DQILDWFVQICLALKHVHDR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKP  201 (350)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT---TCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCC
T ss_pred             HHHHHHHHHHHHHHHHHHHC---CeeeccCCHHHEEECCCCCEEEcccccceeecCCcccccccCCCccccCHHHHCCCC
Confidence            99999999999999999998   9999999999999999999999999999877543  235678999999999999999


Q ss_pred             ceeccCC
Q 046065          158 YYKKFSL  164 (164)
Q Consensus       158 ~~~~~Di  164 (164)
                      |+.++||
T Consensus       202 y~~~~Di  208 (350)
T 4b9d_A          202 YNNKSDI  208 (350)
T ss_dssp             CCHHHHH
T ss_pred             CCcHHHH
Confidence            9999996

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=2.2e-42  Score=249.22  Aligned_cols=155  Identities=25%  Similarity=0.380  Sum_probs=138.5

Q ss_pred             cCCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            3 LPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      ..+|+.||||.+........+.+.+|+.+++.++||||+++ +.+...+.+|+|||||++|+|.+++...    .+++..
T Consensus        96 ~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~----~l~e~~  171 (346)
T 4fih_A           96 RSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT----RMNEEQ  171 (346)
T ss_dssp             TTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHHS----CCCHHH
T ss_pred             CCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHcC----CCCHHH
Confidence            35789999999987655566778999999999999999998 7778888999999999999999988653    289999


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh--hhhhhcccccccCcceecCCcce
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM--ILKQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      +..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++.+...  .....+||+.|||||++.+..|+
T Consensus       172 ~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~  248 (346)
T 4fih_A          172 IAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYG  248 (346)
T ss_dssp             HHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBC
T ss_pred             HHHHHHHHHHHHHHHHHC---CcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcccccccCcCcCCHHHHCCCCCC
Confidence            999999999999999998   9999999999999999999999999999876533  33567899999999999999999


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      .++||
T Consensus       249 ~~~Di  253 (346)
T 4fih_A          249 PEVDI  253 (346)
T ss_dssp             THHHH
T ss_pred             cHHHH
Confidence            99996

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=4.4e-42  Score=244.52  Aligned_cols=156  Identities=25%  Similarity=0.318  Sum_probs=137.1

Q ss_pred             cCCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccC
Q 046065            3 LPDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILD   78 (164)
Q Consensus         3 ~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~   78 (164)
                      ..+|+.||+|.+.++   .....+.+.+|+.+++.++||||+++ ..+.+.+.+|+|||||++|+|.+++.+...   ++
T Consensus        54 ~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~~~~---l~  130 (311)
T 4aw0_A           54 LATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FD  130 (311)
T ss_dssp             TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSS---CC
T ss_pred             CCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcCC---CC
Confidence            357899999999754   33456778999999999999999998 777777889999999999999999976433   89


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh----hhhhhcccccccCcceec
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM----ILKQIQIELGYIPPEYVG  154 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~~aPE~~~  154 (164)
                      +..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+|+.+...    .....+||+.|||||++.
T Consensus       131 e~~~~~~~~qi~~al~ylH~~---~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~  207 (311)
T 4aw0_A          131 ETCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT  207 (311)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHc
Confidence            999999999999999999998   9999999999999999999999999999876432    235678999999999999


Q ss_pred             CCcceeccCC
Q 046065          155 RGVYYKKFSL  164 (164)
Q Consensus       155 ~~~~~~~~Di  164 (164)
                      +..|+.++||
T Consensus       208 ~~~y~~~~Di  217 (311)
T 4aw0_A          208 EKSACKSSDL  217 (311)
T ss_dssp             HSCBCHHHHH
T ss_pred             CCCCCcHHHH
Confidence            9999999985

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.1e-41  Score=251.02  Aligned_cols=155  Identities=25%  Similarity=0.380  Sum_probs=138.6

Q ss_pred             cCCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            3 LPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      ..+|+.||||.+........+.+.+|+.+|+.++||||+++ +.+...+.+|+|||||++|+|.+++...    .+++..
T Consensus       173 ~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~~----~l~e~~  248 (423)
T 4fie_A          173 RSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHT----RMNEEQ  248 (423)
T ss_dssp             TTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHS----CCCHHH
T ss_pred             CCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhcc----CCCHHH
Confidence            35789999999987666666778999999999999999998 7778888999999999999999988643    289999


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh--hhhhhcccccccCcceecCCcce
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM--ILKQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      +..++.|++.||.|||++   +|+||||||+|||++.+|.+||+|||+++.+...  .....+||+.|||||++.+..|+
T Consensus       249 ~~~~~~qil~aL~ylH~~---~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~  325 (423)
T 4fie_A          249 IAAVCLAVLQALSVLHAQ---GVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYG  325 (423)
T ss_dssp             HHHHHHHHHHHHHHHHHT---TEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTCCBC
T ss_pred             HHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEecCccceECCCCCccccccccCcCcCCHHHHCCCCCC
Confidence            999999999999999998   9999999999999999999999999999876533  23567899999999999999999


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      .++||
T Consensus       326 ~~~Di  330 (423)
T 4fie_A          326 PEVDI  330 (423)
T ss_dssp             THHHH
T ss_pred             cHHHH
Confidence            99996

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=3.1e-41  Score=239.91  Aligned_cols=158  Identities=28%  Similarity=0.498  Sum_probs=136.7

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcc----------
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPI----------   72 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----------   72 (164)
                      .++..||||.+........+.+.+|+.+++.++||||+++ +.+.+.+..++||||+++|+|.+++....          
T Consensus        41 ~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~  120 (299)
T 4asz_A           41 QDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGN  120 (299)
T ss_dssp             --CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----
T ss_pred             CCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccC
Confidence            3578899999976655566789999999999999999997 88888889999999999999999996532          


Q ss_pred             cccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh----hhhccccccc
Q 046065           73 RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL----KQIQIELGYI  148 (164)
Q Consensus        73 ~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~  148 (164)
                      ....+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++.......    ....||+.||
T Consensus       121 ~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ym  197 (299)
T 4asz_A          121 PPTELTQSQMLHIAQQIAAGMVYLASQ---HFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM  197 (299)
T ss_dssp             CCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGC
T ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCccCHhhEEECCCCcEEECCcccceecCCCCceeecCceecChhhc
Confidence            123489999999999999999999998   999999999999999999999999999987654322    3356899999


Q ss_pred             CcceecCCcceeccCC
Q 046065          149 PPEYVGRGVYYKKFSL  164 (164)
Q Consensus       149 aPE~~~~~~~~~~~Di  164 (164)
                      |||++.++.|+.|+||
T Consensus       198 APE~~~~~~~~~k~DV  213 (299)
T 4asz_A          198 PPESIMYRKFTTESDV  213 (299)
T ss_dssp             CHHHHHHCCCCHHHHH
T ss_pred             CHHHHcCCCCCchhhH
Confidence            9999999999999996

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=9.2e-41  Score=236.29  Aligned_cols=156  Identities=26%  Similarity=0.335  Sum_probs=131.1

Q ss_pred             CCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEee----CCcEEEEEEecCCCChhhhhhCcccccc
Q 046065            4 PDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIE----TQEYMLIYEYMPKRSLDYFLFDPIRMLI   76 (164)
Q Consensus         4 ~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~   76 (164)
                      .+++.||+|.+...  .....+.+.+|+.+++.++||||+++ +.+..    ...+|+||||+++|+|.+++.+...   
T Consensus        49 ~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~~~---  125 (290)
T 3fpq_A           49 ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV---  125 (290)
T ss_dssp             TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHHSS---
T ss_pred             CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhcCC---
Confidence            56889999998654  33345678999999999999999998 55543    2347899999999999999976433   


Q ss_pred             cCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecC-CCCeEEccccchhhhhhhhhhhhcccccccCcceecC
Q 046065           77 LDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE-DLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGR  155 (164)
Q Consensus        77 ~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~-~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~  155 (164)
                      +++..+..++.|++.||.|||++ ..+|+||||||+|||++. ++.+||+|||+|+..........+||+.|||||++. 
T Consensus       126 l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~~~~~~~GTp~YmAPE~~~-  203 (290)
T 3fpq_A          126 MKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYE-  203 (290)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGG-
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCCccCCcccCccccCHHHcC-
Confidence            89999999999999999999988 123999999999999975 789999999999876555556788999999999986 


Q ss_pred             CcceeccCC
Q 046065          156 GVYYKKFSL  164 (164)
Q Consensus       156 ~~~~~~~Di  164 (164)
                      +.|+.++||
T Consensus       204 ~~y~~~~Di  212 (290)
T 3fpq_A          204 EKYDESVDV  212 (290)
T ss_dssp             TCCCTHHHH
T ss_pred             CCCCcHHHH
Confidence            569999996

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.1e-40  Score=239.96  Aligned_cols=158  Identities=27%  Similarity=0.457  Sum_probs=130.4

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccc---------
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIR---------   73 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---------   73 (164)
                      .+++.||||.+........+.|.+|+.+++.++||||+++ +.+.+.+..++||||+++|+|.+++.....         
T Consensus        69 ~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~  148 (329)
T 4aoj_A           69 QDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGE  148 (329)
T ss_dssp             --CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC--------
T ss_pred             CCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccc
Confidence            3578999999976666667789999999999999999997 888888889999999999999999875321         


Q ss_pred             ---ccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh----hhhhccccc
Q 046065           74 ---MLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI----LKQIQIELG  146 (164)
Q Consensus        74 ---~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~  146 (164)
                         ...+++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++......    .....||+.
T Consensus       149 ~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~  225 (329)
T 4aoj_A          149 DVAPGPLGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR  225 (329)
T ss_dssp             ---CCSCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC----------------CCCCGG
T ss_pred             cccCCCCCHHHHHHHHHHHHHHHHHHhcC---CeecccccHhhEEECCCCcEEEcccccceeccCCCcceecCccccccc
Confidence               23488999999999999999999998   99999999999999999999999999998664322    235679999


Q ss_pred             ccCcceecCCcceeccCC
Q 046065          147 YIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       147 ~~aPE~~~~~~~~~~~Di  164 (164)
                      |||||++.+..|+.++||
T Consensus       226 ymAPE~~~~~~~~~~sDv  243 (329)
T 4aoj_A          226 WMPPESILYRKFTTESDV  243 (329)
T ss_dssp             GCCHHHHTTCCCCHHHHH
T ss_pred             ccChhhhcCCCCCccccc
Confidence            999999999999999996

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.7e-40  Score=235.27  Aligned_cols=158  Identities=23%  Similarity=0.290  Sum_probs=126.4

Q ss_pred             CCCcEEEEEEccccc-cccHHHHHHHHHHHhccCCCceeeE-eEEeeCC------------cEEEEEEecCCCChhhhhh
Q 046065            4 PDGQIIAVKKLSKKS-TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQ------------EYMLIYEYMPKRSLDYFLF   69 (164)
Q Consensus         4 ~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~------------~~~lv~e~~~~~~L~~~~~   69 (164)
                      .+|+.||||.+.... ....+.+.+|+.+++.++||||+++ +.+...+            .+|+|||||++|+|.+++.
T Consensus        28 ~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~  107 (299)
T 4g31_A           28 VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMN  107 (299)
T ss_dssp             TTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHH
T ss_pred             CCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHH
Confidence            578999999987543 3345678899999999999999998 5554333            2689999999999999998


Q ss_pred             CcccccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh------------
Q 046065           70 DPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI------------  137 (164)
Q Consensus        70 ~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~------------  137 (164)
                      ........+...+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+|+.+....            
T Consensus       108 ~~~~~~~~~~~~~~~i~~qi~~al~ylH~~---~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~  184 (299)
T 4g31_A          108 GRCTIEERERSVCLHIFLQIAEAVEFLHSK---GLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY  184 (299)
T ss_dssp             TCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCCCC-------------------
T ss_pred             hcCCCChhHHHHHHHHHHHHHHHHHHHHHC---cCccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccc
Confidence            754433456677889999999999999998   99999999999999999999999999998764321            


Q ss_pred             --hhhhcccccccCcceecCCcceeccCC
Q 046065          138 --LKQIQIELGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       138 --~~~~~~~~~~~aPE~~~~~~~~~~~Di  164 (164)
                        ....+||+.|||||++.+..|+.++||
T Consensus       185 ~~~~~~~GT~~YmAPE~~~~~~y~~~~Di  213 (299)
T 4g31_A          185 ARHTGQVGTKLYMSPEQIHGNSYSHKVDI  213 (299)
T ss_dssp             -------CCCTTSCHHHHTTCCCCTHHHH
T ss_pred             cccCCcccCccccCHHHHcCCCCCCHHHH
Confidence              134579999999999999999999996

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2.5e-41  Score=240.34  Aligned_cols=154  Identities=23%  Similarity=0.235  Sum_probs=128.0

Q ss_pred             CCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            5 DGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         5 ~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      +++.||+|.+.+.  .......+.+|+.+++.++||||+++ +.+...+.+|+|||||++|+|.+++.+...   +++..
T Consensus        51 ~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~---l~e~~  127 (304)
T 3ubd_A           51 ARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVM---FTEED  127 (304)
T ss_dssp             TTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHHHCC---CCHHH
T ss_pred             CCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHhcCC---CCHHH
Confidence            5789999998754  22334567889999999999999998 777788899999999999999999876433   89999


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh--hhhhhcccccccCcceecCCcce
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM--ILKQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      +..++.|++.||.|+|++   +|+||||||+|||++.++.+||+|||+|+.....  .....+||+.|||||++.+..|+
T Consensus       128 ~~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~  204 (304)
T 3ubd_A          128 VKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHT  204 (304)
T ss_dssp             HHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTSCCC
T ss_pred             HHHHHHHHHHHHHHHHHC---CCcCCCCCHHHeEEcCCCCEEecccccceeccCCCccccccccCcccCCHHHhccCCCC
Confidence            999999999999999998   9999999999999999999999999999765432  23567899999999999999999


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      .++||
T Consensus       205 ~~~Di  209 (304)
T 3ubd_A          205 QSADW  209 (304)
T ss_dssp             THHHH
T ss_pred             CCCcc
Confidence            99996

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=4.8e-40  Score=230.93  Aligned_cols=155  Identities=27%  Similarity=0.433  Sum_probs=123.4

Q ss_pred             cCCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccC
Q 046065            3 LPDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILD   78 (164)
Q Consensus         3 ~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~   78 (164)
                      ..+|+.||+|.+.+.   .......+.+|+.+++.++||||+++ +.+...+.+|+||||+ +|+|.+.+.+...   ++
T Consensus        35 ~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~~~~---l~  110 (275)
T 3hyh_A           35 TTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDK---MS  110 (275)
T ss_dssp             TTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHHHSCS---CC
T ss_pred             CCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHHHcCC---CC
Confidence            357899999999755   23345678999999999999999998 7777778899999999 6799888865433   89


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh-hhhhhcccccccCcceecCCc
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM-ILKQIQIELGYIPPEYVGRGV  157 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~  157 (164)
                      +..+..++.|++.||.|+|++   +|+||||||+|||++.++.+||+|||+|+..... .....+||+.|||||++.+..
T Consensus       111 e~~~~~~~~qi~~al~ylH~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~~~~  187 (275)
T 3hyh_A          111 EQEARRFFQQIISAVEYCHRH---KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKL  187 (275)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTCCEEECCSSCC---------------CTTSCHHHHSSSS
T ss_pred             HHHHHHHHHHHHHHHHHHHHC---CcccccCChHHeEECCCCCEEEeecCCCeecCCCCccCCeeECcccCChhhhcCCC
Confidence            999999999999999999998   9999999999999999999999999999876543 335678999999999998888


Q ss_pred             c-eeccCC
Q 046065          158 Y-YKKFSL  164 (164)
Q Consensus       158 ~-~~~~Di  164 (164)
                      | +.++||
T Consensus       188 y~~~~~Di  195 (275)
T 3hyh_A          188 YAGPEVDV  195 (275)
T ss_dssp             CCCTHHHH
T ss_pred             CCCChhhh
Confidence            7 578885

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=3.8e-40  Score=235.20  Aligned_cols=158  Identities=30%  Similarity=0.451  Sum_probs=133.9

Q ss_pred             CCCcEEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcc---------
Q 046065            4 PDGQIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPI---------   72 (164)
Q Consensus         4 ~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---------   72 (164)
                      .+++.||||.+... .....+.|.+|+.+++.++||||+++ +.+...+..++||||+++|+|.+++....         
T Consensus        54 ~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~  133 (308)
T 4gt4_A           54 EQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTD  133 (308)
T ss_dssp             --CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC---
T ss_pred             CCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccc
Confidence            35688999999755 33445789999999999999999997 88888888999999999999999986421         


Q ss_pred             ----cccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh----hhhhccc
Q 046065           73 ----RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI----LKQIQIE  144 (164)
Q Consensus        73 ----~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~----~~~~~~~  144 (164)
                          ....+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++......    .....||
T Consensus       134 ~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt  210 (308)
T 4gt4_A          134 DDRTVKSALEPPDFVHLVAQIAAGMEYLSSH---HVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLP  210 (308)
T ss_dssp             --CCEECCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBC
T ss_pred             cccccccCCCHHHHHHHHHHHHHHHHHHHhC---CCCCCCccccceEECCCCCEEECCcccceeccCCCceeEecccccC
Confidence                123488999999999999999999998   99999999999999999999999999998764332    2446789


Q ss_pred             ccccCcceecCCcceeccCC
Q 046065          145 LGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       145 ~~~~aPE~~~~~~~~~~~Di  164 (164)
                      +.|||||++.++.|+.++||
T Consensus       211 ~~ymAPE~l~~~~~s~ksDV  230 (308)
T 4gt4_A          211 IRWMAPEAIMYGKFSIDSDI  230 (308)
T ss_dssp             GGGCCHHHHHHCCCCHHHHH
T ss_pred             CcccCHHHHhCCCCCccchh
Confidence            99999999999999999996

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=3.3e-40  Score=237.24  Aligned_cols=150  Identities=24%  Similarity=0.234  Sum_probs=129.1

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      .+|+.||||.+..+..     ..+|+.+++.++||||+++ +.+.+.+.+|+||||+++|+|.+++.+...   +++..+
T Consensus        81 ~~g~~vAiK~i~~~~~-----~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~---l~e~~~  152 (336)
T 4g3f_A           81 QTGFQCAVKKVRLEVF-----RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGC---LPEDRA  152 (336)
T ss_dssp             TTCCEEEEEEEETTTC-----CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSS---CCHHHH
T ss_pred             CCCCEEEEEEECHHHh-----HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHcCC---CCHHHH
Confidence            5789999999975422     2469999999999999998 777788889999999999999999976433   899999


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCC-CeEEccccchhhhhhhh-------hhhhcccccccCcceec
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL-KPKISDFGLARILRKMI-------LKQIQIELGYIPPEYVG  154 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~-~~~l~dfg~~~~~~~~~-------~~~~~~~~~~~aPE~~~  154 (164)
                      ..++.|++.||.|+|++   +|+||||||+|||++.++ .+||+|||+|+.+....       ....+||+.|||||++.
T Consensus       153 ~~~~~qi~~aL~ylH~~---~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~  229 (336)
T 4g3f_A          153 LYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVM  229 (336)
T ss_dssp             HHHHHHHHHHHHHHHTT---TEECSCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHT
T ss_pred             HHHHHHHHHHHHHHHHC---CceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHC
Confidence            99999999999999998   999999999999999987 69999999998764321       13357999999999999


Q ss_pred             CCcceeccCC
Q 046065          155 RGVYYKKFSL  164 (164)
Q Consensus       155 ~~~~~~~~Di  164 (164)
                      +..|+.++||
T Consensus       230 ~~~y~~~~Di  239 (336)
T 4g3f_A          230 GKPCDAKVDI  239 (336)
T ss_dssp             TCCCCTHHHH
T ss_pred             CCCCCcHHHH
Confidence            9999999996

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=2.6e-39  Score=230.42  Aligned_cols=153  Identities=27%  Similarity=0.379  Sum_probs=125.7

Q ss_pred             cEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeEeEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHHH
Q 046065            7 QIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVH   84 (164)
Q Consensus         7 ~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~   84 (164)
                      ..||||.++..  .+...+.+.+|+.+++.++||||+++..+...+.+++||||+++|+|.+++.....  .+++..+..
T Consensus        59 ~~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~iVmEy~~gGsL~~~l~~~~~--~l~~~~~~~  136 (307)
T 3omv_A           59 GDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQET--KFQMFQLID  136 (307)
T ss_dssp             SEEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECCSSCBHHHHHHTSCC--CCCHHHHHH
T ss_pred             CcEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECCeEEEEEEcCCCCCHHHHHhhcCC--CCCHHHHHH
Confidence            36999998644  34456789999999999999999998444456778999999999999999865332  388999999


Q ss_pred             HHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh----hhhhhhcccccccCcceecC---Cc
Q 046065           85 IIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK----MILKQIQIELGYIPPEYVGR---GV  157 (164)
Q Consensus        85 ~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~----~~~~~~~~~~~~~aPE~~~~---~~  157 (164)
                      ++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+|+....    ......+||+.|||||++.+   +.
T Consensus       137 i~~qia~gL~yLH~~---~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~  213 (307)
T 3omv_A          137 IARQTAQGMDYLHAK---NIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNP  213 (307)
T ss_dssp             HHHHHHHHHHHHHHT---TCBCSCCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCC
T ss_pred             HHHHHHHHHHHHHHC---CccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCC
Confidence            999999999999998   999999999999999999999999999976542    22355789999999999953   46


Q ss_pred             ceeccCC
Q 046065          158 YYKKFSL  164 (164)
Q Consensus       158 ~~~~~Di  164 (164)
                      |+.|+||
T Consensus       214 y~~ksDV  220 (307)
T 3omv_A          214 FSFQSDV  220 (307)
T ss_dssp             CCHHHHH
T ss_pred             CCcHHHh
Confidence            8999996

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=5.1e-38  Score=227.79  Aligned_cols=157  Identities=27%  Similarity=0.384  Sum_probs=131.7

Q ss_pred             CCcEEEEEEccccc-cccHHHHHHHHHHHhccCC-CceeeE-eEEeeC-CcEEEEEEecCCCChhhhhhCccc-------
Q 046065            5 DGQIIAVKKLSKKS-TQGFEEFKNEVMLTAKLQH-LNLIRV-GFCIET-QEYMLIYEYMPKRSLDYFLFDPIR-------   73 (164)
Q Consensus         5 ~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h-~~i~~~-~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~-------   73 (164)
                      +++.||||.+.... ....+.+.+|+.++..+.| |||+++ +.|... +.+++|||||++|+|.++++....       
T Consensus        93 ~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~  172 (353)
T 4ase_A           93 TCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKV  172 (353)
T ss_dssp             CEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC--
T ss_pred             CCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccc
Confidence            45789999987553 3345678999999999965 999997 777654 468999999999999999965321       


Q ss_pred             ------ccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh----hhhhcc
Q 046065           74 ------MLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI----LKQIQI  143 (164)
Q Consensus        74 ------~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~----~~~~~~  143 (164)
                            ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+|+.+....    ....+|
T Consensus       173 ~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~---~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~g  249 (353)
T 4ase_A          173 APEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL  249 (353)
T ss_dssp             -----CTTCBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEE
T ss_pred             cchhhccccCCHHHHHHHHHHHHHHHHhHhhC---CeecCccCccceeeCCCCCEEECcchhhhhcccCCCceeeccccc
Confidence                  23378899999999999999999998   99999999999999999999999999998664322    245678


Q ss_pred             cccccCcceecCCcceeccCC
Q 046065          144 ELGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       144 ~~~~~aPE~~~~~~~~~~~Di  164 (164)
                      |+.|||||++.++.|+.++||
T Consensus       250 t~~ymAPE~l~~~~y~~ksDV  270 (353)
T 4ase_A          250 PLKWMAPETIFDRVYTIQSDV  270 (353)
T ss_dssp             CGGGCCHHHHHHCCCCHHHHH
T ss_pred             cccccCHHHHhcCCCCCcccE
Confidence            999999999999999999996

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=2.6e-37  Score=220.50  Aligned_cols=155  Identities=23%  Similarity=0.255  Sum_probs=120.5

Q ss_pred             CCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCC----cEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            5 DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQ----EYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      +|+.||||.++.+... ......|+..+..++||||+++ +.+...+    .+++||||+++|+|.+++...    .+++
T Consensus        25 ~g~~VAvK~l~~~~~~-~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~----~l~~   99 (303)
T 3hmm_A           25 RGEEVAVKIFSSREER-SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TVTV   99 (303)
T ss_dssp             TTEEEEEEEECGGGHH-HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC----CBCH
T ss_pred             CCEEEEEEEECccchh-hHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHhC----CCCH
Confidence            5789999998654221 1122345556677899999997 6666543    478999999999999999653    2888


Q ss_pred             HHHHHHHHHHHHHHHHhhhc-----CCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh------hhhhccccccc
Q 046065           80 KKRVHIIKGIIQGLLYLQEY-----FRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI------LKQIQIELGYI  148 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~-----~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~------~~~~~~~~~~~  148 (164)
                      .....++.|++.||.|+|+.     +..+|+||||||+|||++.++.+||+|||+++......      ....+||+.||
T Consensus       100 ~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ym  179 (303)
T 3hmm_A          100 EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYM  179 (303)
T ss_dssp             HHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGC
T ss_pred             HHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeeccccccccccc
Confidence            99999999999999999975     24589999999999999999999999999997654321      23467999999


Q ss_pred             CcceecCC------cceeccCC
Q 046065          149 PPEYVGRG------VYYKKFSL  164 (164)
Q Consensus       149 aPE~~~~~------~~~~~~Di  164 (164)
                      |||++.+.      .|+.|+||
T Consensus       180 APE~l~~~~~~~~~~~~~k~DV  201 (303)
T 3hmm_A          180 APEVLDDSINMKHFESFKRADI  201 (303)
T ss_dssp             CHHHHTTCSCTTCHHHHHHHHH
T ss_pred             CHHHhcccccccCCccChhHhh
Confidence            99999654      57888886

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=8.5e-37  Score=234.78  Aligned_cols=156  Identities=26%  Similarity=0.255  Sum_probs=131.3

Q ss_pred             cCCCcEEEEEEcccc---ccccHHHHHH---HHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccccc
Q 046065            3 LPDGQIIAVKKLSKK---STQGFEEFKN---EVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRML   75 (164)
Q Consensus         3 ~~~~~~vavK~~~~~---~~~~~~~~~~---e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~   75 (164)
                      ..+|+.||+|.+.+.   ..........   ++.+++.++||||+++ ..+.....+|+||||+++|+|..++.+...  
T Consensus       211 ~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~~~--  288 (689)
T 3v5w_A          211 ADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV--  288 (689)
T ss_dssp             TTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCC--
T ss_pred             CCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHhcCC--
Confidence            357899999999754   1222233333   4567778899999998 666777889999999999999999976433  


Q ss_pred             ccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCcceecC
Q 046065           76 ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGR  155 (164)
Q Consensus        76 ~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~  155 (164)
                       +++..+..++.|++.||.|||++   +|+||||||+|||++.+|.+||+|||+|..+........+||+.|||||++.+
T Consensus       289 -l~E~~a~~y~~qIl~aL~yLH~~---gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~~~t~~GTp~YmAPEvl~~  364 (689)
T 3v5w_A          289 -FSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQK  364 (689)
T ss_dssp             -CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSCCCCSCCSCGGGCCHHHHST
T ss_pred             -CCHHHHHHHHHHHHHHHHHHHHC---CccccCCchHHeEEeCCCCEEecccceeeecCCCCCCCccCCcCccCHHHHhC
Confidence             89999999999999999999998   99999999999999999999999999998776666667899999999999965


Q ss_pred             -CcceeccCC
Q 046065          156 -GVYYKKFSL  164 (164)
Q Consensus       156 -~~~~~~~Di  164 (164)
                       ..|+.++|+
T Consensus       365 ~~~y~~~vDi  374 (689)
T 3v5w_A          365 GVAYDSSADW  374 (689)
T ss_dssp             TCCCCTHHHH
T ss_pred             CCCCCcHHHH
Confidence             478999885

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.5e-36  Score=221.34  Aligned_cols=155  Identities=25%  Similarity=0.371  Sum_probs=127.6

Q ss_pred             cCCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEee------CCcEEEEEEecCCCChhhhhhCccc
Q 046065            3 LPDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIE------TQEYMLIYEYMPKRSLDYFLFDPIR   73 (164)
Q Consensus         3 ~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~------~~~~~lv~e~~~~~~L~~~~~~~~~   73 (164)
                      ..+|+.||||.+...  .......+.+|+.+|+.++||||+++ +.+..      .+..|+||||++ |+|.+++.....
T Consensus        76 ~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~~~~  154 (398)
T 4b99_A           76 RLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIHSSQP  154 (398)
T ss_dssp             TTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHHTSSSC
T ss_pred             CCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHHHHHHhcCC
Confidence            357899999999754  23345678899999999999999998 43332      246899999996 679888876443


Q ss_pred             ccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh------hhhhhcccccc
Q 046065           74 MLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM------ILKQIQIELGY  147 (164)
Q Consensus        74 ~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~------~~~~~~~~~~~  147 (164)
                         +++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++.+...      .....+||+.|
T Consensus       155 ---l~~~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y  228 (398)
T 4b99_A          155 ---LTLEHVRYFLYQLLRGLKYMHSA---QVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWY  228 (398)
T ss_dssp             ---CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTT
T ss_pred             ---CCHHHHHHHHHHHHHHHHHHHHC---cCcCCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHh
Confidence               89999999999999999999998   9999999999999999999999999999766432      22457899999


Q ss_pred             cCcceecCCc-ceeccCC
Q 046065          148 IPPEYVGRGV-YYKKFSL  164 (164)
Q Consensus       148 ~aPE~~~~~~-~~~~~Di  164 (164)
                      ||||++.+.. |+.++||
T Consensus       229 ~APEv~~~~~~~~~~~Di  246 (398)
T 4b99_A          229 RAPELMLSLHEYTQAIDL  246 (398)
T ss_dssp             CCHHHHTTCSCCCTHHHH
T ss_pred             cCHHHhcCCCCCCChhhe
Confidence            9999987654 5888885

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=4.7e-36  Score=229.66  Aligned_cols=156  Identities=22%  Similarity=0.278  Sum_probs=135.7

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      .+|+.||+|.+........+.+.+|+.+|+.++||||+++ +.+.....+++||||+++|+|.+++.....  .+++..+
T Consensus       180 ~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~--~l~e~~~  257 (573)
T 3uto_A          180 ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN--KMSEDEA  257 (573)
T ss_dssp             TTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCTTS--CEEHHHH
T ss_pred             CCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHhCC--CCCHHHH
Confidence            5789999999976655556778899999999999999998 777777889999999999999988864322  2889999


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCC--CCeEEccccchhhhhhh-hhhhhcccccccCcceecCCcce
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED--LKPKISDFGLARILRKM-ILKQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~--~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      ..++.|++.||.|||++   +|+||||||+|||++.+  +.+||+|||+++.+... .....+||+.|||||++.+..|+
T Consensus       258 ~~~~~qi~~al~ylH~~---~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~~~~y~  334 (573)
T 3uto_A          258 VEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVG  334 (573)
T ss_dssp             HHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHHTTCCBC
T ss_pred             HHHHHHHHHHHHHHHHC---CeeeccCChhhccccCCCCCCEEEeeccceeEccCCCceeeeEECccccCHHHhCCCCCC
Confidence            99999999999999998   99999999999999854  88999999999876543 33567899999999999999999


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      .++||
T Consensus       335 ~~~Di  339 (573)
T 3uto_A          335 YYTDM  339 (573)
T ss_dssp             HHHHH
T ss_pred             cHHHH
Confidence            99985

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=4.6e-35  Score=213.21  Aligned_cols=150  Identities=20%  Similarity=0.237  Sum_probs=124.6

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      .+++.||+|.+....  ....+.+|+.+++.+ +||||+++ ..+...+.+++||||+++++|.+++..      +++..
T Consensus        47 ~~~~~vAiK~i~~~~--~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~~------l~~~~  118 (361)
T 4f9c_A           47 GPEEKIALKHLIPTS--HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILNS------LSFQE  118 (361)
T ss_dssp             SCEEEEEEEEECTTS--CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHTT------CCHHH
T ss_pred             CCCCEEEEEEEcccc--CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHcC------CCHHH
Confidence            457899999985442  335678899999988 69999998 777777889999999999999998843      88999


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCC-CCeEEccccchhhhhhh------------------------
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED-LKPKISDFGLARILRKM------------------------  136 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~-~~~~l~dfg~~~~~~~~------------------------  136 (164)
                      +..++.|++.||.|+|++   +|+||||||+|||++.+ +.+||+|||+|+.....                        
T Consensus       119 ~~~~~~qll~al~ylH~~---gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (361)
T 4f9c_A          119 VREYMLNLFKALKRIHQF---GIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSI  195 (361)
T ss_dssp             HHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC----------------
T ss_pred             HHHHHHHHHHHHHHHHHC---CeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCccccccccccccccccccccccccc
Confidence            999999999999999998   99999999999999876 79999999999643211                        


Q ss_pred             ------hhhhhcccccccCcceecCC-cceeccCC
Q 046065          137 ------ILKQIQIELGYIPPEYVGRG-VYYKKFSL  164 (164)
Q Consensus       137 ------~~~~~~~~~~~~aPE~~~~~-~~~~~~Di  164 (164)
                            .....+||++|+|||++.+. .|+.++||
T Consensus       196 ~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~Di  230 (361)
T 4f9c_A          196 CLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDM  230 (361)
T ss_dssp             ----------CCCCGGGCCHHHHTTCSCCCTHHHH
T ss_pred             cccccccccccccCccccCHHHHcCCCCCCCccch
Confidence                  11335799999999999765 47888885

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=6.1e-33  Score=199.99  Aligned_cols=155  Identities=25%  Similarity=0.386  Sum_probs=133.7

Q ss_pred             CCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            4 PDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         4 ~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      .+|+.||+|.+...  .+...+.+.+|+.+++.++||||+++ +.+...+..++|||++++++|.+++.....   +++.
T Consensus        38 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---l~~~  114 (328)
T 3fe3_A           38 LTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGR---MKEK  114 (328)
T ss_dssp             TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHCC---CCHH
T ss_pred             CCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHcCC---CCHH
Confidence            57899999998654  33445678899999999999999998 777777889999999999999998865433   8899


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh-hhhhhhcccccccCcceecCCcce
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK-MILKQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      ....++.|++.|+.|+|++   +++||||||+||+++.++.+||+|||++..... ......+||+.|+|||++.+..++
T Consensus       115 ~~~~~~~qi~~al~~lH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  191 (328)
T 3fe3_A          115 EARSKFRQIVSAVQYCHQK---RIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYD  191 (328)
T ss_dssp             HHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCC
T ss_pred             HHHHHHHHHHHHHHHHHHC---CEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCccccccCCcceeCcccccCCCcC
Confidence            9999999999999999998   999999999999999999999999999976543 234567899999999999888774


Q ss_pred             -eccCC
Q 046065          160 -KKFSL  164 (164)
Q Consensus       160 -~~~Di  164 (164)
                       .++||
T Consensus       192 ~~~~Di  197 (328)
T 3fe3_A          192 GPEVDV  197 (328)
T ss_dssp             SHHHHH
T ss_pred             Cchhhh
Confidence             78875

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=1e-32  Score=196.31  Aligned_cols=155  Identities=23%  Similarity=0.366  Sum_probs=135.7

Q ss_pred             cCCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            3 LPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      ..+++.||+|.+........+.+.+|+.+++.++||||+++ +.+...+..++|||++++++|.+++...    .+++..
T Consensus        42 ~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~  117 (297)
T 3fxz_A           42 VATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET----CMDEGQ  117 (297)
T ss_dssp             TTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHS----CCCHHH
T ss_pred             CCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhhc----CCCHHH
Confidence            35788999999876655566778999999999999999997 7777888899999999999999988653    288899


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh--hhhhcccccccCcceecCCcce
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI--LKQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      ...++.|++.|+.|+|+.   +++|+||||+||+++.++.++|+|||++.......  .....||+.|+|||++.+..++
T Consensus       118 ~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  194 (297)
T 3fxz_A          118 IAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG  194 (297)
T ss_dssp             HHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCSCBC
T ss_pred             HHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCCccCCcCccChhhhcCCCCC
Confidence            999999999999999998   99999999999999999999999999987654322  2456799999999999999999


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      .++||
T Consensus       195 ~~~Di  199 (297)
T 3fxz_A          195 PKVDI  199 (297)
T ss_dssp             THHHH
T ss_pred             cHHHH
Confidence            99985

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.7e-32  Score=195.96  Aligned_cols=156  Identities=26%  Similarity=0.400  Sum_probs=134.3

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      .+++.||+|.+........+.+.+|+.+++.++||||+++ +.+...+..++|||++++++|.+++....  ..+++...
T Consensus        33 ~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~  110 (310)
T 3s95_A           33 ETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMD--SQYPWSQR  110 (310)
T ss_dssp             TTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCC--TTSCHHHH
T ss_pred             CCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhcc--CCCCHHHH
Confidence            4688999999866556667788999999999999999997 77778888999999999999999987532  23889999


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh----------------hhhccccc
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL----------------KQIQIELG  146 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~----------------~~~~~~~~  146 (164)
                      ..++.|++.||.|+|+.   +++|+||||+||+++.++.++|+|||++........                ....||+.
T Consensus       111 ~~i~~qi~~al~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  187 (310)
T 3s95_A          111 VSFAKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY  187 (310)
T ss_dssp             HHHHHHHHHHHHHHHHT---TEECSCCSTTSEEECTTSCEEECCCTTCEECC--------------------CCCCSCGG
T ss_pred             HHHHHHHHHHHHHHHhC---CccCCCCCcCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcc
Confidence            99999999999999998   999999999999999999999999999976532211                14578999


Q ss_pred             ccCcceecCCcceeccCC
Q 046065          147 YIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       147 ~~aPE~~~~~~~~~~~Di  164 (164)
                      |+|||++.+..++.++||
T Consensus       188 y~aPE~~~~~~~~~~~Di  205 (310)
T 3s95_A          188 WMAPEMINGRSYDEKVDV  205 (310)
T ss_dssp             GCCHHHHTTCCCCTHHHH
T ss_pred             eeCHHHhcCCCCCcHHHH
Confidence            999999999999999985

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.3e-32  Score=198.85  Aligned_cols=155  Identities=22%  Similarity=0.279  Sum_probs=133.5

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+|+.||+|.+.+.   .......+..|+.+++.++||||+++ ..+...+..++||||+++|+|..++.....   +++
T Consensus        28 ~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~---~~~  104 (337)
T 1o6l_A           28 ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV---FTE  104 (337)
T ss_dssp             TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSC---CCH
T ss_pred             CCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCC---CCH
Confidence            46899999998754   23455678899999999999999998 666677789999999999999988865432   889


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh--hhhhhhcccccccCcceecCCc
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK--MILKQIQIELGYIPPEYVGRGV  157 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~  157 (164)
                      .....++.|++.||.|||++   +|+||||||+||+++.++.++|+|||++.....  ......+||+.|+|||++.+..
T Consensus       105 ~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  181 (337)
T 1o6l_A          105 ERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND  181 (337)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSC
T ss_pred             HHHHHHHHHHHHHHHHHHHC---CeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCcccccccChhhCChhhhcCCC
Confidence            99999999999999999998   999999999999999999999999999875432  2335678999999999999889


Q ss_pred             ceeccCC
Q 046065          158 YYKKFSL  164 (164)
Q Consensus       158 ~~~~~Di  164 (164)
                      ++.++||
T Consensus       182 ~~~~~Di  188 (337)
T 1o6l_A          182 YGRAVDW  188 (337)
T ss_dssp             BCTTHHH
T ss_pred             CCchhhc
Confidence            9999885

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=2.3e-33  Score=214.78  Aligned_cols=149  Identities=17%  Similarity=0.143  Sum_probs=118.6

Q ss_pred             CCcEEEEEEccccc----------cccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcc
Q 046065            5 DGQIIAVKKLSKKS----------TQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPI   72 (164)
Q Consensus         5 ~~~~vavK~~~~~~----------~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~   72 (164)
                      .|+.+|+|.+.++.          ....+.+.+|+++|+.+ .|+||+++ .+.++.+.+||||||++|++|.+.+....
T Consensus       258 fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~  337 (569)
T 4azs_A          258 FGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGE  337 (569)
T ss_dssp             ECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTC
T ss_pred             ccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCC
Confidence            57889999986541          23346789999999999 69999997 77777889999999999999999998754


Q ss_pred             cccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh--hhhhhcccccccCc
Q 046065           73 RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM--ILKQIQIELGYIPP  150 (164)
Q Consensus        73 ~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aP  150 (164)
                      .   ++.   .+++.|++.||.|+|++   +|+||||||+|||++.++.+||+|||+++.....  .....+||+.||||
T Consensus       338 ~---l~~---~~I~~QIl~AL~ylH~~---GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAP  408 (569)
T 4azs_A          338 E---IDR---EKILGSLLRSLAALEKQ---GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVN  408 (569)
T ss_dssp             C---CCH---HHHHHHHHHHHHHHHHT---TCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCSHHHHHHHHHHHH
T ss_pred             C---CCH---HHHHHHHHHHHHHHHHC---CceeccCchHhEEECCCCCEEEeecccCeeCCCCCccccCceechhhccH
Confidence            3   444   35789999999999999   9999999999999999999999999999876543  23567899999999


Q ss_pred             ceecCCcceeccC
Q 046065          151 EYVGRGVYYKKFS  163 (164)
Q Consensus       151 E~~~~~~~~~~~D  163 (164)
                      |++.+ .+..++|
T Consensus       409 E~l~g-~~~~~~d  420 (569)
T 4azs_A          409 ELFAE-NKSWNGF  420 (569)
T ss_dssp             HHC----------
T ss_pred             HHhCC-CCCCccc
Confidence            99964 4555555

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.98  E-value=6.3e-32  Score=194.15  Aligned_cols=158  Identities=24%  Similarity=0.285  Sum_probs=130.6

Q ss_pred             CCCcEEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCC-------------------------------
Q 046065            4 PDGQIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQ-------------------------------   50 (164)
Q Consensus         4 ~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~-------------------------------   50 (164)
                      .+++.||||.+... .+...+.+.+|+.+++.++||||+++ +.+....                               
T Consensus        29 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  108 (332)
T 3qd2_B           29 VDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAP  108 (332)
T ss_dssp             TTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC---------------------
T ss_pred             CCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCCccccc
Confidence            47889999998754 33345778999999999999999997 5554332                               


Q ss_pred             --------------------------cEEEEEEecCCCChhhhhhCcccccccCHHHHHHHHHHHHHHHHHhhhcCCCCe
Q 046065           51 --------------------------EYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTI  104 (164)
Q Consensus        51 --------------------------~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~i  104 (164)
                                                ..++|||++++++|.+++.........+......++.|++.||.|||+.   ++
T Consensus       109 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~i  185 (332)
T 3qd2_B          109 SVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSK---GL  185 (332)
T ss_dssp             -----------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHT---TE
T ss_pred             ccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhC---Ce
Confidence                                      2789999999999999998765544466677889999999999999998   99


Q ss_pred             eeCCCCCCceeecCCCCeEEccccchhhhhhhh--------------hhhhcccccccCcceecCCcceeccCC
Q 046065          105 IHRDLKVSNILLDEDLKPKISDFGLARILRKMI--------------LKQIQIELGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       105 ih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~--------------~~~~~~~~~~~aPE~~~~~~~~~~~Di  164 (164)
                      +|+||||+||+++.++.++|+|||++.......              .....||+.|+|||++.+..++.++||
T Consensus       186 vH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di  259 (332)
T 3qd2_B          186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDI  259 (332)
T ss_dssp             ECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHH
T ss_pred             eecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhH
Confidence            999999999999999999999999987654321              133568999999999998899999985

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=99.98  E-value=3.8e-32  Score=195.10  Aligned_cols=154  Identities=29%  Similarity=0.397  Sum_probs=133.2

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+|+.||+|.+.+.   .....+.+..|..+++.++||||+++ +.+......++|||++++++|.+++.....   +++
T Consensus        29 ~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~---~~~  105 (318)
T 1fot_A           29 HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQR---FPN  105 (318)
T ss_dssp             TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSS---CCH
T ss_pred             CCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHHcCC---CCH
Confidence            47899999998754   23345677889999999999999998 666777789999999999999999875433   889


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCcceecCCcce
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      .....++.|++.||.|||++   +++||||||+||+++.++.++|+|||++..... .....+||+.|+|||++.+..++
T Consensus       106 ~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~-~~~~~~gt~~y~aPE~~~~~~~~  181 (318)
T 1fot_A          106 PVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-VTYTLCGTPDYIAPEVVSTKPYN  181 (318)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSS-CBCCCCSCTTTCCHHHHTTCCBC
T ss_pred             HHHHHHHHHHHHHHHHHHHC---CccccCCChheEEEcCCCCEEEeecCcceecCC-ccccccCCccccCHhHhcCCCCC
Confidence            99999999999999999998   999999999999999999999999999976543 23456899999999999988999


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      .++||
T Consensus       182 ~~~Di  186 (318)
T 1fot_A          182 KSIDW  186 (318)
T ss_dssp             TTHHH
T ss_pred             cccch
Confidence            99885

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.98  E-value=6.6e-32  Score=194.02  Aligned_cols=154  Identities=26%  Similarity=0.415  Sum_probs=135.4

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      .+|+.||||.+........+.+.+|+.+++.++||||+++ +.+...+..++|||++++++|.+++...    .+++..+
T Consensus        68 ~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~l~~~~~  143 (321)
T 2c30_A           68 HSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV----RLNEEQI  143 (321)
T ss_dssp             TTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTC----CCCHHHH
T ss_pred             CCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhc----CCCHHHH
Confidence            4789999999876666666778999999999999999997 7777888899999999999999988653    2889999


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh--hhhhhcccccccCcceecCCccee
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM--ILKQIQIELGYIPPEYVGRGVYYK  160 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~  160 (164)
                      ..++.|++.||.|+|+.   +++|+||||+||+++.++.++|+|||++......  ......||+.|+|||++.+..++.
T Consensus       144 ~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  220 (321)
T 2c30_A          144 ATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYAT  220 (321)
T ss_dssp             HHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCT
T ss_pred             HHHHHHHHHHHHHHHHC---CeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCc
Confidence            99999999999999998   9999999999999999999999999998765432  224567999999999999889999


Q ss_pred             ccCC
Q 046065          161 KFSL  164 (164)
Q Consensus       161 ~~Di  164 (164)
                      ++||
T Consensus       221 ~~Dv  224 (321)
T 2c30_A          221 EVDI  224 (321)
T ss_dssp             HHHH
T ss_pred             hhhH
Confidence            9885

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=99.97  E-value=1.6e-32  Score=199.56  Aligned_cols=155  Identities=24%  Similarity=0.331  Sum_probs=128.5

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccC
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILD   78 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~   78 (164)
                      .+++.||+|.+.+.   .......+..|..++..+ +||||+++ ..+......++||||+++|+|..++.....   ++
T Consensus        46 ~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~---~~  122 (353)
T 3txo_A           46 ETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRR---FD  122 (353)
T ss_dssp             TTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSS---CC
T ss_pred             CCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCC---CC
Confidence            56889999998754   233456678899999988 79999998 666667789999999999999988865433   88


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhh--hhhhhhhcccccccCcceecCC
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILR--KMILKQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~--~~~~~~~~~~~~~~aPE~~~~~  156 (164)
                      +..+..++.|++.||.|||++   +|+||||||+|||++.++.++|+|||++....  .......+||+.|+|||++.+.
T Consensus       123 ~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~  199 (353)
T 3txo_A          123 EARARFYAAEIISALMFLHDK---GIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEM  199 (353)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---------CCGGGCCHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHHC---CCcccCCCHHHEEECCCCCEEEccccceeecccCCccccccCCCcCeEChhhcCCC
Confidence            999999999999999999998   99999999999999999999999999987533  2233567899999999999888


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .|+.++||
T Consensus       200 ~~~~~~Di  207 (353)
T 3txo_A          200 LYGPAVDW  207 (353)
T ss_dssp             HCTTHHHH
T ss_pred             CcCCccCC
Confidence            89998885

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=99.97  E-value=8.3e-32  Score=196.33  Aligned_cols=155  Identities=28%  Similarity=0.335  Sum_probs=133.0

Q ss_pred             CCCcEEEEEEcccccc------ccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccc
Q 046065            4 PDGQIIAVKKLSKKST------QGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLI   76 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~   76 (164)
                      .+|+.||+|.+.....      ...+.+.+|+.+++.++||||+++ +.+......++|||++++++|.+++.....   
T Consensus        35 ~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~---  111 (361)
T 2yab_A           35 STGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKES---  111 (361)
T ss_dssp             TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTCSC---
T ss_pred             CCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHhcCC---
Confidence            4689999999875522      134678899999999999999998 666777789999999999999999876433   


Q ss_pred             cCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCC----CeEEccccchhhhhhh-hhhhhcccccccCcc
Q 046065           77 LDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL----KPKISDFGLARILRKM-ILKQIQIELGYIPPE  151 (164)
Q Consensus        77 ~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~----~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE  151 (164)
                      +++..+..++.|++.|+.|||+.   +++|+||||+||+++.++    .++|+|||++...... .....+||+.|+|||
T Consensus       112 l~~~~~~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE  188 (361)
T 2yab_A          112 LSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE  188 (361)
T ss_dssp             CBHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTCCCCCCCSCGGGCCHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCCccccCCCCccEECch
Confidence            88999999999999999999998   999999999999998776    7999999999766543 235577999999999


Q ss_pred             eecCCcceeccCC
Q 046065          152 YVGRGVYYKKFSL  164 (164)
Q Consensus       152 ~~~~~~~~~~~Di  164 (164)
                      ++.+..++.++||
T Consensus       189 ~~~~~~~~~~~Di  201 (361)
T 2yab_A          189 IVNYEPLGLEADM  201 (361)
T ss_dssp             HHTTCCCCTHHHH
T ss_pred             HHcCCCCCccccH
Confidence            9988899999885

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.97  E-value=4e-32  Score=197.29  Aligned_cols=154  Identities=21%  Similarity=0.244  Sum_probs=133.4

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+|+.||+|.+...   .......+..|+.+++.++||||+++ ..+......++|||++++++|.+++.....   +++
T Consensus        64 ~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~---~~~  140 (350)
T 1rdq_E           64 ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---FSE  140 (350)
T ss_dssp             TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCC---CCH
T ss_pred             CCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCC---CCH
Confidence            46889999998654   23455678899999999999999998 666667789999999999999999875433   889


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCcceecCCcce
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      .....++.|++.||.|||++   +|+||||||+||+++.++.++|+|||++...... ....+||+.|+|||++.+..++
T Consensus       141 ~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~  216 (350)
T 1rdq_E          141 PHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-TWTLCGTPEALAPEIILSKGYN  216 (350)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-BCCCEECGGGCCHHHHTTCCBC
T ss_pred             HHHHHHHHHHHHHHHHHHHC---CcccccCccceEEECCCCCEEEcccccceeccCC-cccccCCccccCHHHhcCCCCC
Confidence            99999999999999999998   9999999999999999999999999999765432 3456899999999999988999


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      .++||
T Consensus       217 ~~~Di  221 (350)
T 1rdq_E          217 KAVDW  221 (350)
T ss_dssp             THHHH
T ss_pred             CcCCE
Confidence            99885

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=99.97  E-value=2.9e-32  Score=200.73  Aligned_cols=155  Identities=21%  Similarity=0.275  Sum_probs=130.8

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccC
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILD   78 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~   78 (164)
                      .+++.||+|.+.+.   .......+..|..++..+ +||||+++ ..+......++||||+++|+|..++.....   ++
T Consensus        75 ~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~---l~  151 (396)
T 4dc2_A           75 KTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK---LP  151 (396)
T ss_dssp             TTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSS---CC
T ss_pred             CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHHcCC---CC
Confidence            46889999998755   233345678899998887 89999998 666677789999999999999988875433   89


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhh--hhhhhhhcccccccCcceecCC
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILR--KMILKQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~--~~~~~~~~~~~~~~aPE~~~~~  156 (164)
                      +..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++...  .......+||+.|+|||++.+.
T Consensus       152 ~~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~  228 (396)
T 4dc2_A          152 EEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE  228 (396)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTC
T ss_pred             HHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEECCCCCEEEeecceeeecccCCCccccccCCcccCCchhhcCC
Confidence            999999999999999999998   99999999999999999999999999997532  2334567899999999999999


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .|+.++|+
T Consensus       229 ~~~~~~Di  236 (396)
T 4dc2_A          229 DYGFSVDW  236 (396)
T ss_dssp             CBCTHHHH
T ss_pred             CCChHHHH
Confidence            99999885

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.97  E-value=4.7e-32  Score=193.90  Aligned_cols=157  Identities=27%  Similarity=0.440  Sum_probs=125.6

Q ss_pred             CCcEEEEEEccccc--cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            5 DGQIIAVKKLSKKS--TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         5 ~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      +++.||+|.+....  ....+.+.+|+.+++.++||||+++ +.+...+..++|||++++++|.+++........+++..
T Consensus        59 ~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~  138 (309)
T 3p86_A           59 HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERR  138 (309)
T ss_dssp             TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHH
T ss_pred             CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHH
Confidence            57889999986552  3344678899999999999999998 77777778999999999999999997654434488999


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCC--eeeCCCCCCceeecCCCCeEEccccchhhhhhhh--hhhhcccccccCcceecCCc
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLT--IIHRDLKVSNILLDEDLKPKISDFGLARILRKMI--LKQIQIELGYIPPEYVGRGV  157 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~--iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~  157 (164)
                      ...++.|++.||.|||+.   +  ++|+||||+||+++.++.++|+|||++.......  .....||+.|+|||++.+..
T Consensus       139 ~~~i~~qi~~aL~~LH~~---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  215 (309)
T 3p86_A          139 RLSMAYDVAKGMNYLHNR---NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEP  215 (309)
T ss_dssp             HHHHHHHHHHHHHHHHTS---SSCCCCTTCCGGGEEECTTCCEEECCCC-----------------CCTTSCHHHHTTCC
T ss_pred             HHHHHHHHHHHHHHHHcC---CCCEECCCCChhhEEEeCCCcEEECCCCCCccccccccccccCCCCccccChhhhcCCC
Confidence            999999999999999998   7  9999999999999999999999999997654332  24567899999999999888


Q ss_pred             ceeccCC
Q 046065          158 YYKKFSL  164 (164)
Q Consensus       158 ~~~~~Di  164 (164)
                      ++.++||
T Consensus       216 ~~~~~Di  222 (309)
T 3p86_A          216 SNEKSDV  222 (309)
T ss_dssp             CCTTHHH
T ss_pred             CCchhhH
Confidence            9999985

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.97  E-value=7.7e-32  Score=196.60  Aligned_cols=155  Identities=26%  Similarity=0.387  Sum_probs=132.2

Q ss_pred             CCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            4 PDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         4 ~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      .+++.||+|.+...  .....+.+.+|+.+++.++||||+++ +.+...+..++|||++++++|.+.+.....   +++.
T Consensus        52 ~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~---~~~~  128 (362)
T 2bdw_A           52 TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF---YSEA  128 (362)
T ss_dssp             TTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCSC---CCHH
T ss_pred             CCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcCC---CCHH
Confidence            46889999998754  23345678899999999999999998 777777889999999999999888865432   8899


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCC---CCeEEccccchhhhhhh-hhhhhcccccccCcceecCC
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED---LKPKISDFGLARILRKM-ILKQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~---~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~~~  156 (164)
                      .+..++.|++.||.|||+.   +|+|+||||+||+++..   +.+||+|||++...... ......||+.|+|||++.+.
T Consensus       129 ~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~  205 (362)
T 2bdw_A          129 DASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKD  205 (362)
T ss_dssp             HHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTTC
T ss_pred             HHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcccccCCCCccccCHHHHccC
Confidence            9999999999999999998   99999999999999865   45999999999766533 23456899999999999988


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .++.++||
T Consensus       206 ~~~~~~Di  213 (362)
T 2bdw_A          206 PYSKPVDI  213 (362)
T ss_dssp             CCCTHHHH
T ss_pred             CCCchhhH
Confidence            99999985

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=99.97  E-value=7.3e-32  Score=197.91  Aligned_cols=155  Identities=23%  Similarity=0.355  Sum_probs=132.8

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+++.||+|.+...   .......+.+|+.+++.++||||+++ ..+......++|||++++|+|..++.....   +++
T Consensus        38 ~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~---l~~  114 (384)
T 4fr4_A           38 DTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVH---FKE  114 (384)
T ss_dssp             TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHTTCC---CCH
T ss_pred             CCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHhcCC---CCH
Confidence            46789999998654   23445678899999999999999998 667777889999999999999999876433   889


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh-hhhhhcccccccCcceecC---
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM-ILKQIQIELGYIPPEYVGR---  155 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~~---  155 (164)
                      ..+..++.|++.||.|||+.   +|+||||||+||+++.++.++|+|||++...... .....+||+.|+|||++..   
T Consensus       115 ~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~  191 (384)
T 4fr4_A          115 ETVKLFICELVMALDYLQNQ---RIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKG  191 (384)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSS
T ss_pred             HHHHHHHHHHHHHHHHHHHC---CceeccCcHHHeEECCCCCEEEeccceeeeccCCCceeccCCCccccCCeeeccCCC
Confidence            99999999999999999998   9999999999999999999999999999766433 3356789999999999963   


Q ss_pred             CcceeccCC
Q 046065          156 GVYYKKFSL  164 (164)
Q Consensus       156 ~~~~~~~Di  164 (164)
                      ..|+.++||
T Consensus       192 ~~~~~~~Di  200 (384)
T 4fr4_A          192 AGYSFAVDW  200 (384)
T ss_dssp             CCBCTTHHH
T ss_pred             CCCCcccee
Confidence            357888885

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.97  E-value=9e-32  Score=191.12  Aligned_cols=155  Identities=23%  Similarity=0.368  Sum_probs=128.1

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+++.||+|.+...   .......+.+|+.+++.++||||+++ +.+...+..++|||++++++|.+++.....   ++.
T Consensus        34 ~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~---~~~  110 (294)
T 4eqm_A           34 ILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSV  110 (294)
T ss_dssp             TTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCS---CCH
T ss_pred             CCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhcCC---CCH
Confidence            46889999998544   22335678899999999999999998 666777789999999999999999875433   889


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh---hhhhcccccccCcceecCC
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI---LKQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~aPE~~~~~  156 (164)
                      .....++.|++.|+.|+|++   +++|+||||+||+++.++.++|+|||++.......   .....||+.|+|||.+.+.
T Consensus       111 ~~~~~~~~qi~~~l~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  187 (294)
T 4eqm_A          111 DTAINFTNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGE  187 (294)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCSSSTTC-------------CCSSCCHHHHHTC
T ss_pred             HHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCCEEEEeCCCccccccccccccCccccCccccCHhHhcCC
Confidence            99999999999999999998   99999999999999999999999999997664322   2446799999999999988


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .++.++||
T Consensus       188 ~~~~~~Di  195 (294)
T 4eqm_A          188 ATDECTDI  195 (294)
T ss_dssp             CCCTTHHH
T ss_pred             CCCchHhH
Confidence            89999885

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.97  E-value=3.7e-32  Score=202.41  Aligned_cols=156  Identities=19%  Similarity=0.187  Sum_probs=131.0

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+++.||+|.+.+.   .......+..|..++..++||||+++ ..+......++||||+++|+|.+++....  ..+++
T Consensus        97 ~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~--~~l~e  174 (437)
T 4aw2_A           97 NADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFE--DRLPE  174 (437)
T ss_dssp             TTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTT--TCCCH
T ss_pred             CCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHcc--CCCCH
Confidence            45789999998653   22233457889999999999999998 66777788999999999999999997632  22899


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh---hhhhcccccccCcceec--
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI---LKQIQIELGYIPPEYVG--  154 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~aPE~~~--  154 (164)
                      .....++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++.......   ....+||+.|+|||++.  
T Consensus       175 ~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~  251 (437)
T 4aw2_A          175 EMARFYLAEMVIAIDSVHQL---HYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAM  251 (437)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhC---CeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhc
Confidence            99999999999999999998   99999999999999999999999999997654322   23468999999999996  


Q ss_pred             ---CCcceeccCC
Q 046065          155 ---RGVYYKKFSL  164 (164)
Q Consensus       155 ---~~~~~~~~Di  164 (164)
                         ...|+.++||
T Consensus       252 ~~~~~~~~~~~Dv  264 (437)
T 4aw2_A          252 EGGKGRYGPECDW  264 (437)
T ss_dssp             HTSCCEECTHHHH
T ss_pred             ccCCCCCCCcCee
Confidence               5678988885

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=99.97  E-value=6.6e-32  Score=195.80  Aligned_cols=155  Identities=22%  Similarity=0.271  Sum_probs=132.1

Q ss_pred             CCCcEEEEEEccccc---cccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccC
Q 046065            4 PDGQIIAVKKLSKKS---TQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILD   78 (164)
Q Consensus         4 ~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~   78 (164)
                      .+++.||+|.+.+..   ......+..|..++..+ +||||+++ ..+......++|||++++++|..++.....   ++
T Consensus        32 ~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~---l~  108 (345)
T 3a8x_A           32 KTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRK---LP  108 (345)
T ss_dssp             TTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSS---CC
T ss_pred             CCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCC---CC
Confidence            468899999987552   23345678899999888 89999998 666677789999999999999988865433   88


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhh--hhhhhhhcccccccCcceecCC
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILR--KMILKQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~--~~~~~~~~~~~~~~aPE~~~~~  156 (164)
                      +..+..++.|++.||.|||++   +|+||||||+||+++.++.++|+|||++....  .......+||+.|+|||++.+.
T Consensus       109 ~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~  185 (345)
T 3a8x_A          109 EEHARFYSAEISLALNYLHER---GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE  185 (345)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTC
T ss_pred             HHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEEeccccccccCCCCcccccCCCccccCccccCCC
Confidence            999999999999999999998   99999999999999999999999999987532  2233567899999999999988


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .++.++||
T Consensus       186 ~~~~~~Di  193 (345)
T 3a8x_A          186 DYGFSVDW  193 (345)
T ss_dssp             CBCTHHHH
T ss_pred             CCChHHhH
Confidence            99999885

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=99.97  E-value=6.3e-32  Score=195.90  Aligned_cols=155  Identities=26%  Similarity=0.326  Sum_probs=132.3

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccC
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILD   78 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~   78 (164)
                      .+++.||+|.+.+.   .......+..|..++..+ +||||+++ ..+......++||||+++|+|.+++.....   ++
T Consensus        40 ~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~---~~  116 (345)
T 1xjd_A           40 KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FD  116 (345)
T ss_dssp             TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSS---CC
T ss_pred             CCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCC---CC
Confidence            46889999998754   233456678899988877 89999998 666677789999999999999998875433   88


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhh--hhhhhhhcccccccCcceecCC
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILR--KMILKQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~--~~~~~~~~~~~~~~aPE~~~~~  156 (164)
                      +.....++.|++.||.|||++   +|+||||||+||+++.++.++|+|||++....  .......+||+.|+|||++.+.
T Consensus       117 ~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~  193 (345)
T 1xjd_A          117 LSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQ  193 (345)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTC
T ss_pred             HHHHHHHHHHHHHHHHHHHHC---CeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcCC
Confidence            999999999999999999998   99999999999999999999999999987543  2234567899999999999988


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .++.++|+
T Consensus       194 ~~~~~~Di  201 (345)
T 1xjd_A          194 KYNHSVDW  201 (345)
T ss_dssp             CBCTHHHH
T ss_pred             CCCChhhh
Confidence            99999885

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.97  E-value=3e-32  Score=201.51  Aligned_cols=154  Identities=22%  Similarity=0.226  Sum_probs=130.6

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+++.||+|.+.+.   .......+..|..+++.++||||+++ ..+......++||||+++|+|.+++...    .+++
T Consensus        92 ~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~----~~~e  167 (410)
T 3v8s_A           92 STRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY----DVPE  167 (410)
T ss_dssp             TTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHC----CCCH
T ss_pred             CCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHcC----CCCH
Confidence            46889999998653   22334567899999999999999998 6666777899999999999999988643    2889


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh---hhhhcccccccCcceecCC
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI---LKQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~aPE~~~~~  156 (164)
                      .....++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++.......   ....+||+.|+|||++.+.
T Consensus       168 ~~~~~~~~qi~~aL~~LH~~---givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~  244 (410)
T 3v8s_A          168 KWARFYTAEVVLALDAIHSM---GFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQ  244 (410)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHHHHC---CeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhcc
Confidence            99999999999999999998   99999999999999999999999999997654332   2467899999999999765


Q ss_pred             c----ceeccCC
Q 046065          157 V----YYKKFSL  164 (164)
Q Consensus       157 ~----~~~~~Di  164 (164)
                      .    |+.++||
T Consensus       245 ~~~~~~~~~~Di  256 (410)
T 3v8s_A          245 GGDGYYGRECDW  256 (410)
T ss_dssp             TTTCEEETHHHH
T ss_pred             CCCcCCCCcceE
Confidence            5    7888885

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=99.97  E-value=1e-31  Score=200.47  Aligned_cols=155  Identities=24%  Similarity=0.331  Sum_probs=132.9

Q ss_pred             CCCcEEEEEEccccc--cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            4 PDGQIIAVKKLSKKS--TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         4 ~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      .+|+.+|+|.+....  ....+.+.+|+.+++.++||||+++ +.+...+..++|||++++|+|.+.+.....   +++.
T Consensus        34 ~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~---~~e~  110 (444)
T 3soa_A           34 LAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY---YSEA  110 (444)
T ss_dssp             TTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHHCSC---CCHH
T ss_pred             CCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHHcCC---CCHH
Confidence            578899999987552  3345678899999999999999998 777777889999999999999888865433   8899


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeec---CCCCeEEccccchhhhhhhh--hhhhcccccccCcceecC
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLD---EDLKPKISDFGLARILRKMI--LKQIQIELGYIPPEYVGR  155 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~---~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~aPE~~~~  155 (164)
                      ....++.|++.|+.|+|+.   +|+||||||+||+++   .++.+||+|||++.......  .....||+.|+|||++.+
T Consensus       111 ~~~~i~~qil~aL~~lH~~---givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~  187 (444)
T 3soa_A          111 DASHCIQQILEAVLHCHQM---GVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRK  187 (444)
T ss_dssp             HHHHHHHHHHHHHHHHHHT---TCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHHHC---CccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcC
Confidence            9999999999999999998   999999999999998   45789999999997665332  245789999999999998


Q ss_pred             CcceeccCC
Q 046065          156 GVYYKKFSL  164 (164)
Q Consensus       156 ~~~~~~~Di  164 (164)
                      ..|+.++||
T Consensus       188 ~~~~~~~DI  196 (444)
T 3soa_A          188 DPYGKPVDL  196 (444)
T ss_dssp             CCBCTHHHH
T ss_pred             CCCCCcccc
Confidence            899999985

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.97  E-value=2.3e-31  Score=191.58  Aligned_cols=155  Identities=28%  Similarity=0.363  Sum_probs=132.7

Q ss_pred             CCCcEEEEEEcccccc------ccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccc
Q 046065            4 PDGQIIAVKKLSKKST------QGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLI   76 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~   76 (164)
                      .+++.||+|.+.....      ...+.+.+|+.+++.++||||+++ +.+......++|||++++++|.+++.....   
T Consensus        34 ~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---  110 (326)
T 2y0a_A           34 STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---  110 (326)
T ss_dssp             TTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTSSC---
T ss_pred             CCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHhcCC---
Confidence            4688999999875422      135678899999999999999998 667777789999999999999999875433   


Q ss_pred             cCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCC----CeEEccccchhhhhh-hhhhhhcccccccCcc
Q 046065           77 LDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL----KPKISDFGLARILRK-MILKQIQIELGYIPPE  151 (164)
Q Consensus        77 ~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~----~~~l~dfg~~~~~~~-~~~~~~~~~~~~~aPE  151 (164)
                      +++.....++.|++.||.|||+.   +++|+||||+||+++.++    .++|+|||++..... .......||+.|+|||
T Consensus       111 ~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE  187 (326)
T 2y0a_A          111 LTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE  187 (326)
T ss_dssp             CBHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCHH
T ss_pred             cCHHHHHHHHHHHHHHHHHHHHC---CeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCccccccCCcCcCCce
Confidence            88999999999999999999998   999999999999998877    799999999976643 2234567999999999


Q ss_pred             eecCCcceeccCC
Q 046065          152 YVGRGVYYKKFSL  164 (164)
Q Consensus       152 ~~~~~~~~~~~Di  164 (164)
                      ++.+..++.++||
T Consensus       188 ~~~~~~~~~~~Di  200 (326)
T 2y0a_A          188 IVNYEPLGLEADM  200 (326)
T ss_dssp             HHTTCCCCTHHHH
T ss_pred             eecCCCCCcHHHH
Confidence            9988899999885

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.97  E-value=1.6e-31  Score=192.40  Aligned_cols=155  Identities=23%  Similarity=0.247  Sum_probs=123.7

Q ss_pred             CCCcEEEEEEccccc----cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccC
Q 046065            4 PDGQIIAVKKLSKKS----TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILD   78 (164)
Q Consensus         4 ~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~   78 (164)
                      .+++.||+|.+....    ......+..|+.+++.++||||+++ +.+...+..++|||++++++|.+++.....   ++
T Consensus        43 ~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~  119 (327)
T 3a62_A           43 NTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGI---FM  119 (327)
T ss_dssp             TTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHHHSS---CC
T ss_pred             CCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHhCCC---CC
Confidence            578999999987542    2334567789999999999999997 777777889999999999999988865332   78


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh--hhhhhhcccccccCcceecCC
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK--MILKQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~~aPE~~~~~  156 (164)
                      +.....++.|++.||.|+|+.   +++|+||||+||+++.++.++|+|||++.....  ......+||+.|+|||++.+.
T Consensus       120 ~~~~~~~~~qi~~al~~lH~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  196 (327)
T 3a62_A          120 EDTACFYLAEISMALGHLHQK---GIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRS  196 (327)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHT---TCCCCCCCTTTEEECTTSCEEECCCSCC----------CTTSSCCTTSCHHHHTTS
T ss_pred             HHHHHHHHHHHHHHHHHHHhC---CEEcccCCHHHeEECCCCcEEEEeCCcccccccCCccccccCCCcCccCHhhCcCC
Confidence            889999999999999999998   999999999999999999999999999875432  223456799999999999888


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .++.++||
T Consensus       197 ~~~~~~Di  204 (327)
T 3a62_A          197 GHNRAVDW  204 (327)
T ss_dssp             CCCTHHHH
T ss_pred             CCCCcccc
Confidence            89999885

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.97  E-value=1.7e-31  Score=195.46  Aligned_cols=156  Identities=28%  Similarity=0.345  Sum_probs=133.2

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      .+|+.||+|.+........+.+.+|+.+++.++||||+++ +.+...+..++||||+++++|.+++....  ..+++...
T Consensus       112 ~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~--~~l~~~~~  189 (373)
T 2x4f_A          112 ATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDES--YNLTELDT  189 (373)
T ss_dssp             TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTG--GGCCHHHH
T ss_pred             CCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcC--CCCCHHHH
Confidence            5688999999876655556778999999999999999998 77777788999999999999988875432  23888999


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceee--cCCCCeEEccccchhhhhhh-hhhhhcccccccCcceecCCcce
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL--DEDLKPKISDFGLARILRKM-ILKQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili--~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      ..++.|++.||.|||+.   +|+|+||||+||++  +..+.++|+|||++...... ......||+.|+|||++.+..++
T Consensus       190 ~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  266 (373)
T 2x4f_A          190 ILFMKQICEGIRHMHQM---YILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVS  266 (373)
T ss_dssp             HHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCBCCCCCSSCTTCCHHHHTTCBCC
T ss_pred             HHHHHHHHHHHHHHHHC---CcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccccccccCCCcEeChhhccCCCCC
Confidence            99999999999999998   99999999999999  56678999999999766433 23456799999999999888899


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      .++||
T Consensus       267 ~~~Di  271 (373)
T 2x4f_A          267 FPTDM  271 (373)
T ss_dssp             HHHHH
T ss_pred             cHHhH
Confidence            99885

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.97  E-value=1.5e-31  Score=195.63  Aligned_cols=157  Identities=26%  Similarity=0.416  Sum_probs=131.5

Q ss_pred             CCcEEEEEEcccc-ccccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccc--------
Q 046065            5 DGQIIAVKKLSKK-STQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIR--------   73 (164)
Q Consensus         5 ~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------   73 (164)
                      ++..||+|.+... .....+.+.+|+.+++.+ +||||+++ +.+...+.+++||||+++|+|.+++.....        
T Consensus       112 ~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~  191 (370)
T 2psq_A          112 EAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYD  191 (370)
T ss_dssp             CEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-------
T ss_pred             cceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCcccccccc
Confidence            4567999998755 333456789999999999 89999998 777777889999999999999999875321        


Q ss_pred             -----ccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh----hhhhhccc
Q 046065           74 -----MLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM----ILKQIQIE  144 (164)
Q Consensus        74 -----~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~----~~~~~~~~  144 (164)
                           ...++...+..++.|++.||.|||++   +++||||||+||+++.++.+||+|||++......    ......++
T Consensus       192 ~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t  268 (370)
T 2psq_A          192 INRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLP  268 (370)
T ss_dssp             ----CCCCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSC
T ss_pred             ccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcc
Confidence                 12378889999999999999999998   9999999999999999999999999999765432    12345567


Q ss_pred             ccccCcceecCCcceeccCC
Q 046065          145 LGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       145 ~~~~aPE~~~~~~~~~~~Di  164 (164)
                      +.|+|||++.+..++.++||
T Consensus       269 ~~y~aPE~~~~~~~~~~~Dv  288 (370)
T 2psq_A          269 VKWMAPEALFDRVYTHQSDV  288 (370)
T ss_dssp             GGGCCHHHHHTCCCCHHHHH
T ss_pred             cceECHhHhcCCCCCcHHHH
Confidence            88999999998999999985

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.97  E-value=2.1e-31  Score=192.56  Aligned_cols=154  Identities=25%  Similarity=0.410  Sum_probs=130.6

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+++.||+|.+...   .......+.+|+.+++.++||||+++ +.+......++||||+ +|+|.+.+.....   +++
T Consensus        32 ~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~~~~---l~~  107 (336)
T 3h4j_B           32 KTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKR---MTE  107 (336)
T ss_dssp             TTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHHHCS---CCH
T ss_pred             CCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHHcCC---CCH
Confidence            57889999998654   22334578899999999999999998 7777778899999999 6788887765433   889


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh-hhhhcccccccCcceecCCcc
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI-LKQIQIELGYIPPEYVGRGVY  158 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~  158 (164)
                      .....++.|++.|+.|+|+.   +++|+||||+||+++.++.+||+|||++....... ....+||+.|+|||++.+..+
T Consensus       108 ~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  184 (336)
T 3h4j_B          108 DEGRRFFQQIICAIEYCHRH---KIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLY  184 (336)
T ss_dssp             HHHHHHHHHHHHHHHHHHHH---TCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSCCSGG
T ss_pred             HHHHHHHHHHHHHHHHHHHC---CeEecCCchhhEEEcCCCCEEEEEeccceeccCCcccccccCCcCcCCHHHHcCCCC
Confidence            99999999999999999999   99999999999999999999999999997665432 355689999999999988877


Q ss_pred             -eeccCC
Q 046065          159 -YKKFSL  164 (164)
Q Consensus       159 -~~~~Di  164 (164)
                       +.++||
T Consensus       185 ~~~~~Di  191 (336)
T 3h4j_B          185 AGPEVDV  191 (336)
T ss_dssp             GCHHHHH
T ss_pred             CCCccch
Confidence             678885

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.97  E-value=1.9e-31  Score=203.65  Aligned_cols=157  Identities=27%  Similarity=0.293  Sum_probs=134.5

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+|+.||+|.+...   .......+..|+.+++.++||||+++ ..+......++||||+++|+|.+++..... ..+++
T Consensus       207 ~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~-~~l~e  285 (576)
T 2acx_A          207 ATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQ-AGFPE  285 (576)
T ss_dssp             TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSS-CCCCH
T ss_pred             CCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCC-CCCCH
Confidence            57899999998654   23345667899999999999999998 666677789999999999999988876432 23889


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh-hhhhcccccccCcceecCCcc
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI-LKQIQIELGYIPPEYVGRGVY  158 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~  158 (164)
                      ..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++....... ....+||+.|+|||++.+..|
T Consensus       286 ~~~~~i~~qIl~aL~yLH~~---gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~  362 (576)
T 2acx_A          286 ARAVFYAAEICCGLEDLHRE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERY  362 (576)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCEECCCSCGGGCCHHHHTTCEE
T ss_pred             HHHHHHHHHHHHHHHHHHHC---CEeccCCchheEEEeCCCCeEEEecccceecccCccccccCCCccccCHHHHcCCCC
Confidence            99999999999999999998   99999999999999999999999999997664332 345689999999999998899


Q ss_pred             eeccCC
Q 046065          159 YKKFSL  164 (164)
Q Consensus       159 ~~~~Di  164 (164)
                      +.++||
T Consensus       363 ~~~~Di  368 (576)
T 2acx_A          363 TFSPDW  368 (576)
T ss_dssp             SSHHHH
T ss_pred             CccchH
Confidence            999885

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=99.97  E-value=1.3e-31  Score=194.79  Aligned_cols=155  Identities=26%  Similarity=0.304  Sum_probs=131.7

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccC
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILD   78 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~   78 (164)
                      .+++.||+|.+.+.   .......+..|..++..+ +||+|+++ ..+......++||||+++|+|.+++.....   ++
T Consensus        43 ~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~---~~  119 (353)
T 2i0e_A           43 GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR---FK  119 (353)
T ss_dssp             TEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSS---CC
T ss_pred             CCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCC---CC
Confidence            35788999998754   234456778899999988 79999998 555666789999999999999998875433   88


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh--hhhhhhcccccccCcceecCC
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK--MILKQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~~aPE~~~~~  156 (164)
                      +..+..++.|++.||.|||++   +|+||||||+||+++.++.++|+|||++.....  ......+||+.|+|||++.+.
T Consensus       120 ~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~  196 (353)
T 2i0e_A          120 EPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQ  196 (353)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTC
T ss_pred             HHHHHHHHHHHHHHHHHHHHC---CEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCcccccccCCccccChhhhcCC
Confidence            999999999999999999998   999999999999999999999999999875422  223567899999999999988


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .++.++|+
T Consensus       197 ~~~~~~Di  204 (353)
T 2i0e_A          197 PYGKSVDW  204 (353)
T ss_dssp             CBSTHHHH
T ss_pred             CcCCcccc
Confidence            99999885

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.97  E-value=9.1e-32  Score=199.03  Aligned_cols=156  Identities=21%  Similarity=0.199  Sum_probs=130.9

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+++.||+|.+.+.   .......+..|..++..++||||+++ ..+......|+||||+++|+|.+++....  ..+++
T Consensus        84 ~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~--~~l~~  161 (412)
T 2vd5_A           84 QTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFG--ERIPA  161 (412)
T ss_dssp             TTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS--SCCCH
T ss_pred             CCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcC--CCCCH
Confidence            57899999998653   22334567889999999999999998 66666778999999999999999986532  13889


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh---hhhhcccccccCcceec--
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI---LKQIQIELGYIPPEYVG--  154 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~aPE~~~--  154 (164)
                      ..+..++.|++.||.|+|++   +|+||||||+||+++.++.+||+|||++.......   ....+||+.|+|||++.  
T Consensus       162 ~~~~~~~~qi~~aL~~LH~~---giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~  238 (412)
T 2vd5_A          162 EMARFYLAEIVMAIDSVHRL---GYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAV  238 (412)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHC---CeeecccCHHHeeecCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhc
Confidence            99999999999999999998   99999999999999999999999999997654332   23468999999999996  


Q ss_pred             -----CCcceeccCC
Q 046065          155 -----RGVYYKKFSL  164 (164)
Q Consensus       155 -----~~~~~~~~Di  164 (164)
                           ...|+.++|+
T Consensus       239 ~~~~~~~~~~~~~Di  253 (412)
T 2vd5_A          239 GGGPGTGSYGPECDW  253 (412)
T ss_dssp             HTCTTCSEECTHHHH
T ss_pred             ccCcCCCCCChHHhh
Confidence                 4678888885

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.97  E-value=3.7e-31  Score=194.44  Aligned_cols=156  Identities=24%  Similarity=0.298  Sum_probs=133.3

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      .+++.||+|.+..........+.+|+.+++.++||||+++ +.+......++|||++++++|.+++....  ..+++..+
T Consensus        74 ~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~--~~l~~~~~  151 (387)
T 1kob_A           74 ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED--YKMSEAEV  151 (387)
T ss_dssp             TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTT--CCBCHHHH
T ss_pred             CCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhc--CCCCHHHH
Confidence            4688999999876655555678899999999999999998 77777788999999999999998886532  23889999


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecC--CCCeEEccccchhhhhhh-hhhhhcccccccCcceecCCcce
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE--DLKPKISDFGLARILRKM-ILKQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~--~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      ..++.|++.||.|||+.   +++|+||||+||+++.  .+.++|+|||++...... ......||+.|+|||++.+..++
T Consensus       152 ~~i~~qi~~aL~~LH~~---givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  228 (387)
T 1kob_A          152 INYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVG  228 (387)
T ss_dssp             HHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBC
T ss_pred             HHHHHHHHHHHHHHHhC---CeeecccchHHeEEecCCCCceEEEecccceecCCCcceeeeccCCCccCchhccCCCCC
Confidence            99999999999999998   9999999999999974  467999999999766433 23456799999999999988899


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      .++||
T Consensus       229 ~~~Di  233 (387)
T 1kob_A          229 FYTDM  233 (387)
T ss_dssp             HHHHH
T ss_pred             CcccE
Confidence            99885

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.97  E-value=2.1e-31  Score=193.56  Aligned_cols=158  Identities=23%  Similarity=0.321  Sum_probs=131.5

Q ss_pred             CCCcEEEEEEccccc-----cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcc-cccc
Q 046065            4 PDGQIIAVKKLSKKS-----TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPI-RMLI   76 (164)
Q Consensus         4 ~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~   76 (164)
                      .+++.||+|.+....     ....+.+.+|+.+++.++||||+++ +.+...+..++|||++++++|.+.+.... ....
T Consensus        47 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~  126 (351)
T 3c0i_A           47 ETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFV  126 (351)
T ss_dssp             TTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCC
T ss_pred             CCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCC
Confidence            568999999986431     2245678899999999999999998 77777888999999999999987775422 2223


Q ss_pred             cCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCC---eEEccccchhhhhhhh--hhhhcccccccCcc
Q 046065           77 LDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK---PKISDFGLARILRKMI--LKQIQIELGYIPPE  151 (164)
Q Consensus        77 ~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~---~~l~dfg~~~~~~~~~--~~~~~~~~~~~aPE  151 (164)
                      +++..+..++.|++.||.|||++   +++|+||||+||+++.++.   ++|+|||++.......  .....||+.|+|||
T Consensus       127 ~~~~~~~~i~~qi~~al~~lH~~---~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE  203 (351)
T 3c0i_A          127 YSEAVASHYMRQILEALRYCHDN---NIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPE  203 (351)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHC---CceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHH
Confidence            78899999999999999999998   9999999999999986554   9999999997665432  24567999999999


Q ss_pred             eecCCcceeccCC
Q 046065          152 YVGRGVYYKKFSL  164 (164)
Q Consensus       152 ~~~~~~~~~~~Di  164 (164)
                      ++.+..++.++||
T Consensus       204 ~~~~~~~~~~~Di  216 (351)
T 3c0i_A          204 VVKREPYGKPVDV  216 (351)
T ss_dssp             HHTTCCBCTHHHH
T ss_pred             HHcCCCCCchHhh
Confidence            9998899999985

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=3.8e-31  Score=190.09  Aligned_cols=155  Identities=19%  Similarity=0.248  Sum_probs=132.4

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      .+++.||+|.+... ......+.+|+.+++.++||||+++ +.+......++|||++++++|.+++....  ..+++..+
T Consensus        28 ~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~--~~~~~~~~  104 (321)
T 1tki_A           28 SSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSA--FELNEREI  104 (321)
T ss_dssp             TTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSS--CCCCHHHH
T ss_pred             CCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcC--CCCCHHHH
Confidence            46889999998644 2334567899999999999999998 77777888999999999999999886532  23889999


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecC--CCCeEEccccchhhhhhh-hhhhhcccccccCcceecCCcce
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE--DLKPKISDFGLARILRKM-ILKQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~--~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      ..++.|++.|+.|||+.   +++|+||||+||+++.  ++.++|+|||++...... ......||+.|+|||++.+..++
T Consensus       105 ~~i~~qi~~al~~lH~~---givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  181 (321)
T 1tki_A          105 VSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVS  181 (321)
T ss_dssp             HHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEEC
T ss_pred             HHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCccccccCChhhcCcHHhcCCCCC
Confidence            99999999999999998   9999999999999987  789999999999766433 23456789999999999888889


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      .++||
T Consensus       182 ~~~Di  186 (321)
T 1tki_A          182 TATDM  186 (321)
T ss_dssp             HHHHH
T ss_pred             chhhH
Confidence            99885

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.97  E-value=3.5e-31  Score=201.35  Aligned_cols=158  Identities=26%  Similarity=0.338  Sum_probs=134.6

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccc-ccccC
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIR-MLILD   78 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~   78 (164)
                      .+|+.||+|.+.+.   .......+..|+.+++.++||||+++ ..+......++||||+++|+|..++..... ...++
T Consensus       208 ~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~  287 (543)
T 3c4z_A          208 ATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQ  287 (543)
T ss_dssp             TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCC
T ss_pred             CCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhccccccc
Confidence            57899999998654   23345678899999999999999998 666667789999999999999988875331 23488


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh--hhhhcccccccCcceecCC
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI--LKQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~aPE~~~~~  156 (164)
                      +.....++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++.......  ....+||+.|+|||++.+.
T Consensus       288 e~~~~~~~~qi~~aL~~LH~~---gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~  364 (543)
T 3c4z_A          288 EPRAIFYTAQIVSGLEHLHQR---NIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGE  364 (543)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTC
T ss_pred             HHHHHHHHHHHHHHHHHHHHc---CCcccCCChHHEEEeCCCCEEEeecceeeeccCCCcccccccCCccccChhhhcCC
Confidence            999999999999999999998   99999999999999999999999999997665432  2446899999999999998


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .|+.++||
T Consensus       365 ~~~~~~Di  372 (543)
T 3c4z_A          365 EYDFSVDY  372 (543)
T ss_dssp             CBCTHHHH
T ss_pred             CCChHHhc
Confidence            99999885

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.97  E-value=6.6e-32  Score=201.70  Aligned_cols=155  Identities=23%  Similarity=0.280  Sum_probs=123.7

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+++.||+|.+...   .......+..|+.+++.++||||+++ ..+...+..++||||+++++|..++.....   +++
T Consensus       171 ~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~  247 (446)
T 4ejn_A          171 ATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERV---FSE  247 (446)
T ss_dssp             TTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHHHSC---CCH
T ss_pred             CCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHhcCC---CCH
Confidence            56889999998754   23344567889999999999999998 777778889999999999999888865432   889


Q ss_pred             HHHHHHHHHHHHHHHHhhh-cCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh--hhhhhhcccccccCcceecCC
Q 046065           80 KKRVHIIKGIIQGLLYLQE-YFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK--MILKQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~-~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~~aPE~~~~~  156 (164)
                      .....++.|++.||.|||+ .   +|+||||||+||+++.++.++|+|||++.....  ......+||+.|+|||++.+.
T Consensus       248 ~~~~~~~~qi~~aL~~LH~~~---giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~  324 (446)
T 4ejn_A          248 DRARFYGAEIVSALDYLHSEK---NVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDN  324 (446)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHT---CCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTS
T ss_pred             HHHHHHHHHHHHHHHHHhhcC---CEEECCCCHHHEEECCCCCEEEccCCCceeccCCCcccccccCCccccCHhhcCCC
Confidence            9999999999999999998 7   999999999999999999999999999875432  223567899999999999999


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .|+.++||
T Consensus       325 ~~~~~~Di  332 (446)
T 4ejn_A          325 DYGRAVDW  332 (446)
T ss_dssp             CCCTHHHH
T ss_pred             CCCCccch
Confidence            99999985

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.97  E-value=2.5e-31  Score=191.21  Aligned_cols=155  Identities=29%  Similarity=0.419  Sum_probs=129.0

Q ss_pred             CCCcEEEEEEccccc-cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            4 PDGQIIAVKKLSKKS-TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         4 ~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      .+++.||+|.+.... ....+.+.+|+.+++.++||||+++ +.+...+..++|||++++++|.+++.....   +++..
T Consensus        30 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~  106 (323)
T 3tki_A           30 VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPD  106 (323)
T ss_dssp             TTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBTTTB---CCHHH
T ss_pred             CCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhhcCC---CCHHH
Confidence            478899999986542 2334568899999999999999998 777777788999999999999998865433   88999


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh----hhhhhcccccccCcceecCCc
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM----ILKQIQIELGYIPPEYVGRGV  157 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~  157 (164)
                      ...++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++..+...    ......||+.|+|||++.+..
T Consensus       107 ~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  183 (323)
T 3tki_A          107 AQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE  183 (323)
T ss_dssp             HHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSS
T ss_pred             HHHHHHHHHHHHHHHHHC---CccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCC
Confidence            999999999999999998   9999999999999999999999999999765322    124567999999999998777


Q ss_pred             c-eeccCC
Q 046065          158 Y-YKKFSL  164 (164)
Q Consensus       158 ~-~~~~Di  164 (164)
                      + +.++||
T Consensus       184 ~~~~~~Di  191 (323)
T 3tki_A          184 FHAEPVDV  191 (323)
T ss_dssp             BCHHHHHH
T ss_pred             CCCCcccH
Confidence            6 778875

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.97  E-value=2.9e-31  Score=190.46  Aligned_cols=159  Identities=38%  Similarity=0.652  Sum_probs=135.0

Q ss_pred             cCCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccc-ccccCHH
Q 046065            3 LPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIR-MLILDCK   80 (164)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~~   80 (164)
                      ..+++.||+|.+........+.+.+|+.+++.++||||+++ +.+...+..++|||++++++|.+++..... ...+++.
T Consensus        60 ~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~  139 (321)
T 2qkw_B           60 LRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWE  139 (321)
T ss_dssp             CTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHH
T ss_pred             ECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHH
Confidence            34688999999876655566788999999999999999998 767777889999999999999998865332 2348889


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh----hhhhhcccccccCcceecCC
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM----ILKQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~~aPE~~~~~  156 (164)
                      ....++.|++.||.|+|+.   +++|+||||+||+++.++.++|+|||++......    ......|++.|+|||++.+.
T Consensus       140 ~~~~i~~~i~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  216 (321)
T 2qkw_B          140 QRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKG  216 (321)
T ss_dssp             HHHHHHHHHHHHHHHHHHT---TEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHC
T ss_pred             HHHHHHHHHHHHHHHhcCC---CeecCCCCHHHEEECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCC
Confidence            9999999999999999998   9999999999999999999999999998754321    12345689999999999888


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .++.++||
T Consensus       217 ~~~~~~Di  224 (321)
T 2qkw_B          217 RLTEKSDV  224 (321)
T ss_dssp             BCCTHHHH
T ss_pred             CCCcccch
Confidence            99999885

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.97  E-value=3.8e-31  Score=198.74  Aligned_cols=155  Identities=25%  Similarity=0.442  Sum_probs=132.9

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+|+.||+|.+...   .......+.+|+.+++.++||||+++ +.+......++|||++++++|.+++.....   +++
T Consensus        39 ~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~---l~~  115 (476)
T 2y94_A           39 LTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGR---LDE  115 (476)
T ss_dssp             TTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTSSSS---CCH
T ss_pred             CCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCC---CCH
Confidence            47899999998654   22345678899999999999999998 777777889999999999999999876433   889


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh-hhhhhcccccccCcceecCCcc
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM-ILKQIQIELGYIPPEYVGRGVY  158 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~  158 (164)
                      .....++.|++.|+.|||+.   +++||||||+||+++.++.+||+|||++...... .....+||+.|+|||++.+..+
T Consensus       116 ~~~~~i~~qi~~aL~~LH~~---givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  192 (476)
T 2y94_A          116 KESRRLFQQILSGVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLY  192 (476)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCB
T ss_pred             HHHHHHHHHHHHHHHHHHHC---CCCcccccHHHEEEecCCCeEEEeccchhhccccccccccCCCcCeEChhhccCCCC
Confidence            99999999999999999998   9999999999999999999999999999766443 2355689999999999987776


Q ss_pred             -eeccCC
Q 046065          159 -YKKFSL  164 (164)
Q Consensus       159 -~~~~Di  164 (164)
                       +.++||
T Consensus       193 ~~~~~Di  199 (476)
T 2y94_A          193 AGPEVDI  199 (476)
T ss_dssp             CSHHHHH
T ss_pred             CCCccee
Confidence             678875

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.97  E-value=2.8e-31  Score=193.65  Aligned_cols=156  Identities=13%  Similarity=0.105  Sum_probs=128.7

Q ss_pred             cCCCcEEEEEEccccccccHHHHHHHHHHHhccC---CCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcc--cccc
Q 046065            3 LPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQ---HLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPI--RMLI   76 (164)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~---h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~   76 (164)
                      ..+++.||+|.+...   ....+..|+.+++.++   |+|++.+ +.+...+..++||||+++|+|.+++....  ....
T Consensus        92 ~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~  168 (365)
T 3e7e_A           92 AKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKV  168 (365)
T ss_dssp             --CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCS
T ss_pred             cccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccC
Confidence            346889999998644   3345677777777775   8999997 77777888999999999999999986421  1234


Q ss_pred             cCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecC-----------CCCeEEccccchhhhh----hhhhhhh
Q 046065           77 LDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE-----------DLKPKISDFGLARILR----KMILKQI  141 (164)
Q Consensus        77 ~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~-----------~~~~~l~dfg~~~~~~----~~~~~~~  141 (164)
                      +++..+..++.|++.||.|||+.   +|+||||||+|||++.           .+.+||+|||++....    .......
T Consensus       169 l~~~~~~~i~~qi~~~L~~lH~~---~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~  245 (365)
T 3e7e_A          169 MPQGLVISFAMRMLYMIEQVHDC---EIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAK  245 (365)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCS
T ss_pred             CCHHHHHHHHHHHHHHHHHHhhC---CeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeee
Confidence            89999999999999999999998   9999999999999988           8999999999996543    1223557


Q ss_pred             cccccccCcceecCCcceeccCC
Q 046065          142 QIELGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       142 ~~~~~~~aPE~~~~~~~~~~~Di  164 (164)
                      +||+.|+|||++.+..++.++||
T Consensus       246 ~gt~~y~aPE~~~~~~~~~~~Di  268 (365)
T 3e7e_A          246 CETSGFQCVEMLSNKPWNYQIDY  268 (365)
T ss_dssp             SCTTSCCCHHHHTTCCBSTHHHH
T ss_pred             cCCCCCCChHHhcCCCCCccccH
Confidence            79999999999999999999986

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.97  E-value=6.7e-31  Score=188.41  Aligned_cols=158  Identities=26%  Similarity=0.364  Sum_probs=131.8

Q ss_pred             CCCcEEEEEEccccc-cccHHHHHHHHHHHhccCCCceeeE-eEEeeCC--cEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKKS-TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQ--EYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+++.||+|.+.... ....+.+.+|+.+++.++||||+++ +.+....  ..++|||++++++|.+++........+++
T Consensus        32 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~  111 (319)
T 4euu_A           32 KTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPE  111 (319)
T ss_dssp             TTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCH
T ss_pred             CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCH
Confidence            468899999987542 3445677899999999999999998 5555443  67899999999999999987555445899


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceee----cCCCCeEEccccchhhhhhh-hhhhhcccccccCcceec
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL----DEDLKPKISDFGLARILRKM-ILKQIQIELGYIPPEYVG  154 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili----~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~  154 (164)
                      .....++.|++.||.|||+.   +++|+||||+||++    +..+.+||+|||++...... ......||+.|+|||++.
T Consensus       112 ~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~  188 (319)
T 4euu_A          112 SEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYE  188 (319)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCceeecccCCCccCHHHhh
Confidence            99999999999999999998   99999999999999    77778999999999766433 234567899999999985


Q ss_pred             --------CCcceeccCC
Q 046065          155 --------RGVYYKKFSL  164 (164)
Q Consensus       155 --------~~~~~~~~Di  164 (164)
                              +..++.++||
T Consensus       189 ~~~~~~~~~~~~~~~~Di  206 (319)
T 4euu_A          189 RAVLRKDHQKKYGATVDL  206 (319)
T ss_dssp             HHTSCCCCCCCBCTTHHH
T ss_pred             hccccccccCCCCcHHHH
Confidence                    5778888885

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.97  E-value=3.5e-31  Score=190.55  Aligned_cols=154  Identities=28%  Similarity=0.457  Sum_probs=128.0

Q ss_pred             CcEEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHH
Q 046065            6 GQIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRV   83 (164)
Q Consensus         6 ~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~   83 (164)
                      +..||+|.+... .....+.+.+|+.+++.++||||+++ +.+......++|||++++++|.+++.....  .++...+.
T Consensus        77 ~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~  154 (325)
T 3kul_A           77 DVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDG--QFTIMQLV  154 (325)
T ss_dssp             CEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTTTT--CSCHHHHH
T ss_pred             CceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhccc--CCCHHHHH
Confidence            456999998754 33445678999999999999999998 777777788999999999999999865322  38899999


Q ss_pred             HHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh-----hhhhcccccccCcceecCCcc
Q 046065           84 HIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI-----LKQIQIELGYIPPEYVGRGVY  158 (164)
Q Consensus        84 ~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~  158 (164)
                      .++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.......     .....+|+.|+|||++.+..+
T Consensus       155 ~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~  231 (325)
T 3kul_A          155 GMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTF  231 (325)
T ss_dssp             HHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEE
T ss_pred             HHHHHHHHHHHHHHHC---CeeCCCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCC
Confidence            9999999999999998   99999999999999999999999999997664321     123445778999999988899


Q ss_pred             eeccCC
Q 046065          159 YKKFSL  164 (164)
Q Consensus       159 ~~~~Di  164 (164)
                      +.++||
T Consensus       232 ~~~~Di  237 (325)
T 3kul_A          232 SSASDV  237 (325)
T ss_dssp             CHHHHH
T ss_pred             CcHHHH
Confidence            999885

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.97  E-value=2.4e-31  Score=194.64  Aligned_cols=155  Identities=23%  Similarity=0.267  Sum_probs=123.0

Q ss_pred             CCCcEEEEEEccccc---cccHHHHHHHHHH-HhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccC
Q 046065            4 PDGQIIAVKKLSKKS---TQGFEEFKNEVML-TAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILD   78 (164)
Q Consensus         4 ~~~~~vavK~~~~~~---~~~~~~~~~e~~~-l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~   78 (164)
                      .+++.||+|.+.+..   ......+..|..+ ++.++||||+++ ..+...+..|+||||+++|+|.+++.....   ++
T Consensus        61 ~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~---~~  137 (373)
T 2r5t_A           61 AEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERC---FL  137 (373)
T ss_dssp             TTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSS---CC
T ss_pred             CCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCC---CC
Confidence            467899999987552   2233455667665 577899999998 666677789999999999999988865432   78


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh--hhhhhhcccccccCcceecCC
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK--MILKQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~~aPE~~~~~  156 (164)
                      +.....++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++.....  ......+||+.|+|||++.+.
T Consensus       138 ~~~~~~~~~qi~~aL~~LH~~---givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~  214 (373)
T 2r5t_A          138 EPRARFYAAEIASALGYLHSL---NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQ  214 (373)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTC
T ss_pred             HHHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEECCCCCEEEeeCccccccccCCCccccccCCccccCHHHhCCC
Confidence            899999999999999999998   999999999999999999999999999975432  233567899999999999988


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .|+.++|+
T Consensus       215 ~~~~~~Di  222 (373)
T 2r5t_A          215 PYDRTVDW  222 (373)
T ss_dssp             CCCTHHHH
T ss_pred             CCCchhhh
Confidence            99999885

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.97  E-value=6.8e-31  Score=193.05  Aligned_cols=157  Identities=18%  Similarity=0.286  Sum_probs=131.5

Q ss_pred             CCCcEEEEEEccccc--cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            4 PDGQIIAVKKLSKKS--TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         4 ~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      .+++.||+|.+....  ......+.+|+.+++.++||||+++ +.+...+..++|||++++++|.+++..... ..+++.
T Consensus        50 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~  128 (389)
T 3gni_B           50 PTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFM-DGMNEL  128 (389)
T ss_dssp             TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCT-TCCCHH
T ss_pred             CCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcc-cCCCHH
Confidence            468999999987552  3345677889999999999999998 777788889999999999999999875422 228899


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh---------hhhhhcccccccCcc
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM---------ILKQIQIELGYIPPE  151 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~---------~~~~~~~~~~~~aPE  151 (164)
                      .+..++.|++.||.|||++   +|+||||||+||+++.++.++|+|||.+......         ......||+.|+|||
T Consensus       129 ~~~~~~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE  205 (389)
T 3gni_B          129 AIAYILQGVLKALDYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPE  205 (389)
T ss_dssp             HHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHH
T ss_pred             HHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHH
Confidence            9999999999999999998   9999999999999999999999999987544221         112347889999999


Q ss_pred             eecC--CcceeccCC
Q 046065          152 YVGR--GVYYKKFSL  164 (164)
Q Consensus       152 ~~~~--~~~~~~~Di  164 (164)
                      ++.+  ..++.++||
T Consensus       206 ~~~~~~~~~~~~~Di  220 (389)
T 3gni_B          206 VLQQNLQGYDAKSDI  220 (389)
T ss_dssp             HHSTTSSCBCTHHHH
T ss_pred             HHhccCCCCCcHhHH
Confidence            9977  578999885

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.97  E-value=1.9e-31  Score=189.25  Aligned_cols=156  Identities=29%  Similarity=0.489  Sum_probs=128.6

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeC--CcEEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIET--QEYMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      .+++.||+|.+........+.+.+|+.+++.++||||+++ +.+...  ...++|||++++++|.+++.....  .++..
T Consensus        37 ~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~  114 (295)
T 3ugc_A           37 NTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE--RIDHI  114 (295)
T ss_dssp             SCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGG--GCCHH
T ss_pred             CCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhccc--ccCHH
Confidence            4688999999876655566788999999999999999998 555433  458899999999999999875432  38889


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh-----hhhhcccccccCcceecC
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI-----LKQIQIELGYIPPEYVGR  155 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~aPE~~~~  155 (164)
                      ....++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.......     .....++..|+|||.+.+
T Consensus       115 ~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  191 (295)
T 3ugc_A          115 KLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTE  191 (295)
T ss_dssp             HHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHhcC---CcccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcC
Confidence            9999999999999999998   99999999999999999999999999997664321     133456778999999998


Q ss_pred             CcceeccCC
Q 046065          156 GVYYKKFSL  164 (164)
Q Consensus       156 ~~~~~~~Di  164 (164)
                      ..++.++||
T Consensus       192 ~~~~~~~Di  200 (295)
T 3ugc_A          192 SKFSVASDV  200 (295)
T ss_dssp             CCCCHHHHH
T ss_pred             CCCChHHHH
Confidence            899999985

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.97  E-value=5.5e-31  Score=192.77  Aligned_cols=155  Identities=28%  Similarity=0.480  Sum_probs=122.2

Q ss_pred             CCcEEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            5 DGQIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         5 ~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      ++..||+|.+... .....+.+.+|+.+++.++||||+++ +.+......++|||++++++|.+++....  ..++...+
T Consensus        72 ~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~--~~~~~~~~  149 (373)
T 2qol_A           72 KEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHD--AQFTVIQL  149 (373)
T ss_dssp             CBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTT--TCSCHHHH
T ss_pred             CceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCC--CCCCHHHH
Confidence            4677999998754 33445678999999999999999998 77777778999999999999999997532  23888999


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh-----hhhhcccccccCcceecCCc
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI-----LKQIQIELGYIPPEYVGRGV  157 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~  157 (164)
                      ..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++.......     .....+++.|+|||++.+..
T Consensus       150 ~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  226 (373)
T 2qol_A          150 VGMLRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRK  226 (373)
T ss_dssp             HHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC----------------------CTTSCHHHHHHCC
T ss_pred             HHHHHHHHHHHHHHHHC---CeeCCCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCC
Confidence            99999999999999998   99999999999999999999999999997664321     12234567899999999889


Q ss_pred             ceeccCC
Q 046065          158 YYKKFSL  164 (164)
Q Consensus       158 ~~~~~Di  164 (164)
                      ++.++||
T Consensus       227 ~~~~~Dv  233 (373)
T 2qol_A          227 FTSASDV  233 (373)
T ss_dssp             CCHHHHH
T ss_pred             cCchhcH
Confidence            9999985

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.97  E-value=9.3e-31  Score=185.52  Aligned_cols=155  Identities=22%  Similarity=0.354  Sum_probs=127.4

Q ss_pred             CCCcEEEEEEccccc--cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            4 PDGQIIAVKKLSKKS--TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         4 ~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      .+++.||+|.+....  ......+.+|+.+++.++||||+++ +.+......++|||++++ ++.+.+....  ..+++.
T Consensus        25 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~--~~l~~~  101 (292)
T 3o0g_A           25 ETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCN--GDLDPE  101 (292)
T ss_dssp             TTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTT--TCCCHH
T ss_pred             CCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHHhCC--CCCCHH
Confidence            468899999987552  3334678899999999999999998 777778889999999986 5544443321  238899


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh--hhhhhhcccccccCcceecCCc-
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK--MILKQIQIELGYIPPEYVGRGV-  157 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~-  157 (164)
                      ....++.|++.|+.|+|+.   +++|+||||+||+++.++.++|+|||++.....  .......+|+.|+|||++.+.. 
T Consensus       102 ~~~~~~~ql~~~l~~lH~~---~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~  178 (292)
T 3o0g_A          102 IVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKL  178 (292)
T ss_dssp             HHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSC
T ss_pred             HHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEeecccceecCCccccccCCccccCCcChHHHcCCCC
Confidence            9999999999999999998   999999999999999999999999999976542  2234567899999999997665 


Q ss_pred             ceeccCC
Q 046065          158 YYKKFSL  164 (164)
Q Consensus       158 ~~~~~Di  164 (164)
                      ++.++||
T Consensus       179 ~~~~~Di  185 (292)
T 3o0g_A          179 YSTSIDM  185 (292)
T ss_dssp             CCTHHHH
T ss_pred             cCchHHH
Confidence            7888885

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.97  E-value=9.7e-31  Score=186.38  Aligned_cols=155  Identities=26%  Similarity=0.415  Sum_probs=130.6

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      .+|+.||+|.+..........+.+|+.+++.++||||+++ +.+......++|||++++++|.+.+.....   +++...
T Consensus        32 ~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~  108 (304)
T 2jam_A           32 LTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGV---YTEKDA  108 (304)
T ss_dssp             TTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSC---CCHHHH
T ss_pred             CCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHcCC---CCHHHH
Confidence            4688999999876544445668899999999999999998 767777789999999999999888865332   788999


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceee---cCCCCeEEccccchhhhhhhhhhhhcccccccCcceecCCcce
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL---DEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      ..++.|++.|+.|+|+.   +++|+||||+||++   +.++.++|+|||++............|++.|+|||.+.+..++
T Consensus       109 ~~~~~qi~~~l~~lH~~---~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  185 (304)
T 2jam_A          109 SLVIQQVLSAVKYLHEN---GIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMSTACGTPGYVAPEVLAQKPYS  185 (304)
T ss_dssp             HHHHHHHHHHHHHHHHT---TCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBTTHHHHSCCCBCCTTTBSSCSCC
T ss_pred             HHHHHHHHHHHHHHHHC---CccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCccccccCCCCccChHHhccCCCC
Confidence            99999999999999998   99999999999999   6788999999999876554444556789999999999988999


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      .++||
T Consensus       186 ~~~Di  190 (304)
T 2jam_A          186 KAVDC  190 (304)
T ss_dssp             HHHHH
T ss_pred             chhhH
Confidence            99885

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.97  E-value=2.2e-31  Score=195.06  Aligned_cols=156  Identities=26%  Similarity=0.386  Sum_probs=130.4

Q ss_pred             CCCcEEEEEEccccc-cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            4 PDGQIIAVKKLSKKS-TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         4 ~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      .+++.||+|.+.... +.....+.+|+.+++.++||||+++ +.+......++|||++++++|.+++....  ..++...
T Consensus       137 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~--~~~~~~~  214 (377)
T 3cbl_A          137 ADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG--ARLRVKT  214 (377)
T ss_dssp             TTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHG--GGCCHHH
T ss_pred             cCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcC--CCCCHHH
Confidence            368899999986542 3334568899999999999999998 77777778999999999999999987532  2378899


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhh----hhcccccccCcceecCCc
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILK----QIQIELGYIPPEYVGRGV  157 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~----~~~~~~~~~aPE~~~~~~  157 (164)
                      ...++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++.........    ...+++.|+|||.+..+.
T Consensus       215 ~~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  291 (377)
T 3cbl_A          215 LLQMVGDAAAGMEYLESK---CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGR  291 (377)
T ss_dssp             HHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCE
T ss_pred             HHHHHHHHHHHHHHHHHC---CcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCC
Confidence            999999999999999998   9999999999999999999999999998764432221    223567899999998889


Q ss_pred             ceeccCC
Q 046065          158 YYKKFSL  164 (164)
Q Consensus       158 ~~~~~Di  164 (164)
                      ++.++||
T Consensus       292 ~~~~~Dv  298 (377)
T 3cbl_A          292 YSSESDV  298 (377)
T ss_dssp             EEHHHHH
T ss_pred             CCchhhH
Confidence            9999985

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.97  E-value=7.7e-31  Score=190.90  Aligned_cols=156  Identities=24%  Similarity=0.316  Sum_probs=133.1

Q ss_pred             CCCcEEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            4 PDGQIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         4 ~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      .+++.||+|.+... .+.....+.+|+.+++.++||||+++ +.+...+..++|||++++++|.+++.....   ++...
T Consensus        56 ~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~  132 (360)
T 3eqc_A           56 PSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQI  132 (360)
T ss_dssp             TTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSS---CCHHH
T ss_pred             CCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHcCC---CCHHH
Confidence            46889999998755 33445678899999999999999997 777778889999999999999999876433   88899


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCcceecCCcceec
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKK  161 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~  161 (164)
                      ...++.+++.|+.|+|+.+  +++|+||||+||+++.++.++|+|||++............|++.|+|||++.+..++.+
T Consensus       133 ~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  210 (360)
T 3eqc_A          133 LGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQ  210 (360)
T ss_dssp             HHHHHHHHHHHHHHHHHHH--CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC----CCCCTTCCHHHHTTCCCSHH
T ss_pred             HHHHHHHHHHHHHHHHHhC--CEEcCCccHHHEEECCCCCEEEEECCCCcccccccccCCCCCCCeECHHHHcCCCCCch
Confidence            9999999999999999831  79999999999999999999999999997766555566789999999999998899999


Q ss_pred             cCC
Q 046065          162 FSL  164 (164)
Q Consensus       162 ~Di  164 (164)
                      +||
T Consensus       211 ~Di  213 (360)
T 3eqc_A          211 SDI  213 (360)
T ss_dssp             HHH
T ss_pred             hhH
Confidence            885

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.97  E-value=4.5e-31  Score=189.71  Aligned_cols=162  Identities=36%  Similarity=0.617  Sum_probs=134.6

Q ss_pred             cCCCcEEEEEEccccc-cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccc-ccccCH
Q 046065            3 LPDGQIIAVKKLSKKS-TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIR-MLILDC   79 (164)
Q Consensus         3 ~~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~~   79 (164)
                      ..+++.||+|.+.... ......+..|+.+++.++||||+++ +.+......++|||++++++|.+++..... ...+++
T Consensus        51 ~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~  130 (326)
T 3uim_A           51 LADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDW  130 (326)
T ss_dssp             CSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCH
T ss_pred             ecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCH
Confidence            3568899999987552 2233468899999999999999998 777777888999999999999999976432 234888


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh---hhhhhcccccccCcceecCC
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM---ILKQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~~aPE~~~~~  156 (164)
                      .....++.|++.||.|||+.+..+++|+||||+||+++.++.++|+|||++......   ......||+.|+|||++.+.
T Consensus       131 ~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  210 (326)
T 3uim_A          131 PKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTG  210 (326)
T ss_dssp             HHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHS
T ss_pred             HHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccC
Confidence            999999999999999999976678999999999999999999999999999765422   22345689999999999888


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .++.++||
T Consensus       211 ~~~~~~Di  218 (326)
T 3uim_A          211 KSSEKTDV  218 (326)
T ss_dssp             EECHHHHH
T ss_pred             CCCccccc
Confidence            89999885

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.97  E-value=1.2e-30  Score=182.89  Aligned_cols=155  Identities=25%  Similarity=0.451  Sum_probs=131.3

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      .+++.||+|.+.... ...+.+.+|+.+++.++||||+++ +.+...+..++|||++++++|.+++.....  .++....
T Consensus        32 ~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~  108 (269)
T 4hcu_A           32 LNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG--LFAAETL  108 (269)
T ss_dssp             TTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTTT--CCCHHHH
T ss_pred             cCCCeEEEEEecccc-cCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcCc--ccCHHHH
Confidence            357789999986543 234678899999999999999998 777777889999999999999999865332  3788999


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh---hhhhcccccccCcceecCCcce
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI---LKQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      ..++.|++.|+.|+|+.   +++|+||||+||+++.++.++|+|||++.......   .....+++.|+|||.+.+..++
T Consensus       109 ~~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  185 (269)
T 4hcu_A          109 LGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS  185 (269)
T ss_dssp             HHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCC
T ss_pred             HHHHHHHHHHHHHHHhC---CeecCCcchheEEEcCCCCEEeccccccccccccccccccCcccccccCCHHHhcCCCCC
Confidence            99999999999999998   99999999999999999999999999997664332   2345567789999999888899


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      .++||
T Consensus       186 ~~~Di  190 (269)
T 4hcu_A          186 SKSDV  190 (269)
T ss_dssp             HHHHH
T ss_pred             chhhh
Confidence            99885

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.97  E-value=2e-31  Score=190.57  Aligned_cols=155  Identities=23%  Similarity=0.297  Sum_probs=123.3

Q ss_pred             CCCcEEEEEEccccc---cccHHHHHHHHHHHhccCCCceeeE-eEEeeCC----cEEEEEEecCCCChhhhhhCccccc
Q 046065            4 PDGQIIAVKKLSKKS---TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQ----EYMLIYEYMPKRSLDYFLFDPIRML   75 (164)
Q Consensus         4 ~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~   75 (164)
                      .+++.||+|.+....   +.....+.+|+.+++.++||||+++ +.+....    ..++|||++++++|.+++.....  
T Consensus        35 ~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~--  112 (311)
T 3ork_A           35 RDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP--  112 (311)
T ss_dssp             TTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHHCS--
T ss_pred             CCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhcCC--
Confidence            578899999987552   2334578899999999999999997 5544433    24899999999999999875432  


Q ss_pred             ccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh-----hhhhhcccccccCc
Q 046065           76 ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM-----ILKQIQIELGYIPP  150 (164)
Q Consensus        76 ~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~~~~aP  150 (164)
                       +++.....++.|++.||.|+|++   +++|+||||+||+++.++.++|+|||++......     ......|++.|+||
T Consensus       113 -~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aP  188 (311)
T 3ork_A          113 -MTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSP  188 (311)
T ss_dssp             -CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEETTSCEEECCCSCC------------------CCTTCCH
T ss_pred             -CCHHHHHHHHHHHHHHHHHHHHC---CCCcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcccCCH
Confidence             88999999999999999999998   9999999999999999999999999999765432     12345789999999


Q ss_pred             ceecCCcceeccCC
Q 046065          151 EYVGRGVYYKKFSL  164 (164)
Q Consensus       151 E~~~~~~~~~~~Di  164 (164)
                      |++.+..++.++||
T Consensus       189 E~~~~~~~~~~~Di  202 (311)
T 3ork_A          189 EQARGDSVDARSDV  202 (311)
T ss_dssp             HHHHTCCCCHHHHH
T ss_pred             HHhcCCCCCchHhH
Confidence            99998899999985

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.97  E-value=6.6e-31  Score=189.85  Aligned_cols=158  Identities=28%  Similarity=0.473  Sum_probs=131.8

Q ss_pred             CCCcEEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccc--------
Q 046065            4 PDGQIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIR--------   73 (164)
Q Consensus         4 ~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------   73 (164)
                      .+++.||+|.+... .....+.+.+|+.+++.++||||+++ +.+......++|||++++++|.+++.....        
T Consensus        75 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~  154 (343)
T 1luf_A           75 EPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH  154 (343)
T ss_dssp             SSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC--------
T ss_pred             CCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCccccccccc
Confidence            45688999998755 33345678899999999999999998 777777889999999999999999865321        


Q ss_pred             -------------ccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh---
Q 046065           74 -------------MLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI---  137 (164)
Q Consensus        74 -------------~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~---  137 (164)
                                   ...+++.....++.|++.||.|||++   +++|+||||+||+++.++.++|+|||++.......   
T Consensus       155 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~  231 (343)
T 1luf_A          155 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK  231 (343)
T ss_dssp             --------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC
T ss_pred             ccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEECCCCeEEEeecCCCcccccCcccc
Confidence                         13488899999999999999999998   99999999999999999999999999997664322   


Q ss_pred             -hhhhcccccccCcceecCCcceeccCC
Q 046065          138 -LKQIQIELGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       138 -~~~~~~~~~~~aPE~~~~~~~~~~~Di  164 (164)
                       .....+++.|+|||++.+..++.++||
T Consensus       232 ~~~~~~~t~~y~aPE~~~~~~~~~~~Di  259 (343)
T 1luf_A          232 ADGNDAIPIRWMPPESIFYNRYTTESDV  259 (343)
T ss_dssp             ----CCBCGGGCCHHHHHHCCCCHHHHH
T ss_pred             ccCCCcccceecChhhhccCCcCccccc
Confidence             234567889999999988889999885

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.97  E-value=6.6e-31  Score=191.95  Aligned_cols=158  Identities=28%  Similarity=0.420  Sum_probs=130.1

Q ss_pred             CCCcEEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcc----ccccc
Q 046065            4 PDGQIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPI----RMLIL   77 (164)
Q Consensus         4 ~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~----~~~~~   77 (164)
                      .+++.||||.+... .......+.+|+.+++.++||||+++ +.+......++|||++++++|.+++....    ....+
T Consensus        99 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~  178 (367)
T 3l9p_A           99 PSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSL  178 (367)
T ss_dssp             -CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCC
T ss_pred             CcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccc
Confidence            35678999998644 33344568899999999999999997 77777778899999999999999987532    12338


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCC---CeEEccccchhhhhhhh----hhhhcccccccCc
Q 046065           78 DCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL---KPKISDFGLARILRKMI----LKQIQIELGYIPP  150 (164)
Q Consensus        78 ~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~---~~~l~dfg~~~~~~~~~----~~~~~~~~~~~aP  150 (164)
                      +...+..++.|++.||.|||+.   +|+||||||+||+++.++   .++|+|||+++......    .....+|+.|+||
T Consensus       179 ~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aP  255 (367)
T 3l9p_A          179 AMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPP  255 (367)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCH
T ss_pred             cHHHHHHHHHHHHHHHHHHHhC---CeeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECH
Confidence            8889999999999999999998   999999999999998554   59999999997664322    1345678899999


Q ss_pred             ceecCCcceeccCC
Q 046065          151 EYVGRGVYYKKFSL  164 (164)
Q Consensus       151 E~~~~~~~~~~~Di  164 (164)
                      |++.+..++.++||
T Consensus       256 E~~~~~~~~~~~Dv  269 (367)
T 3l9p_A          256 EAFMEGIFTSKTDT  269 (367)
T ss_dssp             HHHHHCCCCHHHHH
T ss_pred             HHhcCCCCCcHHHH
Confidence            99988899999985

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.97  E-value=1.2e-30  Score=203.14  Aligned_cols=155  Identities=26%  Similarity=0.309  Sum_probs=131.7

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccC
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILD   78 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~   78 (164)
                      .+++.||||.+.+.   .......+..|..++..+ +||+|+.+ ..+.....+|+||||+++|+|..++.....   ++
T Consensus       364 ~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~---~~  440 (674)
T 3pfq_A          364 GTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGR---FK  440 (674)
T ss_dssp             SSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHHHSS---CC
T ss_pred             CCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhcCC---CC
Confidence            46789999998754   234456778899999988 69999998 445556778999999999999999876433   88


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhh--hhhhhhhcccccccCcceecCC
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILR--KMILKQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~--~~~~~~~~~~~~~~aPE~~~~~  156 (164)
                      +..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++....  .......+||+.|+|||++.+.
T Consensus       441 ~~~~~~~~~qi~~aL~~LH~~---gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~  517 (674)
T 3pfq_A          441 EPHAVFYAAEIAIGLFFLQSK---GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQ  517 (674)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHT---SEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCC
T ss_pred             HHHHHHHHHHHHHHHHHHHhC---CeEeccCChhhEEEcCCCcEEEeecceeeccccCCcccccccCCCcccCHhhhcCC
Confidence            999999999999999999998   99999999999999999999999999997532  2233567899999999999999


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .|+.++||
T Consensus       518 ~~~~~~Dv  525 (674)
T 3pfq_A          518 PYGKSVDW  525 (674)
T ss_dssp             CBSTHHHH
T ss_pred             CCCccceE
Confidence            99999985

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.97  E-value=1.4e-30  Score=183.46  Aligned_cols=155  Identities=27%  Similarity=0.398  Sum_probs=128.6

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+++.||+|.+...   .......+.+|+.+++.++||||+++ +.+......++|||++++++|.+.+.....   ++.
T Consensus        32 ~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~---~~~  108 (279)
T 3fdn_A           32 QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDE  108 (279)
T ss_dssp             TTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSS---CCH
T ss_pred             cCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHhcCC---CCH
Confidence            45778999998644   22334668899999999999999998 777777789999999999999988865433   889


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCcceecCCcce
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      .....++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++............+++.|+|||.+.+..++
T Consensus       109 ~~~~~~~~qi~~~l~~LH~~---~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  185 (279)
T 3fdn_A          109 QRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMHD  185 (279)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---TCEECCCCGGGEEECTTSCEEECSCCEESCC--------CCCCTTCCHHHHTTCCCC
T ss_pred             HHHHHHHHHHHHHHHHHHhC---CEecccCChHhEEEcCCCCEEEEeccccccCCcccccccCCCCCccCHhHhccCCCC
Confidence            99999999999999999988   999999999999999999999999999876655555667899999999999888889


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      .++||
T Consensus       186 ~~~Di  190 (279)
T 3fdn_A          186 EKVDL  190 (279)
T ss_dssp             TTHHH
T ss_pred             ccchh
Confidence            88885

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.97  E-value=9.6e-31  Score=195.85  Aligned_cols=156  Identities=28%  Similarity=0.404  Sum_probs=130.9

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeEeEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRV   83 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~   83 (164)
                      .++..||||.+.... ...+.+.+|+.+++.++||||+++..+......++|||++++|+|.+++..... ..++.....
T Consensus       210 ~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~-~~~~~~~~~  287 (454)
T 1qcf_A          210 NKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEG-SKQPLPKLI  287 (454)
T ss_dssp             TTTEEEEEEEECTTS-BCHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEECCCTTCBHHHHHHSHHH-HTCCHHHHH
T ss_pred             CCccEEEEEEecCCC-ccHHHHHHHHHHHhhCCCCCEeeEEEEEeCCccEEEEeecCCCcHHHHHHhccC-CCCCHHHHH
Confidence            456789999986543 346788999999999999999998444556778999999999999999975322 237888899


Q ss_pred             HHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh---hhhcccccccCcceecCCccee
Q 046065           84 HIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL---KQIQIELGYIPPEYVGRGVYYK  160 (164)
Q Consensus        84 ~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~  160 (164)
                      .++.|++.||.|||++   +++||||||+||+++.++.+||+|||+++.......   ....+++.|+|||++....++.
T Consensus       288 ~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  364 (454)
T 1qcf_A          288 DFSAQIAEGMAFIEQR---NYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTI  364 (454)
T ss_dssp             HHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCH
T ss_pred             HHHHHHHHHHHHHHhC---CccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCc
Confidence            9999999999999998   999999999999999999999999999987643322   3344677899999998889999


Q ss_pred             ccCC
Q 046065          161 KFSL  164 (164)
Q Consensus       161 ~~Di  164 (164)
                      ++||
T Consensus       365 ~~Dv  368 (454)
T 1qcf_A          365 KSDV  368 (454)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            9985

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.97  E-value=1.8e-30  Score=186.91  Aligned_cols=152  Identities=23%  Similarity=0.333  Sum_probs=112.7

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccC-CCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQ-HLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      .+++.||+|.+...   ....+.+|+.+++.+. ||||+++ +.+......++|||++++++|.+++.....   +++..
T Consensus        34 ~~~~~vavK~~~~~---~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~  107 (325)
T 3kn6_A           34 KSNQAFAVKIISKR---MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKH---FSETE  107 (325)
T ss_dssp             TTCCEEEEEEEEGG---GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHCSC---CCHHH
T ss_pred             CCCCEEEEEEEChh---hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHhcCC---CCHHH
Confidence            46889999998643   3356778999999996 9999998 777777789999999999999998876433   88999


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCC---CeEEccccchhhhhh--hhhhhhcccccccCcceecCC
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL---KPKISDFGLARILRK--MILKQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~---~~~l~dfg~~~~~~~--~~~~~~~~~~~~~aPE~~~~~  156 (164)
                      +..++.|++.||.|||+.   +++|+||||+||+++..+   .++|+|||++.....  ......++|+.|+|||++.+.
T Consensus       108 ~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~  184 (325)
T 3kn6_A          108 ASYIMRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQN  184 (325)
T ss_dssp             HHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----------------------C
T ss_pred             HHHHHHHHHHHHHHHHHC---CCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcCC
Confidence            999999999999999998   999999999999997765   799999999975542  223556789999999999989


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .++.++||
T Consensus       185 ~~~~~~Di  192 (325)
T 3kn6_A          185 GYDESCDL  192 (325)
T ss_dssp             CCCHHHHH
T ss_pred             CCCCccch
Confidence            99999885

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.97  E-value=3.9e-30  Score=180.97  Aligned_cols=154  Identities=23%  Similarity=0.323  Sum_probs=131.5

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      .+++.+|+|.+........+.+.+|+.+++.++||||+++ +.+......++|||++++++|.+.+.....   +++...
T Consensus        32 ~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~~~  108 (277)
T 3f3z_A           32 GTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRV---FRESDA  108 (277)
T ss_dssp             TTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCS---CCHHHH
T ss_pred             CCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHcCC---CCHHHH
Confidence            4577899999876655567788999999999999999998 777777789999999999999888765433   889999


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceee---cCCCCeEEccccchhhhhhh-hhhhhcccccccCcceecCCcc
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL---DEDLKPKISDFGLARILRKM-ILKQIQIELGYIPPEYVGRGVY  158 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili---~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~  158 (164)
                      ..++.|++.|+.|+|+.   +++|+||||+||++   +.++.++|+|||++...... ......+++.|+|||++.+ .+
T Consensus       109 ~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~  184 (277)
T 3f3z_A          109 ARIMKDVLSAVAYCHKL---NVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEG-LY  184 (277)
T ss_dssp             HHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTT-CB
T ss_pred             HHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccchhccCCCCCccChHHhcc-cC
Confidence            99999999999999998   99999999999999   77889999999998765433 2345678999999999864 48


Q ss_pred             eeccCC
Q 046065          159 YKKFSL  164 (164)
Q Consensus       159 ~~~~Di  164 (164)
                      +.++||
T Consensus       185 ~~~~Di  190 (277)
T 3f3z_A          185 GPECDE  190 (277)
T ss_dssp             CTTHHH
T ss_pred             Cchhhe
Confidence            888885

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.97  E-value=1.3e-30  Score=184.37  Aligned_cols=151  Identities=24%  Similarity=0.350  Sum_probs=129.4

Q ss_pred             cEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHHHH
Q 046065            7 QIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHI   85 (164)
Q Consensus         7 ~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~   85 (164)
                      ..||+|.+........+.+.+|+.+++.++||||+++ +.+...+..++|||++++++|.+++.....  .++......+
T Consensus        41 ~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~i  118 (289)
T 4fvq_A           41 TEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKN--CINILWKLEV  118 (289)
T ss_dssp             EEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTGG--GCCHHHHHHH
T ss_pred             hhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCCC--CCCHHHHHHH
Confidence            5799999876666667789999999999999999997 777777888999999999999999875432  2788999999


Q ss_pred             HHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCC--------eEEccccchhhhhhhhhhhhcccccccCcceecC-C
Q 046065           86 IKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK--------PKISDFGLARILRKMILKQIQIELGYIPPEYVGR-G  156 (164)
Q Consensus        86 ~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~--------~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~-~  156 (164)
                      +.|++.||.|||+.   +++|+||||+||+++.++.        ++|+|||++......  ....+++.|+|||++.+ .
T Consensus       119 ~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~y~aPE~~~~~~  193 (289)
T 4fvq_A          119 AKQLAAAMHFLEEN---TLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK--DILQERIPWVPPECIENPK  193 (289)
T ss_dssp             HHHHHHHHHHHHHT---TCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH--HHHHHTTTTSCHHHHHCGG
T ss_pred             HHHHHHHHHHHhhC---CeECCCcCcceEEEecCCcccccccceeeeccCcccccccCc--cccCCcCcccCHHHhCCCC
Confidence            99999999999998   9999999999999988876        999999998655332  33557889999999977 6


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .++.++||
T Consensus       194 ~~~~~~Di  201 (289)
T 4fvq_A          194 NLNLATDK  201 (289)
T ss_dssp             GCCHHHHH
T ss_pred             CCCchhHH
Confidence            78988885

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.97  E-value=2.1e-30  Score=193.83  Aligned_cols=153  Identities=26%  Similarity=0.421  Sum_probs=126.9

Q ss_pred             CCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCC-cEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            5 DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQ-EYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      +++.||||.+....  ..+.+.+|+.+++.++||||+++ +.+.... ..++|||++++|+|.+++..... ..++....
T Consensus       215 ~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~-~~~~~~~~  291 (450)
T 1k9a_A          215 RGNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCL  291 (450)
T ss_dssp             TTEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCT-TTCCHHHH
T ss_pred             cCCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCC-CCCCHHHH
Confidence            46789999986543  45678999999999999999997 6655544 68999999999999999975422 22688899


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCcceecCCcceecc
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKKF  162 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~  162 (164)
                      ..++.|++.||.|||++   +++||||||+||+++.++.+||+|||+++..... .....+++.|+|||++.+..++.++
T Consensus       292 ~~~~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~s  367 (450)
T 1k9a_A          292 LKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-QDTGKLPVKWTAPEALREKKFSTKS  367 (450)
T ss_dssp             HHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTSCEEECCCTTCEECC-------CCCTTTSCHHHHHSSCCCHHH
T ss_pred             HHHHHHHHHHHHHHHhC---CeeCCCCCHhhEEECCCCCEEEeeCCCccccccc-ccCCCCCcceeCHHHhcCCCCCcHH
Confidence            99999999999999998   9999999999999999999999999998754322 2233668899999999999999999


Q ss_pred             CC
Q 046065          163 SL  164 (164)
Q Consensus       163 Di  164 (164)
                      ||
T Consensus       368 Dv  369 (450)
T 1k9a_A          368 DV  369 (450)
T ss_dssp             HH
T ss_pred             HH
Confidence            85

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.97  E-value=2.6e-30  Score=183.68  Aligned_cols=154  Identities=25%  Similarity=0.368  Sum_probs=124.6

Q ss_pred             CCCcEEEEEEcccccc--------------------------ccHHHHHHHHHHHhccCCCceeeE-eEEee--CCcEEE
Q 046065            4 PDGQIIAVKKLSKKST--------------------------QGFEEFKNEVMLTAKLQHLNLIRV-GFCIE--TQEYML   54 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~--------------------------~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~--~~~~~l   54 (164)
                      .+++.||+|.+.....                          ...+.+.+|+.+++.++||||+++ +.+..  ....++
T Consensus        36 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l  115 (298)
T 2zv2_A           36 NDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYM  115 (298)
T ss_dssp             TTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEE
T ss_pred             CCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEE
Confidence            5688999999865421                          123567899999999999999998 55554  456889


Q ss_pred             EEEecCCCChhhhhhCcccccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhh
Q 046065           55 IYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILR  134 (164)
Q Consensus        55 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~  134 (164)
                      |||++++++|.++....    .+++.....++.|++.||.|+|+.   +++|+||||+||+++.++.++|+|||++....
T Consensus       116 v~e~~~~~~l~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~  188 (298)
T 2zv2_A          116 VFELVNQGPVMEVPTLK----PLSEDQARFYFQDLIKGIEYLHYQ---KIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK  188 (298)
T ss_dssp             EEECCTTCBSCCSSCSS----CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECS
T ss_pred             EEecCCCCcHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEECCCCCEEEecCCCccccc
Confidence            99999999998765432    388999999999999999999998   99999999999999999999999999997654


Q ss_pred             hh--hhhhhcccccccCcceecCCc---ceeccCC
Q 046065          135 KM--ILKQIQIELGYIPPEYVGRGV---YYKKFSL  164 (164)
Q Consensus       135 ~~--~~~~~~~~~~~~aPE~~~~~~---~~~~~Di  164 (164)
                      ..  ......||+.|+|||++.+..   ++.++||
T Consensus       189 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di  223 (298)
T 2zv2_A          189 GSDALLSNTVGTPAFMAPESLSETRKIFSGKALDV  223 (298)
T ss_dssp             SSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHH
T ss_pred             cccccccCCcCCccccChhhhccCCCCCCCchhhh
Confidence            32  224567999999999997654   3677774

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.97  E-value=2.6e-30  Score=184.98  Aligned_cols=155  Identities=24%  Similarity=0.352  Sum_probs=125.8

Q ss_pred             CCCcEEEEEEccccc--cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            4 PDGQIIAVKKLSKKS--TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         4 ~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      .+++.||+|.+....  ......+.+|+.+++.++||||+++ +.+......++|||++++ +|.+.+.....  .+++.
T Consensus        43 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~--~~~~~  119 (311)
T 3niz_A           43 SQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKT--GLQDS  119 (311)
T ss_dssp             TTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCSE-EHHHHHHTCTT--CCCHH
T ss_pred             CCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCCC-CHHHHHHhccC--CCCHH
Confidence            468899999986542  2234678899999999999999998 777777889999999985 77777765322  38899


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh--hhhhhhcccccccCcceecC-Cc
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK--MILKQIQIELGYIPPEYVGR-GV  157 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~~aPE~~~~-~~  157 (164)
                      .+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....  .......+|+.|+|||++.+ ..
T Consensus       120 ~~~~~~~qi~~~l~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~  196 (311)
T 3niz_A          120 QIKIYLYQLLRGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKK  196 (311)
T ss_dssp             HHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCS
T ss_pred             HHHHHHHHHHHHHHHHHHC---CcccCCCchHhEEECCCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCC
Confidence            9999999999999999998   999999999999999999999999999976542  22345678999999999865 56


Q ss_pred             ceeccCC
Q 046065          158 YYKKFSL  164 (164)
Q Consensus       158 ~~~~~Di  164 (164)
                      ++.++||
T Consensus       197 ~~~~~Di  203 (311)
T 3niz_A          197 YSTSVDI  203 (311)
T ss_dssp             CCTHHHH
T ss_pred             CCchHHh
Confidence            7888885

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.97  E-value=3.2e-30  Score=184.87  Aligned_cols=157  Identities=24%  Similarity=0.365  Sum_probs=129.8

Q ss_pred             CCCcEEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcc---cccccC
Q 046065            4 PDGQIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPI---RMLILD   78 (164)
Q Consensus         4 ~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~~~   78 (164)
                      .+++.||+|.+... .....+.+.+|+.+++.++||||+++ +.+...+..++|||+++ ++|.+++....   ....++
T Consensus        28 ~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~  106 (317)
T 2pmi_A           28 TTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLE  106 (317)
T ss_dssp             SSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCC
T ss_pred             CCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CCHHHHHHhccccccccCCC
Confidence            46889999998755 33345678899999999999999998 77777788999999998 58988876421   122388


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh--hhhhhcccccccCcceecCC
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM--ILKQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~~~  156 (164)
                      ...+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++......  ......+|+.|+|||++.+.
T Consensus       107 ~~~~~~~~~qi~~aL~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~  183 (317)
T 2pmi_A          107 LNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGS  183 (317)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTC
T ss_pred             HHHHHHHHHHHHHHHHHHHHC---CeeeCCCChHHeEEcCCCCEEECcCccceecCCCcccCCCCcccccccCchHhhCC
Confidence            899999999999999999998   9999999999999999999999999999765432  23456789999999999664


Q ss_pred             -cceeccCC
Q 046065          157 -VYYKKFSL  164 (164)
Q Consensus       157 -~~~~~~Di  164 (164)
                       .++.++||
T Consensus       184 ~~~~~~~Di  192 (317)
T 2pmi_A          184 RTYSTSIDI  192 (317)
T ss_dssp             CCCCTHHHH
T ss_pred             CCCCcHHHH
Confidence             67888885

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.97  E-value=2.1e-30  Score=188.90  Aligned_cols=154  Identities=25%  Similarity=0.342  Sum_probs=120.9

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      .+++.||+|.+.... .....+.+|+.+++.++||||+++ +.+......++||||+++++|.+++.....   +++..+
T Consensus        43 ~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~  118 (361)
T 3uc3_A           43 LTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGR---FSEDEA  118 (361)
T ss_dssp             TTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSS---CCHHHH
T ss_pred             CCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcCC---CCHHHH
Confidence            468899999986542 233567899999999999999998 777777889999999999999998865433   889999


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCC--eEEccccchhhhhh-hhhhhhcccccccCcceecCCcce
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK--PKISDFGLARILRK-MILKQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~--~~l~dfg~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      ..++.|++.||.|||++   +++|+||||+||+++.++.  +||+|||++..... .......||+.|+|||++.+..++
T Consensus       119 ~~i~~ql~~~L~~LH~~---~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  195 (361)
T 3uc3_A          119 RFFFQQLLSGVSYCHSM---QICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYD  195 (361)
T ss_dssp             HHHHHHHHHHHHHHHHT---TCCSCCCCGGGEEECSSSSCCEEECCCCCC---------------CTTSCHHHHHCSSCC
T ss_pred             HHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCCCCcCCCCcCChhhhcCCCCC
Confidence            99999999999999998   9999999999999987654  99999999875432 233556799999999999888775


Q ss_pred             ec-cCC
Q 046065          160 KK-FSL  164 (164)
Q Consensus       160 ~~-~Di  164 (164)
                      .+ +||
T Consensus       196 ~~~~Di  201 (361)
T 3uc3_A          196 GKIADV  201 (361)
T ss_dssp             HHHHHH
T ss_pred             CCeeee
Confidence            44 774

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.97  E-value=1.5e-30  Score=188.99  Aligned_cols=153  Identities=26%  Similarity=0.385  Sum_probs=115.9

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      .+++.||+|.+....  ..+.+.+|+.+++.++||||+++ +.+......++|||++++++|.+++.....   +++...
T Consensus        76 ~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~  150 (349)
T 2w4o_A           76 GTQKPYALKVLKKTV--DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGY---YSERDA  150 (349)
T ss_dssp             TTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCSS---CCHHHH
T ss_pred             CCCcEEEEEEeccch--hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHhcCC---CCHHHH
Confidence            467899999986442  23557789999999999999998 777777789999999999999998876433   889999


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecC---CCCeEEccccchhhhhhhh-hhhhcccccccCcceecCCcc
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE---DLKPKISDFGLARILRKMI-LKQIQIELGYIPPEYVGRGVY  158 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~---~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~  158 (164)
                      ..++.|++.||.|+|+.   +++|+||||+||+++.   ++.++|+|||++....... .....||+.|+|||++.+..+
T Consensus       151 ~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  227 (349)
T 2w4o_A          151 ADAVKQILEAVAYLHEN---GIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAY  227 (349)
T ss_dssp             HHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESSSSTTCCEEECCCC----------------CGGGSCHHHHTTCCC
T ss_pred             HHHHHHHHHHHHHHHHC---CeEecCCCcccEEEecCCCCCCEEEccCccccccCcccccccccCCCCccCHHHhcCCCC
Confidence            99999999999999998   9999999999999975   7899999999997665432 345678999999999998899


Q ss_pred             eeccCC
Q 046065          159 YKKFSL  164 (164)
Q Consensus       159 ~~~~Di  164 (164)
                      +.++||
T Consensus       228 ~~~~Di  233 (349)
T 2w4o_A          228 GPEVDM  233 (349)
T ss_dssp             CTHHHH
T ss_pred             Ccccch
Confidence            999985

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.97  E-value=1.5e-30  Score=188.28  Aligned_cols=157  Identities=25%  Similarity=0.382  Sum_probs=129.3

Q ss_pred             CCcEEEEEEcccc-ccccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccc-------
Q 046065            5 DGQIIAVKKLSKK-STQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRM-------   74 (164)
Q Consensus         5 ~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~-------   74 (164)
                      +++.||+|.+... .......+.+|+.+++.+ +||||+++ +.+...+..++|||++++++|.+++......       
T Consensus        74 ~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~  153 (344)
T 1rjb_A           74 VSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIE  153 (344)
T ss_dssp             CEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC------
T ss_pred             cceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccc
Confidence            4568999998754 334456789999999999 89999998 7777778899999999999999998764321       


Q ss_pred             -------------cccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh----
Q 046065           75 -------------LILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI----  137 (164)
Q Consensus        75 -------------~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~----  137 (164)
                                   ..+++.....++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.......    
T Consensus       154 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~  230 (344)
T 1rjb_A          154 YENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVV  230 (344)
T ss_dssp             ---------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEE
T ss_pred             hhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCChhhEEEcCCCcEEeCCCccCcccccCcccee
Confidence                         2378889999999999999999998   99999999999999999999999999997664322    


Q ss_pred             hhhhcccccccCcceecCCcceeccCC
Q 046065          138 LKQIQIELGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       138 ~~~~~~~~~~~aPE~~~~~~~~~~~Di  164 (164)
                      .....+++.|+|||.+.+..++.++||
T Consensus       231 ~~~~~~t~~y~aPE~~~~~~~~~~~Di  257 (344)
T 1rjb_A          231 RGNARLPVKWMAPESLFEGIYTIKSDV  257 (344)
T ss_dssp             ETTEEECGGGCCHHHHHHCCCCHHHHH
T ss_pred             ccCccCccCccCHHHhccCCCChhHhH
Confidence            134557788999999988889999885

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.97  E-value=7.3e-31  Score=190.76  Aligned_cols=158  Identities=27%  Similarity=0.387  Sum_probs=129.5

Q ss_pred             CCCcEEEEEEccccc-cccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCC-cEEEEEEecCCCChhhhhhCccc------
Q 046065            4 PDGQIIAVKKLSKKS-TQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQ-EYMLIYEYMPKRSLDYFLFDPIR------   73 (164)
Q Consensus         4 ~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~------   73 (164)
                      .+++.||||.+.... ....+.+.+|+.++..+ +||||+++ +.+...+ ..++||||+++|+|.+++.....      
T Consensus        50 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~  129 (359)
T 3vhe_A           50 ATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK  129 (359)
T ss_dssp             TCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC
T ss_pred             ccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccc
Confidence            456899999987542 33446789999999999 79999998 6666544 48899999999999999875432      


Q ss_pred             ---------------------------------------------------------ccccCHHHHHHHHHHHHHHHHHh
Q 046065           74 ---------------------------------------------------------MLILDCKKRVHIIKGIIQGLLYL   96 (164)
Q Consensus        74 ---------------------------------------------------------~~~~~~~~~~~~~~~~~~~l~~l   96 (164)
                                                                               ...+++.....++.|++.||.||
T Consensus       130 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~L  209 (359)
T 3vhe_A          130 TKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFL  209 (359)
T ss_dssp             ------------------------------------------------------CTTTTCBCHHHHHHHHHHHHHHHHHH
T ss_pred             cccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHH
Confidence                                                                     11278889999999999999999


Q ss_pred             hhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh----hhhhhcccccccCcceecCCcceeccCC
Q 046065           97 QEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM----ILKQIQIELGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus        97 h~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~Di  164 (164)
                      |+.   +++|+||||+||+++.++.++|+|||++......    ......+|+.|+|||++.+..++.++||
T Consensus       210 H~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di  278 (359)
T 3vhe_A          210 ASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDV  278 (359)
T ss_dssp             HHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHH
T ss_pred             HHC---CcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhh
Confidence            998   9999999999999999999999999999765322    1234567889999999988899999985

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.97  E-value=1.4e-30  Score=195.09  Aligned_cols=154  Identities=23%  Similarity=0.399  Sum_probs=121.6

Q ss_pred             CCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEeeC-----CcEEEEEEecCCCChhhhhhCccccc
Q 046065            4 PDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIET-----QEYMLIYEYMPKRSLDYFLFDPIRML   75 (164)
Q Consensus         4 ~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~   75 (164)
                      .+++.||||.+...  .......+.+|+.+++.++||||+++ +.+...     ...|+|||++. ++|..++.....  
T Consensus        76 ~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~--  152 (458)
T 3rp9_A           76 LEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLFRTPVY--  152 (458)
T ss_dssp             C--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCCS-EEHHHHHHSSCC--
T ss_pred             CCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEeccc-cchhhhcccCCC--
Confidence            46889999998654  23345678899999999999999998 444322     45899999874 688888876433  


Q ss_pred             ccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh--------------------
Q 046065           76 ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK--------------------  135 (164)
Q Consensus        76 ~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~--------------------  135 (164)
                       +++..+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||+++....                    
T Consensus       153 -l~~~~~~~~~~qi~~aL~~LH~~---~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~  228 (458)
T 3rp9_A          153 -LTELHIKTLLYNLLVGVKYVHSA---GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLV  228 (458)
T ss_dssp             -CCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC-----------
T ss_pred             -CCHHHHHHHHHHHHHHHHHHHhC---CcCCCCCChhhEEECCCCCEeecccccchhccCccccccccccCccccccccc
Confidence             88999999999999999999998   999999999999999999999999999976531                    


Q ss_pred             ---------hhhhhhcccccccCccee-cCCcceeccCC
Q 046065          136 ---------MILKQIQIELGYIPPEYV-GRGVYYKKFSL  164 (164)
Q Consensus       136 ---------~~~~~~~~~~~~~aPE~~-~~~~~~~~~Di  164 (164)
                               ......+||++|+|||++ ....|+.++||
T Consensus       229 ~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~Di  267 (458)
T 3rp9_A          229 TFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDV  267 (458)
T ss_dssp             ----------------CCCTTCCHHHHTTCCCCCTHHHH
T ss_pred             cccccccccccccCCcccccccChHHhhCCCCCCcHhHH
Confidence                     122456789999999986 56678999885

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.97  E-value=1.3e-30  Score=191.20  Aligned_cols=157  Identities=27%  Similarity=0.411  Sum_probs=132.0

Q ss_pred             CCcEEEEEEcccc-ccccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccc--------
Q 046065            5 DGQIIAVKKLSKK-STQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIR--------   73 (164)
Q Consensus         5 ~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------   73 (164)
                      ++..||+|.+... .......+.+|+.+++.+ +||||+++ +.+...+..++|||++++++|.+++.....        
T Consensus       100 ~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~  179 (382)
T 3tt0_A          100 RVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYN  179 (382)
T ss_dssp             CEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCC
T ss_pred             cceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccc
Confidence            3467999998655 334456788999999999 89999997 777777889999999999999999875321        


Q ss_pred             -----ccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh----hhhhhccc
Q 046065           74 -----MLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM----ILKQIQIE  144 (164)
Q Consensus        74 -----~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~----~~~~~~~~  144 (164)
                           ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++......    ......++
T Consensus       180 ~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t  256 (382)
T 3tt0_A          180 PSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP  256 (382)
T ss_dssp             CCSSCCCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCG
T ss_pred             cccccccccCHHHHHHHHHHHHHHHHHHHhC---CEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCC
Confidence                 12488999999999999999999998   9999999999999999999999999999765432    12345567


Q ss_pred             ccccCcceecCCcceeccCC
Q 046065          145 LGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       145 ~~~~aPE~~~~~~~~~~~Di  164 (164)
                      +.|+|||++.+..++.++||
T Consensus       257 ~~y~aPE~~~~~~~~~~~Di  276 (382)
T 3tt0_A          257 VKWMAPEALFDRIYTHQSDV  276 (382)
T ss_dssp             GGGSCHHHHHSCCCCHHHHH
T ss_pred             cceeCHHHhcCCCCCchhHH
Confidence            88999999999999999985

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.97  E-value=3.4e-30  Score=184.98  Aligned_cols=155  Identities=28%  Similarity=0.358  Sum_probs=132.4

Q ss_pred             CCCcEEEEEEccccccc------cHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccc
Q 046065            4 PDGQIIAVKKLSKKSTQ------GFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLI   76 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~   76 (164)
                      .+|+.||+|.+......      ....+.+|+.+++.++||||+++ +.+......++|||++++++|.+++.....   
T Consensus        35 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---  111 (321)
T 2a2a_A           35 STGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKES---  111 (321)
T ss_dssp             TTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSC---
T ss_pred             CCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHhcCC---
Confidence            46889999998754221      35678899999999999999998 667777789999999999999999876433   


Q ss_pred             cCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCC----CeEEccccchhhhhhhh-hhhhcccccccCcc
Q 046065           77 LDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL----KPKISDFGLARILRKMI-LKQIQIELGYIPPE  151 (164)
Q Consensus        77 ~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~----~~~l~dfg~~~~~~~~~-~~~~~~~~~~~aPE  151 (164)
                      +++.....++.|++.||.|+|+.   +++|+||||+||+++.++    .++|+|||++....... .....|++.|+|||
T Consensus       112 ~~~~~~~~i~~qi~~aL~~lH~~---~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE  188 (321)
T 2a2a_A          112 LSEEEATSFIKQILDGVNYLHTK---KIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPE  188 (321)
T ss_dssp             EEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhC---CeecCCCChHHEEEecCCCCcCCEEEccCccceecCccccccccCCCCCccCcc
Confidence            78899999999999999999998   999999999999999877    79999999997654432 24567899999999


Q ss_pred             eecCCcceeccCC
Q 046065          152 YVGRGVYYKKFSL  164 (164)
Q Consensus       152 ~~~~~~~~~~~Di  164 (164)
                      ++.+..++.++||
T Consensus       189 ~~~~~~~~~~~Di  201 (321)
T 2a2a_A          189 IVNYEPLGLEADM  201 (321)
T ss_dssp             HHTTCCCCTHHHH
T ss_pred             cccCCCCCCcccc
Confidence            9988899999885

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.97  E-value=3.4e-30  Score=182.39  Aligned_cols=155  Identities=22%  Similarity=0.343  Sum_probs=125.7

Q ss_pred             CCCcEEEEEEccccc--cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            4 PDGQIIAVKKLSKKS--TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         4 ~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      .+++.||+|.+....  ......+.+|+.+++.++||||+++ +.+...+..++|||++++ +|.+++....  ..++..
T Consensus        24 ~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~--~~~~~~  100 (288)
T 1ob3_A           24 NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCE--GGLESV  100 (288)
T ss_dssp             TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHTST--TCCCHH
T ss_pred             CCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CHHHHHHhcc--cCCCHH
Confidence            468899999986542  2334678899999999999999998 777777889999999975 8888876532  238889


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh--hhhhhhcccccccCcceecCC-c
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK--MILKQIQIELGYIPPEYVGRG-V  157 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~~aPE~~~~~-~  157 (164)
                      ....++.|++.||.|+|+.   +++|+||||+||+++.++.+||+|||++.....  .......+|+.|+|||++.+. .
T Consensus       101 ~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~  177 (288)
T 1ob3_A          101 TAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKK  177 (288)
T ss_dssp             HHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCS
T ss_pred             HHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEeECccccccCccccccccccccccccCchheeCCCC
Confidence            9999999999999999998   999999999999999999999999999976542  223456789999999999654 5


Q ss_pred             ceeccCC
Q 046065          158 YYKKFSL  164 (164)
Q Consensus       158 ~~~~~Di  164 (164)
                      ++.++||
T Consensus       178 ~~~~~Di  184 (288)
T 1ob3_A          178 YSTTIDI  184 (288)
T ss_dssp             CCTHHHH
T ss_pred             CCcHHHH
Confidence            7888885

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.97  E-value=1.3e-30  Score=186.18  Aligned_cols=157  Identities=29%  Similarity=0.402  Sum_probs=131.3

Q ss_pred             CCcEEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccc---------
Q 046065            5 DGQIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIR---------   73 (164)
Q Consensus         5 ~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---------   73 (164)
                      +++.||+|.+... .....+.+.+|+.+++.++||||+++ +.+...+..++|||++++++|.+++.....         
T Consensus        52 ~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~  131 (314)
T 2ivs_A           52 GYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSG  131 (314)
T ss_dssp             SEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC---
T ss_pred             CcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCccccc
Confidence            4578999998754 33445678899999999999999997 777777889999999999999999875322         


Q ss_pred             ------------ccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh----
Q 046065           74 ------------MLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI----  137 (164)
Q Consensus        74 ------------~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~----  137 (164)
                                  ...++...+..++.|++.||.|+|+.   +++|+||||+||+++.++.++|+|||++.......    
T Consensus       132 ~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~  208 (314)
T 2ivs_A          132 GSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVK  208 (314)
T ss_dssp             -------------CEECHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEEC
T ss_pred             ccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHC---CCcccccchheEEEcCCCCEEEcccccccccccccccee
Confidence                        12378889999999999999999998   99999999999999999999999999987654321    


Q ss_pred             hhhhcccccccCcceecCCcceeccCC
Q 046065          138 LKQIQIELGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       138 ~~~~~~~~~~~aPE~~~~~~~~~~~Di  164 (164)
                      .....+++.|+|||.+.+..++.++||
T Consensus       209 ~~~~~~~~~y~aPE~~~~~~~~~~~Di  235 (314)
T 2ivs_A          209 RSQGRIPVKWMAIESLFDHIYTTQSDV  235 (314)
T ss_dssp             SSCCCSCGGGCCHHHHHHCEECHHHHH
T ss_pred             ccCCCCcccccChhhhcCCCcCchhhH
Confidence            133456788999999988889999885

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.97  E-value=3.3e-30  Score=194.20  Aligned_cols=154  Identities=29%  Similarity=0.424  Sum_probs=131.2

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+++.||+|.+...   .......+.+|+.+++.++||||+++ +.+...+..++|+|++.+++|.+.+.....   +++
T Consensus        49 ~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~  125 (484)
T 3nyv_A           49 ITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKR---FSE  125 (484)
T ss_dssp             TTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSC---CBH
T ss_pred             CCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHhcCC---CCH
Confidence            47889999998654   23456778999999999999999998 777777889999999999999888866433   889


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeec---CCCCeEEccccchhhhhhh-hhhhhcccccccCcceecC
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLD---EDLKPKISDFGLARILRKM-ILKQIQIELGYIPPEYVGR  155 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~---~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~~  155 (164)
                      ..+..++.|++.||.|||++   +++|+||||+||+++   .++.++|+|||++...... ......||+.|+|||++.+
T Consensus       126 ~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~  202 (484)
T 3nyv_A          126 VDAARIIRQVLSGITYMHKN---KIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG  202 (484)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHT
T ss_pred             HHHHHHHHHHHHHHHHHHHC---CeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccccccCCCCccccCceeecC
Confidence            99999999999999999998   999999999999994   5688999999999776533 2355679999999999865


Q ss_pred             CcceeccCC
Q 046065          156 GVYYKKFSL  164 (164)
Q Consensus       156 ~~~~~~~Di  164 (164)
                       .|+.++||
T Consensus       203 -~~~~~~Di  210 (484)
T 3nyv_A          203 -TYDEKCDV  210 (484)
T ss_dssp             -CCCTHHHH
T ss_pred             -CCCCccee
Confidence             68988885

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.97  E-value=2e-30  Score=186.78  Aligned_cols=153  Identities=19%  Similarity=0.130  Sum_probs=129.7

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      .+++.||+|.+.....  .+.+..|+.+++.+ +||||+++ ..+......++|||++ +++|.+++....  ..+++..
T Consensus        32 ~~~~~vavK~~~~~~~--~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~  106 (330)
T 2izr_A           32 YTNEYVAIKLEPMKSR--APQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCD--RTFSLKT  106 (330)
T ss_dssp             TTTEEEEEEEEETTCS--SCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT--TCCCHHH
T ss_pred             CCCcEEEEEEeccccc--hHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHcC--CCCCHHH
Confidence            5788999999864422  24578999999999 89999998 6667777889999999 899999987532  2388999


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCC-----eEEccccchhhhhhhh---------hhhhcccccc
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK-----PKISDFGLARILRKMI---------LKQIQIELGY  147 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~-----~~l~dfg~~~~~~~~~---------~~~~~~~~~~  147 (164)
                      +..++.|++.||.|||+.   +++||||||+||+++.++.     ++|+|||++..+....         .....||+.|
T Consensus       107 ~~~i~~qi~~~l~~LH~~---~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y  183 (330)
T 2izr_A          107 VLMIAIQLISRMEYVHSK---NLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARY  183 (330)
T ss_dssp             HHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTT
T ss_pred             HHHHHHHHHHHHHHHHhC---CeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccc
Confidence            999999999999999998   9999999999999998876     9999999997654321         1356799999


Q ss_pred             cCcceecCCcceeccCC
Q 046065          148 IPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       148 ~aPE~~~~~~~~~~~Di  164 (164)
                      +|||++.+..++.++||
T Consensus       184 ~aPE~~~~~~~~~~~Di  200 (330)
T 2izr_A          184 MSINTHLGKEQSRRDDL  200 (330)
T ss_dssp             CCHHHHTTCCCCHHHHH
T ss_pred             cChHHHcCCCCCchhHH
Confidence            99999999999999985

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.97  E-value=3.5e-30  Score=194.24  Aligned_cols=154  Identities=29%  Similarity=0.403  Sum_probs=128.8

Q ss_pred             CCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            4 PDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         4 ~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      .+++.||+|.+...  .......+.+|+.+++.++||||+++ +.+.....+++|+|++++++|.+.+.....   +++.
T Consensus        45 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---~~~~  121 (486)
T 3mwu_A           45 ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR---FSEH  121 (486)
T ss_dssp             TTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSS---CCHH
T ss_pred             CCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhcCC---CCHH
Confidence            46889999998644  33456778999999999999999998 777777889999999999999888765433   8899


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecC---CCCeEEccccchhhhhhh-hhhhhcccccccCcceecCC
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE---DLKPKISDFGLARILRKM-ILKQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~---~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~~~  156 (164)
                      .+..++.|++.|+.|||+.   +|+|+||||+||+++.   ++.++|+|||++...... ......||+.|+|||++.+ 
T Consensus       122 ~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-  197 (486)
T 3mwu_A          122 DAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-  197 (486)
T ss_dssp             HHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC----CCTTGGGGCCGGGGGS-
T ss_pred             HHHHHHHHHHHHHHHHHHC---CeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCccCCCcCCCCCCCHHHhCC-
Confidence            9999999999999999998   9999999999999954   567999999999766433 2345679999999999964 


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .|+.++||
T Consensus       198 ~~~~~~Di  205 (486)
T 3mwu_A          198 TYDEKCDV  205 (486)
T ss_dssp             CCCHHHHH
T ss_pred             CCCchhhH
Confidence            58888885

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.97  E-value=2.8e-30  Score=192.26  Aligned_cols=154  Identities=27%  Similarity=0.408  Sum_probs=125.5

Q ss_pred             CCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEeeC-----CcEEEEEEecCCCChhhhhhCccccc
Q 046065            4 PDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIET-----QEYMLIYEYMPKRSLDYFLFDPIRML   75 (164)
Q Consensus         4 ~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~   75 (164)
                      .+++.||||.+...  .......+.+|+.+++.++||||+++ +.+...     ...|+|||+++ ++|.+++.....  
T Consensus        49 ~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~--  125 (432)
T 3n9x_A           49 NTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPIF--  125 (432)
T ss_dssp             TTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCS-EEHHHHHHSSCC--
T ss_pred             CCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCC-cCHHHHHhccCC--
Confidence            56889999998654  23345678899999999999999998 544443     45899999986 599988876433  


Q ss_pred             ccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh-------------------
Q 046065           76 ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM-------------------  136 (164)
Q Consensus        76 ~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~-------------------  136 (164)
                       +++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+++.....                   
T Consensus       126 -l~~~~~~~i~~qil~aL~~LH~~---givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~  201 (432)
T 3n9x_A          126 -LTEEHIKTILYNLLLGENFIHES---GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHN  201 (432)
T ss_dssp             -CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEEC----------------------
T ss_pred             -CCHHHHHHHHHHHHHHHHHHHHC---CCCCCCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccc
Confidence             88999999999999999999998   9999999999999999999999999999765321                   


Q ss_pred             -----hhhhhcccccccCccee-cCCcceeccCC
Q 046065          137 -----ILKQIQIELGYIPPEYV-GRGVYYKKFSL  164 (164)
Q Consensus       137 -----~~~~~~~~~~~~aPE~~-~~~~~~~~~Di  164 (164)
                           .....+||++|+|||++ ....|+.++||
T Consensus       202 ~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~Di  235 (432)
T 3n9x_A          202 KNLKKQLTSHVVTRWYRAPELILLQENYTKSIDI  235 (432)
T ss_dssp             ---------CCCCCTTCCHHHHTTCSCCCTHHHH
T ss_pred             cchhccccCCCCCccccCHHHHhcCCCCCccccc
Confidence                 12556889999999986 56678999885

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.97  E-value=5.1e-30  Score=180.44  Aligned_cols=156  Identities=27%  Similarity=0.433  Sum_probs=112.6

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+++.||+|.+...   .....+.+.+|+.+++.++||||+++ +.+...+..++|+|++++++|.+++....  ..+++
T Consensus        34 ~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~  111 (278)
T 3cok_A           34 HTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRV--KPFSE  111 (278)
T ss_dssp             TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTCS--SCCCH
T ss_pred             cCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhcc--CCCCH
Confidence            57889999998644   22335678899999999999999998 77777778899999999999999987642  23889


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh--hhhhhhcccccccCcceecCCc
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK--MILKQIQIELGYIPPEYVGRGV  157 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~  157 (164)
                      .....++.|++.|+.|+|+.   +++|+||||+||+++.++.++|+|||++.....  .......+++.|+|||.+.+..
T Consensus       112 ~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  188 (278)
T 3cok_A          112 NEARHFMHQIITGMLYLHSH---GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSA  188 (278)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT---TEECSSCCGGGEEECTTCCEEECCCTTCEECC-------------------------
T ss_pred             HHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCcceeccCCCCcCCcchhcCCC
Confidence            99999999999999999998   999999999999999999999999999876542  2223467899999999998888


Q ss_pred             ceeccCC
Q 046065          158 YYKKFSL  164 (164)
Q Consensus       158 ~~~~~Di  164 (164)
                      ++.++||
T Consensus       189 ~~~~~Di  195 (278)
T 3cok_A          189 HGLESDV  195 (278)
T ss_dssp             ---CTHH
T ss_pred             CCchhhH
Confidence            8999885

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.97  E-value=3.4e-30  Score=191.16  Aligned_cols=155  Identities=25%  Similarity=0.374  Sum_probs=120.3

Q ss_pred             CCCcEEEEEEccccc--------cccHHHHHHHHHHHhccCCCceeeEeEEeeCCcEEEEEEecCCCChhhhhhCccccc
Q 046065            4 PDGQIIAVKKLSKKS--------TQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRML   75 (164)
Q Consensus         4 ~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~   75 (164)
                      .+++.||+|.+....        ......+.+|+.+++.++||||+++..+......++|||++++++|.+.+.....  
T Consensus       158 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--  235 (419)
T 3i6u_A          158 KTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKR--  235 (419)
T ss_dssp             TTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESSEEEEEEECCTTCBGGGGTSSSCC--
T ss_pred             CCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecCceEEEEEcCCCCcHHHHHhccCC--
Confidence            568899999986542        1122357889999999999999998555566778999999999999888865433  


Q ss_pred             ccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCC---CeEEccccchhhhhhh-hhhhhcccccccCcc
Q 046065           76 ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL---KPKISDFGLARILRKM-ILKQIQIELGYIPPE  151 (164)
Q Consensus        76 ~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~---~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE  151 (164)
                       +++.....++.|++.||.|||++   +++|+||||+||+++..+   .+||+|||++...... .....+||+.|+|||
T Consensus       236 -~~~~~~~~i~~qi~~~l~~LH~~---~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE  311 (419)
T 3i6u_A          236 -LKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPE  311 (419)
T ss_dssp             -CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC-----------CTTCCTT
T ss_pred             -CCHHHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCCCcceEEEeecccceecCCCccccccCCCCCccCce
Confidence             88999999999999999999998   999999999999997544   5999999999876543 235678999999999


Q ss_pred             eec---CCcceeccCC
Q 046065          152 YVG---RGVYYKKFSL  164 (164)
Q Consensus       152 ~~~---~~~~~~~~Di  164 (164)
                      ++.   ...|+.++||
T Consensus       312 ~~~~~~~~~~~~~~Di  327 (419)
T 3i6u_A          312 VLVSVGTAGYNRAVDC  327 (419)
T ss_dssp             TTC----CTTHHHHHH
T ss_pred             eeecCCCCCCCchhhh
Confidence            984   3677888885

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.97  E-value=2.3e-30  Score=182.79  Aligned_cols=155  Identities=25%  Similarity=0.405  Sum_probs=132.7

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+++.||+|.+...   .......+.+|+.+++.++||||+++ +.+...+..++|||++++++|.+++.....   ++.
T Consensus        37 ~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~  113 (284)
T 2vgo_A           37 QNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGR---FDE  113 (284)
T ss_dssp             TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSS---CCH
T ss_pred             CCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhcCC---CCH
Confidence            45788999998644   22334678899999999999999997 777777889999999999999988875432   889


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCcceecCCcce
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      .....++.|++.|+.|+|+.   +++|+||+|+||+++.++.++|+|||++............|++.|+|||++.+..++
T Consensus       114 ~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  190 (284)
T 2vgo_A          114 QRSATFMEELADALHYCHER---KVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLDYLPPEMIEGKTHD  190 (284)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---TEECCCCSGGGEEECTTCCEEECCCTTCEECSSSCBCCCCSCGGGCCHHHHTTCCBC
T ss_pred             HHHHHHHHHHHHHHHHHHHC---CceecCCCHHHEEEcCCCCEEEecccccccCcccccccccCCCCcCCHHHhccCCCC
Confidence            99999999999999999998   999999999999999999999999999866554444556789999999999988899


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      .++||
T Consensus       191 ~~~Di  195 (284)
T 2vgo_A          191 EKVDL  195 (284)
T ss_dssp             TTHHH
T ss_pred             cccch
Confidence            99885

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.97  E-value=3.1e-30  Score=184.53  Aligned_cols=155  Identities=25%  Similarity=0.313  Sum_probs=126.6

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      .+++.||+|.+..........+.+|+.++..+ +||||+++ +.+...+..++|||++++++|.+++.....   +++..
T Consensus        36 ~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~  112 (316)
T 2ac3_A           36 ITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRH---FNELE  112 (316)
T ss_dssp             SSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHSS---CCHHH
T ss_pred             CCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhccCC---CCHHH
Confidence            46889999999766555667889999999885 79999997 777778889999999999999999875432   88999


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCC---eEEccccchhhhhhh---------hhhhhcccccccC
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK---PKISDFGLARILRKM---------ILKQIQIELGYIP  149 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~---~~l~dfg~~~~~~~~---------~~~~~~~~~~~~a  149 (164)
                      ...++.|++.||.|||+.   +++|+||||+||+++.++.   ++|+|||++......         ......||+.|+|
T Consensus       113 ~~~i~~qi~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a  189 (316)
T 2ac3_A          113 ASVVVQDVASALDFLHNK---GIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMA  189 (316)
T ss_dssp             HHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCC
T ss_pred             HHHHHHHHHHHHHHHHhC---CceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccC
Confidence            999999999999999998   9999999999999987765   999999998755321         1134568999999


Q ss_pred             cceecC-----CcceeccCC
Q 046065          150 PEYVGR-----GVYYKKFSL  164 (164)
Q Consensus       150 PE~~~~-----~~~~~~~Di  164 (164)
                      ||++.+     ..++.++||
T Consensus       190 PE~~~~~~~~~~~~~~~~Di  209 (316)
T 2ac3_A          190 PEVVEAFSEEASIYDKRCDL  209 (316)
T ss_dssp             HHHHHHTSHHHHHHTTTHHH
T ss_pred             hHHhhcccccccCCCccccc
Confidence            999964     567888885

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.97  E-value=5e-30  Score=180.92  Aligned_cols=155  Identities=24%  Similarity=0.401  Sum_probs=131.0

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      .++..||+|.+.... ...+.+.+|+.+++.++||||+++ +.+......++|||++++++|.+++.....  .++....
T Consensus        46 ~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~  122 (283)
T 3gen_A           46 RGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH--RFQTQQL  122 (283)
T ss_dssp             TTTEEEEEEEECTTS-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGGG--CCCHHHH
T ss_pred             cCCCeEEEEEecCCC-CCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhcc--CCCHHHH
Confidence            456789999986442 234678899999999999999998 777777789999999999999999876322  2889999


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh---hhhcccccccCcceecCCcce
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL---KQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      ..++.|++.|+.|+|+.   +++|+||||+||+++.++.++|+|||++........   ....+++.|+|||.+.+..++
T Consensus       123 ~~i~~qi~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  199 (283)
T 3gen_A          123 LEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFS  199 (283)
T ss_dssp             HHHHHHHHHHHHHHHHT---TCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCS
T ss_pred             HHHHHHHHHHHHHHHHC---CccCCCCccceEEEcCCCCEEEccccccccccccccccccCCccCcccCCHHHhccCCCC
Confidence            99999999999999998   999999999999999999999999999976643322   334567789999999888899


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      .++||
T Consensus       200 ~~~Dv  204 (283)
T 3gen_A          200 SKSDI  204 (283)
T ss_dssp             HHHHH
T ss_pred             chhhH
Confidence            99885

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.97  E-value=1.6e-30  Score=196.44  Aligned_cols=155  Identities=25%  Similarity=0.409  Sum_probs=131.6

Q ss_pred             CCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHH
Q 046065            5 DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRV   83 (164)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~   83 (164)
                      ++..||||.+... ....+.+.+|+.+++.++||||+++ +.+......++|||++++|+|.+++..... ..++.....
T Consensus       244 ~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~-~~~~~~~~~  321 (495)
T 1opk_A          244 YSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLL  321 (495)
T ss_dssp             GTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCT-TTSCHHHHH
T ss_pred             CCeEEEEEEecCc-ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCc-CCCCHHHHH
Confidence            4778999998654 3346778999999999999999998 777777889999999999999999875322 237889999


Q ss_pred             HHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh---hhhcccccccCcceecCCccee
Q 046065           84 HIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL---KQIQIELGYIPPEYVGRGVYYK  160 (164)
Q Consensus        84 ~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~  160 (164)
                      .++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+++.......   ....+++.|+|||++....++.
T Consensus       322 ~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  398 (495)
T 1opk_A          322 YMATQISSAMEYLEKK---NFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI  398 (495)
T ss_dssp             HHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECH
T ss_pred             HHHHHHHHHHHHHHhC---CcccCCCChhhEEECCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCc
Confidence            9999999999999998   999999999999999999999999999976643322   3345567899999998889999


Q ss_pred             ccCC
Q 046065          161 KFSL  164 (164)
Q Consensus       161 ~~Di  164 (164)
                      ++||
T Consensus       399 ~sDv  402 (495)
T 1opk_A          399 KSDV  402 (495)
T ss_dssp             HHHH
T ss_pred             HHhH
Confidence            9985

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.97  E-value=2.4e-30  Score=183.97  Aligned_cols=156  Identities=26%  Similarity=0.459  Sum_probs=128.9

Q ss_pred             CCCcEEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeE-eEEeeC--CcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIET--QEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+++.||+|.+... .....+.+.+|+.+++.++||||+++ +.+...  ...++|||++++++|.+++.....  .++.
T Consensus        48 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~  125 (302)
T 4e5w_A           48 NTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKN--KINL  125 (302)
T ss_dssp             SCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTT--TCCH
T ss_pred             ccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhccc--cCCH
Confidence            46889999998754 33455778999999999999999998 555554  558899999999999999854322  2889


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh-----hhhhcccccccCcceec
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI-----LKQIQIELGYIPPEYVG  154 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~aPE~~~  154 (164)
                      .....++.|++.||.|+|+.   +++|+||||+||+++.++.++|+|||++.......     .....++..|+|||.+.
T Consensus       126 ~~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  202 (302)
T 4e5w_A          126 KQQLKYAVQICKGMDYLGSR---QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLM  202 (302)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHhhcC---CcccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeec
Confidence            99999999999999999998   99999999999999999999999999997654321     23456788899999998


Q ss_pred             CCcceeccCC
Q 046065          155 RGVYYKKFSL  164 (164)
Q Consensus       155 ~~~~~~~~Di  164 (164)
                      +..++.++||
T Consensus       203 ~~~~~~~~Di  212 (302)
T 4e5w_A          203 QSKFYIASDV  212 (302)
T ss_dssp             HCEEEHHHHH
T ss_pred             CCCCCcchhH
Confidence            8899999885

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.97  E-value=4e-30  Score=185.64  Aligned_cols=149  Identities=17%  Similarity=0.223  Sum_probs=119.6

Q ss_pred             CCcEEEEEEccccc--------cccHHHHHHHHHHHhccC---------CCceeeE-eEEe-------------------
Q 046065            5 DGQIIAVKKLSKKS--------TQGFEEFKNEVMLTAKLQ---------HLNLIRV-GFCI-------------------   47 (164)
Q Consensus         5 ~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~---------h~~i~~~-~~~~-------------------   47 (164)
                      +|+.||||.+....        ....+.+.+|+.+++.++         |||++++ +...                   
T Consensus        42 ~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~  121 (336)
T 2vuw_A           42 DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNST  121 (336)
T ss_dssp             TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHH
T ss_pred             CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHHHHHHHHhhh
Confidence            57899999987542        223467889999988885         8888876 2211                   


Q ss_pred             -----------eCCcEEEEEEecCCCChhhhhhCcccccccCHHHHHHHHHHHHHHHHHhh-hcCCCCeeeCCCCCCcee
Q 046065           48 -----------ETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQ-EYFRLTIIHRDLKVSNIL  115 (164)
Q Consensus        48 -----------~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~lh-~~~~~~iih~dlk~~nil  115 (164)
                                 .....++||||+++|++.+.+.+    ..+++..+..++.|++.||.||| ++   +|+||||||+|||
T Consensus       122 ~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~aL~~lH~~~---~ivHrDlKp~NIL  194 (336)
T 2vuw_A          122 KGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTASLAVAEASL---RFEHRDLHWGNVL  194 (336)
T ss_dssp             TCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHHHHHHHHHH---CCBCSCCCGGGEE
T ss_pred             ccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHhC---CEeECCCCHHHEE
Confidence                       15679999999999976665543    22789999999999999999999 88   9999999999999


Q ss_pred             ecCCC--------------------CeEEccccchhhhhhhhhhhhcccccccCcceecCCcceeccCC
Q 046065          116 LDEDL--------------------KPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       116 i~~~~--------------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di  164 (164)
                      ++.++                    .+||+|||+++....   ....||+.|+|||++.+.. +.++||
T Consensus       195 l~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~---~~~~gt~~y~aPE~~~g~~-~~~~Di  259 (336)
T 2vuw_A          195 LKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD---GIVVFCDVSMDEDLFTGDG-DYQFDI  259 (336)
T ss_dssp             EEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET---TEEECCCCTTCSGGGCCCS-SHHHHH
T ss_pred             EeccCCcceeeeccCccccccCCCceEEEeeccccEecCC---CcEEEeecccChhhhcCCC-ccceeh
Confidence            99886                    899999999976543   2457999999999997555 777775

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.97  E-value=1.9e-30  Score=191.16  Aligned_cols=158  Identities=27%  Similarity=0.371  Sum_probs=131.0

Q ss_pred             CCCcEEEEEEccccc-cccHHHHHHHHHHHhccCCCceeeE-eEEeeCC--cEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKKS-TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQ--EYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~--~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+++.||+|.+.... ....+.+.+|+.+++.++||||+++ +.+....  ..++||||+++++|.+++........+++
T Consensus        32 ~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~  111 (396)
T 4eut_A           32 KTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPE  111 (396)
T ss_dssp             TTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCH
T ss_pred             CCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCH
Confidence            468899999987542 3345677899999999999999998 5555443  57899999999999999987554444899


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceee----cCCCCeEEccccchhhhhhh-hhhhhcccccccCcceec
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL----DEDLKPKISDFGLARILRKM-ILKQIQIELGYIPPEYVG  154 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili----~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~  154 (164)
                      ..+..++.|++.||.|||+.   +|+|+||||+||++    +.++.+||+|||++...... ......||+.|+|||++.
T Consensus       112 ~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~  188 (396)
T 4eut_A          112 SEFLIVLRDVVGGMNHLREN---GIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYE  188 (396)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHC---CEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCCccccccCCccccCHHHhh
Confidence            99999999999999999998   99999999999999    67778999999999766433 335567999999999986


Q ss_pred             C--------CcceeccCC
Q 046065          155 R--------GVYYKKFSL  164 (164)
Q Consensus       155 ~--------~~~~~~~Di  164 (164)
                      +        ..++.++||
T Consensus       189 ~~~~~~~~~~~~~~~~Di  206 (396)
T 4eut_A          189 RAVLRKDHQKKYGATVDL  206 (396)
T ss_dssp             HHCC--CHHHHHHHHHHH
T ss_pred             ccccccccccCCCcHHHH
Confidence            5        567778775

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.97  E-value=5.7e-30  Score=188.94  Aligned_cols=152  Identities=23%  Similarity=0.299  Sum_probs=118.6

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHh-ccCCCceeeE-eEEee----CCcEEEEEEecCCCChhhhhhCccccccc
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTA-KLQHLNLIRV-GFCIE----TQEYMLIYEYMPKRSLDYFLFDPIRMLIL   77 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~-~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~   77 (164)
                      .+++.||+|.+...     ..+.+|+.++. ..+||||+++ +.+..    ...+++||||+++|+|.+++..... ..+
T Consensus        85 ~~~~~vAiK~~~~~-----~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~-~~l  158 (400)
T 1nxk_A           85 RTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD-QAF  158 (400)
T ss_dssp             TTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC----CC
T ss_pred             CCCCEEEEEEeCcc-----hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCC-CCC
Confidence            46889999998532     34677888764 4589999997 54443    3457899999999999999876432 238


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecC---CCCeEEccccchhhhhhh-hhhhhcccccccCccee
Q 046065           78 DCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE---DLKPKISDFGLARILRKM-ILKQIQIELGYIPPEYV  153 (164)
Q Consensus        78 ~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~---~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~  153 (164)
                      ++..+..++.|++.||.|||+.   +|+||||||+||+++.   ++.+||+|||++...... .....+||+.|+|||++
T Consensus       159 ~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~  235 (400)
T 1nxk_A          159 TEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVL  235 (400)
T ss_dssp             BHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-----------CTTCCGGGS
T ss_pred             CHHHHHHHHHHHHHHHHHHHHC---CccccCcCcceEEEecCCCCccEEEEecccccccCCCCccccCCCCCCccCHhhc
Confidence            8999999999999999999998   9999999999999987   788999999999765432 23567889999999999


Q ss_pred             cCCcceeccCC
Q 046065          154 GRGVYYKKFSL  164 (164)
Q Consensus       154 ~~~~~~~~~Di  164 (164)
                      .+..|+.++||
T Consensus       236 ~~~~~~~~~Di  246 (400)
T 1nxk_A          236 GPEKYDKSCDM  246 (400)
T ss_dssp             CCCCSSSHHHH
T ss_pred             CCCCCCCcccH
Confidence            99999999985

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.96  E-value=1.9e-30  Score=187.48  Aligned_cols=156  Identities=24%  Similarity=0.339  Sum_probs=130.7

Q ss_pred             cCCCcEEEEEEcccccc--------ccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCC-ChhhhhhCcc
Q 046065            3 LPDGQIIAVKKLSKKST--------QGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKR-SLDYFLFDPI   72 (164)
Q Consensus         3 ~~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~-~L~~~~~~~~   72 (164)
                      ..+++.||+|.+.....        .....+..|+.+++.++||||+++ +.+...+..++|||++..| +|.+++....
T Consensus        46 ~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~  125 (335)
T 3dls_A           46 KEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHP  125 (335)
T ss_dssp             TTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHTCC
T ss_pred             CCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHhcC
Confidence            35688999999875421        123456789999999999999998 7777777889999998766 9988887644


Q ss_pred             cccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh-hhhhcccccccCcc
Q 046065           73 RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI-LKQIQIELGYIPPE  151 (164)
Q Consensus        73 ~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~aPE  151 (164)
                      .   +++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++....... .....||+.|+|||
T Consensus       126 ~---l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE  199 (335)
T 3dls_A          126 R---LDEPLASYIFRQLVSAVGYLRLK---DIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPE  199 (335)
T ss_dssp             C---CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECCTTCCBCEECSCGGGCCHH
T ss_pred             C---CCHHHHHHHHHHHHHHHHHHHhC---CeEEeccCHHHEEEcCCCcEEEeecccceECCCCCceeccCCCccccChh
Confidence            3   88999999999999999999998   99999999999999999999999999997665432 34567899999999


Q ss_pred             eecCCcc-eeccCC
Q 046065          152 YVGRGVY-YKKFSL  164 (164)
Q Consensus       152 ~~~~~~~-~~~~Di  164 (164)
                      ++.+..+ +.++||
T Consensus       200 ~~~~~~~~~~~~Di  213 (335)
T 3dls_A          200 VLMGNPYRGPELEM  213 (335)
T ss_dssp             HHTTCCBCSHHHHH
T ss_pred             hhcCCCCCCCcccc
Confidence            9988877 788885

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.96  E-value=9e-30  Score=181.92  Aligned_cols=155  Identities=21%  Similarity=0.196  Sum_probs=122.7

Q ss_pred             CCCcEEEEEEccccc---cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKKS---TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+++.||+|.+....   +.....+.+|+.+++.++||||+++ +.+...+..++|+|++++++|.+++.....   +++
T Consensus        57 ~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~  133 (309)
T 2h34_A           57 VRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGP---LAP  133 (309)
T ss_dssp             TTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHHHCS---CCH
T ss_pred             CCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHhcCC---CCH
Confidence            468899999987542   2234678899999999999999998 777778889999999999999999875432   889


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh---hhhhcccccccCcceecCC
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI---LKQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~aPE~~~~~  156 (164)
                      .....++.|++.|+.|+|+.   +++|+||||+||+++.++.++|+|||++.......   .....+++.|+|||.+.+.
T Consensus       134 ~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  210 (309)
T 2h34_A          134 PRAVAIVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSES  210 (309)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSCCC----------------CCGGGCCGGGTCC-
T ss_pred             HHHHHHHHHHHHHHHHHHHC---cCCcCCCChHHEEEcCCCCEEEecCccCccccccccccccccCCCcCccCHHHHcCC
Confidence            99999999999999999998   99999999999999999999999999987654322   2356789999999999988


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .++.++||
T Consensus       211 ~~~~~~Di  218 (309)
T 2h34_A          211 HATYRADI  218 (309)
T ss_dssp             ---CCCHH
T ss_pred             CCCchHhH
Confidence            99999985

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.96  E-value=4.7e-30  Score=179.74  Aligned_cols=155  Identities=26%  Similarity=0.366  Sum_probs=130.6

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      .++..||+|.+.... ...+.+.+|+.+++.++||||+++ +.+......++|||++++++|.+++....  ..+++...
T Consensus        30 ~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~  106 (268)
T 3sxs_A           30 KGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHG--KGLEPSQL  106 (268)
T ss_dssp             TTTEEEEEEEECBTT-BCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHG--GGCCHHHH
T ss_pred             cCceeEEEEEeccCC-CcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcC--CCCCHHHH
Confidence            456789999986442 334678899999999999999998 77777778999999999999999986532  23889999


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh---hhhcccccccCcceecCCcce
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL---KQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      ..++.|++.|+.|+|+.   +++|+||||+||+++.++.++|+|||++........   ....+++.|+|||.+.+..++
T Consensus       107 ~~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  183 (268)
T 3sxs_A          107 LEMCYDVCEGMAFLESH---QFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYS  183 (268)
T ss_dssp             HHHHHHHHHHHHHHHHT---TEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEE
T ss_pred             HHHHHHHHHHHHHHHHC---CeecCCcCcceEEECCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhccCCc
Confidence            99999999999999998   999999999999999999999999999876543322   334456779999999888999


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      .++||
T Consensus       184 ~~~Di  188 (268)
T 3sxs_A          184 SKSDV  188 (268)
T ss_dssp             TTHHH
T ss_pred             hhhhh
Confidence            99985

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.96  E-value=5.8e-30  Score=180.59  Aligned_cols=155  Identities=26%  Similarity=0.390  Sum_probs=130.7

Q ss_pred             CCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            4 PDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         4 ~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      .+++.||+|.+...  .....+.+.+|+.+++.++||||+++ +.+...+..++|||++++++|.+.+.....   ++..
T Consensus        29 ~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~---~~~~  105 (284)
T 3kk8_A           29 TTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF---YSEA  105 (284)
T ss_dssp             TTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSS---CCHH
T ss_pred             CCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHhcCC---CCHH
Confidence            46889999998654  23345678899999999999999998 667777788999999999999887765432   8899


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCC---eEEccccchhhhhhhh-hhhhcccccccCcceecCC
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK---PKISDFGLARILRKMI-LKQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~---~~l~dfg~~~~~~~~~-~~~~~~~~~~~aPE~~~~~  156 (164)
                      ....++.|++.|+.|+|+.   +++|+||||+||+++.++.   ++|+|||++....... .....|++.|+|||++.+.
T Consensus       106 ~~~~~~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  182 (284)
T 3kk8_A          106 DASHCIQQILESIAYCHSN---GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKD  182 (284)
T ss_dssp             HHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHHHHTTC
T ss_pred             HHHHHHHHHHHHHHHHHHC---CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCccccCCCCCcCCcCchhhcCC
Confidence            9999999999999999998   9999999999999986654   9999999987654332 2456789999999999988


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .++.++||
T Consensus       183 ~~~~~~Di  190 (284)
T 3kk8_A          183 PYSKPVDI  190 (284)
T ss_dssp             CBCTHHHH
T ss_pred             CCCcccch
Confidence            99999885

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.96  E-value=3.8e-30  Score=180.39  Aligned_cols=156  Identities=29%  Similarity=0.423  Sum_probs=118.7

Q ss_pred             CCcEEEEEEccccc----cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            5 DGQIIAVKKLSKKS----TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         5 ~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      +++.||+|.+....    ....+.+.+|+.+++.++||||+++ +.+...+..++|||++++++|.+++...    .+++
T Consensus        29 ~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~  104 (271)
T 3dtc_A           29 IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK----RIPP  104 (271)
T ss_dssp             TTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHTSS----CCCH
T ss_pred             cCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhhcC----CCCH
Confidence            47889999986542    2335678899999999999999998 7777777899999999999999888543    3889


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecC--------CCCeEEccccchhhhhhhhhhhhcccccccCcc
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE--------DLKPKISDFGLARILRKMILKQIQIELGYIPPE  151 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~--------~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE  151 (164)
                      .....++.|++.|+.|+|+....+++|+||||+||+++.        ++.++|+|||++............|++.|+|||
T Consensus       105 ~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~y~aPE  184 (271)
T 3dtc_A          105 DILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPE  184 (271)
T ss_dssp             HHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-------------CCGGGSCHH
T ss_pred             HHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCcccccccccccCCCCccceeCHH
Confidence            999999999999999999981122999999999999986        678999999999876655555678999999999


Q ss_pred             eecCCcceeccCC
Q 046065          152 YVGRGVYYKKFSL  164 (164)
Q Consensus       152 ~~~~~~~~~~~Di  164 (164)
                      .+.+..++.++||
T Consensus       185 ~~~~~~~~~~~Di  197 (271)
T 3dtc_A          185 VIRASMFSKGSDV  197 (271)
T ss_dssp             HHHHCCCSHHHHH
T ss_pred             HhccCCCCchhhH
Confidence            9988889999885

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.96  E-value=2.4e-30  Score=200.42  Aligned_cols=154  Identities=25%  Similarity=0.347  Sum_probs=127.4

Q ss_pred             CCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeEeEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            5 DGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         5 ~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      +++.||||.+...  .....+.+..|+.+++.++||||+++..+......++|||++++++|.+++.....   +++..+
T Consensus       395 ~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~---l~~~~~  471 (635)
T 4fl3_A          395 VVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRH---VKDKNI  471 (635)
T ss_dssp             CEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTEEHHHHHHHCTT---CCHHHH
T ss_pred             cceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEEEccCCCCHHHHHhhCCC---CCHHHH
Confidence            4678999998754  23345788999999999999999998444456778899999999999999865433   889999


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh-----hhhhcccccccCcceecCCc
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI-----LKQIQIELGYIPPEYVGRGV  157 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~  157 (164)
                      ..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++..+....     .....+++.|+|||++.+..
T Consensus       472 ~~i~~qi~~~L~yLH~~---~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~  548 (635)
T 4fl3_A          472 IELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK  548 (635)
T ss_dssp             HHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCC
T ss_pred             HHHHHHHHHHHHHHHHC---CEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCC
Confidence            99999999999999998   99999999999999999999999999998764321     13345678899999999889


Q ss_pred             ceeccCC
Q 046065          158 YYKKFSL  164 (164)
Q Consensus       158 ~~~~~Di  164 (164)
                      ++.++||
T Consensus       549 ~~~~sDv  555 (635)
T 4fl3_A          549 FSSKSDV  555 (635)
T ss_dssp             CCHHHHH
T ss_pred             CCcHHHH
Confidence            9999986

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.96  E-value=7.3e-30  Score=192.83  Aligned_cols=154  Identities=28%  Similarity=0.411  Sum_probs=128.5

Q ss_pred             CCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            4 PDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         4 ~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      .+++.||+|.+...  .......+.+|+.+++.++||||+++ +.+......++|||++++++|.+.+.....   +++.
T Consensus        60 ~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~---~~~~  136 (494)
T 3lij_A           60 VTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMK---FNEV  136 (494)
T ss_dssp             TTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSS---CCHH
T ss_pred             CCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHcCC---CCHH
Confidence            46789999998754  23345678899999999999999998 777777889999999999999887765432   8889


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCC---CCeEEccccchhhhhhh-hhhhhcccccccCcceecCC
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED---LKPKISDFGLARILRKM-ILKQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~---~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~~~  156 (164)
                      .+..++.|++.||.|||++   +|+||||||+||+++..   +.+||+|||++...... ......||+.|+|||++. +
T Consensus       137 ~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~  212 (494)
T 3lij_A          137 DAAVIIKQVLSGVTYLHKH---NIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR-K  212 (494)
T ss_dssp             HHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHT-T
T ss_pred             HHHHHHHHHHHHHHHHHHC---CceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccccccCCCcCeeCHHHHc-c
Confidence            9999999999999999998   99999999999999764   45999999999766533 235567999999999985 5


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .|+.++||
T Consensus       213 ~~~~~~Di  220 (494)
T 3lij_A          213 KYDEKCDV  220 (494)
T ss_dssp             CBCTHHHH
T ss_pred             cCCCchhH
Confidence            68999885

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.96  E-value=3.4e-30  Score=185.30  Aligned_cols=156  Identities=26%  Similarity=0.431  Sum_probs=131.6

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEe--eCCcEEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCI--ETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~--~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      .+++.||+|.+........+.+.+|+.+++.++||||+++ +.+.  .....++|||++++++|.+++.....  .++..
T Consensus        50 ~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~  127 (327)
T 3lxl_A           50 NTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRA--RLDAS  127 (327)
T ss_dssp             SCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGG--GCCHH
T ss_pred             CcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhccc--CCCHH
Confidence            4688999999876666566778999999999999999998 5544  34558899999999999999875322  38899


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh-----hhhhcccccccCcceecC
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI-----LKQIQIELGYIPPEYVGR  155 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~aPE~~~~  155 (164)
                      .+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.......     .....+++.|+|||++.+
T Consensus       128 ~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  204 (327)
T 3lxl_A          128 RLLLYSSQICKGMEYLGSR---RCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSD  204 (327)
T ss_dssp             HHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHhC---CccCCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhcc
Confidence            9999999999999999998   99999999999999999999999999997654321     133457788999999988


Q ss_pred             CcceeccCC
Q 046065          156 GVYYKKFSL  164 (164)
Q Consensus       156 ~~~~~~~Di  164 (164)
                      ..++.++||
T Consensus       205 ~~~~~~~Di  213 (327)
T 3lxl_A          205 NIFSRQSDV  213 (327)
T ss_dssp             CEEEHHHHH
T ss_pred             CCCChHHhH
Confidence            889999885

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.96  E-value=5.5e-30  Score=182.88  Aligned_cols=155  Identities=23%  Similarity=0.275  Sum_probs=125.4

Q ss_pred             CCCcEEEEEEccccc--cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            4 PDGQIIAVKKLSKKS--TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         4 ~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      .+|+.||+|.+....  ......+.+|+.+++.++||||+++ +.+...+..++|||++++++|..+......   ++..
T Consensus        26 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~---~~~~  102 (311)
T 4agu_A           26 DTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRG---VPEH  102 (311)
T ss_dssp             TTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTSSC---CCHH
T ss_pred             CCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhhhcC---CCHH
Confidence            468899999886542  2234567889999999999999997 777778889999999999999888765433   8899


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh--hhhhhcccccccCcceecC-Cc
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM--ILKQIQIELGYIPPEYVGR-GV  157 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~~-~~  157 (164)
                      ....++.|++.|+.|+|+.   +++|+||||+||+++.++.++|+|||++......  ......+++.|+|||++.+ ..
T Consensus       103 ~~~~i~~~l~~~l~~lH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  179 (311)
T 4agu_A          103 LVKSITWQTLQAVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQ  179 (311)
T ss_dssp             HHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECC------------GGGCCHHHHHTCSC
T ss_pred             HHHHHHHHHHHHHHHHHHC---CCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCCC
Confidence            9999999999999999998   9999999999999999999999999999765432  2345678999999999965 56


Q ss_pred             ceeccCC
Q 046065          158 YYKKFSL  164 (164)
Q Consensus       158 ~~~~~Di  164 (164)
                      ++.++||
T Consensus       180 ~~~~~Di  186 (311)
T 4agu_A          180 YGPPVDV  186 (311)
T ss_dssp             CCTHHHH
T ss_pred             CCcchhh
Confidence            7888885

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.96  E-value=2.6e-30  Score=193.93  Aligned_cols=152  Identities=28%  Similarity=0.350  Sum_probs=120.5

Q ss_pred             CCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEeeC------CcEEEEEEecCCCChhhhhhCcccc
Q 046065            4 PDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIET------QEYMLIYEYMPKRSLDYFLFDPIRM   74 (164)
Q Consensus         4 ~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~   74 (164)
                      .+++.||+|.+...  .......+.+|+.+++.++||||+++ +.+...      ...++|||++++ ++.+.+..    
T Consensus        85 ~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~~----  159 (464)
T 3ttj_A           85 VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQM----  159 (464)
T ss_dssp             TTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHTS----
T ss_pred             CCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCC-CHHHHHhh----
Confidence            46889999998754  33345678899999999999999998 555433      346899999976 45555533    


Q ss_pred             cccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh-hhhhhcccccccCccee
Q 046065           75 LILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM-ILKQIQIELGYIPPEYV  153 (164)
Q Consensus        75 ~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~  153 (164)
                       .++...+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||++...... .....+||+.|+|||++
T Consensus       160 -~l~~~~~~~~~~qil~aL~~lH~~---~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~  235 (464)
T 3ttj_A          160 -ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI  235 (464)
T ss_dssp             -CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCCC-----CCCC----CCCTTCCHHHH
T ss_pred             -cCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCChHhEEEeCCCCEEEEEEEeeeecCCCcccCCCcccccccCHHHH
Confidence             278889999999999999999998   9999999999999999999999999999876543 23557899999999999


Q ss_pred             cCCcceeccCC
Q 046065          154 GRGVYYKKFSL  164 (164)
Q Consensus       154 ~~~~~~~~~Di  164 (164)
                      .+..|+.++||
T Consensus       236 ~~~~~~~~~Di  246 (464)
T 3ttj_A          236 LGMGYKENVDI  246 (464)
T ss_dssp             TTCCCCTTHHH
T ss_pred             cCCCCCHHHHH
Confidence            99999999985

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.96  E-value=1.2e-29  Score=179.99  Aligned_cols=155  Identities=26%  Similarity=0.358  Sum_probs=132.0

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+++.||+|.+...   .....+.+..|+.+++.++||||+++ +.+...+..++|||++++++|.+++....   .+++
T Consensus        38 ~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~~~~  114 (294)
T 2rku_A           38 DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK---ALTE  114 (294)
T ss_dssp             TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHC---SCCH
T ss_pred             CCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHhcC---CCCH
Confidence            45789999998654   23345678899999999999999998 77777778899999999999998886533   2889


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh--hhhhhcccccccCcceecCCc
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM--ILKQIQIELGYIPPEYVGRGV  157 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~  157 (164)
                      .....++.|++.|+.|+|+.   +++|+||||+||+++.++.++|+|||++......  ......+++.|+|||.+.+..
T Consensus       115 ~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  191 (294)
T 2rku_A          115 PEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKG  191 (294)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSC
T ss_pred             HHHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEcCCCCEEEEeccCceecccCccccccccCCCCcCCcchhccCC
Confidence            99999999999999999998   9999999999999999999999999998765422  234467899999999998888


Q ss_pred             ceeccCC
Q 046065          158 YYKKFSL  164 (164)
Q Consensus       158 ~~~~~Di  164 (164)
                      ++.++||
T Consensus       192 ~~~~~Di  198 (294)
T 2rku_A          192 HSFEVDV  198 (294)
T ss_dssp             BCTHHHH
T ss_pred             CCchhhH
Confidence            8988885

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.96  E-value=4.7e-30  Score=184.71  Aligned_cols=152  Identities=22%  Similarity=0.325  Sum_probs=122.6

Q ss_pred             EEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeEeEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHHHHH
Q 046065            8 IIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHII   86 (164)
Q Consensus         8 ~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~   86 (164)
                      +||+|.+... .......+.+|+.+++.++||||+++..+...+..++++|++++|+|.+++.....  .++...+..++
T Consensus        46 ~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~--~~~~~~~~~~~  123 (327)
T 3poz_A           46 PVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKD--NIGSQYLLNWC  123 (327)
T ss_dssp             EEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSSEEEEEECCTTCBHHHHHHHSTT--SCCHHHHHHHH
T ss_pred             EEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCcHHHHHHhcCC--CCCHHHHHHHH
Confidence            3688887544 34456788999999999999999998544455668899999999999998875322  38889999999


Q ss_pred             HHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh----hhhhcccccccCcceecCCcceecc
Q 046065           87 KGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI----LKQIQIELGYIPPEYVGRGVYYKKF  162 (164)
Q Consensus        87 ~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~  162 (164)
                      .|++.||.|||+.   +++||||||+||+++.++.+||+|||++.......    .....+|+.|+|||.+.+..++.++
T Consensus       124 ~qi~~~l~~LH~~---~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~  200 (327)
T 3poz_A          124 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS  200 (327)
T ss_dssp             HHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHH
T ss_pred             HHHHHHHHHHhhC---CeeCCCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchh
Confidence            9999999999998   99999999999999999999999999998764321    1344567899999999999999999


Q ss_pred             CC
Q 046065          163 SL  164 (164)
Q Consensus       163 Di  164 (164)
                      ||
T Consensus       201 Di  202 (327)
T 3poz_A          201 DV  202 (327)
T ss_dssp             HH
T ss_pred             hh
Confidence            85

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.96  E-value=5.6e-30  Score=197.74  Aligned_cols=155  Identities=23%  Similarity=0.315  Sum_probs=126.9

Q ss_pred             CCcEEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeEeEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHH
Q 046065            5 DGQIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRV   83 (164)
Q Consensus         5 ~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~   83 (164)
                      ++..||||.+... .....+.+.+|+.+++.++||||+++..+...+..++|||++++|+|.+++....  ..+++..+.
T Consensus       362 ~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~  439 (613)
T 2ozo_A          362 KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKR--EEIPVSNVA  439 (613)
T ss_dssp             CEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESSSEEEEEECCTTCBHHHHHTTCT--TTSCHHHHH
T ss_pred             CcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccCCeEEEEEeCCCCcHHHHHhhcc--CCCCHHHHH
Confidence            4567999999755 3445678999999999999999999844445577999999999999999886532  238899999


Q ss_pred             HHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh-----hhhcccccccCcceecCCcc
Q 046065           84 HIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL-----KQIQIELGYIPPEYVGRGVY  158 (164)
Q Consensus        84 ~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~-----~~~~~~~~~~aPE~~~~~~~  158 (164)
                      .++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++.......     ....+++.|+|||++....+
T Consensus       440 ~i~~qi~~~L~~LH~~---~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~  516 (613)
T 2ozo_A          440 ELLHQVSMGMKYLEEK---NFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF  516 (613)
T ss_dssp             HHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCC
T ss_pred             HHHHHHHHHHHHHHHC---CEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCC
Confidence            9999999999999998   999999999999999999999999999986642211     22345678999999988899


Q ss_pred             eeccCC
Q 046065          159 YKKFSL  164 (164)
Q Consensus       159 ~~~~Di  164 (164)
                      +.++||
T Consensus       517 ~~~sDv  522 (613)
T 2ozo_A          517 SSRSDV  522 (613)
T ss_dssp             CHHHHH
T ss_pred             CcHHHH
Confidence            999986

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.96  E-value=6.6e-30  Score=183.27  Aligned_cols=154  Identities=29%  Similarity=0.442  Sum_probs=129.2

Q ss_pred             CCCcEEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeE-eEEeeC--CcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIET--QEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+++.||+|.+... .+...+.+.+|+.+++.++||||+++ +.+...  ...++|||++++++|.+++....    ++.
T Consensus        58 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~  133 (318)
T 3lxp_A           58 GTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHS----IGL  133 (318)
T ss_dssp             -CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGSC----CCH
T ss_pred             CCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhhCC----CCH
Confidence            36889999998765 33445678999999999999999998 666553  46789999999999999986532    888


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh-----hhhhcccccccCcceec
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI-----LKQIQIELGYIPPEYVG  154 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~aPE~~~  154 (164)
                      .....++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++.......     .....++..|+|||++.
T Consensus       134 ~~~~~i~~~l~~~l~~LH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  210 (318)
T 3lxp_A          134 AQLLLFAQQICEGMAYLHAQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLK  210 (318)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhC---CccCCCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhc
Confidence            99999999999999999998   99999999999999999999999999997664321     23456788899999999


Q ss_pred             CCcceeccCC
Q 046065          155 RGVYYKKFSL  164 (164)
Q Consensus       155 ~~~~~~~~Di  164 (164)
                      +..++.++||
T Consensus       211 ~~~~~~~~Di  220 (318)
T 3lxp_A          211 EYKFYYASDV  220 (318)
T ss_dssp             HCEEEHHHHH
T ss_pred             CCCCCcHHHH
Confidence            8899999885

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.96  E-value=8.8e-30  Score=183.86  Aligned_cols=155  Identities=26%  Similarity=0.358  Sum_probs=132.4

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+++.||+|.+...   .....+.+..|+.+++.++||||+++ +.+...+..++|||++++++|.+++....   .+++
T Consensus        64 ~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---~l~~  140 (335)
T 2owb_A           64 DTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK---ALTE  140 (335)
T ss_dssp             TTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHC---SCCH
T ss_pred             CCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhccC---CCCH
Confidence            45789999998654   23345678899999999999999998 77777778999999999999998886533   2889


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh--hhhhhcccccccCcceecCCc
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM--ILKQIQIELGYIPPEYVGRGV  157 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~  157 (164)
                      .....++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++......  ......|++.|+|||++.+..
T Consensus       141 ~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  217 (335)
T 2owb_A          141 PEARYYLRQIVLGCQYLHRN---RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKG  217 (335)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSC
T ss_pred             HHHHHHHHHHHHHHHHHHHC---CCEecCCCchhEEEcCCCCEEEeeccCceecccCcccccccCCCccccCHHHhccCC
Confidence            99999999999999999998   9999999999999999999999999999765422  234567899999999998888


Q ss_pred             ceeccCC
Q 046065          158 YYKKFSL  164 (164)
Q Consensus       158 ~~~~~Di  164 (164)
                      ++.++||
T Consensus       218 ~~~~~Di  224 (335)
T 2owb_A          218 HSFEVDV  224 (335)
T ss_dssp             BCTHHHH
T ss_pred             CCchhhH
Confidence            8988885

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.96  E-value=1.9e-29  Score=178.60  Aligned_cols=154  Identities=27%  Similarity=0.351  Sum_probs=128.5

Q ss_pred             CCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEee----CCcEEEEEEecCCCChhhhhhCcccccc
Q 046065            4 PDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIE----TQEYMLIYEYMPKRSLDYFLFDPIRMLI   76 (164)
Q Consensus         4 ~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~   76 (164)
                      .++..||+|.+...  .....+.+.+|+.+++.++||||+++ +.+..    ....++|||++++++|.+++.....   
T Consensus        49 ~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---  125 (290)
T 1t4h_A           49 ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV---  125 (290)
T ss_dssp             TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSS---
T ss_pred             CCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHccC---
Confidence            46788999998654  33445678899999999999999997 55443    2347899999999999999875432   


Q ss_pred             cCHHHHHHHHHHHHHHHHHhhhcCCCC--eeeCCCCCCceeec-CCCCeEEccccchhhhhhhhhhhhcccccccCccee
Q 046065           77 LDCKKRVHIIKGIIQGLLYLQEYFRLT--IIHRDLKVSNILLD-EDLKPKISDFGLARILRKMILKQIQIELGYIPPEYV  153 (164)
Q Consensus        77 ~~~~~~~~~~~~~~~~l~~lh~~~~~~--iih~dlk~~nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~  153 (164)
                      ++......++.|++.||.|||+.   +  ++|+||||+||+++ .++.++|+|||++............|++.|+|||++
T Consensus       126 ~~~~~~~~~~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~  202 (290)
T 1t4h_A          126 MKIKVLRSWCRQILKGLQFLHTR---TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMY  202 (290)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHTS---SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGG
T ss_pred             CCHHHHHHHHHHHHHHHHHHHcC---CCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccccccccccCCcCcCCHHHH
Confidence            88899999999999999999998   7  99999999999997 788999999999976655545567799999999988


Q ss_pred             cCCcceeccCC
Q 046065          154 GRGVYYKKFSL  164 (164)
Q Consensus       154 ~~~~~~~~~Di  164 (164)
                      . +.++.++||
T Consensus       203 ~-~~~~~~~Di  212 (290)
T 1t4h_A          203 E-EKYDESVDV  212 (290)
T ss_dssp             G-TCCCTHHHH
T ss_pred             h-ccCCCcchH
Confidence            6 568888885

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.96  E-value=3.3e-30  Score=181.78  Aligned_cols=154  Identities=20%  Similarity=0.299  Sum_probs=119.0

Q ss_pred             CcEEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeEeEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHHH
Q 046065            6 GQIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVH   84 (164)
Q Consensus         6 ~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~   84 (164)
                      +..||+|.+... .....+.+.+|+.+++.++||||+++..+...+..++|||++++++|.+++....  ..++......
T Consensus        43 ~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~  120 (281)
T 1mp8_A           43 ALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRK--YSLDLASLIL  120 (281)
T ss_dssp             CEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEEEECCTTEEHHHHHHHTT--TTSCHHHHHH
T ss_pred             ceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEEccCccEEEEecCCCCCHHHHHHhcC--CCCCHHHHHH
Confidence            457999998654 3334567889999999999999999844456677899999999999999986532  2388899999


Q ss_pred             HHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh---hhhcccccccCcceecCCcceec
Q 046065           85 IIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL---KQIQIELGYIPPEYVGRGVYYKK  161 (164)
Q Consensus        85 ~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~~  161 (164)
                      ++.|++.||.|+|+.   +++|+||||+||+++.++.++|+|||++........   ....+++.|+|||++.+..++.+
T Consensus       121 ~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  197 (281)
T 1mp8_A          121 YAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA  197 (281)
T ss_dssp             HHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHHCCCSHH
T ss_pred             HHHHHHHHHHHHHhC---CeecccccHHHEEECCCCCEEECccccccccCcccccccccCCCcccccChhhcccCCCCCc
Confidence            999999999999998   999999999999999999999999999976643321   33456778999999988889999


Q ss_pred             cCC
Q 046065          162 FSL  164 (164)
Q Consensus       162 ~Di  164 (164)
                      +||
T Consensus       198 ~Di  200 (281)
T 1mp8_A          198 SDV  200 (281)
T ss_dssp             HHH
T ss_pred             cCc
Confidence            885

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.96  E-value=2.1e-29  Score=176.97  Aligned_cols=155  Identities=29%  Similarity=0.422  Sum_probs=130.9

Q ss_pred             CCCcEEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            4 PDGQIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         4 ~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      .+++.||+|.+... .....+.+.+|+.+++.++||||+++ +.+...+..++|+|++++++|.+++.....   ++...
T Consensus        30 ~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~  106 (276)
T 2yex_A           30 VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPD  106 (276)
T ss_dssp             TTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTTB---CCHHH
T ss_pred             CCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhhccC---CCHHH
Confidence            46889999998654 33345678899999999999999997 777777888999999999999998865432   88999


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh----hhhhhcccccccCcceecCCc
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM----ILKQIQIELGYIPPEYVGRGV  157 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~  157 (164)
                      ...++.|++.||.|+|+.   +++|+||+|+||+++.++.++|+|||.+......    ......|++.|+|||.+.+..
T Consensus       107 ~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  183 (276)
T 2yex_A          107 AQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE  183 (276)
T ss_dssp             HHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSS
T ss_pred             HHHHHHHHHHHHHHHHhC---CeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCC
Confidence            999999999999999998   9999999999999999999999999998765322    124567899999999998776


Q ss_pred             c-eeccCC
Q 046065          158 Y-YKKFSL  164 (164)
Q Consensus       158 ~-~~~~Di  164 (164)
                      + +.++||
T Consensus       184 ~~~~~~Di  191 (276)
T 2yex_A          184 FHAEPVDV  191 (276)
T ss_dssp             BCHHHHHH
T ss_pred             CCCCcchH
Confidence            5 777875

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.96  E-value=1e-29  Score=181.87  Aligned_cols=154  Identities=23%  Similarity=0.176  Sum_probs=122.2

Q ss_pred             CCCcEEEEEEcccc--ccccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+++.||||.+...  ..........|+..+..+ +||||+++ +.+...+..++|||++ +++|.+++....  ..+++
T Consensus        80 ~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~l~~  156 (311)
T 3p1a_A           80 EDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWG--ASLPE  156 (311)
T ss_dssp             TTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHHC--SCCCH
T ss_pred             CCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHhcC--CCCCH
Confidence            47899999987644  222333455566555555 89999998 7777888899999999 668888776532  23889


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh-hhhhcccccccCcceecCCcc
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI-LKQIQIELGYIPPEYVGRGVY  158 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~  158 (164)
                      ..+..++.|++.||.|||+.   +|+|+||||+||+++.++.+||+|||++....... .....||+.|+|||++.+ .+
T Consensus       157 ~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~  232 (311)
T 3p1a_A          157 AQVWGYLRDTLLALAHLHSQ---GLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG-SY  232 (311)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECGGGCEEECCCTTCEECC------CCCCCGGGCCGGGGGT-CC
T ss_pred             HHHHHHHHHHHHHHHHHHHC---CEecCCCCHHHEEECCCCCEEEccceeeeecccCCCCcccCCCccccCHhHhcC-CC
Confidence            99999999999999999998   99999999999999999999999999987654332 345668999999999865 78


Q ss_pred             eeccCC
Q 046065          159 YKKFSL  164 (164)
Q Consensus       159 ~~~~Di  164 (164)
                      +.++||
T Consensus       233 ~~~~Di  238 (311)
T 3p1a_A          233 GTAADV  238 (311)
T ss_dssp             STHHHH
T ss_pred             CchhhH
Confidence            999885

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.96  E-value=4.1e-30  Score=184.33  Aligned_cols=157  Identities=24%  Similarity=0.376  Sum_probs=130.3

Q ss_pred             CCcEEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccc-------cc
Q 046065            5 DGQIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIR-------ML   75 (164)
Q Consensus         5 ~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------~~   75 (164)
                      +++.||+|.+... .......+.+|+.+++.++||||+++ +.+......++|||++++++|.+++.....       ..
T Consensus        54 ~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~  133 (322)
T 1p4o_A           54 PETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA  133 (322)
T ss_dssp             EEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCC
T ss_pred             CceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCC
Confidence            4678999998654 23344568899999999999999998 777777789999999999999998865321       12


Q ss_pred             ccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh----hhhhcccccccCcc
Q 046065           76 ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI----LKQIQIELGYIPPE  151 (164)
Q Consensus        76 ~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~aPE  151 (164)
                      .++......++.|++.||.|+|+.   +++|+||||+||+++.++.++|+|||++.......    .....+++.|+|||
T Consensus       134 ~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE  210 (322)
T 1p4o_A          134 PPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE  210 (322)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHH
T ss_pred             CcCHHHHHHHHHHHHHHHHHHHHC---CCccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChh
Confidence            367889999999999999999998   99999999999999999999999999997654332    13345688899999


Q ss_pred             eecCCcceeccCC
Q 046065          152 YVGRGVYYKKFSL  164 (164)
Q Consensus       152 ~~~~~~~~~~~Di  164 (164)
                      .+.+..++.++||
T Consensus       211 ~~~~~~~~~~~Di  223 (322)
T 1p4o_A          211 SLKDGVFTTYSDV  223 (322)
T ss_dssp             HHHHCCCCHHHHH
T ss_pred             hhccCCCCchhhH
Confidence            9988889999885

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.96  E-value=1.7e-29  Score=179.83  Aligned_cols=154  Identities=24%  Similarity=0.375  Sum_probs=133.4

Q ss_pred             CCCcEEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            4 PDGQIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         4 ~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      .+++.||+|.+... .....+.+.+|+.+++.++||||+++ +.+......++|||++++++|.+++...    .++...
T Consensus        45 ~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~----~~~~~~  120 (303)
T 3a7i_A           45 RTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPG----PLDETQ  120 (303)
T ss_dssp             TTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTTS----CCCHHH
T ss_pred             CCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhcC----CCCHHH
Confidence            46889999998755 34456778999999999999999997 7777788899999999999999988653    288999


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh--hhhhcccccccCcceecCCcce
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI--LKQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      ...++.|++.||.++|+.   +++|+||+|+||+++.++.++|+|||++.......  .....+++.|+|||++.+..++
T Consensus       121 ~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  197 (303)
T 3a7i_A          121 IATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYD  197 (303)
T ss_dssp             HHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBC
T ss_pred             HHHHHHHHHHHHHHHHHC---CCccCCCChheEEECCCCCEEEeecccceecCccccccCccCCCcCccCHHHHhcCCCC
Confidence            999999999999999998   99999999999999999999999999987654332  2456789999999999988999


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      .++||
T Consensus       198 ~~~Di  202 (303)
T 3a7i_A          198 SKADI  202 (303)
T ss_dssp             THHHH
T ss_pred             chhhh
Confidence            99885

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.96  E-value=7.8e-30  Score=180.71  Aligned_cols=158  Identities=27%  Similarity=0.405  Sum_probs=130.3

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      .+++.||+|.+........+.+.+|+.+++.++||||+++ +.+...+..++|+|++++++|.+++........+++..+
T Consensus        45 ~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~  124 (295)
T 2clq_A           45 SNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTI  124 (295)
T ss_dssp             TTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHH
T ss_pred             CCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHH
Confidence            5688999999876655566778999999999999999997 777777889999999999999999876433334678888


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecC-CCCeEEccccchhhhhhh--hhhhhcccccccCcceecCCc--
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE-DLKPKISDFGLARILRKM--ILKQIQIELGYIPPEYVGRGV--  157 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~-~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~--  157 (164)
                      ..++.|++.||.|+|+.   +++|+||||+||+++. ++.++|+|||++......  ......|++.|+|||++.+..  
T Consensus       125 ~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  201 (295)
T 2clq_A          125 GFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRG  201 (295)
T ss_dssp             HHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGG
T ss_pred             HHHHHHHHHHHHHHHhC---CEEccCCChhhEEEECCCCCEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCC
Confidence            99999999999999998   9999999999999987 899999999998765432  234567899999999996543  


Q ss_pred             ceeccCC
Q 046065          158 YYKKFSL  164 (164)
Q Consensus       158 ~~~~~Di  164 (164)
                      ++.++||
T Consensus       202 ~~~~~Di  208 (295)
T 2clq_A          202 YGKAADI  208 (295)
T ss_dssp             CSHHHHH
T ss_pred             CCcHHHH
Confidence            7788875

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.96  E-value=9.8e-30  Score=186.87  Aligned_cols=153  Identities=27%  Similarity=0.448  Sum_probs=123.1

Q ss_pred             CCCcEEEEEEcccc--ccccHHHHHHHHHHHhccC-CCceeeE-eEEeeC--CcEEEEEEecCCCChhhhhhCccccccc
Q 046065            4 PDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQ-HLNLIRV-GFCIET--QEYMLIYEYMPKRSLDYFLFDPIRMLIL   77 (164)
Q Consensus         4 ~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~-~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~   77 (164)
                      .+++.||+|.+...  .......+.+|+.+++.+. ||||+++ +.+...  ...++|||+++ ++|...+...    .+
T Consensus        32 ~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~~  106 (388)
T 3oz6_A           32 RTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRAN----IL  106 (388)
T ss_dssp             TTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHHHHHT----CC
T ss_pred             CCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHHHHcC----CC
Confidence            56889999998643  3334567789999999996 9999998 555433  36899999997 5888887653    27


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh----------------------
Q 046065           78 DCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK----------------------  135 (164)
Q Consensus        78 ~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~----------------------  135 (164)
                      +......++.|++.||.|||+.   +|+||||||+||+++.++.+||+|||+++.+..                      
T Consensus       107 ~~~~~~~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~  183 (388)
T 3oz6_A          107 EPVHKQYVVYQLIKVIKYLHSG---GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDD  183 (388)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------
T ss_pred             CHHHHHHHHHHHHHHHHHHHhC---CEEeCCCCHHHeEEcCCCCEEecCCcccccccccccccccccccccccccccccc
Confidence            8888999999999999999998   999999999999999999999999999875421                      


Q ss_pred             -hhhhhhcccccccCcceecC-CcceeccCC
Q 046065          136 -MILKQIQIELGYIPPEYVGR-GVYYKKFSL  164 (164)
Q Consensus       136 -~~~~~~~~~~~~~aPE~~~~-~~~~~~~Di  164 (164)
                       ......+||++|+|||++.+ ..|+.++||
T Consensus       184 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di  214 (388)
T 3oz6_A          184 QPILTDYVATRWYRAPEILLGSTKYTKGIDM  214 (388)
T ss_dssp             ------CCCGGGGCCHHHHTTCCCCCTHHHH
T ss_pred             cccccCCcccCCcCCHHHhcCCCCCCChhhH
Confidence             11244689999999999976 678998885

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.96  E-value=3.2e-30  Score=184.11  Aligned_cols=158  Identities=27%  Similarity=0.375  Sum_probs=132.2

Q ss_pred             CCCcEEEEEEccccc-cccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccc-------
Q 046065            4 PDGQIIAVKKLSKKS-TQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIR-------   73 (164)
Q Consensus         4 ~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------   73 (164)
                      .+++.||+|.+.... ....+.+.+|+.+++.+ +||||+++ +.+...+..++|||++++++|.+++.....       
T Consensus        51 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~  130 (313)
T 1t46_A           51 DAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKT  130 (313)
T ss_dssp             TCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC-----
T ss_pred             chhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccc
Confidence            456789999987553 23456788999999999 89999998 777777889999999999999999875322       


Q ss_pred             --------ccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh----hhh
Q 046065           74 --------MLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL----KQI  141 (164)
Q Consensus        74 --------~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~----~~~  141 (164)
                              ...+++.....++.|++.||.|+|+.   +++|+||||+||+++.++.++|+|||++........    ...
T Consensus       131 ~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  207 (313)
T 1t46_A          131 SPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA  207 (313)
T ss_dssp             ---------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSS
T ss_pred             cccccccccccCCHHHHHHHHHHHHHHHHHHHHC---CeecCCCccceEEEcCCCCEEEccccccccccccccceeccCC
Confidence                    12378899999999999999999998   999999999999999999999999999976643321    334


Q ss_pred             cccccccCcceecCCcceeccCC
Q 046065          142 QIELGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       142 ~~~~~~~aPE~~~~~~~~~~~Di  164 (164)
                      .+++.|+|||.+.+..++.++||
T Consensus       208 ~~~~~y~aPE~~~~~~~~~~~Di  230 (313)
T 1t46_A          208 RLPVKWMAPESIFNCVYTFESDV  230 (313)
T ss_dssp             EECGGGCCHHHHHHCCCCHHHHH
T ss_pred             CCcceeeChHHhcCCCCChHHHH
Confidence            56788999999988889999885

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.96  E-value=2e-29  Score=177.71  Aligned_cols=155  Identities=26%  Similarity=0.346  Sum_probs=128.7

Q ss_pred             CCCcEEEEEEcccccc------ccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccc
Q 046065            4 PDGQIIAVKKLSKKST------QGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLI   76 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~   76 (164)
                      .+++.||+|.+.....      ...+.+.+|+.+++.++||||+++ +.+......++|||++++++|.+++....   .
T Consensus        28 ~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~  104 (283)
T 3bhy_A           28 GTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKE---S  104 (283)
T ss_dssp             TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS---S
T ss_pred             CCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHhcC---C
Confidence            4688999999865421      135678899999999999999998 76777778999999999999999986533   2


Q ss_pred             cCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCC----CeEEccccchhhhhhh-hhhhhcccccccCcc
Q 046065           77 LDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL----KPKISDFGLARILRKM-ILKQIQIELGYIPPE  151 (164)
Q Consensus        77 ~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~----~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE  151 (164)
                      ++......++.|++.||.|+|+.   +++|+||||+||+++.++    .++|+|||++...... ......+++.|+|||
T Consensus       105 ~~~~~~~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE  181 (283)
T 3bhy_A          105 LTEDEATQFLKQILDGVHYLHSK---RIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE  181 (283)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC--------CCCGGGCCHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhC---CccCCCCChHHEEEecCCCCCCceEEEecccceeccCCCcccccCCCcCccCcc
Confidence            88999999999999999999998   999999999999998776    7999999998765432 234567899999999


Q ss_pred             eecCCcceeccCC
Q 046065          152 YVGRGVYYKKFSL  164 (164)
Q Consensus       152 ~~~~~~~~~~~Di  164 (164)
                      ++.+..++.++||
T Consensus       182 ~~~~~~~~~~~Di  194 (283)
T 3bhy_A          182 IVNYEPLGLEADM  194 (283)
T ss_dssp             HHTTCCCCTHHHH
T ss_pred             eecCCCCCcchhh
Confidence            9988889999885

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.96  E-value=6.2e-30  Score=185.64  Aligned_cols=153  Identities=29%  Similarity=0.416  Sum_probs=127.8

Q ss_pred             CCCcEEEEEEccccc---cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKKS---TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+++.||+|.+....   ....+.+.+|+.+++.++||||+++ +.+...+..++|||+++ |++.+.+....  ..+++
T Consensus        77 ~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~--~~l~~  153 (348)
T 1u5q_A           77 RNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHK--KPLQE  153 (348)
T ss_dssp             TTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHHT--SCCCH
T ss_pred             cCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHHhc--CCCCH
Confidence            578899999986542   2334678899999999999999998 77777888999999997 57777764322  23889


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCcceec---CC
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVG---RG  156 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~---~~  156 (164)
                      ..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....  .....||+.|+|||++.   .+
T Consensus       154 ~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~--~~~~~gt~~y~aPE~~~~~~~~  228 (348)
T 1u5q_A          154 VEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--ANSFVGTPYWMAPEVILAMDEG  228 (348)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--BCCCCSCGGGCCHHHHHTTSSC
T ss_pred             HHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEECCCCCEEEeeccCceecCC--CCcccCCcceeCHhhhccccCC
Confidence            99999999999999999998   999999999999999999999999999876542  23467899999999984   56


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .++.++||
T Consensus       229 ~~~~~~Di  236 (348)
T 1u5q_A          229 QYDGKVDV  236 (348)
T ss_dssp             CBCTHHHH
T ss_pred             CCCcHHHH
Confidence            78888885

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.96  E-value=7.3e-30  Score=184.12  Aligned_cols=158  Identities=26%  Similarity=0.409  Sum_probs=129.9

Q ss_pred             CCCcEEEEEEcccc-ccccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccc-------
Q 046065            4 PDGQIIAVKKLSKK-STQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIR-------   73 (164)
Q Consensus         4 ~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-------   73 (164)
                      .+++.||+|.+... .......+..|+.+++.+ +||||+++ +.+...+..++|||++++++|.+++.....       
T Consensus        65 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~  144 (334)
T 2pvf_A           65 KEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY  144 (334)
T ss_dssp             ---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC
T ss_pred             ccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccc
Confidence            35678999998755 334456788999999999 89999997 777777889999999999999999876431       


Q ss_pred             ------ccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh----hhhhcc
Q 046065           74 ------MLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI----LKQIQI  143 (164)
Q Consensus        74 ------~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~----~~~~~~  143 (164)
                            ...++...+..++.|++.||.|+|+.   +++|+||||+||+++.++.++|+|||++.......    .....+
T Consensus       145 ~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~  221 (334)
T 2pvf_A          145 DINRVPEEQMTFKDLVSCTYQLARGMEYLASQ---KCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL  221 (334)
T ss_dssp             --------CCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCC
T ss_pred             cccccccccCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCc
Confidence                  12378889999999999999999998   99999999999999999999999999997654321    233456


Q ss_pred             cccccCcceecCCcceeccCC
Q 046065          144 ELGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       144 ~~~~~aPE~~~~~~~~~~~Di  164 (164)
                      ++.|+|||++.+..++.++||
T Consensus       222 ~~~y~aPE~~~~~~~~~~~Di  242 (334)
T 2pvf_A          222 PVKWMAPEALFDRVYTHQSDV  242 (334)
T ss_dssp             CGGGCCHHHHHHCEECHHHHH
T ss_pred             ccceeChHHhcCCCcChHHHH
Confidence            788999999988889999885

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.96  E-value=7.3e-30  Score=183.88  Aligned_cols=155  Identities=26%  Similarity=0.366  Sum_probs=120.5

Q ss_pred             cCCCcEEEEEEccccc--cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            3 LPDGQIIAVKKLSKKS--TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         3 ~~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      ..+++.||+|.+....  ......+.+|+.+++.++||||+++ +.+......++|||+++ ++|.+++.....   +++
T Consensus        56 ~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~---~~~  131 (329)
T 3gbz_A           56 TVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE-NDLKKYMDKNPD---VSM  131 (329)
T ss_dssp             TTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHCTT---CCH
T ss_pred             CCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCC-CCHHHHHhhcCC---CCH
Confidence            3578899999986542  2234567789999999999999998 77777888999999998 489888865433   889


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeec-----CCCCeEEccccchhhhhhh--hhhhhcccccccCcce
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLD-----EDLKPKISDFGLARILRKM--ILKQIQIELGYIPPEY  152 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~-----~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~  152 (164)
                      ..+..++.|++.||.|||+.   +|+|+||||+||+++     ..+.++|+|||++......  ......+|+.|+|||+
T Consensus       132 ~~~~~i~~ql~~~l~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~  208 (329)
T 3gbz_A          132 RVIKSFLYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEI  208 (329)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-----------CCTTCCHHH
T ss_pred             HHHHHHHHHHHHHHHHHHhC---CEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHH
Confidence            99999999999999999998   999999999999995     4456999999999776432  2345678999999999


Q ss_pred             ecCC-cceeccCC
Q 046065          153 VGRG-VYYKKFSL  164 (164)
Q Consensus       153 ~~~~-~~~~~~Di  164 (164)
                      +.+. .++.++||
T Consensus       209 ~~~~~~~~~~~Di  221 (329)
T 3gbz_A          209 LLGSRHYSTSVDI  221 (329)
T ss_dssp             HTTCCCCCTHHHH
T ss_pred             hcCCCCCCcHHHH
Confidence            9764 47988885

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=4.3e-30  Score=186.90  Aligned_cols=155  Identities=23%  Similarity=0.268  Sum_probs=127.5

Q ss_pred             CCCcEEEEEEccccc----cccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccccccc
Q 046065            4 PDGQIIAVKKLSKKS----TQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLIL   77 (164)
Q Consensus         4 ~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~   77 (164)
                      .+++.||+|.+....    ......+..|+.+++.+ +||||+++ ..+......++||||+++++|.+++.....   +
T Consensus        80 ~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~  156 (355)
T 1vzo_A           80 DTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER---F  156 (355)
T ss_dssp             TTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSC---C
T ss_pred             CCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHcCC---C
Confidence            478999999986432    23345667899999999 69999998 666777789999999999999999875432   8


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh---hhhhhcccccccCcceec
Q 046065           78 DCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM---ILKQIQIELGYIPPEYVG  154 (164)
Q Consensus        78 ~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~~aPE~~~  154 (164)
                      +...+..++.|++.||.|||+.   +|+|+||||+||+++.++.++|+|||+++.+...   ......||+.|+|||++.
T Consensus       157 ~~~~~~~~~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~  233 (355)
T 1vzo_A          157 TEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR  233 (355)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHT
T ss_pred             CHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEECCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhc
Confidence            8999999999999999999998   9999999999999999999999999999765322   224567999999999997


Q ss_pred             C--CcceeccCC
Q 046065          155 R--GVYYKKFSL  164 (164)
Q Consensus       155 ~--~~~~~~~Di  164 (164)
                      +  ..++.++||
T Consensus       234 ~~~~~~~~~~Dv  245 (355)
T 1vzo_A          234 GGDSGHDKAVDW  245 (355)
T ss_dssp             TCC---CTHHHH
T ss_pred             CCCCCCCchhhH
Confidence            5  346788885

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.96  E-value=2.2e-29  Score=181.21  Aligned_cols=157  Identities=26%  Similarity=0.367  Sum_probs=128.7

Q ss_pred             CCCcEEEEEEcccc--ccccHHHHHHHHHHHhccC-CCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQ-HLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~-h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+++.||+|.+...  .......+.+|+.+++.+. ||||+++ +.+......++|||++++++|.+++..... ..+++
T Consensus        52 ~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~  130 (327)
T 3lm5_A           52 STGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELA-EMVSE  130 (327)
T ss_dssp             TTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC--CCCCH
T ss_pred             CCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcc-cCCCH
Confidence            46899999998754  2334567889999999994 6999998 666777789999999999999998865322 23889


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecC---CCCeEEccccchhhhhhhh-hhhhcccccccCcceecC
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE---DLKPKISDFGLARILRKMI-LKQIQIELGYIPPEYVGR  155 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~---~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~aPE~~~~  155 (164)
                      ..+..++.|++.||.|||+.   +++|+||||+||+++.   .+.++|+|||++....... .....|++.|+|||++.+
T Consensus       131 ~~~~~i~~ql~~~L~~LH~~---givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~  207 (327)
T 3lm5_A          131 NDVIRLIKQILEGVYYLHQN---NIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNY  207 (327)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---------CCCGGGCCHHHHTT
T ss_pred             HHHHHHHHHHHHHHHHHHHC---CeecCcCChHHEEEecCCCCCcEEEeeCccccccCCccccccccCCcCccCCeeecC
Confidence            99999999999999999998   9999999999999987   7899999999997665432 345679999999999998


Q ss_pred             CcceeccCC
Q 046065          156 GVYYKKFSL  164 (164)
Q Consensus       156 ~~~~~~~Di  164 (164)
                      ..++.++||
T Consensus       208 ~~~~~~~Di  216 (327)
T 3lm5_A          208 DPITTATDM  216 (327)
T ss_dssp             CCCCTHHHH
T ss_pred             CCCCchhhH
Confidence            899999885

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.96  E-value=1.4e-29  Score=179.95  Aligned_cols=156  Identities=22%  Similarity=0.338  Sum_probs=126.1

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      .+++.||+|.+..........+..|+.+++.++||||+++ +.+...+..++|+|++++++|..++....  ..++....
T Consensus        42 ~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~--~~~~~~~~  119 (302)
T 2j7t_A           42 ETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELD--RGLTEPQI  119 (302)
T ss_dssp             TTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHT--SCCCHHHH
T ss_pred             CCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhc--cCCCHHHH
Confidence            4688999999876666667788999999999999999997 77777788999999999999998876422  22889999


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh--hhhhhcccccccCccee-----cC
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM--ILKQIQIELGYIPPEYV-----GR  155 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~-----~~  155 (164)
                      ..++.|++.|+.|+|+.   +++|+||||+||+++.++.++|+|||++......  ......|++.|+|||++     ..
T Consensus       120 ~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  196 (302)
T 2j7t_A          120 QVVCRQMLEALNFLHSK---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD  196 (302)
T ss_dssp             HHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTS
T ss_pred             HHHHHHHHHHHHHHhcC---CcccCCCCHHHEEECCCCCEEEEECCCCccccccccccccccCChhhcCCeeeccccCCC
Confidence            99999999999999998   9999999999999999999999999998654322  22456789999999998     35


Q ss_pred             CcceeccCC
Q 046065          156 GVYYKKFSL  164 (164)
Q Consensus       156 ~~~~~~~Di  164 (164)
                      ..++.++||
T Consensus       197 ~~~~~~~Di  205 (302)
T 2j7t_A          197 TPYDYKADI  205 (302)
T ss_dssp             TTTTTHHHH
T ss_pred             CCCchhhhH
Confidence            677888885

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.96  E-value=1e-29  Score=183.87  Aligned_cols=158  Identities=27%  Similarity=0.324  Sum_probs=125.0

Q ss_pred             CCCcEEEEEEcccc-----ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccc----
Q 046065            4 PDGQIIAVKKLSKK-----STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIR----   73 (164)
Q Consensus         4 ~~~~~vavK~~~~~-----~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~----   73 (164)
                      .+++.||+|.+...     .+...+.+..|+.+++.++||||+++ +.+...+..++|||++++++|.+++.....    
T Consensus        49 ~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~  128 (345)
T 3hko_A           49 QTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTG  128 (345)
T ss_dssp             TTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTT
T ss_pred             CCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhccccc
Confidence            56789999998644     23455778999999999999999998 777777889999999999999988852100    


Q ss_pred             ---------------------------------ccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCC
Q 046065           74 ---------------------------------MLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL  120 (164)
Q Consensus        74 ---------------------------------~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~  120 (164)
                                                       ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++
T Consensus       129 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIll~~~~  205 (345)
T 3hko_A          129 KCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQ---GICHRDIKPENFLFSTNK  205 (345)
T ss_dssp             EEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCSS
T ss_pred             ccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEecCC
Confidence                                             11135677888999999999999998   999999999999998766


Q ss_pred             --CeEEccccchhhhhhh------hhhhhcccccccCcceecC--CcceeccCC
Q 046065          121 --KPKISDFGLARILRKM------ILKQIQIELGYIPPEYVGR--GVYYKKFSL  164 (164)
Q Consensus       121 --~~~l~dfg~~~~~~~~------~~~~~~~~~~~~aPE~~~~--~~~~~~~Di  164 (164)
                        .++|+|||++..+...      ......||+.|+|||++.+  ..++.++||
T Consensus       206 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Di  259 (345)
T 3hko_A          206 SFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDA  259 (345)
T ss_dssp             SCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHH
T ss_pred             CceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHH
Confidence              8999999999765321      1245678999999999964  678888885

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.96  E-value=6.8e-30  Score=183.73  Aligned_cols=152  Identities=21%  Similarity=0.358  Sum_probs=123.7

Q ss_pred             EEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeEeEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHHHHH
Q 046065            8 IIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHII   86 (164)
Q Consensus         8 ~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~   86 (164)
                      +||+|.+... .......+.+|+.+++.++||||+++..+...+..++|+|++++++|.+++.....  .+++.....++
T Consensus        44 kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~  121 (325)
T 3kex_A           44 PVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQLVTQYLPLGSLLDHVRQHRG--ALGPQLLLNWG  121 (325)
T ss_dssp             EEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECBSSEEEEEECCTTCBSHHHHHSSGG--GSCTTHHHHHH
T ss_pred             EEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCccEEEEEeCCCCCHHHHHHHccc--cCCHHHHHHHH
Confidence            3788877543 23334567789999999999999998445556788999999999999999876422  37888999999


Q ss_pred             HHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh----hhhhhcccccccCcceecCCcceecc
Q 046065           87 KGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM----ILKQIQIELGYIPPEYVGRGVYYKKF  162 (164)
Q Consensus        87 ~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~  162 (164)
                      .|++.||.|||+.   +++|+||||+||+++.++.++|+|||++......    ......+++.|+|||++.+..++.++
T Consensus       122 ~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~  198 (325)
T 3kex_A          122 VQIAKGMYYLEEH---GMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQS  198 (325)
T ss_dssp             HHHHHHHHHHHHT---TCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHH
T ss_pred             HHHHHHHHHHHhC---CCCCCccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhh
Confidence            9999999999998   9999999999999999999999999999876432    12445677899999999888999999


Q ss_pred             CC
Q 046065          163 SL  164 (164)
Q Consensus       163 Di  164 (164)
                      ||
T Consensus       199 Di  200 (325)
T 3kex_A          199 DV  200 (325)
T ss_dssp             HH
T ss_pred             Hh
Confidence            85

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.96  E-value=1.8e-29  Score=181.91  Aligned_cols=155  Identities=28%  Similarity=0.418  Sum_probs=125.5

Q ss_pred             CCCcEEEEEEccccc--cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            4 PDGQIIAVKKLSKKS--TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         4 ~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      .+++.||+|.+....  ......+.+|+.+++.++||||+++ +.+......++|||++++++|..+......   ++..
T Consensus        48 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~---~~~~  124 (331)
T 4aaa_A           48 DTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNG---LDYQ  124 (331)
T ss_dssp             TTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHSTTC---CCHH
T ss_pred             CCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhhccC---CCHH
Confidence            458899999986542  2234557789999999999999997 777778889999999999888887654333   8899


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh--hhhhhcccccccCcceecCC-c
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM--ILKQIQIELGYIPPEYVGRG-V  157 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~~~-~  157 (164)
                      ....++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++......  ......+++.|+|||++.+. .
T Consensus       125 ~~~~~~~qi~~~l~~LH~~---~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~  201 (331)
T 4aaa_A          125 VVQKYLFQIINGIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVK  201 (331)
T ss_dssp             HHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCTTC------------CCCCCTTCCHHHHTTCTT
T ss_pred             HHHHHHHHHHHHHHHHHHC---CEEccCcChheEEEcCCCcEEEEeCCCceeecCCccccCCCcCCccccCcccccCCCC
Confidence            9999999999999999998   9999999999999999999999999999765432  23456789999999999765 6


Q ss_pred             ceeccCC
Q 046065          158 YYKKFSL  164 (164)
Q Consensus       158 ~~~~~Di  164 (164)
                      ++.++||
T Consensus       202 ~~~~~Di  208 (331)
T 4aaa_A          202 YGKAVDV  208 (331)
T ss_dssp             CCTHHHH
T ss_pred             cchHHHH
Confidence            7888885

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.96  E-value=2e-29  Score=177.11  Aligned_cols=155  Identities=23%  Similarity=0.414  Sum_probs=123.4

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+++.||+|.+...   .......+.+|+.+++.++||||+++ +.+......++|+|++++++|.+++.....   ++.
T Consensus        34 ~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~  110 (276)
T 2h6d_A           34 LTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGR---VEE  110 (276)
T ss_dssp             TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCS---CCH
T ss_pred             CCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhccCC---CCH
Confidence            46889999998654   23345678899999999999999998 777777789999999999999999875433   788


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh-hhhhcccccccCcceecCCcc
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI-LKQIQIELGYIPPEYVGRGVY  158 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~  158 (164)
                      .....++.|++.|+.|+|+.   +++|+||+|+||+++.++.++|+|||++....... .....+++.|+|||.+.+..+
T Consensus       111 ~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  187 (276)
T 2h6d_A          111 MEARRLFQQILSAVDYCHRH---MVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLY  187 (276)
T ss_dssp             HHHHHHHHHHHHHHHHHHHH---CSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-------------CCTGGGTTSCC
T ss_pred             HHHHHHHHHHHHHHHHHHHC---CCccCCCChhhEEECCCCCEEEeecccccccCCCcceecccCCccccCHHHHcCCCC
Confidence            99999999999999999999   99999999999999999999999999987664332 245678999999999987765


Q ss_pred             -eeccCC
Q 046065          159 -YKKFSL  164 (164)
Q Consensus       159 -~~~~Di  164 (164)
                       +.++||
T Consensus       188 ~~~~~Di  194 (276)
T 2h6d_A          188 AGPEVDI  194 (276)
T ss_dssp             CHHHHHH
T ss_pred             CCccchH
Confidence             678875

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.96  E-value=4.5e-30  Score=192.13  Aligned_cols=156  Identities=28%  Similarity=0.417  Sum_probs=124.4

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeEeEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRV   83 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~   83 (164)
                      .++..||||.+.... ...+.+.+|+.+++.++||||+++..+...+..++|||++++|+|.+++..... ..++.....
T Consensus       206 ~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~iv~e~~~~gsL~~~l~~~~~-~~~~~~~~~  283 (452)
T 1fmk_A          206 NGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETG-KYLRLPQLV  283 (452)
T ss_dssp             TTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCTTCBHHHHHSHHHH-TTCCHHHHH
T ss_pred             CCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcCCceEEEehhhcCCCHHHHHHhcCC-CCCCHHHHH
Confidence            345679999986543 335678999999999999999998444445778999999999999999864221 237889999


Q ss_pred             HHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh---hhhcccccccCcceecCCccee
Q 046065           84 HIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL---KQIQIELGYIPPEYVGRGVYYK  160 (164)
Q Consensus        84 ~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~  160 (164)
                      .++.|++.||.|||++   +++||||||+||+++.++.+||+|||+++.......   ....+++.|+|||.+....++.
T Consensus       284 ~i~~qi~~~l~~LH~~---~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  360 (452)
T 1fmk_A          284 DMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI  360 (452)
T ss_dssp             HHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCH
T ss_pred             HHHHHHHHHHHHHHhC---CeeCCCCChhhEEECCCCCEEECCCccceecCCCceecccCCcccccccCHhHHhcCCCCc
Confidence            9999999999999998   999999999999999999999999999976653322   3345678899999998889999


Q ss_pred             ccCC
Q 046065          161 KFSL  164 (164)
Q Consensus       161 ~~Di  164 (164)
                      ++||
T Consensus       361 ~sDv  364 (452)
T 1fmk_A          361 KSDV  364 (452)
T ss_dssp             HHHH
T ss_pred             cccH
Confidence            9985

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.96  E-value=2e-29  Score=178.17  Aligned_cols=157  Identities=22%  Similarity=0.300  Sum_probs=126.3

Q ss_pred             CCCcEEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcc-cccccCHH
Q 046065            4 PDGQIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPI-RMLILDCK   80 (164)
Q Consensus         4 ~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~   80 (164)
                      .+++.+|+|.+... .....+.+..|+.+++.++||||+++ +.+......++|||++++++|.+.+.... ....+++.
T Consensus        45 ~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~  124 (285)
T 3is5_A           45 SSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEG  124 (285)
T ss_dssp             TTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHH
T ss_pred             cCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHH
Confidence            46889999998765 33446778899999999999999997 77777788999999999999988885431 12348899


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceee---cCCCCeEEccccchhhhhhhh-hhhhcccccccCcceecCC
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL---DEDLKPKISDFGLARILRKMI-LKQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili---~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~aPE~~~~~  156 (164)
                      .+..++.|++.||.|||+.   +++|+||||+||++   +.++.++|+|||++....... .....+++.|+|||++. +
T Consensus       125 ~~~~i~~qi~~~L~~LH~~---~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~-~  200 (285)
T 3is5_A          125 YVAELMKQMMNALAYFHSQ---HVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK-R  200 (285)
T ss_dssp             HHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----------CTTGGGCCHHHHT-T
T ss_pred             HHHHHHHHHHHHHHHHHhC---CEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcccCcCcccccCcCChHHhc-c
Confidence            9999999999999999998   99999999999999   446789999999997665432 35567899999999985 5


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .++.++||
T Consensus       201 ~~~~~~Di  208 (285)
T 3is5_A          201 DVTFKCDI  208 (285)
T ss_dssp             CCCHHHHH
T ss_pred             CCCcccCe
Confidence            68888885

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.96  E-value=6.3e-30  Score=183.70  Aligned_cols=155  Identities=26%  Similarity=0.347  Sum_probs=124.4

Q ss_pred             CCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCC----cEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            5 DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQ----EYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .++.||||.+..... .......|+.+++.++||||+++ +.+....    .+++|||++++|+|.+++....    +++
T Consensus        46 ~~~~vavK~~~~~~~-~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----~~~  120 (322)
T 3soc_A           46 LNEYVAVKIFPIQDK-QSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV----VSW  120 (322)
T ss_dssp             TTEEEEEEEECGGGH-HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHCC----BCH
T ss_pred             CCCEEEEEEeecCch-HHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHhcC----CCH
Confidence            367899999865432 23345668889999999999997 5555533    3689999999999999986532    889


Q ss_pred             HHHHHHHHHHHHHHHHhhhc-------CCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh----hhhhccccccc
Q 046065           80 KKRVHIIKGIIQGLLYLQEY-------FRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI----LKQIQIELGYI  148 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~-------~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~  148 (164)
                      .....++.|++.||.|||+.       |..+++|+||||+||+++.++.+||+|||++.......    .....||+.|+
T Consensus       121 ~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~  200 (322)
T 3soc_A          121 NELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYM  200 (322)
T ss_dssp             HHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGC
T ss_pred             HHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCcccc
Confidence            99999999999999999975       23489999999999999999999999999997654322    23467899999


Q ss_pred             CcceecC-----CcceeccCC
Q 046065          149 PPEYVGR-----GVYYKKFSL  164 (164)
Q Consensus       149 aPE~~~~-----~~~~~~~Di  164 (164)
                      |||++.+     ..++.++||
T Consensus       201 aPE~~~~~~~~~~~~~~~~Di  221 (322)
T 3soc_A          201 APEVLEGAINFQRDAFLRIDM  221 (322)
T ss_dssp             CHHHHTTCCCCCHHHHHHHHH
T ss_pred             CHhhcccccccCcCCCccchh
Confidence            9999976     466777775

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.96  E-value=7.9e-30  Score=179.80  Aligned_cols=154  Identities=23%  Similarity=0.325  Sum_probs=126.5

Q ss_pred             CcEEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeEeEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHHH
Q 046065            6 GQIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVH   84 (164)
Q Consensus         6 ~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~   84 (164)
                      +..||+|.+... .....+.+.+|+.+++.++||||+++..+...+..++|||++++++|.+++....  ..++......
T Consensus        40 ~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~  117 (281)
T 3cc6_A           40 KINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLERNK--NSLKVLTLVL  117 (281)
T ss_dssp             EEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSSSCEEEEECCTTCBHHHHHHHHT--TTCCHHHHHH
T ss_pred             cceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCEEEEecCCCCCHHHHHHhcc--ccCCHHHHHH
Confidence            346999998755 3344567889999999999999999855555667789999999999999986532  2378899999


Q ss_pred             HHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh---hhhhcccccccCcceecCCcceec
Q 046065           85 IIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI---LKQIQIELGYIPPEYVGRGVYYKK  161 (164)
Q Consensus        85 ~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~  161 (164)
                      ++.|++.|+.|+|+.   +++|+||||+||+++.++.++|+|||++.......   .....+++.|+|||.+.+..++.+
T Consensus       118 ~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~  194 (281)
T 3cc6_A          118 YSLQICKAMAYLESI---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTA  194 (281)
T ss_dssp             HHHHHHHHHHHHHHT---TCCCCCCSGGGEEEEETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHH
T ss_pred             HHHHHHHHHHHHHHC---CcccCCCccceEEECCCCcEEeCccCCCcccccccccccccCCCCcceeCchhhccCCCCch
Confidence            999999999999998   99999999999999999999999999997664322   233456788999999988889999


Q ss_pred             cCC
Q 046065          162 FSL  164 (164)
Q Consensus       162 ~Di  164 (164)
                      +||
T Consensus       195 ~Di  197 (281)
T 3cc6_A          195 SDV  197 (281)
T ss_dssp             HHH
T ss_pred             hcc
Confidence            885

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=9.5e-30  Score=185.84  Aligned_cols=152  Identities=26%  Similarity=0.387  Sum_probs=126.6

Q ss_pred             CCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEeeC------CcEEEEEEecCCCChhhhhhCcccc
Q 046065            4 PDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIET------QEYMLIYEYMPKRSLDYFLFDPIRM   74 (164)
Q Consensus         4 ~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~   74 (164)
                      .+|+.||+|.+...  .......+.+|+.+++.++||||+++ +.+...      ..+++|||++ +++|.+++...   
T Consensus        48 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---  123 (367)
T 1cm8_A           48 RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHE---  123 (367)
T ss_dssp             TTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHHC---
T ss_pred             CCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhcC---
Confidence            56899999998643  23345678899999999999999998 555443      2368999999 78998888652   


Q ss_pred             cccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCcceec
Q 046065           75 LILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVG  154 (164)
Q Consensus        75 ~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~  154 (164)
                       .++......++.|++.||.|||++   +++|+||||+||+++.++.+||+|||+++.... ......+|++|+|||++.
T Consensus       124 -~l~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~-~~~~~~~t~~y~aPE~~~  198 (367)
T 1cm8_A          124 -KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADS-EMTGYVVTRWYRAPEVIL  198 (367)
T ss_dssp             -CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCS-SCCSSCSCGGGCCTHHHH
T ss_pred             -CCCHHHHHHHHHHHHHHHHHHHHC---CccccCcCHHHEEEcCCCCEEEEeeeccccccc-ccCcCcCCCCcCCHHHHh
Confidence             288899999999999999999998   999999999999999999999999999976543 234567899999999987


Q ss_pred             C-CcceeccCC
Q 046065          155 R-GVYYKKFSL  164 (164)
Q Consensus       155 ~-~~~~~~~Di  164 (164)
                      + ..++.++||
T Consensus       199 ~~~~~~~~~Di  209 (367)
T 1cm8_A          199 NWMRYTQTVDI  209 (367)
T ss_dssp             TTTCCCTTHHH
T ss_pred             CCCCCChhhhH
Confidence            6 678988885

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=1.2e-29  Score=179.43  Aligned_cols=155  Identities=23%  Similarity=0.320  Sum_probs=129.8

Q ss_pred             CCcEEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeEeEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHH
Q 046065            5 DGQIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRV   83 (164)
Q Consensus         5 ~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~   83 (164)
                      +++.||+|.+... .....+.+.+|+.+++.++||||+++..+...+..++|||++++++|.+++....  ..++...+.
T Consensus        36 ~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~  113 (287)
T 1u59_A           36 KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKR--EEIPVSNVA  113 (287)
T ss_dssp             CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTEEHHHHHTTCT--TTSCHHHHH
T ss_pred             CcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEecCCCcEEEEEeCCCCCHHHHHHhCC--ccCCHHHHH
Confidence            5778999998764 3345677889999999999999999844446778999999999999999886432  238899999


Q ss_pred             HHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh-----hhhhcccccccCcceecCCcc
Q 046065           84 HIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI-----LKQIQIELGYIPPEYVGRGVY  158 (164)
Q Consensus        84 ~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~  158 (164)
                      .++.|++.||.++|+.   +++|+||||+||+++.++.++|+|||++.......     .....+++.|+|||++.+..+
T Consensus       114 ~~~~qi~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  190 (287)
T 1u59_A          114 ELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF  190 (287)
T ss_dssp             HHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEE
T ss_pred             HHHHHHHHHHHHHHHC---CEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCC
Confidence            9999999999999998   99999999999999999999999999997654321     123456788999999988889


Q ss_pred             eeccCC
Q 046065          159 YKKFSL  164 (164)
Q Consensus       159 ~~~~Di  164 (164)
                      +.++||
T Consensus       191 ~~~~Di  196 (287)
T 1u59_A          191 SSRSDV  196 (287)
T ss_dssp             CHHHHH
T ss_pred             CchhhH
Confidence            999885

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.96  E-value=5.9e-29  Score=177.46  Aligned_cols=156  Identities=27%  Similarity=0.424  Sum_probs=126.3

Q ss_pred             CCCcEEEEEEccccc-----cccHHHHHHHHHHHhccC---CCceeeE-eEEeeCC-----cEEEEEEecCCCChhhhhh
Q 046065            4 PDGQIIAVKKLSKKS-----TQGFEEFKNEVMLTAKLQ---HLNLIRV-GFCIETQ-----EYMLIYEYMPKRSLDYFLF   69 (164)
Q Consensus         4 ~~~~~vavK~~~~~~-----~~~~~~~~~e~~~l~~l~---h~~i~~~-~~~~~~~-----~~~lv~e~~~~~~L~~~~~   69 (164)
                      .+++.||+|.+....     ......+.+|+.+++.++   ||||+++ +.+....     ..++|+|++. ++|.+++.
T Consensus        32 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~  110 (308)
T 3g33_A           32 HSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLD  110 (308)
T ss_dssp             TTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHH
T ss_pred             CCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHh
Confidence            568899999986432     112345677887777664   9999997 5555543     3789999997 59988887


Q ss_pred             CcccccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh-hhhhhccccccc
Q 046065           70 DPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM-ILKQIQIELGYI  148 (164)
Q Consensus        70 ~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~  148 (164)
                      .... ..+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++...... ......||+.|+
T Consensus       111 ~~~~-~~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~  186 (308)
T 3g33_A          111 KAPP-PGLPAETIKDLMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTLWYR  186 (308)
T ss_dssp             TCCT-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCTTTEEECTTSCEEECSCSCTTTSTTCCCSGGGGCCCSSC
T ss_pred             hccC-CCCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEcCCCCEEEeeCccccccCCCcccCCcccccccc
Confidence            6432 2288999999999999999999998   9999999999999999999999999999766533 235577899999


Q ss_pred             CcceecCCcceeccCC
Q 046065          149 PPEYVGRGVYYKKFSL  164 (164)
Q Consensus       149 aPE~~~~~~~~~~~Di  164 (164)
                      |||++.+..++.++||
T Consensus       187 aPE~~~~~~~~~~~Di  202 (308)
T 3g33_A          187 APEVLLQSTYATPVDM  202 (308)
T ss_dssp             CHHHHHTSCCCSTHHH
T ss_pred             CchHHcCCCCCchHHH
Confidence            9999998999999985

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.96  E-value=1.6e-29  Score=179.53  Aligned_cols=150  Identities=28%  Similarity=0.351  Sum_probs=120.1

Q ss_pred             CCcEEEEEEccccccccHHHHHHHHHHHhc--cCCCceeeE-eEEee----CCcEEEEEEecCCCChhhhhhCccccccc
Q 046065            5 DGQIIAVKKLSKKSTQGFEEFKNEVMLTAK--LQHLNLIRV-GFCIE----TQEYMLIYEYMPKRSLDYFLFDPIRMLIL   77 (164)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~-~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~   77 (164)
                      +++.||||.+...   ....+..|.+++..  ++||||+++ +.+..    ....++|||++++++|.+++...    .+
T Consensus        30 ~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~  102 (301)
T 3q4u_A           30 QGENVAVKIFSSR---DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT----TL  102 (301)
T ss_dssp             TTEEEEEEEECGG---GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTTC----CB
T ss_pred             CCEEEEEEEeccc---cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhhc----cc
Confidence            5789999998644   23445566666665  789999997 54433    23478999999999999999643    28


Q ss_pred             CHHHHHHHHHHHHHHHHHhh--------hcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh------hhhhcc
Q 046065           78 DCKKRVHIIKGIIQGLLYLQ--------EYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI------LKQIQI  143 (164)
Q Consensus        78 ~~~~~~~~~~~~~~~l~~lh--------~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~------~~~~~~  143 (164)
                      ++.....++.|++.||.|+|        +.   +++|+||||+||+++.++.+||+|||++.......      .....|
T Consensus       103 ~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g  179 (301)
T 3q4u_A          103 DTVSCLRIVLSIASGLAHLHIEIFGTQGKP---AIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVG  179 (301)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHSCBCSTTCBC---EEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCC
T ss_pred             CHHHHHHHHHHHHHHHHHHHHhhhhccCCC---CeecCCCChHhEEEcCCCCEEEeeCCCeeeccccccccccccccccc
Confidence            89999999999999999999        66   99999999999999999999999999986554321      123478


Q ss_pred             cccccCcceecCC------cceeccCC
Q 046065          144 ELGYIPPEYVGRG------VYYKKFSL  164 (164)
Q Consensus       144 ~~~~~aPE~~~~~------~~~~~~Di  164 (164)
                      |+.|+|||++.+.      .++.++||
T Consensus       180 t~~y~aPE~~~~~~~~~~~~~~~~~Dv  206 (301)
T 3q4u_A          180 TKRYMAPEVLDETIQVDCFDSYKRVDI  206 (301)
T ss_dssp             CGGGCCHHHHTTCCCTTCHHHHHHHHH
T ss_pred             ccceeChhhhcCcCCCCcccCCchhhH
Confidence            9999999999776      56678875

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.96  E-value=5.9e-30  Score=185.39  Aligned_cols=151  Identities=24%  Similarity=0.328  Sum_probs=125.0

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      .+++.||+|.+......    ..+|++++..+ +||||+++ +.+......++|||++++|+|.+.+.....   +++..
T Consensus        45 ~~~~~~avK~~~~~~~~----~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~---~~~~~  117 (342)
T 2qr7_A           45 ATNMEFAVKIIDKSKRD----PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKF---FSERE  117 (342)
T ss_dssp             TTTEEEEEEEEETTTCC----CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCTT---CCHHH
T ss_pred             CCCCEEEEEEEEcccCC----hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcCC---CCHHH
Confidence            46889999998655322    34688888887 79999998 666777788999999999999988876433   88999


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCC----CCeEEccccchhhhhhh--hhhhhcccccccCcceecC
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED----LKPKISDFGLARILRKM--ILKQIQIELGYIPPEYVGR  155 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~----~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~~  155 (164)
                      +..++.|++.||.|||+.   +++||||||+||++...    +.++|+|||++......  .....+||+.|+|||++.+
T Consensus       118 ~~~~~~qi~~al~~lH~~---givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~  194 (342)
T 2qr7_A          118 ASAVLFTITKTVEYLHAQ---GVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLER  194 (342)
T ss_dssp             HHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHC---CcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcC
Confidence            999999999999999998   99999999999998442    35999999999765432  2345678999999999988


Q ss_pred             CcceeccCC
Q 046065          156 GVYYKKFSL  164 (164)
Q Consensus       156 ~~~~~~~Di  164 (164)
                      ..|+.++||
T Consensus       195 ~~~~~~~Di  203 (342)
T 2qr7_A          195 QGYDAACDI  203 (342)
T ss_dssp             HHHHHHHHH
T ss_pred             CCCCCccCe
Confidence            888888885

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.96  E-value=9.1e-30  Score=179.89  Aligned_cols=155  Identities=26%  Similarity=0.411  Sum_probs=131.3

Q ss_pred             CCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHH
Q 046065            5 DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRV   83 (164)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~   83 (164)
                      +++.||+|.+..+ ....+.+.+|+.+++.++||||+++ +.+...+..++|||++++++|.+++..... ..++.....
T Consensus        37 ~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~-~~~~~~~~~  114 (288)
T 3kfa_A           37 YSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVLL  114 (288)
T ss_dssp             GTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCT-TTSCHHHHH
T ss_pred             CCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhccc-CCccHhHHH
Confidence            4778999998643 3345678899999999999999998 777777889999999999999999875322 238889999


Q ss_pred             HHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh---hhhhcccccccCcceecCCccee
Q 046065           84 HIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI---LKQIQIELGYIPPEYVGRGVYYK  160 (164)
Q Consensus        84 ~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~  160 (164)
                      .++.|++.|+.|+|+.   +++|+||||+||+++.++.++|+|||++.......   .....+++.|+|||.+.+..++.
T Consensus       115 ~i~~~i~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  191 (288)
T 3kfa_A          115 YMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI  191 (288)
T ss_dssp             HHHHHHHHHHHHHHHH---TCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCH
T ss_pred             HHHHHHHHHHHHHHHC---CccCCCCCcceEEEcCCCCEEEccCccceeccCCccccccCCccccCcCChhhhccCCCCc
Confidence            9999999999999999   99999999999999999999999999997665332   23455678899999998888999


Q ss_pred             ccCC
Q 046065          161 KFSL  164 (164)
Q Consensus       161 ~~Di  164 (164)
                      ++||
T Consensus       192 ~~Di  195 (288)
T 3kfa_A          192 KSDV  195 (288)
T ss_dssp             HHHH
T ss_pred             hhhH
Confidence            9885

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.96  E-value=3e-29  Score=178.75  Aligned_cols=156  Identities=37%  Similarity=0.515  Sum_probs=130.2

Q ss_pred             CCcEEEEEEcccc----ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            5 DGQIIAVKKLSKK----STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         5 ~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      +++.||+|.+...    .....+.+.+|+.+++.++||||+++ +.+...+..++|||++++++|.+++........+++
T Consensus        53 ~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~  132 (307)
T 2nru_A           53 NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSW  132 (307)
T ss_dssp             SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCH
T ss_pred             CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCH
Confidence            5788999998643    22335678899999999999999998 777777889999999999999999875443344889


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh----hhhhhcccccccCcceecC
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM----ILKQIQIELGYIPPEYVGR  155 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~~aPE~~~~  155 (164)
                      .....++.|++.||.|+|+.   +++|+||||+||+++.++.++|+|||++......    ......|++.|+|||.+. 
T Consensus       133 ~~~~~i~~~i~~~l~~lH~~---~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~-  208 (307)
T 2nru_A          133 HMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALR-  208 (307)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHT-
T ss_pred             HHHHHHHHHHHHHHHHHhcC---CeecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhc-
Confidence            99999999999999999998   9999999999999999999999999998755421    123457899999999885 


Q ss_pred             CcceeccCC
Q 046065          156 GVYYKKFSL  164 (164)
Q Consensus       156 ~~~~~~~Di  164 (164)
                      +.++.++||
T Consensus       209 ~~~~~~~Dv  217 (307)
T 2nru_A          209 GEITPKSDI  217 (307)
T ss_dssp             TEECTHHHH
T ss_pred             CCCCccchh
Confidence            468888885

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.96  E-value=2.6e-29  Score=179.41  Aligned_cols=156  Identities=22%  Similarity=0.288  Sum_probs=121.9

Q ss_pred             CCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeEeEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHHH
Q 046065            5 DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVH   84 (164)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~   84 (164)
                      .++.||+|.+...  ...+.+..|+.+++.++||||+++..+.. +..++||||+++++|.+++........++......
T Consensus        30 ~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~  106 (307)
T 2eva_A           30 RAKDVAIKQIESE--SERKAFIVELRQLSRVNHPNIVKLYGACL-NPVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMS  106 (307)
T ss_dssp             TTEEEEEEECSST--THHHHHHHHHHHHHHCCCTTBCCEEEBCT-TTTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHH
T ss_pred             CCeeEEEEEecCh--hHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHH
Confidence            4678999998533  34467889999999999999999833333 45789999999999999998654434477888999


Q ss_pred             HHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCC-eEEccccchhhhhhhhhhhhcccccccCcceecCCcceeccC
Q 046065           85 IIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK-PKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKKFS  163 (164)
Q Consensus        85 ~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~-~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~D  163 (164)
                      ++.|+++|+.|||+.+..+++|+||||+||+++.++. +||+|||++...... .....|++.|+|||++.+..++.++|
T Consensus       107 ~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~D  185 (307)
T 2eva_A          107 WCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-MTNNKGSAAWMAPEVFEGSNYSEKCD  185 (307)
T ss_dssp             HHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------------CCTTSSCHHHHTCCCCCTHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-cccCCCCCceEChhhhCCCCCCcHHH
Confidence            9999999999999954349999999999999998886 799999998765432 23456899999999999889999998


Q ss_pred             C
Q 046065          164 L  164 (164)
Q Consensus       164 i  164 (164)
                      |
T Consensus       186 i  186 (307)
T 2eva_A          186 V  186 (307)
T ss_dssp             H
T ss_pred             H
Confidence            5

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=1.8e-29  Score=182.11  Aligned_cols=153  Identities=29%  Similarity=0.457  Sum_probs=123.2

Q ss_pred             cEEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHHH
Q 046065            7 QIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVH   84 (164)
Q Consensus         7 ~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~   84 (164)
                      ..||+|.+... .......+.+|+.+++.++||||+++ +.+...+..++|||++++++|.+++....  ..++...+..
T Consensus        74 ~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~  151 (333)
T 1mqb_A           74 VPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKD--GEFSVLQLVG  151 (333)
T ss_dssp             EEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTT--TCSCHHHHHH
T ss_pred             ccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCC--CCCCHHHHHH
Confidence            46999998654 33345678899999999999999998 66777778999999999999999986532  2388899999


Q ss_pred             HHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh-----hhhhcccccccCcceecCCcce
Q 046065           85 IIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI-----LKQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        85 ~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      ++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.......     .....+++.|+|||.+.+..++
T Consensus       152 i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  228 (333)
T 1mqb_A          152 MLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFT  228 (333)
T ss_dssp             HHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCC
T ss_pred             HHHHHHHHHHHHHhC---CeeCCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCC
Confidence            999999999999998   99999999999999999999999999997664321     1233457789999999888999


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      .++||
T Consensus       229 ~~~Di  233 (333)
T 1mqb_A          229 SASDV  233 (333)
T ss_dssp             HHHHH
T ss_pred             chhhh
Confidence            99885

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.96  E-value=1.9e-29  Score=182.60  Aligned_cols=156  Identities=28%  Similarity=0.487  Sum_probs=131.1

Q ss_pred             CCcEEEEEEccccccc---c--------------HHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhh
Q 046065            5 DGQIIAVKKLSKKSTQ---G--------------FEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDY   66 (164)
Q Consensus         5 ~~~~vavK~~~~~~~~---~--------------~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~   66 (164)
                      +++.||+|.+......   .              ...+.+|+.+++.++||||+++ +.+...+..++|||++++++|.+
T Consensus        53 ~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~  132 (348)
T 2pml_X           53 DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILK  132 (348)
T ss_dssp             TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSE
T ss_pred             CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHH
Confidence            6789999998654211   1              1778999999999999999998 77777788999999999999998


Q ss_pred             h------hhCcccccccCHHHHHHHHHHHHHHHHHhhh-cCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhh
Q 046065           67 F------LFDPIRMLILDCKKRVHIIKGIIQGLLYLQE-YFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILK  139 (164)
Q Consensus        67 ~------~~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~-~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~  139 (164)
                      +      +.... ...+++..+..++.|++.|+.|+|+ .   +++|+||+|+||+++.++.++|+|||++.........
T Consensus       133 ~~~~~~~l~~~~-~~~~~~~~~~~i~~qi~~~l~~lH~~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~  208 (348)
T 2pml_X          133 FDEYFFVLDKNY-TCFIPIQVIKCIIKSVLNSFSYIHNEK---NICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK  208 (348)
T ss_dssp             ESSSEESSCSSS-CCCCCHHHHHHHHHHHHHHHHHHHHTS---CEECCCCCGGGEEECTTSCEEECCCTTCEECBTTEEC
T ss_pred             HHHHhhhhhhcc-ccCCCHHHHHHHHHHHHHHHHHHhccC---CEeecCCChHhEEEcCCCcEEEecccccccccccccc
Confidence            8      44321 2348899999999999999999998 7   9999999999999999999999999999776554456


Q ss_pred             hhcccccccCcceecCC-ccee-ccCC
Q 046065          140 QIQIELGYIPPEYVGRG-VYYK-KFSL  164 (164)
Q Consensus       140 ~~~~~~~~~aPE~~~~~-~~~~-~~Di  164 (164)
                      ...+++.|+|||.+.+. .++. ++||
T Consensus       209 ~~~~~~~y~aPE~~~~~~~~~~~~~Di  235 (348)
T 2pml_X          209 GSRGTYEFMPPEFFSNESSYNGAKVDI  235 (348)
T ss_dssp             SSCSCGGGCCGGGGSSCCCEEHHHHHH
T ss_pred             CCCCCcCccCchhhcCCCCCCcchhhH
Confidence            67889999999999877 6665 7775

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.96  E-value=1.6e-29  Score=176.80  Aligned_cols=155  Identities=25%  Similarity=0.437  Sum_probs=130.8

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      .+++.||+|.+..... ..+.+.+|+.+++.++||||+++ +.+...+..++|||++++++|.+++.....  .++....
T Consensus        30 ~~~~~vaiK~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--~~~~~~~  106 (267)
T 3t9t_A           30 LNKDKVAIKTIREGAM-SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRG--LFAAETL  106 (267)
T ss_dssp             TTTEEEEEEEECTTTB-CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTTT--CCCHHHH
T ss_pred             cCCCeEEEEEccccCC-CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCcc--cCCHHHH
Confidence            3577899999865432 34678899999999999999997 777777889999999999999999865322  3788999


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh---hhhhcccccccCcceecCCcce
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI---LKQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      ..++.|++.|+.++|+.   +++|+||||+||+++.++.++|+|||++.......   .....+++.|+|||++.+..++
T Consensus       107 ~~~~~~i~~~l~~lH~~---~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  183 (267)
T 3t9t_A          107 LGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYS  183 (267)
T ss_dssp             HHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCC
T ss_pred             HHHHHHHHHHHHHHHhC---CcccCCCchheEEECCCCCEEEcccccccccccccccccccccccccccChhhhcCCCcc
Confidence            99999999999999998   99999999999999999999999999997664322   2345567889999999888889


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      .++||
T Consensus       184 ~~~Di  188 (267)
T 3t9t_A          184 SKSDV  188 (267)
T ss_dssp             HHHHH
T ss_pred             chhch
Confidence            98885

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.96  E-value=3.3e-29  Score=189.70  Aligned_cols=154  Identities=29%  Similarity=0.419  Sum_probs=129.0

Q ss_pred             CCCcEEEEEEcccccc-------------ccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhh
Q 046065            4 PDGQIIAVKKLSKKST-------------QGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLF   69 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~-------------~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~   69 (164)
                      .+++.||+|.+.....             ...+.+.+|+.+++.++||||+++ +.+......++|||++++++|.+.+.
T Consensus        59 ~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~  138 (504)
T 3q5i_A           59 NGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQII  138 (504)
T ss_dssp             TTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHH
T ss_pred             CCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHH
Confidence            4678999999865421             235678899999999999999998 77777778999999999999988886


Q ss_pred             CcccccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCC---CeEEccccchhhhhhh-hhhhhcccc
Q 046065           70 DPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL---KPKISDFGLARILRKM-ILKQIQIEL  145 (164)
Q Consensus        70 ~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~---~~~l~dfg~~~~~~~~-~~~~~~~~~  145 (164)
                      ....   +++..+..++.|++.||.|||+.   +|+|+||||+||+++..+   .++|+|||++...... ......||+
T Consensus       139 ~~~~---~~~~~~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~  212 (504)
T 3q5i_A          139 NRHK---FDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTA  212 (504)
T ss_dssp             HHSC---CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSCBCCCCSCT
T ss_pred             HcCC---CCHHHHHHHHHHHHHHHHHHHHC---CeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCccccccCCc
Confidence            5433   88999999999999999999998   999999999999998765   6999999999766543 235567999


Q ss_pred             cccCcceecCCcceeccCC
Q 046065          146 GYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       146 ~~~aPE~~~~~~~~~~~Di  164 (164)
                      .|+|||++. +.|+.++||
T Consensus       213 ~y~aPE~~~-~~~~~~~Di  230 (504)
T 3q5i_A          213 YYIAPEVLK-KKYNEKCDV  230 (504)
T ss_dssp             TTCCHHHHT-TCBCTHHHH
T ss_pred             CCCCHHHhc-cCCCchHHH
Confidence            999999986 568988885

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.96  E-value=1.2e-29  Score=178.47  Aligned_cols=158  Identities=27%  Similarity=0.394  Sum_probs=128.9

Q ss_pred             CCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEee--CCcEEEEEEecCCCChhhhhhCccc-cccc
Q 046065            4 PDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIE--TQEYMLIYEYMPKRSLDYFLFDPIR-MLIL   77 (164)
Q Consensus         4 ~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~   77 (164)
                      .+++.||+|.+...  .....+.+..|+.+++.++||||+++ +.+..  ....++|||++++++|.+++..... ...+
T Consensus        29 ~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~  108 (279)
T 2w5a_A           29 SDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYL  108 (279)
T ss_dssp             TTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCC
T ss_pred             CCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCC
Confidence            46889999998754  23445678899999999999999997 55533  4578899999999999999875322 2338


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhcCCCC-----eeeCCCCCCceeecCCCCeEEccccchhhhhhh--hhhhhcccccccCc
Q 046065           78 DCKKRVHIIKGIIQGLLYLQEYFRLT-----IIHRDLKVSNILLDEDLKPKISDFGLARILRKM--ILKQIQIELGYIPP  150 (164)
Q Consensus        78 ~~~~~~~~~~~~~~~l~~lh~~~~~~-----iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aP  150 (164)
                      ++.....++.|++.||.|+|+.   +     ++|+||||+||+++.++.++|+|||++......  ......+++.|+||
T Consensus       109 ~~~~~~~i~~~i~~~l~~lH~~---~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aP  185 (279)
T 2w5a_A          109 DEEFVLRVMTQLTLALKECHRR---SDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSP  185 (279)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHH---C------CCCCCSGGGEEECSSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCH
T ss_pred             CHHHHHHHHHHHHHHHHHHhcc---cCCCCeeEEeccchhhEEEcCCCCEEEecCchheeeccccccccccCCCccccCh
Confidence            8999999999999999999998   7     999999999999999999999999999766432  22456789999999


Q ss_pred             ceecCCcceeccCC
Q 046065          151 EYVGRGVYYKKFSL  164 (164)
Q Consensus       151 E~~~~~~~~~~~Di  164 (164)
                      |.+.+..++.++||
T Consensus       186 E~~~~~~~~~~~Di  199 (279)
T 2w5a_A          186 EQMNRMSYNEKSDI  199 (279)
T ss_dssp             HHHHCC-CCHHHHH
T ss_pred             HHhccCCCCchhhH
Confidence            99988889999885

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.96  E-value=1.2e-29  Score=182.54  Aligned_cols=156  Identities=29%  Similarity=0.489  Sum_probs=130.2

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeC--CcEEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIET--QEYMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      .+++.||+|.+........+.+.+|+.+++.++||||+++ +.+...  ...++|+|++++++|.+++.....  .++..
T Consensus        68 ~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~  145 (326)
T 2w1i_A           68 NTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKE--RIDHI  145 (326)
T ss_dssp             SCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHSTT--SSCHH
T ss_pred             CCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhccc--CCCHH
Confidence            4688999999876656566788999999999999999998 555443  367899999999999999875322  37889


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh-----hhhhcccccccCcceecC
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI-----LKQIQIELGYIPPEYVGR  155 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~aPE~~~~  155 (164)
                      .+..++.|++.||.+||+.   +++|+||||+||+++.++.++|+|||++.......     .....++..|+|||.+.+
T Consensus       146 ~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~  222 (326)
T 2w1i_A          146 KLLQYTSQICKGMEYLGTK---RYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTE  222 (326)
T ss_dssp             HHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcC
Confidence            9999999999999999998   99999999999999999999999999997654321     123456778999999988


Q ss_pred             CcceeccCC
Q 046065          156 GVYYKKFSL  164 (164)
Q Consensus       156 ~~~~~~~Di  164 (164)
                      ..++.++||
T Consensus       223 ~~~~~~~Di  231 (326)
T 2w1i_A          223 SKFSVASDV  231 (326)
T ss_dssp             CEEEHHHHH
T ss_pred             CCCCchhhH
Confidence            889999885

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.96  E-value=2.9e-29  Score=176.92  Aligned_cols=156  Identities=22%  Similarity=0.297  Sum_probs=127.5

Q ss_pred             CCCcEEEEEEcccc--ccccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccc-ccccC
Q 046065            4 PDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIR-MLILD   78 (164)
Q Consensus         4 ~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~-~~~~~   78 (164)
                      .+++.||+|.+...  .......+.+|+..+..+ +||||+++ +.+...+..++|||++++++|.+++..... ...++
T Consensus        34 ~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~  113 (289)
T 1x8b_A           34 LDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFK  113 (289)
T ss_dssp             TTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCC
T ss_pred             CCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCC
Confidence            46899999998754  233456778899999998 89999997 777778889999999999999999875322 13388


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCC-------------------CCeEEccccchhhhhhhhhh
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED-------------------LKPKISDFGLARILRKMILK  139 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~-------------------~~~~l~dfg~~~~~~~~~~~  139 (164)
                      +..+..++.|++.||.|+|++   +++|+||||+||+++.+                   ..++|+|||.+......  .
T Consensus       114 ~~~~~~i~~qi~~al~~lH~~---~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~  188 (289)
T 1x8b_A          114 EAELKDLLLQVGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP--Q  188 (289)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCS--C
T ss_pred             HHHHHHHHHHHHHHHHHHHhC---CEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCc--c
Confidence            999999999999999999998   99999999999999844                   47899999998765432  3


Q ss_pred             hhcccccccCcceecCC-cceeccCC
Q 046065          140 QIQIELGYIPPEYVGRG-VYYKKFSL  164 (164)
Q Consensus       140 ~~~~~~~~~aPE~~~~~-~~~~~~Di  164 (164)
                      ...+++.|+|||++.+. .++.++||
T Consensus       189 ~~~gt~~y~aPE~~~~~~~~~~~~Di  214 (289)
T 1x8b_A          189 VEEGDSRFLANEVLQENYTHLPKADI  214 (289)
T ss_dssp             CCCCCGGGCCHHHHTTCCTTHHHHHH
T ss_pred             ccCCCccccChhHhcCCCCCCchhhH
Confidence            34689999999999766 56778885

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.96  E-value=4.4e-29  Score=178.21  Aligned_cols=158  Identities=20%  Similarity=0.277  Sum_probs=124.0

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcc-cccccC
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPI-RMLILD   78 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~   78 (164)
                      .+++.||+|.+...   .......+.+|+.+++.++||||+++ +.+...+..++|||++++++|.+++.... ....++
T Consensus        55 ~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~  134 (310)
T 2wqm_A           55 LDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIP  134 (310)
T ss_dssp             TTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCC
T ss_pred             CCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCC
Confidence            57889999998653   23345678899999999999999997 77777888999999999999999886421 123388


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh--hhhhcccccccCcceecCC
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI--LKQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~aPE~~~~~  156 (164)
                      ......++.|++.||.|+|+.   +++|+||+|+||+++.++.++|+|||++.......  .....+++.|+|||.+.+.
T Consensus       135 ~~~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  211 (310)
T 2wqm_A          135 ERTVWKYFVQLCSALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHEN  211 (310)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCC------------------CCSSCCHHHHTTC
T ss_pred             HHHHHHHHHHHHHHHHHHhhC---CeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCccccccCCCeeEeChHHhCCC
Confidence            899999999999999999998   99999999999999999999999999987654322  2456789999999999888


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .++.++||
T Consensus       212 ~~~~~~Dv  219 (310)
T 2wqm_A          212 GYNFKSDI  219 (310)
T ss_dssp             CCCHHHHH
T ss_pred             CCCchhhH
Confidence            89999885

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.96  E-value=2.6e-29  Score=183.43  Aligned_cols=155  Identities=26%  Similarity=0.433  Sum_probs=129.4

Q ss_pred             CCCcEEEEEEcccccc--------ccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccc
Q 046065            4 PDGQIIAVKKLSKKST--------QGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIR   73 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~   73 (164)
                      .+|+.||||.+.....        ...+.+..|+.+++.+ +||||+++ +.+......++|||++++++|.+++.... 
T Consensus       117 ~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~-  195 (365)
T 2y7j_A          117 ATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKV-  195 (365)
T ss_dssp             TTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHHS-
T ss_pred             CCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhcC-
Confidence            4789999999865421        1245677899999999 79999998 77777788999999999999999887533 


Q ss_pred             ccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh-hhhhhcccccccCcce
Q 046065           74 MLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM-ILKQIQIELGYIPPEY  152 (164)
Q Consensus        74 ~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~  152 (164)
                        .+++.....++.|++.||.|+|+.   +++|+|+||+||+++.++.++|+|||++...... ......||+.|+|||+
T Consensus       196 --~l~~~~~~~i~~qi~~~L~~LH~~---gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~  270 (365)
T 2y7j_A          196 --ALSEKETRSIMRSLLEAVSFLHAN---NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEI  270 (365)
T ss_dssp             --SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHH
T ss_pred             --CCCHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEECCCCCEEEEecCcccccCCCcccccCCCCCCccChhh
Confidence              288999999999999999999998   9999999999999999999999999998765432 3355789999999999


Q ss_pred             ecC------CcceeccCC
Q 046065          153 VGR------GVYYKKFSL  164 (164)
Q Consensus       153 ~~~------~~~~~~~Di  164 (164)
                      +.+      ..++.++||
T Consensus       271 ~~~~~~~~~~~~~~~~Di  288 (365)
T 2y7j_A          271 LKCSMDETHPGYGKEVDL  288 (365)
T ss_dssp             HHHTTCTTSCCBCTTHHH
T ss_pred             ccccccccCcCCCchhhH
Confidence            853      357888885

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.96  E-value=3.7e-29  Score=181.95  Aligned_cols=154  Identities=23%  Similarity=0.225  Sum_probs=128.7

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccC-----CCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccccccc
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQ-----HLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLIL   77 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~   77 (164)
                      .+++.||+|.+... ......+..|+.+++.+.     ||||+++ +.+...+..++|||++ +++|.+++..... ..+
T Consensus        58 ~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~-~~~  134 (360)
T 3llt_A           58 DNKKYYAVKVVRNI-KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNY-NGF  134 (360)
T ss_dssp             TTCCEEEEEEECSC-HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTT-CCC
T ss_pred             CCCeEEEEEEeccc-hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCC-CCC
Confidence            46889999998633 233455678999999886     9999998 7777788899999999 8899998875332 238


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecC-------------------------CCCeEEccccchhh
Q 046065           78 DCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE-------------------------DLKPKISDFGLARI  132 (164)
Q Consensus        78 ~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~-------------------------~~~~~l~dfg~~~~  132 (164)
                      +...+..++.|++.||.|||+.   +|+|+||||+||+++.                         .+.++|+|||++..
T Consensus       135 ~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~  211 (360)
T 3llt_A          135 HIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATF  211 (360)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEE
T ss_pred             CHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCcee
Confidence            8899999999999999999998   9999999999999975                         78899999999975


Q ss_pred             hhhhhhhhhcccccccCcceecCCcceeccCC
Q 046065          133 LRKMILKQIQIELGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       133 ~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di  164 (164)
                      ... ......||+.|+|||++.+..++.++||
T Consensus       212 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di  242 (360)
T 3llt_A          212 KSD-YHGSIINTRQYRAPEVILNLGWDVSSDM  242 (360)
T ss_dssp             TTS-CCCSCCSCGGGCCHHHHTTCCCCTTHHH
T ss_pred             cCC-CCcCccCcccccCcHHHcCCCCCCccch
Confidence            432 2345678999999999999999999985

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.96  E-value=2e-29  Score=177.43  Aligned_cols=156  Identities=30%  Similarity=0.476  Sum_probs=129.7

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeEeEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRV   83 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~   83 (164)
                      .+++.||+|.+... ....+.+..|+.+++.++||||+++..+...+..++|||++++++|.+++..... ..++.....
T Consensus        35 ~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~-~~~~~~~~~  112 (279)
T 1qpc_A           35 NGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSG-IKLTINKLL  112 (279)
T ss_dssp             TTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCTTCBHHHHTTSHHH-HTCCHHHHH
T ss_pred             cCCcEEEEEEecCC-cccHHHHHHHHHHHHhCCCcCcceEEEEEcCCCcEEEEecCCCCCHHHHHhcCCC-CCCCHHHHH
Confidence            45678999998644 2345678899999999999999998555556678999999999999999875321 238889999


Q ss_pred             HHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh---hhhcccccccCcceecCCccee
Q 046065           84 HIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL---KQIQIELGYIPPEYVGRGVYYK  160 (164)
Q Consensus        84 ~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~  160 (164)
                      .++.|++.||.|+|+.   +++|+||||+||+++.++.++|+|||++........   ....+++.|+|||.+.+..++.
T Consensus       113 ~i~~qi~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  189 (279)
T 1qpc_A          113 DMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI  189 (279)
T ss_dssp             HHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECH
T ss_pred             HHHHHHHHHHHHHHHC---CeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccccCCCCccCccChhhhccCCCCc
Confidence            9999999999999998   999999999999999999999999999976643221   3345677899999998888898


Q ss_pred             ccCC
Q 046065          161 KFSL  164 (164)
Q Consensus       161 ~~Di  164 (164)
                      ++||
T Consensus       190 ~~Di  193 (279)
T 1qpc_A          190 KSDV  193 (279)
T ss_dssp             HHHH
T ss_pred             hhhh
Confidence            8885

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.96  E-value=7.6e-30  Score=183.78  Aligned_cols=156  Identities=27%  Similarity=0.381  Sum_probs=129.6

Q ss_pred             CcEEEEEEccccc-cccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccc---------
Q 046065            6 GQIIAVKKLSKKS-TQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIR---------   73 (164)
Q Consensus         6 ~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---------   73 (164)
                      .+.||+|.+.... ......+.+|+.+++.+ +||||+++ +.+...+..++|||++++++|.+++.....         
T Consensus        76 ~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~  155 (333)
T 2i1m_A           76 VLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFA  155 (333)
T ss_dssp             CCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC----
T ss_pred             hhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhccccccccccc
Confidence            3589999986542 33456788999999999 89999998 777777889999999999999998865321         


Q ss_pred             --ccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh----hhhcccccc
Q 046065           74 --MLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL----KQIQIELGY  147 (164)
Q Consensus        74 --~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~  147 (164)
                        ...++......++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++........    ....+++.|
T Consensus       156 ~~~~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y  232 (333)
T 2i1m_A          156 IANSTASTRDLLHFSSQVAQGMAFLASK---NCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKW  232 (333)
T ss_dssp             ---CCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGG
T ss_pred             ccccccCHHHHHHHHHHHHHHHHHHhcC---CcccCCcccceEEECCCCeEEECccccccccccccceeecCCCCCCccc
Confidence              12368889999999999999999998   999999999999999999999999999976543221    334567889


Q ss_pred             cCcceecCCcceeccCC
Q 046065          148 IPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       148 ~aPE~~~~~~~~~~~Di  164 (164)
                      +|||++.+..++.++||
T Consensus       233 ~aPE~~~~~~~~~~~Di  249 (333)
T 2i1m_A          233 MAPESIFDCVYTVQSDV  249 (333)
T ss_dssp             SCHHHHHHCCCCHHHHH
T ss_pred             cCHHHhccCCCChHHHH
Confidence            99999988889999885

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.96  E-value=1.8e-29  Score=181.16  Aligned_cols=154  Identities=25%  Similarity=0.397  Sum_probs=117.8

Q ss_pred             EEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcE------EEEEEecCCCChhhhhhCcc---ccc
Q 046065            8 IIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEY------MLIYEYMPKRSLDYFLFDPI---RML   75 (164)
Q Consensus         8 ~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~------~lv~e~~~~~~L~~~~~~~~---~~~   75 (164)
                      .||+|.+...  .....+.+.+|+.+++.++||||+++ +.+......      ++|+|++++++|.+++....   ...
T Consensus        53 ~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~  132 (323)
T 3qup_A           53 KVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPF  132 (323)
T ss_dssp             EEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CC
T ss_pred             eEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhcccccc
Confidence            7999998755  34456778999999999999999997 555554433      89999999999999886432   122


Q ss_pred             ccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh----hhhhcccccccCcc
Q 046065           76 ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI----LKQIQIELGYIPPE  151 (164)
Q Consensus        76 ~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~aPE  151 (164)
                      .++...+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.......    .....+++.|+|||
T Consensus       133 ~~~~~~~~~i~~qi~~al~~LH~~---~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE  209 (323)
T 3qup_A          133 NLPLQTLVRFMVDIACGMEYLSSR---NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALE  209 (323)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHH
T ss_pred             ccCHHHHHHHHHHHHHHHHHHHcC---CcccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCch
Confidence            488999999999999999999998   99999999999999999999999999997654322    12345677899999


Q ss_pred             eecCCcceeccCC
Q 046065          152 YVGRGVYYKKFSL  164 (164)
Q Consensus       152 ~~~~~~~~~~~Di  164 (164)
                      .+.+..++.++||
T Consensus       210 ~~~~~~~~~~~Di  222 (323)
T 3qup_A          210 SLADNLYTVHSDV  222 (323)
T ss_dssp             HHHHCCCCHHHHH
T ss_pred             hhcCCCCCCccch
Confidence            9988889999985

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.96  E-value=3.2e-29  Score=183.23  Aligned_cols=152  Identities=26%  Similarity=0.339  Sum_probs=117.5

Q ss_pred             CCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCC------cEEEEEEecCCCChhhhhhCcccc
Q 046065            4 PDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQ------EYMLIYEYMPKRSLDYFLFDPIRM   74 (164)
Q Consensus         4 ~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~   74 (164)
                      .+++.||+|.+...  .......+.+|+.+++.++||||+++ +.+....      ..++|||++++ +|.+.+..    
T Consensus        48 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~----  122 (371)
T 2xrw_A           48 ILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQVIQM----  122 (371)
T ss_dssp             TTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSE-EHHHHHHS----
T ss_pred             CCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCCC-CHHHHHhh----
Confidence            46889999998654  23345678899999999999999998 5554433      57899999974 77777653    


Q ss_pred             cccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh-hhhhhcccccccCccee
Q 046065           75 LILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM-ILKQIQIELGYIPPEYV  153 (164)
Q Consensus        75 ~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~  153 (164)
                       .++...+..++.|++.||.|||++   +++|+||||+||+++.++.+||+|||++...... ......||+.|+|||++
T Consensus       123 -~~~~~~~~~i~~qi~~al~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~  198 (371)
T 2xrw_A          123 -ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI  198 (371)
T ss_dssp             -CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCC----------------CTTCCHHHH
T ss_pred             -ccCHHHHHHHHHHHHHHHHHHHHC---CeecccCCHHHEEEcCCCCEEEEEeecccccccccccCCceecCCccCHHHh
Confidence             278889999999999999999998   9999999999999999999999999999766543 23456789999999999


Q ss_pred             cCCcceeccCC
Q 046065          154 GRGVYYKKFSL  164 (164)
Q Consensus       154 ~~~~~~~~~Di  164 (164)
                      .+..++.++||
T Consensus       199 ~~~~~~~~~Di  209 (371)
T 2xrw_A          199 LGMGYKENVDI  209 (371)
T ss_dssp             TTCCCCTTHHH
T ss_pred             cCCCCCchHhH
Confidence            98899999985

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.96  E-value=1.5e-29  Score=179.20  Aligned_cols=155  Identities=25%  Similarity=0.345  Sum_probs=127.0

Q ss_pred             CCCcEEEEEEccccc--cccHHHHHHHHHHHhccCCCceeeEeEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            4 PDGQIIAVKKLSKKS--TQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         4 ~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      .+++.||+|.+....  +...+.+..|+.+++.++||||+++..+...+..++|+|++++++|.+++.....   ++...
T Consensus        42 ~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~  118 (291)
T 1xbb_A           42 KVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRH---VKDKN  118 (291)
T ss_dssp             SSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEEEECCTTEEHHHHHHHCTT---CCHHH
T ss_pred             CceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEECCCCcEEEEEeCCCCCHHHHHHhCcC---CCHHH
Confidence            346789999987542  3335678899999999999999998444477788999999999999999876433   88899


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh-----hhhhcccccccCcceecCC
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI-----LKQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~  156 (164)
                      ...++.|++.||.|+|+.   +++|+||||+||+++.++.++|+|||++.......     .....+++.|+|||.+.+.
T Consensus       119 ~~~i~~qi~~~l~~LH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~  195 (291)
T 1xbb_A          119 IIELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY  195 (291)
T ss_dssp             HHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHC
T ss_pred             HHHHHHHHHHHHHHHHhC---CeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccC
Confidence            999999999999999998   99999999999999999999999999987654321     1223456889999999888


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .++.++||
T Consensus       196 ~~~~~~Di  203 (291)
T 1xbb_A          196 KFSSKSDV  203 (291)
T ss_dssp             EEEHHHHH
T ss_pred             CCChhhhH
Confidence            89999885

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.96  E-value=2e-29  Score=177.70  Aligned_cols=153  Identities=29%  Similarity=0.417  Sum_probs=127.2

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEee----------------CCcEEEEEEecCCCChhh
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIE----------------TQEYMLIYEYMPKRSLDY   66 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~----------------~~~~~lv~e~~~~~~L~~   66 (164)
                      .+++.||+|.+....    ..+.+|+.+++.++||||+++ +.+..                ....++|||++++++|.+
T Consensus        34 ~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~  109 (284)
T 2a19_B           34 IDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQ  109 (284)
T ss_dssp             TTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHH
T ss_pred             CCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHH
Confidence            468899999986443    346789999999999999997 44432                334789999999999999


Q ss_pred             hhhCcccccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh-hhhhhcccc
Q 046065           67 FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM-ILKQIQIEL  145 (164)
Q Consensus        67 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~  145 (164)
                      ++..... ..+++.....++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++...... ......+++
T Consensus       110 ~l~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  185 (284)
T 2a19_B          110 WIEKRRG-EKLDKVLALELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTL  185 (284)
T ss_dssp             HHHHGGG-SCCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEESSCCSCCCCCCSCC
T ss_pred             HHhhccC-CCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCCHHHEEEcCCCCEEECcchhheeccccccccccCCcc
Confidence            9865322 2388899999999999999999998   9999999999999999999999999998765432 224467899


Q ss_pred             cccCcceecCCcceeccCC
Q 046065          146 GYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       146 ~~~aPE~~~~~~~~~~~Di  164 (164)
                      .|+|||.+.+..++.++||
T Consensus       186 ~y~aPE~~~~~~~~~~~Di  204 (284)
T 2a19_B          186 RYMSPEQISSQDYGKEVDL  204 (284)
T ss_dssp             TTSCHHHHHCSCCCTHHHH
T ss_pred             cccChhhhccCCCcchhhh
Confidence            9999999988889999885

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.96  E-value=5.6e-29  Score=177.87  Aligned_cols=154  Identities=23%  Similarity=0.366  Sum_probs=131.6

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      .+|+.||+|.+....  ..+.+..|+.+++.++||||+++ +.+...+..++|||++++++|.+++....  ..++....
T Consensus        52 ~~~~~vaiK~~~~~~--~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--~~~~~~~~  127 (314)
T 3com_A           52 ETGQIVAIKQVPVES--DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN--KTLTEDEI  127 (314)
T ss_dssp             TTCCEEEEEEEETTS--CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHT--CCCCHHHH
T ss_pred             CCCCEEEEEecCchH--HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcC--CCCCHHHH
Confidence            468899999986542  34678899999999999999997 77777888999999999999999886321  23889999


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh--hhhhcccccccCcceecCCccee
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI--LKQIQIELGYIPPEYVGRGVYYK  160 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~  160 (164)
                      ..++.|++.|+.|+|+.   +++|+||+|+||+++.++.++|+|||++.......  .....+++.|+|||.+.+..++.
T Consensus       128 ~~i~~~i~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  204 (314)
T 3com_A          128 ATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNC  204 (314)
T ss_dssp             HHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCT
T ss_pred             HHHHHHHHHHHHHHHhC---CCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccccCccCCCCCccChhhcCCCCCCc
Confidence            99999999999999998   99999999999999999999999999987654322  24467899999999998888999


Q ss_pred             ccCC
Q 046065          161 KFSL  164 (164)
Q Consensus       161 ~~Di  164 (164)
                      ++||
T Consensus       205 ~~Di  208 (314)
T 3com_A          205 VADI  208 (314)
T ss_dssp             THHH
T ss_pred             cccH
Confidence            9885

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.96  E-value=3.3e-29  Score=177.37  Aligned_cols=154  Identities=29%  Similarity=0.392  Sum_probs=119.4

Q ss_pred             CcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeEeEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHH
Q 046065            6 GQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRV   83 (164)
Q Consensus         6 ~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~   83 (164)
                      ...||+|.+...  .....+.+.+|+.+++.++||||+++..+......++|||++++++|.+++....  ..++...+.
T Consensus        46 ~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~  123 (289)
T 3og7_A           46 HGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHASE--TKFEMKKLI  123 (289)
T ss_dssp             SSEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECCCEEEHHHHHTTC-----CCHHHHH
T ss_pred             cCceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCCccEEEEEecCCCcHHHHHhhcc--CCCCHHHHH
Confidence            446999998654  3344567889999999999999999855667778899999999999998886532  238889999


Q ss_pred             HHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh----hhhhhhcccccccCcceec---CC
Q 046065           84 HIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK----MILKQIQIELGYIPPEYVG---RG  156 (164)
Q Consensus        84 ~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~----~~~~~~~~~~~~~aPE~~~---~~  156 (164)
                      .++.|++.||.|+|+.   +++|+||||+||+++.++.++|+|||++.....    .......|++.|+|||++.   +.
T Consensus       124 ~i~~qi~~~L~~lH~~---~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  200 (289)
T 3og7_A          124 DIARQTARGMDYLHAK---SIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN  200 (289)
T ss_dssp             HHHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTTEEEECCCC------------------CCCTTCCHHHHC----C
T ss_pred             HHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCC
Confidence            9999999999999998   999999999999999999999999999875542    2224567899999999986   56


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .++.++||
T Consensus       201 ~~~~~~Di  208 (289)
T 3og7_A          201 PYSFQSDV  208 (289)
T ss_dssp             CSCHHHHH
T ss_pred             CCCcccch
Confidence            77888885

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=1.3e-29  Score=185.48  Aligned_cols=153  Identities=22%  Similarity=0.385  Sum_probs=119.3

Q ss_pred             cEEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeE-eEEee-CCcEEEEEEecCCCChhhhhhCcccccccCHHHHH
Q 046065            7 QIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIE-TQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRV   83 (164)
Q Consensus         7 ~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~   83 (164)
                      ..||+|.+... .....+.+.+|+.+++.++||||+++ +.+.. .+..++|||++++++|.+++.....  .++.....
T Consensus       118 ~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~--~~~~~~~~  195 (373)
T 3c1x_A          118 IHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NPTVKDLI  195 (373)
T ss_dssp             EEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTTC--CCBHHHHH
T ss_pred             EEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhccc--CCCHHHHH
Confidence            35899998644 33456778999999999999999998 65544 4578899999999999999975332  26788889


Q ss_pred             HHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh------hhhhcccccccCcceecCCc
Q 046065           84 HIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI------LKQIQIELGYIPPEYVGRGV  157 (164)
Q Consensus        84 ~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~------~~~~~~~~~~~aPE~~~~~~  157 (164)
                      .++.|++.||.|||+.   +++|+||||+||+++.++.+||+|||++.......      .....+++.|+|||.+.+..
T Consensus       196 ~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  272 (373)
T 3c1x_A          196 GFGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK  272 (373)
T ss_dssp             HHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC---------------------CCGGGSCHHHHHHCC
T ss_pred             HHHHHHHHHHHHHHHC---CEecCccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCC
Confidence            9999999999999998   99999999999999999999999999997654321      13455678899999999889


Q ss_pred             ceeccCC
Q 046065          158 YYKKFSL  164 (164)
Q Consensus       158 ~~~~~Di  164 (164)
                      ++.++||
T Consensus       273 ~~~~~Dv  279 (373)
T 3c1x_A          273 FTTKSDV  279 (373)
T ss_dssp             CCHHHHH
T ss_pred             CCcHHHH
Confidence            9999985

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.96  E-value=1.3e-29  Score=181.10  Aligned_cols=158  Identities=27%  Similarity=0.386  Sum_probs=129.6

Q ss_pred             CCCcEEEEEEccccc-cccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCC-cEEEEEEecCCCChhhhhhCccc------
Q 046065            4 PDGQIIAVKKLSKKS-TQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQ-EYMLIYEYMPKRSLDYFLFDPIR------   73 (164)
Q Consensus         4 ~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~-~~~lv~e~~~~~~L~~~~~~~~~------   73 (164)
                      .+++.||+|.+.... ......+.+|+.++..+ +||||+++ +.+...+ ..++|+|++++++|.+++.....      
T Consensus        55 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~  134 (316)
T 2xir_A           55 ATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK  134 (316)
T ss_dssp             TCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-
T ss_pred             ccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhccccccccc
Confidence            467899999987553 33446788999999999 69999998 5555544 48899999999999999976432      


Q ss_pred             -------ccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh----hhhhc
Q 046065           74 -------MLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI----LKQIQ  142 (164)
Q Consensus        74 -------~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~----~~~~~  142 (164)
                             ...++...+..++.|++.|+.|+|+.   +++|+||||+||+++.++.++|+|||++.......    .....
T Consensus       135 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~  211 (316)
T 2xir_A          135 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR  211 (316)
T ss_dssp             ------CTTCEEHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEE
T ss_pred             ccchhhhccccCHHHHHHHHHHHHHHHHHHHhC---CcccccCccceEEECCCCCEEECCCccccccccCccceeccCCC
Confidence                   11267889999999999999999998   99999999999999999999999999997654321    23456


Q ss_pred             ccccccCcceecCCcceeccCC
Q 046065          143 IELGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       143 ~~~~~~aPE~~~~~~~~~~~Di  164 (164)
                      +++.|+|||++.+..++.++||
T Consensus       212 ~t~~y~aPE~~~~~~~~~~~Di  233 (316)
T 2xir_A          212 LPLKWMAPETIFDRVYTIQSDV  233 (316)
T ss_dssp             ECGGGCCHHHHHHCCCCHHHHH
T ss_pred             cceeecCchhhccccccchhHH
Confidence            7889999999988889999885

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.96  E-value=9.8e-30  Score=193.77  Aligned_cols=156  Identities=28%  Similarity=0.417  Sum_probs=129.0

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeEeEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRV   83 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~   83 (164)
                      .++..||||.+.... ...+.+.+|+.+++.++||||+++..+......++|||++++|+|.+++..... ..++...+.
T Consensus       289 ~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~-~~l~~~~~~  366 (535)
T 2h8h_A          289 NGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETG-KYLRLPQLV  366 (535)
T ss_dssp             TTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCTTEEHHHHHSHHHH-TTCCHHHHH
T ss_pred             CCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEeeccceEeeehhcCCcHHHHHhhcCC-CCCCHHHHH
Confidence            345679999986543 335678999999999999999998444445778999999999999999864221 237889999


Q ss_pred             HHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh---hhhcccccccCcceecCCccee
Q 046065           84 HIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL---KQIQIELGYIPPEYVGRGVYYK  160 (164)
Q Consensus        84 ~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~aPE~~~~~~~~~  160 (164)
                      .++.|++.||.|||++   +++||||||+|||++.++.+||+|||+++.......   ....++..|+|||++....++.
T Consensus       367 ~i~~qi~~~L~~LH~~---~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~  443 (535)
T 2h8h_A          367 DMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI  443 (535)
T ss_dssp             HHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCH
T ss_pred             HHHHHHHHHHHHHHhC---CeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhccCCCCc
Confidence            9999999999999998   999999999999999999999999999987653322   3345677899999998889999


Q ss_pred             ccCC
Q 046065          161 KFSL  164 (164)
Q Consensus       161 ~~Di  164 (164)
                      ++||
T Consensus       444 ~sDv  447 (535)
T 2h8h_A          444 KSDV  447 (535)
T ss_dssp             HHHH
T ss_pred             hhhH
Confidence            9986

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.96  E-value=6e-29  Score=176.38  Aligned_cols=153  Identities=19%  Similarity=0.205  Sum_probs=127.9

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      .+++.||+|.+....  ....+.+|+.+++.+ +|+|++++ ..+......++|||++ +++|.+++.....  .++...
T Consensus        33 ~~~~~vavK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~--~~~~~~  107 (298)
T 1csn_A           33 LNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGR--KFSVKT  107 (298)
T ss_dssp             TTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTT--CCCHHH
T ss_pred             CCCcEEEEEEeccCC--ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHHhcc--CCCHHH
Confidence            578999999986442  224578899999999 79999997 6666777889999999 9999999875322  388999


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCC-----eEEccccchhhhhhhh---------hhhhcccccc
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK-----PKISDFGLARILRKMI---------LKQIQIELGY  147 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~-----~~l~dfg~~~~~~~~~---------~~~~~~~~~~  147 (164)
                      +..++.|++.||.|+|+.   +++|+||||+||+++.++.     ++|+|||++.......         .....||+.|
T Consensus       108 ~~~i~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y  184 (298)
T 1csn_A          108 VAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY  184 (298)
T ss_dssp             HHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTT
T ss_pred             HHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCccc
Confidence            999999999999999998   9999999999999987765     9999999997654321         2346789999


Q ss_pred             cCcceecCCcceeccCC
Q 046065          148 IPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       148 ~aPE~~~~~~~~~~~Di  164 (164)
                      +|||++.+..++.++||
T Consensus       185 ~aPE~~~~~~~~~~~Di  201 (298)
T 1csn_A          185 MSINTHLGREQSRRDDL  201 (298)
T ss_dssp             CCHHHHTTCCCCHHHHH
T ss_pred             CCchhhcCCCCChHHHH
Confidence            99999998899999985

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.96  E-value=5.6e-29  Score=176.63  Aligned_cols=155  Identities=28%  Similarity=0.407  Sum_probs=122.4

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEee-------------CCcEEEEEEecCCCChhhhhh
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIE-------------TQEYMLIYEYMPKRSLDYFLF   69 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~-------------~~~~~lv~e~~~~~~L~~~~~   69 (164)
                      .+++.||+|.+... ....+.+.+|+.+++.++||||+++ +.+..             ....++|||++++++|.+++.
T Consensus        29 ~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~  107 (303)
T 1zy4_A           29 LDSRYYAIKKIRHT-EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH  107 (303)
T ss_dssp             TTCCEEEEEEEEEE-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHH
T ss_pred             CCCeEEEEEEEecc-HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhh
Confidence            47889999998543 3345678899999999999999997 55433             345789999999999999987


Q ss_pred             CcccccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh--------------
Q 046065           70 DPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK--------------  135 (164)
Q Consensus        70 ~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~--------------  135 (164)
                      ...  ..++......++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++.....              
T Consensus       108 ~~~--~~~~~~~~~~i~~qi~~~l~~LH~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~  182 (303)
T 1zy4_A          108 SEN--LNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG  182 (303)
T ss_dssp             HSC--GGGCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC--------------
T ss_pred             ccc--cccchHHHHHHHHHHHHHHHHHHhC---CeecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccc
Confidence            532  2377888899999999999999998   999999999999999999999999999875531              


Q ss_pred             --hhhhhhcccccccCcceecCC-cceeccCC
Q 046065          136 --MILKQIQIELGYIPPEYVGRG-VYYKKFSL  164 (164)
Q Consensus       136 --~~~~~~~~~~~~~aPE~~~~~-~~~~~~Di  164 (164)
                        .......|++.|+|||++.+. .++.++||
T Consensus       183 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di  214 (303)
T 1zy4_A          183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDM  214 (303)
T ss_dssp             -----------CTTSCHHHHTSCSCCCTHHHH
T ss_pred             cccccccCCCcccccCcccccCCCCCcchhhH
Confidence              112345689999999999754 68888885

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=5.1e-29  Score=176.76  Aligned_cols=153  Identities=27%  Similarity=0.384  Sum_probs=127.7

Q ss_pred             cEEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCc-EEEEEEecCCCChhhhhhCcccccccCHHHHH
Q 046065            7 QIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQE-YMLIYEYMPKRSLDYFLFDPIRMLILDCKKRV   83 (164)
Q Consensus         7 ~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~   83 (164)
                      ..+|+|.+... .....+.+.+|+.+++.++||||+++ +.+...+. .++++|++.+++|.+++.....  .++.....
T Consensus        50 ~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~--~~~~~~~~  127 (298)
T 3pls_A           50 IQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQR--NPTVKDLI  127 (298)
T ss_dssp             EEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTTC--CCBHHHHH
T ss_pred             eeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhcccc--CCCHHHHH
Confidence            37999998654 33445678899999999999999998 66655554 4899999999999999876322  37888899


Q ss_pred             HHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh------hhhhcccccccCcceecCCc
Q 046065           84 HIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI------LKQIQIELGYIPPEYVGRGV  157 (164)
Q Consensus        84 ~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~------~~~~~~~~~~~aPE~~~~~~  157 (164)
                      .++.|++.|+.|||+.   +++|+||||+||+++.++.++|+|||++.......      .....+++.|+|||.+.+..
T Consensus       128 ~i~~qi~~~l~~LH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  204 (298)
T 3pls_A          128 SFGLQVARGMEYLAEQ---KFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYR  204 (298)
T ss_dssp             HHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCC
T ss_pred             HHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCC
Confidence            9999999999999998   99999999999999999999999999997654321      13456788999999999889


Q ss_pred             ceeccCC
Q 046065          158 YYKKFSL  164 (164)
Q Consensus       158 ~~~~~Di  164 (164)
                      ++.++||
T Consensus       205 ~~~~~Di  211 (298)
T 3pls_A          205 FTTKSDV  211 (298)
T ss_dssp             CCHHHHH
T ss_pred             CChhhch
Confidence            9999985

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.96  E-value=2.8e-29  Score=180.55  Aligned_cols=158  Identities=28%  Similarity=0.427  Sum_probs=128.6

Q ss_pred             CCCcEEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccc----cccc
Q 046065            4 PDGQIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIR----MLIL   77 (164)
Q Consensus         4 ~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~----~~~~   77 (164)
                      .+++.||+|.+... .......+.+|+.+++.++||||+++ +.+......++|||++++++|.+++.....    ...+
T Consensus        58 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~  137 (327)
T 2yfx_A           58 PSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSL  137 (327)
T ss_dssp             --CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSC
T ss_pred             CccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccc
Confidence            45778999998644 33445678899999999999999997 777777788999999999999999875321    1337


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecC---CCCeEEccccchhhhhhhh----hhhhcccccccCc
Q 046065           78 DCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE---DLKPKISDFGLARILRKMI----LKQIQIELGYIPP  150 (164)
Q Consensus        78 ~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~---~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~aP  150 (164)
                      +...+..++.|++.||.|||+.   +++|+||||+||+++.   ...++|+|||++.......    .....+++.|+||
T Consensus       138 ~~~~~~~i~~qi~~al~~LH~~---~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aP  214 (327)
T 2yfx_A          138 AMLDLLHVARDIACGCQYLEEN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPP  214 (327)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCH
T ss_pred             cHHHHHHHHHHHHHHHHHHhhC---CeecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCH
Confidence            8889999999999999999998   9999999999999984   4469999999997654322    1345678899999


Q ss_pred             ceecCCcceeccCC
Q 046065          151 EYVGRGVYYKKFSL  164 (164)
Q Consensus       151 E~~~~~~~~~~~Di  164 (164)
                      |.+.+..++.++||
T Consensus       215 E~~~~~~~~~~~Di  228 (327)
T 2yfx_A          215 EAFMEGIFTSKTDT  228 (327)
T ss_dssp             HHHHHCCCCHHHHH
T ss_pred             hHhcCCCCCchhhH
Confidence            99988889999885

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.96  E-value=8.1e-29  Score=177.26  Aligned_cols=158  Identities=22%  Similarity=0.326  Sum_probs=128.3

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEee----CCcEEEEEEecCCCChhhhhhCcc-ccccc
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIE----TQEYMLIYEYMPKRSLDYFLFDPI-RMLIL   77 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~   77 (164)
                      .+++.||+|.+........+.+.+|+.+++.++||||+++ +.+..    ....++|+|++++++|.+++.... ....+
T Consensus        52 ~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~  131 (317)
T 2buj_A           52 HDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFL  131 (317)
T ss_dssp             TTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCC
T ss_pred             CCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCC
Confidence            5788999999876655566788999999999999999997 55542    236789999999999998886521 12348


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh-----------hhhhhhccccc
Q 046065           78 DCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK-----------MILKQIQIELG  146 (164)
Q Consensus        78 ~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~-----------~~~~~~~~~~~  146 (164)
                      ++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....           .......|++.
T Consensus       132 ~~~~~~~i~~qi~~~L~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  208 (317)
T 2buj_A          132 TEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTIS  208 (317)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGG
T ss_pred             CHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcc
Confidence            8999999999999999999998   999999999999999999999999998764321           11234567999


Q ss_pred             ccCcceecCCc---ceeccCC
Q 046065          147 YIPPEYVGRGV---YYKKFSL  164 (164)
Q Consensus       147 ~~aPE~~~~~~---~~~~~Di  164 (164)
                      |+|||++.+..   ++.++||
T Consensus       209 y~aPE~~~~~~~~~~~~~~Di  229 (317)
T 2buj_A          209 YRAPELFSVQSHCVIDERTDV  229 (317)
T ss_dssp             GCCGGGSSCCSEEEECTHHHH
T ss_pred             cCCHhHhccCCCcCCCchhhH
Confidence            99999986543   6778875

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.96  E-value=1e-29  Score=182.76  Aligned_cols=155  Identities=25%  Similarity=0.405  Sum_probs=120.3

Q ss_pred             CCCcEEEEEEcccccc-ccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            4 PDGQIIAVKKLSKKST-QGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      .+++.||+|.+..... .....+.+|+.+++.++||||+++ +.+...+..++|||+++ ++|.+++.....  .++...
T Consensus        25 ~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~--~~~~~~  101 (324)
T 3mtl_A           25 LTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGN--IINMHN  101 (324)
T ss_dssp             TTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHHTTT--CCCHHH
T ss_pred             CCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cCHHHHHHhcCC--CCCHHH
Confidence            4688999999865422 222245579999999999999998 77777788999999997 588887765322  378899


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh--hhhhhhcccccccCcceecC-Ccc
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK--MILKQIQIELGYIPPEYVGR-GVY  158 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~~aPE~~~~-~~~  158 (164)
                      +..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....  .......+|+.|+|||++.+ ..+
T Consensus       102 ~~~~~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~  178 (324)
T 3mtl_A          102 VKLFLFQLLRGLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDY  178 (324)
T ss_dssp             HHHHHHHHHHHHHHHHHT---TEEESSCCGGGEEECTTCCEEECSSSEEECC------------CGGGCCHHHHTTCCCC
T ss_pred             HHHHHHHHHHHHHHHHHC---CccCCCcCHHHEEECCCCCEEEccCcccccccCCccccccccCcccccChhhhcCCCCC
Confidence            999999999999999998   999999999999999999999999999875542  22345678999999999866 567


Q ss_pred             eeccCC
Q 046065          159 YKKFSL  164 (164)
Q Consensus       159 ~~~~Di  164 (164)
                      +.++||
T Consensus       179 ~~~~Di  184 (324)
T 3mtl_A          179 STQIDM  184 (324)
T ss_dssp             CTHHHH
T ss_pred             CcHHHH
Confidence            888885

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.96  E-value=3.9e-29  Score=177.49  Aligned_cols=153  Identities=23%  Similarity=0.385  Sum_probs=126.1

Q ss_pred             cEEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeE-eEEee-CCcEEEEEEecCCCChhhhhhCcccccccCHHHHH
Q 046065            7 QIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIE-TQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRV   83 (164)
Q Consensus         7 ~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~   83 (164)
                      ..+|+|.+... .....+.+.+|+.+++.++||||+++ +.+.. .+..++|||++++++|.+++....  ..++.....
T Consensus        54 ~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~  131 (298)
T 3f66_A           54 IHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNET--HNPTVKDLI  131 (298)
T ss_dssp             EEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTT--CCCCHHHHH
T ss_pred             eEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhcc--cCCCHHHHH
Confidence            35899998654 33445678899999999999999998 65444 457889999999999999997532  237888999


Q ss_pred             HHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh------hhhhcccccccCcceecCCc
Q 046065           84 HIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI------LKQIQIELGYIPPEYVGRGV  157 (164)
Q Consensus        84 ~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~------~~~~~~~~~~~aPE~~~~~~  157 (164)
                      .++.|++.|+.|+|+.   +++|+||||+||+++.++.++|+|||++.......      .....+++.|+|||.+.+..
T Consensus       132 ~i~~ql~~~l~~lH~~---~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  208 (298)
T 3f66_A          132 GFGLQVAKGMKYLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK  208 (298)
T ss_dssp             HHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCC
T ss_pred             HHHHHHHHHHHHHHhC---CccCCCCchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCC
Confidence            9999999999999998   99999999999999999999999999997654321      23456778899999998888


Q ss_pred             ceeccCC
Q 046065          158 YYKKFSL  164 (164)
Q Consensus       158 ~~~~~Di  164 (164)
                      ++.++||
T Consensus       209 ~~~~~Di  215 (298)
T 3f66_A          209 FTTKSDV  215 (298)
T ss_dssp             CCHHHHH
T ss_pred             CChHHHH
Confidence            9999885

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.96  E-value=5.3e-29  Score=178.74  Aligned_cols=155  Identities=25%  Similarity=0.382  Sum_probs=124.4

Q ss_pred             CCCcEEEEEEccccc--------cccHHHHHHHHHHHhccCCCceeeEeEEeeCCcEEEEEEecCCCChhhhhhCccccc
Q 046065            4 PDGQIIAVKKLSKKS--------TQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRML   75 (164)
Q Consensus         4 ~~~~~vavK~~~~~~--------~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~   75 (164)
                      .+++.||+|.+....        ......+..|+.+++.++||||+++..+......++|||++++++|.+.+.....  
T Consensus        33 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--  110 (322)
T 2ycf_A           33 KTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKVVGNKR--  110 (322)
T ss_dssp             TTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTEETHHHHSTTCC--
T ss_pred             CCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCceEEEEecCCCCcHHHHHhccCC--
Confidence            467899999986432        1223457889999999999999998555555668999999999999988865433  


Q ss_pred             ccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCC---eEEccccchhhhhhh-hhhhhcccccccCcc
Q 046065           76 ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK---PKISDFGLARILRKM-ILKQIQIELGYIPPE  151 (164)
Q Consensus        76 ~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~---~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE  151 (164)
                       ++......++.|++.||.|||+.   +++|+||||+||+++.++.   ++|+|||++...... ......|++.|+|||
T Consensus       111 -~~~~~~~~~~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE  186 (322)
T 2ycf_A          111 -LKEATCKLYFYQMLLAVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPE  186 (322)
T ss_dssp             -CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHH
T ss_pred             -CCHHHHHHHHHHHHHHHHHHHHC---CeeccCCCHHHEEEecCCCCCeEEEccCccceecccccccccccCCcCccCch
Confidence             88999999999999999999998   9999999999999987654   999999999766432 234567899999999


Q ss_pred             eec---CCcceeccCC
Q 046065          152 YVG---RGVYYKKFSL  164 (164)
Q Consensus       152 ~~~---~~~~~~~~Di  164 (164)
                      ++.   ...++.++||
T Consensus       187 ~~~~~~~~~~~~~~Di  202 (322)
T 2ycf_A          187 VLVSVGTAGYNRAVDC  202 (322)
T ss_dssp             HHHHTTTTTCTTHHHH
T ss_pred             hhccCCCCCCCchhhH
Confidence            973   5677888885

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.96  E-value=1.6e-28  Score=173.53  Aligned_cols=154  Identities=25%  Similarity=0.447  Sum_probs=123.6

Q ss_pred             CCCcEEEEEEccccccc-------cHHHHHHHHHHHhccCCCceeeEeEEeeCCcEEEEEEecCCCChhhhhhCcccccc
Q 046065            4 PDGQIIAVKKLSKKSTQ-------GFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLI   76 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~-------~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~   76 (164)
                      .+++.||+|.+......       ..+.+.+|+.+++.++||||+++..+..... ++|||++++++|.+.+.....  .
T Consensus        42 ~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~lv~e~~~~~~L~~~l~~~~~--~  118 (287)
T 4f0f_A           42 KDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-RMVMEFVPCGDLYHRLLDKAH--P  118 (287)
T ss_dssp             TTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT-EEEEECCTTCBHHHHHHCTTS--C
T ss_pred             CCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC-eEEEEecCCCCHHHHHhcccC--C
Confidence            57889999998654221       1267889999999999999999844443333 699999999999888765332  3


Q ss_pred             cCHHHHHHHHHHHHHHHHHhhhcCCCC--eeeCCCCCCceeecCCCC-----eEEccccchhhhhhhhhhhhcccccccC
Q 046065           77 LDCKKRVHIIKGIIQGLLYLQEYFRLT--IIHRDLKVSNILLDEDLK-----PKISDFGLARILRKMILKQIQIELGYIP  149 (164)
Q Consensus        77 ~~~~~~~~~~~~~~~~l~~lh~~~~~~--iih~dlk~~nili~~~~~-----~~l~dfg~~~~~~~~~~~~~~~~~~~~a  149 (164)
                      +++.....++.|++.|+.|+|+.   +  ++|+||||+||+++.++.     ++|+|||++..... ......|++.|+|
T Consensus       119 ~~~~~~~~~~~~l~~~l~~lH~~---~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~-~~~~~~g~~~y~a  194 (287)
T 4f0f_A          119 IKWSVKLRLMLDIALGIEYMQNQ---NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH-SVSGLLGNFQWMA  194 (287)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHTS---SSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSS-CEECCCCCCTTSC
T ss_pred             ccHHHHHHHHHHHHHHHHHHHhC---CCCeecCCCCcceEEEeccCCCCceeEEeCCCCccccccc-cccccCCCccccC
Confidence            88999999999999999999998   7  999999999999987765     99999999864432 2345678999999


Q ss_pred             ccee--cCCcceeccCC
Q 046065          150 PEYV--GRGVYYKKFSL  164 (164)
Q Consensus       150 PE~~--~~~~~~~~~Di  164 (164)
                      ||++  ....++.++||
T Consensus       195 PE~~~~~~~~~~~~~Di  211 (287)
T 4f0f_A          195 PETIGAEEESYTEKADT  211 (287)
T ss_dssp             GGGSSCSSCEECHHHHH
T ss_pred             chhhccCCCCcCchhhH
Confidence            9998  45567888885

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.96  E-value=5.9e-29  Score=177.75  Aligned_cols=157  Identities=26%  Similarity=0.418  Sum_probs=120.5

Q ss_pred             CCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCC-----cEEEEEEecCCCChhhhhhCc---cc
Q 046065            5 DGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQ-----EYMLIYEYMPKRSLDYFLFDP---IR   73 (164)
Q Consensus         5 ~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~-----~~~lv~e~~~~~~L~~~~~~~---~~   73 (164)
                      +++.||+|.+...  .....+.+.+|+.+++.++||||+++ +.+....     ..++|+|++++++|.+++...   ..
T Consensus        61 ~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~  140 (313)
T 3brb_A           61 TSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETG  140 (313)
T ss_dssp             CEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTS
T ss_pred             ceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcC
Confidence            4568999998754  23345678899999999999999997 6555433     358999999999999888432   12


Q ss_pred             ccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh----hhhhcccccccC
Q 046065           74 MLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI----LKQIQIELGYIP  149 (164)
Q Consensus        74 ~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~a  149 (164)
                      ...+++..++.++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.......    .....+++.|+|
T Consensus       141 ~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~a  217 (313)
T 3brb_A          141 PKHIPLQTLLKFMVDIALGMEYLSNR---NFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIA  217 (313)
T ss_dssp             CCCCCHHHHHHHHHHHHHHHHHHHTT---TCCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSC
T ss_pred             CccCCHHHHHHHHHHHHHHHHHHHhC---CcccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccC
Confidence            23488999999999999999999998   99999999999999999999999999997654321    133456788999


Q ss_pred             cceecCCcceeccCC
Q 046065          150 PEYVGRGVYYKKFSL  164 (164)
Q Consensus       150 PE~~~~~~~~~~~Di  164 (164)
                      ||.+.+..++.++||
T Consensus       218 PE~~~~~~~~~~~Di  232 (313)
T 3brb_A          218 IESLADRVYTSKSDV  232 (313)
T ss_dssp             HHHHHSSCCCHHHHH
T ss_pred             chhhcCCCccchhhh
Confidence            999998899999985

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=3.5e-29  Score=181.44  Aligned_cols=155  Identities=28%  Similarity=0.371  Sum_probs=125.1

Q ss_pred             CCCcEEEEEEcccccc-----ccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccccccc
Q 046065            4 PDGQIIAVKKLSKKST-----QGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLIL   77 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~   77 (164)
                      .+|+.||+|.+.....     ...+.+.+|+.+++.++||||+++ +.+...+..++|||++++ +|...+....  ..+
T Consensus        33 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~--~~~  109 (346)
T 1ua2_A           33 NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNS--LVL  109 (346)
T ss_dssp             SCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHTTCC--SSC
T ss_pred             CCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHHhcC--cCC
Confidence            4688999999864321     123467899999999999999998 777777889999999986 7877776532  237


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh--hhhhhcccccccCcceecC
Q 046065           78 DCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM--ILKQIQIELGYIPPEYVGR  155 (164)
Q Consensus        78 ~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~~  155 (164)
                      ++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++......  ......+|+.|+|||++.+
T Consensus       110 ~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~  186 (346)
T 1ua2_A          110 TPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFG  186 (346)
T ss_dssp             CSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTT
T ss_pred             CHHHHHHHHHHHHHHHHHHHHC---CEECCCCCHHHEEEcCCCCEEEEecccceeccCCcccCCcccccccccCchHhhC
Confidence            7888999999999999999998   9999999999999999999999999999766432  2345678999999999965


Q ss_pred             C-cceeccCC
Q 046065          156 G-VYYKKFSL  164 (164)
Q Consensus       156 ~-~~~~~~Di  164 (164)
                      . .++.++||
T Consensus       187 ~~~~~~~~Di  196 (346)
T 1ua2_A          187 ARMYGVGVDM  196 (346)
T ss_dssp             CSCCCHHHHH
T ss_pred             CCCCCchhhh
Confidence            4 57888885

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.96  E-value=4.2e-29  Score=179.85  Aligned_cols=152  Identities=22%  Similarity=0.325  Sum_probs=120.2

Q ss_pred             EEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeEeEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHHHHH
Q 046065            8 IIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHII   86 (164)
Q Consensus         8 ~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~   86 (164)
                      +||+|.+... .......+.+|+.+++.++||||+++..+...+..++++|++++++|.+++.....  .++......++
T Consensus        46 kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~v~~~~~~g~L~~~l~~~~~--~~~~~~~~~i~  123 (327)
T 3lzb_A           46 PVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKD--NIGSQYLLNWC  123 (327)
T ss_dssp             EEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSSEEEEECCCSSCBHHHHHHHTTT--CCCHHHHHHHH
T ss_pred             EEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCCceEEEEecCCCcHHHHHHhcCC--CCCHHHHHHHH
Confidence            3577776543 34456788999999999999999998444455668899999999999998875322  28889999999


Q ss_pred             HHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh----hhhhcccccccCcceecCCcceecc
Q 046065           87 KGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI----LKQIQIELGYIPPEYVGRGVYYKKF  162 (164)
Q Consensus        87 ~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~  162 (164)
                      .|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.......    .....+++.|+|||.+.+..++.++
T Consensus       124 ~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~  200 (327)
T 3lzb_A          124 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS  200 (327)
T ss_dssp             HHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHH
T ss_pred             HHHHHHHHHHhhC---CCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHH
Confidence            9999999999998   99999999999999999999999999997664321    2344567789999999989999999


Q ss_pred             CC
Q 046065          163 SL  164 (164)
Q Consensus       163 Di  164 (164)
                      ||
T Consensus       201 Di  202 (327)
T 3lzb_A          201 DV  202 (327)
T ss_dssp             HH
T ss_pred             HH
Confidence            85

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.96  E-value=2.8e-29  Score=181.73  Aligned_cols=153  Identities=25%  Similarity=0.359  Sum_probs=121.9

Q ss_pred             CCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCC--CceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccC
Q 046065            4 PDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQH--LNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILD   78 (164)
Q Consensus         4 ~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h--~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~   78 (164)
                      .+++.||+|.+...  .......+.+|+.+++.++|  |||+++ +.+......++||| +.+++|.+++.....   ++
T Consensus        31 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~~~---~~  106 (343)
T 3dbq_A           31 EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKS---ID  106 (343)
T ss_dssp             TTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHHSCC---CC
T ss_pred             CCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-CCCCCHHHHHHhcCC---CC
Confidence            46789999998654  23344678899999999976  999998 66677778899999 667899999876433   88


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh----hhhhcccccccCcceec
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI----LKQIQIELGYIPPEYVG  154 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~aPE~~~  154 (164)
                      +..+..++.|++.||.|||+.   +|+||||||+||+++ ++.++|+|||++.......    .....||+.|+|||++.
T Consensus       107 ~~~~~~i~~qi~~al~~lH~~---~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~  182 (343)
T 3dbq_A          107 PWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK  182 (343)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHhC---CeecCCCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHh
Confidence            899999999999999999998   999999999999997 5789999999997664322    24567999999999985


Q ss_pred             C-----------CcceeccCC
Q 046065          155 R-----------GVYYKKFSL  164 (164)
Q Consensus       155 ~-----------~~~~~~~Di  164 (164)
                      +           ..++.++||
T Consensus       183 ~~~~~~~~~~~~~~~~~~~Di  203 (343)
T 3dbq_A          183 DMSSSRENGKSKSKISPKSDV  203 (343)
T ss_dssp             HCC-----------CCHHHHH
T ss_pred             hccccccccccccCCCchhhH
Confidence            4           677888885

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.96  E-value=4.7e-29  Score=182.20  Aligned_cols=152  Identities=30%  Similarity=0.370  Sum_probs=113.2

Q ss_pred             CCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEeeC------CcEEEEEEecCCCChhhhhhCcccc
Q 046065            4 PDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIET------QEYMLIYEYMPKRSLDYFLFDPIRM   74 (164)
Q Consensus         4 ~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~------~~~~lv~e~~~~~~L~~~~~~~~~~   74 (164)
                      .+|+.||+|.+...  .......+.+|+.+++.++||||+++ +.+...      ...++|+|++ +++|.+++...   
T Consensus        52 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~---  127 (367)
T 2fst_X           52 KTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKCQ---  127 (367)
T ss_dssp             TTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC-----C---
T ss_pred             CCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhcC---
Confidence            56889999998653  23345678899999999999999998 555432      4578999998 67888887642   


Q ss_pred             cccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCcceec
Q 046065           75 LILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVG  154 (164)
Q Consensus        75 ~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~  154 (164)
                       .++......++.|++.||.|||++   +++|+||||+||+++.++.+||+|||+++..... .....+|+.|+|||++.
T Consensus       128 -~l~~~~~~~i~~qi~~aL~~LH~~---givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-~~~~~~t~~y~aPE~~~  202 (367)
T 2fst_X          128 -KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-MTGYVATRWYRAPEIML  202 (367)
T ss_dssp             -CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECC----------------CCCTTCCHHHHT
T ss_pred             -CCCHHHHHHHHHHHHHHHHHHHHC---CeeeCCCCHhhEEECCCCCEEEeecccccccccc-CCCcCcCcCccChHHHc
Confidence             388999999999999999999998   9999999999999999999999999999765432 34567899999999997


Q ss_pred             C-CcceeccCC
Q 046065          155 R-GVYYKKFSL  164 (164)
Q Consensus       155 ~-~~~~~~~Di  164 (164)
                      + ..++.++||
T Consensus       203 ~~~~~~~~~Di  213 (367)
T 2fst_X          203 NWMHYNQTVDI  213 (367)
T ss_dssp             TCCSCCTTHHH
T ss_pred             CCcCCCchhhH
Confidence            6 678888885

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.96  E-value=7.5e-29  Score=179.87  Aligned_cols=155  Identities=25%  Similarity=0.392  Sum_probs=124.6

Q ss_pred             CCCcEEEEEEccccc--cccHHHHHHHHHHHhccCCCceeeE-eEEee--------CCcEEEEEEecCCCChhhhhhCcc
Q 046065            4 PDGQIIAVKKLSKKS--TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIE--------TQEYMLIYEYMPKRSLDYFLFDPI   72 (164)
Q Consensus         4 ~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~--------~~~~~lv~e~~~~~~L~~~~~~~~   72 (164)
                      .+|+.||+|.+....  ......+.+|+.+++.++||||+++ +.+..        .+..++|||++++ ++...+....
T Consensus        40 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~  118 (351)
T 3mi9_A           40 KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVL  118 (351)
T ss_dssp             TTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCSE-EHHHHHHCTT
T ss_pred             CCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccCC-CHHHHHhhcc
Confidence            578899999986542  3334567899999999999999997 55554        3357899999975 6766665432


Q ss_pred             cccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh------hhhhhhccccc
Q 046065           73 RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK------MILKQIQIELG  146 (164)
Q Consensus        73 ~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~------~~~~~~~~~~~  146 (164)
                      .  .+++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.....      .......||+.
T Consensus       119 ~--~~~~~~~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~  193 (351)
T 3mi9_A          119 V--KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW  193 (351)
T ss_dssp             S--CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGG
T ss_pred             C--CCCHHHHHHHHHHHHHHHHHHHHC---CeeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccC
Confidence            2  288999999999999999999998   999999999999999999999999999876531      12245678999


Q ss_pred             ccCcceecC-CcceeccCC
Q 046065          147 YIPPEYVGR-GVYYKKFSL  164 (164)
Q Consensus       147 ~~aPE~~~~-~~~~~~~Di  164 (164)
                      |+|||++.+ ..++.++||
T Consensus       194 y~aPE~~~~~~~~~~~~Di  212 (351)
T 3mi9_A          194 YRPPELLLGERDYGPPIDL  212 (351)
T ss_dssp             GCCHHHHTTCCSCCTHHHH
T ss_pred             ccCchhhcCCCCCCcHhHH
Confidence            999999865 457888885

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.96  E-value=8.7e-29  Score=175.62  Aligned_cols=155  Identities=28%  Similarity=0.428  Sum_probs=128.8

Q ss_pred             CCCcEEEEEEccccc---------cccHHHHHHHHHHHhccC-CCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcc
Q 046065            4 PDGQIIAVKKLSKKS---------TQGFEEFKNEVMLTAKLQ-HLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPI   72 (164)
Q Consensus         4 ~~~~~vavK~~~~~~---------~~~~~~~~~e~~~l~~l~-h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~   72 (164)
                      .+++.||+|.+....         ....+.+.+|+.+++.+. ||||+++ +.+......++|||++++++|.+++....
T Consensus        40 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~  119 (298)
T 1phk_A           40 PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV  119 (298)
T ss_dssp             TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS
T ss_pred             CcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhccC
Confidence            468899999986442         122456788999999995 9999998 66667778899999999999999987543


Q ss_pred             cccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh-hhhhhcccccccCcc
Q 046065           73 RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM-ILKQIQIELGYIPPE  151 (164)
Q Consensus        73 ~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE  151 (164)
                         .++......++.|++.||.|+|+.   +++|+||+|+||+++.++.++|+|||++...... ......+++.|+|||
T Consensus       120 ---~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE  193 (298)
T 1phk_A          120 ---TLSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPE  193 (298)
T ss_dssp             ---SCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHH
T ss_pred             ---CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCcceEEEcCCCcEEEecccchhhcCCCcccccccCCccccCHH
Confidence               288999999999999999999998   9999999999999999999999999998765432 234567899999999


Q ss_pred             eec------CCcceeccCC
Q 046065          152 YVG------RGVYYKKFSL  164 (164)
Q Consensus       152 ~~~------~~~~~~~~Di  164 (164)
                      ++.      ...++.++||
T Consensus       194 ~~~~~~~~~~~~~~~~~Di  212 (298)
T 1phk_A          194 IIECSMNDNHPGYGKEVDM  212 (298)
T ss_dssp             HHHHHHCTTSCCBCTHHHH
T ss_pred             HhccccccccccCCccccc
Confidence            984      4567888875

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.96  E-value=4.6e-29  Score=183.57  Aligned_cols=153  Identities=25%  Similarity=0.353  Sum_probs=123.3

Q ss_pred             CCCcEEEEEEcccc--ccccHHHHHHHHHHHhccC--CCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccC
Q 046065            4 PDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQ--HLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILD   78 (164)
Q Consensus         4 ~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~--h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~   78 (164)
                      .+++.||||.+...  .......+.+|+.+++.++  ||||+++ +.+...+..++||| +.+++|.+++....   .++
T Consensus        78 ~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~~~L~~~l~~~~---~~~  153 (390)
T 2zmd_A           78 EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKK---SID  153 (390)
T ss_dssp             TTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCSEEHHHHHHHCS---SCC
T ss_pred             CCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCCCCHHHHHHhcC---CCC
Confidence            35789999998654  2334567889999999996  5999998 66677778899999 67889999887643   378


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh----hhhhcccccccCcceec
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI----LKQIQIELGYIPPEYVG  154 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~aPE~~~  154 (164)
                      +..+..++.|++.||.|||+.   +|+||||||+||+++ ++.+||+|||++..+....    ....+||+.|+|||++.
T Consensus       154 ~~~~~~i~~qi~~aL~~lH~~---~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~  229 (390)
T 2zmd_A          154 PWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIK  229 (390)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---TCCCCCCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHHC---CeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhh
Confidence            888999999999999999998   999999999999995 5789999999997664322    24567999999999986


Q ss_pred             C-----------CcceeccCC
Q 046065          155 R-----------GVYYKKFSL  164 (164)
Q Consensus       155 ~-----------~~~~~~~Di  164 (164)
                      +           ..++.++||
T Consensus       230 ~~~~~~~~~~~~~~~~~~~Di  250 (390)
T 2zmd_A          230 DMSSSRENGKSKSKISPKSDV  250 (390)
T ss_dssp             CC------------CCHHHHH
T ss_pred             hccccccccccccCCCChhhH
Confidence            4           467888885

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.96  E-value=5.7e-29  Score=178.92  Aligned_cols=157  Identities=29%  Similarity=0.456  Sum_probs=125.5

Q ss_pred             CCcE--EEEEEcccc-ccccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcc-------
Q 046065            5 DGQI--IAVKKLSKK-STQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPI-------   72 (164)
Q Consensus         5 ~~~~--vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-------   72 (164)
                      +++.  +|+|.+... .....+.+..|+.+++.+ +||||+++ +.+...+..++|||++++++|.+++....       
T Consensus        49 ~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~  128 (327)
T 1fvr_A           49 DGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPA  128 (327)
T ss_dssp             TTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHH
T ss_pred             CCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhccccccccc
Confidence            4554  489988643 334456788999999999 89999997 77777888999999999999999987642       


Q ss_pred             ------cccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh-hhhhcccc
Q 046065           73 ------RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI-LKQIQIEL  145 (164)
Q Consensus        73 ------~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~  145 (164)
                            ....++...++.++.|++.||.|||++   +++|+||||+||+++.++.++|+|||++....... .....+++
T Consensus       129 ~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~  205 (327)
T 1fvr_A          129 FAIANSTASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPV  205 (327)
T ss_dssp             HHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEESSCEECCC----CCT
T ss_pred             ccccccccccCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCccceEEEcCCCeEEEcccCcCccccccccccCCCCCc
Confidence                  123488999999999999999999998   99999999999999999999999999986443221 23345678


Q ss_pred             cccCcceecCCcceeccCC
Q 046065          146 GYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       146 ~~~aPE~~~~~~~~~~~Di  164 (164)
                      .|+|||.+.+..++.++||
T Consensus       206 ~y~aPE~~~~~~~~~~~Di  224 (327)
T 1fvr_A          206 RWMAIESLNYSVYTTNSDV  224 (327)
T ss_dssp             TTCCHHHHHHCEECHHHHH
T ss_pred             cccChhhhccccCCchhcc
Confidence            8999999988888999885

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.96  E-value=7e-30  Score=187.06  Aligned_cols=155  Identities=19%  Similarity=0.222  Sum_probs=120.0

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHH---HHHhccCCCceeeE-e------EEee-CC-----------------cE
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEV---MLTAKLQHLNLIRV-G------FCIE-TQ-----------------EY   52 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~---~~l~~l~h~~i~~~-~------~~~~-~~-----------------~~   52 (164)
                      .+|+.||||.+...   .....+.+.+|+   ..++.++||||+++ +      .+.. .+                 ..
T Consensus        96 ~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  175 (377)
T 3byv_A           96 ETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSR  175 (377)
T ss_dssp             CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESE
T ss_pred             CCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEE
Confidence            56899999998743   334457788999   45555689999986 2      2222 21                 37


Q ss_pred             EEEEEecCCCChhhhhhCcccc----cccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEcccc
Q 046065           53 MLIYEYMPKRSLDYFLFDPIRM----LILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFG  128 (164)
Q Consensus        53 ~lv~e~~~~~~L~~~~~~~~~~----~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg  128 (164)
                      ++|||++ +|+|.+++......    ..+++..+..++.|++.||.|||+.   +|+|+||||+||+++.++.+||+|||
T Consensus       176 ~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DFG  251 (377)
T 3byv_A          176 FFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFE  251 (377)
T ss_dssp             EEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCGG
T ss_pred             EEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEcCCCCEEEEech
Confidence            8999999 57999998753221    1133477888999999999999998   99999999999999999999999999


Q ss_pred             chhhhhhhhhhhhcccccccCcceecCC-----------cceeccCC
Q 046065          129 LARILRKMILKQIQIELGYIPPEYVGRG-----------VYYKKFSL  164 (164)
Q Consensus       129 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~-----------~~~~~~Di  164 (164)
                      ++..... ......| +.|+|||++.+.           .++.++||
T Consensus       252 ~a~~~~~-~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Dv  296 (377)
T 3byv_A          252 HLVRDGA-RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDA  296 (377)
T ss_dssp             GCEETTC-EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHH
T ss_pred             hheecCC-cccCCCC-cCccChhhhcccccccccccccccCChhhhH
Confidence            9975332 2344567 999999999877           88999885

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.96  E-value=8e-29  Score=180.66  Aligned_cols=154  Identities=18%  Similarity=0.152  Sum_probs=122.3

Q ss_pred             CCcEEEEEEccccccc-----------cHHHHHHHHHHHhccCCCceeeE-eEEeeC----CcEEEEEEecCCCChhhhh
Q 046065            5 DGQIIAVKKLSKKSTQ-----------GFEEFKNEVMLTAKLQHLNLIRV-GFCIET----QEYMLIYEYMPKRSLDYFL   68 (164)
Q Consensus         5 ~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~----~~~~lv~e~~~~~~L~~~~   68 (164)
                      .++.||+|.+......           .......|+..++.++||||+++ +.+...    ...++|||++ +++|.+++
T Consensus        64 ~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~  142 (364)
T 3op5_A           64 SDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIY  142 (364)
T ss_dssp             TTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHH
T ss_pred             cccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHH
Confidence            4688999998654211           11233446667778889999997 555443    3478999999 99999998


Q ss_pred             hCcccccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeec--CCCCeEEccccchhhhhhhhh--------
Q 046065           69 FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLD--EDLKPKISDFGLARILRKMIL--------  138 (164)
Q Consensus        69 ~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~--~~~~~~l~dfg~~~~~~~~~~--------  138 (164)
                      ....  ..+++..+..++.|++.||.|||+.   +|+||||||+||+++  .++.++|+|||++..+.....        
T Consensus       143 ~~~~--~~l~~~~~~~i~~qi~~~l~~lH~~---~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~  217 (364)
T 3op5_A          143 EANA--KRFSRKTVLQLSLRILDILEYIHEH---EYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADP  217 (364)
T ss_dssp             HHTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCS
T ss_pred             Hhcc--CCCCHHHHHHHHHHHHHHHHHHHHC---CeEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCc
Confidence            7532  2389999999999999999999998   999999999999999  789999999999976543211        


Q ss_pred             -hhhcccccccCcceecCCcceeccCC
Q 046065          139 -KQIQIELGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       139 -~~~~~~~~~~aPE~~~~~~~~~~~Di  164 (164)
                       ....||+.|+|||++.+..++.++||
T Consensus       218 ~~~~~gt~~y~aPE~~~~~~~~~~~Di  244 (364)
T 3op5_A          218 KRCHDGTIEFTSIDAHNGVAPSRRGDL  244 (364)
T ss_dssp             SCCCCCCTTTCCHHHHTTCCCCHHHHH
T ss_pred             ccccCCCCCccCHHHhCCCCCCchhhH
Confidence             23459999999999998899999986

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.96  E-value=5.5e-29  Score=179.16  Aligned_cols=157  Identities=25%  Similarity=0.295  Sum_probs=114.2

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccC-CCceeeE-eEEe--------eCCcEEEEEEecCCCChhhhhhCccc
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQ-HLNLIRV-GFCI--------ETQEYMLIYEYMPKRSLDYFLFDPIR   73 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~-~~~~--------~~~~~~lv~e~~~~~~L~~~~~~~~~   73 (164)
                      .+++.||+|.+........+.+.+|+.+++.+. ||||+++ +.+.        ....+++++|++. |+|.+++.....
T Consensus        51 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~  129 (337)
T 3ll6_A           51 GSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMES  129 (337)
T ss_dssp             TTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHT
T ss_pred             CCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEecC-CCHHHHHHHhhc
Confidence            478899999986665555677889999999995 9999997 5552        2234789999996 688888765333


Q ss_pred             ccccCHHHHHHHHHHHHHHHHHhhhcCCCC--eeeCCCCCCceeecCCCCeEEccccchhhhhhhh--------------
Q 046065           74 MLILDCKKRVHIIKGIIQGLLYLQEYFRLT--IIHRDLKVSNILLDEDLKPKISDFGLARILRKMI--------------  137 (164)
Q Consensus        74 ~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~--iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~--------------  137 (164)
                      ...+++.....++.|++.||.|||+.   +  ++|+||||+||+++.++.++|+|||++.......              
T Consensus       130 ~~~~~~~~~~~i~~qi~~~l~~LH~~---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~  206 (337)
T 3ll6_A          130 RGPLSCDTVLKIFYQTCRAVQHMHRQ---KPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEE  206 (337)
T ss_dssp             TCSCCHHHHHHHHHHHHHHHHHHHTS---SSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC--------------
T ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhC---CCCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchh
Confidence            33489999999999999999999998   7  9999999999999999999999999987653211              


Q ss_pred             hhhhcccccccCccee---cCCcceeccCC
Q 046065          138 LKQIQIELGYIPPEYV---GRGVYYKKFSL  164 (164)
Q Consensus       138 ~~~~~~~~~~~aPE~~---~~~~~~~~~Di  164 (164)
                      .....+++.|+|||++   .+..++.++||
T Consensus       207 ~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv  236 (337)
T 3ll6_A          207 EITRNTTPMYRTPEIIDLYSNFPIGEKQDI  236 (337)
T ss_dssp             -----------------CCTTSCSSHHHHH
T ss_pred             hccccCCCCcCChhhhhccccCCCChHHhH
Confidence            1245689999999998   56678888885

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.96  E-value=1e-28  Score=172.86  Aligned_cols=153  Identities=22%  Similarity=0.336  Sum_probs=125.9

Q ss_pred             CCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEeeC--CcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            5 DGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIET--QEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         5 ~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~--~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      +++.||+|.+...  .....+.+.+|+.+++.++||||+++ +.+...  ...++|||++++++|.+++..... ..+++
T Consensus        32 ~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~  110 (271)
T 3kmu_A           32 QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTN-FVVDQ  110 (271)
T ss_dssp             TTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSS-CCCCH
T ss_pred             CCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhccc-CCCCH
Confidence            4788999998755  23345678899999999999999998 666555  578999999999999999976432 23889


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCC--eeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCcceecCCc
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLT--IIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGV  157 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~--iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  157 (164)
                      ..+..++.|++.||.|||+.   +  ++|+||||+||+++.++.+++.||+++....   .....+|+.|+|||.+.+..
T Consensus       111 ~~~~~i~~qi~~~l~~lH~~---~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~  184 (271)
T 3kmu_A          111 SQAVKFALDMARGMAFLHTL---EPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ---SPGRMYAPAWVAPEALQKKP  184 (271)
T ss_dssp             HHHHHHHHHHHHHHHHHTTS---SSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS---CTTCBSCGGGSCHHHHHSCG
T ss_pred             HHHHHHHHHHHHHHHHHhcC---CCceecCCCccceEEEcCCcceeEEeccceeeec---ccCccCCccccChhhhccCC
Confidence            99999999999999999988   7  9999999999999999999999888875432   23457899999999997765


Q ss_pred             cee---ccCC
Q 046065          158 YYK---KFSL  164 (164)
Q Consensus       158 ~~~---~~Di  164 (164)
                      ++.   ++||
T Consensus       185 ~~~~~~~~Di  194 (271)
T 3kmu_A          185 EDTNRRSADM  194 (271)
T ss_dssp             GGSCHHHHHH
T ss_pred             CCCCCchhhH
Confidence            544   6775

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.96  E-value=2.5e-28  Score=175.62  Aligned_cols=150  Identities=19%  Similarity=0.305  Sum_probs=125.8

Q ss_pred             cCCCcEEEEEEccccccccHHHHHHHHHHHhccC-CCceeeE-eEEee--CCcEEEEEEecCCCChhhhhhCcccccccC
Q 046065            3 LPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQ-HLNLIRV-GFCIE--TQEYMLIYEYMPKRSLDYFLFDPIRMLILD   78 (164)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~-~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~   78 (164)
                      ..+++.||+|.+...   ....+.+|+.+++.+. ||||+++ +.+..  ....++|||++++++|.+++..      ++
T Consensus        58 ~~~~~~vavK~~~~~---~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~------~~  128 (330)
T 3nsz_A           58 ITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT------LT  128 (330)
T ss_dssp             TTTCCEEEEEEECSC---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGGG------CC
T ss_pred             CCCCcEEEEEEeccc---chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHHh------CC
Confidence            357889999998633   3467889999999996 9999998 55554  4568899999999999988753      78


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCC-CeEEccccchhhhhhh-hhhhhcccccccCcceecC-
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL-KPKISDFGLARILRKM-ILKQIQIELGYIPPEYVGR-  155 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~-~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~~-  155 (164)
                      ......++.|++.||.|||+.   +++|+||||+||+++.++ .++|+|||++...... ......+++.|+|||++.+ 
T Consensus       129 ~~~~~~~~~qi~~~l~~lH~~---~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~  205 (330)
T 3nsz_A          129 DYDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDY  205 (330)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTC
T ss_pred             HHHHHHHHHHHHHHHHHHHhC---CeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCccccccccccccChhhhcCC
Confidence            889999999999999999998   999999999999999776 8999999999765432 2345678999999999976 


Q ss_pred             CcceeccCC
Q 046065          156 GVYYKKFSL  164 (164)
Q Consensus       156 ~~~~~~~Di  164 (164)
                      ..++.++||
T Consensus       206 ~~~~~~~Di  214 (330)
T 3nsz_A          206 QMYDYSLDM  214 (330)
T ss_dssp             CCCCTHHHH
T ss_pred             CcCCchhhH
Confidence            668888885

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.95  E-value=8.5e-29  Score=179.36  Aligned_cols=153  Identities=13%  Similarity=0.109  Sum_probs=125.8

Q ss_pred             CCcEEEEEEccccccc-----------cHHHHHHHHHHHhccCCCceeeE-eEEee----CCcEEEEEEecCCCChhhhh
Q 046065            5 DGQIIAVKKLSKKSTQ-----------GFEEFKNEVMLTAKLQHLNLIRV-GFCIE----TQEYMLIYEYMPKRSLDYFL   68 (164)
Q Consensus         5 ~~~~vavK~~~~~~~~-----------~~~~~~~e~~~l~~l~h~~i~~~-~~~~~----~~~~~lv~e~~~~~~L~~~~   68 (164)
                      +++.+|+|........           ....+.+|+..++.++||||+++ +.+..    ....++|||++ +++|.+++
T Consensus        64 ~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l  142 (345)
T 2v62_A           64 KDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKIS  142 (345)
T ss_dssp             GGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHC
T ss_pred             ccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHH
Confidence            5678999998654221           12345678888999999999997 65555    45688999999 99999998


Q ss_pred             hCcccccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCC--CeEEccccchhhhhhhh---------
Q 046065           69 FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL--KPKISDFGLARILRKMI---------  137 (164)
Q Consensus        69 ~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~--~~~l~dfg~~~~~~~~~---------  137 (164)
                      ....   .+++..+..++.|++.||.|||+.   +++|+||||+||+++.++  .++|+|||++..+....         
T Consensus       143 ~~~~---~~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~  216 (345)
T 2v62_A          143 GQNG---TFKKSTVLQLGIRMLDVLEYIHEN---EYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENP  216 (345)
T ss_dssp             BGGG---BCCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCG
T ss_pred             HhcC---CCCHHHHHHHHHHHHHHHHHHHhC---CeeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhcc
Confidence            7644   389999999999999999999998   999999999999999877  99999999997653221         


Q ss_pred             hhhhcccccccCcceecCCcceeccCC
Q 046065          138 LKQIQIELGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       138 ~~~~~~~~~~~aPE~~~~~~~~~~~Di  164 (164)
                      .....|++.|+|||++.+..++.++||
T Consensus       217 ~~~~~gt~~y~aPE~~~~~~~~~~~Di  243 (345)
T 2v62_A          217 RKGHNGTIEFTSLDAHKGVALSRRSDV  243 (345)
T ss_dssp             GGCSCSCTTTCCHHHHHTCCCCHHHHH
T ss_pred             ccccCCCccccCHHHhcCCCCCchhhH
Confidence            144578999999999998889999985

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.95  E-value=4.5e-29  Score=177.34  Aligned_cols=158  Identities=24%  Similarity=0.377  Sum_probs=115.6

Q ss_pred             CCCcEEEEEEccccc-cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCc-----ccccc
Q 046065            4 PDGQIIAVKKLSKKS-TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDP-----IRMLI   76 (164)
Q Consensus         4 ~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~-----~~~~~   76 (164)
                      .+++.||+|.+.... ....+.+.+|+.+++.++||||+++ +.+...+..++|||++++++|.+++...     .....
T Consensus        38 ~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~  117 (303)
T 2vwi_A           38 PKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGV  117 (303)
T ss_dssp             ---CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCS
T ss_pred             CCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCC
Confidence            467899999986542 3345677899999999999999997 7777778899999999999999888641     11233


Q ss_pred             cCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh-------hhhhhcccccccC
Q 046065           77 LDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM-------ILKQIQIELGYIP  149 (164)
Q Consensus        77 ~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~-------~~~~~~~~~~~~a  149 (164)
                      ++......++.|++.|+.|+|+.   +++|+||+|+||+++.++.++|+|||++......       ......+++.|+|
T Consensus       118 ~~~~~~~~i~~qi~~~l~~lH~~---~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~a  194 (303)
T 2vwi_A          118 LDESTIATILREVLEGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMA  194 (303)
T ss_dssp             SCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCC
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhC---CCCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccC
Confidence            88999999999999999999998   9999999999999999999999999998765321       1234578999999


Q ss_pred             cceecC-CcceeccCC
Q 046065          150 PEYVGR-GVYYKKFSL  164 (164)
Q Consensus       150 PE~~~~-~~~~~~~Di  164 (164)
                      ||++.+ ..++.++||
T Consensus       195 PE~~~~~~~~~~~~Di  210 (303)
T 2vwi_A          195 PEVMEQVRGYDFKADI  210 (303)
T ss_dssp             HHHHHHHHCCCTHHHH
T ss_pred             HHHhccccCCCchhhH
Confidence            999865 457888885

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.95  E-value=5.9e-29  Score=175.07  Aligned_cols=153  Identities=26%  Similarity=0.412  Sum_probs=120.0

Q ss_pred             CCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeC-CcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            5 DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIET-QEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      +++.||+|.+...  ...+.+.+|+.+++.++||||+++ +.+... +..++|+|++++++|.+++..... ..++....
T Consensus        43 ~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~  119 (278)
T 1byg_A           43 RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCL  119 (278)
T ss_dssp             TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHH-HHCCHHHH
T ss_pred             cCCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhccc-ccCCHHHH
Confidence            4788999998643  245678899999999999999998 554443 468999999999999999865321 22788889


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCcceecCCcceecc
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKKF  162 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~  162 (164)
                      ..++.|++.|+.++|+.   +++|+||||+||+++.++.++|+|||++...... .....+++.|+|||.+.+..++.++
T Consensus       120 ~~~~~~i~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~  195 (278)
T 1byg_A          120 LKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-QDTGKLPVKWTAPEALREKKFSTKS  195 (278)
T ss_dssp             HHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-------------CCTTTSCHHHHHHCCCCHHH
T ss_pred             HHHHHHHHHHHHHHHhC---CccccCCCcceEEEeCCCcEEEeecccccccccc-ccCCCccccccCHHHhCCCCCCchh
Confidence            99999999999999998   9999999999999999999999999998755432 2334578899999999888899998


Q ss_pred             CC
Q 046065          163 SL  164 (164)
Q Consensus       163 Di  164 (164)
                      ||
T Consensus       196 Di  197 (278)
T 1byg_A          196 DV  197 (278)
T ss_dssp             HH
T ss_pred             cH
Confidence            85

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.95  E-value=2.8e-28  Score=175.02  Aligned_cols=156  Identities=26%  Similarity=0.362  Sum_probs=121.8

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhcc-CCCceeeE-eEEee------CCcEEEEEEecCCCChhhhhhCccccc
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIE------TQEYMLIYEYMPKRSLDYFLFDPIRML   75 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~------~~~~~lv~e~~~~~~L~~~~~~~~~~~   75 (164)
                      .+++.||+|.+.... .....+..|+.+++.+ +||||+++ +.+..      ....++|||++++++|.+++.... ..
T Consensus        47 ~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~  124 (326)
T 2x7f_A           47 KTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK-GN  124 (326)
T ss_dssp             TTCCEEEEEEEECCS-STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSG-GG
T ss_pred             CCCCeEEEEEEecCc-ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcc-cC
Confidence            478899999986442 3346788999999999 79999997 55554      356889999999999999987532 22


Q ss_pred             ccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh--hhhhhcccccccCccee
Q 046065           76 ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM--ILKQIQIELGYIPPEYV  153 (164)
Q Consensus        76 ~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~  153 (164)
                      .++......++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++......  ......|++.|+|||++
T Consensus       125 ~~~~~~~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~  201 (326)
T 2x7f_A          125 TLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVI  201 (326)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEECTTCCEEECCCTTTC-------------CCGGGCCHHHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCcHHHEEEcCCCCEEEeeCcCceecCcCccccccccCCccccChhhh
Confidence            388899999999999999999998   9999999999999999999999999998765432  22456789999999998


Q ss_pred             c-----CCcceeccCC
Q 046065          154 G-----RGVYYKKFSL  164 (164)
Q Consensus       154 ~-----~~~~~~~~Di  164 (164)
                      .     +..++.++||
T Consensus       202 ~~~~~~~~~~~~~~Di  217 (326)
T 2x7f_A          202 ACDENPDATYDFKSDL  217 (326)
T ss_dssp             C--------CCTTHHH
T ss_pred             ccccccCcCCCccchH
Confidence            6     5677888885

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.95  E-value=2.2e-28  Score=177.96  Aligned_cols=155  Identities=23%  Similarity=0.319  Sum_probs=117.5

Q ss_pred             CCCcEEEEEEcccccc-----------ccHHHHHHHHHHHhccCCCceeeE-eEEeeC-----CcEEEEEEecCCCChhh
Q 046065            4 PDGQIIAVKKLSKKST-----------QGFEEFKNEVMLTAKLQHLNLIRV-GFCIET-----QEYMLIYEYMPKRSLDY   66 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~-----------~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~-----~~~~lv~e~~~~~~L~~   66 (164)
                      .+++.||+|.+.....           ...+.+.+|+.+++.++||||+++ +.+...     ...++|||+++ ++|.+
T Consensus        44 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~  122 (362)
T 3pg1_A           44 SEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQ  122 (362)
T ss_dssp             TTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHH
T ss_pred             CCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHH
Confidence            4588999999864321           113678899999999999999998 555332     25789999998 58877


Q ss_pred             hhhCcccccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh-hhhhhcccc
Q 046065           67 FLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM-ILKQIQIEL  145 (164)
Q Consensus        67 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~  145 (164)
                      .+....  ..++...+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++...... ......+++
T Consensus       123 ~~~~~~--~~~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~  197 (362)
T 3pg1_A          123 VIHDQR--IVISPQHIQYFMYHILLGLHVLHEA---GVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHR  197 (362)
T ss_dssp             HHHCTT--SCCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCTTC---------------CG
T ss_pred             HHHhcc--cCCCHHHHHHHHHHHHHHHHHHHHC---cCEecCCChHHEEEcCCCCEEEEecCcccccccccccceecccc
Confidence            776432  2388999999999999999999998   9999999999999999999999999999755432 234567899


Q ss_pred             cccCcceecC-CcceeccCC
Q 046065          146 GYIPPEYVGR-GVYYKKFSL  164 (164)
Q Consensus       146 ~~~aPE~~~~-~~~~~~~Di  164 (164)
                      .|+|||++.+ ..++.++||
T Consensus       198 ~y~aPE~~~~~~~~~~~~Di  217 (362)
T 3pg1_A          198 WYRAPELVMQFKGFTKLVDM  217 (362)
T ss_dssp             GGCCHHHHTTCTTCCTHHHH
T ss_pred             eecCcHHhcCCCCCCcHhHH
Confidence            9999999876 678888885

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.95  E-value=1.1e-28  Score=182.20  Aligned_cols=154  Identities=25%  Similarity=0.357  Sum_probs=117.4

Q ss_pred             CCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEee--CCcEEEEEEecCCCChhhhhhCcc------ccc
Q 046065            5 DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIE--TQEYMLIYEYMPKRSLDYFLFDPI------RML   75 (164)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~------~~~   75 (164)
                      +++.||+|.+....  ....+.+|+.+++.++||||+++ +.+..  ....++|||+++ ++|.+++....      ...
T Consensus        47 ~~~~vaiK~~~~~~--~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~  123 (405)
T 3rgf_A           47 DDKDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPV  123 (405)
T ss_dssp             CCCCEEEEECSSSS--CCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-EEHHHHHHHHHHHC------
T ss_pred             CCeEEEEEEECCCC--CCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-CCHHHHHHHhcccccccccc
Confidence            57889999986442  23467899999999999999998 55543  457889999997 47777665321      112


Q ss_pred             ccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceee----cCCCCeEEccccchhhhhhh-----hhhhhccccc
Q 046065           76 ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL----DEDLKPKISDFGLARILRKM-----ILKQIQIELG  146 (164)
Q Consensus        76 ~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili----~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~~  146 (164)
                      .+++..+..++.|++.||.|||+.   +|+|+||||+||++    +.++.++|+|||++......     ......||+.
T Consensus       124 ~l~~~~~~~i~~qi~~al~~LH~~---~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~  200 (405)
T 3rgf_A          124 QLPRGMVKSLLYQILDGIHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFW  200 (405)
T ss_dssp             -CCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCT
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHhC---CEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCc
Confidence            388899999999999999999998   99999999999999    67789999999999766432     2245678999


Q ss_pred             ccCcceecCC-cceeccCC
Q 046065          147 YIPPEYVGRG-VYYKKFSL  164 (164)
Q Consensus       147 ~~aPE~~~~~-~~~~~~Di  164 (164)
                      |+|||++.+. .++.++||
T Consensus       201 y~aPE~~~~~~~~~~~~Di  219 (405)
T 3rgf_A          201 YRAPELLLGARHYTKAIDI  219 (405)
T ss_dssp             TCCHHHHTTCCSCCHHHHH
T ss_pred             ccCchhhcCCCcccchhhh
Confidence            9999999764 58988885

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.95  E-value=3.2e-28  Score=172.06  Aligned_cols=154  Identities=28%  Similarity=0.394  Sum_probs=128.0

Q ss_pred             CCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            4 PDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         4 ~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      .+++.||+|.+...  .....+.+.+|+.+++.++||||+++ +.+......++|+|++++++|.+.+.....   ++..
T Consensus        45 ~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~  121 (287)
T 2wei_A           45 ITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR---FSEH  121 (287)
T ss_dssp             TTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSS---CCHH
T ss_pred             CCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhcCC---CCHH
Confidence            36889999998654  33456778999999999999999997 777777889999999999999888765332   8899


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCC---CCeEEccccchhhhhhh-hhhhhcccccccCcceecCC
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED---LKPKISDFGLARILRKM-ILKQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~---~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~~~  156 (164)
                      ....++.|++.|+.+||+.   +++|+||+|+||+++..   +.++|+|||++...... ......+++.|+|||.+.+ 
T Consensus       122 ~~~~i~~qi~~~l~~LH~~---~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-  197 (287)
T 2wei_A          122 DAARIIKQVFSGITYMHKH---NIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-  197 (287)
T ss_dssp             HHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHTT-
T ss_pred             HHHHHHHHHHHHHHHHHHC---CeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCccccccCcccccChHHhcC-
Confidence            9999999999999999998   99999999999999764   46999999998765432 2234568899999999864 


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .++.++||
T Consensus       198 ~~~~~~Di  205 (287)
T 2wei_A          198 TYDEKCDV  205 (287)
T ss_dssp             CCCTHHHH
T ss_pred             CCCCchhh
Confidence            58888885

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.95  E-value=2.3e-28  Score=178.18  Aligned_cols=153  Identities=25%  Similarity=0.362  Sum_probs=125.1

Q ss_pred             CCCcEEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeE-eEEeeC-----CcEEEEEEecCCCChhhhhhCcccccc
Q 046065            4 PDGQIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIET-----QEYMLIYEYMPKRSLDYFLFDPIRMLI   76 (164)
Q Consensus         4 ~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~   76 (164)
                      .+++.||+|.+... .....+.+.+|+.+++.++||||+++ +.+...     ...++|+|+++ ++|.+++...    .
T Consensus        50 ~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~~----~  124 (364)
T 3qyz_A           50 LNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKTQ----H  124 (364)
T ss_dssp             TTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCS-EEHHHHHHHC----C
T ss_pred             CCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccC-cCHHHHHHhC----C
Confidence            46789999998644 23344678899999999999999998 555433     35789999997 5888887643    2


Q ss_pred             cCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh-----hhhhcccccccCcc
Q 046065           77 LDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI-----LKQIQIELGYIPPE  151 (164)
Q Consensus        77 ~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~aPE  151 (164)
                      ++...+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++.......     .....||+.|+|||
T Consensus       125 ~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE  201 (364)
T 3qyz_A          125 LSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE  201 (364)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCH
Confidence            88999999999999999999998   99999999999999999999999999997654322     23457899999999


Q ss_pred             eecCC-cceeccCC
Q 046065          152 YVGRG-VYYKKFSL  164 (164)
Q Consensus       152 ~~~~~-~~~~~~Di  164 (164)
                      ++.+. .++.++||
T Consensus       202 ~~~~~~~~~~~~Di  215 (364)
T 3qyz_A          202 IMLNSKGYTKSIDI  215 (364)
T ss_dssp             HHHTBCSCSTHHHH
T ss_pred             HhcCCCCCCcchhH
Confidence            87544 47888885

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.95  E-value=1.2e-28  Score=191.52  Aligned_cols=154  Identities=20%  Similarity=0.302  Sum_probs=125.7

Q ss_pred             CcEEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeEeEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHHH
Q 046065            6 GQIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVH   84 (164)
Q Consensus         6 ~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~   84 (164)
                      +..||+|.+... .....+.+.+|+.+++.++||||+++..+...+..++|||++++|+|.+++....  ..+++.....
T Consensus       418 ~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~lv~E~~~~g~L~~~l~~~~--~~l~~~~~~~  495 (656)
T 2j0j_A          418 AMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRK--FSLDLASLIL  495 (656)
T ss_dssp             CEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCTTCBHHHHHHHTT--TTCCHHHHHH
T ss_pred             cEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCceEEEEEcCCCCcHHHHHHhcc--CCCCHHHHHH
Confidence            457999998654 3334467889999999999999999844445677899999999999999987532  2378899999


Q ss_pred             HHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh---hhhhcccccccCcceecCCcceec
Q 046065           85 IIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI---LKQIQIELGYIPPEYVGRGVYYKK  161 (164)
Q Consensus        85 ~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~~~  161 (164)
                      ++.|++.||.|||+.   +++||||||+||+++.++.++|+|||++.......   .....+++.|+|||++.+..++.+
T Consensus       496 i~~qi~~aL~~LH~~---givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~  572 (656)
T 2j0j_A          496 YAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA  572 (656)
T ss_dssp             HHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHH
T ss_pred             HHHHHHHHHHHHHhC---CccccccchHhEEEeCCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCch
Confidence            999999999999998   99999999999999999999999999997664322   123456788999999988889999


Q ss_pred             cCC
Q 046065          162 FSL  164 (164)
Q Consensus       162 ~Di  164 (164)
                      +||
T Consensus       573 ~Di  575 (656)
T 2j0j_A          573 SDV  575 (656)
T ss_dssp             HHH
T ss_pred             hhH
Confidence            885

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.95  E-value=1.3e-28  Score=192.27  Aligned_cols=148  Identities=22%  Similarity=0.322  Sum_probs=120.8

Q ss_pred             CCcEEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCc-----EEEEEEecCCCChhhhhhCccccccc
Q 046065            5 DGQIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQE-----YMLIYEYMPKRSLDYFLFDPIRMLIL   77 (164)
Q Consensus         5 ~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~-----~~lv~e~~~~~~L~~~~~~~~~~~~~   77 (164)
                      +++.||||.+... .......+..|+.+++.++||||+++ +.+...+.     .|+||||+++++|.+++..     .+
T Consensus       105 ~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~-----~l  179 (681)
T 2pzi_A          105 NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-----KL  179 (681)
T ss_dssp             TTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C-----CC
T ss_pred             CCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC-----CC
Confidence            5789999998644 33345567899999999999999998 66655444     6999999999999887654     28


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCcceecCCc
Q 046065           78 DCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGV  157 (164)
Q Consensus        78 ~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  157 (164)
                      ++.....++.|++.+|.|+|++   +|+|+||||+||+++.+ .+||+|||++......  ....||+.|+|||++.+. 
T Consensus       180 ~~~~~~~~~~qi~~aL~~lH~~---giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~--~~~~gt~~y~aPE~~~~~-  252 (681)
T 2pzi_A          180 PVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF--GYLYGTPGFQAPEIVRTG-  252 (681)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSS-CEEECCCTTCEETTCC--SCCCCCTTTSCTTHHHHC-
T ss_pred             CHHHHHHHHHHHHHHHHHHHHC---CCeecccChHHeEEeCC-cEEEEecccchhcccC--CccCCCccccCHHHHcCC-
Confidence            8999999999999999999998   99999999999999875 8999999999765432  456799999999998644 


Q ss_pred             ceeccCC
Q 046065          158 YYKKFSL  164 (164)
Q Consensus       158 ~~~~~Di  164 (164)
                      ++.++||
T Consensus       253 ~~~~sDi  259 (681)
T 2pzi_A          253 PTVATDI  259 (681)
T ss_dssp             SCHHHHH
T ss_pred             CCCceeh
Confidence            4888885

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.95  E-value=2.6e-28  Score=176.15  Aligned_cols=150  Identities=23%  Similarity=0.290  Sum_probs=122.5

Q ss_pred             CCcEEEEEEccccccccHHHHHHHHHHHhc--cCCCceeeE-eEEeeCC----cEEEEEEecCCCChhhhhhCccccccc
Q 046065            5 DGQIIAVKKLSKKSTQGFEEFKNEVMLTAK--LQHLNLIRV-GFCIETQ----EYMLIYEYMPKRSLDYFLFDPIRMLIL   77 (164)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~e~~~l~~--l~h~~i~~~-~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~   77 (164)
                      +++.||+|.+...   ....+..|++++..  ++||||+++ +.+....    ..++|||++++++|.+++...    .+
T Consensus        64 ~~~~vavK~~~~~---~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~  136 (342)
T 1b6c_B           64 RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TV  136 (342)
T ss_dssp             TTEEEEEEEECGG---GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHHC----CB
T ss_pred             cCccEEEEEeCch---hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhcc----Cc
Confidence            5789999998643   33556788888877  689999998 5555544    688999999999999998653    28


Q ss_pred             CHHHHHHHHHHHHHHHHHhh--------hcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh------hhhhcc
Q 046065           78 DCKKRVHIIKGIIQGLLYLQ--------EYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI------LKQIQI  143 (164)
Q Consensus        78 ~~~~~~~~~~~~~~~l~~lh--------~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~------~~~~~~  143 (164)
                      ++.....++.|++.|+.|+|        +.   +++|+||||+||+++.++.++|+|||++.......      .....|
T Consensus       137 ~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~---~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~g  213 (342)
T 1b6c_B          137 TVEGMIKLALSTASGLAHLHMEIVGTQGKP---AIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVG  213 (342)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHCCBCSTTCBC---EEECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCC
T ss_pred             cHHHHHHHHHHHHHHHHHHHHHHhhhcccC---CeeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCc
Confidence            88999999999999999999        66   99999999999999999999999999987654322      234578


Q ss_pred             cccccCcceecCC------cceeccCC
Q 046065          144 ELGYIPPEYVGRG------VYYKKFSL  164 (164)
Q Consensus       144 ~~~~~aPE~~~~~------~~~~~~Di  164 (164)
                      ++.|+|||++.+.      .++.++||
T Consensus       214 t~~y~aPE~~~~~~~~~~~~~~~~~Di  240 (342)
T 1b6c_B          214 TKRYMAPEVLDDSINMKHFESFKRADI  240 (342)
T ss_dssp             CGGGCCHHHHTSCCCTTCHHHHHHHHH
T ss_pred             CcccCCHhhhcccccccccccCCcccH
Confidence            9999999999765      44567774

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.95  E-value=3.1e-28  Score=178.04  Aligned_cols=151  Identities=26%  Similarity=0.398  Sum_probs=121.6

Q ss_pred             CCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCc------EEEEEEecCCCChhhhhhCcccc
Q 046065            4 PDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQE------YMLIYEYMPKRSLDYFLFDPIRM   74 (164)
Q Consensus         4 ~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~------~~lv~e~~~~~~L~~~~~~~~~~   74 (164)
                      .+|+.||+|.+...  .......+.+|+.+++.++||||+++ +.+...+.      +++|||++. ++|.+.+...   
T Consensus        65 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~---  140 (371)
T 4exu_A           65 RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGME---  140 (371)
T ss_dssp             TTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTTSC---
T ss_pred             CCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHhhcC---
Confidence            56889999998654  23335678899999999999999998 66655443      389999997 5787776432   


Q ss_pred             cccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCcceec
Q 046065           75 LILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVG  154 (164)
Q Consensus        75 ~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~  154 (164)
                        +++..+..++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++...... .....+|+.|+|||++.
T Consensus       141 --~~~~~~~~i~~qi~~aL~~LH~~---~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-~~~~~~t~~y~aPE~~~  214 (371)
T 4exu_A          141 --FSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-MTGYVVTRWYRAPEVIL  214 (371)
T ss_dssp             --CCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECSTTCC---------CTTCCCTTSCHHHHS
T ss_pred             --CCHHHHHHHHHHHHHHHHHHHHC---CCcCCCcCHHHeEECCCCCEEEEecCcccccccC-cCCcccCccccCHHHhc
Confidence              88999999999999999999998   9999999999999999999999999999765432 34567899999999997


Q ss_pred             C-CcceeccCC
Q 046065          155 R-GVYYKKFSL  164 (164)
Q Consensus       155 ~-~~~~~~~Di  164 (164)
                      + ..++.++||
T Consensus       215 ~~~~~~~~~Di  225 (371)
T 4exu_A          215 SWMHYNQTVDI  225 (371)
T ss_dssp             CCSCCCTTHHH
T ss_pred             CCCCCCcHHhH
Confidence            6 678988885

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.95  E-value=1.4e-28  Score=174.00  Aligned_cols=152  Identities=26%  Similarity=0.295  Sum_probs=121.6

Q ss_pred             EEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeEeEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHHH
Q 046065            8 IIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVH   84 (164)
Q Consensus         8 ~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~   84 (164)
                      .||+|.+...   .+...+.+.+|+.+++.++||||+++..+...+..++|+|++++++|.+++....  ..++......
T Consensus        48 ~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~--~~~~~~~~~~  125 (291)
T 1u46_A           48 SVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRKHQ--GHFLLGTLSR  125 (291)
T ss_dssp             EEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCTTCBHHHHHHHHG--GGSCHHHHHH
T ss_pred             EEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCCceeeEecccCCCHHHHHHhcc--CCcCHHHHHH
Confidence            6899998654   2344567889999999999999999855555556889999999999999887532  2388899999


Q ss_pred             HHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh-----hhhhcccccccCcceecCCcce
Q 046065           85 IIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI-----LKQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        85 ~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      ++.|++.|+.|+|+.   +++|+||||+||+++.++.++|+|||++.......     .....+++.|+|||.+.+..++
T Consensus       126 ~~~~i~~~l~~lH~~---~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~  202 (291)
T 1u46_A          126 YAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFS  202 (291)
T ss_dssp             HHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEE
T ss_pred             HHHHHHHHHHHHHhC---CcccCCCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCC
Confidence            999999999999998   99999999999999999999999999987654321     1345577889999999888889


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      .++||
T Consensus       203 ~~~Di  207 (291)
T 1u46_A          203 HASDT  207 (291)
T ss_dssp             HHHHH
T ss_pred             chhhH
Confidence            99885

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.95  E-value=3.7e-28  Score=174.35  Aligned_cols=156  Identities=26%  Similarity=0.408  Sum_probs=125.4

Q ss_pred             CCCcEEEEEEccccc--cccHHHHHHHHHHHhcc---CCCceeeE-eEEe-----eCCcEEEEEEecCCCChhhhhhCcc
Q 046065            4 PDGQIIAVKKLSKKS--TQGFEEFKNEVMLTAKL---QHLNLIRV-GFCI-----ETQEYMLIYEYMPKRSLDYFLFDPI   72 (164)
Q Consensus         4 ~~~~~vavK~~~~~~--~~~~~~~~~e~~~l~~l---~h~~i~~~-~~~~-----~~~~~~lv~e~~~~~~L~~~~~~~~   72 (164)
                      .+++.||+|.+....  ......+.+|+.+++.+   +||||+++ +.+.     .....++|+|+++ ++|.+++....
T Consensus        35 ~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~  113 (326)
T 1blx_A           35 NGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVP  113 (326)
T ss_dssp             TTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSC
T ss_pred             CCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcc
Confidence            467899999986542  22234566778777766   89999997 5554     3346789999998 59988886532


Q ss_pred             cccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh-hhhhhcccccccCcc
Q 046065           73 RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM-ILKQIQIELGYIPPE  151 (164)
Q Consensus        73 ~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE  151 (164)
                      . ..++...+..++.|++.||.|+|+.   +++|+||||+||+++.++.++|+|||++...... ......+++.|+|||
T Consensus       114 ~-~~~~~~~~~~~~~qi~~~l~~lH~~---gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE  189 (326)
T 1blx_A          114 E-PGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPE  189 (326)
T ss_dssp             T-TCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHH
T ss_pred             c-CCCCHHHHHHHHHHHHHHHHHHHHC---CceeccCCHHHeEEcCCCCEEEecCcccccccCCCCccccccccceeCHH
Confidence            2 2378999999999999999999998   9999999999999999999999999998765433 334567899999999


Q ss_pred             eecCCcceeccCC
Q 046065          152 YVGRGVYYKKFSL  164 (164)
Q Consensus       152 ~~~~~~~~~~~Di  164 (164)
                      ++.+..++.++||
T Consensus       190 ~~~~~~~~~~~Di  202 (326)
T 1blx_A          190 VLLQSSYATPVDL  202 (326)
T ss_dssp             HHTTCCCCTHHHH
T ss_pred             HHhcCCCCcchhH
Confidence            9998899999885

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.95  E-value=4.8e-28  Score=171.57  Aligned_cols=153  Identities=21%  Similarity=0.220  Sum_probs=125.5

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceee-EeEE-eeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFC-IETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~-~~~~-~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      .+++.||+|.+.....  .+.+..|+.+++.++|++++. +..+ ......++|||++ +++|.+++....  ..+++..
T Consensus        32 ~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--~~~~~~~  106 (296)
T 3uzp_A           32 AAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCS--RKFSLKT  106 (296)
T ss_dssp             TTTEEEEEEEEESCSS--CCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT--TCCCHHH
T ss_pred             CCCcEEEEEEecCCcc--hhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHhhc--cCCCHHH
Confidence            5789999999765432  245789999999999877666 5444 4556678999999 899999886422  2388999


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceee---cCCCCeEEccccchhhhhhhh---------hhhhcccccccC
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL---DEDLKPKISDFGLARILRKMI---------LKQIQIELGYIP  149 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili---~~~~~~~l~dfg~~~~~~~~~---------~~~~~~~~~~~a  149 (164)
                      +..++.|++.||.|+|++   +++|+||||+||++   +.++.++|+|||++.......         .....|++.|+|
T Consensus       107 ~~~i~~qi~~~l~~lH~~---~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~a  183 (296)
T 3uzp_A          107 VLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS  183 (296)
T ss_dssp             HHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCC
T ss_pred             HHHHHHHHHHHHHHHHhC---CeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCC
Confidence            999999999999999998   99999999999999   478899999999997654322         245678999999


Q ss_pred             cceecCCcceeccCC
Q 046065          150 PEYVGRGVYYKKFSL  164 (164)
Q Consensus       150 PE~~~~~~~~~~~Di  164 (164)
                      ||.+.+..++.++||
T Consensus       184 PE~~~~~~~~~~~Di  198 (296)
T 3uzp_A          184 INTHLGIEQSRRDDL  198 (296)
T ss_dssp             HHHHTTCCCCHHHHH
T ss_pred             hhhhcCCCCCcchhh
Confidence            999999899999985

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.95  E-value=4.8e-28  Score=173.11  Aligned_cols=153  Identities=27%  Similarity=0.409  Sum_probs=124.7

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEe--------------eCCcEEEEEEecCCCChhhhh
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCI--------------ETQEYMLIYEYMPKRSLDYFL   68 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~--------------~~~~~~lv~e~~~~~~L~~~~   68 (164)
                      .+++.||+|.+....+...+.+.+|+.+++.++||||+++ +.+.              .....++|||+++ ++|.+++
T Consensus        34 ~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~  112 (320)
T 2i6l_A           34 DCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVL  112 (320)
T ss_dssp             TTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHH
T ss_pred             CCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHh
Confidence            4588999999876666666788999999999999999997 4442              2356789999997 5998888


Q ss_pred             hCcccccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeec-CCCCeEEccccchhhhhhh-----hhhhhc
Q 046065           69 FDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLD-EDLKPKISDFGLARILRKM-----ILKQIQ  142 (164)
Q Consensus        69 ~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~-~~~~~~l~dfg~~~~~~~~-----~~~~~~  142 (164)
                      ...    .++......++.|++.||.|||++   +++|+||||+||+++ .++.++|+|||++......     ......
T Consensus       113 ~~~----~~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~  185 (320)
T 2i6l_A          113 EQG----PLLEEHARLFMYQLLRGLKYIHSA---NVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGL  185 (320)
T ss_dssp             TTC----CCCHHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGG
T ss_pred             hcC----CccHHHHHHHHHHHHHHHHHHHhC---CEecCCCCHHHEEEcCCCCeEEEccCccccccCCCccccccccccc
Confidence            653    278899999999999999999998   999999999999997 4678999999999765421     123456


Q ss_pred             ccccccCcceecC-CcceeccCC
Q 046065          143 IELGYIPPEYVGR-GVYYKKFSL  164 (164)
Q Consensus       143 ~~~~~~aPE~~~~-~~~~~~~Di  164 (164)
                      ++..|+|||.+.+ ..++.++||
T Consensus       186 ~~~~y~aPE~~~~~~~~~~~~Di  208 (320)
T 2i6l_A          186 VTKWYRSPRLLLSPNNYTKAIDM  208 (320)
T ss_dssp             SCCTTCCHHHHHCTTCCCHHHHH
T ss_pred             ccccccCcHHhcCcccCCchhhh
Confidence            7889999998865 678888885

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.95  E-value=8.2e-29  Score=179.82  Aligned_cols=150  Identities=17%  Similarity=0.192  Sum_probs=123.2

Q ss_pred             CCcEEEEEEccccccccHHHHHHHHHHHhccCCCceee---------------E-eEEee-CCcEEEEEEecCCCChhhh
Q 046065            5 DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR---------------V-GFCIE-TQEYMLIYEYMPKRSLDYF   67 (164)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~---------------~-~~~~~-~~~~~lv~e~~~~~~L~~~   67 (164)
                      +++.||+|.+...     ..+.+|+.+++.++||||++               + +.+.. ....++|||++ +++|.++
T Consensus        74 ~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~  147 (352)
T 2jii_A           74 QKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSA  147 (352)
T ss_dssp             ---CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHH
T ss_pred             cCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHH
Confidence            5789999998643     35789999999999999987               3 34444 56788999999 9999999


Q ss_pred             hhCcccccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCC--CeEEccccchhhhhhhh--------
Q 046065           68 LFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL--KPKISDFGLARILRKMI--------  137 (164)
Q Consensus        68 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~--~~~l~dfg~~~~~~~~~--------  137 (164)
                      +.... ...+++..+..++.|++.||.|||+.   +++|+||||+||+++.++  .++|+|||++..+....        
T Consensus       148 l~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~  223 (352)
T 2jii_A          148 LDVSP-KHVLSERSVLQVACRLLDALEFLHEN---EYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEG  223 (352)
T ss_dssp             HHHSG-GGCCCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTT
T ss_pred             HHhCC-cCCCCHHHHHHHHHHHHHHHHHHHhC---CccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCcccccccc
Confidence            97542 13389999999999999999999998   999999999999999988  89999999997654321        


Q ss_pred             -hhhhcccccccCcceecCCcceeccCC
Q 046065          138 -LKQIQIELGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       138 -~~~~~~~~~~~aPE~~~~~~~~~~~Di  164 (164)
                       .....|++.|+|||++.+..++.++||
T Consensus       224 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di  251 (352)
T 2jii_A          224 SRSPHEGDLEFISMDLHKGCGPSRRSDL  251 (352)
T ss_dssp             SSCTTCSCTTTCCHHHHTTCCCCHHHHH
T ss_pred             ccccccCCccccCHHHHccCCCCchhhH
Confidence             133578999999999998899999985

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.95  E-value=3.9e-28  Score=178.14  Aligned_cols=154  Identities=23%  Similarity=0.309  Sum_probs=121.3

Q ss_pred             cCCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeC--------------------------------
Q 046065            3 LPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIET--------------------------------   49 (164)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~--------------------------------   49 (164)
                      ..+|+.||+|.+..+...    ..+|+.+++.++||||+++ +.+...                                
T Consensus        29 ~~~~~~vAiK~~~~~~~~----~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  104 (383)
T 3eb0_A           29 IESGKRFALKKVLQDPRY----KNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVI  104 (383)
T ss_dssp             TTTCCEEEEEEEECCTTS----CCHHHHHHTTCCCTTBCCEEEEEEEC--------------------------------
T ss_pred             CCCCCEEEEEEEecCcch----HHHHHHHHHHcCCCCccchhheeeecCccccccccccccccccccccccccccccccc
Confidence            357899999998644222    2369999999999999997 555332                                


Q ss_pred             ------CcEEEEEEecCCCChhhhhhCc-ccccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeec-CCCC
Q 046065           50 ------QEYMLIYEYMPKRSLDYFLFDP-IRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLD-EDLK  121 (164)
Q Consensus        50 ------~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~-~~~~  121 (164)
                            ...++|||+++ ++|.+.+... .....+++..+..++.|++.||.|||+.   +++|+||||+||+++ .++.
T Consensus       105 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---gi~H~Dikp~Nil~~~~~~~  180 (383)
T 3eb0_A          105 VNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNSKDNT  180 (383)
T ss_dssp             -----CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCCGGGEEEETTTTE
T ss_pred             ccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC---cCccCccCHHHEEEcCCCCc
Confidence                  23779999998 4777666531 1123388999999999999999999988   999999999999998 5789


Q ss_pred             eEEccccchhhhhhh-hhhhhcccccccCcceecCC-cceeccCC
Q 046065          122 PKISDFGLARILRKM-ILKQIQIELGYIPPEYVGRG-VYYKKFSL  164 (164)
Q Consensus       122 ~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~~~-~~~~~~Di  164 (164)
                      ++|+|||++...... ......+|+.|+|||.+.+. .++.++||
T Consensus       181 ~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di  225 (383)
T 3eb0_A          181 LKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDL  225 (383)
T ss_dssp             EEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHH
T ss_pred             EEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhh
Confidence            999999999765432 33456789999999998765 48999885

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.95  E-value=5.2e-28  Score=175.63  Aligned_cols=151  Identities=26%  Similarity=0.392  Sum_probs=120.9

Q ss_pred             CCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCc------EEEEEEecCCCChhhhhhCcccc
Q 046065            4 PDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQE------YMLIYEYMPKRSLDYFLFDPIRM   74 (164)
Q Consensus         4 ~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~------~~lv~e~~~~~~L~~~~~~~~~~   74 (164)
                      .+|+.||+|.+...  .......+.+|+.+++.++||||+++ +.+.....      +++|||+++ ++|.+++..    
T Consensus        47 ~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~----  121 (353)
T 3coi_A           47 RSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMGL----  121 (353)
T ss_dssp             TTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTTS----
T ss_pred             CCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEecccc-CCHHHHhcC----
Confidence            46889999998654  22334678899999999999999998 55554432      489999997 588777643    


Q ss_pred             cccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCcceec
Q 046065           75 LILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVG  154 (164)
Q Consensus        75 ~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~  154 (164)
                       .+++..+..++.|++.||.|||++   +++|+||||+||+++.++.++|+|||++...... .....+++.|+|||++.
T Consensus       122 -~~~~~~~~~i~~qi~~al~~LH~~---~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-~~~~~~t~~y~aPE~~~  196 (353)
T 3coi_A          122 -KFSEEKIQYLVYQMLKGLKYIHSA---GVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-MTGYVVTRWYRAPEVIL  196 (353)
T ss_dssp             -CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSSCCGGGEEECTTCCEEECSTTCTTC---------CCSBCCSCHHHHS
T ss_pred             -CCCHHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEeECCCCcEEEeecccccCCCCC-ccccccCcCcCCHHHHh
Confidence             288899999999999999999998   9999999999999999999999999999765432 34567899999999987


Q ss_pred             C-CcceeccCC
Q 046065          155 R-GVYYKKFSL  164 (164)
Q Consensus       155 ~-~~~~~~~Di  164 (164)
                      + ..++.++||
T Consensus       197 ~~~~~~~~~Di  207 (353)
T 3coi_A          197 SWMHYNQTVDI  207 (353)
T ss_dssp             CCSCCCTTHHH
T ss_pred             CcCCCCchhhH
Confidence            6 677888885

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.95  E-value=3.4e-28  Score=176.36  Aligned_cols=153  Identities=25%  Similarity=0.376  Sum_probs=123.5

Q ss_pred             CCCcEEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeE-eEEeeC-----CcEEEEEEecCCCChhhhhhCcccccc
Q 046065            4 PDGQIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIET-----QEYMLIYEYMPKRSLDYFLFDPIRMLI   76 (164)
Q Consensus         4 ~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~-----~~~~lv~e~~~~~~L~~~~~~~~~~~~   76 (164)
                      .+|+.||+|.+... .+.....+.+|+.+++.++||||+++ +.+...     ...++|+|++. ++|.+++...    .
T Consensus        34 ~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~----~  108 (353)
T 2b9h_A           34 PTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVISTQ----M  108 (353)
T ss_dssp             TTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHHC----C
T ss_pred             CCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHHHhhc----C
Confidence            46889999998644 33345667899999999999999998 444332     56889999997 5888887642    2


Q ss_pred             cCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh------------hhhhccc
Q 046065           77 LDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI------------LKQIQIE  144 (164)
Q Consensus        77 ~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~------------~~~~~~~  144 (164)
                      ++......++.|++.||.|||++   +++|+||||+||+++.++.++|+|||++.......            .....||
T Consensus       109 ~~~~~~~~~~~qi~~~L~~LH~~---~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt  185 (353)
T 2b9h_A          109 LSDDHIQYFIYQTLRAVKVLHGS---NVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVAT  185 (353)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCC
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhcccc
Confidence            88999999999999999999998   99999999999999999999999999987653211            1234689


Q ss_pred             ccccCcceecC-CcceeccCC
Q 046065          145 LGYIPPEYVGR-GVYYKKFSL  164 (164)
Q Consensus       145 ~~~~aPE~~~~-~~~~~~~Di  164 (164)
                      +.|+|||++.+ ..++.++||
T Consensus       186 ~~y~aPE~~~~~~~~~~~~Di  206 (353)
T 2b9h_A          186 RWYRAPEVMLTSAKYSRAMDV  206 (353)
T ss_dssp             GGGCCHHHHHSCCCCCHHHHH
T ss_pred             ccccCCeeeccCCCccchhhH
Confidence            99999998754 678888885

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=1.1e-27  Score=172.45  Aligned_cols=150  Identities=25%  Similarity=0.321  Sum_probs=117.3

Q ss_pred             CCcEEEEEEccccccccHHHHHHHHHHHhcc--CCCceeeE-eEEeeC----CcEEEEEEecCCCChhhhhhCccccccc
Q 046065            5 DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKL--QHLNLIRV-GFCIET----QEYMLIYEYMPKRSLDYFLFDPIRMLIL   77 (164)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l--~h~~i~~~-~~~~~~----~~~~lv~e~~~~~~L~~~~~~~~~~~~~   77 (164)
                      +++.||+|.+....   ......|.+++...  +||||+++ +.+...    ...++|||++++++|.+++...    .+
T Consensus        59 ~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~----~~  131 (337)
T 3mdy_A           59 RGEKVAVKVFFTTE---EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST----TL  131 (337)
T ss_dssp             TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHC----CB
T ss_pred             CCceEEEEEEeccc---cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhcc----CC
Confidence            47889999985432   23345566655554  89999997 665555    5688999999999999998653    28


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhcC-----CCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh------hhhccccc
Q 046065           78 DCKKRVHIIKGIIQGLLYLQEYF-----RLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL------KQIQIELG  146 (164)
Q Consensus        78 ~~~~~~~~~~~~~~~l~~lh~~~-----~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~------~~~~~~~~  146 (164)
                      ++.....++.|++.||.|+|+..     ..+++|+||||+||+++.++.+||+|||++........      ....||+.
T Consensus       132 ~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~  211 (337)
T 3mdy_A          132 DAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKR  211 (337)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGG
T ss_pred             CHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcc
Confidence            89999999999999999999751     23899999999999999999999999999966543221      24578999


Q ss_pred             ccCcceecCCcceec
Q 046065          147 YIPPEYVGRGVYYKK  161 (164)
Q Consensus       147 ~~aPE~~~~~~~~~~  161 (164)
                      |+|||++.+..++.+
T Consensus       212 y~aPE~~~~~~~~~~  226 (337)
T 3mdy_A          212 YMPPEVLDESLNRNH  226 (337)
T ss_dssp             GCCHHHHTTCCCTTC
T ss_pred             eeChhhcccccCCcc
Confidence            999999977665554

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.95  E-value=1.7e-28  Score=182.02  Aligned_cols=153  Identities=24%  Similarity=0.343  Sum_probs=118.2

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeC----C--cEEEEEEecCCCChhhhhhCc-cccc
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIET----Q--EYMLIYEYMPKRSLDYFLFDP-IRML   75 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~----~--~~~lv~e~~~~~~L~~~~~~~-~~~~   75 (164)
                      .+++.||||.+.....    ...+|+.+++.++||||+++ ..+...    .  .+++||||+++ ++.+.+... ....
T Consensus        77 ~~~~~vaiK~~~~~~~----~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~  151 (420)
T 1j1b_A           77 DSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQ  151 (420)
T ss_dssp             TTCCEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTC
T ss_pred             CCCcEEEEEEecccch----hHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccC
Confidence            4689999999864422    23469999999999999998 444332    1  25699999975 565554321 1123


Q ss_pred             ccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCC-CCeEEccccchhhhhhh-hhhhhcccccccCccee
Q 046065           76 ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED-LKPKISDFGLARILRKM-ILKQIQIELGYIPPEYV  153 (164)
Q Consensus        76 ~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~-~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~  153 (164)
                      .+++.....++.|++.||.|||++   +|+||||||+|||++.+ +.+||+|||+++..... ......+|+.|+|||++
T Consensus       152 ~l~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~  228 (420)
T 1j1b_A          152 TLPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELI  228 (420)
T ss_dssp             CCCHHHHHHHHHHHHHHHHHHHTT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHH
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHC---CccccCCChhhEEEeCCCCeEEeccchhhhhcccCCCceeeeeCCCcCCHHHH
Confidence            388999999999999999999998   99999999999999965 56899999999765432 23456789999999999


Q ss_pred             cCC-cceeccCC
Q 046065          154 GRG-VYYKKFSL  164 (164)
Q Consensus       154 ~~~-~~~~~~Di  164 (164)
                      .+. .|+.++||
T Consensus       229 ~~~~~~~~~~Di  240 (420)
T 1j1b_A          229 FGATDYTSSIDV  240 (420)
T ss_dssp             TTCSSCCTHHHH
T ss_pred             cCCCCCCchhhh
Confidence            654 78998885

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.95  E-value=2e-28  Score=189.24  Aligned_cols=158  Identities=27%  Similarity=0.326  Sum_probs=132.0

Q ss_pred             CCCcEEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeE-eEEee------CCcEEEEEEecCCCChhhhhhCccccc
Q 046065            4 PDGQIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIE------TQEYMLIYEYMPKRSLDYFLFDPIRML   75 (164)
Q Consensus         4 ~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~------~~~~~lv~e~~~~~~L~~~~~~~~~~~   75 (164)
                      .+|+.||+|.+... .+.....+..|+.+++.++||||+++ +.+..      .+..++||||+++++|.+++.......
T Consensus        37 ~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~  116 (676)
T 3qa8_A           37 DTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCC  116 (676)
T ss_dssp             TTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTT
T ss_pred             CCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCC
Confidence            46889999998654 34445678899999999999999997 44333      456789999999999999998754444


Q ss_pred             ccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCC---eEEccccchhhhhhhh-hhhhcccccccCcc
Q 046065           76 ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK---PKISDFGLARILRKMI-LKQIQIELGYIPPE  151 (164)
Q Consensus        76 ~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~---~~l~dfg~~~~~~~~~-~~~~~~~~~~~aPE  151 (164)
                      .+++..+..++.|++.|+.|+|+.   +++|+||||+||+++.++.   ++|+|||++....... .....|++.|+|||
T Consensus       117 ~lse~~i~~I~~QLl~aL~yLHs~---gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE  193 (676)
T 3qa8_A          117 GLKEGPIRTLLSDISSALRYLHEN---RIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPE  193 (676)
T ss_dssp             CCCSSHHHHHHHHHHHHHHHHHHT---TBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSC
T ss_pred             CCCHHHHHHHHHHHHHHHHHHHHC---CCccCCCCHHHeEeecCCCceeEEEcccccccccccccccccccCCcccCChH
Confidence            488889999999999999999998   9999999999999997664   8999999997665432 34567899999999


Q ss_pred             eecCCcceeccCC
Q 046065          152 YVGRGVYYKKFSL  164 (164)
Q Consensus       152 ~~~~~~~~~~~Di  164 (164)
                      .+.+..++.++||
T Consensus       194 ~l~~~~~s~ksDI  206 (676)
T 3qa8_A          194 LLEQKKYTVTVDY  206 (676)
T ss_dssp             SSCCSCCSTTHHH
T ss_pred             HhccCCCCchhHH
Confidence            9998999999985

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.95  E-value=1.3e-28  Score=180.03  Aligned_cols=154  Identities=12%  Similarity=0.156  Sum_probs=109.4

Q ss_pred             CCCcEEEEEEccccc---cccHHHHHHHHHHHhcc--CCCceeeE-e-------EEeeC-----------------CcEE
Q 046065            4 PDGQIIAVKKLSKKS---TQGFEEFKNEVMLTAKL--QHLNLIRV-G-------FCIET-----------------QEYM   53 (164)
Q Consensus         4 ~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l--~h~~i~~~-~-------~~~~~-----------------~~~~   53 (164)
                      .+++.||+|.+....   ....+.+.+|+.+++.+  +||||+++ .       .+...                 ...+
T Consensus        85 ~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (371)
T 3q60_A           85 ERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYL  164 (371)
T ss_dssp             TTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEE
T ss_pred             CCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEE
Confidence            578899999987653   23345667785544444  69998873 2       11111                 2378


Q ss_pred             EEEEecCCCChhhhhhCcccccccCHHHH------HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccc
Q 046065           54 LIYEYMPKRSLDYFLFDPIRMLILDCKKR------VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDF  127 (164)
Q Consensus        54 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~------~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~df  127 (164)
                      +||||++ ++|.+++......  ++....      ..++.|++.||.|||++   +|+||||||+||+++.++.+||+||
T Consensus       165 lv~e~~~-~~L~~~l~~~~~~--~~~~~~~~~~vk~~i~~qi~~aL~~LH~~---~ivHrDikp~NIll~~~~~~kL~DF  238 (371)
T 3q60_A          165 LLMPAAS-VDLELLFSTLDFV--YVFRGDEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDV  238 (371)
T ss_dssp             EEECCCS-EEHHHHHHHHHHS--CCCCHHHHHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGGEEECTTSCEEECCG
T ss_pred             EEecCCC-CCHHHHHHHhccc--cchhhhhhhhhHHHHHHHHHHHHHHHHHC---CCccCcCCHHHEEECCCCCEEEEec
Confidence            9999998 8999998763221  344444      56779999999999998   9999999999999999999999999


Q ss_pred             cchhhhhhhhhhhhcccccccCcceecC--CcceeccCC
Q 046065          128 GLARILRKMILKQIQIELGYIPPEYVGR--GVYYKKFSL  164 (164)
Q Consensus       128 g~~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Di  164 (164)
                      |++....... ....+++.|+|||++.+  ..++.++||
T Consensus       239 G~a~~~~~~~-~~~~~t~~y~aPE~~~~~~~~~~~~~Di  276 (371)
T 3q60_A          239 SALWKVGTRG-PASSVPVTYAPREFLNASTATFTHALNA  276 (371)
T ss_dssp             GGEEETTCEE-EGGGSCGGGCCHHHHTCSEEECCHHHHH
T ss_pred             ceeeecCCCc-cCccCCcCCcChhhccCCCCCcCccccH
Confidence            9997654322 24556699999999977  778999985

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.95  E-value=6e-28  Score=175.46  Aligned_cols=156  Identities=22%  Similarity=0.255  Sum_probs=120.2

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCc-------EEEEEEecCCCChhhhhhC-cccc
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQE-------YMLIYEYMPKRSLDYFLFD-PIRM   74 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~-------~~lv~e~~~~~~L~~~~~~-~~~~   74 (164)
                      .+++.||||.+..+ .........++..+..++||||+++ +.+...+.       .++|||++++ +|...+.. ....
T Consensus        46 ~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~  123 (360)
T 3e3p_A           46 STGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQ  123 (360)
T ss_dssp             TTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTT
T ss_pred             CCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcc
Confidence            56889999988544 2333456778888899999999998 55544332       7799999986 54443332 1122


Q ss_pred             cccCHHHHHHHHHHHHHHHHHhh--hcCCCCeeeCCCCCCceeecC-CCCeEEccccchhhhhhhh-hhhhcccccccCc
Q 046065           75 LILDCKKRVHIIKGIIQGLLYLQ--EYFRLTIIHRDLKVSNILLDE-DLKPKISDFGLARILRKMI-LKQIQIELGYIPP  150 (164)
Q Consensus        75 ~~~~~~~~~~~~~~~~~~l~~lh--~~~~~~iih~dlk~~nili~~-~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~aP  150 (164)
                      ..++......++.|++.|+.|+|  +.   +++|+||||+||+++. ++.++|+|||++....... .....||+.|+||
T Consensus       124 ~~~~~~~~~~~~~qi~~al~~lH~~~~---~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aP  200 (360)
T 3e3p_A          124 VAPPPILIKVFLFQLIRSIGCLHLPSV---NVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAP  200 (360)
T ss_dssp             CCCCHHHHHHHHHHHHHHHHHHTSTTT---CCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCH
T ss_pred             cCCCHHHHHHHHHHHHHHHHHHhCCCC---CeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCCcccccCCcceeCH
Confidence            33788899999999999999999  66   9999999999999997 8999999999997665332 3456789999999


Q ss_pred             ceecCCc-ceeccCC
Q 046065          151 EYVGRGV-YYKKFSL  164 (164)
Q Consensus       151 E~~~~~~-~~~~~Di  164 (164)
                      |++.+.. ++.++||
T Consensus       201 E~~~~~~~~~~~~Di  215 (360)
T 3e3p_A          201 ELIFGNQHYTTAVDI  215 (360)
T ss_dssp             HHHTTCSSCCTHHHH
T ss_pred             HHHcCCCCCCcHHHH
Confidence            9986554 7988885

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.95  E-value=8.1e-28  Score=173.72  Aligned_cols=152  Identities=22%  Similarity=0.284  Sum_probs=103.8

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHH-HHHhccCCCceeeE-eEEee----CCcEEEEEEecCCCChhhhhhCccccccc
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEV-MLTAKLQHLNLIRV-GFCIE----TQEYMLIYEYMPKRSLDYFLFDPIRMLIL   77 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~-~~l~~l~h~~i~~~-~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~   77 (164)
                      .+++.||+|.+....     ....|+ ..++.++||||+++ +.+..    ....++|||++++++|.+++..... ..+
T Consensus        52 ~~~~~vavK~~~~~~-----~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~-~~l  125 (336)
T 3fhr_A           52 RTGQKCALKLLYDSP-----KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGD-QAF  125 (336)
T ss_dssp             TTCCEEEEEEEESSH-----HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-C-CCC
T ss_pred             CCCCEEEEEEecCcH-----HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCC-CCC
Confidence            468899999985431     122333 34666799999997 55443    2347899999999999999976432 238


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecC---CCCeEEccccchhhhhhhhhhhhcccccccCcceec
Q 046065           78 DCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE---DLKPKISDFGLARILRKMILKQIQIELGYIPPEYVG  154 (164)
Q Consensus        78 ~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~---~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~  154 (164)
                      ++..+..++.|++.||.|||+.   +++|+||||+||+++.   ++.++|+|||++............+++.|+|||++.
T Consensus       126 ~~~~~~~i~~ql~~~l~~LH~~---~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~t~~y~aPE~~~  202 (336)
T 3fhr_A          126 TEREAAEIMRDIGTAIQFLHSH---NIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLG  202 (336)
T ss_dssp             BHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC---------------------
T ss_pred             CHHHHHHHHHHHHHHHHHHHhC---CeecCCCCHHHEEEEecCCCceEEEeccccceeccccccccCCCCcCccChhhhC
Confidence            8999999999999999999998   9999999999999976   455999999999776655556678899999999998


Q ss_pred             CCcceeccCC
Q 046065          155 RGVYYKKFSL  164 (164)
Q Consensus       155 ~~~~~~~~Di  164 (164)
                      +..++.++||
T Consensus       203 ~~~~~~~~Di  212 (336)
T 3fhr_A          203 PEKYDKSCDM  212 (336)
T ss_dssp             -CHHHHHHHH
T ss_pred             CCCCCchhhH
Confidence            8899999885

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.95  E-value=8.8e-28  Score=178.68  Aligned_cols=154  Identities=20%  Similarity=0.191  Sum_probs=125.8

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhcc------CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccc
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKL------QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLI   76 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l------~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~   76 (164)
                      .+++.||||.+... ......+..|+.+++.+      +|+||+++ +.+......++|||++. ++|.+++..... ..
T Consensus       120 ~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~  196 (429)
T 3kvw_A          120 KVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLS-MNLYELIKKNKF-QG  196 (429)
T ss_dssp             TTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCCC-CBHHHHHHHTTT-CC
T ss_pred             CCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEeccC-CCHHHHHHhccC-CC
Confidence            46789999998643 23345567788877777      56799997 77777888999999996 588888765322 22


Q ss_pred             cCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCC--eEEccccchhhhhhhhhhhhcccccccCcceec
Q 046065           77 LDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK--PKISDFGLARILRKMILKQIQIELGYIPPEYVG  154 (164)
Q Consensus        77 ~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~--~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~  154 (164)
                      +++..+..++.|++.||.|||+.   +|+||||||+||+++.++.  +||+|||++..... ......||+.|+|||++.
T Consensus       197 ~~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~-~~~~~~gt~~y~aPE~~~  272 (429)
T 3kvw_A          197 FSLPLVRKFAHSILQCLDALHKN---RIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ-RVYTYIQSRFYRAPEVIL  272 (429)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHH---TEECSCCSGGGEEESSTTSCCEEECCCTTCEETTC-CCCSSCSCGGGCCHHHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHC---CeecCCCCHHHeEEccCCCcceEEeecccceecCC-cccccCCCCCccChHHHh
Confidence            88899999999999999999999   9999999999999999887  99999999865432 234567899999999999


Q ss_pred             CCcceeccCC
Q 046065          155 RGVYYKKFSL  164 (164)
Q Consensus       155 ~~~~~~~~Di  164 (164)
                      +..++.++||
T Consensus       273 ~~~~~~~~Di  282 (429)
T 3kvw_A          273 GARYGMPIDM  282 (429)
T ss_dssp             TBCCCTHHHH
T ss_pred             CCCCCchHHH
Confidence            9999999986

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.95  E-value=1.9e-28  Score=176.66  Aligned_cols=153  Identities=29%  Similarity=0.374  Sum_probs=116.7

Q ss_pred             CCcEEEEEEccccccccHHHHHHHHHH--HhccCCCceeeE-eEEee-----CCcEEEEEEecCCCChhhhhhCcccccc
Q 046065            5 DGQIIAVKKLSKKSTQGFEEFKNEVML--TAKLQHLNLIRV-GFCIE-----TQEYMLIYEYMPKRSLDYFLFDPIRMLI   76 (164)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~e~~~--l~~l~h~~i~~~-~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~~~~   76 (164)
                      +++.||+|.+....   ...+..|..+  +..++||||+++ +.+..     ...+++||||+++++|.+++....    
T Consensus        35 ~~~~vavK~~~~~~---~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~----  107 (336)
T 3g2f_A           35 DERPVAVKVFSFAN---RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----  107 (336)
T ss_dssp             TTEEEEEEEEEGGG---HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHCC----
T ss_pred             CCeEEEEEEeeccc---hhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhcc----
Confidence            57899999986442   2334444444  455899999997 43221     124689999999999999986533    


Q ss_pred             cCHHHHHHHHHHHHHHHHHhhhcC------CCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh----------hhhh
Q 046065           77 LDCKKRVHIIKGIIQGLLYLQEYF------RLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM----------ILKQ  140 (164)
Q Consensus        77 ~~~~~~~~~~~~~~~~l~~lh~~~------~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~----------~~~~  140 (164)
                      .+......++.|++.||.|||+.+      ..+++|+||||+||+++.++.+||+|||++......          ....
T Consensus       108 ~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~  187 (336)
T 3g2f_A          108 SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAIS  187 (336)
T ss_dssp             BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CC
T ss_pred             cchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceeecccccccCcccccccccc
Confidence            577888999999999999999753      228999999999999999999999999999765321          1234


Q ss_pred             hcccccccCcceecC-------CcceeccCC
Q 046065          141 IQIELGYIPPEYVGR-------GVYYKKFSL  164 (164)
Q Consensus       141 ~~~~~~~~aPE~~~~-------~~~~~~~Di  164 (164)
                      ..||+.|+|||++.+       ..++.++||
T Consensus       188 ~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Di  218 (336)
T 3g2f_A          188 EVGTIRYMAPEVLEGAVNLRDXESALKQVDM  218 (336)
T ss_dssp             TTSCGGGCCHHHHTTCCCGGGHHHHHHHHHH
T ss_pred             CCCccceeCchhhcCCcccccccccccccch
Confidence            579999999999976       466777775

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.95  E-value=6.8e-28  Score=170.73  Aligned_cols=153  Identities=22%  Similarity=0.235  Sum_probs=124.1

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceee-EeEE-eeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFC-IETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~-~~~~-~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      .+++.||+|.+.....  ...+..|+.+++.++|++++. +..+ ......++|||++ +++|.+++.....  .+++..
T Consensus        32 ~~~~~vavK~~~~~~~--~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~--~~~~~~  106 (296)
T 4hgt_A           32 AAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSR--KFSLKT  106 (296)
T ss_dssp             TTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTS--CCCHHH
T ss_pred             CCCceEEEEeeccccc--chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHHhcC--CCCHHH
Confidence            5788999998654422  235788999999998877776 4554 4556778999999 8999998874222  288999


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceee---cCCCCeEEccccchhhhhhhh---------hhhhcccccccC
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL---DEDLKPKISDFGLARILRKMI---------LKQIQIELGYIP  149 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili---~~~~~~~l~dfg~~~~~~~~~---------~~~~~~~~~~~a  149 (164)
                      ...++.|++.||.|+|+.   +++|+||||+||++   +.++.++|+|||++.......         .....|++.|+|
T Consensus       107 ~~~i~~qi~~~l~~LH~~---~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~a  183 (296)
T 4hgt_A          107 VLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS  183 (296)
T ss_dssp             HHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCC
T ss_pred             HHHHHHHHHHHHHHHHHC---CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccc
Confidence            999999999999999998   99999999999999   788999999999997654321         135678999999


Q ss_pred             cceecCCcceeccCC
Q 046065          150 PEYVGRGVYYKKFSL  164 (164)
Q Consensus       150 PE~~~~~~~~~~~Di  164 (164)
                      ||.+.+..++.++||
T Consensus       184 PE~~~~~~~~~~~Di  198 (296)
T 4hgt_A          184 INTHLGIEQSRRDDL  198 (296)
T ss_dssp             HHHHTTCCCCHHHHH
T ss_pred             hHHhcCCCCCchhHH
Confidence            999998899999985

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.95  E-value=8.7e-28  Score=169.80  Aligned_cols=158  Identities=23%  Similarity=0.277  Sum_probs=113.1

Q ss_pred             CCCcEEEEEEccccc-c-ccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCc-ccccccCH
Q 046065            4 PDGQIIAVKKLSKKS-T-QGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDP-IRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~~-~-~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~   79 (164)
                      .+++.||+|.+.... . ...+.+.++...++.++||||+++ +.+...+..++|||+++ ++|.+++... .....+++
T Consensus        30 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~  108 (290)
T 3fme_A           30 PSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPE  108 (290)
T ss_dssp             TTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCH
T ss_pred             CCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc-cchHHHHHHHHhcCCCCCH
Confidence            578899999986542 2 222334455556888899999998 77777788999999997 4887766541 11233889


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh-hhhcccccccCccee----c
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL-KQIQIELGYIPPEYV----G  154 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~aPE~~----~  154 (164)
                      .....++.|++.|+.|+|+.  .+++|+||||+||+++.++.++|+|||++........ ....|++.|+|||.+    .
T Consensus       109 ~~~~~i~~qi~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~  186 (290)
T 3fme_A          109 DILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELN  186 (290)
T ss_dssp             HHHHHHHHHHHHHHHHHHHH--SCCCCCCCSGGGCEECTTCCEEBCCC---------------CCCCCCSCHHHHSCCTT
T ss_pred             HHHHHHHHHHHHHHHHHhhc--CCeecCCCCHHHEEECCCCCEEEeecCCcccccccccccccCCCccccChhhcChhhc
Confidence            99999999999999999973  2899999999999999999999999999976654332 445799999999996    5


Q ss_pred             CCcceeccCC
Q 046065          155 RGVYYKKFSL  164 (164)
Q Consensus       155 ~~~~~~~~Di  164 (164)
                      +..++.++||
T Consensus       187 ~~~~~~~~Di  196 (290)
T 3fme_A          187 QKGYSVKSDI  196 (290)
T ss_dssp             C--CCHHHHH
T ss_pred             CcCCCcHHHH
Confidence            6677888885

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.95  E-value=4.3e-28  Score=178.61  Aligned_cols=153  Identities=22%  Similarity=0.279  Sum_probs=116.6

Q ss_pred             CCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCc------EEEEEEecCCCChhhhhhCccccccc
Q 046065            5 DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQE------YMLIYEYMPKRSLDYFLFDPIRMLIL   77 (164)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~------~~lv~e~~~~~~L~~~~~~~~~~~~~   77 (164)
                      ++..+|+|.+......    ..+|+.+++.++||||+++ ..+.....      .++||||++++.+............+
T Consensus        63 ~~~~~aikk~~~~~~~----~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~  138 (394)
T 4e7w_A           63 ESDEVAIKKVLQDKRF----KNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTM  138 (394)
T ss_dssp             TTEEEEEEEEECCTTS----CCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEEHHHHHHHHHHTTSCC
T ss_pred             CCCeEEEEEEecCcch----HHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCccHHHHHHHHHhhcCCC
Confidence            3456898887544221    2369999999999999998 55544322      77999999864433322211112338


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeec-CCCCeEEccccchhhhhhh-hhhhhcccccccCcceecC
Q 046065           78 DCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLD-EDLKPKISDFGLARILRKM-ILKQIQIELGYIPPEYVGR  155 (164)
Q Consensus        78 ~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~-~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~~  155 (164)
                      +...+..++.|++.||.|||+.   +|+||||||+||+++ .++.+||+|||++...... ......+|+.|+|||++.+
T Consensus       139 ~~~~~~~~~~qi~~aL~~LH~~---~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~  215 (394)
T 4e7w_A          139 PMLLIKLYMYQLLRSLAYIHSI---GICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFG  215 (394)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTT
T ss_pred             CHHHHHHHHHHHHHHHHHHHHC---CccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCCCcccccCcCccCHHHHcC
Confidence            8999999999999999999998   999999999999999 7899999999999765432 2345678999999999865


Q ss_pred             C-cceeccCC
Q 046065          156 G-VYYKKFSL  164 (164)
Q Consensus       156 ~-~~~~~~Di  164 (164)
                      . .|+.++||
T Consensus       216 ~~~~~~~~Di  225 (394)
T 4e7w_A          216 ATNYTTNIDI  225 (394)
T ss_dssp             CSSCCTHHHH
T ss_pred             CCCCCcHHHH
Confidence            4 58988885

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.95  E-value=1e-27  Score=178.46  Aligned_cols=152  Identities=25%  Similarity=0.279  Sum_probs=116.1

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      .+++.||||.+.....   ..+.+|+.+++.+ +||||+++ +.+......++|||+++ ++|.+++......  .....
T Consensus        46 ~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~~~~--~~~~~  119 (432)
T 3p23_A           46 FDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFA--HLGLE  119 (432)
T ss_dssp             SSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHSSSCC--CCSSC
T ss_pred             eCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHhcCCC--ccchh
Confidence            4688999999864422   2356899999999 79999998 66777778899999996 5998888764321  34445


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecC-----CCCeEEccccchhhhhhh-----hhhhhcccccccCcc
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE-----DLKPKISDFGLARILRKM-----ILKQIQIELGYIPPE  151 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~-----~~~~~l~dfg~~~~~~~~-----~~~~~~~~~~~~aPE  151 (164)
                      ...++.|++.||.|||+.   +|+||||||+||+++.     ...++|+|||++......     ......||+.|+|||
T Consensus       120 ~~~i~~qi~~aL~~LH~~---~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE  196 (432)
T 3p23_A          120 PITLLQQTTSGLAHLHSL---NIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPE  196 (432)
T ss_dssp             HHHHHHHHHHHHHHHHHT---TCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGG
T ss_pred             HHHHHHHHHHHHHHHHHC---cCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChh
Confidence            678999999999999998   9999999999999953     235789999999766432     224567999999999


Q ss_pred             eec---CCcceeccCC
Q 046065          152 YVG---RGVYYKKFSL  164 (164)
Q Consensus       152 ~~~---~~~~~~~~Di  164 (164)
                      ++.   ...++.++||
T Consensus       197 ~l~~~~~~~~t~~~Di  212 (432)
T 3p23_A          197 MLSEDCKENPTYTVDI  212 (432)
T ss_dssp             GTSCC---CCCTHHHH
T ss_pred             hhhcccccCCCcHHHH
Confidence            996   4566778875

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.95  E-value=1.3e-27  Score=172.05  Aligned_cols=154  Identities=18%  Similarity=0.228  Sum_probs=126.5

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCc------eeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccc
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLN------LIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLI   76 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~------i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~   76 (164)
                      .+++.||+|.+... ......+.+|+.+++.++|++      ++++ ..+...+..++|||++ +++|.+++..... ..
T Consensus        38 ~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~-~~  114 (339)
T 1z57_A           38 AGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGF-LP  114 (339)
T ss_dssp             TTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTT-CC
T ss_pred             CCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhcCC-CC
Confidence            46789999998643 334566788999999887654      8886 7777788899999999 8899888865432 23


Q ss_pred             cCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecC-------------------CCCeEEccccchhhhhhhh
Q 046065           77 LDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE-------------------DLKPKISDFGLARILRKMI  137 (164)
Q Consensus        77 ~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~-------------------~~~~~l~dfg~~~~~~~~~  137 (164)
                      ++...+..++.|++.||.|+|++   +++|+||||+||+++.                   ++.++|+|||++..... .
T Consensus       115 ~~~~~~~~~~~qi~~~l~~lH~~---~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~-~  190 (339)
T 1z57_A          115 FRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDE-H  190 (339)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTS-C
T ss_pred             CcHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCcc-c
Confidence            78899999999999999999998   9999999999999987                   66799999999875432 2


Q ss_pred             hhhhcccccccCcceecCCcceeccCC
Q 046065          138 LKQIQIELGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       138 ~~~~~~~~~~~aPE~~~~~~~~~~~Di  164 (164)
                      .....||+.|+|||++.+..++.++||
T Consensus       191 ~~~~~gt~~y~aPE~~~~~~~~~~~Di  217 (339)
T 1z57_A          191 HSTLVSTRHYRAPEVILALGWSQPCDV  217 (339)
T ss_dssp             CCSSCSCGGGCCHHHHTTSCCCTHHHH
T ss_pred             cccccCCccccChHHhhCCCCCcchhh
Confidence            345678999999999998899999985

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.95  E-value=5.6e-28  Score=179.96  Aligned_cols=154  Identities=24%  Similarity=0.275  Sum_probs=115.1

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccccc----cc
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRML----IL   77 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~----~~   77 (164)
                      .+|+.||||.+..+   ..+.+..|+.+++.+ +||||+++ +.+......++|||+++ ++|.+++.......    ..
T Consensus        37 ~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~  112 (434)
T 2rio_A           37 FQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQ  112 (434)
T ss_dssp             SSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC----------
T ss_pred             ECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhc
Confidence            46889999998643   234567899999876 89999998 66666778899999996 69999987643211    01


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCC-------------CCeEEccccchhhhhhhh------h
Q 046065           78 DCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED-------------LKPKISDFGLARILRKMI------L  138 (164)
Q Consensus        78 ~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~-------------~~~~l~dfg~~~~~~~~~------~  138 (164)
                      +......++.|++.||.|||++   +|+|+||||+||+++..             +.++|+|||++.......      .
T Consensus       113 ~~~~~~~i~~qi~~aL~~LH~~---~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~  189 (434)
T 2rio_A          113 KEYNPISLLRQIASGVAHLHSL---KIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNL  189 (434)
T ss_dssp             --CCHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC---------
T ss_pred             cchhHHHHHHHHHHHHHHHHHC---CccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeee
Confidence            2334567999999999999998   99999999999999754             479999999997664321      2


Q ss_pred             hhhcccccccCcceecC-------CcceeccCC
Q 046065          139 KQIQIELGYIPPEYVGR-------GVYYKKFSL  164 (164)
Q Consensus       139 ~~~~~~~~~~aPE~~~~-------~~~~~~~Di  164 (164)
                      ....||+.|+|||++.+       ..++.++||
T Consensus       190 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Di  222 (434)
T 2rio_A          190 NNPSGTSGWRAPELLEESNNLQTKRRLTRSIDI  222 (434)
T ss_dssp             -----CCTTSCHHHHSCCCTTSCCCCCCTHHHH
T ss_pred             cCCCCCCCccCHHHhccccccccccCcchhhhh
Confidence            34679999999999965       678888885

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.95  E-value=2.9e-28  Score=174.92  Aligned_cols=156  Identities=22%  Similarity=0.334  Sum_probs=128.6

Q ss_pred             cCCCcEEEEEEccccccc------cHHHHHHHHHHHhccC--CCceeeE-eEEeeCCcEEEEEEecCC-CChhhhhhCcc
Q 046065            3 LPDGQIIAVKKLSKKSTQ------GFEEFKNEVMLTAKLQ--HLNLIRV-GFCIETQEYMLIYEYMPK-RSLDYFLFDPI   72 (164)
Q Consensus         3 ~~~~~~vavK~~~~~~~~------~~~~~~~e~~~l~~l~--h~~i~~~-~~~~~~~~~~lv~e~~~~-~~L~~~~~~~~   72 (164)
                      ..+++.||+|.+......      ....+..|+.+++.+.  |+||+++ +.+...+..++|+|++.+ ++|.+++....
T Consensus        65 ~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~  144 (320)
T 3a99_A           65 VSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG  144 (320)
T ss_dssp             TTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHC
T ss_pred             CCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccC
Confidence            357889999998654211      2245678999999995  5999997 777777888999999876 89998887533


Q ss_pred             cccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeec-CCCCeEEccccchhhhhhhhhhhhcccccccCcc
Q 046065           73 RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLD-EDLKPKISDFGLARILRKMILKQIQIELGYIPPE  151 (164)
Q Consensus        73 ~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE  151 (164)
                      .   ++......++.|++.||.|||+.   +++|+||||+||+++ .++.++|+|||++............|++.|+|||
T Consensus       145 ~---l~~~~~~~i~~qi~~~L~~LH~~---~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~~~~~~gt~~y~aPE  218 (320)
T 3a99_A          145 A---LQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE  218 (320)
T ss_dssp             S---CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCCTTCEECCSSCBCCCCSCGGGSCHH
T ss_pred             C---CCHHHHHHHHHHHHHHHHHHHHC---CcEeCCCCHHHEEEeCCCCCEEEeeCccccccccccccCCCCCccCCChH
Confidence            2   88899999999999999999998   999999999999999 6789999999999876655555677999999999


Q ss_pred             eecCCcc-eeccCC
Q 046065          152 YVGRGVY-YKKFSL  164 (164)
Q Consensus       152 ~~~~~~~-~~~~Di  164 (164)
                      ++.+..+ +.++||
T Consensus       219 ~~~~~~~~~~~~Di  232 (320)
T 3a99_A          219 WIRYHRYHGRSAAV  232 (320)
T ss_dssp             HHHHSCBCHHHHHH
T ss_pred             HhccCCCCCccchH
Confidence            9976666 677775

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.95  E-value=1.8e-27  Score=169.41  Aligned_cols=156  Identities=27%  Similarity=0.299  Sum_probs=122.6

Q ss_pred             CCCcEEEEEEccccc----cccHHHHHHHHHHHhccCCCceeeE-eEEe--eCCcEEEEEEecCCCChhhhhhCcccccc
Q 046065            4 PDGQIIAVKKLSKKS----TQGFEEFKNEVMLTAKLQHLNLIRV-GFCI--ETQEYMLIYEYMPKRSLDYFLFDPIRMLI   76 (164)
Q Consensus         4 ~~~~~vavK~~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~--~~~~~~lv~e~~~~~~L~~~~~~~~~~~~   76 (164)
                      .+++.||+|.+....    +.....+.+|+.+++.++||||+++ +.+.  .....++|||+++++ +.+.+.... ...
T Consensus        28 ~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~-~~~  105 (305)
T 2wtk_C           28 ETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVP-EKR  105 (305)
T ss_dssp             TTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHST-TCS
T ss_pred             CCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhCc-ccc
Confidence            467899999986542    3345678899999999999999998 5553  345789999999876 666554422 223


Q ss_pred             cCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh----hhhhhcccccccCcce
Q 046065           77 LDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM----ILKQIQIELGYIPPEY  152 (164)
Q Consensus        77 ~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~~aPE~  152 (164)
                      ++......++.|++.||.|||+.   +++|+||||+||+++.++.++|+|||++......    ......+++.|+|||+
T Consensus       106 ~~~~~~~~~~~qi~~al~~LH~~---~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~  182 (305)
T 2wtk_C          106 FPVCQAHGYFCQLIDGLEYLHSQ---GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEI  182 (305)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHH
T ss_pred             cCHHHHHHHHHHHHHHHHHHHHC---CeeecCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhh
Confidence            88999999999999999999998   9999999999999999999999999998765321    2234568999999999


Q ss_pred             ecCCc--ceeccCC
Q 046065          153 VGRGV--YYKKFSL  164 (164)
Q Consensus       153 ~~~~~--~~~~~Di  164 (164)
                      +.+..  ++.++||
T Consensus       183 ~~~~~~~~~~~~Di  196 (305)
T 2wtk_C          183 ANGLDTFSGFKVDI  196 (305)
T ss_dssp             HTCCSCEESHHHHH
T ss_pred             ccCcccCCcchhhH
Confidence            96543  3667775

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.94  E-value=2.8e-27  Score=178.07  Aligned_cols=153  Identities=21%  Similarity=0.221  Sum_probs=124.5

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCC-ceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHL-NLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      .+++.||||.+.....  ...+..|+.+++.++|+ ++..+ .+.......++|||++ +++|.+++.....  .+++..
T Consensus        30 ~~~~~vAvK~~~~~~~--~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~~~--~l~~~~  104 (483)
T 3sv0_A           30 QTNEEVAIKLENVKTK--HPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSR--KLSLKT  104 (483)
T ss_dssp             TTCCEEEEEEEETTCS--SCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTT--CCCHHH
T ss_pred             CCCcEEEEEEeccccc--cHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHhhcC--CCCHHH
Confidence            5688999998764422  23478899999999864 45556 4445566788999999 8999999874322  388999


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceee---cCCCCeEEccccchhhhhhhhh---------hhhcccccccC
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL---DEDLKPKISDFGLARILRKMIL---------KQIQIELGYIP  149 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili---~~~~~~~l~dfg~~~~~~~~~~---------~~~~~~~~~~a  149 (164)
                      ++.++.|++.||.|||+.   +|+|+||||+|||+   +..+.++|+|||++..+.....         ....||+.|+|
T Consensus       105 ~~~i~~qi~~aL~yLH~~---gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~a  181 (483)
T 3sv0_A          105 VLMLADQMINRVEFVHSK---SFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYAS  181 (483)
T ss_dssp             HHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCC
T ss_pred             HHHHHHHHHHHHHHHHHC---CEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccC
Confidence            999999999999999998   99999999999999   5788999999999976543221         25679999999


Q ss_pred             cceecCCcceeccCC
Q 046065          150 PEYVGRGVYYKKFSL  164 (164)
Q Consensus       150 PE~~~~~~~~~~~Di  164 (164)
                      ||++.+..++.++||
T Consensus       182 PE~~~~~~~s~~sDv  196 (483)
T 3sv0_A          182 VNTHLGIEQSRRDDL  196 (483)
T ss_dssp             HHHHTTCCCCHHHHH
T ss_pred             HHHhcCCCCChHHHH
Confidence            999999999999986

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.94  E-value=3.2e-28  Score=173.86  Aligned_cols=155  Identities=23%  Similarity=0.333  Sum_probs=123.5

Q ss_pred             CCCcEEEEEEcccccc------ccHHHHHHHHHHHhcc----CCCceeeE-eEEeeCCcEEEEEEe-cCCCChhhhhhCc
Q 046065            4 PDGQIIAVKKLSKKST------QGFEEFKNEVMLTAKL----QHLNLIRV-GFCIETQEYMLIYEY-MPKRSLDYFLFDP   71 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l----~h~~i~~~-~~~~~~~~~~lv~e~-~~~~~L~~~~~~~   71 (164)
                      .+++.||+|.+.....      .....+..|+.++..+    +||||+++ +.+...+..++|+|+ +.+++|.+++...
T Consensus        54 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~  133 (312)
T 2iwi_A           54 TDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEK  133 (312)
T ss_dssp             TTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHH
T ss_pred             cCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhc
Confidence            4688999999865422      1223456788888888    89999998 666667788899999 7889999998764


Q ss_pred             ccccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeec-CCCCeEEccccchhhhhhhhhhhhcccccccCc
Q 046065           72 IRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLD-EDLKPKISDFGLARILRKMILKQIQIELGYIPP  150 (164)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aP  150 (164)
                      ..   +++.....++.|++.||.|+|+.   +++|+||||+||+++ .++.++|+|||++............+++.|+||
T Consensus       134 ~~---~~~~~~~~~~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~y~aP  207 (312)
T 2iwi_A          134 GP---LGEGPSRCFFGQVVAAIQHCHSR---GVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRVYSPP  207 (312)
T ss_dssp             CS---CCHHHHHHHHHHHHHHHHHHHHH---TEECCCCSGGGEEEETTTTEEEECCCSSCEECCSSCBCCCCSCTTTSCH
T ss_pred             CC---CCHHHHHHHHHHHHHHHHHHHHC---CeeecCCChhhEEEeCCCCeEEEEEcchhhhcccCcccccCCcccccCc
Confidence            32   88999999999999999999999   999999999999999 788999999999987665555667789999999


Q ss_pred             ceecCCcc-eeccCC
Q 046065          151 EYVGRGVY-YKKFSL  164 (164)
Q Consensus       151 E~~~~~~~-~~~~Di  164 (164)
                      |++.+..+ +.++||
T Consensus       208 E~~~~~~~~~~~~Di  222 (312)
T 2iwi_A          208 EWISRHQYHALPATV  222 (312)
T ss_dssp             HHHHHSCBCHHHHHH
T ss_pred             eeeecCCCCCccchH
Confidence            99976666 457774

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.94  E-value=2.2e-27  Score=174.25  Aligned_cols=155  Identities=22%  Similarity=0.246  Sum_probs=121.9

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccC--------CCceeeE-eEEe----eCCcEEEEEEecCCCChhhhhhC
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQ--------HLNLIRV-GFCI----ETQEYMLIYEYMPKRSLDYFLFD   70 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~--------h~~i~~~-~~~~----~~~~~~lv~e~~~~~~L~~~~~~   70 (164)
                      .+++.||+|.+... ......+.+|+.+++.++        |+||+++ +.+.    .....++|||++ ++++.+.+..
T Consensus        60 ~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~  137 (397)
T 1wak_A           60 QGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIK  137 (397)
T ss_dssp             TTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHH
T ss_pred             CCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHh
Confidence            56889999998643 334566788999999885        7889997 5444    234688999999 4555555543


Q ss_pred             cccccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCC------------------------------
Q 046065           71 PIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL------------------------------  120 (164)
Q Consensus        71 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~------------------------------  120 (164)
                      .. ...+++..+..++.|++.||.|||+++  +|+||||||+|||++.++                              
T Consensus       138 ~~-~~~~~~~~~~~i~~qi~~aL~~lH~~~--givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  214 (397)
T 1wak_A          138 SN-YQGLPLPCVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAP  214 (397)
T ss_dssp             TT-TSCCCHHHHHHHHHHHHHHHHHHHHTT--CEECCCCSGGGEEECCCHHHHHHHHHHHC-------------------
T ss_pred             cc-cCCCCHHHHHHHHHHHHHHHHHHHHhC--CEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCC
Confidence            21 123889999999999999999999842  799999999999998765                              


Q ss_pred             -------------------CeEEccccchhhhhhhhhhhhcccccccCcceecCCcceeccCC
Q 046065          121 -------------------KPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       121 -------------------~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di  164 (164)
                                         .++|+|||++...... .....||+.|+|||++.+..++.++||
T Consensus       215 ~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~Di  276 (397)
T 1wak_A          215 ATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-FTEDIQTRQYRSLEVLIGSGYNTPADI  276 (397)
T ss_dssp             --CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-SCSCCSCGGGCCHHHHHTSCCCTHHHH
T ss_pred             cccccccccccccccccccceEecccccccccccc-CccCCCCCcccCChhhcCCCCCcHHHH
Confidence                               7999999999765432 345678999999999998899999985

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.94  E-value=4.5e-27  Score=168.04  Aligned_cols=153  Identities=24%  Similarity=0.352  Sum_probs=120.7

Q ss_pred             CCCcEEEEEEcccc--ccccHHHHHHHHHHHhccC--CCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccC
Q 046065            4 PDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQ--HLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILD   78 (164)
Q Consensus         4 ~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~--h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~   78 (164)
                      .+++.||+|.+...  .......+.+|+.+++.++  ||||+++ +.+...+..++||| +.+++|.+++.....   ++
T Consensus        50 ~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~~~~---~~  125 (313)
T 3cek_A           50 EKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKS---ID  125 (313)
T ss_dssp             TTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHHCSS---CC
T ss_pred             CCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCCCcHHHHHHhcCC---CC
Confidence            45789999998654  2334567889999999996  5999997 67777778889999 667899999875432   78


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh----hhhhcccccccCcceec
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI----LKQIQIELGYIPPEYVG  154 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~aPE~~~  154 (164)
                      ......++.|++.||.|+|+.   +++|+||||+||+++. +.++|+|||++.......    .....|++.|+|||.+.
T Consensus       126 ~~~~~~i~~qi~~aL~~LH~~---~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  201 (313)
T 3cek_A          126 PWERKSYWKNMLEAVHTIHQH---GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIK  201 (313)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEEET-TEEEECCCSSSCC--------------CCGGGCCHHHHT
T ss_pred             HHHHHHHHHHHHHHHHHHHHC---CceecCCCcccEEEEC-CeEEEeeccccccccCccccccccCCCCCCCcCCHHHHh
Confidence            889999999999999999998   9999999999999964 889999999997654322    23457899999999986


Q ss_pred             C-----------CcceeccCC
Q 046065          155 R-----------GVYYKKFSL  164 (164)
Q Consensus       155 ~-----------~~~~~~~Di  164 (164)
                      +           ..++.++||
T Consensus       202 ~~~~~~~~~~~~~~~~~~~Di  222 (313)
T 3cek_A          202 DMSSSRENGKSKSKISPKSDV  222 (313)
T ss_dssp             TCC----------CCCHHHHH
T ss_pred             hcccccccccccccCCchHHH
Confidence            5           467888875

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.94  E-value=8.7e-27  Score=167.47  Aligned_cols=158  Identities=26%  Similarity=0.332  Sum_probs=106.6

Q ss_pred             CCCcEEEEEEccccc-cccHHHHHHHHH-HHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCc--ccccccC
Q 046065            4 PDGQIIAVKKLSKKS-TQGFEEFKNEVM-LTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDP--IRMLILD   78 (164)
Q Consensus         4 ~~~~~vavK~~~~~~-~~~~~~~~~e~~-~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~   78 (164)
                      .+++.||+|.+.... ......+..|+. +++.++||||+++ +.+...+..++|||++++ +|.+++...  .....++
T Consensus        45 ~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~  123 (327)
T 3aln_A           45 PSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST-SFDKFYKYVYSVLDDVIP  123 (327)
T ss_dssp             TTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-EHHHHHHHHHHTTCCCCC
T ss_pred             CCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-ChHHHHHHHHhhhcccCc
Confidence            468899999987542 223344555665 7788899999998 777777889999999985 777766531  1122388


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh-hhhcccccccCccee----
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL-KQIQIELGYIPPEYV----  153 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~aPE~~----  153 (164)
                      ......++.|++.|+.|+|+.  .+++|+||||+||+++.++.++|+|||++........ ....|++.|+|||++    
T Consensus       124 ~~~~~~i~~~i~~~l~~lH~~--~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  201 (327)
T 3aln_A          124 EEILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSA  201 (327)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHH--HSCCCSCCCGGGEEEETTTEEEECCCSSSCC--------------------------
T ss_pred             HHHHHHHHHHHHHHHHHHhcc--CCEeECCCCHHHEEEcCCCCEEEccCCCceecccccccccCCCCccccCceeecccc
Confidence            899999999999999999974  2799999999999999999999999999976654322 345789999999998    


Q ss_pred             cCCcceeccCC
Q 046065          154 GRGVYYKKFSL  164 (164)
Q Consensus       154 ~~~~~~~~~Di  164 (164)
                      .+..++.++||
T Consensus       202 ~~~~~~~~~Di  212 (327)
T 3aln_A          202 SRQGYDVRSDV  212 (327)
T ss_dssp             ----CCSHHHH
T ss_pred             CcCCCCchhhH
Confidence            56678888885

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.94  E-value=9.1e-27  Score=166.52  Aligned_cols=155  Identities=23%  Similarity=0.301  Sum_probs=111.5

Q ss_pred             CCCcEEEEEEcccccc-cc-HHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            4 PDGQIIAVKKLSKKST-QG-FEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~-~~-~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      .+++.||+|.+..... .. .+.+.++..+++.++||||+++ +.+...+..++|||++ ++.+..+.....  ..+++.
T Consensus        48 ~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~~~--~~~~~~  124 (318)
T 2dyl_A           48 KTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQ--GPIPER  124 (318)
T ss_dssp             TTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHHHT--SCCCHH
T ss_pred             cCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHHhc--cCCCHH
Confidence            4688999999865422 22 2334445567888899999998 7777778899999999 444544443211  238899


Q ss_pred             HHHHHHHHHHHHHHHhhh-cCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh-hhhhhcccccccCcceec----
Q 046065           81 KRVHIIKGIIQGLLYLQE-YFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM-ILKQIQIELGYIPPEYVG----  154 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~-~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~----  154 (164)
                      ....++.|++.||.|+|+ .   +++|+||||+||+++.++.++|+|||++...... ......+++.|+|||++.    
T Consensus       125 ~~~~~~~~i~~~l~~lH~~~---~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~  201 (318)
T 2dyl_A          125 ILGKMTVAIVKALYYLKEKH---GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDP  201 (318)
T ss_dssp             HHHHHHHHHHHHHHHHHHHH---CCCCCCCCGGGEEECTTSCEEECCCTTC--------------CCTTCCHHHHC----
T ss_pred             HHHHHHHHHHHHHHHHHhhC---CEEeCCCCHHHEEECCCCCEEEEECCCchhccCCccccccCCCccccChhhcccccc
Confidence            999999999999999998 5   8999999999999999999999999998765432 234567899999999994    


Q ss_pred             -CCcceeccCC
Q 046065          155 -RGVYYKKFSL  164 (164)
Q Consensus       155 -~~~~~~~~Di  164 (164)
                       ...++.++||
T Consensus       202 ~~~~~~~~~Di  212 (318)
T 2dyl_A          202 TKPDYDIRADV  212 (318)
T ss_dssp             ----CCTHHHH
T ss_pred             cccCCccccch
Confidence             5567888875

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.94  E-value=1.3e-26  Score=169.96  Aligned_cols=156  Identities=23%  Similarity=0.244  Sum_probs=124.4

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccC-CC-----ceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccc
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQ-HL-----NLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLI   76 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~-----~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~   76 (164)
                      .+++.||||.+... ......+..|+.+++.+. |+     +++++ ..+...+..++|||+++ ++|.+++..... ..
T Consensus        77 ~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~-~~  153 (382)
T 2vx3_A           77 VEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNF-RG  153 (382)
T ss_dssp             TTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTT-SC
T ss_pred             CCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecCC-CCHHHHHhhcCc-CC
Confidence            46789999998643 233456677888888885 55     38887 66777788999999996 599888865321 23


Q ss_pred             cCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeec--CCCCeEEccccchhhhhhhhhhhhcccccccCcceec
Q 046065           77 LDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLD--EDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVG  154 (164)
Q Consensus        77 ~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~--~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~  154 (164)
                      +++.....++.|++.||.|+|+. ..+|+||||||+||+++  .++.+||+|||++..... ......+|+.|+|||++.
T Consensus       154 ~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~-~~~~~~~t~~y~aPE~~~  231 (382)
T 2vx3_A          154 VSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ-RIYQYIQSRFYRSPEVLL  231 (382)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTC-CCCSSCSCGGGCCHHHHT
T ss_pred             CCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCceeccc-ccccccCCccccChHHHc
Confidence            88899999999999999999953 34899999999999995  467899999999976543 234567899999999999


Q ss_pred             CCcceeccCC
Q 046065          155 RGVYYKKFSL  164 (164)
Q Consensus       155 ~~~~~~~~Di  164 (164)
                      +..++.++||
T Consensus       232 ~~~~~~~~Di  241 (382)
T 2vx3_A          232 GMPYDLAIDM  241 (382)
T ss_dssp             TCCCCTHHHH
T ss_pred             CCCCCcHHHH
Confidence            8899999985

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.94  E-value=1.3e-26  Score=167.79  Aligned_cols=152  Identities=18%  Similarity=0.227  Sum_probs=121.7

Q ss_pred             CcEEEEEEccccccccHHHHHHHHHHHhccCCCc------eeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccC
Q 046065            6 GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLN------LIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILD   78 (164)
Q Consensus         6 ~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~------i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~   78 (164)
                      ++.||+|.+... ....+.+..|+.+++.++|++      ++.+ ..+...+..++|||++ ++++.+.+.... ...++
T Consensus        45 ~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~-~~~~~  121 (355)
T 2eu9_A           45 KSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENN-FQPYP  121 (355)
T ss_dssp             TEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT-TCCCC
T ss_pred             ceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEecc-CCChHHHHHhcc-CCCCC
Confidence            368999998643 234456788999999997665      7776 6666778899999999 556666654422 12388


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceee-------------------cCCCCeEEccccchhhhhhhhhh
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL-------------------DEDLKPKISDFGLARILRKMILK  139 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili-------------------~~~~~~~l~dfg~~~~~~~~~~~  139 (164)
                      ...+..++.|++.||.|||++   +++|+||||+||++                   +.++.++|+|||++..... ...
T Consensus       122 ~~~~~~i~~qi~~~L~~lH~~---~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~-~~~  197 (355)
T 2eu9_A          122 LPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE-HHT  197 (355)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTS-CCC
T ss_pred             HHHHHHHHHHHHHHHHHHHHC---CcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCccccccc-ccc
Confidence            999999999999999999998   99999999999999                   5678899999999875432 234


Q ss_pred             hhcccccccCcceecCCcceeccCC
Q 046065          140 QIQIELGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       140 ~~~~~~~~~aPE~~~~~~~~~~~Di  164 (164)
                      ...||+.|+|||++.+..++.++||
T Consensus       198 ~~~gt~~y~aPE~~~~~~~~~~~Di  222 (355)
T 2eu9_A          198 TIVATRHYRPPEVILELGWAQPCDV  222 (355)
T ss_dssp             SSCSCGGGCCHHHHTTCCCCTHHHH
T ss_pred             CCcCCCcccCCeeeecCCCCCccch
Confidence            5678999999999998899999985

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.94  E-value=9.4e-28  Score=171.79  Aligned_cols=152  Identities=27%  Similarity=0.403  Sum_probs=120.9

Q ss_pred             cEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHH
Q 046065            7 QIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRV   83 (164)
Q Consensus         7 ~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~   83 (164)
                      ..+|+|.+...  .....+.+.+|+.+++.++||||+++ +.+...+..++|+|++++++|.+++....  ..++.....
T Consensus        56 ~~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~--~~~~~~~~~  133 (319)
T 2y4i_B           56 GEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAK--IVLDVNKTR  133 (319)
T ss_dssp             SSEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSC--CCCCSHHHH
T ss_pred             CeEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhcC--CCCCHHHHH
Confidence            35899998654  23334567789999999999999997 77777788999999999999999987643  237889999


Q ss_pred             HHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh-------hhhhhhcccccccCcceecC-
Q 046065           84 HIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK-------MILKQIQIELGYIPPEYVGR-  155 (164)
Q Consensus        84 ~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~-------~~~~~~~~~~~~~aPE~~~~-  155 (164)
                      .++.|++.|+.|+|+.   +++|+||||+||+++ ++.++|+|||++.....       .......|++.|+|||++.. 
T Consensus       134 ~i~~qi~~al~~lH~~---~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~  209 (319)
T 2y4i_B          134 QIAQEIVKGMGYLHAK---GILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL  209 (319)
T ss_dssp             HHHHHHHHHHHHHHHT---TCCCCCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCB
T ss_pred             HHHHHHHHHHHHHHhC---CccccCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhc
Confidence            9999999999999998   999999999999998 67899999999765431       11234568899999999964 


Q ss_pred             --------CcceeccCC
Q 046065          156 --------GVYYKKFSL  164 (164)
Q Consensus       156 --------~~~~~~~Di  164 (164)
                              ..++.++||
T Consensus       210 ~~~~~~~~~~~~~~~Di  226 (319)
T 2y4i_B          210 SPDTEEDKLPFSKHSDV  226 (319)
T ss_dssp             SCC--CCCSCCCHHHHH
T ss_pred             cccccccccCCCchhhH
Confidence                    456888875

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.93  E-value=1.2e-26  Score=176.70  Aligned_cols=143  Identities=20%  Similarity=0.164  Sum_probs=114.7

Q ss_pred             CCcEEEEEEcccccc--------ccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccccc
Q 046065            5 DGQIIAVKKLSKKST--------QGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRML   75 (164)
Q Consensus         5 ~~~~vavK~~~~~~~--------~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~   75 (164)
                      .++.+++|.......        ...+++.+|+.+++.++||||+++ .+.......++||||+++++|.+++..     
T Consensus       358 ~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~-----  432 (540)
T 3en9_A          358 LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED-----  432 (540)
T ss_dssp             SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT-----
T ss_pred             CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH-----
Confidence            466788888643311        113457899999999999999975 444566778999999999999998865     


Q ss_pred             ccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh---------hhhhccccc
Q 046065           76 ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI---------LKQIQIELG  146 (164)
Q Consensus        76 ~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~---------~~~~~~~~~  146 (164)
                            ...++.|++.+|.|+|++   +|+||||||+|||++.  .+||+|||+++......         .....||+.
T Consensus       433 ------~~~i~~qi~~aL~~LH~~---gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~  501 (540)
T 3en9_A          433 ------NLDIAYKIGEIVGKLHKN---DVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHH  501 (540)
T ss_dssp             ------CTHHHHHHHHHHHHHHHT---TEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCG
T ss_pred             ------HHHHHHHHHHHHHHHHHC---cCccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCC
Confidence                  357899999999999998   9999999999999998  99999999998764321         246789999


Q ss_pred             ccCcceecC--CcceeccC
Q 046065          147 YIPPEYVGR--GVYYKKFS  163 (164)
Q Consensus       147 ~~aPE~~~~--~~~~~~~D  163 (164)
                      |||||++..  ..|+..+|
T Consensus       502 y~APEv~~~~~~~Y~~~~d  520 (540)
T 3en9_A          502 EKFDEIWERFLEGYKSVYD  520 (540)
T ss_dssp             GGHHHHHHHHHHHHHHHCT
T ss_pred             cCCHHHHHHHHHHHHHHHh
Confidence            999999966  45665555

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.93  E-value=1.9e-26  Score=168.23  Aligned_cols=155  Identities=17%  Similarity=0.207  Sum_probs=122.9

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccC-----------CCceeeE-eEEeeCC----cEEEEEEecCCCChhhh
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQ-----------HLNLIRV-GFCIETQ----EYMLIYEYMPKRSLDYF   67 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~-~~~~~~~----~~~lv~e~~~~~~L~~~   67 (164)
                      .+++.||+|.+... ......+.+|+.+++.+.           ||||+++ +.+...+    ..++|+|++ +++|.++
T Consensus        42 ~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~  119 (373)
T 1q8y_A           42 VNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLAL  119 (373)
T ss_dssp             TTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHH
T ss_pred             CCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHH
Confidence            56889999998643 223456788999888876           7899997 5554432    578999999 8899988


Q ss_pred             hhCcccccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecC------CCCeEEccccchhhhhhhhhhhh
Q 046065           68 LFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE------DLKPKISDFGLARILRKMILKQI  141 (164)
Q Consensus        68 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~------~~~~~l~dfg~~~~~~~~~~~~~  141 (164)
                      +..... ..++...+..++.|++.||.|||+.+  +++|+||||+||+++.      .+.++|+|||++...... ....
T Consensus       120 ~~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~--~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~-~~~~  195 (373)
T 1q8y_A          120 IKKYEH-RGIPLIYVKQISKQLLLGLDYMHRRC--GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH-YTNS  195 (373)
T ss_dssp             HHHTTT-SCCCHHHHHHHHHHHHHHHHHHHHTT--CEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC-CCSC
T ss_pred             HHHhhc-cCCcHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC-CCCC
Confidence            865322 22888999999999999999999831  8999999999999953      347999999999765432 3445


Q ss_pred             cccccccCcceecCCcceeccCC
Q 046065          142 QIELGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       142 ~~~~~~~aPE~~~~~~~~~~~Di  164 (164)
                      .+|+.|+|||++.+..++.++||
T Consensus       196 ~~t~~y~aPE~~~~~~~~~~~Di  218 (373)
T 1q8y_A          196 IQTREYRSPEVLLGAPWGCGADI  218 (373)
T ss_dssp             CSCGGGCCHHHHHTCCCCTHHHH
T ss_pred             CCCccccCcHHHhCCCCCchHhH
Confidence            78999999999998899999985

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.90  E-value=1e-23  Score=149.20  Aligned_cols=121  Identities=7%  Similarity=-0.002  Sum_probs=103.1

Q ss_pred             CCCcEEEEEEccccc---cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKKS---TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+++.||+|.+....   ....+.+.+|+..+..++||||+++ +.+...+..|+||||+++++|.+++...     ...
T Consensus        54 ~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~-----~~~  128 (286)
T 3uqc_A           54 ALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTS-----PSP  128 (286)
T ss_dssp             TTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTTC-----CCH
T ss_pred             CCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhcC-----CCh
Confidence            458899999997552   2334678899999999999999998 7777778899999999999999998643     344


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhh
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARI  132 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~  132 (164)
                      .....++.|++.||.|+|++   +++|+||||+||+++.++.++|++++....
T Consensus       129 ~~~~~i~~ql~~aL~~lH~~---givH~Dikp~NIll~~~g~~kl~~~~~~~~  178 (286)
T 3uqc_A          129 VGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPATMPD  178 (286)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT---TCCCCCCSGGGEEEETTSCEEECSCCCCTT
T ss_pred             HHHHHHHHHHHHHHHHHHHC---CCccCCCCcccEEEcCCCCEEEEeccccCC
Confidence            56788999999999999998   999999999999999999999998776543

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.90  E-value=2.7e-24  Score=159.24  Aligned_cols=156  Identities=17%  Similarity=0.166  Sum_probs=113.1

Q ss_pred             cCCCcEEEEEEccccc---cccHHHHHHHHHHHhccCC-Ccee----------eEeEE------------ee-----CCc
Q 046065            3 LPDGQIIAVKKLSKKS---TQGFEEFKNEVMLTAKLQH-LNLI----------RVGFC------------IE-----TQE   51 (164)
Q Consensus         3 ~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h-~~i~----------~~~~~------------~~-----~~~   51 (164)
                      ..+|+.||||.+....   ....+.+.+|+.+++.+.| .|..          .+...            ..     ...
T Consensus       100 ~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  179 (413)
T 3dzo_A          100 QETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLS  179 (413)
T ss_dssp             TTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC---------------CCS
T ss_pred             cCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCccccccCCCccccccc
Confidence            3578999999987432   2235678899999999976 2111          11000            00     123


Q ss_pred             EEEEEEecCCCChhhhhhCc----ccccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccc
Q 046065           52 YMLIYEYMPKRSLDYFLFDP----IRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDF  127 (164)
Q Consensus        52 ~~lv~e~~~~~~L~~~~~~~----~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~df  127 (164)
                      ++++|+. ..++|.+++...    .....+++.....++.|++.||.|||++   +|+||||||+|||++.++.+||+||
T Consensus       180 ~~~~~~~-~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~iiHrDiKp~NILl~~~~~~kL~DF  255 (413)
T 3dzo_A          180 RFFLYPR-MQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGF  255 (413)
T ss_dssp             EEEEEEC-CSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCG
T ss_pred             eEEEeeh-hcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhC---CcccCCcccceEEEecCCeEEEEec
Confidence            5566665 467898887421    1122367778889999999999999998   9999999999999999999999999


Q ss_pred             cchhhhhhhhhhhhcccccccCccee----------cCCcceeccCC
Q 046065          128 GLARILRKMILKQIQIELGYIPPEYV----------GRGVYYKKFSL  164 (164)
Q Consensus       128 g~~~~~~~~~~~~~~~~~~~~aPE~~----------~~~~~~~~~Di  164 (164)
                      |+++..... ....+| +.|+|||++          .+..++.++||
T Consensus       256 G~a~~~~~~-~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~Dv  300 (413)
T 3dzo_A          256 EHLVRDGAS-AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDT  300 (413)
T ss_dssp             GGCEETTEE-ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHH
T ss_pred             cceeecCCc-cccCCC-CceeCchhhhccccccccccCcCCCchhhH
Confidence            998765433 345567 999999999          66678888885

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.90  E-value=2.9e-23  Score=147.54  Aligned_cols=122  Identities=23%  Similarity=0.309  Sum_probs=101.5

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHH-hccCCCceeeE-eEEee----CCcEEEEEEecCCCChhhhhhCccccccc
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLT-AKLQHLNLIRV-GFCIE----TQEYMLIYEYMPKRSLDYFLFDPIRMLIL   77 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l-~~l~h~~i~~~-~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~~   77 (164)
                      .+++.||+|.+...     ..+.+|+.++ +..+||||+++ +.+..    ....++|||++++++|.+++..... ..+
T Consensus        41 ~~~~~vaiK~~~~~-----~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~  114 (299)
T 3m2w_A           41 RTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD-QAF  114 (299)
T ss_dssp             TTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTT-CCC
T ss_pred             CCCcEEEEEEeccc-----HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccC-CCC
Confidence            56889999998532     3467788877 55689999997 55544    4568899999999999999876332 238


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecC---CCCeEEccccchhhhh
Q 046065           78 DCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE---DLKPKISDFGLARILR  134 (164)
Q Consensus        78 ~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~---~~~~~l~dfg~~~~~~  134 (164)
                      ++.....++.|++.||.|+|+.   +++|+||||+||+++.   ++.++|+|||++....
T Consensus       115 ~~~~~~~i~~qi~~~l~~lH~~---~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  171 (299)
T 3m2w_A          115 TEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT  171 (299)
T ss_dssp             BHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT
T ss_pred             CHHHHHHHHHHHHHHHHHHHhC---CcccCCCCHHHEEEecCCCCCcEEEeccccccccc
Confidence            8999999999999999999998   9999999999999998   7889999999986543

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.87  E-value=8.8e-23  Score=144.15  Aligned_cols=123  Identities=18%  Similarity=0.088  Sum_probs=93.7

Q ss_pred             CCCcEEEEEEcccccc------------------ccHHHHHHHHHHHhccCCCceeeEeEEeeCCcEEEEEEecCCCChh
Q 046065            4 PDGQIIAVKKLSKKST------------------QGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLD   65 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~------------------~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~   65 (164)
                      .+|+.||+|.+.....                  .....+.+|+.+++.++  | +++..+...+..++|||++++++|.
T Consensus       112 ~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~~~~~~~lvmE~~~g~~L~  188 (282)
T 1zar_A          112 EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVYAWEGNAVLMELIDAKELY  188 (282)
T ss_dssp             TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEEEEETTEEEEECCCCEEGG
T ss_pred             CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEEeccceEEEEEecCCCcHH
Confidence            4688999999864321                  12346789999999998  4 4542233446679999999999998


Q ss_pred             hhhhCcccccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccc
Q 046065           66 YFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIEL  145 (164)
Q Consensus        66 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  145 (164)
                      + +..         .....++.|++.|+.++|+.   +++|+||||+|||++ ++.++|+|||++...           .
T Consensus       189 ~-l~~---------~~~~~i~~qi~~~l~~lH~~---giiHrDlkp~NILl~-~~~vkl~DFG~a~~~-----------~  243 (282)
T 1zar_A          189 R-VRV---------ENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVS-EEGIWIIDFPQSVEV-----------G  243 (282)
T ss_dssp             G-CCC---------SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEE-TTEEEECCCTTCEET-----------T
T ss_pred             H-cch---------hhHHHHHHHHHHHHHHHHHC---CCEeCCCCHHHEEEE-CCcEEEEECCCCeEC-----------C
Confidence            8 421         12346899999999999998   999999999999999 999999999998642           3


Q ss_pred             cccCcceec
Q 046065          146 GYIPPEYVG  154 (164)
Q Consensus       146 ~~~aPE~~~  154 (164)
                      .++|||.+.
T Consensus       244 ~~~a~e~l~  252 (282)
T 1zar_A          244 EEGWREILE  252 (282)
T ss_dssp             STTHHHHHH
T ss_pred             CCCHHHHHH
Confidence            456677664

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.75  E-value=4.1e-18  Score=118.79  Aligned_cols=98  Identities=18%  Similarity=0.166  Sum_probs=74.5

Q ss_pred             HHHHHHHHHhccCCCceeeEeEEeeCCcEEEEEEecCC-C----ChhhhhhCcccccccCHHHHHHHHHHHHHHHHHhh-
Q 046065           24 EFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPK-R----SLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQ-   97 (164)
Q Consensus        24 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~-~----~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~lh-   97 (164)
                      ++..|+..+..+.|+++.....+.. ...++||||+.+ |    +|.+....      .++.....++.|++.++.++| 
T Consensus       116 ~~~~E~~~l~~l~~~~i~~p~~~~~-~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~  188 (258)
T 1zth_A          116 WTEKEFRNLERAKEAGVSVPQPYTY-MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQ  188 (258)
T ss_dssp             HHHHHHHHHHHHHHTTCCCCCEEEE-ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCCeEEEc-CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHH
Confidence            5788999999998876533322221 356899999942 3    45444321      224456788999999999999 


Q ss_pred             hcCCCCeeeCCCCCCceeecCCCCeEEccccchhhh
Q 046065           98 EYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARIL  133 (164)
Q Consensus        98 ~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~  133 (164)
                      ..   +++|+|+||+|||++.  .++|+|||++...
T Consensus       189 ~~---givHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          189 EA---ELVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             TS---CEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             HC---CEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence            87   9999999999999988  8999999998654

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.53  E-value=4.2e-15  Score=108.51  Aligned_cols=115  Identities=15%  Similarity=0.143  Sum_probs=76.5

Q ss_pred             CCCcEEEEEEccccc--------------cccHHHH--------HHHHHHHhccCCCceeeEeEEeeCCcEEEEEEecCC
Q 046065            4 PDGQIIAVKKLSKKS--------------TQGFEEF--------KNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPK   61 (164)
Q Consensus         4 ~~~~~vavK~~~~~~--------------~~~~~~~--------~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~   61 (164)
                      ++|+.||||++....              ......+        ..|...+..+.+.++.-...+. ....++||||+++
T Consensus       117 ~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~vp~p~~-~~~~~LVME~i~G  195 (397)
T 4gyi_A          117 EKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPVPEPIA-QSRHTIVMSLVDA  195 (397)
T ss_dssp             TTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSCCCEEE-EETTEEEEECCSC
T ss_pred             CCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCCCeeee-ccCceEEEEecCC
Confidence            578999999875320              0011112        2355555555443332221111 1234799999998


Q ss_pred             CChhhhhhCcccccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCC----------CeEEccccchh
Q 046065           62 RSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL----------KPKISDFGLAR  131 (164)
Q Consensus        62 ~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~----------~~~l~dfg~~~  131 (164)
                      ++|.++..       .  .....++.|++.++.++|.+   +++||||||.|||++.++          .+.|+||+-+-
T Consensus       196 ~~L~~l~~-------~--~~~~~l~~qll~~l~~lH~~---gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V  263 (397)
T 4gyi_A          196 LPMRQVSS-------V--PDPASLYADLIALILRLAKH---GLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMV  263 (397)
T ss_dssp             EEGGGCCC-------C--SCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCE
T ss_pred             ccHhhhcc-------c--HHHHHHHHHHHHHHHHHHHC---CCcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCcc
Confidence            88865532       1  22356789999999999998   999999999999998765          37899999653

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.34  E-value=7.6e-12  Score=86.98  Aligned_cols=120  Identities=16%  Similarity=0.082  Sum_probs=86.3

Q ss_pred             CCcEEEEEEccccccccHHHHHHHHHHHhccC-CCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            5 DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQ-HLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      +++.+++|............+.+|+.+++.+. +..+.++ ......+..|+|||+++|.++.+....        ....
T Consensus        36 ~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~~--------~~~~  107 (263)
T 3tm0_A           36 ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED--------EQSP  107 (263)
T ss_dssp             SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCCT--------TTCH
T ss_pred             CCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhccCC--------cccH
Confidence            36789999976432223345788999999884 5666666 555566788999999999888765321        1122


Q ss_pred             HHHHHHHHHHHHHhhhcC--------------------------------------------------------CCCeee
Q 046065           83 VHIIKGIIQGLLYLQEYF--------------------------------------------------------RLTIIH  106 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~--------------------------------------------------------~~~iih  106 (164)
                      ..++.+++.++..+|+..                                                        ...++|
T Consensus       108 ~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~H  187 (263)
T 3tm0_A          108 EKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSH  187 (263)
T ss_dssp             HHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEEC
T ss_pred             HHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEEC
Confidence            356778888888888710                                                        135899


Q ss_pred             CCCCCCceeecCCCCeEEccccchhh
Q 046065          107 RDLKVSNILLDEDLKPKISDFGLARI  132 (164)
Q Consensus       107 ~dlk~~nili~~~~~~~l~dfg~~~~  132 (164)
                      +|++|.||+++..+.+.|+||+.+..
T Consensus       188 gDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          188 GDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             SSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             CCCCcCcEEEECCcEEEEEEchhccc
Confidence            99999999998765567999998753

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.14  E-value=2.3e-10  Score=79.10  Aligned_cols=115  Identities=17%  Similarity=0.179  Sum_probs=76.8

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCce--eeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNL--IRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i--~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      .+|+.+++|.....   ....+..|+.+++.+.+.++  .++ ......+..++|||++++.++.  ...      ..  
T Consensus        42 ~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~~------~~--  108 (264)
T 1nd4_A           42 QGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SSH------LA--  108 (264)
T ss_dssp             TTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TSC------CC--
T ss_pred             CCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cCc------CC--
Confidence            34677899986433   22457789999988854343  445 4444456789999999998874  211      11  


Q ss_pred             HHHHHHHHHHHHHHHhhhcC-------------------------------------------------------CCCee
Q 046065           81 KRVHIIKGIIQGLLYLQEYF-------------------------------------------------------RLTII  105 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~-------------------------------------------------------~~~ii  105 (164)
                       ...++.+++..+..+|+..                                                       ...++
T Consensus       109 -~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~  187 (264)
T 1nd4_A          109 -PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVT  187 (264)
T ss_dssp             -HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEE
T ss_pred             -HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEE
Confidence             1234455666666666531                                                       12399


Q ss_pred             eCCCCCCceeecCCCCeEEccccchhh
Q 046065          106 HRDLKVSNILLDEDLKPKISDFGLARI  132 (164)
Q Consensus       106 h~dlk~~nili~~~~~~~l~dfg~~~~  132 (164)
                      |+|++|.||+++.++.+.++||+.+..
T Consensus       188 HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          188 HGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             CSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             CCCCCCCcEEEECCcEEEEEcchhccc
Confidence            999999999998776667999998753

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.99  E-value=4e-09  Score=76.48  Aligned_cols=122  Identities=15%  Similarity=0.232  Sum_probs=82.1

Q ss_pred             CcEEEEEEcc--ccc-cccHHHHHHHHHHHhccCC--CceeeE-eEEeeC---CcEEEEEEecCCCChhhhhhCcccccc
Q 046065            6 GQIIAVKKLS--KKS-TQGFEEFKNEVMLTAKLQH--LNLIRV-GFCIET---QEYMLIYEYMPKRSLDYFLFDPIRMLI   76 (164)
Q Consensus         6 ~~~vavK~~~--~~~-~~~~~~~~~e~~~l~~l~h--~~i~~~-~~~~~~---~~~~lv~e~~~~~~L~~~~~~~~~~~~   76 (164)
                      +..+++|...  ... ......+.+|+.+++.+..  ..+.++ ..+...   +..|+|||++++..+.+...     ..
T Consensus        61 ~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~~~-----~~  135 (359)
T 3dxp_A           61 GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQSL-----PG  135 (359)
T ss_dssp             SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCTTC-----TT
T ss_pred             CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCCcc-----cc
Confidence            3567777754  221 1123457789999999863  445555 444433   34789999999877743211     11


Q ss_pred             cCHHHHHHHHHHHHHHHHHhhhcC-------------------------------------------------------C
Q 046065           77 LDCKKRVHIIKGIIQGLLYLQEYF-------------------------------------------------------R  101 (164)
Q Consensus        77 ~~~~~~~~~~~~~~~~l~~lh~~~-------------------------------------------------------~  101 (164)
                      ++......+..+++..|..+|+..                                                       .
T Consensus       136 l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~  215 (359)
T 3dxp_A          136 MSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADL  215 (359)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSC
T ss_pred             CCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCC
Confidence            566677778888999999998731                                                       2


Q ss_pred             CCeeeCCCCCCceeecCCCC--eEEccccchhh
Q 046065          102 LTIIHRDLKVSNILLDEDLK--PKISDFGLARI  132 (164)
Q Consensus       102 ~~iih~dlk~~nili~~~~~--~~l~dfg~~~~  132 (164)
                      ..++|+|+++.||+++.++.  +.++||+.+..
T Consensus       216 ~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          216 TSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             CEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             ceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence            46899999999999987653  68999998764

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.41  E-value=1.4e-06  Score=61.65  Aligned_cols=119  Identities=23%  Similarity=0.246  Sum_probs=72.7

Q ss_pred             cEEEEEEccccccccHHHHHHHHHHHhcc-CCCce--eeEeEEee-CC---cEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            7 QIIAVKKLSKKSTQGFEEFKNEVMLTAKL-QHLNL--IRVGFCIE-TQ---EYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         7 ~~vavK~~~~~~~~~~~~~~~e~~~l~~l-~h~~i--~~~~~~~~-~~---~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      ..+++|.....  .....+..|+.+++.+ .+..+  .++..... ..   ..|+||++++|.++......     .++.
T Consensus        41 ~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~~-----~l~~  113 (304)
T 3sg8_A           41 RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLLN-----NLPK  113 (304)
T ss_dssp             TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHHH-----TSCH
T ss_pred             CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCccccc-----cCCH
Confidence            35677774322  2345678899999887 34333  22322222 22   34789999999777542211     1344


Q ss_pred             HHHHHHHHHHHHHHHHhhhc-------------------------------------------------------CCCCe
Q 046065           80 KKRVHIIKGIIQGLLYLQEY-------------------------------------------------------FRLTI  104 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~-------------------------------------------------------~~~~i  104 (164)
                      .....++.+++..+..+|+.                                                       ....+
T Consensus       114 ~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~  193 (304)
T 3sg8_A          114 QSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCL  193 (304)
T ss_dssp             HHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEE
T ss_pred             HHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCcee
Confidence            44445555555555555531                                                       12358


Q ss_pred             eeCCCCCCceeecC--CCCeEEccccchhh
Q 046065          105 IHRDLKVSNILLDE--DLKPKISDFGLARI  132 (164)
Q Consensus       105 ih~dlk~~nili~~--~~~~~l~dfg~~~~  132 (164)
                      +|+|++|.|++++.  ...+.++||+.+..
T Consensus       194 ~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~  223 (304)
T 3sg8_A          194 IHNDFSSDHILFDTEKNTICGIIDFGDAAI  223 (304)
T ss_dssp             ECSCCCGGGEEEETTTTEEEEECCCTTCEE
T ss_pred             EeCCCCcccEEEeCCCCCEEEEEeCCCCcc
Confidence            99999999999988  45678999998753

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.38  E-value=6.2e-06  Score=57.22  Aligned_cols=117  Identities=16%  Similarity=0.176  Sum_probs=71.3

Q ss_pred             CcEEEEEEccccccccHHHHHHHHHHHhccC-CCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHH
Q 046065            6 GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQ-HLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRV   83 (164)
Q Consensus         6 ~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~   83 (164)
                      +..+.+|.-.   +.....+..|...++.+. +-.+.++ ..+...+..++|||++++.++.+......       ....
T Consensus        50 ~~~~~lk~~~---~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~~-------~~~~  119 (272)
T 4gkh_A           50 APELFLKHGK---GSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEYP-------DSGE  119 (272)
T ss_dssp             CCCEEEEEEE---THHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHCG-------GGHH
T ss_pred             CeEEEEEECC---CCCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCCH-------HHHH
Confidence            4567777743   223345778999988884 3334454 55566778899999999877654432100       0111


Q ss_pred             HHHHHHHHHHHHhhhc---------------------------------------------------C----CCCeeeCC
Q 046065           84 HIIKGIIQGLLYLQEY---------------------------------------------------F----RLTIIHRD  108 (164)
Q Consensus        84 ~~~~~~~~~l~~lh~~---------------------------------------------------~----~~~iih~d  108 (164)
                      .+..++...+..||..                                                   .    ...++|+|
T Consensus       120 ~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGD  199 (272)
T 4gkh_A          120 NIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGD  199 (272)
T ss_dssp             HHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSC
T ss_pred             HHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCC
Confidence            1222222222223221                                                   0    12379999


Q ss_pred             CCCCceeecCCCCeEEccccchhh
Q 046065          109 LKVSNILLDEDLKPKISDFGLARI  132 (164)
Q Consensus       109 lk~~nili~~~~~~~l~dfg~~~~  132 (164)
                      +.+.|+|++..+.+-|+||+.+..
T Consensus       200 l~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          200 FSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             CCTTSEEEETTEEEEECCCTTCEE
T ss_pred             CCCCeEEEECCeEEEEEECccccc
Confidence            999999998877677999998753

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.34  E-value=6.8e-06  Score=58.33  Aligned_cols=59  Identities=17%  Similarity=0.099  Sum_probs=37.0

Q ss_pred             CcEEEEEEccccccccHHHHHHHHHHHhccCCC---ceeeE-eEEe-eCCcEEEEEEecCCCChhh
Q 046065            6 GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHL---NLIRV-GFCI-ETQEYMLIYEYMPKRSLDY   66 (164)
Q Consensus         6 ~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~---~i~~~-~~~~-~~~~~~lv~e~~~~~~L~~   66 (164)
                      +..+++|+-.  .+.....+..|+.+++.+.+.   .+.++ .... ..+..+++||+++|.++..
T Consensus        39 g~~~VlR~~~--~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~  102 (306)
T 3tdw_A           39 NGDWVFRFPK--SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGE  102 (306)
T ss_dssp             TTTEEEEEES--SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHH
T ss_pred             CCEEEEEecC--CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECch
Confidence            3456777732  222345678999999998642   23333 2222 2345789999999877754

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.92  E-value=6e-05  Score=54.38  Aligned_cols=30  Identities=17%  Similarity=0.298  Sum_probs=25.3

Q ss_pred             CCeeeCCCCCCceeecCCCCeEEccccchh
Q 046065          102 LTIIHRDLKVSNILLDEDLKPKISDFGLAR  131 (164)
Q Consensus       102 ~~iih~dlk~~nili~~~~~~~l~dfg~~~  131 (164)
                      ..++|+|+.+.||+++....+.|+||+.+.
T Consensus       222 ~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~  251 (357)
T 3ats_A          222 PVLLWGDARVGNVLYRDFQPVAVLDWEMVA  251 (357)
T ss_dssp             CEEECSSCSGGGEEEETTEEEEECCGGGCE
T ss_pred             ceEEeCCCCCCeEEEeCCcEEEEEcccccc
Confidence            478999999999999854457899999875

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.24  E-value=0.0005  Score=50.32  Aligned_cols=30  Identities=33%  Similarity=0.378  Sum_probs=25.0

Q ss_pred             CCCeeeCCCCCCceeecCCCCeEEccccchh
Q 046065          101 RLTIIHRDLKVSNILLDEDLKPKISDFGLAR  131 (164)
Q Consensus       101 ~~~iih~dlk~~nili~~~~~~~l~dfg~~~  131 (164)
                      ...++|+|+.+.||+++.++ +.++||..+.
T Consensus       226 ~~~L~HGDl~~~Nil~~~~~-~~lID~e~a~  255 (397)
T 2olc_A          226 AETLIHGDLHTGSIFASEHE-TKVIDPEFAF  255 (397)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCE
T ss_pred             CCceeeCCCCcCcEEEeCCC-eEEEeCcccc
Confidence            34799999999999997654 8999997654

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.15  E-value=0.0029  Score=44.18  Aligned_cols=61  Identities=20%  Similarity=0.117  Sum_probs=37.4

Q ss_pred             cCCCcEEEEEEccccccccHHHHHHHHHHHhccCCC-ceeeEeEEeeCCcEEEEEEecCCCCh
Q 046065            3 LPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHL-NLIRVGFCIETQEYMLIYEYMPKRSL   64 (164)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~-~i~~~~~~~~~~~~~lv~e~~~~~~L   64 (164)
                      +.||+.|.+|.-....+.....+..|+..|+.+.-. .+.-...+.. +..++|||+++++..
T Consensus        36 l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~-~~~~lv~e~l~~~~~   97 (288)
T 3f7w_A           36 LADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW-DDRTLAMEWVDERPP   97 (288)
T ss_dssp             ETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE-ETTEEEEECCCCCCC
T ss_pred             ECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec-cCceEEEEeecccCC
Confidence            578999999986544444444577899999888422 2221211111 234688999876543

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.10  E-value=0.0083  Score=42.67  Aligned_cols=57  Identities=23%  Similarity=0.166  Sum_probs=38.3

Q ss_pred             CCcEEEEEEccccccccHHHHHHHHHHHhccC-C--CceeeE-eEEeeCCcEEEEEEecCCCCh
Q 046065            5 DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQ-H--LNLIRV-GFCIETQEYMLIYEYMPKRSL   64 (164)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h--~~i~~~-~~~~~~~~~~lv~e~~~~~~L   64 (164)
                      ++..+++|.....   ....+..|+..++.+. .  ..++++ ......+..++|||++++..+
T Consensus        58 ~~~~~vlK~~~~~---~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~  118 (312)
T 3jr1_A           58 EVQTVFVKINERS---YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN  118 (312)
T ss_dssp             SSCEEEEEEEEGG---GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred             CCCeEEEEeCCcc---cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence            3567888875432   3456788999888884 2  345554 444445678999999988654

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.08  E-value=0.0027  Score=45.29  Aligned_cols=32  Identities=25%  Similarity=0.496  Sum_probs=26.9

Q ss_pred             CCCeeeCCCCCCceeecCC----CCeEEccccchhh
Q 046065          101 RLTIIHRDLKVSNILLDED----LKPKISDFGLARI  132 (164)
Q Consensus       101 ~~~iih~dlk~~nili~~~----~~~~l~dfg~~~~  132 (164)
                      ...++|+|+.+.|+|++.+    +.+.++||+.+..
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            4579999999999999874    6789999998753

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.99  E-value=0.0035  Score=44.09  Aligned_cols=29  Identities=28%  Similarity=0.290  Sum_probs=24.8

Q ss_pred             CCeeeCCCCCCceeecCCCCeEEccccchh
Q 046065          102 LTIIHRDLKVSNILLDEDLKPKISDFGLAR  131 (164)
Q Consensus       102 ~~iih~dlk~~nili~~~~~~~l~dfg~~~  131 (164)
                      ..++|+|+.+.|++ ..++.+.++||..+.
T Consensus       173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~  201 (301)
T 3dxq_A          173 LAACHCDPLCENFL-DTGERMWIVDWEYSG  201 (301)
T ss_dssp             CEEECSCCCGGGEE-ECSSCEEECCCTTCE
T ss_pred             ceeeccCCCcCCEE-ECCCCEEEEeccccc
Confidence            45899999999999 566778999998775

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.86  E-value=0.0052  Score=44.92  Aligned_cols=31  Identities=26%  Similarity=0.383  Sum_probs=27.0

Q ss_pred             CCeeeCCCCCCceeecCC----CCeEEccccchhh
Q 046065          102 LTIIHRDLKVSNILLDED----LKPKISDFGLARI  132 (164)
Q Consensus       102 ~~iih~dlk~~nili~~~----~~~~l~dfg~~~~  132 (164)
                      ..++|+|+.+.||+++.+    +.+.++||..+..
T Consensus       220 ~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          220 VVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             EEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             cEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            468999999999999876    6899999998763

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=96.40  E-value=0.0051  Score=43.69  Aligned_cols=31  Identities=23%  Similarity=0.298  Sum_probs=27.5

Q ss_pred             CCCeeeCCCCCCceeecCCCCeEEccccchh
Q 046065          101 RLTIIHRDLKVSNILLDEDLKPKISDFGLAR  131 (164)
Q Consensus       101 ~~~iih~dlk~~nili~~~~~~~l~dfg~~~  131 (164)
                      ...++|+|+.+.|++++.++.+.++||+.+.
T Consensus       221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             SCCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             cCceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            4589999999999999877889999999774

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=95.45  E-value=0.016  Score=42.68  Aligned_cols=31  Identities=19%  Similarity=0.378  Sum_probs=26.9

Q ss_pred             CCCeeeCCCCCCceeecCCCCeEEccccchhh
Q 046065          101 RLTIIHRDLKVSNILLDEDLKPKISDFGLARI  132 (164)
Q Consensus       101 ~~~iih~dlk~~nili~~~~~~~l~dfg~~~~  132 (164)
                      ...++|+|+.|.|||++.++ +.++||+.+..
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~  261 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFY  261 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence            45899999999999998776 99999988753

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=94.42  E-value=0.013  Score=41.43  Aligned_cols=30  Identities=30%  Similarity=0.342  Sum_probs=25.8

Q ss_pred             CCeeeCCCCCCceeecCCCCeEEccccchh
Q 046065          102 LTIIHRDLKVSNILLDEDLKPKISDFGLAR  131 (164)
Q Consensus       102 ~~iih~dlk~~nili~~~~~~~l~dfg~~~  131 (164)
                      ..++|+|+.+.|++++.++.+.++||+.+.
T Consensus       187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          187 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            478999999999999877656899998775

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=93.65  E-value=0.11  Score=36.64  Aligned_cols=29  Identities=34%  Similarity=0.466  Sum_probs=24.7

Q ss_pred             CCCeeeCCCCCCceeecCCCCeEEccccchh
Q 046065          101 RLTIIHRDLKVSNILLDEDLKPKISDFGLAR  131 (164)
Q Consensus       101 ~~~iih~dlk~~nili~~~~~~~l~dfg~~~  131 (164)
                      ...++|+|+.+.||+++ + .+.++||+.+.
T Consensus       194 ~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~  222 (328)
T 1zyl_A          194 TVLRLHGDCHAGNILWR-D-GPMFVDLDDAR  222 (328)
T ss_dssp             CCEECCSSCSGGGEEES-S-SEEECCCTTCC
T ss_pred             CeeeeeCCCCcccEeEc-C-CCEEEECCCCC
Confidence            34689999999999998 4 78999998764

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=92.58  E-value=1.1  Score=30.18  Aligned_cols=84  Identities=7%  Similarity=0.001  Sum_probs=54.6

Q ss_pred             CCCceeeEeEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHHHHHHHHHHHHH-HhhhcCCCCeeeCCCCCCce
Q 046065           36 QHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLL-YLQEYFRLTIIHRDLKVSNI  114 (164)
Q Consensus        36 ~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~-~lh~~~~~~iih~dlk~~ni  114 (164)
                      .||.. ....-...+.+.+.++.-+++-=..-++.      ++....+.++.+++.... +++     .-++--+.|+|+
T Consensus        48 ~~~~f-~~~I~~~eD~~~i~y~~~~~~~~f~~i~~------~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~NL  115 (219)
T 4ano_A           48 VDPCI-VRDIDVSEDEVKVVIKPPSSFLTFAAIRK------TTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPENL  115 (219)
T ss_dssp             SCSSS-EEEEEECSSEEEEEEECCTTCEEHHHHHT------SCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGGE
T ss_pred             cCCCC-CeEEEEeCCEEEEEEEcCcccCcHHHHHh------cCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCceE
Confidence            57777 54444555666666554322111222222      666777777777766544 333     567888999999


Q ss_pred             eecCCCCeEEccccchh
Q 046065          115 LLDEDLKPKISDFGLAR  131 (164)
Q Consensus       115 li~~~~~~~l~dfg~~~  131 (164)
                      +++.++.+++.-.|+-.
T Consensus       116 ~f~~~~~p~i~hRGi~~  132 (219)
T 4ano_A          116 MFNRALEPFFLHVGVKE  132 (219)
T ss_dssp             EECTTCCEEESCCEETT
T ss_pred             EEeCCCcEEEEEcCCcc
Confidence            99999999999988743

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=92.50  E-value=0.068  Score=38.57  Aligned_cols=29  Identities=24%  Similarity=0.439  Sum_probs=24.2

Q ss_pred             CCeeeCCCCCCceeecCCCCeEEccccchh
Q 046065          102 LTIIHRDLKVSNILLDEDLKPKISDFGLAR  131 (164)
Q Consensus       102 ~~iih~dlk~~nili~~~~~~~l~dfg~~~  131 (164)
                      ..++|+|+.+.||+++.++ +.++||..+.
T Consensus       212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a~  240 (369)
T 3c5i_A          212 IVFCHNDLQENNIINTNKC-LRLIDFEYSG  240 (369)
T ss_dssp             EEEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred             eEEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence            4689999999999997554 8999998775

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=92.13  E-value=0.84  Score=30.54  Aligned_cols=84  Identities=12%  Similarity=0.065  Sum_probs=55.4

Q ss_pred             CCCceeeEeEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCcee
Q 046065           36 QHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNIL  115 (164)
Q Consensus        36 ~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nil  115 (164)
                      .+|+.+........+.+.+.++.-  .+...+-.    ....+....+.++.+++....+++     .-+|--+.|+|++
T Consensus        43 ~~~~Fl~~~I~e~eD~v~~~y~~~--~~~~~f~~----ik~~~~~eKlr~l~ni~~l~~~~~-----~r~tf~L~P~NL~  111 (215)
T 4ann_A           43 HSPYFIDAELTELRDSFQIHYDIN--DNHTPFDN----IKSFTKNEKLRYLLNIKNLEEVNR-----TRYTFVLAPDELF  111 (215)
T ss_dssp             CCTTBCCEEEEECSSEEEEEECCC--TTSEEGGG----GGGSCHHHHHHHHHHGGGGGGGGG-----SSEECCCSGGGEE
T ss_pred             cCCcccceEEEEcccEEEEEEEcC--cccCCHHH----HHhcCHHHHHHHHHHHHHHHHHhc-----CceEEEEecceEE
Confidence            578777765555556555554432  22222221    112667777778888776654443     4678889999999


Q ss_pred             ecCCCCeEEccccch
Q 046065          116 LDEDLKPKISDFGLA  130 (164)
Q Consensus       116 i~~~~~~~l~dfg~~  130 (164)
                      ++.++.+++.-.|+.
T Consensus       112 f~~~~~p~i~~RGik  126 (215)
T 4ann_A          112 FTRDGLPIAKTRGLQ  126 (215)
T ss_dssp             ECTTSCEEESCCEET
T ss_pred             EcCCCCEEEEEccCc
Confidence            999999999988864

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=91.85  E-value=0.061  Score=38.51  Aligned_cols=31  Identities=19%  Similarity=0.370  Sum_probs=27.0

Q ss_pred             CCeeeCCCCCCceeecCCCCeEEccccchhh
Q 046065          102 LTIIHRDLKVSNILLDEDLKPKISDFGLARI  132 (164)
Q Consensus       102 ~~iih~dlk~~nili~~~~~~~l~dfg~~~~  132 (164)
                      ..++|+|+.+.|++++.++.+.++||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            4689999999999998778899999987653

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=91.72  E-value=0.083  Score=39.19  Aligned_cols=31  Identities=35%  Similarity=0.485  Sum_probs=25.3

Q ss_pred             CCeeeCCCCCCceeecCC----------------------------CCeEEccccchhh
Q 046065          102 LTIIHRDLKVSNILLDED----------------------------LKPKISDFGLARI  132 (164)
Q Consensus       102 ~~iih~dlk~~nili~~~----------------------------~~~~l~dfg~~~~  132 (164)
                      ..++|+|+.+.|||++.+                            +.+.++||..+..
T Consensus       249 ~v~~H~Dl~~gNiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lIDfEya~~  307 (429)
T 1nw1_A          249 VTFCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYASY  307 (429)
T ss_dssp             EEEECSCCCGGGEEEEC------------------------------CCEECCCTTCEE
T ss_pred             eEEEeCCCCCCeEEeeCCccccccccccccccccccccccccccCCCeEEEEecccCCc
Confidence            358999999999999875                            6789999988753

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=91.54  E-value=0.11  Score=38.88  Aligned_cols=54  Identities=17%  Similarity=0.147  Sum_probs=29.6

Q ss_pred             cEEEEEEccccccccHHHHHHHHHHHhccCCCceee-EeEEeeCCcEEEEEEecCCCCh
Q 046065            7 QIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSL   64 (164)
Q Consensus         7 ~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~-~~~~~~~~~~~lv~e~~~~~~L   64 (164)
                      +.+.+|......... -....|..+++.+...++.. +..+. .+  .+|+||+++.++
T Consensus       134 ~~~vLRi~g~~~~~~-idR~~E~~vl~~L~~~gl~P~ll~~~-~~--G~v~e~I~G~~l  188 (458)
T 2qg7_A          134 AKYLIRLYGPKTDEI-INREREKKISCILYNKNIAKKIYVFF-TN--GRIEEFMDGYAL  188 (458)
T ss_dssp             EEEEEEEECC-CCSC-SCHHHHHHHHHHHTTSSSBCCEEEEE-TT--EEEEECCCSEEC
T ss_pred             ceEEEEECCCChhhh-cCHHHHHHHHHHHHhcCCCCCEEEEe-CC--eEEEEeeCCccC
Confidence            567777753222111 11257888888886544543 32222 22  259999987444

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=89.45  E-value=0.21  Score=36.55  Aligned_cols=30  Identities=33%  Similarity=0.393  Sum_probs=24.9

Q ss_pred             CeeeCCCCCCceeec------CCCCeEEccccchhh
Q 046065          103 TIIHRDLKVSNILLD------EDLKPKISDFGLARI  132 (164)
Q Consensus       103 ~iih~dlk~~nili~------~~~~~~l~dfg~~~~  132 (164)
                      -++|+|+.+.|||+.      ....+.++||..|..
T Consensus       245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            357999999999993      456799999998864

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=86.83  E-value=0.35  Score=35.89  Aligned_cols=30  Identities=27%  Similarity=0.491  Sum_probs=26.3

Q ss_pred             CCeeeCCCCCCceeecCCCCeEEccccchhh
Q 046065          102 LTIIHRDLKVSNILLDEDLKPKISDFGLARI  132 (164)
Q Consensus       102 ~~iih~dlk~~nili~~~~~~~l~dfg~~~~  132 (164)
                      ..++|+|+.+.|++ +..+.+.++||..+..
T Consensus       262 ~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~  291 (424)
T 3mes_A          262 LVFAHNDLQENNLL-QTQNNIRMIDYEYSAI  291 (424)
T ss_dssp             EEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             ceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence            46899999999999 7788899999998864

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	164
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	4e-33
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	4e-31
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-30
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	1e-29
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-29
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	5e-29
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	6e-29
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	7e-29
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	7e-29
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	8e-29
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	4e-28
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-27
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-27
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-26
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	1e-26
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-26
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-26
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-26
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-26
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-25
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-25
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	5e-25
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	1e-24
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-24
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-24
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-24
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	4e-24
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	4e-24
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-23
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	3e-23
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	4e-23
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	6e-23
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	1e-22
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	3e-22
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	4e-22
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	5e-22
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-21
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	5e-20
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	6e-20
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	9e-20
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	2e-19
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-19
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-19
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	7e-19
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	8e-19
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	9e-19
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-18
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-18
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-18
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	6e-18
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-17
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	4e-17
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	2e-16
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	2e-16
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	3e-16
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-16
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	4e-16
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	4e-15
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	7e-14
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	6e-13
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-11
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	3e-10
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	8e-10

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (293), Expect = 4e-33
 Identities = 38/161 (23%), Positives = 69/161 (42%), Gaps = 7/161 (4%)

Query: 3   LPDGQIIAVKKLSKKSTQGF-EEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMP 60
            P G ++A K +  +       +   E+ +  +     ++   G      E  +  E+M 
Sbjct: 28  KPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMD 87

Query: 61  KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL 120
             SLD  L    R   +  +    +   +I+GL YL+E  +  I+HRD+K SNIL++   
Sbjct: 88  GGSLDQVLKKAGR---IPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRG 142

Query: 121 KPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKK 161
           + K+ DFG++  L   +         Y+ PE +    Y  +
Sbjct: 143 EIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQ 183

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (277), Expect = 4e-31
 Identities = 42/157 (26%), Positives = 73/157 (46%), Gaps = 9/157 (5%)

Query: 1   GVLPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMP 60
           G       + +  ++  + Q  + FKNEV +  K +H+N++         +  ++ ++  
Sbjct: 27  GKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWCE 86

Query: 61  KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL 120
             SL + L         +  K + I +   QG+ YL      +IIHRDLK +NI L EDL
Sbjct: 87  GSSLYHHLHIIETKF--EMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDL 141

Query: 121 KPKISDFGLARILRKM----ILKQIQIELGYIPPEYV 153
             KI DFGLA +  +       +Q+   + ++ PE +
Sbjct: 142 TVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVI 178

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (273), Expect = 3e-30
 Identities = 36/162 (22%), Positives = 66/162 (40%), Gaps = 8/162 (4%)

Query: 3   LPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPK 61
                + A K +  KS +  E++  E+ + A   H N++++           ++ E+   
Sbjct: 34  KETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 93

Query: 62  RSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK 121
            ++D  + +  R   L   +   + K  +  L YL +     IIHRDLK  NIL   D  
Sbjct: 94  GAVDAVMLELER--PLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGD 148

Query: 122 PKISDFGLARILRKMI--LKQIQIELGYIPPEYVGRGVYYKK 161
            K++DFG++    + I           ++ PE V       +
Sbjct: 149 IKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 190

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (267), Expect = 1e-29
 Identities = 45/169 (26%), Positives = 73/169 (43%), Gaps = 10/169 (5%)

Query: 3   LPDGQIIAVKKLSKKST--QGFEEFKNEVMLTAKLQHLNLIRVGFCIETQE---YMLIYE 57
             DG+I+  K+L   S      +   +EV L  +L+H N++R    I  +      ++ E
Sbjct: 26  KSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVME 85

Query: 58  YMPKRSLDYFLFDPIRML-ILDCKKRVHIIKGIIQGLLYL--QEYFRLTIIHRDLKVSNI 114
           Y     L   +    +    LD +  + ++  +   L     +     T++HRDLK +N+
Sbjct: 86  YCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANV 145

Query: 115 LLDEDLKPKISDFGLARILRK--MILKQIQIELGYIPPEYVGRGVYYKK 161
            LD     K+ DFGLARIL       K       Y+ PE + R  Y +K
Sbjct: 146 FLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEK 194

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (266), Expect = 2e-29
 Identities = 49/164 (29%), Positives = 80/164 (48%), Gaps = 8/164 (4%)

Query: 1   GVLPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMP 60
           G       +AVK L K+ +   + F  E  L  +LQH  L+R+   +  +   +I EYM 
Sbjct: 32  GYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYME 90

Query: 61  KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL 120
             SL  FL  P   + L   K + +   I +G+ +++E      IHRDL+ +NIL+ + L
Sbjct: 91  NGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTL 146

Query: 121 KPKISDFGLARIL---RKMILKQIQIELGYIPPEYVGRGVYYKK 161
             KI+DFGLAR++        +  +  + +  PE +  G +  K
Sbjct: 147 SCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 190

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (263), Expect = 5e-29
 Identities = 41/161 (25%), Positives = 71/161 (44%), Gaps = 10/161 (6%)

Query: 5   DGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMP 60
              I+A+K L K          + + EV + + L+H N++R+ G+  +     LI EY P
Sbjct: 30  SKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAP 89

Query: 61  KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL 120
             ++   L    +    D ++    I  +   L Y        +IHRD+K  N+LL    
Sbjct: 90  LGTVYRELQKLSK---FDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAG 143

Query: 121 KPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKK 161
           + KI+DFG +          +   L Y+PPE +   ++ +K
Sbjct: 144 ELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDEK 184

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (263), Expect = 6e-29
 Identities = 46/164 (28%), Positives = 76/164 (46%), Gaps = 8/164 (4%)

Query: 1   GVLPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMP 60
           G       +A+K L K  T   E F  E  +  KL+H  L+++   +  +   ++ EYM 
Sbjct: 36  GTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMS 94

Query: 61  KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL 120
           K SL  FL        L   + V +   I  G+ Y++       +HRDL+ +NIL+ E+L
Sbjct: 95  KGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENL 150

Query: 121 KPKISDFGLARILRK---MILKQIQIELGYIPPEYVGRGVYYKK 161
             K++DFGLAR++        +  +  + +  PE    G +  K
Sbjct: 151 VCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 194

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (261), Expect = 7e-29
 Identities = 40/165 (24%), Positives = 74/165 (44%), Gaps = 10/165 (6%)

Query: 1   GVLPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYM 59
           G   +   +A+K + ++     E+F  E  +  KL H  L+++ G C+E     L++E+M
Sbjct: 24  GYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82

Query: 60  PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
               L  +L    +  +   +  + +   + +G+ YL+E     +IHRDL   N L+ E+
Sbjct: 83  EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGEN 137

Query: 120 LKPKISDFGLARILRKMILKQ---IQIELGYIPPEYVGRGVYYKK 161
              K+SDFG+ R +           +  + +  PE      Y  K
Sbjct: 138 QVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 182

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  104 bits (261), Expect = 7e-29
 Identities = 38/165 (23%), Positives = 73/165 (44%), Gaps = 10/165 (6%)

Query: 1   GVLPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYM 59
           G       +A+K + K+ +   +EF  E  +   L H  L+++ G C + +   +I EYM
Sbjct: 23  GKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81

Query: 60  PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
               L  +L +         ++ + + K + + + YL+       +HRDL   N L+++ 
Sbjct: 82  ANGCLLNYLREMRHRF--QTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQ 136

Query: 120 LKPKISDFGLARILRKMILKQ---IQIELGYIPPEYVGRGVYYKK 161
              K+SDFGL+R +           +  + + PPE +    +  K
Sbjct: 137 GVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 181

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  105 bits (264), Expect = 8e-29
 Identities = 42/155 (27%), Positives = 67/155 (43%), Gaps = 12/155 (7%)

Query: 3   LPDGQIIAVKKLSKKSTQG---FEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEY 58
           + + +++A+KK+S    Q    +++   EV    KL+H N I+  G  +      L+ EY
Sbjct: 37  VRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEY 96

Query: 59  MPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE 118
               + D           L   +   +  G +QGL YL       +IHRD+K  NILL E
Sbjct: 97  CLGSASDLLEVHKKP---LQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSE 150

Query: 119 DLKPKISDFGLARILRKMILKQIQIELGYIPPEYV 153
               K+ DFG A I+             ++ PE +
Sbjct: 151 PGLVKLGDFGSASIMAPA--NSFVGTPYWMAPEVI 183

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (257), Expect = 4e-28
 Identities = 35/163 (21%), Positives = 64/163 (39%), Gaps = 11/163 (6%)

Query: 5   DGQIIAVKKLSKKSTQGF-EEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
               +A+K L + + +   EE   E  +  +L +  ++R+    + +  ML+ E      
Sbjct: 35  KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGP 94

Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           L  FL        +       ++  +  G+ YL+       +HRDL   N+LL      K
Sbjct: 95  LHKFLVGKREE--IPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAK 149

Query: 124 ISDFGLARIL-----RKMILKQIQIELGYIPPEYVGRGVYYKK 161
           ISDFGL++ L             +  L +  PE +    +  +
Sbjct: 150 ISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR 192

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  102 bits (254), Expect = 1e-27
 Identities = 45/163 (27%), Positives = 71/163 (43%), Gaps = 12/163 (7%)

Query: 3   LPDGQIIAVKKLSKKSTQGF-EEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMP 60
               + +AVK +  K      E  K E+ +   L H N+++  G   E     L  EY  
Sbjct: 27  RVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 86

Query: 61  KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL 120
              L   +   I    +           ++ G++YL     + I HRD+K  N+LLDE  
Sbjct: 87  GGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERD 140

Query: 121 KPKISDFGLARIL----RKMILKQIQIELGYIPPEYVGRGVYY 159
             KISDFGLA +     R+ +L ++   L Y+ PE + R  ++
Sbjct: 141 NLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 183

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (251), Expect = 3e-27
 Identities = 41/159 (25%), Positives = 74/159 (46%), Gaps = 9/159 (5%)

Query: 5   DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYM-LIYEYMPKR 62
            G  +AVK +   +T   + F  E  +  +L+H NL+++ G  +E +  + ++ EYM K 
Sbjct: 29  RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKG 86

Query: 63  SLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKP 122
           SL  +L    R  +L     +     + + + YL+       +HRDL   N+L+ ED   
Sbjct: 87  SLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVA 142

Query: 123 KISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKK 161
           K+SDFGL +          ++ + +  PE +    +  K
Sbjct: 143 KVSDFGLTKEASST-QDTGKLPVKWTAPEALREKKFSTK 180

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 99.8 bits (248), Expect = 1e-26
 Identities = 39/161 (24%), Positives = 75/161 (46%), Gaps = 9/161 (5%)

Query: 5   DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRS 63
               +AVK L + + +  EEF  E  +  +++H NL+++ G C     + +I E+M   +
Sbjct: 41  YSLTVAVKTLKEDTMEV-EEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGN 99

Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           L  +L +  R   +     +++   I   + YL+   +   IHRDL   N L+ E+   K
Sbjct: 100 LLDYLRECNRQE-VSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVK 155

Query: 124 ISDFGLARILRKMILK---QIQIELGYIPPEYVGRGVYYKK 161
           ++DFGL+R++           +  + +  PE +    +  K
Sbjct: 156 VADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 196

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  100 bits (250), Expect = 1e-26
 Identities = 35/163 (21%), Positives = 61/163 (37%), Gaps = 9/163 (5%)

Query: 3   LPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPK 61
              G   A K +        E  + E+   + L+H  L+ +     +  E ++IYE+M  
Sbjct: 48  RATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG 107

Query: 62  RSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL--DED 119
             L   + D      +   + V  ++ + +GL ++ E      +H DLK  NI+      
Sbjct: 108 GELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRS 162

Query: 120 LKPKISDFGLARIL-RKMILKQIQIELGYIPPEYVGRGVYYKK 161
            + K+ DFGL   L  K  +K       +  PE          
Sbjct: 163 NELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYY 205

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 99.7 bits (248), Expect = 1e-26
 Identities = 36/162 (22%), Positives = 72/162 (44%), Gaps = 10/162 (6%)

Query: 3   LPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPK 61
           +  GQ +A+++++ +     E   NE+++  + ++ N++      +   E  ++ EY+  
Sbjct: 42  VATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101

Query: 62  RSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK 121
            SL   + +       D  +   + +  +Q L +L       +IHRD+K  NILL  D  
Sbjct: 102 GSLTDVVTETCM----DEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGS 154

Query: 122 PKISDFGLARIL--RKMILKQIQIELGYIPPEYVGRGVYYKK 161
            K++DFG    +   +     +     ++ PE V R  Y  K
Sbjct: 155 VKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 99.2 bits (246), Expect = 2e-26
 Identities = 44/184 (23%), Positives = 82/184 (44%), Gaps = 30/184 (16%)

Query: 5   DGQIIAVKKLSKKSTQGFE-EFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKR 62
              ++AVK L ++++   + +F+ E  L A+  + N+++ +G C   +   L++EYM   
Sbjct: 42  PFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYG 101

Query: 63  SLDYFLFDPIRMLI---------------------LDCKKRVHIIKGIIQGLLYLQEYFR 101
            L+ FL       +                     L C +++ I + +  G+ YL E   
Sbjct: 102 DLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER-- 159

Query: 102 LTIIHRDLKVSNILLDEDLKPKISDFGLARIL----RKMILKQIQIELGYIPPEYVGRGV 157
              +HRDL   N L+ E++  KI+DFGL+R +             I + ++PPE +    
Sbjct: 160 -KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNR 218

Query: 158 YYKK 161
           Y  +
Sbjct: 219 YTTE 222

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.5 bits (245), Expect = 2e-26
 Identities = 41/164 (25%), Positives = 65/164 (39%), Gaps = 12/164 (7%)

Query: 5   DGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQE----YMLIYE 57
               +A  +L  +  +    + FK E  +   LQH N++R       T +     +L+ E
Sbjct: 33  TTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTE 92

Query: 58  YMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL- 116
            M   +L  +L    R  ++  K      + I++GL +L       IIHRDLK  NI + 
Sbjct: 93  LMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFIT 148

Query: 117 DEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYK 160
                 KI D GLA + R    K +     ++ PE         
Sbjct: 149 GPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEKYDES 192

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.3 bits (244), Expect = 3e-26
 Identities = 37/164 (22%), Positives = 69/164 (42%), Gaps = 13/164 (7%)

Query: 5   DGQIIAVKKLSKKSTQG--FEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKR 62
             + +AVK L  ++      +E   E  +  +L +  ++R+    E + +ML+ E     
Sbjct: 33  VVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELG 92

Query: 63  SLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKP 122
            L+ +L        +  K  + ++  +  G+ YL+       +HRDL   N+LL      
Sbjct: 93  PLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYA 146

Query: 123 KISDFGLARILR-----KMILKQIQIELGYIPPEYVGRGVYYKK 161
           KISDFGL++ LR            +  + +  PE +    +  K
Sbjct: 147 KISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSK 190

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 97.5 bits (242), Expect = 1e-25
 Identities = 44/166 (26%), Positives = 74/166 (44%), Gaps = 14/166 (8%)

Query: 5   DGQIIAVKKLSKKST-QGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKR 62
               +A+K L    T +   +F +E  +  +  H N+I + G   ++   M+I E+M   
Sbjct: 53  REIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENG 112

Query: 63  SLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKP 122
           SLD FL            + V +++GI  G+ YL     +  +HRDL   NIL++ +L  
Sbjct: 113 SLDSFLRQNDGQF--TVIQLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVC 167

Query: 123 KISDFGLARILRKMILKQ-------IQIELGYIPPEYVGRGVYYKK 161
           K+SDFGL+R L               +I + +  PE +    +   
Sbjct: 168 KVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSA 213

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.6 bits (240), Expect = 2e-25
 Identities = 34/167 (20%), Positives = 61/167 (36%), Gaps = 14/167 (8%)

Query: 3   LPDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEY 58
           L   +  A+K L K+             E  + ++L H   +++     + ++      Y
Sbjct: 30  LATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSY 89

Query: 59  MPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE 118
                L  ++                      + +  L+      IIHRDLK  NILL+E
Sbjct: 90  AKNGELLKYIRKIGSF------DETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNE 143

Query: 119 DLKPKISDFGLARIL----RKMILKQIQIELGYIPPEYVGRGVYYKK 161
           D+  +I+DFG A++L    ++           Y+ PE +      K 
Sbjct: 144 DMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKS 190

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score = 96.3 bits (239), Expect = 5e-25
 Identities = 37/160 (23%), Positives = 67/160 (41%), Gaps = 9/160 (5%)

Query: 3   LPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPK 61
              G++   K ++          KNE+ +  +L H  LI +     +  E +LI E++  
Sbjct: 51  KATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 110

Query: 62  RSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLD--ED 119
             L   +        +   + ++ ++   +GL ++ E    +I+H D+K  NI+ +  + 
Sbjct: 111 GELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKA 165

Query: 120 LKPKISDFGLARILRK-MILKQIQIELGYIPPEYVGRGVY 158
              KI DFGLA  L    I+K       +  PE V R   
Sbjct: 166 SSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPV 205

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.5 bits (234), Expect = 1e-24
 Identities = 38/175 (21%), Positives = 67/175 (38%), Gaps = 21/175 (12%)

Query: 5   DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQ----EYMLIYEYM 59
            G+ +AVK  S +  + +   + E+  T  L+H N++       +      +  L+ +Y 
Sbjct: 25  RGEEVAVKIFSSREERSWF-REAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYH 83

Query: 60  PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYF-----RLTIIHRDLKVSNI 114
              SL    FD +    +  +  + +      GL +L         +  I HRDLK  NI
Sbjct: 84  EHGSL----FDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNI 139

Query: 115 LLDEDLKPKISDFGLARILR------KMILKQIQIELGYIPPEYVGRGVYYKKFS 163
           L+ ++    I+D GLA           +          Y+ PE +   +  K F 
Sbjct: 140 LVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFE 194

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 94.4 bits (234), Expect = 1e-24
 Identities = 44/163 (26%), Positives = 71/163 (43%), Gaps = 11/163 (6%)

Query: 3   LPDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEY 58
             +G+  A+K L K+     +  E   +E ++ + + H  +IR+ G   + Q+  +I +Y
Sbjct: 26  RHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDY 85

Query: 59  MPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE 118
           +    L   L    R      K     +       L L+      II+RDLK  NILLD+
Sbjct: 86  IEGGELFSLLRKSQRFPNPVAKFYAAEV------CLALEYLHSKDIIYRDLKPENILLDK 139

Query: 119 DLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKK 161
           +   KI+DFG A+ +  +    +     YI PE V    Y K 
Sbjct: 140 NGHIKITDFGFAKYVPDVT-YTLCGTPDYIAPEVVSTKPYNKS 181

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.7 bits (232), Expect = 2e-24
 Identities = 44/163 (26%), Positives = 74/163 (45%), Gaps = 12/163 (7%)

Query: 6   GQIIAVKKLSKKSTQGF-EEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRS 63
              +A+K L    T+    +F  E  +  +  H N+IR  G   + +  M+I EYM   +
Sbjct: 36  EVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGA 95

Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           LD FL +          + V +++GI  G+ Y      +  +HRDL   NIL++ +L  K
Sbjct: 96  LDKFLREKDGEF--SVLQLVGMLRGIAAGMKY---LANMNYVHRDLAARNILVNSNLVCK 150

Query: 124 ISDFGLARIL-----RKMILKQIQIELGYIPPEYVGRGVYYKK 161
           +SDFGL+R+L             +I + +  PE +    +   
Sbjct: 151 VSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSA 193

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.5 bits (234), Expect = 2e-24
 Identities = 40/184 (21%), Positives = 75/184 (40%), Gaps = 30/184 (16%)

Query: 5   DGQIIAVKKLSKKSTQGF-EEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPK 61
               +AVK L +K+     E   +E+ +  +L  H N++ + G C  +    LI+EY   
Sbjct: 66  VSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCY 125

Query: 62  RSLDYFLFDPIRML--------------------ILDCKKRVHIIKGIIQGLLYLQEYFR 101
             L  +L                           +L  +  +     + +G+ +L+    
Sbjct: 126 GDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF--- 182

Query: 102 LTIIHRDLKVSNILLDEDLKPKISDFGLARILRK----MILKQIQIELGYIPPEYVGRGV 157
            + +HRDL   N+L+      KI DFGLAR +      ++    ++ + ++ PE +  G+
Sbjct: 183 KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGI 242

Query: 158 YYKK 161
           Y  K
Sbjct: 243 YTIK 246

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.3 bits (231), Expect = 4e-24
 Identities = 43/180 (23%), Positives = 72/180 (40%), Gaps = 25/180 (13%)

Query: 4   PDGQIIAVKKLSKKSTQGF-EEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMP 60
                +AVK L   +     E   +E+ + + L  H+N++ + G C      ++I EY  
Sbjct: 51  DAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCC 110

Query: 61  KRSLDYFLFDPIRMLI---------------LDCKKRVHIIKGIIQGLLYLQEYFRLTII 105
              L  FL       I               LD +  +     + +G+ +L        I
Sbjct: 111 YGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCI 167

Query: 106 HRDLKVSNILLDEDLKPKISDFGLARILRK----MILKQIQIELGYIPPEYVGRGVYYKK 161
           HRDL   NILL      KI DFGLAR ++     ++    ++ + ++ PE +   VY  +
Sbjct: 168 HRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFE 227

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.3 bits (231), Expect = 4e-24
 Identities = 34/161 (21%), Positives = 75/161 (46%), Gaps = 10/161 (6%)

Query: 6   GQIIAVKKLSK-KSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSL 64
              +A+K+L +  S +  +E  +E  + A + + ++ R+     T    LI + MP   L
Sbjct: 38  KIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCL 97

Query: 65  DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKI 124
             ++ +      +  +  ++    I +G+ YL       ++HRDL   N+L+      KI
Sbjct: 98  LDYVRE--HKDNIGSQYLLNWCVQIAKGMNYL---EDRRLVHRDLAARNVLVKTPQHVKI 152

Query: 125 SDFGLARIL----RKMILKQIQIELGYIPPEYVGRGVYYKK 161
           +DFGLA++L    ++   +  ++ + ++  E +   +Y  +
Sbjct: 153 TDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQ 193

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score = 92.5 bits (229), Expect = 2e-23
 Identities = 41/164 (25%), Positives = 64/164 (39%), Gaps = 13/164 (7%)

Query: 3   LPDGQIIAVKKLSKKSTQG------FEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLI 55
              G++ A+K L KK  +           +  + L +      ++ +        +   I
Sbjct: 26  ADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFI 85

Query: 56  YEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNIL 115
            + M    L Y L         D +        II GL ++       +++RDLK +NIL
Sbjct: 86  LDLMNGGDLHYHLSQHGVFSEADMR---FYAAEIILGLEHMHN---RFVVYRDLKPANIL 139

Query: 116 LDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYY 159
           LDE    +ISD GLA    K          GY+ PE + +GV Y
Sbjct: 140 LDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGVAY 183

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.1 bits (225), Expect = 3e-23
 Identities = 36/172 (20%), Positives = 71/172 (41%), Gaps = 16/172 (9%)

Query: 4   PDGQIIAVKKLSKKSTQGF-EEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPK 61
                +A+K +++ ++     EF NE  +  +    +++R +G   + Q  ++I E M +
Sbjct: 48  EPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTR 107

Query: 62  RSLDYFLFDPIRMLI-------LDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNI 114
             L  +L      +            K + +   I  G+ YL        +HRDL   N 
Sbjct: 108 GDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNC 164

Query: 115 LLDEDLKPKISDFGLARILRK----MILKQIQIELGYIPPEYVGRGVYYKKF 162
           ++ ED   KI DFG+ R + +        +  + + ++ PE +  GV+    
Sbjct: 165 MVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYS 216

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 90.6 bits (224), Expect = 4e-23
 Identities = 34/165 (20%), Positives = 67/165 (40%), Gaps = 14/165 (8%)

Query: 6   GQIIAVKKLSKKSTQGF-EEFKNEVMLTAKLQHLNLIRV-GFCIETQ-EYMLIYEYMPKR 62
               AVK L++ +  G   +F  E ++     H N++ + G C+ ++   +++  YM   
Sbjct: 55  KIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHG 114

Query: 63  SLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKP 122
            L  F+ +              +I   +Q    ++       +HRDL   N +LDE    
Sbjct: 115 DLRNFIRNETHNP-----TVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTV 169

Query: 123 KISDFGLARILRKMILKQIQIE------LGYIPPEYVGRGVYYKK 161
           K++DFGLAR +       +  +      + ++  E +    +  K
Sbjct: 170 KVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTK 214

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 90.7 bits (224), Expect = 6e-23
 Identities = 39/166 (23%), Positives = 69/166 (41%), Gaps = 10/166 (6%)

Query: 3   LPDGQIIAVKKLSKKSTQGF-EEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMP 60
             +   +A+KK+S    Q + +    E+ +  + +H N+I +           +   Y+ 
Sbjct: 30  NVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLV 89

Query: 61  KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL 120
              +   L+  ++   L      + +  I++GL Y+       ++HRDLK SN+LL+   
Sbjct: 90  THLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTC 146

Query: 121 KPKISDFGLARIL-----RKMILKQIQIELGYIPPEYVGRGVYYKK 161
             KI DFGLAR+          L +      Y  PE +     Y K
Sbjct: 147 DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 192

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 89.5 bits (221), Expect = 1e-22
 Identities = 44/172 (25%), Positives = 73/172 (42%), Gaps = 20/172 (11%)

Query: 7   QIIAVKKLSK-KSTQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRS 63
              A+K++ +  S     +F  E+ +  KL  H N+I + G C       L  EY P  +
Sbjct: 38  MDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGN 97

Query: 64  LDYFLFDPIRML-------------ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLK 110
           L  FL     +               L  ++ +H    + +G+ YL +      IHRDL 
Sbjct: 98  LLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLA 154

Query: 111 VSNILLDEDLKPKISDFGLARILRKMILKQ-IQIELGYIPPEYVGRGVYYKK 161
             NIL+ E+   KI+DFGL+R     + K   ++ + ++  E +   VY   
Sbjct: 155 ARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN 206

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 88.2 bits (218), Expect = 3e-22
 Identities = 35/162 (21%), Positives = 71/162 (43%), Gaps = 6/162 (3%)

Query: 3   LPDGQIIAVKKLSKKSTQGFEE-FKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMP 60
               +++A+K ++KK+ +G E   +NE+ +  K++H N++ +           LI + + 
Sbjct: 31  KRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVS 90

Query: 61  KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL 120
              L   + +         +    +I  ++  + YL +   +    +   +    LDED 
Sbjct: 91  GGELFDRIVEKGF---YTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDS 147

Query: 121 KPKISDFGLARIL-RKMILKQIQIELGYIPPEYVGRGVYYKK 161
           K  ISDFGL+++     +L       GY+ PE + +  Y K 
Sbjct: 148 KIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKA 189

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.5 bits (216), Expect = 4e-22
 Identities = 31/161 (19%), Positives = 60/161 (37%), Gaps = 9/161 (5%)

Query: 5   DGQIIAVKKLSKKSTQGF-EEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRS 63
               +A+K     ++    E+F  E +   +  H +++++   I      +I E      
Sbjct: 34  PALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGE 93

Query: 64  LDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPK 123
           L  FL    R   LD    +     +   L YL+       +HRD+   N+L+  +   K
Sbjct: 94  LRSFLQV--RKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVK 148

Query: 124 ISDFGLARILRKMILKQIQIELG---YIPPEYVGRGVYYKK 161
           + DFGL+R +      +         ++ PE +    +   
Sbjct: 149 LGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA 189

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.1 bits (215), Expect = 5e-22
 Identities = 42/165 (25%), Positives = 65/165 (39%), Gaps = 13/165 (7%)

Query: 5   DGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPK 61
               +AVK L        +  ++F  EV     L H NLIR+   + T    ++ E  P 
Sbjct: 35  KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPL 94

Query: 62  RSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK 121
            SL   L       +L    R      + +G+ YL+       IHRDL   N+LL     
Sbjct: 95  GSLLDRLRKHQGHFLLGTLSR--YAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDL 149

Query: 122 PKISDFGLARILRK-----MILKQIQIELGYIPPEYVGRGVYYKK 161
            KI DFGL R L +     ++ +  ++   +  PE +    +   
Sbjct: 150 VKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHA 194

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 85.5 bits (211), Expect = 3e-21
 Identities = 30/163 (18%), Positives = 60/163 (36%), Gaps = 10/163 (6%)

Query: 3   LPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPK 61
               +    K +  K T      K E+ +    +H N++ +       +E ++I+E++  
Sbjct: 27  TSSKKTYMAKFVKVKGTDQ-VLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISG 85

Query: 62  RSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLD--ED 119
             +   +        L+ ++ V  +  + + L +L       I H D++  NI+      
Sbjct: 86  LDIFERINT--SAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRS 140

Query: 120 LKPKISDFGLARILRK-MILKQIQIELGYIPPEYVGRGVYYKK 161
              KI +FG AR L+     + +     Y  PE     V    
Sbjct: 141 STIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTA 183

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 82.5 bits (203), Expect = 5e-20
 Identities = 42/166 (25%), Positives = 62/166 (37%), Gaps = 13/166 (7%)

Query: 3   LPDGQIIAVKKLSKKST---QGFEEFKNEV-MLTAKLQHLNLIRV-GFCIETQEYMLIYE 57
               Q  A+K L K         E    E  +L+   +H  L  +       +    + E
Sbjct: 24  KKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVME 83

Query: 58  YMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLD 117
           Y+    L Y +    +    D  +       II GL +L       I++RDLK+ NILLD
Sbjct: 84  YLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLD 137

Query: 118 EDLKPKISDFGLARILRKMILKQIQIE--LGYIPPEYVGRGVYYKK 161
           +D   KI+DFG+ +       K         YI PE +    Y   
Sbjct: 138 KDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHS 183

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 81.9 bits (201), Expect = 6e-20
 Identities = 41/180 (22%), Positives = 71/180 (39%), Gaps = 24/180 (13%)

Query: 3   LPDGQIIAVKKLSKKSTQG-FEEFKNEVMLTAKLQHLNLIRV--GFCIETQEY-MLIYEY 58
               + +AVK L + +T        +E+ +   + H   +    G C +     M+I E+
Sbjct: 40  TATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEF 99

Query: 59  MPKRSLDYFLF-------------DPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTII 105
               +L  +L              + +    L  +  +     + +G+ +L        I
Sbjct: 100 CKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CI 156

Query: 106 HRDLKVSNILLDEDLKPKISDFGLARILRK----MILKQIQIELGYIPPEYVGRGVYYKK 161
           HRDL   NILL E    KI DFGLAR + K    +     ++ L ++ PE +   VY  +
Sbjct: 157 HRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQ 216

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 81.5 bits (200), Expect = 9e-20
 Identities = 34/164 (20%), Positives = 70/164 (42%), Gaps = 9/164 (5%)

Query: 3   LPDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMP 60
              G+++A+KK+     +         E+ L  +L H N++++   I T+  + +     
Sbjct: 24  KLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFL 83

Query: 61  KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL 120
            + L  F+ D   +  +        +  ++QGL +   +    ++HRDLK  N+L++ + 
Sbjct: 84  HQDLKKFM-DASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEG 139

Query: 121 KPKISDFGLARIL---RKMILKQIQIELGYIPPEYVGRGVYYKK 161
             K++DFGLAR      +    ++       P   +G   Y   
Sbjct: 140 AIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTA 183

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score = 80.5 bits (198), Expect = 2e-19
 Identities = 43/171 (25%), Positives = 77/171 (45%), Gaps = 18/171 (10%)

Query: 3   LPDGQIIAVKKLSKKSTQGF---------EEFKNEVMLTAKLQ-HLNLIRV-GFCIETQE 51
            P  +  AVK +       F         E    EV +  K+  H N+I++         
Sbjct: 25  KPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTF 84

Query: 52  YMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKV 111
           + L+++ M K  L  +L + +    L  K+   I++ +++ +  L +   L I+HRDLK 
Sbjct: 85  FFLVFDLMKKGELFDYLTEKVT---LSEKETRKIMRALLEVICALHK---LNIVHRDLKP 138

Query: 112 SNILLDEDLKPKISDFGLARILRK-MILKQIQIELGYIPPEYVGRGVYYKK 161
            NILLD+D+  K++DFG +  L     L+++     Y+ PE +   +    
Sbjct: 139 ENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNH 189

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 80.5 bits (198), Expect = 2e-19
 Identities = 33/171 (19%), Positives = 67/171 (39%), Gaps = 15/171 (8%)

Query: 3   LPDGQIIAVKKLSKKSTQGFEE------FKNEVMLTAKLQ--HLNLIRV-GFCIETQEYM 53
           + D   +A+K + K     + E         EV+L  K+      +IR+  +      ++
Sbjct: 26  VSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFV 85

Query: 54  LIYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSN 113
           LI E        +          L  +        +++ + +        ++HRD+K  N
Sbjct: 86  LILERPEPVQDLFDFIT--ERGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDEN 140

Query: 114 ILLDED-LKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKKFS 163
           IL+D +  + K+ DFG   +L+  +         Y PPE++    Y+ + +
Sbjct: 141 ILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIRYHRYHGRSA 191

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score = 79.8 bits (196), Expect = 3e-19
 Identities = 36/172 (20%), Positives = 65/172 (37%), Gaps = 19/172 (11%)

Query: 3   LPDGQIIAVKKLSKKSTQG---FEEFKNEVMLTAKLQHLNLIRVGFCIETQE-----YML 54
           L   + +AVK L     +    +  F+ E    A L H  ++ V    E +        +
Sbjct: 29  LRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYI 88

Query: 55  IYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNI 114
           + EY+   +L   +        +  K+ + +I    Q L +  +     IIHRD+K +NI
Sbjct: 89  VMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANI 142

Query: 115 LLDEDLKPKISDFGLARIL-----RKMILKQIQIELGYIPPEYVGRGVYYKK 161
           ++      K+ DFG+AR +            +     Y+ PE         +
Sbjct: 143 MISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDAR 194

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 79.1 bits (194), Expect = 7e-19
 Identities = 43/177 (24%), Positives = 74/177 (41%), Gaps = 23/177 (12%)

Query: 5   DGQIIAVKKLSKKSTQ-GFEEFKNEVMLTAKL-QHLNLIR-VGFCIETQEYMLIYEYMPK 61
               +AVK L   +T+    +  +E+ +   + +H N+I  +G C +     +I EY  K
Sbjct: 44  RVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 103

Query: 62  RSLDYFLFDPIRMLI-------------LDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRD 108
            +L  +L       +             L  K  V     + +G+ YL        IHRD
Sbjct: 104 GNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRD 160

Query: 109 LKVSNILLDEDLKPKISDFGLARILRK----MILKQIQIELGYIPPEYVGRGVYYKK 161
           L   N+L+ ED   KI+DFGLAR +            ++ + ++ PE +   +Y  +
Sbjct: 161 LAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQ 217

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 79.4 bits (195), Expect = 8e-19
 Identities = 39/166 (23%), Positives = 65/166 (39%), Gaps = 16/166 (9%)

Query: 3   LPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQE------YMLI 55
              G+++A+KK+ +           E+ +  KL H N++R+  F   + E        L+
Sbjct: 42  CDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 97

Query: 56  YEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNIL 115
            +Y+P+               L        +  + + L Y+       I HRD+K  N+L
Sbjct: 98  LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLL 154

Query: 116 LDED-LKPKISDFGLARILRKMILKQIQIEL-GYIPPEYVGRGVYY 159
           LD D    K+ DFG A+ L +       I    Y  PE +     Y
Sbjct: 155 LDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDY 200

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 78.7 bits (193), Expect = 9e-19
 Identities = 38/165 (23%), Positives = 66/165 (40%), Gaps = 14/165 (8%)

Query: 5   DGQIIAVKKLSKKSTQGFEE-----FKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEY 58
             QI+A+KK+        ++        E+ L  +L H N+I +           L++++
Sbjct: 22  TNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81

Query: 59  MPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE 118
           M          + + +         HI   ++  L  L+   +  I+HRDLK +N+LLDE
Sbjct: 82  METDLEVIIKDNSLVL------TPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDE 135

Query: 119 DLKPKISDFGLARILRKMILKQIQIE--LGYIPPEYVGRGVYYKK 161
           +   K++DFGLA+                 Y  PE +     Y  
Sbjct: 136 NGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGV 180

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 78.8 bits (193), Expect = 1e-18
 Identities = 31/163 (19%), Positives = 65/163 (39%), Gaps = 18/163 (11%)

Query: 3   LPDGQIIAVKKLSKKSTQG--FEEFKNEVMLTAKLQHLNLIRVGFCIETQEY-------- 52
              GQ +A+KK+  ++ +         E+ +   L+H N++ +     T+          
Sbjct: 32  RKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGS 91

Query: 53  -MLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKV 111
             L++++             ++       +   +++ ++ GL Y+       I+HRD+K 
Sbjct: 92  IYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKA 145

Query: 112 SNILLDEDLKPKISDFGLARILRKMILKQIQIELGYI-PPEYV 153
           +N+L+  D   K++DFGLAR        Q       +    Y 
Sbjct: 146 ANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 188

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 78.7 bits (193), Expect = 1e-18
 Identities = 30/164 (18%), Positives = 61/164 (37%), Gaps = 10/164 (6%)

Query: 3   LPDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYM 59
              G+  A+K L K+   +         E  +    +H  L  + +  +T + +      
Sbjct: 27  KATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEY 86

Query: 60  PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
                   LF  +    +  ++R        + +  L+      +++RD+K+ N++LD+D
Sbjct: 87  ANGG---ELFFHLSRERVFTEERARFY--GAEIVSALEYLHSRDVVYRDIKLENLMLDKD 141

Query: 120 LKPKISDFGLARILRKMILKQIQIE--LGYIPPEYVGRGVYYKK 161
              KI+DFGL +                 Y+ PE +    Y + 
Sbjct: 142 GHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRA 185

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 77.2 bits (189), Expect = 3e-18
 Identities = 34/164 (20%), Positives = 69/164 (42%), Gaps = 11/164 (6%)

Query: 1   GVLPDGQIIAVKKL--SKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYE 57
                G+  A+KK+   K+          E+ +  +L+H N++++       +  +L++E
Sbjct: 21  AQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80

Query: 58  YMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLD 117
           ++ +            +      + V     ++Q L  +       ++HRDLK  N+L++
Sbjct: 81  HLDQDLKKLLDVCEGGL------ESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLIN 134

Query: 118 EDLKPKISDFGLARILRKMILKQIQI--ELGYIPPEYVGRGVYY 159
            + + KI+DFGLAR     + K       L Y  P+ +     Y
Sbjct: 135 REGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKY 178

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 76.5 bits (187), Expect = 6e-18
 Identities = 32/165 (19%), Positives = 64/165 (38%), Gaps = 12/165 (7%)

Query: 3   LPDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYM 59
               +I+A+K++               E+ L  +L+H N++R        ++  L++E+ 
Sbjct: 24  RETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC 83

Query: 60  PKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED 119
            +    YF                 +   + Q L  L       ++HRDLK  N+L++ +
Sbjct: 84  DQDLKKYFDSCN------GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRN 137

Query: 120 LKPKISDFGLARIL---RKMILKQIQIELGYIPPEYVGRGVYYKK 161
            + K+++FGLAR      +    ++       P    G  +Y   
Sbjct: 138 GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTS 182

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 76.0 bits (186), Expect = 1e-17
 Identities = 33/163 (20%), Positives = 61/163 (37%), Gaps = 11/163 (6%)

Query: 3   LPDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEY 58
              G   A+K L K+     +  E   NE  +   +    L+++     +     ++ EY
Sbjct: 63  KESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEY 122

Query: 59  MPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE 118
           +    +   L    R               I+    YL     L +I+RDLK  N+L+D+
Sbjct: 123 VAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQ 176

Query: 119 DLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKK 161
               +++DFG A+ ++      +      + PE +    Y K 
Sbjct: 177 QGYIQVTDFGFAKRVKGRT-WTLCGTPEALAPEIILSKGYNKA 218

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 74.4 bits (182), Expect = 4e-17
 Identities = 44/168 (26%), Positives = 68/168 (40%), Gaps = 18/168 (10%)

Query: 3   LPDGQIIAVKKLSKKSTQGF------EEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLI 55
              G   A K + K+ T+        E+ + EV +  ++QH N+I +        + +LI
Sbjct: 32  KSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILI 91

Query: 56  YEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNIL 115
            E +    L  FL +      L  ++    +K I+ G   +     L I H DLK  NI+
Sbjct: 92  LELVAGGELFDFLAEKES---LTEEEATEFLKQILNG---VYYLHSLQIAHFDLKPENIM 145

Query: 116 LDEDLKP----KISDFGLARILRKM-ILKQIQIELGYIPPEYVGRGVY 158
           L +   P    KI DFGLA  +      K I     ++ PE V     
Sbjct: 146 LLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPL 193

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 72.5 bits (177), Expect = 2e-16
 Identities = 28/174 (16%), Positives = 60/174 (34%), Gaps = 22/174 (12%)

Query: 3   LPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLI-RVGFCIETQEYMLIYEYMPK 61
           L + Q +A+K   ++S     + ++E      L     I  V +  +   + ++   +  
Sbjct: 27  LLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLG 84

Query: 62  RSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLK 121
            SL+  L    R      K      K ++  +  + E    ++++RD+K  N L+     
Sbjct: 85  PSLEDLLDLCGRKF--SVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNS 139

Query: 122 P-----KISDFGLARILRKMILKQIQIE---------LGYIPPEYVGRGVYYKK 161
                  + DFG+ +  R  + KQ               Y+           ++
Sbjct: 140 KNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRR 193

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 72.4 bits (177), Expect = 2e-16
 Identities = 35/169 (20%), Positives = 64/169 (37%), Gaps = 19/169 (11%)

Query: 3   LPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKL-QHLNLIRV-----GFCIETQEYMLIY 56
               +  A+K L         + + EV L  +  Q  +++R+           +  +++ 
Sbjct: 34  KRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 88

Query: 57  EYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILL 116
           E +    L   + D         ++   I+K I + + YL     + I HRD+K  N+L 
Sbjct: 89  ECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLY 144

Query: 117 D---EDLKPKISDFGLARILRK-MILKQIQIELGYIPPEYVGRGVYYKK 161
                +   K++DFG A+       L        Y+ PE +G   Y K 
Sbjct: 145 TSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKS 193

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 72.2 bits (176), Expect = 3e-16
 Identities = 32/152 (21%), Positives = 61/152 (40%), Gaps = 12/152 (7%)

Query: 4   PDGQIIAVKKLSKKS----TQGFEEFKNEVMLTAKLQHLNLIRV--GFCIETQEYMLIYE 57
             G++ A+K L K +     +  E  + E  +   ++    +           +  LI +
Sbjct: 50  DTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILD 109

Query: 58  YMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLD 117
           Y+    L   L    R           +   + + +L L+   +L II+RD+K+ NILLD
Sbjct: 110 YINGGELFTHLSQRERFTEH------EVQIYVGEIVLALEHLHKLGIIYRDIKLENILLD 163

Query: 118 EDLKPKISDFGLARILRKMILKQIQIELGYIP 149
            +    ++DFGL++       ++     G I 
Sbjct: 164 SNGHVVLTDFGLSKEFVADETERAYDFCGTIE 195

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 72.2 bits (176), Expect = 3e-16
 Identities = 37/168 (22%), Positives = 67/168 (39%), Gaps = 17/168 (10%)

Query: 3   LPDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQ-------EYM 53
              G  +A+KKL +   S    +    E+ L   ++H N+I +              ++ 
Sbjct: 40  GRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFY 99

Query: 54  LIYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSN 113
           L+  +M            ++   L   +   ++  +++GL Y+       IIHRDLK  N
Sbjct: 100 LVMPFMGTDLGKL-----MKHEKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGN 151

Query: 114 ILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKK 161
           + ++ED + KI DFGLAR     +   +       P   +    Y + 
Sbjct: 152 LAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQT 199

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 71.8 bits (175), Expect = 4e-16
 Identities = 37/170 (21%), Positives = 75/170 (44%), Gaps = 13/170 (7%)

Query: 2   VLPDGQIIAVKKLSKKSTQG--FEEFKNEVMLTAKL---QHLNLIRV-GFCIETQEYMLI 55
           +   G+ +A+K++  ++ +         EV +   L   +H N++R+   C  ++     
Sbjct: 29  LKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRET 88

Query: 56  YEYMPKRSLD---YFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVS 112
              +    +D       D +    +  +    ++  +++GL +L  +    ++HRDLK  
Sbjct: 89  KLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQ 145

Query: 113 NILLDEDLKPKISDFGLARILRKM-ILKQIQIELGYIPPEYVGRGVYYKK 161
           NIL+    + K++DFGLARI      L  + + L Y  PE + +  Y   
Sbjct: 146 NILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATP 195

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 68.7 bits (167), Expect = 4e-15
 Identities = 31/173 (17%), Positives = 55/173 (31%), Gaps = 22/173 (12%)

Query: 3   LPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV--GFCIETQEYMLIYEYMP 60
           +  G+ +A+K    K+     +   E  +   +Q    I        E    +++ E + 
Sbjct: 29  IAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG 86

Query: 61  KRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNIL---LD 117
               D F F   +      K  + +   +I  + Y+        IHRD+K  N L     
Sbjct: 87  PSLEDLFNFCSRK---FSLKTVLLLADQMISRIEYI---HSKNFIHRDVKPDNFLMGLGK 140

Query: 118 EDLKPKISDFGLARILR---------KMILKQIQIELGYIPPEYVGRGVYYKK 161
           +     I DFGLA+  R             K +     Y            ++
Sbjct: 141 KGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRR 193

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 65.7 bits (159), Expect = 7e-14
 Identities = 41/163 (25%), Positives = 68/163 (41%), Gaps = 7/163 (4%)

Query: 3   LPDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYE--Y 58
              G  +AVKKLS+   S    +    E+ L   ++H N+I +         +  +   Y
Sbjct: 40  TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVY 99

Query: 59  MPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE 118
           +    +   L + ++   L       +I  I++GL Y+        IHRDLK SN+ ++E
Sbjct: 100 LVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADI---IHRDLKPSNLAVNE 156

Query: 119 DLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKK 161
           D + KI DFGLAR     +   +       P   +    Y + 
Sbjct: 157 DCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMHYNQT 199

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 62.9 bits (152), Expect = 6e-13
 Identities = 30/163 (18%), Positives = 64/163 (39%), Gaps = 18/163 (11%)

Query: 3   LPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQ-HLNLIRVGFCIETQE---YMLIYEY 58
           + + + + VK L        ++ K E+ +   L+   N+I +   ++        L++E+
Sbjct: 57  ITNNEKVVVKILKPVKK---KKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 113

Query: 59  MPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLD- 117
           +                 L        +  I++ L Y      + I+HRD+K  N+++D 
Sbjct: 114 VNNTDFKQL------YQTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDH 164

Query: 118 EDLKPKISDFGLARILRKMILKQIQIE-LGYIPPEYVGRGVYY 159
           E  K ++ D+GLA          +++    +  PE +     Y
Sbjct: 165 EHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMY 207

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 59.2 bits (142), Expect = 1e-11
 Identities = 36/139 (25%), Positives = 61/139 (43%), Gaps = 18/139 (12%)

Query: 3   LPDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-------GFCIETQEYM 53
               + +A+KKLS+   +    +    E++L   + H N+I +           E Q+  
Sbjct: 39  AVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVY 98

Query: 54  LIYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSN 113
           L+ E M          +       D ++  +++  ++ G+ +L        IHRDLK SN
Sbjct: 99  LVMELMDANLCQVIQMEL------DHERMSYLLYQMLCGIKHLHSAGI---IHRDLKPSN 149

Query: 114 ILLDEDLKPKISDFGLARI 132
           I++  D   KI DFGLAR 
Sbjct: 150 IVVKSDCTLKILDFGLART 168

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 55.0 bits (131), Expect = 3e-10
 Identities = 32/179 (17%), Positives = 65/179 (36%), Gaps = 24/179 (13%)

Query: 3   LPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIET---QEYMLIYEYM 59
           + +   +A+K + +      E  ++E+ L  ++   +  +          +         
Sbjct: 35  MVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKG 93

Query: 60  PKRSLDYFLFDPIRMLILDCKKR-----------VHIIKGIIQGLLYLQEYFRLTIIHRD 108
           P       +F+ +   +L   K+             I K ++ GL Y+  + R  IIH D
Sbjct: 94  PNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYM--HRRCGIIHTD 151

Query: 109 LKVSNILLDED------LKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKK 161
           +K  N+L++        ++ KI+D G A    +     IQ    Y  PE +    +   
Sbjct: 152 IKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQT-REYRSPEVLLGAPWGCG 209

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 52.9 bits (126), Expect = 8e-10
 Identities = 18/143 (12%), Positives = 43/143 (30%), Gaps = 19/143 (13%)

Query: 1   GVLPDGQIIAVKKLSKKST----------QGFEEFKNEVMLTAKLQHLNLIRVGFCIETQ 50
                     VK      T           G   F    + +A+ +   L ++      +
Sbjct: 19  CYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPK 78

Query: 51  EYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLK 110
            Y      +    ++      +  + ++      ++  I++ +          I+H DL 
Sbjct: 79  VYAWEGNAV---LMELIDAKELYRVRVENPDE--VLDMILEEVAKFYHRG---IVHGDLS 130

Query: 111 VSNILLDEDLKPKISDFGLARIL 133
             N+L+  +    I DF  +  +
Sbjct: 131 QYNVLVS-EEGIWIIDFPQSVEV 152

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	164
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	99.98
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	99.98
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	99.97
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	99.97
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	99.97
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	99.97
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	99.97
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	99.97
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	99.97
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.97
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	99.97
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.97
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.97
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.96
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.96
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.91
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.78
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.48
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.79
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.38
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	96.37
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	96.26
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	95.55

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-40  Score=235.67  Aligned_cols=156  Identities=24%  Similarity=0.311  Sum_probs=136.5

Q ss_pred             cCCCcEEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            3 LPDGQIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         3 ~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      ..+|+.||+|.+..+ .+.....+.+|+.+++.++||||+++ +.+...+..++||||+++|+|.+++.+...   +++.
T Consensus        28 ~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~~~---l~~~  104 (322)
T d1s9ja_          28 KPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGR---IPEQ  104 (322)
T ss_dssp             TTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHHSS---CCHH
T ss_pred             CCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhcCC---CCHH
Confidence            357899999998765 34445678999999999999999998 777788889999999999999999875433   8999


Q ss_pred             HHHHHHHHHHHHHHHhhh-cCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCcceecCCcce
Q 046065           81 KRVHIIKGIIQGLLYLQE-YFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~-~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      .+..++.|++.||.|+|+ +   +|+||||||+|||++.++.+||+|||+|...........+||+.|+|||++.+..|+
T Consensus       105 ~~~~~~~qil~aL~yLH~~~---~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~~GT~~Y~APEvl~~~~y~  181 (322)
T d1s9ja_         105 ILGKVSIAVIKGLTYLREKH---KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYS  181 (322)
T ss_dssp             HHHHHHHHHHHHHHHHHHHH---CCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHTC---CCSSCCCCHHHHHCSCCC
T ss_pred             HHHHHHHHHHHHHHHHHHhC---CEEccccCHHHeeECCCCCEEEeeCCCccccCCCccccccCCccccCchHHcCCCCC
Confidence            999999999999999997 4   799999999999999999999999999988776666778999999999999999999


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      .++||
T Consensus       182 ~~~Di  186 (322)
T d1s9ja_         182 VQSDI  186 (322)
T ss_dssp             TTHHH
T ss_pred             cHHHH
Confidence            99996

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-40  Score=230.14  Aligned_cols=155  Identities=23%  Similarity=0.365  Sum_probs=137.1

Q ss_pred             cCCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            3 LPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      ..+|+.||||.+..+.....+.+.+|+.+++.++||||+++ +.+...+..|+||||+++|+|.+++...    .+++..
T Consensus        42 ~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~~----~l~~~~  117 (293)
T d1yhwa1          42 VATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET----CMDEGQ  117 (293)
T ss_dssp             TTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHS----CCCHHH
T ss_pred             CCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhcc----CCCHHH
Confidence            35789999999876655566788999999999999999998 7777888899999999999999887543    289999


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh--hhhhhcccccccCcceecCCcce
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM--ILKQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      +..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++.+...  .....+||+.|+|||++.++.|+
T Consensus       118 ~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~  194 (293)
T d1yhwa1         118 IAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYG  194 (293)
T ss_dssp             HHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSCBC
T ss_pred             HHHHHHHHHHHHHHHHHC---CCcccCCcHHHeEECCCCcEeeccchhheeeccccccccccccCCCccChhhhcCCCCC
Confidence            999999999999999998   9999999999999999999999999999876432  23567899999999999999999


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      .++||
T Consensus       195 ~~~Di  199 (293)
T d1yhwa1         195 PKVDI  199 (293)
T ss_dssp             THHHH
T ss_pred             chhce
Confidence            99996

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-40  Score=228.72  Aligned_cols=155  Identities=27%  Similarity=0.396  Sum_probs=137.2

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+++.||+|.+.+.   .......+.+|+.+++.++||||+++ +.+.+.+..++||||+++|+|.+++.....   +++
T Consensus        29 ~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~~~---l~e  105 (263)
T d2j4za1          29 QSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDE  105 (263)
T ss_dssp             TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSS---CCH
T ss_pred             CCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhhcCC---CCH
Confidence            57889999998644   33445678899999999999999998 777777889999999999999998875433   899


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCcceecCCcce
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      ..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++............||+.|+|||++.+..|+
T Consensus       106 ~~~~~i~~qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~Gt~~Y~APE~~~~~~~~  182 (263)
T d2j4za1         106 QRTATYITELANALSYCHSK---RVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHD  182 (263)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCCEETTEEGGGCCHHHHTTCCCC
T ss_pred             HHHHHHHHHHHHHHHHHHHC---CeeeeeeccccceecCCCCEeecccceeeecCCCcccccCCCCcccCHHHHcCCCCC
Confidence            99999999999999999998   999999999999999999999999999987665555667899999999999999999


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      .++||
T Consensus       183 ~~~Di  187 (263)
T d2j4za1         183 EKVDL  187 (263)
T ss_dssp             TTHHH
T ss_pred             chhhh
Confidence            99996

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-40  Score=229.08  Aligned_cols=155  Identities=29%  Similarity=0.411  Sum_probs=131.4

Q ss_pred             CCCcEEEEEEccccc-cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            4 PDGQIIAVKKLSKKS-TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         4 ~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      .+|+.||||.+..+. ....+.+.+|+.+++.++||||+++ +.+...+..|+||||+++|+|.+++....   .+++..
T Consensus        28 ~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~---~l~e~~  104 (271)
T d1nvra_          28 VTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI---GMPEPD  104 (271)
T ss_dssp             TTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTT---BCCHHH
T ss_pred             CCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhcCC---CCCHHH
Confidence            578999999987552 3344678899999999999999998 77788888999999999999999986543   389999


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh----hhhhhcccccccCcceecCCc
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM----ILKQIQIELGYIPPEYVGRGV  157 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~  157 (164)
                      +..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+|......    .....+||+.|||||++.+..
T Consensus       105 ~~~i~~qi~~al~ylH~~---~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~  181 (271)
T d1nvra_         105 AQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRRE  181 (271)
T ss_dssp             HHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSS
T ss_pred             HHHHHHHHHHHHHHHHHc---CCccCcccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCC
Confidence            999999999999999998   9999999999999999999999999999876422    234578999999999998877


Q ss_pred             c-eeccCC
Q 046065          158 Y-YKKFSL  164 (164)
Q Consensus       158 ~-~~~~Di  164 (164)
                      + +.++||
T Consensus       182 ~~~~~~Di  189 (271)
T d1nvra_         182 FHAEPVDV  189 (271)
T ss_dssp             BCHHHHHH
T ss_pred             CCCCceee
Confidence            6 677885

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-39  Score=226.27  Aligned_cols=156  Identities=23%  Similarity=0.318  Sum_probs=135.4

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      .+++.||+|.+........+.+.+|+.+++.++||||+++ +.+...+..++||||+++|+|.+++.+..  ..+++..+
T Consensus        35 ~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~--~~l~e~~~  112 (288)
T d2jfla1          35 ETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE--RPLTESQI  112 (288)
T ss_dssp             TTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHT--SCCCHHHH
T ss_pred             CCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcC--CCCCHHHH
Confidence            5788999999987766667789999999999999999998 77788889999999999999998875432  23899999


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh--hhhhhcccccccCccee-----cC
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM--ILKQIQIELGYIPPEYV-----GR  155 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~-----~~  155 (164)
                      ..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++......  ......||+.|+|||++     .+
T Consensus       113 ~~i~~qi~~gL~ylH~~---~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~  189 (288)
T d2jfla1         113 QVVCKQTLDALNYLHDN---KIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKD  189 (288)
T ss_dssp             HHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTT
T ss_pred             HHHHHHHHHHHHHHHHC---CEEEeecChhheeECCCCCEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCC
Confidence            99999999999999998   9999999999999999999999999999765433  23567899999999998     35


Q ss_pred             CcceeccCC
Q 046065          156 GVYYKKFSL  164 (164)
Q Consensus       156 ~~~~~~~Di  164 (164)
                      ..|+.++||
T Consensus       190 ~~y~~k~Di  198 (288)
T d2jfla1         190 RPYDYKADV  198 (288)
T ss_dssp             SSTTTHHHH
T ss_pred             CCCChhhhH
Confidence            567889886

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-39  Score=225.54  Aligned_cols=155  Identities=25%  Similarity=0.311  Sum_probs=133.2

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+|+.||||.+.++   .....+.+.+|+.+++.++||||+++ +.+...+..|+||||+++|+|.+++.....   +++
T Consensus        31 ~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~~---l~e  107 (288)
T d1uu3a_          31 ATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGS---FDE  107 (288)
T ss_dssp             TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSS---CCH
T ss_pred             CCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhccCC---CCH
Confidence            57899999998754   23455778999999999999999998 777777889999999999999988765433   899


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh----hhhhhcccccccCcceecC
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM----ILKQIQIELGYIPPEYVGR  155 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~~aPE~~~~  155 (164)
                      ..+..++.|++.||.|+|++   +|+||||||+|||++.++.+||+|||+++.+...    .....+||+.|+|||++.+
T Consensus       108 ~~~~~~~~qi~~al~ylH~~---~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~  184 (288)
T d1uu3a_         108 TCTRFYTAEIVSALEYLHGK---GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTE  184 (288)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHT
T ss_pred             HHHHHHHHHHHHHHHhhccc---cEEcCcCCccccccCCCceEEecccccceecccCCcccccccccCCccccCceeecc
Confidence            99999999999999999998   9999999999999999999999999999876422    2345689999999999999


Q ss_pred             CcceeccCC
Q 046065          156 GVYYKKFSL  164 (164)
Q Consensus       156 ~~~~~~~Di  164 (164)
                      ..|+.++||
T Consensus       185 ~~~~~~~Di  193 (288)
T d1uu3a_         185 KSACKSSDL  193 (288)
T ss_dssp             CCCCHHHHH
T ss_pred             CCCCcccce
Confidence            999999996

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.7e-39  Score=224.30  Aligned_cols=162  Identities=27%  Similarity=0.366  Sum_probs=123.6

Q ss_pred             cCCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEee--CCcEEEEEEecCCCChhhhhhCcc-cccc
Q 046065            3 LPDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIE--TQEYMLIYEYMPKRSLDYFLFDPI-RMLI   76 (164)
Q Consensus         3 ~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~-~~~~   76 (164)
                      ..+|+.||+|.+...  .+...+.+.+|+.+++.++||||+++ +.+.+  .+.+|+||||+++|+|.+++.+.. ....
T Consensus        26 ~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~  105 (269)
T d2java1          26 KSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQY  105 (269)
T ss_dssp             TTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCC
T ss_pred             CCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCC
Confidence            357899999998755  33445678899999999999999998 55543  356899999999999999886532 2234


Q ss_pred             cCHHHHHHHHHHHHHHHHHhhhcC--CCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh--hhhhhcccccccCcce
Q 046065           77 LDCKKRVHIIKGIIQGLLYLQEYF--RLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM--ILKQIQIELGYIPPEY  152 (164)
Q Consensus        77 ~~~~~~~~~~~~~~~~l~~lh~~~--~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~  152 (164)
                      +++..++.++.|++.||.|+|+..  ..+|+||||||+|||++.++.+||+|||+++.+...  ......||+.|+|||+
T Consensus       106 l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~  185 (269)
T d2java1         106 LDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQ  185 (269)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-----------CCCSCCCHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCCCccccCCCCcccCCHHH
Confidence            899999999999999999999862  124999999999999999999999999999877543  2356789999999999


Q ss_pred             ecCCcceeccCC
Q 046065          153 VGRGVYYKKFSL  164 (164)
Q Consensus       153 ~~~~~~~~~~Di  164 (164)
                      +.+..|+.++||
T Consensus       186 l~~~~~~~~~DI  197 (269)
T d2java1         186 MNRMSYNEKSDI  197 (269)
T ss_dssp             HTTCCCCHHHHH
T ss_pred             HcCCCCChHHHH
Confidence            999999999996

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-38  Score=220.12  Aligned_cols=156  Identities=26%  Similarity=0.336  Sum_probs=130.1

Q ss_pred             CCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEee----CCcEEEEEEecCCCChhhhhhCcccccc
Q 046065            4 PDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIE----TQEYMLIYEYMPKRSLDYFLFDPIRMLI   76 (164)
Q Consensus         4 ~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~   76 (164)
                      .+++.||+|.+...  .....+.+.+|+++++.++||||+++ +.+..    ...+++||||+++|+|.+++.+...   
T Consensus        32 ~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~---  108 (270)
T d1t4ha_          32 ETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKV---  108 (270)
T ss_dssp             TTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSS---
T ss_pred             CCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhcccc---
Confidence            56889999998654  23345678899999999999999998 55543    2347899999999999999875433   


Q ss_pred             cCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeec-CCCCeEEccccchhhhhhhhhhhhcccccccCcceecC
Q 046065           77 LDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLD-EDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGR  155 (164)
Q Consensus        77 ~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~-~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~  155 (164)
                      +++..+..++.|++.||.|||++ ..+|+||||||+|||++ .++.+||+|||+++..........+||+.|+|||++. 
T Consensus       109 ~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~~~~~~GT~~Y~aPE~~~-  186 (270)
T d1t4ha_         109 MKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYE-  186 (270)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTSBEESCSSCCCCCGGGGG-
T ss_pred             ccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCCccCCcccCccccCHHHhC-
Confidence            88999999999999999999988 12299999999999996 4789999999999876555556778999999999986 


Q ss_pred             CcceeccCC
Q 046065          156 GVYYKKFSL  164 (164)
Q Consensus       156 ~~~~~~~Di  164 (164)
                      +.|+.++||
T Consensus       187 ~~~~~~~DI  195 (270)
T d1t4ha_         187 EKYDESVDV  195 (270)
T ss_dssp             TCCCTHHHH
T ss_pred             CCCCCcCch
Confidence            469999986

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-38  Score=226.86  Aligned_cols=155  Identities=22%  Similarity=0.279  Sum_probs=136.4

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+|+.||+|.+.++   .......+.+|+.+++.++||||+++ ..+.+...+|+||||+++|+|..++.....   +++
T Consensus        28 ~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~~~~---~~e  104 (337)
T d1o6la_          28 ATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERV---FTE  104 (337)
T ss_dssp             TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSC---CCH
T ss_pred             CCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhhcccC---CcH
Confidence            57899999999754   33456778899999999999999998 777777889999999999999988876443   889


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh--hhhhhhcccccccCcceecCCc
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK--MILKQIQIELGYIPPEYVGRGV  157 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~~aPE~~~~~~  157 (164)
                      ..+..++.|++.||.|+|++   +|+||||||+|||++.+|.+||+|||+|+....  ......+||+.|+|||++.+..
T Consensus       105 ~~~~~~~~qil~al~ylH~~---~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~  181 (337)
T d1o6la_         105 ERARFYGAEIVSALEYLHSR---DVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDND  181 (337)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSC
T ss_pred             HHHHHHHHHHhhhhhhhhhc---CccccccCHHHeEecCCCCEEEeecccccccccCCcccccceeCHHHhhhhhccCCC
Confidence            99999999999999999999   999999999999999999999999999986543  2335678999999999999999


Q ss_pred             ceeccCC
Q 046065          158 YYKKFSL  164 (164)
Q Consensus       158 ~~~~~Di  164 (164)
                      |+.++||
T Consensus       182 y~~~~Di  188 (337)
T d1o6la_         182 YGRAVDW  188 (337)
T ss_dssp             BCTTHHH
T ss_pred             CChhhcc
Confidence            9999985

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.3e-38  Score=223.68  Aligned_cols=155  Identities=25%  Similarity=0.373  Sum_probs=118.2

Q ss_pred             CCCcEEEEEEccccc-cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            4 PDGQIIAVKKLSKKS-TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         4 ~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      .+++.||||.+..+. ......+.+|+.+++.++||||+++ +.+...+..|+||||+++|+|.+++.....   +++..
T Consensus        32 ~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~~~~---l~e~~  108 (307)
T d1a06a_          32 RTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGF---YTERD  108 (307)
T ss_dssp             TTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSC---CCHHH
T ss_pred             CCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhcccC---CCHHH
Confidence            578999999987653 2234567789999999999999998 777777889999999999999999876433   89999


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeec---CCCCeEEccccchhhhhhh-hhhhhcccccccCcceecCCc
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLD---EDLKPKISDFGLARILRKM-ILKQIQIELGYIPPEYVGRGV  157 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~---~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~  157 (164)
                      +..++.|++.||.|||++   +|+||||||+||++.   .++.+||+|||++...... .....+||+.|+|||++.+..
T Consensus       109 ~~~~~~qi~~al~ylH~~---~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~~~  185 (307)
T d1a06a_         109 ASRLIFQVLDAVKYLHDL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKP  185 (307)
T ss_dssp             HHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEESSSSTTCCEEECCC------------------CTTSCHHHHTTCC
T ss_pred             HHHHHHHHHHHHHhhhhc---eeeeEEecccceeecccCCCceEEEeccceeEEccCCCeeeeeeeCccccCcHHHcCCC
Confidence            999999999999999998   999999999999995   4688999999999866543 335678999999999999999


Q ss_pred             ceeccCC
Q 046065          158 YYKKFSL  164 (164)
Q Consensus       158 ~~~~~Di  164 (164)
                      |+.++||
T Consensus       186 ~~~~~Di  192 (307)
T d1a06a_         186 YSKAVDC  192 (307)
T ss_dssp             CCTHHHH
T ss_pred             CCcHHHh
Confidence            9999996

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.2e-38  Score=219.57  Aligned_cols=156  Identities=25%  Similarity=0.445  Sum_probs=126.1

Q ss_pred             cCCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            3 LPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      ..+++.||||.+... ....+.+.+|+.+++.++||||+++ +.+...+..++||||+++|+|.+++.....  .+++..
T Consensus        26 ~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~--~~~~~~  102 (263)
T d1sm2a_          26 WLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRG--LFAAET  102 (263)
T ss_dssp             ETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTT--CCCHHH
T ss_pred             ECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhcccc--CCCHHH
Confidence            456788999998654 3345678999999999999999998 778888899999999999999998865432  278889


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh---hhhhcccccccCcceecCCcc
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI---LKQIQIELGYIPPEYVGRGVY  158 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~  158 (164)
                      ...++.|++.||.|+|+.   +|+||||||+||+++.++.+||+|||+++......   .....||+.|+|||++.+..|
T Consensus       103 ~~~i~~qia~gl~~lH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~  179 (263)
T d1sm2a_         103 LLGMCLDVCEGMAYLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY  179 (263)
T ss_dssp             HHHHHHHHHHHHHHHHHT---TCCCTTCSGGGEEECGGGCEEECSCC------------------CTTSCCHHHHTTCCC
T ss_pred             HHHHHHHHHHHHHhhhcc---ceeecccchhheeecCCCCeEecccchheeccCCCceeecceecCcccCChHHhcCCCC
Confidence            999999999999999998   99999999999999999999999999998765432   234678999999999999999


Q ss_pred             eeccCC
Q 046065          159 YKKFSL  164 (164)
Q Consensus       159 ~~~~Di  164 (164)
                      +.++||
T Consensus       180 ~~k~DV  185 (263)
T d1sm2a_         180 SSKSDV  185 (263)
T ss_dssp             CHHHHH
T ss_pred             Cchhhh
Confidence            999996

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=8.5e-38  Score=222.37  Aligned_cols=154  Identities=29%  Similarity=0.394  Sum_probs=134.8

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+|+.||||.+.++   .....+.+.+|+.+++.++||||+++ +.+...+..|+||||+++|+|...+.....   +++
T Consensus        27 ~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~~~~---~~~  103 (316)
T d1fota_          27 HNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQR---FPN  103 (316)
T ss_dssp             TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSS---CCH
T ss_pred             CCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCcccccccccccc---ccc
Confidence            57899999998754   34456788999999999999999998 777777889999999999999888875443   788


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCcceecCCcce
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      .....++.|++.|+.|+|++   +|+||||||+|||++.++.+||+|||+++..... ....+||+.|+|||++.+..|+
T Consensus       104 ~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-~~~~~Gt~~Y~APE~l~~~~y~  179 (316)
T d1fota_         104 PVAKFYAAEVCLALEYLHSK---DIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-TYTLCGTPDYIAPEVVSTKPYN  179 (316)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-BCCCCSCTTTCCHHHHTTCCBC
T ss_pred             cHHHHHHHHHHHhhhhhccC---cEEccccCchheeEcCCCCEEEecCccceEeccc-cccccCcccccCHHHHcCCCCC
Confidence            88899999999999999998   9999999999999999999999999999765432 3457899999999999989999


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      .++||
T Consensus       180 ~~~Di  184 (316)
T d1fota_         180 KSIDW  184 (316)
T ss_dssp             TTHHH
T ss_pred             chhhc
Confidence            99986

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=1.6e-37  Score=223.78  Aligned_cols=156  Identities=23%  Similarity=0.287  Sum_probs=135.6

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      .+|+.||||.+..........+.+|+.+++.++||||+++ +.+...+.+|+||||+++|+|.+.+....  ..+++..+
T Consensus        52 ~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~--~~l~e~~~  129 (352)
T d1koba_          52 ATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED--YKMSEAEV  129 (352)
T ss_dssp             TTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTT--CCBCHHHH
T ss_pred             CCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcC--CCCCHHHH
Confidence            5789999999876655556678899999999999999998 77777788999999999999988775432  23899999


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeec--CCCCeEEccccchhhhhhhh-hhhhcccccccCcceecCCcce
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLD--EDLKPKISDFGLARILRKMI-LKQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~--~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      ..++.|++.||.|||++   +|+||||||+|||++  .++.+||+|||++....... .....||+.|+|||++.+..|+
T Consensus       130 ~~i~~qi~~aL~ylH~~---~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  206 (352)
T d1koba_         130 INYMRQACEGLKHMHEH---SIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVG  206 (352)
T ss_dssp             HHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBC
T ss_pred             HHHHHHHHHHHHHHHHC---CeeecccccccccccccCCCeEEEeecccceecCCCCceeeccCcccccCHHHHcCCCCC
Confidence            99999999999999998   999999999999997  56899999999998765433 3557899999999999999999


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      .++||
T Consensus       207 ~~~Di  211 (352)
T d1koba_         207 FYTDM  211 (352)
T ss_dssp             HHHHH
T ss_pred             Cccch
Confidence            99986

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1.1e-37  Score=224.36  Aligned_cols=156  Identities=22%  Similarity=0.278  Sum_probs=135.9

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      .+|+.||||.+........+.+.+|+.+++.++||||+++ +.+...+.+++||||+++|+|.+++.+...  .+++..+
T Consensus        49 ~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~--~l~e~~~  126 (350)
T d1koaa2          49 ATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHN--KMSEDEA  126 (350)
T ss_dssp             TTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTTS--CBCHHHH
T ss_pred             CCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhcC--CCCHHHH
Confidence            5789999999976655566778999999999999999998 777888899999999999999998864322  2899999


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecC--CCCeEEccccchhhhhhh-hhhhhcccccccCcceecCCcce
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE--DLKPKISDFGLARILRKM-ILKQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~--~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      ..++.|++.||.|||++   +++||||||+|||++.  ++.+||+|||++..+... ......||+.|||||++.+..|+
T Consensus       127 ~~i~~qi~~aL~ylH~~---~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~  203 (350)
T d1koaa2         127 VEYMRQVCKGLCHMHEN---NYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVG  203 (350)
T ss_dssp             HHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHTCCBC
T ss_pred             HHHHHHHHHHHHHHHhc---CCeeeeechhHeeeccCCCCeEEEeecchheecccccccceecCcccccCHHHHcCCCCC
Confidence            99999999999999998   9999999999999964  578999999999876543 33557899999999999999999


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      .++||
T Consensus       204 ~~~Di  208 (350)
T d1koaa2         204 YYTDM  208 (350)
T ss_dssp             HHHHH
T ss_pred             hhHhh
Confidence            99986

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.9e-38  Score=221.00  Aligned_cols=156  Identities=26%  Similarity=0.407  Sum_probs=134.3

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      .+++.||||.+..+ ....+.+.+|+.+++.++||||+++ +.+...+..++||||+++|+|..++..... ..+++..+
T Consensus        40 ~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~-~~~~~~~~  117 (287)
T d1opja_          40 KYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNR-QEVSAVVL  117 (287)
T ss_dssp             GGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCT-TTSCHHHH
T ss_pred             CCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhccc-cchHHHHH
Confidence            35789999998654 3345678999999999999999998 777788889999999999999998865322 23889999


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh---hhhhcccccccCcceecCCcce
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI---LKQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      ..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++......   .....|++.|+|||++.++.|+
T Consensus       118 ~~i~~qi~~gL~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~  194 (287)
T d1opja_         118 LYMATQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS  194 (287)
T ss_dssp             HHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCS
T ss_pred             HHHHHHHHHHHHHHHHC---CcccCccccCeEEECCCCcEEEccccceeecCCCCceeeccccccccccChHHHcCCCCC
Confidence            99999999999999998   99999999999999999999999999998765432   2345688899999999999999


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      .|+||
T Consensus       195 ~k~Di  199 (287)
T d1opja_         195 IKSDV  199 (287)
T ss_dssp             HHHHH
T ss_pred             chhhh
Confidence            99996

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.6e-38  Score=218.08  Aligned_cols=157  Identities=30%  Similarity=0.468  Sum_probs=132.7

Q ss_pred             cCCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeEeEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            3 LPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      ..+++.||||.+... ....+.+.+|+.+++.++||||+++..+...+..++||||+++|+|.+++..... ..+++..+
T Consensus        34 ~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~iv~Ey~~~g~L~~~~~~~~~-~~l~~~~~  111 (272)
T d1qpca_          34 YNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSG-IKLTINKL  111 (272)
T ss_dssp             ETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCTTCBHHHHTTSHHH-HTCCHHHH
T ss_pred             ECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeeccCCeEEEEEeCCCCcHHHHHhhcCC-CCCCHHHH
Confidence            456788999998654 3345678999999999999999998444556678999999999999987765322 23889999


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh---hhhhcccccccCcceecCCcce
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI---LKQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      ..++.|++.||.|+|++   +|+||||||+|||++.++.+||+|||+++......   .....|++.|+|||++..+.|+
T Consensus       112 ~~i~~qi~~gl~~lH~~---~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~  188 (272)
T d1qpca_         112 LDMAAQIAEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFT  188 (272)
T ss_dssp             HHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEEC
T ss_pred             HHHHHHHHHHHHHHHhC---CcccCccchhheeeecccceeeccccceEEccCCccccccccCCcccccChHHHhCCCCC
Confidence            99999999999999998   99999999999999999999999999998765332   2456788999999999989999


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      .++||
T Consensus       189 ~~sDv  193 (272)
T d1qpca_         189 IKSDV  193 (272)
T ss_dssp             HHHHH
T ss_pred             chhhh
Confidence            99996

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-38  Score=219.31  Aligned_cols=154  Identities=25%  Similarity=0.347  Sum_probs=128.2

Q ss_pred             CCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeEeEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            5 DGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         5 ~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      +++.||||.+...  .+...+.+.+|+.+++.++||||+++..+...+..++||||+++|+|.+++.+...   +++..+
T Consensus        33 ~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~~~lvmE~~~~g~L~~~l~~~~~---l~~~~~  109 (277)
T d1xbba_          33 VVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQNRH---VKDKNI  109 (277)
T ss_dssp             SEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEEEECCTTEEHHHHHHHCTT---CCHHHH
T ss_pred             cCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccCCEEEEEEcCCCCcHHHHHhhccC---CCHHHH
Confidence            4578999998654  33445678999999999999999998334456678899999999999999876433   889999


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh-----hhhhcccccccCcceecCCc
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI-----LKQIQIELGYIPPEYVGRGV  157 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~  157 (164)
                      ..++.|++.||.|+|+.   +|+||||||+||+++.++.++++|||+++......     .....||+.|+|||++.+..
T Consensus       110 ~~i~~qi~~gl~ylH~~---~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~  186 (277)
T d1xbba_         110 IELVHQVSMGMKYLEES---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYK  186 (277)
T ss_dssp             HHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCE
T ss_pred             HHHHHHHHHHHhhHHhC---CcccCCCcchhhcccccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCC
Confidence            99999999999999998   99999999999999999999999999997654321     23457899999999999999


Q ss_pred             ceeccCC
Q 046065          158 YYKKFSL  164 (164)
Q Consensus       158 ~~~~~Di  164 (164)
                      ++.++||
T Consensus       187 ~~~~sDi  193 (277)
T d1xbba_         187 FSSKSDV  193 (277)
T ss_dssp             EEHHHHH
T ss_pred             CCchhhh
Confidence            9999996

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.2e-38  Score=221.51  Aligned_cols=154  Identities=29%  Similarity=0.434  Sum_probs=131.0

Q ss_pred             cCCCcEEEEEEccccc---cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccC
Q 046065            3 LPDGQIIAVKKLSKKS---TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILD   78 (164)
Q Consensus         3 ~~~~~~vavK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~   78 (164)
                      ..+++.||||.+....   ....+.+.+|+.+++.++||||+++ +.+...+..|+||||+++|++..+.....   .++
T Consensus        37 ~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~~~---~l~  113 (309)
T d1u5ra_          37 VRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK---PLQ  113 (309)
T ss_dssp             TTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHTS---CCC
T ss_pred             CCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHhCC---CCC
Confidence            3578999999987552   2344678899999999999999998 77778888999999999998876655433   389


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCcceec---C
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVG---R  155 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~---~  155 (164)
                      +..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++.....  .....||+.|+|||++.   .
T Consensus       114 e~~~~~i~~qi~~aL~yLH~~---~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~--~~~~~GT~~Y~APE~~~~~~~  188 (309)
T d1u5ra_         114 EVEIAAVTHGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--ANSFVGTPYWMAPEVILAMDE  188 (309)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHT---TCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--BCCCCSCGGGCCHHHHTTTTS
T ss_pred             HHHHHHHHHHHHHHHHHHHhC---CEeccCCCcceEEECCCCCEEEeecccccccCC--CCccccCccccCHHHHhccCC
Confidence            999999999999999999998   999999999999999999999999999976543  24567999999999985   3


Q ss_pred             CcceeccCC
Q 046065          156 GVYYKKFSL  164 (164)
Q Consensus       156 ~~~~~~~Di  164 (164)
                      +.|+.++||
T Consensus       189 ~~y~~~~Di  197 (309)
T d1u5ra_         189 GQYDGKVDV  197 (309)
T ss_dssp             CCBCTHHHH
T ss_pred             CCcCchhhh
Confidence            468999986

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-37  Score=217.08  Aligned_cols=153  Identities=30%  Similarity=0.402  Sum_probs=125.7

Q ss_pred             cEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeEeEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHHH
Q 046065            7 QIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVH   84 (164)
Q Consensus         7 ~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~   84 (164)
                      ..||||.+...  .+...+.+.+|+.+++.++||||+++..+...+..++||||+++|+|.+++.....  .+++..+..
T Consensus        31 ~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~--~~~~~~~~~  108 (276)
T d1uwha_          31 GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIET--KFEMIKLID  108 (276)
T ss_dssp             SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECCCEEEHHHHHHTSCC--CCCHHHHHH
T ss_pred             CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEeccEEEEEEecCCCCCHHHHHhhccC--CCCHHHHHH
Confidence            46999998654  34456788999999999999999998445566778999999999999998865322  388999999


Q ss_pred             HHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh----hhhhhcccccccCcceecC---Cc
Q 046065           85 IIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM----ILKQIQIELGYIPPEYVGR---GV  157 (164)
Q Consensus        85 ~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~----~~~~~~~~~~~~aPE~~~~---~~  157 (164)
                      ++.|+++||.|||++   +|+||||||+|||++.++.+||+|||+++.....    ......||+.|||||++..   ..
T Consensus       109 i~~qi~~gl~yLH~~---~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~  185 (276)
T d1uwha_         109 IARQTAQGMDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNP  185 (276)
T ss_dssp             HHHHHHHHHHHHHHT---TCCCSCCCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCC
T ss_pred             HHHHHHHHHHHHhcC---CEeccccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCC
Confidence            999999999999998   9999999999999999999999999999765421    2345689999999999853   35


Q ss_pred             ceeccCC
Q 046065          158 YYKKFSL  164 (164)
Q Consensus       158 ~~~~~Di  164 (164)
                      |+.++||
T Consensus       186 ~~~~sDi  192 (276)
T d1uwha_         186 YSFQSDV  192 (276)
T ss_dssp             CCHHHHH
T ss_pred             CCchhhh
Confidence            8999986

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-37  Score=218.15  Aligned_cols=155  Identities=23%  Similarity=0.327  Sum_probs=130.8

Q ss_pred             CCcEEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeEeEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHH
Q 046065            5 DGQIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRV   83 (164)
Q Consensus         5 ~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~   83 (164)
                      ++..||||.+... .+...+.+.+|+.+++.++||||+++..+...+..++||||+++|+|.+++.....  .+++..+.
T Consensus        35 ~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~lvmE~~~~g~L~~~l~~~~~--~l~~~~~~  112 (285)
T d1u59a_          35 KQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGKRE--EIPVSNVA  112 (285)
T ss_dssp             CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTEEHHHHHTTCTT--TSCHHHHH
T ss_pred             CcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccCeEEEEEEeCCCCcHHHHhhcccc--CCCHHHHH
Confidence            3557999998755 34456788999999999999999998434456678999999999999998754322  38999999


Q ss_pred             HHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh-----hhhhcccccccCcceecCCcc
Q 046065           84 HIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI-----LKQIQIELGYIPPEYVGRGVY  158 (164)
Q Consensus        84 ~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~  158 (164)
                      .++.|++.||.|+|++   +|+||||||+||+++.++.+||+|||+++......     .....||+.|+|||++..+.+
T Consensus       113 ~i~~qi~~gL~ylH~~---~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  189 (285)
T d1u59a_         113 ELLHQVSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKF  189 (285)
T ss_dssp             HHHHHHHHHHHHHHHT---TEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEE
T ss_pred             HHHHHHHHHHHHHHhC---CeecCcCchhheeeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCC
Confidence            9999999999999998   99999999999999999999999999998664321     134568899999999998999


Q ss_pred             eeccCC
Q 046065          159 YKKFSL  164 (164)
Q Consensus       159 ~~~~Di  164 (164)
                      +.++||
T Consensus       190 ~~ksDV  195 (285)
T d1u59a_         190 SSRSDV  195 (285)
T ss_dssp             CHHHHH
T ss_pred             Cccchh
Confidence            999996

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=4.4e-37  Score=217.28  Aligned_cols=152  Identities=28%  Similarity=0.474  Sum_probs=121.9

Q ss_pred             EEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHHHH
Q 046065            8 IIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHI   85 (164)
Q Consensus         8 ~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~   85 (164)
                      .||||.+... .....+.+.+|+.+++.++||||+++ +.+...+..++||||+++|+|.+++.....  .+++..+..+
T Consensus        56 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~--~l~~~~~~~i  133 (299)
T d1jpaa_          56 FVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG--QFTVIQLVGM  133 (299)
T ss_dssp             EEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTT--CSCHHHHHHH
T ss_pred             EEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccC--CCCHHHHHHH
Confidence            5899998654 34455679999999999999999998 777778889999999999999998875332  3889999999


Q ss_pred             HHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh-------hhhcccccccCcceecCCcc
Q 046065           86 IKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL-------KQIQIELGYIPPEYVGRGVY  158 (164)
Q Consensus        86 ~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~-------~~~~~~~~~~aPE~~~~~~~  158 (164)
                      +.|++.||.|||++   +++||||||+|||++.++.+||+|||+++.+.....       ....+|+.|||||++.++.|
T Consensus       134 ~~qia~gl~yLH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~  210 (299)
T d1jpaa_         134 LRGIAAGMKYLADM---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKF  210 (299)
T ss_dssp             HHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCC
T ss_pred             HHHHHHHHHHHhhC---CCccCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCC
Confidence            99999999999998   999999999999999999999999999987643211       23457889999999999999


Q ss_pred             eeccCC
Q 046065          159 YKKFSL  164 (164)
Q Consensus       159 ~~~~Di  164 (164)
                      +.++||
T Consensus       211 ~~~sDv  216 (299)
T d1jpaa_         211 TSASDV  216 (299)
T ss_dssp             CHHHHH
T ss_pred             Cccccc
Confidence            999996

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=9.7e-37  Score=219.57  Aligned_cols=154  Identities=21%  Similarity=0.244  Sum_probs=135.3

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+|+.||||.+.+.   .....+.+.+|+.+++.++||||+++ +.+......++|+|++.+|+|...+.....   +++
T Consensus        64 ~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~~~---l~e  140 (350)
T d1rdqe_          64 ESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---FSE  140 (350)
T ss_dssp             TTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCC---CCH
T ss_pred             CCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccccccccchhhhHhhcCC---CCH
Confidence            57899999998654   33456778999999999999999998 777777888999999999999988865433   899


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCcceecCCcce
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      ..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++..... .....||+.|||||++.+..|+
T Consensus       141 ~~~~~i~~qi~~aL~yLH~~---~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-~~~~~Gt~~Y~APE~~~~~~~~  216 (350)
T d1rdqe_         141 PHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-TWTLCGTPEALAPEIILSKGYN  216 (350)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-BCCCEECGGGCCHHHHTTCCBC
T ss_pred             HHHHHHHHHHHHHHHHHHhC---CEecCcCCHHHcccCCCCCEEeeeceeeeecccc-cccccCccccCCHHHHcCCCCC
Confidence            99999999999999999998   9999999999999999999999999999766432 3457899999999999999999


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      .++||
T Consensus       217 ~~~Di  221 (350)
T d1rdqe_         217 KAVDW  221 (350)
T ss_dssp             THHHH
T ss_pred             ccccc
Confidence            99986

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-36  Score=213.49  Aligned_cols=155  Identities=28%  Similarity=0.352  Sum_probs=134.1

Q ss_pred             CCCcEEEEEEccccc------cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccc
Q 046065            4 PDGQIIAVKKLSKKS------TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLI   76 (164)
Q Consensus         4 ~~~~~vavK~~~~~~------~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~   76 (164)
                      .+|+.||||.+.+..      ....+.+.+|+.+++.++||||+++ +.+...+..++||||+++|+|.+++.....   
T Consensus        33 ~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~---  109 (293)
T d1jksa_          33 STGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKES---  109 (293)
T ss_dssp             TTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSS---
T ss_pred             CCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhccccc---
Confidence            578999999986541      2235678999999999999999998 777778889999999999999999876433   


Q ss_pred             cCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCC----CeEEccccchhhhhhh-hhhhhcccccccCcc
Q 046065           77 LDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL----KPKISDFGLARILRKM-ILKQIQIELGYIPPE  151 (164)
Q Consensus        77 ~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~----~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE  151 (164)
                      +++..+..++.|++.||.|||++   +|+||||||+||+++.++    .+|++|||++...... ......||+.|+|||
T Consensus       110 l~~~~~~~~~~qi~~al~yLH~~---~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE  186 (293)
T d1jksa_         110 LTEEEATEFLKQILNGVYYLHSL---QIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPE  186 (293)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHH
T ss_pred             cchhHHHHHHHHHHHHHHhhhhc---ceeecccccceEEEecCCCcccceEecchhhhhhcCCCccccccCCCCcccCHH
Confidence            89999999999999999999998   999999999999998766    4999999999776533 335578899999999


Q ss_pred             eecCCcceeccCC
Q 046065          152 YVGRGVYYKKFSL  164 (164)
Q Consensus       152 ~~~~~~~~~~~Di  164 (164)
                      ++.+..++.++||
T Consensus       187 ~~~~~~~~~~~Di  199 (293)
T d1jksa_         187 IVNYEPLGLEADM  199 (293)
T ss_dssp             HHTTCCBCTHHHH
T ss_pred             HHcCCCCCCcccc
Confidence            9998899999996

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.4e-36  Score=218.50  Aligned_cols=156  Identities=26%  Similarity=0.258  Sum_probs=130.3

Q ss_pred             cCCCcEEEEEEccccc---cccHHHHHH---HHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccccc
Q 046065            3 LPDGQIIAVKKLSKKS---TQGFEEFKN---EVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRML   75 (164)
Q Consensus         3 ~~~~~~vavK~~~~~~---~~~~~~~~~---e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~   75 (164)
                      ..+|+.||||.+.+..   ......+.+   |+.+++.++||||+++ ..+...+..|+||||+++|+|.+++.....  
T Consensus        26 ~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~--  103 (364)
T d1omwa3          26 ADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGV--  103 (364)
T ss_dssp             TTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCS--
T ss_pred             CCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHhccc--
Confidence            3578999999986431   122223333   4667788899999998 777777889999999999999999876433  


Q ss_pred             ccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCcceecC
Q 046065           76 ILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGR  155 (164)
Q Consensus        76 ~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~  155 (164)
                       +++..+..++.|++.||.|+|++   +++||||||+|||++.++.+||+|||+++.+........+||+.|+|||++.+
T Consensus       104 -~~e~~~~~~~~qi~~aL~ylH~~---~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~~~~~~GT~~y~APE~~~~  179 (364)
T d1omwa3         104 -FSEADMRFYAAEIILGLEHMHNR---FVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQK  179 (364)
T ss_dssp             -CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECSSSCEEECCCTTCEECSSSCCCSCCSCGGGCCHHHHST
T ss_pred             -ccHHHHHHHHHHHHHHHHHHHHC---CccceeeccceeEEcCCCcEEEeeeceeeecCCCcccccccccccchhHHhhc
Confidence             78899999999999999999998   99999999999999999999999999998776655667789999999999965


Q ss_pred             -CcceeccCC
Q 046065          156 -GVYYKKFSL  164 (164)
Q Consensus       156 -~~~~~~~Di  164 (164)
                       ..|+.++||
T Consensus       180 ~~~~~~~~Di  189 (364)
T d1omwa3         180 GVAYDSSADW  189 (364)
T ss_dssp             TCCCCTHHHH
T ss_pred             CCCCCcccch
Confidence             468999986

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.9e-36  Score=215.37  Aligned_cols=155  Identities=26%  Similarity=0.400  Sum_probs=128.8

Q ss_pred             cEEEEEEcccc-ccccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccc----------
Q 046065            7 QIIAVKKLSKK-STQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIR----------   73 (164)
Q Consensus         7 ~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~----------   73 (164)
                      ..||+|.+... .......+.+|+.++..+ +||||+++ +.+...+..++||||+++|+|.+++.+...          
T Consensus        68 ~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~  147 (325)
T d1rjba_          68 IQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYE  147 (325)
T ss_dssp             EEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC--------
T ss_pred             eEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhc
Confidence            46999998654 344456788999999998 89999998 778888889999999999999999875321          


Q ss_pred             ----------ccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh----h
Q 046065           74 ----------MLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL----K  139 (164)
Q Consensus        74 ----------~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~----~  139 (164)
                                ...+++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+|+.......    .
T Consensus       148 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~---~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~  224 (325)
T d1rjba_         148 NQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRG  224 (325)
T ss_dssp             -------------CCHHHHHHHHHHHHHHHHHHHHT---TEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEET
T ss_pred             cccccccccccCCCCHHHHHHHHHHHHHHHHHHHhC---CeeeccCchhccccccCCeEEEeeccccccccCCCceeeec
Confidence                      12378889999999999999999998   999999999999999999999999999976654321    3


Q ss_pred             hhcccccccCcceecCCcceeccCC
Q 046065          140 QIQIELGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       140 ~~~~~~~~~aPE~~~~~~~~~~~Di  164 (164)
                      ...||+.|||||++.++.|+.++||
T Consensus       225 ~~~gt~~y~aPE~l~~~~~~~~~Di  249 (325)
T d1rjba_         225 NARLPVKWMAPESLFEGIYTIKSDV  249 (325)
T ss_dssp             TEEECGGGCCHHHHHHCCCCHHHHH
T ss_pred             cccCCCccCChHHHcCCCCCcceec
Confidence            4668999999999999999999996

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-36  Score=211.03  Aligned_cols=153  Identities=29%  Similarity=0.464  Sum_probs=124.8

Q ss_pred             cEEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHHH
Q 046065            7 QIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVH   84 (164)
Q Consensus         7 ~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~   84 (164)
                      ..||||.+... .+.....+.+|+.+++.++||||+++ +.+...+..++|+|++.++++.+.+.....  .+++..+..
T Consensus        37 ~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~~--~~~~~~~~~  114 (283)
T d1mqba_          37 VPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDG--EFSVLQLVG  114 (283)
T ss_dssp             EEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTT--CSCHHHHHH
T ss_pred             EEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhcccc--cccHHHHHH
Confidence            46999998654 33345578899999999999999998 777788889999999999999887764322  388899999


Q ss_pred             HHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh-----hhhhcccccccCcceecCCcce
Q 046065           85 IIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI-----LKQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        85 ~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      ++.|++.|+.|+|+.   +|+||||||+|||++.++.+||+|||+++......     .....||+.|+|||++.++.++
T Consensus       115 i~~~i~~gl~~lH~~---~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~  191 (283)
T d1mqba_         115 MLRGIAAGMKYLANM---NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFT  191 (283)
T ss_dssp             HHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCC
T ss_pred             HHHHHHHhhhhcccc---ccccCccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCC
Confidence            999999999999998   99999999999999999999999999998764321     2345688999999999999999


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      .++||
T Consensus       192 ~~sDI  196 (283)
T d1mqba_         192 SASDV  196 (283)
T ss_dssp             HHHHH
T ss_pred             Ccccc
Confidence            99996

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-36  Score=208.37  Aligned_cols=156  Identities=23%  Similarity=0.391  Sum_probs=134.2

Q ss_pred             cCCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            3 LPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      ..+++.||||.+... ....+.+.+|+.+++.++||||+++ +.+...+.+++||||+++|++..++.....  .+++..
T Consensus        25 ~~~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~~--~~~~~~  101 (258)
T d1k2pa_          25 WRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRH--RFQTQQ  101 (258)
T ss_dssp             ETTTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGGG--CCCHHH
T ss_pred             ECCCCEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhcccc--CCcHHH
Confidence            356789999998754 3345678999999999999999998 777888899999999999999888765433  278889


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh---hhhhcccccccCcceecCCcc
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI---LKQIQIELGYIPPEYVGRGVY  158 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~  158 (164)
                      +..++.|+++||.|||+.   +|+||||||+||+++.++.+||+|||+++......   .....+|+.|+|||.+....|
T Consensus       102 ~~~i~~qi~~gl~~LH~~---~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~  178 (258)
T d1k2pa_         102 LLEMCKDVCEAMEYLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF  178 (258)
T ss_dssp             HHHHHHHHHHHHHHHHHT---TBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCC
T ss_pred             HHHHHHHHHHHHHHHhhc---CcccccccceeEEEcCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCCC
Confidence            999999999999999998   99999999999999999999999999997654322   234668899999999999999


Q ss_pred             eeccCC
Q 046065          159 YKKFSL  164 (164)
Q Consensus       159 ~~~~Di  164 (164)
                      +.|+||
T Consensus       179 ~~ksDi  184 (258)
T d1k2pa_         179 SSKSDI  184 (258)
T ss_dssp             CHHHHH
T ss_pred             Ccceee
Confidence            999996

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-35  Score=211.44  Aligned_cols=155  Identities=26%  Similarity=0.325  Sum_probs=132.3

Q ss_pred             CCCcEEEEEEcccc---ccccHHHHHHHHHHHh-ccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccC
Q 046065            4 PDGQIIAVKKLSKK---STQGFEEFKNEVMLTA-KLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILD   78 (164)
Q Consensus         4 ~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~-~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~   78 (164)
                      .+++.||||.+.++   .....+.+..|..++. .++||||+++ +.+...+..|+||||+++|+|.+++.....   ++
T Consensus        25 ~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~~~~---~~  101 (320)
T d1xjda_          25 KTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FD  101 (320)
T ss_dssp             TTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSS---CC
T ss_pred             CCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhccCC---CC
Confidence            57899999999754   2344556667777654 6899999998 777778889999999999999999876443   88


Q ss_pred             HHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh--hhhhhhcccccccCcceecCC
Q 046065           79 CKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK--MILKQIQIELGYIPPEYVGRG  156 (164)
Q Consensus        79 ~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~~aPE~~~~~  156 (164)
                      +..+..++.|++.||.|||++   +++||||||+|||++.++.+||+|||+++....  .......||+.|+|||++.+.
T Consensus       102 e~~~~~~~~qi~~al~ylH~~---~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~  178 (320)
T d1xjda_         102 LSRATFYAAEIILGLQFLHSK---GIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQ  178 (320)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHT---TCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTC
T ss_pred             HHHHHHHHHHHHHHHHHHHhC---CeeeccCcccceeecCCCceeccccchhhhcccccccccccCCCCCcCCHHHHcCC
Confidence            999999999999999999999   999999999999999999999999999976543  223457899999999999999


Q ss_pred             cceeccCC
Q 046065          157 VYYKKFSL  164 (164)
Q Consensus       157 ~~~~~~Di  164 (164)
                      .|+.++||
T Consensus       179 ~~~~~~Di  186 (320)
T d1xjda_         179 KYNHSVDW  186 (320)
T ss_dssp             CBCTHHHH
T ss_pred             CCCchhhh
Confidence            99999996

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-36  Score=209.76  Aligned_cols=156  Identities=28%  Similarity=0.416  Sum_probs=126.6

Q ss_pred             cCCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            3 LPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      ..+++.||||.+... ....+.+.+|+.+++.++||||+++ +.+ ..+..++||||+++|+|...+.... ...+++..
T Consensus        38 ~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~-~~~~~~lv~Ey~~~g~l~~~~~~~~-~~~l~~~~  114 (285)
T d1fmka3          38 WNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSLLDFLKGET-GKYLRLPQ  114 (285)
T ss_dssp             ETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEE-CSSSCEEEECCCTTCBHHHHHSHHH-HTTCCHHH
T ss_pred             ECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEE-ecCCeEEEEEecCCCchhhhhhhcc-cccchHHH
Confidence            346678999998644 3345679999999999999999998 655 5567889999999999988876432 12388999


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh---hhhhcccccccCcceecCCcc
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI---LKQIQIELGYIPPEYVGRGVY  158 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~aPE~~~~~~~  158 (164)
                      +..++.|++.||.|||+.   +++||||||+|||++.++.+||+|||+++......   .....||+.|+|||.+..+.+
T Consensus       115 ~~~i~~~i~~gl~~LH~~---~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  191 (285)
T d1fmka3         115 LVDMAAQIASGMAYVERM---NYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRF  191 (285)
T ss_dssp             HHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCC
T ss_pred             HHHHHHHHHHHHHHHhhh---heecccccceEEEECCCCcEEEcccchhhhccCCCceeeccccccccccChHHHhCCCC
Confidence            999999999999999998   99999999999999999999999999997664322   234678999999999999999


Q ss_pred             eeccCC
Q 046065          159 YKKFSL  164 (164)
Q Consensus       159 ~~~~Di  164 (164)
                      +.++||
T Consensus       192 ~~ksDI  197 (285)
T d1fmka3         192 TIKSDV  197 (285)
T ss_dssp             CHHHHH
T ss_pred             CcHHhh
Confidence            999996

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.9e-35  Score=206.89  Aligned_cols=156  Identities=22%  Similarity=0.293  Sum_probs=124.5

Q ss_pred             cCCCcEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCC----cEEEEEEecCCCChhhhhhCcccc
Q 046065            3 LPDGQIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQ----EYMLIYEYMPKRSLDYFLFDPIRM   74 (164)
Q Consensus         3 ~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~   74 (164)
                      ..+|+.||||.+..+   .+.....+.+|+.+++.++||||+++ +.+....    ..|+||||+++++|...+..... 
T Consensus        29 ~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~~-  107 (277)
T d1o6ya_          29 LRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP-  107 (277)
T ss_dssp             TTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHHCS-
T ss_pred             CCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhcccCC-
Confidence            357899999999755   23345678899999999999999997 5544432    37899999999999988765433 


Q ss_pred             cccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh-----hhhhhhcccccccC
Q 046065           75 LILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK-----MILKQIQIELGYIP  149 (164)
Q Consensus        75 ~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~-----~~~~~~~~~~~~~a  149 (164)
                        +++..+..++.|++.||.|+|++   +|+||||||+||+++.++..+++|||.+.....     ......+||+.|+|
T Consensus       108 --l~~~~~~~i~~qi~~al~~lH~~---~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~a  182 (277)
T d1o6ya_         108 --MTPKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLS  182 (277)
T ss_dssp             --CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTSCEEECCCTTCEECC----------------TTCC
T ss_pred             --CCHHHHHHHHHHHHHHHHHHHhC---CccCccccCcccccCccccceeehhhhhhhhccccccccccccccCcccccC
Confidence              88999999999999999999998   999999999999999999999999998765432     12355789999999


Q ss_pred             cceecCCcceeccCC
Q 046065          150 PEYVGRGVYYKKFSL  164 (164)
Q Consensus       150 PE~~~~~~~~~~~Di  164 (164)
                      ||++.+..|+.++||
T Consensus       183 PE~~~~~~~~~~~Di  197 (277)
T d1o6ya_         183 PEQARGDSVDARSDV  197 (277)
T ss_dssp             HHHHTTCCCCHHHHH
T ss_pred             HHHHcCCCCCcceec
Confidence            999998899999996

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-35  Score=208.78  Aligned_cols=155  Identities=26%  Similarity=0.325  Sum_probs=126.7

Q ss_pred             CCCcEEEEEEcccccc-----ccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccccccc
Q 046065            4 PDGQIIAVKKLSKKST-----QGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLIL   77 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~   77 (164)
                      .+|+.||||.+.....     .....+.+|+.+++.++||||+++ +.+...+..++||||+.++.+........   .+
T Consensus        21 ~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~~~~---~l   97 (299)
T d1ua2a_          21 NTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSL---VL   97 (299)
T ss_dssp             SCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTCCS---SC
T ss_pred             CCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhhhccc---CC
Confidence            5789999999865421     123568899999999999999998 77778888999999998877766654332   38


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh--hhhhhcccccccCcceecC
Q 046065           78 DCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM--ILKQIQIELGYIPPEYVGR  155 (164)
Q Consensus        78 ~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~~  155 (164)
                      ++..+..++.|++.||.|+|++   +|+||||||+|||++.++.+||+|||++......  .....+||+.|+|||++..
T Consensus        98 ~~~~~~~~~~qil~aL~~lH~~---~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~  174 (299)
T d1ua2a_          98 TPSHIKAYMLMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFG  174 (299)
T ss_dssp             CSSHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTT
T ss_pred             CHHHHHHHHHHHHHHHHHhhcc---ceecccCCcceEEecCCCccccccCccccccCCCcccccceecChhhccHHHHcc
Confidence            8889999999999999999998   9999999999999999999999999999766542  2245679999999999865


Q ss_pred             C-cceeccCC
Q 046065          156 G-VYYKKFSL  164 (164)
Q Consensus       156 ~-~~~~~~Di  164 (164)
                      . .|+.++||
T Consensus       175 ~~~~~~~~Di  184 (299)
T d1ua2a_         175 ARMYGVGVDM  184 (299)
T ss_dssp             CSCCCHHHHH
T ss_pred             CCCCChhhhh
Confidence            4 57999986

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=6.4e-35  Score=204.03  Aligned_cols=155  Identities=28%  Similarity=0.421  Sum_probs=130.9

Q ss_pred             CCCcEEEEEEcccccc---------ccHHHHHHHHHHHhccC-CCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcc
Q 046065            4 PDGQIIAVKKLSKKST---------QGFEEFKNEVMLTAKLQ-HLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPI   72 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~---------~~~~~~~~e~~~l~~l~-h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~   72 (164)
                      .+|+.||||.+.+...         .....+.+|+.+++.++ ||||+++ +.+.+.+..|+||||+++|+|.+++....
T Consensus        26 ~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~  105 (277)
T d1phka_          26 PTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV  105 (277)
T ss_dssp             TTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS
T ss_pred             CCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHhcC
Confidence            5789999999875521         12345788999999996 9999998 77777788999999999999999997543


Q ss_pred             cccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh-hhhhhcccccccCcc
Q 046065           73 RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM-ILKQIQIELGYIPPE  151 (164)
Q Consensus        73 ~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE  151 (164)
                      .   +++..+..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+++.+... ......||+.|+|||
T Consensus       106 ~---l~e~~~~~~~~qi~~al~~lH~~---~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE  179 (277)
T d1phka_         106 T---LSEKETRKIMRALLEVICALHKL---NIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPE  179 (277)
T ss_dssp             S---CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHH
T ss_pred             C---CCHHHHHHHHHHHHHHHHHHHHc---CCcccccccceEEEcCCCCeEEccchheeEccCCCceeeeeccCCCCCHH
Confidence            3   89999999999999999999998   9999999999999999999999999999876543 335577999999999


Q ss_pred             eecC------CcceeccCC
Q 046065          152 YVGR------GVYYKKFSL  164 (164)
Q Consensus       152 ~~~~------~~~~~~~Di  164 (164)
                      .+.+      ..++.++||
T Consensus       180 ~~~~~~~~~~~~~~~~~Di  198 (277)
T d1phka_         180 IIECSMNDNHPGYGKEVDM  198 (277)
T ss_dssp             HHHHHHCTTSCCBCTHHHH
T ss_pred             HhhccccccCCCCCchheE
Confidence            9853      345777875

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.3e-35  Score=208.99  Aligned_cols=153  Identities=23%  Similarity=0.297  Sum_probs=126.5

Q ss_pred             cCCCcEEEEEEccccccccHHHHHHHHHHHhc-cCCCceeeE-eEEee----CCcEEEEEEecCCCChhhhhhCcccccc
Q 046065            3 LPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAK-LQHLNLIRV-GFCIE----TQEYMLIYEYMPKRSLDYFLFDPIRMLI   76 (164)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~-l~h~~i~~~-~~~~~----~~~~~lv~e~~~~~~L~~~~~~~~~~~~   76 (164)
                      ..+++.||||.+...     ..+.+|+.++.+ .+||||+++ +.+..    ...+|+|||||++|+|.+++.+... ..
T Consensus        34 ~~~~~~vAiK~i~~~-----~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~-~~  107 (335)
T d2ozaa1          34 KRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGD-QA  107 (335)
T ss_dssp             TTTCCEEEEEEEECS-----HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSC-CC
T ss_pred             CCCCCEEEEEEECCc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCC-CC
Confidence            357899999998532     346789988655 489999998 44433    2457899999999999999976322 23


Q ss_pred             cCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecC---CCCeEEccccchhhhhh-hhhhhhcccccccCcce
Q 046065           77 LDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE---DLKPKISDFGLARILRK-MILKQIQIELGYIPPEY  152 (164)
Q Consensus        77 ~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~---~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~aPE~  152 (164)
                      +++..+..++.|++.|+.|||++   +|+||||||+||+++.   .+.+||+|||+++.... ......+||+.|+|||+
T Consensus       108 l~e~~~~~i~~qi~~al~ylH~~---~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~  184 (335)
T d2ozaa1         108 FTEREASEIMKSIGEAIQYLHSI---NIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEV  184 (335)
T ss_dssp             EEHHHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCC
T ss_pred             cCHHHHHHHHHHHHHHHHHHHHc---CCccccccccccccccccccccccccccceeeeccCCCccccccCCcccCCcHH
Confidence            89999999999999999999998   9999999999999975   46799999999976643 33356789999999999


Q ss_pred             ecCCcceeccCC
Q 046065          153 VGRGVYYKKFSL  164 (164)
Q Consensus       153 ~~~~~~~~~~Di  164 (164)
                      +.+..|+.++||
T Consensus       185 ~~~~~y~~~~Di  196 (335)
T d2ozaa1         185 LGPEKYDKSCDM  196 (335)
T ss_dssp             CCGGGGSHHHHH
T ss_pred             HcCCCCCHHHHH
Confidence            999999999996

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-34  Score=206.58  Aligned_cols=155  Identities=19%  Similarity=0.255  Sum_probs=133.0

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      .+++.||+|.+..... +...+.+|+.+++.++||||+++ +.+.+.+.+|+|||||++|+|.+.+....  ..+++..+
T Consensus        28 ~~~~~~AiK~i~~~~~-~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~--~~l~e~~~  104 (321)
T d1tkia_          28 SSKKTYMAKFVKVKGT-DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSA--FELNEREI  104 (321)
T ss_dssp             TTTEEEEEEEECCCTH-HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSS--CCCCHHHH
T ss_pred             CCCcEEEEEEEcCCcc-cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcC--CCCCHHHH
Confidence            5788999999975532 33567899999999999999998 77778889999999999999999987543  23899999


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCC--CCeEEccccchhhhhhh-hhhhhcccccccCcceecCCcce
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED--LKPKISDFGLARILRKM-ILKQIQIELGYIPPEYVGRGVYY  159 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~--~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~  159 (164)
                      ..++.|++.||.|||++   +|+||||||+|||++.+  ..++|+|||++...... ......+++.|+|||...+..|+
T Consensus       105 ~~i~~qi~~al~yLH~~---~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~~~~~  181 (321)
T d1tkia_         105 VSYVHQVCEALQFLHSH---NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVS  181 (321)
T ss_dssp             HHHHHHHHHHHHHHHHT---TEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEEC
T ss_pred             HHHHHHHHHHHHHHHHc---CCCcccccccceeecCCCceEEEEcccchhhccccCCcccccccccccccchhccCCCCC
Confidence            99999999999999998   99999999999999854  47999999999766543 33556789999999999999999


Q ss_pred             eccCC
Q 046065          160 KKFSL  164 (164)
Q Consensus       160 ~~~Di  164 (164)
                      .++||
T Consensus       182 ~~~Di  186 (321)
T d1tkia_         182 TATDM  186 (321)
T ss_dssp             HHHHH
T ss_pred             chhhc
Confidence            99986

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-35  Score=206.77  Aligned_cols=152  Identities=22%  Similarity=0.325  Sum_probs=124.6

Q ss_pred             EEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeEeEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHHHHH
Q 046065            8 IIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVHII   86 (164)
Q Consensus         8 ~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~   86 (164)
                      +||+|.+... .....+.+.+|+.+++.++||||+++..+...+..++++|++.+++|.+.+.....  .+++..+..++
T Consensus        40 ~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~v~e~~~~~~l~~~~~~~~~--~~~~~~~~~i~  117 (317)
T d1xkka_          40 PVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKD--NIGSQYLLNWC  117 (317)
T ss_dssp             EEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTCBHHHHHHHTSS--SCCHHHHHHHH
T ss_pred             EEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeeEEEEeccCCccccccccccc--CCCHHHHHHHH
Confidence            6899987644 44456789999999999999999998444445677889999999999887765322  38899999999


Q ss_pred             HHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh----hhhhcccccccCcceecCCcceecc
Q 046065           87 KGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI----LKQIQIELGYIPPEYVGRGVYYKKF  162 (164)
Q Consensus        87 ~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~aPE~~~~~~~~~~~  162 (164)
                      .|++.||.|||++   +|+||||||+||+++.++.+||+|||+++......    .....||+.|+|||++.++.|+.++
T Consensus       118 ~qi~~gl~yLH~~---~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~s  194 (317)
T d1xkka_         118 VQIAKGMNYLEDR---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQS  194 (317)
T ss_dssp             HHHHHHHHHHHHT---TCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHH
T ss_pred             HHHHHHHHHHHHc---CcccCcchhhcceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhh
Confidence            9999999999998   99999999999999999999999999998764322    2345689999999999999999999


Q ss_pred             CC
Q 046065          163 SL  164 (164)
Q Consensus       163 Di  164 (164)
                      ||
T Consensus       195 Dv  196 (317)
T d1xkka_         195 DV  196 (317)
T ss_dssp             HH
T ss_pred             hh
Confidence            96

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=6.8e-35  Score=206.23  Aligned_cols=158  Identities=28%  Similarity=0.470  Sum_probs=132.3

Q ss_pred             CCCcEEEEEEccccc-cccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcc---------
Q 046065            4 PDGQIIAVKKLSKKS-TQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPI---------   72 (164)
Q Consensus         4 ~~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~---------   72 (164)
                      .+++.||||.+.... ......+.+|+.+++.++||||+++ +.+......++++|++++|+|.+++....         
T Consensus        41 ~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~  120 (301)
T d1lufa_          41 EPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSH  120 (301)
T ss_dssp             SSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC--------
T ss_pred             CCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccc
Confidence            456789999987553 3345678999999999999999998 77778888999999999999999885321         


Q ss_pred             ------------cccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh---
Q 046065           73 ------------RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI---  137 (164)
Q Consensus        73 ------------~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~---  137 (164)
                                  ....+++.....++.|++.||.|+|+.   +++||||||+||+++.++.+||+|||+++...+..   
T Consensus       121 ~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~---~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~  197 (301)
T d1lufa_         121 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYK  197 (301)
T ss_dssp             --------------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC
T ss_pred             cccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccC---CeEeeEEcccceEECCCCcEEEccchhheeccCCcccc
Confidence                        112377889999999999999999998   99999999999999999999999999998664322   


Q ss_pred             -hhhhcccccccCcceecCCcceeccCC
Q 046065          138 -LKQIQIELGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       138 -~~~~~~~~~~~aPE~~~~~~~~~~~Di  164 (164)
                       .....+++.|+|||.+.+..|+.|+||
T Consensus       198 ~~~~~~~~~~y~aPE~~~~~~~t~ksDV  225 (301)
T d1lufa_         198 ADGNDAIPIRWMPPESIFYNRYTTESDV  225 (301)
T ss_dssp             ----CCBCGGGCCHHHHHHCCCCHHHHH
T ss_pred             ccCCCCcCcCcCCHHHHccCCCChhhhh
Confidence             234678899999999999999999996

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-35  Score=203.46  Aligned_cols=154  Identities=20%  Similarity=0.293  Sum_probs=119.4

Q ss_pred             CcEEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeEeEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHHHH
Q 046065            6 GQIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVH   84 (164)
Q Consensus         6 ~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~   84 (164)
                      +..||||.+... .......+.+|+.+++.++||||+++..+...+..++||||+++|++..++....  ..+++.....
T Consensus        35 ~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~iv~E~~~~g~l~~~~~~~~--~~l~~~~~~~  112 (273)
T d1mp8a_          35 ALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQVRK--YSLDLASLIL  112 (273)
T ss_dssp             CEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEEEECCTTEEHHHHHHHTT--TTSCHHHHHH
T ss_pred             eEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCeEEEEEEeccCCcHHhhhhccC--CCCCHHHHHH
Confidence            346899998654 3334567899999999999999999844445677899999999999988775432  2388999999


Q ss_pred             HHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh---hhhhhcccccccCcceecCCcceec
Q 046065           85 IIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM---ILKQIQIELGYIPPEYVGRGVYYKK  161 (164)
Q Consensus        85 ~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~---~~~~~~~~~~~~aPE~~~~~~~~~~  161 (164)
                      ++.|++.||.|+|++   +++||||||+||+++.++.+||+|||+++.....   ......||+.|+|||++.+..|+.+
T Consensus       113 ~~~qi~~gl~ylH~~---~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~  189 (273)
T d1mp8a_         113 YAYQLSTALAYLESK---RFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSA  189 (273)
T ss_dssp             HHHHHHHHHHHHHHT---TCCCSCCSGGGEEEEETTEEEECC-------------------CCGGGCCHHHHHHCCCSHH
T ss_pred             HHHHHHHHhhhhccc---CeeccccchhheeecCCCcEEEccchhheeccCCcceeccceecCcccchhhHhccCCCCCc
Confidence            999999999999998   9999999999999999999999999999866432   2244568899999999999999999


Q ss_pred             cCC
Q 046065          162 FSL  164 (164)
Q Consensus       162 ~Di  164 (164)
                      +||
T Consensus       190 ~Di  192 (273)
T d1mp8a_         190 SDV  192 (273)
T ss_dssp             HHH
T ss_pred             ccc
Confidence            996

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-35  Score=206.50  Aligned_cols=158  Identities=27%  Similarity=0.387  Sum_probs=120.8

Q ss_pred             CCCcEEEEEEcccc-ccccHHHHHHHHHHHhcc-CCCceeeE-eEEeeC-CcEEEEEEecCCCChhhhhhCccc------
Q 046065            4 PDGQIIAVKKLSKK-STQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIET-QEYMLIYEYMPKRSLDYFLFDPIR------   73 (164)
Q Consensus         4 ~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~------   73 (164)
                      .+++.||||.+... .....+.+..|...+..+ +|+||+.+ ..+... ..+++||||+++|+|.+++.....      
T Consensus        41 ~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~  120 (299)
T d1ywna1          41 ATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK  120 (299)
T ss_dssp             SCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC--
T ss_pred             cCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccc
Confidence            35678999998754 333455677888877777 68999997 555443 468899999999999999864321      


Q ss_pred             -------ccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh----hhhhc
Q 046065           74 -------MLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI----LKQIQ  142 (164)
Q Consensus        74 -------~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~----~~~~~  142 (164)
                             ...+++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++......    .....
T Consensus       121 ~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~---~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~  197 (299)
T d1ywna1         121 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASR---KCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDAR  197 (299)
T ss_dssp             ---------CBCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCC
T ss_pred             cchhhhhcccCCHHHHHHHHHHHHHHHHHHHhC---CCcCCcCCccceeECCCCcEEEccCcchhhccccccccccCcee
Confidence                   12378899999999999999999998   99999999999999999999999999997654321    23467


Q ss_pred             ccccccCcceecCCcceeccCC
Q 046065          143 IELGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       143 ~~~~~~aPE~~~~~~~~~~~Di  164 (164)
                      ||+.|+|||++.+..++.++||
T Consensus       198 gt~~y~APE~l~~~~~~~~sDi  219 (299)
T d1ywna1         198 LPLKWMAPETIFDRVYTIQSDV  219 (299)
T ss_dssp             CGGGGCCHHHHHHCCCCHHHHH
T ss_pred             eCccccchhHhhcCCCCcccce
Confidence            8999999999999999999996

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-34  Score=200.63  Aligned_cols=157  Identities=21%  Similarity=0.338  Sum_probs=126.7

Q ss_pred             cCCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            3 LPDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         3 ~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      ..+|+.||||.+...  .......+.+|+.+++.++||||+++ +.+...+..++|||++.++.+.......  ...+++
T Consensus        24 ~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~--~~~l~e  101 (298)
T d1gz8a_          24 KLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASA--LTGIPL  101 (298)
T ss_dssp             TTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTT--TTCCCH
T ss_pred             CCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCCchhhhhhhhc--ccCCCH
Confidence            357899999998654  23345678899999999999999998 7778888999999999764444333221  223899


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh--hhhhhcccccccCcceecCCc
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM--ILKQIQIELGYIPPEYVGRGV  157 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~  157 (164)
                      ..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||+++.....  ......||+.|+|||++....
T Consensus       102 ~~~~~~~~qil~~L~yLH~~---~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~  178 (298)
T d1gz8a_         102 PLIKSYLFQLLQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK  178 (298)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCS
T ss_pred             HHHHHHHHHHHHHHHHhhcC---CEEccccCchheeecccCcceeccCCcceeccCCcccceeecccceeeehhhhcccc
Confidence            99999999999999999998   9999999999999999999999999999766432  234568999999999987766


Q ss_pred             c-eeccCC
Q 046065          158 Y-YKKFSL  164 (164)
Q Consensus       158 ~-~~~~Di  164 (164)
                      + +.++||
T Consensus       179 ~~~~~~Di  186 (298)
T d1gz8a_         179 YYSTAVDI  186 (298)
T ss_dssp             SCCTHHHH
T ss_pred             CCCccccc
Confidence            5 788885

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-34  Score=198.08  Aligned_cols=153  Identities=26%  Similarity=0.413  Sum_probs=122.1

Q ss_pred             CCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEee-CCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            5 DGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIE-TQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      .|++||||.++.+  ...+.+.+|+.+++.++||||+++ +.+.+ .+.+++||||+++|+|.+++..... ..+++..+
T Consensus        29 ~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~-~~l~~~~~  105 (262)
T d1byga_          29 RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCL  105 (262)
T ss_dssp             TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHH-HHCCHHHH
T ss_pred             CCeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCC-CCCCHHHH
Confidence            4778999998643  344678999999999999999998 66654 4568999999999999999865321 23789999


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCcceecCCcceecc
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVGRGVYYKKF  162 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~  162 (164)
                      ..++.|++.|+.|+|+.   +++|+||||+||+++.++.++++|||+++..... .....++..|+|||++.+..+++++
T Consensus       106 ~~i~~~i~~al~ylH~~---~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-~~~~~~~~~y~aPE~l~~~~~t~~s  181 (262)
T d1byga_         106 LKFSLDVCEAMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-QDTGKLPVKWTAPEALREKKFSTKS  181 (262)
T ss_dssp             HHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTSCEEECCCCC-------------CCTTTSCHHHHHHCCCCHHH
T ss_pred             HHHHHHHHhhccccccC---ceeccccchHhheecCCCCEeecccccceecCCC-CccccccccCCChHHHhCCCCChHH
Confidence            99999999999999998   9999999999999999999999999999765432 3445678899999999999999999


Q ss_pred             CC
Q 046065          163 SL  164 (164)
Q Consensus       163 Di  164 (164)
                      ||
T Consensus       182 DI  183 (262)
T d1byga_         182 DV  183 (262)
T ss_dssp             HH
T ss_pred             HH
Confidence            96

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-34  Score=198.74  Aligned_cols=152  Identities=27%  Similarity=0.319  Sum_probs=122.5

Q ss_pred             cEEEEEEcccc---ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHHHH
Q 046065            7 QIIAVKKLSKK---STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKR   82 (164)
Q Consensus         7 ~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~   82 (164)
                      ..||||.+...   .+...+.+.+|+.+++.++||||+++ +.+ ..+..++|+||++++++.+.+....  ..+++..+
T Consensus        37 ~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~-~~~~~~lv~e~~~~~~l~~~~~~~~--~~l~~~~~  113 (273)
T d1u46a_          37 VSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVV-LTPPMKMVTELAPLGSLLDRLRKHQ--GHFLLGTL  113 (273)
T ss_dssp             EEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEE-CSSSCEEEEECCTTCBHHHHHHHHG--GGSCHHHH
T ss_pred             EEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-eecchheeeeeecCcchhhhhhccc--CCCCHHHH
Confidence            36899998754   33445678999999999999999998 555 4567789999999999988776432  23889999


Q ss_pred             HHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh-----hhhhcccccccCcceecCCc
Q 046065           83 VHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI-----LKQIQIELGYIPPEYVGRGV  157 (164)
Q Consensus        83 ~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~aPE~~~~~~  157 (164)
                      ..++.|++.||.|||++   +|+||||||+||+++.++.+||+|||+++......     .....++..|+|||++.+..
T Consensus       114 ~~~~~qi~~gl~ylH~~---~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~  190 (273)
T d1u46a_         114 SRYAVQVAEGMGYLESK---RFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRT  190 (273)
T ss_dssp             HHHHHHHHHHHHHHHHT---TEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCE
T ss_pred             HHHHHHHHHHHHHhhhC---CEeeeeecHHHhccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCC
Confidence            99999999999999998   99999999999999999999999999998764321     23456788999999999999


Q ss_pred             ceeccCC
Q 046065          158 YYKKFSL  164 (164)
Q Consensus       158 ~~~~~Di  164 (164)
                      ++.++||
T Consensus       191 ~~~~~Di  197 (273)
T d1u46a_         191 FSHASDT  197 (273)
T ss_dssp             EEHHHHH
T ss_pred             CCcchhh
Confidence            9999986

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-33  Score=198.84  Aligned_cols=152  Identities=22%  Similarity=0.392  Sum_probs=129.0

Q ss_pred             EEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeE-eEEee-CCcEEEEEEecCCCChhhhhhCcccccccCHHHHHH
Q 046065            8 IIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIE-TQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKKRVH   84 (164)
Q Consensus         8 ~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~-~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~   84 (164)
                      .||||.++.. .......+.+|+.++++++||||+++ +.+.. .+..++||||+++++|.+++.....  ..+...+..
T Consensus        57 ~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~~--~~~~~~~~~  134 (311)
T d1r0pa_          57 HCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH--NPTVKDLIG  134 (311)
T ss_dssp             EEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTTC--CCBHHHHHH
T ss_pred             EEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhccccc--cchHHHHHH
Confidence            5899998643 44556789999999999999999997 77665 4578999999999999998875332  266788889


Q ss_pred             HHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh------hhhhcccccccCcceecCCcc
Q 046065           85 IIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI------LKQIQIELGYIPPEYVGRGVY  158 (164)
Q Consensus        85 ~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~------~~~~~~~~~~~aPE~~~~~~~  158 (164)
                      ++.|++.||.|+|+.   +|+||||||+|||++.++.+||+|||+++......      .....||+.|+|||.+....+
T Consensus       135 i~~qia~gL~~lH~~---~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  211 (311)
T d1r0pa_         135 FGLQVAKGMKFLASK---KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF  211 (311)
T ss_dssp             HHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCC
T ss_pred             HHHHHHHhhhhhccc---CcccCCccHHhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCC
Confidence            999999999999998   99999999999999999999999999997654321      234568899999999999999


Q ss_pred             eeccCC
Q 046065          159 YKKFSL  164 (164)
Q Consensus       159 ~~~~Di  164 (164)
                      +.++||
T Consensus       212 ~~ksDI  217 (311)
T d1r0pa_         212 TTKSDV  217 (311)
T ss_dssp             CHHHHH
T ss_pred             CChhHh
Confidence            999996

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-34  Score=200.68  Aligned_cols=156  Identities=22%  Similarity=0.330  Sum_probs=127.7

Q ss_pred             cCCCcEEEEEEcccccc------ccHHHHHHHHHHHhccC--CCceeeE-eEEeeCCcEEEEEEecCC-CChhhhhhCcc
Q 046065            3 LPDGQIIAVKKLSKKST------QGFEEFKNEVMLTAKLQ--HLNLIRV-GFCIETQEYMLIYEYMPK-RSLDYFLFDPI   72 (164)
Q Consensus         3 ~~~~~~vavK~~~~~~~------~~~~~~~~e~~~l~~l~--h~~i~~~-~~~~~~~~~~lv~e~~~~-~~L~~~~~~~~   72 (164)
                      ..+|+.||||.+.....      .....+.+|+.+++.++  ||||+++ +.+...+..++|||++.+ +++.+++....
T Consensus        26 ~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~~  105 (273)
T d1xwsa_          26 VSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERG  105 (273)
T ss_dssp             TTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHC
T ss_pred             CCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhccC
Confidence            35789999999875411      11234678999999986  8999998 777777889999999975 56666665433


Q ss_pred             cccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCC-CCeEEccccchhhhhhhhhhhhcccccccCcc
Q 046065           73 RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDED-LKPKISDFGLARILRKMILKQIQIELGYIPPE  151 (164)
Q Consensus        73 ~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~-~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE  151 (164)
                      .   +++..+..++.|++.||.|+|++   +|+||||||+||+++.+ +.+||+|||++............||+.|+|||
T Consensus       106 ~---l~e~~~~~~~~qi~~al~~lH~~---~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~~~~~~~GT~~y~aPE  179 (273)
T d1xwsa_         106 A---LQEELARSFFWQVLEAVRHCHNC---GVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE  179 (273)
T ss_dssp             S---CCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEEETTTTEEEECCCTTCEECCSSCBCCCCSCGGGSCHH
T ss_pred             C---CCHHHHHHHHHHHHHHHHHHHHC---CCccccCcccceEEecCCCeEEECccccceecccccccccccCCCcCCHH
Confidence            2   89999999999999999999998   99999999999999864 78999999999876655556678999999999


Q ss_pred             eecCCcc-eeccCC
Q 046065          152 YVGRGVY-YKKFSL  164 (164)
Q Consensus       152 ~~~~~~~-~~~~Di  164 (164)
                      ++.+..+ +.++||
T Consensus       180 ~~~~~~~~~~~~Di  193 (273)
T d1xwsa_         180 WIRYHRYHGRSAAV  193 (273)
T ss_dssp             HHHHSCBCHHHHHH
T ss_pred             HHcCCCCCCccccc
Confidence            9977766 567785

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-33  Score=200.38  Aligned_cols=154  Identities=28%  Similarity=0.442  Sum_probs=127.1

Q ss_pred             EEEEEEcccc-ccccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCc-------------
Q 046065            8 IIAVKKLSKK-STQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDP-------------   71 (164)
Q Consensus         8 ~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~-------------   71 (164)
                      .||||.+... .....+.+.+|+.++..+ +||||+++ +.+...+..++||||+++|+|.+++...             
T Consensus        39 ~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~  118 (309)
T d1fvra_          39 DAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN  118 (309)
T ss_dssp             EEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHT
T ss_pred             EEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccc
Confidence            4788887544 344556789999999998 79999997 8888888999999999999999998653             


Q ss_pred             ccccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhh-hhhcccccccCc
Q 046065           72 IRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMIL-KQIQIELGYIPP  150 (164)
Q Consensus        72 ~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~aP  150 (164)
                      .....+++.....++.|++.|+.|+|+.   +++||||||+|||++.++.+||+|||+++....... ....||..|+||
T Consensus       119 ~~~~~l~~~~~~~~~~qia~gl~~lH~~---~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aP  195 (309)
T d1fvra_         119 STASTLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAI  195 (309)
T ss_dssp             TBSCSSCHHHHHHHHHHHHHHHHHHHHT---TEECSCCSGGGEEECGGGCEEECCTTCEESSCEECCC----CCTTTCCH
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHhhhcC---CccccccccceEEEcCCCceEEccccccccccccccccceecCCcccch
Confidence            1223489999999999999999999998   999999999999999999999999999976554332 345689999999


Q ss_pred             ceecCCcceeccCC
Q 046065          151 EYVGRGVYYKKFSL  164 (164)
Q Consensus       151 E~~~~~~~~~~~Di  164 (164)
                      |.+..+.|+.++||
T Consensus       196 E~l~~~~~~~~sDv  209 (309)
T d1fvra_         196 ESLNYSVYTTNSDV  209 (309)
T ss_dssp             HHHHHCEECHHHHH
T ss_pred             HHhccCCCCcccee
Confidence            99999999999996

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-33  Score=198.88  Aligned_cols=157  Identities=27%  Similarity=0.407  Sum_probs=133.1

Q ss_pred             CCcEEEEEEccccc-cccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccc--------
Q 046065            5 DGQIIAVKKLSKKS-TQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIR--------   73 (164)
Q Consensus         5 ~~~~vavK~~~~~~-~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~--------   73 (164)
                      ++..||||.+..+. ......+..|...+..+ +||||+++ +.+.+.+..++||||+++|+|.+++.....        
T Consensus        44 ~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~  123 (299)
T d1fgka_          44 RVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYN  123 (299)
T ss_dssp             CEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC-------
T ss_pred             CceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccc
Confidence            34579999997653 33456778888888888 79999998 777778889999999999999999975321        


Q ss_pred             -----ccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh----hhhhccc
Q 046065           74 -----MLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI----LKQIQIE  144 (164)
Q Consensus        74 -----~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~----~~~~~~~  144 (164)
                           ...+++..+..++.|++.||.|+|+.   +++||||||+|||++.++.+||+|||++.......    .....++
T Consensus       124 ~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~---~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~  200 (299)
T d1fgka_         124 PSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP  200 (299)
T ss_dssp             -----CCCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCG
T ss_pred             cccCccccCCHHHHHHHHHHHHHHHHHhhhC---CEEeeeecccceeecCCCCeEeccchhhccccccccccccccCCCC
Confidence                 23488999999999999999999999   99999999999999999999999999998765432    2446788


Q ss_pred             ccccCcceecCCcceeccCC
Q 046065          145 LGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       145 ~~~~aPE~~~~~~~~~~~Di  164 (164)
                      +.|+|||.+.++.|+.|+||
T Consensus       201 ~~y~aPE~l~~~~y~~k~Di  220 (299)
T d1fgka_         201 VKWMAPEALFDRIYTHQSDV  220 (299)
T ss_dssp             GGGSCHHHHHHCCCCHHHHH
T ss_pred             hhhhhhhHhcCCCCCchhhh
Confidence            99999999999999999996

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-33  Score=200.20  Aligned_cols=158  Identities=27%  Similarity=0.374  Sum_probs=133.4

Q ss_pred             CCCcEEEEEEcccc-ccccHHHHHHHHHHHhcc-CCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcc--------
Q 046065            4 PDGQIIAVKKLSKK-STQGFEEFKNEVMLTAKL-QHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPI--------   72 (164)
Q Consensus         4 ~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l-~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~--------   72 (164)
                      .+++.||||.+... .......+..|+.+++.+ +||||+++ +.+......++||||+++|+|..++....        
T Consensus        51 ~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~  130 (311)
T d1t46a_          51 DAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKT  130 (311)
T ss_dssp             TCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC-----
T ss_pred             CCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhcccccccccc
Confidence            45678999998754 334456788999999999 69999998 77777888999999999999999886432        


Q ss_pred             -------cccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh----hhhh
Q 046065           73 -------RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI----LKQI  141 (164)
Q Consensus        73 -------~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~----~~~~  141 (164)
                             ....+++..+..++.|++.|+.|||++   +++||||||+||+++..+.++++|||.++......    ....
T Consensus       131 ~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~---~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~  207 (311)
T d1t46a_         131 SPAIMEDDELALDLEDLLSFSYQVAKGMAFLASK---NCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNA  207 (311)
T ss_dssp             ---------CCCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSS
T ss_pred             ccccccccccCCCHHHHHHHHHHHHHHHHHHHhC---CeeecccccccccccccCcccccccchheeccCCCcceEeeec
Confidence                   122378899999999999999999999   99999999999999999999999999998664321    2456


Q ss_pred             cccccccCcceecCCcceeccCC
Q 046065          142 QIELGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       142 ~~~~~~~aPE~~~~~~~~~~~Di  164 (164)
                      .||+.|+|||++.+..++.++||
T Consensus       208 ~gt~~y~aPE~~~~~~~~~~~DI  230 (311)
T d1t46a_         208 RLPVKWMAPESIFNCVYTFESDV  230 (311)
T ss_dssp             EECGGGCCHHHHHHCCCCHHHHH
T ss_pred             ccChHHcCHHHhcCCCCCCcccc
Confidence            78999999999998999999986

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=4.5e-33  Score=197.40  Aligned_cols=156  Identities=24%  Similarity=0.377  Sum_probs=131.2

Q ss_pred             CcEEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcc-------cccc
Q 046065            6 GQIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPI-------RMLI   76 (164)
Q Consensus         6 ~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~-------~~~~   76 (164)
                      +..||||.+... .......+.+|+.+++.++||||+++ +.+......++|||++++|+|.+++....       ....
T Consensus        50 ~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~  129 (308)
T d1p4oa_          50 ETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP  129 (308)
T ss_dssp             EEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCC
T ss_pred             CcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCC
Confidence            568999998754 23334568899999999999999998 77777888999999999999998886421       1123


Q ss_pred             cCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh----hhhhcccccccCcce
Q 046065           77 LDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI----LKQIQIELGYIPPEY  152 (164)
Q Consensus        77 ~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~aPE~  152 (164)
                      ++...+..++.|++.||.|||+.   +|+||||||+|||++.++.+||+|||++.......    .....+++.|+|||.
T Consensus       130 ~~~~~~~~i~~~ia~gl~~LH~~---~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~  206 (308)
T d1p4oa_         130 PSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPES  206 (308)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHT---TCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHH
T ss_pred             CCHHHHHHHHHHHHHHHHHHhhC---CeeeceEcCCceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHH
Confidence            67788899999999999999998   99999999999999999999999999998765432    234568999999999


Q ss_pred             ecCCcceeccCC
Q 046065          153 VGRGVYYKKFSL  164 (164)
Q Consensus       153 ~~~~~~~~~~Di  164 (164)
                      +.++.++.++||
T Consensus       207 l~~~~~~~~~Dv  218 (308)
T d1p4oa_         207 LKDGVFTTYSDV  218 (308)
T ss_dssp             HHHCCCCHHHHH
T ss_pred             HccCCCCccccc
Confidence            999999999985

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=99.98  E-value=9.1e-33  Score=193.99  Aligned_cols=155  Identities=21%  Similarity=0.331  Sum_probs=126.7

Q ss_pred             CCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            4 PDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         4 ~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      .+|+.||||.+...  .......+.+|+.+++.++||||+++ ..+...+..++++|++.++.+..+.....   .+++.
T Consensus        24 ~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~~~---~l~~~  100 (286)
T d1ob3a_          24 NYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG---GLESV  100 (286)
T ss_dssp             TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTSTT---CCCHH
T ss_pred             CCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHhhcC---Ccchh
Confidence            46899999998655  23345778999999999999999998 77777888999999998766666654432   38999


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh--hhhhhcccccccCcceecCCc-
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM--ILKQIQIELGYIPPEYVGRGV-  157 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~-  157 (164)
                      .+..++.|++.||.|+|++   +|+||||||+|||++.++.+|++|||.+......  ......+++.|+|||.+.+.. 
T Consensus       101 ~~~~i~~qi~~~L~~LH~~---~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~  177 (286)
T d1ob3a_         101 TAKSFLLQLLNGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKK  177 (286)
T ss_dssp             HHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCS
T ss_pred             hhHHHHHHHHHHHHHhccC---cEEecCCCCceeeEcCCCCEEecccccceecccCccccceecccchhhhHHHHhCCCC
Confidence            9999999999999999998   9999999999999999999999999999776432  224457899999999997654 


Q ss_pred             ceeccCC
Q 046065          158 YYKKFSL  164 (164)
Q Consensus       158 ~~~~~Di  164 (164)
                      ++.++||
T Consensus       178 ~~~~~Di  184 (286)
T d1ob3a_         178 YSTTIDI  184 (286)
T ss_dssp             CCTHHHH
T ss_pred             CCcceee
Confidence            5888885

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.1e-32  Score=194.90  Aligned_cols=153  Identities=24%  Similarity=0.286  Sum_probs=119.9

Q ss_pred             CCcEEEEEEccccccccHHHHHH--HHHHHhccCCCceeeE-eEEeeCC----cEEEEEEecCCCChhhhhhCccccccc
Q 046065            5 DGQIIAVKKLSKKSTQGFEEFKN--EVMLTAKLQHLNLIRV-GFCIETQ----EYMLIYEYMPKRSLDYFLFDPIRMLIL   77 (164)
Q Consensus         5 ~~~~vavK~~~~~~~~~~~~~~~--e~~~l~~l~h~~i~~~-~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~~   77 (164)
                      +|+.||||.+..+..   ..+..  |+..+..++||||+++ +.+...+    ..++||||+++|+|.+++.+.    .+
T Consensus        25 ~g~~vAvK~~~~~~~---~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~----~l   97 (303)
T d1vjya_          25 RGEEVAVKIFSSREE---RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY----TV   97 (303)
T ss_dssp             TTEEEEEEEECGGGH---HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC----CB
T ss_pred             CCEEEEEEEECccch---hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhcC----CC
Confidence            578999999864422   23334  4455567799999997 6665443    478999999999999999753    28


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhc-----CCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh------hhhhhccccc
Q 046065           78 DCKKRVHIIKGIIQGLLYLQEY-----FRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM------ILKQIQIELG  146 (164)
Q Consensus        78 ~~~~~~~~~~~~~~~l~~lh~~-----~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~------~~~~~~~~~~  146 (164)
                      ++.....++.+++.|+.|+|+.     +.++|+||||||+|||++.++.+||+|||+++.....      ......||+.
T Consensus        98 ~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~  177 (303)
T d1vjya_          98 TVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR  177 (303)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGG
T ss_pred             CHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccC
Confidence            8899999999999999999973     2359999999999999999999999999999766432      1245679999


Q ss_pred             ccCcceecCC------cceeccCC
Q 046065          147 YIPPEYVGRG------VYYKKFSL  164 (164)
Q Consensus       147 ~~aPE~~~~~------~~~~~~Di  164 (164)
                      |+|||++...      .++.|+||
T Consensus       178 y~aPE~~~~~~~~~~~~~~~k~Di  201 (303)
T d1vjya_         178 YMAPEVLDDSINMKHFESFKRADI  201 (303)
T ss_dssp             GCCHHHHTTCSCTTCHHHHHHHHH
T ss_pred             cCChhhccccccccCCCcCcchhh
Confidence            9999998654      36778885

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.2e-32  Score=194.96  Aligned_cols=155  Identities=26%  Similarity=0.411  Sum_probs=123.2

Q ss_pred             CCcEEEEEEcccc--ccccHHHHHHHHHHHhcc---CCCceeeE-eEEee-----CCcEEEEEEecCCCChhhhhhCccc
Q 046065            5 DGQIIAVKKLSKK--STQGFEEFKNEVMLTAKL---QHLNLIRV-GFCIE-----TQEYMLIYEYMPKRSLDYFLFDPIR   73 (164)
Q Consensus         5 ~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l---~h~~i~~~-~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~   73 (164)
                      +++.||||.+..+  .......+.+|+.+++.+   +||||+++ +.+..     ....++++|++.++.+.......  
T Consensus        32 ~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~--  109 (305)
T d1blxa_          32 GGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVP--  109 (305)
T ss_dssp             TTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSC--
T ss_pred             CCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhcc--
Confidence            3667999998654  222334566788777666   79999997 55432     23578999999887765444332  


Q ss_pred             ccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh-hhhhhhcccccccCcce
Q 046065           74 MLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK-MILKQIQIELGYIPPEY  152 (164)
Q Consensus        74 ~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~aPE~  152 (164)
                      ...+++.....++.|++.||.|||++   +|+||||||+|||++..+.+||+|||++..... .......||+.|+|||+
T Consensus       110 ~~~~~~~~~~~~~~qi~~aL~yLH~~---~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~  186 (305)
T d1blxa_         110 EPGVPTETIKDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV  186 (305)
T ss_dssp             TTCSCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHH
T ss_pred             CCCCCHHHHHHHHHHHHHHHHHHHhC---CEEecCCCccEEEEcCCCCeeecchhhhhhhcccccCCCcccChhhcCcch
Confidence            22388999999999999999999998   999999999999999999999999999876543 33467789999999999


Q ss_pred             ecCCcceeccCC
Q 046065          153 VGRGVYYKKFSL  164 (164)
Q Consensus       153 ~~~~~~~~~~Di  164 (164)
                      +.+..|+.++||
T Consensus       187 ~~~~~y~~~~Di  198 (305)
T d1blxa_         187 LLQSSYATPVDL  198 (305)
T ss_dssp             HTTCCCCTHHHH
T ss_pred             hcCCCCChhehh
Confidence            999999999996

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=4.7e-32  Score=194.84  Aligned_cols=155  Identities=25%  Similarity=0.319  Sum_probs=125.2

Q ss_pred             cCCCcEEEEEEcccc-ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCC----cEEEEEEecCCCChhhhhhCcccccc
Q 046065            3 LPDGQIIAVKKLSKK-STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQ----EYMLIYEYMPKRSLDYFLFDPIRMLI   76 (164)
Q Consensus         3 ~~~~~~vavK~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~----~~~lv~e~~~~~~L~~~~~~~~~~~~   76 (164)
                      ..+|+.||||.+.+. .......+.+|+.+++.++||||+++ ..+....    ..+++++++.+++|.+++...    .
T Consensus        30 ~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l~~~----~  105 (345)
T d1pmea_          30 NVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQ----H  105 (345)
T ss_dssp             TTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHHHHC----C
T ss_pred             CCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhhhcC----C
Confidence            357899999998754 33345678899999999999999997 5554332    234556677799999998643    2


Q ss_pred             cCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhh-----hhhhcccccccCcc
Q 046065           77 LDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMI-----LKQIQIELGYIPPE  151 (164)
Q Consensus        77 ~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~aPE  151 (164)
                      +++..+..++.|++.||.|||++   +|+||||||+|||++.++.+||+|||++.......     ....+||+.|+|||
T Consensus       106 l~~~~i~~i~~qil~al~yLH~~---~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE  182 (345)
T d1pmea_         106 LSNDHICYFLYQILRGLKYIHSA---NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE  182 (345)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGG
T ss_pred             CCHHHHHHHHHHHHHHHHHHHHC---CCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeeccccccceechHH
Confidence            89999999999999999999998   99999999999999999999999999997654321     24567899999999


Q ss_pred             eecCC-cceeccCC
Q 046065          152 YVGRG-VYYKKFSL  164 (164)
Q Consensus       152 ~~~~~-~~~~~~Di  164 (164)
                      ++... .++.++||
T Consensus       183 ~l~~~~~~~~~~Di  196 (345)
T d1pmea_         183 IMLNSKGYTKSIDI  196 (345)
T ss_dssp             GTTTBCSCSTHHHH
T ss_pred             HhhcCCCCCchhhh
Confidence            98444 56888885

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=99.97  E-value=1.4e-31  Score=191.16  Aligned_cols=149  Identities=19%  Similarity=0.287  Sum_probs=123.7

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccC-CCceeeE-eEEee--CCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQ-HLNLIRV-GFCIE--TQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~-~~~~~--~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      .+|+.||||.+...   ..+.+.+|+.+++.+. ||||+++ ..+..  ....++|||++++++|....+.      +++
T Consensus        58 ~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~------l~e  128 (328)
T d3bqca1          58 TNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT------LTD  128 (328)
T ss_dssp             TTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTTTS------CCH
T ss_pred             CCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHhcC------CCH
Confidence            57899999998643   3467889999999995 9999998 55443  3458899999999999776432      889


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCC-CeEEccccchhhhhhh-hhhhhcccccccCcceecCCc
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL-KPKISDFGLARILRKM-ILKQIQIELGYIPPEYVGRGV  157 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~-~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~  157 (164)
                      ..+..++.|++.||.|||++   +|+||||||+|||++..+ .++|+|||++...... ......+|+.|+|||.+.+..
T Consensus       129 ~~i~~i~~qil~aL~~LH~~---gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~  205 (328)
T d3bqca1         129 YDIRFYMYEILKALDYCHSM---GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ  205 (328)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCC
T ss_pred             HHHHHHHHHHHHHHHHHhhc---ccccccccccceEEcCCCCeeeecccccceeccCCCcccccccCccccCcccccCCC
Confidence            99999999999999999999   999999999999998755 6899999999876543 345677899999999987654


Q ss_pred             -ceeccCC
Q 046065          158 -YYKKFSL  164 (164)
Q Consensus       158 -~~~~~Di  164 (164)
                       ++.++||
T Consensus       206 ~~~~~~Di  213 (328)
T d3bqca1         206 MYDYSLDM  213 (328)
T ss_dssp             CCCTHHHH
T ss_pred             CCCcccch
Confidence             6888885

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=8.5e-32  Score=193.85  Aligned_cols=154  Identities=24%  Similarity=0.336  Sum_probs=120.3

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceeeE-eEEeeCC------cEEEEEEecCCCChhhhhhCcccccc
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQ------EYMLIYEYMPKRSLDYFLFDPIRMLI   76 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~~~   76 (164)
                      .+|+.||||.+..+...    ..+|+.+++.++||||+++ +.+....      ..++||||++++.+..+.........
T Consensus        43 ~~~~~vAiK~i~~~~~~----~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~  118 (350)
T d1q5ka_          43 DSGELVAIKKVLQDKRF----KNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQT  118 (350)
T ss_dssp             TTCCEEEEEEEECCSSS----CCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCC
T ss_pred             CCCCEEEEEEECccchH----HHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCC
Confidence            57899999998655322    2469999999999999997 5554321      26799999986544333322222334


Q ss_pred             cCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCC-CeEEccccchhhhhh-hhhhhhcccccccCcceec
Q 046065           77 LDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDL-KPKISDFGLARILRK-MILKQIQIELGYIPPEYVG  154 (164)
Q Consensus        77 ~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~-~~~l~dfg~~~~~~~-~~~~~~~~~~~~~aPE~~~  154 (164)
                      +++..+..++.|++.||.|||++   +|+||||||+|||++.++ .+||+|||++..... .......|++.|+|||.+.
T Consensus       119 l~~~~~~~i~~qil~aL~yLH~~---~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~  195 (350)
T d1q5ka_         119 LPVIYVKLYMYQLFRSLAYIHSF---GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIF  195 (350)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHT
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhc---CCcccCCCcceEEEecCCCceeEecccchhhccCCcccccccccccccChHHhh
Confidence            89999999999999999999998   999999999999999775 899999999976643 3345678999999999886


Q ss_pred             C-CcceeccCC
Q 046065          155 R-GVYYKKFSL  164 (164)
Q Consensus       155 ~-~~~~~~~Di  164 (164)
                      + ..|+.++||
T Consensus       196 ~~~~~~~~~DI  206 (350)
T d1q5ka_         196 GATDYTSSIDV  206 (350)
T ss_dssp             TCSSCCTHHHH
T ss_pred             cccCCCcceee
Confidence            5 468999885

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.2e-31  Score=192.72  Aligned_cols=152  Identities=26%  Similarity=0.391  Sum_probs=125.4

Q ss_pred             CCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCC------cEEEEEEecCCCChhhhhhCcccc
Q 046065            4 PDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQ------EYMLIYEYMPKRSLDYFLFDPIRM   74 (164)
Q Consensus         4 ~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~------~~~lv~e~~~~~~L~~~~~~~~~~   74 (164)
                      .+|+.||||.+...  .....+.+.+|+.+|+.++||||+++ +.+...+      .+++|||++ +.+|..+....   
T Consensus        41 ~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~---  116 (346)
T d1cm8a_          41 RTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKHE---  116 (346)
T ss_dssp             TTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHHC---
T ss_pred             CCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHHHhc---
Confidence            57899999999754  33345678899999999999999998 5555433      468999999 45677666432   


Q ss_pred             cccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCcceec
Q 046065           75 LILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVG  154 (164)
Q Consensus        75 ~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~  154 (164)
                       .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.++++|||++...... .....||+.|+|||++.
T Consensus       117 -~l~~~~~~~~~~qi~~aL~~LH~~---~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~-~~~~~~t~~y~aPE~~~  191 (346)
T d1cm8a_         117 -KLGEDRIQFLVYQMLKGLRYIHAA---GIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-MTGYVVTRWYRAPEVIL  191 (346)
T ss_dssp             -CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTCCEEECCCTTCEECCSS-CCSSCSCGGGCCTHHHH
T ss_pred             -cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCcchhhcccccccccccccceeccCCc-cccccccccccCHHHHc
Confidence             289999999999999999999998   9999999999999999999999999999765432 35577899999999986


Q ss_pred             CC-cceeccCC
Q 046065          155 RG-VYYKKFSL  164 (164)
Q Consensus       155 ~~-~~~~~~Di  164 (164)
                      +. .++.++||
T Consensus       192 ~~~~~~~~~Di  202 (346)
T d1cm8a_         192 NWMRYTQTVDI  202 (346)
T ss_dssp             TTTCCCTTHHH
T ss_pred             CCCCCCccchh
Confidence            65 45888885

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.9e-31  Score=189.67  Aligned_cols=155  Identities=23%  Similarity=0.366  Sum_probs=121.8

Q ss_pred             CCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEee--------CCcEEEEEEecCCCChhhhhhCcc
Q 046065            4 PDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIE--------TQEYMLIYEYMPKRSLDYFLFDPI   72 (164)
Q Consensus         4 ~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~--------~~~~~lv~e~~~~~~L~~~~~~~~   72 (164)
                      .+|+.||||.+...  .......+.+|+.+++.++|||++++ ..+..        .+..++|||++.++.+........
T Consensus        33 ~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~  112 (318)
T d3blha1          33 KTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV  112 (318)
T ss_dssp             TTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTCTTC
T ss_pred             CCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhhccc
Confidence            57899999998655  33345678899999999999999997 44433        235789999998766654443322


Q ss_pred             cccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh------hhhhhccccc
Q 046065           73 RMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM------ILKQIQIELG  146 (164)
Q Consensus        73 ~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~------~~~~~~~~~~  146 (164)
                         .+++...+.++.|++.||.|+|++   +|+||||||+||+++.++.++++|||++..+...      .....+||+.
T Consensus       113 ---~~~~~~~~~i~~qil~~l~~lH~~---~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~  186 (318)
T d3blha1         113 ---KFTLSEIKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW  186 (318)
T ss_dssp             ---CCCHHHHHHHHHHHHHHHHHHHHT---TEECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGG
T ss_pred             ---ccccHHHHHHHHHHHHHHHHhccC---CEEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHH
Confidence               388899999999999999999998   9999999999999999999999999999755421      1234579999


Q ss_pred             ccCcceecCC-cceeccCC
Q 046065          147 YIPPEYVGRG-VYYKKFSL  164 (164)
Q Consensus       147 ~~aPE~~~~~-~~~~~~Di  164 (164)
                      |+|||++.+. .|+.++||
T Consensus       187 Y~aPE~~~~~~~~~~k~Di  205 (318)
T d3blha1         187 YRPPELLLGERDYGPPIDL  205 (318)
T ss_dssp             GCCHHHHTTCSSCCTHHHH
T ss_pred             HhhHHHHcCCCCCCcHHHc
Confidence            9999998655 57899885

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.97  E-value=3.2e-31  Score=186.63  Aligned_cols=154  Identities=19%  Similarity=0.199  Sum_probs=125.3

Q ss_pred             cCCCcEEEEEEccccccccHHHHHHHHHHHhccCC-CceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCHH
Q 046065            3 LPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQH-LNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCK   80 (164)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h-~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~   80 (164)
                      ..+|+.||||.+.....  ...+.+|++.++.+.| +|++.+ .........++|||++ +++|.+++.....  .++..
T Consensus        27 ~~~~~~vAvK~~~~~~~--~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~~~~--~~~~~  101 (293)
T d1csna_          27 LLNNQQVAIKFEPRRSD--APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGR--KFSVK  101 (293)
T ss_dssp             TTTTEEEEEEEEECCTT--SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTT--CCCHH
T ss_pred             CCCCCEEEEEEEccccC--cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHhhcc--chhhH
Confidence            35789999999865422  2346788999999965 888887 6666777889999998 6799888765332  38889


Q ss_pred             HHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecC-----CCCeEEccccchhhhhhh---------hhhhhccccc
Q 046065           81 KRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE-----DLKPKISDFGLARILRKM---------ILKQIQIELG  146 (164)
Q Consensus        81 ~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~-----~~~~~l~dfg~~~~~~~~---------~~~~~~~~~~  146 (164)
                      ....++.|++.||.|+|++   +|+||||||+||+++.     .+.++|+|||+++.+...         ......||+.
T Consensus       102 ~~~~i~~q~~~~l~~lH~~---giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~  178 (293)
T d1csna_         102 TVAMAAKQMLARVQSIHEK---SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTAR  178 (293)
T ss_dssp             HHHHHHHHHHHHHHHHHTT---TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTT
T ss_pred             HHHHHHHHHHHHHHHHHHC---CceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchh
Confidence            9999999999999999998   9999999999999974     567999999999765422         1234679999


Q ss_pred             ccCcceecCCcceeccCC
Q 046065          147 YIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       147 ~~aPE~~~~~~~~~~~Di  164 (164)
                      |||||++.+..++.++||
T Consensus       179 y~aPE~~~~~~~~~~~Di  196 (293)
T d1csna_         179 YMSINTHLGREQSRRDDL  196 (293)
T ss_dssp             TCCHHHHTTCCCCHHHHH
T ss_pred             hcCHHHhcCCCCChHHHH
Confidence            999999999999999996

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.2e-31  Score=190.89  Aligned_cols=155  Identities=23%  Similarity=0.280  Sum_probs=128.7

Q ss_pred             CCCcEEEEEEcccc----ccccHHHHHHHHHHHhccCC-CceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCccccccc
Q 046065            4 PDGQIIAVKKLSKK----STQGFEEFKNEVMLTAKLQH-LNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLIL   77 (164)
Q Consensus         4 ~~~~~vavK~~~~~----~~~~~~~~~~e~~~l~~l~h-~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~   77 (164)
                      .+|+.||||.+...    .....+.+.+|+.++++++| |||+++ ..+......++++|++.+++|.+++.....   +
T Consensus        50 ~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~---~  126 (322)
T d1vzoa_          50 DTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER---F  126 (322)
T ss_dssp             TTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSC---C
T ss_pred             CCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHHhccc---c
Confidence            36889999998654    22345677899999999976 899998 666777889999999999999998876443   7


Q ss_pred             CHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhh---hhhhhhcccccccCcceec
Q 046065           78 DCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRK---MILKQIQIELGYIPPEYVG  154 (164)
Q Consensus        78 ~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~---~~~~~~~~~~~~~aPE~~~  154 (164)
                      ++.....++.|++.|+.|+|++   +++||||||+||+++.++.++|+|||++..+..   .......|++.|+|||.+.
T Consensus       127 ~e~~~~~~~~Qi~~al~~lH~~---~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~  203 (322)
T d1vzoa_         127 TEHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVR  203 (322)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHT
T ss_pred             cHHHHHHHHHHHHHHHHHhhcC---CEEeccCCccceeecCCCCEEEeeccchhhhcccccccccccccccccchhHHhh
Confidence            7889999999999999999998   999999999999999999999999999976543   2234577999999999996


Q ss_pred             CC--cceeccCC
Q 046065          155 RG--VYYKKFSL  164 (164)
Q Consensus       155 ~~--~~~~~~Di  164 (164)
                      +.  .++.++||
T Consensus       204 ~~~~~~~~ksDI  215 (322)
T d1vzoa_         204 GGDSGHDKAVDW  215 (322)
T ss_dssp             TCC---CTHHHH
T ss_pred             cCCcCCCchhhh
Confidence            54  45778886

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=6.6e-31  Score=184.76  Aligned_cols=156  Identities=22%  Similarity=0.352  Sum_probs=130.9

Q ss_pred             cCCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEeeCCcEEEEEEecCCCChhhhhhCcccccccCH
Q 046065            3 LPDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIETQEYMLIYEYMPKRSLDYFLFDPIRMLILDC   79 (164)
Q Consensus         3 ~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~   79 (164)
                      ..+++.||||.+...  .+.....+.+|+.+++.++||||+++ ..+......++++|++.++++..+......   +++
T Consensus        24 ~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~~~~---~~~  100 (292)
T d1unla_          24 RETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGD---LDP  100 (292)
T ss_dssp             TTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHTTTC---CCH
T ss_pred             CCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeeccccccccccccccc---cch
Confidence            357899999998654  33446788999999999999999998 777777788999999999888877765433   788


Q ss_pred             HHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh--hhhhhcccccccCcceecCCc
Q 046065           80 KKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM--ILKQIQIELGYIPPEYVGRGV  157 (164)
Q Consensus        80 ~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~~~~aPE~~~~~~  157 (164)
                      ..+..++.|++.||.|+|++   +|+||||||+||+++.++.+|++|||.+......  ......+++.|+|||.+....
T Consensus       101 ~~~~~~~~q~~~aL~~lH~~---~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~  177 (292)
T d1unla_         101 EIVKSFLFQLLKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAK  177 (292)
T ss_dssp             HHHHHHHHHHHHHHHHHHHT---TEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCS
T ss_pred             hHHHHHHHHHHHHHHHhhcC---CEeeecccCcccccccCCceeeeecchhhcccCCCccceeeccccchhhhhHhccCC
Confidence            99999999999999999998   9999999999999999999999999999765432  224456788899999987665


Q ss_pred             -ceeccCC
Q 046065          158 -YYKKFSL  164 (164)
Q Consensus       158 -~~~~~Di  164 (164)
                       ++.++||
T Consensus       178 ~~~~~~Di  185 (292)
T d1unla_         178 LYSTSIDM  185 (292)
T ss_dssp             CCCTHHHH
T ss_pred             CCCchhhc
Confidence             5888885

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=5.8e-31  Score=189.78  Aligned_cols=152  Identities=27%  Similarity=0.333  Sum_probs=118.0

Q ss_pred             CCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEee------CCcEEEEEEecCCCChhhhhhCcccc
Q 046065            4 PDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIE------TQEYMLIYEYMPKRSLDYFLFDPIRM   74 (164)
Q Consensus         4 ~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~------~~~~~lv~e~~~~~~L~~~~~~~~~~   74 (164)
                      .+|+.||||.+...  .......+.+|+.+++.++||||+++ ..+..      ....|+||||+.++.+..+ ..    
T Consensus        40 ~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~~~-~~----  114 (355)
T d2b1pa1          40 VLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI-QM----  114 (355)
T ss_dssp             TTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHHH-TS----
T ss_pred             CCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccchHHHHhh-hc----
Confidence            57899999998754  23345678899999999999999997 55532      3468899999976555443 22    


Q ss_pred             cccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhh-hhhhhcccccccCccee
Q 046065           75 LILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKM-ILKQIQIELGYIPPEYV  153 (164)
Q Consensus        75 ~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~  153 (164)
                       .+++..+..++.|++.|+.|||++   +|+||||||+|||++.++.++++|||+++..... ......+|+.|+|||++
T Consensus       115 -~~~~~~i~~~~~qil~gl~~LH~~---giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l  190 (355)
T d2b1pa1         115 -ELDHERMSYLLYQMLCGIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI  190 (355)
T ss_dssp             -CCCHHHHHHHHHHHHHHHHHHHHT---TCCCSCCCGGGEEECTTCCEEECCCCC---------------CCTTCCHHHH
T ss_pred             -CCCHHHHHHHHHHHHHHHHHhhhc---ccccccCCccccccccccceeeechhhhhccccccccccccccccccChhhh
Confidence             288999999999999999999999   9999999999999999999999999998765433 33566789999999999


Q ss_pred             cCCcceeccCC
Q 046065          154 GRGVYYKKFSL  164 (164)
Q Consensus       154 ~~~~~~~~~Di  164 (164)
                      .+..++.++||
T Consensus       191 ~~~~~~~~~Di  201 (355)
T d2b1pa1         191 LGMGYKENVDI  201 (355)
T ss_dssp             TTCCCCTTHHH
T ss_pred             cCCCCCCCccc
Confidence            98899999985

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.96  E-value=1.9e-30  Score=183.15  Aligned_cols=153  Identities=21%  Similarity=0.210  Sum_probs=120.0

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccCCCceee-EeEE-eeCCcEEEEEEecCCCChhhhhhCcccccccCHHH
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFC-IETQEYMLIYEYMPKRSLDYFLFDPIRMLILDCKK   81 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~-~~~~-~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~   81 (164)
                      .+|+.||||.+..+..  ...+..|+++++.++|+|++. +..+ ......++|||+++ +++...+....  ..++...
T Consensus        30 ~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~-~~l~~~~~~~~--~~~~~~~  104 (299)
T d1ckia_          30 AAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG-PSLEDLFNFCS--RKFSLKT  104 (299)
T ss_dssp             TTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTT--TCCCHHH
T ss_pred             CCCCEEEEEEEchhcc--CHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcC-Cchhhhhhhcc--CCCcHHH
Confidence            5688999999765422  235788999999998766555 5444 55567789999885 56655544322  2388999


Q ss_pred             HHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecC---CCCeEEccccchhhhhhhh---------hhhhcccccccC
Q 046065           82 RVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDE---DLKPKISDFGLARILRKMI---------LKQIQIELGYIP  149 (164)
Q Consensus        82 ~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~---~~~~~l~dfg~~~~~~~~~---------~~~~~~~~~~~a  149 (164)
                      +..++.|++.||.|+|++   +|+||||||+||+++.   +..++++|||+++.+....         .....||+.|+|
T Consensus       105 ~~~~~~qi~~~l~~lH~~---~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~a  181 (299)
T d1ckia_         105 VLLLADQMISRIEYIHSK---NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS  181 (299)
T ss_dssp             HHHHHHHHHHHHHHHHHT---TEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCC
T ss_pred             HHHHHHHHHHHHHHHHHC---CeeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccC
Confidence            999999999999999998   9999999999999864   4579999999998764321         234679999999


Q ss_pred             cceecCCcceeccCC
Q 046065          150 PEYVGRGVYYKKFSL  164 (164)
Q Consensus       150 PE~~~~~~~~~~~Di  164 (164)
                      ||.+.+..++.++||
T Consensus       182 PE~~~~~~~~~~~Di  196 (299)
T d1ckia_         182 INTHLGIEQSRRDDL  196 (299)
T ss_dssp             HHHHTTBCCCHHHHH
T ss_pred             HHHHhCCCCCChhhE
Confidence            999999999999996

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=4.1e-30  Score=184.82  Aligned_cols=154  Identities=28%  Similarity=0.334  Sum_probs=122.3

Q ss_pred             cCCCcEEEEEEcccc--ccccHHHHHHHHHHHhccCCCceeeE-eEEee-----CCcEEEEEEecCCCChhhhhhCcccc
Q 046065            3 LPDGQIIAVKKLSKK--STQGFEEFKNEVMLTAKLQHLNLIRV-GFCIE-----TQEYMLIYEYMPKRSLDYFLFDPIRM   74 (164)
Q Consensus         3 ~~~~~~vavK~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~-~~~~~-----~~~~~lv~e~~~~~~L~~~~~~~~~~   74 (164)
                      ..+|+.||||.+...  .......+.+|+.+++.++|||++++ ..+..     ....+++++++.+|+|.+++...   
T Consensus        40 ~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~~~---  116 (348)
T d2gfsa1          40 TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ---  116 (348)
T ss_dssp             TTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHTTC---
T ss_pred             CCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhcccc---
Confidence            367899999999755  23344578899999999999999998 44432     22346677888899999988643   


Q ss_pred             cccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhhhhhhhhhhcccccccCcceec
Q 046065           75 LILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARILRKMILKQIQIELGYIPPEYVG  154 (164)
Q Consensus        75 ~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~aPE~~~  154 (164)
                       .+++..+..++.|++.||.|||++   +|+||||||+|||++.++.++++|||++..... ......|++.|+|||...
T Consensus       117 -~l~e~~~~~i~~qil~aL~~LH~~---giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~-~~~~~~g~~~y~apE~~~  191 (348)
T d2gfsa1         117 -KLTDDHVQFLIYQILRGLKYIHSA---DIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-EMTGYVATRWYRAPEIML  191 (348)
T ss_dssp             -CCCHHHHHHHHHHHHHHHHHHHHT---TCCCCCCCGGGEEECTTCCEEECCC----CCTG-GGSSSCHHHHTSCHHHHT
T ss_pred             -cccHHHHHHHHHHHHHHHHHHHhC---CCcccccCCccccccccccccccccchhcccCc-ccccccccccccCchhhc
Confidence             289999999999999999999998   999999999999999999999999999865543 234567889999999876


Q ss_pred             CCc-ceeccCC
Q 046065          155 RGV-YYKKFSL  164 (164)
Q Consensus       155 ~~~-~~~~~Di  164 (164)
                      +.. ++.++||
T Consensus       192 ~~~~~~~~~Di  202 (348)
T d2gfsa1         192 NWMHYNQTVDI  202 (348)
T ss_dssp             TCSCCCTTHHH
T ss_pred             CCccCCcccch
Confidence            665 4788885

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.91  E-value=4.5e-25  Score=158.98  Aligned_cols=157  Identities=17%  Similarity=0.162  Sum_probs=116.3

Q ss_pred             cCCCcEEEEEEccccccccHHHHHHHHHHHhccC-----------CCceeeE-eEEee--CCcEEEEEEecCCCChhhhh
Q 046065            3 LPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQ-----------HLNLIRV-GFCIE--TQEYMLIYEYMPKRSLDYFL   68 (164)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-----------h~~i~~~-~~~~~--~~~~~lv~e~~~~~~L~~~~   68 (164)
                      ..+|+.||||.+..+ ....+.+.+|+.+++.++           |+||+++ ..+..  ....+++++++.........
T Consensus        35 ~~~g~~vAvKvi~~~-~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  113 (362)
T d1q8ya_          35 MVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLAL  113 (362)
T ss_dssp             TTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHH
T ss_pred             CCCCCEEEEEEEecc-ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeecccccccccc
Confidence            367899999998644 223456678888887775           4778886 44433  24456777776554433332


Q ss_pred             hCcccccccCHHHHHHHHHHHHHHHHHhhh-cCCCCeeeCCCCCCceeecCCC------CeEEccccchhhhhhhhhhhh
Q 046065           69 FDPIRMLILDCKKRVHIIKGIIQGLLYLQE-YFRLTIIHRDLKVSNILLDEDL------KPKISDFGLARILRKMILKQI  141 (164)
Q Consensus        69 ~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~-~~~~~iih~dlk~~nili~~~~------~~~l~dfg~~~~~~~~~~~~~  141 (164)
                      ........+++..+..++.|++.|+.|+|+ .   +|+||||||+|||++..+      .++++|||.+..... .....
T Consensus       114 ~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~---~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~-~~~~~  189 (362)
T d1q8ya_         114 IKKYEHRGIPLIYVKQISKQLLLGLDYMHRRC---GIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE-HYTNS  189 (362)
T ss_dssp             HHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB-CCCSC
T ss_pred             cccccccCCcHHHHHHHHHHHHHHHHHHhhhc---CcccccCChhHeeeeccCcccccceeeEeeccccccccc-ccccc
Confidence            222223347889999999999999999997 5   899999999999997654      389999999865432 23556


Q ss_pred             cccccccCcceecCCcceeccCC
Q 046065          142 QIELGYIPPEYVGRGVYYKKFSL  164 (164)
Q Consensus       142 ~~~~~~~aPE~~~~~~~~~~~Di  164 (164)
                      .||+.|+|||++....|+.++||
T Consensus       190 ~gt~~y~aPE~~~~~~~~~~~Di  212 (362)
T d1q8ya_         190 IQTREYRSPEVLLGAPWGCGADI  212 (362)
T ss_dssp             CSCGGGCCHHHHHTCCCCTHHHH
T ss_pred             cccccccChhhccccCCCccccc
Confidence            79999999999999999999985

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.78  E-value=6.5e-19  Score=116.10  Aligned_cols=114  Identities=20%  Similarity=0.161  Sum_probs=83.7

Q ss_pred             cCCCcEEEEEEcccccc--------------c----cHHHHHHHHHHHhccCCCceeeEeEEeeCCcEEEEEEecCCCCh
Q 046065            3 LPDGQIIAVKKLSKKST--------------Q----GFEEFKNEVMLTAKLQHLNLIRVGFCIETQEYMLIYEYMPKRSL   64 (164)
Q Consensus         3 ~~~~~~vavK~~~~~~~--------------~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L   64 (164)
                      ..+|+.||||.+.....              .    .......|...+..+.|++++....+.   ..+++||++++..+
T Consensus        21 ~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~---~~~lvme~~~~~~~   97 (191)
T d1zara2          21 SEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE---GNAVLMELIDAKEL   97 (191)
T ss_dssp             ETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE---TTEEEEECCCCEEG
T ss_pred             CCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec---CCEEEEEeeccccc
Confidence            35789999998643200              0    012334577888889998887753222   23799999987554


Q ss_pred             hhhhhCcccccccCHHHHHHHHHHHHHHHHHhhhcCCCCeeeCCCCCCceeecCCCCeEEccccchhhh
Q 046065           65 DYFLFDPIRMLILDCKKRVHIIKGIIQGLLYLQEYFRLTIIHRDLKVSNILLDEDLKPKISDFGLARIL  133 (164)
Q Consensus        65 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~iih~dlk~~nili~~~~~~~l~dfg~~~~~  133 (164)
                      .+          ++......++.|++.++.++|.+   +++|+||||+|||++.++ ++|+|||.+...
T Consensus        98 ~~----------l~~~~~~~i~~ql~~~l~~lH~~---giiHrDiKP~NILv~~~~-~~liDFG~a~~~  152 (191)
T d1zara2          98 YR----------VRVENPDEVLDMILEEVAKFYHR---GIVHGDLSQYNVLVSEEG-IWIIDFPQSVEV  152 (191)
T ss_dssp             GG----------CCCSCHHHHHHHHHHHHHHHHHT---TEECSCCSTTSEEEETTE-EEECCCTTCEET
T ss_pred             cc----------hhhHHHHHHHHHHHHHHHHHhhC---CEEEccCChhheeeeCCC-EEEEECCCcccC
Confidence            33          34445567889999999999998   999999999999998655 899999988654

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.48  E-value=9e-07  Score=59.52  Aligned_cols=63  Identities=11%  Similarity=-0.007  Sum_probs=41.2

Q ss_pred             CCCcEEEEEEccccccccHHHHHHHHHHHhccC-CCceeeE-eEEeeCCcEEEEEEecCCCChhh
Q 046065            4 PDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQ-HLNLIRV-GFCIETQEYMLIYEYMPKRSLDY   66 (164)
Q Consensus         4 ~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~-~~~~~~~~~~lv~e~~~~~~L~~   66 (164)
                      .+++.+.+|............+..|...+..+. +--+.++ ......+..++||+++++.++..
T Consensus        35 ~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~   99 (263)
T d1j7la_          35 GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSE   99 (263)
T ss_dssp             CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHH
T ss_pred             eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccc
Confidence            345667888876554444445678888877763 3234444 44455677889999999877644

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.79  E-value=6.5e-05  Score=49.85  Aligned_cols=29  Identities=21%  Similarity=0.296  Sum_probs=25.1

Q ss_pred             CeeeCCCCCCceeecCCCCeEEccccchh
Q 046065          103 TIIHRDLKVSNILLDEDLKPKISDFGLAR  131 (164)
Q Consensus       103 ~iih~dlk~~nili~~~~~~~l~dfg~~~  131 (164)
                      .++|+|+.|.|+|++.+..+-|+||+.+.
T Consensus       176 ~liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         176 VVTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             EEECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             eEEeCCCCCcceEEeCCceEEEEEchhcc
Confidence            37999999999999877667799999875

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.38  E-value=0.00068  Score=48.01  Aligned_cols=29  Identities=34%  Similarity=0.398  Sum_probs=25.0

Q ss_pred             CCeeeCCCCCCceeecCCCCeEEccccchh
Q 046065          102 LTIIHRDLKVSNILLDEDLKPKISDFGLAR  131 (164)
Q Consensus       102 ~~iih~dlk~~nili~~~~~~~l~dfg~~~  131 (164)
                      ..++|+|+.|.|||++.++ ++++|+.++.
T Consensus       223 ~~LiHGDl~~gNIlv~~~~-~~vID~E~a~  251 (392)
T d2pula1         223 ETLIHGDLHTGSIFASEHE-TKVIDPEFAF  251 (392)
T ss_dssp             CEEECSCCCGGGEEECSSC-EEECCCTTCE
T ss_pred             cceeccCCcCCceeEcCCc-eEEechhhcc
Confidence            4689999999999998765 8999998864

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=96.37  E-value=0.019  Score=39.20  Aligned_cols=58  Identities=10%  Similarity=0.063  Sum_probs=35.0

Q ss_pred             cCCCcEEEEEEccccccccHHHHHHHHHHHhccCCCce--e---eE---eEEeeCCcEEEEEEecCC
Q 046065            3 LPDGQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNL--I---RV---GFCIETQEYMLIYEYMPK   61 (164)
Q Consensus         3 ~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i--~---~~---~~~~~~~~~~lv~e~~~~   61 (164)
                      +++|+.+++|+.... ......+..|...+..+...++  +   ..   ......+..+.++++++|
T Consensus        43 ~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G  108 (325)
T d1zyla1          43 DEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGG  108 (325)
T ss_dssp             CTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCC
T ss_pred             cCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCC
Confidence            568889999996432 2234557788887777732111  1   12   222344567788888875

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=96.26  E-value=0.014  Score=40.99  Aligned_cols=54  Identities=15%  Similarity=0.103  Sum_probs=29.6

Q ss_pred             CcEEEEEEccccccccHHHHHHHHHHHhccCCCceee-EeEEeeCCcEEEEEEecCCCCh
Q 046065            6 GQIIAVKKLSKKSTQGFEEFKNEVMLTAKLQHLNLIR-VGFCIETQEYMLIYEYMPKRSL   64 (164)
Q Consensus         6 ~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~-~~~~~~~~~~~lv~e~~~~~~L   64 (164)
                      ++.|.+++.- . ........+|..+++.+.-.++.. +.++..   -++|+||+++.++
T Consensus        74 ~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~---~g~I~efi~g~~l  128 (395)
T d1nw1a_          74 PNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFS---GGRLEEYIPSRPL  128 (395)
T ss_dssp             CSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEET---TEEEECCCCEEEC
T ss_pred             CCcEEEEecC-C-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcC---CceEEEEeccccC
Confidence            3456666643 2 222334567888888885334443 423322   2578898876443

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=95.55  E-value=0.0018  Score=44.18  Aligned_cols=31  Identities=29%  Similarity=0.322  Sum_probs=27.4

Q ss_pred             CCCeeeCCCCCCceeecCCCCeEEccccchh
Q 046065          101 RLTIIHRDLKVSNILLDEDLKPKISDFGLAR  131 (164)
Q Consensus       101 ~~~iih~dlk~~nili~~~~~~~l~dfg~~~  131 (164)
                      +.+++|+|+.+.|++++.+...-++||+.+.
T Consensus       182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccccccCCcchhhhhcccccceeEecccccc
Confidence            4579999999999999988777899999875